FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Barroso, RC
   Lopes, RT
   Goncalves, OD
   de Jesus, EFO
AF Barroso, RC
   Lopes, RT
   Goncalves, OD
   de Jesus, EFO
TI Angle-dispersive diffraction with synchrotron radiation at Laboratorio
   Nacional de Luz Sincrotron (Brazil): potential for use in biomedical
   imaging
SO APPLIED RADIATION AND ISOTOPES
LA English
DT Article; Proceedings Paper
CT 4th Topical Meeting on the Industrial Radiation and Radioisotope
   Measurement Applications (IRRMA 99)
CY OCT 03-07, 1999
CL RALEIGH, NORTH CAROLINA
SP Amer Nuclear Soc, Isotopes & Radiat Div, Amer Nuclear Soc, Eastern Carolinas Sect, N Carolina State Univ, Ctr Engn Applicat Radioisotopes, Quantum Res Serv Inc
DE synchrotron radiation; X-ray diffraction; computed tomography; medical
   imaging
ID RAY-SCATTERING; TOMOGRAPHY
AB At low angles the scattering of X-rays in the diagnostic energy range (low-momentum transfer), it is probable that the scattering interaction will be coherent, This coherence gives rise to interference effects resulting in X-ray diffraction patterns that are characteristic of the scattering material. The usefulness of coherent scattering is not limited to crystallography. It can provide information about biological material as well. The interatomic and intermolecular co-operative effects which modify the Free-atom coherent scattering process are well known for highly ordered structures such as crystalline materials but are important for amorphous solids and liquids where short-range ordering occurs.
   X-ray diffraction using synchrotron radiation has became a well established technique. This work introduces a non-destructive synchrotron radiation X-ray diffraction imaging technique. The feasibility of the X-ray diffraction computed microtomography using synchrotron radiation has been investigated. This research was carried out at the X-ray diffraction beam line of the National Synchrotron Light Laboratory supported by the National Council for Scientific and Technological Development (LNLS/CNPq) in Brazil.
   These experimental patterns were carried out with a 500 mu m slit in front of the detector and an 11.101 keV beam (lambda=1.117 Angstrom) monochromatic beam from the double crystal monochromator. The diffracted beam was detected by a fast scintillation detector (10(6) counts s(-1)) designed specifically to meet the needs of high quality X-ray diffraction and synchrotron radiation experiments. The data were recorded at rates of one second per degree of 2 theta (angular steps equal to 0.05 +/- 0.010) and registered by a multichannel analyzer.
   These experimental data could be used to evaluate the scattering properties of different tissue-substitute (water, lucite, nylon, plastic and polystyrene) and bone-substitute (hydroxyapatite and aluminum) materials. The data are in good agreement with those obtained by other authors, indicating the feasibility of the imaging technique. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Fed Rio de Janeiro, COPPE, Lab Instrumentacao Nucl, BR-21945970 Rio De Janeiro, Brazil.
   Univ Estado Rio de Janeiro, Inst Fis, Rio De Janeiro, Brazil.
RP Lopes, RT (reprint author), Univ Fed Rio de Janeiro, COPPE, Lab Instrumentacao Nucl, POB 68-509, BR-21945970 Rio De Janeiro, Brazil.
RI Goncalves, Odair/J-2457-2016
CR Barroso RC, 1998, NUCL INSTRUM METH A, V418, P458, DOI 10.1016/S0168-9002(98)00759-1
   Barroso RC, 1999, NUCL INSTRUM METH A, V422, P718, DOI 10.1016/S0168-9002(98)01024-9
   BRADLEY DA, 1989, MED PHYS, V16, P851, DOI 10.1118/1.596310
   CARLSSON CA, 1999, PHYS MED BIOL, V44, pR23
   Csonka PL, 1999, NUCL INSTRUM METH A, V431, P306, DOI 10.1016/S0168-9002(99)00260-0
   Cusatis C, 1998, J SYNCHROTRON RADIAT, V5, P491, DOI 10.1107/S0909049598000685
   Elleaume H, 1999, NUCL INSTRUM METH A, V428, P513, DOI 10.1016/S0168-9002(99)00167-9
   GRANT JA, 1993, MEAS SCI TECHNOL, V4, P83, DOI 10.1088/0957-0233/4/1/014
   HARDING G, 1987, MED PHYS, V14, P515, DOI 10.1118/1.596063
   Hubbell J. H., 1975, Journal of Physical and Chemical Reference Data, V4, P471
   ROYLE GJ, 1991, PHYS MED BIOL, V36, P383, DOI 10.1088/0031-9155/36/3/006
   SWANSON T, 1953, 539 NATL BUR STAND
   Westera G, 1996, EUR J NUCL MED, V23, P5, DOI 10.1007/BF01736983
NR 13
TC 3
Z9 4
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-8043
J9 APPL RADIAT ISOTOPES
JI Appl. Radiat. Isot.
PD OCT-NOV
PY 2000
VL 53
IS 4-5
BP 717
EP 724
DI 10.1016/S0969-8043(00)00211-6
PG 8
WC Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology,
   Nuclear Medicine & Medical Imaging
SC Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 345TE
UT WOS:000088830600030
PM 11003511
DA 2018-10-20
ER

PT J
AU Lee, HJ
   Park, KD
   Park, HD
   Lee, WK
   Han, DK
   Kim, SH
   Kim, YH
AF Lee, HJ
   Park, KD
   Park, HD
   Lee, WK
   Han, DK
   Kim, SH
   Kim, YH
TI Platelet and bacterial repellence on sulfonated poly(ethylene
   glycol)-acrylate copolymer surfaces
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE sulfonated-PEG acrylate copolymers; platelet adhesion; bacterial
   adhesion
ID POLYETHYLENE OXIDE; POLYURETHANE SURFACES; PROTEIN ADSORPTION;
   OXIDE)-GRAFTED POLYURETHANE; ADHESION; BIOCOMPATIBILITY; POLYMERS;
   TISSUES
AB Novel poly(ethylene glycol) (PEG) and sulfonated PEG (PEG-SO3) acrylate copolymers have been prepared and characterized to apply as coating and blending materials for biomedical applications. The modified surfaces using acrylate copolymers demonstrated increased hydrophilicity, possibly due to the hypothesized reorientation of PEG/PEG-SO3 chains into water phase. All copolymer surfaces demonstrated less platelet adhesion than control. In addition, platelet adhesion on copolymer surfaces decreased as the chain length of PEG and sulfonated PEG in copolymers increases. All copolymer surfaces reduced bacterial adhesion significantly and the adhesion level differs depending on surfaces as well as media. The obtained results attest to the usefulness of these copolymers as a coating or additive material to improve the blood compatibility of blood contacting devices. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.
EM kdp@kist.re.kr
RI Park, Hee-Deung/D-2596-2013
OI Han, Dong Keun/0000-0003-4641-7883; Kim, Soo Hyun/0000-0002-8391-3686
CR BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   HAN DK, 1993, J BIOMAT SCI-POLYM E, V4, P401
   HAN DK, 1995, BIOMATERIALS, V16, P467, DOI 10.1016/0142-9612(95)98819-Z
   HAN DK, 1993, J BIOMED MATER RES, V27, P1063, DOI 10.1002/jbm.820270812
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P163
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P667
   HAN DK, 1993, ASAIO J, V39, P537
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Kim YH, 1997, MACROMOL SYMP, V118, P565, DOI 10.1002/masy.19971180174
   KIM YH, 1997, SULFONATED POLYETHYL, P53
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   Lee JH, 1997, J BIOMED MATER RES, V34, P105, DOI 10.1002/(SICI)1097-4636(199701)34:1<105::AID-JBM14>3.0.CO;2-J
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   LEE JH, 1990, BIOMATERIALS, V11, P455, DOI 10.1016/0142-9612(90)90058-X
   NAGAOKA S, 1995, ASAIO J, V41, pM365, DOI 10.1097/00002480-199507000-00032
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Park KD, 1997, BIOMATERIALS, V18, P47, DOI 10.1016/S0142-9612(96)00096-8
   PARK KD, 1996, ASAIO J, V42, P876
   PARK KD, 1994, ASAIO J, V40, P377
   RABINOW BE, 1994, J BIOMAT SCI-POLYM E, V6, P91, DOI 10.1163/156856295X00788
   SCHIERHOLZ J, 1991, NEW POLYM MAT, V3, P61
   SIOSHANISI P, 1993, MED PLASTICS BIOMATE, P50
   WESSLEN B, 1994, BIOMATERIALS, V15, P278, DOI 10.1016/0142-9612(94)90052-3
   Woodyard LL, 1996, J CONTROL RELEASE, V40, P23, DOI 10.1016/0168-3659(95)00135-2
NR 26
TC 36
Z9 37
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD OCT
PY 2000
VL 18
IS 3-4
BP 355
EP 370
DI 10.1016/S0927-7765(99)00161-7
PG 16
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 345HG
UT WOS:000088810100017
DA 2018-10-20
ER

PT J
AU Barron, V
   Buggy, M
   Mas, A
   Schue, F
AF Barron, V
   Buggy, M
   Mas, A
   Schue, F
TI Durability of APC2/polyurethane adhesive joints for biomedical
   applications
SO INTERNATIONAL JOURNAL OF ADHESION AND ADHESIVES
LA English
DT Article
DE polyurethane (A); surface treatment by excited gases (B); contact angle
   (C); durability (D); carbon fibre-reinforced polyetheretherketone
ID THERMOPLASTIC FIBER COMPOSITES; CORONA-TREATED POLYPROPYLENE;
   PLASMA-TREATMENT; POLY(ETHYLENE-TEREPHTHALATE); PEEK
AB Thermoplastic polyurethane elastomer was thermally bonded to carbon fibre-reinforced polyetheretherketone (APC2) in the development of a biomedical device. Argon plasma treatment of the APC2 substrate was investigated as a means of enhancing bonding. Contact angle measurements were used to optimise the surface treatment and, it was observed that the wettability decreased on ageing. Kinetic analysis gave an activation energy of 25 kJ/mol, which was consistent with a bond rotation mechanism. Optimally treated substrates were bonded to polyurethane and bond stability at 37 degrees C was evaluated. While the bond was stable in air for over 1 year, storage in aqueous media lead to rapid deterioration of bond strength. This phenomenon was observed both in distilled water and in Ringer's solution. Measured diffusion rates for both environments were very similar and it is suggested that the observed faster rate of loss of bond strength in Ringer's solution is by the interaction of buffered components from the Ringers or solubilisation of low molecular weight material by the Ringers. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Limerick, Dept Mat Sci & Technol, Limerick, Ireland.
   Univ Montpellier 2, Lab Chim Macromol, F-34095 Montpellier 5, France.
RP Barron, V (reprint author), Univ Limerick, Dept Mat Sci & Technol, Limerick, Ireland.
RI Barron, Valerie/A-1468-2013; Barron, Valerie/C-5941-2014; Irish Centre
   for Composites, Research (ICOMP)/D-4887-2011
OI Barron, Valerie/0000-0001-5520-0649; 
CR Ameen AP, 1996, POLYM DEGRAD STABIL, V51, P179, DOI 10.1016/0141-3910(95)00187-5
   BARRON V, 1998, THESIS U LIMERICK
   BARRON VM, 1998, P AMPT 98 KUAL LUMP, P290
   BLACKMAN BRK, 1994, COMPOSITES, V25, P332, DOI 10.1016/S0010-4361(94)80003-0
   Bowditch MR, 1996, INT J ADHES ADHES, V16, P73, DOI 10.1016/0143-7496(96)00001-2
   BRENNAN WJ, 1991, POLYMER, V32, P1527, DOI 10.1016/0032-3861(91)90436-M
   CHATELIER RC, 1995, LANGMUIR, V11, P2576, DOI 10.1021/la00007a042
   Comyn J, 1996, INT J ADHES ADHES, V16, P97, DOI 10.1016/0143-7496(96)89798-3
   Comyn J., 1983, DURABILITY STRUCTURA, P85, DOI DOI 10.1002/(SICI)1099-0488(19971130)35:16<2659::AIDPOLB9>3.0.CO;2-K
   DAVIES P, 1991, J MATER SCI LETT, V10, P335, DOI 10.1007/BF00719701
   Hill JM, 1995, J ADHES SCI TECHNOL, V9, P1575, DOI 10.1163/156856195X00211
   *ICI, 1988, APC22 ICI FIB CORP P
   KINLOCH AJ, 1992, PHILOS T ROY SOC A, V338, P83, DOI 10.1098/rsta.1992.0004
   KINLOCH AJ, 1992, POLYM SCI ENG, V67, P19
   MOORE WJ, 1972, PHYSICAL CHEM, P766
   MUNRO HS, 1988, J COATINGS TECH, P41
   STROBEL JM, 1991, J ADHES SCI TECHNOL, V5, P119, DOI 10.1163/156856191X00080
   STROBEL M, 1992, J ADHES SCI TECHNOL, V6, P429, DOI 10.1163/156856192X00764
NR 18
TC 6
Z9 6
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0143-7496
J9 INT J ADHES ADHES
JI Int. J. Adhes. Adhes.
PD OCT
PY 2000
VL 20
IS 5
BP 361
EP 366
DI 10.1016/S0143-7496(00)00009-9
PG 6
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 341BX
UT WOS:000088572100004
DA 2018-10-20
ER

PT J
AU Salih, V
   Franks, K
   James, M
   Hastings, GW
   Knowles, JC
   Olsen, I
AF Salih, V
   Franks, K
   James, M
   Hastings, GW
   Knowles, JC
   Olsen, I
TI Development of soluble glasses for biomedical use Part II: The
   biological response of human osteoblast cell lines to phosphate-based
   soluble glasses
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID RELEASE
AB Soluble glasses are considered to be of potential clinical value in orthopaedic and dental surgery. However, the biological response to these materials is not well understood. To determine the effects of these glasses, two human osteoblast cell lines, MG63 and HOS (TE85), were incubated in vitro in the presence of increasing concentrations of extracts of the glasses. The effects of the extracts on cell growth was measured using the MTT assay and an ELISA assay was used to measure the expression of bone sialoprotein (BSP), osteonectin (ON) and fibronectin (FN), antigens which play a fundamental part in the integrity and function of hard connective tissue. The results showed that the proliferation of the cells was adversely affected only by the more soluble glasses, which also down-regulated the expression of the bone-associated proteins. In contrast, the extract of the glass with the lowest dissolution rate, which contains relatively elevated levels of Ca2+, was found to enhance bone cell growth and antigen expression. These findings suggest that the compositions of these glasses at least partly determine the response of cells and thus, that the glasses could be modified to elicit a more optimal biological response and clinical efficacy. (C) 2000 Kluwer Academic Publishers.
C1 Univ London, Eastman Dent Inst, Dept Biomat, London WC1X 8LD, England.
   Univ London, Eastman Dent Inst, Dept Periodontol, London WC1X 8LD, England.
   Natl Univ Singapore, Inst Mat Res & Engn, Singapore 119260, Singapore.
RP Knowles, JC (reprint author), Univ London, Eastman Dent Inst, Dept Biomat, 256 Grays Inn Rd, London WC1X 8LD, England.
RI Knowles, Jonathan Campbell/B-9019-2008
OI Knowles, Jonathan Campbell/0000-0003-3917-3446
CR BUNKER BC, 1984, J NON-CRYST SOLIDS, V64, P291, DOI 10.1016/0022-3093(84)90184-4
   BURNIE J, 1983, CERAMICS SURG, P169
   CALGUT P, 1990, BIOMATERIALS, V11, P561
   Cartmell SH, 1998, J MATER SCI-MATER M, V9, P773, DOI 10.1023/A:1008923523428
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   FRANKS K, 2000, J MAT SCI
   Haberland A, 1999, BBA-GENE STRUCT EXPR, V1445, P21, DOI 10.1016/S0167-4781(99)00017-2
   Han WP, 1999, J NEUROSCI, V19, P900
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   HOLMES RE, 1987, J ORTHOPAED RES, V5, P114, DOI 10.1002/jor.1100050114
   Knabe C, 1998, J MATER SCI-MATER M, V9, P337, DOI 10.1023/A:1008854930676
   Mamoshin VL, 1997, GLASS CERAM+, V54, P45, DOI 10.1007/BF02767143
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   OTAIGBE JU, 1997, TRIP, V11, P369
   SHAND EB, 1954, J AM CERAM SOC, V37, P52, DOI 10.1111/j.1151-2916.1954.tb14005.x
   Uo M, 1998, BIOMATERIALS, V19, P2277, DOI 10.1016/S0142-9612(98)00136-7
   YAMAMURO T, 1990, HDB BIOACTIVE CERAMI, V1, P241
NR 19
TC 120
Z9 120
U1 0
U2 22
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2000
VL 11
IS 10
BP 615
EP 620
DI 10.1023/A:1008901612674
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 348JH
UT WOS:000088981400003
PM 15348085
DA 2018-10-20
ER

PT J
AU Lutz, PJ
AF Lutz, PJ
TI Control of macromolecular architectures by various polymerization
   methods: Advantages and drawbacks
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 39th Microsymposium of the Prague Meetings on Macromolecules Advances in
   Polymerization Methods/Controlled Synthesis of Functionalized Polymers
CY JUL 12-15, 1999
CL PRAGUE, CZECH REPUBLIC
SP Unipetrol Inc, Sigma-Aldrich Ltd, Eastman Chem Europe BV, Bayer AG, Exxon Chem Europe
ID TRANSFER RADICAL POLYMERIZATION; ANIONIC-POLYMERIZATION; MACROMONOMERS;
   COPOLYMERIZATION; METHACRYLATE; POLYSTYRENE; POLYMERS
AB The present work compares the efficiency of various polymerization methods in macromolecular engineering and discusses advantages and drawbacks of different approaches. Anionic polymerization remains the method of choice to synthesize cyclic polymers, functional polymers including macromonomers or functional star-shaped polymers. The controlled radical polymerization is an interesting alternative to anionic polymerization for the controlled homopolymerization of macromonomers yielding well-defined branched species. By combining classic radical polymerization with a heterogeneous reaction, networks were synthesized by homopolymerization of bifunctional poly(ethylene oxide) macromonomers. The resulting hydrogels, obtained directly in water, are new materials for biomedical applications.
C1 Inst Charles Sadron, CNRS, UPR 22, F-67083 Strasbourg, France.
RP Lutz, PJ (reprint author), Inst Charles Sadron, CNRS, UPR 22, 6 Rue Boussingault, F-67083 Strasbourg, France.
CR Angot S, 1998, MACROMOLECULES, V31, P7218, DOI 10.1021/ma980712y
   AUDOUIN F, UNPUB MACROMOL CHEM
   BAMFORD CH, 1954, NATURE, V176, P778
   Carrot G, 1998, POLYM BULL, V40, P181, DOI 10.1007/s002890050240
   DEFFIEUX A, 1996, POLYM MAT ENCY, P3887
   Ederle Y, 1998, MACROMOL SYMP, V132, P197, DOI 10.1002/masy.19981320119
   EDERLE Y, 1999, MAT SCI TECHNOLOGY C, P622
   GILLMANN KF, 1967, POLYM LETT, V5, P477
   Gnanou Y, 1996, J MACROMOL SCI R M C, VC36, P77
   Hild G, 1998, PROG POLYM SCI, V23, P1019, DOI 10.1016/S0079-6700(97)00055-5
   JACOB S, 1998, ADV POLYM SCI, V146, P1
   JACOBSON H, 1950, J CHEM PHYS, V18, P1600, DOI 10.1063/1.1747547
   Knischka R, 1999, LANGMUIR, V15, P4752, DOI 10.1021/la981594a
   KNISCHKA R, UNPUB MACROMOLECULES
   MISHRA M, 1999, STARS HYBERBRANCHED, P59
   NARAGHI KS, 1998, POLYM PREPR AM CHEM, V39, P196
   NARAGHI KS, 1999, MACROMOL RAPID COMM, V199, P569
   NARAGHI KS, UNPUB
   Patten TE, 1996, SCIENCE, V272, P866, DOI 10.1126/science.272.5263.866
   PLENTZMENEGHETT.S, 1999, STARS HYPERBRANCHED, P27
   REMPP P, 1994, J MACROMOL SCI PURE, VA31, P891
   REMPP PF, 1984, ADV POLYM SCI, V58, P1
   Riess G., 1985, ENCY POLYM SCI ENG, V2, P324
   SCHMITT B, 1995, MACROMOL SYMP, V93, P117, DOI 10.1002/masy.19950930116
   SCHULZ GO, 1982, J APPL POLYM SCI, V27, P4773, DOI 10.1002/app.1982.070271222
   SEMLYEN JA, 1997, LARGE RING MOL, P1
   Szwarc M., 1968, CARBANIONS LIVING PO
   TSUKAHARA Y, 1999, MACROMOLECULAR DESIG, P161
   WEBSTER OW, 1992, MAKROMOL CHEM-M SYMP, V60, P287, DOI 10.1002/masy.19920600126
NR 29
TC 7
Z9 7
U1 1
U2 5
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA PO BOX 10 11 61, D-69451 BERLIN, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD OCT
PY 2000
VL 161
BP 53
EP 61
DI 10.1002/1521-3900(200010)161:1<53::AID-MASY53>3.0.CO;2-3
PG 9
WC Polymer Science
SC Polymer Science
GA 386ML
UT WOS:000166065600007
DA 2018-10-20
ER

PT J
AU Nakabayashi, N
AF Nakabayashi, N
TI Preparation of new biomedical materials and their application in clinics
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 7th Society-of-Polymer-Science-Japan International Polymer Conference
CY OCT 26-29, 1999
CL YOKOHAMA, JAPAN
SP Soc Polymer Sci Japan
AB Biomaterials - tissues interaction is important to study in biomaterials science. The information is indispensable to make medical devises and artificial organs and to predict their performance. It is also very useful to consider a hypothesis to design new biomaterials. New materials have brought big progress in the society as we know. There are few biomaterials specially designed to use in biomedical fields. The most important effort must be preparation of biocompatible materials, that must be essential to develop new type high performance devices and artificial organs. Preparation of new dental biomaterials used in bonding of prostheses to dentinal tissues that require fundamental change in modern dentistry and a new methacrylate, MPC, to develop promising several kinds of biomaterials with unusually excellent biocompatibility and functions are going to present. Topics in tissue engineering are also discussed.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
RP Nakabayashi, N (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
CR DOI K, 1996, AM SOC ARTIF INT ORG, V42, P394
   Ishihara K, 1997, TRENDS POLYM SCI, V5, P401
   NAKABAYASHI N, 1998, HYBRIDIZATION DENTAL
   Yoneyama T, 1998, J BIOMED MATER RES, V43, P15, DOI 10.1002/(SICI)1097-4636(199821)43:1<15::AID-JBM2>3.0.CO;2-P
NR 4
TC 2
Z9 2
U1 0
U2 0
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA PO BOX 10 11 61, D-69451 BERLIN, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD OCT
PY 2000
VL 159
BP 27
EP 34
DI 10.1002/1521-3900(200010)159:1<27::AID-MASY27>3.0.CO;2-H
PG 8
WC Polymer Science
SC Polymer Science
GA 386MJ
UT WOS:000166065300005
DA 2018-10-20
ER

PT J
AU Suter, M
   Jacob, SWA
   Synal, HA
AF Suter, M
   Jacob, SWA
   Synal, HA
TI Tandem AMS at sub-MeV energies - Status and prospects
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 8th International Conference on Accelerator Mass Spectrometry
CY SEP 06-10, 1999
CL VIENNA, AUSTRIA
DE accelerator mass spectrometry; radiocarbon dating
ID ACCELERATOR MASS-SPECTROMETRY; ION-SOURCE; ENVIRONMENTAL MATERIALS;
   BIOMEDICAL APPLICATIONS; C-14; SYSTEM; CA-41; FUTURE; CARBON; FOILS
AB Recently new small and compact accelerator mass spectrometry (AMS) facilities for radiocarbon analysis came into operation, using terminal voltages below 1 MV and ions in charge state 1(+) or 2(+). A special method is applied to eliminate interfering molecules. The present status of this new technique is summarized and the associated problems are described. The potential and the limitations of this technique for analyzing other radionuclides are also discussed. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 ETH Honggerberg, Inst Particle Phys, CH-8093 Zurich, Switzerland.
   ETH Honggerberg, Paul Scherrer Inst, CH-8093 Zurich, Switzerland.
RP Suter, M (reprint author), ETH Honggerberg, Inst Particle Phys, E114, CH-8093 Zurich, Switzerland.
EM suter@particle.phys.ethz.ch
CR BELSHAW NS, 1995, INT J MASS SPECTROM, V142, P55, DOI 10.1016/0168-1176(94)04125-Q
   BRONK CR, 1990, NUCL INSTRUM METH B, V52, P322, DOI 10.1016/0168-583X(90)90430-3
   DittrichHannen B, 1996, NUCL INSTRUM METH B, V113, P453, DOI 10.1016/0168-583X(95)01302-4
   FINK D, 1990, NUCL INSTRUM METH B, V52, P572, DOI 10.1016/0168-583X(90)90479-E
   Freeman SPHT, 1997, NUCL INSTRUM METH B, V123, P266, DOI 10.1016/S0168-583X(96)00701-X
   GARTENMANN P, 1999, THESIS ETH ZURICH
   HEINEMEIER J, 1977, NUCL INSTRUM METHODS, V141, P183, DOI 10.1016/0029-554X(77)90764-9
   Hughey BJ, 1997, NUCL INSTRUM METH B, V123, P153, DOI 10.1016/S0168-583X(96)00420-X
   Hughey BJ, 2000, NUCL INSTRUM METH B, V172, P40, DOI 10.1016/S0168-583X(00)00118-X
   Hughey BJ, 1997, NUCL INSTRUM METH B, V123, P186, DOI 10.1016/S0168-583X(96)00408-9
   Hvelplund P., 1970, Nuclear Instruments and Methods, V90, P315, DOI 10.1016/0029-554X(70)90688-9
   Jacob SAW, 2000, NUCL INSTRUM METH B, V172, P235, DOI 10.1016/S0168-583X(00)00205-6
   KILIUS LR, 1987, NUCL INSTRUM METH B, V29, P72, DOI 10.1016/0168-583X(87)90207-2
   Kilius LR, 1997, NUCL INSTRUM METH B, V123, P10, DOI 10.1016/S0168-583X(96)00421-1
   LENNARD WN, 1981, NUCL INSTRUM METHODS, V179, P413, DOI 10.1016/0029-554X(81)90166-X
   LITHERLAND AE, 1984, NUCL INSTRUM METH B, V5, P100, DOI 10.1016/0168-583X(84)90491-9
   MIDDLETON R, 1989, NUCL INSTRUM METH B, V43, P231, DOI 10.1016/0168-583X(89)90043-8
   Mous DJW, 1997, NUCL INSTRUM METH B, V123, P159, DOI 10.1016/S0168-583X(96)00423-5
   Mous DJW, 1998, RADIOCARBON, V40, P283
   Mous DJW, 1999, AIP CONF PROC, V475, P657
   Ognibene TJ, 2000, NUCL INSTRUM METH B, V172, P47, DOI 10.1016/S0168-583X(00)00151-8
   PURSER KH, 1994, NUCL INSTRUM METH B, V92, P201, DOI 10.1016/0168-583X(94)96005-4
   PURSER KH, 1990, NUCL INSTRUM METH B, V52, P424, DOI 10.1016/0168-583X(90)90450-9
   Raisbeck G, 1981, P S ACCELERATOR MASS, P426
   RAISBECK GM, 1984, NUCL INSTRUM METH B, V5, P175, DOI 10.1016/0168-583X(84)90505-6
   RYDING G, 1970, PHYS REV A, V188, P1081
   Schneider RJ, 1997, NUCL INSTRUM METH B, V123, P546, DOI 10.1016/S0168-583X(96)00607-6
   Suter M, 1997, NUCL INSTRUM METH B, V123, P148, DOI 10.1016/S0168-583X(96)00613-1
   Suter M, 1999, AIP CONF PROC, V475, P665
   Suter M, 1998, NUCL INSTRUM METH B, V139, P150, DOI 10.1016/S0168-583X(97)00945-2
   Synal HA, 2000, NUCL INSTRUM METH B, V161, P29, DOI 10.1016/S0168-583X(99)00881-2
   Synal HA, 2000, NUCL INSTRUM METH B, V172, P1, DOI 10.1016/S0168-583X(00)00376-1
   von Blanckenburg F, 1996, CHEM GEOL, V129, P93, DOI 10.1016/0009-2541(95)00157-3
NR 33
TC 41
Z9 41
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD OCT
PY 2000
VL 172
BP 144
EP 151
DI 10.1016/S0168-583X(00)00359-1
PG 8
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 372JR
UT WOS:000165231000026
DA 2018-10-20
ER

PT J
AU Nishiizumi, K
   Caffee, MW
   DePaolo, DJ
AF Nishiizumi, K
   Caffee, MW
   DePaolo, DJ
TI Preparation of Ca-41 AMS standards
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 8th International Conference on Accelerator Mass Spectrometry
CY SEP 06-10, 1999
CL VIENNA, AUSTRIA
DE cosmogenic nuclide; standard; surface ionization mass spectrometry;
   Ca-41
ID ACCELERATOR MASS-SPECTROMETRY; HALF-LIFE; COSMOGENIC CA-41; BE-10
AB Absolute accelerator mass spectrometry (AMS) measurements require reliable standards for calibration. The Space Sciences Laboratory at the University of California, Berkeley, and the Center for Accelerator Mass Spectrometry at Lawrence Livermore National Laboratory (LLNL) have prepared new Ca-41 AMS standards. The highly enriched (CaCO3)-Ca-41 was obtained from Oak Ridge National Laboratory. After purification of the CaCO3, the precise Ca-41/Ca ratio in the original material was determined by surface ionization mass spectrometry. The Ca-41 was sequentially diluted with natural Ca to obtain Ca-41/Ca ratios of 1.155 x 10(-10) 9.755 x 10(-12) 5.139 x 10(-12) 1.095 x 10(-12) and 5.884 x 10(-13). A solution with a Ca-41/Ca ratio of 10(-6) was also prepared for biomedical research. The solutions having Ca-41/Ca ratios between 10(-10) and 10(-12) were measured by AMS. Although the present blank level, 5 x 10(-14) Ca-41/Ca, was higher than anticipated, excellent linearity was obtained from 6 x 10(-13) to 1.2 x 10(-10) Ca-41/Ca. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA.
   Univ Calif Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94550 USA.
   Univ Calif Berkeley, Dept Geol & Geophys, Berkeley, CA 94720 USA.
   EO Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA.
RP Nishiizumi, K (reprint author), Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA.
RI Caffee, Marc/K-7025-2015
OI Caffee, Marc/0000-0002-6846-8967
CR DAVIS JC, 1990, NUCL INSTRUM METH B, V52, P269, DOI 10.1016/0168-583X(90)90419-U
   FELTON JS, 1990, NUCL INSTRUM METH B, V52, P517, DOI 10.1016/0168-583X(90)90469-B
   FINK D, 1990, NUCL INSTRUM METH B, V47, P79, DOI 10.1016/0168-583X(90)90049-Z
   Fink D, 1998, GEOCHIM COSMOCHIM AC, V62, P2389, DOI 10.1016/S0016-7037(98)00134-3
   KLEIN J, 1991, EARTH PLANET SC LETT, V103, P79, DOI 10.1016/0012-821X(91)90151-7
   KUBIK PW, 1986, NATURE, V319, P568, DOI 10.1038/319568a0
   MABUCHI H, 1974, J INORG NUCL CHEM, V36, P1687, DOI 10.1016/0022-1902(74)80493-8
   Nishiizumi K, 1997, EARTH PLANET SC LETT, V148, P545, DOI 10.1016/S0012-821X(97)00051-4
   NISHIIZUMI K, 1984, EARTH PLANET SC LETT, V70, P157, DOI 10.1016/0012-821X(84)90001-3
   Nishiizumi K, 1998, METEORIT PLANET SCI, V33, pA117
   PAUL M, 1991, Z PHYS A-HADRON NUCL, V340, P249, DOI 10.1007/BF01294672
   RUSSELL WA, 1978, GEOCHIM COSMOCHIM AC, V42, P1075, DOI 10.1016/0016-7037(78)90105-9
   SHARMA P, 1990, NUCL INSTRUM METH B, V52, P410, DOI 10.1016/0168-583X(90)90447-3
   Skulan J, 1997, GEOCHIM COSMOCHIM AC, V61, P2505, DOI 10.1016/S0016-7037(97)00047-1
   SOUTHON JR, 1994, NUCL INSTRUM METH B, V92, P489, DOI 10.1016/0168-583X(94)96060-7
NR 15
TC 36
Z9 37
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD OCT
PY 2000
VL 172
BP 399
EP 403
DI 10.1016/S0168-583X(00)00150-6
PG 5
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 372JR
UT WOS:000165231000069
DA 2018-10-20
ER

PT J
AU Jackson, GS
   Elmore, D
   Rickey, FA
   Musameh, SM
   Sharma, P
   Hillegonds, D
   Coury, L
   Kissinger, P
AF Jackson, GS
   Elmore, D
   Rickey, FA
   Musameh, SM
   Sharma, P
   Hillegonds, D
   Coury, L
   Kissinger, P
TI The PRIME lab biomedical program
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 8th International Conference on Accelerator Mass Spectrometry
CY SEP 06-10, 1999
CL VIENNA, AUSTRIA
DE tracers; bone resorption; vaccines; implant materials; biomedical
   accelerator mass spectrometry
ID ACCELERATOR MASS-SPECTROMETRY; SAMPLE PREPARATION; CA-41 AMS; SCIENCES
AB The biomedical accelerator mass spectrometry (AMS) initiative at PRIME Lab including the status of equipment and sample preparation is described. Several biomedical projects are underway involving one or more of the nuclides: C-14, Al-26 and Ca-41. Routine production of CaF2 and graphite is taking place. Finally, the future direction and plans for improvement of the biomedical program at PRIME Lab are discussed. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Purdue Univ, Dept Phys, PRIME Lab, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.
   Bioanlyt Syst Inc, W Lafayette, IN 47906 USA.
   An Najah Univ, Dept Phys, Nablus, West Bank, Israel.
RP Elmore, D (reprint author), Purdue Univ, Dept Phys, PRIME Lab, 1396 Phys Bldg, W Lafayette, IN 47907 USA.
CR ELMORE D, 1987, BIOL TRACE ELEM RES, V12, P231, DOI 10.1007/BF02796683
   ELMORE D, 1990, NUCL INSTRUM METH B, V52, P531, DOI 10.1016/0168-583X(90)90471-6
   FLAREND R, COMMUNICATION
   Flarend RE, 1997, VACCINE, V15, P1314, DOI 10.1016/S0264-410X(97)00041-8
   FREEMAN SPHT, 1995, INT J MASS SPECTROM, V143, P247, DOI 10.1016/0168-1176(95)04157-G
   FREEMAN SPHT, 1995, NUCL INSTRUM METH B, V99, P557, DOI 10.1016/0168-583X(95)00342-8
   Koslowsky VT, 1997, NUCL INSTRUM METH B, V123, P203, DOI 10.1016/S0168-583X(96)00628-3
   SHARMA P, 1990, ANAL CHIM ACTA, V233, P101, DOI 10.1016/S0003-2670(00)83465-0
   SHARMA P, 1987, NUCL INSTRUM METH B, V29, P63, DOI 10.1016/0168-583X(87)90205-9
   TAYLOR GW, COMMUNICATION
   VOGEL JS, 1992, RADIOCARBON, V34, P344
   VOGEL JS, 1990, NUCL INSTRUM METH B, V52, P524, DOI 10.1016/0168-583X(90)90470-F
   VOGEL JS, 1990, RADIOCARBON, V32, P81
   VOGEL JS, 1994, NUCL INSTRUM METH B, V92, P445, DOI 10.1016/0168-583X(94)96052-6
NR 14
TC 6
Z9 6
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD OCT
PY 2000
VL 172
BP 899
EP 903
DI 10.1016/S0168-583X(00)00231-7
PG 5
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 372JR
UT WOS:000165231000151
DA 2018-10-20
ER

PT J
AU Wang, DA
   Ji, J
   Feng, LX
AF Wang, DA
   Ji, J
   Feng, LX
TI Various-sized stearyl poly(ethylene oxide) coupling-polymer blending
   poly(ether urethane) material for surface study and biomedical
   applications
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
ID BLOOD COMPATIBILITY; PROTEIN ADSORPTION; POLYURETHANES; SPECTROSCOPY;
   COPOLYMERS; BLOCK
AB Three types of stearyl poly(ethylene oxide) with different values of M-n, 2300, 6000 and 12000, were synthesized by an anion polymerization from the ethylene oxide (EO) monomer with the initiator, sodium salt of stearyl alcohol. Consequently the amphiphilic coupling polymers of 4,4'-diphenylmethane diiso-cyanate (MDI)-SPEO (SPEO-MDI-SPEO, MSPEO 2300, 6000 and 12000) were synthesized and the blended polyurethane) samples of PELMSPEOs (PEL-MSPEO 6000 and 12000) were prepared via a solution process. The surface analysis with ATR-FTIR, angle-dependent XPS and two methods of contact angle measurements (sessile drop and captive bubble) were performed. The results of the analysis indicate that the dominant factor for the monoblock behavior of long-chained MSPEO 12000 is the PEO chain. However, for shea-chained MSPEO the factor is C-18 and the dominant effect is not so overwhelming compared to that of PEO for long-chained MSPEO. Simultaneously, the size of the molecule will also dramatically affect MSPEOs' kinetic behavior including the monoblock mobility and the reconstructing of the surface a, i.e. the smaller the size, the faster the The static test of clotting time, PRT, was also med The results indicated that the modified surface resist the clotting much more effectively than thatof the untreated surface.
C1 Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
RP Feng, LX (reprint author), Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
RI Wang, Dong-an/G-6195-2010
OI Ji, Jian/0000-0001-9870-4038
CR ANDRADE JD, 1985, SURFACE INTERFACIAL, V1, P270
   Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   Freij-Larsson C, 2000, BIOMATERIALS, V21, P307, DOI 10.1016/S0142-9612(99)00195-7
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GRASEL TG, 1986, BIOMATERIALS, V7, P315, DOI 10.1016/0142-9612(86)90002-5
   GREGONIS DE, 1982, MACROMOLECULAR SOLUT, P120
   HARTHCOCK MA, 1989, POLYMER, V30, P1234, DOI 10.1016/0032-3861(89)90041-4
   Jannasch P, 1998, MACROMOLECULES, V31, P1341, DOI 10.1021/ma971351+
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   LELAH MD, 1986, J BIOMED MATER RES, V20, P433, DOI 10.1002/jbm.820200403
   LELAH MD, 1986, POLYURETHANES MED, P57
   MACRONI M, 1994, MACROMOL CHEM PHYS, V185, P875
   MUNRO MS, 1983, ASAIO J, V6, P65
   OHTA K, 1985, APPL SPECTROSC, V39, P418, DOI 10.1366/0003702854248719
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   PITT WG, 1988, BIOMATERIALS, V9, P36, DOI 10.1016/0142-9612(88)90067-1
   WANG DA, 1999, UNPUB MACROMOLECULES
   WESSLEN B, 1994, BIOMATERIALS, V15, P278, DOI 10.1016/0142-9612(94)90052-3
NR 19
TC 13
Z9 15
U1 1
U2 11
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 1022-1352
J9 MACROMOL CHEM PHYSIC
JI Macromol. Chem. Phys.
PD SEP 28
PY 2000
VL 201
IS 14
BP 1574
EP 1584
DI 10.1002/1521-3935(20000901)201:14<1574::AID-MACP1574>3.0.CO;2-B
PG 11
WC Polymer Science
SC Polymer Science
GA 363LZ
UT WOS:000089838300002
DA 2018-10-20
ER

PT J
AU Udipi, K
   Ornberg, RL
   Thurmond, KB
   Settle, SL
   Forster, D
   Riley, D
AF Udipi, K
   Ornberg, RL
   Thurmond, KB
   Settle, SL
   Forster, D
   Riley, D
TI Modification of inflammatory response to implanted biomedical materials
   in vivo by surface bound superoxide dismutase mimics
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE superoxide dismutase mimics; ultrahigh molecular weight polyethylene;
   polyurethane; inflammatory response
ID DNA-BINDING ACTIVITY; NITRIC-OXIDE; REDOX REGULATION; IN-VIVO; INJURY;
   PEROXYNITRITE; BIOSTABILITY; TRANSCRIPTION; POTENTIATION; ACTIVATION
AB The healing response to implanted biomedical materials involves varying degrees and stages of inflammation and healing which in some cases leads to device failure. In this article, we describe synthetic methods and in vivo results of a novel surface treatment for biomedical materials involving covalent conjugation of a low molecular weight superoxide dismutase mimic (SODm), which imparts antiinflammatory character to the material. SODm investigated in this study are a new class of anti-inflammatory drugs consisting of a Mn(II) complex of a macrocyclic polyamine ring that catalyze the dismutation of superoxide at rates equivalent to that of native enzyme. The SODms were covalently linked to small disks of ultra-high molecular weight polyethylene, poly(etherurethane urea), and tantalum metal at two concentrations and implanted in a subcutaneous rat implant model for 3, 7, 14, and 28 days. Histological examination of the implant tissue performed at 3 and 28 days revealed striking anti-inflammatory effects on both acute and chronic inflammatory responses. At 3 days, the formation of a neutrophil-rich acute inflammatory infiltrate seen in control implants was inhibited for all three materials treated with SODm. At 28 days, foreign body giant cell formation (number of FBGCs per field) and fibrous capsule formation (mean thickness of implant capsule) were also significantly inhibited over untreated control implants. A mechanism based on our current understanding of superoxide as an inflammatory mediator at implanted biomedical materials is proposed. (C) 2000 John Wiley & Sons, Inc.
C1 Metaphore Pharmaceut Inc, St Louis, MO 63114 USA.
   GD Searle Monsanto Co, Monsanto Corp Res, Chesterfield, MO 63017 USA.
   GD Searle Monsanto Co, Discovery Oncol, Chesterfield, MO 63017 USA.
RP Udipi, K (reprint author), Metaphore Pharmaceut Inc, 1910 Innerbelt Business Ctr Dr, St Louis, MO 63114 USA.
CR ABATE C, 1990, CELL GROWTH DIFFER, V1, P455
   ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682
   AIKENS J, 1991, J BIOL CHEM, V266, P15091
   Anderson J.M., 1994, PROB GEN SURG, V11, P147
   ARCHAMBAULT JG, 1998, T 24 ANN M SOC BIOM, P251
   BECKMAN JS, 1993, BIOCHEM SOC T, V21, P330, DOI 10.1042/bst0210330
   BLACK SC, 1994, J PHARMACOL EXP THER, V270, P1208
   Clark RAF, 1996, MOL CELLULAR BIOL WO
   CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405
   Crow J P, 1995, Curr Top Microbiol Immunol, V196, P57
   Crow J P, 1995, Adv Pharmacol, V34, P17
   CROW JP, 1994, FREE RADICAL BIO MED, V16, P331, DOI 10.1016/0891-5849(94)90034-5
   Crow JP, 1996, ADV EXP MED BIOL, V387, P147
   Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6
   FREDERICKS GS, 1993, FASEB J, V7, P2457
   FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761
   Glowinski J, 1997, EUR SURG RES, V29, P368, DOI 10.1159/000129545
   HARDY MM, 1994, J BIOL CHEM, V15, P269
   JORAL A, 1993, J INVEST ALLERG CLIN, V3, P103
   Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3
   KASTEN TP, 1995, P SOC EXP BIOL MED, V208, P170
   KILGORE KS, 1994, J MOL CELL CARDIOL, V26, P995, DOI 10.1006/jmcc.1994.1120
   Land W, 1997, TRANSPLANT P, V29, P2567, DOI 10.1016/S0041-1345(97)00509-5
   Lefaix JL, 1996, INT J RADIAT ONCOL, V35, P305, DOI 10.1016/0360-3016(96)00061-2
   Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245
   Mates Jose M., 1999, Frontiers in Bioscience, V4, pD339, DOI 10.2741/Mates
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   MENG YY, 1995, J AM COLL CARDIOL, V25, P269, DOI 10.1016/0735-1097(94)00349-U
   Oury TD, 1996, LAB INVEST, V75, P617
   RILEY DP, 1994, J AM CHEM SOC, V116, P387, DOI 10.1021/ja00080a051
   ROOS D, 1980, CELL BIOL INFLAMMATI, P337
   Salvemini D, 1999, SCIENCE, V286, P304, DOI 10.1126/science.286.5438.304
   SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   Sen CK, 1996, FASEB J, V10, P709
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   VENTURINI CM, 1994, BIOL NITRIC OXIDE, V3, P65
   WEISIGER RA, 1973, J BIOL CHEM, V248, P3582
   Weiss RH, 1996, J BIOL CHEM, V271, P26149, DOI 10.1074/jbc.271.42.26149
   WU Y, 1991, J BIOMED MATER RES, V25, P725, DOI 10.1002/jbm.820250604
   Zwacka RM, 1998, NAT MED, V4, P698, DOI 10.1038/nm0698-698
NR 43
TC 45
Z9 49
U1 1
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 15
PY 2000
VL 51
IS 4
BP 549
EP 560
DI 10.1002/1097-4636(20000915)51:4<549::AID-JBM2>3.0.CO;2-Z
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 330PK
UT WOS:000087970300002
PM 10880102
DA 2018-10-20
ER

PT J
AU Carew, EO
   Barber, JE
   Vesely, I
AF Carew, EO
   Barber, JE
   Vesely, I
TI Role of preconditioning and recovery time in repeated testing of aortic
   valve tissues: Validation through quasilinear viscoelastic theory
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE soft tissue modeling; predictive model; strain history; porcine
ID QUASI-LINEAR THEORY; MUSCLE; RESPONSES; BEHAVIOR; FRESH
AB We investigated how preconditioning history and specimen recovery time affect the accuracy of measurements of mechanical properties obtained from sequential, repeated materials testing of porcine aortic valve (PAV) cusps. Strain history protocols were modeled by quasilinear viscoelastic theory and the results compared with the experimental data. Assuming that the model was predictive, the accuracy of predicting experimental data was related to the suitability of the materials testing protocol. We found that the preconditioned state of the PAV material was not unique but was a function of the deformation history that had occurred before the preconditioning cycles. Preconditioning without an adequate rest period between tests increased predictive errors, whereas allowing the material to rest without preconditioning reduced errors. Modeling more of the strain history reduced errors for specimens briefly rested between tests but had no impact on specimens with long rest periods. The smallest predictive errors were obtained for a loading protocol with a 24 h specimen recovery period followed by material preconditioning. We recommend the use of this protocol for estimating material properties of PAV tissues. (C) 2000 Biomedical Engineering Society. [S0090-6964(00)00509-9].
C1 Cleveland Clin Fdn, Dept Biomed Engn ND20, Lerner Res Inst, Cleveland, OH 44195 USA.
RP Vesely, I (reprint author), Cleveland Clin Fdn, Dept Biomed Engn ND20, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.
FU NHLBI NIH HHS [HL57236]
CR BEST TM, 1994, J BIOMECH, V27, P413, DOI 10.1016/0021-9290(94)90017-5
   Carew EO, 1999, J BIOMECH ENG-T ASME, V121, P386, DOI 10.1115/1.2798335
   Fung Y.C., 1993, BIOMECHANICS MECH PR, P277
   HAUT RC, 1972, J BIOMECH, V5, P423, DOI 10.1016/0021-9290(72)90001-2
   HUYGHE JM, 1991, J BIOMECH, V24, P841, DOI 10.1016/0021-9290(91)90309-B
   KWAN MK, 1993, J BIOMECH, V26, P447, DOI 10.1016/0021-9290(93)90008-3
   LEE JM, 1984, J BIOMED MATER RES, V18, P61, DOI 10.1002/jbm.820180108
   MYERS BS, 1991, J BIOMECH, V24, P811, DOI 10.1016/0021-9290(91)90306-8
   PINTO JG, 1980, J BIOMECH ENG-T ASME, V102, P57, DOI 10.1115/1.3138199
   ROUSSEAU EPM, 1983, J BIOMECH, V16, P339, DOI 10.1016/0021-9290(83)90017-9
   SAUREN AAHJ, 1983, J BIOMECH, V16, P327, DOI 10.1016/0021-9290(83)90016-7
   TALMAN E, 1997, ASME BED, V36, P55
   Vesely I, 1996, ASAIO J, V42, P993, DOI 10.1097/00002480-199642060-00012
   VESELY I, 1993, J BIOMECH, V26, P121, DOI 10.1016/0021-9290(93)90043-E
   VESELY I, 1998, P 3 WORLD C BIOM SAP, P193
   VESELY I, 1997, ASME BIOENG DIV PUBL, V36, P57
   WOO SLY, 1980, J BIOMECH ENG-T ASME, V102, P85, DOI 10.1115/1.3138220
   WOO SLY, 1981, J BIOMECH ENG-T ASME, V103, P293, DOI 10.1115/1.3138295
NR 18
TC 62
Z9 63
U1 1
U2 6
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD SEP
PY 2000
VL 28
IS 9
BP 1093
EP 1100
DI 10.1114/1.1310221
PG 8
WC Engineering, Biomedical
SC Engineering
GA 379LN
UT WOS:000165643700005
PM 11132193
DA 2018-10-20
ER

PT J
AU Whyne, CM
   Hu, SS
   Workman, KL
   Lotz, JC
AF Whyne, CM
   Hu, SS
   Workman, KL
   Lotz, JC
TI Biphasic material properties of lytic bone metastases
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE biomechanics; poroelasticity; tumor; hydraulic permeability; aggregate
   modulus
ID ARTICULAR-CARTILAGE; INTERVERTEBRAL DISC; DRUG-DELIVERY; COMPRESSION;
   MODELS; CREEP; FLUID
AB It is necessary to prescribe the mechanical properties of timer tissue when modeling the metastatically involved skeleton for clarifying the mechanisms of fracture. This study provides mechanical property data for lytic bone metastases. Specimens of human lytic tumor were tested under a confined compression uniaxial creep protocol and the mechanical behavior of the tumor tissue was modeled using linear biphasic theory. The tumor tissue was found to have an aggregate modulus (H-A) of 3.6 +/- 1.6 kPa and a hydraulic permeability (k) of 0.59 +/- 0.46 mm(4)N(-1)s(-1). Tumors with a higher percentage of stromal content were found to be stiffer and more permeable than those with a more cellular composition. No significant differences in aggregate modulus or hydraulic permeability were found between lyric metastases of different types. These data are useful for the development of models to simulate the behavior of the metastatically involved skeleton using theoretical or finite-element analysis techniques and also have significance for developing effective tumor-drug-transport models. We anticipate that specification of the mechanical behavior of this tissue may help to better focus future treatment of lyric bony metastases through better assessment of fracture risk and improved drug delivery. (C) 2000 Biomedical Engineering Society. [S0090-6964(00)00909-7].
C1 Univ Calif San Francisco, Dept Orthopaed Surg, Orthopaed Bioengn Lab, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, UC Berkeley, UDSF Joint Grad Grp Bioengn, San Francisco, CA 94143 USA.
   Sunnybrook & Womens Coll, Hlth Sci Ctr, Orthopaed Biomech Lab, Toronto, ON, Canada.
RP Lotz, JC (reprint author), Univ Calif San Francisco, Dept Orthopaed Surg, Orthopaed Bioengn Lab, 533 Parnassus Ave, San Francisco, CA 94143 USA.
CR Ateshian GA, 1997, J BIOMECH, V30, P1157, DOI 10.1016/S0021-9290(97)85606-0
   Bass EC, 1997, SPINE, V22, P2867, DOI 10.1097/00007632-199712150-00009
   BIOT MA, 1955, J APPL PHYS, V26, P182, DOI 10.1063/1.1721956
   Boucher Y, 1998, BRIT J CANCER, V78, P1442, DOI 10.1038/bjc.1998.705
   DIRESTA GR, 1993, MICROVASC RES, V46, P158, DOI 10.1006/mvre.1993.1044
   El-Kareh AW, 1997, CRIT REV BIOMED ENG, V25, P503, DOI 10.1615/CritRevBiomedEng.v25.i6.20
   JAIN RK, 1987, CANCER RES, V47, P3039
   KLISH S, 1999, THESIS UC BERKELEY
   Krol A, 1999, CANCER RES, V59, P4136
   LAIBLE JP, 1993, SPINE, V18, P659, DOI 10.1097/00007632-199304000-00019
   MCGOWAN DP, 1993, J SPINAL DISORD, V6, P130
   MIZRAHI J, 1992, J BIOMED ENG, V14, P467, DOI 10.1016/0141-5425(92)90098-6
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Netti P. A., 1995, Biorheology, V32, P346, DOI 10.1016/0006-355X(95)92330-D
   ROONEY F, 1996, MATH MODEL SCI COMPU, V6, P715
   SARNTINORANONT M, 1999, THESIS UC BERKELEY
   SARNTINORANONT M, 1996, THESIS UC BERKELEY
   Silva M J, 1993, Eur Spine J, V2, P118, DOI 10.1007/BF00301407
   SIMON BR, 1985, SPINE, V10, P494, DOI 10.1097/00007632-198507000-00003
   SWABB EA, 1974, CANCER RES, V34, P2814
NR 21
TC 22
Z9 23
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD SEP
PY 2000
VL 28
IS 9
BP 1154
EP 1158
DI 10.1114/1.1313773
PG 5
WC Engineering, Biomedical
SC Engineering
GA 379LN
UT WOS:000165643700011
PM 11132199
DA 2018-10-20
ER

PT J
AU Sanchez-Carbayo, MS
   Bornmann, W
   Cordon-Cardo, C
AF Sanchez-Carbayo, MS
   Bornmann, W
   Cordon-Cardo, C
TI DNA microchips: Technical and practical considerations
SO CURRENT ORGANIC CHEMISTRY
LA English
DT Article
ID GENE-EXPRESSION PATTERNS; CDNA MICROARRAYS; MESSENGER-RNA; HUMAN GENOME;
   OLIGONUCLEOTIDE MICROARRAYS; GEL-ELECTROPHORESIS; COMPLEMENTARY-DNA;
   LARGE-SCALE; CANCER; HYBRIDIZATION
AB The development of high throughput techniques, such as DNA microarrays, engages interest in many biomedical research fields. They are becoming one of the preferred methods for large-scale expression analyses. The power of this technology is that it allows the profiling of thousands of genes in one single experiment. There are two main array-based technologies: cDNA and oligonucleotide arrays. cDNA arrays consist of microscope slides or nylon membranes containing hundreds to thousands of immobilized DNA probes, which are hybridized to fluorescent or radioactive complementary cDNA obtained from a target sample. Oligonucleotide chips differ in that probes are 20-25 mer selected oligonucleotides, which are bound to glass substrates and that the DNA obtained from a target sample can only be fluorescently labeled. In this review, we describe the different types of DNA-chips, the steps involved in the production of microchips, the methodological and technical aspects of microchip utilization, and their potential applications including some practical considerations utilizing clinical material.
C1 Mem Sloan Kettering Canc Ctr, Div Mol Pathol, New York, NY 10021 USA.
   Mem Sloan Kettering Canc Ctr, Organ Chem Facil Core, New York, NY 10021 USA.
RP Sanchez-Carbayo, MS (reprint author), Mem Sloan Kettering Canc Ctr, Div Mol Pathol, 1275 York Ave, New York, NY 10021 USA.
CR ALIDAZEH AA, 2000, NATURE, V403, P503
   ALWINE JC, 1977, P NATL ACAD SCI USA, V74, P5350, DOI 10.1073/pnas.74.12.5350
   AMBELE M, 1999, ANAL CELL PATHOL, V19, P53
   Bassett DE, 1999, NAT GENET, V21, P51, DOI 10.1038/4478
   BAXEVANIS AD, 1998, BIOINFORMATICS PRACT
   Benson DA, 1997, NUCLEIC ACIDS RES, V25, P1, DOI 10.1093/nar/25.1.1
   BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0
   Bernard K, 1996, NUCLEIC ACIDS RES, V24, P1435, DOI 10.1093/nar/24.8.1435
   Bertucci F, 1999, HUM MOL GENET, V8, P1715, DOI 10.1093/hmg/8.9.1715
   BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332
   Bowtell DDL, 1999, NAT GENET, V21, P25, DOI 10.1038/4455
   Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462
   BROWNSTEIN MJ, 1998, FUNCTIONAL GENOMICS, P27
   Bubendorf L, 1999, J NATL CANCER I, V91, P1758, DOI 10.1093/jnci/91.20.1758
   Chen JJW, 1998, GENOMICS, V51, P313, DOI 10.1006/geno.1998.5354
   CHEN Y, 1997, BIOMED OPTICS, V2, P364
   Cheung VG, 1999, NAT GENET, V21, P15, DOI 10.1038/4439
   *CLONT, ATL ARR
   Cole KA, 1999, NAT GENET, V21, P38, DOI 10.1038/4466
   Debouck C, 1999, NAT GENET, V21, P48, DOI 10.1038/4475
   DeRisi J, 1996, NAT GENET, V14, P457
   DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680
   Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434
   Eberwine J, 1996, BIOTECHNIQUES, V20, P584
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Ekins R, 1997, J Int Fed Clin Chem, V9, P100
   Elek J, 2000, IN VIVO, V14, P173
   Ermolaeva O, 1998, NAT GENET, V20, P19
   Ferea TL, 1999, CURR OPIN GENET DEV, V9, P715, DOI 10.1016/S0959-437X(99)00033-7
   Ge H, 2000, Nucleic Acids Res, V28, pe3, DOI 10.1093/nar/28.2.e3
   *GEN SYST, GEN DISC ARR
   Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531
   Granjeaud S, 1996, GENET ANAL-BIOMOL E, V12, P151, DOI 10.1016/1050-3862(95)00128-X
   GRANJEAUD S, 1999, BIOESSAYS, V21, P1
   Gunderson KL, 1998, GENOME RES, V8, P1142, DOI 10.1101/gr.8.11.1142
   Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469
   Harris TM, 2000, NAT BIOTECHNOL, V18, P384, DOI 10.1038/74435
   Heiskanen MA, 2000, CANCER RES, V60, P799
   Imbert MC, 1999, NUCLEIC ACIDS RES, V27, P601, DOI 10.1093/nar/27.2.601
   KANEHISA M, 1998, DATABASES BIOL INFOR, P24
   Karpf AR, 1999, P NATL ACAD SCI USA, V96, P14007, DOI 10.1073/pnas.96.24.14007
   Kaufman L, 1990, FINDING GROUPS DATA
   Khan J, 1999, ELECTROPHORESIS, V20, P223, DOI 10.1002/(SICI)1522-2683(19990201)20:2<223::AID-ELPS223>3.0.CO;2-A
   Khan J, 1998, CANCER RES, V58, P5009
   KLIMECKI WT, 1994, BIOTECHNIQUES, V16, P1021
   Lander ES, 1999, NAT GENET, V21, P3, DOI 10.1038/4427
   LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393
   Lieberman R, 1998, CLIN CHEM, V44, P420
   Lin BY, 1999, CANCER RES, V59, P4180
   Lin BY, 2000, CANCER RES, V60, P858
   Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447
   Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675
   Loftus SK, 1999, P NATL ACAD SCI USA, V96, P9277, DOI 10.1073/pnas.96.16.9277
   Marshall A, 1998, NAT BIOTECHNOL, V16, P27, DOI 10.1038/nbt0198-27
   McEntyre J, 1998, TRENDS GENET, V14, P39, DOI 10.1016/S0168-9525(97)01325-5
   Nelson N, 1996, J NATL CANCER I, V88, P1803, DOI 10.1093/jnci/88.24.1803
   NGUYEN C, 1995, GENOMICS, V29, P207, DOI 10.1006/geno.1995.1233
   Okamoto T, 2000, NAT BIOTECHNOL, V18, P438
   Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212
   Phillips Jennifer, 1996, Methods (Orlando), V10, P283, DOI 10.1006/meth.1996.0104
   Ramsay W., 1898, FENNIA, V16, P1
   *RES GEN, GEN FILT
   Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432
   Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614
   Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439
   Schuler GD, 1996, METHOD ENZYMOL, V266, P141
   Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540
   Sgroi DC, 1999, CANCER RES, V59, P5656
   Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639
   Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664
   Southern E, 1999, NAT GENET, V21, P5, DOI 10.1038/4429
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   Thorp HH, 1998, TRENDS BIOTECHNOL, V16, P117, DOI 10.1016/S0167-7799(97)01162-1
   VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484
   VOLLRATH D, 1987, NUCLEIC ACIDS RES, V15, P7865, DOI 10.1093/nar/15.19.7865
   Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077
   Wang E, 2000, NAT BIOTECHNOL, V18, P457
   Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10
   ZHAO ND, 1995, GENE, V156, P207, DOI 10.1016/0378-1119(95)00023-Y
NR 81
TC 16
Z9 17
U1 0
U2 0
PU BENTHAM SCIENCE PUBL LTD
PI HILVERSUM
PA PO BOX 1673, 1200 BR HILVERSUM, NETHERLANDS
SN 1385-2728
J9 CURR ORG CHEM
JI Curr. Org. Chem.
PD SEP
PY 2000
VL 4
IS 9
BP 945
EP 971
DI 10.2174/1385272003375987
PG 27
WC Chemistry, Organic
SC Chemistry
GA 357TB
UT WOS:000089516000005
DA 2018-10-20
ER

PT J
AU Bishop, JW
   Marshall, CJ
   Bentz, JS
AF Bishop, JW
   Marshall, CJ
   Bentz, JS
TI New technologies in gynecologic cytology
SO JOURNAL OF REPRODUCTIVE MEDICINE
LA English
DT Article; Proceedings Paper
CT International Consensus Conference on the Fight Against Cervical Cancer
CY MAR 18-22, 2000
CL CHICAGO, ILLINOIS
SP IAC Task Force
DE cytology; biomedical technology; cervix neoplasms; cervical smears
ID INVASIVE CERVICAL-CANCER; AUTOPAP-300 QC SYSTEM; SQUAMOUS-CELL
   CARCINOMA; PAPNET TESTING SYSTEM; MULTICENTER CLINICAL-TRIALS;
   HUMAN-PAPILLOMAVIRUS DNA; FALSE-NEGATIVE SMEARS; PAPANICOLAOU SMEAR;
   QUALITY-CONTROL; SCREENING SYSTEM
AB New technologies are trying to make significant changes in the way we perform the Pap smear test, a test that has undergone no significant modification since its inception. Efforts have focused on improving sampling with liquid-based methods, improving detection of abnormal cells with automated screening and improving the detection of human papillomavirus with assays practical for use in routine clinical material. This article reviews the performance of the new technologies to date, with an emphasis on those that are currently approved for cervical cytology testing. In the aggregate, these technologies call have a positive impact on cervical disease detection and intervention.
C1 Univ Calif Davis, Med Ctr, Dept Pathol, Sacramento, CA 95817 USA.
   Univ Utah, Dept Pathol, Salt Lake City, UT USA.
RP Bishop, JW (reprint author), Univ Calif Davis, Med Ctr, Dept Pathol, 4400 V St, Sacramento, CA 95817 USA.
CR ADAMI HO, 1994, CANCER-AM CANCER SOC, V73, P140, DOI 10.1002/1097-0142(19940101)73:1<140::AID-CNCR2820730124>3.0.CO;2-2
   *AG HLTH CAR POL R, 1999, EV REP EV CERV CYT
   ALBERT A, 1981, JNCI-J NATL CANCER I, V67, P571
   ANDERSON GH, 1992, OBSTET GYNECOL, V80, P1
   [Anonymous], 1986, BMJ-BRIT MED J, V293, P659
   APONTECIPRIANI SL, 1995, ACTA CYTOL, V39, P623
   Ashfaq R, 1999, ACTA CYTOL, V43, P81, DOI 10.1159/000330872
   ASHFAQ R, 1995, DIAGN CYTOPATHOL, V13, P188
   ATTWOOD ME, 1985, ACTA CYTOL, V29, P108
   Austin RM, 1999, ACTA CYTOL, V43, P4, DOI 10.1159/000330535
   AUSTOKER J, 1994, BRIT MED J, V309, P241, DOI 10.1136/bmj.309.6949.241
   AUSTOKER J, 1994, BRIT MED J, V309, P452
   AWEN C, 1994, DIAGN CYTOPATHOL, V11, P33, DOI 10.1002/dc.2840110109
   Baldauf JJ, 1997, ACTA CYTOL, V41, P1431, DOI 10.1159/000332855
   BARRETT DL, 1977, J HISTOCHEM CYTOCHEM, V25, P495, DOI 10.1177/25.7.893998
   Bartels PH, 1999, ACTA CYTOL, V43, P7, DOI 10.1159/000330554
   BENEDET JL, 1981, GYNECOL ONCOL, V12, pS280, DOI 10.1016/0090-8258(81)90081-0
   BENOIT AG, 1984, AM J OBSTET GYNECOL, V148, P690, DOI 10.1016/0002-9378(84)90775-0
   BERKELEY AS, 1980, LANCET, V2, P375
   BERKOWITZ RS, 1979, GYNECOL ONCOL, V8, P311, DOI 10.1016/0090-8258(79)90040-4
   Bibbo M, 1999, ACTA CYTOL, V43, P23, DOI 10.1159/000330863
   Bibbo M, 1999, ACTA CYTOL, V43, P27, DOI 10.1159/000330864
   Birdsong GG, 1996, HUM PATHOL, V27, P468, DOI 10.1016/S0046-8177(96)90090-8
   Bishop JW, 1998, ACTA CYTOL, V42, P189, DOI 10.1159/000331545
   Bishop JW, 1997, ACTA CYTOL, V41, P15, DOI 10.1159/000332299
   Bishop JW, 1999, ACTA CYTOL, V43, P34, DOI 10.1159/000330866
   Bishop JW, 2000, ACTA CYTOL, V44, P128, DOI 10.1159/000326349
   BOGDANICH W, 1987, WALL STREET J   1102, P1
   Bolick DR, 1998, ACTA CYTOL, V42, P209, DOI 10.1159/000331548
   BOON ME, 1994, MODERN PATHOL, V7, P957
   BOSCH FX, 1995, J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796
   BOSCH MMC, 1992, ACTA CYTOL, V36, P711
   BOYES DA, 1977, AM J OBSTET GYNECOL, V128, P692, DOI 10.1016/0002-9378(77)90223-X
   BOYES DA, 1982, CLIN INVEST MED, V5, P1
   BRINTON LA, 1993, GYNECOL ONCOL, V51, P301, DOI 10.1006/gyno.1993.1294
   BUR M, 1995, ACTA CYTOL, V39, P631
   CARMICHAEL JA, 1984, AM J OBSTET GYNECOL, V148, P685, DOI 10.1016/0002-9378(84)90774-9
   Carpenter AB, 1999, CANCER CYTOPATHOL, V87, P105, DOI 10.1002/(SICI)1097-0142(19990625)87:3<105::AID-CNCR2>3.0.CO;2-Z
   CECCHINI S, 1985, ACTA CYTOL, V29, P329
   CHRISTOPHERSON WM, 1970, CANCER-AM CANCER SOC, V26, P808, DOI 10.1002/1097-0142(197010)26:4<808::AID-CNCR2820260411>3.0.CO;2-S
   CHRISTOPHERSON WM, 1970, CANCER-AM CANCER SOC, V26, P29, DOI 10.1002/1097-0142(197007)26:1<29::AID-CNCR2820260104>3.0.CO;2-G
   Clavel C, 1999, BRIT J CANCER, V80, P1306, DOI 10.1038/sj.bjc.6690523
   COLGAN TJ, 1995, ACTA CYTOL, V39, P1191
   Colgan TJ, 1997, ACTA CYTOL, V41, P50, DOI 10.1159/000332305
   COPPLESON LW, 1974, AM J OBSTET GYNECOL, V119, P953, DOI 10.1016/0002-9378(74)90013-1
   Corkill M, 1998, J Low Genit Tract Dis, V2, P12, DOI 10.1097/00128360-199801000-00003
   Corkill M, 1997, ACTA CYTOL, V41, P39, DOI 10.1159/000332303
   CRAMER DW, 1974, CANCER, V34, P2018, DOI 10.1002/1097-0142(197412)34:6<2018::AID-CNCR2820340621>3.0.CO;2-B
   Davey DD, 1996, ARCH PATHOL LAB MED, V120, P440
   Denaro TJ, 1997, ACTA CYTOL, V41, P65, DOI 10.1159/000332307
   DEVESA SS, 1987, J NATL CANCER I, V79, P701
   Diaz-Rosario LA, 1999, ARCH PATHOL LAB MED, V123, P817
   DICKINSON L, 1972, MAYO CLIN PROC, V47, P534
   Doornewaard H, 1997, CYTOPATHOLOGY, V8, P313, DOI 10.1111/j.1365-2303.1997.tb00555.x
   DUNN JE, 1981, AM J OBSTET GYNECOL, V139, P868, DOI 10.1016/0002-9378(81)90951-0
   Dupree WB, 1998, CANCER CYTOPATHOL, V84, P202, DOI 10.1002/(SICI)1097-0142(19980825)84:4<202::AID-CNCR4>3.0.CO;2-O
   ELIAS A, 1983, ACTA CYTOL, V27, P225
   FAHEY MT, 1995, AM J EPIDEMIOL, V141, P680, DOI 10.1093/oxfordjournals.aje.a117485
   Ferenczy A, 1996, ACTA CYTOL, V40, P1136
   Ferenczy A, 1996, AM J OBSTET GYNECOL, V175, P651
   Fetherston W C, 1983, Clin Obstet Gynecol, V26, P929, DOI 10.1097/00003081-198312000-00017
   Fetterman B, 1999, ACTA CYTOL, V43, P13, DOI 10.1159/000330862
   FIDLER H. K., 1968, J OBSTET GYNAECOL BRIT COMMONW, V75, P392
   Fiel-Gan MD, 1999, ACTA CYTOL, V43, P1034, DOI 10.1159/000331350
   FIGGE DC, 1970, AM J OBSTET GYNECOL, V108, P422, DOI 10.1016/0002-9378(70)90425-4
   GAY JD, 1985, ACTA CYTOL, V29, P1043
   GEYER JW, 1993, DIAGN CYTOPATHOL, V9, P417, DOI 10.1002/dc.2840090409
   Goodman A, 1996, J REPROD MED, V41, P239
   Greer BE, 1997, ARCH PATHOL LAB MED, V121, P246
   Guidos BJ, 1999, DIAGN CYTOPATHOL, V20, P70, DOI 10.1002/(SICI)1097-0339(199902)20:2<70::AID-DC5>3.0.CO;2-E
   GUZICK DS, 1978, AM J PUBLIC HEALTH, V68, P125, DOI 10.2105/AJPH.68.2.125
   HAKAMA M, 1976, AM J EPIDEMIOL, V103, P512, DOI 10.1093/oxfordjournals.aje.a112253
   HAMMOND EC, 1968, CANCER, V22, P1096, DOI 10.1002/1097-0142(196811)22:6<1096::AID-CNCR2820220604>3.0.CO;2-7
   Henry JA, 1996, ACTA CYTOL, V40, P529
   Hildesheim A, 1999, AM J OBSTET GYNECOL, V180, P571, DOI 10.1016/S0002-9378(99)70256-5
   Howell LP, 1998, ACTA CYTOL, V42, P171, DOI 10.1159/000331542
   Howell LP, 1999, ACTA CYTOL, V43, P58, DOI 10.1159/000330869
   Huang TW, 1999, ACTA CYTOL, V43, P363, DOI 10.1159/000331082
   HUSAIN OAN, 1974, J CLIN PATHOL, V27, P935, DOI 10.1136/jcp.27.12.935
   HUTCHINSON ML, 1991, AM J CLIN PATHOL, V96, P300
   HUTCHINSON ML, 1992, ACTA CYTOL, V36, P499
   HUTCHINSON ML, 1994, AM J CLIN PATHOL, V101, P215, DOI 10.1093/ajcp/101.2.215
   Hutchinson ML, 1999, CANCER CYTOPATHOL, V87, P48, DOI 10.1002/(SICI)1097-0142(19990425)87:2<48::AID-CNCR2>3.0.CO;2-D
   Hutchison Martha, 1992, Acta Cytologica, V36, P577
   INHORN SL, 1998, J LOWER GENITAL TRAC, V2, P208
   JANERICH DT, 1995, AM J PUBLIC HEALTH, V85, P791, DOI 10.2105/AJPH.85.6.791
   JONES B, 1994, CERVICAL BIOPSY CYTO, P93
   Jones BA, 1995, ARCH PATHOL LAB MED, V119, P1097
   Kinney WK, 1998, OBSTET GYNECOL, V91, P973, DOI 10.1016/S0029-7844(98)00080-5
   Koss LG, 1997, HUM PATHOL, V28, P1196, DOI 10.1016/S0046-8177(97)90258-6
   KOSS LG, 1993, CANCER, V71, P1406, DOI 10.1002/cncr.2820710405
   KOSS LG, 1994, AM J CLIN PATHOL, V101, P220, DOI 10.1093/ajcp/101.2.220
   Krieger P, 1997, ACTA CYTOL, V41, P11, DOI 10.1159/000332298
   KRISTENSEN GB, 1991, ACTA CYTOL, V35, P47
   KUNKEL WB, 1948, J APPL PHYS, V19, P1056, DOI 10.1063/1.1698010
   KUNZ J, 1998, SCHWEIZ RUNDSCH MED, V87, P1434
   LAARA E, 1987, LANCET, V1, P1247
   Laverty CR, 1997, ANAL QUANT CYTOL, V19, P239
   LAVERTY CRA, 1995, CYTOPATHOLOGY, V6, P140, DOI 10.1111/j.1365-2303.1995.tb00466.x
   Lee JSJ, 1997, ACTA CYTOL, V41, P56, DOI 10.1159/000332306
   Lee JSJ, 1998, ACTA CYTOL, V42, P221, DOI 10.1159/000331550
   Lee KR, 1997, OBSTET GYNECOL, V90, P278, DOI 10.1016/S0029-7844(97)00228-7
   LENTRICHIA BB, 2000, OBSTET GYNECOL S1, V95, pS3
   Liaw KL, 1999, J NATL CANCER I, V91, P954, DOI 10.1093/jnci/91.11.954
   LYNGE E, 1989, CANCER RES, V49, P2157
   MACGREGOR JE, 1986, IARC SCI PUBL, V76, P25
   MANGO LJ, 1994, CANCER LETT, V77, P155, DOI 10.1016/0304-3835(94)90098-1
   Mango LJ, 1998, ACTA CYTOL, V42, P227, DOI 10.1159/000331551
   Manos MM, 1999, JAMA-J AM MED ASSOC, V281, P1605, DOI 10.1001/jama.281.17.1605
   Marshall CJ, 1999, DIAGN CYTOPATHOL, V20, P170, DOI 10.1002/(SICI)1097-0339(199903)20:3<170::AID-DC12>3.3.CO;2-Y
   MARTIN PL, 1972, AM J OBSTET GYNECOL, V113, P541, DOI 10.1016/S0002-9378(15)32505-9
   Martinez I, 1984, Bol Asoc Med P R, V76, P100
   McGoogan E, 1996, ACTA CYTOL, V40, P107
   Minge L, 2000, J REPROD MED, V45, P179
   MITCHELL H, 1990, BRIT MED J, V300, P1622, DOI 10.1136/bmj.300.6740.1622
   MORELL ND, 1982, OBSTET GYNECOL, V60, P41
   NIELSEN NH, 1993, APMIS, V101, P290, DOI 10.1111/j.1699-0463.1993.tb00113.x
   Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X
   OTTO K, 1979, ANAL QUANT CYTOL, V1, P127
   OUD PS, 1984, CYTOMETRY, V5, P509, DOI 10.1002/cyto.990050512
   OUWERKERKNOORDAM E, 1994, CYTOPATHOLOGY, V5, P211, DOI 10.1111/j.1365-2303.1994.tb00422.x
   Papanicolaou GN, 1941, AM J OBSTET GYNECOL, V42, P193
   Papillo JL, 1998, ACTA CYTOL, V42, P203, DOI 10.1159/000331547
   PATERSON MEL, 1984, BRIT MED J, V289, P896, DOI 10.1136/bmj.289.6449.896
   Patten SF, 1996, ACTA CYTOL, V40, P45
   Patten SF, 1997, CANCER CYTOPATHOL, V81, P337, DOI 10.1002/(SICI)1097-0142(19971225)81:6<337::AID-CNCR7>3.0.CO;2-I
   Patten SF, 1997, CANCER CYTOPATHOL, V81, P343, DOI 10.1002/(SICI)1097-0142(19971225)81:6<343::AID-CNCR8>3.0.CO;2-M
   PETERS RK, 1988, AM J OBSTET GYNECOL, V158, P926, DOI 10.1016/0002-9378(88)90096-8
   PRENDIVILLE W, 1980, LANCET, V2, P853
   REMMINK AJ, 1995, INT J CANCER, V61, P306, DOI 10.1002/ijc.2910610305
   RIES LA, 1994, SEER CANC STAT REV 1
   ROBERTS AW, 1985, MED J AUSTRALIA, V143, P333
   Roberts JM, 1997, MED J AUSTRALIA, V167, P466
   Rosenthal DL, 1996, ACTA CYTOL, V40, P120
   ROSENTHAL DL, 1987, ANAL QUANT CYTOL, V9, P55
   ROSENTHAL DL, 1979, ANAL QUANT CYTOL, V1, P84
   RUBIO CA, 1981, ACTA CYTOL, V25, P199
   RUBIO CA, 1977, OBSTET GYNECOL, V49, P576
   RYLANDER E, 1977, ACTA OBSTET GYN SCAN, V56, P115, DOI 10.3109/00016347709158352
   RYLANDER E, 1976, ACTA OBSTET GYN SCAN, V55, P361, DOI 10.3109/00016347609158514
   Sampson AJ, 1997, ARCH PATHOL LAB MED, V121, P241
   Sato S, 1998, ACTA CYTOL, V42, P299, DOI 10.1159/000331607
   Sawaya GF, 1999, OBSTET GYNECOL, V94, P307, DOI 10.1016/S0029-7844(99)00289-6
   Schiffman M, 2000, JAMA-J AM MED ASSOC, V283, P87, DOI 10.1001/jama.283.1.87
   SCHWARZ G, 1983, ANAL QUANT CYTOL, V5, P189
   SFAMENI SF, 1989, AUST NZ J OBSTET GYN, V29, P40, DOI 10.1111/j.1479-828X.1989.tb02874.x
   Sherman ME, 1998, MODERN PATHOL, V11, P837
   Sherman ME, 1997, CANCER CYTOPATHOL, V81, P89
   SHERMAN ME, 1994, MODERN PATHOL, V7, P578
   Shield PW, 1999, MED J AUSTRALIA, V170, P255
   SLAGEL DD, 1995, DIAGN CYTOPATHOL, V13, P26, DOI 10.1002/dc.2840130107
   Sprenger E, 1996, ACTA CYTOL, V40, P81
   Stanley MW, 1998, AM J CLIN PATHOL, V109, P6
   STENKVIST B, 1984, JAMA-J AM MED ASSOC, V252, P1423, DOI 10.1001/jama.252.11.1423
   Stevens MW, 1997, DIAGN CYTOPATHOL, V16, P505, DOI 10.1002/(SICI)1097-0339(199706)16:6<505::AID-DC7>3.0.CO;2-8
   Stevens MW, 1998, DIAGN CYTOPATHOL, V18, P236, DOI 10.1002/(SICI)1097-0339(199803)18:3<236::AID-DC15>3.0.CO;2-L
   Takahashi M, 1998, ACTA CYTOL, V42, P185, DOI 10.1159/000331544
   Takahashi M, 1997, ACTA CYTOL, V41, P1785
   TANAKA N, 1981, ANAL QUANT CYTOL, V3, P96
   TEZUKA F, 1995, ACTA CYTOL, V39, P837
   Tezuka F, 1996, ACTA CYTOL, V40, P513
   VANDRIELKULKER AMJ, 1980, ANAL QUANT CYTOL, V2, P243
   Varner CD, 1997, ARCH PATHOL LAB MED, V121, P315
   Vassilakos P, 1998, ACTA CYTOL, V42, P198, DOI 10.1159/000331546
   Vassilakos P, 2000, J REPROD MED, V45, P11
   Vassilakos P, 1996, ACTA CYTOL, V40, P496
   Vassilakos P, 1999, ACTA CYTOL, V43, P65, DOI 10.1159/000330870
   Vassilakos P, 1998, INT J GYNECOL OBSTET, V61, P45, DOI 10.1016/S0020-7292(98)00012-5
   VOOIJS PG, 1985, ACTA CYTOL, V29, P323
   WAIN GV, 1992, MED J AUSTRALIA, V157, P14
   Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
   WALKER EM, 1983, BRIT J OBSTET GYNAEC, V90, P1087, DOI 10.1111/j.1471-0528.1983.tb06449.x
   WALTON RJ, 1976, CAN MED ASSOC J, V114, P981
   Wang TY, 1999, J FORMOS MED ASSOC, V98, P500
   Weintraub J, 2000, DIAGN CYTOPATHOL, V22, P52, DOI 10.1002/(SICI)1097-0339(200001)22:1<52::AID-DC14>3.0.CO;2-#
   WEINTRAUB J, 1997, REF GYNECOL OBSTET, V5, P2
   Wertlake P, 1999, J REPROD MED, V44, P11
   WHEELESS LL, 1974, J HISTOCHEM CYTOCHEM, V22, P522, DOI 10.1177/22.7.522
   Wilbur DC, 1997, ACTA CYTOL, V41, P24, DOI 10.1159/000332300
   WILBUR DC, 1994, AM J CLIN PATHOL, V101, P209, DOI 10.1093/ajcp/101.2.209
   Wilbur DC, 1998, ACTA CYTOL, V42, P214, DOI 10.1159/000331549
   Wilbur DC, 1996, DIAGN CYTOPATHOL, V14, P201, DOI 10.1002/(SICI)1097-0339(199604)14:3<201::AID-DC2>3.3.CO;2-2
   Wilbur DC, 1996, ACTA CYTOL, V40, P127
   Wilbur DC, 1999, CANCER CYTOPATHOL, V87, P354
   WOODMAN CBJ, 1989, LANCET, V2, P88
   Wright TC, 1998, AM J OBSTET GYNECOL, V178, P962, DOI 10.1016/S0002-9378(98)70531-9
NR 186
TC 13
Z9 13
U1 0
U2 0
PU SCI PRINTERS & PUBL INC
PI ST LOUIS
PA P.O. DRAWER 12425 8342 OLIVE BLVD, ST LOUIS, MO 63132 USA
SN 0024-7758
J9 J REPROD MED
JI J. Reprod. Med.
PD SEP
PY 2000
VL 45
IS 9
BP 701
EP 719
PG 19
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 359UB
UT WOS:000089629500003
PM 11027079
DA 2018-10-20
ER

PT J
AU Wang, YJ
AF Wang, YJ
TI Development of new polycations for cell encapsulation with alginate
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Bionic Design Workshop
CY FEB 22-23, 1999
CL TOKYO, JAPAN
DE microcapsules; mechanical strength; cross-linking; polycations; alginate
ID LIVING CELLS; MICROENCAPSULATION; MICROCAPSULES; MEMBRANES
AB Microencapsulation is one of the most important techniques used in immobilizing cells for biomedical applications. Of the many microcapsules derived from various materials, the one formed by alginate and poly(L-lysine) is probably the most common. These microcapsules, prepared under mild conditions, provide an adequate environment for cell growth. Unfortunately, they usually lack mechanical strength due to the ionic interaction, instead of covalent bonding, between alginate and polycations.
   In order to improve the mechanical strength, we have investigated the feasibility of using poly(vinylamine) and poly(allylamine) to replace the conventional poly(L-lysine). Of these two polycations, poly(allylamine) formed microcapsules of about the same strength as that prepared from poly(L-lysine). On the other hand, microcapsules prepared from alginate and poly(vinylamine) have about 40% of capsules weaker than that prepared from poly(L-lysine). However, the remaining 60% of its population remained intact even after 48 h of mechanical vibration test.
   An alternative strengthening method is to cross-link poly(L-lysine) by chemical or photochemical process. The chemical method was conducted by treating microcapsules with tosylated poly(vinylalcohol). This treatment resulted in the cross-linking of poly(L-lysine) in the capsular membrane and therefore, a significant improvement of capsular strength. For the photochemical method, a photosensitive polycation was prepared by partially modifying the amino groups of the poly(L-lysine) with alpha -phenylcinnamyldieneacetyl chloride. The capsules formed from alginate and this photosensitive polymer yield the highest mechanical strength after irradiation of light at similar to 320 nm. All microcapsules investigated were permeable to the proteins of mid-size molecular weight such as myoglobin. Cells can be entrapped and cultured by using this encapsulation technology. (C) 2000 Elsevier Science S.A. All rights reserved.
C1 Natl Yang Ming Univ, Inst Biomed Engn, Taipei 112, Taiwan.
RP Wang, YJ (reprint author), Natl Yang Ming Univ, Inst Biomed Engn, Taipei 112, Taiwan.
CR BANO MC, 1991, BIO-TECHNOL, V9, P468, DOI 10.1038/nbt0591-468
   BAYER E, 1980, MAKROMOL CHEM, V181, P503
   Chang SJ, 1999, J BIOMAT SCI-POLYM E, V10, P531
   Chang T M, 1992, ASAIO J, V38, P128, DOI 10.1097/00002480-199204000-00013
   CHANG TMS, 1964, SCIENCE, V146, P524, DOI 10.1126/science.146.3643.524
   HALLE JP, 1993, TRANSPLANTATION, V55, P350, DOI 10.1097/00007890-199302000-00023
   KUNG IM, 1995, BIOMATERIALS, V16, P649, DOI 10.1016/0142-9612(95)93863-9
   LIM F, 1981, J PHARM SCI, V70, P351, DOI 10.1002/jps.2600700402
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   SAWHNEY AS, 1992, BIOMATERIALS, V13, P863, DOI 10.1016/0142-9612(92)90180-V
   TANAKA H, 1972, J POLYM SCI A1, V10, P1729, DOI 10.1002/pol.1972.150100614
   Thu B, 1996, BIOMATERIALS, V17, P1031, DOI 10.1016/0142-9612(96)84680-1
   ULUDAG H, 1992, BIOTECHNOL BIOENG, V39, P672, DOI 10.1002/bit.260390612
   WANG FF, 1992, BIOTECHNOL BIOENG, V40, P1115, DOI 10.1002/bit.260400916
   Zekorn T, 1995, TRANSPLANT P, V27, P3362
NR 15
TC 25
Z9 28
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD SEP 1
PY 2000
VL 13
IS 1-2
SI SI
BP 59
EP 63
DI 10.1016/S0928-4931(00)00177-6
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 367BA
UT WOS:000090040600010
DA 2018-10-20
ER

PT J
AU Eastwood, S
   Derish, PA
   Berger, MS
AF Eastwood, S
   Derish, PA
   Berger, MS
TI Biomedical publication for neurosurgery residents: A program and guide
SO NEUROSURGERY
LA English
DT Article
DE biomedical publication; biomedical writing; critical appraisal skills;
   professional training; publication ethics
ID REQUIRING PROLONGED OBSERVATION; RANDOMIZED CONTROLLED TRIALS;
   CRITICAL-APPRAISAL SKILLS; JOURNAL CLUB; EMERGENCY-MEDICINE; ATTITUDES;
   KNOWLEDGE; IMPACT; INTERVENTION; CURRICULUM
AB ONE OF THE most pressing obligations in academic neurosurgery is the publication of clinical and basic science research results. Publication documents intellectual property and communicates findings among researchers working to improve neurosurgical treatment. It documents productivity, justifies funding for research, creates reputations, and builds careers. Nonetheless, the actual writing of reports is a skill often learned by osmosis in academic medicine. To give residents the tools necessary to negotiate the biomedical publication process successfully, we developed a publications program based on the premise that residents seeking an academic career must be prepared to generate publishable reports with maximum efficiency. The program consists of a "publication kit," a series of seminars, and one-on-one tutorials with academic biomedical editors that permit residents individually to improve the quality of their reporting. We describe this program, provide guidelines that can help residents write high-quality papers and publish their work more efficiently, and summarize important content regarding the framework for a successful paper, the elements of a conventional research report, brief guidelines for specific types of papers, reporting standards for clinical trials and meta-analyses, keys to citation in bibliographic indexes, and ethical and legal considerations related to research approval, confidentiality requirements, copyright law, permission to use previously published material, and conflict of interest. Residents who are able to view their work with a sharp critical focus and are educated about the standards of biomedical publication are better prepared to succeed in building a career in academic medicine.
C1 Univ Calif San Francisco, Dept Neurol Surg, Div Publ & Grants Writing, Sch Med, Emeryville, CA 94662 USA.
RP Eastwood, S (reprint author), Univ Calif San Francisco, Dept Neurol Surg, Div Publ & Grants Writing, Sch Med, POB 8099, Emeryville, CA 94662 USA.
CR Alguire PC, 1998, J GEN INTERN MED, V13, P347, DOI 10.1046/j.1525-1497.1998.00102.x
   Avery L, 1996, NATURE, V379, P293, DOI 10.1038/379293b0
   Bailar III J. C., 1992, MED USES STAT
   BARR SI, 1989, J CAN DIET ASSOC, V50, P219
   Bazarian JJ, 1999, ANN EMERG MED, V34, P148, DOI 10.1016/S0196-0644(99)70222-2
   Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637
   BENNETT KJ, 1987, JAMA-J AM MED ASSOC, V257, P2451, DOI 10.1001/jama.257.18.2451
   BENZEL EC, 1999, CHANGING FACE ACAD P
   Blanda M, 1999, ACAD EMERG MED, V6, P286, DOI 10.1111/j.1553-2712.1999.tb00390.x
   BROWNER WS, 1999, PUBLISHING PRESENTIN
   Burstein JL, 1996, AM J EMERG MED, V14, P561, DOI 10.1016/S0735-6757(96)90099-6
   CASSUTO L, 1998, CHRONICLE HIGHE 1127, pB4
   Clever LH, 1997, ANN INTERN MED, V126, P36, DOI 10.7326/0003-4819-126-1-199701010-00006
   COHEN SJ, 1985, SOC SCI MED, V21, P909, DOI 10.1016/0277-9536(85)90147-9
   Coleridge S T, 1993, J Am Osteopath Assoc, V93, P936
   COX DR, 1984, ANAL SURVIVAL DATA
   DAWSONSAUNDERS B, 1994, BASIC CLIN BIOSTATIS
   DICHIRO G, 1989, RADIOLOGY, V170, P569, DOI 10.1148/radiology.170.2.2911688
   Eastwood S, 2000, ETHICAL ISSUES IN BIOMEDICAL PUBLICATION, P250
   EASTWOOD S, 1993, PANEL SCI RESPONSIBI, V2
   Eastwood Susan, 1996, Sci Eng Ethics, V2, P89, DOI 10.1007/BF02639320
   EDWARDS CG, 1999, HMS BEAGLE 63
   Fackler ML, 1996, ANN INTERN MED, V124, P741, DOI 10.7326/0003-4819-124-8-199604150-00007
   Fish JS, 1998, PLAST RECONSTR SURG, V101, P1400, DOI 10.1097/00006534-199804050-00043
   Franck G, 1999, SCIENCE, V286, P53, DOI 10.1126/science.286.5437.53
   FYE WB, 1990, ANN INTERN MED, V113, P317, DOI 10.7326/0003-4819-113-4-317
   Glass G. V., 1977, REV RES EDUC, V5, P351, DOI [10.2307/1167179, DOI 10.3102/0091732X005001351]
   GLAZER S, 1997, CQ RES, V7, P3
   Green ML, 1997, J GEN INTERN MED, V12, P742, DOI 10.1046/j.1525-1497.1997.07159.x
   Greenhalgh T., 1997, READ PAPER BASICS EV
   Heiligman R M, 1991, Fam Med, V23, P152
   Huth E. J., 1990, WRITE PUBLISH PAPERS
   JONES J, 1987, ANN EMERG MED, V16, P347, DOI 10.1016/S0196-0644(87)80186-5
   KITCHENS JM, 1989, J GEN INTERN MED, V4, P384, DOI 10.1007/BF02599686
   KROGH CL, 1985, MED EDUC, V19, P392, DOI 10.1111/j.1365-2923.1985.tb01343.x
   LANDRY FJ, 1994, J GEN INTERN MED, V9, P436, DOI 10.1007/BF02599058
   LINZER M, 1988, JAMA-J AM MED ASSOC, V260, P2537, DOI 10.1001/jama.260.17.2537
   MARKERT RJ, 1989, ACAD MED, V64, P223, DOI 10.1097/00001888-198904000-00014
   Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5
   Morris B A, 1994, Fam Med, V26, P579
   *NAT I HLTH REM UP, 1992, NIH GUIDE GRANTS CON, V21, P2
   National Asthma Education and Prevention Program, 1997, EX SUMM NIH REP, P6
   NIEDERHUBER JE, 1996, ONCOLOGIST, V1, pR7
   Norman GR, 1998, CAN MED ASSOC J, V158, P177
   *OFF RES INT US PU, 1993, ORI NEWSLETTER, V1, P8
   ORDWAY S, 1994, GUIDE PUBLISHING BIO
   PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1
   PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220
   SEELIG CB, 1991, J GEN INTERN MED, V6, P330
   SIPE TA, 1995, THESIS U MICROFILMS
   Smith R, 1998, BRIT MED J, V316, P949, DOI 10.1136/bmj.316.7136.949
   Spickard A, 1996, J GEN INTERN MED, V11, P475, DOI 10.1007/BF02599042
   Spillane AJ, 1998, AUST NZ J SURG, V68, P288, DOI 10.1111/j.1445-2197.1998.tb02085.x
   STERN DT, 1995, ACAD MED, V70, P152, DOI 10.1097/00001888-199502000-00021
   Stevermer JJ, 1999, ACAD MED, V74, P70
   Supino PG, 1999, ACAD EMERG MED, V6, P280, DOI 10.1111/j.1553-2712.1999.tb00389.x
   TAUBES G, 1995, SCIENCE, V268, P1711, DOI 10.1126/science.7792592
   TAUBES G, 1995, SCIENCE, V268, P1714, DOI 10.1126/science.7605516
   Valentini RP, 1997, POSTGRAD MED J, V73, P81, DOI 10.1136/pgmj.73.856.81
   Williams RL, 1998, ACAD MED, V73, P333, DOI 10.1097/00001888-199803000-00023
   Woodford F. P., 1999, TEACH SCI COMMUNICAT
   Zeiger M., 1991, ESSENTIALS WRITING B
   1988, C NEUR SURG BYL C NE
   1996, NATURE, V384, P497
NR 64
TC 18
Z9 18
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0148-396X
J9 NEUROSURGERY
JI Neurosurgery
PD SEP
PY 2000
VL 47
IS 3
BP 739
EP 748
DI 10.1097/00006123-200009000-00043
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 349GJ
UT WOS:000089037100095
PM 10981762
DA 2018-10-20
ER

PT J
AU Cui, FZ
   Li, DJ
AF Cui, FZ
   Li, DJ
TI A review of investigations on biocompatibility of diamond-like carbon
   and carbon nitride films
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 2nd Asian-European International Conference on Plasma Surface
   Engineering (AEPSE '99)
CY SEP 15-19, 1999
CL BEIJING, PEOPLES R CHINA
SP Tsinghua Univ, Taiyuan Univ Technol, Dalian Univ Technol, Natl Adv Mat Comm China, Natl Nat Sci Fdn China, Surface & Coatings Technol & Thin Solid Films, European Joint Comm Plasma & Ion Surface Engn
DE diamond-like carbon; carbon nitride; biocompatibility
ID BEAM-ASSISTED DEPOSITION; THIN-FILMS; LOW-TEMPERATURE; WEAR;
   BIOMATERIALS; MACROPHAGES; CULTURE; PLASMA
AB This paper reviews the present status of studies of biocompatibility of diamond-like carbon (DLC) and carbon nitride (CN) coatings. DLC and CN coatings, due to their novel mechanical and tribological properties, chemical inertness, electrical and optical properties, and biocompatibility, are excellent candidates for biomedical applications. A number of clinical applications for DLC are now being considered by commercial manufacturers of surgical implants. Preliminary studies have shown that DLC coating can be adherent on a range of biomaterials with desirable bulk properties, no toxicity toward living cells, no inflammatory response or loss of cell integrity, as well no cellular damage. Despite only a few reports about biocompatibility of CN coating, which, with its mechanical and chemical properties comparable with DLC, is a very attraction coating material for future biomedical applications. This paper outlines the present level of research and suggests areas for future research, these include in vivo tests and a more detailed investigation of coating bond structure or properties. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Tsinghua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
   Tianjin Normal Univ, Dept Phys, Tianjin 300074, Peoples R China.
RP Cui, FZ (reprint author), Tsinghua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
EM cuifz@sun.ihep.ac.cn
CR AISENBERG S, 1971, J APPL PHYS, V42, P2953, DOI 10.1063/1.1660654
   Allen Matthew, 1994, Clinical Materials, V17, P1, DOI 10.1016/0267-6605(94)90041-8
   AMARATUNGA G, 1989, APPL PHYS LETT, V55, P634, DOI 10.1063/1.101808
   ANDERSSON LP, 1981, THIN SOLID FILMS, V86, P193, DOI 10.1016/0040-6090(81)90288-1
   ANGUS JC, 1988, SCIENCE, V241, P913, DOI 10.1126/science.241.4868.913
   BULL SJ, 1992, DIAM RELAT MATER, V1, P1049, DOI 10.1016/0925-9635(92)90075-Y
   CATHERINE Y, 1991, NATO ADV SCI I B-PHY, V266, P193
   CHARNLEY J, 1975, CLIN ORTHOP RELAT R, V112, P170
   CHO NH, 1990, J MATER RES, V5, P2543, DOI 10.1557/JMR.1990.2543
   Clay KJ, 1998, DIAM RELAT MATER, V7, P1100, DOI 10.1016/S0925-9635(98)00159-9
   COURTNEY JM, 1993, MANAGEMENT BLEEDING, P236
   Cui FZ, 1999, SURF COAT TECH, V112, P278, DOI 10.1016/S0257-8972(98)00763-4
   CUOMO JJ, 1991, APPL PHYS LETT, V58, P466, DOI 10.1063/1.104609
   De Giorgi ML, 1998, APPL SURF SCI, V127, P481, DOI 10.1016/S0169-4332(97)00678-8
   Dion I., 1993, Bio-Medical Materials and Engineering, V3, P51
   Du C, 1998, BIOMATERIALS, V19, P651, DOI 10.1016/S0142-9612(97)00159-2
   FUJIMOTO F, 1993, JPN J APPL PHYS 2, V32, pL420, DOI 10.1143/JJAP.32.L420
   GOODMAN SB, 1989, CLIN ORTHOP RELAT R, V244, P182
   HAN HX, 1988, SOLID STATE COMMUN, V65, P921, DOI 10.1016/0038-1098(88)90732-6
   HARRIS SJ, 1993, SURF COAT TECH, V62, P550, DOI 10.1016/0257-8972(93)90298-3
   He XM, 1996, J VAC SCI TECHNOL A, V14, P2039, DOI 10.1116/1.580079
   Ianno NJ, 1995, THIN SOLID FILMS, V270, P275, DOI 10.1016/0040-6090(95)06710-8
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   LI D, 1993, J APPL PHYS, V74, P219, DOI 10.1063/1.355304
   Li DJ, 1999, APPL SURF SCI, V137, P30, DOI 10.1016/S0169-4332(98)00485-1
   Li DJ, 1999, J ADHES SCI TECHNOL, V13, P169, DOI 10.1163/156856199X00370
   LI HD, 1994, B MATER SCI, V17, P1415, DOI 10.1007/BF02747239
   LIU AY, 1989, SCIENCE, V245, P841, DOI 10.1126/science.245.4920.841
   Lu Luo, 1993, Bio-Medical Materials and Engineering, V3, P223
   MARTON D, 1994, PHYS REV LETT, V73, P118, DOI 10.1103/PhysRevLett.73.118
   MAYA L, 1991, J AM CERAM SOC, V74, P1686, DOI 10.1111/j.1151-2916.1991.tb07161.x
   MCCOLL IR, 1994, DIAM RELAT MATER, V3, P83, DOI 10.1016/0925-9635(94)90035-3
   Michler T, 1998, DIAM RELAT MATER, V7, P459, DOI 10.1016/S0925-9635(97)00236-7
   MIN Z, 1992, VACUUM, V43, P945, DOI 10.1016/0042-207X(92)90004-G
   MIYOSHI K, 1992, SURF COAT TECH, V55, P428, DOI 10.1016/S0257-8972(07)80061-2
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   NIU CM, 1993, SCIENCE, V261, P334, DOI 10.1126/science.261.5119.334
   OJHA SM, 1977, THIN SOLIF SILMS, V40, pL13
   PAPPAS DL, 1992, J APPL PHYS, V71, P5675, DOI 10.1063/1.350501
   PARKER TL, 1994, DIAM RELAT MATER, V3, P1120, DOI 10.1016/0925-9635(94)90104-X
   PARKER TL, 1993, DIAMOND FILMS, V93, P118
   Patil DS, 1998, J ALLOY COMPD, V278, P130, DOI 10.1016/S0925-8388(98)00601-X
   Quiros C, 1999, VACUUM, V52, P199, DOI 10.1016/S0042-207X(98)00220-6
   ROBERTSON J, 1994, PURE APPL CHEM, V66, P1789, DOI 10.1351/pac199466091789
   SAVVIDES N, 1986, J VAC SCI TECHNOL A, V4, P504, DOI 10.1116/1.573869
   SAVVIDES N, 1985, J APPL PHYS, V58, P518, DOI 10.1063/1.335656
   Sioshansi P, 1996, SURF COAT TECH, V83, P175, DOI 10.1016/0257-8972(95)02838-2
   SONG HW, 1994, J PHYS-CONDENS MAT, V6, P6125, DOI 10.1088/0953-8984/6/31/011
   SPENCER EG, 1976, APPL PHYS LETT, V29, P118, DOI 10.1063/1.88963
   Su XW, 1996, SURF COAT TECH, V84, P388, DOI 10.1016/S0257-8972(95)02809-9
   Su XW, 1996, NUCL INSTRUM METH B, V111, P59, DOI 10.1016/0168-583X(95)01300-8
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   TORNG CJ, 1990, J MATER RES, V5, P2490, DOI 10.1557/JMR.1990.2490
   WEISSMANTEL C, 1981, J VAC SCI TECHNOL, V18, P179, DOI 10.1116/1.570719
   WEISSMANTEL C, 1981, THIN SOLID FILMS, V61, pL1
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   WOLTER JR, 1990, BIOMATERIALS OPHTHAL
NR 57
TC 275
Z9 286
U1 3
U2 59
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD SEP 1
PY 2000
VL 131
IS 1-3
BP 481
EP 487
DI 10.1016/S0257-8972(00)00809-4
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 377WA
UT WOS:000165548200093
DA 2018-10-20
ER

PT J
AU Lin, J
AF Lin, J
TI Recent development and applications of optical and fiber-optic pH
   sensors
SO TRAC-TRENDS IN ANALYTICAL CHEMISTRY
LA English
DT Review
DE pH sensors; fiber-optic pH sensors; optical pH sensors
ID GEL IMMOBILIZATION TECHNIQUE; EVANESCENT-WAVE ABSORPTION; SINGLE LIVING
   CELLS; CARBON-DIOXIDE; IMAGING FIBER; SENSITIVITY ENHANCEMENT;
   FLUORESCENCE LIFETIMES; CHEMICAL-ANALYSIS; PEBBLE SENSORS; FILM SENSORS
AB This article provides a brief review on the development and applications of optical and fiber-optic pH sensors in the 1990s. Various methods and materials for immobilization of pH indicators are surveyed. Different spectroscopic methods used for measurement with pH sensors are briefly discussed. Several special optical and fiber-optic pH sensors ave reviewed, including pH sensors based on conductive polymers, imaging fibers, microparticles and nanospheres, as well as micron and sub-micron fiber-optic pH sensors, distributed fiber-optic pH sensors, pH sensors for high acidity and alkalinity, pH sensors with broad dynamic range and linear response, and CO2 and NH3 sensors based on pH indicators. Applications of fiberoptic sensors in environmental detection, biomedical research, medical monitoring and industrial process control are summarized. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Portland State Univ, Dept Chem, Portland, OR 97207 USA.
RP Lin, J (reprint author), Portland State Univ, Dept Chem, Portland, OR 97207 USA.
CR AHARONSON N, 1994, MATER RES SOC SYMP P, V346, P519
   Allain LR, 1997, ANAL CHEM, V69, P3076, DOI 10.1021/ac970258g
   Allain LR, 2000, ANAL CHEM, V72, P1078, DOI 10.1021/ac990908b
   ALLAIN LR, 1998, J PROCESS ANAL CHEM, V3, P98
   BACCI M, 1991, APPL SPECTROSC, V45, P1508, DOI 10.1366/0003702914335472
   BAKKER E, 1993, ANAL CHIM ACTA, V278, P211, DOI 10.1016/0003-2670(93)85102-P
   BALDINI F, 1994, APPL SPECTROSC, V48, P549, DOI 10.1366/0003702944924871
   BALDINI F, 1993, SENSOR ACTUAT A-PHYS, V37-8, P180, DOI 10.1016/0924-4247(93)80031-B
   BARNARD SM, 1991, NATURE, V353, P338, DOI 10.1038/353338a0
   Blue R, 1997, ELECTRON LETT, V33, P526, DOI 10.1049/el:19970321
   BRINKER CJ, 1990, SOL GEL SCI PHYSICS
   BRONK KS, 1994, ANAL CHEM, V66, P3519, DOI 10.1021/ac00092a035
   BRONK KS, 1995, ANAL CHEM, V67, P2750, DOI 10.1021/ac00113a005
   Browne CA, 1996, ANAL CHEM, V68, P2289, DOI 10.1021/ac960078r
   BUTLER TM, 1995, P SOC PHOTO-OPT INS, V2508, P168, DOI 10.1117/12.221730
   CARDWELL TJ, 1993, TALANTA, V40, P765, DOI 10.1016/0039-9140(93)80293-Z
   Clark HA, 1999, ANAL CHEM, V71, P4831, DOI 10.1021/ac990629o
   Clark HA, 1999, ANAL CHEM, V71, P4837, DOI 10.1021/ac990630n
   CUI DF, 1993, SENSOR ACTUAT B-CHEM, V12, P29
   DEBOUX BJC, 1995, J LIGHTWAVE TECHNOL, V13, P1407, DOI 10.1109/50.400705
   deMarcos S, 1996, ANAL CHIM ACTA, V334, P149, DOI 10.1016/S0003-2670(96)00290-5
   DING JY, 1991, ELECTRON LETT, V27, P1560, DOI 10.1049/el:19910978
   DRAXLER S, 1993, SENSOR ACTUAT B-CHEM, V11, P421
   DRAXLER S, 1995, P SOC PHOTO-OPT INS, V2388, P363, DOI 10.1117/12.208494
   Dybko A, 1998, SENSOR ACTUAT B-CHEM, V51, P208, DOI 10.1016/S0925-4005(98)00192-0
   Dybko A., 1992, International Journal of Optoelectronics, V7, P443
   DYBKO A, 1993, SPIE, V2085, P131
   DYBKO A, 1997, SENSOR ACTUAT B-CHEM, V38, P207
   Egami C, 1997, JPN J APPL PHYS 1, V36, P2902, DOI 10.1143/JJAP.36.2902
   Egami C, 1996, OPT COMMUN, V122, P122, DOI 10.1016/0030-4018(95)00536-6
   Ensafi AA, 1999, MICROCHEM J, V63, P381, DOI 10.1006/mchj.1999.1757
   Ferguson JA, 1997, ANAL CHIM ACTA, V340, P123, DOI 10.1016/S0003-2670(96)00510-7
   Flannery D, 1997, OPT LETT, V22, P567, DOI 10.1364/OL.22.000567
   GABOR G, 1995, ANAL CHIM ACTA, V313, P131, DOI 10.1016/0003-2670(95)00248-X
   GABOR G, 1991, ANAL CHEM, V63, P793, DOI 10.1021/ac00008a011
   GE ZF, 1993, ANAL CHEM, V65, P2335, DOI 10.1021/ac00065a028
   Grant SA, 1997, SENSOR ACTUAT B-CHEM, V45, P35, DOI 10.1016/S0925-4005(97)00263-3
   Grummt UW, 1997, ANAL CHIM ACTA, V357, P253, DOI 10.1016/S0003-2670(97)00572-2
   Gupta BD, 1998, OPT COMMUN, V154, P282, DOI 10.1016/S0030-4018(98)00321-6
   HAO TY, 1993, SENSOR ACTUAT B-CHEM, V10, P155, DOI 10.1016/0925-4005(93)80040-I
   Healey BG, 1997, ANAL CHEM, V69, P2213, DOI 10.1021/ac961058s
   HOLOBAR A, 1993, SENSOR ACTUAT B-CHEM, V11, P425, DOI 10.1016/0925-4005(93)85283-G
   IGARASHI S, 1994, ANAL SCI, V10, P821, DOI 10.2116/analsci.10.821
   JONES TP, 1991, APPL SPECTROSC, V45, P1271, DOI 10.1366/0003702914335814
   KOSTOV Y, 1993, ANAL CHIM ACTA, V280, P15, DOI 10.1016/0003-2670(93)80235-D
   KOSTOV YV, 1992, SENSOR ACTUAT B-CHEM, V8, P99, DOI 10.1016/0925-4005(92)85015-O
   Kuswandi B, 1999, FRESEN J ANAL CHEM, V364, P605, DOI 10.1007/s002160051394
   LEINER MJP, 1991, FIBER OPTIC CHEM SEN, V1, P359
   Lin J, 2000, ANAL CHIM ACTA, V408, P49, DOI 10.1016/S0003-2670(99)00840-5
   Lin J, 1997, TRAC-TREND ANAL CHEM, V16, P200, DOI 10.1016/S0165-9936(97)00021-6
   Lobnik A, 1998, ANAL CHIM ACTA, V367, P159, DOI 10.1016/S0003-2670(97)00708-3
   MACCRAITH BD, 1991, ELECTRON LETT, V27, P1247, DOI 10.1049/el:19910781
   MAHER MH, 1993, J TEST EVAL, V21, P448
   McCulloch S, 1997, IEE P-OPTOELECTRON, V144, P162, DOI 10.1049/ip-opt:19971269
   Mendoza EA, 1996, P SOC PHOTO-OPT INS, V2836, P242, DOI 10.1117/12.260598
   Michael KL, 1999, ANAL BIOCHEM, V273, P168, DOI 10.1006/abio.1999.4173
   Michael KL, 1999, ANAL CHEM, V71, P2766, DOI 10.1021/ac990085q
   MIGNANI AG, 1995, J LIGHTWAVE TECHNOL, V13, P1396, DOI 10.1109/50.400704
   Millar D, 1998, CHEM COMMUN, P477, DOI 10.1039/a708160j
   MILLS A, 1992, ANAL CHEM, V64, P1383, DOI 10.1021/ac00037a015
   MOHR GJ, 1994, ANAL CHIM ACTA, V292, P41, DOI 10.1016/0003-2670(94)00096-4
   MOTELLIER S, 1995, SENSOR ACTUAT B-CHEM, V29, P345, DOI 10.1016/0925-4005(95)01705-4
   MOTELLIER S, 1993, SENSOR ACTUAT B-CHEM, V11, P467, DOI 10.1016/0925-4005(93)85289-M
   MULLEN KI, 1992, ANAL CHEM, V64, P930, DOI 10.1021/ac00032a018
   MULLER C, 1994, P SOC PHOTO-OPT INS, V2131, P555
   Narang U, 1996, J SOL-GEL SCI TECHN, V6, P113, DOI 10.1007/BF00402594
   NIWA M, 1991, J CHEM SOC CHEM COMM, P444, DOI 10.1039/c39910000444
   Noire MH, 1998, SENSOR ACTUAT B-CHEM, V51, P214, DOI 10.1016/S0925-4005(98)00193-2
   Panova AA, 1997, ANAL CHEM, V69, P1635, DOI 10.1021/ac961025c
   PANTANO P, 1995, ANAL CHEM, V67, pA481, DOI 10.1021/ac00111a002
   Papkovsky DB, 1997, J PHOTOCH PHOTOBIO A, V104, P151, DOI 10.1016/S1010-6030(97)04592-9
   PARKER JW, 1993, ANAL CHEM, V65, P2329, DOI 10.1021/ac00065a027
   Plaschke M, 1997, P SOC PHOTO-OPT INS, V3105, P31, DOI 10.1117/12.276178
   Price JM, 1998, ANAL CHEM, V70, P265, DOI 10.1021/ac9707848
   Pringsheim E, 1997, ANAL CHIM ACTA, V357, P247, DOI 10.1016/S0003-2670(97)00563-1
   RAO BS, 1991, J APPL POLYM SCI, V43, P925, DOI 10.1002/app.1991.070430510
   Rottman C, 1998, J SOL-GEL SCI TECHN, V13, P17, DOI 10.1023/A:1008630701220
   Safavi A, 1996, ANAL CHIM ACTA, V335, P227, DOI 10.1016/S0003-2670(96)00357-1
   Safavi A, 1998, ANAL CHIM ACTA, V367, P167, DOI 10.1016/S0003-2670(98)00079-8
   SAMUEL J, 1994, MATER LETT, V21, P431, DOI 10.1016/0167-577X(94)90254-2
   SCHULMAN SG, 1995, ANAL CHIM ACTA, V304, P165, DOI 10.1016/0003-2670(94)00631-U
   SERRA G, 1990, ANAL CHIM ACTA, V232, P337, DOI 10.1016/S0003-2670(00)81251-9
   SHAHRIARI MR, 1994, SOL GEL OPTICS PROCE, P279
   SHAKHSHER Z, 1994, ANAL CHEM, V66, P1731, DOI 10.1021/ac00082a021
   SHAPIRO B A, 1992, Respiratory Care, V37, P165
   Shi YN, 1997, CHEM MATER, V9, P821, DOI 10.1021/cm960495k
   Song A, 1997, ANAL CHEM, V69, P863, DOI 10.1021/ac960917+
   Sotomayor MDT, 1997, ANAL CHIM ACTA, V353, P275
   SZMACINSKI H, 1993, ANAL CHEM, V65, P1668, DOI 10.1021/ac00061a007
   Tabacco MB, 1999, ANAL CHEM, V71, P154, DOI 10.1021/ac980513c
   TAKAI N, 1993, SENSOR ACTUAT B-CHEM, V13, P427, DOI 10.1016/0925-4005(93)85418-A
   TAN WH, 1992, ANAL CHEM, V64, P2985, DOI 10.1021/ac00047a019
   TAN WH, 1992, SCIENCE, V258, P778, DOI 10.1126/science.1439785
   THOMPSON RB, 1993, ANAL CHEM, V65, P853, DOI 10.1021/ac00055a005
   Trinkel M, 1996, ANAL CHIM ACTA, V320, P235, DOI 10.1016/0003-2670(95)00540-4
   Vishnoi G, 1999, P SOC PHOTO-OPT INS, V3538, P319, DOI 10.1117/12.335760
   VISHNOI G, 1998, P SOC PHOTO-OPT INS, V3538, P319
   Wallace PA, 1997, J LUMIN, V72-4, P1017, DOI 10.1016/S0022-2313(97)80797-1
   Wallace PA, 1998, P SOC PHOTO-OPT INS, V3483, P128, DOI 10.1117/12.309656
   WEIGL BH, 1995, ANAL CHIM ACTA, V302, P249, DOI 10.1016/0003-2670(94)00473-Y
   WERNER T, 1995, ANALYST, V120, P1627, DOI 10.1039/an9952001627
   WERNER T, 1993, FRESEN J ANAL CHEM, V346, P564, DOI 10.1007/BF00321245
   Werner T, 1997, FRESEN J ANAL CHEM, V359, P150, DOI 10.1007/s002160050552
   WOLFBEIS OS, 1992, MIKROCHIM ACTA, V108, P133, DOI 10.1007/BF01242422
   WOLFBEIS OS, 1991, FIBER OPTIC CHEM SEN, V1
   WOLFBEIS OS, 1996, STRUCT BOND, V85, P51
   WOLFBEIS OS, 1991, FIBER OPTIC CHEM SEN, V2
   WOLFBEIS OS, 1991, FIBER OPTIC CHEM SEN, V1, P267
   Wroblewski W, 1998, SENSOR ACTUAT B-CHEM, V48, P471, DOI 10.1016/S0925-4005(98)00087-2
   Xu WY, 1999, P SOC PHOTO-OPT INS, V3534, P456, DOI 10.1117/12.339027
   Xu Z, 1998, J BIOMED MATER RES, V39, P9, DOI 10.1002/(SICI)1097-4636(199801)39:1<9::AID-JBM2>3.0.CO;2-U
   YANG L, 1995, ANAL CHEM, V67, P1307, DOI 10.1021/ac00104a002
   Zhang L, 1997, TALANTA, V44, P1691, DOI 10.1016/S0039-9140(97)00080-5
   ZHANG S, 1995, MED BIOL ENG COMPUT, V33, P152, DOI 10.1007/BF02523033
   ZUSMAN R, 1990, J NONCRYST SOLIDS, V122, P109
NR 115
TC 179
Z9 183
U1 7
U2 143
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0165-9936
J9 TRAC-TREND ANAL CHEM
JI Trac-Trends Anal. Chem.
PD SEP
PY 2000
VL 19
IS 9
BP 541
EP 552
DI 10.1016/S0165-9936(00)00034-0
PG 12
WC Chemistry, Analytical
SC Chemistry
GA 354GT
UT WOS:000089321900003
DA 2018-10-20
ER

PT J
AU Sousa, RA
   Kalay, G
   Reis, RL
   Cunha, AM
   Bevis, MJ
AF Sousa, RA
   Kalay, G
   Reis, RL
   Cunha, AM
   Bevis, MJ
TI Injection molding of a starch/EVOH blend aimed as an alternative
   biomaterial for temporary applications
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE starch; biodegradable; biomaterial; injection molding; SCORIM; design of
   experiments
ID SHEAR CONTROLLED ORIENTATION; PHYSICAL PROPERTY RELATIONSHIPS; MOLDED
   ISOTACTIC POLYPROPYLENE; BIODEGRADABLE POLYMERS; MECHANICAL-PROPERTIES;
   DEGRADATION; INVITRO
AB Biodegradable polymers show great potential to be used as materials for temporary implants and bone replacement applications in orthopedics. However, its use in high load-bearing applications will depend on the successful development of biodegradable implants with a mechanical performance matching that of human bone. This article describes the optimization of the injection molding process of an alternative biodegradable starch-based polymer aimed at biomedical applications. A blend of starch with a copolymer of ethylene-vinyl alcohol (SEVA-C) was studied. Both conventional injection molding and shear controlled orientation (SCORIM) were optimized with the support of design of experiments and analysis of variance techniques. The mechanical characterization was performed by tensile testing. The structure developed within the moldings was assessed by wide-angle X-ray diffraction and differential scanning calorimetry. Increases up to 30% in the tangent modulus and 20% in the ultimate tensile strength compared with conventional molding were achieved with the application of SCORIM. The holding pressure and the frequency of the shear applied have the strongest influence on the morphology development and consequently on the mechanical performance. The solidification of SEVA-C at high cavity pressures enhances stiffness for long durations of the shearing stage in SCORIM. However, the effect of viscous heating of SEVA-C is important and ought to be considered. A decrease of the material phase miscibility in SEVA-C occurs as result of the shear fields imposed. The microstructure evaluation suggests that the mechanical properties enhancement in SCORIM molded SEVA-C is attributable to preferred orientation developed during processing. (C) 2000 John Wiley & Sons, Inc.
C1 Brunel Univ, Wolfson Ctr Mat Proc, Uxbridge UB8 3PH, Middx, England.
   Univ Minho, Dept Polymer Engn, P-4800 Guimaraes, Portugal.
RP Kalay, G (reprint author), Brunel Univ, Wolfson Ctr Mat Proc, Uxbridge UB8 3PH, Middx, England.
RI Group, 3Bs/E-4374-2012; Reis, Rui L./A-8938-2008
OI Group, 3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129; Sousa,
   Rui/0000-0003-0362-7418; Cunha M., Antonio/0000-0003-3860-7732
CR Allan P. S., 1990, COMPOSITES MANUFACTU, V1, P79
   ALLAN PS, 1987, PLAST RUB PROC APPL, V7, P3
   ALLAN PS, Patent No. 2170140
   Bastioli C, 1993, J ENVIRON POLYM DEGR, V1, P181
   Bonfield W., 1996, BIOCERAMICS, V9, P11
   HASTINGS G, 1991, COMPOSITES MAT BIOME, P23
   HAYASHI T, 1994, PROG POLYM SCI, V19, P663, DOI 10.1016/0079-6700(94)90030-2
   Isaac D. H., 1994, Clinical Materials, V15, P79, DOI 10.1016/0267-6605(94)90073-6
   Kalay G, 1997, J POLYM SCI POL PHYS, V35, P241, DOI 10.1002/(SICI)1099-0488(19970130)35:2<241::AID-POLB5>3.0.CO;2-V
   Kalay G, 1997, J POLYM SCI POL PHYS, V35, P265
   Kalay G, 1997, J POLYM SCI POL PHYS, V35, P415, DOI 10.1002/(SICI)1099-0488(199702)35:3<415::AID-POLB2>3.0.CO;2-R
   Kalay G, 1996, POLYMER, V37, P2077, DOI 10.1016/0032-3861(96)85852-6
   Kalay G, 1997, KUNSTST-PLAST EUR, V87, P768
   KNOWLES JC, 1992, J MATER SCI-MATER M, V3, P352, DOI 10.1007/BF00705367
   KNOWLES JC, 1993, J MATER SCI-MATER M, V4, P102, DOI 10.1007/BF00120377
   LITSKY AS, 1993, J APPL BIOMATER, V4, P109, DOI 10.1002/jab.770040116
   MONTGOMERY DC, 1991, DESIGN ANAL EXPT
   OGBONNA CI, 1995, J APPL POLYM SCI, V58, P2131, DOI 10.1002/app.1995.070581126
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   Reis R. L., 1997, MED PLAST BIOMATER, V4, P46
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reis RL, 1996, POLYM ADVAN TECHNOL, V7, P784, DOI 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
   Reis RL, 1997, POLYM INT, V43, P347
   REIS RL, 1998, ANTEC 98 PLASTICS MY
   REIS RL, 1997, ADV POLYM TECHNOL, V4, P276
   ROKKANEN PU, 1991, ANN MED, V23, P109, DOI 10.3109/07853899109148033
   ROSS JP, 1998, TAGUCHI TECHNIQUES Q
   SCHMIDT SR, 1994, UNDERSTANDING IND DE
   SIMMONS S, 1995, J APPL POLYM SCI, V58, P2259, DOI 10.1002/app.1995.070581215
   SOLTESZ U, 1988, ANN NY ACAD SCI, P137
   VAINIONPAA S, 1989, PROG POLYM SCI, V14, P679, DOI 10.1016/0079-6700(89)90013-0
   Williams D., 1990, CONCISE ENCY MED DEN
   1991, Patent No. 2025
NR 33
TC 35
Z9 35
U1 0
U2 10
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 8
PY 2000
VL 77
IS 6
BP 1303
EP 1315
DI 10.1002/1097-4628(20000808)77:6<1303::AID-APP15>3.0.CO;2-1
PG 13
WC Polymer Science
SC Polymer Science
GA 320BF
UT WOS:000087380600015
DA 2018-10-20
ER

PT J
AU Mazhari, R
   McCulloch, AD
AF Mazhari, R
   McCulloch, AD
TI Integrative models for understanding the structural basis of regional
   mechanical dysfunction in ischemic myocardium
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT Physiome Symposium on Integrated Biology of the Heart
CY SEP 09-11, 2000
CL SEATTLE, WASHINGTON
DE stunned myocardium; finite-element model; diastolic properties;
   functional border zone; transmural function; regional blood flow
ID CANINE LEFT-VENTRICLE; STUNNED MYOCARDIUM; BLOOD-FLOW; CONTRACTILE
   FUNCTION; NONISCHEMIC MYOCARDIUM; CORONARY OCCLUSIONS; COLLAGEN MATRIX;
   BORDER ZONE; WALL STRESS; RAT HEARTS
AB Myocardial ischemia and many other cardiac pathologies are associated with regional ventricular dysfunction. Since the distributions of stress and material properties cannot be measured directly in intact myocardium, understanding how regional alterations in myocardial strain or segment function are related to underlying cellular dysfunction must be deduced from theoretical models. Here, we describe how anatomically detailed, three-dimensional computational models can be used in conjunction with experimental or clinical studies to elucidate the structural basis of regional dysfunction in acutely ischemic and ischemic-reperfused ("stunned") myocardium in vivo. Integrative experimental and computational analysis shows that: (1) in acutely ischemic myocardium, the transition from abnormal systolic strain in the ischemic region to normal shortening in adjacent, normally perfused tissue is governed primarily by systolic blood pressure and regional fiber orientation rather than the geometry of the perfusion boundary; and (2) in stunned myocardium, the degree of reperfusion injury to the contractile apparatus may be uniform across the wall thickness despite observations that the extent of ischemia and the impairment of regional strain during reperfusion are both significantly greater in the subendocardium. (C) 2000 Biomedical Engineering Society. [S0090-6964(00)01208-X].
C1 Univ Calif San Diego, Dept Bioengn, Whitaker Inst Biomed Engn, La Jolla, CA 92093 USA.
RP McCulloch, AD (reprint author), Univ Calif San Diego, Dept Bioengn, Whitaker Inst Biomed Engn, 9500 Gilman Dr, La Jolla, CA 92093 USA.
FU NHLBI NIH HHS [HL07089-24, HL-41603, HL0708923]
CR ALLEN DG, 1987, CIRC RES, V60, P153, DOI 10.1161/01.RES.60.2.153
   Armour JA, 1999, CARDIOVASC RES, V41, P41, DOI 10.1016/S0008-6363(98)00252-1
   BOGEN DK, 1980, CIRC RES, V47, P728, DOI 10.1161/01.RES.47.5.728
   BOLLI R, 1988, AM J PHYSIOL, V254, pH102
   BOLLI R, 1989, AM J PHYSIOL, V257, pH375
   BOLLI R, 1990, CIRCULATION, V82, P723, DOI 10.1161/01.CIR.82.3.723
   Bovendeerd PHM, 1996, AM J PHYSIOL-HEART C, V270, pH398
   Bradley CP, 1997, ANN BIOMED ENG, V25, P96, DOI 10.1007/BF02738542
   BRAUNWALD E, 1982, CIRCULATION, V66, P1146, DOI 10.1161/01.CIR.66.6.1146
   CANTY JM, 1988, CIRC RES, V63, P821, DOI 10.1161/01.RES.63.4.821
   CHARNEY RH, 1992, CIRCULATION, V85, P1483, DOI 10.1161/01.CIR.85.4.1483
   Costa KD, 1996, J BIOMECH ENG-T ASME, V118, P464, DOI 10.1115/1.2796032
   DOWNEY JM, 1974, CIRC RES, V34, P286, DOI 10.1161/01.RES.34.3.286
   EDWARDS NC, 1992, AM J PHYSIOL, V262, pH568
   Ehring T, 1993, Am J Cardiovasc Pathol, V4, P358
   ELBEERY JR, 1992, AM J PHYSIOL, V263, pH559
   EMERY LJ, 1997, AM J PHYSIOL, V272, pH2299
   GALLAGHER KP, 1987, AM J PHYSIOL, V253, pH826
   GALLAGHER KP, 1986, CIRC RES, V58, P570, DOI 10.1161/01.RES.58.4.570
   GALLAGHER KP, 1980, CIRCULATION, V62, P1266, DOI 10.1161/01.CIR.62.6.1266
   GALLAGHER KP, 1987, AM J PHYSIOL, V252, pH826
   GALLAGHER KP, 1984, AM J PHYSIOL, V247, pH727
   GALLAGHER KP, 1987, CIRC 60 SCI SESS, P373
   Gao WD, 1997, CIRC RES, V80, P393, DOI 10.1161/01.res.0000435855.49359.47
   Gao WD, 1996, CIRCULATION, V94, P2597, DOI 10.1161/01.CIR.94.10.2597
   Gao WD, 1996, CIRC RES, V78, P455
   GAO WD, 1995, CIRC RES, V76, P1036, DOI 10.1161/01.RES.76.6.1036
   GOTO Y, 1986, AM J PHYSIOL, V250, pH151
   GROSSMAN W, 1980, AM J MED, V69, P576, DOI 10.1016/0002-9343(80)90471-4
   GUCCIONE JM, 1991, J BIOMECH ENG-T ASME, V113, P42, DOI 10.1115/1.2894084
   GUCCIONE JM, 1995, J BIOMECH, V28, P1167, DOI 10.1016/0021-9290(94)00174-3
   GUTH BD, 1984, AM HEART J, V107, P458, DOI 10.1016/0002-8703(84)90086-3
   Hampton TG, 1998, AM J PHYSIOL-HEART C, V274, pH1821, DOI 10.1152/ajpheart.1998.274.5.H1821
   HASHIMA AR, 1993, J BIOMECH, V26, P19, DOI 10.1016/0021-9290(93)90610-Q
   HEARSE D J, 1986, Canadian Journal of Cardiology, V2, P48
   HEARSE DJ, 1977, J MOL CELL CARDIOL, V9, P605, DOI 10.1016/S0022-2828(77)80357-X
   HEYNDRICKX GR, 1978, AM J PHYSIOL, V234, pH653
   HOIT BD, 1988, AM J PHYSIOL, V254, pH1065
   HUISMAN RM, 1980, CARDIOVASC RES, V14, P142, DOI 10.1093/cvr/14.3.142
   Hunter PJ, 1998, PROG BIOPHYS MOL BIO, V69, P289, DOI 10.1016/S0079-6107(98)00013-3
   KERBER RE, 1975, CIRCULATION, V52, P1097, DOI 10.1161/01.CIR.52.6.1097
   Kloner RA, 1998, CIRCULATION, V97, P1848, DOI 10.1161/01.CIR.97.18.1848
   KUSUOKA H, 1992, ANNU REV PHYSIOL, V54, P243, DOI 10.1146/annurev.ph.54.030192.001331
   KUSUOKA H, 1990, CIRC RES, V66, P1268, DOI 10.1161/01.RES.66.5.1268
   LEW WYW, 1985, CIRC RES, V56, P351, DOI 10.1161/01.RES.56.3.351
   LEW WYW, 1991, ACUTE MYOCARDIAL INF, V7, P112
   LIMA JAC, 1985, CIRCULATION, V71, P1048, DOI 10.1161/01.CIR.71.5.1048
   Lin DHS, 1998, J BIOMECH ENG-T ASME, V120, P504, DOI 10.1115/1.2798021
   LONGHURST JC, 1984, PROG CARDIOVASC DIS, V27, P201, DOI 10.1016/0033-0620(84)90005-7
   MACKENNA DA, 1994, AM J PHYSIOL, V266, pH1007
   MALLIANI A, 1983, J AUTONOM NERV SYST, V7, P295, DOI 10.1016/0165-1838(83)90082-6
   Mazhari R, 1998, ANN BIOMED ENG, V26, P743, DOI 10.1114/1.74
   MAZHARI R, 1999, REGIONAL FLOW FUNCTI
   MAZHARI R, 1999, P ASME 4 SUMM BIOENG, V4, P43
   McCulloch AD, 1998, CARDIOVASC RES, V37, P636, DOI 10.1016/S0008-6363(97)00290-3
   MURDOCK RH, 1983, CIRC RES, V52, P451, DOI 10.1161/01.RES.52.4.451
   NIELSEN PMF, 1991, AM J PHYSIOL, V260, pH1365
   OPIE LH, 1997, HEART PHYSL CELL CIR
   PARMLEY WW, 1973, AM J CARDIOL, V32, P889, DOI 10.1016/S0002-9149(73)80153-5
   PINZEN FW, 1989, EUR J PHYSL, V415, P220
   PRINZEN FW, 1984, J BIOMECH, V17, P801, DOI 10.1016/0021-9290(84)90111-8
   PRZYKLENK K, 1989, AM J CARDIOL, V64, pF18, DOI 10.1016/0002-9149(89)90741-8
   PZYKLENK K, 1987, AM J CARDIOL, V60, P1211
   ROSS J, 1991, CIRCULATION, V83, P1076, DOI 10.1161/01.CIR.83.3.1076
   RYNNING SE, 1993, ACTA PHYSIOL SCAND, V149, P441, DOI 10.1111/j.1748-1716.1993.tb09641.x
   SAKAI K, 1985, AM J PHYSIOL, V249, pH88
   STREETER DD, 1973, CIRC RES, V33, P656, DOI 10.1161/01.RES.33.6.656
   Stuyvers BDMY, 1997, J PHYSIOL-LONDON, V502, P661, DOI 10.1111/j.1469-7793.1997.661bj.x
   Tennant R, 1935, AM J PHYSIOL, V112, P351
   Thames MD, 1996, CLIN EXP PHARMACOL P, V23, P709, DOI 10.1111/j.1440-1681.1996.tb01763.x
   TORRY RJ, 1991, AM HEART J, V122, P1292, DOI 10.1016/0002-8703(91)90568-3
   TYBERG JV, 1969, CIRC RES, V25, P569, DOI 10.1161/01.RES.25.5.569
   TYBERG JV, 1974, CIRCULATION, V49, P748
   Van Eyk JE, 1998, CIRC RES, V82, P261
   VANLEUVEN SL, 1994, AM J PHYSIOL-HEART C, V267, pH2348
   VATNER SF, 1980, CIRC RES, V47, P201, DOI 10.1161/01.RES.47.2.201
   VILLARREAL FJ, 1991, CIRC RES, V68, P368, DOI 10.1161/01.RES.68.2.368
   WEIGNER AW, 1978, AM J PHYSIOL, V4, pH776
   WEINTRAUB WS, 1981, CIRC RES, V48, P430, DOI 10.1161/01.RES.48.3.430
   WEISMAN HF, 1987, PROG CARDIOVASC DIS, V30, P73, DOI 10.1016/0033-0620(87)90004-1
   Westerhof N, 1997, ADV EXP MED BIOL, V430, P111
   WHITTAKER P, 1991, AM HEART J, V121, P434, DOI 10.1016/0002-8703(91)90709-Q
   WIJNS W, 1986, J AM COLL CARDIOL, V7, P455, DOI 10.1016/S0735-1097(86)80453-3
   WYATT HL, 1976, AM J CARDIOL, V37, P366, DOI 10.1016/0002-9149(76)90285-X
   YELLON DM, 1981, AM J CARDIOL, V47, P1233, DOI 10.1016/0002-9149(81)90252-6
   YIN FCP, 1981, CIRC RES, V49, P829, DOI 10.1161/01.RES.49.4.829
   YOUNG AA, 1992, RADIOLOGY, V185, P241, DOI 10.1148/radiology.185.1.1523316
   ZHAO MJ, 1987, J AM COLL CARDIOL, V10, P1322, DOI 10.1016/S0735-1097(87)80137-7
NR 88
TC 19
Z9 19
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD AUG
PY 2000
VL 28
IS 8
BP 979
EP 990
DI 10.1114/1.1308502
PG 12
WC Engineering, Biomedical
SC Engineering
GA 378UZ
UT WOS:000165604200018
PM 11144683
DA 2018-10-20
ER

PT J
AU Bassingthwaighte, JB
AF Bassingthwaighte, JB
TI Strategies for the physiome project
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT Physiome Symposium on Integrated Biology of the Heart
CY SEP 09-11, 2000
CL SEATTLE, WASHINGTON
DE simulation analysis; biological systems modeling; complexity; chaos;
   dynamic systems; milieu interieure; homeodynamics; homeostasis;
   metabolism; control
ID DYNAMIC-MODEL; FIBERS; HEART; FLOW
AB The physiome is the quantitative description of the functioning organism in normal and pathophysiological states. The human physiome can be regarded as the virtual human. It is built upon the morpheme,the quantitative description of anatomical structure, chemical and biochemical composition, and material properties of an intact organism, including its genome, proteome, cell, tissue, and organ structures up to those of the whole intact being. The Physiome Project is a multicentric integrated program to design, develop, implement, test and document, archive and disseminate quantitative information, and integrative models of the functional behavior of molecules, organelles, cells, tissues, organs, and intact organisms from bacteria to man. A fundamental and major feature of the project is the databasing of experimental observations for retrieval and evaluation. Technologies allowing many groups to work together are being rapidly developed. Internet II will facilitate this immensely. When problems are huge and complex, a particular working group can be expert in only a small part of the overall project. The strategies to be worked out must therefore include how to pull models composed of many submodules together even when the expertise in each is scattered amongst diverse institutions. The technologies of bioinformatics will contribute greatly to this effort. Developing and implementing code for large-scale systems has many problems. Most of the submodules are complex, requiring consideration of spatial and temporal events and processes. Submodules have to be linked to one another in a way that preserves mass balance and gives an accurate representation of variables in nonlinear complex biochemical networks with many signaling and controlling pathways. Microcompartmentalization vitiates the use of simplified model structures. The stiffness of the systems of equations is computationally costly. Faster computation is needed when using models as thinking tools and for iterative data analysis. Perhaps the most serious problem is the current lack of definitive information on kinetics and dynamics of systems, due in part to the almost total lack of databased observations, but also because, though we are nearly drowning in new information being published each day, either the information required for the modeling cannot be found or has never been obtained. "Simple" things like tissue composition, material properties, and mechanical behavior of cells and tissues are not generally available. The development of comprehensive models of biological systems is a key to pharmaceutics and drug design, for the models will become gradually better predictors of the results of interventions, both genomic and pharmaceutic. Good models will be useful in predicting the side effects and long term effects of drugs and toxins, and when the models are really good, to predict where genomic intervention will be effective and where the multiple redundancies in our biological systems will render a proposed intervention useless. The Physiome Project will provide the integrating scientific basis for the Genes to Health initiative, and make physiological genomics a reality applicable to whole organisms, from bacteria to man. (C) 2000 Biomedical Engineering Society. [S0090-6964(00)02208-6].
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Bassingthwaighte, JB (reprint author), Univ Washington, Dept Bioengn, Box 35-7962, Seattle, WA 98195 USA.
FU NCRR NIH HHS [P41 RR001243, RR1243, P41 RR001243-21]; NIBIB NIH HHS [R01
   EB001973-22, R01 EB001973]; NHLBI NIH HHS [HL07403, T32 HL007403]
CR BASSINGTHWAIGHT.JB, 1972, ELECTRICAL PHENOMENA, P353
   BASSINGTHWAIGHT.JB, 1998, WHOLE ORGAN APPROACH, P575
   Bassingthwaighte J.B., 1994, FRACTAL PHYSL, P364, DOI [DOI 10.1007/978-1-4614-7572-9, 10.1007/978-1-4614-7572-9]
   BASSINGTHWAIGHTE JB, 1989, CIRC RES, V65, P578, DOI 10.1161/01.RES.65.3.578
   BASSINGTHWAIGHTE JB, 1995, CIRC RES, V77, P1212, DOI 10.1161/01.RES.77.6.1212
   BASSINGTHWAIGHTE JB, 1989, CIRC RES, V65, P997, DOI 10.1161/01.RES.65.4.997
   Beadle GW, 1941, P NATL ACAD SCI USA, V27, P499, DOI 10.1073/pnas.27.11.499
   Beard DA, 2000, J VASC RES, V37, P282, DOI 10.1159/000025742
   Beard DA, 2000, ANN BIOMED ENG, V28, P253, DOI 10.1114/1.273
   BEELER GW, 1977, J PHYSIOL-LONDON, V268, P177, DOI 10.1113/jphysiol.1977.sp011853
   BLINKS JR, 1978, J PHYSIOL-LONDON, V277, P291, DOI 10.1113/jphysiol.1978.sp012273
   BOYD CAR, 1993, LOGIC LIFE CHALLENGE, P226
   CALDWELL JH, 1994, AM J PHYSIOL, V267, pH654
   Ch'en FFT, 1998, PROG BIOPHYS MOL BIO, V69, P515, DOI 10.1016/S0079-6107(98)00023-6
   Cowley AW, 2000, PHYSIOL GENOMICS, V2, P107
   DIFRANCESCO D, 1985, PHILOS T ROY SOC B, V307, P353, DOI 10.1098/rstb.1985.0001
   Gillis HL, 1999, ANN BIOMED ENG, V27, P14, DOI 10.1114/1.161
   Gillis HL, 1999, J APPL PHYSIOL, V86, P2001
   Glass L, 1991, THEORY HEART BIOMECH, P611
   GUYTON AC, 1972, ANNU REV PHYSIOL, V34, P13, DOI 10.1146/annurev.ph.34.030172.000305
   HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764
   HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310
   Jafri MS, 1998, BIOPHYS J, V74, P1149, DOI 10.1016/S0006-3495(98)77832-4
   JALIFE J, 1991, J CARDIOVASC ELECTR, V2, pS133
   KASSAB GS, 1993, AM J PHYSIOL, V265, pH350
   Koshland DE, 1998, SCIENCE, V280, P852, DOI 10.1126/science.280.5365.852
   KOSHLAND DE, 1987, TRENDS BIOCHEM SCI, V12, P225, DOI 10.1016/0968-0004(87)90114-9
   LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571
   LUO CH, 1994, CIRC RES, V74, P1097, DOI 10.1161/01.RES.74.6.1097
   LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071
   MCCULLOCH A, 1998, COMPUTATIONAL BIOL H, V69, P151
   MONTANI JP, 1989, INT J BIOMED COMPUT, V24, P41, DOI 10.1016/0020-7101(89)90006-8
   NOBLE D, 1969, J PHYSIOL-LONDON, V200, P205, DOI 10.1113/jphysiol.1969.sp008689
   PLATT JR, 1964, SCIENCE, V146, P347, DOI 10.1126/science.146.3642.347
   Ringer S, 1883, J Physiol, V4, P29
   SCHOMBURG D, 1990, ENZYME HDB
   Vetter FJ, 2000, ANN BIOMED ENG, V28, P781, DOI 10.1114/1.1289469
   Vetter FJ, 1998, PROG BIOPHYS MOL BIO, V69, P157, DOI 10.1016/S0079-6107(98)00006-6
   WEIDMANN S, 1952, J PHYSIOL-LONDON, V118, P348, DOI 10.1113/jphysiol.1952.sp004799
   Wilson E. O., 1998, CONSILIENCE UNITY KN, P332
   Winslow RL, 2000, ANNU REV BIOMED ENG, V2, P119, DOI 10.1146/annurev.bioeng.2.1.119
   Winslow RL, 1999, CIRC RES, V84, P571, DOI 10.1161/01.RES.84.5.571
   WOOD EH, 1969, CIRC RES, V24, P409, DOI 10.1161/01.RES.24.3.409
   ZAMIR M, 1987, BLOOD VESSELS, V24, P76
NR 44
TC 121
Z9 126
U1 0
U2 23
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD AUG
PY 2000
VL 28
IS 8
BP 1043
EP 1058
DI 10.1114/1.1313771
PG 16
WC Engineering, Biomedical
SC Engineering
GA 378UZ
UT WOS:000165604200025
PM 11144666
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Alanazi, A
   Nojiri, C
   Kido, T
   Noguchi, T
   Ohgoe, Y
   Matsuda, T
   Hirakuri, K
   Funakubo, A
   Sakai, K
   Fukui, Y
AF Alanazi, A
   Nojiri, C
   Kido, T
   Noguchi, T
   Ohgoe, Y
   Matsuda, T
   Hirakuri, K
   Funakubo, A
   Sakai, K
   Fukui, Y
TI Engineering analysis of diamond-like carbon coated polymeric materials
   for biomedical applications
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 7th Congress of the International-Society-for-Rotary-Blood-Pumps
CY AUG 26-27, 1999
CL TOKYO, JAPAN
SP Int Soc Rotary Blood Pumps
DE diamond-like carbon; blood compatibility
ID EPIFLUORESCENT VIDEO MICROSCOPY
AB Diamond-like carbon (DLC) films have received much attention recently owing to their properties, which are similar to diamond: hardness, thermal conductivity, corrosion resistance against chemicals, abrasion resistance, good biocompatibility, and uniform flat surface. Furthermore, DLC films can be deposited easily on many substrates for wide area coat at room temperature. DLC films were developed for applications as biomedical materials in blood contacting-devices (e.g., rotary blood pump) and showed good biocompatibility for these applications. In this study, we investigated the surface roughness by Atomic Force Microscopy (AFM) and Hi-vision camera, SEM for surface imaging. The DLC films were produced by radio frequency glow discharge plasma decomposed of hydrocarbon gas at room temperature and low pressure (53 Pa) on several kinds of polycarbonate substrates. For the evaluation of the relation between deposition rate and platelet adhesion that we investigated in a previous study, DLC films were deposited at the same methane pressure for several deposition times, and film thickness was investigated, in addition, the deposition rate of DLC films on polymeric substrates is similar to the deposition rate of those deposited on Si substrates. There were no significant differences in substrates' surface roughness that were coated by DLC films in different deposition rates (16-40 nm). The surface energy and the contact angle of the DLC films were investigated. The chemical bond of DLC films also was evaluated. The evaluation of surface properties by many methods and measurements and the relationship between the platelet adhesion and film thickness is discussed. Finally, the presented DLC films appear to be premising candidates for biomedical applications and merit investigation.
C1 Tokyo Denki Univ, Fac Sci & Engn, Dept Appl Syst Engn, Hatoyama, Saitama 3500394, Japan.
   Waseda Univ, Tokyo, Japan.
   Terumo Corp, Inst Biomed Sci, Kanagawa, Japan.
   D Ctr, Kanagawa, Japan.
RP Alanazi, A (reprint author), Tokyo Denki Univ, Fac Sci & Engn, Dept Appl Syst Engn, Hatoyama, Saitama 3500394, Japan.
CR ALANAZI A, 1997, J SOC APPL PHYS, V58
   ALANAZI A, 1999, INT S ADV BIOM TISS
   ALANAZI A, 1998, VACUUM, V51, P363
   ALANAZI A, 1999, ASAIO J, P45
   KAWAGOISHI N, 1994, ARTIF ORGANS, V18, P588, DOI 10.1111/j.1525-1594.1994.tb03383.x
   KOBAYASHI K, 1988, THIN SOLID FILMS, V158, P233, DOI 10.1016/0040-6090(88)90025-9
   KURODA S, 1996, HEART REPLACEMENT AR, V5, P21
   Mizumoto D, 1997, ASAIO J, V43, pM500
   NOJIRI C, 1989, T ASAIO, V35, P357
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
NR 10
TC 46
Z9 54
U1 0
U2 13
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD AUG
PY 2000
VL 24
IS 8
BP 624
EP 627
DI 10.1046/j.1525-1594.2000.06576.x
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 349PM
UT WOS:000089054900009
PM 10971249
DA 2018-10-20
ER

PT J
AU Emrich, J
   Lambert, K
AF Emrich, J
   Lambert, K
TI Radiation safety education for laboratory animal science
SO HEALTH PHYSICS
LA English
DT Article
DE operational topics; laboratory animals; education; radiation, biology
AB Students enrolled in the laboratory animal science graduate program at MCP Hahnemann University seek to gain entrance to veterinary school or to manage an animal facility within an academic institution, pharmaceutical or biotechnology company conducting biomedical research. Ongoing interaction between faculty in the radiation oncology, radiation safety, and lab animal science disciplines revealed an acute need for radiation safety education for laboratory animal science students who will likely interact with researchers either designing and writing protocols for animal studies using radiation or radioactive materials, or veterinary staff who will use sources of radiation to diagnose and/or treat possible animal injuries and diseases. A core course in the Radiation Sciences graduate program was modified to address the needs of these students, instructing them in radiation safety, detection and counting instrumentation, and radiation biology. These fundamental areas were integrated to help the students gain a sound, basic knowledge of radiation and radioactive materials used in biomedical research.
C1 Med Coll Penn & Hahnemann Univ, Dept Radiat Oncol, Philadelphia, PA 19102 USA.
   Med Coll Penn & Hahnemann Univ, Dept Radiat Phys & Safety, Philadelphia, PA 19102 USA.
EM emrichj@drexel.edu
NR 0
TC 2
Z9 2
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD AUG
PY 2000
VL 79
IS 2
SU S
BP S12
EP S16
DI 10.1097/00004032-200008001-00005
PG 5
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 335PA
UT WOS:000088250800004
PM 10910396
DA 2018-10-20
ER

PT J
AU McDermott, PJ
AF McDermott, PJ
TI Rutgers University case study: A guide to non-routine high dose rate
   procedures for biomedical facilities
SO HEALTH PHYSICS
LA English
DT Article
DE operational topics; Co-60; shielding radioactive materials
AB Non-routine potentially high dose rate procedures occasionally present themselves at biomedical facilities. Lacking significant operational experience, many biomedical facilities decide to contract out the work to consulting firms without seriously considering doing the work themselves. This study shares the University's experiences during a non-routine procedure to extract a Co-60 irradiation source from an underground storage facility and relocate it to an above-ground shielded storage cask.
C1 Rutgers State Univ, Piscataway, NJ 08854 USA.
EM mcdermott@rehs.rutgers.edu
CR CEMBER H, 1989, INTRO HLTH PHYSICS
   *KNOLLS AT POW LAB, 1988, CHART NUCL
NR 2
TC 2
Z9 2
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD AUG
PY 2000
VL 79
IS 2
SU S
BP S6
EP S11
DI 10.1097/00004032-200008001-00004
PG 6
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 335PA
UT WOS:000088250800003
PM 10910395
DA 2018-10-20
ER

PT J
AU Ilev, IK
   Waynant, RW
   Ediger, MN
   Bonaguidi, MA
AF Ilev, IK
   Waynant, RW
   Ediger, MN
   Bonaguidi, MA
TI Ultraviolet laser delivery using an uncoated hollow taper
SO IEEE JOURNAL OF QUANTUM ELECTRONICS
LA English
DT Article
DE laser beam focusing; laser biomedical applications; multimode
   transmission lines; optical fiber couple; optical materials; optical
   waveguide components; ultraviolet imaging
ID FIBER
AB We demonstrate a simple grazing-incidence-based method for ultraviolet (UV) laser delivery and direct laser-to-taper coupling using an uncoated glass hollow taper. The taper serves as a mode homogenizer that converts the strongly multimode distribution of the input laser emission into a high-quality smooth profile at the taper output. An uncoated pyrex-glass hollow taper is used for direct launching, without any intermediate focusing elements, of UV laser emission from the third harmonic (lambda = 355 nm) of a Q-switched Nd:YAG laser into the taper. The linear hollow taper provides a laser-to-taper coupling efficiency exceeding 70%.
C1 US FDA, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA.
   Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53201 USA.
RP Ilev, IK (reprint author), US FDA, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA.
CR AMITAY N, 1987, J LIGHTWAVE TECHNOL, V5, P70, DOI 10.1109/JLT.1987.1075414
   ARNOLD WH, 1995, IEEE J SEL TOP QUANT, V1, P765
   BORN M, 1964, PRINCIPLES OPTICS
   DRISCOLL WG, 1978, HDB OPTICS
   ILEV IK, 1991, OPT QUANT ELECTRON, V23, P1011, DOI 10.1007/BF00611437
   Ilev IK, 1999, APPL PHYS LETT, V74, P2921, DOI 10.1063/1.123966
   KOPRINKOV IG, 1992, J LIGHTWAVE TECHNOL, V10, P135, DOI 10.1109/50.120567
   Marcuse D, 1974, THEORY DIELECTRIC OP
   Matsuura Y, 1997, OPT LETT, V22, P1308, DOI 10.1364/OL.22.001308
   Matsuura Y, 1997, APPL OPTICS, V36, P7818, DOI 10.1364/AO.36.007818
   PRESBY HM, 1989, J LIGHTWAVE TECHNOL, V7, P274, DOI 10.1109/50.17767
   REN QS, 1990, IEEE J QUANTUM ELECT, V26, P2284, DOI 10.1109/3.64366
   Snyder A.W., 1983, OPTICAL WAVEGUIDE TH
   Welford WT, 1989, HIGH COLLECTION NONI
NR 14
TC 13
Z9 13
U1 1
U2 4
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 0018-9197
J9 IEEE J QUANTUM ELECT
JI IEEE J. Quantum Electron.
PD AUG
PY 2000
VL 36
IS 8
BP 944
EP 948
DI 10.1109/3.853551
PG 5
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA 339YK
UT WOS:000088505300007
DA 2018-10-20
ER

PT J
AU Li, BY
   Rong, LJ
   Li, YY
   Gjunter, VE
AF Li, BY
   Rong, LJ
   Li, YY
   Gjunter, VE
TI A recent development in producing porous Ni-Ti shape memory alloys
SO INTERMETALLICS
LA English
DT Article
DE intermetallics, miscellaneous; powder metallurgy; biomedical
   applications; shape-memory alloy applications
AB Porous Ni-Ti shape memory alloys (SMAs) are promising candidates for biomedical materials. In the present study, a bulk porous Ni-Ti SMA with a banded structure of channels and 54 vol.% porosity has been successfully prepared by self-propagating high-temperature synthesis (SHS). The Ni-Ti SMA synthesized has an open porous structure, also its pores and channels with various size and shape are three-dimensionally interconnected. Compared to the conventional pou der sintering method, the present method extends the porosity range of porous Ni-Ti SMAs. A schematic representation of SHS synthesized Ni-Ti SMAs has been suggested. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Chinese Acad Sci, Inst Met Res, Shenyang 110015, Peoples R China.
   VD Kuznetsov Siberian Phys Tech Inst, Tomsk 634050, Russia.
RP Li, BY (reprint author), Chinese Acad Sci, Inst Met Res, Shenyang 110015, Peoples R China.
RI Li, Bingyun/P-5320-2018; Li, Bingyun/A-9484-2009; Gunther,
   Viktor/O-6678-2014
OI Li, Bingyun/0000-0002-5766-5666; 
CR FUNAMI K, 1984, J JPN I MET, V48, P1113, DOI 10.2320/jinstmet1952.48.11_1113
   JARDINE AP, 1990, SCRIPTA METALL MATER, V24, P2391
   Li BY, 1998, J MATER RES, V13, P2847, DOI 10.1557/JMR.1998.0389
   Munir Z. A., 1989, Material Science Reports, V3, P277, DOI 10.1016/0920-2307(89)90001-7
   OTAGUCHI M, 1990, JAPAN I METALS, V54, P21
   Otsuka K, 1999, INTERMETALLICS, V7, P511, DOI 10.1016/S0966-9795(98)00070-3
   PAKHOMENKO JS, 1996, P INT C JUN 1996 TOM, P20
   PILLIAR RMJ, 1998, BIOMED MAT RES, V21, P1
   YI HC, 1988, SCRIPTA METALL MATER, V22, P1889, DOI 10.1016/S0036-9748(88)80232-1
NR 9
TC 83
Z9 91
U1 2
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-9795
J9 INTERMETALLICS
JI Intermetallics
PD AUG
PY 2000
VL 8
IS 8
BP 881
EP 884
DI 10.1016/S0966-9795(00)00024-8
PG 4
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 348LV
UT WOS:000088987000006
DA 2018-10-20
ER

PT J
AU Verne, E
   Brovarone, CV
   Milanese, D
AF Verne, E
   Brovarone, CV
   Milanese, D
TI Glass-matrix biocomposites: Synthesis and characterization
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bioactivity; glasses; coatings; biocomposites; sintering
ID PLASMA SPRAY DEPOSITION; BIOACTIVE GLASS; COMPOSITES; COATINGS
AB CaO-SiO(2) base glass-matrix/Ti particle biocomposite coatings on Ti6A14V substrates have been prepared by means of Vacuum Plasma Spray. The base glass is considered bioactive, because, when soaked in a fluid that simulates the inorganic ion concentration of human plasma (SBF), it develops a bonelike apatite layer on its surface. The aim of this research activity was to toughen this brittle bioactive material and to broaden its biomedical applications. Pure titanium was chosen as toughening phase because of its well-known biocompatibility, and Ti6A14V alloy as substrate because of both its biocompatibility and its mechanical reliability. At first the composites were prepared as bulk materials, by means of a simple sintering process. Then, by ball-milling the sintered composite, the as-obtained "composite powders" were sprayed by Vacuum Plasma Spray (VPS) on the substrate. By means of Differential Thermal Analysis (DTA) and Differential Scanning Calorimetry (DSC), the characteristic temperatures of the base glasses were determined. The thermal properties of mixtures of glass powders and different vol% Ti particles were studied by means of DTA, DSC, hot-stage microscopy, and dilatometry, with the aim of optimizing the sintering conditions. Both the bulk and the coated samples have been characterized by means of X-ray diffraction (XRD), scanning electron microscopy (SEM), compositional analysis (EDS), Vickers indentations, and leaching tests after soaking in a simulated body fluid (SBF). (C) 2000 John Wiley & Sons, Inc.
C1 Politecn Torino, Dept Chem Engn & Mat Sci, I-10129 Turin, Italy.
RP Verne, E (reprint author), Politecn Torino, Dept Chem Engn & Mat Sci, C Duca degli Abruzzi 24, I-10129 Turin, Italy.
EM verne@athena.polito.it
RI Milanese, Daniel/A-7366-2015
OI Vitale-Brovarone, Chiara/0000-0003-2413-5594; Milanese,
   Daniel/0000-0002-6257-3600; Verne, Enrica/0000-0002-8649-4739
CR FAUCHAIS P, 1996, CERAM INT, V22, P293
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   Ferraris M, 1996, J EUR CERAM SOC, V16, P421, DOI 10.1016/0955-2219(95)00114-X
   Ferraris M, 1996, J AM CERAM SOC, V79, P1515, DOI 10.1111/j.1151-2916.1996.tb08759.x
   FERRARIS M, 1995, MAT CLIN APPL ADV SC, P281
   FERRARIS M, 1997, BIOCERAMICS, V10, P195
   FERRARIS M, 1998, P ECCM 8 3 6 JUN 199, V1, P359
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   KIM HM, 1995, J AM CERAM SOC, V78, P2405, DOI 10.1111/j.1151-2916.1995.tb08677.x
   KOKUBO T, 1992, J MATER SCI-MATER M, V3, P79, DOI 10.1007/BF00705272
   LIN CK, 1995, J AM CERAM SOC, V78, P1406, DOI 10.1111/j.1151-2916.1995.tb08505.x
   LOEHMAN RE, 1996, CERAMIC JOINING SHOR
   Pazo A, 1998, ACTA MATER, V46, P2551, DOI 10.1016/S1359-6454(98)80039-6
   Sbaizero O, 1996, J EUR CERAM SOC, V16, P813, DOI 10.1016/0955-2219(96)00005-2
   Verne E, 1999, J EUR CERAM SOC, V19, P2039, DOI 10.1016/S0955-2219(99)00036-9
   Verne E, 1998, J EUR CERAM SOC, V18, P363, DOI 10.1016/S0955-2219(97)00134-9
   Verne E, 2000, J EUR CERAM SOC, V20, P473, DOI 10.1016/S0955-2219(99)00181-8
   VERNE E, 1995, BIOCERAMICS, V8, P147
   VERNE E, 1999, MAT CLIN APPL ADV SC, V28, P223
   VERNE E, 1997, BIOCERAMICS COATINGS, P37
   VERNE E, 1995, CERAMIC ORAL SURG, P231
NR 21
TC 7
Z9 10
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 2000
VL 53
IS 4
BP 408
EP 413
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 336MU
UT WOS:000088307500015
PM 10898882
DA 2018-10-20
ER

PT J
AU Magnani, A
   Rappuoli, R
   Lamponi, S
   Barbucci, R
AF Magnani, A
   Rappuoli, R
   Lamponi, S
   Barbucci, R
TI Novel polysaccharide hydrogels: Characterization and properties
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article
DE synthesis; polysaccharide; hydrogels; physicochemical properties; cell
   adhesion
ID CARBOXYMETHYLCELLULOSE
AB New chemical hydrogels, potentially suitable for biomedical applications, have been synthesized and characterized by C-13 NMR, and FT-IR spectroscopy. The polysaccharide components of these hydrogels are hyaluronane, alginate and carboxymethylcellulose, while the novel cross-linking procedure consists of activating the carboxylate moieties by 2-chloro-1-methylpyridinium iodide CMPJ and using 1,3-diaminopropane as a chemical bridge. Varying the amount of CMPJ three series of hydrogels were obtained with different cross-linking degrees (5, 50, 100%). their percentages were determined by C-13 NMR and FT-IR analysis. The morphology of the gels was studies by scanning electron-microscopy and the pore sizes were determined in order to find a relationship with the swelling properties.
   Cell adhesion,using human hepatocytes, abd platelet adhesion studies on the different series of cross-linked compounds allowed us to envisage their utilization as extracellular matrix materials and cardiovascular biomaterials. Copyright (C) 2000 John Wiley & Sons, Ltd.
C1 Univ Siena, CRISMA, I-53100 Siena, Italy.
RP Barbucci, R (reprint author), Univ Siena, CRISMA, Via Ettore Bastianini 12, I-53100 Siena, Italy.
RI Magnani, Agnese/E-7999-2017
OI Magnani, Agnese/0000-0002-6960-9418
CR ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   BARBUCCI R, 2000, IN PRESS J BIOMAT SC
   Godo MN, 1999, BIOMATERIALS, V20, P1117, DOI 10.1016/S0142-9612(99)00012-5
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HEIDRICK GW, 1994, J REPROD MED, V39, P575
   JOHN MS, 1973, J BIOMED MATER RES, V7, P509
   KITANO T, 1991, SPINE, V16, P820, DOI 10.1097/00007632-199107000-00023
   LAURENT TC, 1998, CHEM BIOL ITS DERIVA
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
NR 10
TC 24
Z9 26
U1 1
U2 14
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 1042-7147
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD AUG-DEC
PY 2000
VL 11
IS 8-12
BP 488
EP 495
DI 10.1002/1099-1581(200008/12)11:8/12<488::AID-PAT995>3.0.CO;2-5
PG 8
WC Polymer Science
SC Polymer Science
GA 374DK
UT WOS:000165329000018
DA 2018-10-20
ER

PT J
AU Gower, MC
AF Gower, MC
TI Industrial applications of laser micromachining
SO OPTICS EXPRESS
LA English
DT Article
ID EXCIMER-LASER
AB The use of pulsed lasers for microprocessing material in several manufacturing industries is presented. Microvia, ink jet printer nozzle and biomedical catheter hole drilling, thin-film scribing and micro-electromechanical system (MEMS) fabrication applications are reviewed. (C)2000 Optical Society of America.
C1 Exitech Ltd, Oxford OX8 8LH, England.
RP Gower, MC (reprint author), Exitech Ltd, Hanborough Pk, Oxford OX8 8LH, England.
CR ALLEN SD, 1982, CLEO C SUMM
   BACHER W, 1995, IEEE T IND ELECTRON, V42, P431, DOI 10.1109/41.464604
   Bachmann F., 1989, Chemtronics, V4, P149
   BLOEMBERGEN N, 1994, AIP C P, V288
   FRAZIER AB, 1995, IEEE T IND ELECTRON, V42, P423, DOI 10.1109/41.464603
   Gifford R. S., 1998, OPN Optics & Photonics News, V9, P27
   GOWER MC, 1996, NANOTECHNOLOGY MED B
   Harvey EC, 1997, P SOC PHOTO-OPT INS, V3223, P26, DOI 10.1117/12.284497
   HOLDEN H, 1997, FUTURE CIRCUITS INT, V1, P71
   KAWAMURA Y, 1982, APPL PHYS LETT, V40, P374, DOI 10.1063/1.93108
   Kiyama S., 1990, JSPE, V11, P2069
   LANKARD JR, 1992, APPL PHYS A-MATER, V54, P355, DOI 10.1007/BF00324201
   MCKEOWN P, 1997, EMERGING TECHNOLOGY, V1
   Miller J.C., 1994, LASER ABLATION PRINC
   PATEL RS, 1996, LASER FOCUS WORL JAN
   Pethig R, 1998, J MICROMECH MICROENG, V8, P57, DOI 10.1088/0960-1317/8/2/004
   ROWAN C, 1995, LASER FOCUS WORL AUG
   South A, 1998, Med Device Technol, V9, P30
   SRINIVASAN R, 1982, APPL PHYS LETT, V41, P576, DOI 10.1063/1.93601
   Watson M. N., 1984, Circuit World, V11, P13, DOI 10.1108/eb043747
NR 20
TC 128
Z9 132
U1 3
U2 37
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1094-4087
J9 OPT EXPRESS
JI Opt. Express
PD JUL 17
PY 2000
VL 7
IS 2
BP 56
EP 67
DI 10.1364/OE.7.000056
PG 12
WC Optics
SC Optics
GA 335XC
UT WOS:000088269500004
PM 19404370
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Bradley, CP
   Pullan, AJ
   Hunter, PJ
AF Bradley, CP
   Pullan, AJ
   Hunter, PJ
TI Effects of material properties and geometry on electrocardiographic
   forward simulations
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE forward problem; electrocardiographic simulation; conductivity effects;
   geometric effects; coupled FEM/BEM; high order interpolation
ID ECCENTRIC SPHERES MODEL; EPICARDIAL POTENTIALS; INVERSE PROBLEM;
   FINITE-ELEMENT; BODY-SURFACE; TORSO INHOMOGENEITIES; REALISTIC HEART;
   CONDUCTIVITY; DISTRIBUTIONS; FORMULATION
AB This paper investigates the effect on torso potentials of changes in the material properties of the torso volume conductor and changes in the relative geometry of the heart and torso. The investigations are performed using a number of forward simulations with a high-order coupled finite element/boundary clement torso model. This torso model contains descriptions of the epicardium, lungs, skeletal muscle (with a continuously varying fiber field) and subcutaneous fat. The number of nodes, elements and solution degrees-of-freedom used in the computational torso model are considerably smaller than previous torso models of similar complexity. The successful forward simulations in this paper hence demonstrate the use of the high-order coupled approach with realistic problems. The results of the torso simulations show that the torso inhomogeneities do affect the torso potentials but do not affect the distribution or pattern of the torso potentials. The inhomogeneities considered are found to have a varying, but important, effect on the torso potentials. The effect of the subcutaneous fat is found to be more important and the effect of the skeletal muscle is found to be less important than previous reports in the literature. The results also show that the relative geometry of the heart and torso is very important in determining the torso potential magnitudes and distributions. (C) 2000 Biomedical Engineering Society. [S0090-6964(00)00407-0].
C1 Univ Auckland, Dept Engn Sci, Auckland, New Zealand.
RP Pullan, AJ (reprint author), Univ Auckland, Dept Engn Sci, Private Bag 92019, Auckland, New Zealand.
OI Bradley, Chris/0000-0001-6554-1463; Hunter, Peter/0000-0001-9665-4145
CR AKIYAMA T, 1978, CARDIOVASC RES, V12, P697, DOI 10.1093/cvr/12.12.697
   Bradley CP, 1997, ANN BIOMED ENG, V25, P96, DOI 10.1007/BF02738542
   BRADLEY CP, 1998, UNPUB IEEE T BIOMED
   BRODY DA, 1956, CIRC RES, V4, P731, DOI 10.1161/01.RES.4.6.731
   BUDGETT DM, 1993, J ELECTROCARDIOL, V26, P165
   CLAYDON FJ, 1988, IEEE T BIO-MED ENG, V35, P981, DOI 10.1109/10.8680
   Czapski P, 1996, IEEE T BIO-MED ENG, V43, P95, DOI 10.1109/10.477705
   DOWNER CE, 1980, CLIN CARDIOL, V3, P87
   FOSTER KR, 1989, CRIT REV BIOMED ENG, V17, P25
   GEDDES LA, 1967, MED BIOL ENG, V5, P271, DOI 10.1007/BF02474537
   GREEN LS, 1991, CIRCULATION, V84, P2513, DOI 10.1161/01.CIR.84.6.2513
   GREENSITE F, 1994, ANN BIOMED ENG, V22, P172, DOI 10.1007/BF02390375
   GULRAJANI RM, 1988, CRIT REV BIOMED ENG, V16, P1
   GULRAJANI RM, 1983, CIRC RES, V52, P45, DOI 10.1161/01.RES.52.1.45
   HUISKAMP G, 1989, IEEE T BIO-MED ENG, V36, P827, DOI 10.1109/10.30808
   Hunter P., 1997, COMPUTATIONAL BIOL H, P345
   HUNTER PJ, 1988, PROG BIOPHYS MOL BIO, V52, P101, DOI 10.1016/0079-6107(88)90004-1
   HUNTER PJ, 1997, COMPUTATIONAL BIOL H, P171
   JOHNSON CR, 1992, COMPUT BIOL MED, V22, P305, DOI 10.1016/0010-4825(92)90020-N
   JORGENSON DB, 1995, IEEE T BIO-MED ENG, V42, P172, DOI 10.1109/10.341830
   KARLON WJ, 1994, IEEE T BIO-MED ENG, V41, P1010, DOI 10.1109/10.335838
   Klepfer RN, 1997, IEEE T BIO-MED ENG, V44, P706, DOI 10.1109/10.605427
   KRASSOWSKA W, 1994, IEEE T BIO-MED ENG, V41, P143, DOI 10.1109/10.284925
   LORANGE M, 1993, J ELECTROCARDIOL, V26, P263, DOI 10.1016/0022-0736(93)90048-I
   MCFEE R, 1968, AM HEART J, V76, P48, DOI 10.1016/0002-8703(68)90294-9
   MESSINGERRAPPORT BJ, 1986, IEEE T BIO-MED ENG, V33, P667, DOI 10.1109/TBME.1986.325756
   MESSINGERRAPPORT BJ, 1990, CIRC RES, V66, P1023, DOI 10.1161/01.RES.66.4.1023
   Pullan A, 1996, IEEE T BIO-MED ENG, V43, P292, DOI 10.1109/10.486286
   Pullan AJ, 1996, COMPUT MECH, V18, P356
   RUDY Y, 1982, CIRCULATION, V65, P440, DOI 10.1161/01.CIR.65.3.440
   RUDY Y, 1979, CIRC RES, V44, P104, DOI 10.1161/01.RES.44.1.104
   RUDY Y, 1980, CIRC RES, V46, P283, DOI 10.1161/01.RES.46.2.283
   RUDY Y, 1979, IEEE T BIO-MED ENG, V26, P392, DOI 10.1109/TBME.1979.326417
   RUDY Y, 1988, CRIT REV BIOMED ENG, V16, P215
   RUSH S, 1963, CIRC RES, V12, P40, DOI 10.1161/01.RES.12.1.40
   SPACH MS, 1977, CIRCULATION, V55, P268, DOI 10.1161/01.CIR.55.2.268
   STANLEY PC, 1991, IEEE T BIO-MED ENG, V38, P1069, DOI 10.1109/10.99070
   STANLEY PC, 1986, IEEE T BIO-MED ENG, V33, P273, DOI 10.1109/TBME.1986.325711
   Tomlinson K, 1996, INT J NUMER METH ENG, V39, P451, DOI 10.1002/(SICI)1097-0207(19960215)39:3<451::AID-NME863>3.0.CO;2-1
   UIJEN GJH, 1988, P 14 INT C EL
   VANOOSTEROM A, 1989, J ELECTROCARDIOL, V22, P53, DOI 10.1016/0022-0736(89)90023-X
   WALKER SJ, 1987, CIRC RES, V61, P504, DOI 10.1161/01.RES.61.4.504
   WEI DM, 1995, IEEE T BIO-MED ENG, V42, P343, DOI 10.1109/10.376128
NR 43
TC 40
Z9 42
U1 0
U2 0
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL
PY 2000
VL 28
IS 7
BP 721
EP 741
DI 10.1114/1.1289467
PG 21
WC Engineering, Biomedical
SC Engineering
GA 357GM
UT WOS:000089490200003
PM 11016411
DA 2018-10-20
ER

PT J
AU Vetter, FJ
   McCulloch, AD
AF Vetter, FJ
   McCulloch, AD
TI Three-dimensional stress and strain in passive rabbit left ventricle: A
   model study
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE ventricular mechanics; scalable parallel computation; finite element
   analysis
ID FINITE-ELEMENT MODEL; WALL MECHANICS; MYOCARDIUM; HEART; DEFORMATIONS
AB To determine regional stress and strain distributions in rabbit ventricular myocardium, an anatomically detailed finite element model was used to solve the equations of stress equilibrium during passive filling of the left ventricle. Computations were conducted on a scalable parallel processing computer and performance was found to scale well with the number of processors used, so that stimulations previously requiring approximately 60 min were completed in just over 5 min. Epicardial strains from the model analysis showed good agreement (RMSE=0.007332) with experimental measurements when material properties were chosen such that cross fiber strain was more heterogeneous than fiber strain, which is also consistent with experimental observations in other species. (C) 2000 Biomedical Engineering Society, [S0090-6964(00)00507-5].
C1 Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
RP McCulloch, AD (reprint author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA.
FU NCRR NIH HHS [RR08065]
CR BOVENDEERD PHM, 1994, J BIOMECH, V27, P941, DOI 10.1016/0021-9290(94)90266-6
   Bovendeerd PHM, 1996, AM J PHYSIOL-HEART C, V270, pH398
   BOVENDEERD PHM, 1992, J BIOMECH, V25, P1129, DOI 10.1016/0021-9290(92)90069-D
   BRADFIELD JWB, 1977, BRIT HEART J, V39, P806
   Costa KD, 1996, J BIOMECH ENG-T ASME, V118, P464, DOI 10.1115/1.2796032
   Costa KD, 1997, AM J PHYSIOL-HEART C, V273, pH1968
   COSTA KD, 1996, THESIS U CALIFORNIA
   Dias da Cunha R., 1994, Advances in Computational Mathematics, V2, P261
   Emery JL, 1997, AM J PHYSIOL-HEART C, V272, pH2299
   Gallagher AM, 1997, CARDIOVASC PATHOBIOL, V2, P25
   GRAY RA, 1995, CIRCULATION, V91, P2454, DOI 10.1161/01.CIR.91.9.2454
   GREEN AE, 1970, LARGE ELAST DEFORMAT
   GUCCIONE JM, 1991, J BIOMECH ENG-T ASME, V113, P42, DOI 10.1115/1.2894084
   GUCCIONE JM, 1995, J BIOMECH, V28, P1167, DOI 10.1016/0021-9290(94)00174-3
   Holmes JW, 1997, AM J PHYSIOL-HEART C, V272, pH2123
   HUGHES TJR, 1983, COMPUT METHOD APPL M, V36, P241, DOI 10.1016/0045-7825(83)90115-9
   HUMPHREY JD, 1989, CIRC RES, V65, P805, DOI 10.1161/01.RES.65.3.805
   HUTCHINSON SA, 1998, AZTEC USERS GUIDE VE
   HUYGHE JM, 1991, J BIOMECH, V24, P527, DOI 10.1016/0021-9290(91)90286-V
   HUYGHE JM, 1992, AM J PHYSIOL, V262, pH1256
   JONES MT, 1997, 9548 ARG NAT LAB
   LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571
   Lin DHS, 1998, J BIOMECH ENG-T ASME, V120, P504, DOI 10.1115/1.2798021
   NIELSEN PMF, 1991, AM J PHYSIOL, V260, pH1365
   ODELL WG, 1998, ADV BIOENG BED, V39, P1
   ODELL WG, 1998, P 1998 ASME INT MECH
   OMENS JH, 1991, AM J PHYSIOL, V261, pH918
   OMENS JH, 1993, J BIOMECH, V26, P665, DOI 10.1016/0021-9290(93)90030-I
   SAAD Y, 2000, 55455 MN U MINN DEP
   STREETER DD, 1979, HDB PHYSL 2, V1, P61
   Vetter FJ, 1998, PROG BIOPHYS MOL BIO, V69, P157, DOI 10.1016/S0079-6107(98)00006-6
   WALDMAN LK, 1991, THEORY OF HEART, P145
   WATHEN AJ, 1989, COMPUT METHOD APPL M, V74, P271, DOI 10.1016/0045-7825(89)90052-2
   WATKINS MW, 1992, AM J PHYSIOL, V263, pH1811
   Yeckel A, 1997, PARALLEL COMPUT, V23, P1379, DOI 10.1016/S0167-8191(97)00059-8
   Yin FCP, 1996, AM J PHYSIOL-HEART C, V271, pH1864
NR 36
TC 90
Z9 94
U1 0
U2 6
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL
PY 2000
VL 28
IS 7
BP 781
EP 792
DI 10.1114/1.1289469
PG 12
WC Engineering, Biomedical
SC Engineering
GA 357GM
UT WOS:000089490200007
PM 11016415
DA 2018-10-20
ER

PT J
AU Alanazi, A
   Nojiri, C
   Noguchi, T
   Kido, T
   Komatsu, Y
   Hirakuri, K
   Funakubo, A
   Sakai, K
   Fukui, Y
AF Alanazi, A
   Nojiri, C
   Noguchi, T
   Kido, T
   Komatsu, Y
   Hirakuri, K
   Funakubo, A
   Sakai, K
   Fukui, Y
TI Improved blood compatibility of DLC coated polymeric material
SO ASAIO JOURNAL
LA English
DT Article
ID SURFACES; INVITRO
AB There is currently an increasing interest in the use of DLC (diamond like carbon) films in biomedical applications. These investigations making use of DLC in the biomedical area indicate its attractive properties. In this study, we succeeded in depositing DLC on polymer substrates and found the best conditions and method for this application. We evaluated the blood compatibility of polycarbonate substrates coated by DLC (PC-DLC) under different conditions by using epifluorescent video microscopy (EVM) combined with a parallel plate flow chamber. Segmented polyurethane (SPU), which has been used to fabricate medical devices including an artificial heart, and proven to have acceptable blood compatibility, was compared with polycarbonate substrates coated with DLC film. The EVM system measured platelet adhesion on the surface of the DLC, by using whole human blood containing Mepacrine labeled platelets perfuse at a wall shear rate of 100 s(-1) at 1 min intervals for a period of 20 min. PC-DLC demonstrated that Tecoflex showed higher complement activation than PC-DLC. There were significant differences between the PC-DLC substrates. On the basis of these results, it is recommended for use as a coating material in implantable blood contacting devices such as artificial hearts, pacemakers, and other devices. This DLC seems to be a promising candidate for biomaterials applications and merits further investigation.
C1 Tokyo Denki Univ, Dept Appl Syst Engn, Fac Sci & Engn, Hatoyama, Saitama 3500394, Japan.
   Terumo Co Ltd, R&D Ctr, Inst Biomed Sci, Kanagawa, Japan.
   Waseda Univ, Shinjyuku Ku, Tokyo, Japan.
RP Alanazi, A (reprint author), Tokyo Denki Univ, Dept Appl Syst Engn, Fac Sci & Engn, Hatoyama, Saitama 3500394, Japan.
CR ALANAZI A, J SOC APPL PHYS  AUT, P58
   ALANAZI A, 1999, INT S ADV BIOM TISS
   ALANAZI A, 1998, VACUUM, V49, P1
   GRAINGER DW, 1989, J BIOMED MATER RES, V23, P979, DOI 10.1002/jbm.820230903
   HOLLAND L, 1976, THIN SOLID FILMS, V38, pL17, DOI 10.1016/0040-6090(76)90214-5
   HOLLAND L, 1977, J VAC SCI TECHNOL, V14, P5, DOI 10.1116/1.569159
   KAWAGOISHI N, 1994, ARTIF ORGANS, V18, P588, DOI 10.1111/j.1525-1594.1994.tb03383.x
   KIM SW, 1987, ANN NY ACAD SCI, V516, P116, DOI 10.1111/j.1749-6632.1987.tb33035.x
   KIM SW, 1974, T AM SOC ART INT ORG, VB 20, P449
   KOBAYASHI K, 1988, THIN SOLID FILMS, P158
   KURODA S, 1996, HEART REPLACEMENT AR, V5, P21
   LINDON JN, 1978, J LAB CLIN MED, V92, P904
   Mizumoto D, 1997, ASAIO J, V43, pM500
   NDRADE JD, 1987, ASAIO J, V10, P75
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1151, DOI 10.1002/jbm.820240903
   NOJIRI C, 1995, ARTIF ORGANS, V19, P32, DOI 10.1111/j.1525-1594.1995.tb02241.x
   NOJIRI C, 1990, ASAIO J T, V36, P168
   NOJIRI C, 1987, T AM SOC ART INT ORG, V33, P596
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P1095, DOI 10.1002/jbm.820250905
   TURITTO VT, 1982, PROG HEMOST THROMB, V6, P139
NR 20
TC 25
Z9 27
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1058-2916
EI 1538-943X
J9 ASAIO J
JI Asaio J.
PD JUL-AUG
PY 2000
VL 46
IS 4
BP 440
EP 443
DI 10.1097/00002480-200007000-00014
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 368VX
UT WOS:000090139100014
PM 10926142
OA Bronze
DA 2018-10-20
ER

PT J
AU Sawyer-Glover, AM
   Shellock, FG
AF Sawyer-Glover, AM
   Shellock, FG
TI Pre-MRI procedure screening: Recommendations and safety considerations
   for biomedical implants and devices
SO JOURNAL OF MAGNETIC RESONANCE IMAGING
LA English
DT Review
DE Magnetic Resonance Imaging; safety; screening; bioeffects; implants
ID NUCLEAR MAGNETIC-RESONANCE; CLIP VARIABILITY ISSUES; ANEURYSM CLIP;
   FERROMAGNETIC PROPERTIES; CARDIAC-PACEMAKERS; PULSE GENERATORS;
   ARTIFACTS; COMPATIBILITY; TITANIUM; PATIENT
AB Maintaining a safe MR environment is a daily challenge for MR healthcare workers, especially in consideration of the increasing number of clinical MR applications and the large and growing variety of biomedical implants and devices that are currently used in patients. This review article presents policies and procedures that should be used to screen all patients and individuals before allowing them to enter the magnetic resonance (MR) environment. Information pertaining to MR safety and the relative risk factors for implants, devices and materials is discussed. A comprehensive pre-MRI procedure screening form that is recommended for use by MR facilities is also included. (C) 2000 Wiley-Liss, Inc.
C1 Stanford Univ, Sch Med, Radiol Sci Lab, Richard M Lucas Ctr MRSI,Dept Radiol, Stanford, CA 94305 USA.
RP Sawyer-Glover, AM (reprint author), Stanford Univ, Sch Med, Radiol Sci Lab, Richard M Lucas Ctr MRSI,Dept Radiol, Mail Code 5488,Room P273,1201 Welch Rd, Stanford, CA 94305 USA.
CR ALAGONA P, 1989, PACE, V12, P619, DOI 10.1111/j.1540-8159.1989.tb02707.x
   *ASTM, 1994, ANN BOOK AM SOC TEST
   BECKER RL, 1988, AM J NEURORADIOL, V9, P885
   BONNET CA, 1990, AM HEART J, V120, P696, DOI 10.1016/0002-8703(90)90031-R
   Dujovny M, 1997, RADIOLOGY, V202, P637, DOI 10.1148/radiology.202.3.9051008
   DUJOVNY M, 1985, NEUROSURGERY, V17, P543, DOI 10.1227/00006123-198510000-00002
   DUJOVNY M, 1985, CEREBRAL VASCULAR SU, P1
   *ECRI, 1998, NEW MRI COMPL
   ERLEBACHER JA, 1986, AM J CARDIOL, V57, P437, DOI 10.1016/0002-9149(86)90768-X
   *FDA, 1988, PREM NOT 510 REG REQ
   FETTER J, 1984, PACE, V7, P720, DOI 10.1111/j.1540-8159.1984.tb05602.x
   Fleckenstein JL, 1997, RADIOLOGY, V202, P640, DOI 10.1148/radiology.202.3.9051009
   GANGAROSA RE, 1987, MAGN RESON IMAGING, V5, P287, DOI 10.1016/0730-725X(87)90006-3
   GEGAUFF AG, 1990, J ORAL REHABIL, V17, P403, DOI 10.1111/j.1365-2842.1990.tb01411.x
   HAYES DL, 1987, J AM COLL CARDIOL, V10, P782, DOI 10.1016/S0735-1097(87)80270-X
   HOLMES DR, 1986, PACE, V9, P360, DOI 10.1111/j.1540-8159.1986.tb04490.x
   JOHNSON GC, 1993, RADIOLOGY, V188, P287, DOI 10.1148/radiology.188.1.8511314
   Kanal E, 1996, RADIOLOGY, V200, P576, DOI 10.1148/radiology.200.2.8685361
   KANAL E, 1990, RADIOLOGY, V176, P593, DOI 10.1148/radiology.176.3.2202008
   Kanal E, 1997, RADIOLOGY, V202, P641, DOI 10.1148/radiology.202.3.641
   KANAL E, 1994, AM J NEURORADIOL, V15, P1394
   Kanal E, 1997, RADIOLOGY, V202, P638, DOI 10.1148/radiology.202.3.638
   KLUCZNIK RP, 1993, RADIOLOGY, V187, P855, DOI 10.1148/radiology.187.3.8497645
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   PAVLICEK W, 1983, RADIOLOGY, V147, P149, DOI 10.1148/radiology.147.1.6828720
   PERSSON BRR, 1989, HLTH SAFETY CLIN NMR
   SHELLOCK F G, 1989, Magnetic Resonance Quarterly, V5, P243
   Shellock F. G., 1996, MAGNETIC RESONANCE B
   SHELLOCK FG, 1991, RADIOLOGY, V180, P541, DOI 10.1148/radiology.180.2.2068325
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   Shellock FG, 1998, RADIOLOGY, V206, P838, DOI 10.1148/radiology.206.3.9494511
   SHELLOCK FG, 1991, JMRI-J MAGN RESON IM, V1, P97, DOI 10.1002/jmri.1880010114
   Shellock FG, 1998, RADIOLOGY, V207, P587, DOI 10.1148/radiology.207.3.9609877
   Shellock FG, 2000, POCKET GUIDE MR PROC
   SHELLOCK FG, 1992, REV MAGN RESON IMAGI, V4, P21
   Shellock FG, 1997, POCKET GUIDE MR PROC
   Wichmann W, 1997, AM J NEURORADIOL, V18, P939
   ZIMMERMANN BH, 1984, DIAGN IMAG CLIN MED, V53, P53
NR 38
TC 62
Z9 65
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 1053-1807
J9 J MAGN RESON IMAGING
JI J. Magn. Reson. Imaging
PD JUL
PY 2000
VL 12
IS 1
BP 92
EP 106
DI 10.1002/1522-2586(200007)12:1<92::AID-JMRI11>3.0.CO;2-7
PG 15
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 477PZ
UT WOS:000171294600011
PM 10931569
DA 2018-10-20
ER

PT J
AU Johnson, GS
   Mucalo, MR
   Lorier, MA
AF Johnson, GS
   Mucalo, MR
   Lorier, MA
TI The processing and characterization of animal-derived bone to yield
   materials with biomedical applications - Part 1: Modifiable porous
   implants from bovine condyle cancellous bone and characterization of
   bone materials as a function of processing
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TRANSFORM INFRARED-SPECTROSCOPY; RAY PHOTOELECTRON-SPECTROSCOPY;
   RAMAN-SPECTROSCOPY; CALCIUM-PHOSPHATE; MAGNETIC-RESONANCE; EARLY
   DEPOSITS; SOLID-PHASE; PO4 DOMAIN; HYDROXYAPATITE; ENAMEL
AB A study on the development of a process to form materials suitable for biomedical xenograft implants from bovine cancellous bone is presented. Bone cubes cut from the condyle portion of bovine femurs sourced from abattoir waste were subjected to a defatting and subsequent deproteination procedure to produce shape-modifiable materials in which the biocompatible mineral calcium hydroxycarbonate apatite component was preserved in the original osseous architecture of the bovine bone. Optimum defatting was achieved by (1) thawing of the precut bone cubes in water, (2) pressure cooking at 15 psi in water, (3) soaking in 0.1 mol l(-1) NaOH followed by a thorough rinse under running water, (4) microwave heating of the bone cubes in water, (5) refluxing in methyl acetate and finally (6) removal of internal liquid from the cubes by shaking and then air drying. Subsequent deproteination of the defatted bone cubes was optimally achieved by (1) soaking in 5% sodium hypochlorite solution at ambient temperature using ultrasonication, (2) thorough rinsing of the cubes in water followed by drying. The final product is a defatted/deproteinated, bleached material that can be molded into various shapes for implant use in the body. The bone specimens were characterized by a suite of analytical techniques (i.e. infrared, P-31 and C-13 solid magic-angle spinning (MAS) nuclear magnetic resonance (NMR), X-ray photoelectron spectroscopies, atomic absorption (AA) spectrometry, inductively coupled plasma (ICP) spectrometry, differential scanning calorimetry (DSC), and scanning electron microscopy (SEM)) in order to follow compositional changes during the various stages of processing. In general, bovine condyles proved to be the best source of xenograft materials with condyles from other animal species (i.e. deer, sheep and ostrich) being too small to constitute a utilizable source of cancellous bone. This study shows how value can be added to a hitherto underutilized abattoir by-product by using simple processing techniques. (C) 2000 Kluwer Academic Publishers.
C1 Univ Waikato, Dept Chem, Hamilton, New Zealand.
   MIRINZ Food Technol & Res Ltd, Hamilton, New Zealand.
RP Mucalo, MR (reprint author), Univ Waikato, Dept Chem, Private Bag 3105, Hamilton, New Zealand.
RI Mucalo, Michael/E-5263-2013
OI Mucalo, Michael/0000-0002-7655-9885
CR ABDELFATTAH WI, 1993, THERMOCHIM ACTA, V218, P465, DOI 10.1016/0040-6031(93)80445-G
   AKAZAWA T, 1991, PHOSPHORUS RES B, V1, P215
   *ASS OFF AN CHEM, 1995, AOAC INT, V2, P7
   AUE WP, 1984, BIOCHEMISTRY-US, V23, P6110, DOI 10.1021/bi00320a032
   BEM H, 1982, ANAL CHIM ACTA, V135, P129, DOI 10.1016/S0003-2670(01)85272-7
   BERTOLUZZA A, 1994, J RAMAN SPECTROSC, V25, P109, DOI 10.1002/jrs.1250250116
   BESHAH K, 1990, J SOLID STATE CHEM, V84, P71, DOI 10.1016/0022-4596(90)90185-Z
   Broz JJ, 1997, J MATER SCI-MATER M, V8, P395, DOI 10.1023/A:1018545303184
   CHAPPARD D, 1993, BIOMATERIALS, V14, P507, DOI 10.1016/0142-9612(93)90238-W
   CRAIG NL, 1975, ANAL LETT, V8, P831, DOI 10.1080/00032717508059056
   CUNNINGHAM WT, 1980, ORAL SURG ORAL MED O, V49, P175, DOI 10.1016/0030-4220(80)90313-8
   ELLIOT JC, 1994, STUDIES INORGANIC CH, V18, P229
   FRAYSSINET P, 1995, J MATER SCI-MATER M, V6, P473, DOI 10.1007/BF00123372
   GANZLER K, 1986, J CHROMATOGR, V371, P299, DOI 10.1016/S0021-9673(01)94714-4
   GELINAS Y, 1992, ANAL CHIM ACTA, V269, P115, DOI 10.1016/0003-2670(92)85140-2
   GRYNPAS MD, 1987, BIOL TRACE ELEM RES, V13, P333, DOI 10.1007/BF02796644
   HASEGAWA K, 1994, CALCIFIED TISSUE INT, V55, P381, DOI 10.1007/BF00299319
   HERCULES DM, 1976, J DENT RES, V55, P829, DOI 10.1177/00220345760550051901
   JOBLING A, 1983, P EAST SCH AGR SCI U, V36, P183
   KANO S, 1991, P 1 INT S AP MISH JU, P91
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   LANDIS WJ, 1982, MICROBEAN ANAL, P121
   LEUNG YC, 1995, J BIOMED MATER RES, V29, P591, DOI 10.1002/jbm.820290506
   MINGOS DMP, 1991, CHEM SOC REV, V20, P12
   MOORE JR, 1995, MAGNET RESON MED, V33, P293, DOI 10.1002/mrm.1910330303
   OTTER M, 1988, J ORTHOP RES, V6, P346, DOI 10.1002/jor.1100060306
   RADU GL, 1993, J MOL STRUCT, V293, P265, DOI 10.1016/0022-2860(93)80064-3
   REHMAN I, 1995, J BIOMED MATER RES, V29, P1287, DOI 10.1002/jbm.820291016
   REY C, 1989, CALCIFIED TISSUE INT, V45, P157, DOI 10.1007/BF02556059
   REY C, 1991, CALCIFIED TISSUE INT, V49, P383, DOI 10.1007/BF02555847
   REY C, 1990, CALCIFIED TISSUE INT, V46, P384, DOI 10.1007/BF02554969
   SAUER GR, 1994, CALCIFIED TISSUE INT, V54, P414, DOI 10.1007/BF00305529
   Savarino L, 1998, J MATER SCI-MATER M, V9, P109, DOI 10.1023/A:1008855216755
   SHARP DJ, 1990, J BIOMECH, V23, P853, DOI 10.1016/0021-9290(90)90032-X
   SWAN JE, 1991, 883 MIRINZ
   WALSH WR, 1994, J MATER SCI-MATER M, V5, P72, DOI 10.1007/BF00121694
   WALTERS MA, 1991, CALCIFIED TISSUE INT, V48, P368, DOI 10.1007/BF02556157
   WALTERS MA, 1990, J INORG BIOCHEM, V39, P193, DOI 10.1016/0162-0134(90)84002-7
NR 38
TC 39
Z9 43
U1 0
U2 13
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2000
VL 11
IS 7
BP 427
EP 441
DI 10.1023/A:1008987908917
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 321NF
UT WOS:000087461000004
PM 15348008
DA 2018-10-20
ER

PT J
AU Albertsson, AC
   Edlund, U
   Stridsberg, K
AF Albertsson, AC
   Edlund, U
   Stridsberg, K
TI Controlled ring-opening polymerization of lactones and lactides
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT International Symposium on Ionic Polymerization (IP 99)
CY JUL 19-23, 1999
CL KYOTO, JAPAN
SP Int Union Pure & Appl Chem, Macromolec Div, Chem Soc Japan, Soc Polymer Sci, Japan Chem Innovat Inst
ID POLYMERS
AB 1,5-dioxepan-2-one (DXO) is presented as a versatile component in biodegradable polymers for biomedical applications. Copolymerization of DXO and L-lactide yielded a semi-crystalline, yet flexible, material where the extent of crystallinity and erosion characteristics were controlled by an appropriate choice of copolymer composition. Crosslinked PDXO was polymerized as a novel biodegradable elastomer. The degradation behavior of these materials were explored in vitro. Microspheres from poly(DXO-co-L-LA) were prepared and shown to be promising candidates for controlled release. The polymer composition and drug solubility provided effective means of controlling the drug delivery pattern.
C1 Royal Inst Technol, Dept Polymer Technol, S-10044 Stockholm, Sweden.
RP Albertsson, AC (reprint author), Royal Inst Technol, Dept Polymer Technol, S-10044 Stockholm, Sweden.
RI Albertsson, Ann-Christine/Q-6107-2016
OI Albertsson, Ann-Christine/0000-0001-8696-9143; /0000-0002-1631-1781
CR ALBERTSSON AC, 1995, J MACROMOL SCI PURE, VA32, P41, DOI 10.1080/10601329508011063
   ALBERTSSON AC, 1995, J APPL POLYM SCI, V57, P87, DOI 10.1002/app.1995.070570109
   ALBERTSSON AC, 1998, ENCY ENV ANAL REMEDI
   Edlund U, 1999, J POLYM SCI POL CHEM, V37, P1877, DOI 10.1002/(SICI)1099-0518(19990615)37:12<1877::AID-POLA17>3.0.CO;2-4
   Palmgren R, 1997, J POLYM SCI POL CHEM, V35, P1635, DOI 10.1002/(SICI)1099-0518(19970715)35:9<1635::AID-POLA5>3.0.CO;2-Q
   STRIDSBERG K, IN PRESS J POLYM SCI
NR 6
TC 20
Z9 20
U1 0
U2 13
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JUL
PY 2000
VL 157
BP 39
EP 46
DI 10.1002/1521-3900(200007)157:1<39::AID-MASY39>3.0.CO;2-1
PG 8
WC Polymer Science
SC Polymer Science
GA 359VF
UT WOS:000089632200006
DA 2018-10-20
ER

PT J
AU de Certaines, JD
   Chauvel, BP
   Bouk'hil, H
   Cathelineau, G
AF de Certaines, JD
   Chauvel, BP
   Bouk'hil, H
   Cathelineau, G
TI A safety approach of magnetic compatibility of metallic biomaterials in
   Magnetic Resonance Imaging
SO PHYSICA MEDICA
LA English
DT Article
DE Magnetic Resonance Imaging; metallic implants; biohazards; safety
ID MR PROCEDURES; BIOMEDICAL IMPLANTS; POTENTIAL HAZARDS; FOREIGN-BODIES;
   ANEURYSM CLIPS; ARTIFACTS; NMR; DEVICES; FERROMAGNETISM; THRESHOLDS
AB Interactions of metallic implants and monitoring devices with magnetic field must be an important safety consideration for both patients and staff in Magnetic Resonance Imaging. Metallic materials can be a contra-indication for MRI when it leads to safety issue (biohazards) or image misinterpretation (artefacts). Tests and safety guidelines are proposed concerning the MRI compatibility of non-active metallic materials. The evolution of laws concerning health and medical attitudes leads to set up standardized tests as a pre-requisite before marketing new medical implants or instruments. Furthermore, for not yet registered or miscellaneous materials, implanted or not, a clinical safety attitude is proposed and has to be respected by the MRI staff to detect and identify them in order to avoid potential accidents.
C1 Univ Rennes 1, Lab Resonance Magnet Biol & Med, Fac Med, F-35000 Rennes, France.
   Univ Rennes 1, Lab Biomat Site Osseux, Fac Med, F-35000 Rennes, France.
CR ADAIR E R, 1986, Magnetic Resonance Imaging, V4, P321, DOI 10.1016/0730-725X(86)91042-8
   ATHEY TW, 1992, ANN NY ACAD SCI, P649
   BOTTOMLEY PA, 1992, ANN NY ACAD SCI, V649, P144, DOI 10.1111/j.1749-6632.1992.tb49604.x
   BOUTIN RD, 1994, AM J ROENTGENOL, V162, P189, DOI 10.2214/ajr.162.1.8273663
   BUCHLI R, 1998, MAGNET RESON MED, V18, P255
   BUDINGER TF, 1992, ANN NY ACAD SCI, V649, P1, DOI 10.1111/j.1749-6632.1992.tb49592.x
   BUDINGER TF, 1981, J COMPUT ASSIST TOMO, V5, P800, DOI 10.1097/00004728-198112000-00003
   Chauvel B, 1996, JMRI-J MAGN RESON IM, V6, P936, DOI 10.1002/jmri.1880060615
   DAVIS PL, 1981, AM J ROENTGENOL, V137, P857, DOI 10.2214/ajr.137.4.857
   Elmquist C, 1995, JMRI-J MAGN RESON IM, V5, P784, DOI 10.1002/jmri.1880050629
   ELSTER AD, 1994, AM J ROENTGENOL, V162, P195, DOI 10.2214/ajr.162.1.8273665
   *FDAS GOOD GUID PR, 1997, PRIM MED DEV INT MAG
   GO KG, 1989, CLIN NEUROL NEUROSUR, V91, P109, DOI 10.1016/S0303-8467(89)80030-7
   GRANDOLFO M, 1990, BIOELECTROMAGNETICS, V11, P117, DOI 10.1002/bem.2250110203
   HARAMATI N, 1994, JMRI-J MAGN RESON IM, V4, P209, DOI 10.1002/jmri.1880040219
   JOHNSON GC, 1993, RADIOLOGY, V188, P287, DOI 10.1148/radiology.188.1.8511314
   Jolesz FA, 1998, JMRI-J MAGN RESON IM, V8, P8, DOI 10.1002/jmri.1880080105
   KAGETSU NJ, 1991, RADIOLOGY, V179, P505, DOI 10.1148/radiology.179.2.2014301
   KANAL E, 1990, RADIOLOGY, V176, P593, DOI 10.1148/radiology.176.3.2202008
   Kanal E., 1988, MAGN RESON IMAGIN S1, V7, P106
   KANAL E, 1990, SOC MAGN RES, V1, P274
   KELLY WM, 1986, AM J NEURORADIOL, V7, P243
   LECERF J, 1994, ITBM, V15, pP5
   MCROBBIE D, 1984, CLIN PHYS PHYSIOL M, V5, P67, DOI 10.1088/0143-0815/5/2/002
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   *NRPB, 1981, RADIOGRAPHY, V47, P258
   POHOST GM, 1992, NY ACAD SCI, P302
   Pusey E, 1986, Radiographics, V6, P891
   Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854
   Schueler BA, 1999, JMRI-J MAGN RESON IM, V9, P596, DOI 10.1002/(SICI)1522-2586(199904)9:4<596::AID-JMRI14>3.0.CO;2-T
   SHELLOCK F G, 1989, Magnetic Resonance Quarterly, V5, P243
   SHELLOCK FG, 1991, RADIOLOGY, V180, P541, DOI 10.1148/radiology.180.2.2068325
   SHELLOCK FG, 1994, JMRI-J MAGN RESON IM, V4, P749, DOI 10.1002/jmri.1880040519
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P811, DOI 10.2214/ajr.151.4.811
   SHELLOCK FG, 1992, ANN NY ACAD SCI, V649, P260, DOI 10.1111/j.1749-6632.1992.tb49615.x
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   Shellock FG, 1999, AM J ROENTGENOL, V173, P543, DOI 10.2214/ajr.173.3.10470877
   Shellock FG, 1998, RADIOLOGY, V206, P838, DOI 10.1148/radiology.206.3.9494511
   SHELLOCK FG, 1993, RADIOLOGY, V189, P587, DOI 10.1148/radiology.189.2.8210394
   SHELLOCK FG, 1992, APPL RADIOL      NOV, P44
   TEITELBAUM GP, 1988, RADIOLOGY, V166, P657, DOI 10.1148/radiology.166.3.3340759
   TENFORDE TS, 1986, MED MONOGRAPH, V14, P493
   TIMMS WE, 1992, J MED ENG TECHNOL, V16, P69, DOI 10.3109/03091909209021963
   VOGL T, 1988, MED PHYS, V15, P562, DOI 10.1118/1.596207
   WALKER PM, 1989, PHYS MED BIOL, V34, P5, DOI 10.1088/0031-9155/34/1/002
   Wickersheim K A, 1982, Prog Clin Biol Res, V107, P547
   WILLIAMS DF, 1987, PROG BIOMED ENG, V4, P4
   1993, J OFFICIEL COMMUNAUT
NR 48
TC 1
Z9 1
U1 0
U2 2
PU ISTITUTI EDITORIALI E POLGRAFICI INTERNAZIONALI
PI PISA
PA CASELLA POSTALE N 1, SUCCURSALE N 8, 56123 PISA, ITALY
SN 1120-1797
J9 PHYS MEDICA
JI Phys. Medica
PD JUL-SEP
PY 2000
VL 16
IS 3
BP 97
EP 106
PG 10
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 378EL
UT WOS:000165572000001
DA 2018-10-20
ER

PT J
AU Chan, B
   Donzelli, PS
   Spilker, RL
AF Chan, B
   Donzelli, PS
   Spilker, RL
TI A mixed-penalty biphasic finite element formulation incorporating
   viscous fluids and material interfaces
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE biphasic finite element formulation; fluid viscosity; material
   interface; Couette flow
ID ARTICULAR-CARTILAGE; CONTACT; OSTEOARTHRITIS; LUBRICATION; COMPRESSION;
   TISSUES; LAYERS
AB The fluid viscosity term of the fluid phase constitutive equation and the interface boundary conditions between biphasic, solid and fluid domains have been incorporated into a mixed-penalty finite element formulation of the linear biphasic theory for hydrated soft tissue. The finite element code can now model a single-phase viscous incompressible fluid, or a single-phase elastic solid, as limiting cases of a biphasic material. Interface boundary conditions allow the solution of problems involving combinations of biphasic, fluid and solid regions. To incorporate these conditions, the volume-weighted mixture velocity is introduced as a degree of freedom at interface nodes so that the kinematic continuity conditions are satisfied by conventional finite element assembly techniques. Results comparing our numerical method with an independent, analytic solution for the problem of Couette flow over rigid and deformable porous biphasic layers show that the finite element code accurately predicts the viscous fluid flows and deformation in the porous biphasic region. Thus, the analysis can be used to model the interface between synovial fluid and articular cartilage in diarthrodial joints. This is an important step toward modeling and understanding the mechanisms of joint lubrication and another step toward fully modeling the in vivo behavior of a diarthrodial joint. (C) 2000 Biomedical Engineering Society. [S0090-6964(00)00506-3].
C1 Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
   Rensselaer Polytech Inst, Dept Mech Engn Aeronaut Engn & Mech, Troy, NY 12180 USA.
   Rensselaer Polytech Inst, Sci Computat Res Ctr, Troy, NY 12180 USA.
RP Spilker, RL (reprint author), Rensselaer Polytech Inst, Dept Biomed Engn, JEC 7049, Troy, NY 12180 USA.
FU NIAMS NIH HHS [R01 AR42850]
CR ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013
   ATESHIAN G, 1991, THESIS COLUMBIA U NE
   ATESHIAN GA, 1994, J BIOMECH, V27, P1347, DOI 10.1016/0021-9290(94)90044-2
   ATESHIAN GA, 1995, J BIOMECH, V28, P1341, DOI 10.1016/0021-9290(95)00008-6
   CHAN B, 1991, THESIS RENNSELAER PO
   Donzelli PS, 1998, COMPUT METHOD APPL M, V153, P63, DOI 10.1016/S0045-7825(97)00065-0
   Freeman MAR, 1979, ADULT ARTICULAR CART, P487
   GUILAK F, 1994, J ORTHOPAED RES, V12, P474, DOI 10.1002/jor.1100120404
   HLAVACEK M, 1995, J BIOMECH, V28, P1199, DOI 10.1016/0021-9290(94)00178-7
   HOU J, 1989, INTERFACE CONDITIONS, P175
   HOU JS, 1989, J BIOMECH ENG-T ASME, V111, P78, DOI 10.1115/1.3168343
   HOWELL DS, 1992, OSTEOARTHRITIS DIAGN, pCH9
   HUGHES T, 1987, FINITE ELEMENT METHO
   JIN Z, 1992, P I MECH ENG C-MECH, V209, P117
   LAI WM, 1980, BIORHEOLOGY, V17, P111
   LAI WM, 1978, J BIOMECH ENG-T ASME, V100, P169, DOI 10.1115/1.3426208
   Mankin H. J., 1986, J RHEUMATOL, V13, P1130
   MAXIAN TA, 1989, 6 NODE TRIANGULAR EL
   Moskowitz RW, 1992, OSTEOARTHRITIS DIAGN
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   RADIN EL, 1972, LANCET, V1, P519
   Spilker R.L., 1988, COMPUTATIONAL METHOD, P81
   SPILKER RL, 1990, INT J NUMER METH ENG, V30, P1063, DOI 10.1002/nme.1620300508
   SPILKER RL, 1987, 1987 BIOM S NEW YORK, P49
   SPILKER RL, 1990, BIOMECHANICS DIARTHR, P401
   SUH JK, 1989, 1989 ADV BIOENGINEER
   VANDERVOET A, 1993, RECENT ADV COMPUTER
   VERMILYEA ME, 1990, 1990 ADV BIOENGINEER, P211
NR 28
TC 8
Z9 9
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUN
PY 2000
VL 28
IS 6
BP 589
EP 597
DI 10.1114/1.1305529
PG 9
WC Engineering, Biomedical
SC Engineering
GA 349LF
UT WOS:000089046000001
PM 10983705
DA 2018-10-20
ER

PT J
AU McGuire, J
   Bower, CK
   Bothwell, MK
AF McGuire, J
   Bower, CK
   Bothwell, MK
TI On the molecular origins of protein structure and function at interfaces
SO AUSTRALIAN JOURNAL OF DAIRY TECHNOLOGY
LA English
DT Editorial Material
ID AIR-WATER-INTERFACE; BROMIDE-MEDIATED ELUTABILITY; SYNTHETIC STABILITY
   MUTANTS; SILANIZED SILICA SURFACES; SOLID LIQUID INTERFACES; T4 PHAGE
   LYSOZYME; BACTERIOPHAGE-T4 LYSOZYME; COLLOIDAL SILICA; WILD-TYPE;
   COMPARATIVE ADSORPTION
AB Protein films can profoundly affect the properties of materials onto which they adsorb. This can lead to serious consequences in a number of applications in food, pharmaceutical, and biomedical technology. To study the behaviour of proteins at interfaces, we used bacteriophage T4 lysozyme variants that differed at the molecular level by only one amino acid residue. The results from this research suggest that adsorbed protein can be adequately described as existing in one of two conformational states, that differ in occupied area and binding strength. The competitive adsorption behaviour of a protein, as well as its biological function, are inextricably linked to protein structure at the interface. By quantifying protein-surface interactions, it should be possible to predict and control protein interfacial function in practical circumstances.
C1 Oregon State Univ, Corvallis, OR 97331 USA.
RP McGuire, J (reprint author), Oregon State Univ, 116 Gilmore Hall, Corvallis, OR 97331 USA.
CR ALBER T, 1987, METHOD ENZYMOL, V154, P511
   Andrade J. D., 1996, INTERFACIAL PHENOMEN, P19
   ARAI T, 1990, COLLOID SURFACE, V51, P17, DOI 10.1016/0166-6622(90)80128-Q
   ARAI T, 1990, COLLOID SURFACE, V51, P1, DOI 10.1016/0166-6622(90)80127-P
   BANIJABER A, 2000, IN PRESS J FOOD SCI
   BILLSTEN P, 1995, J COLLOID INTERF SCI, V175, P77, DOI 10.1006/jcis.1995.1431
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   Bower CK, 1998, J DAIRY SCI, V81, P2771, DOI 10.3168/jds.S0022-0302(98)75835-7
   BOWER CK, 1995, J IND MICROBIOL, V15, P227, DOI 10.1007/BF01569829
   Bower CK, 1998, BIOTECHNOL BIOENG, V58, P658, DOI 10.1002/(SICI)1097-0290(19980620)58:6<658::AID-BIT13>3.0.CO;2-3
   Bower CK, 1999, BIOTECHNOL BIOENG, V64, P373, DOI 10.1002/(SICI)1097-0290(19990805)64:3<373::AID-BIT14>3.0.CO;2-J
   BOWER CK, 1995, APPL ENVIRON MICROB, V61, P992
   Brash J. L., 1995, ACS SYM SER, V602, P1
   ELWING H, 1988, J COLLOID INTERF SCI, V123, P306, DOI 10.1016/0021-9797(88)90249-4
   Froberg JC, 1998, LANGMUIR, V14, P456, DOI 10.1021/la970674w
   GRUTTER MG, 1982, J MOL BIOL, V154, P525, DOI 10.1016/S0022-2836(82)80011-9
   HORBETT TA, 1987, ACS SYM SER, V343, P1
   HORSLEY D, 1987, ACS SYM SER, V343, P290
   KATO A, 1988, PROTEIN ENG, V2, P153, DOI 10.1093/protein/2.2.153
   KONDO A, 1992, BIOTECHNOL BIOENG, V40, P889, DOI 10.1002/bit.260400804
   KONDO A, 1991, J COLLOID INTERF SCI, V143, P214, DOI 10.1016/0021-9797(91)90454-G
   Lakamraju M, 1996, J COLLOID INTERF SCI, V178, P495, DOI 10.1006/jcis.1996.0144
   LEE SH, 1988, J COLLOID INTERF SCI, V125, P365, DOI 10.1016/0021-9797(88)90001-X
   Lee WK, 1999, J COLLOID INTERF SCI, V213, P265, DOI 10.1006/jcis.1999.6135
   LUEY JK, 1991, J COLLOID INTERF SCI, V143, P489, DOI 10.1016/0021-9797(91)90282-D
   LUNDSTROM I, 1990, J COLLOID INTERF SCI, V136, P68, DOI 10.1016/0021-9797(90)90079-4
   MATSUMURA M, 1988, NATURE, V334, P406, DOI 10.1038/334406a0
   MATSUMURA M, 1989, SCIENCE, V243, P792, DOI 10.1126/science.2916125
   MATTHEWS BW, 1973, J MOL BIOL, V78, P575, DOI 10.1016/0022-2836(73)90478-6
   McGuire J, 1995, ACS SYM SER, V602, P52
   MCGUIRE J, 1995, J COLLOID INTERF SCI, V170, P193, DOI 10.1006/jcis.1995.1088
   MCGUIRE J, 1995, J COLLOID INTERF SCI, V170, P182, DOI 10.1006/jcis.1995.1087
   MCGUIRE J, 1999, ENCY BIOPROCESS TECH, P42
   NORDE W, 1992, COLLOID SURFACE, V64, P87, DOI 10.1016/0166-6622(92)80164-W
   NORDE W, 1978, J COLLOID INTERF SCI, V66, P257, DOI 10.1016/0021-9797(78)90303-X
   NORDE W, 1986, ADV COLLOID INTERFAC, V25, P267, DOI 10.1016/0001-8686(86)80012-4
   Podhipleux N, 1999, COLLOID SURFACE B, V13, P167, DOI 10.1016/S0927-7765(99)00008-9
   Podhipleux N, 1996, FOOD HYDROCOLLOID, V10, P285, DOI 10.1016/S0268-005X(96)80003-8
   SHIRAHAMA H, 1990, J COLLOID INTERF SCI, V139, P177, DOI 10.1016/0021-9797(90)90455-W
   Singla B, 1996, J COLLOID INTERF SCI, V182, P292, DOI 10.1006/jcis.1996.0463
   SUTTIPRASIT P, 1993, FOOD HYDROCOLLOID, V7, P241, DOI 10.1016/S0268-005X(09)80175-6
   Suvajittanont W, 2000, BIOTECHNOL BIOENG, V67, P12, DOI 10.1002/(SICI)1097-0290(20000105)67:1<12::AID-BIT2>3.0.CO;2-#
   Tian MH, 1998, J COLLOID INTERF SCI, V200, P146, DOI 10.1006/jcis.1997.5348
   Wang J, 1997, J COLLOID INTERF SCI, V185, P317, DOI 10.1006/jcis.1996.4619
   WEI AP, 1990, DEV BIOTHER, V1, P305
   XU SQ, 1993, J COLLOID INTERF SCI, V159, P124, DOI 10.1006/jcis.1993.1304
NR 46
TC 5
Z9 5
U1 0
U2 1
PU DAIRY INDUSTRY ASSOC AUSTRALIA
PI NORTH MELBOURNE
PA PO BOX 351, 1FL4, 484 WILLIAM ST, NORTH MELBOURNE, VIC 3051, AUSTRALIA
SN 0004-9433
J9 AUST J DAIRY TECHNOL
JI Aust. J. Dairy Technol.
PD JUN
PY 2000
VL 55
IS 2
BP 65
EP 70
PG 6
WC Agriculture, Dairy & Animal Science; Food Science & Technology
SC Agriculture; Food Science & Technology
GA 336NM
UT WOS:000088309200007
DA 2018-10-20
ER

PT J
AU Chance, JJ
   Li, DJ
   Sokoll, LJ
   Silberman, MA
   Engelstad, ME
   Nichols, JH
   Liu, XH
   Mohammad, AA
   Petersen, JR
   Okorodudu, AO
AF Chance, JJ
   Li, DJ
   Sokoll, LJ
   Silberman, MA
   Engelstad, ME
   Nichols, JH
   Liu, XH
   Mohammad, AA
   Petersen, JR
   Okorodudu, AO
TI Multiple site analytical evaluation of a portable blood gas/electrolyte
   analyzer for point of care testing
SO CRITICAL CARE MEDICINE
LA English
DT Article
DE critical care medicine; point of care testing; blood gases;
   electrolytes; portable; tonometry; cost; correlation
ID CLINICAL ANALYZER; UNIT
AB Objective: To evaluate the analytical performance of the SenDx 100 portable blood gas and electrolyte analyzer (SenDx Medical, Carlsbad, CA).
   Design: Accuracy was evaluated by correlation of whole blood patient samples with the Nova Stat Profile 5 (Nova Biomedical, Waltham, MA) and the Ciba Coming 865 (Chiron Diagnostics, Medford, MA). Precision was evaluated using quality control materials (RNA Medical, Acton, MA).
   Setting: Critical care laboratories and operating rooms in two institutions.
   Measurements and Main Results:Precision studies performed at three different concentration levels for each analyte demonstrated intra-assay precision of less than or equal to 2.5% coefficient of variation and interassay precision of less than or equal to 4.0% coefficient of variation in all cases. Analysis of patient specimens in general showed good to excellent correlation to reference analyzers. Regression Variables are tabulated.
   Conclusions: The SenDx 100 portable blood gas and electrolyte analyzer is a simple and easy to use analyzer demonstrating acceptable performance compared with reference methods.
C1 Johns Hopkins Hosp, Dept Pathol, Div Clin Chem, Baltimore, MD 21287 USA.
   Univ Texas, Med Branch, Dept Pathol, Div Clin Chem, Galveston, TX 77550 USA.
RP Nichols, JH (reprint author), Johns Hopkins Hosp, Dept Pathol, Div Clin Chem, 600 N Wolfe St,Meyer B-125, Baltimore, MD 21287 USA.
CR BURKE MD, 1993, AM J CLIN PATHOL, V100, P89
   *COLL AM PATH, 1998, CRIT CAR AQ BLOOD GA
   Gault MH, 1996, CLIN BIOCHEM, V29, P117, DOI 10.1016/0009-9120(96)02028-0
   HERR DM, 1995, AM J CLIN PATHOL, V104, pS54
   JACOBS E, 1993, CLIN CHEM, V39, P1890
   Lamb L S Jr, 1995, Am J Crit Care, V4, P429
   Murthy JN, 1997, CLIN BIOCHEM, V30, P385, DOI 10.1016/S0009-9120(97)00046-5
   WONG RJ, 1994, CLIN CHEM, V40, P124
NR 8
TC 7
Z9 7
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0090-3493
J9 CRIT CARE MED
JI Crit. Care Med.
PD JUN
PY 2000
VL 28
IS 6
BP 2081
EP 2085
DI 10.1097/00003246-200006000-00069
PG 5
WC Critical Care Medicine
SC General & Internal Medicine
GA 324YF
UT WOS:000087649000063
PM 10890668
DA 2018-10-20
ER

PT J
AU Stieglitz, T
   Beutel, H
   Meyer, JU
AF Stieglitz, T
   Beutel, H
   Meyer, JU
TI "Microflex" - A new assembling technique for interconnects
SO JOURNAL OF INTELLIGENT MATERIAL SYSTEMS AND STRUCTURES
LA English
DT Article
ID HISTOLOGICAL REACTION; POLYIMIDE; STIMULATION; ELECTRODES; FILMS
AB A new interconnection technique has been developed that allows versatile multiple strand connections between microsensors, sensor arrays, and chips designed for wire bonding. The new technique has been termed "Microflex interconnection" technique (MFI).
   Conventional wire bonding technique is commonly restricted to planar interconnects with a limited degree of freedom for placing microsystem components in hybrid assemblies. The MFI technique has overcome this limitation by interconnecting microsystem components through custom designed flexible substrates with embedded metallized conductors, pad arrays for integrated circuits' assembly and substrate integrated electrodes. Standard CMOS components without additional pad metallization can be used. The integration density of the MFI technique corresponds to one of the flip-chip technology. Special advantages of the MFI technique are three-dimensional interconnects, the flexibility in design and shape, and easy visual inspection of alignment qualities. The method is especially suitable for small volumes of customer specified devices and biomedical implants because all materials used are biocompatible.
   Within this paper, the MFI technique is introduced, described in detail, and tested according to international standards. The evaluation of the electrical and mechanical properties of the interconnection sites exhibited promising results regarding stability and reliability. First applications in the biomedical field were presented on the example of a neural implant and a sensorized cardiac catheter.
C1 Fraunhofer Inst Biomed Engn, Sensor Syst Microsyst Dept, D-66386 Sankt Ingbert, Germany.
RP Stieglitz, T (reprint author), Fraunhofer Inst Biomed Engn, Sensor Syst Microsyst Dept, Ensheimer Str 48, D-66386 Sankt Ingbert, Germany.
EM thomas.stieglitz@ibmt.fhg.de
RI Stieglitz, Thomas/C-7916-2013
OI Stieglitz, Thomas/0000-0002-7349-4254
CR BEEBE DJ, 1994, SENSOR ACTUAT A-PHYS, V44, P57, DOI 10.1016/0924-4247(93)00775-Y
   BEUTEL H, Patent No. 19730388
   CHANG LH, 1991, METALLIZATION PERFOR, V1596, P34
   CHMIEL G, 1994, MICR SYST TECHN 94 I, P587
   FRAZIER BA, 1995, SENSOR ACTUAT A-PHYS, V45, P47
   HAGGERTY HS, 1989, ACTA OTO-LARYNGOL, V107, P13, DOI 10.3109/00016488909127474
   HETKE JF, 1990, SENSOR ACTUAT A-PHYS, V23, P999, DOI 10.1016/0924-4247(90)87076-U
   KIM YW, 1991, IEEE T ELECTRON DEV, P651
   KOENINGER V, VERBINDNGSTECHNIK EL, P193
   KOOPMAN NG, 1989, MICROELECTRONICS PAC, P366
   KOOPMAN NG, 1989, MICROELECTRONICS PAC, P391
   LOEB GE, 1977, J BIOMED MATER RES, V11, P195, DOI 10.1002/jbm.820110206
   Navarro X, 1998, J PERIPHER NERV SYST, V3, P91
   RICHARDSON RR, 1993, J BIOMAT, P627
   Rodriguez FJ, 2000, J NEUROSCI METH, V98, P105, DOI 10.1016/S0165-0270(00)00192-8
   ROSSI RD, 1990, SOLID STATE TECHNOL, P21
   Stieglitz T, 1998, TOP CURR CHEM, V194, P131
   Stieglitz T, 1997, P ANN INT IEEE EMBS, V19, P2307, DOI 10.1109/IEMBS.1997.758825
   Stieglitz T, 1997, SENSOR ACTUAT A-PHYS, V60, P240, DOI 10.1016/S0924-4247(97)01494-5
   VANDERPUIJE PD, 1989, ANN OTO RHINOL LARYN, V98, P466, DOI 10.1177/000348948909800614
NR 20
TC 29
Z9 29
U1 0
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1045-389X
EI 1530-8138
J9 J INTEL MAT SYST STR
JI J. Intell. Mater. Syst. Struct.
PD JUN
PY 2000
VL 11
IS 6
BP 417
EP 425
AR PII R7BV511B21RJR2FA
DI 10.1106/R7BV-511B-21RJ-R2FA
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 413QR
UT WOS:000167623700001
DA 2018-10-20
ER

PT J
AU Rheinlander, T
   Roessner, D
   Weitschies, W
   Semmler, W
AF Rheinlander, T
   Roessner, D
   Weitschies, W
   Semmler, W
TI Comparison of size-selective techniques for the fractionation of
   magnetic fluids
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article
DE magnetic fluid; field-flow fractionation; size-exclusion chromatography;
   magnetic relaxation
ID SUPERPARAMAGNETIC IRON-OXIDE; FIELD-FLOW FRACTIONATION;
   LIGHT-SCATTERING; PARTICLES; SYSTEM
AB Nanoparticles in magnetic fluids commonly display a broad distribution of magnetic and nonmagnetic parameters such as particle size. Nevertheless, magnetic fluids are used in many fields of application like material separation and biomedicine. Thereby, it is often the case that only a small number of particles contribute to the desired magnetic effect. Two fractionation methods, which separate according to the particle size, were tested in order to optimize magnetic fluids for applications. On the one hand, flow field-flow fractionation was used with an online multi-angle laser light-scattering detector that measures the particle size independently. For comparison, on the other hand, well-known size-exclusion chromatography was performed. The fractions obtained by both methods were magnetically characterized by magnetorelaxometry, a biomedical application of magnetic nanoparticles. The fractionations yielded are similar, independent of the method used. In this respect, flow field-flow fractionation has several advantages over size-exclusion chromatography in analytical use. Thus, flow field-flow fractionation requires neither the addition of electrolytes nor column materials. The fractions obtained display distinctly different magnetic properties compared to the original sample and are therefore especially suited for applications like magnetorelaxometry. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Inst Diagnost Forsch GMBH, D-14050 Berlin, Germany.
   Wyatt Technol Deutschland GMBH, D-57614 Woldert, Germany.
   Univ Greifswald, Inst Pharm, D-17487 Greifswald, Germany.
   Deutsch Krebsforschungszentrum, Abt Biophys & Med Strahlenphys, D-69120 Heidelberg, Germany.
RP Rheinlander, T (reprint author), Mifa AG, Rheinstr 99, CH-4402 Frenkendorf, Switzerland.
OI Weitschies, Werner/0000-0003-3492-7747
CR FRIJA G, 1994, INVEST RADIOL, V29, pS75, DOI 10.1097/00004424-199406001-00025
   GIDDINGS JC, 1993, SCIENCE, V260, P1456, DOI 10.1126/science.8502990
   Haller A, 1999, SUPERCOND SCI TECH, V12, P956, DOI 10.1088/0953-2048/12/11/378
   HASEGAWA M, 1987, Patent No. 4101435
   Jiang Y, 1999, J MAGN MAGN MATER, V194, P53, DOI 10.1016/S0304-8853(98)00577-0
   KOCH H, 1991, IEEE T MAGN, V27, P2793, DOI 10.1109/20.133788
   LEWIS JM, 1990, Patent No. 9001899
   MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203
   Neel L., 1949, ANN GEOPHYS, V5, P99
   NUNES AC, 1989, J MAGN MAGN MATER, V78, P241, DOI 10.1016/0304-8853(89)90274-6
   Rheinlander T, 2000, COLLOID POLYM SCI, V278, P259, DOI 10.1007/s003960050041
   RHEINLANDER T, 1999, IEEE T MAGN, V34, P4055
   Sjogren CE, 1997, MAGN RESON IMAGING, V15, P55, DOI 10.1016/S0730-725X(96)00335-9
   THIELKING H, 1995, ANAL CHEM, V67, P3229, DOI 10.1021/ac00114a020
   WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474
   Weitschies W., 1997, Pharmaceutical and Pharmacological Letters, V7, P5
   WILLIAMS SKR, 1990, J MAGN MAGN MATER, V194, P248
   WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S
NR 18
TC 21
Z9 21
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD JUN
PY 2000
VL 214
IS 3
BP 269
EP 275
DI 10.1016/S0304-8853(00)00198-0
PG 7
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 317ZW
UT WOS:000087259500015
DA 2018-10-20
ER

PT J
AU Yoneyama, T
   Doi, H
   Kobayashi, E
   Hamanaka, H
   Tanabe, Y
   Bonfield, W
AF Yoneyama, T
   Doi, H
   Kobayashi, E
   Hamanaka, H
   Tanabe, Y
   Bonfield, W
TI Stress transmission through Ti-Ni alloy, titanium and stainless steel in
   impact compression test
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SHAPE-MEMORY
AB Impact stress transmission of Ti-Ni alloy was evaluated for biomedical stress shielding. Transformation temperatures of the alloy were investigated by means of DSC. An impact compression test was carried out with use of split-Hopkinson pressure-bar technique with cylindrical specimens of Ti-Ni alloy, titanium and stainless steel. As a result, the transmitted pulse through Ti-Ni alloy was considerably depressed as compared with those through titanium and stainless steel. The initial stress reduction was large through Ti-Ni alloy and titanium, but the stress reduction through Ti-Ni alloy was more continuous than titanium. The maximum value in the stress difference between incident and transmitted pulses through Ti-Ni alloy or titanium was higher than that through stainless steel, while the stress reduction in the maximum stress through Ti-Ni alloy was statistically larger than that through titanium or stainless steel. Ti-Ni alloy transmitted less impact stress than titanium or stainless steel, which suggested that the loading stress to adjacent tissues could be decreased with use of Ti-Ni alloy as a component material in an implant system. (C) 2000 Kluwer Academic Publishers.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Met, Div Biomat,Chiyoda Ku, Tokyo 1010062, Japan.
   Niigata Univ, Dept Mech Engn, Niigata 9502181, Japan.
   Queen Mary Univ London, IRC Biomed Mat, London E1 4NS, England.
RP Yoneyama, T (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Met, Div Biomat,Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM yoneyama@i-mde.tmd.ac.jp
CR CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   DOTTER CT, 1983, RADIOLOGY, V147, P259, DOI 10.1148/radiology.147.1.6828741
   HAMANAKA H, 1989, J DENT RES, V68, P1529, DOI 10.1177/00220345890680111201
   HUANG Y, 1985, SCRIPTA METALL MATER, V19, P1033, DOI 10.1016/0036-9748(85)90004-3
   JAMES DW, 1969, MATER SCI ENG, V4, P1, DOI 10.1016/0025-5416(69)90033-0
   LIN HC, 1993, METALL TRANS A, V24, P2189, DOI 10.1007/BF02648593
   LING HC, 1980, METALL TRANS A, V11, P77, DOI 10.1007/BF02700440
   MIURA F, 1986, AM J ORTHOD DENTOFAC, V90, P1, DOI 10.1016/0889-5406(86)90021-1
   MIURA H, 1996, J JPN DENT MAT, V15, P559
   OONISHI H, 1982, T 8 ANN M SOC BIOM O, pP8
   SIMON M, 1977, RADIOLOGY, V125, P89, DOI 10.1148/125.1.89
   SPECK KM, 1980, J DENT RES, V59, P1590, DOI 10.1177/00220345800590100601
   SUZUKI K, 1984, NIPPON DENT REV, V506, P14
   Takahashi J, 1985, Dent Mater J, V4, P146
   TANABE YJ, 1994, J MATER SCI-MATER M, V5, P397, DOI 10.1007/BF00058972
   WALIA H, 1988, J ENDODONT, V14, P346, DOI 10.1016/S0099-2399(88)80196-1
   YONEYAMA T, 1994, BIOMATERIALS, V15, P71, DOI 10.1016/0142-9612(94)90201-1
   YONEYAMA T, 1988, J JPN DENT MAT, V7, P262
NR 18
TC 5
Z9 6
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2000
VL 11
IS 6
BP 333
EP 336
DI 10.1023/A:1008991405784
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 319XW
UT WOS:000087371700001
PM 15348013
DA 2018-10-20
ER

PT J
AU Barns, I
   Schibeci, R
   Davison, A
   Shaw, R
AF Barns, I
   Schibeci, R
   Davison, A
   Shaw, R
TI "What do you think about genetic medicine?" - Facilitating sociable
   public discourse on developments in the new genetics
SO SCIENCE TECHNOLOGY & HUMAN VALUES
LA English
DT Article
ID BIOTECHNOLOGY; TECHNOLOGY; DEBATE
AB An important aspect of any meaningful public discussion about developments in gene technology is the provision of opportunities for interested publics to engage in sociable public discourse with other lay people and with experts. This article reports on a series of peer group conversations conducted in late 1996 and early 1997 with sixteen community groups in Perth, Western Australia, interested in gene therapy technology. With the case of cystic fibrosis as a particular focus, and using background resource material as a stimulus for discussion, the participating groups explored a range of value issues arising from the new genetic medicine. This more discursive context enabled participants to express a number of background or life-world concerns about genetic medicine, concerns that are often obscured by the dominant biomedical and bioethical discourses.
C1 Murdoch Univ, Sch Educ, Perth, WA, Australia.
   Murdoch Univ, Inst Sustainabil & Technol Policy, Perth, WA, Australia.
RP Barns, I (reprint author), Murdoch Univ, Sch Educ, Perth, WA, Australia.
RI Davison, Aidan/N-3863-2013
OI Davison, Aidan/0000-0002-5618-7068
CR Borgmann A., 1984, TECHNOLOGY CHARACTER
   Boyte H. C., 1996, BUILDING AM DEMOCRAT
   COX E, 1995, TRULY CIVIL SOC 1995
   DRAPER E, 1991, RISKY BUSINESS EXLUS
   Emanuel E., 1991, ENDS HUMAN LIFE MED
   Frank A, 1995, WOUNDED STORYTELLER
   FRIEDMANN T, 1997, SCI AM, V276, P80
   FRIEDMANN T, 1994, GENE THERAPY FACT FI
   Gamson W. A, 1992, TALKING POLITICS
   GOLDBLATT J, 1996, GENETICS RESOURCE BO
   GOLDMAN AE, 1987, GROUP DEPTH INTERVIE
   HARRIS J, 1995, PUBLIC UNDERST SCI, V4, P232
   Hauerwas S., 1990, NAMING SILENCES GOD
   Hepburn ER, 1996, J MED ETHICS, V22, P105, DOI 10.1136/jme.22.2.105
   *INT ASS CYST FIBR, 1997, 47 INT ASS CYST FIBR
   JENNINGS B, 1987, HASTINGS CTR REP JAN, P1
   JOSS S, 1995, PUBLIC PARTICIPATION
   Kerr A, 1998, PUBLIC UNDERST SCI, V7, P41, DOI 10.1088/0963-6625/7/1/004
   KOMERSAROFF P, TROUBLED BODIES CRIT
   LEEDER S, 1996, CURRENT AFFAIRS  JUN, P18
   MACER D, 1990, BIOETHICS PEOPLE PEO
   MACER DRJ, 1995, HUM GENE THER, V6, P791, DOI 10.1089/hum.1995.6.6-791
   MATTHEWS T, 1988, AUST J PUBL ADMIN, V47, P147, DOI 10.1111/j.1467-8500.1988.tb01053.x
   MESSER M, 1996, P LECT SER COMM NEW
   Michael M, 1997, PUBLIC UNDERST SCI, V6, P1, DOI 10.1088/0963-6625/6/1/001
   MORGAN DL, 1988, FOCUS GROUPS QUALITY
   *NAT HLTH MED RES, 1994, HUM GEN THER REL PRO
   ORKIN SH, 1995, REPORT RECOMMENDATIO
   PRIEST SH, 1995, J COMMUN, V45, P39, DOI 10.1111/j.1460-2466.1995.tb00713.x
   PRIEST SH, 1994, SCI COMMUN, V16, P166, DOI 10.1177/0164025994016002004
   *PRIV COMM, 1996, 5 AUSTR GOV PUBL SER
   Putnam RD, 1993, MAKING DEMOCRACY WOR
   Redding P., 1995, TROUBLED BODIES CRIT, P87
   RIHCARDS M, 1996, TROUBLED HELIX SOCIA, P3
   Schibeci R, 1997, PUBLIC UNDERST SCI, V6, P167, DOI 10.1088/0963-6625/6/2/004
   Schibeci R, 1998, SCI COMMUN, V20, P204, DOI 10.1177/1075547098020002003
   SHAKESPEARE T, 1995, CRIT SOC POLICY, V44, P22, DOI DOI 10.1177/026101839501504402
   Stewart D. W., 1990, FOCUS GROUPS THEORY
   VINES G, 1995, NEW SCI, P14
   WALTERS L, 1997, ETHICS GENE THERAPY
   Walzer M, 1991, DISSENT          SPR, P293
   Weston Anthony, 1991, J Soc Philos, V22, P109, DOI 10.1111/j.1467-9833.1991.tb00042.x
   Wingerson L., 1990, MAPPING OUR GENES GE
   WINNER L, 1992, INQUIRY, V35, P341, DOI 10.1080/00201749208602298
   Winner L, 1986, WHALE REACTOR SEARCH, P3
   Wynne Brian, 1998, RISK ENV MODERNITY N, P44, DOI DOI 10.4135/9781446221983.N3
   YESLEY M, 1992, BIBLIO ETHICAL LEGAL
NR 47
TC 28
Z9 28
U1 1
U2 8
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0162-2439
J9 SCI TECHNOL HUM VAL
JI Sci. Technol. Hum. Values
PD SUM
PY 2000
VL 25
IS 3
BP 283
EP 308
DI 10.1177/016224390002500302
PG 26
WC Social Issues
SC Social Issues
GA 330HH
UT WOS:000087956400002
PM 15362239
DA 2018-10-20
ER

PT J
AU Ikeyama, M
   Nakao, S
   Morikawa, H
   Yokogawa, Y
   Wielunski, LS
   Clissold, RA
   Bell, T
AF Ikeyama, M
   Nakao, S
   Morikawa, H
   Yokogawa, Y
   Wielunski, LS
   Clissold, RA
   Bell, T
TI Increase of surface hardness induced by O, Ca or P ion implantation into
   titanium
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 11th International Conference on Surface Modification of Metals by Ion
   Beams (SMMIB-99)
CY SEP 19-24, 1999
CL BEIJING, PEOPLES R CHINA
SP Beijing Normal Univ, Tsinghua Univ, Chinese Acad Sci, Shanghai Inst Met, Chinese Mat Res Soc
DE ion implantation; titanium; hardness
ID NITROGEN
AB Titanium or titanium alloys are very attractive materials for use as biomedical materials. Non-toxic elements of oxygen, calcium and phosphorus were implanted into titanium and the changes of surface hardness were measured using an ultra microindenter (UMIS-2000) with the multiple load-unload procedure. Depth profiles of implanted ions were obtained by SIMS measurement. O implantation resulted in the greatest improvement in hardness, up to 2.2 times higher than the unimplanted titanium at the peak. Ca implantation did not improve the hardness as much. The cause may be the formation of a glass-like layer of CaTiO3 and TiO2 on the surface. For P implantation, the depth of maximum hardness increased with increasing implantation energy. The depth of the peak hardness was approximately one-third to one-eighth of the projected range of the implanted ions. (C) 2000 Elsevier Science S.A. All rights reserved.
C1 Natl Ind Res Inst Nagoya, Kita Ku, Nagoya, Aichi 4628510, Japan.
   CSIRO, Div Telecommun & Ind Phys, Lindfield, NSW 2070, Australia.
RP Ikeyama, M (reprint author), Natl Ind Res Inst Nagoya, Kita Ku, Hirate Cho 1-1, Nagoya, Aichi 4628510, Japan.
CR Alonso F, 1996, SURF COAT TECH, V83, P301, DOI 10.1016/0257-8972(96)02767-3
   Bell TJ, 1998, MATER RES SOC SYMP P, V522, P15, DOI 10.1557/PROC-522-15
   FIELD JS, 1993, J MATER RES, V8, P297, DOI 10.1557/JMR.1993.0297
   GARIA A, 1997, SURF COAT TECH, V97, P499
   Hanawa T, 1996, CORROS SCI, V38, P2061, DOI 10.1016/S0010-938X(96)89124-4
   Krupa D, 1997, SURF COAT TECH, V96, P223, DOI 10.1016/S0257-8972(97)00107-2
   Sarkissian AH, 1998, SURF COAT TECH, V98, P1336, DOI 10.1016/S0257-8972(97)00399-X
   Seidel F, 1998, SURF COAT TECH, V98, P1174, DOI 10.1016/S0257-8972(97)00148-5
   ZIEGLER JF, 1985, STOPPING RANGE ION S
NR 9
TC 10
Z9 10
U1 0
U2 2
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUN-JUL
PY 2000
VL 128
BP 400
EP 403
DI 10.1016/S0257-8972(00)00617-4
PG 4
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 329FY
UT WOS:000087897500073
DA 2018-10-20
ER

PT J
AU Grimes, RN
AF Grimes, RN
TI Metallacarboranes in the new millennium
SO COORDINATION CHEMISTRY REVIEWS
LA English
DT Review
DE metallacarboranes; carborane ligands; milennium
ID NEUTRON-CAPTURE THERAPY; ORGANOTRANSITION-METAL METALLACARBORANES;
   ALKYNE INSERTION REACTIONS; VENUS FLYTRAP CLUSTER; SOLID-STATE
   SYNTHESIS; L = CO; MOLECULAR-STRUCTURE; COBALT DICARBOLLIDE; SANDWICH
   COMPOUNDS; METALLOSUPRAMOLECULAR CHEMISTRY
AB The field of metallacarborane chemistry has grown in many different directions and now interfaces with several other disciplines including metal cluster and organometallic chemistry, transition-metal catalysis, materials science, environmental science, and biomedical applications. In this turn-of-the-century overview, some of the more significant recent developments and trends in this area are selectively examined and an attempt is made to project some useful directions in which this chemistry might develop over the next decade or two. (C) 2000 Elsevier Science S.A. All rights reserved.
C1 Univ Virginia, Dept Chem, Charlottesville, VA 22901 USA.
RP Grimes, RN (reprint author), Univ Virginia, Dept Chem, Mccormick Rd, Charlottesville, VA 22901 USA.
CR ALLCOCK HR, 1992, SCIENCE, V255, P1106, DOI 10.1126/science.255.5048.1106
   AMATO I, 1993, SCIENCE, V260, P753, DOI 10.1126/science.260.5109.753
   Armspach D, 1998, J ORGANOMET CHEM, V550, P193, DOI 10.1016/S0022-328X(97)00238-6
   BAKER RT, 1978, J AM CHEM SOC, V100, P8266, DOI 10.1021/ja00494a041
   BARNUM BA, 1995, ORGANOMETALLICS, V14, P4463, DOI 10.1021/om00010a008
   Base K, 1999, INORG CHEM, V38, P287, DOI 10.1021/ic980872q
   BEER DC, 1973, J AM CHEM SOC, V95, P3046, DOI 10.1021/ja00790a070
   BEHNKEN PE, 1983, ANGEW CHEM INT EDIT, V22, P722, DOI 10.1002/anie.198307221
   Bei XH, 1998, ORGANOMETALLICS, V17, P1085, DOI 10.1021/om970962n
   BICERANO J, 1978, INORG CHEM, V17, P3443, DOI 10.1021/ic50190a028
   BICERANO J, 1978, INORG CHEM, V17, P2041, DOI 10.1021/ic50185a079
   Boring E, 1997, ORGANOMETALLICS, V16, P3993, DOI 10.1021/om9703447
   Boring E, 1998, ORGANOMETALLICS, V17, P3865, DOI 10.1021/om980242w
   Bould J, 1998, INORG CHEM COMMUN, V1, P365, DOI 10.1016/S1387-7003(98)00091-4
   Boyd ASF, 1998, POLYHEDRON, V17, P2627, DOI 10.1016/S0277-5387(98)00011-4
   BROWN LD, 1977, INORG CHEM, V16, P2989, DOI 10.1021/ic50178a001
   CARR N, 1990, J CHEM SOC DALTON, P2253, DOI 10.1039/dt9900002253
   CHEETHAM AK, 1994, SCIENCE, V264, P794, DOI 10.1126/science.264.5160.794
   CHIN TM, UNPUB
   Chin TT, 1999, INORG CHEM, V38, P93, DOI 10.1021/ic980382y
   Chizhevsky IT, 1999, ORGANOMETALLICS, V18, P726, DOI 10.1021/om9806592
   Chizhevsky IT, 1997, J ORGANOMET CHEM, V536, P223, DOI 10.1016/S0022-328X(96)06724-1
   CONSTABLE EC, 1994, CHEM IND-LONDON, P56
   COTTON FA, 1999, ADV INORG CHEM, P659
   Cuadrado I, 1997, J AM CHEM SOC, V119, P7613, DOI 10.1021/ja971496w
   Cuadrado I, 1996, ORGANOMETALLICS, V15, P5278, DOI 10.1021/om9605948
   Curtis MA, 1998, J ORGANOMET CHEM, V550, P469, DOI 10.1016/S0022-328X(97)00555-X
   Curtis MA, 1996, INORG CHEM, V35, P6703, DOI 10.1021/ic960691t
   Curtis MA, 1998, INORG CHEM, V37, P102, DOI 10.1021/ic971297d
   CURTIS MA, UNPUB
   CURTIS MA, 1996, BUSA MEX C BOR CHEM
   DOXSEE KM, 1993, ORGANOMETALLICS, V12, P4682, DOI 10.1021/om00035a066
   DUBAY WJ, 1994, J ORG CHEM, V59, P6898, DOI 10.1021/jo00102a009
   Dunn S, 1997, ANGEW CHEM INT EDIT, V36, P645, DOI 10.1002/anie.199706451
   Evans W. J., 1974, J CHEM SOC CHEM COMM, P38
   Fino SA, 1997, INORG CHEM, V36, P4604, DOI 10.1021/ic961182u
   Galsworthy JR, 1997, J ORGANOMET CHEM, V531, P165, DOI 10.1016/S0022-328X(96)06706-X
   Garrioch RM, 1999, J ORGANOMET CHEM, V575, P57, DOI 10.1016/S0022-328X(98)00957-7
   Goeta AE, 1998, CHEM COMMUN, P1713, DOI 10.1039/a804305a
   GREEN M, 1987, J CHEM SOC DALTON, P61, DOI 10.1039/dt9870000061
   Greenwood N.N., 1973, CHEM BORON
   Grimes RN, 1999, J ORGANOMET CHEM, V581, P1, DOI 10.1016/S0022-328X(99)00050-9
   GRIMES RN, 1995, COORDIN CHEM REV, V143, P71, DOI 10.1016/0010-8545(94)07006-6
   Grimes RN, 1996, APPL ORGANOMET CHEM, V10, P209, DOI 10.1002/(SICI)1099-0739(199604)10:3/4<209::AID-AOC469>3.0.CO;2-Q
   GRIMES RN, 1983, ADV INORG CHEM RAD, V26, P55, DOI 10.1016/S0898-8838(08)60091-4
   GRIMES RN, 1992, CHEM REV, V92, P251, DOI 10.1021/cr00010a004
   GRIMES RN, 1982, COMPREHENSIVE ORGANO
   GRIMES RN, 1995, COMPREHENSIVE ORGA 2, V1, P373
   GRIMES RN, 1999, P IMEBORON 10 INT M
   Hagenau U, 1996, INORG CHEM, V35, P7863, DOI 10.1021/ic960443x
   Hall IH, 2000, APPL ORGANOMET CHEM, V14, P108, DOI 10.1002/(SICI)1099-0739(200002)14:2<108::AID-AOC963>3.0.CO;2-4
   HALL IH, UNPUB
   HART DW, 1975, J AM CHEM SOC, V97, P679, DOI 10.1021/ja00836a056
   HARWELL DE, 1995, CAN J CHEM, V73, P1044, DOI 10.1139/v95-129
   HAWTHORNE MF, 1965, J AM CHEM SOC, V87, P1818, DOI 10.1021/ja01086a053
   HAWTHORNE MF, 1968, J AM CHEM SOC, V90, P896, DOI 10.1021/ja01006a009
   Hawthorne MF, 1998, MOL MED TODAY, V4, P174, DOI 10.1016/S1357-4310(98)01226-X
   HAWTHORNE MF, 1990, J AM CHEM SOC, V112, P5365, DOI 10.1021/ja00169a062
   HAWTHORNE MF, 1988, ADV BORON BORANES, P225
   Herberich GE, 1996, ORGANOMETALLICS, V15, P5236, DOI 10.1021/om960536m
   HERBERICH GE, 1981, ANGEW CHEM INT EDIT, V20, P472, DOI 10.1002/anie.198104721
   HERBERICH GE, 1995, COMPREHENSIVE ORGANO, V2, pCH1
   HLATKY GG, 1989, J AM CHEM SOC, V111, P2728, DOI 10.1021/ja00189a064
   HONG E, 1999, 10 INT C BOR CHEM IM
   Hosmane N.S., 1997, ADV BORON CHEM, P349
   Hosmane NS, 1999, J ORGANOMET CHEM, V581, P13, DOI 10.1016/S0022-328X(99)00089-3
   Hosmane NS, 1996, ORGANOMETALLICS, V15, P626, DOI 10.1021/om950691l
   HOSMANE NS, 1993, J CLUST SCI, V4, P297
   HOUSEKNECHT KL, 1995, J AM CHEM SOC, V117, P1163, DOI 10.1021/ja00108a047
   HOWARD JW, 1972, INORG CHEM, V11, P263, DOI 10.1021/ic50108a013
   Hughes DL, 1996, ORGANOMETALLICS, V15, P663, DOI 10.1021/om9507843
   HURLBURT PK, 1995, INORG CHEM, V34, P5215, DOI 10.1021/ic00125a021
   JEFFERY JC, 1993, J CHEM SOC DALTON, P1083, DOI 10.1039/dt9930001083
   Jeffery JC, 1996, ORGANOMETALLICS, V15, P4737, DOI 10.1021/om9604435
   JELLISS PA, 1995, J ORGANOMET CHEM, V500, P307, DOI 10.1016/0022-328X(95)00502-H
   Kabalka GW, 1998, EXPERT OPIN THER PAT, V8, P545, DOI 10.1517/13543776.8.5.545
   KABALKA GW, 1994, CURRENT TOPICS CHEM
   Kawamura K, 1998, INORG CHEM, V37, P608, DOI 10.1021/ic9712784
   Kim JH, 1997, CHEM COMMUN, P1761, DOI 10.1039/a704161f
   Kim JH, 1996, INORG CHEM, V35, P5112, DOI 10.1021/ic960223j
   KOPFMAIER P, 1984, ANGEW CHEM INT EDIT, V23, P456, DOI 10.1002/anie.198404561
   KOPFMAIER P, 1984, J CANCER RES CLIN, V108, P336, DOI 10.1007/BF00390468
   Lebedev VN, 1997, J ORGANOMET CHEM, V536, P537, DOI 10.1016/S0022-328X(96)06600-4
   Lebedev VN, 1997, RUSS CHEM B+, V46, P550, DOI 10.1007/BF02495414
   LIAO YH, 1995, ORGANOMETALLICS, V14, P2130, DOI 10.1021/om00005a002
   Liu GX, 1996, ORGANOMETALLICS, V15, P5257, DOI 10.1021/om960716w
   LYNCH TJ, 1989, ORGANOMETALLICS, V8, P1959, DOI 10.1021/om00110a018
   Mashima K, 1997, ORGANOMETALLICS, V16, P1345, DOI 10.1021/om9610051
   MAXWELL WM, 1977, J AM CHEM SOC, V99, P4008, DOI 10.1021/ja00454a020
   McKinney JD, 1997, J ORGANOMET CHEM, V547, P253, DOI 10.1016/S0022-328X(97)00386-0
   MENG XS, 1993, J AM CHEM SOC, V115, P6143, DOI 10.1021/ja00067a033
   MERKERT JW, 1991, ORGANOMETALLICS, V10, P3545, DOI 10.1021/om00056a026
   MILLER VR, 1977, J AM CHEM SOC, V99, P5646, DOI 10.1021/ja00459a020
   MINGOS DMP, 1990, INTRO CLUSTER CHEM
   MIRABELLI MGL, 1986, ORGANOMETALLICS, V5, P1510, DOI 10.1021/om00138a040
   Mortimer MD, 1996, INORG CHEM, V35, P5750, DOI 10.1021/ic960353s
   MOTOHASHI N, 1991, J ORGANOMET CHEM, V418, P107
   Nemoto H, 1999, J ORGANOMET CHEM, V581, P170, DOI 10.1016/S0022-328X(99)00049-2
   NEUSE EW, 1985, TRANSIT METAL CHEM, V10, P135, DOI 10.1007/BF00641583
   NEUSE EW, 1990, APPL ORGANOMET CHEM, V4, P19, DOI 10.1002/aoc.590040105
   NICOUD JF, 1994, SCIENCE, V263, P636, DOI 10.1126/science.263.5147.636
   OKI AR, 1992, ANGEW CHEM INT EDIT, V31, P432, DOI 10.1002/anie.199204321
   OKI AR, 1991, J AM CHEM SOC, V113, P8351
   Parker KG, 1999, COLLECT CZECH CHEM C, V64, P819, DOI 10.1135/cccc19990819
   PARKINSON B, 1995, SCIENCE, V270, P1157, DOI 10.1126/science.270.5239.1157
   PAXTON RJ, 1991, P NATL ACAD SCI USA, V88, P3387, DOI 10.1073/pnas.88.8.3387
   PETASIS NA, 1993, ORGANOMETALLICS, V12, P3776, DOI 10.1021/om00033a059
   PETASIS NA, 1993, J AM CHEM SOC, V115, P7208, DOI 10.1021/ja00069a018
   PIEPGRASS KW, 1993, INORG CHEM, V32, P2156, DOI 10.1021/ic00062a046
   PIPAL JR, 1993, ORGANOMETALLICS, P4452
   PIPAL JR, 1993, ORGANOMETALLICS, P4459
   Pisareva LV, 1998, INORG CHIM ACTA, V280, P233
   PLESEK J, 1978, COLLECT CZECH CHEM C, V43, P1325, DOI 10.1135/cccc19781325
   PLESEK J, 1992, CHEM REV, V92, P269, DOI 10.1021/cr00010a005
   PLESEK J, 1995, COLLECT CZECH CHEM C, V60, P1297, DOI 10.1135/cccc19951297
   Plesek J, 1998, ACTA CRYSTALLOGR C, V54, P36, DOI 10.1107/S0108270197012742
   PLUMB CA, 1992, ORGANOMETALLICS, V11, P1665, DOI 10.1021/om00040a042
   POOL R, 1992, SCIENCE, V255, P1077, DOI 10.1126/science.255.5048.1077
   Rabinovich D, 1996, INORG CHEM, V35, P1425, DOI 10.1021/ic951444c
   RAIS J, 1976, J INORG NUCL CHEM, V38, P1376, DOI 10.1016/0022-1902(76)80156-X
   Rosair GM, 1998, ORGANOMETALLICS, V17, P3227, DOI 10.1021/om980353v
   RUSSELL JA, UNPUB
   Schleyer PV, 1998, INORG CHEM, V37, P6765, DOI 10.1021/ic980359c
   SCRIBNER BA, UNPUB
   Service RF, 1996, SCIENCE, V271, P920, DOI 10.1126/science.271.5251.920
   SERVICE RF, 1994, SCIENCE, V265, P316, DOI 10.1126/science.8023152
   SIEBERT W, 1993, ADV ORGANOMET CHEM, V35, P187, DOI 10.1016/S0065-3055(08)60491-8
   SIEBERT W, 1988, PURE APPL CHEM, V60, P1345, DOI 10.1351/pac198860081345
   SIEBERT W, 1985, ANGEW CHEM INT EDIT, V24, P943, DOI 10.1002/anie.198509431
   SIEBERT W, 1994, CURRENT TOPICS CHEM, P275
   Siebert W., 1997, ADV BORON CHEM
   Soloway AH, 1999, J ORGANOMET CHEM, V581, P150, DOI 10.1016/S0022-328X(99)00085-6
   Soloway AH, 1998, CHEM REV, V98, P1515, DOI 10.1021/cr941195u
   STEIN A, 1993, SCIENCE, V259, P1558, DOI 10.1126/science.259.5101.1558
   Stibr B, 1995, COLLECT CZECH CHEM C, V60, P2023, DOI 10.1135/cccc19952023
   Valerio C, 1997, J AM CHEM SOC, V119, P2588, DOI 10.1021/ja964127t
   Vanura P, 1998, COLLECT CZECH CHEM C, V63, P338, DOI 10.1135/cccc19980338
   Vinas C, 1998, INORG CHEM, V37, P3640, DOI 10.1021/ic971467m
   Vinas C, 1999, J ORGANOMET CHEM, V581, P188, DOI 10.1016/S0022-328X(99)00057-1
   Vinas C., 1998, DALTON T, P2849
   WANG XT, 1994, J AM CHEM SOC, V116, P2687, DOI 10.1021/ja00085a086
   Wasczcak MD, 1997, ANGEW CHEM INT EDIT, V36, P2228, DOI 10.1002/anie.199722281
   Weller AS, 1999, ORGANOMETALLICS, V18, P853, DOI 10.1021/om980814c
   Wrackmeyer B, 1999, EUR J INORG CHEM, P533
   Yoshida M, 1997, ORGANOMETALLICS, V16, P4508, DOI 10.1021/om970752a
   Yoshida M, 1997, ORGANOMETALLICS, V16, P1349, DOI 10.1021/om970058v
   ZAKHARKIN LI, 1982, J ORGANOMET CHEM, V226, P217, DOI 10.1016/S0022-328X(00)83405-1
   Zakharkin LI, 1998, RUSS CHEM B+, V47, P1222, DOI 10.1007/BF02503502
   ZHANG HM, 1995, ACTA CRYSTALLOGR C, V51, P635, DOI 10.1107/S0108270194008164
   ZHIGAREVA GG, 1994, RUSS J GEN CHEM+, V64, P564
   1991, PURE APPL CHEM, V63
NR 151
TC 176
Z9 177
U1 2
U2 47
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0010-8545
J9 COORDIN CHEM REV
JI Coord. Chem. Rev.
PD MAY
PY 2000
VL 200
BP 773
EP 811
DI 10.1016/S0010-8545(00)00262-9
PG 39
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA 345HC
UT WOS:000088809700024
DA 2018-10-20
ER

PT J
AU Haase, WC
   Seeberger, PH
AF Haase, WC
   Seeberger, PH
TI Recent progress in polymer-supported synthesis of oligosaccharides and
   carbohydrate libraries
SO CURRENT ORGANIC CHEMISTRY
LA English
DT Review
ID SOLID-PHASE-SYNTHESIS; ORTHOGONAL GLYCOSYLATION STRATEGY;
   PHYTOALEXIN-ELICITOR ACTIVITY; BETA-LINKED OLIGOSACCHARIDES; GLYCAL
   ASSEMBLY METHOD; N-PENTENYL GLYCOSIDES; CONTROLLED-PORE GLASS;
   COMBINATORIAL CHEMISTRY; ORGANIC-SYNTHESIS; HIGH-RESOLUTION
AB Glycobiology is a rapidly evolving field and tackles many phenomena of biomedical importance. Driven by the need to create more efficient methods for the synthesis of complex oligosaccharides, the last few years have seen a major push toward a general approach amenable to solid-phase synthesis. Different strategies have been explored and a host of glycosylating agents have been investigated. New linker systems, different solid support materials and a variety of protective groups have been evaluated. The development of on-resin analytical techniques such as MAS-NMR have greatly facilitated the development of new methods for solid-phase oligosaccharide synthesis. These methodological advances have been demonstrated by preparation of several complex oligosaccharides. As the coupling yields have been improved to 95% and above, the desired products could be obtained in good yield even after seven glycosylations.
   In addition to single target structures, carbohydrates have generated rapidly increasing interest with respect to sets of diverse, carbohydrate containing molecules. These efforts are of increasing importance for providing molecular tools to elucidate biological processes.
   While much has been achieved to date, the difficulties encountered in the solid-phase assembly of oligosaccharides underscore the need for the developments of all facets of carbohydrate chemistry. Given the rapid progress in the past eight years, it is conceivable that the synthesis of 'simple' oligosaccharides may soon be automated. Careful investigations into many parameters will eventually allow the synthetic chemist to enable even non-specialists to create important tools for biochemical, biophysical, and medical applications.
C1 MIT, Dept Chem, Cambridge, MA 02139 USA.
RP Seeberger, PH (reprint author), MIT, Dept Chem, Cambridge, MA 02139 USA.
CR Adinolfi M, 1996, TETRAHEDRON LETT, V37, P5007, DOI 10.1016/0040-4039(96)01020-9
   Adinolfi M, 1998, TETRAHEDRON LETT, V39, P1953, DOI 10.1016/S0040-4039(98)00103-8
   Allen H.J., 1992, GLYCOCONJUGATES COMP
   ANDERSON RC, 1995, J ORG CHEM, V60, P2650, DOI 10.1021/jo00114a003
   Andrade RB, 1999, ORG LETT, V1, P1811, DOI 10.1021/ol991071+
   Arya P, 1997, ANGEW CHEM INT EDIT, V36, P1280, DOI 10.1002/anie.199712801
   Atherton E, 1989, SOLID PHASE PEPTIDE
   BAYER E, 1991, ANGEW CHEM INT EDIT, V30, P113, DOI 10.1002/anie.199101133
   BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146
   Brill WKD, 1998, SYNLETT, P1085
   CARUTHERS MH, 1985, SCIENCE, V230, P281, DOI 10.1126/science.3863253
   CHAN TH, 1985, J CHEM SOC CHEM COMM, P909, DOI 10.1039/c39850000909
   Czarnik A. W., 1997, PRACTICAL GUIDE COMB, P123
   DANISHEFSKY SJ, 1993, SCIENCE, V260, P1307, DOI 10.1126/science.8493573
   Danishefsky SJ, 1996, ANGEW CHEM INT EDIT, V35, P1380, DOI 10.1002/anie.199613801
   FITCH WL, 1994, J ORG CHEM, V59, P7955, DOI 10.1021/jo00105a006
   FRASERREID B, 1992, SYNLETT, P927
   Frechet J. M., 1980, POLYM SUPPORTED REAC, P407
   FRECHET JM, 1972, J AM CHEM SOC, V94, P604, DOI 10.1021/ja00757a047
   FRECHET JM, 1971, J AM CHEM SOC, V93, P492
   Fukase K, 1997, MOL DIVERS, V2, P182, DOI 10.1007/BF01715633
   Fukase K, 1999, SYNLETT, P1074
   Garegg PJ, 1997, ADV CARBOHYD CHEM BI, V52, P179, DOI 10.1016/S0065-2318(08)60091-8
   GIRALT E, 1984, TETRAHEDRON, V40, P4141, DOI 10.1016/0040-4020(84)85095-4
   GRIFFITH DA, 1990, J AM CHEM SOC, V112, P5811, DOI 10.1021/ja00171a021
   GUTHRIE RD, 1971, J CHEM SOC C, P2690, DOI 10.1039/j39710002690
   GUTRIE RD, 1973, J CHEM SOC P1, P2414
   HALCOMB RL, 1989, J AM CHEM SOC, V111, P6661, DOI 10.1021/ja00199a028
   HAMADA T, 1986, J AM CHEM SOC, V108, P140, DOI 10.1021/ja00261a023
   Heckel A, 1998, SYNLETT, P171
   HINDSGAUL O, 1998, GLYCOIMMUNOLOGY, V2, P219
   HIRABAYASHI Y, 1990, J BIOL CHEM, V265, P8144
   Hummel G, 1999, ANGEW CHEM INT EDIT, V38, P1782, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1782::AID-ANIE1782>3.0.CO;2-1
   Hunt JA, 1996, J AM CHEM SOC, V118, P9998, DOI 10.1021/ja962128f
   Ito Y, 1998, CURR OPIN CHEM BIOL, V2, P701, DOI 10.1016/S1367-5931(98)80106-3
   Ito Y, 1996, ANGEW CHEM INT EDIT, V35, P2510, DOI 10.1002/anie.199625101
   Ito Y, 1997, J AM CHEM SOC, V119, P5562, DOI 10.1021/ja964093p
   JENNIFER R, 1999, J AM CHEM SOC, V121, P10875
   Jensen KJ, 1998, J AM CHEM SOC, V120, P5441, DOI 10.1021/ja974116f
   Kahne D, 1997, CURR OPIN CHEM BIOL, V1, P130, DOI 10.1016/S1367-5931(97)80119-6
   KAHNE D, 1989, J AM CHEM SOC, V111, P6881, DOI 10.1021/ja00199a081
   Kallus C, 1999, TETRAHEDRON LETT, V40, P7783, DOI 10.1016/S0040-4039(99)01690-1
   KANEMITSU T, 1998, ANGEW CHEM INT EDIT, V37, P3418
   KANIE O, 1994, J AM CHEM SOC, V116, P12073, DOI 10.1021/ja00105a066
   Keifer PA, 1996, J MAGN RESON SER A, V119, P65, DOI 10.1006/jmra.1996.0052
   Khan S. H., 1996, MODERN METHODS CARBO
   Knerr L, 1999, SYNLETT, P1802
   KOBATA A, 1993, ACCOUNTS CHEM RES, V26, P319, DOI 10.1021/ar00030a004
   LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808
   LEE YC, 1994, NEOGLYCOCONJUGATES P
   Lerchen HG, 1999, ANGEW CHEM INT EDIT, V38, P3680, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3680::AID-ANIE3680>3.0.CO;2-9
   LEVY DE, 1994, ANNU REP MED CHEM, V29, P215
   Liang R, 1996, SCIENCE, V274, P1520, DOI 10.1126/science.274.5292.1520
   LLOYD KO, 1991, CANCER BIOL, V2, P421
   MELEAN LG, UNPUB
   MERRIFIELD RB, 1985, ANGEW CHEM INT EDIT, V24, P799, DOI 10.1002/anie.198507993
   Merritt JR, 1996, J CARBOHYD CHEM, V15, P65, DOI 10.1080/07328309608005425
   MILLER DJ, 1992, NATURE, V357, P589, DOI 10.1038/357589a0
   MROSS E, 1999, POSTER EUROCARB, V10
   MURRAY RW, 1985, J ORG CHEM, V50, P2847, DOI 10.1021/jo00216a007
   NICOLAOU KC, 1995, ANGEW CHEM INT EDIT, V34, P2289, DOI 10.1002/anie.199522891
   NICOLAOU KC, 1992, J AM CHEM SOC, V114, P3126, DOI 10.1021/ja00034a063
   Nicolaou KC, 1997, J AM CHEM SOC, V119, P449, DOI 10.1021/ja963482g
   Nicolaou KC, 1998, ANGEW CHEM INT EDIT, V37, P1559, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1559::AID-ANIE1559>3.0.CO;2-E
   Nukada T, 1999, J ORG CHEM, V64, P9030, DOI 10.1021/jo990712b
   Nunns CL, 1999, TETRAHEDRON LETT, V40, P9341, DOI 10.1016/S0040-4039(99)01978-4
   OHLMEYER MHJ, 1993, P NATL ACAD SCI USA, V90, P10922, DOI 10.1073/pnas.90.23.10922
   OPDENAKKER G, 1993, FASEB J, V7, P1330
   Osborn HMI, 1999, TETRAHEDRON, V55, P1807, DOI 10.1016/S0040-4020(98)01200-9
   OSSOWSKI P, 1983, ANGEW CHEM INT EDIT, V22, P793, DOI 10.1002/anie.198307931
   PETRAKOVA E, 1992, CAN J CHEM, V70, P233, DOI 10.1139/v92-034
   PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274
   Plante OJ, 1999, ORG LETT, V1, P211, DOI 10.1021/ol9905452
   POLLEY MJ, 1991, P NATL ACAD SCI USA, V88, P6224, DOI 10.1073/pnas.88.14.6224
   PPLANTE OJ, UNPUB
   Race RR, 1975, BLOOD GROUPS MAN
   Rademann J, 1996, TETRAHEDRON LETT, V37, P3989, DOI 10.1016/0040-4039(96)00763-0
   Rademann J, 1998, ANGEW CHEM INT EDIT, V37, P1241, DOI 10.1002/(SICI)1521-3773(19980518)37:9<1241::AID-ANIE1241>3.0.CO;2-6
   Rademann J, 1999, J AM CHEM SOC, V121, P5459, DOI 10.1021/ja984355i
   Rademann J, 1997, J ORG CHEM, V62, P3650, DOI 10.1021/jo970087f
   RANDOLPH JT, 1994, ANGEW CHEM INT EDIT, V33, P1470, DOI 10.1002/anie.199414701
   RANDOLPH JT, 1995, J AM CHEM SOC, V117, P5712, DOI 10.1021/ja00126a012
   ROBERGE JY, 1995, SCIENCE, V269, P202, DOI 10.1126/science.7618080
   Rodebaugh R, 1999, J ORG CHEM, V64, P1758, DOI 10.1021/jo9718509
   Rodebaugh R, 1997, J ORG CHEM, V62, P5660, DOI 10.1021/jo970216s
   Sarkar SK, 1996, J AM CHEM SOC, V118, P2305, DOI 10.1021/ja952434d
   SCHMIDT RR, 1994, ADV CARBOHYD CHEM BI, V50, P21, DOI 10.1016/S0065-2318(08)60150-X
   SCHULZE IT, 1992, GLYCOCONJUGATE J, V9, P63, DOI 10.1007/BF00731698
   Schweizer F, 1999, CURR OPIN CHEM BIOL, V3, P291, DOI 10.1016/S1367-5931(99)80045-3
   Seeberger PH, 1997, ANGEW CHEM INT EDIT, V36, P491, DOI 10.1002/anie.199704911
   Seeberger PH, 1997, J AM CHEM SOC, V119, P10064, DOI 10.1021/ja971640d
   Seeberger PH, 1997, ALDRICHIM ACTA, V30, P75
   Seeberger PH, 1998, ACCOUNTS CHEM RES, V31, P685, DOI 10.1021/ar9600648
   SHARON N, 1986, LECTINS, P494
   Shimizu H, 1996, BIOORG MED CHEM LETT, V6, P2841, DOI 10.1016/S0960-894X(96)00535-5
   SHOOLERY JN, 1977, PROG NUCL MAG RES SP, V11, P79, DOI 10.1016/0079-6565(77)80003-4
   Sofia MJ, 1999, J MED CHEM, V42, P3193, DOI 10.1021/jm990212a
   Sofia MJ, 1998, MOL DIVERS, V3, P75, DOI 10.1023/A:1009650424835
   Sofia MJ, 1998, COMBINATORIAL CHEMISTRY AND MOLECULAR DIVERSITY IN DRUG DISCOVERY, P243
   SPOHR U, 1988, CARBOHYD RES, V174, P211, DOI 10.1016/0008-6215(88)85093-6
   Tolborg JF, 2000, CHEM COMMUN, P147, DOI 10.1039/a908446k
   TOSHIMA K, 1993, CHEM REV, V93, P1503, DOI 10.1021/cr00020a006
   UGI I, 1982, ANGEW CHEM INT EDIT, V21, P810, DOI 10.1002/anie.198208101
   VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97
   Veeneman GH, 1998, CARBOHYDRATE CHEMISTRY, P98
   VERDUYN R, 1993, RECL TRAV CHIM PAY B, V112, P464
   Wong CH, 1998, J AM CHEM SOC, V120, P7137, DOI 10.1021/ja9813616
   Wunberg T, 1998, ANGEW CHEM INT EDIT, V37, P2503, DOI 10.1002/(SICI)1521-3773(19981002)37:18<2503::AID-ANIE2503>3.0.CO;2-R
   YAKI T, 1986, J BIOL CHEM, V261, P3075
   YAN L, 1994, J AM CHEM SOC, V116, P6953, DOI 10.1021/ja00094a067
   ZEMLYANUKHINA TV, 1990, BIOORG KHIM+, V16, P1096
   ZHENG C, 1998, ANGEW CHEM INT EDIT, V37, P789
   Zheng CS, 1998, J ORG CHEM, V63, P1126, DOI 10.1021/jo971606h
   Zhu T, 1998, ANGEW CHEM INT EDIT, V37, P1898, DOI 10.1002/(SICI)1521-3773(19980803)37:13/14<1898::AID-ANIE1898>3.0.CO;2-T
NR 114
TC 40
Z9 40
U1 1
U2 20
PU BENTHAM SCIENCE PUBL BV
PI HILVERSUM
PA PO BOX 1673, 1200 BR HILVERSUM, NETHERLANDS
SN 1385-2728
J9 CURR ORG CHEM
JI Curr. Org. Chem.
PD MAY
PY 2000
VL 4
IS 5
BP 481
EP 511
DI 10.2174/1385272003376193
PG 31
WC Chemistry, Organic
SC Chemistry
GA 310NH
UT WOS:000086833900003
DA 2018-10-20
ER

PT J
AU Tsap, LV
   Goldgof, DB
   Sarkar, S
AF Tsap, LV
   Goldgof, DB
   Sarkar, S
TI Nonrigid motion analysis based on dynamic refinement of finite element
   models
SO IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE
LA English
DT Article
DE physically-based vision; deformable models; nonrigid motion analysis;
   biomedical applications; finite element analysis
ID INTERFACE; IMAGES
AB In this paper, we propose new algorithms for accurate nonrigid motion tracking. Given an initial model representing general knowledge of the object, a set of sparse correspondences, and incomplete or missing information about geometry or material properties, we can recover dense motion vectors using finite element models. The method is based on the iterative analysis of the differences between the actual and predicted behavior. Large differences indicate that an object's properties are not captured properly by the model describing it. Feedback from the images during the motion allows the refinement of the model by minimizing the error between the expected and true position of the object's points. These errors are due to flaws in the model parameter estimation such as geometry and material properties. Unknown parameters are recovered using an iterative descent search for the best nonlinear finite element model that approximates nonrigid motion of the given object. During this search process, we not only estimate material properties. but also infer dense point correspondences from our initial set of sparse correspondences. Thus, during tracking, the model is refined which, in turn, improves tracking quality. As a result, we obtain a more precise description of nonrigid motion. Experimental results demonstrate the success of the proposed algorithm. The method was applied to man-made elastic materials and human skin to recover unknown elasticity. to complex 3D objects to find details of their geometry, and to a hand motion analysis application. Our work demonstrates the possibility of accurate quantitative analysis of nonrigid motion in range image sequences with objects consisting of multiple materials and 3D volumes.
C1 Lawrence Livermore Natl Lab, Ctr Appl Sci Comp, Livermore, CA 94551 USA.
   Univ S Florida, Dept Comp Sci & Engn, Tampa, FL 33620 USA.
RP Tsap, LV (reprint author), Lawrence Livermore Natl Lab, Ctr Appl Sci Comp, Livermore, CA 94551 USA.
EM tsap1@llnl.gov; goldgof@bigpine.csee.usf.edu;
   sarkar@bigpine.csee.usf.edu
RI Sarkar, Sudeep/A-8213-2009
OI Sarkar, Sudeep/0000-0001-7332-4207
CR Aggarwal JK, 1997, IEEE NONRIGID AND ARTICULATED MOTION WORKSHOP, PROCEEDINGS, P90, DOI 10.1109/NAMW.1997.609859
   Alexander R.M., 1992, HUMAN MACHINE
   Basu S, 1997, IEEE NONRIGID AND ARTICULATED MOTION WORKSHOP, PROCEEDINGS, P46, DOI 10.1109/NAMW.1997.609851
   BRAUER JR, 1993, WHAT EVERY ENG SHOUL
   BRIDGEMAN GB, 1979, BRIDGEMANS COMPLETE
   Burnett D., 1988, FINITE ELEMENT ANAL
   Davis MH, 1997, IEEE T MED IMAGING, V16, P317, DOI 10.1109/42.585766
   DECARLO D, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P834, DOI 10.1109/ICCV.1995.466851
   Delingette H., 1994, Proceedings of the 1994 IEEE Workshop on Motion of Non-Rigid and Articulated Objects (Cat. No.94TH0671-8), P152, DOI 10.1109/MNRAO.1994.346242
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   HUANG WC, 1993, P AS C COMP VIS OS J, P256
   HUGHES T, 1984, THEORETICAL FDN LARG
   Kita Y, 1996, IEEE T PATTERN ANAL, V18, P1150, DOI 10.1109/34.546253
   KUCH JJ, 1995, VISION BASED HAND MO, P666
   LARRABEE WF, 1986, LARYNGOSCOPE, V96, P399
   MAENO T, 1996, P 10 C EUR C BIOM, P3122
   Metaxas D., 1991, Proceedings 1991 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (91CH2983-5), P337, DOI 10.1109/CVPR.1991.139712
   METAXAS D, 1993, SPIE, V2031, P160
   Nastar C, 1996, IEEE T PATTERN ANAL, V18, P1067, DOI 10.1109/34.544076
   Neuenschwander W., 1995, Proceedings. Fifth International Conference on Computer Vision (Cat. No.95CB35744), P828, DOI 10.1109/ICCV.1995.466852
   OOMENS CWJ, 1985, THESIS TH TWENTE NET
   PRESS WH, 1988, NUMERICAL RECIPES C
   REHG JM, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P612, DOI 10.1109/ICCV.1995.466882
   REHG JM, 1994, P EUR C COMP VIS, V2, P35
   Sclaroff S., 1994, Proceedings of the 1994 IEEE Workshop on Motion of Non-Rigid and Articulated Objects (Cat. No.94TH0671-8), P158, DOI 10.1109/MNRAO.1994.346241
   SilverThorn MB, 1996, J REHABIL RES DEV, V33, P253
   *SWANS AN SYST INC, 1996, ANSYS US MAN REV 5 3
   TERZOPOULOS D, 1993, IEEE T PATTERN ANAL, P580
   THACKER JG, 1976, THESIS U VIRGINIA
   TODD BA, 1994, J REHABIL RES DEV, V31, P111
   Tsap LV, 1998, IEEE T MED IMAGING, V17, P620, DOI 10.1109/42.730406
   Tsap LV, 1999, IMAGE VISION COMPUT, V17, P997, DOI 10.1016/S0262-8856(98)00185-1
   Tsap LV, 1998, COMPUT VIS IMAGE UND, V69, P330, DOI 10.1006/cviu.1998.0663
   VANNAH WM, 1993, J REHABIL RES DEV, V30, P205
   WEISS JA, 1995, P 2 WORLD C BIOM AMS, P149
   Young A., 1992, Proceedings. 1992 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No.92CH3168-2), P399, DOI 10.1109/CVPR.1992.223158
   ZHANG M, 1995, MED ENG PHYS, V17, P559, DOI 10.1016/1350-4533(95)00002-5
NR 37
TC 46
Z9 49
U1 0
U2 3
PU IEEE COMPUTER SOC
PI LOS ALAMITOS
PA 10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA
SN 0162-8828
EI 1939-3539
J9 IEEE T PATTERN ANAL
JI IEEE Trans. Pattern Anal. Mach. Intell.
PD MAY
PY 2000
VL 22
IS 5
BP 526
EP 543
DI 10.1109/34.857007
PG 18
WC Computer Science, Artificial Intelligence; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA 337FV
UT WOS:000088347500008
DA 2018-10-20
ER

PT J
AU Licciulli, A
   Greco, A
   Maffezzoli, A
AF Licciulli, A
   Greco, A
   Maffezzoli, A
TI Development of a pre-ceramic suspension for free form fabrication of
   ceramic parts by stereolithography
SO INDUSTRIAL CERAMICS
LA English
DT Article
AB Laser Stereolithography represents one the most widely used processes for rapid prototyping with new equipments and materials covering each year new applications. Recently the application of stereolithography to the production of ceramic objects for engineering and biomedical applications has been proposed. In this work the development of UV curable pre-ceramic suspensions for free form fabrication of aluminosilicate ceramic parts by stereolithography is presented. The ceramic green is obtained in a stereo:lithographic system operating with a He-Cd laser (325 nm). The suspensions is characterised by at least 50% by volume of pou der content and by a viscosity similar to that one of commercial resins. The building of ceramic objects a described in detail for each stage of the process. Finally; some characterisation of the macroscopic properties and microstructure of samples is also presented.
C1 CNRSM, PASTIS, Brindisi, Italy.
   Univ Lecce, Dipartimento Sci Mat, I-73100 Lecce, Italy.
RI maffezzoli, alfonso/L-7217-2015
OI maffezzoli, alfonso/0000-0002-6371-4030; Licciulli, Antonio
   Alessandro/0000-0002-0505-5268
CR Agarwala M, 1995, RAPID PROTOTYPING J, V1, P26, DOI 10.1108/13552549510078113
   Burns M, 1993, AUTOMATED FABRICATIO
   Callister W. D., 1990, MAT SCI ENG
   Edirisinghe M, 1997, MATER WORLD, V5, P138
   GRIFFITH ML, 1995, INT SAMPE TECH C, V27, P970
   Jacobs PF, 1992, RAPID PROTOTYPING MA
NR 6
TC 5
Z9 5
U1 0
U2 7
PU TECHNA SRL
PI FAENZA
PA PO BOX 174, 48018 FAENZA, ITALY
SN 1121-7588
J9 IND CERAM
JI Ind. Ceram.
PD MAY-AUG
PY 2000
VL 20
IS 2
BP 97
EP 99
PG 3
WC Materials Science, Ceramics
SC Materials Science
GA 373GZ
UT WOS:000165282100007
DA 2018-10-20
ER

PT J
AU Gottenbos, B
   van der Mei, HC
   Busscher, HJ
AF Gottenbos, B
   van der Mei, HC
   Busscher, HJ
TI Initial adhesion and surface growth of Staphylococcus epidermidis and
   Pseudomonas aeruginosa on biomedical polymers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biomaterial-centered infections; biofilm formation; bacterial adhesion;
   bacterial surface growth; parallel plate flow chamber
ID MICROBIAL ADHESION; BACTERIAL ADHESION; FLOW CHAMBER; INTERFACES;
   INFECTION
AB The infection risk of biomaterials implants varies between different materials and is determined by an interplay of adhesion and surface growth of the infecting organisms. In this study, we compared initial adhesion and surface growth of Staphylococcus epidermidis HBH2 102 and Pseudomonas aeruginosa AK1 on poly(dimethylsiloxane), Teflon, polyethylene, polypropylene, polyurethane, poly(ethylene terephthalate), poly(methyl methacrylate), and glass. Initial adhesion was measured in situ in a parallel plate now chamber with microorganisms suspended in phosphate-buffered saline, while subsequent surface growth was followed in full and in 20 times diluted growth medium, initial adhesion of both bacterial strains was similar to all biomaterials in full growth medium, generation times of surface growing S. epidermidis ranged from 17 to 38 min with no relation to wettability, while in diluted growth medium generation times increased from 44 to 98 min with increasing surface wettability. For P. aeruginosa no influence of surface wettability on generation times was observed, but generation times increased with decreasing desorption rates, maximal generation times being 47 min and minimal values down to 30 min. Generally, generation times of adhering bacteria were shorter than of planktonic bacteria. In conclusion, surface grow th of initially adhering bacteria is influenced by biomaterials surface properties to a greater extent than initial adhesion. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Groningen, Dept Biomed Engn, NL-9712 KZ Groningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Dept Biomed Engn, Bloemsingel 10, NL-9712 KZ Groningen, Netherlands.
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Anwar H., 1992, ASM NEWS, V58, P665
   Barton AJ, 1996, J BIOMED MATER RES, V32, P271, DOI 10.1002/(SICI)1097-4636(199610)32:2<271::AID-JBM17>3.0.CO;2-M
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   BOUTTIER S, 1994, COLLOID SURFACE B, V2, P57, DOI 10.1016/0927-7765(94)80018-9
   BUSSCHER HJ, 1995, METHOD ENZYMOL, V253, P455
   BUSSCHER HJ, 1995, FEMS MICROBIOL LETT, V128, P229, DOI 10.1016/0378-1097(95)00103-C
   CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P27
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   ESCHER A, 1990, BIOFILMS, P445
   GEESEY GG, 1990, ANNU REV MICROBIOL, V44, P579
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Habash MB, 1997, MICROBIOL-UK, V143, P2569, DOI 10.1099/00221287-143-8-2569
   HARKES G, 1992, J BIOMAT SCI-POLYM E, V3, P403, DOI 10.1163/156856292X00213
   HOEDEMAKER HOT, 1997, BIOMEDICAL MAT RES G, P109
   VANLOOSDRECHT MCM, 1990, MICROBIOL REV, V54, P75
NR 16
TC 117
Z9 121
U1 3
U2 32
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 2000
VL 50
IS 2
BP 208
EP 214
DI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 288BH
UT WOS:000085541600016
PM 10679686
DA 2018-10-20
ER

PT J
AU Hellstrom, WJG
   Reddy, S
AF Hellstrom, WJG
   Reddy, S
TI Application of pericardial graft in the surgical management of
   Peyronie's disease
SO JOURNAL OF UROLOGY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the American-Urological-Association
CY MAY 01-06, 1999
CL DALLAS, TEXAS
SP Amer Urol Assoc
DE penile induration; penis; transplants; pericardium
ID TUNICA ALBUGINEA; NATURAL-HISTORY; PENIS
AB Purpose: We investigated the use of Tutoplast dagger cadaveric pericardium as an alternative material for grafting the tunica albuginea defect after Peyronie's plaque excision.
   Materials and Methods: A total of 11 patients with significant penile curvature interfering with sexual intercourse were evaluated after at least 12 months of conservative therapy. Preoperative evaluation in all cases included penile duplex Doppler ultrasound studies. Chemically processed and gamma irradiated pericardium was used to graft the cavernosal defect after surgical excision of the penile plaque. In 3 patients se penile prosthesis was simultaneously placed secondary to documented erectile dysfunction at duplex Doppler ultrasound evaluation.
   Results: Penile curvature resolved in all patients, allowing for normal sexual function after a mean followup of 14 months (range 9 to 19). No postoperative evidence of tissue rejection or infection was noted. In 1 patient urethro-corporal communication developed and a single penile cylinder was explanted. Another patient had a mild dorsal bulge at the site of graft placement when the prosthesis was fully inflated.
   Conclusions: Polymeric silicone material used to provide satisfactory results in the surgical treatment of Peyronie's disease but it is no longer available for biomedical use. We demonstrate the effective use of cadaveric pericardium as a graft material for cavernosal defects after Peyronie's plaque excision. Overall patient satisfaction, absence of a second surgical incision, relative low risk and ease of surgical placement make this material ideal for the surgical treatment of this disease process.
C1 Tulane Univ, Sch Med, Dept Urol, New Orleans, LA 70112 USA.
RP Hellstrom, WJG (reprint author), Tulane Univ, Sch Med, Dept Urol, New Orleans, LA 70112 USA.
CR Akkus E, 1997, BRIT J UROL, V79, P47, DOI 10.1046/j.1464-410X.1997.26511.x
   Brock G, 1997, J UROLOGY, V157, P276, DOI 10.1016/S0022-5347(01)65359-X
   Carrieri MP, 1998, J CLIN EPIDEMIOL, V51, P511, DOI 10.1016/S0895-4356(98)00015-8
   Davis CJ, 1997, J UROLOGY, V157, P282, DOI 10.1016/S0022-5347(01)65360-6
   DESANCTIS PN, 1967, J UROLOGY, V97, P114, DOI 10.1016/S0022-5347(17)62993-8
   Devine CJ, 1997, J UROLOGY, V157, P285, DOI 10.1016/S0022-5347(01)65361-8
   DEVINE CJ, 1974, J UROLOGY, V111, P44, DOI 10.1016/S0022-5347(17)59886-9
   GELBARD MK, 1990, J UROLOGY, V144, P1376, DOI 10.1016/S0022-5347(17)39746-X
   GELBARD MK, 1991, J UROLOGY, V145, P772, DOI 10.1016/S0022-5347(17)38447-1
   GELBARD MK, 1985, J UROLOGY, V134, P280, DOI 10.1016/S0022-5347(17)47123-0
   HELLSTROM WJG, 1994, INT J IMPOT RES, V6, P32
   LEVINE LA, 1994, J UROLOGY, V151, P1522, DOI 10.1016/S0022-5347(17)35291-6
   Lue TF, 1998, J UROLOGY, V160, P2047, DOI 10.1016/S0022-5347(01)62239-0
   NESBIT RM, 1965, J UROLOGY, V93, P230, DOI 10.1016/S0022-5347(17)63751-0
   PESCH HJ, 1985, FACIAL NERVE, P506
   PRYOR JP, 1979, J UROLOGY, V122, P622, DOI 10.1016/S0022-5347(17)56530-1
   Raviv T, 1998, J GLAUCOMA, V7, P27
   Sibayan SAB, 1997, OPHTHALMIC SURG LAS, V28, P334
   SOMERS KD, 1989, J UROLOGY, V141, P629, DOI 10.1016/S0022-5347(17)40920-7
   WEGNER HEH, 1995, EUR UROL, V28, P236
   WILLIAMS JL, 1970, J UROLOGY, V103, P75, DOI 10.1016/S0022-5347(17)61894-9
   WILSON SK, 1994, J UROLOGY, V152, P1121, DOI 10.1016/S0022-5347(17)32519-3
   YACHIA D, 1993, J UROLOGY, V149, P869, DOI 10.1016/S0022-5347(17)36243-2
NR 23
TC 63
Z9 65
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD MAY
PY 2000
VL 163
IS 5
BP 1445
EP 1447
DI 10.1016/S0022-5347(05)67639-2
PG 3
WC Urology & Nephrology
SC Urology & Nephrology
GA 303HN
UT WOS:000086416600011
PM 10751854
DA 2018-10-20
ER

PT J
AU Fu, YQ
   Yan, BB
   Loh, NL
   Sun, CQ
   Hing, P
AF Fu, YQ
   Yan, BB
   Loh, NL
   Sun, CQ
   Hing, P
TI Characterization and tribological evaluation of MW-PACVD diamond
   coatings deposited on pure titanium
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE diamond; MW-PACVD; titanium; tribology; wear; coefficient of friction
ID CHEMICAL-VAPOR-DEPOSITION; THIN-FILMS; INTERNAL-STRESS; WEAR; FRICTION;
   RAMAN; BEHAVIOR; ALLOYS; GROWTH; STEEL
AB Titanium alloys are widely used in aerospace and biomedical conditions, however, they are notorious for the poor tribological properties. The deposition of a well adherent diamond coating is a promising way to solve this problem. Ln this study, diamond coatings were deposited on pure titanium using microwave plasma assisted chemical vapour deposition (MW-PACVD). Characterisation of diamond coatings was performed using scanning electron microscopy (SEM), laser profilometry, Raman spectroscopy, grazing incidence X-ray diffraction (GIXD) and atomic force microscopy (AFM). Tribological properties of diamond coatings were evaluated using a ball-on-disk wear tester (sliding with Al2O3 balls) and a scratch tester (sliding with diamond pin). Results showed that the friction and wear properties of polycrystalline diamond coatings as well as the wear of the counterface were dependent significantly on the surface roughness, the morphology and crystalline structure of diamond coatings as well as the counterface materials. For (111)-textured diamond coatings with rough surface and sharp asperities sliding with Al2O3 balls, the coefficient of friction was much higher than that of (100)-textured coatings, and the wear of the counterface material was quite high. After polishing the diamond coating, the surface roughness, coefficient of friction and wear of counterface decreased significantly. If sliding with diamond pins, the coefficient of friction of diamond coating shows a quite low and stable value. To improve the tribological properties, a three-step deposition method was proposed to obtain a smooth and nano-crystalline diamond layer on bulk diamond coatings. The so-formed diamond coating showed the highest load bearing capacity, the lowest coefficient of friction and the lowest wear of the counterface. (C) 2000 Elsevier Science S.A. All rights reserved.
C1 Nanyang Technol Univ, Mat Lab, Sch Mech & Prod Engn, Singapore 639798, Singapore.
   Nanyang Technol Univ, Sch Appl Sci, Singapore 639798, Singapore.
RP Fu, YQ (reprint author), Nanyang Technol Univ, Mat Lab, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RI Sun, Chang/B-8698-2008; Hing, Peter/G-2945-2010; FU, Richard, Yong
   Qing/D-2723-2009
OI Sun, Chang/0000-0003-2076-1133; FU, Richard, Yong
   Qing/0000-0001-9797-4036
CR Avigal Y, 1997, DIAM RELAT MATER, V6, P381, DOI 10.1016/S0925-9635(96)00625-5
   BACHMANN PK, 1994, DIAM RELAT MATER, V3, P1308, DOI 10.1016/0925-9635(94)90143-0
   BHUSHAN B, 1993, J APPL PHYS, V74, P4174, DOI 10.1063/1.354421
   BUDINSKI KG, 1991, WEAR, V151, P203, DOI 10.1016/0043-1648(91)90249-T
   BULL SJ, 1994, SURF COAT TECH, V68, P603, DOI 10.1016/0257-8972(94)90224-0
   BULL SJ, 1992, DIAM RELAT MATER, V1, P1049, DOI 10.1016/0925-9635(92)90075-Y
   DION I, 1993, INT J ARTIF ORGANS, V16, P623
   Fan WD, 1997, SURF COAT TECH, V91, P32, DOI 10.1016/S0257-8972(96)03107-6
   Fu YQ, 1999, J MATER SCI, V34, P2269, DOI 10.1023/A:1004569406535
   GANGOPADHYAY AK, 1993, WEAR, V169, P221, DOI 10.1016/0043-1648(93)90302-3
   Gilbert DR, 1998, J MATER RES, V13, P1735, DOI 10.1557/JMR.1998.0240
   Grogler T, 1998, INT J REFRACT MET H, V16, P217, DOI 10.1016/S0263-4368(98)00021-3
   Grogler T, 1998, DIAM RELAT MATER, V7, P1342, DOI 10.1016/S0925-9635(98)00202-7
   Habig KH, 1995, SURF COAT TECH, V76-77, P540, DOI 10.1016/0257-8972(95)02548-0
   Heinrich G, 1997, SURF COAT TECH, V94-5, P514, DOI 10.1016/S0257-8972(97)00459-3
   Hogmark S, 1996, WEAR, V200, P225, DOI 10.1016/S0043-1648(96)07279-1
   Khurshudov A., 1996, Tribology Letters, V2, P13
   Liu E, 1996, SURF COAT TECH, V80, P264, DOI 10.1016/0257-8972(95)02460-3
   Miyoshi K, 1996, MAT SCI ENG A-STRUCT, V209, P38, DOI 10.1016/0921-5093(95)10114-4
   Molinari A, 1997, WEAR, V208, P105, DOI 10.1016/S0043-1648(96)07454-6
   Morrison NA, 1996, DIAM RELAT MATER, V5, P1118, DOI 10.1016/0925-9635(96)00532-8
   Nakamura Y, 1997, THIN SOLID FILMS, V308, P249, DOI 10.1016/S0040-6090(97)00383-0
   NAMBA Y, 1992, J APPL PHYS, V72, P1748, DOI 10.1063/1.351698
   NEMANICH RJ, 1988, J VAC SCI TECHNOL A, V6, P1783, DOI 10.1116/1.575297
   Nistor LC, 1997, DIAM RELAT MATER, V6, P159, DOI 10.1016/S0925-9635(96)00743-1
   OKUZUMI F, 1995, P 3 INT C APPL DIAM, P201
   Park JB., 1984, BIOMATERIALS SCI ENG, P193
   PARK SS, 1991, J APPL PHYS, V69, P2618, DOI 10.1063/1.348653
   Ralchenko V. G., 1995, Proceedings of the Applied Diamond Conference 1995. Applications of Diamond Films and Related Materials: Third International Conference (NIST SP 885), P225
   Rats D, 1997, SURF COAT TECH, V94-5, P555, DOI 10.1016/S0257-8972(97)00465-9
   Schmitt M, 1998, THIN SOLID FILMS, V332, P124, DOI 10.1016/S0040-6090(98)00986-9
   SKOPP A, 1997, TRIBOTEST, V4, P3
   Stals LMM, 1997, SURF COAT TECH, V91, P230, DOI 10.1016/S0257-8972(96)03119-2
   Stockel R, 1998, J APPL PHYS, V83, P531, DOI 10.1063/1.366667
   Stoneham AM, 1998, MRS BULL, V23, P28, DOI 10.1557/S0883769400029328
   WANG WL, 1992, THIN SOLID FILMS, V215, P174
   WU RLC, 1993, SURF COAT TECH, V62, P589, DOI 10.1016/0257-8972(93)90304-7
   Yang BX, 1995, THIN SOLID FILMS, V270, P210, DOI 10.1016/0040-6090(95)06859-7
   Zuiker C, 1995, THIN SOLID FILMS, V270, P154, DOI 10.1016/0040-6090(95)06882-1
NR 39
TC 34
Z9 36
U1 2
U2 19
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD APR 30
PY 2000
VL 282
IS 1-2
BP 38
EP 48
DI 10.1016/S0921-5093(99)00782-0
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 295LB
UT WOS:000085966600006
DA 2018-10-20
ER

PT J
AU Stroup, DF
   Berlin, JA
   Morton, SC
   Olkin, I
   Williamson, GD
   Rennie, D
   Moher, D
   Becker, BJ
   Sipe, TA
   Thacker, SB
AF Stroup, DF
   Berlin, JA
   Morton, SC
   Olkin, I
   Williamson, GD
   Rennie, D
   Moher, D
   Becker, BJ
   Sipe, TA
   Thacker, SB
CA MOOSE Grp
TI Meta-analysis of observational studies in epidemiology - A proposal for
   reporting
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Article
ID SYSTEMATIC REVIEWS; ORAL-CONTRACEPTIVES; CONTROLLED TRIALS;
   METAANALYSIS; QUALITY; HEALTH; HETEROGENEITY; EXPOSURE; CANCER; BIAS
AB Objective Because of the pressure for timely, informed decisions in public health and clinical practice and the explosion of information in the scientific literature, research results must be synthesized. Meta-analyses are increasingly used to address this problem, and they often evaluate observational studies. A workshop was held in Atlanta, Ga, in April 1997, to examine the reporting of meta-analyses of observational studies and to make recommendations to aid authors, reviewers, editors, and readers.
   Participants Twenty-seven participants were selected by a steering committee, based on expertise in clinical practice, trials, statistics, epidemiology, social sciences, and biomedical editing. Deliberations of the workshop were open to other interested scientists. Funding for this activity was provided by the Centers for Disease Control and Prevention.
   Evidence We conducted a systematic review of the published literature on the conduct and reporting of meta-analyses in observational studies using MEDLINE, Educational Research Information Center (ERIC), PsycLIT, and the Current Index to Statistics. We also examined reference lists of the 32 studies retrieved and contacted experts in the field. Participants were assigned to small-group discussions on the subjects of bias, searching and abstracting, heterogeneity, study categorization, and statistical methods.
   Consensus Process From the material presented at the workshop, the authors developed a checklist summarizing recommendations for reporting meta-analyses of observational studies. The checklist and supporting evidence were circulated to all conference attendees and additional experts. All suggestions for revisions were addressed.
   Conclusions The proposed checklist contains specifications for reporting of meta-analyses of observational studies in epidemiology, including background, search strategy, methods, results, discussion, and conclusion. Use of the checklist should improve the usefulness of meta-analyses for authors, reviewers, editors, readers, and decision makers. An evaluation plan is suggested and research areas are explored.
C1 Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.
   Univ Penn, Sch Med, Philadelphia, PA 19104 USA.
   RAND Corp, Santa Monica, CA USA.
   Univ Calif San Francisco, San Francisco, CA 94143 USA.
   Stanford Univ, Stanford, CA 94305 USA.
   JAMA, Chicago, IL USA.
   Childrens Hosp Eastern Ontario, Res Inst, Thomas C Chalmers Ctr Systemat Rev, Ottawa, ON, Canada.
   Michigan State Univ, E Lansing, MI 48824 USA.
   Georgia State Univ, Atlanta, GA 30303 USA.
RP Stroup, DF (reprint author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mail Stop C09, Atlanta, GA 30333 USA.
RI Karayel, Bora/E-2173-2017; Sipe, Theresa/C-2262-2012
OI Karayel, Bora/0000-0001-5997-1424; Moher, David/0000-0003-2434-4206;
   Becker, Betsy Jane/0000-0003-3438-560X
CR Badgett RG, 1997, ANN INTERN MED, V126, P886, DOI 10.7326/0003-4819-126-11-199706010-00006
   BERLIN JA, 1995, AM J EPIDEMIOL, V142, P383, DOI 10.1093/oxfordjournals.aje.a117645
   Berlin JA, 1999, JAMA-J AM MED ASSOC, V281, P830, DOI 10.1001/jama.281.9.830
   Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5
   Berlin JA, 1999, JAMA-J AM MED ASSOC, V282, P1083, DOI 10.1001/jama.282.11.1083
   Bero LA, 1997, ANN INTERN MED, V127, P37, DOI 10.7326/0003-4819-127-1-199707010-00007
   Blettner M, 1999, INT J EPIDEMIOL, V28, P1, DOI 10.1093/ije/28.1.1
   Chalmers T C, 1993, Stat Methods Med Res, V2, P161
   COLDITZ GA, 1995, AM J EPIDEMIOL, V142, P371, DOI 10.1093/oxfordjournals.aje.a117644
   Cole MG, 1997, CAN MED ASSOC J, V157, P1055
   COOK DJ, 1995, J CLIN EPIDEMIOL, V48, P167, DOI 10.1016/0895-4356(94)00172-M
   Dickersin K, 1993, ONLINE J CURR C 0428
   EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y
   Egger M, 1998, BRIT MED J, V316, P140
   EMERSON JD, 1990, CONTROL CLIN TRIALS, V11, P339, DOI 10.1016/0197-2456(90)90175-2
   FRANCESCHI S, 1986, TUMORI, V72, P21
   FRIEDENREICH CM, 1994, EPIDEMIOLOGY, V5, P66, DOI 10.1097/00001648-199401000-00011
   FRUMKIN H, 1988, AM J IND MED, V14, P79, DOI 10.1002/ajim.4700140110
   GREENLAND S, 1994, AM J EPIDEMIOL, V140, P290, DOI 10.1093/oxfordjournals.aje.a117248
   GREENLAND S, 1987, EPIDEMIOL REV, V9, P1
   HASSELBLAD V, 1992, J AIR WASTE MANAGE, V42, P662, DOI 10.1080/10473289.1992.10467018
   HEDGES L, 1985, STAT METHODS META AN
   HETHERINGTON J, 1989, PEDIATRICS, V84, P374
   Huston P, 1996, CAN MED ASSOC J, V155, P1697
   Huston P, 1996, CAN MED ASSOC J, V154, P1389
   Ioannidis J P, 1999, Jt Comm J Qual Improv, V25, P462
   Jadad A, 2000, ANN M AM AC ALL ASTH
   Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054
   Kheifets LI, 1997, J OCCUP ENVIRON MED, V39, P1074, DOI 10.1097/00043764-199711000-00008
   LANG TA, 1997, REPORT STAT MED
   Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7
   Lipsett M, 1999, AM J PUBLIC HEALTH, V89, P1009, DOI 10.2105/AJPH.89.7.1009
   MANN CC, 1994, SCIENCE, V266, P960, DOI 10.1126/science.7973676
   McManus RJ, 1998, BRIT MED J, V317, P1562, DOI 10.1136/bmj.317.7172.1562
   Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X
   Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5
   Ohlsson A, 1994, Scand J Clin Lab Invest Suppl, V219, P25
   Peipert JF, 1998, CLIN OBSTET GYNECOL, V41, P235, DOI 10.1097/00003081-199806000-00004
   PETITTI D, 1994, META ANAL DECISION A
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638
   Saag KG, 1996, ARTHRITIS RHEUM, V39, P1818, DOI 10.1002/art.1780391107
   Schlesselman JJ, 1997, HUM REPROD, V12, P1851, DOI 10.1093/humrep/12.9.1851
   SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408
   SHAPIRO S, 1994, AM J EPIDEMIOL, V140, P771, DOI 10.1093/oxfordjournals.aje.a117324
   Sipe T., 1997, INT J EDUC RES, V25, P583, DOI [10.1016/S0883-0355(96)80001-2, DOI 10.1016/S0883-0355(96)80001-2]
   Steinberg K, 1997, AM J EPIDEMIOL, V145, P1917
   STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K
   STROUP DF, 1997, INT C BIOM PEER REV
   THACKER SB, 1988, JAMA-J AM MED ASSOC, V259, P1685, DOI 10.1001/jama.259.11.1685
   Vickers A, 1997, INT J TECHNOL ASSESS, V13, P111, DOI 10.1017/S0266462300010278
NR 50
TC 8008
Z9 8120
U1 52
U2 570
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610 USA
SN 0098-7484
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD APR 19
PY 2000
VL 283
IS 15
BP 2008
EP 2012
DI 10.1001/jama.283.15.2008
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA 303RC
UT WOS:000086436600037
PM 10789670
DA 2018-10-20
ER

PT J
AU Meijer, HAJ
   Neubert, REM
   Visser, GH
AF Meijer, HAJ
   Neubert, REM
   Visser, GH
TI Cross contamination in dual inlet isotope ratio mass spectrometers
SO INTERNATIONAL JOURNAL OF MASS SPECTROMETRY
LA English
DT Article
DE gas isotope ratio mass spectrometry; stable isotopes; cross
   contamination; normalization; isotopic reference materials
ID NATURAL-WATERS; DEUTERIUM
AB Since the early days of geochemical isotope ratio mass spectrometry there has always been the problem of cross contamination, i.e. the contamination of the sample gas with traces of reference gas land vice versa) in a dual inlet system and the analyzer itself. This was attributable to valve leakages and could be corrected for. In modem leak-free machines this problem still influences the measurements by scale contraction. It limits the interlaboratory comparability to values unacceptable for, e.g. global carbon cycle investigations on atmospheric delta(13)CO(2), with the need to integrate global datasets at a 0.01 parts per thousand precision level. No matter what the reason of apparent cross contamination (physical leakage, low pump efficiency, gas-wall interactions), we present a method to measure the actual cross contamination as well as algorithms to correct for it. By using isotopically enriched sample gas the effect on the reference gas is directly shown. Especially for biomedical applications, employing highly enriched materials, the nonlinear correction has to be applied. A long-time record of two machines shows the influence of vacuum breakage and the inlet system setup. We present a survey of cross contamination in some of the frequently used machines. The relatively poor raw results of two recent interlaboratory comparison experiments are explained in terms of cross contamination. Whereas the linear two-point normalization procedure considered by itself may be appropriate for some routine applications at natural isotope abundances, it always relies on relative delta values of two reference materials. There is an urgent need to establish absolute values for all scale-determining reference materials. We recommend the use of cross contamination measurements to at least determine the isotopic composition of all normalization materials as long as absolute measurements are not available. In principle, the cross contamination measurements should be used as a diagnostic tool on a regular basis. (C) 2000 Elsevier Science B.V.
C1 Univ Groningen, Ctr IsotopenOnderzoek, NL-9747 AG Groningen, Netherlands.
RP Neubert, REM (reprint author), Univ Groningen, Ctr IsotopenOnderzoek, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.
EM neubert@phys.rug.nl
RI Neubert, Rolf/U-2766-2017; Meijer, Harro/A-5787-2012
OI Neubert, Rolf/0000-0001-8848-4721; 
CR ALLISON CE, 1995, P CONS M VIENN 1 3 D
   BOHLKE JK, 1995, P CONS M VIENN 1 3 D
   BRAND WA, 1999, IN PRESS D H RING TE
   DeWit J.C., 1980, GEOSTANDARD NEWSLETT, V4, P33, DOI DOI 10.1111/J.1751-908X.1980.TB00270.X
   FRANCEY RJ, 1994, IAEA CRP M VIENN 7 1
   GONFIANTINI R, 1978, NATURE, V271, P534, DOI 10.1038/271534a0
   Gonfiantini R, 1997, INT J MASS SPECTROM, V171, P231, DOI 10.1016/S0168-1176(97)00129-8
   Gonfiantini R, 1984, REPORT DIRECTOR GEN
   HAGEMANN R, 1970, TELLUS, V22, P712
   HUT G, 1987, REPORT DIRECTOR GENE
   MCKINNEY CR, 1950, REV SCI INSTRUM, V21, P724, DOI 10.1063/1.1745698
   Neubert R., 1998, THESIS U HEIDELBERG
   NIELSEN H, 1984, REPORT DIRECTOR GEN
   Robinson B. W., 1995, P CONS M VIENN 1 3 D
   STICHLER W, 1995, P CONS M VIENN 1 3 D
   TSE RS, 1980, ANAL CHEM, V52, P2445, DOI 10.1021/ac50064a053
   *U GRON, 1998, 7 IAEA CONS M REF MA
   Verkouteren RM, 1999, ANAL CHEM, V71, P4740, DOI 10.1021/ac990233c
   VERKOUTEREN RM, 1995, P CONS M VIENN 1 3 D
   VISSER GH, CIO INTERNAL REPORT
NR 20
TC 60
Z9 60
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1387-3806
J9 INT J MASS SPECTROM
JI Int. J. Mass Spectrom.
PD APR 14
PY 2000
VL 198
IS 1-2
BP 45
EP 61
DI 10.1016/S1387-3806(99)00266-3
PG 17
WC Physics, Atomic, Molecular & Chemical; Spectroscopy
SC Physics; Spectroscopy
GA 302GU
UT WOS:000086358000005
OA Green Published
DA 2018-10-20
ER

PT J
AU Seliktar, D
   Black, RA
   Vito, RP
   Nerem, RM
AF Seliktar, D
   Black, RA
   Vito, RP
   Nerem, RM
TI Dynamic mechanical conditioning of collagen-gel blood vessel constructs
   induces remodeling in vitro
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE tissue engineering; vascular; mechanical properties; cyclic strain;
   remodeling
ID HYBRID VASCULAR TISSUE; SMOOTH-MUSCLE CELLS; IN-VITRO; MATRIX
   REORGANIZATION; FIBROBLASTS; CONTRACTION; LATTICES; MEDIA;
   RECONSTRUCTION; EQUIVALENTS
AB Dynamic mechanical conditioning is investigated as a means of improving the mechanical properties of tissue-engineered blood vessel constructs composed of living cells embedded in a collagen-gel scaffold. This approach attempts to elicit a unique response from the embedded cells so as to reorganize their surrounding matrix, thus improving the overall mechanical stability of the constructs. Mechanical conditioning, in the form of cyclic strain, was applied to the tubular constructs at a frequency of 1 Hz for 4 and 8 days. The response to conditioning thus evinced involved increased contraction and mechanical strength, as compared to statically cultured controls. Significant increases in ultimate stress and material modulus were seen over an 8 day culture period. Accompanying morphological changes showed increased circumferential orientation in response to the cyclic stimulus. We conclude that dynamic mechanical conditioning during tissue culture leads to an improvement in the properties of tissue-engineered blood vessel constructs in terms of mechanical strength and histological organization. This concept, in conjunction with a proper biochemical environment, could present a better model for engineering vascular constructs. (C) 2000 Biomedical Enginerring Society.
C1 Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Univ Liverpool, Dept Clin Engn, Liverpool L69 3GA, Merseyside, England.
RP Seliktar, D (reprint author), Georgia Inst Technol, Inst Bioengn & Biosci, 315 Ferst Dr, Atlanta, GA 30332 USA.
OI Seliktar, Dror/0000-0001-6964-8567
FU NIGMS NIH HHS [GM08433]
CR Barocas VH, 1998, J BIOMECH ENG-T ASME, V120, P660, DOI 10.1115/1.2834759
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Eastwood M, 1998, CELL MOTIL CYTOSKEL, V40, P13, DOI 10.1002/(SICI)1097-0169(1998)40:1<13::AID-CM2>3.0.CO;2-G
   Eastwood M, 1996, J CELL PHYSIOL, V166, P33, DOI 10.1002/(SICI)1097-4652(199601)166:1<33::AID-JCP4>3.0.CO;2-H
   EHRLICH HP, 1986, J CELL SCI, V82, P281
   Fung Y, 1993, BIOMECHANICS MECH PR, P261
   GILLERY P, 1986, EXP CELL RES, V167, P29, DOI 10.1016/0014-4827(86)90201-6
   Girton TS, 1999, J BIOMED MATER RES, V46, P87, DOI 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K
   GIRTON TS, IN PRESS J BIOMECH E
   Gotwals PJ, 1996, J CLIN INVEST, V97, P2469, DOI 10.1172/JCI118693
   Hirai J, 1994, ASAIO J, V40, pM383, DOI 10.1097/00002480-199407000-00027
   HIRAI J, 1995, CELL TRANSPLANT, V4, P597, DOI 10.1016/0963-6897(95)00029-1
   KANDA K, 1994, CELL TRANSPLANT, V3, P537, DOI 10.1177/096368979400300611
   Kanda K, 1993, ASAIO J, V39, pM561
   KANDA K, 1994, CELL TRANSPLANT, V3, P481, DOI 10.1177/096368979400300605
   L'Heureux N, 1998, FASEB J, V12, P47
   Langelier E, 1999, ANN BIOMED ENG, V27, P67, DOI 10.1114/1.166
   LEE RT, 1995, CIRC RES, V76, P209, DOI 10.1161/01.RES.76.2.209
   LHEUREUX N, 1993, J VASC SURG, V17, P499, DOI 10.1016/0741-5214(93)90150-K
   Matsuda T, 1989, ASAIO Trans, V35, P553, DOI 10.1097/00002480-198907000-00123
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   OAKES BW, 1982, EUR J CELL BIOL, V27, P34
   Ogle BM, 1999, TISSUE ENG, V5, P387, DOI 10.1089/ten.1999.5.387
   SCHNETZER KJ, 1996, THESIS GEORGIA I TEC
   Spina M, 1999, BIOPOLYMERS, V49, P255, DOI 10.1002/(SICI)1097-0282(199903)49:3<255::AID-BIP6>3.0.CO;2-2
   STOPAK D, 1982, DEV BIOL, V90, P383, DOI 10.1016/0012-1606(82)90388-8
   Tranquillo RT, 1999, BIOCHEM SOC SYMP, V65, P27
   Tranquillo RT, 1996, BIOMATERIALS, V17, P349, DOI 10.1016/0142-9612(96)85573-6
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   YAMATO M, 1995, J BIOCHEM-TOKYO, V117, P940, DOI 10.1093/oxfordjournals.jbchem.a124824
   ZIEGLER T, 1995, ANN BIOMED ENG, V23, P216, DOI 10.1007/BF02584424
NR 31
TC 376
Z9 390
U1 1
U2 66
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD APR
PY 2000
VL 28
IS 4
BP 351
EP 362
DI 10.1114/1.275
PG 12
WC Engineering, Biomedical
SC Engineering
GA 322PT
UT WOS:000087518500001
PM 10870892
DA 2018-10-20
ER

PT J
AU Huczko, A
AF Huczko, A
TI Template-based synthesis of nanomaterials
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Review
ID FILLING CARBON NANOTUBES; ATOMIC-SCALE MANIPULATION; ALUMINUM-OXIDE;
   ELECTRONIC-PROPERTIES; SUBSTITUTION-REACTION; MAGNETIC-PROPERTIES;
   METALLIC NANOWIRES; NITRIDE NANORODS; NANOMETER-SCALE; FIELD-EMISSION
AB The large interest in nanostructures results from their numerous potential applications in various areas such as materials and biomedical sciences, electronics, optics, magnetism, energy storage, and electrochemistry. Ultrasmall building blocks have been found to exhibit a broad range of enhanced mechanical, optical, magnetic, and electronic properties compared to coarser-grained matter of the same chemical composition. In this paper various template techniques suitable for nanotechnology applications with emphasis on characterization of created arrays of tailored nanomaterials have been reviewed. These methods involve the fabrication of the desired material within the pores or channels of a nanoporous template. Track-etch membranes, porous alumina, and other nanoporous structures have been characterized as templates. They have been used to prepare nanometer-sized fibrils, rods, and tubules of conductive polymers, metals, semiconductors, carbons, and other solid matter. Electrochemical and electroless depositions, chemical polymerization, sol-gel deposition, and chemical vapour deposition have been presented as major template synthetic strategies. In particular, the template-based synthesis of carbon nanotubes has been demonstrated as this is the most promising class of new carbon-based materials for electronic and optic nanodevices as well as reinforcement nanocomposites.
C1 Univ Warsaw, Dept Chem, PL-02093 Warsaw, Poland.
RP Huczko, A (reprint author), Univ Warsaw, Dept Chem, Pasteura 1, PL-02093 Warsaw, Poland.
EM ahuczko@chem.uw.edu.pl
OI Huczko, Andrzej/0000-0003-3688-1121
CR AJAYAN PM, 1993, NATURE, V361, P333, DOI 10.1038/361333a0
   AJAYAN PM, 1995, NATURE, V375, P564, DOI 10.1038/375564a0
   AJAYAN PM, 1994, SCIENCE, V265, P1212, DOI 10.1126/science.265.5176.1212
   Ajiki H, 1997, SOLID STATE COMMUN, V102, P135, DOI 10.1016/S0038-1098(96)00707-7
   ALMAWLAWI D, 1991, J APPL PHYS, V70, P4421, DOI 10.1063/1.349125
   ANDERSON MW, 1993, CHEM COMMUN, P533
   Anthony TR, 1996, CARBON, V34, P1323, DOI 10.1016/S0008-6223(96)00060-7
   BAIBICH MN, 1988, PHYS REV LETT, V61, P2472, DOI 10.1103/PhysRevLett.61.2472
   Bandosz TJ, 1996, CHEM MATER, V8, P2023, DOI 10.1021/cm960233i
   Barbara B, 1997, CURR OPIN SOLID ST M, V2, P220, DOI 10.1016/S1359-0286(97)80069-1
   BEENAKKER CWJ, 1991, SOLID STATE PHYS, V44, P1
   Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826
   BRUMLIK CJ, 1994, J MATER RES, V9, P1174, DOI 10.1557/JMR.1994.1174
   BRUMLIK CJ, 1991, J AM CHEM SOC, V113, P3174, DOI 10.1021/ja00008a057
   CAI ZH, 1991, CHEM MATER, V3, P960, DOI 10.1021/cm00017a036
   CAI ZH, 1989, J AM CHEM SOC, V111, P4138, DOI 10.1021/ja00193a077
   Cassell AM, 1998, ANGEW CHEM INT EDIT, V37, P1528, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1528::AID-ANIE1528>3.0.CO;2-Q
   Cepak VM, 1997, CHEM MATER, V9, P1065, DOI 10.1021/cm970014c
   Che G, 1998, CHEM MATER, V10, P260, DOI 10.1021/cm970412f
   Che GL, 1998, NATURE, V393, P346, DOI 10.1038/30694
   Chen XH, 1999, THIN SOLID FILMS, V339, P6, DOI 10.1016/S0040-6090(98)00809-8
   Chernozatonskii LA, 1998, CHEM PHYS LETT, V297, P257, DOI 10.1016/S0009-2614(98)01100-2
   CHERNOZATONSKII LA, 1995, PHYS LETT A, V197, P40, DOI 10.1016/0375-9601(94)00885-S
   Chu A, 1996, CHEM MATER, V8, P2751, DOI 10.1021/cm960246w
   Collins PG, 1997, SCIENCE, V278, P100, DOI 10.1126/science.278.5335.100
   COOK J, 1996, CHEM IND 600
   CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218
   DAGANI R, 1999, CHEM ENG NEWS, P25
   Dai HJ, 1996, NATURE, V384, P147, DOI 10.1038/384147a0
   DAI HJ, 1995, NATURE, V375, P769, DOI 10.1038/375769a0
   DAIMON H, 1993, J APPL PHYS, V73, P5391, DOI 10.1063/1.353742
   DAVIS WR, 1953, NATURE, V171, P756, DOI 10.1038/171756a0
   De Vito S, 1998, CHEM MATER, V10, P1738, DOI 10.1021/cm9801690
   DEHEER WA, 1995, SCIENCE, V268, P845, DOI 10.1126/science.268.5212.845
   DEHEER WA, 1995, SCIENCE, V270, P1179, DOI 10.1126/science.270.5239.1179
   Demoncy N, 1998, EUR PHYS J B, V4, P147, DOI 10.1007/s100510050363
   DICKEY FH, 1949, P NATL ACAD SCI USA, V35, P227, DOI 10.1073/pnas.35.5.227
   Dillon AC, 1997, NATURE, V386, P377, DOI 10.1038/386377a0
   DIMITRYEV SN, 1997, KHIM VYS ENERG, V31, P286
   DRESSELHAUS MS, 1993, MATER SCI ENG, V354, P192
   DREW SM, 1991, J ELECTROANAL CHEM, V317, P117, DOI 10.1016/0022-0728(91)85007-C
   DUJARDIN E, 1994, SCIENCE, V265, P1850, DOI 10.1126/science.265.5180.1850
   EBBESEN TW, 1992, NATURE, V358, P220, DOI 10.1038/358220a0
   ENZEL P, 1992, CHEM COMMUN, P633
   Fan SS, 1999, SCIENCE, V283, P512, DOI 10.1126/science.283.5401.512
   Feldheim DL, 1998, CHEM SOC REV, V27, P1
   Fleisher R. L., 1975, NUCL TRACKS SOLIDS
   Frackowiak E, 1999, CARBON, V37, P61, DOI 10.1016/S0008-6223(98)00187-0
   Frank S, 1998, SCIENCE, V280, P1744, DOI 10.1126/science.280.5370.1744
   Freemantle M, 1997, CHEM ENG NEWS, V75, P33, DOI 10.1021/cen-v075n038.p033
   Gadd GE, 1997, SCIENCE, V277, P933, DOI 10.1126/science.277.5328.933
   GARCIA RG, 1992, APPL PHYS LETT, V60, P1960, DOI 10.1063/1.107137
   GE MH, 1993, SCIENCE, V260, P515, DOI 10.1126/science.260.5107.515
   GE MH, 1994, APPL PHYS LETT, V64, P710, DOI 10.1063/1.111042
   HADJIPANAYIS GC, 1994, NANOPHASE MAT SYNTHE, P260
   Han WQ, 1997, SCIENCE, V277, P1287, DOI 10.1126/science.277.5330.1287
   Han WQ, 1999, CHEM PHYS LETT, V299, P368, DOI 10.1016/S0009-2614(98)01307-4
   Han WQ, 1997, APPL PHYS LETT, V71, P2271, DOI 10.1063/1.120550
   Han WQ, 1998, APPL PHYS LETT, V73, P3085, DOI 10.1063/1.122680
   HEATH JR, 1995, SCIENCE, V270, P1315, DOI 10.1126/science.270.5240.1315
   Hernadi K, 1996, SYNTHETIC MET, V77, P31, DOI 10.1016/0379-6779(96)80051-8
   HODES G, 1992, J ELECTROCHEM SOC, V139, P3136, DOI 10.1149/1.2069045
   HOTCHANDANI S, 1992, J ELECTROCHEM SOC, V139, P1630, DOI 10.1149/1.2069468
   HSU WK, 1995, NATURE, V377, P687, DOI 10.1038/377687a0
   Hsu WK, 1996, CHEM PHYS LETT, V262, P161, DOI 10.1016/0009-2614(96)01041-X
   Hulteen JC, 1997, J MATER CHEM, V7, P1075, DOI 10.1039/a700027h
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   IVANOV V, 1994, CHEM PHYS LETT, V223, P329, DOI 10.1016/0009-2614(94)00467-6
   Jirage KB, 1997, SCIENCE, V278, P655, DOI 10.1126/science.278.5338.655
   JONAS S, 1995, SZKLO CERAMIKA, V46, P25
   KARPINSKI ZJ, 1993, J ELECTROANAL CHEM, V349, P285, DOI 10.1016/0022-0728(93)80179-L
   KIVELSON S, 1988, SYNTHETIC MET, V22, P371, DOI 10.1016/0379-6779(88)90108-7
   KLEIN JD, 1993, CHEM MATER, V5, P902, DOI 10.1021/cm00031a002
   Kong J, 1998, NATURE, V395, P878, DOI 10.1038/27632
   KYOTANI T, 1988, NATURE, V331, P331, DOI 10.1038/331331a0
   Kyotani T, 1996, CHEM MATER, V8, P2109, DOI 10.1021/cm960063+
   Kyotani T, 1997, CHEM COMMUN, P701, DOI 10.1039/a608439g
   Lago R. M., 1995, CHEM COMMUN, P1355
   Lakshmi BB, 1997, CHEM MATER, V9, P2544, DOI 10.1021/cm970268y
   LANDAUER R, 1989, J PHYS-CONDENS MAT, V1, P8099, DOI 10.1088/0953-8984/1/43/011
   LANDMAN U, 1991, J VAC SCI TECHNOL B, V9, P414, DOI 10.1116/1.585583
   Lange H, 1998, CHEM PHYS LETT, V289, P174, DOI 10.1016/S0009-2614(98)00382-0
   LEE PA, 1985, REV MOD PHYS, V57, P287, DOI 10.1103/RevModPhys.57.287
   LEI JT, 1992, SYNTHETIC MET, V46, P53, DOI 10.1016/0379-6779(92)90318-D
   Li FY, 1998, CHEM MATER, V10, P2470, DOI 10.1021/cm980163a
   Li WZ, 1996, SCIENCE, V274, P1701, DOI 10.1126/science.274.5293.1701
   LIANG WB, 1990, J AM CHEM SOC, V112, P9666, DOI 10.1021/ja00182a051
   LIN M, 1995, CARBON, V33, P225
   LYO IW, 1991, SCIENCE, V253, P173, DOI 10.1126/science.253.5016.173
   Marinakos SM, 1998, CHEM MATER, V10, P1214, DOI 10.1021/cm980059t
   MARTIN CR, 1994, SCIENCE, V266, P1961, DOI 10.1126/science.266.5193.1961
   Martin CR, 1996, CHEM MATER, V8, P1739, DOI 10.1021/cm960166s
   MATTHEW RW, 1987, J PHYS CHEM-US, V91, P238
   MEYER GJ, 1993, ELECTROCHEMICAL SOC, V23
   Monty C.J.A., 1994, HIGH TEMP CHEM PROCE, V3, P467
   MULLEN K, 1988, PHYS REV B, V37, P98, DOI 10.1103/PhysRevB.37.98
   MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335
   Murray PW, 1998, PHYS REV LETT, V80, P988, DOI 10.1103/PhysRevLett.80.988
   Nishizawa M, 1997, J ELECTROCHEM SOC, V144, P1923, DOI 10.1149/1.1837722
   PARTHASARATHY RV, 1995, ADV MATER, V7, P896, DOI 10.1002/adma.19950071103
   PASCUAL JI, 1995, SCIENCE, V267, P1793, DOI 10.1126/science.267.5205.1793
   Piraux L, 1997, NUCL INSTRUM METH B, V131, P357, DOI 10.1016/S0168-583X(97)00363-7
   POSSIN GE, 1970, REV SCI INSTRUM, V41, P772, DOI 10.1063/1.1684640
   Raman NK, 1996, CHEM MATER, V8, P1682, DOI 10.1021/cm960138+
   REIHS K, 1995, THIN SOLID FILMS, V264, P135, DOI 10.1016/0040-6090(95)05857-5
   Ren ZF, 1998, SCIENCE, V282, P1105, DOI 10.1126/science.282.5391.1105
   RODRIGUEZ NM, 1993, J MATER RES, V8, P3233, DOI 10.1557/JMR.1993.3233
   ROHRER H, 1994, NUOVO CIMENTO A, V107, P989, DOI 10.1007/BF02730855
   Routkevitch D, 1997, ELEC SOC S, V97, P350
   Saito Y, 1998, APPL PHYS A-MATER, V67, P95, DOI 10.1007/s003390050743
   Sakaki H, 1996, CURR OPIN SOLID ST M, V1, P17, DOI 10.1016/S1359-0286(96)80004-0
   Satishkumar BC, 1997, J MATER RES, V12, P604, DOI 10.1557/JMR.1997.0089
   SCHMID G, 1997, SOLID STATE MAT SCI, V2, P204
   Schonenberger C, 1997, J PHYS CHEM B, V101, P5497, DOI 10.1021/jp963938g
   Service RF, 1998, SCIENCE, V281, P940, DOI 10.1126/science.281.5379.940
   SIEGEL RW, 1993, MAT SCI ENG B-SOLID, V19, P37, DOI 10.1016/0921-5107(93)90162-G
   Smith BW, 1998, NATURE, V396, P323, DOI 10.1038/24521
   SMITH RL, 1992, J APPL PHYS, V71, pR1, DOI 10.1063/1.350839
   Sohn LL, 1998, NATURE, V394, P131, DOI 10.1038/28058
   SONG XY, 1995, J MATER RES, V10, P251, DOI 10.1557/JMR.1995.0251
   SONOBE N, 1988, J PHYS CHEM-US, V92, P7029, DOI 10.1021/j100335a037
   Sun HD, 1999, SOLID STATE COMMUN, V109, P365, DOI 10.1016/S0038-1098(98)00588-2
   Tang BZ, 1999, MACROMOLECULES, V32, P2569, DOI 10.1021/ma981825k
   Tang ZK, 1998, APPL PHYS LETT, V73, P2287, DOI 10.1063/1.121704
   Terrones M, 1997, NATURE, V388, P52, DOI 10.1038/40369
   TOMASSI P, 1998, 11 SEM TEMP JEP 0903
   TOMITA A, 1997, Patent No. 09142819
   TSANG SC, 1994, NATURE, V372, P159, DOI 10.1038/372159a0
   VLACHOPOULOS N, 1988, J AM CHEM SOC, V110, P1216, DOI 10.1021/ja00212a033
   Wei B, 1997, J MATER SCI LETT, V16, P402, DOI 10.1023/A:1018519016775
   White CT, 1998, NATURE, V393, P240, DOI 10.1038/30420
   WHITNEY TM, 1993, SCIENCE, V261, P1316, DOI 10.1126/science.261.5126.1316
   Wong EW, 1996, CHEM MATER, V8, P2041, DOI 10.1021/cm960083b
   Wong SS, 1998, NATURE, V394, P52
   WU CG, 1994, SCIENCE, V264, P1757, DOI 10.1126/science.264.5166.1757
   Zelenski CM, 1998, J AM CHEM SOC, V120, P734, DOI 10.1021/ja972170q
   ZHANG XB, 1994, EUROPHYS LETT, V27, P141, DOI 10.1209/0295-5075/27/2/011
   ZHU J, 1999, J MATER RES, V14, P7
NR 138
TC 483
Z9 502
U1 16
U2 447
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0947-8396
EI 1432-0630
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD APR
PY 2000
VL 70
IS 4
BP 365
EP 376
DI 10.1007/s003390051050
PG 12
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 307HT
UT WOS:000086648400001
DA 2018-10-20
ER

PT J
AU Lopes, MA
   Silva, RF
   Monteiro, FJ
   Santos, JD
AF Lopes, MA
   Silva, RF
   Monteiro, FJ
   Santos, JD
TI Microstructural dependence of Young's and shear moduli of P2O5 glass
   reinforced hydroxyapatite for biomedical applications
SO BIOMATERIALS
LA English
DT Article
DE Young's modulus; shear modulus; Duckworth-Knudsen model; hydroxyapatite
   glass composites
ID MECHANICAL-PROPERTIES; SINTERED HYDROXYAPATITE
AB P2O5 glass reinforced hydroxyapatite composite materials were prepared through a liquid-phase sintering process. Secondary phases, beta- and alpha-tricalcium phosphates (beta-TCP and alpha-TCP), were formed in the microstructure of the composites, due to the reaction between the liquid glassy phase and the hydroxyapatite matrix. The dynamic Young's modulus (E) and shear modulus (G) of these composites were determined using an impulse excitation method. By applying the Duckworth-Knudsen equation, the elastic property results were correlated with the relative proportion of beta-TCP and alpha-TCP phases and with the porosity percentage present in the microstructure. Glass reinforced hydroxyapatite composites showed lower Young's and shear moduli than unmodified hydroxyapatite, mainly due to the presence of beta-TCP phase. The Duckworth-Knudsen model demonstrated an exponential dependence of E and G modulus with porosity and mathematical equations were derived for composite materials with porosity correction factors (b) of 4.04 and 4.11, respectively, indicating that porosity largely decreased both E and G moduli. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Inst Biomed Engn, Lab Biomat, P-4150 Porto, Portugal.
   Univ Porto, Fac Engn, Dept Met & Mat Engn, P-4099 Oporto, Portugal.
   Univ Aveiro, Dept Ceram & Glass Engn, UIMC, P-3810193 Aveiro, Portugal.
RP Santos, JD (reprint author), Inst Biomed Engn, Lab Biomat, Rua Campo Alegre 823, P-4150 Porto, Portugal.
RI Silva, Rui/B-8208-2008; Lopes, Maria A./P-4442-2014; Lopes,
   Cristina/A-4241-2010
OI Silva, Rui/0000-0002-2584-1792; Lopes, Maria A./0000-0003-4105-8148;
   Santos, Jose Domingos/0000-0002-6871-9850; Monteiro,
   Fernando/0000-0002-1361-4605
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF02402799
   AOKI H, 1991, SCI MED APPL HYDROXY
   BURSTEIN AH, 1994, FUNDAMENTALS ORTHOPA
   CARTER DR, 1991, BONE-BIOMATERIAL INTERFACE, P367
   CHATAL V, 1990, LINEAR PROGRAMMING
   DEWITH G, 1981, J MATER SCI, V16, P1592
   *ENV, 1995, 8432 ENV 2
   KATZ JL, 1989, BIOCERAMICS, V1, P86
   Knowles JC, 1996, BIOMATERIALS, V17, P1437, DOI 10.1016/0142-9612(96)87287-5
   KNOWLES JC, 1994, BRIT CERAM T, V93, P100
   Lopes MA, 1998, J BIOMED MATER RES, V39, P244, DOI 10.1002/(SICI)1097-4636(199802)39:2<244::AID-JBM11>3.0.CO;2-D
   Lopes MA, 1998, J BIOMED MATER RES, V41, P649, DOI 10.1002/(SICI)1097-4636(19980915)41:4<649::AID-JBM17>3.0.CO;2-9
   LOPES MA, 1998, BIOCERAMICS, V10, P575
   MURTAGE B, 1981, ADV LINEAR PROGRAMMI
   Rice R.W., 1977, TREATISE MATERIALS S, VII, P200
   SANTOS JD, 1994, BIOMATERIALS, V15, P5, DOI 10.1016/0142-9612(94)90188-0
   SAX M, 1995, CERAMIC PROCESSING S, V51, P701
   SCHREIBER E, 1989, ELASTIC CONSTANT THE
   Tampieri A, 1997, J MATER SCI-MATER M, V8, P29, DOI 10.1023/A:1018538212328
NR 19
TC 42
Z9 43
U1 3
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2000
VL 21
IS 7
BP 749
EP 754
DI 10.1016/S0142-9612(99)00248-3
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 288TZ
UT WOS:000085581700010
PM 10711972
DA 2018-10-20
ER

PT J
AU Sepulveda, P
   Binner, JGP
   Rogero, SO
   Higa, OZ
   Bressiani, JC
AF Sepulveda, P
   Binner, JGP
   Rogero, SO
   Higa, OZ
   Bressiani, JC
TI Production of porous hydroxyapatite by the gel-casting of foams and
   cytotoxic evaluation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE porous ceramics; hydroxyapatite; gel-cast foams; cytotoxicity; bone
   implants
ID CERAMICS; POROSITY
AB This study presents the manufacture of highly porous hydroxyapatite by a novel technique that employs the foaming of suspensions prior to the in situ polymerization of organic monomers contained in the compositions. This method produces strong gelled bodies with up to 90% porosity that can withstand machining in the green state. Complex-shaped components can be obtained if the process comprises casting in one of the processing steps. The organic additives are eliminated at temperatures above 300 degrees C, and sintering is carried out for consolidation of the ceramic matrix. Spherical interconnected cells with sizes ranging from 20 to 1000 mu m characterize the porous structure, depending on the specimen density. Cytotoxicity tests were conducted on extracts from sintered HA foams based on a quantitative method of cell colony formation and the determination of cell death after indirect contact of the porous material with mammalian cells. This in vitro test of biological evaluation revealed that the original purity of the biomedical-grade hydroxyapatite powder was affected neither through processing nor by the employed reagents. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Fed Sao Carlos, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil.
   Univ Nottingham, Dept Mat Engn & Mat Design, Nottingham NG7 2RD, England.
   IPEN CNEN SP, Sao Paulo, Brazil.
RP Sepulveda, P (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Prince Consort Rd, London SW7 2BP, England.
RI Bressiani, Jose/I-1426-2012; Binner, Jon/H-1007-2011; Sepulveda,
   Pilar/D-4093-2009
CR ARITA IH, 1995, BIOMATERIALS, V16, P403, DOI 10.1016/0142-9612(95)98858-B
   Constantino PD, 1994, OTOLARYNGOL CLIN N A, V27, P1037
   FABRI M, 1995, BIOMATERIALS, V16, P225
   *INT STAND, 1993, BIOL EV MED DEV 5, V10, P993
   IOKU K, 1994, P 7 INT S CER MED TU, V7
   Janney M. A., 1991, US pat, Patent No. [5 028 362, 5028362, US 5028362 A.]
   Liu DM, 1996, KEY ENG MAT, V115, P209, DOI 10.4028/www.scientific.net/KEM.115.209
   Liu DM, 1997, CERAM INT, V23, P135, DOI 10.1016/S0272-8842(96)00009-0
   MIQUEL JL, 1990, COLLOID SURFACE, V45, P427, DOI 10.1016/0166-6622(90)80041-2
   ODIAN G, 1991, PRINCIPLES POLYM
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   ROSEN MJ, 1989, SURFACTANTS INTERFAC, P277
   Sepulveda P, 1997, AM CERAM SOC BULL, V76, P61
   Sepulveda P, 1999, J EUR CERAM SOC, V19, P2059, DOI 10.1016/S0955-2219(99)00024-2
   YOUNG AC, 1991, J AM CERAM SOC, V74, P612, DOI 10.1111/j.1151-2916.1991.tb04068.x
NR 15
TC 158
Z9 165
U1 3
U2 49
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 2000
VL 50
IS 1
BP 27
EP 34
DI 10.1002/(SICI)1097-4636(200004)50:1<27::AID-JBM5>3.0.CO;2-6
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 274NP
UT WOS:000084772200005
PM 10644960
DA 2018-10-20
ER

PT J
AU Boelens, JJ
   Dankert, J
   Murk, JL
   Weening, JJ
   van der Poll, T
   Dingemans, KP
   Koole, L
   Laman, JD
   Zaat, SAJ
AF Boelens, JJ
   Dankert, J
   Murk, JL
   Weening, JJ
   van der Poll, T
   Dingemans, KP
   Koole, L
   Laman, JD
   Zaat, SAJ
TI Biomaterial-associated persistence of Streptococcus epidermidis in
   pericatheter macrophages
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article; Proceedings Paper
CT 39th Interscience Conference on Antimicrobial Agents and Chemotherapy
CY SEP 26-29, 1998
CL SAN FRANCISCO, CALIFORNIA
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; FOREIGN-BODY INFECTIONS;
   TUMOR-NECROSIS-FACTOR; BIOMEDICAL POLYMERS; INTERFERON-GAMMA;
   INTERLEUKIN-10; ADHESION; MODEL; PATHOGENESIS; NEUTROPHILS
AB Biomaterial surfaces may be modified to reduce bacterial adhesion. The susceptibility in mice to Staphylococcus epidermidis infection in tissue surrounding the commonly used catheter materials-silicon elastomer (SE), polyamide (PA), and their surface-modified polyvinylpyrrolidone (PVP)-grafted derivatives, SE-PVP and PA-PVP, respectively-was assessed. Abscesses developed around SE-PVP Around SE, PA, and PA-PVP catheters, no signs of infection were observed, although mice carrying PA-PVP developed septicemia after 14-21 days. S. epidermidis was cultured from the tissue surrounding PA-PVP segments. Cells around PA-PVP segments containing large numbers of bacteria were identified as macrophages by use of immunohistochemistry and electron microscopy. This persistence of intracellular bacteria was also observed around SE-PVP, SE, and PA, catheters, although to a lesser extent. The cytokine profiles around the 4 materials were different. Implanted biomaterial induces an inflammatory response favorable to the persistence of S. epidermidis. Intracellular persistence of bacteria inside macrophages may be a pivotal process in the pathogenesis of biomaterial-associated infection.
C1 Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.
   Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.
   Univ Amsterdam, Acad Med Ctr, Dept Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands.
   Maastricht Ctr Biomat Res, Maastricht, Netherlands.
   Erasmus Univ, Dept Immunol, NL-3000 DR Rotterdam, Netherlands.
RP Boelens, JJ (reprint author), Leiden Univ, Med Ctr, Dept Pediat, J6-S-208,POB 9600, NL-2300 RC Leiden, Netherlands.
OI Boelens, Jaap Jan/0000-0003-2232-6952
CR ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   BADDOUR LM, 1984, J INFECT DIS, V150, P721, DOI 10.1093/infdis/150.5.721
   Bisno AL, 1994, INFECT ASS INDWELLIN
   Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749
   BOELENS J, 1998, 38 INT C ANT AG CHEM
   BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549
   CHRISTENSEN GD, 1983, INFECT IMMUN, V40, P407
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   CHRISTENSEN GD, 1983, J CLIN MICROBIOL, V18, P258
   COSTERTON J, 1975, J ANTIMICROB CHEMOTH, V4, P363
   COSTERTON JW, 1981, CRC CR REV MICROBIOL, V8, P303, DOI 10.3109/10408418109085082
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   DUQUID I, 1992, J ANTIMICROB CHEMOTH, V30, P803
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   EMILIE D, 1995, REV RHUM, V62, P229
   Fleer A, 1989, J Invest Surg, V2, P391, DOI 10.3109/08941938909018264
   GRAY ED, 1987, ZBL BAKT HYG S, V16, P45
   GREENBERGER MJ, 1995, J IMMUNOL, V155, P722
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   Henke PK, 1997, J SURG RES, V69, P372, DOI 10.1006/jsre.1997.5088
   HERRMANN M, 1990, J CLIN INVEST, V86, P942
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   HUME DA, 1984, ANAT REC, V210, P503, DOI 10.1002/ar.1092100311
   JAMES RC, 1961, BRIT J EXP PATHOL, V42, P266
   JOHNSON GM, 1987, ZENTRALBLATT BAKTE S, V16, P33
   Kanangat S, 1999, INFECT IMMUN, V67, P2834
   Kaplan SS, 1999, INFECT IMMUN, V67, P1640
   KAPLAN SS, 1994, J BIOMED MATER RES, V28, P377, DOI 10.1002/jbm.820280313
   Kaplan SS, 1996, J BIOMED MATER RES, V30, P67
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   KAUFMANN S, 1993, LEPROSY, P57
   Kaufmann SHE, 1995, CIBA F SYMP, V195, P123
   KLOCK JC, 1976, BLOOD, V48, P149
   Kruft MAB, 1997, BIOMATERIALS, V18, P31, DOI 10.1016/S0142-9612(96)00085-3
   Lalani I, 1997, ANN ALLERG ASTHMA IM, V79, P469, DOI 10.1016/S1081-1206(10)63052-9
   LAMAN J, 1998, J NEUROIMMUNOL, V86, P303
   LEE SH, 1985, J EXP MED, V161, P475, DOI 10.1084/jem.161.3.475
   Mack D, 1999, INFECT IMMUN, V67, P1004
   Myrvik Q N, 1989, J Invest Surg, V2, P381, DOI 10.3109/08941938909018263
   NOBLE WC, 1965, BRIT J EXP PATHOL, V46, P254
   OSWALD IP, 1992, P NATL ACAD SCI USA, V89, P8676, DOI 10.1073/pnas.89.18.8676
   PAUL WE, 1993, FUNDAMENTAL IMMUNOLO
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   Seifert H., 1997, CATHETER RELATED INF
   SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205
   TAUBLER JH, 1966, J INFECT DIS, V116, P257, DOI 10.1093/infdis/116.3.257
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   Trinchieri G, 1997, CURR OPIN IMMUNOL, V9, P17, DOI 10.1016/S0952-7915(97)80154-9
   VAUDAUX P, 1992, J INFECT DIS, V166, P58, DOI 10.1093/infdis/166.1.58
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 56
TC 72
Z9 73
U1 2
U2 10
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA
SN 0022-1899
J9 J INFECT DIS
JI J. Infect. Dis.
PD APR
PY 2000
VL 181
IS 4
BP 1337
EP 1349
DI 10.1086/315369
PG 13
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 311KT
UT WOS:000086883900014
PM 10762565
OA Bronze
DA 2018-10-20
ER

PT J
AU Li, SM
   Chen, XH
   Gross, RA
   McCarthy, SP
AF Li, SM
   Chen, XH
   Gross, RA
   McCarthy, SP
TI Hydrolytic degradation of PCL/PEO copolymers in alkaline media
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MASSIVE POLY(ALPHA-HYDROXY ACIDS); STRUCTURE-PROPERTY RELATIONSHIPS;
   BLOCK-COPOLYMERS; AQUEOUS-MEDIA; POLY(ETHYLENE GLYCOL); MULTIBLOCK
   COPOLYMERS; POLYETHYLENE GLYCOLS; POLY(DL-LACTIC ACID); L-LACTIDE
AB PCL/PEO copolymers with different compositions were obtained from ring opening polymerization of epsilon-caprolactone in the presence of ethylene oxide and characterized by various analytical techniques. Data collected from DSC and X-ray diffractometry suggested that the copolymer chains possess a blocky structure, leading to both PCL and PEO-type crystalline structures. Hydrolytic degradation of these copolymers was carried out in a pH=10.6 carbonate buffer solution at 37 degrees C. Comparison was made with a PCL homopolymer and a PCL/PEG blend which had the same gross composition as one of the copolymers. The results showed that the presence of PEO sequences considerably enhanced the hydrophilicity of the copolymers as compared with PCL homopolymer. Nevertheless, the degradability of PCL chains was not enhanced due to the phase separation between the two components. These materials should be of great interest for biomedical uses such as matrices for sustained drug delivery because of the presence of both hydrophilic and hydrophobic microdomains. (C) 2000 Kluwer Academic Publishers.
C1 Univ Massachusetts, Dept Plast Engn, Lowell, MA 01851 USA.
   Univ Massachusetts, Dept Chem, Lowell, MA 01851 USA.
RP Li, SM (reprint author), Fac Pharm, Res Ctr Artificial Biopolymers, 15 Ave Charles Flahault, F-34060 Montpellier, France.
RI Li, Suming/D-1300-2014; Li, Suming/J-2868-2013
OI Li, Suming/0000-0002-3345-1479; Li, Suming/0000-0002-3345-1479
CR CERRAI P, 1994, J MATER SCI-MATER M, V5, P308, DOI 10.1007/BF00058953
   CHEN X, IN PRESS
   DENG XM, 1990, J POLYM SCI POL LETT, V28, P411, DOI 10.1002/pol.1990.140281303
   Dunn Richard L., 1995, P17
   HARRIS JM, 1985, J MACROMOL SCI R M C, VC25, P325, DOI 10.1080/07366578508081960
   HEROLD DA, 1989, BIOCHEM PHARMACOL, V38, P73, DOI 10.1016/0006-2952(89)90151-2
   HOLLAND S J, 1986, Journal of Controlled Release, V4, P155, DOI 10.1016/0168-3659(86)90001-5
   JEDLINSKI Z, 1993, MAKROMOL CHEM, V194, P1681
   Li S, 1995, DEGRADABLE POLYM PRI, P43
   Li SM, 1998, J APPL POLYM SCI, V68, P989, DOI 10.1002/(SICI)1097-4628(19980509)68:6<989::AID-APP12>3.0.CO;2-J
   LI SM, 1990, J MATER SCI-MATER M, V1, P131, DOI 10.1007/BF00700872
   LI SM, 1990, J MATER SCI-MATER M, V1, P198, DOI 10.1007/BF00701077
   LI SM, 1994, MACROMOLECULES, V27, P3107, DOI 10.1021/ma00089a031
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   Li SM, 1996, MACROMOLECULES, V29, P57, DOI 10.1021/ma950531l
   LI YX, 1994, J CONTROL RELEASE, V32, P121
   MANOLOVA N, 1993, EUR POLYM J, V29, P721, DOI 10.1016/0014-3057(93)90134-2
   PAUL DR, 1978, POLYM BLENDS, P56
   Petrova T, 1998, POLYM INT, V45, P419
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   PITT CG, 1992, BIODEGRADABLE POLYM, P1
   Rashkov I, 1996, MACROMOLECULES, V29, P50, DOI 10.1021/ma950530t
   RICHTER AW, 1983, INT ARCH ALLER A IMM, V70, P124, DOI 10.1159/000233309
   THERIN M, 1992, BIOMATERIALS, V13, P594, DOI 10.1016/0142-9612(92)90027-L
   VERT M, 1991, J CONTROL RELEASE, V16, P15, DOI 10.1016/0168-3659(91)90027-B
   WANG WQ, 1993, CHINESE CHEM LETT, V4, P363
   YOUNES H, 1987, J BIOMED MATER RES, V21, P1301, DOI 10.1002/jbm.820211103
   ZALIPSKY S, 1983, EUR POLYM J, V19, P1177, DOI 10.1016/0014-3057(83)90016-2
   ZHU KJ, 1990, J APPL POLYM SCI, V39, P1, DOI 10.1002/app.1990.070390101
NR 29
TC 42
Z9 43
U1 1
U2 19
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2000
VL 11
IS 4
BP 227
EP 233
DI 10.1023/A:1008920326988
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289LU
UT WOS:000085623900006
PM 15348037
DA 2018-10-20
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI New director of biomedical materials
SO MATERIALS WORLD
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INST MATERIALS
PI LONDON
PA 1 CARLTON HOUSE TERRACE, LONDON SW1Y 5DB, ENGLAND
SN 0967-8638
J9 MATER WORLD
JI Mater. World
PD APR
PY 2000
VL 8
IS 4
BP 8
EP 8
PG 1
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 302ZC
UT WOS:000086395500021
DA 2018-10-20
ER

PT J
AU Chauhan, GS
   Dhiman, SK
   Guleria, LK
   Misra, BN
   Kaur, I
AF Chauhan, GS
   Dhiman, SK
   Guleria, LK
   Misra, BN
   Kaur, I
TI Polymers from renewable resources: kinetics of 4-vinyl pyridine
   radiochemical grafting onto cellulose extracted from pine needles
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article
ID ISOTACTIC POLYPROPYLENE; METHYL ACRYLATE; COPOLYMERIZATION;
   DESALINATION; MEMBRANES; MONOMERS; GELATIN; FIBER; WOOL
AB In view of the marked thrust of research activities in the area of biodegradable polymers use of pine needles as renewable stock of polymeric materials has been made to synthesize graft copolymers for biomedical and industrial applications. 4-Vinyl pyridine (4-VP) has been radiochemically grafted onto cellulose extracted from pine needles using simultaneous irradiation method in limited aqueous medium. Optimum grafting conditions and kinetic parameters such as percent grafting, grafting efficiency, total conversion of monomer and rates of polymerization, homopolymerization and grafting have been evaluated as a function of total dose, monomer concentration and amount of water. It is observed that variation in both total dose and monomer concentration leads to inconsistent increase and decrease of the grafting parameters. However, rate of polymerization shows unsteady but regular increase with increasing monomer concentration and total dose radiation. While optimum amount of water is required for maximum percent grafting, addition of methanol on the other hand leads to regular decrease in percent grafting as a consequence of fall in the rate of grafting contrary to some earlier reported studies. Evidence of grafting has been based on the comparative studies of cellulose and grafted cellulose by infrared spectroscopy, elemental analysis and thermal analysis. Grafting enhances thermal stability of cellulose backbone. The trends in the results have been explained by kinetic interpretation and suitable mechanism for grafting has been proposed. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Himachal Pradesh Univ, Dept Chem, Simla 171005, Himachal Prades, India.
RP Chauhan, GS (reprint author), Himachal Pradesh Univ, Dept Chem, Summer Hill, Simla 171005, Himachal Prades, India.
OI Chauhan, Ghanshyam/0000-0002-5032-5706
CR Bojanic V, 1996, J APPL POLYM SCI, V60, P1719, DOI 10.1002/(SICI)1097-4628(19960606)60:10<1719::AID-APP24>3.0.CO;2-Y
   Chauhan GS, 1998, CHEM PAP-CHEM ZVESTI, V52, P182
   Chauhan GS, 1999, J POLYM SCI POL CHEM, V37, P1763, DOI 10.1002/(SICI)1099-0518(19990615)37:12<1763::AID-POLA5>3.3.CO;2-J
   Chauhan GS, 1997, J APPL POLYM SCI, V65, P191
   GARNETT JL, 1976, J POLYM SCI POL LETT, V14, P35, DOI 10.1002/pol.1976.130140107
   KANBARA T, 1992, J POLYM SCI A, V35, P2787
   Kaur I, 1997, DESALINATION, V110, P115, DOI 10.1016/S0011-9164(97)00091-X
   Kaur I, 1997, POLYM POLYM COMPOS, V5, P291
   Kaur I, 1998, POLYM INT, V46, P275, DOI 10.1002/(SICI)1097-0126(199808)46:4<275::AID-PI991>3.0.CO;2-0
   Kaur I, 1997, DESALINATION, V110, P129, DOI 10.1016/S0011-9164(97)00092-1
   Mark HF, 1968, ENCY POLYM SCI TECHN
   MASSON JF, 1991, MACROMOLECULES, V24, P5914, DOI 10.1021/ma00022a004
   MEHTA IK, 1994, J APPL POLYM SCI, V54, P1171, DOI 10.1002/app.1994.070540820
   MEHTA IK, 1990, J APPL POLYM SCI, V41, P1171, DOI 10.1002/app.1990.070410526
   Misra BN, 1996, COLLECT CZECH CHEM C, V61, P259, DOI 10.1135/cccc19960259
NR 15
TC 32
Z9 32
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-806X
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD APR
PY 2000
VL 58
IS 2
BP 181
EP 190
DI 10.1016/S0969-806X(99)00363-1
PG 10
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA 311KR
UT WOS:000086883800010
DA 2018-10-20
ER

PT J
AU Thomann, UI
   Uggowitzer, PJ
AF Thomann, UI
   Uggowitzer, PJ
TI Wear-corrosion behavior of biocompatible austenitic stainless steels
SO WEAR
LA English
DT Article
DE wear-corrosion; biocompatible; nickel-free; stainless steel
ID NITROGEN; CRACKING; DEVICES
AB The present work compares 316L and Rex734 stainless steels - currently used for biomedical applications - with the recently developed P558 alloy in terms of mechanical properties, corrosion and dry wear resistance as well as the combined wear-corrosion behavior. Pin-on-drum tests were conducted to determine the dry wear resistance of test materials. Wear-corrosion behavior was studied in slurry tests and pin-on-disk experiments in distilled water, Hank's artificial physiological solution, and 22% NaCl aqueous solution. Corrosion resistance was determined by potentiodynamic tests and critical crevice corrosion temperature measurements. Due to its combination of outstanding mechanical properties and excellent corrosion resistance, P558 performed much better than 316L in all tests. P558 also proved to be more resistant against dry wear, wear-corrosion, and crevice corrosion than Rex734. The resistance of P558 against pitting corrosion was found to be equal to the resistance of Rex734. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 ETH Zurich, Inst Met, Swiss Fed Inst Technol, CH-8092 Zurich, Switzerland.
RP Thomann, UI (reprint author), Swiss Fed Inst Technol, Inst Design & Construct Methods, Wagistr 6,Postfach, CH-8952 Schlieren, Switzerland.
RI Uggowitzer, Peter/H-3581-2012
OI Uggowitzer, Peter/0000-0002-9504-5652
CR BALL A, 1983, WEAR, V91, P201, DOI 10.1016/0043-1648(83)90254-5
   BLICKENSDERFER R, 1988, J TEST EVAL, V16, P516
   BULARD SJ, 1996, NACE INT ANN C EXP C
   Eckenrod J., 1979, ASTM STP, V679, P17
   HEATHCOCK CJ, 1982, WEAR, V81, P311, DOI 10.1016/0043-1648(82)90278-2
   HOLCOMB GR, 1997, MICROSTRUCT SCI, V25, P191
   *ISIJ, 1996, HIGH NITR STEELS, V36
   KAIN RM, 1990, J TEST EVAL, V18, P309
   KEARNS JR, 1985, J MAT ENG, V7, P16
   MADSON BW, 1986, NACE INT ANN C EXP C
   Mills DJ, 1998, WEAR, V215, P83, DOI 10.1016/S0043-1648(97)00273-1
   MOZHI TA, 1986, CORROSION, V42, P197, DOI 10.5006/1.3585997
   MULLNER P, 1993, MAT SCI ENG A-STRUCT, V164, P164, DOI 10.1016/0921-5093(93)90655-X
   Nielsen K., 1987, British Corrosion Journal, V22, P272
   OGAWA T, 1982, WELD J, V61, P139
   Ornhagen C, 1996, J BIOMED MATER RES, V31, P97, DOI 10.1002/(SICI)1097-4636(199605)31:1<97::AID-JBM12>3.0.CO;2-J
   Robinson PW, 1985, J HEAT TREATING, V4, P69
   SIVAKUMAR M, 1992, J MATER SCI LETT, V11, P1039, DOI 10.1007/BF00729754
   SIVAKUMAR M, 1994, J MATER ENG PERFORM, V3, P744, DOI 10.1007/BF02818375
   SPEIDEL MO, 1993, P MAT WEEK 92 CHIC, P135
   SPEIDEL MO, 1998, MAT MED, P191
   Truman JE., 1989, P INT C HIGH NITR ST, P225
   Uggowitzer PJ, 1996, ISIJ INT, V36, P901, DOI 10.2355/isijinternational.36.901
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
NR 24
TC 82
Z9 94
U1 1
U2 9
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
J9 WEAR
JI Wear
PD APR
PY 2000
VL 239
IS 1
BP 48
EP 58
DI 10.1016/S0043-1648(99)00372-5
PG 11
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 307ZC
UT WOS:000086683200006
DA 2018-10-20
ER

PT J
AU Mukkamala, R
   Kushner, AM
   Bertozzi, CR
AF Mukkamala, R
   Kushner, AM
   Bertozzi, CR
TI Hydrogel polymers from alkylthio acrylates for biomedical applications:
   Effect of sulfur oxidation state on materials' properties.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 26
PY 2000
VL 219
MA 529-POLY
BP U445
EP U445
PN 2
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 317UW
UT WOS:000087246202477
DA 2018-10-20
ER

PT J
AU Morita, A
   Fukui, H
   Tadano, H
   Hayashi, S
   Hasegawa, J
   Niinomi, M
AF Morita, A
   Fukui, H
   Tadano, H
   Hayashi, S
   Hasegawa, J
   Niinomi, M
TI Alloying titanium and tantalum by cold crucible levitation melting
   (CCLM) furnace
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Proceedings Paper
CT International-Union-of-Materials-Research-Societies International
   Conference on Advanced Materials (IUMRS-ICAM 99)
CY JUN 13-18, 1999
CL BEIJING, PEOPLES R CHINA
SP Int Union Mat Res Soc
DE biomedical titanium alloys; alloying titanium and tantalum; cold
   crucible levitation melting; CCLM; making an alloy of base metals;
   single melting (no re-melting) process
AB Recently, titanium alloys have been studied as implant materials for dental and orthopedic surgery. Titanium alloys have distinguished characteristics of biocompatibility, corrosion resistance and mechanical properties. Having non-poisonous character to a living body, Ta, Zr and Nb have been used for addition to titanium alloys, which are free of vanadium and aluminum. It is well-known that titanium and tantalum are difficult metals to alloy in usual furnaces as these are very reactive metals, having great differences in melting point anti specific gravity. To produce an alloy of titanium and tantalum, cold crucible levitation melting (CCLM) is effective in obtaining a uniform composition. Notable features of CCLM are that it can (1) melt metals with a high melting point, (2) create an alloy of uniform composition with a strong stirring effect by an electromagnetic force and (3) allow metals to be melted without contamination. We have melted 850 g of titanium and 150 g of tantalum by a CCLM furnace and have successfully made 1.0 kg of uniform composite Ti-15wt.% Ta alloy. It is noteworthy that the alloy was produced from pure base metals which were not alloyed beforehand and was made by a single melting (no re-melting) process. (C) 2000 Elsevier Science S.A. All rights reserved.
C1 Fuji Elect Furnace Co Ltd, Suzuka, Mie 5138633, Japan.
   Aichi Gakuin Univ, Sch Dent, Dept Dent Mat, Chikusa Ku, Nagoya, Aichi 464, Japan.
   Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418550, Japan.
RP Tadano, H (reprint author), Fuji Elect Furnace Co Ltd, 5520 Minami Tamagaki Cho, Suzuka, Mie 5138633, Japan.
RI Niinomi, Mitsuo/B-5965-2011
CR FUKUI H, 1999, P 9 WORLD C TIT ST P
   FUKUZAWA A, 1994, P INT S ELECTROMAGNE, P172
   IMAM A, 1996, ASTM STP, V1272, P3
   KANIUMA K, 1996, P 13 INT C EL APPL B, pMII9
   Mishra A. K., 1996, ASTM STP, V1272, P96
   NAKAMURA Y, 1998, 3 WORLD BIOM C KYOT, P202
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 1998, NON-AEROSPACE APPLICATIONS OF TITANIUM, P217
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   Steinemann S., 1980, EVALUATION BIOMATERI
   TADANO H, 1994, IEEE T MAGN, V30, P4740, DOI 10.1109/20.334207
   TADANO H, 1997, P 2 INT C EL PROC MA, V1, P377
   Wang KK, 1996, ASTM STP, V1272, P76
   Zardiackas L., 1996, ASTM STP, P60
NR 14
TC 41
Z9 41
U1 1
U2 22
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD MAR 15
PY 2000
VL 280
IS 1
BP 208
EP 213
DI 10.1016/S0921-5093(99)00668-1
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 293FA
UT WOS:000085839800036
DA 2018-10-20
ER

PT J
AU Dai, LM
   Mau, AWH
AF Dai, LM
   Mau, AWH
TI Surface and interface control of polymeric biomaterials, conjugated
   polymers, and carbon nanotubes
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Review
ID LIGHT-EMITTING-DIODES; SELF-ASSEMBLED MONOLAYERS; ORGANIC
   ELECTROLUMINESCENT DEVICES; TRIBLOCK COPOLYMER CHAINS;
   THIN-FILM-TRANSISTOR; PHENYLENE VINYLENE OLIGOMER; SCANNING FORCE
   MICROSCOPY; LARGE-SCALE SYNTHESIS; CONDUCTING POLYMERS;
   ELECTROCHEMICAL-CELLS
AB Surface and interface play an important role in controlling the properties of a broad range of materials. With the recent development of various advanced surface analytical techniques, our understanding of material surfaces and interfaces has been significantly increased, as with our ability to control and even to tailor the surface and interfacial characteristics for specific applications. This is a very broad field which includes material synthesis, structural determination, surface/interface design and modification. In this article, we present some of the important issues concerning the surface and interface control of polymeric biomaterials, conjugated polymers, and carbon nanotubes for biomedical and optoelectronic applications and describe the use of X-ray photoelectron spectroscopy (XPS), surface force apparatus (SFA), and neutron reflectometry (NR) for elucidation of the surface and interface structures.
C1 CSIRO, Clayton S, Vic 3169, Australia.
RP Dai, LM (reprint author), CSIRO, Bag 10, Clayton S, Vic 3169, Australia.
CR AJAYAN PM, 1995, ADV MATER, V7, P489, DOI 10.1002/adma.19950070520
   AJAYAN PM, 1994, SCIENCE, V265, P1212, DOI 10.1126/science.265.5176.1212
   AJAYAN PM, 1997, REP PROG PHYS, V60, P1026
   AJAYAN PM, 1994, SCIENCE, V265, P1211
   AKARI S, 1995, ADV MATER, V7, P549, DOI 10.1002/adma.19950070607
   ALEXANDER S, 1977, J PHYS-PARIS, V38, P983, DOI 10.1051/jphys:01977003808098300
   Anastassopoulos DL, 1998, MACROMOLECULES, V31, P9369, DOI 10.1021/ma980379y
   Armes SP, 1996, CURR OPIN COLLOID IN, V1, P214, DOI 10.1016/S1359-0294(96)80007-0
   AUROY P, 1992, MACROMOLECULES, V25, P4134, DOI 10.1021/ma00042a014
   BAKER GL, 1988, ADV CHEM SER, V218
   Baldo MA, 1998, NATURE, V395, P151
   Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340
   Baughman RH, 1996, SYNTHETIC MET, V78, P339, DOI 10.1016/0379-6779(96)80158-5
   BAUGHMAN RH, 1990, SCI APPL CONDUCTING
   Beamson G., 1992, HIGH RESOLUTION XPS
   BERGGREN M, 1994, J APPL PHYS, V76, P7530, DOI 10.1063/1.357984
   BHUSHAN B, 1995, NATURE, V374, P607, DOI 10.1038/374607a0
   BIGGS S, 1995, LANGMUIR, V11, P156, DOI 10.1021/la00001a028
   BIRKETT PR, 1999, CHEM BR          MAY, P45
   Bjorling M, 1998, MACROMOLECULES, V31, P9033, DOI 10.1021/ma971732n
   BLACK J, 1992, BIOL PERFORMANCE MAT
   Bonard JM, 1998, ULTRAMICROSCOPY, V73, P7, DOI 10.1016/S0304-3991(97)00129-0
   BORISOV OV, 1995, MACROMOLECULES, V28, P7180, DOI 10.1021/ma00125a021
   BORMAN S, 1990, CHEM ENG NEWS   0507, P53
   BOWDEN MJ, 1988, ADV CHEM SER, V218
   Bradley D.D.C., 1995, ORGANIC ELECTROLUMIN
   Braithwaite GJC, 1996, LANGMUIR, V12, P4224, DOI 10.1021/la960154l
   Bredas J. L., 1991, CONJUGATED POLYM
   BROCHARDWYART F, 1994, MACROMOL SYMP, V79, P1, DOI 10.1002/masy.19940790103
   BROWN AR, 1992, APPL PHYS LETT, V61, P2793, DOI 10.1063/1.108094
   BROWN AR, 1996, SYNTHETIC MET, V80, P119
   BUM PL, 1992, NATURE, V356, P47
   Burghard M, 1998, ADV MATER, V10, P584, DOI 10.1002/(SICI)1521-4095(199805)10:8<584::AID-ADMA584>3.3.CO;2-0
   BURROUGHES JH, 1990, NATURE, V347, P539, DOI 10.1038/347539a0
   CALVERT P, 1988, NATURE, V333, P296, DOI 10.1038/333296a0
   Campbell SE, 1996, NATURE, V382, P520, DOI 10.1038/382520a0
   Cazabat AM, 1997, INTERFACE SCI, V5, P129, DOI 10.1023/A:1008657225779
   Chambers A, 1998, J PHYS CHEM B, V102, P4253, DOI 10.1021/jp980114l
   Chan C. M, 1994, POLYM SURFACE MODIFI
   CHATELIER R, Patent No. 9406485
   CHATELIER RC, 1995, LANGMUIR, V11, P2585, DOI 10.1021/la00007a043
   Chavrolin J., 1990, LIQUIDS INTERFACES
   Che GL, 1998, NATURE, V393, P346, DOI 10.1038/30694
   Chen P, 1999, SCIENCE, V285, P91, DOI 10.1126/science.285.5424.91
   Chien J. C. W., 1984, POLYACETYLENE CHEM P
   CHO I, 1995, MACROMOL RAPID COMM, V16, P851, DOI 10.1002/marc.1995.030161111
   Choong V, 1996, APPL PHYS LETT, V69, P1492, DOI 10.1063/1.116918
   Cleland AN, 1998, NATURE, V392, P160, DOI 10.1038/32373
   CONWELL EM, 1993, SPIE P, V1910
   COSGROVE T, 1991, MACROMOLECULES, V24, P94, DOI 10.1021/ma00001a015
   Courvoisier A, 1998, LANGMUIR, V14, P3727, DOI 10.1021/la971041k
   CROWLEY TL, 1991, COLLOID SURFACE, V52, P85, DOI 10.1016/0166-6622(91)80007-B
   Curran SA, 1998, ADV MATER, V10, P1091, DOI 10.1002/(SICI)1521-4095(199810)10:14<1091::AID-ADMA1091>3.0.CO;2-L
   d'Agostino R., 1990, PLASMA DEPOSITION TR
   DAGANI R, 1995, C E NEWS        0424, P42
   Dai HJ, 1996, NATURE, V384, P147, DOI 10.1038/384147a0
   DAI L, 1991, EUROPHYS LETT, V16, P331, DOI 10.1209/0295-5075/16/4/003
   DAI L, 1997, MACROMOL CHEM PHYS, V189, P1723
   DAI L, 1996, SURFACE MODIFICATION
   DAI L, 1999, ACS S SER, V735
   DAI L, 1995, CHIN J MAT RES ENG, V9, P397
   DAI L, 1989, SYNTHETIC MET, V28, P69
   Dai LM, 1999, POLYM ADVAN TECHNOL, V10, P357, DOI 10.1002/(SICI)1099-1581(199907)10:7<357::AID-PAT886>3.0.CO;2-9
   Dai LM, 1999, J MACROMOL SCI R M C, VC39, P273
   Dai LM, 1996, MACROMOLECULES, V29, P282, DOI 10.1021/ma951054+
   DAI LM, 1991, POLYMER, V32, P2120, DOI 10.1016/0032-3861(91)90034-G
   Dai LM, 1997, POLYMER, V38, P775, DOI 10.1016/S0032-3861(96)00573-3
   Dai LM, 1997, J PHYS CHEM B, V101, P9548, DOI 10.1021/jp970562d
   Dai LM, 2000, SURF INTERFACE ANAL, V29, P46, DOI 10.1002/(SICI)1096-9918(200001)29:1<46::AID-SIA692>3.0.CO;2-6
   Dai LM, 1998, J PHYS CHEM B, V102, P4049, DOI 10.1021/jp980410y
   DAI LM, 1993, EUR POLYM J, V29, P645, DOI 10.1016/0014-3057(93)90122-V
   DAI LM, 1994, MACROMOLECULES, V27, P6728, DOI 10.1021/ma00101a008
   DAI LM, 1992, J PHYS CHEM-US, V96, P6469, DOI 10.1021/j100194a067
   DAI LM, 1993, J POLYM SCI POL PHYS, V31, P3, DOI 10.1002/polb.1993.090310102
   Dai LM, 1997, SYNTHETIC MET, V85, P1379, DOI 10.1016/S0379-6779(97)80281-0
   DAI LM, 1995, MACROMOLECULES, V28, P5512, DOI 10.1021/ma00120a015
   DAI LM, 1992, MACROMOLECULES, V25, P6000, DOI 10.1021/ma00048a022
   DANNETUM P, 1994, ORGANIC MAT ELECT CO
   DANNETUN P, 1993, MOL CRYST LIQ CRYST, V228, P43, DOI 10.1080/10587259308032141
   DANNETUN P, 1993, SYNTHETIC MET, V55, P212, DOI 10.1016/0379-6779(93)90935-P
   DEGENNES PG, 1985, CR ACAD SCI II, V300, P839
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   deGennes PG, 1979, SCALING CONCEPTS POL
   DEHEER WA, 1995, SCIENCE, V268, P845, DOI 10.1126/science.268.5212.845
   DEHEER WA, 1995, SCIENCE, V270, P1179, DOI 10.1126/science.270.5239.1179
   deHeer WA, 1997, ADV MATER, V9, P87, DOI 10.1002/adma.19970090122
   DELLACHERIE E, 1993, POLYM BULL, V31, P145, DOI 10.1007/BF00329959
   Derjaguin B, 1934, KOLLOID Z, V69, P155, DOI 10.1007/BF01433225
   Dillon AC, 1997, NATURE, V386, P377, DOI 10.1038/386377a0
   DORGAN JR, 1993, MACROMOLECULES, V26, P5321, DOI 10.1021/ma00072a008
   Dresselhaus M.S., 1996, SCI FULLERENES CARBO
   DUMITRIU S, 1994, POLYM BIOMATERIALS
   EBBESEN TW, 1992, NATURE, V358, P220, DOI 10.1038/358220a0
   Ebbesen TW, 1996, PHYS TODAY, V49, P26, DOI 10.1063/1.881603
   Ebbsen T., 1997, CARBON NANOTUBES
   Edelmann FT, 1999, ANGEW CHEM INT EDIT, V38, P1381, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1381::AID-ANIE1381>3.0.CO;2-V
   FAN FRF, 1985, CHEM PHYS LETT, V116, P400, DOI 10.1016/0009-2614(85)80192-5
   Fan SS, 1999, SCIENCE, V283, P512, DOI 10.1126/science.283.5401.512
   FEIJEN J, 1994, J MACROMOL SCI PURE, VA31, P1153
   FERNANDEZ ML, 1988, POLYMER, V29, P1923, DOI 10.1016/0032-3861(88)90162-0
   FERREIRA M, 1995, MACROMOLECULES, V28, P7107, DOI 10.1021/ma00125a012
   FERREIRA M, 1994, THIN SOLID FILMS, V244, P806, DOI 10.1016/0040-6090(94)90575-4
   FIELD JB, 1992, J PHYS II, V2, P2221
   FIELD JB, 1992, MACROMOLECULES, V25, P434, DOI 10.1021/ma00027a067
   Frank S, 1998, SCIENCE, V280, P1744, DOI 10.1126/science.280.5370.1744
   FREIJLARSSON C, 1993, J APPL POLYM SCI, V50, P345, DOI 10.1002/app.1993.070500215
   Friend RH, 1999, NATURE, V397, P121, DOI 10.1038/16393
   FRISBIE CD, 1994, SCIENCE, V265, P2071, DOI 10.1126/science.265.5181.2071
   Gadd GE, 1997, SCIENCE, V277, P933, DOI 10.1126/science.277.5328.933
   GALAEV IY, 1995, RUSS CHEM REV, V64, P471
   GAO Y, 1993, J APPL PHYS, V73, P7894, DOI 10.1063/1.353941
   GARNIER F, 1990, ADV MATER, V2, P592, DOI 10.1002/adma.19900021207
   Graupner W, 1996, PHYS REV LETT, V76, P847, DOI 10.1103/PhysRevLett.76.847
   Greenham N. C., 1995, SOLID STATE PHYS, V49, P1
   GREENHAM NC, 1993, NATURE, V365, P628, DOI 10.1038/365628a0
   GRIESSER H, 1998, MITTAL FESTSCHRIFT A
   GRIESSER HJ, 1991, LANGMUIR, V7, P2484, DOI 10.1021/la00059a015
   Guffond MC, 1997, LANGMUIR, V13, P5691, DOI 10.1021/la970377r
   Guo ZJ, 1998, ADV MATER, V10, P701, DOI 10.1002/(SICI)1521-4095(199806)10:9<701::AID-ADMA701>3.0.CO;2-4
   Gyoutoku A, 1997, SYNTHETIC MET, V91, P73, DOI 10.1016/S0379-6779(98)80067-2
   HADZIIOANNOU G, 1986, J AM CHEM SOC, V108, P2869, DOI 10.1021/ja00271a014
   Haliloglu T, 1997, MACROMOL THEOR SIMUL, V6, P667, DOI 10.1002/mats.1997.040060306
   HALPERIN A, 1992, ADV POLYM SCI, V100, P31
   HALPERIN A, 1991, MACROMOLECULES, V24, P5393, DOI 10.1021/ma00019a029
   Hamaguchi M, 1996, APPL PHYS LETT, V69, P143, DOI 10.1063/1.116901
   Harlev E, 1996, ADV MATER, V8, P994, DOI 10.1002/adma.19960081211
   Harrison JA, 1997, J PHYS CHEM B, V101, P9682, DOI 10.1021/jp972261+
   HAYASHI T, 1993, BIOMEDICAL APPL POLY
   HEVENS OS, 1965, OPTICAL PROPERTIES T
   Hiberer A., 1997, MACROMOL CHEM PHYS, V198, P2211
   Hide F, 1997, ACCOUNTS CHEM RES, V30, P430, DOI 10.1021/ar950191o
   Higgins J. S., 1994, POLYM NEUTRON SCATTE
   HOLMES AB, 1993, SYNTHETIC MET, V55, P4031
   Holzer L, 1999, SYNTHETIC MET, V100, P71, DOI 10.1016/S0379-6779(98)00171-4
   Hong HP, 1998, ADV MATER, V10, P1104, DOI 10.1002/(SICI)1521-4095(199810)10:14<1104::AID-ADMA1104>3.3.CO;2-6
   Horowitz G, 1998, ADV MATER, V10, P365, DOI 10.1002/(SICI)1521-4095(199803)10:5<365::AID-ADMA365>3.0.CO;2-U
   Hoyer P, 1996, ADV MATER, V8, P857, DOI 10.1002/adma.19960081022
   Hsieh BR, 1996, SYNTHETIC MET, V78, P269, DOI 10.1016/0379-6779(96)80149-4
   Hu B, 1998, SYNTHETIC MET, V92, P157, DOI 10.1016/S0379-6779(98)80105-7
   Hu B, 1998, CHEM PHYS, V227, P263, DOI 10.1016/S0301-0104(97)00306-6
   Huang SM, 1999, J MATER CHEM, V9, P1221, DOI 10.1039/a901839e
   Huang SM, 1999, J PHYS CHEM B, V103, P4223, DOI 10.1021/jp990342v
   Huang ZY, 1997, LANGMUIR, V13, P6480, DOI 10.1021/la970537z
   HUGHES AE, 1988, J ELECTRON SPECTROSC, V46, P31, DOI 10.1016/0368-2048(88)80003-3
   HUGHES DJ, 1954, NEUTRON OPTICS
   Hung LS, 1997, APPL PHYS LETT, V70, P152, DOI 10.1063/1.118344
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   IMANISHI Y, 1992, SYNTHESIS BIOCOMPOSI
   ISRAELACHVILI JN, 1992, INTERMOLECULAR SURFA
   Ito Y, 1997, J AM CHEM SOC, V119, P1619, DOI 10.1021/ja963418z
   IWAO T, 1993, MATER RES SOC S P, V290, P311
   Jabbour GE, 1997, APPL PHYS LETT, V71, P1762, DOI 10.1063/1.119392
   JACKMAN RJ, 1999, CHEMTECH         MAY, P18
   JEON H, 1992, APPL PHYS LETT, V60, P892, DOI 10.1063/1.106496
   Jirage KB, 1997, SCIENCE, V278, P655, DOI 10.1126/science.278.5338.655
   Kaner R. B., 1988, SCI AM           FEB, P106
   KAO K, 1993, P 7 INT C POL MED SU, P193
   Karg S, 1996, SYNTHETIC MET, V80, P111, DOI 10.1016/S0379-6779(96)03690-9
   Katz HE, 1997, J MATER CHEM, V7, P369, DOI 10.1039/a605274f
   Kim YE, 1996, APPL PHYS LETT, V69, P599, DOI 10.1063/1.117919
   KLEIN J, 1991, NATURE, V352, P143, DOI 10.1038/352143a0
   KLEIN J, 1994, NATURE, V370, P634, DOI 10.1038/370634a0
   Klein J., 1988, MOL CONFORMATION DYN
   KONSTADINIDIS K, 1995, J APPL PHYS, V77, P5642, DOI 10.1063/1.359206
   KOSMAS M, 1994, J PHYS II, V4, P501, DOI 10.1051/jp2:1994140
   Kraft A, 1998, ANGEW CHEM INT EDIT, V37, P402, DOI 10.1002/(SICI)1521-3773(19980302)37:4<402::AID-ANIE402>3.0.CO;2-9
   Kugler T, 1999, ACCOUNTS CHEM RES, V32, P225, DOI 10.1021/ar980041o
   Kugler T, 1999, SYNTHETIC MET, V100, P163, DOI 10.1016/S0379-6779(98)00162-3
   KUMAR A, 1994, SCIENCE, V263, P60, DOI 10.1126/science.263.5143.60
   Kusunoki M, 1997, APPL PHYS LETT, V71, P2620, DOI 10.1063/1.120158
   Kyotani T, 1996, CHEM MATER, V8, P2109, DOI 10.1021/cm960063+
   LAI PY, 1992, MACROMOLECULES, V25, P6693, DOI 10.1021/ma00050a045
   LEKNER J, 1987, THEOY REFLECTION
   LEKNER J, 1987, THEORY REFLECTION
   Leyden D.E., 1988, CHEM MODIFIED SURFAC
   Li WZ, 1996, SCIENCE, V274, P1701, DOI 10.1126/science.274.5293.1701
   LIANG WB, 1992, POLYMER, V35, P3101
   Lidzey DG, 1996, SYNTHETIC MET, V82, P141, DOI 10.1016/S0379-6779(96)03781-2
   LIN H, 1995, MACROMOLECULES, V28, P1470, DOI 10.1021/ma00109a018
   Liu J, 1999, CHEM PHYS LETT, V303, P125, DOI 10.1016/S0009-2614(99)00209-2
   Liu J, 1997, NATURE, V385, P780, DOI 10.1038/385780b0
   LOPEZ GP, 1993, LANGMUIR, V9, P1513, DOI 10.1021/la00030a015
   Lovinger AJ, 1996, J MATER RES, V11, P1581, DOI 10.1557/JMR.1996.0198
   LUCKHAM PF, 1993, ADV COLLOID INTERFAC, V44, P183, DOI 10.1016/0001-8686(93)80024-6
   MACDIARMID AG, 1995, SYNTHETIC MET, V69, P85, DOI 10.1016/0379-6779(94)02374-8
   MacDiarmid AG, 1999, SYNTHETIC MET, V100, P131, DOI 10.1016/S0379-6779(98)00164-7
   MacDiarmid AG, 1997, SYNTHETIC MET, V84, P27, DOI 10.1016/S0379-6779(97)80658-3
   MACDIARMID AG, 1996, ACS MONOGRAPH
   MANSFIELD TL, 1995, MACROMOLECULES, V28, P492, DOI 10.1021/ma00106a012
   MARCIANO Y, 1995, MACROMOLECULES, V28, P985, DOI 10.1021/ma00108a028
   Marks RN, 1997, PHILOS T R SOC A, V355, P763, DOI 10.1098/rsta.1997.0042
   Martin JI, 1996, LANGMUIR, V12, P4950, DOI 10.1021/la960305k
   MATSUDA T, 1995, LANGMUIR, V11, P2272
   MATSUDA T, 1995, LANGMUIR, V11, P2267
   MATTOUSSI H, 1993, J CHEM PHYS, V99, P9188, DOI 10.1063/1.465534
   MESSERSCHMIDT GL, 1988, J CLIN ONCOL, V6, P203, DOI 10.1200/JCO.1988.6.2.203
   MILLER JS, 1993, ADV MATER, V5, P671, DOI 10.1002/adma.19930050918
   MILLER JS, 1993, ADV MATER, V5, P587, DOI 10.1002/adma.19930050718
   MILLER JS, 1994, ANGEW CHEM INT EDIT, V33, P385, DOI 10.1002/anie.199403851
   MILLIARAS GG, 1993, ADV MATER, V10, P721
   MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905
   MILNER ST, 1988, EUROPHYS LETT, V5, P413, DOI 10.1209/0295-5075/5/5/006
   MILNER ST, 1988, MACROMOLECULES, V21, P2610, DOI 10.1021/ma00186a051
   MILNER ST, 1992, MACROMOLECULES, V25, P5495, DOI 10.1021/ma00046a057
   MISRA S, 1994, MACROMOLECULES, V27, P5037, DOI 10.1021/ma00096a028
   MISRA S, 1994, MACROMOLECULES, V27, P2058, DOI 10.1021/ma00086a013
   Mukerjee P., 1971, 36 NSRDSNBS US DEP C
   MYLNIKOV VS, 1994, ADV POLYM SCI, V115
   NAKAYAMA T, 1993, APPL PHYS LETT, V63, P594, DOI 10.1063/1.109959
   Nalwa H.S., 1997, HDB ORGANIC CONDUCTI
   NEUSCH F, 1997, ADV MATER, V9, P222
   Nguyen TP, 1995, SYNTHETIC MET, V75, P175, DOI 10.1016/0379-6779(96)80004-X
   Nguyen TP, 1996, VACUUM, V47, P1153, DOI 10.1016/0042-207X(96)00179-0
   NGUYEN TP, 1995, SYNTHETIC MET, V72, P35, DOI 10.1016/0379-6779(94)02312-M
   NguyenMisra M, 1996, MACROMOLECULES, V29, P1407, DOI 10.1021/ma950802s
   NGUYENMISRA M, 1995, MACROMOLECULES, V28, P6976, DOI 10.1021/ma00124a039
   NISHIDE H, 1995, ADV MATER, V7, P937, DOI 10.1002/adma.19950071116
   Niu CM, 1997, APPL PHYS LETT, V70, P1480, DOI 10.1063/1.118568
   Noach S, 1996, APPL PHYS LETT, V69, P3650, DOI 10.1063/1.117012
   OHKAWA K, 1991, JPN J APPL PHYS 1, V30, P3873, DOI 10.1143/JJAP.30.3873
   OKAHATA Y, 1986, MACROMOLECULES, V19, P494
   Orita K, 1997, SYNTHETIC MET, V91, P155, DOI 10.1016/S0379-6779(98)80078-7
   OSHEA SJ, 1993, LANGMUIR, V9, P1826, DOI 10.1021/la00031a034
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   Pan ZW, 1998, NATURE, V394, P631, DOI 10.1038/29206
   Park Y, 1997, PHYS REV LETT, V78, P3955, DOI 10.1103/PhysRevLett.78.3955
   PATEL S, 1989, ANNU REV PHYS CHEM, P40
   PATTIL AO, 1988, CHEM REV, V88, P183
   PAUCK T, 1995, CHEM PHYS LETT, V244, P171, DOI 10.1016/0009-2614(95)00867-4
   Pei Q, 1997, SYNTHETIC MET, V85, P1229, DOI 10.1016/S0379-6779(97)80216-0
   Pei QB, 1996, J AM CHEM SOC, V118, P3922, DOI 10.1021/ja953695q
   PEI QB, 1995, SCIENCE, V269, P1086, DOI 10.1126/science.269.5227.1086
   Penfold J, 1997, J CHEM SOC FARADAY T, V93, P3899, DOI 10.1039/a702836i
   PERKINS TT, 1995, SCIENCE, V268, P83, DOI 10.1126/science.7701345
   PLANEIX JM, 1994, J AM CHEM SOC, V116, P7935, DOI 10.1021/ja00096a076
   Poncharal P, 1999, SCIENCE, V283, P1513, DOI 10.1126/science.283.5407.1513
   Prasad P. N., 1991, FRONTIERS POLYM RES
   PRITCHARD DJ, 1995, ANGEW CHEM INT EDIT, V34, P91, DOI 10.1002/anie.199500911
   PYRAMITSYU VA, 1987, MODERN PROBLEMS PHYS
   RABIN Y, 1990, EUROPHYS LETT, V13, P49, DOI 10.1209/0295-5075/13/1/009
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   RAO CNR, 1998, J CHEM SOC CHEM COMM, V1525
   Ratner B. D., 1996, SURFACE MODIFICATION
   Ren ZF, 1998, SCIENCE, V282, P1105, DOI 10.1126/science.282.5391.1105
   RICHARDS RW, 1994, TRENDS POLYM SCI, V2, P5
   Romero DB, 1996, ADV MATER, V8, P899, DOI 10.1002/adma.19960081105
   ROTHMAN T, 1988, SCI AM           AUG, P12
   ROZSNYAI LF, 1995, LANGMUIR, V11, P3913, DOI 10.1021/la00010a048
   ROZSNYAI LF, 1994, J AM CHEM SOC, V116, P5993, DOI 10.1021/ja00092a070
   RUSSELL TP, 1991, ANNU REV MATER SCI, V21, P249
   RUSSELL TP, 1988, MACROMOLECULES, V21, P1890, DOI 10.1021/ma00184a066
   Saito R., 1998, PHYSICAL PROPERTIES
   Saito Y, 1997, JPN J APPL PHYS 2, V36, pL1340, DOI 10.1143/JJAP.36.L1340
   Salaneck W. R., 1996, CONJUGATED POLYM SUR
   Salaneck WR, 1996, ADV MATER, V8, P48, DOI 10.1002/adma.19960080108
   SARICIFTCI NS, 1994, INT J MOD PHYS B, V8, P237, DOI 10.1142/S0217979294000105
   Sarid D., 1991, SCANNING FORCE MICRO
   SAVILLE PM, 1994, J PHYS CHEM-US, V98, P5935, DOI 10.1021/j100074a020
   SCHERF U, 1999, CARBON RICH COMPOUND, V2
   SCHEUTJENS JMHM, 1979, J PHYS CHEM-US, V83, P1619, DOI 10.1021/j100475a012
   Schick M. J., 1987, NONIONIC SURFACTANTS
   SCHIERBAUM KD, 1994, SCIENCE, V265, P1413, DOI 10.1126/science.265.5177.1413
   Schmid H, 1997, APPL PHYS LETT, V70, P2679, DOI 10.1063/1.118978
   SCHMID W, 1993, ACTA POLYM, V44, P208, DOI 10.1002/actp.1993.010440407
   SCHMID W, 1996, LAMBDA HIGHLIGHTS, V42, P4
   SCHUHMANN W, 1995, BIOSENS BIOELECTRON, V10, P181, DOI 10.1016/0956-5663(95)96805-9
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   Scott JC, 1996, J APPL PHYS, V79, P2745, DOI 10.1063/1.361096
   SEIDLE P, 1995, LANGMUIR, V11, P1065
   Service RF, 1998, SCIENCE, V279, P1135
   SINGH J, 1992, J MACROMOL SCI R M C, VC32, P521, DOI 10.1080/15321799208021431
   Sinitsyn NI, 1997, APPL SURF SCI, V111, P145, DOI 10.1016/S0169-4332(96)00695-2
   Skotheim T.A, 1998, HDB CONDUCTING POLYM
   Smith DE, 1999, SCIENCE, V283, P1724, DOI 10.1126/science.283.5408.1724
   Spatz JP, 1997, MACROMOLECULES, V30, P3874, DOI 10.1021/ma9607372
   SRINIVASAN R, 1989, CHEM REV, V89, P1303, DOI 10.1021/cr00096a003
   STAMM M, 1991, EUROPHYS LETT, V14, P1441
   STAMM M, 1992, ADV POLYM SCI, V100, P419
   STUART JK, 1995, LANGMUIR, V11, P1368, DOI 10.1021/la00004a051
   STUCKY DG, 1991, ACS S SERIES, V455
   SUGAWARA T, 1994, MACROMOLECULES, V27, P7809, DOI 10.1021/ma00104a040
   Sun RG, 1996, JPN J APPL PHYS 2, V35, pL1506, DOI 10.1143/JJAP.35.L1506
   Takikawa H, 1998, JPN J APPL PHYS 2, V37, pL187, DOI 10.1143/JJAP.37.L187
   Tang H, 1997, APPL PHYS LETT, V71, P2560, DOI 10.1063/1.119325
   Tang WH, 1996, MACROMOLECULES, V29, P4412, DOI 10.1021/ma951547e
   Tans SJ, 1998, NATURE, V393, P49
   Tasch S, 1999, SYNTHETIC MET, V102, P1046, DOI 10.1016/S0379-6779(98)00229-X
   TAUNTON HJ, 1990, MACROMOLECULES, V23, P571, DOI 10.1021/ma00204a033
   TAUNTON HJ, 1988, NATURE, V332, P712, DOI 10.1038/332712a0
   Terrones M, 1997, NATURE, V388, P52, DOI 10.1038/40369
   Terrones M, 1996, PHILOS T R SOC A, V354, P2025, DOI 10.1098/rsta.1996.0090
   Terrones M, 1998, CHEM PHYS LETT, V285, P299, DOI 10.1016/S0009-2614(98)00093-1
   THAKUR M, 1988, MACROMOLECULES, V21, P661, DOI 10.1021/ma00181a021
   TOPRAKCIOGLU C, 1993, PROG COLL POL SCI S, V91, P83
   TRIPP CP, 1994, LANGMUIR, V10, P4031, DOI 10.1021/la00023a022
   Tsuruta T., 1993, BIOMEDICAL APPL POLY
   TURNBULL MM, 1996, ACS S SERIES, V644
   ULMAN A, 1990, ADV MATER, V2, P573, DOI 10.1002/adma.19900021203
   VANLENT B, 1989, MACROMOLECULES, V22, P1931, DOI 10.1021/ma00194a069
   Vargo T. G., 1995, SUPRAMOL SCI, V2, P169
   VOIVODOV K, 1993, MAKROMOL CHEM-M SYMP, V70-1, P275, DOI 10.1002/masy.19930700129
   Walls J., 1990, METHODS SURFACE ANAL
   Wang HL, 1996, SYNTHETIC MET, V80, P97, DOI 10.1016/S0379-6779(96)03688-0
   Wang HL, 1996, SYNTHETIC MET, V78, P33, DOI 10.1016/0379-6779(95)03569-6
   Wang QH, 1997, APPL PHYS LETT, V70, P3308, DOI 10.1063/1.119146
   Wang YZ, 1997, APPL PHYS LETT, V70, P3215, DOI 10.1063/1.119129
   Wang YZ, 1996, APPL PHYS LETT, V68, P894, DOI 10.1063/1.116222
   Wei PK, 1996, ADV MATER, V8, P573, DOI 10.1002/adma.19960080708
   WIJMANS CM, 1994, J COLLOID INTERF SCI, V167, P124, DOI 10.1006/jcis.1994.1340
   WILLIAMS DRM, 1993, MACROMOLECULES, V26, P5806, DOI 10.1021/ma00073a040
   WILLIAMS EW, 1987, LUMINESCENCE LIGHT E
   Winkler B, 1999, CHEM MATER, V11, P704, DOI 10.1021/cm980570m
   WINKLER B, 2000, PHYS CHEM CHEM PHYS, V2, P29
   Wirth MJ, 1997, SCIENCE, V275, P44, DOI 10.1126/science.275.5296.44
   Wong SS, 1998, NATURE, V394, P52
   Wong SS, 1998, J AM CHEM SOC, V120, P603, DOI 10.1021/ja9737735
   Wu CC, 1997, APPL PHYS LETT, V70, P1348, DOI 10.1063/1.118575
   XU X, 1995, P INT WORKSH EL EL 9
   Yakobson BI, 1997, AM SCI, V85, P324
   YAKOBSON BI, 1997, AM SCI, V85, P325
   YAMAKAWA H, 1971, MODERN THEORY POLYM
   YAN M, 1995, PHYS REV LETT, V75, P1992, DOI 10.1103/PhysRevLett.75.1992
   YANG Y, 1994, MOL CRYST LIQ CRYS A, V256, P537, DOI 10.1080/10587259408039288
   YANG Y, 1994, NATURE, V372, P344, DOI 10.1038/372344a0
   Yang Y, 1996, APPL PHYS LETT, V68, P2708, DOI 10.1063/1.116316
   Yang YY, 1999, J AM CHEM SOC, V121, P10832, DOI 10.1021/ja992945q
   YANG Z, 1995, MACROMOLECULES, V28, P6151, DOI 10.1021/ma00122a023
   YANG Z, 1993, MACROMOLECULES, V26, P6570, DOI 10.1021/ma00076a040
   Yang Z, 1998, J MACROMOL SCI PURE, VA35, P233, DOI 10.1080/10601329808001975
   YANG Z, 1993, MACROMOLECULES, V26, P1188, DOI 10.1021/ma00057a047
   YANG Z, 1997, MACROMOL S, V83, P83
   Yasuda H., 1985, PLASMA POLYM
   Yoshida M, 1996, APPL PHYS LETT, V69, P734, DOI 10.1063/1.117874
   Yoshida M, 1996, JPN J APPL PHYS 2, V35, pL397, DOI 10.1143/JJAP.35.L397
   ZHAO W, 1994, MACROMOLECULES, V27, P2933, DOI 10.1021/ma00089a007
   Zhulina E, 1996, MACROMOLECULES, V29, P2667, DOI 10.1021/ma951396f
   ZYSS J, 1987, NONLINEAR OPTICAL PR
   1992, CHEM ENG NEWS    JUL, P4
   1998, CHEM ENG NEWS   0612
   1988, NEW SCI         0728, P39
NR 340
TC 49
Z9 50
U1 1
U2 22
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1089-5647
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD MAR 9
PY 2000
VL 104
IS 9
BP 1891
EP 1915
DI 10.1021/jp9926793
PG 25
WC Chemistry, Physical
SC Chemistry
GA 291ZT
UT WOS:000085770200002
DA 2018-10-20
ER

PT J
AU Tapia, A
   Mejina, D
   Rengifo, M
   Blanch, A
   Ferreira, B
AF Tapia, A
   Mejina, D
   Rengifo, M
   Blanch, A
   Ferreira, B
TI Improving the aesthetics of the cheek bone projection during facial
   lifting
SO AESTHETIC PLASTIC SURGERY
LA English
DT Article
DE zygomatic prominence; rhytidectomy; facelift; SMAS; nasogenian fold
ID MALAR; RHYTIDECTOMY; AUGMENTATION; IMPLANTS; FACE
AB This paper shows how one of the flaps of the SMAS, which is normally eliminated during a facelift as excess tissue, can be folded up and used to improve the projection of cheekbone. The improvement of the projection of this facial area enhances the aesthetic result, when the desired aesthetic result is discreet, in rhytidectomy without having to resort to biomedical material or complex surgical techniques. Our technique, which is safe and easy to handle, simplifies this procedure, providing a long-lasting satisfactory result for both the patient and the surgeon. Our report was done following rhytidectomy on 126 female patients and after an approximately 3-year follow-up.
RP Tapia, A (reprint author), C Balmes 203,4 2A, Barcelona 08006, Spain.
CR Bonnefon A, 1995, Ann Chir Plast Esthet, V40, P327
   FURNAS DW, 1989, PLAST RECONSTR SURG, V83, P11, DOI 10.1097/00006534-198901000-00003
   GONZALEZULLOA M, 1974, PLAST RECONSTR SURG, V53, P293, DOI 10.1097/00006534-197403000-00007
   HAMRA ST, 1990, PLAST RECONSTR SURG, V86, P53, DOI 10.1097/00006534-199007000-00008
   HINDERER UT, 1975, PLAST RECONSTR SURG, V56, P157, DOI 10.1097/00006534-197508000-00007
   JOST G, 1984, PLAST RECONSTR SURG, V74, P42, DOI 10.1097/00006534-198407000-00006
   MITZ V, 1986, ANN PLAS SURG, V17, P184, DOI 10.1097/00000637-198609000-00004
   MOLE B, 1992, PLAST RECONSTR SURG, V90, P200, DOI 10.1097/00006534-199290020-00007
   OWSLEY JQ, 1993, RECONSTR SURG, V91, P464
   PERPERE C H, 1992, Annales de Chirurgie Plastique et Esthetique, V37, P95
   SIEMIAN WR, 1988, PLAST RECONSTR SURG, V82, P395, DOI 10.1097/00006534-198809000-00003
   STUZIN JM, 1992, PLAST RECONSTR SURG, V89, P441, DOI 10.1097/00006534-199203000-00007
   STUZIN JM, 1990, ANN M AM SOC AESTH P
   TAPIA A, 1992, 10 C INT CONF PLAST, V1, P475
   TAPIA A, 1993, AESTH PLAST SURG
   TAPIA A, 1999, IN PRESS PLAST RECON
   WHITAKER LA, 1987, PLAST RECONSTR SURG, V80, P337, DOI 10.1097/00006534-198709000-00001
   WILKINSON TS, 1983, PLAST RECONSTR SURG, V71, P643, DOI 10.1097/00006534-198305000-00011
NR 18
TC 4
Z9 4
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0364-216X
J9 AESTHET PLAST SURG
JI Aesthet. Plast. Surg.
PD MAR-APR
PY 2000
VL 24
IS 2
BP 85
EP 89
DI 10.1007/s002660010016
PG 5
WC Surgery
SC Surgery
GA 311VY
UT WOS:000086907600001
PM 10833230
DA 2018-10-20
ER

PT J
AU Wu, JZ
   Herzog, W
AF Wu, JZ
   Herzog, W
TI Finite element simulation of location- and time-dependent mechanical
   behavior of chondrocytes in unconfined compression tests
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE biphasic; poroelastic; cartilage; finite element analysis; cell
   mechanics; tissue growth; adaptation
ID BOVINE ARTICULAR-CARTILAGE; LOCAL TISSUE STRAIN; DIFFERENTIAL SCHEME;
   AGAROSE CULTURE; DEFORMATION; MATRIX; BIOSYNTHESIS; MODULI
AB Experimental evidence suggests that cells are extremely sensitive to their mechanical environment and react directly to mechanical stimuli. At present, it is technically difficult to measure fluid pressure, stress, and strain in cells, and to determine the time-dependent deformation of chondrocytes. For this reason, there are no data in the published Literature that show the dynamic behavior of chondrocytes in articular cartilage. Similarly, the dynamic chondrocyte mechanics have not been calculated using theoretical models that account for the influence of cell volumetric fraction on cartilage mechanical properties. In the present investigation, the location- and time-dependent stress-strain state and fluid pressure distribution in chondrocytes in unconfined compression tests were simulated numerically using a finite element method. The technique involved two basic steps: first, cartilage was approximated as a macroscopically homogenized material and the mechanical behavior of cartilage was obtained using the homogenized model; second, the solution of the time-dependent displacements and fluid pressure fields of the homogenized model was used as the time-dependent boundary conditions for a microscopic submodel to obtain average location- and time-dependent mechanical behavior of cells. Cells and extracellular matrix were assumed to be biphasic materials composed of a fluid phase and a hyperelastic solid phase. The hydraulic permeability was assumed to be deformation dependent and the analysis was performed using a finite deformation approach. Numerical tests were made using configurations similar to those of experiments described in the literature. Our simulations show that the mechanical response of chondrocytes to cartilage loading depends on time, fluid boundary conditions, and the locations of the cells within the specimen. The present results are the first to suggest that chondrocyte deformation in a stress-relaxation type test may exceed the imposed system deformation by a factor of 3-4, that chondrocyte deformations are highly dynamic and do not reach a steady state within about 20 min of steady compression (in an unconfirmed test), and that cell deformations are very much location dependent. (C) 2000 Biomedical Engineering Society [S0090694(00)00303-3].
C1 Univ Calgary, Fac Kinesiol, Human Performance Lab, Dept Mech Engn, Calgary, AB T2N 1N4, Canada.
RP Herzog, W (reprint author), Univ Calgary, Fac Kinesiol, Human Performance Lab, Dept Mech Engn, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.
CR Ateshian GA, 1997, J BIOMECH, V30, P1157, DOI 10.1016/S0021-9290(97)85606-0
   ATHANASIOU KA, 1991, J ORTHOP RES, V9, P330, DOI 10.1002/jor.1100090304
   Bachrach NM, 1995, J BIOMECH, V28, P1561, DOI 10.1016/0021-9290(95)00103-4
   BUSCHMANN MD, 1995, J CELL SCI, V108, P1497
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Christensen R. M., 1991, MECH COMPOSITE MAT
   CLARK AL, 1999, P 17 C INT SOC BIOM, P339
   ESHELBY JD, 1956, SOLID STATE PHYS, V3, P79
   Glanz J, 1997, SCIENCE, V276, P678
   GRAY ML, 1988, J ORTHOPAED RES, V6, P777, DOI 10.1002/jor.1100060602
   Guilak F, 1995, J BIOMECH, V28, P1529, DOI 10.1016/0021-9290(95)00100-X
   GUILAK F, 1995, J ORTHOP RES, V13, P410, DOI 10.1002/jor.1100130315
   GUILAK F, 1992, ADV BIOENG, V22, P21
   HASHIN Z, 1962, J APPL PHYS, V33, P3125, DOI 10.1063/1.1728579
   HOLMES MH, 1990, J BIOMECH, V23, P1145, DOI 10.1016/0021-9290(90)90007-P
   HOLMES MH, 1986, J BIOMECH ENG-T ASME, V108, P372, DOI 10.1115/1.3138633
   HOU JS, 1989, J BIOMECH ENG-T ASME, V111, P78, DOI 10.1115/1.3168343
   *IMSL, 1990, US MAN IMSL MATH LIB, pCH5
   Jones WR, 1997, T ORTHOPAEDIC RES SO, V22, P199
   LAI WM, 1981, J BIOMECH ENG-T ASME, V103, P61, DOI 10.1115/1.3138261
   MCLAUGHLIN R, 1977, INT J ENG SCI, V15, P237, DOI 10.1016/0020-7225(77)90058-1
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   MOW VC, 1994, CELL MECHANICS AND CELLULAR ENGINEERING, P345
   NORRIS AN, 1985, MECH MATER, V4, P1, DOI 10.1016/0167-6636(85)90002-X
   SAAMANEN AM, 1987, CONNECT TISSUE RES, V16, P163, DOI 10.3109/03008208709002004
   SAH RLY, 1991, ARTICULAR CARTILAGE, P373
   Schinagl RM, 1997, J ORTHOPAED RES, V15, P499, DOI 10.1002/jor.1100150404
   SCHNEIDERMAN R, 1986, J ORTHOPAED RES, V4, P393, DOI 10.1002/jor.1100040402
   Shin D, 1997, T ORTHOPAEDIC RES SO, V22, P352
   Stockwell RA., 1979, BIOL CARTILAGE CELLS
   Torzilli PA, 1997, J BIOMECH, V30, P1, DOI 10.1016/S0021-9290(96)00117-0
   Wong M, 1997, J ORTHOPAED RES, V15, P189, DOI 10.1002/jor.1100150206
   Wu JZ, 1998, J BIOMECH, V31, P165
   Wu JZ, 1999, J BIOMECH, V32, P563, DOI 10.1016/S0021-9290(99)00034-2
   ZIMMERMAN RW, 1991, MECH MATER, V12, P17, DOI 10.1016/0167-6636(91)90049-6
NR 35
TC 78
Z9 80
U1 0
U2 5
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2000
VL 28
IS 3
BP 318
EP 330
DI 10.1114/1.271
PG 13
WC Engineering, Biomedical
SC Engineering
GA 316EA
UT WOS:000087153600010
PM 10784096
DA 2018-10-20
ER

PT J
AU de Lima, CJ
   Sathaiah, S
   Silveira, L
   Zangaro, RA
   Pacheco, MTT
AF de Lima, CJ
   Sathaiah, S
   Silveira, L
   Zangaro, RA
   Pacheco, MTT
TI Development of catheters with low fiber background signals for Raman
   spectroscopic diagnosis applications
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 1st Latin American Congress for Artificial Organs and Biomaterials
CY DEC 10-13, 1998
CL BELO HORIZONT, BRAZIL
SP Int Soc Artificial Organs, Financier Studies & Projects, Fdn Res Support St Minas Gerais, Fed Univ Minas Gerais, Brizilian Inst Biomat
DE multifiber catheters; fiber optics
ID FLUORESCENCE; SYSTEM
AB Utilization of optical-fiber catheters can turn the Raman spectroscopy system into a powerful remote biomedical diagnostic probe. An in vivo (a qualitative and a quantitative) biochemical diagnosis of biotissues is possible by developing the Raman-fiber probes with a good flexibility and less background signals generated in the probes themselves. Considering the isotropic nature of Raman scattering, the amount of Raman signal guided through the fiber is expected to depend on the numerical aperture (NA) of the fiber. To study the dependence for catheter probes experimentally, various flexible probes (with small diameter fibers) with different combinations of numerical apertures and with different assembling materials (biocompatible) have been developed. The catheter probes have been characterized by collecting the near infrared excited Raman scattered light from cholesterol powder. The results demonstrate that the catheters with a combination of lower NA (0.12) fibers used for laser excitation and relatively higher NA (0.22) fibers for Raman signal collection will have lower background signals generated in the probes. Furthermore, the catheters with a black Teflon tubing cover and black epoxy resin adhesives were found to give better results.
C1 UNIVAP, Inst Pesquisas & Desenvolvimento, BR-12244400 Sao Jose Dos Campos, Brazil.
RP Zangaro, RA (reprint author), UNIVAP, Inst Pesquisas & Desenvolvimento, Av Shishima Hifumi 2911, BR-12244400 Sao Jose Dos Campos, Brazil.
RI Silveira, Landulfo/I-2474-2012; Pacheco, Marcos/B-7991-2012
OI Silveira, Landulfo/0000-0002-6616-3334; Pacheco,
   Marcos/0000-0002-1725-4803
CR ARCHIBALD DD, 1988, APPL SPECTROSC, V42, P1558, DOI 10.1366/0003702884429643
   BRENNAN JF, 1993, APPL SPECTROSC, V47, P2081, DOI 10.1366/0003702934066505
   CHAVANTES MC, 1998, VATS 97 4 INT S THOR, P89
   CHAVANTES MC, 1996, LASER SURG MED, V8, P1
   CHONG CK, 1992, VIB SPECTROSC, V3, P35
   DALY JC, 1984, FIBER OPTICS, V3, P70
   GILMORE DA, 1995, APPL SPECTROSC, V49, P508, DOI 10.1366/0003702953964390
   GIOZZA WF, 1991, FIBRAS OPTICAS TECHN
   HOYT CC, 1988, LASER SURG MED, V8, P1, DOI 10.1002/lsm.1900080104
   IAN RL, 1996, APPL SPEC, V50, pA12
   SATHAIAH S, 1996, P INT C RAM SPECTR U, V15, P1120
   SCHWAB SD, 1984, ANAL CHEM, V56, P2199, DOI 10.1021/ac00276a049
   Zangaro RA, 1996, APPL OPTICS, V35, P5211, DOI 10.1364/AO.35.005211
NR 13
TC 17
Z9 17
U1 0
U2 2
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD MAR
PY 2000
VL 24
IS 3
BP 231
EP 234
DI 10.1046/j.1525-1594.2000.06525.x
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 300GL
UT WOS:000086244500016
PM 10759647
DA 2018-10-20
ER

PT J
AU Schroeder, A
   Francz, G
   Bruinink, A
   Hauert, R
   Mayer, J
   Wintermantel, E
AF Schroeder, A
   Francz, G
   Bruinink, A
   Hauert, R
   Mayer, J
   Wintermantel, E
TI Titanium containing amorphous hydrogenated carbon films (a-C : H/Ti):
   surface analysis and evaluation of cellular reactions using bone marrow
   cell cultures in vitro
SO BIOMATERIALS
LA English
DT Article
DE a-C : H; bone; culture; titanium
ID DIAMOND-LIKE CARBON; IN-VITRO; STROMAL CELLS; COATINGS; IMPLANTS; WEAR;
   BIOCOMPATIBILITY; MACROPHAGES; PHOSPHATASE; RESORPTION
AB Amorphous hydrogenated carbon (a-C:H) coatings, also called diamond-like carbon (DLC), have many properties required for a protective coating material in biomedical applications. The purpose of this study is to evaluate a new surface coating for bone-related implants by combining the hardness and inertness of a-C : H films with the biological acceptance of titanium. For this purpose, different amounts of titanium were incorporated into a-C:H films by a combined radio frequency (rf) and magnetron sputtering set-up. The X-ray photoelectron spectroscopy (XPS) of air-exposed a-C:H/titanium (a-C:H/Ti) films revealed that the films were composed of TiO2 and TiC embedded in and connected to an a-C:H matrix. Cell culture tests using primary adult rat bone marrow cell cultures (BMC) were performed to determine effects on cell number and on osteoblast and osteoclast differentiation, By adding titanium to the carbon matrix, cellular reactions such as increased proliferation and reduced osteoclast-like cell activity could be obtained, while these reactions were not seen on pure a-C :H films and on glass control samples. In summary, a-C:H/Ti could be a valuable coating for bone implants, by supporting bone cell proliferation while reducing osteoclast-like cell activation. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Swiss Fed Inst Technol, Chair Biocompat Mat Sci & Engn, CH-8952 Zurich, Switzerland.
   EMPA, Swiss Fed Labs Mat Testing & Res, Dubendorf, Switzerland.
RP Wintermantel, E (reprint author), Swiss Fed Inst Technol, Chair Biocompat Mat Sci & Engn, Wagistr 23, CH-8952 Zurich, Switzerland.
OI Hauert, Roland/0000-0001-6154-9337
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Allen Matthew, 1994, Clinical Materials, V17, P1, DOI 10.1016/0267-6605(94)90041-8
   Betts F, 1992, Clin Orthop Relat Res, P75
   BOAYN B, 1996, BIOMATERIALS, V17, P137
   BODO P, 1988, J VAC SCI TECHNOL A, V6, P2396, DOI 10.1116/1.575562
   Bruinink A, 1992, BRAIN BITS PIECES, P23
   BUTTER R, 1995, DIAM RELAT MATER, V4, P857, DOI 10.1016/0925-9635(94)05280-8
   Butter R. S., 1995, Journal of Chemical Vapor Deposition, V3, P182
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   Dearnaley G., 1993, Clinical Materials, V12, P237, DOI 10.1016/0267-6605(93)90078-L
   Dowling DP, 1997, DIAM RELAT MATER, V6, P390, DOI 10.1016/S0925-9635(96)00687-5
   Du C, 1998, BIOMATERIALS, V19, P651, DOI 10.1016/S0142-9612(97)00159-2
   Firkins P, 1998, J MATER SCI-MATER M, V9, P597, DOI 10.1023/A:1008917727604
   Francz G, 1999, SURF INTERFACE ANAL, V28, P3, DOI 10.1002/(SICI)1096-9918(199908)28:1<3::AID-SIA609>3.0.CO;2-U
   FratzlZelman N, 1997, BONE, V20, P225, DOI 10.1016/S8756-3282(96)00367-5
   GOODMAN SB, 1993, BIOMATERIALS, V14, P522, DOI 10.1016/0142-9612(93)90241-S
   Lu Luo, 1993, Bio-Medical Materials and Engineering, V3, P223
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   McColl I. R., 1994, T IMF, V<bold>72</bold>, P120, DOI 10.1080/00202967.1994.11871035
   MCCOLL IR, 1994, DIAM RELAT MATER, V3, P83, DOI 10.1016/0925-9635(94)90035-3
   MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252
   MITURA E, 1994, DIAM RELAT MATER, V3, P896, DOI 10.1016/0925-9635(94)90295-X
   MIYOSHI K, 1989, MATER SCI FORUM, V52, P645
   Moulder J.F., 1992, HDB XRAY PHOTOELECTR, P213
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   Nichols KG, 1997, J BIOMED MATER RES, V35, P265
   OLBORSKA A, 1994, DIAM RELAT MATER, V3, P899, DOI 10.1016/0925-9635(94)90296-8
   RAGO R, 1990, ANAL BIOCHEM, V191, P31
   RAMQVIST L, 1969, J PHYS CHEM SOLIDS, V30, P1835, DOI 10.1016/0022-3697(69)90252-2
   Scheven BAA, 1997, BIOCHEM BIOPH RES CO, V231, P231, DOI 10.1006/bbrc.1996.6040
   SCHIER V, 1993, FRESEN J ANAL CHEM, V346, P227, DOI 10.1007/BF00321420
   SIMON D, 1976, J MICROSC SPECT ELEC, V1, P175
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   Thompson GJ, 1996, BIOMATERIALS, V17, P1949, DOI 10.1016/0142-9612(96)00009-9
   THOMPSON GJ, 1995, J APPL BIOMATER, V6, P249, DOI 10.1002/jab.770060406
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326
   WAGNER CD, 1980, ANAL CHEM, V52, P1445, DOI 10.1021/ac50059a017
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
NR 40
TC 123
Z9 124
U1 1
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2000
VL 21
IS 5
BP 449
EP 456
DI 10.1016/S0142-9612(99)00135-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 280YN
UT WOS:000085131500003
PM 10674809
DA 2018-10-20
ER

PT J
AU Rheinlander, T
   Kotitz, R
   Weitschies, W
   Semmler, W
AF Rheinlander, T
   Kotitz, R
   Weitschies, W
   Semmler, W
TI Different methods for the fractionation of magnetic fluids
SO COLLOID AND POLYMER SCIENCE
LA English
DT Article
DE magnetic fluids; magnetic nanoparticles; magnetic fractionation;
   size-exclusion chromatography; magnetic relaxation
ID SUPERPARAMAGNETIC IRON-OXIDE; PARTICLES; SIZE
AB Magnetic fluids are used in many fields of application, such as material separation and biomedicine. Magnetic fluids consist of magnetic nanoparticles, which commonly display a broad distribution of magnetic and nonmagnetic parameters. Therefore, upon application only a small number of particles contribute to the desired magnetic effect. In order to optimize magnetic fluids for applications preference is given to methods that separate magnetic nanoparticles according to their magnetic properties. Hence, a magnetic method was developed for the fractionation of magnetic fluids. Familiar size-exclusion chromatography of two different magnetic fluids was carried out for comparison. The fractions obtained and the original samples were also magnetically characterized by magnetic resonance and magnetorelaxometry, two biomedical applications. The size-exclusion fractions are similar to those of magnetic fractionation, despite the different separation mechanisms. In this respect, magnetic fractionation has several advantages in practical use over size-exclusion chromatography: the magnetic method is faster and has a higher capacity. The fractions obtained by both methods show distinctly different magnetic properties compared to the original samples and are therefore especially suited for applications such as magnetorelaxometry.
C1 Free Univ Berlin, Inst Diagnost Forsch GmbH, D-14050 Berlin, Germany.
   Univ Greifswald, Inst Pharm, D-17487 Greifswald, Germany.
RP Rheinlander, T (reprint author), Free Univ Berlin, Inst Diagnost Forsch GmbH, Spandauer Damm 130, D-14050 Berlin, Germany.
CR FRIJA G, 1994, INVEST RADIOL, V29, pS75, DOI 10.1097/00004424-199406001-00025
   HASEGAWA S, 1987, FISH PHYSIOL BIOCHEM, V4, P101, DOI 10.1007/BF02044319
   KIRPOTIN D, Patent No. 5411730
   KOCH H, 1991, IEEE T MAGN, V27, P2793, DOI 10.1109/20.133788
   LEWIS JM, 1990, Patent No. 01899
   MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203
   MULLER RN, 1991, MAGNET RESON MED, V22, P178, DOI 10.1002/mrm.1910220203
   Neel L., 1949, ANN GEOPHYS, V5, P99
   NUNES AC, 1989, J MAGN MAGN MATER, V78, P241, DOI 10.1016/0304-8853(89)90274-6
   OGRADY K, 1986, IEEE T MAGN, V22, P1134, DOI 10.1109/TMAG.1986.1064450
   RHEINLANDER T, 1999, IEEE T MAGN, V35, P40551
   Sjogren CE, 1997, MAGN RESON IMAGING, V15, P55, DOI 10.1016/S0730-725X(96)00335-9
   Stierstadt K., 1990, Physikalische Blaetter, V46, P377
   WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474
   Weitschies W., 1997, Pharmaceutical and Pharmacological Letters, V7, P5
   1992, Patent No. 5160725
NR 16
TC 12
Z9 12
U1 0
U2 3
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0303-402X
J9 COLLOID POLYM SCI
JI Colloid Polym. Sci.
PD MAR
PY 2000
VL 278
IS 3
BP 259
EP 263
DI 10.1007/s003960050041
PG 5
WC Chemistry, Physical; Polymer Science
SC Chemistry; Polymer Science
GA 295CT
UT WOS:000085949500011
DA 2018-10-20
ER

PT J
AU Ellertson, C
   Shochet, T
   Blanchard, K
   Trussell, J
AF Ellertson, C
   Shochet, T
   Blanchard, K
   Trussell, J
TI Emergency contraception: A review of the programmatic and social science
   literature
SO CONTRACEPTION
LA English
DT Review
DE emergency contraception; delivery of health care; contraceptives;
   postcoital
ID POSTCOITAL CONTRACEPTION; WOMENS KNOWLEDGE; GENERAL-PRACTICE; YUZPE
   REGIMEN; REQUESTING TERMINATION; TEENAGERS KNOWLEDGE; PILLS; PREGNANCY;
   ATTITUDES; POPULATION
AB Many biomedical aspects of emergency contraception have been investigated and documented for >30 years now. A large number of social science questions, however, remain to be answered. In this article, WE review the rapidly growing but geographically lopsided literature on this topic. Using computer database searches supplemented by reference reviews and professional correspondence with those active iu the field, we gathered literature on the social science and service delivery aspects Of emergency contraception published in English zip through December 1998, as well as a few unpublished papers from the same time and slightly later, representing regions where published material is practically nonexistent. Methodologically acceptable papers are summarized in our tables and text, and form the basis for suggested improvements in existing emergency contraceptive services, The review also offers ideas for designing new emergency contraception services where they do not yet exist. WE conclude by proposing an agenda for further social science research in this area. CONTRACEPTION 2000;61:145-186 (C) 2000 Elsevier Science Inc. All rights reserved.
C1 Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA.
   Col Villa Coyoacan, Populat Council, Mexico City, DF, Mexico.
   Populat Council, Johannesburg, South Africa.
RP Trussell, J (reprint author), Princeton Univ, Off Populat Res, 21 Prospect Ave, Princeton, NJ 08544 USA.
EM trussell@princeton.edu
CR Adinma J. I. B., 1993, Advances in Contraception, V9, P341, DOI 10.1007/BF01983213
   AHMED Y, 1999, SETTING NEW AGENDA R
   *AM COLL OBST GYN, 1996, EM OR CONTR ACOG PRA
   Bako A. U., 1998, Journal of Obstetrics and Gynaecology (Abingdon), V18, P151
   BIRD ST, 1998, J AM MED WOMENS A S2, V53, P262
   Blanchard K, 1998, J Am Med Womens Assoc (1972), V53, P238
   BRACKEN MB, 1990, OBSTET GYNECOL, V76, P552
   Breitbart V, 1998, J Am Med Womens Assoc (1972), V53, P255
   BREITBART V, 1998, J AM MED WOM ASS S2, V53, P265
   BROMHAM DR, 1993, BRIT MED J, V306, P556, DOI 10.1136/bmj.306.6877.556
   Brown JW, 1998, AM J PUBLIC HEALTH, V88, P1380, DOI 10.2105/AJPH.88.9.1380
   Bullock J, 1997, Community Nurse, V3, P28
   BURTON R, 1990, BR J FAM PLANN, V15, P119
   Camp S I, 1998, J Am Med Womens Assoc (1972), V53, P225
   CAMP SL, 1994, STUDY TOUR REPORT EM
   Cheng YM, 1997, CONTRACEPTION, V55, P15
   CHRISTENSEN A, 1995, PLANN PARENTHOOD EUR, V24, P18
   Cohall A T, 1998, J Am Med Womens Assoc (1972), V53, P258
   Crosier A, 1996, BRIT J FAM PLAN, V22, P87
   Crosier A., 1997, EMERGENCY CONTRACEPT
   Delbanco S F, 1998, J Am Med Womens Assoc (1972), V53, P242
   Delbanco SF, 1998, ARCH PEDIAT ADOL MED, V152, P727
   Delbanco SF, 1997, OBSTET GYNECOL, V89, P1006, DOI 10.1016/S0029-7844(97)00142-7
   DUNCAN G, 1990, BRIT J FAM PLANN, V15, P112
   Ellertson C, 1998, J Am Med Womens Assoc (1972), V53, P226
   ELLERTSON C, 1997, CONT OB GYN, V42, P102
   Ellertson C., 1998, J AM MED WOM ASS S2, V53, P232
   *FOOD DRUG ADM, 1997, FED REGISTER, V62, P8610
   Galvao L, 1999, INT FAM PLAN PERSPEC, V25, P168, DOI 10.2307/2991880
   Gbolade BA, 1996, BRIT J FAM PLAN, V22, P120
   GEORGE J, 1994, BRIT J GEN PRACT, V44, P451
   Glasier A, 1998, NEW ENGL J MED, V339, P1, DOI 10.1056/NEJM199807023390101
   Glasier A, 1996, FAM PLANN PERSPECT, V28, P49, DOI 10.2307/2136123
   Glasier A, 1998, J Am Med Womens Assoc (1972), V53, P219
   Glasier A, 1996, INT FAM PLAN PERSPEC, V22, P57, DOI 10.2307/2950732
   Gold MA, 1997, FAM PLANN PERSPECT, V29, P15, DOI 10.2307/2953348
   Gooder P, 1996, BRIT J FAM PLAN, V22, P81
   Goodyear L, 1998, J Am Med Womens Assoc (1972), V53, P266
   GORDON AF, 1998, J OBSTET GYNAECOL, V18, P93
   Graham A, 1996, BRIT MED J, V312, P1567, DOI 10.1136/bmj.312.7046.1567
   Griffiths M, 1990, BRIT J FAM PLANN, V16, P16
   GROU F, 1994, AM J OBSTET GYNECOL, V171, P1529, DOI 10.1016/0002-9378(94)90396-4
   Harper C, 1995, Fam Plann Perspect, V27, P149, DOI 10.2307/2136258
   HARPER CC, 1995, AM J OBSTET GYNECOL, V173, P1438, DOI 10.1016/0002-9378(95)90630-4
   HOUGHTON A, 1994, BRIT J FAM PLAN, V20, P69
   Hughes H, 1996, BRIT J FAM PLAN, V22, P77
   Hutchings J, 1998, J Am Med Womens Assoc (1972), V53, P230
   *INT PLANN PAR FED, 1994, IPPF MED B, V28, P1
   JOHNSTON TA, 1985, BRIT MED J, V290, P1040, DOI 10.1136/bmj.290.6474.1040-a
   Kishen M, 1996, BRIT J FAM PLAN, V22, P25
   Kosunen E, 1997, CONTRACEPTION, V55, P153, DOI 10.1016/S0010-7824(97)00022-X
   Lahteenmaki P, 1995, Plan Parent Eur, V24, P13
   Langer A, 1999, CONTRACEPTION, V60, P233, DOI 10.1016/S0010-7824(99)00088-8
   Lewis C, 1996, BRIT J FAM PLAN, V22, P16
   Lewis C, 1996, BRIT J FAM PLAN, V22, P52
   LING WY, 1979, FERTIL STERIL, V32, P297
   Little P, 1998, BRIT MED J, V316, P1948, DOI 10.1136/bmj.316.7149.1948
   Maxwell M, 1996, BRIT J FAM PLAN, V22, P79
   Muia E, 1999, CONTRACEPTION, V60, P223, DOI 10.1016/S0010-7824(99)00089-X
   MUIA E, 1998, J OBSTET GYNAECOL E, V14, P25
   Nanthakumaran H, 1998, INT J STD AIDS, V9, P48, DOI 10.1258/0956462981920865
   Ngoc NTN, 1997, INT FAM PLAN PERSPEC, V23, P68, DOI 10.2307/2950826
   ni Riain A, 1998, Eur J Contracept Reprod Health Care, V3, P124
   Olaitan A, 1996, BRIT J FAM PLAN, V22, P127
   Pappenheim K, 1995, Plan Parent Eur, V24, P20
   PEARSON VAH, 1995, BRIT MED J, V310, P1644, DOI 10.1136/bmj.310.6995.1644
   PERCIVALSMITH RKL, 1988, CONTRACEPTION, V37, P425, DOI 10.1016/0010-7824(88)90119-9
   PEREZ MR, 1995, PLANN PARENTHOOD EUR, V24, P11
   Petitti D B, 1998, J Am Med Womens Assoc (1972), V53, P251
   Piaggio G, 1999, LANCET, V353, P721, DOI 10.1016/S0140-6736(98)05718-3
   Price SJ, 1997, PUBLIC HEALTH, V111, P377
   Priddy A, 1996, BRIT J FAM PLAN, V21, P139
   Pyett PM, 1996, AUST NZ J OBSTET GYN, V36, P347, DOI 10.1111/j.1479-828X.1996.tb02726.x
   Renne E.P., 1998, REPROD HEALTH MATTER, V6, P107
   ROBERTS RN, 1995, BRIT J FAM PLAN, V21, P22
   Rogala C, 1995, Plan Parent Eur, V24, P15
   Rowlands S, 1998, J ROY SOC MED, V91, P297, DOI 10.1177/014107689809100603
   ROWLANDS S, 1991, BR J FAM PLANN, V17, P23
   Rutgers RAK, 1998, S AFR MED J, V88, P143
   Sawyer RG, 1996, J AM COLL HEALTH, V44, P139, DOI 10.1080/07448481.1996.9937520
   Sawyer RG, 1996, J AM COLL HEALTH, V44, P145, DOI 10.1080/07448481.1996.9937521
   Schilling L H, 1984, J Am Coll Health, V32, P244
   Seamark CJ, 1997, J ROY SOC MED, V90, P443, DOI 10.1177/014107689709000807
   Senanayake P, 1996, INT FAM PLAN PERSPEC, V22, P69, DOI 10.2307/2950735
   Simmonte M, 1996, BRIT J FAM PLAN, V22, P139
   Skibiak J, 1999, TESTING STRATEGIES I
   Skolnick AA, 1997, JAMA-J AM MED ASSOC, V278, P101, DOI 10.1001/jama.278.2.101
   Smith BH, 1996, BRIT J OBSTET GYNAEC, V103, P1109, DOI 10.1111/j.1471-0528.1996.tb09592.x
   SMITH LFP, 1995, BRIT J GEN PRACT, V45, P409
   Society for Family Health, 1998, EM CONTR NIG
   Stevenson J, 1996, BRIT J FAM PLAN, V22, P75
   Swahn ML, 1996, ACTA OBSTET GYN SCAN, V75, P738, DOI 10.3109/00016349609065738
   THOMPSON E, 1994, BR J FAM PLANN, V19, P278
   *TOR DEP HLTH, 1996, UPD EM CONTR CAMP
   TRUSSELL J, 1992, FAM PLANN PERSPECT, V24, P269, DOI 10.2307/2135857
   Trussell J, 1998, J Am Med Womens Assoc (1972), V53, P247
   Trussell J, 1999, OBSTET GYNECOL, V93, P872, DOI 10.1016/S0029-7844(98)00380-9
   Trussell J, 1998, CONTRACEPTION, V57, P363, DOI 10.1016/S0010-7824(98)00042-0
   Trussell J, 1995, FERTILITY CONTROL RE, V4, P8
   Tyden T, 1998, ADV CONTRACEPT, V14, P171, DOI 10.1023/A:1006604214517
   *UK FAM PLANN RES, 1993, BR J FAM PLANN, V19, P218
   VAUGHAN B, 1998, UNPUB TABULATIONS 19
   VERNON R, 1997, EMERGENCY CONTRACEPT
   WALSH J, 1995, BRIT J FAM PLAN, V20, P121
   Walsh J, 1996, BRIT J FAM PLAN, V22, P27
   Webb A., 1993, Advances in Contraception, V9, P75, DOI 10.1007/BF02115904
   Webb A., 1995, FERTILITY CONTROL RE, V4, P16
   WEBB A, 1993, BR J FAMILY PLANNING, V18, P113
   WEISBERG E, 1995, MED J AUSTRALIA, V162, P136
   Wells ES, 1998, FAM PLANN PERSPECT, V30, P288, DOI 10.2307/2991505
   WELLS ES, 1997, INVESTIGATION USE PH
   Westley E, 1998, J Am Med Womens Assoc (1972), V53, P215
   Westley E, 1998, J AM MED WOM ASS S2, P37
   WESTLEY E, 1999, DELIVERANCE DANGER C
   *WHO, 1996, WHOFRHFPP969
   WILSON S, 1994, CONTRACEPTION, V50, P77, DOI 10.1016/0010-7824(94)90082-5
   YELLIN S, 1993, BR J FAM PLAN, V19, P160
   YOUNG L, 1995, NEW ZEAL MED J, V108, P145
   Ziebland S, 1998, FAM PRACT, V15, P449, DOI 10.1093/fampra/15.5.449
   Ziebland S, 1996, BRIT J FAM PLAN, V22, P84
NR 120
TC 66
Z9 66
U1 1
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0010-7824
EI 1879-0518
J9 CONTRACEPTION
JI Contraception
PD MAR
PY 2000
VL 61
IS 3
BP 145
EP 186
DI 10.1016/S0010-7824(00)00091-3
PG 42
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 314KY
UT WOS:000087056000001
PM 10827331
DA 2018-10-20
ER

PT J
AU Tsap, LV
   Goldgof, DB
   Sarkar, S
   Powers, PS
AF Tsap, LV
   Goldgof, DB
   Sarkar, S
   Powers, PS
TI A method for increasing precision and reliability of elasticity analysis
   in complicated burn scar cases
SO INTERNATIONAL JOURNAL OF PATTERN RECOGNITION AND ARTIFICIAL INTELLIGENCE
LA English
DT Article
DE physically-based vision; deformable models; nonrigid motion analysis;
   active contours; biomedical applications; iterative descent search;
   finite element analysis
ID DEFORMATIONS; CONTOURS; TRACKING; MODEL
AB In this paper we propose a method for increasing precision and reliability of elasticity analysis in complicated burn scar cases. The need for a technique that would help physicians by objectively assessing elastic properties of scars, motivated our original algorithm. This algorithm successfully employed active contours for tracking and finite element models for strain analysis. However, the previous approach considered only one normal area and one abnormal area within the region of interest, and scar shapes which were somewhat simplified. Most burn scars have rather complicated shapes and may include multiple regions with different elastic properties. Hence, we need a method capable of adequately addressing these characteristics. The new method can split the region into more than two localities with different material properties, select and quantify abnormal areas, and apply different forces if it is necessary for a better shape description of the scar.
   The method also demonstrates the application of scale and mesh refinement techniques in this important domain. It is accomplished by increasing the number of Finite Element Method (FEM) areas as well as the number of elements within the area. The method is successfully applied to elastic materials and real burn scar cases. We demonstrate all of the proposed techniques and investigate the behavior of elasticity function in a 3-D space. Recovered properties of elastic materials are compared with those obtained by a conventional mechanics-based approach. Scar ratings achieved with the method are correlated against the judgments of physicians.
C1 Univ Calif Lawrence Livermore Natl Lab, Ctr Appl Sci Comp, Livermore, CA 94551 USA.
   Univ S Florida, Dept Comp Sci & Engn, Tampa, FL 33620 USA.
   Univ S Florida, Dept Psychiat, Tampa Bay Reg Burn Ctr, Tampa, FL 33620 USA.
RP Tsap, LV (reprint author), Univ Calif Lawrence Livermore Natl Lab, Ctr Appl Sci Comp, POB 5508, Livermore, CA 94551 USA.
RI Sarkar, Sudeep/A-8213-2009
OI Sarkar, Sudeep/0000-0001-7332-4207
CR Amini AA, 1998, IEEE T MED IMAGING, V17, P344, DOI 10.1109/42.712124
   Basu S, 1997, IEEE NONRIGID AND ARTICULATED MOTION WORKSHOP, PROCEEDINGS, P46, DOI 10.1109/NAMW.1997.609851
   Chandran S, 1998, IEEE T PATTERN ANAL, V20, P546, DOI 10.1109/34.682184
   Davis MH, 1997, IEEE T MED IMAGING, V16, P317, DOI 10.1109/42.585766
   DECARLO D, 1995, P 5 INT C COMP VIS B, P834
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   Gunn SR, 1997, IEEE T PATTERN ANAL, V19, P63, DOI 10.1109/34.566812
   HUGHES T, 1984, THEORETICAL FDN LARG
   *INC SWANS AN SYST, 1996, ANSYS US MAN REV 5 3
   Kallel F, 1996, IEEE T MED IMAGING, V15, P299, DOI 10.1109/42.500139
   Kass M., 1988, INT J COMPUT VISION, V1, P321, DOI DOI 10.1007/BF00133570
   KUMAR S, 1994, IEEE T MED IMAGING, V13, P122, DOI 10.1109/42.276150
   LARRABEE WF, 1986, LARYNGOSCOPE, V96, P413
   Luenberger DG, 1984, LINEAR NONLINEAR PRO
   Martin J, 1998, IEEE T PATTERN ANAL, V20, P97, DOI 10.1109/34.659928
   McEachen JC, 1997, IEEE T MED IMAGING, V16, P270, DOI 10.1109/42.585761
   McHugh A. A., 1997, Journal of Burn Care and Rehabilitation, V18, P104, DOI 10.1097/00004630-199703000-00003
   Metaxas D., 1991, Proceedings 1991 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (91CH2983-5), P337, DOI 10.1109/CVPR.1991.139712
   METAXAS D, 1993, SPIE, V2031, P160
   Powers PS, 1999, J BURN CARE REHABIL, V20, P54, DOI 10.1097/00004630-199901001-00011
   Sclaroff S., 1994, Proceedings of the 1994 IEEE Workshop on Motion of Non-Rigid and Articulated Objects (Cat. No.94TH0671-8), P158, DOI 10.1109/MNRAO.1994.346241
   Singh A., 1998, DEFORMABLE MODELS ME
   SULLIVAN T, 1990, Journal of Burn Care and Rehabilitation, V11, P256, DOI 10.1097/00004630-199005000-00014
   Tagare HD, 1997, IEEE T MED IMAGING, V16, P108, DOI 10.1109/42.552060
   TERZOPOULOS D, 1993, IEEE T PATTERN ANAL, V15, P569, DOI 10.1109/34.216726
   Tsap LV, 1998, IEEE T MED IMAGING, V17, P620, DOI 10.1109/42.730406
   Tsap LV, 1998, COMPUT VIS IMAGE UND, V69, P330, DOI 10.1006/cviu.1998.0663
   TSAP LV, 1998, P IEEE WORKSH BIOM I, P193
   WEISS JA, 1995, P 2 WORLD C BIOM AMS, P149
   WILLIAMS DJ, 1992, CVGIP-IMAG UNDERSTAN, V55, P14, DOI 10.1016/1049-9660(92)90003-L
   Yezzi A, 1997, IEEE T MED IMAGING, V16, P199, DOI 10.1109/42.563665
   Young A., 1992, Proceedings. 1992 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No.92CH3168-2), P399, DOI 10.1109/CVPR.1992.223158
NR 32
TC 2
Z9 2
U1 0
U2 0
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA JOURNAL DEPT PO BOX 128 FARRER ROAD, SINGAPORE 912805, SINGAPORE
SN 0218-0014
J9 INT J PATTERN RECOGN
JI Int. J. Pattern Recognit. Artif. Intell.
PD MAR
PY 2000
VL 14
IS 2
BP 189
EP 210
DI 10.1142/S0218001400000131
PG 22
WC Computer Science, Artificial Intelligence
SC Computer Science
GA 312QX
UT WOS:000086955100005
DA 2018-10-20
ER

PT J
AU Erlat, AG
   Wang, BC
   Spontak, RJ
   Tropsha, Y
   Mar, KD
   Montgomery, DB
   Vogler, EA
AF Erlat, AG
   Wang, BC
   Spontak, RJ
   Tropsha, Y
   Mar, KD
   Montgomery, DB
   Vogler, EA
TI Morphology and gas barrier properties of thin SiOx coatings on
   polycarbonate: Correlations with plasma-enhanced chemical vapor
   deposition conditions
SO JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
ID FILMS; PERMEATION; OXYGEN; HEXAMETHYLDISILOXANE; DIFFUSION
AB Plasma-enhanced chemical vapor deposition of SiOx coatings on thermoplastics provides a viable route for production of transparent composite materials with high fracture toughness and high gas barrier properties, which are important considerations in the food packaging and biomedical device industries. By examining several series of systematically varied SiOx/polycarbonate composites, we have identified design correlations between coating characteristics (thickness, density, surface roughness, and O-2 transmission) and deposition conditions (time, power, pressure, and flow rates). Of particular interest is the observation that the thermal activation energy for O-2 permeation through these composites increases (by up to 17 kJ/mol) as their barrier efficacy increases.
C1 N Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
   N Carolina State Univ, Dept Chem Engn, Raleigh, NC 27695 USA.
   Becton Dickinson Technol, Polymer Sci & Technol Dept, Res Triangle Pk, NC 27709 USA.
RP Spontak, RJ (reprint author), N Carolina State Univ, Dept Mat Sci & Engn, Box 7907, Raleigh, NC 27695 USA.
CR *ASM INT, 1988, ENG PLAST ENG MAT HD, V2, P151
   BARKER CP, 1995, THIN SOLID FILMS, V46, P259
   BATEY J, 1986, J APPL PHYS, V60, P3136, DOI 10.1063/1.337726
   Bauer T, 1998, MACROMOLECULES, V31, P7651, DOI 10.1021/ma9808169
   Benmalek M, 1995, SURF COAT TECH, V76-77, P821, DOI 10.1016/0257-8972(95)02601-0
   BOGART KHA, 1995, J VAC SCI TECHNOL A, V13, P476, DOI 10.1116/1.579382
   BORN M, 1965, PRINCIPLES OPTICS, P83
   CHAHROUDI D, 1991, SVC 34 ANN TECHN C P, P130
   CHAHROUDI D, 1988, SVC 31 ANN TECHN C P, P145
   CHAHROUDI D, 1989, SVC 32 ANN TECHN C P, P29
   CHANG RPH, 1983, J VAC SCI TECHNOL B, V1, P935, DOI 10.1116/1.582715
   COSTELLO LM, 1994, J POLYM SCI POL PHYS, V32, P701, DOI 10.1002/polb.1994.090320412
   DOREMUS RH, 1973, GLASS SCI, P213
   EDEN JG, 1991, THIN FILM PROCESSES, V2, P443
   Erlat AG, 1999, J PHYS CHEM B, V103, P6047, DOI 10.1021/jp990737e
   FELTS JR, 1990, SOC VACC COAT 33 ANN, P184
   FELTS JT, 1992, J VAC SCI TECHNOL A, V10, P1675, DOI 10.1116/1.577768
   FELTS JT, 1991, SOC VAC COAT 34 ANN, P99
   GarciaAyuso G, 1996, SURF COAT TECH, V80, P203, DOI 10.1016/0257-8972(95)02712-2
   HERRAK TV, 1990, J APPL PHYS, V67, P6347
   JAMIESON EHH, 1983, J MATER SCI, V18, P64, DOI 10.1007/BF00543811
   JANSEN F, 1996, AVS SHORT COURS PROG
   KEISER J, 1984, THIN SOLID FILMS, V118, P203
   KNOLL RW, 1995, SOC VAC COAT 38 ANN, P425
   KORZEC D, 1995, SURF COAT TECH, V74-5, P67, DOI 10.1016/0257-8972(95)08223-9
   KORZEC D, 1995, J VAC SCI TECHNOL A, V13, P2074, DOI 10.1116/1.579523
   KRUG T, 1993, SVC 36 ANN TECH C P, P302
   KRUG TG, 1990, SOC VACUUM COATERS, P163
   LEE JH, 1996, J ELECTROCHEM SOC, V143, P1442
   Magonov SN, 1997, SURF SCI, V375, P385
   MENGES G, 1989, COATINGS, V22, P2
   MERCEA PV, 1991, J MEMBRANE SCI, V59, P353, DOI 10.1016/S0376-7388(00)80822-4
   MONTGOMERY BD, 1998, Patent No. 5766362
   NELSON RJ, 1992, SVC 35 ANN TECHN C P, P75
   NORTON FJ, 1961, NATURE, V191, P701, DOI 10.1038/191701a0
   NORTON FJ, 1953, J AM CERAM SOC, V36, P90, DOI 10.1111/j.1151-2916.1953.tb12843.x
   PERKINS WG, 1971, J CHEM PHYS, V54, P1683, DOI 10.1063/1.1675072
   Philips R. W., 1993, SVC 36 ANN TECHN C P, P293
   *PLAST DES LIBR, 1995, PERM OTH FILM PROP P, P113
   ROBERTS AP, UNPUB
   SAHLI S, 1994, THIN SOLID FILMS, V250, P206, DOI 10.1016/0040-6090(94)90187-2
   SHELEKHIN AB, 1995, AICHE J, V41, P58, DOI 10.1002/aic.690410107
   Shepard TA, 1997, J POLYM SCI POL PHYS, V35, P2617, DOI 10.1002/(SICI)1099-0488(19971130)35:16<2617::AID-POLB5>3.0.CO;2-M
   Stannett V., 1968, DIFFUSION POLYM, P41
   THEIL JA, 1994, J VAC SCI TECHNOL A, V12, P1365, DOI 10.1116/1.579323
   TROPSHA YG, 1997, J PHYS CHEM B, V101, P2239
   Wang BC, 1999, J MATER SCI LETT, V18, P311, DOI 10.1023/A:1006687324051
   WANG BC, 1997, AM CHEM SOC POLYM PR, V38, P1018
   YANAKA M, IN PRESS THIN SOLID
   YASUDA H, 1985, PLASMAS POLYM, P277
NR 50
TC 45
Z9 45
U1 2
U2 20
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0884-2914
J9 J MATER RES
JI J. Mater. Res.
PD MAR
PY 2000
VL 15
IS 3
BP 704
EP 717
DI 10.1557/JMR.2000.0103
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA 290VK
UT WOS:000085698400018
DA 2018-10-20
ER

PT J
AU Armani, DK
   Liu, C
AF Armani, DK
   Liu, C
TI Mircofabrication technology for polycaprolactone, a biodegradable
   polymer
SO JOURNAL OF MICROMECHANICS AND MICROENGINEERING
LA English
DT Article
ID GOLD
AB In this paper, we report the development of micromachining techniques for a biodegradable polymer for the first time. By virtue of their ability to naturally degrade in tissues, biodegradable polymers hold immense promise as new materials for implantable biomedical microdevices. This work focuses on the establishment of microfabrication processes for biodegradable microstructures and microdevices. Three unique fabrication processes have been established: (1) a micro-molding process to form 3D microstructures in polycaprolactone (PCL) via a silicon micromachined mold, (2) a method of transferring metal patterns to surfaces of PCL substrates, (3) techniques for sealing both dry and liquid-filled PCL micro-cavities with a metal thin Nm (e.g. gold). The chemical compatibility of PCL with common micromachining chemicals have been investigated.
C1 Univ Illinois, MASS Grp, Microelect Lab, Urbana, IL 61801 USA.
RP Liu, C (reprint author), 313 Microelect Lab,208 N Wright St, Urbana, IL 61801 USA.
RI Liu, Chang/B-7249-2009
CR ANDERSON RC, 1998, IEEE WORKSH SOL STAT, P7
   Armani D, 1999, 12 IEEE INT C MICR E, P222
   BOONE T, 1998, INT WORKSH SOL STAT, P87
   FRANKENTHAL RP, 1982, J ELECTROCHEM SOC, V129, P1192, DOI 10.1149/1.2124085
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   Hollinger J.O., 1995, BIOMEDICAL APPL SYNT
   Koleske J. V., 1978, POLYM BLENDS, V2, P369
   Lanza R P, 1998, PRINCIPLES TISSUE EN
   MAN PF, 1997, 10 INT WORKSH MEMS M, P311
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   Merchant B, 1998, BIOLOGICALS, V26, P49, DOI 10.1006/biol.1997.0123
   Pitt C. G., 1983, J APPL POLYM SCI, V28, P3779
   PITT CG, 1987, ACS SYM SER, V348, P49
   Santini J. T., 1999, 10 INT C SOL STAT SE, P746
   Wilbur JL, 1996, NANOTECHNOLOGY, V7, P452, DOI 10.1088/0957-4484/7/4/028
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
   POLYCAPROLACTONE
NR 17
TC 89
Z9 92
U1 2
U2 10
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0960-1317
J9 J MICROMECH MICROENG
JI J. Micromech. Microeng.
PD MAR
PY 2000
VL 10
IS 1
BP 80
EP 84
DI 10.1088/0960-1317/10/1/311
PG 5
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Instruments & Instrumentation; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Instruments &
   Instrumentation; Physics
GA 317BV
UT WOS:000087206400011
DA 2018-10-20
ER

PT J
AU Furuta, M
   Ohashi, I
   Oka, M
   Hayashi, T
AF Furuta, M
   Ohashi, I
   Oka, M
   Hayashi, T
TI Irradiation effects on hydrases for biomedical applications
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 11th International Meeting on Radiation Processing (IMRP-11)
CY MAR 14-19, 1999
CL MELBOURNE, AUSTRALIA
DE irradiation; Co-60-gamma rays; papain; residual activity; sterilization
AB To apply an irradiation technique to sterilize "Hybrid" biomedical materials including enzymes, we selected papain, a well-characterized plant endopeptidase as a model to examine durability of enzyme activity under the practical irradiation condition in which limited data were available for irradiation inactivation of enzymes. Dry powder and frozen aqueous solution of papain showed significant durability against Co-60-gamma irradiation suggesting that, the commercial irradiation sterilizing method is applicable without modification. Although irradiation of unfrozen aqueous papain solution showed an unusual change of the enzymatic activity with the increasing doses, and was totally inactivated at 15 kGy, we managed to keep the residual activity more than 50% of initial activity after 30-kGy irradiation, taking such optimum conditions as increasing enzyme concentration from 10 to 100 mg/ml and purging with N-2 gas to suppress the formation of free radicals. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Osaka Prefecture, Adv Sci & Technol Res Inst, Sakai, Osaka 5998570, Japan.
RP Furuta, M (reprint author), Univ Osaka Prefecture, Adv Sci & Technol Res Inst, 1-2 Gakuen Cho, Sakai, Osaka 5998570, Japan.
CR *AAMI, 1991, PROC CONTR GUID GAMM
   Arnon R., 1970, METHOD ENZYMOL, V19, P226, DOI DOI 10.1016/0076-6879(70)19017-3
   FURUTA J, 1970, ANN REP RAD CTR OSAK, V10, P65
   LIN WS, 1975, CAN J BIOCHEM CELL B, V53, P298, DOI 10.1139/o75-042
   SATTAR A, 1983, LEBENSM WIS U TECHNO, V21, P319
   VINK P, 1986, BIOMATERIALS, V7, P225, DOI 10.1016/0142-9612(86)90108-0
NR 6
TC 4
Z9 4
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-806X
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD MAR
PY 2000
VL 57
IS 3-6
BP 455
EP 457
DI 10.1016/S0969-806X(99)00414-4
PG 3
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA 307LA
UT WOS:000086653700056
DA 2018-10-20
ER

PT J
AU Nie, X
   Leyland, A
   Matthews, A
AF Nie, X
   Leyland, A
   Matthews, A
TI Deposition of layered bioceramic hydroxyapatite/TiO2 coatings on
   titanium alloys using a hybrid technique of micro-arc oxidation and
   electrophoresis
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 1999 E-MRS Conference, Symposium B: Protective Coatings and Thin Films
CY JUN 01-04, 1999
CL STRASBOURG, FRANCE
SP French Minist Def, DGA/DPS, USN, Off Res Int Field Off, Europe European Off Aerosp Res & Dev, French Minist Natl Educ Res & Technol
DE biomaterials; biomedical implant; electrophoretic deposition;
   hydroxyapatite; micro-arc oxidation; titanium oxide
AB Titanium alloys have been used with some success in several bioimplant applications. However, they can suffer certain disadvantages, such as poor osteoinductive properties and low corrosive-wear resistance. Attempts to overcome the first of these drawbacks have involved coating the metal with the bioceramic material hydroxyapatite (HA), a primary component of bone and a very good osteoinductor. Since TiO2 coatings are also known to be effective as chemical barriers against the in-vivo release of metal ions from the implants, a double layer HA-TiO2 coating on titanium alloys with HA as the top layer and a dense TiO2 film as the inner layer should possess a very good combination of bioactivity, chemical stability and mechanical integrity.
   This paper describes efforts to improve implant biocompatibility and durability by applying a hybrid treatment of micro-are discharge oxidation (MDO) and electrophoretic deposition. The most common structural titanium alloy (Ti-6Al-4V) was used as the substrate material. A phosphate salt solution and an HA powder aqueous suspension were used as the electrolyte for micro-arc oxidation and the solution for HA electrophoretic deposition, respectively. It is shown that a relatively thick and hard TiO2 coating can be produced by anodic micro-are oxidation of titanium, and an HA coating incorporated on top of the TiO2 layer can simultaneously be formed using a combination of plasma electrolysis and electrophoresis, with the suspension held at high values of pH.
   X-ray diffraction (XRD), scanning electron microscopy (SEM) and Fourier transform infrared spectroscopy (FTIR) have been used to investigate the microstructure and morphology of the coatings. The adhesive strength between the coating and substrate has been assessed using scratch adhesion testing. The corrosion resistance of the specimens was examined using potentiodynamic tests in a buffered physiological solution. The results indicate that a hybrid combination of micro-are oxidation and electrophoretic deposition can provide a phase-pure HA top layer and anticorrosive TiO2 interlayer, which should show good mechanical and biochemical stability in the corrosive environment of the human body. (C) 2000 Elsevier Science S.A. All rights reserved.
C1 Univ Hull, Res Ctr Surface Engn, Hull HU6 7RX, N Humberside, England.
RP Nie, X (reprint author), Univ Hull, Res Ctr Surface Engn, Hull HU6 7RX, N Humberside, England.
RI Leyland, Adrian/A-4714-2009; Matthews, Allan/H-2394-2012
OI Leyland, Adrian/0000-0002-5569-7293; Matthews, Allan/0000-0002-9282-1425
CR CIGADA A, 1992, J MATER SCI-MATER M, V3, P408, DOI 10.1007/BF00701236
   Cui FZ, 1997, J MATER SCI-MATER M, V8, P403, DOI 10.1023/A:1018597320022
   Ding SJ, 1999, J BIOMED MATER RES, V44, P266, DOI 10.1002/(SICI)1097-4636(19990305)44:3<266::AID-JBM5>3.0.CO;2-4
   FU XQ, 1998, SURF COAT TECH, V107, P133
   Heimann RB, 1997, EUR J MINERAL, V9, P597
   Kurzweg H, 1998, BIOMATERIALS, V19, P1507, DOI 10.1016/S0142-9612(98)00067-2
   Li P, 1996, J SOL-GEL SCI TECHN, V7, P27, DOI 10.1007/BF00401880
   NIE X, 1999, SURF COAT TECH, V116, P1061
   Ogiso M, 1998, J LONG-TERM EFF MED, V8, P193
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   Sarkar P, 1996, J AM CERAM SOC, V79, P1987, DOI 10.1111/j.1151-2916.1996.tb08929.x
   Slosarczyk A, 1998, J MATER SCI-MATER M, V9, P103, DOI 10.1023/A:1008803232685
   Voevodin AA, 1996, SURF COAT TECH, V86-7, P516, DOI 10.1016/S0257-8972(96)03069-1
   Yang CY, 1996, J MATER SCI-MATER M, V7, P167, DOI 10.1007/BF00121256
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
   YEROKHIN AL, UNPUB SURF COAT TECH
   Zhang Y, 1998, ACTA PHYS-CHIM SIN, V14, P68, DOI 10.3866/PKU.WHXB19980113
   Zhitomirsky I, 1997, J MATER SCI-MATER M, V8, P213, DOI 10.1023/A:1018587623231
NR 19
TC 305
Z9 338
U1 10
U2 163
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD MAR
PY 2000
VL 125
IS 1-3
BP 407
EP 414
DI 10.1016/S0257-8972(99)00612-X
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 295BG
UT WOS:000085945600074
DA 2018-10-20
ER

PT J
AU Bae, YH
   Huh, KM
   Kim, Y
   Park, KH
AF Bae, YH
   Huh, KM
   Kim, Y
   Park, KH
TI Biodegradable amphiphilic multiblock copolymers and their implications
   for biomedical applications
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article; Proceedings Paper
CT 5th Symposium on Controlled Drug Delivery
CY APR 01-03, 1998
CL NOORDWIJK AAN ZEE, NETHERLANDS
SP Alza Corp, 3M Medica GmbH, N V Organon, Akzo Nobel, Cordis Corp, Depotech Corp, DSM Fine Chem, Emisphere Technol Inc, Janssen Pharmaceut, Merck KgaA, Novaritis Pharms AG, Pharmacia & Upjohn AB, Inst Rech Int Servier, TheraTech
DE poly(ethylene oxide); poly(epsilon-caprolactone); poly(l-lactic acid);
   alternating multiblock copolymers; physical crosslinking; thermoplastic
   biodegradable hydrogel; wound healing
ID FIBROBLAST GROWTH-FACTOR; IN-VITRO; RELEASE; HYDROGELS
AB Alternating multiblock copolymers composed of short blocks of poly(ethylene oxide) (PEO) and poly(epsilon-caprolactone) (PCL) or poly(L-lactic acid) (PLLA) were synthesized by a coupling reaction. The block copolymers of relatively high molecular weights (M-n > 20,000) formed a physically crosslinked thermoplastic network, while low molecular weight polymers were water-soluble. The block copolymers demonstrated solubility in a variety of solvents including acetone, tetrahydrofuran, methylene chloride, dioxane, water/acetone mixtures, and water/ethanol mixtures. The degree of swelling, optical transparency, and mechanical property of the films, prepared by a solvent casting method, were affected by the nature of the hydrophobic block used, polymer composition, temperature, and thermal history. The crystalline melting temperatures of PCL and PLLA in the block copolymers were significantly lowered due to the chemical structure of difunctional PCL and PLLA, and partial phase mixing with PEO segments. The properties of the block copolymers may be useful for biomedical applications as well as controlled drug release formulations. When PEO/PLLA multiblock copolymers were applied as a wound healing material loaded with basic fibroblast growth factor (bFGF), the feasibility study showed improved wound healing when compared to controls of no treatment and the same wound covering without bFGF, indicating that a certain degree of the bioactivity of bFGF is preserved. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Kwangju Inst Sci & Technol, Dept Mat Sci & Engn, Kwangsan Ku, Kwangju 506712, South Korea.
RP Bae, YH (reprint author), Kwangju Inst Sci & Technol, Dept Mat Sci & Engn, Kwangsan Ku, 572 Sangam Dong, Kwangju 506712, South Korea.
EM yhbae@matla.kjist.ac.kr
CR Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Bae YH, 1997, CONTROLLED DRUG DELI, P147
   BUCKLEYSTURROCK A, 1989, J CELL PHYSIOL, V138, P70, DOI 10.1002/jcp.1041380111
   Chen XH, 1997, MACROMOLECULES, V30, P4295, DOI 10.1021/ma970385e
   DELGUERRA RS, 1994, J MATER SCI-MATER M, V5, P891, DOI 10.1007/BF01172032
   EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L
   FALCONE DJ, 1993, J BIOL CHEM, V268, P11951
   GAJDUSEK CM, 1993, J CELL PHYSIOL, V157, P133, DOI 10.1002/jcp.1041570118
   GOSPODAROWICZ D, 1975, J CELL BIOL, V66, P451, DOI 10.1083/jcb.66.2.451
   GUENET JMM, 1992, THERMOREVERSIBLE GEL
   HERGENROTHER RW, 1994, BIOMATERIALS, V15, P635, DOI 10.1016/0142-9612(94)90215-1
   HUH KM, 1999, IN PRESS POLYMER
   KIM SW, 1992, PHARMACEUT RES, V9, P283, DOI 10.1023/A:1015887213431
   MORRISER, 1978, BRIT MED BULL, V34, P49
   PARK K, 1993, BIODEGRADABLE HYDROG
   PEZRON E, 1988, MACROMOLECULES, V21, P1121, DOI 10.1021/ma00182a045
   RICHARDS M, 1991, J BIOMED MATER RES, V25, P1151, DOI 10.1002/jbm.820250908
   TANAKA F, 1992, MACROMOLECULES, V25, P1516, DOI 10.1021/ma00031a024
   VILLASCHI S, 1993, AM J PATHOL, V143, P181
   ZALIPSKY S, 1983, EUR POLYM J, V19, P1177, DOI 10.1016/0014-3057(83)90016-2
NR 20
TC 135
Z9 138
U1 3
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD FEB 14
PY 2000
VL 64
IS 1-3
BP 3
EP 13
DI 10.1016/S0168-3659(99)00126-1
PG 11
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 285FK
UT WOS:000085378900002
PM 10640641
DA 2018-10-20
ER

PT J
AU Thomas, CA
   Zong, K
   Schottland, P
   Reynolds, JR
AF Thomas, CA
   Zong, K
   Schottland, P
   Reynolds, JR
TI Poly(3,4-alkylenedioxypyrrole)s as highly stable aqueous-compatible
   conducting polymers,vith biomedical implications
SO ADVANCED MATERIALS
LA English
DT Article
ID REDUCTION; FILMS
AB Polypyrrole (PPy) may be set to revolutionize biological applications such as tissue engineering and biosensors due to its high electroactivity/conductivity and the water compatibility of its films. However, inherent weaknesses in PPy-based materials arise from defect sites along the PPy polymer backbone, and its instability to reduction by biologically relevant reducing agents such as dithiothreitol (DTT) and glutathione. Here is presented a family of electron-rich poly(3,4-alkylenedioxypyrrole)s that address these structural weaknesses and are stable in the conducting, oxidized form, rendering them immune to strong biological reducing agents.
C1 Univ Florida, Dept Chem, Ctr Macromol Sci & Engn, Gainesville, FL 32611 USA.
RP Reynolds, JR (reprint author), Univ Florida, Dept Chem, Ctr Macromol Sci & Engn, Gainesville, FL 32611 USA.
CR Anderson JM, 1999, J CONTROL RELEASE, V57, P107, DOI 10.1016/S0168-3659(98)00178-3
   Cosnier S, 1999, ELECTROCHIM ACTA, V44, P1833, DOI 10.1016/S0013-4686(98)00294-1
   Garner B, 1999, J MATER SCI-MATER M, V10, P19, DOI 10.1023/A:1008835925998
   Granstrom M, 1997, SUPRAMOL SCI, V4, P27, DOI 10.1016/S0968-5677(96)00050-8
   Guiseppi-Elie A., 1998, HDB CONDUCTING POLYM, P963
   Hukins DWL, 1999, J MATER CHEM, V9, P629, DOI 10.1039/a807411i
   LAMOUREUX GV, 1993, J ORG CHEM, V58, P633, DOI 10.1021/jo00055a015
   MERZ A, 1995, SYNTHESIS-STUTTGART, P795
   MILLER LL, 1987, MACROMOLECULES, V20, P1594, DOI 10.1021/ma00173a027
   MILLIS KK, 1993, J ORG CHEM, V58, P4144, DOI 10.1021/jo00067a060
   Pande R, 1998, BIOMATERIALS, V19, P1657, DOI 10.1016/S0142-9612(98)00043-X
   PERNAUT JM, 1989, J ELECTROANAL CHEM, V274, P225, DOI 10.1016/0022-0728(89)87043-3
   PFLUGER P, 1984, J CHEM PHYS, V80, P544, DOI 10.1063/1.446428
   PREZYNA LA, 1991, MACROMOLECULES, V24, P5283, DOI 10.1021/ma00019a010
   Savage D., 1997, US patent, Patent No. [5,665,498, 5665498]
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   SKOTEHEIM TA, 1998, HDB CONDUCTING POLYM
   VALDES LB, 1954, P IRE, V42, P420, DOI 10.1109/JRPROC.1954.274680
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   ZOTTI G, 1995, SYNTHETIC MET, V72, P275, DOI 10.1016/0379-6779(95)03280-0
NR 20
TC 85
Z9 89
U1 0
U2 8
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD FEB 3
PY 2000
VL 12
IS 3
BP 222
EP +
DI 10.1002/(SICI)1521-4095(200002)12:3<222::AID-ADMA222>3.0.CO;2-D
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 281CT
UT WOS:000085141100016
DA 2018-10-20
ER

PT J
AU Soltz, MA
   Ateshian, GA
AF Soltz, MA
   Ateshian, GA
TI Interstitial fluid pressurization during confined compression cyclical
   loading of articular cartilage
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE biphasic theory; diarthrodial joints; cartilage stresses
ID BIOSYNTHETIC RESPONSE; MECHANICAL-PROPERTIES; DYNAMIC COMPRESSION;
   STRESS-RELAXATION; BEHAVIOR; MATRIX; DEFORMATION; EXPLANTS; CONTACT;
   MODEL
AB The objective of this study was to experimentally verify the well-accepted but untested hypothesis that cartilage interstitial fluid pressurizes variously under the action of an applied cyclical stress in confined compression over a range of loading frequencies, contributing significantly to the cartilage dynamic stiffness. Eighteen bovine cartilage cylindrical samples were tested under load control using a porous indenter in a confined compression chamber fitted with a microchip pressure transducer at its bottom. Over a static stress of 130 kPa. a cyclical stress of amplitude 33 kPa was applied with the indenter at frequencies ranging from 0.0001 to 0.1 Hz. The cartilage interstitial fluid pressure and deformation were measured simultaneously as a function of time. The displacement response at the lowest tested frequency was curvefitted in the time domain to determine the linear biphasic material properties, H-A=0.70 +/- 0.10 MPa and k(o) = 2.4 x 10(-16) +/- 0.64 x 10(-16) m(4)/N s. These properties were employed in the biphasic theory to predict the interstitial fluid pressure response and compare it to experiment, resulting in nonlinear coefficients of determination ranging from r(2)=0.89 +/- 0.15 to 0.96 +/- 0.03 depending on frequency. It was found for the samples of this study that above a characteristic frequency of 0.000 44 Hz, the magnitude and phase of fluid pressurization marched the applied stress, reducing the tissue strain at the impermeable bottom surface to nearly zero. The findings of this study verify the hypothesis that cartilage dynamic stiffness derives primarily from flow-dependent viscoelasticity as predicted by the linear biphasic theory; they demonstrate experimentally the significance of interstitial fluid pressurization as the fundamental mechanism of cartilage load support over a wide range of frequencies. (C) 2000 Biomedical Engineering Society. [S0090-6964(00)00202-2].
C1 Columbia Univ, Dept Mech Engn, New York, NY 10027 USA.
RP Ateshian, GA (reprint author), Columbia Univ, Dept Mech Engn, 500 W 120th St,Rm 220 Mudd Bldg, New York, NY 10027 USA.
FU NIAMS NIH HHS [1R29-AR43628]
CR Ateshian GA, 1997, J BIOMECH, V30, P1157, DOI 10.1016/S0021-9290(97)85606-0
   ATESHIAN GA, 1995, J BIOMECH, V28, P1341, DOI 10.1016/0021-9290(95)00008-6
   Ateshian GA, 1998, J TRIBOL-T ASME, V120, P241, DOI 10.1115/1.2834416
   ATHANASIOU KA, 1991, J ORTHOP RES, V9, P330, DOI 10.1002/jor.1100090304
   Bachrach NM, 1998, J BIOMECH, V31, P445, DOI 10.1016/S0021-9290(98)00035-9
   Brooks SV, 1998, J MUSCLE RES CELL M, V19, P179, DOI 10.1023/A:1005364713451
   Buschmann MD, 1998, J BIOMECH, V31, P171
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   BUSCHMANN MD, 1996, J BIOMECH, V30, P197
   FRANK EH, 1987, J BIOMECH, V20, P629, DOI 10.1016/0021-9290(87)90283-1
   FUNG YCB, BIOMECHANICS MECH PR, V181, P226
   GRAY ML, 1988, J ORTHOPAED RES, V6, P777, DOI 10.1002/jor.1100060602
   GUILAK F, 1989, ASME BIOM S AMD, V98, P113
   GUILAK F, IN PRESS J BIOMECH E
   Higginson G. R., 1979, Engineering in Medicine, V8, P11
   HOLMES MH, 1985, J BIOMECH ENG-T ASME, V107, P206
   Kelkar R, 1999, J APPL MECH-T ASME, V66, P137, DOI 10.1115/1.2789140
   KVALSETH TO, 1985, AM STAT, V39, P279, DOI 10.2307/2683704
   LEE RC, 1981, J BIOMECH ENG-T ASME, V103, P280, DOI 10.1115/1.3138294
   MACIROWSKI T, 1994, ASME, V116, P11
   MAK AF, 1986, J BIOMECH ENG-T ASME, V108, P123, DOI 10.1115/1.3138591
   MANSOUR JM, 1998, T ORTHOP RES SOC, V23, P479
   McCutchen C, 1962, WEAR, V5, P1, DOI DOI 10.1016/0043-1648(62)90176-X
   MEYERLEHNERT H, 1994, EXP NEPHROL, V2, P101
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   MOW VC, 1990, BIOMECHANICS DIARTHR, V2, P215
   OLOYEDE A, 1991, CLIN BIOMECH, V6, P206, DOI 10.1016/0268-0033(91)90048-U
   PARKKINEN JJ, 1992, J ORTHOPAED RES, V10, P610, DOI 10.1002/jor.1100100503
   SAH RLY, 1989, J ORTHOPAED RES, V7, P619, DOI 10.1002/jor.1100070502
   Schinagl RM, 1996, ANN BIOMED ENG, V24, P500, DOI 10.1007/BF02648112
   SETTON LA, 1993, J BIOMECH, V26, P581, DOI 10.1016/0021-9290(93)90019-B
   Soltz MA, 1998, J BIOMECH, V31, P927, DOI 10.1016/S0021-9290(98)00105-5
   SUH JK, 1995, J BIOMECH, V28, P357, DOI 10.1016/0021-9290(94)00103-B
   Suh JK, 1996, BIORHEOLOGY, V33, P289, DOI 10.1016/0006-355X(96)00023-6
   Torzilli PA, 1997, J BIOMECH, V30, P1, DOI 10.1016/S0021-9290(96)00117-0
   WAYNE JS, 1995, ANN BIOMED ENG, V23, P40, DOI 10.1007/BF02368299
NR 36
TC 117
Z9 120
U1 0
U2 14
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD FEB
PY 2000
VL 28
IS 2
BP 150
EP 159
DI 10.1114/1.239
PG 10
WC Engineering, Biomedical
SC Engineering
GA 287TT
UT WOS:000085523100002
PM 10710186
DA 2018-10-20
ER

PT J
AU Sobel, ME
AF Sobel, ME
TI New challenges for biomedical research utilizing human biological
   materials
SO JOURNAL OF MOLECULAR DIAGNOSTICS
LA English
DT Article
ID TISSUE
C1 NCI, Pathol Lab, NIH, Mol Pathol Sect, Bethesda, MD 20892 USA.
RP Sobel, ME (reprint author), NCI, Pathol Lab, NIH, Mol Pathol Sect, Bldg 10,Rm 2A33,10 Ctr Dr MSC 1500, Bethesda, MD 20892 USA.
CR Andrews L, 1998, LANCET, V351, P53, DOI 10.1016/S0140-6736(05)78066-1
   Grizzle W, 1999, ARCH PATHOL LAB MED, V123, P296
   *INT MIL TRIB, 1950, TRIALS WAR CRIM NUR
   KNOPPERS BM, 1995, JAMA-J AM MED ASSOC, V274, P1806, DOI 10.1001/jama.274.22.1806
   Merz JF, 1999, SCIENCE, V283, P1647, DOI 10.1126/science.283.5408.1647
   *NAT BIOETH ADV CO, 1999, RES INV HUM BIOL MAT, V1
   Shuster E, 1997, NEW ENGL J MED, V337, P1436, DOI 10.1056/NEJM199711133372006
   Sobel ME, 1999, ARCH PATHOL LAB MED, V123, P1076
   1979, RED REG         0418
NR 9
TC 5
Z9 5
U1 0
U2 4
PU AMER SOC INVESTIGATIVE PATHOLOGY, INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3993 USA
SN 1525-1578
J9 J MOL DIAGN
JI J. Mol. Diagn.
PD FEB
PY 2000
VL 2
IS 1
BP 1
EP 4
DI 10.1016/S1525-1578(10)60608-3
PG 4
WC Pathology
SC Pathology
GA 365EG
UT WOS:000089935000001
PM 11272896
OA Green Published
DA 2018-10-20
ER

PT J
AU Bansal, R
AF Bansal, R
TI Studying biomedical issues of high-frequency radiation
SO MICROWAVES & RF
LA English
DT Article
AB STORIES about potential health risks from (and occasionally about medical applications of) electromagnetic (EM) fields can be found everywhere from technical journals to supermarket tabloids. In the 1970s and 1980s, microwave radar and communication antennas received a lot of alarming press and more recently, the EM fields from cellular telephones have come under heavy scrutiny. This primer is intended to provide a basic framework for tackling bioelectromagnetic issues. It is by no means an all-encompassing study of the biomedical effects of EM radiation, but is meant to include only those ideas which may one day be useful for performing quick calculations of EM radiation and safety. The interested reader can, of course, consult the references for additional details or data as there is no shortage of specialized material (see, for example, references 2 and 3).
C1 Univ Connecticut, Dept Elect & Syst Engn, Storrs, CT 06269 USA.
RP Bansal, R (reprint author), Univ Connecticut, Dept Elect & Syst Engn, U-157,260 Glenbrook Rd, Storrs, CT 06269 USA.
CR BANSAL R, 1997, IEEE AP S MAGAZI APR, V39, P96
   BANSAL R, 1997, IEEE POTENTIALS  AUG, P3
   *EPRI, 1989, EL MAGN FIELD FUND E
   FISCHETTI M, 1993, IEEE SPECTRUM    JUN, P48
   FOSTER KR, 1986, SCI AM           SEP, P32
   Gandhi O. P., 1990, BIOL EFFECTS MED APP
   *IEE, C9511991 IEEE
   JOHNSON CC, 1972, PR INST ELECTR ELECT, V60, P692, DOI 10.1109/PROC.1972.8728
   Kumar A, 1996, MICROWAVES RF, V35, P157
   Osepchuk J. M., 1983, BIOL EFFECTS ELECTRO
   OSEPCHUK JM, 1978, MICROWAVE J      OCT, P18
   POZAR DM, 1990, MICROWAVE ENG A W
   STUCHLY MA, 1987, IEEE ENG MED BIOL, V6, P15, DOI 10.1109/MEMB.1987.5006368
   *US DOE, 1995, QUEST ANSW EMF EL MA
   WHITE JF, 1981, MICROWAVE J      JAN, P16
NR 15
TC 1
Z9 1
U1 0
U2 1
PU PENTON MEDIA, INC
PI CLEVELAND
PA 1100 SUPERIOR AVE, CLEVELAND, OH 44114-2543 USA
SN 0745-2993
J9 MICROWAVES RF
JI Microw. RF
PD FEB
PY 2000
VL 39
IS 2
BP 105
EP 106
PG 2
WC Engineering, Electrical & Electronic; Telecommunications
SC Engineering; Telecommunications
GA 287MG
UT WOS:000085509200026
DA 2018-10-20
ER

PT J
AU Allen, BW
   Piantadosi, CA
   Coury, LA
AF Allen, BW
   Piantadosi, CA
   Coury, LA
TI Electrode materials for nitric oxide detection
SO NITRIC OXIDE-BIOLOGY AND CHEMISTRY
LA English
DT Article
ID RELEASE
AB Nitric oxide oxidation signals were compared for uniform test electrodes of platinum, iridium, palladium, rhodium, ruthenium, gold, graphite, and a nickel-porphyrin on graphite in deaerated phosphate-buffered saline (pH 7.0) at 35 degrees C. All tested materials detected NO. amperometrically, Current densities (A/M/cm(2) +/- S.D.) were Ir (0.021 +/- 0.002), Rh (0.088 +/- 0.012), graphite (0.117 +/- 0.018), Pd (0.118 +/- 0.033), Au (0.149 +/- 0.039), Pt (0.237 +/- 0.117), Ni (II)-tetra(3-methoxy-4-hydroxyphenyl) porphyrin on graphite (0.239 +/- 0.009), and Ru (0.680 +/- 0.058). NO. oxidation current on ruthenium was maximal at 675 mV (vs Ag/AgCl), nearly three times that on the next-best materials, platinum and Ni-porphyrin on graphite poised at 800 mV, The measured limit of detection for NO. on Ru was below 3 nM, Enhanced NO. oxidation current on ruthenium is apparently due to formation of nitrosyl-or chloronitrosyl-ruthenium complexes at the electrode surface. At fixed potentials above 675 mV, ruthenium exhibited an even larger NO. response, characterized by current flow opposite in polarity to an oxidation, which we hypothesize reflects suppression of the oxidative background current (presumably due to chloride oxidation or to the electrolysis of water) by a film consisting of nitrosyl- or chloronitrosyl-ruthenium complexes. The sensitive response of the ruthenium electrode to the direct oxidation of NO. may be useful in sensors for biomedical applications. (C) 2000 Academic Press.
C1 Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA.
   Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.
   Duke Univ, Dept Chem, Durham, NC 27708 USA.
RP Allen, BW (reprint author), Duke Univ, Med Ctr, Dept Anesthesiol, Box 3823, Durham, NC 27710 USA.
FU NHLBI NIH HHS [2P01 HL42444-06]
CR ALI H, 1997, ADV RHEUMATOLOGY, P1
   Barker SLR, 1998, ANAL CHEM, V70, P971, DOI 10.1021/ac970706k
   BEDIOUI F, 1994, J ELECTROANAL CHEM, V377, P295, DOI 10.1016/0022-0728(94)03642-X
   CLARK LC, 1953, J APPL PHYSIOL, V6, P189
   EVANS MO, 1978, LANCET          1230, P1371
   GRIFFITH WP, 1967, CHEMISTRY RARER PLAT, P174
   HOARE JP, 1968, ELECTROCHEMISTRY OXY, P423
   Kudo S, 1997, ANAL BIOCHEM, V247, P193, DOI 10.1006/abio.1997.2097
   LLOPIS JF, 1976, RUTHENIUM ENCY ELECT, V6
   MALINSKI T, 1992, NATURE, V358, P676, DOI 10.1038/358676a0
   MIYOSHI H, 1994, FEBS LETT, V345, P47, DOI 10.1016/0014-5793(94)00417-X
   PARIENTE F, 1994, J ELECTROANAL CHEM, V379, P191, DOI 10.1016/0022-0728(94)87138-8
   Pourbaix M., 1966, ATLAS ELECTROCHEMICA, P644
   RICHTERADDO CB, 1992, METAL NITROSYLS
   Saito Y., 1968, REV POLAROGR JAPAN, V15, P177
   SEDDON EA, 1984, CHEM RUTHEMIUM TOPIC, V19, P1369
   SHI YA, 1993, J PEDIATR-US, V123, P435, DOI 10.1016/S0022-3476(05)81753-6
   SHIBUKI K, 1990, NEUROSCI RES, V9, P69, DOI 10.1016/0168-0102(90)90048-J
   TRASATTI S, 1980, STUDIES PHYSICAL THE, VA, pR5
   VADIMSKY RG, 1979, J ELECTROCHEM SOC, V126, P2017, DOI 10.1149/1.2128846
   Wink David A., 1995, Methods (Orlando), V7, P71, DOI 10.1006/meth.1995.1010
   YEAGER HL, 1981, J ELECTROCHEM SOC, V128, P1880, DOI 10.1149/1.2127757
NR 22
TC 24
Z9 26
U1 0
U2 14
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1089-8603
J9 NITRIC OXIDE-BIOL CH
JI Nitric Oxide-Biol. Chem.
PD FEB
PY 2000
VL 4
IS 1
BP 75
EP 84
DI 10.1006/niox.2000.0273
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 323GL
UT WOS:000087557700009
PM 10733875
DA 2018-10-20
ER

PT J
AU Lee, KY
   Bouhadir, KH
   Mooney, DJ
AF Lee, KY
   Bouhadir, KH
   Mooney, DJ
TI Degradation behavior of covalently cross-linked poly(aldehyde
   guluronate) hydrogels
SO MACROMOLECULES
LA English
DT Article
ID SYNTHETIC EXTRACELLULAR MATRICES; SWELLING BEHAVIOR; ACID; WATER
AB There is a significant need in the biomedical field for hydrogels with controllable mechanical and degradative properties. We now report the degradation behavior of novel hydrogels formed by the cross-linking of poly(aldehyde guluronate) (PAG). PAG was prepared from alginate by acid hydrolysis and oxidation and was covalently cross-linked with adipic acid dihydrazide (AAD) to form hydrogels. These hydrogels were degradable in aqueous media due to the hydrolysis of hydrazone bonds formed between the aldehyde of PAG and the hydrazide of AAD. We confirmed the degradation behavior of FAG hydrogels cross-linked with different concentrations of AAD by monitoring the changes of dry weight, modulus, and degree of swelling. The degradation behavior generally depends on the cross-linking density as calculated from the Flory-Rehner equation. However, hydrogels with many dangling single-end molecules showed a retarded degradation behavior irrespective of their low initial modulus and low degree of cross-linking density. We hypothesize this is due to re-cross-linking of dangling single-end molecules during degradation. The mechanical properties and degradation time of hydrogels typically increase or decrease together as the degree of cross-linking is varied. However, the findings of the current study suggest that the mechanical properties and degradation time can be decoupled by utilizing partially bound cross-linking molecules that are capable of reversibly cross-linking the polymer to form the hydrogel. This approach to control the properties of hydrogels may find wide utility in the biomedical field and other applications of these materials.
C1 Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
RP Mooney, DJ (reprint author), Univ Michigan, Dept Chem Engn, 3074 HH Dow Bldg,2300 Hayward St, Ann Arbor, MI 48109 USA.
OI Lee, Kuen Yong/0000-0002-5759-5952
CR ANBERGEN U, 1990, POLYMER, V31, P1854, DOI 10.1016/0032-3861(90)90006-K
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Bell CL, 1996, BIOMATERIALS, V17, P1203, DOI 10.1016/0142-9612(96)84941-6
   Bouhadir KH, 1999, POLYMER, V40, P3575, DOI 10.1016/S0032-3861(98)00550-3
   BOUHADIR KH, UNPUB
   DE SMEDT SC, 1995, MACROMOLECULES, V28, P5082, DOI 10.1021/ma00118a042
   DeRossi D., 1991, POLYM GELS FUNDAMENT
   DRAGET KI, 1990, TIBTECH, V8, P71
   Dubrovskii SA, 1997, MACROMOLECULES, V30, P7478, DOI 10.1021/ma970788e
   DUBROVSKII SA, 1992, POLYM BULL, V29, P587, DOI 10.1007/BF00296722
   EDWARDSLEVY F, 1993, INT J PHARM, V96, P85, DOI 10.1016/0378-5173(93)90215-2
   Eiselt P, 1999, MACROMOLECULES, V32, P5561, DOI 10.1021/ma990514m
   Figuly GD, 1997, MACROMOLECULES, V30, P6174, DOI 10.1021/ma9702509
   Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792
   HAUG A, 1966, ACTA CHEM SCAND, V20, P183, DOI 10.3891/acta.chem.scand.20-0183
   INGBER D, 1993, PHYS FORCES MAMMALIA, pCH2
   Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K
   JHON MS, 1973, J BIOMED MATER RES, V7, P509, DOI 10.1002/jbm.820070604
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kuijpers AJ, 1999, MACROMOLECULES, V32, P3325, DOI 10.1021/ma981929v
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Mark J. E., 1988, RUBBER ELASTICITY MO
   MORGAN SM, 1995, INT J PHARM, V122, P121, DOI 10.1016/0378-5173(95)00059-R
   PATEL SK, 1992, MACROMOLECULES, V25, P2541
   PEPPAS NA, 1977, J APPL POLYM SCI, V21, P1763, DOI 10.1002/app.1977.070210704
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Ratner B. D., 1976, ACS SYM SER, V31, P1, DOI [DOI 10.1021/SYMPOSIUM, 10.1021/bk-1976-0031.ch001]
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   TRELORA LRG, 1975, PHYSICS RUBBER ELAST
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
NR 32
TC 135
Z9 138
U1 2
U2 69
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JAN 11
PY 2000
VL 33
IS 1
BP 97
EP 101
DI 10.1021/ma991286z
PG 5
WC Polymer Science
SC Polymer Science
GA 275BJ
UT WOS:000084799300017
DA 2018-10-20
ER

PT J
AU Hu, ZH
   Srinivasan, MP
   Ni, YM
AF Hu, ZH
   Srinivasan, MP
   Ni, YM
TI Preparation of mesoporous high-surface-area activated carbon
SO ADVANCED MATERIALS
LA English
DT Article
ID UNIQUE ADSORPTION
AB A simple, cost effective method for producing carbons with high mesopore content is presented. The effect of the ratio of activating agent (ZnCl2) to carbon precursor (coconut shell) on pore size is investigated as is the nitrogen adsorption isotherm of these carbonaceous materials at 77 K. The mesoporosity is substantiated by the absorption capacity for phenol, methylene blue, and erythrosine red. Mesoporous high-surface-area activated carbons. which up to now have proved difficult to prepare, have applications as catalytic, battery electrode, capacitor, gas storage, and biomedical engineering materials.
C1 Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China.
   Natl Univ Singapore, Dept Chem Engn, Singapore 119260, Singapore.
RP Hu, ZH (reprint author), Tongji Univ, Dept Chem, 1239 Spring Rd, Shanghai 200092, Peoples R China.
RI MP, Srinivasan/E-6068-2011
OI MP, Srinivasan/0000-0002-3440-1422
CR Bansal R.C., 1988, ACTIVE CARBON, P121
   Choma J, 1997, POL J CHEM, V71, P380
   Gregg S J, 1982, ADSORPTION SURFACE A, P90
   Hussein MZ, 1996, CARBON, V34, P1447, DOI 10.1016/0008-6223(96)88755-0
   Leboda R, 1997, LANGMUIR, V13, P1211, DOI 10.1021/la951564x
   LOPEZGONZALEZ JD, 1980, CARBON, V18, P413
   Lu W, 1997, CARBON, V35, P427, DOI 10.1016/S0008-6223(97)89614-5
   Tamai H, 1997, ADV MATER, V9, P55
   Tamai H, 1996, CHEM MATER, V8, P454, DOI 10.1021/cm950381t
   TorregrosaMacia R, 1997, CARBON, V35, P447, DOI 10.1016/S0008-6223(97)83724-4
   VANSANT EF, 1994, SEPAR TECHNOL, P229
   YAMADA Y, 1996, PREPR AM CHEM SOC DI, V41, P274
   Yoshizawa N, 1997, ENERG FUEL, V11, P327, DOI 10.1021/ef9601475
NR 13
TC 145
Z9 148
U1 5
U2 84
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD JAN 7
PY 2000
VL 12
IS 1
BP 62
EP +
DI 10.1002/(SICI)1521-4095(200001)12:1<62::AID-ADMA62>3.0.CO;2-B
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 271RB
UT WOS:000084606300016
DA 2018-10-20
ER

PT B
AU Neuman, MR
   Lindner, E
   Cristalli, A
   Gyurcsanyi, RE
   Cheema, K
   Pandolf, M
AF Neuman, MR
   Lindner, E
   Cristalli, A
   Gyurcsanyi, RE
   Cheema, K
   Pandolf, M
BE Dittmar, A
   Beebe, D
TI Thin- and thick-film structures for miniature biomedical sensors
SO 1ST ANNUAL INTERNATIONAL IEEE-EMBS SPECIAL TOPIC CONFERENCE ON
   MICROTECHNOLOGIES IN MEDICINE & BIOLOGY, PROCEEDINGS
LA English
DT Proceedings Paper
CT 1st Annual International IEEE-EMBS Special Topic Conference on
   Microtechnologies in Medicine & Biology
CY OCT 12-14, 2000
CL LYON, FRANCE
SP IEEE, Engn Med & Biol Soc
AB Physical and chemical miniature biomedical sensors can be fabricated using thin- and thick-film technology. Devices such as biopotential electrodes; temperature, force, and compliant strain gauge sensors; and ion-selective electrodes have been designed, constructed, and applied to biomedical problems. Some times there are advantages to depositing non-conventional materials, thicker films, and thin-thick-film hybrid structures in fabricating biomedical sensors.
C1 Univ Memphis, Herff Coll Engn, Joint Program Biomed Engn, Memphis, TN 38152 USA.
RP Neuman, MR (reprint author), Univ Memphis, Herff Coll Engn, Joint Program Biomed Engn, Memphis, TN 38152 USA.
RI Gyurcsanyi, Robert/F-5865-2010
CR BAIRD TM, 1992, 14 ANN INT C IEEE EN
   COSOFRET VV, 1995, ANAL CHEM, V67, P1647, DOI 10.1021/ac00106a001
   JANZ GJ, 1968, ANN NY ACAD SCI, V148, P210, DOI 10.1111/j.1749-6632.1968.tb20350.x
   NEUMAN MR, 1994, IEEE ENG MED BIOL, V13, P409, DOI 10.1109/51.294013
   NEUMAN MR, 1973, INT C MED BIOL ENG
NR 5
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-6603-4
PY 2000
BP 211
EP 215
DI 10.1109/MMB.2000.893774
PG 5
WC Engineering, Multidisciplinary; Engineering, Biomedical; Instruments &
   Instrumentation
SC Engineering; Instruments & Instrumentation
GA BT71M
UT WOS:000173833000046
DA 2018-10-20
ER

PT B
AU Duncan, AC
   Weisbuch, F
   Rouais, F
   Lazare, S
   Baquey, C
AF Duncan, AC
   Weisbuch, F
   Rouais, F
   Lazare, S
   Baquey, C
BE Dittmar, A
   Beebe, D
TI Laser microfabricated polymer surfaces: Effect of microtopography on
   cell growth
SO 1ST ANNUAL INTERNATIONAL IEEE-EMBS SPECIAL TOPIC CONFERENCE ON
   MICROTECHNOLOGIES IN MEDICINE & BIOLOGY, PROCEEDINGS
LA English
DT Proceedings Paper
CT 1st Annual International IEEE-EMBS Special Topic Conference on
   Microtechnologies in Medicine & Biology
CY OCT 12-14, 2000
CL LYON, FRANCE
SP IEEE, Engn Med & Biol Soc
ID EXCIMER-LASER; MICROARCHITECTURAL DESIGN; BIOMEDICAL APPLICATIONS
AB The relatively recent introduction of microelectronics technology into the area of biological sciences has drastically revolutionized the field. New foreseeable applications include miniaturized, multiparametric biosensors for high performance multianalyte assays or DNA sequencing, biocomputers, and substrates for controlled cell growth (i.e. tissue engineering). The objectives of this work were to investigate new methods combining microphotolithographical techniques with high energy KrF excimer laser beam technology to create surfaces with well defined 3-D microdomains in order to delineate critical microscopic topographical surface features that are relevant in governing material-cell interaction. Another obvious application of this study pertains to the fabrication of cell-based biosensors. Reproducible submicron features could also be obtained using this method. Subsequently, model osteoblast-like cells plated onto the laser modified surfaces showed preferential cell deposition on surfaces presenting "smooth" microtopographical transitions. This system may provide an interesting model for further insights into correlations between 3-D surface microtopography and cell response with new applications in the field of biosensor, biomaterial and pharmaceutical engineering sciences (e.g. new cell based biosensors, controlled synthesis of immobilized cell derived active ingredients).
C1 Univ Bordeaux 2, Natl Inst Hlth & Med Res, INSERM, U443, F-33076 Bordeaux, France.
RP Duncan, AC (reprint author), Univ Bordeaux 2, Natl Inst Hlth & Med Res, INSERM, U443, 146 Rue Leo Saignat, F-33076 Bordeaux, France.
CR CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   COREY JM, 1991, J NEUROSCI RES, V30, P300, DOI 10.1002/jnr.490300204
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Hunt JA, 1995, J MATER SCI-MATER M, V6, P813, DOI 10.1007/BF00134323
   LAZARE S, 1989, LASER CHEM, V10, P25, DOI 10.1155/1989/18750
   LEE JS, 1994, APPL PHYS LETT, V65, P400, DOI 10.1063/1.112314
   Matsuda T, 1996, J BIOMED MATER RES, V31, P235, DOI 10.1002/(SICI)1097-4636(199606)31:2<235::AID-JBM10>3.0.CO;2-K
   NAKAYAMA Y, 1995, J BIOMED MATER RES, V29, P1295, DOI 10.1002/jbm.820291017
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P675
   VILAMITJANAAMEDEE J, 1993, IN VITRO CELL DEV-AN, V29, P699
NR 11
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-6603-4
PY 2000
BP 542
EP 544
DI 10.1109/MMB.2000.893843
PG 3
WC Engineering, Multidisciplinary; Engineering, Biomedical; Instruments &
   Instrumentation
SC Engineering; Instruments & Instrumentation
GA BT71M
UT WOS:000173833000115
DA 2018-10-20
ER

PT B
AU Lithgow, BJ
   Zakis, JD
AF Lithgow, BJ
   Zakis, JD
BE Pudlowski, ZJ
   Jensen, HP
TI Modern biomedical engineering curriculum design
SO 4TH BALTIC REGION SEMINAR ON ENGINEERING EDUCATION, SEMINAR PROCEEDINGS
SE MONASH ENGINEERING EDUCATION SERIES
LA English
DT Proceedings Paper
CT 4th Baltic Region Seminar on Engineering Education
CY SEP 01-03, 2000
CL TECH UNIV DENMARK, COPENHAGEN, DENMARK
SP UNESCO, Int Ctr Engn Educ, Int Liaison Grp Engn Educ, UNESCO
HO TECH UNIV DENMARK
AB This paper details the formative forces impacting on the development of biomedical engineering curricula. These formative forces include those from professional societies, Government policy, funding allocation priorities, academic research direction, industry developments and university academic profile. European and American biomedical engineering curricula are compared with those in Australia. All three regions recognise the need to include subject material in the newly developing areas of biomedical engineering such as biomolecular engineering. A modern postgraduate curriculum is presented together with two new subjects representing some of the newly developing areas in biomedical engineering, namely current biomedical engineering research as well as bioelectromagnetism.
C1 Monash Univ, Melbourne, Vic 3004, Australia.
RP Lithgow, BJ (reprint author), Monash Univ, Melbourne, Vic 3004, Australia.
CR BARBENEL J, 1999, EUROPEAN COMMISSION
   BURKE G, EXPENDITURE ED TRAIN, P159
   Lithgow B J, 1993, J Clin Eng, V18, P335
   LITHGOW BJ, 1999, PROCEEE 99, P156
   Stokely E, 2000, IEEE ENG MED BIOL, V19, P12
NR 5
TC 0
Z9 0
U1 0
U2 0
PU UICEE, FACULTY ENGINEERING
PI CLAYTON
PA MONASH UNIVERSITY, CLAYTON, MELBOURNE VIC 3168, AUSTRALIA
BN 0-7326-2143-7
J9 MONAS ENGN EDUC SER
PY 2000
BP 121
EP 125
PG 3
WC Education, Scientific Disciplines; Engineering, Multidisciplinary
SC Education & Educational Research; Engineering
GA BR26K
UT WOS:000165966000028
DA 2018-10-20
ER

PT J
AU Spearing, SM
AF Spearing, SM
TI Materials issues in microelectromechanical systems (MEMS)
SO ACTA MATERIALIA
LA English
DT Review
DE microelectromechanical systems; scaling; microfabrication; material
   selection; mechanical properties
ID ELECTROSTATIC-COMB DRIVE; THIN-FILMS; SILICON-CARBIDE; MICROSTRUCTURES;
   MICROACTUATORS; MICROSYSTEMS; FABRICATION; CHALLENGES; TECHNOLOGY;
   MODULUS
AB Microelectromechanical systems (MEMS) have recently become an important area of technology, building on the success of the microelectronics industry over the past 50 years. MEMS combine mechanical and electrical function in devices at very small scales. Examples include pressure sensors, accelerometers, gyroscopes and optical devices, as well as chemical, biomedical and fluidic applications. The status of MEMS technology is reviewed with particular emphasis on materials issues therein. The materials issues in MEMS are divided into three categories, the MEMS material set, microfabrication processes, and material characterization and design. Each of these areas is addressed, with particular emphasis on the potential impact of materials solutions. A discussion of the future of MEMS and the role of materials in that Future is given. (C) 2000 Acta Metallurgica Inc. Published by Elsevier Science Ltd. All rights reserved.
C1 MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA.
RP Spearing, SM (reprint author), MIT, Dept Aeronaut & Astronaut, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
CR Ahn CH, 1998, IEEE T IND ELECTRON, V45, P866, DOI 10.1109/41.735330
   ALLEN MG, 1987, APPL PHYS LETT, V51, P241, DOI 10.1063/1.98460
   ALLEN MG, 1988, J ADHESION, V25, P303, DOI 10.1080/00218468808071269
   ANTHONY TR, 1983, J APPL PHYS, V54, P2419, DOI 10.1063/1.332357
   Arzt E, 1998, ACTA MATER, V46, P5611, DOI 10.1016/S1359-6454(98)00231-6
   Ashby M. F., 1992, MAT SELECTION MECH D
   Ayon AA, 1999, J ELECTROCHEM SOC, V146, P339, DOI 10.1149/1.1391611
   BAGCHI A, 1994, J MATER RES, V9, P1734, DOI 10.1557/JMR.1994.1734
   Balaraju JN, 1998, J MATER SCI LETT, V17, P1297, DOI 10.1023/A:1006528229614
   Ballarini R, 1998, MATER RES SOC SYMP P, V518, P137, DOI 10.1557/PROC-518-137
   BARRETT DL, 1993, J CRYST GROWTH, V128, P358, DOI 10.1016/0022-0248(93)90348-Z
   BASSOUS E, 1977, APPL PHYS LETT, V31, P135, DOI 10.1063/1.89587
   BENGTSSON S, 1992, J ELECTRON MATER, V21, P841
   Berlin AA, 1997, IEEE COMPUT SCI ENG, V4, P12, DOI 10.1109/99.590851
   BHUSAN B, 1998, TRIBOLOGY ISSUES OPP
   Bisson C., 1998, P SOL STAT SENS ACT, P1
   BOONE TD, 1988, P SOL STAT SENS ACT, P87
   Brittain S, 1998, PHYS WORLD, V11, P31
   BROWN S, 1998, MAT RES SOC S P, V518
   BUSCHVISHNIAC IJ, 1992, SENSOR ACTUAT A-PHYS, V33, P207, DOI 10.1016/0924-4247(92)80168-3
   Bustillo JM, 1998, P IEEE, V86, P1552, DOI 10.1109/5.704260
   Butler JE, 1998, MRS BULL, V23, P22, DOI 10.1557/S0883769400029316
   Chaudhuri B, 1998, MICROSYST TECHNOL, V4, P159, DOI 10.1007/s005420050121
   CHEN KS, 1999, MATER RES SOC S P, V546, P51
   CHEN KS, IN PRESS J AM CERAM
   Choyke W J, 1997, SILICON CARBIDE REV, VII
   Choyke W J, 1997, SILICON CARBIDE REV, VI
   Cornella G, 1998, MATER RES SOC SYMP P, V518, P81, DOI 10.1557/PROC-518-81
   Daschner W, 1995, J VAC SCI TECHNOL B, V13, P2729, DOI 10.1116/1.588254
   DEWA AS, 1997, P TRANSD 97 CHIC JUN, P757
   DREXEL KE, 1992, NANOSYSTEMS MOL MACH
   EHRFELD W, 1997, MICROMECHANICS MEMS, P623
   Epstein AH, 1997, SCIENCE, V276, P1211, DOI 10.1126/science.276.5316.1211
   Epstein AH, 1997, 28 AIAA FLUID DYN C
   Esashi M, 1998, P IEEE, V86, P1627, DOI 10.1109/5.704268
   EVANS AG, 1995, ACTA METALL MATER, V43, P2507, DOI 10.1016/0956-7151(94)00444-M
   FITZGERALD AM, 1999, IN PRESS P TRANSD 99
   Flannery AF, 1998, SENSOR ACTUAT A-PHYS, V70, P48, DOI 10.1016/S0924-4247(98)00111-3
   Flynn A. M., 1992, Journal of Microelectromechanical Systems, V1, P44, DOI 10.1109/84.128055
   FREUND LB, 1987, J APPL MECH-T ASME, V54, P553, DOI 10.1115/1.3173068
   FUKUDA T, 1998, HDB SENSORS ACTUATOR, V6
   Gabriel KJ, 1998, P IEEE, V86, P1534, DOI 10.1109/5.704257
   GHANDHI SK, 1994, VLSI FABRICATION PRI
   Gui C, 1998, J ELECTROCHEM SOC, V145, P2198, DOI 10.1149/1.1838616
   Henry S, 1998, J PHARM SCI, V87, P922, DOI 10.1021/js980042+
   HEUER AH, 1999, MAT RES SOC S P, V546
   HIRATA Y, 1995, MICRO ELECTRO MECHANICAL SYSTEMS - IEEE PROCEEDINGS, 1995, P191, DOI 10.1109/MEMSYS.1995.472581
   Hommel M, 1999, MATER RES SOC SYMP P, V546, P133
   Horsley DA, 1998, IEEE-ASME T MECH, V3, P175, DOI 10.1109/3516.712113
   Huff M. A., 1993, Journal of Microelectromechanical Systems, V2, P74, DOI 10.1109/84.232603
   HUI EE, 1998, SOL STAT SENS ACT WO, P256
   IMTHURN GP, 1992, J APPL PHYS, V72, P2526, DOI 10.1063/1.352345
   Kahn H, 1998, J MICROMECH MICROENG, V8, P213, DOI 10.1088/0960-1317/8/3/007
   KELLER CG, 1995, TRANSDUCERS 95, P99
   Keller RM, 1998, J MATER RES, V13, P1307, DOI 10.1557/JMR.1998.0186
   Kitabatake M, 1999, SENSOR MATER, V11, P1
   Ko W. H., 1985, MICROMACHINING MICRO, P41
   Kovacs GTA, 1998, P IEEE, V86, P1536, DOI 10.1109/5.704259
   KRULEVITCH P, 1996, DSC 59 MICROELECTROM, P301
   Lee I, 1999, EXP FLUIDS, V26, P27, DOI 10.1007/s003480050262
   Lee SH, 1998, MATER RES SOC SYMP P, V518, P143, DOI 10.1557/PROC-518-143
   LIN CC, 1998, SOL STAT SENS ACT WO, P25
   Lu MSC, 1998, MATER RES SOC SYMP P, V518, P27, DOI 10.1557/PROC-518-27
   MADOU M, 1997, FUNDAMENTALS MICROFA, P405
   Madou MJ, 1997, FUNDAMENTALS MICROFA
   MASZARA WP, 1991, J ELECTROCHEM SOC, V138, P341, DOI 10.1149/1.2085575
   MASZARA WP, 1993, MICROELECTRON ENG, V22, P299, DOI 10.1016/0167-9317(93)90178-8
   MEHREGANY M, 1992, IEEE T ELECTRON DEV, V39, P2060, DOI 10.1109/16.155878
   Mehregany M, 1998, P IEEE, V86, P1594, DOI 10.1109/5.704265
   Mohr J, 1998, SENSOR MATER, V10, P363
   Muhlstein C.L., 1998, TRIBOLOGY ISSUES OPP, P529
   Nix WD, 1997, MAT SCI ENG A-STRUCT, V234, P37
   NIX WD, 1989, METALL TRANS A, V20, P2217, DOI 10.1007/BF02666659
   Ohring M., 1992, MAT SCI THIN FILMS, P413
   Okojie RS, 1997, P TRANSD 97 IEEE, P1407
   Olivas JD, 1998, JOM-J MIN MET MAT S, V50, P38, DOI 10.1007/s11837-998-0066-3
   Osterberg PM, 1997, J MICROELECTROMECH S, V6, P107, DOI 10.1109/84.585788
   PALMOUR JW, 1995, COMPOUND SEMICONDUCT, V141, P377
   Park JY, 1998, J MICROMECH MICROENG, V8, P307, DOI 10.1088/0960-1317/8/4/008
   RAJAN N, 1998, P SOL STAT SENS ACT, P31
   REMBETSKI JF, 1995, SOLID STATE TECHNOL, V38, P67
   RISTIC LJ, 1994, SENSOR TECHNOLOGY DE, pCH5
   ROMBACH R, 1994, SENSOR ACTUAT A-PHYS, V41, P410
   ROSLER J, 1990, ACTA METALL MATER, V38, P671, DOI 10.1016/0956-7151(90)90223-4
   Ruprecht R, 1998, MICROSYST TECHNOL, V5, P44, DOI 10.1007/s005420050139
   Rymuza Z, 1999, MICROSYST TECHNOL, V5, P173, DOI 10.1007/s005420050160
   Saito T, 1998, J APPL ELECTROCHEM, V28, P559, DOI 10.1023/A:1003233715362
   Schmidt MA, 1998, P IEEE, V86, P1575, DOI 10.1109/5.704262
   Senturia SD, 1998, P IEEE, V86, P1611, DOI 10.1109/5.704266
   SENTURIA SD, 1997, MICROMECHANICS MEMS, P659
   SENTURIA SD, 1998, SENSOR ACTUAT A-PHYS, P1
   Sharpe WN, 1998, MATER RES SOC SYMP P, V518, P57, DOI 10.1557/PROC-518-57
   Sharpe WN, 1999, EXP MECH, V39, P162, DOI 10.1007/BF02323548
   Smith D. L., 1995, THIN FILM DEPOSITION, P196
   Sniegowski JJ, 1996, IEEE ELECTR DEVICE L, V17, P366, DOI 10.1109/55.506369
   SOULOFF RE, 1998, TRIBOLOGY ISSUES OPP
   SPEARING S M, 1997, CERAM ENG SCI P, V18, P11
   SRINIVASAN R, 1997, P INT C SOL STAT SEN, P163
   Tada H, 1998, MATER RES SOC SYMP P, V518, P161, DOI 10.1557/PROC-518-161
   TANG WC, 1990, SENSOR ACTUAT A-PHYS, V21, P328, DOI 10.1016/0924-4247(90)85065-C
   Taniguchi J, 1997, JPN J APPL PHYS 1, V36, P7691, DOI 10.1143/JJAP.36.7691
   Tian CY, 1998, SENSOR ACTUAT B-CHEM, V52, P119, DOI 10.1016/S0925-4005(98)00265-2
   Tong Q.-Y., 1998, SEMICONDUCTOR WAFER
   Trimmer W., 1997, MICROMECHANICS MEMS
   TURNER K, 1998, MATER RES SOC S P, V518, P191
   Van Kessel PF, 1998, P IEEE, V86, P1687, DOI 10.1109/5.704274
   VLASSAK JJ, 1992, J MATER RES, V7, P3242, DOI 10.1557/JMR.1992.3242
   Wang SN, 1998, SENSOR MATER, V10, P375
   Whitesides G, 1998, TECHNOL REV, V101, P84
   WIESNER JR, 1993, SOLID STATE TECHNOL, V36, P63
   Wilson CJ, 1996, J MICROELECTROMECH S, V5, P142, DOI 10.1109/84.536620
   Wise KD, 1998, P IEEE, V86, P1531
   WOLFFENBUTTEL RF, 1994, SENSOR ACTUAT A-PHYS, V43, P223, DOI 10.1016/0924-4247(93)00653-L
   Ye WJ, 1998, J MICROELECTROMECH S, V7, P16, DOI 10.1109/84.661380
   Yoshino Y, 1998, MATER RES SOC SYMP P, V518, P9, DOI 10.1557/PROC-518-9
   Zhang X, 1998, THIN SOLID FILMS, V335, P97, DOI 10.1016/S0040-6090(98)00952-3
   Ziebart V, 1999, MATER RES SOC SYMP P, V546, P103
NR 117
TC 449
Z9 475
U1 11
U2 239
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-6454
EI 1873-2453
J9 ACTA MATER
JI Acta Mater.
PD JAN 1
PY 2000
VL 48
IS 1
BP 179
EP 196
DI 10.1016/S1359-6454(99)00294-3
PG 18
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 281ZN
UT WOS:000085191500011
DA 2018-10-20
ER

PT J
AU Peppas, NA
   Huang, Y
   Torres-Lugo, M
   Ward, JH
   Zhang, J
AF Peppas, NA
   Huang, Y
   Torres-Lugo, M
   Ward, JH
   Zhang, J
TI Physicochemical, foundations and structural design of hydrogels in
   medicine and biology
SO ANNUAL REVIEW OF BIOMEDICAL ENGINEERING
LA English
DT Review
DE controlled release; diffusion; polymer network; responsive hydrogels;
   swelling
ID DEXTRAN HYDROGELS; SENSITIVE HYDROGELS; COPOLYMER NETWORKS;
   CONTROLLED-RELEASE; PHASE-TRANSITIONS; ORAL DELIVERY; DRUG-DELIVERY;
   GELS; POLYMER; PH
AB Hydrogels are cross-linked hydrophilic polymers that can imbibe water or biological fluids. Their biomedical and pharmaceutical applications include a very wide range of systems and processes that utilize several molecular design characteristics. This review discusses the molecular structure, dynamic behavior, and structural modifications of hydrogels as well as the various applications of these biohydrogels.
   Recent advances in the preparation of three-dimensional structures with exact chain conformations, as well as tethering of functional groups, allow for the preparation of promising new hydrogels. Meanwhile, intelligent biohydrogels with pH- or temperature-sensitivity continue to be important materials in medical applications.
C1 Purdue Univ, Sch Chem Engn, Program Therapeut & Diagnost Devices, Biomat & Drug Delivery Labs, W Lafayette, IN 47907 USA.
RP Peppas, NA (reprint author), Purdue Univ, Sch Chem Engn, Program Therapeut & Diagnost Devices, Biomat & Drug Delivery Labs, W Lafayette, IN 47907 USA.
EM peppas@ecn.purdue.edu
CR Amsden B, 1998, MACROMOLECULES, V31, P8382, DOI 10.1021/ma980765f
   ANDRADE JD, 1976, HYDROGELS MED RELATE, V31
   ANDREWS AT, 1986, ELECTROPHORESIS
   Ansell RJ, 1996, CURR OPIN BIOTECH, V7, P89, DOI 10.1016/S0958-1669(96)80101-7
   ANSETH KS, 1994, CHEM ENG SCI, V49, P2207, DOI 10.1016/0009-2509(94)E0055-U
   BAE YH, 1997, CONTROLLED DRUG DELI, V8, P147
   BELL CL, 1995, ADV POILYMN SCI, V122, P126
   BRANNONPEPPAS L, 1990, ABSORBENT POLYM TECH, P67
   CASTILLO EJ, 1985, BIOMATERIALS, V6, P338, DOI 10.1016/0142-9612(85)90089-4
   Chaikof EL, 1996, CHEMTECH, V26, P17
   CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0
   CHEN J, 1998, P INT S CONTR REL BI, V25, P60
   Cheong SH, 1997, MACROMOLECULES, V30, P1317, DOI 10.1021/ma961014l
   Cormack PAG, 1999, REACT FUNCT POLYM, V41, P115, DOI 10.1016/S1381-5148(99)00024-3
   Dillow AK, 1998, CURR OPIN SOLID ST M, V3, P252, DOI 10.1016/S1359-0286(98)80099-5
   DUKE T, 1994, BIOPOLYMERS, V34, P239, DOI 10.1002/bip.360340210
   Dvornic PR, 1996, CURR OPIN COLLOID IN, V1, P221, DOI 10.1016/S1359-0294(96)80008-2
   Escobedo FA, 1999, PHYS REP, V318, P86, DOI 10.1016/S0370-1573(99)00012-5
   Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   GALAEV IY, 1995, RUSS CHEM REV, V64, P471
   GRIFFITH L, 1995, MACROMOLECULES, V28, P6787
   HALPERIN A, 1992, ADV POLYM SCI, V100, P31
   Hayakawa M, 1997, LANGMUIR, V13, P3595, DOI 10.1021/la970195x
   Hennink WE, 1996, J CONTROL RELEASE, V39, P47, DOI 10.1016/0168-3659(95)00132-8
   Hennink WE, 1997, J CONTROL RELEASE, V48, P107, DOI 10.1016/S0168-3659(97)00047-3
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   HOFFMAN AS, 1995, POLYM MAT ENCY, P3282
   HOLLY FJ, 1976, HYDROGELS MED RELATE, P252
   Holtz JH, 1997, NATURE, V389, P829
   Horbett T. A., 1986, HYDROGELS MED PHARM, V1, P127
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hubert SJ, 1998, MACROMOLECULES, V31, P181, DOI 10.1021/ma970763f
   Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K
   Kaneko Y, 1996, MACROMOL SYMP, V109, P41, DOI 10.1002/masy.19961090105
   KINNEY AB, 1994, ACS SYM SER, V480, P2
   KOHN J, 1996, BIOMATERIALS SCI INT, V2, P64
   KOKUFATA E, 1991, NATURE, V351, P302, DOI 10.1038/351302a0
   Lowman AM, 1999, J PHARM SCI, V88, P933, DOI 10.1021/js980337n
   Lowman AM, 1997, MACROMOLECULES, V30, P4959, DOI 10.1021/ma970399k
   LOWMAN AM, 1998, A BENZON S, V43, P206
   LOWMAN AM, 1999, ENCY CONTROLLED DRUG, P397
   LUMPKIN OJ, 1985, BIOPOLYMERS, V24, P1573, DOI 10.1002/bip.360240812
   MALLAPRAGADA SK, 1999, HDB BIOMATERIAL EVAL, V27, P425
   Masaro L, 1999, PROG POLYM SCI, V24, P731, DOI 10.1016/S0079-6700(99)00016-7
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Moriyama K, 1996, J CONTROL RELEASE, V42, P237, DOI 10.1016/0168-3659(96)01456-3
   Mosbach K, 1998, J MOL RECOGNIT, V11, P62, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<62::AID-JMR391>3.0.CO;2-5
   MUHR AH, 1982, POLYMER, V23, P1012, DOI 10.1016/0032-3861(82)90402-5
   Nakayama Y, 1999, LANGMUIR, V15, P1667, DOI 10.1021/la981169h
   OKANO T, 1998, BIORELATED POLYM
   Okay O, 1999, J APPL POLYM SCI, V74, P2181, DOI 10.1002/(SICI)1097-4628(19991128)74:9<2181::AID-APP8>3.0.CO;2-J
   Osada Y, 1998, ADV MATER, V10, P827, DOI 10.1002/(SICI)1521-4095(199808)10:11<827::AID-ADMA827>3.0.CO;2-L
   PANDE VS, 1994, P NATL ACAD SCI USA, V91, P12976, DOI 10.1073/pnas.91.26.12976
   Park TG, 1999, BIOMATERIALS, V20, P517, DOI 10.1016/S0142-9612(98)00197-5
   Peppas N. A., 1986, HYDROGELS MED PHARM, V1, P57
   Peppas N. A., 1986, HYDROGELS MED PHARM, VI, P1
   Peppas N. A., 1986, HYDROGELS MED PHARM, V1
   PEPPAS NA, 1976, J POLYM SCI POL CHEM, V14, P441, DOI 10.1002/pol.1976.170140215
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Peppas NA, 1997, CURR OPIN COLLOID IN, V2, P531, DOI 10.1016/S1359-0294(97)80103-3
   Peppas NA, 1986, HYDROGELS MED PHARM, V1, P27
   PEPPAS NA, 1964, BIOMATERIALS SCI, P60
   Putney SD, 1998, NAT BIOTECHNOL, V16, P153, DOI 10.1038/nbt0298-153
   RAMKISSOONGANOR.C, 1999, J CONTROL RELEASE, V59, P87
   Ratner B. D., 1986, HYDROGELS MED PHARM, V1, P85
   RICKA J, 1984, MACROMOLECULES, V17, P2916, DOI 10.1021/ma00142a081
   Schwarte LM, 1998, POLYMER, V39, P6057, DOI 10.1016/S0032-3861(98)00087-1
   SCHWARTE LM, 1998, TAILORED POLYM MAT C, V3, P57
   Shakhnovich EI, 1998, FOLD DES, V3, pR45, DOI 10.1016/S1359-0278(98)00021-2
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   TANAKA N, 1989, ADV CHROMATOGR, V30, P81
   TANAKA T, 1979, POLYMER, V20, P1404, DOI 10.1016/0032-3861(79)90281-7
   Tanaka T, 1998, BER BUNSEN PHYS CHEM, V102, P1529, DOI 10.1002/bbpc.19981021103
   Tanaka T, 1995, FARADAY DISCUSS, V101, P201, DOI 10.1039/fd9950100201
   TIRRELL JG, 1994, CHEM ENG NEWS, V72, P40, DOI 10.1021/cen-v072n051.p040
   Torres-Lugo M, 1999, MACROMOLECULES, V32, P6646, DOI 10.1021/ma990541c
   Vakkalanka SK, 1996, J BIOMAT SCI-POLYM E, V8, P119, DOI 10.1163/156856296X00192
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   WULFF G, 1995, ANGEW CHEM INT EDIT, V34, P1812, DOI 10.1002/anie.199518121
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   ZHU S, 1993, MAKROMOL CHEM-THEOR, V2, P587
NR 84
TC 614
Z9 625
U1 4
U2 153
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 1523-9829
EI 1545-4274
J9 ANNU REV BIOMED ENG
JI Annu. Rev. Biomed. Eng.
PY 2000
VL 2
BP 9
EP 29
DI 10.1146/annurev.bioeng.2.1.9
PG 21
WC Engineering, Biomedical
SC Engineering
GA 364HR
UT WOS:000089887400002
PM 11701505
DA 2018-10-20
ER

PT B
AU Piconi, C
   Casarci, M
AF Piconi, C
   Casarci, M
BE Rammlmair, D
   Mederer, J
   Oberthur, T
   Heimann, RB
   Pentinghaus, H
TI Purification of chemicals for production of biomedical grade YTZP
   ceramics
SO APPLIED MINERALOGY, VOLS 1 AND 2: RESEARCH, ECONOMY, TECHNOLOGY, ECOLOGY
   AND CULTURE
LA English
DT Proceedings Paper
CT 6th International Congress on Applied Mineralogy (ICAM 2000)
CY JUL 17-19, 2000
CL GOTTINGEN, GERMANY
SP German Mineral Soc, Deutsch Forsch Gemeinschaft, BEB Erdgas & Erdol GmbH, Hannover, UTR Umwelt GmbH, Gladbeck, PPM Pure Metals GmbH, Langelsheim, Int Council Appl Mineral, Fed Inst Geosci & Nat Resources, Geol Survey State Lower Saxony, Univ Gottingen, Dept Mineral, Agcy Technol Transfer & Innovat Lower Saxony
AB Total Hip Replacements (THR) lifetime is limited principally by the body reaction to the wear debris of Ultra High Molecular Weight Polyethylene (UHMWPE) sockets used in the acetabular component. Ceramic ball heads made of alumina or zirconia greatly reduce the wear volume of UHMWPE sockets, enhancing THRs lifetime. Today, more than 500.000 zirconia ball heads were implanted worldwide, and new breakthroughs are expected in the future, such as the introduction of zirconia components in knee replacements.
   A main problem in the development of zirconia for biomedical application was its content of radioactive impurities. In this work, cation exchange in a Continuous Annular Chromatograph (CAC) was used to purify zirconium chemical precursors. The multi-component liquid chromatographic separations was obtained using a slowly rotating annular bed of sorbing material. The CAC throughput can be significantly increased using thicker columns: the effects of this variation on the separation efficiency are being investigated.
CR CANON RM, 1980, SEPAR SCI TECHNOL, V15, P655, DOI 10.1080/01496398008068502
   CANON RM, 1978, J LIQ CHROMATOGR, V1, P427, DOI 10.1080/01483917808060009
   HURST FJ, 1983, HYDROMETALLURGY, V10, P1, DOI 10.1016/0304-386X(83)90072-5
   MARTIN AJP, 1949, DISCUSS FARADAY SOC, P332
   SCOTT CD, 1976, J CHROMATOGR, V126, P381, DOI 10.1016/S0021-9673(01)84087-5
NR 5
TC 2
Z9 2
U1 0
U2 0
PU A A BALKEMA PUBLISHERS
PI LEIDEN
PA SCHIPHOLWEG 107C, PO BOX 447, 2316 XC LEIDEN, NETHERLANDS
BN 90-5809-163-5
PY 2000
BP 205
EP 207
PG 3
WC Mineralogy
SC Mineralogy
GA BQ78W
UT WOS:000089525700054
DA 2018-10-20
ER

PT B
AU Lei, PP
   Ferrari, M
   Vogel, V
   Baker, JR
AF Lei, PP
   Ferrari, M
   Vogel, V
   Baker, JR
BE Kraft, DH
TI The frontiers of nanotechnology and nanomedicine
SO ASIS 2000: PROCEEDINGS OF THE 63RD ASIS ANNUAL MEETING, VOL 37, 2000
SE PROCEEDINGS OF THE ASIS ANNUAL MEETINGS
LA English
DT Proceedings Paper
CT 63rd Annual Meeting of the American-Society-for-Information-Science
CY NOV 12-16, 2000
CL CHICAGO, IL
SP Amer Soc Informat Sci
AB The future of medicine is slowly migrating to the use of nanotechnology to manipulate biomolecules that regulate life and death. Nanotechnology is the fabrication of objects and devices on the scale of nanometers for whatever purpose they serve. Within the past four years, there are five nanotechnology centers established in the United States doing nanoresearch on better health care delivery. The hottest nanoresearch areas presently are on gene therapy, cancer detection, and to regulate better drug delivery to stubborn diseases such as diabetes. Hopefully by the end of this decade, patients will be wearing minuscule "smart bombs" that find cancer cells, kill them with the help of lasers and report the kills. Or patients will be implanted a miniaturized sensor for diabetes that mimics the glucose-detection system and monitors the brood-sugar levels and releases insulin as needed. Other nanodevices for drug delivery will be microchips that will hold nanoliters of anything from painkillers to antibiotics for releases into the hunan body. These are some of the examples of how nanotechnology and nanomedicine are linked. The three speakers, listed above, who graciously have agreed to speak at ASIS, are pioneers in nanomedicine. They believe that nanomedicine will bring safer and more effective way to repair genes and treat ailments. They also believe in using nonbiological substances that will not trigger an immune response in the human body. Both Dr. Baker and Dr. Ferrari were profiled in Technology Review from MIT and Dr. Baker was also written up in Newsweek. Dr. Vogel's interest is on molecular bioengineenng and the engineering of manmade devices and materials on the molecular level. She is well known in her field of research. All these three researchers received grants from NIH for their innovative nanoresearch. This proposal will surely bring interests to members of ASIS, including the biomedical professionals, because this will touch on everyone's future health concerns. Knowledge is power, ASIS can be the first to disseminate what is new in technology.
C1 Univ Arizona, Arizona Hlth Sci Lib, Tucson, AZ 85724 USA.
NR 0
TC 0
Z9 0
U1 2
U2 10
PU INFORMATION TODAY INC
PI MEDFORD
PA 143 OLD MARLTON PIKE, MEDFORD, NJ 08055 USA
BN 1-57387-108-7
J9 P ASIS ANN
PY 2000
VL 37
BP 496
EP 496
PG 1
WC Computer Science, Information Systems; Information Science & Library
   Science
SC Computer Science; Information Science & Library Science
GA BR69E
UT WOS:000167173500072
DA 2018-10-20
ER

PT S
AU Malafaya, PB
   Stappers, F
   Reis, RL
AF Malafaya, PB
   Stappers, F
   Reis, RL
BE Giannini, S
   Moroni, A
TI Emulsion crosslinking as a new manufacturing route to produce
   hydroxylapatite particulates in a network of starch
SO BIOCERAMICS
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 13th International Symposium on Ceramic in Medicine /Symposium on
   Ceramic Materials in Orthopaedic Surgery: Clinical Results in the Year
   2000
CY NOV 22-26, 2000
CL BOLOGNA, ITALY
SP Bologna Univ, Ilalian Soc Orthopaed & Tranumatol, European Federat Natl Assoc Orthoped & Traumatol, Japanese Soc Orthoped Implants, Italian Soc Biomat, Soc Biomat, Korean Soc Biomat, Japanese Soc Biomat, Australian Soc Biomat, Ceramic Soc Japan, Int & Amer Assoc Dental Res
DE bioactive; calcium phosphate; carrier; fillers; particulate;
   reinforcement
AB Bioactive particulates with tailored resorption rates can be very useful on biomedical applications such as filling of bone and dentistry defects, carriers for controlled release of bioactive agents and reinforcement in polymer/bioceramic orthopaedic composites. The aim of the present study was to develop a new processing route to produce composite particulates based on hydroxylapatite (HA) and starch. The newly proposed processing route consists on the crosslinking of starch that is able to encapsulate the IIA particles creating a composite material with different sizes (from 3000-700 mum) which is resorbable and bioactive. This work also involves the characterization of the developed material, as well as the study of the in-vitro degradation and bioactive behaviour of the particulates. The particulate biomaterials have shown to be bioactive even after small immersion periods on a simulated body fluid (SBF). The obtained results (in vitvo) indicate that particulates will be expected to be resorbed when implanted. The developed materials present an interesting combination of morphological and chemical properties that make them potential biomaterials to be used as fillers of bone defects, drug delivery carriers or as reinforcement of bioactive starch-based composites.
C1 Univ Minho, Dept Polymer Engn, PT-4710057 Braga, Portugal.
RP Malafaya, PB (reprint author), Univ Minho, Dept Polymer Engn, Campus Gualtar, PT-4710057 Braga, Portugal.
RI Malafaya, Patricia/M-3994-2013; Reis, Rui L./A-8938-2008; Group,
   3Bs/E-4374-2012
OI Malafaya, Patricia/0000-0002-7916-5910; Reis, Rui
   L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456
CR GATTI AM, 1992, BIOMATERIALS HARD TI, P97
   GOMES ME, 2000, IN PRESS BIOMATERIAL
   Grimandi G, 1998, J BIOMED MATER RES, V39, P660, DOI 10.1002/(SICI)1097-4636(19980315)39:4<660::AID-JBM22>3.0.CO;2-9
   Lemons J E, 1988, Ann N Y Acad Sci, V523, P278, DOI 10.1111/j.1749-6632.1988.tb38521.x
   MENDES S, 1998, 24 ANN M SOC BIOM SA, P9
   Oonishi H., 1992, BIOMATERIALS HARD TI, P17
   Pereira CS, 1998, J MATER SCI-MATER M, V9, P825, DOI 10.1023/A:1008944127971
   Reis RL, 1997, POLYM INT, V43, P347
   Reis RL, 1997, J MATER SCI-MATER M, V8, P897, DOI 10.1023/A:1018514107669
NR 9
TC 2
Z9 2
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-866-4
J9 KEY ENG MAT
PY 2000
VL 192-1
BP 243
EP 246
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BS01D
UT WOS:000168303700061
DA 2018-10-20
ER

PT S
AU Feng, LY
   Li, SP
   Yan, YH
   Liu, CS
AF Feng, LY
   Li, SP
   Yan, YH
   Liu, CS
BE Giannini, S
   Moroni, A
TI The effect of CaCO3 and TiO2 nanometer particles on A(549) and L-929
   cells
SO BIOCERAMICS
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 13th International Symposium on Ceramic in Medicine /Symposium on
   Ceramic Materials in Orthopaedic Surgery: Clinical Results in the Year
   2000
CY NOV 22-26, 2000
CL BOLOGNA, ITALY
SP Bologna Univ, Ilalian Soc Orthopaed & Tranumatol, European Federat Natl Assoc Orthoped & Traumatol, Japanese Soc Orthoped Implants, Italian Soc Biomat, Soc Biomat, Korean Soc Biomat, Japanese Soc Biomat, Australian Soc Biomat, Ceramic Soc Japan, Int & Amer Assoc Dental Res
DE biological effect; cell culture; morphology; nano-meter particles
AB Biomedical nanometer materials are a new field of biomaterials. In this work, CaCO3 and TiO2 nanometer particles were prepared by sol-gel and chemical homogeneous precipitation reaction with ultrasonic wave irradiation. Cell proliferation was measured by MTT method. It is shown that in vitro CaCO3 particles inhibited significantly on growth and proliferation of lung cancer cells A(549), but improved slightly the growth of L-929 cells. On the other hand, TiO2 particles had the same effect of inhibition on A549 cells, however, it obviously restrained the growth of L929 SEM observation demonstrated that L929 cells faded somehow after treatment of TiO2 particles, but the morphology of L-929 cells was not changed after treatment of CaCO3 particles. A(549) cells became the typical apoptosis body after treated by TiO2 and CaCO3 particles.
C1 Wuhan Univ Technol, Biomed Mat & Engn Res Ctr, Wuhan 430070, Peoples R China.
RP Feng, LY (reprint author), Wuhan Univ Technol, Biomed Mat & Engn Res Ctr, 122 Luoshi Rd, Wuhan 430070, Peoples R China.
CR ABRAHAM T, 1996, CERAMIC T, V62, P3
   Aoki H., 1991, SCI MED APPL HYDROXY, P13
   FENG LY, 1998, CHINESE J BIOMED ENG, V17, P374
   Li S., 1996, BIOCERAMICS, V9, P225
   YAMASHITAK U, 1992, J CERAMIC SOC JPN, V100, P426
NR 5
TC 0
Z9 1
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-866-4
J9 KEY ENG MAT
PY 2000
VL 192-1
BP 325
EP 328
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BS01D
UT WOS:000168303700081
DA 2018-10-20
ER

PT S
AU Burger, W
   Richter, HG
AF Burger, W
   Richter, HG
BE Giannini, S
   Moroni, A
TI High strength and toughness alumina matrix composites by transformation
   toughening and 'in situ' platelet reinforcement (ZPTA) - The new
   generation of bioceramics
SO BIOCERAMICS
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 13th International Symposium on Ceramic in Medicine /Symposium on
   Ceramic Materials in Orthopaedic Surgery: Clinical Results in the Year
   2000
CY NOV 22-26, 2000
CL BOLOGNA, ITALY
SP Bologna Univ, Ilalian Soc Orthopaed & Tranumatol, European Federat Natl Assoc Orthoped & Traumatol, Japanese Soc Orthoped Implants, Italian Soc Biomat, Soc Biomat, Korean Soc Biomat, Japanese Soc Biomat, Australian Soc Biomat, Ceramic Soc Japan, Int & Amer Assoc Dental Res
DE Al2O3 : Cr; bioceramics; 'in situ' platelet formation; SrAl12-xCrxO19;
   tetragonal zirconia; transformation toughening; ZPTA; ZTA
ID CERAMICS
AB High purity alumina ceramics have been used for more than 25 years in biomedical applications due to their excellent wear behaviour and high strength. Nevertheless great effort have been undertaken to develop a material with increased strength combined with excellent wear properties. One candidate material family is ZTA-ceramics. Out of this family a new generation of that material is available now in which high strength, high toughness, high hardness and wear properties are combined. This material is a zirconia and platelet reinforced alumina ceramic (ZPTA).
   In more details ZPTA-ceramics are based on an alumina matrix containing homogeneously distributed metastable zirconia particles and "in situ" formed hexagonal ternary aluminate platelets of a length of about 3 mum and a thickness of 0.3 mum The chemical composition and the microstructure were optimised to achieve a ceramic material combining all required properties: strength of more than 1200 MPa, fracture toughness of 6,5 MPa rootm and Vickers hardness HV1 of 1975 are typical. Extremely low wear rates have been detected in ring-on-disc and HIP simulator tests.
C1 CeramTec AG, Cent Dev Dept, DE-73201 Plochingen, Germany.
RP Burger, W (reprint author), CeramTec AG, Cent Dev Dept, POB 1149, DE-73201 Plochingen, Germany.
CR BURGER W, 1998, KERAM Z, V50, P18
   Dworak U., 1978, Berichte der Deutschen Keramischen Gesellschaft, V55, P98
   Gregori G, 1999, MAT SCI ENG A-STRUCT, V271, P401, DOI 10.1016/S0921-5093(99)00383-4
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
NR 4
TC 9
Z9 9
U1 1
U2 10
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-866-4
J9 KEY ENG MAT
PY 2000
VL 192-1
BP 545
EP 548
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BS01D
UT WOS:000168303700130
DA 2018-10-20
ER

PT S
AU Friberg, J
   Fernandez, E
   Sarda, S
   Nilsson, M
   Ginebra, MP
   Martinez, S
   Planell, JA
AF Friberg, J
   Fernandez, E
   Sarda, S
   Nilsson, M
   Ginebra, MP
   Martinez, S
   Planell, JA
BE Giannini, S
   Moroni, A
TI An experimental approach to the study of the rheology behaviour of
   synthetic bone calcium phosphate cements
SO BIOCERAMICS
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 13th International Symposium on Ceramic in Medicine /Symposium on
   Ceramic Materials in Orthopaedic Surgery: Clinical Results in the Year
   2000
CY NOV 22-26, 2000
CL BOLOGNA, ITALY
SP Bologna Univ, Ilalian Soc Orthopaed & Tranumatol, European Federat Natl Assoc Orthoped & Traumatol, Japanese Soc Orthoped Implants, Italian Soc Biomat, Soc Biomat, Korean Soc Biomat, Japanese Soc Biomat, Australian Soc Biomat, Ceramic Soc Japan, Int & Amer Assoc Dental Res
DE calcium phosphate cement; injectability; viscosity; alpha-tricalcium
   phosphate
ID SETTING REACTION; CLINICAL-APPLICATIONS; SYSTEM
AB Calcium phosphate cements were developed to fit surgical needs in biomedical fields such as odontology or traumatology. Nowadays, a broad field of new applications have been found for this kind of materials. Drug delivery systems, tissue-engineering scaffolds and osteoporotic bone filling applications are some of the new fields that are being benefited with these materials. Looking at both, commercial and new experimental calcium phosphate cements it is found that cr-tricalcium phosphate is the main reactive powder responsible for the setting and the hardening of the cement. Thus, it is important to know how alpha -tricalcium phosphate affects injectability of these cements. The aim of this study was to investigate the theological behaviour of alpha -tricalcium phosphate slurries in order to know how the cement injectability should be modified. Factors such as liquid to powder ratio, particle size of the main reactive powder and the addition of dispersants have been considered. The results showed that viscosity decreased when particle size of reactant was increased and when liquid to powder ratio was increased. It was also found that a minimum of viscosity exists at an optimum value of the weight percentage of dispersant.
C1 Univ Politecn Catalunya, Dept Mat Sci & Met Engn, CREB, ES-08028 Barcelona, Spain.
   Univ Barcelona, Dept Cristallog Mineral & Recursos Minerals, ES-08028 Barcelona, Spain.
RP Friberg, J (reprint author), Univ Politecn Catalunya, Dept Mat Sci & Met Engn, CREB, Av Diagonal 647, ES-08028 Barcelona, Spain.
RI Ginebra, Maria-Pau/J-8149-2017; Martinez, Salvador/L-5777-2014
OI Ginebra, Maria-Pau/0000-0002-4700-5621; Martinez,
   Salvador/0000-0002-3346-3947
CR Fernandez E, 1998, J MATER SCI-MATER M, V9, P789, DOI 10.1023/A:1008979708407
   Fernandez E, 1996, J BIOMED MATER RES, V32, P367, DOI 10.1002/(SICI)1097-4636(199611)32:3<367::AID-JBM9>3.0.CO;2-Q
   Fernandez E, 1998, J BIOMED MATER RES, V42, P403, DOI 10.1002/(SICI)1097-4636(19981205)42:3<403::AID-JBM8>3.0.CO;2-N
   Fernandez E, 1999, J BIOMED MATER RES, V47, P466, DOI 10.1002/(SICI)1097-4636(19991215)47:4<466::AID-JBM2>3.3.CO;2-I
   Fernandez E, 1999, J MATER SCI-MATER M, V10, P169, DOI 10.1023/A:1008937507714
   Fernandez E, 1999, J MATER SCI-MATER M, V10, P177, DOI 10.1023/A:1008989525461
   Ginebra MP, 1999, J AM CERAM SOC, V82, P2808
   Khairoun I, 1998, J MATER SCI-MATER M, V9, P425, DOI 10.1023/A:1008811215655
   KHAIROUN I, 1999, P 15 EUR C BIOM SEPT
NR 9
TC 1
Z9 1
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-866-4
J9 KEY ENG MAT
PY 2000
VL 192-1
BP 777
EP 780
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BS01D
UT WOS:000168303700185
DA 2018-10-20
ER

PT J
AU Dhawan, R
   Kadijk, MGA
   Joikinen, TJ
   Feng, M
   Ansell, SM
AF Dhawan, R
   Kadijk, MGA
   Joikinen, TJ
   Feng, M
   Ansell, SM
TI Synthesis of polyamide oligomers based on
   14-amino-3,6,9,12-tetraoxatetradecanoic acid
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article
ID POLY(ETHYLENE GLYCOL); CIRCULATION TIME; LIPOSOMES; CONJUGATION;
   POLYMERS; PROLONG; FUSION
AB A series of oligomers of polyamides based on 14-amino-3,6,9,12-tetraoxatetradecanoic acid monomers (ATTAn) was synthesized. These materials were designed as monodisperse analogues of poly(ethylene glycol) for use in biomedical applications where reproducible behavior is important. Synthesis of the monomer was evaluated using two routes. For small-scale preparations, tetraethylene glycol (TEG) was monoprotected with dihydropyran, converted to an alkoxide, and alkylated with ethyl bromoacetate. On larger scales, TEG was alkylated directly by treatment with sodium, followed by ethyl bromoacetate. The amine function was introduced by mesylation followed by treatment with sodium azide. Reduction of the azide to amino groups was performed over Pd/C using either hydrogen or formic acid as proton sources. Assembly of the oligomers was accomplished using standard DCC/ NHS chemistry and an iterative dimerization sequence after appropriate deprotection of a pair of monomers. The amino group was protected by retaining the azido group as a latent amine. A series of ATTAn oligomers was prepared (n = 1-8). A lipid conjugate of the octamer, ATTA8-DSPE,was synthesized.
C1 Inex Pharmaceut Corp, Burnaby, BC V5J 5J8, Canada.
RP Ansell, SM (reprint author), Inex Pharmaceut Corp, 100-8900 Glenlyon Pkwy, Burnaby, BC V5J 5J8, Canada.
CR Adlakha-Hutcheon G, 1999, NAT BIOTECHNOL, V17, P775
   AGBACK H, 1991, Patent No. 9100497
   ALLEN TM, 1994, ADV DRUG DELIVER REV, V13, P285, DOI 10.1016/0169-409X(94)90016-7
   Ansell SM, 1999, BIOCONJUGATE CHEM, V10, P653, DOI 10.1021/bc990005p
   BERTOZZI CR, 1991, J ORG CHEM, V56, P4326, DOI 10.1021/jo00013a053
   Bradley AJ, 1998, ARCH BIOCHEM BIOPHYS, V357, P185, DOI 10.1006/abbi.1998.0798
   Chen YY, 1999, J ORG CHEM, V64, P6870, DOI 10.1021/jo990620m
   HARASYM TO, 1995, BIOCONJUGATE CHEM, V6, P187, DOI 10.1021/bc00032a006
   Holland JW, 1996, BIOCHEMISTRY-US, V35, P2618, DOI 10.1021/bi952000v
   KEEGSTRA EMD, 1992, J ORG CHEM, V57, P6678, DOI 10.1021/jo00050a065
   KINUGASA S, 1992, MACROMOLECULES, V25, P4848, DOI 10.1021/ma00045a003
   KLIBANOV AL, 1991, BIOCHIM BIOPHYS ACTA, V1062, P142, DOI 10.1016/0005-2736(91)90385-L
   Lasic DD, 1995, CHEM REV, V95, P2601, DOI 10.1021/cr00040a001
   Mayer LD, 1998, MEDICAL APPLICATIONS OF LIPOSOMES, P231, DOI 10.1016/B978-044482917-7/50014-4
   Mori A, 1998, J LIPOSOME RES, V8, P195, DOI 10.3109/08982109809035526
   PARR MJ, 1994, BBA-BIOMEMBRANES, V1195, P21, DOI 10.1016/0005-2736(94)90004-3
   Rose K, 1999, J AM CHEM SOC, V121, P7034, DOI 10.1021/ja9909879
   Schwabacher AW, 1998, J ORG CHEM, V63, P1727, DOI 10.1021/jo971802o
   Torchilin Vladimir P., 1996, Journal of Liposome Research, V6, P99, DOI 10.3109/08982109609037204
   TORCHILIN VP, 1994, BBA-BIOMEMBRANES, V1195, P11, DOI 10.1016/0005-2736(94)90003-5
   Webb MS, 1998, BBA-BIOMEMBRANES, V1372, P272, DOI 10.1016/S0005-2736(98)00077-7
   Wheeler JJ, 1999, GENE THER, V6, P271, DOI 10.1038/sj.gt.3300821
   WOODLE MC, 1994, BIOCONJUGATE CHEM, V5, P493, DOI 10.1021/bc00030a001
   ZALIPSKY S, 1995, BIOCONJUGATE CHEM, V6, P150, DOI 10.1021/bc00032a002
NR 24
TC 2
Z9 2
U1 1
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD JAN-FEB
PY 2000
VL 11
IS 1
BP 14
EP 21
DI 10.1021/bc9801427
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 279EH
UT WOS:000085031100004
PM 10639080
DA 2018-10-20
ER

PT J
AU Mowery, KA
   Schoenfisch, MH
   Saavedra, JE
   Keefer, LK
   Meyerhoff, ME
AF Mowery, KA
   Schoenfisch, MH
   Saavedra, JE
   Keefer, LK
   Meyerhoff, ME
TI Preparation and characterization of hydrophobic polymeric films that are
   thromboresistant via nitric oxide release
SO BIOMATERIALS
LA English
DT Article
DE nitric oxide; polymer materials; blood compatibility; biomaterial
   surfaces
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; PLATELET-AGGREGATION; IN-VIVO;
   9-FLUORENYLMETHYL CHLOROFORMATE; PRECOLUMN DERIVATIZATION; VASCULAR
   ENDOTHELIUM; MEMBRANE-ELECTRODE; HEPARIN; SENSORS; BIOCOMPATIBILITY
AB The preparation of hydrophobic polymer films (polyurethane and poly(vinyl chloride)) containing nitric oxide (NO)-releasing diazeniumdiolate functions is reported as a basis for improving the thromboresistivity of such polymeric materials for biomedical applications. Several different approaches for preparing NO-releasing polymer films are presented, including: (1) dispersion of diazeniumdiolate molecules within the polymer matrix; (2) covalent attachment of the diazeniumdiolate to the polymer backbone; and (3) ion-pairing of a diazeniumdiolated heparin species to form an organic soluble complex that can be blended into the polymer. Each approach is characterized in terms of NO release rates and in vitro biocompatibility. Results presented indicate that the polymer films prepared by each approach release NO for variable periods of time (10-72 h), although they differ in the mechanism, location and amount of NO released. In vitro platelet adhesion studies demonstrate that the localized NO release may prove to be an effective strategy for improving blood compatibility of polymer materials for a wide range of medical devices. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
   NCI, Frederick Canc Res & Dev Ctr, SAIC Frederick, Frederick, MD 21702 USA.
   NCI, Frederick Canc Res & Dev Ctr, Comparat Carcinogenesis Lab, Frederick, MD 21702 USA.
RP Meyerhoff, ME (reprint author), Univ Michigan, Dept Chem, 930 N Univ Ave, Ann Arbor, MI 48109 USA.
RI Keefer, Larry/N-3247-2014
OI Keefer, Larry/0000-0001-7489-9555
FU NCI NIH HHS [N01-CO-56000]; NIGMS NIH HHS [GM 56991]
CR ANDERSON J M, 1985, Critical Reviews in Biocompatibility, V1, P111
   ANNICH GM, 1999, IN PRESS CRIT CARE M
   Banerjee R, 1997, J BIOMATER APPL, V12, P57, DOI 10.1177/088532829701200104
   BENMAKROHA Y, 1995, MED BIOL ENG COMPUT, V33, P811, DOI 10.1007/BF02523013
   Chen JH, 1998, J BIOMED MATER RES, V41, P633, DOI 10.1002/(SICI)1097-4636(19980915)41:4<633::AID-JBM16>3.0.CO;2-F
   CHOLAKIS CH, 1989, J BIOMED MATER RES, V23, P417, DOI 10.1002/jbm.820230404
   DAVIDSON GWR, 1984, BIOMATERIALS, V5, P227, DOI 10.1016/0142-9612(84)90020-6
   DAVSON H, 1952, PERMEABILITY NATURAL, P38
   ESPADASTORRE C, 1995, ANAL CHEM, V67, P3108, DOI 10.1021/ac00114a003
   EspadasTorre C, 1997, J AM CHEM SOC, V119, P2321, DOI 10.1021/ja963054a
   FU B, 1995, MACROMOLECULES, V28, P5834, DOI 10.1021/ma00121a021
   FU B, 1994, ANAL CHEM, V66, P2250, DOI 10.1021/ac00086a009
   Hanson S R, 1995, Adv Pharmacol, V34, P383
   Hrabie JA, 1999, ORG PREP PROCED INT, V31, P189, DOI 10.1080/00304949909355709
   HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030
   HULANICKI A, 1987, ANAL CHIM ACTA, V194, P119, DOI 10.1016/S0003-2670(00)84765-0
   IGNARRO LJ, 1993, P NATL ACAD SCI USA, V90, P8103, DOI 10.1073/pnas.90.17.8103
   Keefer LK, 1996, METHOD ENZYMOL, V268, P281
   KELM M, 1996, METHODS NITRIC OXIDE, P47
   KUSY RP, 1994, POLYMER, V35, P2141, DOI 10.1016/0032-3861(94)90241-0
   KYROLAINEN M, 1995, ACTA ANAESTH SCAND, V39, P55, DOI 10.1111/j.1399-6576.1995.tb04255.x
   LANE DA, 1994, NEPHROL DIAL TRANSPL, V9, P18
   Li Z, 1996, ANAL CHEM, V68, P1717, DOI 10.1021/ac950557a
   LLANOS GR, 1992, BIOMATERIALS, V13, P421, DOI 10.1016/0142-9612(92)90161-G
   LOEPPKY RN, 1994, ACS SYM SER, V553, P1
   Marois Y, 1996, BIOMATERIALS, V17, P3, DOI 10.1016/0142-9612(96)80749-6
   Merchant K, 1996, CHEM RES TOXICOL, V9, P891, DOI 10.1021/tx950102g
   MEYERHOFF ME, 1993, TRAC-TREND ANAL CHEM, V12, P257, DOI 10.1016/0165-9936(93)87065-6
   MIWA H, 1994, J VASC SURG, V19, P658, DOI 10.1016/S0741-5214(94)70039-7
   MIWA M, 1987, CARCINOGENESIS, V8, P955, DOI 10.1093/carcin/8.7.955
   MONROE JM, 1980, BIOMATER ARTIF CELL, V8, P103, DOI 10.3109/10731198009118976
   Mowery KA, 1999, POLYMER, V40, P6203, DOI 10.1016/S0032-3861(99)00187-1
   MOWERY KA, 1999, IN PRESS ELECTROANAL
   Pasic M, 1996, EUR J CARDIO-THORAC, V10, P372, DOI 10.1016/S1010-7940(96)80097-2
   RADOMSKI MW, 1987, BRIT J PHARMACOL, V92, P639, DOI 10.1111/j.1476-5381.1987.tb11367.x
   RADOMSKI MW, 1992, BRIT J PHARMACOL, V107, P745, DOI 10.1111/j.1476-5381.1992.tb14517.x
   RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1
   Ramamurthy N, 1998, CLIN CHEM, V44, P606
   Ratner BD, 1998, MACROMOL SYMP, V130, P327, DOI 10.1002/masy.19981300128
   SAAVEDRA JE, 1992, J ORG CHEM, V57, P6134, DOI 10.1021/jo00049a017
   SAAVEDRA JE, 1999, IN PRESS J ORG CHEM
   SABRI MI, 1989, J NEUROSCI METH, V29, P27, DOI 10.1016/0165-0270(89)90105-2
   SALVEMINI D, 1990, BRIT J PHARMACOL, V101, P991, DOI 10.1111/j.1476-5381.1990.tb14194.x
   SALZMAN EW, 1980, J CLIN INVEST, V65, P64, DOI 10.1172/JCI109661
   SCHMIDT HHH, 1996, METHODS NITRIC OXIDE, P491
   SCHOENFISCH MH, 1998, 216 ACS NAT M BOST M
   SCHOENFISCH MH, UNPUB IMPROVING THRO
   SCHWAKE A, 1997, P EUROSENSORS 11, V1, P243
   SINEY L, 1992, EUR J PHARMACOL, V229, P223, DOI 10.1016/0014-2999(92)90559-M
   Smith DJ, 1996, J MED CHEM, V39, P1148, DOI 10.1021/jm950652b
   Stead DA, 1996, J CHROMATOGR B, V675, P295, DOI 10.1016/0378-4347(95)00355-X
   Suh H, 1998, YONSEI MED J, V39, P87, DOI 10.3349/ymj.1998.39.2.87
   THOMSON C, 1973, CLIN SCI MOL MED, V45, P485, DOI 10.1042/cs0450485
   Walpoth BH, 1998, CIRCULATION, V98, pII319
   Weerwind PW, 1998, INT J ARTIF ORGANS, V21, P291
   YANG VC, 1993, CHEMTECH, V23, P25
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
   YUN JH, 1993, ELECTROANAL, V5, P719, DOI 10.1002/elan.1140050903
NR 58
TC 151
Z9 157
U1 0
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2000
VL 21
IS 1
BP 9
EP 21
DI 10.1016/S0142-9612(99)00127-1
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 266FW
UT WOS:000084290800003
PM 10619674
DA 2018-10-20
ER

PT S
AU Faris, GW
   Dyer, MJ
AF Faris, GW
   Dyer, MJ
GP OSA
   OSA
TI Upconverting chelates for biomedical diagnostics
SO BIOMEDICAL TOPICAL MEETINGS, TECHNICAL DIGEST
SE OSA TRENDS IN OPTICS AND PHOTONICS
LA English
DT Proceedings Paper
CT Biomedical Topical Meeting
CY APR 02-05, 2000
CL MIAMI BEACH, FL
ID FIBER LASER
AB We are developing a new type of reporter for biomedical diagnostics. Upconverting chelates consist of lanthanide ions in an organic ligand. These materials have narrow emission features and no autofluorescent background. (C) 1999 Optical Society of America.
C1 SRI Int, Mol Phys Lab, Menlo Pk, CA 94025 USA.
RP Faris, GW (reprint author), SRI Int, Mol Phys Lab, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.
CR ALLAIN JY, 1990, ELECTRON LETT, V26, P261, DOI 10.1049/el:19900174
   ALLAIN JY, 1990, ELECTRON LETT, V26, P166, DOI 10.1049/el:19900113
   AUZEL FE, 1973, P IEEE, V61, P758, DOI 10.1109/PROC.1973.9155
   Chen YH, 1999, PROC SPIE, V3600, P151, DOI 10.1117/12.351025
   Faris G. W., 1996, OSA Trends in Optics and Photonics on Biomedical Optical Spectroscopy and Diagnostics. Vol.3. From the Topical Meeting, P225
   MACFARLANE RM, 1988, APPL PHYS LETT, V52, P1300, DOI 10.1063/1.99681
   MCFARLANE RA, 1989, APPL PHYS LETT, V54, P2301, DOI 10.1063/1.101108
NR 7
TC 0
Z9 0
U1 0
U2 1
PU OPTICAL SOC AMERICA
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1094-5695
BN 1-55752-632-X
J9 OSA TRENDS OPT PHOTO
PY 2000
VL 38
BP 241
EP 241
PG 1
WC Optics; Spectroscopy
SC Optics; Spectroscopy
GA BU51D
UT WOS:000176203200070
DA 2018-10-20
ER

PT S
AU Hassan, CM
   Peppas, NA
AF Hassan, CM
   Peppas, NA
BE Abe, A
TI Structure and applications of poly(vinyl alcohol) hydrogels produced by
   conventional crosslinking or by freezing/thawing methods
SO BIOPOLYMERS/PVA HYDROGELS/ANIONIC POLYMERISATION NANOCOMPOSITES
SE Advances in Polymer Science
LA English
DT Review
DE poly(vinyl alcohol); hydrogels; freezing/thawing; crystallinity;
   biomedical applications; crosslinking; crystallites
ID DIFFERENTIAL SCANNING CALORIMETRY; DIMETHYLSULFOXIDE WATER SOLUTIONS;
   ACID) INTERPENETRATING NETWORKS; CONTROLLED RELEASE SYSTEMS; SMALL-ANGLE
   NEUTRON; POLY(ACRYLIC ACID); POLYVINYL-ALCOHOL; DRUG-DELIVERY; POLYMER
   SYSTEMS; MOLECULAR MOBILITY
AB Poly(vinyl alcohol) (PVA) is a polymer of great interest because of its many desirable characteristics specifically for various pharmaceutical and biomedical applications. The crystalline nature of PVA has been of specific interest particularly for physically crosslinked hydrogels prepared by repeated cycles of freezing and thawing. This review includes details on the structure and properties of PVA, the synthesis of its hydrogels, the crystallization of PVA, as well as its applications. An analysis of previous work in the development of freezing and thawing processes is presented focusing on the implications of such materials for a variety of applications. PVA blends that have been developed with enhanced properties for specific applications will also be discussed briefly. Finally, the future directions involving the further development of freeze/thawed PVA hydrogels are addressed.
C1 Purdue Univ, Sch Chem Engn, Polymer Sci Lab, W Lafayette, IN 47907 USA.
   Purdue Univ, Sch Chem Engn, Engn Lab, W Lafayette, IN 47907 USA.
RP Hassan, CM (reprint author), Purdue Univ, Sch Chem Engn, Polymer Sci Lab, W Lafayette, IN 47907 USA.
CR Argade AB, 1998, J APPL POLYM SCI, V70, P817, DOI 10.1002/(SICI)1097-4628(19981024)70:4<817::AID-APP23>3.0.CO;2-S
   BAO QB, 1991, Patent No. 5047055
   BERGHMANS H, 1986, INTEGRATION FUNDAMEN, P218
   BUNN CW, 1948, NATURE, V161, P929, DOI 10.1038/161929a0
   CHA WI, 1991, KOBUNSHI RONBUNSHU, V48, P425, DOI 10.1295/koron.48.425
   CHA WI, 1993, MAKROMOL CHEM, V194, P2433
   Cha WI, 1996, MACROMOL SYMP, V109, P115, DOI 10.1002/masy.19961090111
   DANNO A, 1958, J PHYS SOC JPN, V13, P722, DOI 10.1143/JPSJ.13.722
   DIEU J, 1959, LARGE RAD SOURCES IN, V1, P341
   FICEK BJ, 1993, J CONTROL RELEASE, V27, P259, DOI 10.1016/0168-3659(93)90156-Y
   FICEK BJ, 1994, MATER RES SOC SYMP P, V331, P223
   Finch C. A., 1973, POLYVINYL ALCOHOL PR
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   Fujii K, 1973, PVA PROPERTIES APPL, P203
   FUJIMOTO K, 1994, ACS SYM SER, V540, P228
   GANDER B, 1989, PHARMACEUT RES, V6, P578, DOI 10.1023/A:1015949330425
   GANDER B, 1983, P INT S CONTR REL PH, P5
   GANDER B, 1988, P INT S CONTR REL BI, V15, P109
   GUDEMAN LF, 1995, J MEMBRANE SCI, V107, P239, DOI 10.1016/0376-7388(95)00120-7
   GUDEMAN LF, 1995, J APPL POLYM SCI, V55, P919, DOI 10.1002/app.1995.070550610
   HARRIS HE, 1966, J POLYM SCI A1, V4, P665, DOI 10.1002/pol.1966.150040320
   Hassan CM, 1998, WATER SOLUBLE POLYMERS: SOLUTION PROPERTIES AND APPLICATIONS, P31
   HASSAN CM, 1998, POLYM MAT SCI ENG P, V79, P473
   HASSAN CM, 1998, P INT S CONTROL REL, V25, P50
   HATAKEYAMA T, 1987, EUR POLYM J, V23, P361, DOI 10.1016/0014-3057(87)90164-9
   HICKEY AS, 1995, J MEMBRANE SCI, V107, P229, DOI 10.1016/0376-7388(95)00119-0
   Hickey AS, 1997, POLYMER, V38, P5931, DOI 10.1016/S0032-3861(97)00163-8
   HIRAI T, 1992, J APPL POLYM SCI, V46, P1449, DOI 10.1002/app.1992.070460815
   HIRAI T, 1992, J APPL POLYM SCI, V45, P1849, DOI 10.1002/app.1992.070451019
   HIRAI T, 1991, POLYM PREPR JPN, V40, P1297
   HIRAI T, 1990, POLYM PREPR JPN, V39, P942
   HYON SH, 1994, J BIOMAT SCI-POLYM E, V5, P397, DOI 10.1163/156856294X00103
   HYON SH, 1989, KOBUNSHI RONBUNSHU, V46, P673, DOI 10.1295/koron.46.673
   HYON SH, 1987, Patent No. 4663358
   HYON SH, 1993, POLYM PREPR JPN, P42
   Inamura I, 1997, POLYM J, V29, P119, DOI 10.1295/polymj.29.119
   INAMURA I, 1986, POLYM J, V18, P269, DOI 10.1295/polymj.18.269
   KANAYA T, 1995, MACROMOLECULES, V28, P3168, DOI 10.1021/ma00113a019
   KANAYA T, 1994, MACROMOLECULES, V27, P5609, DOI 10.1021/ma00098a014
   KELLER A, 1957, PHILOS MAG, V2, P1171, DOI 10.1080/14786435708242746
   KIM CJ, 1990, POLYM MAT SCI ENG, V63, P64
   KORSMEYER RW, 1981, J MEMBRANE SCI, V9, P211, DOI 10.1016/S0376-7388(00)80265-3
   KURIAKI M, 1989, KOBUNSHI RONBUNSHU, V46, P739, DOI 10.1295/koron.46.739
   LLANOS GR, 1991, MACROMOLECULES, V24, P6066
   LOZINSKY VI, 1992, J APPL POLYM SCI, V44, P1423, DOI 10.1002/app.1992.070440813
   LOZINSKY VI, 1986, POLYM BULL, V15, P333
   LOZINSKY VI, 1995, J APPL POLYM SCI, V58, P171, DOI 10.1002/app.1995.070580119
   Lozinsky VI, 1996, J APPL POLYM SCI, V61, P1991, DOI 10.1002/(SICI)1097-4628(19960912)61:11<1991::AID-APP13>3.0.CO;2-2
   Lozinsky VI, 1998, RUSS CHEM REV, V67, P573, DOI DOI 10.1070/RC1998V067N07ABEH000399
   LUTTRELL AS, 1994, ABSTR AICHE M, pC202
   Mallapragada S. K., 1995, POLYM MAT SCI ENG P, V73, P22
   Mallapragada SK, 1997, J BIOMED MATER RES, V36, P125, DOI 10.1002/(SICI)1097-4636(199707)36:1<125::AID-JBM15>3.0.CO;2-H
   Mallapragada SK, 1997, J CONTROL RELEASE, V45, P87, DOI 10.1016/S0168-3659(96)01549-0
   Mallapragada SK, 1997, AICHE J, V43, P870, DOI 10.1002/aic.690430403
   Mallapragada SK, 1996, J POLYM SCI POL PHYS, V34, P1339, DOI 10.1002/(SICI)1099-0488(199605)34:7<1339::AID-POLB15>3.0.CO;2-B
   MALLAPRAGADA SK, 1996, POLYM MAT SCI ENG P, V74, P416
   Mandelkern L., 1967, J POLYM SCI C, V18, P51
   MANO I, 1986, MAGNET RESON MED, V3, P921, DOI 10.1002/mrm.1910030612
   Masaro L, 1998, MACROMOLECULES, V31, P3880, DOI 10.1021/ma9710242
   Mongia NK, 1996, J BIOMAT SCI-POLYM E, V7, P1055, DOI 10.1163/156856296X00543
   MORIMOTO K, 1989, CHEM PHARM BULL, V37, P2491
   MORIMOTO K, 1989, PHARMACEUT RES, V6, P338, DOI 10.1023/A:1015958710435
   MURASE K, 1991, POLYM PREPR JPN, V40, P952
   NAMBU M, 1984, Patent No. 4472542
   Narasimhan B, 1999, MACROMOLECULES, V32, P704, DOI 10.1021/ma981382k
   NISHINARI K, 1983, POLYM COMMUN, V24, P345
   NOGUCHI T, 1991, J APPL BIOMATER, V2, P101, DOI 10.1002/jab.770020205
   OHKURA M, 1992, POLYMER, V33, P5044, DOI 10.1016/0032-3861(92)90056-3
   OHKURA M, 1992, POLYMER, V33, P3686, DOI 10.1016/0032-3861(92)90656-H
   OKA M, 1990, Clinical Materials, V6, P361, DOI 10.1016/0267-6605(90)90053-X
   OKAZAKI M, 1995, J APPL POLYM SCI, V58, P2235, DOI 10.1002/app.1995.070581212
   Peppas N. A., 1987, HYDROGELS MED PHARM, V2, P1
   Peppas N. A., 1987, HYDROGELS MED PHARM, V1-3
   PEPPAS NA, 1991, J CONTROL RELEASE, V16, P305, DOI 10.1016/0168-3659(91)90007-Z
   PEPPAS NA, 1977, J APPL POLYM SCI, V21, P1763, DOI 10.1002/app.1977.070210704
   PEPPAS NA, 1975, MAKROMOL CHEM, V176, P3433
   Peppas NA, 1997, EUR J PHARM BIOPHARM, V43, P51, DOI 10.1016/S0939-6411(96)00010-0
   PEPPAS NA, 1976, J POLYM SCI POL CHEM, V14, P441, DOI 10.1002/pol.1976.170140215
   PEPPAS NA, 1992, J CONTROL RELEASE, V18, P95, DOI 10.1016/0168-3659(92)90178-T
   PEPPAS NA, 1976, J APPL POLYM SCI, V20, P1457, DOI 10.1002/app.1976.070200604
   PEPPAS NA, 1982, J APPL POLYM SCI, V27, P4787, DOI 10.1002/app.1982.070271223
   Peppas NA, 1998, EUR J PHARM BIOPHARM, V46, P15, DOI 10.1016/S0939-6411(97)00113-6
   Peppas NA, 1996, MACROMOLECULES, V29, P8798, DOI 10.1021/ma9613392
   PEPPAS NA, 1976, EUR POLYM J, V12, P495, DOI 10.1016/0014-3057(76)90004-5
   PEPPAS NA, 1977, MAKROMOL CHEM, V178, P595
   PEPPAS NA, 1977, J BIOMED MATER RES, V11, P423, DOI 10.1002/jbm.820110309
   PEPPAS NA, 1980, BIOMATERIALS, V1, P158, DOI 10.1016/0142-9612(80)90039-3
   PEPPAS NA, 1980, P IUPAC, V27, P28
   PEPPAS NA, 1979, P IUPAC, V26, P1539
   PEPPAS NA, 1996, REORT POVAL COMMITTE, V108, P96
   PEPPAS NA, 1974, TECN CHRON, V43, P559
   PEPPAS NA, 1996, P INT S CONTR REL BI, V23, P157
   PEPPAS NA, 1996, P INT S CONTR REL BI, V23, P145
   PEPPAS NA, 1996, P TOP C PROC STRUCT, V1, P321
   PEPPAS NA, 1977, CHEM PROPERTIES CROS, P469
   PEPPAS NA, 1976, ORG COAT PLAST CHEM, V36, P541
   PEPPAS NA, 1997, BIOMATERIALS CARRIER, P328
   Peppas NA, 1979, P IUPAC MEMBR S MAR, V26, P1108
   PEPPAS NA, 1995, P WORLD M APGI APV, V1, P817
   PEPPAS NA, 1996, T WORLD BIOMATER C, V5, P643
   PEPPAS NA, 1977, POLYM PREP AM CHEM S, V18, P794
   RAY JC, 1973, J APPL POLYM SCI, V17, P3781
   REINHART CT, 1981, INT J PHARM TECHN PR, V2, P9
   SAITO O, 1959, J PHYS SOC JPN, V14, P792, DOI 10.1143/JPSJ.14.792
   SAKURADA I, 1959, SEN-I GAKKAISHI, V15, P948
   Sakurada I., 1955, KOBUNSHI KAGAKU, V12, P510
   SAWATARI C, 1996, TOYOTA KENKYU HOKOKU, V49, P77
   Scotchford CA, 1998, BIOMATERIALS, V19, P1, DOI 10.1016/S0142-9612(97)00236-6
   Shin HS, 1997, J APPL POLYM SCI, V65, P685
   Shin HS, 1998, J APPL POLYM SCI, V69, P479, DOI 10.1002/(SICI)1097-4628(19980718)69:3<479::AID-APP7>3.0.CO;2-D
   Snaar JEM, 1998, MAGN RESON IMAGING, V16, P691, DOI 10.1016/S0730-725X(98)00021-6
   SONE Y, 1953, KOBUNSHI KAGAKU, V10, P7
   STAUFFER SR, 1992, POLYMER, V33, P3932, DOI 10.1016/0032-3861(92)90385-A
   Suzuki M, 1996, MACROMOL SYMP, V109, P55, DOI 10.1002/masy.19961090106
   SUZUKI M, 1991, POLYM PREPR JPN, V40, P953
   TADOKORO H, 1961, B CHEM SOC JPN, V34, P1504, DOI 10.1246/bcsj.34.1504
   TAKAMURA A, 1987, YAKUGAKU ZASSHI, V107, P233, DOI 10.1248/yakushi1947.107.3_233
   TAKAMURA A, 1992, J CONTROL RELEASE, V20, P21, DOI 10.1016/0168-3659(92)90135-E
   TAKAMURA A, 1991, YAKUGAKU ZASSHI, V111, P45, DOI 10.1248/yakushi1947.111.1_45
   TAKESHITA H, 1995, POLYM PREPR JPN, V44, P139
   TAMURA K, 1986, T AM SOC ART INT ORG, V32, P605
   TANIGAMI T, 1994, POLYMER, V35, P2573, DOI 10.1016/0032-3861(94)90381-6
   TANIGAMI T, 1995, POLYMER, V36, P2941, DOI 10.1016/0032-3861(95)94343-R
   TANIGAMI T, 1995, J MATER SCI, V30, P5110, DOI 10.1007/BF00356057
   TAZAKI M, 1989, KOBUNSHI RONBUNSHU, V46, P733, DOI 10.1295/koron.46.733
   TRIEU HH, 1994, COLLOID POLYM SCI, V272, P301, DOI 10.1007/BF00655501
   TSUTSUMI K, 1994, STP PHARMA SCI, V4, P230
   TUBBS RK, 1966, J POLYM SCI A1, V4, P623, DOI 10.1002/pol.1966.150040316
   URUSHIZAKI F, 1990, INT J PHARM, V58, P135
   URUSHIZAKI F, 1986, YAKUGAKU ZASSHI, V106, P491, DOI 10.1248/yakushi1947.106.6_491
   WATASE M, 1985, J POLYM SCI POL PHYS, V23, P1803, DOI 10.1002/pol.1985.180230906
   WATASE M, 1989, MAKROMOL CHEM, V190, P155
   Yamaura K, 1998, J APPL POLYM SCI, V70, P1661, DOI 10.1002/(SICI)1097-4628(19981128)70:9<1661::AID-APP3>3.0.CO;2-T
   YAMAURA K, 1995, J APPL POLYM SCI, V58, P1787, DOI 10.1002/app.1995.070581017
   Yamaura K, 1997, J APPL POLYM SCI, V64, P1283, DOI 10.1002/(SICI)1097-4628(19970516)64:7<1283::AID-APP6>3.0.CO;2-F
   YOKOYAMA F, 1986, COLLOID POLYM SCI, V264, P595, DOI 10.1007/BF01412597
NR 136
TC 694
Z9 711
U1 20
U2 259
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 3-540-67313-X
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 2000
VL 153
BP 37
EP 65
PG 29
WC Polymer Science
SC Polymer Science
GA BR11L
UT WOS:000165688300002
DA 2018-10-20
ER

PT B
AU Barbucci, R
   Lamponi, S
   Magnani, A
AF Barbucci, R
   Lamponi, S
   Magnani, A
BE Fabbrizzi, L
   Poggi, A
TI Biological performance of materials
SO CHEMISTRY AT THE BEGINNING OF THE THIRD MILLENNIUM: MOLECULAR DESIGN,
   SUPRAMOLECULES, NANOTECHNOLOGY AND BEYOND
LA English
DT Proceedings Paper
CT German-Italian Meeting of Coimbra Group Universities Meeting on
   Chemistry at the Beginning of the 3rd Millennium
CY OCT 07-10, 1999
CL PAVIA, ITALY
SP Coimbra Grp Univ
ID BLOOD COMPATIBILITY; POLYMER SURFACES; HYDROGELS; SCIENCE; BIOMATERIALS;
   PRECURSORS; MONOLAYERS; TOPOGRAPHY; ACTIVATION; CHEMISTRY
AB The biomaterial science, the study of the application of materials to biological and biomedical problems is a field characterised by medical needs, basic research, advanced technological development, industrial involvement, ethical considerations and regulations. The biological performance of materials largely depends on their bulk and surface properties.
   Some general concepts necessary to define the biological performance of materials are discussed. Current approaches of surface modification of materials and methods of synthesis for creating surfaces with specific biofuncionality are reviewed.
C1 Univ Siena, Dipartimento Sci & Tecnol Chim & Biosistemi, I-53100 Siena, Italy.
RP Barbucci, R (reprint author), Univ Siena, Dipartimento Sci & Tecnol Chim & Biosistemi, Via E Bastianini 12, I-53100 Siena, Italy.
RI Magnani, Agnese/E-7999-2017
CR ALBANESE A, 1994, BIOMATERIALS, V15, P129, DOI 10.1016/0142-9612(94)90262-3
   ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   BAMFORD C H, 1992, Clinical Materials, V10, P243, DOI 10.1016/0267-6605(92)90018-O
   BARBUCCI R, 1994, BIOMATERIALS, V15, P955, DOI 10.1016/0142-9612(94)90075-2
   BHATIA SK, 1992, J AM CHEM SOC, V114, P4432, DOI 10.1021/ja00037a077
   BRANKER JH, 1995, J BIOMED MATER RES, V29, P1517
   CHAMILTON D, UNPUB IMPLICATIONS C
   Chen GP, 1997, BIOCONJUGATE CHEM, V8, P730, DOI 10.1021/bc9700493
   CHILKOTI A, 1993, ANAL CHEM, V65, P1736, DOI 10.1021/ac00061a017
   Curtis A, 1996, ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY SYSTEMS, P158
   CURTIS ASG, 1988, TOPOGRAPHY CONTROL C, V7, P141
   ENGBERS GH, 1991, INT J ARTIF ORGANS, V14, P199
   FERGUSON GS, 1993, MACROMOLECULES, V26, P5870, DOI 10.1021/ma00074a007
   FOWKES FM, 1988, ENCY POLYM SCI ENG S, P1
   GARBASSI F, 1989, SURF INTERFACE ANAL, V14, P585, DOI 10.1002/sia.740141004
   Godo MN, 1999, BIOMATERIALS, V20, P1117, DOI 10.1016/S0142-9612(99)00012-5
   GRIESSER HJ, 1990, J APPL POLYM SCI APP, V46, P361
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   HOFFMAN AS, 1985, POLYM MED, V2, P157
   JOHN MS, 1973, J BIOMED MATER RES, V7, P509
   JOZEFONVICZ J, 1990, Journal of Biomaterials Science Polymer Edition, V1, P147
   KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030
   LAURENT TC, 1998, CHEM BIOL HYALURONAN
   LEWIS KB, 1993, J COLLOID INTERF SCI, V159, P77, DOI 10.1006/jcis.1993.1299
   LOPEZ GP, 1992, J POLYM SCI POL CHEM, V30, P2415, DOI 10.1002/pola.1992.080301116
   Magnani A, 1996, THROMB RES, V81, P383, DOI 10.1016/0049-3848(96)00009-6
   MAGNANI A, 1995, J MATER CHEM, V5, P1321, DOI 10.1039/jm9950501321
   MAGNANI A, 1993, TEST PROCEDURES BLOO, P171
   MAGNANI A, UNPUB IN VITRO STUDY
   MAGNANI A, IN PRESS NOVEL POLYS
   MALLIK S, 1994, NEW J CHEM, V18, P299
   NOCENTINI M, 1993, TEST PROCEDURES BLOO, P151
   OKANO T, 1993, J BIOMED MATER RES, V27, P1519, DOI 10.1002/jbm.820271208
   PIGLOWSKI J, 1994, BIOMATERIALS, V15, P909, DOI 10.1016/0142-9612(94)90116-3
   PLATE NA, 1986, ADV POLYM SCI, V79, P95
   PRITCHARD DJ, 1995, ANAL CHEM, V67, P3605, DOI 10.1021/ac00115a034
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   RATNER BD, 1993, CARDIOVASC PATHOL S, V2, P875
   RATNER BD, 1993, ACS POLYM PREPR, V34, P643
   RATNER BD, 1988, POLYM SURFACE DYNAMI, P137
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   ROZSNYAI LF, 1995, LANGMUIR, V11, P3913, DOI 10.1021/la00010a048
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   SOMORJAI GA, 1990, J PHYS CHEM-US, V94, P1013, DOI 10.1021/j100366a001
   SOMORJAI GA, 1991, LANGMUIR, V7, P3176, DOI 10.1021/la00060a043
   SUM F, 1994, J VAC SCI TECHNOL A, V12, P2499
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   WILLIAMS DF, 1988, ADV BIOMATER, V8, P11
   WOICIAKSTOTHARD B, 1997, DEV BIOL ANIMAL, V33, P110
   WOJCIAKSTOTHARD B, 1995, CELL BIOL INT, V19, P485, DOI 10.1006/cbir.1995.1092
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Wu S, 1982, POLYM INTERFACE ADHE
NR 58
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
BN 3-540-67460-8
PY 2000
BP 161
EP 183
PG 23
WC Chemistry, Inorganic & Nuclear; Chemistry, Organic; Chemistry, Physical
SC Chemistry
GA BQ71C
UT WOS:000089239800008
DA 2018-10-20
ER

PT S
AU Tuchin, VV
   Zimnykov, DA
   Gaianzha, EI
   Ulianov, SS
   Sinichkin, YP
   Mishin, AB
   Chaussky, AA
   Ryabukho, VP
AF Tuchin, VV
   Zimnykov, DA
   Gaianzha, EI
   Ulianov, SS
   Sinichkin, YP
   Mishin, AB
   Chaussky, AA
   Ryabukho, VP
BE Tuchin, VV
   Izatt, JA
   Fujimoto, JG
TI Dynamical and structural diagnostics of living tissues using speckle
   techniques
SO COHERENCE DOMAIN OPTICAL METHODS IN BIOMEDICAL SCIENCE AND CLINICAL
   APPLICATIONS IV
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Coherence Domain Optical Methods in Biomedical Science and
   Clinical Applications IV
CY JAN 24-26, 2000
CL SAN JOSE, CA
SP SPIE, Int Biomed Opt Soc
DE speckles; interferometry; scattering,. tissue; blood; lymph; visual
   acuity
ID OPTICAL COHERENCE TOMOGRAPHY; BLOOD-FLOW; BIOLOGICAL TISSUE; LASER
   SPECKLE; SCATTERING MEDIUM; POLARIZED-LIGHT; LYMPH-FLOW; DOPPLER; SKIN;
   PHOTONS
AB Basing on such fundamental optical phenomena as elastic and quasi-elastic light scattering, diffraction, and interference of optical fields we have designed coherent optical methods offering much promise for biomedical applications. The scope of research includes the development of photon-correlation spectroscopy, speckle-interferometry, coherent micro-topography of living tissues, and study of optical images contrasting due to reduction of scattering properties of surrounding medium using immersion liquids.
   It was shown that speckle methods can be used as high resolution and high-performance tomographic techniques for imaging of both anatomical (on a micro- and nano-scale) and functional (blood and lymph flow) states of a tissue. Many advantages can be achieved in the field of speckle-polarization effects providing additional selectivity and sensitivity to tissue structure and material anisotropy. Speckle techniques using focused laser beams, including speckle-correlometry, speckle-interferometry, and spatial-domain laser technique, for tissue structure monitoring with a subcellular resolution and in vivo study of changes of velocity of blood and lymph in microvessels were developed. In vivo experimental study of optical and structural properties of such living tissues as skin, impregnated by glycerol and some other ointments were done.
C1 Saratov NG Chernyshevskii State Univ, Saratov 410026, Russia.
RP Tuchin, VV (reprint author), Saratov NG Chernyshevskii State Univ, 83 Astrakhanskaya, Saratov 410026, Russia.
EM tuchin@sgu.ssu.runnet.ru
RI Tuchin, Valery/C-7865-2013; Ryabukho, Vladimir/D-5227-2013
OI Tuchin, Valery/0000-0001-7479-2694; Ryabukho,
   Vladimir/0000-0002-1849-7380
CR AIZU Y, 1991, OPT LASER TECHNOL, V23, P205, DOI 10.1016/0030-3992(91)90085-3
   AIZU Y, 1992, APPL OPTICS, V31, P3020, DOI 10.1364/AO.31.003020
   BERKOVITS R, 1990, PHYS REV LETT, V65, P3120, DOI 10.1103/PhysRevLett.65.3120
   BICOUT D, 1994, PHYS REV E, V49, P1767, DOI 10.1103/PhysRevE.49.1767
   BOAS DA, 1995, PHYS REV LETT, V75, P1855, DOI 10.1103/PhysRevLett.75.1855
   Briers J D, 1996, J Biomed Opt, V1, P174, DOI 10.1117/12.231359
   Briers JD, 1996, J OPT SOC AM A, V13, P345, DOI 10.1364/JOSAA.13.000345
   Briers JD, 1999, J BIOMED OPT, V4, P164, DOI 10.1117/1.429903
   deBoer JF, 1997, OPT LETT, V22, P934, DOI 10.1364/OL.22.000934
   Demos SG, 1997, APPL OPTICS, V36, P150, DOI 10.1364/AO.36.000150
   Fercher A F, 1996, J Biomed Opt, V1, P157, DOI 10.1117/12.231361
   FREUND I, 1990, PHYS REV B, V42, P2613, DOI 10.1103/PhysRevB.42.2613
   Hielscher AH, 1997, APPL OPTICS, V36, P125, DOI 10.1364/AO.36.000125
   HORINAKA H, 1995, OPT LETT, V20, P1501, DOI 10.1364/OL.20.001501
   Izatt J., 1997, OPT PHOTONICS NEWS, V8, P41
   IZATT JA, 2000, P SPIE, V4001
   JACQUES SL, 2000, P SPIE, V4001
   KONISHI N, 1995, OPT ENG, V34, P753, DOI 10.1117/12.195203
   KOROLEVICH AN, 1994, OPT SPEKTROSK+, V77, P278
   Morgan SP, 1997, APPL OPTICS, V36, P1560, DOI 10.1364/AO.36.001560
   MUELLER G, 1993, SPIE
   RACOVIC MJ, 1999, APPL OPTICS, V38, P3399
   RUTH B, 1994, MED ENG PHYS, V16, P105, DOI 10.1016/1350-4533(94)90023-X
   Ryabukho V. P., 1995, Photonics and Optoelectronics, V3, P77
   Ryabukho VP, 1998, P SOC PHOTO-OPT INS, V3251, P247, DOI 10.1117/12.306064
   RYABUKHO VP, 1996, P SOC PHOTO-OPT INS, V2732, P100
   SCHMITT JM, 1992, APPL OPTICS, V31, P6535, DOI 10.1364/AO.31.006535
   Shepherd A.P, 1990, LASER DOPPLER BLOOD
   Tuchin V V, 1997, J Biomed Opt, V2, P401, DOI 10.1117/12.281502
   Tuchin VV, 1998, LASER PHYS, V8, P807
   Tuchin VV, 1999, J BIOMED OPT, V4, P106, DOI 10.1117/1.429926
   Ulyanov SS, 1998, J BIOMED OPT, V3, P237, DOI 10.1117/1.429879
   ULYANOV SS, 1995, OPT ENG, V34, P2850, DOI 10.1117/12.210740
   UlYanov SS, 1996, LASER MED SCI, V11, P97, DOI 10.1007/BF02133206
   ULYANOV SS, 1994, OPT ENG, V33, P3179
   WARDELL K, 1994, MICROVASC RES, V48, P26, DOI 10.1006/mvre.1994.1036
   YAMAMOTO T, 1990, J CLIN MED SURG, V8, P35
   Yao G, 1999, OPT LETT, V24, P537, DOI 10.1364/OL.24.000537
   ZANG B, 1994, APPL OPTICS, V33, P231
   Zimnyakov DA, 1996, APPL OPTICS, V35, P4325, DOI 10.1364/AO.35.004325
   Zimnyakov DA, 1997, APPL OPTICS, V36, P5594, DOI 10.1364/AO.36.005594
   ZIMNYAKOV DA, 1994, OPT SPEKTROSK+, V76, P838
   ZIMNYAKOV DA, 1999, P SPIE, V3599
NR 43
TC 1
Z9 1
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3531-7
J9 PROC SPIE
PY 2000
VL 3915
BP 137
EP 151
DI 10.1117/12.384151
PG 15
WC Engineering, Biomedical; Optics
SC Engineering; Optics
GA BQ40F
UT WOS:000088256000018
DA 2018-10-20
ER

PT J
AU Phillips, WM
AF Phillips, WM
TI Biomedical engineering: Issues and opportunity
SO CRITICAL REVIEWS IN BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT 18th Southern Biomedical Engineering Conference/2nd International
   Conference on Ethical Issues in Biomedical Engineering
CY MAY 21-23, 1999
CL CLEMSON UNIV, CLEMSON, SOUTH CAROLINA
HO CLEMSON UNIV
AB As defined by the National Institutes of Health (NIH), bioengineering is an interdisciplinary field that applies physical, chemical, and mathematical sciences and engineering principles to the study of biology, medicine, behavior, and health. It advances knowledge from the molecular to the organ systems level, and develops new and novel biologics, materials, processes, implants, devices, and informational approaches for the prevention, diagnosis, and treatment of disease for patient rehabilitation and for improving health.
C1 Univ Florida, Grad Sch, Gainesville, FL 32611 USA.
RP Phillips, WM (reprint author), Univ Florida, Grad Sch, Gainesville, FL 32611 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BEGELL HOUSE INC
PI NEW YORK
PA 79 MADISON AVE, SUITE 1205, NEW YORK, NY 10016-7892 USA
SN 0278-940X
J9 CRIT REV BIOMED ENG
JI Crit. Rev. Biomed. Eng.
PY 2000
VL 28
IS 1-2
BP 1
EP 2
PG 2
WC Engineering, Biomedical
SC Engineering
GA 352ZA
UT WOS:000089248200002
PM 10999356
DA 2018-10-20
ER

PT J
AU Cammas-Marion, S
   Guerin, P
AF Cammas-Marion, S
   Guerin, P
TI 4-alkyloxycarbonyl-2-oxetanones and
   3-alkyl-4-alkyloxycarbonyl-2-oxetanones as versatile chiral precursors
   in the design of functionalized polyesters with a controlled
   architecture
SO DESIGNED MONOMERS AND POLYMERS
LA English
DT Article
DE 4-alkyloxycarbonyl-2-oxetanones; 3-alkyl-4-alkyloxycarbonyl;
   2-oxetanones; beta-substituted; beta-lactones; poly(beta-malic acid)
   derivatives; functionalized polyesters; biomedical field
ID RADIOLABELED POLY(BETA-MALIC ACID); RING-OPENING POLYMERIZATION; 2
   STEREOGENIC CENTERS; DRUG CARRIER; INVIVO FATE; POLYMERS; DERIVATIVES;
   POLYSTEREOISOMERS; ESTERS; ROUTE
AB The necessity for accessing a very large variety of high-molecular-weight racemic and optically active polyesters aimed at biomedical or chemical al,plications has lied to the growth of a large series of racemic and optically active 4-alkyloxycarbonyl-2-oxetanones and 3-alkyl-4-alkyloxycarbonyl-2-oxetanones. Different synthesis routes have been established to prepare these monomers according to the bound ester group structure and the required enantiomeric or diastereomeric excess. The basic molecules were aspartic acid, malic acid or their 3-alkyl derivatives. The introduced ester group can be chiral, reactive, hydrophobic, hydrophilic or bioactive. The major interest in this enlarged monomer family lies in the possibility of have at one's disposal beta-substituted beta-lactones with very strict control of the stereogenic center configuration. This property is important with regard to the tailoring of well-defined polymeric materials. A second benefit lies in the tailor-making of complex architectures by the copolymerization of two or more beta-substituted beta-lactones. In al cases, the resulting materials have the composition of the monomer feed and a completely controlled configurational structure.
C1 Univ Paris 12, Lab Rech Polymeres, CNRS, UMR C7581, F-94320 Thiais, France.
RP Cammas-Marion, S (reprint author), Univ Paris 12, Lab Rech Polymeres, CNRS, UMR C7581, 2-8 Rue Henry Dunant, F-94320 Thiais, France.
CR ARNOLD SC, 1986, MAKROMOL CHEM-M SYMP, V6, P285, DOI 10.1002/masy.19860060128
   BARBAUD C, IN PRESS POLYM B
   Bear MM, 1998, MACROMOL SYMP, V132, P337, DOI 10.1002/masy.19981320131
   Bear MM, 1997, CR ACAD SCI II B, V325, P165, DOI 10.1016/S1251-8069(97)86832-7
   BEAR MM, IN PRESS ENANTIOMER
   BOUTAULT K, 1995, MACROMOLECULES, V28, P3516, DOI 10.1021/ma00114a004
   BRAUD C, 1992, POLYM BULL, V29, P177, DOI 10.1007/BF00558054
   BRAUD C, 1988, POLYM PREPR AM CHEM, V29, P600
   Cammas S, 1996, POLYMER, V37, P4215, DOI 10.1016/0032-3861(96)00204-2
   CAMMAS S, 1993, TETRAHEDRON-ASYMMETR, V4, P1925, DOI 10.1016/S0957-4166(00)80433-4
   CAMMAS S, 1994, TETRAHEDRON-ASYMMETR, V5, P1589, DOI 10.1016/0957-4166(94)80129-0
   CAMMASMARION S, IN PRESS MACROMOL CH
   CARON A, 1990, POLYMER, V31, P1797, DOI 10.1016/0032-3861(90)90205-D
   FOURNIE P, 1992, J BIOACT COMPAT POL, V7, P113, DOI 10.1177/088391159200700201
   FOURNIE P, 1990, J BIOACT COMPAT POL, V5, P381, DOI 10.1177/088391159000500401
   FUJINO T, 1985, POLYM PRPR JPN, V35, P2330
   FUJISHIRO K, 1992, LIQ CRYST, V12, P417, DOI 10.1080/02678299208031058
   GUERIN P, 1986, MAKROMOL CHEM-M SYMP, V6, P305, DOI 10.1002/masy.19860060129
   GUERIN P, 1985, POLYM BULL, V14, P187, DOI 10.1007/BF00708479
   Jeanbat-Mimaud V, 1999, CR ACAD SCI II C, V2, P393, DOI 10.1016/S1387-1609(00)88551-5
   LeboucherDurand MA, 1996, POLYM BULL, V36, P35, DOI 10.1007/BF00296005
   LeboucherDurand MA, 1996, REACT FUNCT POLYM, V31, P57, DOI 10.1016/1381-5148(96)00048-X
   Moine L, 1997, POLYMER, V38, P3121, DOI 10.1016/S0032-3861(96)01097-X
   Moine L, 1998, MACROMOL SYMP, V130, P45, DOI 10.1002/masy.19981300105
   Monne C, 1996, CHIRALITY, V8, P300, DOI 10.1002/(SICI)1520-636X(1996)8:4<300::AID-CHIR2>3.0.CO;2-J
   OUCHI T, 1990, J CONTROL RELEASE, V12, P143, DOI 10.1016/0168-3659(90)90090-G
   RAMIANDRASOA P, 1993, POLYM BULL, V30, P501, DOI 10.1007/BF00296467
   Renard E, 1996, POLYM BULL, V36, P585, DOI 10.1007/BF00342450
   RENARD I, 1996, ACS POLYM PREPRINTS, V37, P137
   VERT M, 1986, MAKROMOL CHEM-M SYMP, V6, P109, DOI 10.1002/masy.19860060113
   Vert M., 1979, ACS POLYM PREPT, V20, P608
   VERT M, 1986, CRITICAL REV THERAPE, P291
NR 32
TC 10
Z9 10
U1 0
U2 3
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 1385-772X
J9 DES MONOMERS POLYM
JI Des. Monomers Polym.
PY 2000
VL 3
IS 1
BP 77
EP 93
DI 10.1163/156855500750198744
PG 17
WC Polymer Science
SC Polymer Science
GA 346CN
UT WOS:000088853100007
DA 2018-10-20
ER

PT S
AU Chan, RC
   Kaufhold, J
   Lees, RS
   Karl, WC
AF Chan, RC
   Kaufhold, J
   Lees, RS
   Karl, WC
BE Suresh, R
   Pien, HH
TI Ultrasound analysis of vascular structure and deformation
SO DIGITIZATION OF THE BATTLESPACE V AND BATTLEFIELD BIOMEDICAL
   TECHNOLOGIES II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 5th Battlespace Digitization Conference
CY APR 24-27, 2000
CL ORLANDO, FL
SP SPIE
DE ultrasound; blood vessels; carotid artery; border detection;
   segmentation; motion tracking; change detection; vascular injury;
   battlefield biomedical imaging
ID OPTICAL-FLOW; MODEL; SEGMENTATION; MOTION; SIMULATION; EVOLUTION;
   TRACKING; IMAGES; FIELD
AB Low-power, portable ultrasound imaging devices are well-suited for the diagnostic requirements of healthcare delivery on the modern battlefield. The non-invasiveness and good spatiotemporal resolution of ultrasonography allow for early detection of changes in tissue anatomy and material behavior that signal the presence of injury from exposure to biological hazards or disease processes that can jeopardize the performance of personnel in the field. This potential has not been fully realized however due to the presence of image degrading factors that make ultrasound imagery notoriously difficult to interpret. To detect and quantify tissue pathology from ultrasound, anatomical boundaries and tissue deformation in the images must be estimated accurately; this requires image processing in a way that suppresses noise while retaining salient tissue borders in the imagery. We focus here on detecting abnormalities in cross-sections of the carotid vessel which often exhibits early changes in response to injurious stimuli. We present a novel approach to vessel boundary extraction and deformation tracking over time for the purpose of detecting abnormal tissue characteristics. We validate this concept in noisy simulated images derived from finite-element models of normal and abnormal Vessel cross-sections, and in real ultrasound images from a human subject.
C1 Boston Heart Fdn, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02142 USA.
RP Chan, RC (reprint author), Boston Heart Fdn, Harvard MIT Div Hlth Sci & Technol, 139 Main St, Cambridge, MA 02142 USA.
CR Akgul YS, 1999, IEEE T MED IMAGING, V18, P1035, DOI 10.1109/42.811315
   BAMBER JC, 1980, PHYS MED BIOL, V25, P463, DOI 10.1088/0031-9155/25/3/006
   CHIN TM, 1994, IEEE T IMAGE PROCESS, V3, P773, DOI 10.1109/83.336247
   Delfino A, 1997, J BIOMECH, V30, P777, DOI 10.1016/S0021-9290(97)00025-0
   Dutt V, 1996, IEEE T MED IMAGING, V15, P802, DOI 10.1109/42.544498
   HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2
   KIMIA BB, 1992, J MATH ANAL APPL, V163, P438, DOI 10.1016/0022-247X(92)90260-K
   Lefebvre F, 1998, IEEE T MED IMAGING, V17, P45, DOI 10.1109/42.668693
   MAILLOUX GE, 1989, IEEE T MED IMAGING, V8, P143, DOI 10.1109/42.24862
   MALLADI R, 1995, IEEE T PATTERN ANAL, V17, P158, DOI 10.1109/34.368173
   Meairs S, 1999, STROKE, V30, P1807, DOI 10.1161/01.STR.30.9.1807
   MEUNIER J, 1995, IEEE T MED IMAGING, V14, P293, DOI 10.1109/42.387711
   Mikic I, 1998, IEEE T MED IMAGING, V17, P274, DOI 10.1109/42.700739
   RICHARDSON PD, 1989, LANCET, V2, P941
   Sethian JA, 1996, CAMBRIDGE MONOGRAPHS, V3
   Shah J, 1996, PROC CVPR IEEE, P136, DOI 10.1109/CVPR.1996.517065
   Vogel CR, 1998, IEEE T IMAGE PROCESS, V7, P813, DOI 10.1109/83.679423
   Yeung F, 1998, ULTRASOUND MED BIOL, V24, P427, DOI 10.1016/S0301-5629(97)00281-0
   Yezzi A, 1997, IEEE T MED IMAGING, V16, P199, DOI 10.1109/42.563665
NR 19
TC 0
Z9 0
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3663-1
J9 P SOC PHOTO-OPT INS
PY 2000
VL 4037
BP 233
EP 244
DI 10.1117/12.395046
PG 12
WC Engineering, Biomedical; Multidisciplinary Sciences
SC Engineering; Science & Technology - Other Topics
GA BR35L
UT WOS:000166174000026
DA 2018-10-20
ER

PT J
AU McDonald, JC
   Duffy, DC
   Anderson, JR
   Chiu, DT
   Wu, HK
   Schueller, OJA
   Whitesides, GM
AF McDonald, JC
   Duffy, DC
   Anderson, JR
   Chiu, DT
   Wu, HK
   Schueller, OJA
   Whitesides, GM
TI Fabrication of microfluidic systems in poly(dimethylsiloxane)
SO ELECTROPHORESIS
LA English
DT Review
DE microfluidics; rapid prototyping; poly(dimethylsiloxane); review
ID INTEGRATED CAPILLARY ELECTROPHORESIS; ORGANIC POLYMER CAPILLARIES;
   PROTEIN CHARGE LADDERS; SEPARATION SYSTEMS; DNA ANALYSIS; GLASS CHIPS;
   MICROCHIP; INJECTION; DEVICES; MICROFABRICATION
AB Microfluidic devices are finding increasing application as analytical systems, biomedical devices, tools for chemistry and biochemistry, and systems for fundamental research. Conventional methods of fabricating microfluidic devices have centered on etching in glass and silicon. Fabrication of microfluidic devices in poly(dimethylsiloxane) (PMS) by soft lithography provides faster, less expensive routes than these conventional methods to devices that handle aqueous solutions. These soft-lithographic Cambridge, MA, USA methods are based on rapid prototyping and replica molding and are more accessible to chemists and biologists working under benchtop conditions than are the microelectronics-derived methods because, in soft lithography, devices do not need to be fabricated in a cleanroom. This paper describes devices fabricated in PDMS for separations, patterning of biological and nonbiological material, and components for integrated systems.
C1 Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.
   Gamera Biosci, Medford, MA USA.
RP Whitesides, GM (reprint author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.
FU NIGMS NIH HHS [GM51559]
CR Bakajin O., 1998, SOLID STATE SENSOR A, P116
   Bayer H, 1996, J MICROCOLUMN SEP, V8, P479
   Braxton S, 1998, CURR OPIN BIOTECH, V9, P643, DOI 10.1016/S0958-1669(98)80144-4
   Brody JP, 1996, BIOPHYS J, V71, P3430, DOI 10.1016/S0006-3495(96)79538-3
   Burggraf N, 1998, ANALYST, V123, P1443, DOI 10.1039/a801478g
   Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484
   Burns MA, 1996, P NATL ACAD SCI USA, V93, P5556, DOI 10.1073/pnas.93.11.5556
   Carbeck JD, 1998, ACCOUNTS CHEM RES, V31, P343, DOI 10.1021/ar970255q
   CHAUDHURY MK, 1991, LANGMUIR, V7, P1013, DOI 10.1021/la00053a033
   CHAUDHURY MK, 1992, SCIENCE, V255, P1230, DOI 10.1126/science.255.5049.1230
   Cheng J, 1998, ANAL BIOCHEM, V257, P101, DOI 10.1006/abio.1997.2531
   Chiem N, 1997, ANAL CHEM, V69, P373, DOI 10.1021/ac9606620
   Chou HP, 1999, P NATL ACAD SCI USA, V96, P11, DOI 10.1073/pnas.96.1.11
   Colton IJ, 1997, J AM CHEM SOC, V119, P12701, DOI 10.1021/ja9723491
   Colyer CL, 1997, ELECTROPHORESIS, V18, P1733, DOI 10.1002/elps.1150181006
   DeBusschere B.D., 1998, SOL STAT SENS ACT C, P358
   Delamarche E, 1997, ADV MATER, V9, P741, DOI 10.1002/adma.19970090914
   Delamarche E, 1998, J AM CHEM SOC, V120, P500, DOI 10.1021/ja973071f
   Delamarche E, 1997, SCIENCE, V276, P779, DOI 10.1126/science.276.5313.779
   Dorre K., 1997, Bioimaging, V5, P139, DOI 10.1002/1361-6374(199709)5:3<139::AID-BIO8>3.3.CO;2-R
   Duffy DC, 1999, J MICROMECH MICROENG, V9, P211, DOI 10.1088/0960-1317/9/3/301
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Effenhauser CS, 1997, ELECTROPHORESIS, V18, P2203, DOI 10.1002/elps.1150181211
   Effenhauser CS, 1997, ANAL CHEM, V69, P3451, DOI 10.1021/ac9703919
   Ermakov SV, 1998, ANAL CHEM, V70, P4494, DOI 10.1021/ac980551w
   ERMAKOV SV, 1998, ANAL CHEM, V70, P4504
   Fluri K, 1996, ANAL CHEM, V68, P4285, DOI 10.1021/ac9604090
   Folch A, 1998, BIOTECHNOL PROGR, V14, P388, DOI 10.1021/bp980037b
   Ford SM, 1999, J BIOMECH ENG-T ASME, V121, P13, DOI 10.1115/1.2798035
   Freemantle M, 1999, CHEM ENG NEWS, V77, P27, DOI 10.1021/cen-v077n008.p027
   Hadd AG, 1997, ANAL CHEM, V69, P3407, DOI 10.1021/ac970192p
   HARRISON DJ, 1993, SCIENCE, V261, P895, DOI 10.1126/science.261.5123.895
   Jacobson SC, 1998, ANAL CHEM, V70, P3476, DOI 10.1021/ac980349t
   Kenis PJA, 1999, SCIENCE, V285, P83, DOI 10.1126/science.285.5424.83
   Khandurina J, 1999, ANAL CHEM, V71, P1815, DOI 10.1021/ac981161c
   Konrad R., 1998, MICROREACTION TECHNO, P348
   Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046
   Kovacs G T. A., 1998, MICROMACHINED TRANSD
   Kricka LJ, 1998, CLIN CHEM, V44, P2008
   Kricka LJ, 1996, PURE APPL CHEM, V68, P1831, DOI 10.1351/pac199668101831
   Kutter JP, 1998, ANAL CHEM, V70, P3291, DOI 10.1021/ac971367y
   Lauks IR, 1998, ACCOUNTS CHEM RES, V31, P317, DOI 10.1021/ar9700670
   Li PCH, 1997, ANAL CHEM, V69, P1564, DOI 10.1021/ac9606564
   Liang ZH, 1996, ANAL CHEM, V68, P1040, DOI 10.1021/ac950768f
   Liu SR, 1999, ANAL CHEM, V71, P566, DOI 10.1021/ac980783v
   MAMMEN M, 1995, ANAL CHEM, V67, P3526, DOI 10.1021/ac00115a023
   MANZ A, 1990, SENSOR ACTUAT B-CHEM, V1, P244, DOI 10.1016/0925-4005(90)80209-I
   MANZ A, 1993, ADV CHROMATOGR, V33, P1
   MANZ A, 1997, INT C SOL STAT SENS, P915
   Martynova L, 1997, ANAL CHEM, V69, P4783, DOI 10.1021/ac970558y
   McCormick RM, 1997, ANAL CHEM, V69, P2626, DOI 10.1021/ac9701997
   MORRA M, 1990, J COLLOID INTERF SCI, V137, P11, DOI 10.1016/0021-9797(90)90038-P
   Northrup MA, 1998, ANAL CHEM, V70, P918, DOI 10.1021/ac970486a
   Ogura M, 1998, CLIN CHEM, V44, P2249
   Peled N, 1996, PURE APPL CHEM, V68, P1837, DOI 10.1351/pac199668101837
   Qin D, 1998, TOP CURR CHEM, V194, P1
   Qin D, 1996, ADV MATER, V8, P917, DOI 10.1002/adma.19960081110
   RAMSEY JM, 1995, NAT MED, V1, P1093, DOI 10.1038/nm1095-1093
   Roberts MA, 1997, ANAL CHEM, V69, P2035, DOI 10.1021/ac961038q
   ROHLICEK V, 1994, J CHROMATOGR A, V662, P369, DOI 10.1016/0021-9673(94)80523-7
   SalimiMoosavi H, 1997, J AM CHEM SOC, V119, P8716, DOI 10.1021/ja971735f
   Santini JT, 1999, NATURE, V397, P335
   Schueller OJA, 1999, ADV MATER, V11, P37, DOI 10.1002/(SICI)1521-4095(199901)11:1<37::AID-ADMA37>3.0.CO;2-0
   SCHUELLER OJA, 1999, IN PRESS SENS ACTU A
   SCHUTZNER W, 1992, ANAL CHEM, V64, P1991, DOI 10.1021/ac00041a039
   SEILER K, 1993, ANAL CHEM, V65, P1481, DOI 10.1021/ac00058a029
   Shaw JM, 1997, IBM J RES DEV, V41, P81, DOI 10.1147/rd.411.0081
   Simpson PC, 1998, P NATL ACAD SCI USA, V95, P2256, DOI 10.1073/pnas.95.5.2256
   Takayama S, 1999, P NATL ACAD SCI USA, V96, P5545, DOI 10.1073/pnas.96.10.5545
   TERRY SC, 1979, IEEE T ELECTRON DEV, V26, P1880, DOI 10.1109/T-ED.1979.19791
   Tortora GJ, 1996, PRINCIPLES ANATOMY P
   VANDENBERG A, 1993, SENSOR ACTUAT B-CHEM, V13, P396, DOI 10.1016/0925-4005(93)85410-C
   VANDENBERG A, 1995, MICRO TOTAL ANAL SYS
   Waters LC, 1998, ANAL CHEM, V70, P5172, DOI 10.1021/ac980447e
   Weigl BH, 1999, SCIENCE, V283, P346, DOI 10.1126/science.283.5400.346
   Woolley AT, 1998, ANAL CHEM, V70, P684, DOI 10.1021/ac971135z
   WOOLLEY AT, 1995, ANAL CHEM, V67, P3676, DOI 10.1021/ac00116a010
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Yao S, 1999, P NATL ACAD SCI USA, V96, P5372, DOI 10.1073/pnas.96.10.5372
   ZHU HP, 1994, ANAL CHEM, V66, P1941, DOI 10.1021/ac00085a004
NR 80
TC 2147
Z9 2180
U1 91
U2 1617
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 0173-0835
J9 ELECTROPHORESIS
JI Electrophoresis
PD JAN
PY 2000
VL 21
IS 1
BP 27
EP 40
DI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C
PG 14
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 279VM
UT WOS:000085065800004
PM 10634468
DA 2018-10-20
ER

PT J
AU Hamosh, A
   Scott, AF
   Amberger, J
   Valle, D
   McKusick, VA
AF Hamosh, A
   Scott, AF
   Amberger, J
   Valle, D
   McKusick, VA
TI Online Mendelian Inheritance in Man (OMIM)
SO HUMAN MUTATION
LA English
DT Article
DE MDI; OMIM; MIM; central database; medical genetics; electronic
   publication; mutation database; clinical genetics
AB Online Mendelian Inheritance In Man (OMIM) is a public database of bibliographic information about human genes and genetic disorders. Begun by Dr. Victor McKusick as the authoritative reference Mendelian Inheritance in Man, it is now distributed electronically by the National Center for Biotechnology Information (NCBI). Material in OMIM is derived from the biomedical literature and is written by Dr. McKusick and his colleagues at Johns Hopkins University and elsewhere. Each OMIM entry has a full text summary of a genetic phenotype and/or gene and has copious links to other genetic resources such as DNA and protein sequence, PubMed references, mutation databases, approved gene nomenclature, and more. In addition, NCBI's neighboring feature allows users to identify related articles from PubMed selected on the basis of key words in the OMIM entry. Through its many features, OMIM is increasingly becoming a major gateway for clinicians, students, and basic researchers to the ever growing literature and resources of human genetics. Hum Mutat 15:57-61, 2000. (C) 2000 Wiley-Liss, Inc.
C1 Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA.
RP Scott, AF (reprint author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, 600 N Wolfe St,Blalock 1033, Baltimore, MD 21287 USA.
CR AITSCHUL SF, 1990, J MOL BIOL, V215, P403
   Cuticchia AJ, 2000, HUM MUTAT, V15, P62, DOI 10.1002/(SICI)1098-1004(200001)15:1<62::AID-HUMU13>3.0.CO;2-R
   Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T
   McKusick V, 1997, MENDELIAN INHERITANC
   Scriver CR, 2000, HUM MUTAT, V15, P99, DOI 10.1002/(SICI)1098-1004(200001)15:1<99::AID-HUMU18>3.0.CO;2-P
NR 5
TC 169
Z9 172
U1 1
U2 16
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 1059-7794
J9 HUM MUTAT
JI Hum. Mutat.
PY 2000
VL 15
IS 1
BP 57
EP 61
DI 10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA 271VE
UT WOS:000084613900011
PM 10612823
OA Bronze
DA 2018-10-20
ER

PT B
AU Hafez, M
   Benjamin, S
   Sidler, T
AF Hafez, M
   Benjamin, S
   Sidler, T
BE Christensen, P
TI Compact laser system for micro-processing applications.
SO ICALEO (R)'99: PROCEEDING OF THE LASER MATERIALS PROCESSING CONFERENCE,
   VOL 87, PTS 1 AND 2
SE LASER INSTITUTE OF AMERICA - PROCEEDINGS
LA English
DT Proceedings Paper
CT Laser Materials Processing Conference (ICALEO(R)99)
CY NOV 15-18, 1999
CL SAN DIEGO, CA
SP Laser Inst Amer
AB We propose a compact laser system for micro-machining and micro-fabrication applications. The system is mainly composed of a laser source and a beam handling system for 2D scanning combined with an auto focus allowing a third degree of freedom.
   The laser source is a high power direct diode side-pumped pulsed solid state laser, which produces a high quality and high intensity laser beam. The crystal is a Nd:YAG emitting at 1.06 mu m for industrial micro-material processing, at 1.35 mu m and also at 1.44 mu m for tissue treatments in biomedical applications.
   The beam handling system consists of a very compact, highly innovative two-axis tilt laser scanner. Electromagnetic actuators drive the mirror and its suspension is based on a cone-ball bearing. It achieves a scan range of +/-3 degrees around x and y with an accuracy better than 0.1%. Such a system finds diverse applications: in the field of industrial cutting, drilling and welding. Furthermore, its small volume allows an easy integration in fabrication processes.
C1 Ecole Polytech Fed Lausanne, Inst Appl Opt, CH-1015 Lausanne, Switzerland.
RP Hafez, M (reprint author), Ecole Polytech Fed Lausanne, Inst Appl Opt, CH-1015 Lausanne, Switzerland.
CR FREITAG I, 1995, LASER OPTOELECTRONIC, V27
   GOLLA D, 1993, LASER OPTOELECTRONIC, V25
   HAFEZ M, 1999, S INT SYST ADV MAN 9
   HATTORI S, 1987, Patent No. 4660941
   LAKERVELD HG, 1978, Patent No. 4073567
   MASOTTI L, 1997, Patent No. 0790512
   Smith S. T., 1992, FDN ULTRAPRECISION M
   UMEKI N, 1979, Patent No. 4175832
   ZAGO L, 1997, SPAC MICR ACC CONTR
NR 9
TC 0
Z9 0
U1 0
U2 2
PU LASER INST AMERICA
PI ORLANDO
PA 12424 RESEARCH PKWY, STE 130, ORLANDO, FL 32826 USA
BN 0-912035-60-9
J9 LIA P
PY 2000
VL 87
BP A115
EP A123
PN 1&2
PG 5
WC Metallurgy & Metallurgical Engineering; Optics; Physics, Applied
SC Metallurgy & Metallurgical Engineering; Optics; Physics
GA BQ62Z
UT WOS:000089016200014
DA 2018-10-20
ER

PT B
AU Yu, Q
   Takeda, T
   Yuasa, T
   Hasegawa, Y
   Zeniya, T
   Hyodo, K
   Itai, Y
   Akatsuka, T
AF Yu, Q
   Takeda, T
   Yuasa, T
   Hasegawa, Y
   Zeniya, T
   Hyodo, K
   Itai, Y
   Akatsuka, T
BE Zheng, XX
   He, B
   Zhang, YT
TI Minimal detectability of contrast materials in fluorescent x-ray
   computed tomography using synchrotron radiation
SO IEEE-EMBS ASIA PACIFIC CONFERENCE ON BIOMEDICAL ENGINEERING -
   PROCEEDINGS, PTS 1 & 2
LA English
DT Proceedings Paper
CT IEEE-EMBS Asia-Pacific Conference on Biomedical Engineering
CY SEP 26-28, 2000
CL HANGZHOU, PEOPLES R CHINA
SP IEEE, Engn Med & Biol Soc, EMB, Asia-Pacific Congress Biomed Engn, KC Wong Educ Fdn, Natl Nat Sci Fdn China, Minist Educ China, Hong Kong Inst Engn, Biomed Div, IEEE, State Dev Planning Commiss, Dept High Tech Ind, Chinese Inst Electr, Biomed Electr Soc, Chineses Soc Biomed Engn, Japan Soc Med Electr & Biol Engn, Publ Hlth Bur Zhenjiang Province, Zhejiang Soc Med, Zhejiang Soc Biomed Engn, Zhejiang Sci & Technol Exchange Ctr Foreign Countries, Zhejiang Univ, Chinese Univ Hong Kong
DE fluorescent X-ray; synchrotron radiation; computed tomography; minimal
   detectability
AB Fluorescent x-ray computed tomography (FXCT) with synchrotron radiation is being developed to depict the distribution of high Z elements within the biomedical specimens. Minimal detectability limit of iodine was investigated in the FXCT with a 10-mm-diameter phantom with the spatial resolution of 100 x 100 mu m(2). We can conclude FXCT could detect 1 mu g/ml specific elements within biomedical specimens.
C1 Yamagata Univ, Dept Biosyst Engn, Yamagata 990, Japan.
RP Yu, Q (reprint author), Yamagata Univ, Dept Biosyst Engn, Yamagata 990, Japan.
CR Rust GF, 1998, IEEE T NUCL SCI, V45, P75, DOI 10.1109/23.659557
   Takeda T, 1996, P SOC PHOTO-OPT INS, V2708, P685, DOI 10.1117/12.237832
   Takeda T, 1999, P SOC PHOTO-OPT INS, V3772, P258, DOI 10.1117/12.363728
   TAKEDA T, IN PRESS CELLULAR MO
   YU Q, UNPUB MED IMAGING TE
   Yuasa T, 1997, IEEE T NUCL SCI, V44, P54, DOI 10.1109/23.554824
NR 6
TC 0
Z9 0
U1 0
U2 0
PU WORLD PUBLISHING CORPORATION
PI BEIJING
PA 137 CHAONEI DAJIE, BEIJING 100010, PEOPLES R CHINA
BN 7-5062-4828-X
PY 2000
BP 230
EP 231
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BR17W
UT WOS:000165806500110
DA 2018-10-20
ER

PT B
AU McQuiston, BK
AF McQuiston, BK
BE Zheng, XX
   He, B
   Zhang, YT
TI Emerging technologies in biomedical engineering
SO IEEE-EMBS ASIA PACIFIC CONFERENCE ON BIOMEDICAL ENGINEERING -
   PROCEEDINGS, PTS 1 & 2
LA English
DT Proceedings Paper
CT IEEE-EMBS Asia-Pacific Conference on Biomedical Engineering
CY SEP 26-28, 2000
CL HANGZHOU, PEOPLES R CHINA
SP IEEE, Engn Med & Biol Soc, EMB, Asia-Pacific Congress Biomed Engn, KC Wong Educ Fdn, Natl Nat Sci Fdn China, Minist Educ China, Hong Kong Inst Engn, Biomed Div, IEEE, State Dev Planning Commiss, Dept High Tech Ind, Chinese Inst Electr, Biomed Electr Soc, Chineses Soc Biomed Engn, Japan Soc Med Electr & Biol Engn, Publ Hlth Bur Zhenjiang Province, Zhejiang Soc Med, Zhejiang Soc Biomed Engn, Zhejiang Sci & Technol Exchange Ctr Foreign Countries, Zhejiang Univ, Chinese Univ Hong Kong
DE biosensors; chip; microfluidics; fluidic; Biochemical
AB Recent advances in chip based chemistry has been made in the area of microfluidics chip based technology for advanced bio-chemical analysis. These technologies take advantage of IC chip processing techniques, sophisticated integrated platform design, and new materials, advanced manufacturing processes and unique sensor designs. Microfluidic technology can produce a highly integrated measurement system for the long-term monitoring of physiological conditions and various measurements relevant to bioprocessing. YSI has developed biosensors including the first glucose, lactate, oxygen and a chip-based system that utilizes biosensor technology based on the YSI amperometric biosensor technology. These sensor measurements are used for continuous monitoring of pharmaceutical, food and biotechnology industrial applications. This microfluidic design is a monolithic structure with a miniature Flow Injection Analysis system formed in plastic. Biosensors are formed within this structure and created with a general morphology that benefits for the unique dynamics produced through miniaturization and unique understanding of microfluidic flow. This paper will review the design of this disposable chip including the functional features that make up the monolithic device. Review of the enzymatic sensor design and unique sensor morphology will also be discussed. Careful examples will be presented on design considerations, system performance characteristics and applications.
C1 YSI, Yellow Springs, OH 45387 USA.
RP McQuiston, BK (reprint author), YSI, 1700 Brannum Lane,POB 279, Yellow Springs, OH 45387 USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WORLD PUBLISHING CORPORATION
PI BEIJING
PA 137 CHAONEI DAJIE, BEIJING 100010, PEOPLES R CHINA
BN 7-5062-4828-X
PY 2000
BP 698
EP 699
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BR17W
UT WOS:000165806500347
DA 2018-10-20
ER

PT B
AU Asim, R
   Harris, MB
   Sikander, AS
   Masroor, AK
   Fahd, U
AF Asim, R
   Harris, MB
   Sikander, AS
   Masroor, AK
   Fahd, U
BE Zheng, XX
   He, B
   Zhang, YT
TI New design of Biomedical electrodes for physiological data acquisition
SO IEEE-EMBS ASIA PACIFIC CONFERENCE ON BIOMEDICAL ENGINEERING -
   PROCEEDINGS, PTS 1 & 2
LA English
DT Proceedings Paper
CT IEEE-EMBS Asia-Pacific Conference on Biomedical Engineering
CY SEP 26-28, 2000
CL HANGZHOU, PEOPLES R CHINA
SP IEEE, Engn Med & Biol Soc, EMB, Asia-Pacific Congress Biomed Engn, KC Wong Educ Fdn, Natl Nat Sci Fdn China, Minist Educ China, Hong Kong Inst Engn, Biomed Div, IEEE, State Dev Planning Commiss, Dept High Tech Ind, Chinese Inst Electr, Biomed Electr Soc, Chineses Soc Biomed Engn, Japan Soc Med Electr & Biol Engn, Publ Hlth Bur Zhenjiang Province, Zhejiang Soc Med, Zhejiang Soc Biomed Engn, Zhejiang Sci & Technol Exchange Ctr Foreign Countries, Zhejiang Univ, Chinese Univ Hong Kong
AB The study has been made on Biomedical electrode function and their adverse effect on the biological system. From material point of view these sensors have been classified according to application and various applications are studied. The possibility of producing these electrodes domestically i.e. in Pakistan with a new design and with the provision of improving the quality and life for the existing electrodes has been modeled. New proposed model is subjected to make the non repairable electrodes not only disposable but cheaper.
C1 Sir Syed Univ Engn & Technol, Dept Biomed Engn, Karachi, Pakistan.
RP Asim, R (reprint author), Sir Syed Univ Engn & Technol, Dept Biomed Engn, Karachi, Pakistan.
CR ARTHUR C, 1986, MED PHYSL
   CROMWELL L, 1993, BIOMEDICAL INSTRUMEN
   HENCH LL, 1982, BIOMATERIALS
   JANZ GJ, 1968, ANN NY ACAD SCI, V148, P210, DOI 10.1111/j.1749-6632.1968.tb20350.x
NR 4
TC 0
Z9 0
U1 0
U2 0
PU WORLD PUBLISHING CORPORATION
PI BEIJING
PA 137 CHAONEI DAJIE, BEIJING 100010, PEOPLES R CHINA
BN 7-5062-4828-X
PY 2000
BP 749
EP 750
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BR17W
UT WOS:000165806500372
DA 2018-10-20
ER

PT B
AU Qin, SJ
   Li, WJ
AF Qin, SJ
   Li, WJ
BE Zheng, XX
   He, B
   Zhang, YT
TI 3-D micro channel system in a quartz cube for biomedical applications
SO IEEE-EMBS ASIA PACIFIC CONFERENCE ON BIOMEDICAL ENGINEERING -
   PROCEEDINGS, PTS 1 & 2
LA English
DT Proceedings Paper
CT IEEE-EMBS Asia-Pacific Conference on Biomedical Engineering
CY SEP 26-28, 2000
CL HANGZHOU, PEOPLES R CHINA
SP IEEE, Engn Med & Biol Soc, EMB, Asia-Pacific Congress Biomed Engn, KC Wong Educ Fdn, Natl Nat Sci Fdn China, Minist Educ China, Hong Kong Inst Engn, Biomed Div, IEEE, State Dev Planning Commiss, Dept High Tech Ind, Chinese Inst Electr, Biomed Electr Soc, Chineses Soc Biomed Engn, Japan Soc Med Electr & Biol Engn, Publ Hlth Bur Zhenjiang Province, Zhejiang Soc Med, Zhejiang Soc Biomed Engn, Zhejiang Sci & Technol Exchange Ctr Foreign Countries, Zhejiang Univ, Chinese Univ Hong Kong
DE micro channel; laser micro-machining; quartz
AB A novel technology is presented to create three dimensional (3-D) micro channel systems bounded by a solid 3-D quartz substrate by means of a special laser micromachining process in this paper. The special process was developed to surmount the problems of using Nd:YAG laser to micro-machine transparent materials. This technology allows the rapid construction of complex 3-D channel paths inside the quartz cube without damaging the surface and neighboring area due to quartz's transparency at the Nd:YAG laser wavelength. The dimension of the micro channels can be controlled from 50 mum to 200 mum. Channels in different directions can be connected easily. The performance of the micro channels is carried out by resistance measurement. The behavior of laser micro-machining on quartz is also investigated.
C1 Chinese Univ Hong Kong, Dept Automat & Comp Aided Engn, Adv Microsyst Lab, Hong Kong, Hong Kong, Peoples R China.
RP Qin, SJ (reprint author), Chinese Univ Hong Kong, Dept Automat & Comp Aided Engn, Adv Microsyst Lab, Hong Kong, Hong Kong, Peoples R China.
RI Li, Wen Jung/M-9995-2013; Li, Wen Jung/A-6153-2010
OI Li, Wen Jung/0000-0001-9616-6213; Li, Wen Jung/0000-0001-9616-6213
CR KIKUCHI T, 1999, MICROPROCESSES NANOT, P179
   Nakanishi H, 1997, PROC IEEE MICR ELECT, P299, DOI 10.1109/MEMSYS.1997.581834
   NONHOF CJ, 1988, MAT PROCESSING ND LA
NR 3
TC 0
Z9 0
U1 0
U2 0
PU WORLD PUBLISHING CORPORATION
PI BEIJING
PA 137 CHAONEI DAJIE, BEIJING 100010, PEOPLES R CHINA
BN 7-5062-4828-X
PY 2000
BP 792
EP 793
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BR17W
UT WOS:000165806500394
DA 2018-10-20
ER

PT J
AU Ang, BY
   Chua, CK
   Du, ZH
AF Ang, BY
   Chua, CK
   Du, ZH
TI Study of trapped material in rapid prototyping parts
SO INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY
LA English
DT Article
DE algorithm; rapid prototyping; remedies; trapped material; trapped
   volume; warping
AB Since the launch of the first commercial system in 1988, rapid prototyping (RP) technology is fast being accepted in the fields of product design and development, in the tool and die making industry and recently, for biomedical applications. Although, in theory, RP is able to produce an object of any complexity, problems such as having material trapped inside parts with hollow features till frequently occur during normal operation. this research project seeks to achieve a better understanding of the formation of trapped material inside RP parts, with the eventual aim of developing an algorithm to avoid this problem. In this paper, the causes and effects of trapped material will be discussed for stereolithography apparatus (SLA), solid ground curing (SGC), selective laser sintering (SLS), and laminated object manufacturing (LOM). Finally, current remedies will be presented.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RP Chua, CK (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, Nanyang Ave, Singapore 639798, Singapore.
RI Chua, Chee Kai/B-6171-2009
CR *ALL, 1998, EX HTG 324
   *ALL, 1998, EX HTG 35X
   *CAD CAM PUBL, 1997, RAPID PROTOTYPING RE, V7, P3
   *CAD CAM PUBL, 1996, RAPID PROTOTYPING RE, V6, P6
   CHENG ADY, 1995, GRAVITATION COSMOLOG, V1, P12
   CHUA CK, 1994, COMPUT CONTROL ENG J, V5, P200, DOI 10.1049/cce:19940407
   CHUA CK, 1995, RAPID PROTOTYPING J, V1, P4
   DAVIS M, 1998, RECOATER PROBLEMS
   DURHAM M, 1996, SLS SLA DIFFERENT TE
   *ENN FABR TECHN, 1996, RAPID PROTOTYPING RE, V6, P2
   Frank D., 1994, Proceedings of The Fifth International Conference on Rapid Prototyping - 1994
   JACOBS PF, 1992, RAPID PROTOTYPING MA, P14
   MATHEWSON BB, 1995, P SOL FREEF FABR S A, P253
   MCCLURKIN J, 1996, VARIATION 2 CIBA GIE
   MCCLURKIN J, 1996, VARIATION 3 CIBA GIE
   MILLER MW, 1998, RE HOLLOW SLAS
   Newman WS, 1996, ROBOT CIM-INT MANUF, V12, P293, DOI 10.1016/S0736-5845(96)00022-1
   OKKEMA B, 1998, RE RECOATER PROBLEMS
   PERSALL E, 1996, TRAPPED V S
   STAHLHUT T, 1996, SLA ASTERISK AMPERSA
   SUH YS, 1995, P SOL FREEF FABR AUS, P334
   WEI P, 1997, P 6 EUR C RAP PROT M, P95
   Wohlers T., 1997, RAPID PROTOTYPING ST
   Xu F, 1997, RAPID PROTOTYPING J, V3, P76, DOI 10.1108/13552549710185644
NR 24
TC 20
Z9 21
U1 0
U2 6
PU SPRINGER-VERLAG LONDON LTD
PI GODALMING
PA SWEETAPPLE HOUSE CATTESHALL ROAD, GODALMING GU7 3DJ, SURREY, ENGLAND
SN 0268-3768
J9 INT J ADV MANUF TECH
JI Int. J. Adv. Manuf. Technol.
PY 2000
VL 16
IS 2
BP 120
EP 130
DI 10.1007/s001700050017
PG 11
WC Automation & Control Systems; Engineering, Manufacturing
SC Automation & Control Systems; Engineering
GA 283FR
UT WOS:000085266200007
DA 2018-10-20
ER

PT J
AU Ang, BY
   Chua, CK
   Du, ZH
AF Ang, BY
   Chua, CK
   Du, ZH
TI Development of an advisory system for trapped material in rapid
   prototyping parts
SO INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY
LA English
DT Article
DE feature recognition; rapid prototyping; trapped material; trapped
   volume; user function
AB Since the launch of the first commercial system in 1988, rapid prototyping (RP) technology is fast being accepted in the fields of product design and development, tool and die making, and recently, for biomedical applications. Although RP is able to produce objects of any complexities in theory, problems such as having material trapped inside parts with hollow features still occur frequently during normal operation. This could result in a distorted part being built, or the system being damaged. To reduce such occurrences, the purpose of this project was to develop an application program using the Unigraphics CAD/CAM system, to search automatically for the problematic features in a CAD file, and to provide the necessary modifications or recommendations. The initial focus has been on providing solutions for objects produced by stereolithography apparatus (SLA) and selective laser sintering (SLS). Provision has been made through the use of modular programming to allow more upgrades in future to other RP systems.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RP Chua, CK (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, Nanyang Ave, Singapore 639798, Singapore.
EM mckchua@ntu.edu.sg
RI Chua, Chee Kai/B-6171-2009
CR ANG BY, 1998, IN PRESS INT J ADV M
   CAMPBELL RI, 1998, P 1 INT C RAP PROT M, P632
   CHUA CK, 1997, RAPID PROTOTYPING J
   DURHAM M, 1996, SLS SLA DIFFERENT TE
   *EL DAT SYST CORP, 1995, US FUNCT SYST OV
   Guo YH, 2003, INT J ADV MANUF TECH, V21, P596, DOI 10.1007/s00170-002-1315-1
   JACOBS PF, 1992, RAPID PROTOTYPING MA, P14
   Wohlers T., 1997, RAPID PROTOTYPING ST
   1996, RAPID PROTOTYPING RE, P6
NR 9
TC 7
Z9 7
U1 0
U2 6
PU SPRINGER-VERLAG LONDON LTD
PI GODALMING
PA SWEETAPPLE HOUSE CATTESHALL ROAD, GODALMING GU7 3DJ, SURREY, ENGLAND
SN 0268-3768
J9 INT J ADV MANUF TECH
JI Int. J. Adv. Manuf. Technol.
PY 2000
VL 16
IS 10
BP 733
EP 738
PG 6
WC Automation & Control Systems; Engineering, Manufacturing
SC Automation & Control Systems; Engineering
GA 355ZN
UT WOS:000089418600007
DA 2018-10-20
ER

PT J
AU Thomas, M
   Valette, P
   Mausset, AL
   Dejardin, P
AF Thomas, M
   Valette, P
   Mausset, AL
   Dejardin, P
TI High molecular weight kininogen adsorption on hemodialysis membranes:
   influence of pH and relationship with contact phase activation of blood
   plasma. Influence of pre-treatment with poly(ethyleneimine)
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE hemodialysis; kininogen; contact phase; adsorption
ID SOLID-SURFACES; FIBRINOGEN; PROTEIN
AB Protein adsorption is an essential parameter for the evaluation of the hemocompatibility of biomedical materials. In effect, protein adsorption often generates unfavorable, complex, biochemical reactions and precedes cell adhesion on artificial interfaces. It is therefore necessary to modify the surface in contact with blood in order to minimize the onset of undesirable, biochemical, cascade reactions. Adsorption of high molecular weight kininogen (HK), which participates in the contact phase activation of the endogenous blood coagulation cascade, was evaluated at 37 degrees C. This paper also presents the results of contact phase activation tests carried out in vitro with 1:20 diluted human plasma flowing through minidialyzers containing hollow fibers of synthetic hemodialysis. membranes. These tests showed that contact phase activation is strongly dependent on pH around the physiological value (ranging from 7.35 to 7.80) for negatively-charged membranes. The same pH effect was observed on the AN69(R) membrane as regards HK adsorption from binary labeled solutions of I-125-HK and I-131-Fibrinogen at concentrations corresponding to 1% diluted plasma. It is suggested that the influence of pH could be related to imidazole pK(a) values in histidine residues of kininogen D5(H), domain. The same study was also conducted with hemodialysis membranes pretreated with poly(ethyleneimine). Both HK adsorption and contact phase activation proved to be greatly reduced, irrespective of the pH value (between 7.0 and 7.8). Hence, positively-charged poly(ethyleneimine) adsorbed on the membrane through strong ionic interactions with sulfonate groups of the surface probably constitutes a repelling, wafer-swollen layer for the kininogen en molecule. In addition, the advantages of the high levels of adsorbance of small molecules on the AN69(R) membrane leading to blood epuration, due to its high porosity and for some of them to its charge density should not be lost by such a surface treatment.
C1 Univ Montpellier 2, Lab Mat & Procedes Membranaires, CNRS,UMR 5635, ENSCM,UM 2, F-34095 Montpellier, France.
   Gambro Grp, Hosp R&D Int, Lyon, France.
RP Dejardin, P (reprint author), Univ Montpellier 2, Lab Mat & Procedes Membranaires, CNRS,UMR 5635, ENSCM,UM 2, 2 Pl Eugene Bataillon, F-34095 Montpellier, France.
RI Dejardin, Philippe/C-5845-2008
CR ANFINSEN CB, 1972, BIOCHEM J, V128, P737, DOI 10.1042/bj1280737
   Bouman CSC, 1998, BLOOD PURIFICAT, V16, P261, DOI 10.1159/000014343
   BOUMAZA F, 1992, BIOPHYS CHEM, V42, P87, DOI 10.1016/0301-4622(92)80010-3
   BRASH JL, 1988, BLOOD, V71, P932
   Colman RW, 1997, BLOOD, V90, P3819
   CREIGHTON TE, 1996, PROTEINS STRUCTURES, P13
   Dejardin P, 1998, POLYMERS AND SURFACES: A VERSATILE COMBINATION, P211
   DEJARDIN P, 1995, LANGMUIR, V11, P4001, DOI 10.1021/la00010a061
   FRIBERGER P, 1979, KININS, V2, P67
   FURLAND M, 1992, HUMAN PROTEIN DATA
   Le MT, 1998, LANGMUIR, V14, P3356, DOI 10.1021/la9713513
   MULLER EW, 1992, HUMAN PROTEIN DATA
   Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123
   REGOECZI E, 1984, IODINE LABELED PLASM, P49
   Renaux JL, 1999, KIDNEY INT, V55, P1097, DOI 10.1046/j.1523-1755.1999.0550031097.x
   SADLER PJ, 1993, EUR J BIOCHEM, V212, P811, DOI 10.1111/j.1432-1033.1993.tb17722.x
   SLACK SM, 1989, J COLLOID INTERF SCI, V133, P148, DOI 10.1016/0021-9797(89)90288-9
   Tishmack PA, 1997, BIOCHEMISTRY-US, V36, P11984, DOI 10.1021/bi9712448
   Valette P, 1999, BIOMATERIALS, V20, P1621, DOI 10.1016/S0142-9612(99)00070-8
   VROMAN L, 1980, BLOOD, V55, P156
   YAN F, 1992, J BIOMAT SCI-POLYM E, V3, P3811
   YU LP, 1994, BBA-PROTEIN STRUCT M, V1209, P24, DOI 10.1016/0167-4838(94)90132-5
NR 22
TC 37
Z9 39
U1 1
U2 5
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD JAN
PY 2000
VL 23
IS 1
BP 20
EP 26
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 287WT
UT WOS:000085530200004
PM 12118833
DA 2018-10-20
ER

PT J
AU Britchi, M
   Olteanu, M
   Jitianu, G
   Branzei, M
   Gheorghe, D
   Nita, P
AF Britchi, M
   Olteanu, M
   Jitianu, G
   Branzei, M
   Gheorghe, D
   Nita, P
TI Vitroceramic coatings on metallic supports with biomedical applications
SO INTERNATIONAL JOURNAL OF MATERIALS & PRODUCT TECHNOLOGY
LA English
DT Article
DE bioactive materials; biocompatible; Cr-Niaustenitic steels; enamelling
   process; titanium; vitroceramic coatings
ID GLASS-CERAMICS; CRYSTALLIZATION; BIOMATERIALS
AB Vitroceramic coatings from the oxidic system SiO2-CaO-B2O3-TiO2-R2O (R = Na and K) were applied on metallic supports (titanium and austenitic steels with high Cr and Ni contents). The coating procedure was classical enamelling. The metals were coated by either immersion or by painting over a thin layer from a mixture of frit (having the best composition For each metallic support) with a liquid mixture (triethanol amine : ethyl alcohol 1 : 10), which was subsequently fired at the enamelling temperature. A good adherence between the two different materials has been thus achieved. Vitroceramic coating - metallic support couples were then characterized by optical microscopy (OM), electronic microscopy (EDS and WDS), and X-ray diffraction (XRD). The adherence of the vitroceramic layers onto metallic supports was tested by microhardness trials at the interface. The processes at the interface, i. e. gas bubble evolution, micropore formation, chemical bonding and diffusion, were evidenced. These coating layers can be employed as both bioactive and biocompatible materials.
C1 Romanian Acad, Inst Phys Chem IG Murgulescu, Bucharest, Romania.
   Politehn Univ Bucharest, Sci & Engn Mat Fac, Bucharest, Romania.
   Aviat Met METAV SA, Bucharest, Romania.
RI BRANZEI, MIHAI/C-7101-2012
CR BUNDY KJ, 1994, CRIT REV BIOMED ENG, V22, P139
   COLAN H, 1968, STUDIUL METALELOR, P117
   DAVID HK, 1998, CURRENT OPINION SOLI, V3, P309
   FRIGGE M, 1996, MIKROCHIM ACTA S, V13, P299
   FUJIO T, 1982, Patent No. 2080281
   Holand W, 1997, J NON-CRYST SOLIDS, V219, P192, DOI 10.1016/S0022-3093(97)00329-3
   HOLAND W, 1991, J NON-CRYST SOLIDS, V129, P152, DOI 10.1016/0022-3093(91)90091-J
   HOLAND W, 1995, J NON-CRYST SOLIDS, V180, P292, DOI 10.1016/0022-3093(94)00464-1
   JAMES PF, 1995, J NON-CRYST SOLIDS, V181, P1, DOI 10.1016/0022-3093(94)00515-X
   Kasuga T, 1999, BIOMATERIALS, V20, P1415, DOI 10.1016/S0142-9612(99)00047-2
   LUPESCU M, 1997, THESIS BUCHAREST
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Saha SK, 1998, PHYS CHEM GLASSES, V39, P118
   Saha SK, 1996, SURF INTERFACE ANAL, V24, P113, DOI 10.1002/(SICI)1096-9918(199602)24:2<113::AID-SIA100>3.0.CO;2-C
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   YOKOKAWA H, 1993, J ELECTROCHEM SOC, V140, P3565, DOI 10.1149/1.2221127
NR 16
TC 3
Z9 3
U1 1
U2 2
PU INDERSCIENCE ENTERPRISES LTD
PI GENEVA AEROPORT
PA WORLD TRADE CENTER BLDG 110 AVE LOUSIS CASAI CP 306, CH-1215 GENEVA
   AEROPORT, SWITZERLAND
SN 0268-1900
J9 INT J MATER PROD TEC
JI Int. J. Mater. Prod. Technol.
PY 2000
VL 15
IS 6
BP 446
EP 457
DI 10.1504/IJMPT.2000.001257
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 387VH
UT WOS:000166142200001
DA 2018-10-20
ER

PT B
AU Raghunathan, R
   Sitaraman, SK
AF Raghunathan, R
   Sitaraman, SK
BE Kromann, GB
   Culham, JR
   Ramakrishna, K
TI Qualification guidelines for automotive packaging devices
SO ITHERM 2000: SEVENTH INTERSOCIETY CONFERENCE ON THERMAL AND
   THERMOMECHANICAL PHENOMENA IN ELECTRONIC SYSTEMS, VOL I, PROCEEDINGS
LA English
DT Proceedings Paper
CT 7th Intersociety Conference on Thermal and Thermomechanical Phenomena in
   Electronic Systems
CY MAY 23-26, 2000
CL LAS VEGAS, NV
SP IEEE, CPMT, Amer Soc Mechan Engineers, US Natl Inst Stand & Technol, Int Microelectr & Packaging Soc
DE FCOB; FCCSP; qualification guidelines; thermal cycling; accumulated
   equivalent inelastic strain; strain energy density; power-law creep
   model; Anand's visco-plastic model; die cracking
AB With the continued demand for miniaturization, with the advent of new materials and processes, and with increased demand for better performance and lower cost, reliability of microelectronic devices continues to be a major concern. As microelectronic packages are used in a wide range of applications from automotive to aerospace to telecommunications to biomedical devices, there is a need for developing suitable qualification standards for these application domains. The ongoing work at Georgia Tech aims to develop a comprehensive virtual qualification system taking into consideration the process mechanics of substrate fabrication and component assembly, time- and temperature-dependent material behavior, process-induced defects, and critical geometric features of the assembly.
   The objective of this paper is to present one such virtual qualification technique for microelectronic packages used in automotive applications. Numerical models have been developed that take into account the creep behavior of the solder joints, the viscoelastic behavior of the underfill and the temperature-dependent orthotropic properties of the substrate. The models account for the solder reflow process and underfill cure process. They also account for multiple reflow and burn-in testing of the devices. Based on the information collected in terms of weather, underhood conditions, and driving profiles, qualification temperature cycling guidelines have been developed for automotive devices. The possibility of backside die cracking due to tensile stresses has also been investigated. The results from the models are being compared against experimental data from in-house as well as industrial sources.
C1 Georgia Inst Technol, George W Woodruff Sch Mech Engn, Comp Aided Simulat Packaging Reliabil Lab, Atlanta, GA 30332 USA.
RP Raghunathan, R (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Comp Aided Simulat Packaging Reliabil Lab, Atlanta, GA 30332 USA.
CR BROWN SB, 1989, INT J PLASTICITY, V5, P95, DOI 10.1016/0749-6419(89)90025-9
   *EL IND ASS, 1989, JESD22A104A EL IND A
   ENGELMAIER W, 1983, IEEE T COMPONENTS HY, V6, P52
   HANNA CE, 1999, P 49 EL COMP TECHN C, P1001
   JU SH, 1994, AM SOC TEST MATER, V1153, P1, DOI 10.1520/STP23913S
   Knecht S., 1991, SOLDER JOINT RELIABI, P508
   Michaelides S, 1999, IEEE TRANS ADV PACK, V22, P602, DOI 10.1109/6040.803452
   *MIL STAND, 1987, MILSTD883E
   PANG HL, 1998, 48 EL COMP TECHN C I, P878
   SOLOMON HD, 1985, ASTM SPECIAL TECHNIC, P342
   SYED A, 1999, P 49 EL COMP TECHN C, P111
   van Kessel C. G. M., 1983, Proceedings of the 33rd Electronic Components Conference, P237
   Wilde J, 1999, INTERNATIONAL SYMPOSIUM ON ADVANCED PACKAGING MATERIALS: PROCESSES, PROPERTIES AND INTERFACES, PROCEEDINGS, P144, DOI 10.1109/ISAPM.1999.757302
   YEO CK, 1996, IEEE P 46 ECTC, P1222
NR 14
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-5912-7
PY 2000
BP 385
EP 392
DI 10.1109/ITHERM.2000.866851
PG 8
WC Thermodynamics; Engineering, Electrical & Electronic
SC Thermodynamics; Engineering
GA BQ63S
UT WOS:000089019500050
DA 2018-10-20
ER

PT J
AU Bacon, JR
   Crain, JS
   Van Vaeck, L
   Williams, JG
AF Bacon, JR
   Crain, JS
   Van Vaeck, L
   Williams, JG
TI Atomic mass spectrometry
SO JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY
LA English
DT Review
ID INDUCTIVELY-COUPLED PLASMA; DYNAMIC REACTION CELL; LA-ICP-MS; ISOTOPE
   RATIO MEASUREMENTS; LONG-LIVED RADIONUCLIDES; AIRBORNE PARTICULATE
   MATTER; TRACE-ELEMENT DETERMINATION; PAIR LIQUID-CHROMATOGRAPHY;
   QUADRUPOLE ION-TRAP; GC-C-IRMS
AB This Update follows on from last year's, but only covers a period of approximately ten months as the production schedule has been brought forward by two months. The format remains the same with some minor changes in the section headings. Although an attempt is made to consider all relevant refereed papers, conference abstracts, reports, book chapters and patents for inclusion, this review does not aim at being comprehensive in its coverage. The selection of papers is based on criteria applied to focus sharply on the most significant developments in instrumentation and methodology or improved understanding of the fundamental phenomena involved in the MS process. Routine applications of atomic MS are not covered in this Update and readers are referred to the Updates on Industrial analysis: metals, chemicals and advanced materials, Environmental analysis and Clinical and biological materials, foods and beverages.
   Trends noted in last year's Update have generally been maintained. Although the scope of this review includes the rapidly increasing use of MS for speciation analysis, reported developments should involve or be intended for studies of speciation in natural systems. However, some degree of judgement has still been required to set the limits. Attention has continued to be paid mainly to sample preparation and introduction, in particular to meet the need for analysis of smaller samples. The sensitivity of many of the MS techniques is exemplified by the growing use of AMS in biomedical and pharmaceutical studies, made possible through the use of such low levels of radiocarbon tracers that the doses fall below natural background levels and regulatory limits. The overall trend in published material on ICP-MS continues to grow mainly in the applications and sample introduction areas, at the expense of fundamental studies. The exception to this is a considerable activity in the development and application of collision and reaction cells for reduction or removal of polyatomic species. Many applications exploit the isotope capability of MS, identified in last year's review as a growth area for ICP-MS.
C1 Macaulay Land Use Res Inst, Aberdeen AB15 8QH, Scotland.
   Union Carbide Corp, Ctr Tech, S Charleston, WV 25303 USA.
   Univ Instelling Antwerp, Dept Chem, Micro & Trace Anal Ctr, B-2610 Antwerp, Belgium.
   Kingston Univ, Sch Geol Sci, Ctr Earth & Environm Sci Res, NERC ICP MS Facil, Kingston upon Thames KT1 2EE, Surrey, England.
RP Bacon, JR (reprint author), Macaulay Land Use Res Inst, Aberdeen AB15 8QH, Scotland.
CR Adriaens A, 1999, MASS SPECTROM REV, V18, P48, DOI 10.1002/(SICI)1098-2787(1999)18:1<48::AID-MAS2>3.3.CO;2-9
   Al-Ammar A, 1999, SPECTROCHIM ACTA B, V54, P1077, DOI 10.1016/S0584-8547(99)00045-2
   Al-Ammar AS, 1999, J ANAL ATOM SPECTROM, V14, P793, DOI 10.1039/a808391f
   Amoruso S, 1999, APPL SURF SCI, V138, P250, DOI 10.1016/S0169-4332(98)00402-4
   Andrews AH, 1999, CAN J FISH AQUAT SCI, V56, P1329, DOI 10.1139/cjfas-56-8-1329
   ARAMAKI T, 1999, JAERI RES, V1
   Aurisicchio C, 1999, EUR J MINERAL, V11, P237
   Avci R, 1999, SURF INTERFACE ANAL, V27, P789
   Bacon JR, 1999, J ANAL ATOM SPECTROM, V14, P1633, DOI 10.1039/a905419g
   Baker SA, 1999, APPL SPECTROSC, V53, P471, DOI 10.1366/0003702991946767
   Baldwin MJ, 1999, THIN SOLID FILMS, V345, P108, DOI 10.1016/S0040-6090(99)00066-8
   Bandura DR, 1999, ATOM SPECTROSC, V20, P69
   Bantan T, 1999, J ANAL ATOM SPECTROM, V14, P1743, DOI 10.1039/a904213j
   Baranov VI, 1999, J ANAL ATOM SPECTROM, V14, P1133, DOI 10.1039/a809889a
   Barker J, 1999, RAPID COMMUN MASS SP, V13, P285, DOI 10.1002/(SICI)1097-0231(19990228)13:4<285::AID-RCM469>3.0.CO;2-R
   Barshick CM, 1999, ANAL CHEM, V71, P483, DOI 10.1021/ac980854q
   Barwick VJ, 1999, ANAL CHIM ACTA, V394, P281, DOI 10.1016/S0003-2670(99)00302-5
   Bayon MM, 1999, J ANAL ATOM SPECTROM, V14, P1317, DOI 10.1039/a901760g
   Becker JS, 1999, J ANAL ATOM SPECTROM, V14, P933, DOI 10.1039/a809252d
   Becker JS, 1999, J ANAL ATOM SPECTROM, V14, P1493, DOI 10.1039/a901762c
   Bellino M, 1999, AIP CONF PROC, V475, P644
   Ben Younes ME, 1999, J ANAL ATOM SPECTROM, V14, P1703, DOI 10.1039/a903269j
   Biersack J, 1999, NUCL INSTRUM METH B, V153, P398, DOI 10.1016/S0168-583X(98)01029-5
   Bisling P, 1999, FRESEN J ANAL CHEM, V364, P79, DOI 10.1007/s002160051304
   Bogaerts A, 1999, FRESEN J ANAL CHEM, V364, P367, DOI 10.1007/s002160051352
   Bogaerts A, 1999, J ANAL ATOM SPECTROM, V14, P1375, DOI 10.1039/a900772e
   Bollhofer A, 1999, ANAL CHIM ACTA, V390, P227, DOI 10.1016/S0003-2670(99)00182-8
   Booth CA, 1999, FUEL, V78, P1665, DOI 10.1016/S0016-2361(99)00113-1
   Borisov OV, 1999, SPECTROCHIM ACTA B, V54, P1351, DOI 10.1016/S0584-8547(99)00083-X
   Boue-Bigne F, 1999, J ANAL ATOM SPECTROM, V14, P1665, DOI 10.1039/a905479k
   Brauer RD, 1999, NUCL INSTRUM METH B, V152, P129, DOI 10.1016/S0168-583X(98)01092-1
   Brazier JL, 1999, ANALUSIS, V27, P218, DOI 10.1051/analusis:1999270218
   Brede C, 2000, J ANAL ATOM SPECTROM, V15, P55, DOI 10.1039/a904211c
   Brede C, 1999, J CHROMATOGR A, V849, P553, DOI 10.1016/S0021-9673(99)00561-0
   Brenninkmeijer CAM, 1999, RAPID COMMUN MASS SP, V13, P2028, DOI 10.1002/(SICI)1097-0231(19991030)13:20<2028::AID-RCM751>3.0.CO;2-J
   Buchholz BA, 1999, ANAL BIOCHEM, V269, P348, DOI 10.1006/abio.1999.4041
   Bushaw BA, 1999, SPECTROCHIM ACTA B, V54, P321, DOI 10.1016/S0584-8547(98)00250-X
   Butler IB, 1999, EARTH PLANET SC LETT, V167, P335, DOI 10.1016/S0012-821X(99)00038-2
   Campbell AJ, 1999, ANAL CHEM, V71, P939, DOI 10.1021/ac9808425
   Campbell MJ, 1999, J ANAL ATOM SPECTROM, V14, P1313, DOI 10.1039/a901639b
   Casiot C, 1999, ANAL COMMUN, V36, P77, DOI 10.1039/a900319c
   Cave MR, 2000, J ANAL ATOM SPECTROM, V15, P181, DOI 10.1039/b000063i
   Chartier F, 1999, J ANAL ATOM SPECTROM, V14, P1461, DOI 10.1039/a902318f
   Chatterjee A, 1999, J ANAL ATOM SPECTROM, V14, P1853, DOI 10.1039/a905078g
   Chen P, 1999, J AM SOC MASS SPECTR, V10, P153, DOI 10.1016/S1044-0305(98)00133-0
   Chen ZX, 1999, J ANAL ATOM SPECTROM, V14, P1823, DOI 10.1039/a903272j
   Chin CJ, 1999, J ANAL ATOM SPECTROM, V14, P663, DOI 10.1039/a807275b
   Clifford AJ, 1998, ADV EXP MED BIOL, V445, P239
   Coedo AG, 1999, ANAL CHIM ACTA, V389, P247, DOI 10.1016/S0003-2670(99)00125-7
   Collon P, 1999, RADIOCHIM ACTA, V85, P13
   Compston W, 1999, MINERAL MAG, V63, P297, DOI 10.1180/002646199548475
   Cuynen E, 1999, RAPID COMMUN MASS SP, V13, P2287, DOI 10.1002/(SICI)1097-0231(19991215)13:23<2287::AID-RCM788>3.0.CO;2-J
   Dagnac T, 1999, TALANTA, V48, P763, DOI 10.1016/S0039-9140(98)00093-9
   Dangin M, 1999, AM J PHYSIOL-ENDOC M, V276, pE212, DOI 10.1152/ajpendo.1999.276.1.E212
   Daolio S, 1999, RAPID COMMUN MASS SP, V13, P782, DOI 10.1002/(SICI)1097-0231(19990515)13:9<782::AID-RCM564>3.3.CO;2-C
   Debrah E, 1999, ATOM SPECTROSC, V20, P73
   DEBRAH E, 1999, SPEC PUBL R SOC CHEM, V241, P20
   Dennapanray PNK, 1999, J APPL PHYS, V85, P3993, DOI 10.1063/1.370302
   Devos W, 1999, J ANAL ATOM SPECTROM, V14, P621, DOI 10.1039/a900073i
   Douglas DJ, 1998, INDUCTIVELY COUPLED PLASMAS MASS SPECTROMETRY, P615
   Douglas MA, 1998, SURF INTERFACE ANAL, V26, P984, DOI 10.1002/(SICI)1096-9918(199812)26:13<984::AID-SIA446>3.0.CO;2-K
   DOUTHITT CB, 1999, ICP INFORM NEWSL, V25, P90
   Du ZH, 1999, J ANAL ATOM SPECTROM, V14, P1111, DOI 10.1039/a804022b
   Duersch BS, 1999, SPECTROCHIM ACTA B, V54, P545, DOI 10.1016/S0584-8547(99)00012-9
   Duersch BS, 1999, J ANAL ATOM SPECTROM, V14, P615, DOI 10.1039/a809063g
   Dunemann L, 1999, FRESEN J ANAL CHEM, V363, P466, DOI 10.1007/s002160051224
   Durrant SF, 1999, J ANAL ATOM SPECTROM, V14, P1385, DOI 10.1039/a901765h
   Eccles AJ, 1999, APPL SURF SCI, V144-45, P106, DOI 10.1016/S0169-4332(98)00776-4
   Eiden GC, 1999, J ANAL ATOM SPECTROM, V14, P1129, DOI 10.1039/a806433d
   Fairman B, 1999, J ANAL ATOM SPECTROM, V14, P1937, DOI 10.1039/a908094e
   Farquhar J, 1999, EARTH PLANET SC LETT, V171, P607, DOI 10.1016/S0012-821X(99)00177-6
   Feldmann I, 1999, FRESEN J ANAL CHEM, V365, P422, DOI 10.1007/s002160051634
   Feldmann I, 1999, FRESEN J ANAL CHEM, V365, P415, DOI 10.1007/s002160051633
   Fifield LK, 1999, REP PROG PHYS, V62, P1223, DOI 10.1088/0034-4885/62/8/202
   Fried M, 1998, J LUMIN, V80, P147, DOI 10.1016/S0022-2313(98)00086-6
   GALER SJG, 1998, MINERAL MAG A, V62, P491, DOI DOI 10.1180/MINMAG.1998.62A.1.260
   Gammelgaard B, 1999, J ANAL ATOM SPECTROM, V14, P867, DOI 10.1039/a900940j
   Gautier B, 1998, SURF INTERFACE ANAL, V26, P974, DOI 10.1002/(SICI)1096-9918(199812)26:13<974::AID-SIA445>3.3.CO;2-F
   Gavrilov KL, 1999, J AM CERAM SOC, V82, P1001, DOI 10.1111/j.1151-2916.1999.tb01866.x
   Gebhardt O, 1999, FRESEN J ANAL CHEM, V365, P117, DOI 10.1007/s002160051456
   Gerlock JL, 1999, POLYM DEGRAD STABIL, V65, P37, DOI 10.1016/S0141-3910(98)00214-6
   Ghazi AM, 2000, ANALYST, V125, P205, DOI 10.1039/a908980b
   Gillen G, 1999, J VAC SCI TECHNOL A, V17, P845, DOI 10.1116/1.581657
   Gillman L, 1999, MATH INTELL, V21, P3, DOI 10.1007/BF03025407
   Gilmore IS, 1999, APPL SURF SCI, V144-45, P113, DOI 10.1016/S0169-4332(98)00779-X
   Gleixner G, 1999, RAPID COMMUN MASS SP, V13, P1278, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1278::AID-RCM649>3.0.CO;2-N
   Gleixner G, 1998, ACS SYM SER, V707, P34
   GOMEZARIZA JL, 1998, ANALYST CAMBRIDGE, V124, P75
   Gonzalez J, 1999, J AGR FOOD CHEM, V47, P2316, DOI 10.1021/jf981093v
   Goschnick J, 1999, SURF INTERFACE ANAL, V28, P56
   Goschnick J, 1999, APPL SURF SCI, V144-45, P201, DOI 10.1016/S0169-4332(98)00797-1
   Goschnick J, 1998, THIN SOLID FILMS, V332, P215, DOI 10.1016/S0040-6090(98)00990-0
   Goschnick J, 1999, APPL SURF SCI, V144-45, P31, DOI 10.1016/S0169-4332(98)00758-2
   Goss SH, 1999, PHYS REV B, V59, P10662, DOI 10.1103/PhysRevB.59.10662
   Gregoire DC, 1999, SPECTROCHIM ACTA B, V54, P773, DOI 10.1016/S0584-8547(99)00008-7
   Grotti M, 1999, J ANAL ATOM SPECTROM, V14, P1171, DOI 10.1039/a902625h
   Guevremont R, 2000, J ANAL ATOM SPECTROM, V15, P37, DOI 10.1039/a903914g
   Gunther D, 1999, J ANAL ATOM SPECTROM, V14, P1369, DOI 10.1039/a901649j
   Gunther D, 1999, J ANAL ATOM SPECTROM, V14, P1363, DOI 10.1039/a901648a
   Gunther D, 1999, SPECTROCHIM ACTA B, V54, P381, DOI 10.1016/S0584-8547(99)00011-7
   Guzowski JP, 1999, J ANAL ATOM SPECTROM, V14, P1121, DOI 10.1039/a903113h
   Halas S, 1999, ANAL CHEM, V71, P3254, DOI 10.1021/ac9900174
   Hall JA, 1999, RAPID COMMUN MASS SP, V13, P1231, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1231::AID-RCM579>3.0.CO;2-B
   Hamester M, 1999, FRESEN J ANAL CHEM, V364, P495, DOI 10.1007/s002160051374
   Hamoudi S, 1999, J CATAL, V185, P333, DOI 10.1006/jcat.1999.2519
   Hang W, 1999, J ANAL ATOM SPECTROM, V14, P1523, DOI 10.1039/a902211b
   HARUHARA Y, 1998, TOK DAIG GENSH KENK, P169
   He C, 1999, J APPL PHYS, V86, P3463, DOI 10.1063/1.371230
   Held A, 1999, J ANAL ATOM SPECTROM, V14, P1075, DOI 10.1039/a809098j
   Hellborg R, 1999, AIP CONF PROC, V475, P636
   Herec J, 1999, NUKLEONIKA, V44, P103
   Herec J, 1999, NUKLEONIKA, V44, P119
   Higashi Y, 1999, SPECTROCHIM ACTA B, V54, P109, DOI 10.1016/S0584-8547(98)00193-1
   HIGASHI Y, 1999, J SURF ANAL, V5, P136
   Hilkert AW, 1999, RAPID COMMUN MASS SP, V13, P1226, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1226::AID-RCM575>3.0.CO;2-9
   HILL SJ, 1999, INDUCTIVELY COUPLED, P208
   Hinz KP, 1999, J AM SOC MASS SPECTR, V10, P648, DOI 10.1016/S1044-0305(99)00028-8
   Hirata T, 1999, J ANAL ATOM SPECTROM, V14, P1455, DOI 10.1039/a901389j
   Hongo C, 1999, APPL SURF SCI, V144-45, P306, DOI 10.1016/S0169-4332(98)00815-0
   Horlick G, 1998, INDUCTIVELY COUPLED PLASMAS MASS SPECTROMETRY, P503
   HOSHI T, 1999, J SURF ANAL, V5, P132
   Hoskin PWO, 1999, GEOSTANDARD NEWSLETT, V23, P69, DOI 10.1111/j.1751-908X.1999.tb00560.x
   Hou HB, 1999, ATOM SPECTROSC, V20, P20
   Hou HB, 1999, ANAL SCI, V15, P911, DOI 10.2116/analsci.15.911
   INFANTE HG, 1959, J ANAL ATOM SPECTROM, V14, P143
   Ingram JC, 1999, ANAL CHEM, V71, P1712, DOI 10.1021/ac9811571
   Inoue M, 1999, ANAL CHIM ACTA, V395, P165, DOI 10.1016/S0003-2670(99)00334-7
   Ivanov VP, 1999, INT J MASS SPECTROM, V188, P183, DOI 10.1016/S1387-3806(99)00036-6
   Iwamura T, 1999, BUNSEKI KAGAKU, V48, P555
   Jackson SM, 1999, RAPID COMMUN MASS SP, V13, P1329
   Jenett H, 1999, NUCL INSTRUM METH B, V155, P13, DOI 10.1016/S0168-583X(99)00291-8
   Jiang ZX, 1999, SURF INTERFACE ANAL, V27, P125, DOI 10.1002/(SICI)1096-9918(199903)27:3<125::AID-SIA490>3.3.CO;2-#
   Johnson CM, 1999, INT J MASS SPECTROM, V193, P87, DOI 10.1016/S1387-3806(99)00158-X
   Jones AM, 1999, CHEM GEOL, V153, P241, DOI 10.1016/S0009-2541(98)00162-4
   JONES VD, 1998, ASTM SPEC TECH PUBL, V1344, P41
   KANEKO N, 1999, CHISHITSU CHOSASHO G, V50, P383
   Kang HJ, 1999, NUCL INSTRUM METH B, V153, P429, DOI 10.1016/S0168-583X(98)01021-0
   Kawai Y, 1999, INT J MASS SPECTROM, V193, P29, DOI 10.1016/S1387-3806(99)00134-7
   KAWASHIMA Y, 1999, J SURF ANAL, V5, P116
   KINOSHITA J, 1999, J SURF ANAL, V5, P185
   Konarski P, 1999, NUKLEONIKA, V44, P143
   Kornexl BE, 1999, RAPID COMMUN MASS SP, V13, P1685
   Kornexl BE, 1999, RAPID COMMUN MASS SP, V13, P1248, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1248::AID-RCM560>3.0.CO;2-H
   Kotrebai M, 1999, ANAL COMMUN, V36, P249, DOI 10.1039/a902770j
   Kotrebai M, 2000, ANALYST, V125, P71, DOI 10.1039/a906320j
   Kotrebai M, 1999, SPECTROCHIM ACTA B, V54, P1573, DOI 10.1016/S0584-8547(99)00086-5
   KRUEGER D, 1998, DIFFUS DEFECT DATA B, V63, P465
   Kurt R, 1999, FRESEN J ANAL CHEM, V363, P179, DOI 10.1007/s002160051167
   LaFuente JMG, 1999, TALANTA, V50, P207, DOI 10.1016/S0039-9140(99)00121-6
   Lam JW, 1999, ATOM SPECTROSC, V20, P79
   Lam JWH, 1999, SPECTROCHIM ACTA B, V54, P443, DOI 10.1016/S0584-8547(98)00255-9
   Langer D, 1999, APPL SPECTROSC, V53, P1244, DOI 10.1366/0003702991945489
   Leach AM, 2000, J ANAL ATOM SPECTROM, V15, P151, DOI 10.1039/a905825g
   Lee KM, 1999, ANAL CHIM ACTA, V395, P179, DOI 10.1016/S0003-2670(99)00319-0
   Lewis CL, 1999, ANAL CHEM, V71, P230, DOI 10.1021/ac9806916
   Liang HD, 1999, CHINESE SCI BULL, V44, P1242, DOI 10.1007/BF02885975
   Litherland AE, 1999, AIP CONF PROC, V473, P426
   Liu Yonghao, 1999, Nuclear Science and Techniques, V10, P116
   Loader NJ, 1999, RAPID COMMUN MASS SP, V13, P1828, DOI 10.1002/(SICI)1097-0231(19990930)13:18<1828::AID-RCM724>3.0.CO;2-G
   Lochner F, 1999, ANAL CHIM ACTA, V401, P299, DOI 10.1016/S0003-2670(99)00476-6
   Lofthouse SD, 1999, J ANAL ATOM SPECTROM, V14, P1839, DOI 10.1039/a907308f
   Loger RL, 1999, AIP CONF PROC, V475, P640
   Lopez-Gutierrez JM, 1999, APPL RADIAT ISOTOPES, V51, P315, DOI 10.1016/S0969-8043(98)00201-2
   Mahoney PP, 1999, ANAL CHEM, V71, P1378, DOI 10.1021/ac9811625
   Makarov VV, 1999, SURF INTERFACE ANAL, V27, P801, DOI 10.1002/(SICI)1096-9918(199909)27:9<801::AID-SIA575>3.0.CO;2-Z
   Mank AJG, 1999, J ANAL ATOM SPECTROM, V14, P1143, DOI 10.1039/a903304a
   Marcus RK, 2000, J ANAL ATOM SPECTROM, V15, P1, DOI 10.1039/a907692a
   Marechal CN, 1999, CHEM GEOL, V156, P251, DOI 10.1016/S0009-2541(98)00191-0
   Mason PM, 1998, ANALYST, V123, P2405, DOI 10.1039/a805529g
   MATSUZAKI H, 1998, TOK DAIG GENSH KENK, P173
   MAXWELL SL, 1998, NUCL MAT MANAGE, V27, P1190
   Mazeas L, 1999, ANALUSIS, V27, P200, DOI 10.1051/analusis:1999270200
   McConville C, 1999, RAPID COMMUN MASS SP, V13, P1339, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1339::AID-RCM559>3.0.CO;2-N
   McSheehy Shona, 2000, Journal of Analytical Atomic Spectrometry, V15, P79, DOI 10.1039/a906890b
   Meier-Augenstein W, 1999, J CHROMATOGR A, V842, P351, DOI 10.1016/S0021-9673(98)01057-7
   Merchel S, 1999, RADIOCHIM ACTA, V84, P215
   MERREN TO, 1999, Patent No. 302963
   MERREN TO, 1998, Patent No. 831920
   MERREN TO, 1999, Patent No. 952607
   Mester Z, 1999, RAPID COMMUN MASS SP, V13, P1999, DOI 10.1002/(SICI)1097-0231(19991030)13:20<1999::AID-RCM744>3.3.CO;2-3
   Mester Z, 1999, J CHROMATOGR A, V832, P183, DOI 10.1016/S0021-9673(98)01011-5
   Metges C. C., 1999, METH NUTR SER, P121
   Metson JB, 1999, SURF INTERFACE ANAL, V28, P159, DOI 10.1002/(SICI)1096-9918(199908)28:1<159::AID-SIA597>3.3.CO;2-W
   Michalke B, 1999, FRESEN J ANAL CHEM, V363, P456, DOI 10.1007/s002160051222
   Miller MF, 1999, RAPID COMMUN MASS SP, V13, P1211, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1211::AID-RCM576>3.0.CO;2-M
   Montaser A, 1998, INDUCTIVELY COUPLED PLASMAS MASS SPECTROMETRY, P809
   Montaser A, 1998, INDUCTIVELY COUPLED PLASMAS MASS SPECTROMETRY, P1
   MOON DW, 1999, J SURF ANAL, V6, P34
   Moor C, 2000, J ANAL ATOM SPECTROM, V15, P143, DOI 10.1039/a909296j
   Muller U, 1999, SURF INTERFACE ANAL, V27, P904
   Neubauer K, 1999, ATOM SPECTROSC, V20, P64
   Nohda S, 1999, GEOCHEM J, V33, P133, DOI 10.2343/geochemj.33.133
   OCONNOR G, 1999, INDUCTIVELY COUPLED, P119
   OHLSSON KEA, 1998, ANALYST CAMBRIDGE, V124, P571
   Okamoto Y, 1999, J ANAL ATOM SPECTROM, V14, P1631, DOI 10.1039/a905374c
   Okuyama F, 1999, INT J MASS SPECTROM, V189, P173, DOI 10.1016/S1387-3806(99)00070-6
   OLESIK JW, 1999, SPEC PUBL R SOC CHEM, V241, P3
   Ormsby TJ, 1999, APPL SURF SCI, V144-45, P292, DOI 10.1016/S0169-4332(98)00812-5
   Pakhomov AV, 1999, APPL SPECTROSC, V53, P979, DOI 10.1366/0003702991947649
   Park CJ, 1999, J ANAL ATOM SPECTROM, V14, P1061, DOI 10.1039/a902882j
   Parks CC, 1999, J VAC SCI TECHNOL A, V17, P1130, DOI 10.1116/1.581785
   Patterson JE, 1999, SPECTROCHIM ACTA B, V54, P537, DOI 10.1016/S0584-8547(99)00013-0
   PERGANTIS SA, 1999, EUR WINT C PLASM SPE
   Pfander JA, 1999, FRESEN J ANAL CHEM, V364, P376, DOI 10.1007/s002160051353
   Pratt AR, 1999, CR ACAD SCI II A, V328, P309, DOI 10.1016/S1251-8050(99)80122-0
   Pretty JR, 1998, RAPID COMMUN MASS SP, V12, P1644, DOI 10.1002/(SICI)1097-0231(19981115)12:21<1644::AID-RCM377>3.0.CO;2-7
   Prohaska T, 1999, J ANAL ATOM SPECTROM, V14, P1501, DOI 10.1039/a901973a
   PUPYSHEV A, 1998, P SEM AT SPECTR 14 S, P330
   Pupyshev AA, 1999, J ANAL ATOM SPECTROM, V14, P1485, DOI 10.1039/a902167a
   Ramakumar KL, 1999, INT J MASS SPECTROM, V184, P109, DOI 10.1016/S1387-3806(98)14273-2
   Ramanujam VMS, 1999, BIOL TRACE ELEM RES, V68, P143, DOI 10.1007/BF02784403
   Ranville JF, 1999, ANAL CHIM ACTA, V381, P315, DOI 10.1016/S0003-2670(98)00702-8
   RAR A, 1999, J SURF ANAL, V6, P29
   Rau I, 1999, NUCL INSTRUM METH B, V155, P53, DOI 10.1016/S0168-583X(99)00227-X
   Richter S, 1999, J ANAL ATOM SPECTROM, V14, P889, DOI 10.1039/a900774a
   Richter S, 1999, FRESEN J ANAL CHEM, V364, P478, DOI 10.1007/s002160051371
   Richter S, 1999, INT J MASS SPECTROM, V193, P9, DOI 10.1016/S1387-3806(99)00102-5
   ROSENBERG E, 1999, INSTRUMENTAL METHODS
   ROSENBERG E, 1999, EUR WINT C PLASM SPE
   Rucklidge JC, 1999, AIP CONF PROC, V475, P629
   Russow R, 1999, RAPID COMMUN MASS SP, V13, P1334
   Russow R, 1998, ARCH AGRON SOIL SCI, V43, P349
   Sah RN, 1998, BIOL TRACE ELEM RES, V66, P39, DOI 10.1007/BF02783124
   Saprykin AI, 1999, J ANAL CHEM+, V54, P671
   Saprykin AI, 1999, FRESEN J ANAL CHEM, V364, P763, DOI 10.1007/s002160051429
   Saprykin AI, 1999, IND LAB+, V65, P83
   Sartoros C, 1999, SPECTROCHIM ACTA B, V54, P1557, DOI 10.1016/S0584-8547(99)00089-0
   Sato T, 1999, SURF SCI, V433, P711, DOI 10.1016/S0039-6028(99)00159-4
   Schaumloffel D, 1999, FRESEN J ANAL CHEM, V364, P452, DOI 10.1007/s002160051366
   Schenkel T, 1999, PHYS SCRIPTA, VT80A, P73, DOI 10.1238/Physica.Topical.080a00073
   Schneider RJ, 1999, AIP CONF PROC, V473, P422
   Schramel O, 1999, J ANAL ATOM SPECTROM, V14, P1339, DOI 10.1039/a900494g
   Schramel O, 1999, FRESEN J ANAL CHEM, V363, P452, DOI 10.1007/s002160051221
   Schuhmacher M, 1999, FRESEN J ANAL CHEM, V365, P12, DOI 10.1007/s002160051438
   SCHWIETERS J, 1998, MINERAL MAG 3, V62, P1360
   Seki S, 1999, APPL SURF SCI, V147, P14, DOI 10.1016/S0169-4332(99)00124-5
   SHAKRA FA, 1999, SPEC PUBL R SOC CHEM, V241, P120
   Shepherd TJ, 1998, EUR J MINERAL, V10, P1097
   SHICHI H, 1999, J SURF ANAL, V5, P212
   Shimizu K, 1998, CAN J CHEM, V76, P1796, DOI 10.1139/cjc-76-12-1796
   Shimizu N, 1999, ANAL SCI, V15, P685, DOI 10.2116/analsci.15.685
   Sich I, 1999, RAPID COMMUN MASS SP, V13, P1325, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1325::AID-RCM622>3.0.CO;2-K
   Sie SH, 1999, AIP CONF PROC, V475, P648
   Slaets S, 1999, J ANAL ATOM SPECTROM, V14, P851, DOI 10.1039/a809296f
   SMEHTKOWSKI VS, 1999, J VAC SCI TECHNOL A, V17, P2634
   Socki RA, 1999, ANAL CHEM, V71, P2250, DOI 10.1021/ac981140i
   Song K, 1999, J KOREAN PHYS SOC, V35, P217
   Stevie FA, 1999, J VAC SCI TECHNOL B, V17, P2476, DOI 10.1116/1.591115
   Stewart II, 1999, J AM SOC MASS SPECTR, V10, P159, DOI 10.1016/S1044-0305(98)00136-6
   Stewart II, 1999, SPECTROCHIM ACTA B, V54, P1649, DOI 10.1016/S0584-8547(99)00110-X
   STIRLING CH, 1998, MINERAL MAG 3, V62, P1462
   Stoll B, 1999, FRESEN J ANAL CHEM, V364, P380, DOI 10.1007/s002160051354
   Stone JA, 1999, INT J MASS SPECTROM, V185, P227, DOI 10.1016/S1387-3806(98)14063-0
   Striegel AM, 1999, J AM SOC MASS SPECTR, V10, P254, DOI 10.1016/S1044-0305(98)00140-8
   Suess DT, 1999, CHEM REV, V99, P3007, DOI 10.1021/cr980138o
   Sundquist ML, 1999, AIP CONF PROC, V475, P661
   SUTTON KL, 1999, INDUCTIVELY COUPLED, P245
   SUZUKI S, 1999, J SURF ANAL, V5, P278
   Tanner SD, 1999, ATOM SPECTROSC, V20, P45
   Tanner SD, 1999, J AM SOC MASS SPECTR, V10, P1083, DOI 10.1016/S1044-0305(99)00081-1
   TANNER SD, 1999, SPEC PUBL R SOC CHEM, V241, P46
   Taylor A, 2000, J ANAL ATOM SPECTROM, V15, P451, DOI 10.1039/b000839g
   Taylor HE, 1998, INDUCTIVELY COUPLED PLASMAS MASS SPECTROMETRY, P681
   Thomas KV, 1999, J CHROMATOGR A, V833, P105, DOI 10.1016/S0021-9673(98)01009-7
   Tian XD, 1999, J ANAL ATOM SPECTROM, V14, P1807, DOI 10.1039/a906762k
   Tian XD, 1999, ATOM SPECTROSC, V20, P127
   Todoli JL, 1999, SPECTROCHIM ACTA B, V54, P895, DOI 10.1016/S0584-8547(99)00041-5
   Tomascak PB, 1999, GEOCHIM COSMOCHIM AC, V63, P907, DOI 10.1016/S0016-7037(98)00318-4
   Tomascak PB, 1999, CHEM GEOL, V158, P145, DOI 10.1016/S0009-2541(99)00022-4
   TOMASCAK PB, 1998, MINERAL MAG A 1, V62, P1523
   Toniazzo V, 1999, APPL SURF SCI, V143, P229, DOI 10.1016/S0169-4332(98)00918-0
   Toyoda S, 1999, ANAL CHEM, V71, P4711, DOI 10.1021/ac9904563
   Turner IL, 1998, INDUCTIVELY COUPLED PLASMAS MASS SPECTROMETRY, P265
   Turner PJ, 1998, INDUCTIVELY COUPLED PLASMAS MASS SPECTROMETRY, P421
   Uggerud HT, 1999, SPECTROCHIM ACTA B, V54, P1625, DOI 10.1016/S0584-8547(99)00093-2
   Valkiers S, 1999, INT J MASS SPECTROM, V193, P1, DOI 10.1016/S1387-3806(99)00101-3
   van der Heide PAW, 1999, NUCL INSTRUM METH B, V157, P126, DOI 10.1016/S0168-583X(99)00453-X
   Van Vaeck L, 1999, MASS SPECTROM REV, V18, P1
   Vanhaecke F, 1999, FRESEN J ANAL CHEM, V364, P440, DOI 10.1007/s002160051365
   VANHAECKE F, 1999, INDUCTIVELY COUPLED, P145
   Verkleij D, 1999, MICRON, V30, P227, DOI 10.1016/S0968-4328(99)00007-4
   Verkouteren RM, 1999, ANAL CHEM, V71, P4740, DOI 10.1021/ac990233c
   Verlinden G, 1999, J AM SOC MASS SPECTR, V10, P1016, DOI 10.1016/S1044-0305(99)00064-1
   Vickers PE, 1999, APPL SURF SCI, V150, P244, DOI 10.1016/S0169-4332(99)00250-0
   VOLIKOPF U, 1999, SPEC PUBL R SOC CHEM, V241, P63
   Vollkopf U, 1999, ATOM SPECTROSC, V20, P53
   Waggoner JW, 2000, J ANAL ATOM SPECTROM, V15, P13, DOI 10.1039/a905906g
   Wang CF, 1999, ANAL CHIM ACTA, V389, P257, DOI 10.1016/S0003-2670(99)00162-2
   Wang HJ, 1999, ANAL CHEM, V71, P4166, DOI 10.1021/ac981375u
   Wang L, 1999, J ELECTRON MATER, V28, P793, DOI 10.1007/s11664-999-0072-4
   Wanner B, 1999, SPECTROCHIM ACTA B, V54, P289, DOI 10.1016/S0584-8547(98)00245-6
   Wassenaar LI, 1999, ANAL CHEM, V71, P4965, DOI 10.1021/ac9903961
   Wayne DM, 1999, APPL SPECTROSC, V53, P266, DOI 10.1366/0003702991946640
   Wei MT, 1999, J ANAL ATOM SPECTROM, V14, P1177, DOI 10.1039/a903199e
   Wen B, 1999, ANALYST, V124, P621, DOI 10.1039/a809854i
   Wendt K, 1999, FRESEN J ANAL CHEM, V364, P471, DOI 10.1007/s002160051370
   Wendt K, 1999, J KOREAN PHYS SOC, V35, P143
   Wennrich R, 1999, CHEM ANAL-WARSAW, V44, P523
   Werner RA, 1999, RAPID COMMUN MASS SP, V13, P1237, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1237::AID-RCM633>3.0.CO;2-C
   WHITAKER TJ, 1999, ADV SCI TECHNOL, V19, P97
   Wiedemann B, 1999, FRESEN J ANAL CHEM, V364, P768, DOI 10.1007/s002160051430
   Wiedemann B, 1999, FRESEN J ANAL CHEM, V364, P772, DOI 10.1007/s002160051431
   Wieser ME, 1999, RAPID COMMUN MASS SP, V13, P1218, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1218::AID-RCM652>3.0.CO;2-C
   Willey KF, 1999, J VAC SCI TECHNOL A, V17, P1127, DOI 10.1116/1.581908
   Willey KF, 1999, APPL SURF SCI, V144-45, P36, DOI 10.1016/S0169-4332(98)00760-0
   Wittmaack K, 1999, SURF SCI, V429, P84, DOI 10.1016/S0039-6028(99)00341-6
   Wittmaack K, 1999, APPL PHYS LETT, V74, P3969, DOI 10.1063/1.124239
   Wolkenstein M, 1999, FRESEN J ANAL CHEM, V365, P63, DOI 10.1007/s002160051446
   Woll DM, 1999, FRESEN J ANAL CHEM, V365, P70, DOI 10.1007/s002160051447
   Xu GH, 1999, MATER RES SOC SYMP P, V563, P257, DOI 10.1557/PROC-563-257
   Yan XP, 1998, ANAL CHEM, V70, P4736, DOI 10.1021/ac980654e
   Yang DW, 1999, J MASS SPECTROM, V34, P1130
   YONEDA S, 1998, B NATL SCI MUS TOK E, V21, P1
   Yorozu M, 1999, APPL PHYS B-LASERS O, V69, P129, DOI 10.1007/s003400050784
   Young ED, 1998, GEOCHIM COSMOCHIM AC, V62, P3161, DOI 10.1016/S0016-7037(98)00216-6
   Yu LL, 1999, J ANAL ATOM SPECTROM, V14, P669, DOI 10.1039/a809797f
   Yue RF, 1999, SURF INTERFACE ANAL, V27, P98
   Zapata AM, 1999, J ANAL ATOM SPECTROM, V14, P1187, DOI 10.1039/a902656h
   Zhang BL, 1999, ANAL CHEM, V71, P2301, DOI 10.1021/ac9812375
   Zhang H, 1998, INDUCTIVELY COUPLED PLASMAS MASS SPECTROMETRY, P891
   Zhao JT, 1999, J RARE EARTH, V17, P1
NR 321
TC 10
Z9 10
U1 2
U2 15
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0267-9477
EI 1364-5544
J9 J ANAL ATOM SPECTROM
JI J. Anal. At. Spectrom.
PY 2000
VL 15
IS 8
BP 1025
EP 1053
DI 10.1039/b004111o
PG 29
WC Chemistry, Analytical; Spectroscopy
SC Chemistry; Spectroscopy
GA 339FU
UT WOS:000088467600020
DA 2018-10-20
ER

PT J
AU Petrini, P
   Tanzi, MC
   Visai, L
   Casolini, F
   Speziale, P
AF Petrini, P
   Tanzi, MC
   Visai, L
   Casolini, F
   Speziale, P
TI Novel poly(urethane-aminoamides): an in vitro study of the interaction
   with heparin
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE segmented polyurethanes; poly(urethane-amides); radiolabelled heparin;
   heparin adsorption; heparin release; coagulation tests
ID IMMOBILIZED HEPARIN; THROMBIN
AB In order to obtain heparin-binding polyurethanes, tertiary amino-groups have been introduced in the polymer backbone by attributing a key-role to the chain extender, i.e. substituting butane diol, commonly used in polyurethane synthesis, with a tailor-made diamino-diamide-diol. In this work a poly(ether-urethane-aminoamide) (PEU/PIME/al) was obtained with poly(oxytetramethylene) glycol 2000, 1,6-hexamethylene-diisocyanate and the new chain extender, in the molar ratio 1 :2: 1. The heparin binding capacity of PEU/PIME/al was evaluated with I-125 labelled heparin, using for comparison the analogous polymer obtained with a diamide-diol (i.e. the poly(ether-urethane-amide) PEU/PIBLO/al), and two commercially available biomedical polyurethanes (Pellethane 2363 and Corethane). pH and ionic strength dependence of the heparin uptake were investigated by treating all the polyurethanes with solutions of I-125 heparin into buffers from pH 4 to 9 or NaCl molarity from 0.0 to 1.0. The stability of the interaction with bound heparin was investigated by sequential washing treatments (PBS, 1 N NaOH, 2% SDS solution), then analysing the residual radioactivity on the materials.
   Results indicated that the heparin binding of PEU/PIME/al is significantly higher and more stable than that of the other polyurethanes, with a time-dependent kinetic. The interaction with heparin appears to bi prevalently ionic, with the contribution of other electrostatic and hydrophobic interactions. Activated partial thromboplastin time (APTT), performed on human plasma with polyurethane-coated, heparinized test tubes, indicated that bound heparin maintains its biological activity after the adsorption.
C1 Politecn Milan, Dipartimento Bioingn, I-20133 Milan, Italy.
   Univ Pavia, Dipartimento Biochim, I-27100 Pavia, Italy.
RP Tanzi, MC (reprint author), Politecn Milan, Dipartimento Bioingn, Piazza L da Vinci 32, I-20133 Milan, Italy.
RI Tanzi, Maria Cristina/I-4620-2013; Petrini, Paola/A-3150-2013
OI Tanzi, Maria Cristina/0000-0002-4913-6633; Petrini,
   Paola/0000-0002-5081-5254
CR ALBANESE A, 1994, BIOMATERIALS, V15, P129, DOI 10.1016/0142-9612(94)90262-3
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529
   Byun Y, 1996, J BIOMED MATER RES, V30, P423, DOI 10.1002/jbm.820300403
   BYUN Y, 1994, J BIOMATER SCI POLYM, V6
   DIDISHEIM P, 1989, T AM SOC ART INT ORG, V35, P54
   Eloy R, 1988, J Biomater Appl, V2, P475
   Ferruti P., 1996, POLYM MAT ENCY, V5, P3334
   ITO Y, 1986, J BIOMED MATER RES, V20, P1017, DOI 10.1002/jbm.820200715
   Kang IK, 1996, BIOMATERIALS, V17, P841, DOI 10.1016/0142-9612(96)81422-0
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   LIN S, 1985, J ELASTOM PLAST, V17, P140
   OLSON ST, 1991, J BIOL CHEM, V266, P6353
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   PLATE NA, 1986, ADV POLYM SCI BIOPOL
   Ratner BD, 1990, PLASMA DEPOSITION TR, P463
   RATNER BD, 1996, BIOMATERIAL SCI INTR, V7, P298
   ROSEMBERG RD, 1983, HEPARIN, V2
   TANZI MC, 1992, BIOMATERIALS, V13
   TANZI MC, 1999, Patent No. 5955560
   VanDelden CJ, 1996, J BIOMAT SCI-POLYM E, V7, P989, DOI 10.1163/156856296X00390
NR 21
TC 8
Z9 9
U1 0
U2 4
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2000
VL 11
IS 4
BP 353
EP 365
DI 10.1163/156856200743751
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 331AB
UT WOS:000087993600003
PM 10903035
DA 2018-10-20
ER

PT J
AU Mukherjee, C
   Case, ED
   Lee, A
AF Mukherjee, C
   Case, ED
   Lee, A
TI Silica coatings on bismaleimide (BMI) polymeric substrates
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID INDENTATION; SYSTEM; FILMS; PMMA
AB For many years, ceramics have been added to polymeric materials as reinforcements or extenders. Recently, thin ceramic coatings have been applied to polymers for biomedical applications, and in this paper ceramic coatings are applied to an aerospace polymer, bismaleimide (BMI). Unreinforced BMI specimens were coated with a thin, protective layer of a dense silicate ceramic material. Vickers indentation testing on the coated and uncoated BMI specimens indicated that the coatings adhere surprisingly well to the substrate, with cracking of the coating taking place only within a diamond-shaped region with diagonal dimensions equivalent to the Vickers indentation impression. (C) 2000 Kluwer Academic Publishers.
C1 Michigan State Univ, Dept Mech & Mat Sci, E Lansing, MI 48824 USA.
RP Case, ED (reprint author), Michigan State Univ, Dept Mech & Mat Sci, E Lansing, MI 48824 USA.
CR CHAUDHARI M, 1985, SAMPE J, V21, P17
   CRAWFORD J, 1987, PLASTICS ENG
   DIAO DF, 1994, J TRIBOL-T ASME, V116, P860, DOI 10.1115/1.2927346
   DOREMUS RH, 1973, GLASS SCI, P284
   DUCHATELARD P, 1995, J DENT RES, V74, P940
   DUCHATELARD P, 1994, THIN SOLID FILMS, V250, P142, DOI 10.1016/0040-6090(94)90178-3
   Flores A, 1998, J MATER SCI, V33, P3567, DOI 10.1023/A:1004643026386
   GAMLEN CA, 1991, APPL PHYS LETT, V59, P2529, DOI 10.1063/1.105942
   LAWN BR, 1983, FRACTURE MECHANICS C, V5, P1
   LEE BH, 1988, POLYM NEWS, V13, P297
   LEE DG, 1998, SURF COAT TECH, V101, P187
   LI J, 1998, J ENG MATER-T ASME, V120, P152
   LINCOLN JE, UNPUB SAMPE J ADV MA
   Liu C, 1997, EXP TECHNIQUES, V21, P28, DOI 10.1111/j.1747-1567.1997.tb00506.x
   LIU C, 1997, EXPT MECH, V37, P179
   Low IM, 1998, J APPL POLYM SCI, V70, P2349, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2349::AID-APP6>3.0.CO;2-T
   MORGAN RJ, 1993, POLYMER, V34, P835, DOI 10.1016/0032-3861(93)90371-G
   MORGAN RJ, 1997, THERMAL CHARACTERIZA, pCH9
   MORGAN RJ, 1994, CHARACTERIZATION CRI
   MORGAN RJ, 1985, ADV POLYM SCI, V12, pCH1
   MOSKOWITZ M, 1993, PLAST WORLD, V51, P47
   PARK JB, 1992, BIOMATERIALS INTRO, P154
   Pharr GM, 1998, MAT SCI ENG A-STRUCT, V253, P151, DOI 10.1016/S0921-5093(98)00724-2
   SHIN EE, 1997, P AM SOC COMP 12 TEC, P1113
   Suwanprateeb J, 1998, POLYM TEST, V17, P495, DOI 10.1016/S0142-9418(97)00040-8
   Ward LP, 1996, J MATER PROCESS TECH, V56, P364, DOI 10.1016/0924-0136(95)01850-6
NR 26
TC 4
Z9 4
U1 0
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PY 2000
VL 35
IS 6
BP 1389
EP 1396
DI 10.1023/A:1004746528322
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 281XD
UT WOS:000085186000012
DA 2018-10-20
ER

PT S
AU Chu, C
   Bachman, M
   Chiang, YM
   Gonzales, F
   Li, GP
AF Chu, C
   Bachman, M
   Chiang, YM
   Gonzales, F
   Li, GP
BE DeBoer, MP
   Heuer, AH
   Jacobs, SJ
   Peeters, E
TI Characterizations of metallized plastic MEMS
SO MATERIALS SCIENCE OF MICROELECTROMECHANICAL SYSTEMS (MEMS) DEVICES II
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium MM on Materials Science of Microelectromechanical Systems
   (MEMS) Devices II held at the 1999 MRS Fall Meeting
CY NOV 29-DEC 01, 1999
CL BOSTON, MA
SP Mat Res Soc
AB Metallization of plastic devices is of interest to newer non-silicon based MEMS which are being developed for biomedical and other applications. The electrical properties of the metallization will depend, in part, on the material on which they are patterned and the method of deposition. Of interest are the electrical characterizations during usage which must be studied to allow plastic MEMS designs to proceed wisely. Flexible microdevices may develop open circuits or shorts after excessive bending; joule heating may adversely affect the plastic substrates, leading to failure. We present some experimental studies on electrical characterization of metallized plastics as it relates to various processing conditons and usage scenarios.
C1 Univ Calif Irvine, Dept Elect & Comp Engn, Irvine, CA 92697 USA.
RP Chu, C (reprint author), Univ Calif Irvine, Dept Elect & Comp Engn, Irvine, CA 92697 USA.
RI Li, Guann-Pyng/B-8466-2009
CR AVIRAM A, 1984, Patent No. 4440801
   BERNARD A, 1998, LANGMUIR, V14
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   GOLDIE W, 1969, METALLIC COATING PLA, V1
   GOLDIE W, 1969, METALLIC COATING PLA, V2
   Ogura M, 1998, CLIN CHEM, V44, P2249
   LOCTITE DESIGN GUIDE, V2
NR 7
TC 1
Z9 1
U1 0
U2 1
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-513-7
J9 MATER RES SOC SYMP P
PY 2000
VL 605
BP 97
EP 102
PG 6
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Materials Science, Characterization & Testing
SC Engineering; Materials Science
GA BR05E
UT WOS:000165506600014
DA 2018-10-20
ER

PT S
AU Rodriguez, GP
   Calderon, A
   Hernandez, RAM
   Orea, AC
   Mendez, M
   Sinencio, FS
AF Rodriguez, GP
   Calderon, A
   Hernandez, RAM
   Orea, AC
   Mendez, M
   Sinencio, FS
BE AlvaradoGil, JJ
   Contreras, JG
   Corral, GH
TI Microstructure and thermal characterization of dense bone and metals for
   biomedical use
SO MEDICAL PHYSICS
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT 4th Mexican Symposium on Medical Physics
CY MAR 01-04, 2000
CL MERIDA, MEXICO
SP CINVESTAV Gen Directorate, Natl Univ, Coordinat Sci Res, Natl Univ, Phys Inst
ID DIFFUSIVITY; SILICON
AB We present a microstructural study and thermal diffusivity measurements at room temperature in two different sections of bull dense bone, bull bone and commercial hydroxyapatite, the last two in powder form. A comparison was realised between these measured values and those obtained from metallic samples frequently used in implants, as high purity titanium and 316L stainless steel. Our results show that the porosity and its orientation in the bone are two important factors for the heat flux through the bone. On the other hand, we obtained that the hydroxyapatite, in compact powder form, presents a thermal diffusivity value close to those obtained for the samples of bone which gives a good thermal agreement between these materials. Finally, it was obtained at one order of magnitude difference between the thermal diffusivity values of metallic samples and those corresponding values to bone and hydroxyapatite being this difference greater in titanium than in stainless steel.
C1 IPN, Escuela Super Fis & Matemat, Mexico City 07300, DF, Mexico.
RP Rodriguez, GP (reprint author), IPN, Escuela Super Fis & Matemat, AP 75526,Colonia Lindavisia, Mexico City 07300, DF, Mexico.
CR Bento AC, 1996, J APPL PHYS, V79, P6848, DOI 10.1063/1.362650
   Calderon A, 1998, J APPL PHYS, V84, P6327, DOI 10.1063/1.368957
   Calderon A, 1997, PHYS REV LETT, V79, P5022, DOI 10.1103/PhysRevLett.79.5022
   GOMEZ ML, 1994, THESIS UNAM
   MARQUEZINI MV, 1991, MEAS SCI TECHNOL, V2, P396, DOI 10.1088/0957-0233/2/4/020
   NAGAI M, 1991, J MATER SCI, V26, P2949, DOI 10.1007/BF01124826
   ROSENSWAIG A, 1980, PHOTOACOUSTIC PHOTOA
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   ZIEGLER G, 1981, J MATER SCI, V16, P495, DOI 10.1007/BF00738642
NR 9
TC 0
Z9 0
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 1-56396-963-7
J9 AIP CONF PROC
PY 2000
VL 538
BP 192
EP 195
PG 4
WC Engineering, Biomedical; Physics, Applied
SC Engineering; Physics
GA BR18J
UT WOS:000165808400022
DA 2018-10-20
ER

PT B
AU Loo, GS
AF Loo, GS
BE Valafar, F
TI Information technology in biomedicine: Recognition of noxious plants
   (ITBRONP)
SO METMBS'00: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON MATHEMATICS
   AND ENGINEERING TECHNIQUES IN MEDICINE AND BIOLOGICAL SCIENCES, VOLS I
   AND II
LA English
DT Proceedings Paper
CT International Conference on Mathematics and Engineering Techniques in
   Medicine and Biological Sciences (METMBS 00)
CY JUN 26-29, 2000
CL LAS VEGAS, NV
SP Comp Sci, Res, Educ & Applicat Press, Int Technol Inst, Korea Informat Processing Soc, PDPTA
DE biomedical; image database; inference engine; ingested herbaceous
   matter; noxious plants; restructuring modelling
AB This paper presents a medical simulation system that allows training in the recognition of poisonous plants and presents personnel with a simulation of a patient case who has ingested poisonous plant matter. Currently it is difficult for clinicians to make identification of the source of poisoning from ingesting herbaceous matter. Patients presenting symptoms of poisoning often cannot identify the herbaceous material by name, but are usually able to give a description and sometimes arrive at the admitting hospital/clinic with a sample of the plant matter.
   ITBRONP has the fundamental structure of many expert systems. The methodology of Restructuring Modelling is used, allowing the successful completion of a simulation situation through the choice of several paths. ITBRONP consists of a knowledge base that contains rules and facts, art inference engine and underlying explanation, knowledge acquisition and user interface subsystems. An image database of plants enables rite health personnel to identify the treatment for the particular type of poison.
   The experimental system designed and developed is a biomedical system for the education of medical personnel. It has two components: the Plant Identification System (PIS), and the Medical Simulation System (MSS).
C1 Univ Auckland, Dept Management Sci & Informat Syst, Auckland 1, New Zealand.
RP Loo, GS (reprint author), Univ Auckland, Dept Management Sci & Informat Syst, Private Bag 92019, Auckland 1, New Zealand.
CR FOUKARIDIS G, 1995, S AFR J SCI, V951, P570
   *IPC, 1995, INTOX SYST US MAN PO
   KERSTEN G, 1994, P 2 WORLD C EXP SYST, P1130
   KERSTEN GE, 1991, MANAGE SCI, V37, P1269, DOI 10.1287/mnsc.37.10.1269
   *POIS UN GUYS ST T, 1995, POIS PLANTS BRIT IR
   SAFETY 2000 PRESCHOO
NR 6
TC 0
Z9 0
U1 0
U2 0
PU C S R E A PRESS
PI ATHENS
PA 115 AVALON DR, ATHENS, GA 30606 USA
BN 1-892512-62-9
PY 2000
BP 353
EP 359
PG 7
WC Computer Science, Artificial Intelligence; Computer Science,
   Interdisciplinary Applications; Engineering, Biomedical; Mathematics,
   Interdisciplinary Applications
SC Computer Science; Engineering; Mathematics
GA BR81W
UT WOS:000167662700053
DA 2018-10-20
ER

PT B
AU Walker, FL
   Thoma, GR
AF Walker, FL
   Thoma, GR
BE Williams, ME
TI Read it to me!
SO NATIONAL ONLINE MEETING, PROCEEDINGS 2000
LA English
DT Proceedings Paper
CT 21st National Online Meeting
CY MAY 16-18, 2000
CL NEW YORK, NY
SP Informat Today Inc, Lexis Nexis
DE DocMorph Server; speech synthesis; image processing; World Wide Web;
   TIFF; PDF; OCR; DocView; NLM; Ariel; Internet
AB New technology and software such as Ariel and DocView have made it possible for libraries to distribute information to patrons over the Internet. Ariel, a product of the Research Libraries Group, converts paper-based documents to monochrome bitmapped images, and delivers them over the Internet, while the National Library of Medicine's DocView enables library patrons to receive, display and manage documents received from Ariel systems. While libraries and their patrons are beginning to reap the benefits of this new technology, both technological and social barriers still exist that lead to difficulties in the use of library document information. For example, the formats of files received through the Internet may not be usable on the recipient's computer. In addition, disadvantaged groups of people such as the blind and visually impaired often have difficulties in reading either printed or electronic information. To investigate solutions to some of these barriers, the Communications Engineering Branch of the Lister Hill National Center for Biomedical Communications, an R&D division of NLM, has developed a web site called the DocMorph Server. This is part of an ongoing R&D program in document imaging that has spanned many aspects of electronic document conversion and preservation, Internet document transmission and document usage. The DocMorph Server web site allows users to upload document image files via the Internet for conversion to alternative formats (e.g., TIFF to PDF), thereby enabling wider delivery and easier usage of library document information. A recent development in the DocMorph Server is speech synthesis to permit users to convert scanned images of the printed word into the spoken word. From any place on the Internet, a user can upload scanned images of a book, for example, and have DocMorph return a web page that allows the user's computer to read the material out loud. This reading facility enables certain groups of people to read material that would otherwise be difficult or impossible to read. This paper describes the architecture of the prototype DocMorph Server and the design of its computer-assisted reading facility.
C1 Natl Lib Med, Bethesda, MD 20894 USA.
CR *ALD CORP, 1992, TIFF REV 6 0
   Berger M. A., 1996, College & Undergraduate Libraries, V3, P49, DOI 10.1300/J106v03n02_05
   BORENSTEIN N, 1992, MIME MULTIPURPOSE IN
   *CDCP, 1995, TRENDS HLTH OLD AM U
   Postel J, 1985, FILE TRANSFER PROTOC
   *URL, INF GROUP EL DOC INT
   WALKER FL, 1996, P IOLS 96, P107
   WALKER FL, 1995, P IOLS 95, P165
   WALKER FL, 2000, P IS T SPIE C INT IM, P268
NR 9
TC 0
Z9 0
U1 0
U2 1
PU INFORMATION TODAY INC
PI MEDFORD
PA 143 OLD MARLTON PIKE, MEDFORD, NJ 08055 USA
BN 1-57387-102-8
PY 2000
BP 473
EP 483
PG 11
WC Information Science & Library Science
SC Information Science & Library Science
GA BR04Z
UT WOS:000165502800047
DA 2018-10-20
ER

PT S
AU Suslick, KS
AF Suslick, KS
BE Lauterborn, W
   Kurz, T
TI Sonochemistry: A physical perspective
SO NONLINEAR ACOUSTICS AT THE TURN OF THE MILLENNIUM
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT 15th International Symposium on Nonlinear Acoustics
CY SEP 01-04, 1999
CL GOTTINGEN, GERMANY
SP Int Union Pure & Appl Phys, Deutsch Forsch Gemeinsch, WE Heraeus Stiftung, State Niedersachsen
ID AMORPHOUS IRON; ULTRASOUND; SONOLUMINESCENCE
AB Both sonochemistry and sonoluminescence derive from acoustic cavitation. Bubble collapse in liquids results in an enormous concentration of energy from the conversion of the kinetic energy of liquid motion into heating of the contents of the bubble. The high local temperatures and pressures, combined with extraordinarily rapid cooling, provide a unique means for driving chemical reactions under extreme conditions. A diverse set of applications of ultrasound to enhance chemical reactivity has been explored, with important applications in mixed phase synthesis, materials chemistry, and biomedical uses. For example, the sonochemical decomposition of volatile organometallic precursors in low-volatility solvents produces nanostructured materials in various forms with high catalytic activities. Nanostructured metals, alloys, carbides and sulfides, nanometer colloids, and nanostructured supported-catalysts can all be prepared by this general route.
C1 Univ Illinois, Sch Chem Sci, Urbana, IL 61801 USA.
RP Suslick, KS (reprint author), Univ Illinois, Sch Chem Sci, 600 S Mathews Av, Urbana, IL 61801 USA.
RI Suslick, Kenneth/C-3281-2011
OI Suslick, Kenneth/0000-0001-5422-0701
CR BELLISSENT R, 1993, PHYS REV B, V48, P15797, DOI 10.1103/PhysRevB.48.15797
   Berkovsky B. M., 1993, MAGNETIC FLUIDS ENG
   DOKTYCZ SJ, 1990, SCIENCE, V247, P1067, DOI 10.1126/science.2309118
   FLINT EB, 1989, J AM CHEM SOC, V111, P6987, DOI 10.1021/ja00200a014
   FLINT EB, 1991, SCIENCE, V253, P1325
   GATES BC, 1992, CATALYTIC CHEM, P387
   GRINSTAFF MW, 1993, PHYS REV B, V48, P269, DOI 10.1103/PhysRevB.48.269
   JEFFRIES JB, 1992, SCIENCE, V256, P248, DOI 10.1126/science.256.5054.248
   Leighton T., 1994, ACOUSTIC BUBBLE
   Mason T. J., 1996, CHEM EXTREME NONCLAS, P317
   Mdleleni MM, 1998, J AM CHEM SOC, V120, P6189, DOI 10.1021/ja9800333
   Moser W. R., 1996, ADV CATALYSTS NANOST
   PECORARO TA, 1981, J CATAL, V67, P430, DOI 10.1016/0021-9517(81)90303-1
   Rayleigh, 1917, PHILOS MAG, V34, P94, DOI 10.1080/14786440808635681
   Richards WT, 1927, J AM CHEM SOC, V49, P3086, DOI 10.1021/ja01411a015
   Suslick K.S., 1990, ADV SONOCHEMISTRY, V1, P197
   Suslick K. S., 1998, KIRKOTHMER ENCY CHEM, V26, P517
   Suslick K.S, 1997, HDB HETEROGENEOUS CA, V3, P1350
   Suslick KS, 1996, CHEM MATER, V8, P2172, DOI 10.1021/cm960056l
   Suslick KS, 1998, HANDBOOK OF ACOUSTICS, P243
   Suslick KS, 1996, J AM CHEM SOC, V118, P11960, DOI 10.1021/ja961807n
   SUSLICK KS, 1990, SCIENCE, V247, P1439, DOI 10.1126/science.247.4949.1439
   SUSLICK KS, 1986, J AM CHEM SOC, V108, P5641, DOI 10.1021/ja00278a055
   SUSLICK KS, 1991, NATURE, V353, P414, DOI 10.1038/353414a0
   SUSLICK KS, 1995, MRS BULL, V20, P29, DOI 10.1557/S088376940004464X
   SUSLICK KS, 1993, J PHYS CHEM-US, V97, P3098, DOI 10.1021/j100115a007
   SUSLICK KS, 1994, ENCY INORGANIC CHEM, V7, P3890
NR 27
TC 3
Z9 3
U1 0
U2 9
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 1-56396-945-9
J9 AIP CONF PROC
PY 2000
VL 524
BP 95
EP 104
PG 10
WC Acoustics; Mechanics; Physics, Fluids & Plasmas
SC Acoustics; Mechanics; Physics
GA BQ75G
UT WOS:000089403000010
DA 2018-10-20
ER

PT J
AU Corey, JP
   Mamikoglu, B
   Akbar, I
   Houser, SM
   Gungor, A
AF Corey, JP
   Mamikoglu, B
   Akbar, I
   Houser, SM
   Gungor, A
TI ImmunoCAP and HY.TEC enzyme immunoassays in the detection of
   allergen-specific IgE compared with serial skin end-point titration by
   receiver operating characteristic analysis
SO OTOLARYNGOLOGY-HEAD AND NECK SURGERY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the
   American-Academy-of-Otolaryngology-Head-and-Neck-Surgery
CY SEP 13-16, 1998
CL SAN ANTONIO, TEXAS
SP Amer Acad Otolaryngol Head & Neck Surg
ID ROC
AB OBJECTIVES: In this study we compared 2 different immunoassays, HY IEC enzyme immunoassay (Hycor Biomedical Inc, Garden Grove, CA) and Pharmacia Upjohn ImmunoCAP (Pharmacia and Upjohn, Kalamazoo, MI) using skin end-point titration as a gold standard by receiver operating chatacteristic analysis.
   MATERIALS: One hundred patients were enrolled in this study and were tested with the above 3 modalities. The results were analyzed by receiver operating characteristic analysis, in which the curves give a decision criterion for any diagnostic test relative to its sensitivity and specificity against an accepted gold standard test. Only inhalant allergens (Dermatophagoides pteronyssinos, Dermatophagoides farina, cat dander, giant ragweed, English plantain weed, timothy grass, Alternaria tenuis, Aspergillus fumigatus, meadow fescue, oak tree, white ash tree, and lamb's-quarter weed) were studied.
   RESULTS: The results obtained with both ImmunoCAP and HY.TEC showed a good correlation with skin end-point titration for D pteronyssinus, D farina, cat dander, giant ragweed, timothy grass, A tenuis, and meadow fescue, with sensitivities ranging from 71% to 88%. However, the sensitivity of both tests to English plantain weed, lamb's-quarter weed, oak free, and white ash tree was lower (66% down to 39%). Additionally, HY.TEC results were not satisfactory for detecting specific IgE to A fumigatus (30% sensitivity). The overall sensitivity for each test was 65.67% for the HY.TEC and 71.25% for the ImmunoCAP.
   CONCLUSION: The 2 in vitro testing systems are comparable for most of the allergens, except for A fumigatus, English plantain, lamb's-quarter, and white ash tree; ImmunoCAP and HY.TEC would benefit from improved technology for detecting these specific IgE antibodies. The HY.TEC assay did not give acceptable results for A fumigatus. The overall assay characteristics were good to excellent for each system tested.
C1 Univ Chicago Hosp, Otolaryngol Sect, Dept Surg, Chicago, IL 60637 USA.
   Univ Chicago Hosp, Otolaryngol Sect, Nasal Physiol & Allergy Lab, Chicago, IL 60637 USA.
RP Corey, JP (reprint author), Univ Chicago Hosp, Otolaryngol Sect, Dept Surg, 5841 S Maryland Ave,MC 1035, Chicago, IL 60637 USA.
CR ALANSO R, 1995, J INVESTIG ALLERGOL, V5, P156
   COREY JP, 1995, OTOLARYNG HEAD NECK, V112, P665, DOI 10.1016/S0194-5998(95)70173-7
   GLEESON M, 1996, CLIN EXP ALLERGY, V26, P597
   Kontis K J, 1997, Allergol Immunopathol (Madr), V25, P63
   Mabry R. L., 1994, AAOA MONOGRAPH SERIE
   METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2
   METZ CE, 1986, INVEST RADIOL, V21, P720, DOI 10.1097/00004424-198609000-00009
   Nolte H, 1997, ANN ALLERG ASTHMA IM, V79, P27, DOI 10.1016/S1081-1206(10)63080-3
   OWNBY DR, 1992, ANN ALLERGY, V68, P3
NR 9
TC 6
Z9 6
U1 0
U2 1
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0194-5998
J9 OTOLARYNG HEAD NECK
JI Otolaryngol. Head Neck Surg.
PD JAN
PY 2000
VL 122
IS 1
BP 64
EP 70
DI 10.1016/S0194-5998(00)70146-X
PG 7
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA 274LX
UT WOS:000084768300013
PM 10629485
DA 2018-10-20
ER

PT J
AU Wu, LM
   You, B
   Li, D
   Qian, F
AF Wu, LM
   You, B
   Li, D
   Qian, F
TI The in vitro and in vivo stability of poly(urethaneurea)s as biomedical
   materials
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE PDMS; PEUU; hydration; implantation
ID DEGRADATION; BIOSTABILITY; MORPHOLOGY
AB The in vitro and in vivo stability of poly(ether urethaneurea) (PEUU) films and blood sacs with or without chemically modification by poly(dimethyl siloxane) (PDMS) has been investigated, respectively. Gel permeation chromatography (GPC) experiments showed an increase in average molecular weight for both films hydrated in saline solution at 37 degrees C and the blood sacs utilized in electric total artificial hearts implanted in calves duo to the possible leaching of low molecular weight species and the chain extensions of residual free isocyanate groups. Correspondingly, hydration and implantation displayed an increase in mechanical strength. But excessive implantation for PDMS-modified PEUU blood sacs (such as over similar to 100 day implantation) still caused possible decrease in average molecular weight and mechanical strength duo to more and more chemical degradation, just as observed in PEUU blood sacs without being modified by PDMS. Dynamical mechanical analysis (DMA) showed an increasing phase separation between hard and soft segments after immersion. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Fudan Univ, Dept Mat Sci, Shanghai 200433, Peoples R China.
RP Wu, LM (reprint author), Fudan Univ, Dept Mat Sci, Shanghai 200433, Peoples R China.
CR HAN DK, 1993, J BIOMAT SCI-POLYM E, V4, P401
   HAN DK, 1993, J BIOMED MATER RES, V27, P1063, DOI 10.1002/jbm.820270812
   ISHIHARA H, 1984, J MACROMOL SCI PHYS, VB22, P713, DOI 10.1080/00222348308215209
   JOHNSON DH, 1954, J PHYS CHEM-US, V58, P1073, DOI 10.1021/j150522a006
   MEIJS GF, 1993, J BIOMED MATER RES, V27, P345, DOI 10.1002/jbm.820270308
   Noll W., 1968, CHEM TECHNOLOGY SILI
   SRICHATRAPIMUK VW, 1978, J MACROMOL SCI PHYS, VB15, P267, DOI 10.1080/00222347808212599
   TAKAHARA A, 1985, POLYMER, V26, P987, DOI 10.1016/0032-3861(85)90218-6
   TAKAHARA AJ, 1995, J BIOMED MATER RES, V19, P13
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   Wu LM, 1999, J BIOMED MATER RES, V44, P371, DOI 10.1002/(SICI)1097-4636(19990315)44:4<371::AID-JBM2>3.0.CO;2-I
   WU Y, 1992, J APPL POLYM SCI, V46, P201, DOI 10.1002/app.1992.070460202
   WU Y, 1991, J BIOMED MATER RES, V25, P725, DOI 10.1002/jbm.820250604
   XI TF, 1994, J BIOMED MATER RES, V28, P483, DOI 10.1002/jbm.820280411
NR 14
TC 6
Z9 6
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PY 2000
VL 70
IS 1
BP 65
EP 69
DI 10.1016/S0141-3910(00)00089-6
PG 5
WC Polymer Science
SC Polymer Science
GA 350MM
UT WOS:000089105300010
DA 2018-10-20
ER

PT S
AU Lenart, M
   Tarjan, PP
AF Lenart, M
   Tarjan, PP
BE Enderle, JD
TI Cardiovascular anatomy, physiology and engineering - A distance learning
   course
SO PROCEEDINGS OF THE 22ND ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 22nd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY JUL 23-28, 2000
CL CHICAGO, IL
SP IEEE, Engn Med & Biol Soc, Amer Assoc Physicists Med, Amer Inst Med & Biol Engn, Int Union Phys & Engn Sci Med, Int Federat Med & Biol Engn, Int Org Med Phys
DE distance learning; physiology and anatomy
AB A pilot study in the development of a Computer Supported Distance Learning (CSDL) course was completed. Its subject was cardiovascular physiology, anatomy as well as diagnostic and therapeutic devices, Its target was a class of first veer graduate students in biomedical engineering with undergraduate degrees in other engineering disciplines. The format of CSDL seems to overcome many of the problems of our conventional course: Unified Medical Sciences, a course team-taught by physicians anti life scientists, as the CSDL format allows self-paced study, exploration of unfamiliar areas, skipping unneeded reviews and assisting the students to dig deeper with guidance and possibly with editorial assistance from the developers of the course. - Knowledge of the way living systems have evolved to solve challenges may become more necessary for engineers in other disciplines. The pilot study should provide a springboard far the development of suitable course material for such a course.
C1 Univ Miami, Dept Biomed Engn, Coll Engn, Coral Gables, FL 33124 USA.
RP Lenart, M (reprint author), Univ Miami, Dept Biomed Engn, Coll Engn, POB 248294, Coral Gables, FL 33124 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-6466-X
J9 P ANN INT IEEE EMBS
PY 2000
VL 22
BP 1023
EP 1025
PN 1-4
PG 3
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BR59S
UT WOS:000166896300286
DA 2018-10-20
ER

PT S
AU Devey, GB
AF Devey, GB
BE Enderle, JD
TI Undergraduate and graduate design projects
SO PROCEEDINGS OF THE 22ND ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 22nd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY JUL 23-28, 2000
CL CHICAGO, IL
SP IEEE, Engn Med & Biol Soc, Amer Assoc Physicists Med, Amer Inst Med & Biol Engn, Int Union Phys & Engn Sci Med, Int Federat Med & Biol Engn, Int Org Med Phys
AB The National Science Foundation (NSF) was established in 1950 as an independent Agency of the Federal Government with the broad mission to promote and advance scientific progress in the U.S. This is accomplished primarily by supporting research and education in ail disciplines of the natural and social sciences, mathematics, and engineering, Support is provided principally in the form of grants awarded on a competitive basis under a rigorous peer review process; NSF does not conduct research itself. In 1992, NSF defined a project eligible for support as bioengineering research as one "... with diagnosis or treatment-related goals, that applies engineering principles to problems in biology and medicine while advancing engineering knowledge is eligible for support. Bioengineering research to aid persons with disabilities is also eligible".(1) Bioengineering at NSF has two defined programs: 1- "Biochemical Engineering", and 2- a two-component activity "Biomedical Engineering" (BME) and "Research to Aid Persons with Disabilities" (RAPD), The material that follows describes the Undergraduate and Graduate Design Projects, which is part of the RAPD component of the bioengineering program.
C1 Rensselaer Polytech Inst, Troy, NY 12181 USA.
RP Devey, GB (reprint author), Rensselaer Polytech Inst, Troy, NY 12181 USA.
CR *REN POLYT I, CURR FAC SUP REH ENG
   *US NAT SCI FDN, 992 NSF, pCH1
NR 2
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-6466-X
J9 P ANN INT IEEE EMBS
PY 2000
VL 22
BP 2373
EP 2374
PN 1-4
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BR59S
UT WOS:000166896300661
DA 2018-10-20
ER

PT S
AU Khoo, M
   Liu, C
AF Khoo, M
   Liu, C
BE Enderle, JD
TI A novel micromachined magnetic membrane microfluid pump
SO PROCEEDINGS OF THE 22ND ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 22nd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY JUL 23-28, 2000
CL CHICAGO, IL
SP IEEE, Engn Med & Biol Soc, Amer Assoc Physicists Med, Amer Inst Med & Biol Engn, Int Union Phys & Engn Sci Med, Int Federat Med & Biol Engn, Int Org Med Phys
DE micropump; microfluidic system; membrane; magnetic actuation; silicone
   elastomer
AB We present results on the design, fabrication, and testing of a new, micromachined magnetic pump for integrated microfluidic systems. Structurally, the pump consists of a magnetic microactuator and two polymer-based one-way diffuser valves. The microactuator is based on a thin membrane made of polydimethyl siloxane (PDMS), a soft silicone elastomer. Membrane displacement is caused by the interaction between ferromagnetic pieces (embedded within the thickness of the membrane) and an external magnet. This novel mechanism reduces fabrication and packaging complexity, and allows for remote operation of the micropump without any tether wires for power input. The operation is simple as no precise alignment is required between the external magnet and the pump. PDMS is bio-compatible compared to silicon. One future application of this tetherless micropump is implanted biomedical microfluidic systems.
   We developed a novel micromachining process for embedding ferromagnetic materials (Permalloy, Ni(80)Pe(20)) within a thin, spin-casted PDMS membrane. Unique pump and diffuser mechanisms that allow for continuous pumping are also developed. Diffuser elements containing no moving parts are fabricated using polymer micromachining techniques, Micro Permalloy pieces are strategically positioned within a 2x2mm(2), 40-mum-thick PDMS membrane, Dimensions and locations of the membrane and the Permalloy pieces are optimized using computer simulations for maximum membrane vertical displacement under a given magnetic field. Experimentally, we have demonstrated successful on-chip, fluid pumping. In the presence of an oscillating 2.85x10(5)-A/m external magnetic field, a 1.2-mul/min flow rate was measured for an actuation frequency of 2.9-Hz. The flow rate can be easily varied by the frequency.
C1 Univ Illinois, Microelect Lab, Micro Actuators Sensors & Syst MASS Grp, Urbana, IL 61801 USA.
RP Khoo, M (reprint author), Univ Illinois, Microelect Lab, Micro Actuators Sensors & Syst MASS Grp, 208 N Wright St, Urbana, IL 61801 USA.
CR BIEIDER C, 1995, TRANSD 95 INT C SOL, V2, P284
   ELWENSPOEK M, 1994, J MICROMECH MICROENG, V4, P227, DOI 10.1088/0960-1317/4/4/008
   JEONG OC, 1999, TRANSD 99 INT C SOL, V2, P1780
   Koch M, 1998, J MICROMECH MICROENG, V8, P119, DOI 10.1088/0960-1317/8/2/019
   Liu C, 1998, MECHATRONICS, V8, P613, DOI 10.1016/S0957-4158(98)00016-6
   Olsson A, 1996, SENSOR ACTUAT A-PHYS, V57, P137, DOI 10.1016/S0924-4247(97)80104-5
   OLSSON A, 1997, TRANSD 97 INT C SOL, V2, P1039
   Sadler DJ, 1998, P SOC PHOTO-OPT INS, V3515, P46, DOI 10.1117/12.322094
   YANG Y, 1995, TRANSD 95 INT C SOL, V3, P81
   ZERLENGE R, 1992, IEEE MICRO STRUCTURE, P19
   ZHANG W, 1996, 1996 SOL STAT SENS A, P94
NR 11
TC 15
Z9 15
U1 2
U2 9
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-6466-X
J9 P ANN INT IEEE EMBS
PY 2000
VL 22
BP 2394
EP 2397
PN 1-4
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BR59S
UT WOS:000166896300667
DA 2018-10-20
ER

PT S
AU Otsuka, H
   Nagasaki, Y
   Okano, T
   Kataoka, K
AF Otsuka, H
   Nagasaki, Y
   Okano, T
   Kataoka, K
BE Enderle, JD
TI Functionalization of polylactide(PLA) surface using heterobifunctional
   PEG/PLA block copolymers for the control of cell behavior at surfaces
SO PROCEEDINGS OF THE 22ND ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 22nd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY JUL 23-28, 2000
CL CHICAGO, IL
SP IEEE, Engn Med & Biol Soc, Amer Assoc Physicists Med, Amer Inst Med & Biol Engn, Int Union Phys & Engn Sci Med, Int Federat Med & Biol Engn, Int Org Med Phys
DE poly(ethylene glycol)(PEG); polylactide(PLA); aldehyde; hepatocyte
ID POLY(ETHYLENE
AB This paper deals with novel approaches established by our group for the construction of a functionalized poly(ethylene glycol) (PEG) layer, PEG-brushed layer possessing a reactive group at the free end of tethered PEG chain, on substrates. An AB-type block copolymer composed of alpha -acetal-poly(ethylene glycol) (PEG) as the hydrophilic segment and polylactide (PLA) as the hydrophobic segment was synthesized, and utilized to construct the functionalized PEG layer on the biodegradable polylactide surface by simple coating. In this way, a PEG-brushed layer with a terminal aldehyde group was readily prepared which may have both non-fouling and ligand-binding properties. Non-fouling property of PEG strands eliminates nonspecific and uncontrolled interactions of the surface with biological components, including cells and proteins, while presentation of tethered ligands attached to the chain end of PEG brush allows cell behavior at the surface to be modulated in a specific manner via receptor-mediated signaling. Based on the characterization of these PEGylated surfaces from a physiochemical (contact angle, atomic force microscopy, electron spin resonance) as well as biological (protein adsorption/cell adhesion) point of view, our strategy to construct a functionalized PEG layer was confirmed. Active functional groups were present at the tethered PEG-chain end, these materials will provide new insights into controlling cell behavior at surfaces for tissue engineering and biomedical applications.
C1 Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Tokyo 1138656, Japan.
RP Otsuka, H (reprint author), Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Hongo 7-3-1, Tokyo 1138656, Japan.
CR AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   Feast W. J., 1993, POLYM SURFACES INTER
   GOOD RJ, 1979, SURFACE COLLOID SCI, V11
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   Nagasaki Y, 1998, MACROMOLECULES, V31, P1473, DOI 10.1021/ma971294k
   Nagasaki Y, 1997, MACROMOLECULES, V30, P6489, DOI 10.1021/ma9705026
   OTSUKA H, IN PRESS ACS S SERIE
   OTSUKA H, UNPUB SCI TECHNOLOGY
   OTSUKA H, UNPUB BIOMACROMOLECU
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   TERAYA T, 1990, POLYMER, V31, P1149, DOI 10.1016/0032-3861(90)90265-Z
NR 12
TC 0
Z9 0
U1 2
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-6466-X
J9 P ANN INT IEEE EMBS
PY 2000
VL 22
BP 2936
EP 2939
PN 1-4
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BR59S
UT WOS:000166896300818
DA 2018-10-20
ER

PT S
AU van Alste, JA
AF van Alste, JA
BE Enderle, JD
TI A new educational program on Biomedical Engineering
SO PROCEEDINGS OF THE 22ND ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 22nd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY JUL 23-28, 2000
CL CHICAGO, IL
SP IEEE, Engn Med & Biol Soc, Amer Assoc Physicists Med, Amer Inst Med & Biol Engn, Int Union Phys & Engn Sci Med, Int Federat Med & Biol Engn, Int Org Med Phys
DE biomedical engineering; education; healthcare technology; materials and
   tissue engineering; restoration of human function
AB At the University of Twente together with, the Free University of Amsterdam a new educational program on Biomedical Engineering will be developed, The academic program with a five-year duration will start in September 2001. After a general, broad education in Biomedical Engineering in the first three years, the students specialise in one of the following areas: Materials and Tissue engineering; Technology for restoration of human function; healthcare technology.
C1 Univ Twente, NL-7500 AE Enschede, Netherlands.
RP van Alste, JA (reprint author), Univ Twente, POB 217, NL-7500 AE Enschede, Netherlands.
CR Enderle J., 2000, INTRO BIOMEDICAL ENG
   *U TWENT, 1998, INT BIOM ENG REST HU
   VANALSTE JA, 1999, BIOMEDISCHE TECHNOLO
   WILLEMS, 1999, HET ARBEIDSPERSPECTI
NR 4
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-6466-X
J9 P ANN INT IEEE EMBS
PY 2000
VL 22
BP 2952
EP 2954
PN 1-4
PG 3
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BR59S
UT WOS:000166896300823
DA 2018-10-20
ER

PT S
AU Russell, GK
AF Russell, GK
BE Balls, M
   VanZeller, AM
   Halder, ME
TI Alternatives in the teaching of biology at secondary and university
   levels: an ongoing success story
SO PROGRESS IN THE REDUCTION, REFINEMENT AND REPLACEMENT OF ANIMAL
   EXPERIMENTATION
SE DEVELOPMENTS IN ANIMAL AND VETERINARY SCIENCES
LA English
DT Proceedings Paper
CT 3rd World Congress on Alternatives and Animal Use in the Life Science
CY AUG 29-SEP 02, 1999
CL BOLOGNA, ITALY
SP Colgate Palmolive Co, European Commiss, Environm DIrector Gen, European Commiss, Joint Res Ctr, Toiletry & Perfumery Assoc, European Cosmet, Gillette Co, Glaxo Wellcome, Int Fdn Eth Res, Kimberly Clark Corp, L Oreal, Procter & Gamble Co, Unilever Res, Utrecht Congress
AB Increasingly, humane alternatives are being developed to teach fundamental concepts of biology in secondary schools and universities. Basic principles of physiology, including cardiac and pulmonary function, muscle action and elements of exercise physiology, galvanic skin responses, and numerous other processes can be investigated by using the students themselves as experimental subjects. At least one manufacturer of physiology apparatus for instructional purposes has established an on-line user sire for the sharing of experience and the collection of useful ideas and innovations. Cell cultures, computer simulations and video/CD-ROM materials, as well as numerous other alternatives, can be adopted for a wide variety of classroom and laboratory exercises. Meaningful alternatives to animal dissection are also available. Taught by such methods, students can study biology in a manner that is pedagogically sound, but does not involve unnecessary destruction of animal life. In many learning situations, however, the ethical context is omitted from classroom discussion and students fail to evaluate the ethical dimensions of animal studies. The use of alternatives in pedagogy provides the framework for the development of a new ethos involving animal use, not only in a learning environment, but also in biomedical research and in society.
C1 Adelphi Univ, Dept Biol, Garden City, NY 11530 USA.
RP Russell, GK (reprint author), Adelphi Univ, Dept Biol, Garden City, NY 11530 USA.
CR Balcombe JP, 1997, DEV AN VET, V27, P441
   BALCOMBE JP, COMP STUDIES DISSECT, P96
   *HUM SOC US, 1998, DISS WANT KNOW SIMPL
   *INT SCI ENG FAIR, 1999, GUID SCI PROJ
   KRUTCH JW, 1956, GREAT CHAIN LIFE
   MAYER WV, 1973, AM BIOL TEACH, V35, P27, DOI 10.2307/4444187
   *NAT ASS BIOL TEAC, 1995, US AN BIOL ED
   Orlans FB, 1993, NAME SCI ISSUES RESP
   RUSSELL GK, 1972, AM BIOL TEACH, V34, P254, DOI 10.2307/4443923
   RUSSELL GK, 1988, ORION, V7, P48
   RUSSELL GK, 1978, LAB INVESTIGATIONS H
   Russell W. M. S., 1959, PRINCIPLES HUMANE EX
   Singer Peter, 1990, ANIMAL LIBERATION
   ZINKO U, 1997, GUINEA PIG COMPUTER
NR 14
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-5168
BN 0-444-50529-6
J9 DEV AN VET
JI Dev. Anim. Vet. Sci.
PY 2000
VL 31
BP 79
EP 90
PN A & B
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA BS42Q
UT WOS:000169797500009
DA 2018-10-20
ER

PT S
AU Duffee, NE
   Fallon, MT
   Laber, KE
AF Duffee, NE
   Fallon, MT
   Laber, KE
BE Balls, M
   VanZeller, AM
   Halder, ME
TI A multi-media training program for biomedical researchers: working with
   laboratory animals
SO PROGRESS IN THE REDUCTION, REFINEMENT AND REPLACEMENT OF ANIMAL
   EXPERIMENTATION
SE DEVELOPMENTS IN ANIMAL AND VETERINARY SCIENCES
LA English
DT Proceedings Paper
CT 3rd World Congress on Alternatives and Animal Use in the Life Science
CY AUG 29-SEP 02, 1999
CL BOLOGNA, ITALY
SP Colgate Palmolive Co, European Commiss, Environm DIrector Gen, European Commiss, Joint Res Ctr, Toiletry & Perfumery Assoc, European Cosmet, Gillette Co, Glaxo Wellcome, Int Fdn Eth Res, Kimberly Clark Corp, L Oreal, Procter & Gamble Co, Unilever Res, Utrecht Congress
AB A project supported by two funding sources will produce computer-based and videotape training materials to address the training needs of researchers using laboratory animals. By June 2000, the first of 13 modules will be completed, Working M with the Laboratory Dog. Information on these programs and the progress of this project is available on a Web site (http://www.wwla.org). A self-assessment Web server is also being developed to administer content examinations that cover these modules.
C1 Washington Univ, Sch Med, Div Comparat Med, St Louis, MO 63110 USA.
RP Duffee, NE (reprint author), Washington Univ, Sch Med, Div Comparat Med, St Louis, MO 63110 USA.
CR LIVINGSTON S, 1982, PASSING SCORES
   Russell W. M. S., 1959, PRINCIPLES HUMANE EX
NR 2
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-5168
BN 0-444-50529-6
J9 DEV AN VET
PY 2000
VL 31
BP 1415
EP 1421
PN A & B
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA BS42Q
UT WOS:000169797500141
DA 2018-10-20
ER

PT S
AU Stitzel, JD
   Bowlin, GL
   Mansfield, K
   Wnek, GE
   Simpson, DG
AF Stitzel, JD
   Bowlin, GL
   Mansfield, K
   Wnek, GE
   Simpson, DG
BE Adams, PJ
   Elsworth, SA
   Petkauskos, MJ
   Walton, TC
TI Electrospraying and electrospinning of polymers for biomedical
   applications. Poly(lactic-co-glycolic acid) and
   poly(ethylene-co-vinylacetate)
SO REVOLUTIONARY MATERIALS: TECHNOLOGY AND ECONOMICS
SE INTERNATIONAL SAMPE TECHNICAL CONFERENCE SERIES
LA English
DT Proceedings Paper
CT 32nd International SAMPE Technical Conference
CY NOV 05-09, 2000
CL BOSTON, MA
SP Soc Advancement Mat & Process Engn
DE biomaterials; applications-medical; fibers
ID DIAMETER FIBERS
AB Significant opportunities exist for the processing of polymers (homopolymers and blends) using electric fields. Specific attention is given here to electrospinning, but we note that electroaerosol formation and field-modulated film casting represent additional processing options. Of particular interest is the ability to generate polymer fibers of sub-micron dimensions using electrospinning, down to about 0.05 microns (50 nm), a size range that has been traditionally difficult to access. In our work, poly(lactic-co-glycolic acid), PLA/PGA, poly(lactic acid) PLA, and poly(ethylene-co-vinylacetate) (PEVA) have been deposited from solutions in methylene chloride or chloroform by electrospraying or electrospinning to afford morphologically tailored materials for tissue engineering and related applications. Low solution concentrations tend to favor electrostatic spraying ('electro-aerosolization') while higher concentrations lead to spinning on fibrous mats. Preliminary observations of muscle cell growth on PLA electrospun mats are reported.
C1 Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23284 USA.
RP Stitzel, JD (reprint author), Virginia Commonwealth Univ, Dept Biomed Engn, Med Coll Virginia Campus, Richmond, VA 23284 USA.
RI Bowlin, Gary/E-8617-2010
CR Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   Cockshott I.D., 1977, U.S. Patent, Patent No. [4043331, 4,043,331]
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0
   Mooney D. J., 1995, BIOMEDICAL ENG HDB
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   REYDERMAN L, 1995, INT J PHARM, V124, P75, DOI 10.1016/0378-5173(95)00078-W
NR 7
TC 17
Z9 17
U1 1
U2 21
PU SOC ADVANCEMENT MATERIAL & PROCESS ENGINEERING
PI COVINA
PA 1161 PARKVIEW DR,, COVINA, CA 91724-3748 USA
SN 0892-2624
BN 0-938994-89-1
J9 INT SAMPE TECH CONF
PY 2000
VL 32
BP 205
EP 211
PG 5
WC Engineering, Aerospace; Materials Science, Multidisciplinary; Materials
   Science, Characterization & Testing; Materials Science, Coatings &
   Films; Materials Science, Composites
SC Engineering; Materials Science
GA BR79P
UT WOS:000167557000020
DA 2018-10-20
ER

PT B
AU Abe, M
   Nishimura, K
   Kitamoto, Y
AF Abe, M
   Nishimura, K
   Kitamoto, Y
BE Mishra, B
   Yamauchi, C
TI Ferrite thin film devices fabricated by low temperature processing in
   aqueous solution
SO SECOND INTERNATIONAL CONFERENCE ON PROCESSING MATERIALS FOR PROPERTIES
LA English
DT Proceedings Paper
CT 2nd International Conference on Processing Materials for Properties
CY NOV 05-08, 2000
CL SAN FRANCISCO, CA
SP Minerals, Met & Mat Soc, Min & Mat Proc Inst Japan
ID HIGH COERCIVITY; CO; MICROSPHERES; MAGNETITE; NI
AB Ferrite plating is a chemical processing which utilizes Fe2+ --> Fe3+ oxidation to synthesizing polycrystalline films of ferromagnetic spinels (MFe2O4, M = Fe, Co, Ni, Zn, Al, Cr, Ti, etc.) directly from an aqueous solution at 24 - 100 degreesC. This low temperature process allows us to fabricate new ferrite film devices on substrates of such non-heat-resistant materials as plastics, GaAs integrated circuits, and biomaterials. Synthesized from an aqueous solution the ferrite plated films are highly biocompatible. Thus various magnetic device and biomedical applications have been proposed and realized using ferrite-plated films. Ferrite-encapsulated polymer microspheres are applied to antibody carries for enzyme immunoassay, and also to toners/carriers for photocopying. Perpendicular magnetic recording media utilizing plated CoNi ferrite films are proposed. The low-temperature synthesized films of NiZn and Co ferrites are potentially used as soft-magnetic and/or insulating layers, respectively at high/microwave frequencies.
C1 Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan.
RP Abe, M (reprint author), Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Ookayama, Tokyo 1528552, Japan.
RI Dom, Rekha/B-7113-2012
CR Abe M, 1997, J PHYS IV, V7, P467, DOI 10.1051/jp4:19971190
   Abe M, 1997, IEEE T MAGN, V33, P3649, DOI 10.1109/20.619526
   ABE M, 1987, IEEE T MAGN, V23, P3432, DOI 10.1109/TMAG.1987.1065550
   ABE M, 1983, JPN J APPL PHYS 2, V22, pL511, DOI 10.1143/JJAP.22.L511
   ABE M, 1992, THIN SOLID FILMS, V216, P155, DOI 10.1016/0040-6090(92)90887-H
   Abe M, 1996, IEEE T MAGN, V32, P4183, DOI 10.1109/20.539331
   ABE M, 1991, MATER RES SOC SYMP P, V232, P107, DOI 10.1557/PROC-232-107
   ABE M, 1992, FERRITES, P472
   ABE M, 2000, 8 INT C FERR ICF 8 K
   HORI S, 1992, JPN J APPL PHYS 1, V31, P1185, DOI 10.1143/JJAP.31.1185
   ITOH T, 1991, J APPL PHYS, V69, P5911, DOI 10.1063/1.347837
   Kitamoto Y, 1999, IEEE T MAGN, V35, P2694, DOI 10.1109/20.800954
   Kitamoto Y, 1999, J APPL PHYS, V85, P4708, DOI 10.1063/1.370455
   KITAMOTO Y, 1998, J MAGN SOC JPN SS1, V22, P167
   MIYAWAKI F, 1998, 3 WORLD C BIOM WCB 9, P365
   Nishimura K, 1999, IEEE T MAGN, V35, P3043, DOI 10.1109/20.801079
   NISHIMURA K, 2000, 8 INT C FERR ICF 8 K
   NISHIZONO I, 1991, CLIN CHEM, V37, P1639
   Ojima M, 1999, IEEE T MAGN, V35, P4118, DOI 10.1109/20.800774
   POURBAIX M, 1966, ATLAS ELECTROCHEMICA, P312
   SAKAI S, 2000, 8 INT C FERR ICF 8 K
   TALISA SH, 1988, J APPL PHYS, V64, P5819, DOI 10.1063/1.342217
   ZAAG PJ, 1999, IEEE T MAGN, V35, P3436
   Zhang F, 1999, IEEE T MAGN, V35, P2751, DOI 10.1109/20.800974
   ZHANG F, 2000, 8 INT C FERR ICF 8 K
   Zhang MJ, 1997, JPN J APPL PHYS 1, V36, P243, DOI 10.1143/JJAP.36.243
NR 26
TC 1
Z9 1
U1 1
U2 4
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-495-X
PY 2000
BP 219
EP 224
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mining &
   Mineral Processing
GA BR45F
UT WOS:000166445900041
DA 2018-10-20
ER

PT S
AU Carter, GE
   Casady, JB
   Bonds, J
   Okhuysen, ME
   Scofield, JD
   Saddow, SE
AF Carter, GE
   Casady, JB
   Bonds, J
   Okhuysen, ME
   Scofield, JD
   Saddow, SE
BE Carter, CH
   Devaty, RP
   Rohrer, GS
TI Preliminary investigation of SiC on silicon for biomedical applications
SO SILICON CARBIDE AND RELATED MATERIALS - 1999 PTS, 1 & 2
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT International Conference on Silicon Carbide and Related Materials
CY OCT 10-15, 1999
CL RES TRIANGLE PK, NORTH CAROLINA
SP NASA, Glenn Res Ctr, USAF, Res Lab, mat & Mfg Directoirate, USN, Off Res, Def Res & Engn, Cree Inc, Charles & Colvard Inc, ABB Semicond, Sterling Semicond Inc, ATMI Inc, Epigress AB, Aixtron AG, Northrop Grumman, Siemens AG, EMCORE Inc, GE, Corp R & D, Litton Airton, II-VI Inc
DE 3C; biomedical probe; MEMS; microelectromechanical; reactive ion
   etching; RIE; SF6
ID SYSTEM
AB Reactive ion etching experiments were conducted with the intent of constructing a 3C-SiC on silicon heart probe to be used for biomedical applications. Experiments were performed with 3C-SiC as well as 4H-SiC in order to optimize the process for the heart probe construction. The heart probes were patterned on 3C-SiC on silicon to create a hybrid device that would combine the strength and inertness of the 3C-SiC material with the electronic compatibility of Si material to provide a complete probe suitable for reliable and disposable use required by the medical industry.
C1 Mississippi State Univ, Dept Elect & Comp Engn, Emerging Mat Res Lab, Mississippi State, MS 39762 USA.
   USAF, Res Lab, Wright Patterson AFB, OH 45433 USA.
RP Carter, GE (reprint author), Mississippi State Univ, Dept Elect & Comp Engn, Emerging Mat Res Lab, Mississippi State, MS 39762 USA.
CR Casady JB, 1996, J ELECTROCHEM SOC, V143, P1750, DOI 10.1149/1.1836711
   Chandra K, 1998, MATER SCI FORUM, V264-2, P635, DOI 10.4028/www.scientific.net/MSF.264-268.635
   Hong LS, 1996, INST PHYS CONF SER, V142, P93
   MASTROTOTARO JJ, 1992, IEEE T BIO-MED ENG, V39, P271, DOI 10.1109/10.125012
   Moller H, 1996, INST PHYS CONF SER, V142, P497
   OKHUYSEN ME, 1998, MAT RES SOC
   PADIYATH R, 1991, APPL PHYS LETT, V58, P1053, DOI 10.1063/1.104420
   Samant AV, 1998, MATER SCI FORUM, V264-2, P627, DOI 10.4028/www.scientific.net/MSF.264-268.627
   SCOFIELD JD, 1998, APPL PHYS LETT  0706
   Yih PH, 1997, PHYS STATUS SOLIDI B, V202, P605, DOI 10.1002/1521-3951(199707)202:1<605::AID-PSSB605>3.0.CO;2-Y
NR 10
TC 12
Z9 12
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2000
VL 338-3
BP 1149
EP 1152
DI 10.4028/www.scientific.net/MSF.338-342.1149
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films
SC Materials Science
GA BR27W
UT WOS:000165996700280
DA 2018-10-20
ER

PT S
AU Slaughter, JC
   Dapino, MJ
   Smith, RC
   Flatau, AB
AF Slaughter, JC
   Dapino, MJ
   Smith, RC
   Flatau, AB
BE Werely, NM
TI Modeling of a Terfenol-D ultrasonic transducer
SO SMART STRUCTURES AND MATERIAL 2000: SMART STRUCTURES AND INTEGRATED
   SYSTEMS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2000 Conference
CY MAR 05-09, 2000
CL NEWPORT BEACH, CA
SP SPIE, Soc Exptl Mech, Amer Soc Mech Engn, BFGoodrich, Def Adv Res Projects Agcy, USA Res Off, USAF Res Lab, Ceram Soc Japan, Intelligent Mat Forum, Japan
DE Terfenol-D; transducer model; ultrasonic; magnetostrictive; giant
   magnetostrictive material
ID HYSTERESIS
AB A large variety of applications exist which take advantage of the high dynamic strain and high energy coupling factor exhibited by "giant" magnetostrictive materials. One such material is the rare earth-iron compound Terfenol-D (Tb0.3DY0.7Fe1.95), which is being increasingly used in industrial, biomedical and defense applications. In order to fully realize the performance of this material, it is necessary to accurately model magnetostrictive transducer behavior from DC through the low ultrasonic regimes where the material is used. This paper has been motivated by the need for physically-based performance models of magnetostrictive materials as used in transducers. To this end, a recent magnetoelastic model for magnetostrictive transducers is employed to characterize the magnetization and strain behavior of Terfenol-D at frequencies from 1 Hz to 30 kHz. Model simulations were compared to experimental measurements at various drive levels and frequencies of operation, both under magnetically unbiased and biased conditions. The model provides an accurate characterization of the magnetization and strain for all operating conditions studied. However, further progress in strain simulations may be achieved through improvements in minor loop closure techniques and additional parameter identification.
C1 ETREMA Prod Inc, Ames, IA 50010 USA.
RP Slaughter, JC (reprint author), ETREMA Prod Inc, Ames, IA 50010 USA.
CR ADLY AA, 1996, IEEE T MAGN, V32, P4473
   Basso V, 1996, IEEE T MAGN, V32, P4210, DOI 10.1109/20.539336
   CALKINS FT, 1999, THESIS IOWA STATE U
   CARMAN GP, 1995, J INTEL MAT SYST STR, V6, P673, DOI 10.1177/1045389X9500600508
   CRAWFORD AE, 1955, ULTRASONIC ENG PARTI, P47
   DAPINO MJ, 1999, THESIS IOWA STATE U
   DAPINO MJ, 1999, WILEY ENCY ELECT ELE, P292
   DAPINO MJ, 1999, IN PRESS P ACTIVE 99
   DUENAS TA, 1996, ADV SMART MAT FUNDAM
   ENGDAHL G, 1997, J APPL PHYS, V79, P4689
   FREDERICK JR, 1965, ULTRASONIC ENG, P60
   JILES DC, 1995, J PHYS D APPL PHYS, V28, P1537, DOI 10.1088/0022-3727/28/8/001
   JILES DC, 1986, J MAGN MAGN MATER, V61, P48, DOI 10.1016/0304-8853(86)90066-1
   JILES DC, 1994, IEEE T MAGN, V30, P4326, DOI 10.1109/20.334076
   KANNAN KS, 1995, AD MAT S SUMM M ASME
   *NIST ADV TECHN PR, 97010023 NIST
   RESTORFF JB, 1990, J APPL PHYS, V67, P5016, DOI 10.1063/1.344708
   SABLIK MJ, 1993, IEEE T MAGN, V29, P2113, DOI 10.1109/20.221036
   SABLIK MJ, 1988, J APPL PHYS, V64, P5402, DOI 10.1063/1.342383
   Smith RC, 1997, P SOC PHOTO-OPT INS, V3041, P243, DOI 10.1117/12.275690
NR 20
TC 23
Z9 27
U1 1
U2 5
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3603-8
J9 P SOC PHOTO-OPT INS
PY 2000
VL 3985
BP 366
EP 377
DI 10.1117/12.388838
PG 12
WC Automation & Control Systems; Engineering, Electrical & Electronic;
   Materials Science, Ceramics
SC Automation & Control Systems; Engineering; Materials Science
GA BQ59C
UT WOS:000088899900033
DA 2018-10-20
ER

PT S
AU Jeong, HK
   Jeong, OC
   Yang, SS
AF Jeong, HK
   Jeong, OC
   Yang, SS
BE Varadan, VK
TI Fabrication of an electromagnetic actuator with the planar coil
SO SMART STRUCTURES AND MATERIALS 2000: SMART ELECTRONICS AND MEMS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2000 Conference
CY MAR 05-09, 2000
CL NEWPORT BEACH, CA
SP SPIE, Soc Exptl Mech, Amer Soc Mech Engn, BFGoodrich, Def Adv Res Projects Agcy, USA Res Off, USAF Res Lab, Ceram Soc Japan, Intelligent Mat Forum, Japan
DE electromagnetic actuator; copper coil; parylene C diaphragm;
   electroplating
AB This paper first presents the fabrication of an electromagnetic microactuator using an electroplated spiral copper coil on a parylene C diaphragm. The parylene is a bio-compatible material and has a very low Young's modulus less than 2.8 Cpa, which makes the large deflection for the low power consumption. The actuator consists of an electroplated coil on the parylene C diaphragm, a small-size permanent magnet and a core. The diaphragm is actuated by the Lorenz force generated by the current through the coil in the magnetic field of the magnet. The size of the actuator diaphragm is 4 x 4 mm(2) and 5 mu m thick. The resistance and inductance of the copper spiral coil are 2 Omega and 11 mu H at 100 Hz, respectively. The center deflection of the actuator diaphragm is measured with a the laser vibrometer. When the current through the coil is 380 mA, the peak-to-peak deflection of the actuator is 143 Fun below the resonant frequency of 35 Hz. The mechanical sensitivity of the actuator diaphragm is 900 mu m/A and 3200 mu m/A at 10 Hz and 35 Hz, respectively. An electromagnetic microactuator using the electroplated copper coil on the parylene diaphragm is expected to be useful in making a micropump for the biomedical use.
C1 Ajou Univ, Sch Elect Engn, Paldal Gu, Suwon 442749, South Korea.
RP Jeong, HK (reprint author), Ajou Univ, Sch Elect Engn, Paldal Gu, San 5 Wonchun Dong, Suwon 442749, South Korea.
OI Jeong, Ok Chan/0000-0002-2089-000X
CR LAMMERINK TSJ, 1993, P IEEE MEMS WORKSH F, P25
   OLSSON A, 1995, IEEE INT C SOL STAT, V2, P291
   Park J. Y., 1997, THESIS GEORGIA I TEC
   RYU JC, 1999, P 1 KOR MEMS C APR 1, P29
   Shinozawa Y, 1997, PROC IEEE MICR ELECT, P233, DOI 10.1109/MEMSYS.1997.581809
   Yang EH, 1995, SENSOR ACTUAT A-PHYS, V50, P151, DOI 10.1016/0924-4247(96)80100-2
NR 6
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3608-9
J9 P SOC PHOTO-OPT INS
PY 2000
VL 3990
BP 272
EP 280
DI 10.1117/12.388905
PG 9
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BQ59W
UT WOS:000088917700030
DA 2018-10-20
ER

PT S
AU Healey, G
   Slater, D
AF Healey, G
   Slater, D
BE Bearman, GH
   Cabib, D
   Levenson, RM
TI Lessons learned: Technology transfer from terrestrial spectroscopy to
   biomedicine
SO SPECTRAL IMAGING: INSTRUMENTATION, APPLICATIONS, AND ANALYSIS
SE PROGRESS IN BIOMEDICAL OPTICS
LA English
DT Proceedings Paper
CT Conference on Spectral Imaging - Instrumentation, Applications, and
   Analysis
CY JAN 25, 2000
CL SAN JOSE, CA
SP SPIE, Int Biomed Opt Soc
ID IMAGING SPECTROMETER AVIRIS; SURFACE-REFLECTANCE; RETINEX THEORY;
   ILLUMINATION; RECOGNITION; SPECTRA
AB The spectral radiance measured by an imaging spectrometer for a material on the earth's surface has significant dependence on environmental factors such as the illumination environment and the atmospheric conditions. This dependence has limited the success of material identification algorithms that rely on hyperspectral image data without associated ground truth information. An important advantage of hyperspectral data is that the sensor spectral dimensionality typically exceeds the dimensionality of the signature variability for any material of interest. We have shown, for example, that the set of observed 0.4-2.5 mu m spectral radiance vectors for a material on the earth's surface lies in a low-dimensional subspace of the hyperspectral measurement space. This analysis has led to robust algorithms for invariant subpixel image analysis that have been applied to a number of remote sensing applications. Similar computational methods can be applied to biomedical images by introducing variability models for the signatures of interest. We present results for material identification in remote sensing images as well as for the quantification of cell populations in 3-D brain tissue samples.
C1 Univ Calif Irvine, Dept Elect & Comp Engn, Irvine, CA 92697 USA.
RP Healey, G (reprint author), Univ Calif Irvine, Dept Elect & Comp Engn, Irvine, CA 92697 USA.
EM healey@ece.uci.edu; dslater@ece.uci.edu
CR Aldrich WS, 1996, P SOC PHOTO-OPT INS, V2758, P354, DOI 10.1117/12.243230
   BASEDOW RW, 1995, P SOC PHOTO-OPT INS, V2480, P258, DOI 10.1117/12.210881
   Berk A., 1989, GLTR890122
   BRAINARD DH, 1986, J OPT SOC AM A, V3, P1651, DOI 10.1364/JOSAA.3.001651
   CHRIEN TG, 1990, SPIE, V1298, P37
   CONEL J, 1987, SPIE P, V834, P140
   Duda R. O., 1973, PATTERN CLASSIFICATI
   Gaddis LR, 1996, IEEE T GEOSCI REMOTE, V34, P163, DOI 10.1109/36.481901
   GAO BC, 1993, REMOTE SENS ENVIRON, V44, P165, DOI 10.1016/0034-4257(93)90014-O
   GOETZ AFH, 1985, SCIENCE, V228
   Golub G. H., 1983, MATRIX COMPUTATIONS
   GREEN R, 1998, JPL AIRB EARTH SCI W, P193
   GREEN RO, 1993, P SOC PHOTO-OPT INS, V1937, P2, DOI 10.1117/12.157054
   Healey G, 1997, IEEE T IMAGE PROCESS, V6, P1002, DOI 10.1109/83.597275
   HEALEY G, 1995, J OPT SOC AM A, V12, P1877, DOI 10.1364/JOSAA.12.001877
   HEALEY G, 1994, J OPT SOC AM A, V11, P3003, DOI 10.1364/JOSAA.11.003003
   Healey G, 1999, IEEE T GEOSCI REMOTE, V37, P2706, DOI 10.1109/36.803418
   Healey G, 1998, J OPT SOC AM A, V15, P2216, DOI 10.1364/JOSAA.15.002216
   HEALEY G, 1999, HDB PATTERN RECOGNIT, P283
   HEALEY GE, 1992, PHYSICS BASED VISION
   JUDD DB, 1964, J OPT SOC AM, V54, P1031, DOI 10.1364/JOSA.54.001031
   KRUSE FA, 1988, REMOTE SENS ENVIRON, V24, P31, DOI 10.1016/0034-4257(88)90004-1
   LAND EH, 1971, J OPT SOC AM, V61, P1, DOI 10.1364/JOSA.61.000001
   PARKKINEN JPS, 1989, J OPT SOC AM A, V6, P318, DOI 10.1364/JOSAA.6.000318
   Slater D, 1998, J OPT SOC AM A, V15, P2913, DOI 10.1364/JOSAA.15.002913
   Slater D, 1998, J IMAGING SCI TECHN, V42, P234
   SLATER D, 1999, SPIE C ALG MULT HYP, V5
   SLATER D, 1999, SPIE P, V3753, P308
   SUEN P, 1999, SPIE P, V3753
   THAI B, 1999, SPIE P, V3717
   VANE G, 1993, REMOTE SENS ENVIRON, V44, P127, DOI 10.1016/0034-4257(93)90012-M
NR 31
TC 0
Z9 0
U1 1
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 1017-2661
BN 0-8194-3536-8
J9 PROG BIOM O
PY 2000
VL 1
BP 2
EP 13
DI 10.1117/12.379583
PG 12
WC Optics; Radiology, Nuclear Medicine & Medical Imaging
SC Optics; Radiology, Nuclear Medicine & Medical Imaging
GA BP87U
UT WOS:000086469300001
DA 2018-10-20
ER

PT S
AU Smith, RD
   Nelson, MP
   Treado, PJ
AF Smith, RD
   Nelson, MP
   Treado, PJ
BE Bearman, GH
   Cabib, D
   Levenson, RM
TI Raman chemical imaging using flexible fiberscope technology
SO SPECTRAL IMAGING: INSTRUMENTATION, APPLICATIONS, AND ANALYSIS
SE PROGRESS IN BIOMEDICAL OPTICS
LA English
DT Proceedings Paper
CT Conference on Spectral Imaging - Instrumentation, Applications, and
   Analysis
CY JAN 25, 2000
CL SAN JOSE, CA
SP SPIE, Int Biomed Opt Soc
DE Raman spectroscopy; chemical imaging; fiberscope; endoscope; remote
   inspection
AB Raman chemical imaging microscopy has been proven to be a powerful methodology for analyzing a wide range of solid state materials. For biomedical applications, Raman chemical imaging has been shown to be effective in assessing clinical samples including breast tissue lesions and arterial plaques. With Raman chemical imaging systems based on microscopes, materials can be analyzed with molecular specificity, without labor intensive sample preparation or the use of dyes and stains at diffraction limited spatial resolution (<250nm). However, microscopes cannot readily be used to perform in vivo measurements. With the recent development of flexible fiberscope technology, Raman chemical imaging can be applied within remote and confined environments and the potential exists for in vivo use. This manuscript provides the first description of novel Raman chemical imaging fiberscope technology, including data analysis strategies for extracting information from Raman chemical imaging data sets.
C1 Chemicon Inc, Pittsburgh, PA 15208 USA.
RP Smith, RD (reprint author), Chemicon Inc, Pittsburgh, PA 15208 USA.
CR Morris HR, 1999, LANGMUIR, V15, P2961, DOI 10.1021/la980653h
   Morris HR, 1996, APPL SPECTROSC, V50, P805, DOI 10.1366/0003702963905655
   Schaeberle MD, 1999, ANAL CHEM, V71, p175A, DOI 10.1021/ac990251u
   ZUGATES CT, 1999, INTERNET J VIB SPECT, V2
NR 4
TC 28
Z9 28
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 1017-2661
BN 0-8194-3536-8
J9 PROG BIOM O
PY 2000
VL 1
BP 14
EP 20
DI 10.1117/12.379593
PG 7
WC Optics; Radiology, Nuclear Medicine & Medical Imaging
SC Optics; Radiology, Nuclear Medicine & Medical Imaging
GA BP87U
UT WOS:000086469300002
DA 2018-10-20
ER

PT J
AU Paul, W
   Sharma, CP
AF Paul, W
   Sharma, CP
TI Chitosan, a drug carrier for the 21st century: a review
SO STP PHARMA SCIENCES
LA English
DT Review
DE chitosan; toxicity; drug delivery; pharmaceutics; microspheres; films;
   gels; implants; transdermal delivery systems; nasal administration;
   ocular administration
ID IN-VITRO EVALUATION; CISPLATIN ALBUMIN MICROSPHERES; PREDNISOLONE
   SODIUM-PHOSPHATE; SUSTAINED-RELEASE FORMULATION; DIRECTLY COMPRESSED
   TABLETS; MOLECULAR-WEIGHT CHITOSAN; EHRLICH ASCITES-CARCINOMA; POORLY
   ABSORBABLE DRUGS; NASAL DELIVERY SYSTEM; ALGINATE GEL BEADS
AB Chitosan, a polysaccharide with structural characteristics similar to glycosamino glycan, was studied for various biomedical applications including membranes in hemodialysis, artificial skin or bioactive wound dressings, as an excipient in drug delivery systems as a matrix in perfusion columns and as a material possessing hemostatic potential to promote nerve growth. Chitosan is, in fact, prescribed for obesity since it is an excellent fat binder. With these multiple applications, chitosan - a biodegradable and naturally available material - will emerge as a household name and as an important biomedical material of the 21(st) century. In this paper, we aim to present the various drug delivery applications of this interesting biopolymer.
C1 Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Biosurface Technol, Thiruvananthapuram 695012, Kerala, India.
RP Sharma, CP (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Biosurface Technol, Thiruvananthapuram 695012, Kerala, India.
RI Paul, Willi/D-2438-2009; Sharma, Chandra/A-4140-2009
OI Paul, Willi/0000-0002-0398-4258; Sharma, Chandra/0000-0002-6982-0926
CR ACARTURK F, 1993, PHARMAZIE, V48, P605
   ACARTURK F, 1989, PHARMAZIE, V44, P547
   ACARTURK F, 1993, STP PHARMA SCI, V3, P369
   Acikgoz M, 1996, J MICROENCAPSUL, V13, P141, DOI 10.3109/02652049609052903
   Aiedeh K, 1997, J MICROENCAPSUL, V14, P567, DOI 10.3109/02652049709006810
   AKBUGA J, 1994, INT J PHARM, V111, P217, DOI 10.1016/0378-5173(94)90344-1
   Akbuga J, 1996, J MICROENCAPSUL, V13, P161, DOI 10.3109/02652049609052904
   Al-Helw AA, 1998, J MICROENCAPSUL, V15, P373, DOI 10.3109/02652049809006864
   ALAMELU S, 1991, J MICROENCAPSUL, V8, P505, DOI 10.3109/02652049109021874
   ALEXAKIS T, 1995, APPL BIOCHEM BIOTECH, V50, P93, DOI 10.1007/BF02788043
   ALONSO FMJ, 1997, Patent No. 0771566
   ALONSO MJ, 1998, Patent No. 0860166
   ARAI K, 1968, B TOKAI REGIONAL FIS, V56, P89
   ARTURSSON P, 1994, PHARMACEUT RES, V11, P1358, DOI 10.1023/A:1018967116988
   Aspden TJ, 1997, J PHARM SCI, V86, P509, DOI 10.1021/js960182o
   ASPDEN TJ, 1995, P 22 INT S CONTR REL, P550
   Bayomi M A, 1998, Pharm Acta Helv, V73, P187, DOI 10.1016/S0031-6865(98)00020-X
   BEENA MS, 1995, ARTIF CELL BLOOD SUB, V23, P175, DOI 10.3109/10731199509117937
   BENNY KJ, 1993, THESIS U KERALA
   Bernkop-Schnurch A, 1998, J DRUG TARGET, V6, P207, DOI 10.3109/10611869808997895
   Bernkop-Schnurch A, 1998, PHARMACEUT RES, V15, P263, DOI 10.1023/A:1011970703087
   Bernkop-Schnurch A, 1998, J CONTROL RELEASE, V50, P215, DOI 10.1016/S0168-3659(97)00136-3
   Bernkop-Schnurch A, 1998, J PHARM SCI, V87, P430, DOI 10.1021/js970410u
   Berthold A, 1996, J CONTROL RELEASE, V39, P17, DOI 10.1016/0168-3659(95)00129-8
   BLOCK LH, 1998, Patent No. 5830883
   BODMEIER R, 1989, PHARMACEUT RES, V6, P413, DOI 10.1023/A:1015987516796
   Braconnot H., 1811, ANN CHIM PHYS, V79, P265
   Bugamelli F, 1998, ARCH PHARM, V331, P133, DOI 10.1002/(SICI)1521-4184(199804)331:4<133::AID-ARDP133>3.0.CO;2-H
   Calvo P, 1997, INT J PHARM, V153, P41, DOI 10.1016/S0378-5173(97)00083-5
   Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
   Calvo P, 1997, PHARMACEUT RES, V14, P1431, DOI 10.1023/A:1012128907225
   CALVO P, 1997, COLLOID POLY SCI, V275, P45
   CALVO P, 1998, P 2 WORLD M APGI APV, P111
   *CENTR DRUG RES I, 1998, 73602 CDRI
   Chanda J, 1996, BIOMATERIALS, V17, P1087, DOI 10.1016/0142-9612(96)85909-6
   CHANDY T, 1991, BIOMAT ARTIF CELL IM, V19, P745, DOI 10.3109/10731199109117852
   Chandy T, 1996, BIOMATERIALS, V17, P577, DOI 10.1016/0142-9612(96)88708-4
   CHANDY T, 1992, BIOMATERIALS, V13, P949, DOI 10.1016/0142-9612(92)90119-9
   CHANDY T, 1993, BIOMATERIALS, V14, P939, DOI 10.1016/0142-9612(93)90136-P
   Chandy T, 1996, BIOMATERIALS, V17, P61, DOI 10.1016/0142-9612(96)80756-3
   CHANDY T, 1993, BIOMATER LIVING SYST, V1, P163
   CHANDY T, 1990, BIOMATER ARTIF CELLS, V8, P1
   CHEIN YW, 1983, DRUG DEV IND PHARM, V9, P1291
   Dangprasirt P, 1998, DRUG DEV IND PHARM, V24, P947, DOI 10.3109/03639049809097274
   Dumitriu S., 1997, US Patent, Patent No. 5620706
   El Fattah EA, 1998, DRUG DEV IND PHARM, V24, P541
   El-Samaligy MS, 1996, DRUG DELIV, V3, P93
   Elcin YM, 1996, ARTIF CELL BLOOD SUB, V24, P257, DOI 10.3109/10731199609117438
   Erbacher P, 1998, PHARMACEUT RES, V15, P1332, DOI 10.1023/A:1011981000671
   FilipovicGrcic J, 1996, INT J PHARM, V135, P183, DOI 10.1016/0378-5173(96)04470-5
   FRIEDMAN D, 1998, Patent No. 5744155
   GENTA I, 1995, STP PHARMA SCI, V5, P202
   Genta I, 1997, J PHARM PHARMACOL, V49, P737, DOI 10.1111/j.2042-7158.1997.tb06103.x
   Genta I, 1998, DRUG DEV IND PHARM, V24, P779, DOI 10.3109/03639049809082726
   GENTA I, 1996, P 23 INT S CONTR REL, P135
   Giunchedi P, 1998, BIOMATERIALS, V19, P157, DOI 10.1016/S0142-9612(97)00181-6
   GOSCONDA SR, 1993, DRUG DEV IND PHARM, V19, P915
   Hari PR, 1996, J MICROENCAPSUL, V13, P319, DOI 10.3109/02652049609026019
   Hari PR, 1996, J APPL POLYM SCI, V59, P1795
   HASSAN EE, 1992, PHARMACEUT RES, V9, P390, DOI 10.1023/A:1015803321609
   Hassan EE, 1993, J DRUG TARGET, V1, P7, DOI 10.3109/10611869308998759
   Henriksen I, 1996, INT J PHARM, V145, P231, DOI 10.1016/S0378-5173(96)04776-X
   HILLYARD IW, 1964, P SOC EXP BIOL MED, V115, P1108
   Hoppe-Seiler F., 1994, BER DTSCH CHEM GES, V27, P3329
   HOU WM, 1985, CHEM PHARM BULL, V33, P3986
   Huang RG, 1999, PHARM DEV TECHNOL, V4, P107, DOI 10.1081/PDT-100101345
   Ichikawa H, 1993, Drug Des Discov, V10, P343
   Illum L, 1996, BIOPHARM DRUG DISPOS, V17, P717, DOI 10.1002/(SICI)1099-081X(199611)17:8<717::AID-BDD985>3.0.CO;2-I
   ILLUM L, 1994, PHARMACEUT RES, V11, P1186, DOI 10.1023/A:1018901302450
   ILLUM L, 1998, Patent No. 5744166
   Inouye K, 1988, Drug Des Deliv, V2, P165
   Inouye K, 1987, Drug Des Deliv, V1, P297
   Inouye K, 1989, Drug Des Deliv, V4, P55
   Jabbal-Gill I, 1998, VACCINE, V16, P2039, DOI 10.1016/S0264-410X(98)00077-2
   JAMEELA SR, 1994, J BIOMAT SCI-POLYM E, V6, P621, DOI 10.1163/156856294X00563
   Jameela SR, 1998, J CONTROL RELEASE, V52, P17, DOI 10.1016/S0168-3659(97)00187-9
   JAMEELA SR, 1995, BIOMATERIALS, V16, P769, DOI 10.1016/0142-9612(95)99639-4
   Jameela SR, 1996, J PHARM PHARMACOL, V48, P685, DOI 10.1111/j.2042-7158.1996.tb03951.x
   Jing SB, 1997, J PHARM PHARMACOL, V49, P721, DOI 10.1111/j.2042-7158.1997.tb06099.x
   JOHN J, 1994, THESIS U KERALA
   Johnson JD, 1995, TRENDS CARBOHYDRATE, P133
   KANKE M, 1989, CHEM PHARM BULL, V37, P523
   KAWASHIMA Y, 1985, CHEM PHARM BULL, V33, P2107
   KAWASHIMA Y, 1985, CHEM PHARM BULL, V33, P2469
   KAWASHIMA Y, 1985, J PHARM SCI, V74, P264, DOI 10.1002/jps.2600740308
   KAWASHIMA Y, 1983, J PHARM SCI, V72, P514, DOI 10.1002/jps.2600720509
   KIM JH, 1992, J APPL POLYM SCI, V44, P1823, DOI 10.1002/app.1992.070441015
   KNAPCZYK J, 1989, CHITIN CHITOSAN SOUR, P757
   Knapczyk J., 1989, CHITIN CHITOSAN SOUR, P665
   Kotze AF, 1999, J PHARM SCI, V88, P253, DOI 10.1021/js980233c
   Kuribayashi R, 1996, ARTIF ORGANS, V20, P761, DOI 10.1111/j.1525-1594.1996.tb04537.x
   Lee BJ, 1998, J MICROENCAPSUL, V15, P775, DOI 10.3109/02652049809008260
   Lee KY, 1998, J CONTROL RELEASE, V51, P213, DOI 10.1016/S0168-3659(97)00173-9
   LEE YC, 1990, POLLIMO, V14, P342
   LEHR CM, 1992, INT J PHARM, V78, P43, DOI 10.1016/0378-5173(92)90353-4
   Leong KW, 1998, J CONTROL RELEASE, V53, P183, DOI 10.1016/S0168-3659(97)00252-6
   Li Y., 1991, STP PHARMA SCI, V1, P363
   LIN SY, 1992, STP PHARMA SCI, V2, P500
   LIU LS, 1995, P 22 INT S CONTR REL, P542
   LIU X J, 1991, Yaoxue Xuebao, V26, P782
   Lorenz D. H., 1995, US Patent, Patent No. [5,420,197, 5420197]
   Lorenzo-Lamosa ML, 1998, J CONTROL RELEASE, V52, P109, DOI 10.1016/S0168-3659(97)00203-4
   LYMAN DJ, 1971, FED PROC, V30, P658
   Machida Y, 1986, Drug Des Deliv, V1, P119
   MACHIDA Y, 1993, YAKUGAKU ZASSHI, V113, P356, DOI 10.1248/yakushi1947.113.5_356
   Macleod GS, 1999, J CONTROL RELEASE, V58, P303, DOI 10.1016/S0168-3659(98)00168-0
   Maysinger D, 1996, EXP NEUROL, V141, P47, DOI 10.1006/exnr.1996.0138
   MCCURDY JD, 1992, ADVANCES IN CHITIN AND CHITOSAN, P659
   Mi FL, 1997, J MICROENCAPSUL, V14, P577, DOI 10.3109/02652049709006811
   Miekka SI, 1998, HAEMOPHILIA, V4, P436, DOI 10.1046/j.1365-2516.1998.440436.x
   MITTAL S, 1994, NEUROREPORT, V5, P2577, DOI 10.1097/00001756-199412000-00043
   MIURA T, 1995, BIOL PHARM BULL, V18, P1623
   Miwa A, 1998, PHARMACEUT RES, V15, P1844, DOI 10.1023/A:1011901921995
   MIYAZAKI S, 1988, J PHARM PHARMACOL, V40, P642, DOI 10.1111/j.2042-7158.1988.tb05325.x
   MIYAZAKI S, 1981, CHEM PHARM BULL, V29, P3067
   MIYAZAKI S, 1995, INT J PHARM, V118, P257, DOI 10.1016/0378-5173(94)00396-M
   MIYAZAKI S, 1988, CHEM PHARM BULL, V36, P4033
   MIYAZAKI S, 1994, BIOL PHARM BULL, V17, P745
   MIYAZAKI S, 1990, ACTA PHARM NORDICA, V2, P401
   Miyazaki T, 1990, EISEI SHIKENJO HOKOK, V108, P95
   Mooren FC, 1998, PHARMACEUT RES, V15, P58, DOI 10.1023/A:1011996619500
   MURATA Y, 1993, INT J PHARM, V96, P139, DOI 10.1016/0378-5173(93)90221-Z
   Murata Y, 1996, J CONTROL RELEASE, V38, P101, DOI 10.1016/0168-3659(95)00098-4
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Muzzarelli R.A.A., 1977, CHITIN, P45
   Nagai T., 1984, CHITIN CHITOSAN RELA, P21
   Needleman IG, 1997, J CLIN PERIODONTOL, V24, P394, DOI 10.1111/j.1600-051X.1997.tb00203.x
   Needleman IG, 1998, J CLIN PERIODONTOL, V25, P74, DOI 10.1111/j.1600-051X.1998.tb02366.x
   NISHIMURA K, 1986, J BIOMED MATER RES, V20, P1359, DOI 10.1002/jbm.820200910
   NISHIOKA Y, 1992, CHEM PHARM BULL, V40, P267, DOI 10.1248/cpb.40.267
   NISHIOKA Y, 1989, CHEM PHARM BULL, V37, P3074
   NISHIOKA Y, 1990, CHEM PHARM BULL, V38, P2871, DOI 10.1248/cpb.38.2871
   Ohe T, 1996, SCI TOTAL ENVIRON, V181, P1, DOI 10.1016/0048-9697(95)04949-5
   OHYA Y, 1993, J MICROENCAPSUL, V10, P1, DOI 10.3109/02652049309015307
   Okhamafe AO, 1996, J MICROENCAPSUL, V13, P497, DOI 10.3109/02652049609026035
   Ormrod DJ, 1998, ATHEROSCLEROSIS, V138, P329, DOI 10.1016/S0021-9150(98)00045-8
   OUCHI T, 1989, MAKROMOL CHEM, V190, P1817
   OUCHI T, 1988, T SOC BIOMED, V11, P232
   Patashnik S, 1997, J DRUG TARGET, V4, P371, DOI 10.3109/10611869709017894
   Patel VR, 1996, PHARMACEUT RES, V13, P588, DOI 10.1023/A:1016054306763
   PATHAK YV, 1990, BIOMATERIALS, V11, P718, DOI 10.1016/0142-9612(90)90034-N
   Paul W, 1995, J MATER SCI LETT, V14, P1792, DOI 10.1007/BF00271009
   PAVANETTO F, 1995, P 10 INT S MICR AUST, P49
   POLK A, 1984, J PHARM SCI, V83, P178
   Ramdas M, 1999, J BIOMATER APPL, V13, P290, DOI 10.1177/088532829901300402
   RAMDAS M, 1999, P INT C POL 99 IIT D, P835
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Remunan-Lopez C, 1998, J CONTROL RELEASE, V55, P143, DOI 10.1016/S0168-3659(98)00044-3
   Remunan-Lopez C, 1998, EUR J PHARM BIOPHARM, V45, P49, DOI 10.1016/S0939-6411(97)00122-7
   ROBERTS G. A. F, 1992, CHITIN CHEM, V1st, P1
   Rouget C., 1859, CR HEBD ACAD SCI, V48, P792
   Roy K, 1999, NAT MED, V5, P387
   SABINIS S, 1997, PHARM DEV TECHNOL, V2, P243
   SAVAGE P, 1995, CHITIN KEY LOW COST
   SAWAYANAGI Y, 1982, CHEM PHARM BULL, V30, P4216
   SAWAYANAGI Y, 1982, CHEM PHARM BULL, V30, P4213
   SAWAYANAGI Y, 1983, CHEM PHARM BULL, V31, P2507
   SAWAYANAGI Y, 1982, CHEM PHARM BULL, V30, P3297
   SAWAYANAGI Y, 1982, CHEM PHARM BULL, V30, P2935
   Sawayanagi Y, 1983, CHEM PHARM BULL, V31, P2062, DOI [10.1248/cpb.31.2064, DOI 10.1248/CPB.31.2064]
   SAWAYANAGI Y, 1982, CHEM PHARM BULL, V30, P4454
   Schipper NGM, 1996, PHARMACEUT RES, V13, P1686, DOI 10.1023/A:1016444808000
   Schipper NGM, 1997, PHARMACEUT RES, V14, P923, DOI 10.1023/A:1012160102740
   SEZER AD, 1995, INT J PHARM, V121, P113, DOI 10.1016/0378-5173(94)00413-Y
   SEZERA D, 1999, J MICROENCAPSUL, V16, P195
   SHETH PR, 1984, DRUG DEV IND PHARM, V10, P313, DOI 10.3109/03639048409064653
   SHIRAISHI S, 1990, CHEM PHARM BULL, V38, P185
   SHIRAISHI S, 1993, J CONTROL RELEASE, V25, P217, DOI 10.1016/0168-3659(93)90080-O
   Singh UV, 1998, J MICROENCAPSUL, V15, P581, DOI 10.3109/02652049809008242
   Skaugrud Oyvind, 1995, P96
   Soane RJ, 1999, INT J PHARM, V178, P55, DOI 10.1016/S0378-5173(98)00367-6
   Song YH, 1996, J CONTROL RELEASE, V42, P93, DOI 10.1016/0168-3659(96)01372-7
   Sugimoto K, 1998, BIOL PHARM BULL, V21, P1202
   Szymonowicz M, 1997, Polim Med, V27, P17
   TAKAYAMA K, 1990, CHEM PHARM BULL, V38, P1993
   TAKEUCHI H, 1994, CHEM PHARM BULL, V42, P1954
   Takeuchi H, 1996, PHARMACEUT RES, V13, P896, DOI 10.1023/A:1016009313548
   Tanaka Y, 1997, BIOMATERIALS, V18, P591, DOI 10.1016/S0142-9612(96)00182-2
   Tasker RAR, 1997, J VET PHARMACOL THER, V20, P362, DOI 10.1046/j.1365-2885.1997.00072.x
   Tasker RAR, 1998, LAB ANIM, V32, P270, DOI 10.1258/002367798780559220
   THACHARODI D, 1995, BIOMATERIALS, V16, P145, DOI 10.1016/0142-9612(95)98278-M
   THACHARODI D, 1993, J CHEM TECHNOL BIOT, V58, P177
   Thacharodi D, 1996, BIOMATERIALS, V17, P1307, DOI 10.1016/0142-9612(96)88676-5
   THANOO BC, 1992, J PHARM PHARMACOL, V44, P283, DOI 10.1111/j.2042-7158.1992.tb03607.x
   Tian XX, 1999, J PHARM PHARMACOL, V51, P151, DOI 10.1211/0022357991772268
   Torzsas TL, 1996, FOOD CHEM TOXICOL, V34, P73, DOI 10.1016/0278-6915(95)00083-6
   Tozaki H, 1997, J PHARM SCI, V86, P1016, DOI 10.1021/js970018g
   Uchegbu IF, 1998, J PHARM PHARMACOL, V50, P453, DOI 10.1111/j.2042-7158.1998.tb06185.x
   Vasudev SC, 1997, BIOMATERIALS, V18, P375, DOI 10.1016/S0142-9612(96)00131-7
   VURAL I, 1991, CHIMICAOGGI, V9, P49
   WAN LSC, 1994, STP PHARMA SCI, V4, P195
   Wang Y. M., 1995, Yaoxue Xuebao, V30, P891
   Watts PJ, 1998, Drug delivery composition containing chitosan or derivative thereof having a defined z. potential, Patent No. [US5840341, 5840341]
   Yagi M, 1998, NEPHRON, V78, P433, DOI 10.1159/000044973
   YAMOTA C, 1994, YAKUGAKU ZASSHI, V114, P257
   Yao T, 1997, CHEM PHARM BULL, V45, P1510
   ZHANG Y, 1997, CHUNG KUO HSIU FU CH, V11, P309
   1996, Patent No. 5554388
NR 198
TC 229
Z9 241
U1 0
U2 53
PU EDITIONS SANTE
PI PARIS
PA 47 RUE GALILEE, 75116 PARIS, FRANCE
SN 1157-1489
J9 STP PHARMA SCI
JI STP Pharma Sci.
PD JAN-FEB
PY 2000
VL 10
IS 1
BP 5
EP 22
PG 18
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 294CC
UT WOS:000085891500001
DA 2018-10-20
ER

PT S
AU Afanasyeva, N
   Kolyakov, S
   Bruch, R
   Gummuluri, S
AF Afanasyeva, N
   Kolyakov, S
   Bruch, R
   Gummuluri, S
BE Nguyen, C
TI Biomedical, environmental and industrial application of fiberoptical
   infrared spectroscopy
SO SUBSURFACE SENSING TECHNOLOGIES AND APPLICATIONS II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 2nd International Conference on Subsurface Sensing Technologies and
   Applications
CY JUL 31-AUG 03, 2000
CL SAN DIEGO, CA
SP SPIE
DE infrared interferometry; fiber optics; noninvasive in vivo diagnostics;
   medicine; environment; and industry
ID FEW-FTIR SPECTROSCOPY; EVANESCENT-WAVE SPECTROSCOPY; BREAST-CANCER
   TISSUES; DIAGNOSTICS IN-VIVO; STRUCTURAL-ANALYSIS; POLYMER SURFACES;
   LIVING TISSUE; DNA; CHEMICALS; MODELS
AB An advanced infrared (IR) interferometric method using fiber optics has been developed for biomedical, environmental and industrial applications. The fiberoptic Evanescent Wave Fourier Transform Infrared (FEW-FTIR) spectroscopy method has been applied to diagnostics of numerous materials including living tissue without sample preparation. This highly sensitive diagnostics tool can conduct surface and subsurface analysis at the molecular level on such diverse materials as human tissue and body fluids, plants, soil, rocks, chemicals, oil, paper and polymers nondestructively, noninvasively in vivo. Operating in the attenuated total reflection (ATR) regime in the middle-infrared (MIR) range, the FEW-FTIR technique provides direct contact between the fiber probe and any surface. Our fiber optical spectroscopic device is compact, portable for any application and operates upto a distance of three meters with extremely low loss and nontoxic fibers. This method allows the detection of functional chemical groups and bonds directly from a surface by soft touching of a surface for 15sec. Applications of this method include (i) early diagnostics of precancerous conditions and other diseases, (ii) sun, laser radiation and the influence of other environmental factors (water, pollution and weather). (iii) quality control during manufacturing processes, in process analysis.
C1 Univ Nevada, Dept Phys, Reno, NV 89557 USA.
RP Afanasyeva, N (reprint author), Univ Nevada, Dept Phys, Reno, NV 89557 USA.
CR Afanasyeva N, 1999, P SOC PHOTO-OPT INS, V3752, P90, DOI 10.1117/12.365688
   AFANASYEVA N, 1995, MACROMOL SYMP, V94, P269, DOI 10.1002/masy.19950940124
   Afanasyeva N, 1999, P SOC PHOTO-OPT INS, V3596, P152, DOI 10.1117/12.346712
   Afanasyeva NI, 1999, SURF INTERFACE ANAL, V27, P204, DOI 10.1002/(SICI)1096-9918(199904)27:4<204::AID-SIA545>3.0.CO;2-U
   Afanasyeva NI, 1999, MACROMOL SYMP, V141, P117, DOI 10.1002/masy.19991410112
   Afanasyeva NI, 1999, P SOC PHOTO-OPT INS, V3590, P472, DOI 10.1117/12.351003
   Afanasyeva NI, 1996, P SOC PHOTO-OPT INS, V2928, P154, DOI 10.1117/12.259954
   Afanasyeva NI, 1997, P SOC PHOTO-OPT INS, V2979, P478, DOI 10.1117/12.280279
   Afanasyeva NI, 1998, P SOC PHOTO-OPT INS, V3250, P140, DOI 10.1117/12.305383
   Afanasyeva NI, 1998, P SOC PHOTO-OPT INS, V3257, P260, DOI 10.1117/12.306092
   AFANASYEVA NI, 1997, P SOC PHOTO-OPT INS, V3195, P314
   AFANASYEVA NI, 1994, SPIE, V2089, P354
   AFANESYEVA NI, 1999, MACR S, V119, P207
   ARTJUSHENKO VG, 1994, P SOC PHOTO-OPT INS, V2321, P758
   Bellamy L. J., 1980, INFRARED SPECTRA COM
   Bormashenko E, 1999, P SOC PHOTO-OPT INS, V3570, P100, DOI 10.1117/12.336947
   Brooks A, 1999, SURF INTERFACE ANAL, V27, P221, DOI 10.1002/(SICI)1096-9918(199904)27:4<221::AID-SIA547>3.0.CO;2-V
   Brooks A, 1999, P SOC PHOTO-OPT INS, V3596, P140, DOI 10.1117/12.346711
   Coates J, 2000, SPECTROSCOPY, V15, P19
   Eytan O, 1999, P SOC PHOTO-OPT INS, V3596, P74, DOI 10.1117/12.346718
   Harrick N. J, 1967, INTERNAL REFLECTION
   KRIMM S, 1987, VIB SPECTRA STRUCT, V16, P1
   LIPPINCOTT E, 1961, ANAL CHEM, V33, P137, DOI 10.1021/ac60169a044
   Malins DC, 1997, NAT MED, V3, P927, DOI 10.1038/nm0897-927
   Malins DC, 1997, P NATL ACAD SCI USA, V94, P3611, DOI 10.1073/pnas.94.8.3611
   MALINS DC, 1994, P NATL ACAD SCI USA, V91, P13038, DOI 10.1073/pnas.91.26.13038
   MANTSH H, 1996, INFRARED SPECTROSCOP, pCH11
   Marechal Y., 1987, Vibrational spectra and structure. A series of Advances. Vol.16, P311
   NAKAMOTO K, 1997, INFRARED RAMAN SPECT
   Nakanishi K., 1997, INFRARED ABSORPTION
   PARKER FS, 1971, INFRARED SPECTROSCOP
   Ryland S.G., 1995, PRACTICAL GUIDE INFR
   STARK PB, 1993, APPL SPECTROSC, V47, P1820, DOI 10.1366/0003702934066163
   Weiner S., 1990, SPECTROSCOPY, V5, P46
NR 34
TC 1
Z9 1
U1 3
U2 6
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3774-3
J9 P SOC PHOTO-OPT INS
PY 2000
VL 4129
BP 272
EP 283
DI 10.1117/12.390624
PG 12
WC Instruments & Instrumentation; Optics; Spectroscopy
SC Instruments & Instrumentation; Optics; Spectroscopy
GA BR51N
UT WOS:000166690700028
DA 2018-10-20
ER

PT J
AU van der Mei, HC
   de Vries, J
   Busscher, HJ
AF van der Mei, HC
   de Vries, J
   Busscher, HJ
TI X-ray photoelectron spectroscopy for the study of microbial cell
   surfaces
SO SURFACE SCIENCE REPORTS
LA English
DT Review
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; GRAM-POSITIVE BACTERIA;
   SACCHAROMYCES-CEREVISIAE; ORAL STREPTOCOCCI; ESCHERICHIA-COLI;
   YEAST-CELLS; ELEMENTAL COMPOSITION; BIOCHEMICAL-ANALYSIS; CULTURE
   CONDITIONS; VOICE PROSTHESES
AB X-ray photoelectron spectroscopy (XPS) is well known for the characterisation of material surfaces, but at first glance, is an unexpected technique to study the composition of microbial cell surfaces. Despite the fact that intimate contact between materials and microbial cell surfaces occurs in many situations, such as on oil-platforms, in water pipelines and bioreactors or on biomedical implants, XPS studies on the composition of microbial cell surfaces are less known, but equally relevant. In this review, microbial sample preparations are discussed, as well as relationships between microbial compositions using XPS. Biochemical and physical properties, such as microbial cell surface charge and hydrophobicity are also discussed. A reference guide, giving the overall cell surface composition of 210 strains determined by XPS, as collected from the literature is given. Hierarchical cluster analysis on these data reveals interesting new insights on staphylococcal cell surfaces, as well as a distinction between staphylococci, yeasts and other microorganisms. It is concluded that XPS on microbial cell surfaces yields useful information, complementing other biochemical and physical cell surface characterisations. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP van der Mei, HC (reprint author), Univ Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
CR AMORY DE, 1988, BIOCHIM BIOPHYS ACTA, V938, P61, DOI 10.1016/0005-2736(88)90122-8
   AMORY DE, 1988, SURF INTERFACE ANAL, V11, P478, DOI 10.1002/sia.740110904
   AMORY DE, 1988, FEMS MICROBIOL LETT, V49, P107, DOI 10.1016/0378-1097(88)90110-3
   Andrade J. D., 1985, SURFACE INTERFACIAL, V1, P105
   Bos R, 1996, COLLOID SURFACE B, V7, P101, DOI 10.1016/0927-7765(96)01293-3
   BOTT TR, 1992, APPL SCI, V223, P3
   BRUNETT JH, 1968, FUNDAMENTALS MYCOLOG
   BUCHS J, 1988, APPL MICROBIOL BIOT, V29, P119
   BUSSCHER HJ, 1994, COLLOID SURFACE B, V2, P73, DOI 10.1016/0927-7765(94)80020-0
   BUSSCHER HJ, 1990, J MICROBIOL METH, V12, P101, DOI 10.1016/0167-7012(90)90020-7
   BUSSCHER HJ, 1995, COLLOID SURFACE B, V5, P111, DOI 10.1016/0927-7765(95)01224-7
   Busscher HJ, 1997, J BIOMED MATER RES, V34, P201, DOI 10.1002/(SICI)1097-4636(199702)34:2<201::AID-JBM9>3.0.CO;2-U
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   BUSSCHER HJ, 1991, MICROBIAL CELL SURFA
   CAPDEVILLE B, 1992, APPL SCI, V223, P13
   COWAN MM, 1992, J GEN MICROBIOL, V138, P2707, DOI 10.1099/00221287-138-12-2707
   COWAN MM, 1992, APPL ENVIRON MICROB, V58, P1326
   CUPERUS PL, 1992, CELL MATER, V2, P271
   CUPERUS PL, 1993, J COLLOID INTERF SCI, V156, P319, DOI 10.1006/jcis.1993.1118
   CUPERUS PL, 1995, MICROBIOS, V82, P49
   DENGIS PB, 1995, COLLOID SURFACE B, V4, P199, DOI 10.1016/0927-7765(94)01171-Z
   Dengis PB, 1996, J MICROBIOL METH, V26, P171, DOI 10.1016/0167-7012(96)00909-8
   Dengis PB, 1997, YEAST, V13, P931, DOI 10.1002/(SICI)1097-0061(199708)13:10<931::AID-YEA149>3.0.CO;2-T
   DENYER SP, 1990, J CLIN MICROBIOL, V28, P1813
   DILLON JK, 1986, J MICROBIOL METH, V6, P13, DOI 10.1016/0167-7012(86)90027-8
   Dufrene YF, 1996, COLLOID SURFACE B, V7, P271, DOI 10.1016/0927-7765(96)01295-7
   Dufrene YF, 1997, J BACTERIOL, V179, P1023, DOI 10.1128/jb.179.4.1023-1028.1997
   GEERTSEMADOORNBUSCH GI, 1993, J MICROBIOL METH, V18, P61, DOI 10.1016/0167-7012(93)90072-P
   GOLDMANN DA, 1993, CLIN MICROBIOL REV, V6, P176
   GRISTINA AG, 1989, MOL MECHANISMS MICRO
   Hammond S.M., 1984, BACTERIAL CELL SURFA
   Harkes G, 1992, Cell Biophys, V20, P17, DOI 10.1007/BF02782652
   HEDMAN P, 1991, J INFECTION, V23, P145, DOI 10.1016/0163-4453(91)92045-7
   HERBEN PFG, 1990, BIOCHIM BIOPHYS ACTA, V1033, P184, DOI 10.1016/0304-4165(90)90010-T
   JAMES AM, 1991, MICROBIAL CELL SURFA
   JONSSON P, 1983, CURR MICROBIOL, V8, P347
   Kiely LJ, 1997, COLLOID SURFACE B, V9, P297, DOI 10.1016/S0927-7765(97)00037-4
   Lalande M., 1989, Biofouling, V1, P233
   LATRACHE H, 1994, COLLOID SURFACE B, V2, P47, DOI 10.1016/0927-7765(94)80017-0
   LINDAHL M, 1981, BIOCHIM BIOPHYS ACTA, V677, P471, DOI 10.1016/0304-4165(81)90261-0
   Lynch J.L., 1988, Biofouling, V1, P147
   Marsh P, 1992, ORAL MICROBIOLOGY
   MARSHALL KC, 1994, COLLOID SURFACE B, V2, P371, DOI 10.1016/0927-7765(94)80050-2
   MARTIN AH, 1992, APPL SCI, V223, P461
   Matsumura M, 1997, J FERMENT BIOENG, V84, P144, DOI 10.1016/S0922-338X(97)82544-5
   MEDRZYCKA KB, 1991, COLLOID POLYM SCI, V269, P85, DOI 10.1007/BF00654663
   MILLARD MM, 1977, ANAL CHEM, V49, P1290, DOI 10.1021/ac50017a004
   Millsap KW, 1997, CAN J MICROBIOL, V43, P284, DOI 10.1139/m97-039
   MIORNER H, 1982, INFECT IMMUN, V36, P227
   MOZES N, 1988, BIOCHIM BIOPHYS ACTA, V945, P324, DOI 10.1016/0005-2736(88)90495-6
   MOZES N, 1989, COLLOID SURFACE, V42, P313
   MOZES N, 1995, MICROBIOL-SGM, V141, P11, DOI 10.1099/00221287-141-1-11
   MOZES N, 1987, J MICROBIOL METH, V6, P99, DOI 10.1016/0167-7012(87)90058-3
   MOZES N, 1994, COLLOID SURFACE B, V3, P63
   NEU TR, 1993, BIOMATERIALS, V14, P459, DOI 10.1016/0142-9612(93)90149-V
   NICKEL JC, 1989, UROLOGY, V34, P284
   NODA Y, 1986, J BACTERIOL, V167, P1016, DOI 10.1128/jb.167.3.1016-1019.1986
   NORDSTROM KM, 1994, COLLOID SURFACE B, V2, P67, DOI 10.1016/0927-7765(94)80019-7
   Richmond M.D., 1991, Biofouling, V3, P151
   ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1016/0378-1097(80)90106-8
   ROUXHET PG, 1994, COLLOID SURFACE B, V2, P347, DOI 10.1016/0927-7765(94)80049-9
   Schakenraad J M, 1992, Cell Biophys, V20, P57, DOI 10.1007/BF02782654
   SJOLLEMA J, 1990, FEMS MICROBIOL LETT, V69, P263
   STRAVER MH, 1994, COLLOID SURFACE B, V2, P173, DOI 10.1016/0927-7765(94)80032-4
   TENBOSCH JJ, 1991, BIOFOULING, V4, P141
   TIMPERLEY DA, 1992, APPL SCI, V223, P379
   TYBUSSEK R, 1994, APPL MICROBIOL BIOT, V41, P13, DOI 10.1007/s002530050100
   van der Mei H C, 1997, Adv Dent Res, V11, P388
   van der Mei H C, 1992, Cell Biophys, V20, P99
   van der Mei HC, 1997, MICROBIOL-UK, V143, P3861, DOI 10.1099/00221287-143-12-3861
   VANDERMEI HC, 1991, CURR MICROBIOL, V23, P337, DOI 10.1007/BF02104136
   VANDERMEI HC, 1989, BIOCHIM BIOPHYS ACTA, V991, P395, DOI 10.1016/0304-4165(89)90063-9
   VANDERMEI HC, 1991, CARIES RES, V25, P415, DOI 10.1159/000261404
   VANDERMEI HC, 1989, ARCH ORAL BIOL, V34, P889, DOI 10.1016/0003-9969(89)90146-5
   VANDERMEI HC, 1988, COLLOID SURFACE, V32, P297, DOI 10.1016/0166-6622(88)80024-6
   vanderMei HC, 1996, EUR J ORAL SCI, V104, P48
   VANDERMEI HC, 1988, J BACTERIOL, V170, P2462, DOI 10.1128/jb.170.6.2462-2466.1988
   VANDERMEI HC, 1989, APPL ENVIRON MICROB, V55, P2806
   VANDERMEI HC, 1992, CAN J MICROBIOL, V38, P1033
   VANDERMEI HC, 1993, APPL ENVIRON MICROB, V59, P4305
   VANDERMEI HC, 1987, J MICROBIOL METH, V6, P77
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   Zhong W, 1998, APPL ENVIRON MICROB, V64, P2418
NR 83
TC 25
Z9 25
U1 2
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-5729
J9 SURF SCI REP
JI Surf. Sci. Rep.
PY 2000
VL 39
IS 1
BP 3
EP 24
PG 22
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 329YR
UT WOS:000087936500001
DA 2018-10-20
ER

PT B
AU El Fray, M
AF El Fray, M
BE Yagci, Y
   Mishra, MK
   Nuyken, O
   Ito, K
   Wnek, G
TI Selection of polymeric materials for biomedical applications
SO TAILORED POLYMERS & APPLICATIONS
LA English
DT Proceedings Paper
CT 3rd International Symposium on Advanced Polymers via Macromolecular
   Engineering
CY JUL 31-AUG 04, 1999
CL WILLIAMSBURG, VA
DE sterilization methods; degradation of polymers; synthetic polyesters
ID DEGRADATION; ADHESION
C1 Tech Univ Szczecin, Dept Chem Fibers & Phys Chem Polymers, PL-70322 Szczecin, Poland.
RP El Fray, M (reprint author), Tech Univ Szczecin, Dept Chem Fibers & Phys Chem Polymers, Pulaskiego Str 10, PL-70322 Szczecin, Poland.
RI El Fray, Miroslawa/J-4128-2016
CR ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   BAKKER D, 1990, J BIOMED MATER RES, V24, P277, DOI 10.1002/jbm.820240302
   BAKKUM EA, 1995, J MATER SCI-MATER M, V6, P41, DOI 10.1007/BF00121246
   CHU CC, 1981, J APPL POLYM SCI, V26, P1727, DOI 10.1002/app.1981.070260527
   Dawids S. G., 1993, TEST PROCEDURES BLOO
   Domb AJ, 1998, ACTA POLYM, V49, P526, DOI 10.1002/(SICI)1521-4044(199810)49:10/11<526::AID-APOL526>3.0.CO;2-C
   DOMB AJ, 1994, BIOMEDICAL POLYM DES
   DUMITRIU S, 1994, POLYM BIOMATERIALS
   El Fray M, 1996, ANGEW MAKROMOL CHEM, V234, P103
   ELFRAY M, IN PRESS J MAT SCI M
   ELFRAY M, 1998, Patent No. 329794
   Kroschwitz J I, 1989, POLYM BIOMATERIALS M
   Mazurkiewicz S, 1999, POLIMERY-W, V44, P403
   RADDER AM, 1995, J MATER SCI-MATER M, V6, P510, DOI 10.1007/BF00151031
   Schnabel W., 1981, POLYM DEGRADATION PR
   Tsuruta T., 1993, BIOMEDICAL APPL POLY
   VANHAASTERT RM, 1994, J MATER SCI-MATER M, V5, P764, DOI 10.1007/BF00120373
   VELD PJA, 1982, ADV BIOMATER, V10, P420
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   WILLIAMS DF, 1982, BIOCOMPATIBILITY CLI
   YUI N, 1984, POLYM J, V16, P119, DOI 10.1295/polymj.16.119
   1965, MEILLIAND TEXTILBERI, V9, P1008
NR 22
TC 1
Z9 1
U1 0
U2 0
PU VSP BV-C/O BRILL ACAD PUBL
PI LEIDEN
PA PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
BN 90-6764-326-2
PY 2000
BP 133
EP 138
PG 6
WC Polymer Science
SC Polymer Science
GA BW50N
UT WOS:000182233300010
DA 2018-10-20
ER

PT J
AU Vretzakis, G
   Papaziogas, B
   Matsaridou, E
   Vasiliadou, G
   Papadopoulos, G
   Patsialas, C
   Kostopoulou, F
AF Vretzakis, G
   Papaziogas, B
   Matsaridou, E
   Vasiliadou, G
   Papadopoulos, G
   Patsialas, C
   Kostopoulou, F
TI Continuous monitoring of arterial blood gases and pH during
   intraoperative rapid blood administration using a paratrend sensor
SO VOX SANGUINIS
LA English
DT Article
ID SYSTEM; MODEL
AB Background and Objectives: The aim of this study was to determine the effects of rapid transfusion of packed red cells on the arterial blood gases and acid-base status of the recipient. Materials and Methods: We studied 16 patients (mean age 66.3 +/- 9.9 years) who received rapid transfusion of 632.8 +/- 287.2 g of packed red cells in CPDA-1, stored before use for a period of 15.2 +/- 4.4 days. During transfusion, monitoring of pH, PCO2 and PO2 was continuous using an intra-arterial multiparameter sensor (Paratrend 7, Biomedical Sensors, UK), Results: The rate of the transfusion was 73.1 +/- 9.6 g/min and the duration of observation was 35.8 +/- 12.8 min. Arterial pH decreased from 7.446 +/- 0.023 to 7.385 +/- 0.034 (p < 0.001) and PCO2 increased from 32.31 +/- 1.35 to 36.41 +/- 1.86 mmHg (p<0.001). Delta pH and Delta PCO2 showed significant correlation to the weight and the age of the transfused blood (p<0.001 for both dependent variables). The rate of pH change was positively but insignificantly correlated to the rate of the transfusion. Base excess was significantly decreased and end-tidal CO2 (PetCO(2)) was increased from 25.8 +/- 2.0 to 28.1 +/- 2.3 mmHg (p < 0.05), significantly correlating to the amount and age of the administered component (p < 0.05), PetCO(2) was not elevated when PCO2 changes were minimal. Alterations in PO2 were not specific and our clinical impression was that they were related to unmeasured parameters. Conclusion: Our findings suggest that the fall in pH and the elevation in PCO2 which occur during rapid transfusion of packed red cells may go undetected or be misinterpreted if the acid-base status of the recipient is not monitored continously. These alterations are mainly of metabolic character and depend on the amount and age of the transfused component. Our data suggest that arterial sampling is essential during massive transfusions. Copyright (C) 2000 S. Karger AG, Basel.
C1 G Gennimatas Hosp, Dept Anaesthesiol, Salonika, Greece.
   Aristotelian Univ Salonika, Surg Clin 2, GR-54006 Salonika, Greece.
   Univ Ioannina, Anaesthesiol Clin, GR-45110 Ioannina, Greece.
RP Papaziogas, B (reprint author), Tsimiski St 128, GR-54621 Salonika, Greece.
CR GOOD M, 1990, ANESTHESIOLOGY REFRE
   Ishikawa S, 1998, CAN J ANAESTH, V45, P273, DOI 10.1007/BF03012916
   Miller R., 1986, ANESTHESIA
   Nose Y, 1996, J PAEDIATR CHILD H, V32, P177, DOI 10.1111/j.1440-1754.1996.tb00918.x
   Oropello JM, 1996, CHEST, V109, P1049, DOI 10.1378/chest.109.4.1049
   PALMER TEA, 1995, ANAESTH INTENS CARE, V23, P200
   PENG K, 1994, CHUN HUA HSUEH TSA C, V54, P73
   Roupie EE, 1996, INTENS CARE MED, V22, P1162, DOI 10.1007/BF01709330
   STOCKWELL MA, 1989, ANAESTH INTENS CARE, V17, P482
   VENKATESH B, 1995, RESUSCITATION, V29, P135, DOI 10.1016/0300-9572(95)00834-G
   VENKATESH B, 1994, CRIT CARE MED, V22, P588, DOI 10.1097/00003246-199404000-00013
   VLAHAKES GJ, 1990, J THORAC CARDIOV SUR, V100, P379
   WILSON RF, 1992, AM SURGEON, V58, P535
   Zollinger A, 1997, BRIT J ANAESTH, V79, P47
NR 14
TC 2
Z9 2
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0042-9007
J9 VOX SANG
JI Vox Sang.
PY 2000
VL 78
IS 3
BP 158
EP 163
PG 6
WC Hematology
SC Hematology
GA 314EV
UT WOS:000087043100004
PM 10838516
DA 2018-10-20
ER

PT S
AU Lai, B
   Kemner, KM
   Maser, J
   Schneegurt, MA
   Cai, Z
   Ilinski, PP
   Kulpa, CF
   Legnini, DG
   Nealson, KH
   Pratt, ST
   Rodrigues, W
   Tischler, ML
   Yun, W
AF Lai, B
   Kemner, KM
   Maser, J
   Schneegurt, MA
   Cai, Z
   Ilinski, PP
   Kulpa, CF
   Legnini, DG
   Nealson, KH
   Pratt, ST
   Rodrigues, W
   Tischler, ML
   Yun, W
BE Dunford, RW
   Gemmell, DS
   Kanter, EP
   Krassig, B
   Southworth, SH
   Young, L
TI High-resolution x-ray imaging for microbiology at the Advanced Photon
   Source
SO X-RAY AND INNER-SHELL PROCESSES
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT 18th International Conference on X-ray and Inner-Shell Processes
CY AUG 23-27, 1999
CL CHICAGO, IL
SP Argonne Natl Lab, Natl Sci Fdn, Int Union Pure & Appl Phys, Roper Scientific
AB Exciting new applications of high-resolution x-ray imaging have emerged recently due to major advances in high-brilliance synchrotron sources and high-performance zone plate optics. Imaging with submicron resolution is now routine with hard x-rays: we have demonstrated 150 nm in the 6-10 keV range with x-ray microscopes at the Advanced Photon Source (APS), a third-generation synchrotron radiation facility. This has fueled interest in using x-ray imaging in applications ranging from the biomedical, environmental, and materials science fields to the microelectronics industry.
   One important application we have pursued at the APS is a study of the microbiology of bacteria and their associated extracellular material (biofilms) using fluorescence microanalysis. No microscopy techniques were previously available with sufficient resolution to study live bacteria (approximate to 1 mu m x 4 mu m in size) and biofilms in their natural hydrated state with better than part-per-million elemental sensitivity and the capability of determining chemical speciation, In vivo x-ray imaging minimizes artifacts due to sample fixation, drying, and staining. This provides key insights into the transport of metal contaminants by bacteria in the environment and potential new designs for remediation and sequestration strategies.
C1 Argonne Natl Lab, Argonne, IL 60439 USA.
RP Lai, B (reprint author), Argonne Natl Lab, 9700 S Cass Ave, Argonne, IL 60439 USA.
RI Maser, Jorg/K-6817-2013
CR ENG PJ, 1998, SPIE P, V3449, P145
   LAI B, 1992, APPL PHYS LETT, V61, P1877, DOI 10.1063/1.108400
   MACDOWELL A, 1998, SPIE P, V3449, P137
   Yun W, 1998, J SYNCHROTRON RADIAT, V5, P1390, DOI 10.1107/S0909049598007225
   Yun W, 1999, REV SCI INSTRUM, V70, P2238, DOI 10.1063/1.1149744
   1995, MOL ENV SCI SPECIATI
NR 6
TC 3
Z9 3
U1 0
U2 3
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 1-56396-713-8
J9 AIP CONF PROC
PY 2000
VL 506
BP 585
EP 589
PG 5
WC Physics, Atomic, Molecular & Chemical; Spectroscopy
SC Physics; Spectroscopy
GA BP76A
UT WOS:000086079900045
DA 2018-10-20
ER

PT J
AU Werner, C
   Konig, U
   Augsburg, A
   Arnhold, C
   Korber, H
   Zimmermann, R
   Jacobasch, HJ
AF Werner, C
   Konig, U
   Augsburg, A
   Arnhold, C
   Korber, H
   Zimmermann, R
   Jacobasch, HJ
TI Electrokinetic surface characterization of biomedical polymers - a
   survey
SO COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
LA English
DT Article; Proceedings Paper
CT Conference on Electrokinetic Phenomena
CY APR 14-17, 1998
CL SLAZBURG, AUSTRIA
SP Minist Sci & Transport, Salzburg, Reg & City, A Paar, BASF, Lenzing, Pall, Zumtobel, OMV
DE streaming potential measurements; biomedical polymers; blood
   compatibility; protein adsorption; surface conductivity
ID STREAMING POTENTIAL MEASUREMENTS; ADSORPTION; MEMBRANES; HEMODIALYSIS;
   KINETICS
AB The application of streaming potential measurements in support of the development of blood compatible polymers is reviewed. Current knowledge about the relevance of interfacial charge of materials with respect to thrombogenicity of and coagulation activation by medical devices is discussed.
   Potentialities of streaming potential measurements for the characterization of biomedical polymers comprise the distinction:between interfacial charge formation processes, the derivation of acid-base characteristics of surface functions, and the estimation of the relative contribution of known molecular surface sites to the interfacial charge density. Frequently, polymer surfaces consist of different types of surface sites. Beyond sites with Bronsted-acidic or -basic character the preferential adsorption of electrolyte ions onto indifferent surface sites may substantially contribute to the interfacial charge. Examples are given for the detection of acidic and basic properties of hemodialysis membranes of different shape made of poly(sulfone)/poly(vinylpyrrolidone) and cellulose derivates. For partially amine-modified cellulose flat membranes the percentage of basic surface sites is derived from the shift of the isoelectric paint.
   Further, the use of streaming potential measurements is demonstrated in the optimization of surface modifications of cardiovascular implant materials by low pressure plasma treatments. The introduction of basic groups into the poly(tetrafluoroethylene) implant surfaces by ammonia plasma treatments manifests itself in the shift of the isoelectric point.
   A correlation between hydrophobicity and charge formation of the polymer-solution interface by preferential ion adsorption is confirmed for polymers without dissociating functions. This is based on the comparison of water contact angles for a series of poly(styrene) derivates of different hydrophobicity and the maximum zeta potential of these polymer films in potassium hydroxide solutions.
   Advanced applications of streaming potential measurements for the characterization of biomedical polymers are comprise the:in situ characterization of protein adsorption processes onto polymer solids. This approach is demonstrated for the adsorption of the blood plasma proteins albumin and fibrinogen onto a fluorocarbon polymer substrate.
   The potentialities of a recently developed microslit electrokinetic setup are illustrated which permits to study simultaneously zeta potential and surface conductivity of flat polymer-liquid interfaces. Data gained by the microslit electrokinetic setup reveal the dramatic increase of the surface conductivity of a fluorocarbon polymer-solution interface caused by fibrinogen adsorption. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Inst Polymerforsch Dresden eV, D-01069 Dresden, Germany.
RP Werner, C (reprint author), Inst Polymerforsch Dresden eV, Hohe Str 6, D-01069 Dresden, Germany.
RI Werner, Carsten/F-8127-2010; Umlauf, Ursula/D-3356-2014
OI Werner, Carsten/0000-0003-0189-3448; 
CR Andrade J.D., 1985, SURFACE INTERFACIAL, V1, P1985
   AUGSBURG A, 1998, IN PRESS ACTA POLYM
   BALDAMUS CA, 1990, IMPROVEMENT HEMODIAL
   BAMFORD CH, 1992, VROMAN EFFECT
   BARTHEL M, 1997, GERINNUNGSANALYSEN
   BAUMANN H, 1991, J MEMBRANE SCI, V61, P53
   BONOMI V, 1995, DIALYSIS MEMBRANES S
   Charef S, 1996, BIOMATERIALS, V17, P903, DOI 10.1016/0142-9612(96)83286-8
   CHENOWETH DE, 1987, ARTIF ORGANS, V11, P155, DOI 10.1111/j.1525-1594.1987.tb02649.x
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   Dukhin S. S., 1974, SURF COLLOID SCI, V7
   ELGERSMA AV, 1992, COLLOID SURFACE, V65, P17, DOI 10.1016/0166-6622(92)80171-W
   FUERSTENAU DW, 1956, J PHYS CHEM-US, V60, P981, DOI 10.1021/j150541a039
   GALLIN JL, 1992, INFLAMMATION, pCH6
   GRIEP MA, 1986, BIOCHEMISTRY-US, V25, P6688, DOI 10.1021/bi00369a054
   HEALY TW, 1978, ADV COLLOID INTERFAC, V9, P303, DOI 10.1016/0001-8686(78)85002-7
   HINKE E, 1991, J APPL POLYM SCI, V42, P2951, DOI 10.1002/app.1991.070421112
   HUNTER RJ, 1981, ZETA POTENTIAL COLLO, pCH4
   HUNTER RJ, 1981, ZETA POTENTIAL COLLO, pCH7
   Ivanov VB, 1996, SURF INTERFACE ANAL, V24, P257, DOI 10.1002/(SICI)1096-9918(199604)24:4<257::AID-SIA107>3.0.CO;2-1
   Jacobasch H.-J., 1988, PROG COLLOID POLYM S, V77, P40
   Jacobasch H.-J., 1984, OBERFLACHENCHEMIE FA
   JACOBASCH HJ, 1985, COLLOID POLYM SCI, V263, P3, DOI 10.1007/BF01411243
   KONIG U, 1998, UNPUB BIOMATERIALS
   KORBER H, 1993, Patent No. 43312101
   KUEHN N, 1986, ACTA POLYM, V37, P394, DOI 10.1002/actp.1986.010370617
   LANE DA, 1994, NEPHROL DIAL TRANSPL, V9, P18
   LaPorte R J, 1997, HYDROPHILIC POLYM CO
   LYKLEMA J, 1995, FUNDAMENTALS INTERFA, V2, pCH6
   NORDE W, 1990, J COLLOID INTERF SCI, V139, P169, DOI 10.1016/0021-9797(90)90454-V
   NORDE W, 1989, COLLOIDS SURFACE, V41, P1
   NYSTROM M, 1994, J MEMBRANE SCI, V87, P245, DOI 10.1016/0376-7388(94)87031-4
   PEPPAS N, 1995, SCIENCE, V263, P1715
   Put A. V. D., 1983, J COLLOID INTERF SCI, V92, P499
   RAGALLER M, 1998, KIDNEY INT, V53, P84
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Sabbatini L., 1993, SURFACE CHARACTERIZA
   SCHAEFER RM, 1987, BLOOD PURIFICAT, V5, P262, DOI 10.1159/000169475
   SCHULTZE G, 1986, BIOMAT MED EV ARTIF, V15, P195
   Stern O, 1924, Z ELKTROCHEM ANGEW P, V30, P508
   SZYCHER M, 1991, HIGH PERFORMANCE BIO, pCH31
   Tsuruta T., 1993, BIOMEDICAL APPL POLY
   VANDENHOVEN TJJ, 1987, COLLOID SURFACE, V22, P187
   VANWAGENEN RA, 1980, J COLLOID INTERF SCI, V76, P305, DOI 10.1016/0021-9797(80)90374-4
   Vickerman J. C., 1996, SURFACE ANAL TECHNIQ
   VIENKEN J, 1995, ARTIF ORGANS, V19, P398, DOI 10.1111/j.1525-1594.1995.tb02349.x
   WACHTFOGEL YT, 1993, THROMB RES, V72, P1, DOI 10.1016/0049-3848(93)90168-N
   Weidenhammer P., 1996, POLYM PREPR AM CHEM, V37, P614
   Werner C, 1996, MACROMOL SYMP, V103, P43, DOI 10.1002/masy.19961030107
   Werner C, 1998, J COLLOID INTERF SCI, V208, P329, DOI 10.1006/jcis.1998.5787
   WERNER C, 1995, J BIOMAT SCI-POLYM E, V7, P61, DOI 10.1163/156856295X00832
   WERNER C, 1997, INT J ARTIF ORGANS, V20, P505
   ZEMBALA M, 1994, COLLOID SURFACE B, V3, P119
NR 53
TC 86
Z9 87
U1 2
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7757
J9 COLLOID SURFACE A
JI Colloid Surf. A-Physicochem. Eng. Asp.
PD DEC 5
PY 1999
VL 159
IS 2-3
BP 519
EP 529
DI 10.1016/S0927-7757(99)00290-3
PG 11
WC Chemistry, Physical
SC Chemistry
GA 260ZV
UT WOS:000083984100033
DA 2018-10-20
ER

PT J
AU Colombo, P
AF Colombo, P
TI Novel processing of silicon oxycarbide ceramic foams
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID PRECERAMIC POLYMER; POROUS CERAMICS; GLASSES
AB Cellular ceramics are the material of choice in various high temperature technological applications and new applications are now being found in the electronic and biomedical area. Paolo Colombo here describes a new direct foaming approach that allows the production of SiOC foams in a one-step process. Additionally, a great versatility in terms of foam morphology and possible shapes enables the synthesis of materials with tailored composition and properties.
C1 Univ Bologna, Dipartimento Chim Applicata & Sci Mat, I-40136 Bologna, Italy.
RP Colombo, P (reprint author), Univ Bologna, Dipartimento Chim Applicata & Sci Mat, V Risorgimento 2, I-40136 Bologna, Italy.
CR ASHBY MF, 1983, METALL TRANS A, V14, P1755, DOI 10.1007/BF02645546
   Colombo P, 1999, J SOL-GEL SCI TECHN, V14, P103, DOI 10.1023/A:1008736100788
   Colombo P, 1999, J AM CERAM SOC, V82, P573, DOI 10.1111/j.1151-2916.1999.tb01803.x
   FUJIU T, 1990, J AM CERAM SOC, V73, P85, DOI 10.1111/j.1151-2916.1990.tb05095.x
   MINNEAR WP, 1992, CERAMICS T, V26, P149
   Montanaro L, 1998, J EUR CERAM SOC, V18, P1339, DOI 10.1016/S0955-2219(98)00063-6
   Nettleship I, 1996, KEY ENG MATER, V122-1, P305, DOI 10.4028/www.scientific.net/KEM.122-124.305
   Pantano CG, 1999, J SOL-GEL SCI TECHN, V14, P7, DOI 10.1023/A:1008765829012
   RENLUND GM, 1991, J MATER RES, V6, P2723, DOI 10.1557/JMR.1991.2723
   SAGGIOWOYANSKY J, 1992, AM CERAM SOC BULL, V71, P1674
   Sepulveda P, 1997, AM CERAM SOC BULL, V76, P61
   SHERMAN AJ, 1991, AM CERAM SOC BULL, V70, P1025
   Tulliani JM, 1999, J AM CERAM SOC, V82, P961, DOI 10.1111/j.1151-2916.1999.tb01860.x
NR 13
TC 10
Z9 11
U1 1
U2 5
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD DEC
PY 1999
VL 1
IS 3-4
BP 203
EP 205
DI 10.1002/(SICI)1527-2648(199912)1:3/4<203::AID-ADEM203>3.0.CO;2-M
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA 357JM
UT WOS:000089494800019
DA 2018-10-20
ER

PT J
AU Zheng, YP
   Maev, RG
   Solodov, IY
AF Zheng, YP
   Maev, RG
   Solodov, IY
TI Nonlinear acoustic applications for material characterization: A review
SO CANADIAN JOURNAL OF PHYSICS
LA English
DT Review
ID DIAGNOSTIC MEDICAL ULTRASOUND; ZIRCONATE-TITANATE CERAMICS; HIGHER-ORDER
   NONLINEARITY; PULSED WAVE-PROPAGATION; HARMONIC-GENERATION; BIOLOGICAL
   MEDIA; 2ND-HARMONIC GENERATION; BIOMEDICAL FREQUENCIES; CONTACT
   INTERFACE; PRESSURE FIELD
AB The nonlinear acoustic applications for material characterization are reviewed. The general theoretical analysis of the effects of nonlinearity, dissipation, dispersion, and diffraction on intense acoustic-wave propagation is given. Acoustic nonlinear parameters and their determination methods are introduced. The investigations of nonlinear acoustic applications for solid material evaluation are discussed for different levels of disruption, from asymmetry of lattice structure and dislocation in crystals to disbonds and cracks in engineering materials. The experimental methods involved in these investigations are also considered. The techniques used for nonlinear acoustic imaging are divided into two categories, concerned with resolution improvement by using higher harmonics, and nonlinear parametric imaging. The nonlinear acoustic applications in biomedical imaging, acoustic microscopy, and nonlinear nondestructive evaluation are presented. Finally, the issues that need further investigations in this area are discussed.
C1 Univ Windsor, Dept Phys, Ultrason Res Lab, Windsor, ON N9B 3P4, Canada.
   Moscow MV Lomonosov State Univ, Dept Phys, Moscow 119899, Russia.
RP Maev, RG (reprint author), Univ Windsor, Dept Phys, Ultrason Res Lab, Windsor, ON N9B 3P4, Canada.
RI CHEN, Jiangang/A-1549-2011
OI Zheng, Yong-Ping/0000-0002-3407-9226; Solodov, Igor/0000-0002-1361-9780
CR AANONSEN SI, 1984, J ACOUST SOC AM, V75, P749, DOI 10.1121/1.390585
   Achenbach J. D., 1982, J NONDESTRUCT EVAL, V3, P229
   Adler L, 1995, P SOC PHOTO-OPT INS, V2643, P228, DOI 10.1117/12.222748
   ALLISON SG, 1984, P IEEE ULTR S NEW HO, P997
   ARMYAKOV DV, 1998, DEFEKTOSKOPIYA, V12, P34
   ASAINOV AF, 1992, SOV PHYS ACOUST+, V38, P293
   ASAINOV AF, 1993, ACOUST PHYS+, V39, P311
   Baker AC, 1996, J ACOUST SOC AM, V100, P2062, DOI 10.1121/1.417916
   BAKER AC, 1991, PHYS MED BIOL, V36, P1457, DOI 10.1088/0031-9155/36/11/005
   BAKER AC, 1995, J ACOUST SOC AM, V97, P3510, DOI 10.1121/1.412437
   BAKER AC, 1992, J ACOUST SOC AM, V91, P713, DOI 10.1121/1.402533
   BATEMAN T, 1961, J APPL PHYS, V32, P928, DOI 10.1063/1.1736135
   BEYER RT, 1960, J ACOUST SOC AM, V32, P719, DOI 10.1121/1.1908195
   BIRCH F, 1966, HDB PHYSICAL CONSTAN, P97
   BOINOTT GN, 1993, LAUR933839 LOS AL NA, P121
   BREAZEAL.MA, 1965, J APPL PHYS, V36, P3486, DOI 10.1063/1.1703023
   Breazeale M. A., 1981, METHODS EXPT PHYSICS, V19, P67
   BREAZEALE MA, 1963, APPL PHYS LETT, V3, P77, DOI 10.1063/1.1753876
   BRIGGS A., 1992, ACOUSTIC MICROSCOPY
   BRYSEV AP, 1984, FIZ TVERD TELA+, V26, P2104
   BUCK O, 1978, APPL PHYS LETT, V33, P371, DOI 10.1063/1.90399
   BUCK O, 1979, PHYS STATUS SOLIDI A, V55, P223, DOI 10.1002/pssa.2210550125
   CAIN CA, 1986, J ACOUST SOC AM, V80, P28, DOI 10.1121/1.394186
   CANTRELL JH, 1994, PHILOS MAG A, V69, P315, DOI 10.1080/01418619408244346
   Cantrell JH, 1997, J APPL PHYS, V81, P2957, DOI 10.1063/1.364327
   CANTRELL JH, 1994, J APPL PHYS, V76, P3372, DOI 10.1063/1.357463
   CANTRELL JH, 1991, INT MATER REV, V36, P125, DOI 10.1179/imr.1991.36.1.125
   Cantrell JH, 1998, J APPL PHYS, V84, P5469, DOI 10.1063/1.368309
   CANTRELL JH, 1986, P IEEE ULTRASONICS S, P1075
   CARSTENSEN EL, 1980, ULTRASOUND MED BIOL, V6, P359, DOI 10.1016/0301-5629(80)90005-8
   CERVENKA P, 1990, J ACOUST SOC AM, V88, P473, DOI 10.1121/1.399926
   COOK BD, 1961, J ACOUST SOC AM, V33, P832, DOI 10.1121/1.1936786
   DACE GE, 1992, VIBROACOUSTIC CHARAC, V14, P221
   DARVENNES CM, 1990, J ACOUST SOC AM, V87, P1955, DOI 10.1121/1.399322
   DARVENNES CM, 1991, J ACOUST SOC AM, V89, P1028, DOI 10.1121/1.400645
   DU GH, 1987, J ACOUST SOC AM, V81, P51, DOI 10.1121/1.394932
   DU GH, 1986, J ACOUST SOC AM, V80, P212, DOI 10.1121/1.394166
   ERMILIN KK, 1974, PHYS MAT, V38, P880
   Fassbender SU, 1996, MATER SCI FORUM, V210-2, P783, DOI 10.4028/www.scientific.net/MSF.210-213.783
   Field EH, 1997, NATURE, V390, P599, DOI 10.1038/37586
   GARRETT GS, 1983, J ACOUST SOC AM, V74, P1013, DOI 10.1121/1.389933
   GEDROITS AA, 1963, DOKL AKAD NAUK SSSR+, V150, P515
   GEDROITS AA, 1963, SOV PHYS JETP-USSR, V16, P1122
   GERLICH D, 1988, J APPL PHYS, V63, P5712, DOI 10.1063/1.340308
   GERMAIN L, 1989, J ACOUST SOC AM, V86, P1560, DOI 10.1121/1.398716
   GERMAIN L, 1988, J ACOUST SOC AM, V83, P942, DOI 10.1121/1.395971
   GONG XF, 1989, J ACOUST SOC AM, V86, P1, DOI 10.1121/1.398326
   GRELSSON B, 1989, REV PROGR QUANTITATI, V9, P1441
   GUSEV VE, 1993, LASER ACOUSTICS
   Guyer RA, 1998, GEOPHYS RES LETT, V25, P1585, DOI 10.1029/98GL51231
   GUYER RA, 1995, PHYS REV LETT, V74, P3491, DOI 10.1103/PhysRevLett.74.3491
   HADIMIOGLU B, 1983, APPL PHYS LETT, V43, P1006, DOI 10.1063/1.94223
   HAMILTON MF, 1985, J ACOUST SOC AM, V78, P202, DOI 10.1121/1.392560
   HEYMAN JS, 1983, P S NDE APPL MAT PRO, P177
   HIKATA A, 1963, APPL PHYS LETT, V3, P195, DOI 10.1063/1.1753845
   HIROSE S, 1993, J ACOUST SOC AM, V93, P142, DOI 10.1121/1.405651
   HOLCOMB DJ, 1981, J GEOPHYS RES, V86, P6235, DOI 10.1029/JB086iB07p06235
   HUGHES DS, 1953, PHYS REV, V92, P1145, DOI 10.1103/PhysRev.92.1145
   Hurley DC, 1997, REV PROG Q, V16, P1383
   ICHIDA N, 1984, IEEE T SON ULTRASON, V31, P635, DOI 10.1109/T-SU.1984.31548
   ICHIDA N, 1983, ULTRASONIC IMAGING, V5, P295, DOI 10.1177/016173468300500401
   JIA X, 1993, APPL PHYS LETT, V63, P2192, DOI 10.1063/1.110550
   JOHNSON PA, 1991, J ACOUST SOC AM, V89, P598, DOI 10.1121/1.400384
   Johnson PA, 1996, J GEOPHYS RES-SOL EA, V101, P11553, DOI 10.1029/96JB00647
   KARAKI K, 1990, PHYSICA B, V165, P131
   KARAKI K, 1991, APPL PHYS LETT, V59, P909
   Kino G. S., 1980, Journal of Nondestructive Evaluation, V1, P67, DOI 10.1007/BF00566232
   KOMPFNER R, 1976, APPL PHYS LETT, V28, P295, DOI 10.1063/1.88759
   Korotkov A. S., 1994, AKUST ZH, V40, P84
   KOROTKOV AS, 1994, ACOUSTICS LETT, V18, P59
   Kuznetsov V. P., 1970, SOV PHYS ACOUST+, V16, P467
   LANDAU L, 1986, THEORY ELASTICITY
   LAW WK, 1985, ULTRASOUND MED BIOL, V11, P307, DOI 10.1016/0301-5629(85)90130-9
   LEN KS, 1991, SOV PHYS ACOUST+, V37, P610
   LEN KS, 1993, ACOUST PHYS+, V39, P149
   LEN KS, 1993, THESIS MOSCOW STATE
   LEN KS, 1994, ACAD SCI DPR KOREA, V3, P29
   LEVIN VM, 1991, ACOUST IMAGING, V19, P651
   Lyamov V. E., 1983, POLARIZATION EFFECTS
   MAEV RG, 1999, ABSTRACTS REV PROGR, P46
   MAEV RG, 1995, ACOUST IMAGING, V22, P323
   MAEV RG, 1995, ACOUST IMAGING, V22, P779
   MAEV RG, 1998, P IEEE ULTR S SEND J, V1, P707
   MAO YW, 1989, APPL PHYS LETT, V55, P2394, DOI 10.1063/1.102026
   MAYERGOYZ ID, 1985, J APPL PHYS, V57, P3803, DOI 10.1063/1.334925
   McCall K., 1996, NONLINEAR PROC GEOPH, V3, P89
   MCCALL KR, 1994, J GEOPHYS RES-SOL EA, V99, P23887, DOI 10.1029/94JB01941
   MEEGAN GD, 1993, J ACOUST SOC AM, V94, P3387, DOI 10.1121/1.407191
   MELNGAILIS J, 1963, PHYS REV, V131, P172
   MOREAU A, 1995, J ACOUST SOC AM, V98, P2745, DOI 10.1121/1.413240
   MORRIS WL, 1979, J APPL PHYS, V50, P6737, DOI 10.1063/1.325917
   MUIR TG, 1980, ULTRASOUND MED BIOL, V6, P345, DOI 10.1016/0301-5629(80)90004-6
   NA JK, 1994, J ACOUST SOC AM, V95, P3213, DOI 10.1121/1.409985
   Na JK, 1996, REV PROG Q, V15, P1347
   Nagy PB, 1998, ULTRASONICS, V36, P375, DOI 10.1016/S0041-624X(97)00040-1
   NAKAGAWA Y, 1984, P IEEE ULTR S, P673
   NAMKUNG M, 1985, REV PROGR QUANTITA B, V5, P1481
   NAZAROV VE, 1991, AKUST ZH, V37, P150
   OSTROVSKY LA, 1991, J ACOUST SOC AM, V90, P3332, DOI 10.1121/1.401444
   Papadakis E.P., 1976, PHYS ACOUSTICS, V12, P277
   PETERS RD, 1968, APPL PHYS LETT, V12, P106, DOI 10.1063/1.1651894
   PODGORNOV AA, 1984, THESIS MOSCOW STATE
   Preisach F, 1935, Z PHYS, V94, P277, DOI 10.1007/BF01349418
   RAO RR, 1980, PHYS STATUS SOLIDI A, V58, P11, DOI 10.1002/pssa.2210580102
   RAZVI S, 1987, REV PROGR QUANTITA B, V6, P1403
   RICHARDSON JM, 1979, INT J ENG SCI, V17, P73, DOI 10.1016/0020-7225(79)90008-9
   RUDENKO OV, 1993, VESTN MOSK U FIZ AS+, V34, P94
   RUGAR D, 1984, J APPL PHYS, V56, P1338, DOI 10.1063/1.334124
   SALAMA K, 1980, J APPL PHYS, V51, P1505, DOI 10.1063/1.327800
   SATO T, 1992, ACOUST IMAG, V19, P363
   SATO T, 1985, ULTRASONIC IMAGING, V7, P49, DOI 10.1016/0161-7346(85)90015-X
   SCHNEIDER E, 1984, P IEEE ULTR S NEW YO, P944
   SEVERIN FM, 1988, VESTN MOSK U FIZ AS+, V29, P84
   SEVERIN FM, 1988, VESTN MOSK U FIZ AS+, V29, P94
   SEVERIN FM, 1990, THESIS MOSCOW STATE
   SEVERIN FM, 1999, VESTNIK MOSKOVSKOGO, V40, P34
   SEVERIN FM, 1999, REV PROGR QUANTITATI, P230
   SHAUN CT, 1993, J ACOUST SOC AM, V93, P148
   SHUI YG, 1988, J APPL PHYS, V64, P6155, DOI 10.1063/1.342120
   SOLODOV IY, 1993, ULTRASONICS, V31, P91, DOI 10.1016/0041-624X(93)90038-2
   Solodov IY, 1996, NON DESTRUCTIVE TESTING, P73
   SOLODOV IY, 1988, J APPL PHYS, V64, P2901, DOI 10.1063/1.341574
   SOLODOV IY, 1993, ACOUST PHYS+, V39, P476
   STARRITT HC, 1986, PHYS MED BIOL, V31, P1401, DOI 10.1088/0031-9155/31/12/007
   TAN MRT, 1985, J APPL PHYS, V57, P4931, DOI 10.1063/1.335317
   TenCate JA, 1996, J ACOUST SOC AM, V100, P1383, DOI 10.1121/1.415985
   Thompson R. B., 1984, Review of Progress in Quantitative Nondestructive Evaluation. Vol.3. Proceedings of the Tenth Annual Review, P207
   THOMPSON RB, 1984, NONDESTRUCTIVE METHO, P161
   THURSTON RN, 1967, J ACOUST SOC AM, V41, P1112, DOI 10.1121/1.1910443
   TIOTTA JN, 1988, J ACOUST SOC AM, V83, P487, DOI 10.1121/1.396143
   TJOTTA JN, 1981, J ACOUST SOC AM, V69, P1644, DOI 10.1121/1.385942
   TREBITS RN, 1972, THESIS GEORGIA I TEC
   Truell R., 1969, ULTRASONIC METHODS S
   Uhlendorf V, 1996, ACOUST IMAG, V22, P233
   VandenAbeele K, 1996, J ACOUST SOC AM, V99, P1430, DOI 10.1121/1.414722
   VandenAbeele KEA, 1997, J ACOUST SOC AM, V101, P1885, DOI 10.1121/1.418198
   VandenAbeele KEA, 1996, J ACOUST SOC AM, V99, P3346, DOI 10.1121/1.414891
   VandenAbeele KEA, 1996, J ACOUST SOC AM, V99, P3334, DOI 10.1121/1.414890
   VELLA PJ, 1974, J APPL PHYS, V45, P1993, DOI 10.1063/1.1663536
   Ward B, 1997, J ACOUST SOC AM, V101, P143, DOI 10.1121/1.417977
   WESTERVELT PJ, 1963, J ACOUST SOC AM, V35, P535, DOI 10.1121/1.1918525
   WICKRAMASINGHE HK, 1977, J APPL PHYS, V48, P4951, DOI 10.1063/1.323624
   Yakovkin I. B., 1979, LIGHT DIFFRACTION SU
   YOST WT, 1981, J APPL PHYS, V52, P126, DOI 10.1063/1.328443
   ZABOLOTSKAYA EA, 1969, SOV PHYS ACOUST+, V15, P35
   Zarembo L.K., 1966, Akusticheskii Zhurnal, V12, P486
   ZHOU SQ, 1995, J APPL PHYS, V78, P39, DOI 10.1063/1.360615
NR 147
TC 127
Z9 132
U1 2
U2 36
PU NATL RESEARCH COUNCIL CANADA
PI OTTAWA
PA RESEARCH JOURNALS, MONTREAL RD, OTTAWA, ONTARIO K1A 0R6, CANADA
SN 0008-4204
J9 CAN J PHYS
JI Can. J. Phys.
PD DEC
PY 1999
VL 77
IS 12
BP 927
EP 967
DI 10.1139/cjp-77-12-927
PG 41
WC Physics, Multidisciplinary
SC Physics
GA 305JY
UT WOS:000086537400001
DA 2018-10-20
ER

PT J
AU Mitura, S
   Mitura, A
   Niedzielski, P
   Couvrat, P
AF Mitura, S
   Mitura, A
   Niedzielski, P
   Couvrat, P
TI Nanocrystalline diamond coatings
SO CHAOS SOLITONS & FRACTALS
LA English
DT Article
ID RF DENSE-PLASMA; CARBON COATINGS; BIOMEDICAL APPLICATIONS; FILMS; STEEL;
   CVD
AB Carbon-in the form of diamond coatings (nanocrystalline diamond-NCD) on suitable substrates-has attractive properties for biomedical applications. The excellent chemical inertness of NCD films makes them a promising material for medical implants, cardiovascular surgery and for coating of certain components of artificial heart valves.
   The medical applications of carbon films impose some special requirements on their quality, purity, phase content and the state of the surface. Of particular importance is the smoothness of the surface and good adhesion of the coatings to the substrate. We have investigated carbon films which were synthesized by Radio Frequency Plasma Chemical Vapour Deposition (RF-PCVD).
   The specimens obtained have been rested to show their structure and their biological, mechanical and chemical resistance. Additional investigations of the NCD films were carried out by micro-X-ray spectroscopy, Raman spectroscopy, AFM, Auger spectroscopy, corrosion tests, breakdown tests and clinical investigations. Nanocrystalline diamond (NCD) layers obtained by a new method of RF dense plasma CVD onto AISI-316L steel used in surgery were investigated to determine their suitability as biomaterials. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.
C1 Lodz Tech Univ, Inst Mat Sci & Engn, Div Thin Films, PL-90924 Lodz, Poland.
   Univ London Imperial Coll Sci Technol & Med, Blackett Lab, HEP Diamond Grp, London SW7 2BZ, England.
   Ecole Catholique Arts & Metiers, F-69321 Lyon, France.
RP Mitura, S (reprint author), Lodz Tech Univ, Inst Mat Sci & Engn, Div Thin Films, Stefanowskiegol 15, PL-90924 Lodz, Poland.
RI Mitura, Stanislaw/L-6013-2014; Karczemska, Anna/D-4893-2015
OI Mitura, Stanislaw/0000-0001-9280-3748; Karczemska,
   Anna/0000-0003-4635-8019; Niedzielski, Piotr/0000-0002-6966-9154
CR BUTTER R, 1995, DIAM RELAT MATER, V4, P857, DOI 10.1016/0925-9635(94)05280-8
   CHANDRA L, 1994, DIAM RELAT MATER, V4, P852
   CHUAN CC, 1974, CHARACTERIZATION SOL, P535
   COUVRAT P, 1995, DIAM RELAT MATER, V4, P1251, DOI 10.1016/0925-9635(95)00307-X
   Davis L. E., 1976, HDB AUGER ELECT SPEC
   DUSEK V, 1993, DIAM RELAT MATER, V2, P397, DOI 10.1016/0925-9635(93)90090-O
   Glozman O, 1997, DIAM RELAT MATER, V6, P796, DOI 10.1016/S0925-9635(96)00671-1
   GRANT DM, 1992, DIAM RELAT MATER, V1, P727, DOI 10.1016/0925-9635(92)90198-W
   LETTINGTON AH, 1992, DIAM RELAT MATER, V1, P805, DOI 10.1016/0925-9635(92)90104-V
   MARCINIAK J, 1993, WERKST KORROS, V44, P379
   MERMOUX M, 1996, DIAM RELAT MATER, V1, P798
   MITURA E, 1994, DIAM RELAT MATER, V3, P896, DOI 10.1016/0925-9635(94)90295-X
   MITURA S, 1995, DIAM RELAT MATER, V4, P302, DOI 10.1016/0925-9635(94)05203-4
   MITURA S, 1995, ADV SCI TECHNOLOGY, V6, P273
   NIEDZIELSKI P, 1995, 2 INT C CBN D 95 JAB
   OLBORSKA A, 1994, DIAM RELAT MATER, V3, P899, DOI 10.1016/0925-9635(94)90296-8
NR 16
TC 47
Z9 49
U1 1
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-0779
J9 CHAOS SOLITON FRACT
JI Chaos Solitons Fractals
PD DEC
PY 1999
VL 10
IS 12
BP 2165
EP 2176
DI 10.1016/S0960-0779(98)00251-3
PG 12
WC Mathematics, Interdisciplinary Applications; Physics, Multidisciplinary;
   Physics, Mathematical
SC Mathematics; Physics
GA 228KK
UT WOS:000082135500012
DA 2018-10-20
ER

PT J
AU Hisaka, M
   Sugiura, T
   Kawata, S
AF Hisaka, M
   Sugiura, T
   Kawata, S
TI Ultrasound-assisted optical reflectometry in highly scattering media
SO JAPANESE JOURNAL OF APPLIED PHYSICS PART 2-LETTERS
LA English
DT Article
DE optical reflectometry; scattering media; ultrasound; biomedical optics
ID TURBID MEDIA; TOMOGRAPHY; OBJECTS
AB We have developed an optical reflectometry system to investigate the inside of a scattering medium by using focused ultrasound wave to specify the measuring point. The reflected light is generated by the variation of the refractive indices induced by a focused ultrasound wave, The optical reflectometry technique enables us to observe an internal structure such as a human tissue noninvasively for biomedical applications. We have observed samples which consist of an agarose block with a cubic piece of agarose stained with a dye as an absorptive material, The intensity of the light reflected from the focal region of the ultrasound is decreased when the measuring point was in the stained agarose section because of absorption by the dye. Furthermore, we have observed a sample with a weak scattering object made of agarose surrounded by strong scattering agarose that contains poly(methyl methacrylate) (PMMA) particles.
C1 Osaka Univ, Dept Appl Phys, Suita, Osaka 5650871, Japan.
RP Hisaka, M (reprint author), Osaka Univ, Dept Appl Phys, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
RI Kawata, Satoshi/N-7228-2013
CR BORN M, 1980, PRINCIPLES OPTICS, P593
   Fishkin JB, 1997, APPL OPTICS, V36, P10, DOI 10.1364/AO.36.000010
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   Leveque S, 1999, OPT LETT, V24, P181, DOI 10.1364/OL.24.000181
   Wang LH, 1997, APPL OPTICS, V36, P7277, DOI 10.1364/AO.36.007277
   WANG LH, 1995, OPT LETT, V20, P629, DOI 10.1364/OL.20.000629
NR 6
TC 4
Z9 4
U1 0
U2 0
PU JAPAN J APPLIED PHYSICS
PI MINATO-KU TOKYO
PA DAINI TOYOKAIJI BLDG 24-8 SHINBASHI 4-CHOME, MINATO-KU TOKYO, 105, JAPAN
SN 0021-4922
J9 JPN J APPL PHYS 2
JI Jpn. J. Appl. Phys. Part 2 - Lett.
PD DEC 1
PY 1999
VL 38
IS 12A
BP L1478
EP L1481
DI 10.1143/JJAP.38.L1478
PG 4
WC Physics, Applied
SC Physics
GA 268ZM
UT WOS:000084451100040
DA 2018-10-20
ER

PT J
AU Gordon, MJ
   Chu, KC
   Margaritis, A
   Martin, AJ
   Ethier, CR
   Rutt, BK
AF Gordon, MJ
   Chu, KC
   Margaritis, A
   Martin, AJ
   Ethier, CR
   Rutt, BK
TI Measurement of Gd-DTPA diffusion through PVA hydrogel using a novel
   magnetic resonance imaging method
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE diffusivity; diffusion; Gd-DTPA; polyvinyl alcohol cryogel (PVA-C);
   magnetic resonance (MR) imaging; isoconcentration contour; biomedical;
   biochemical applications
ID POLYVINYL-ALCOHOL GEL; DOSIMETRY GELS; MRI; TRANSPORT
AB Polyvinyl alcohol-cryogel (PVA-C) is a hydrogel that is an excellent tissue mimic. In order to characterize mass transfer in this material, as well as to demonstrate in principle the ability to noninvasively measure solute diffusion in tissue, we measured the diffusion coefficient of the magnetic resonance (MR) contrast agent gadolinium diethylene triaminopentaacetic acid (Gd-DTPA) through PVA-C using a clinical MR imager. The method involved filling thick-walled rectangular PVA-C "cups" with known concentrations of Gd-DTPA solutions. Then by using a fast inversion recovery spin echo MR imaging protocol, a signal "null" contour was created in the MR image that corresponded to a second, known concentration of Gd-DTPA. By collecting a series of MR images through the PVA-C wall as a function of time, the displacement of this second known isoconcentration contour could be tracked. Application of Fick's second law of diffusion yielded the diffusion coefficient. Seven separate experiments were performed using various combinations of initial concentrations of Gd-DTPA within the PVA-C cups (3.2, 25.6, or 125 mM) and tracked isoconcentrations contours (0.096, 0.182, or 0.435 mM Gd-DTPA). The experimental results and the predictions of Fick's law were in excellent agreement. The diffusivity of Gd-DTPA through 10% PVA hydrogel was found to be (2.6 +/- 0.04) x 10(-10) m(2)/s (mean +/- s.e.m.). Separate permeability studies showed that the diffusion coefficient of Gd-DTPA through this hydrogel did not change with an applied pressure of up to 7.1 kPa. Accurate measurements could be made within 30 min if suitable Gd-DTPA concentrations were selected. Due to the excellent repeatability and fast data acquisition time, this technique Is very promising for future in vivo studies of species transport in tissue. (C) 1999 John Wiley & Sons, Inc.
C1 Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
   Univ Western Ontario, Dept Med Biophys, London, ON, Canada.
   Univ Western Ontario, Dept Diagnost Radiol, London, ON, Canada.
   Univ Western Ontario, John P Robarts Res Inst, London, ON, Canada.
RP Margaritis, A (reprint author), Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
OI Margaritis, Argyrios/0000-0003-1838-560X
CR ATALAR E, 1994, IEEE T MED IMAGING, V13, P152, DOI 10.1109/42.276154
   BALCOM BJ, 1995, PHYS MED BIOL, V40, P1665, DOI 10.1088/0031-9155/40/10/008
   BALCOM BJ, 1993, J AM CHEM SOC, V115, P3300, DOI 10.1021/ja00061a031
   Bertsch F, 1998, MAGN RESON IMAGING, V16, P393, DOI 10.1016/S0730-725X(97)00311-1
   Blanch H W, 1996, BIOCH ENG
   BOUCHARD LS, 1998, P CAN ORG MED PHYS, V1, P341
   CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630
   Chu KC, 1997, MAGNET RESON MED, V37, P314, DOI 10.1002/mrm.1910370230
   CRANK J, 1964, MATH DIFFUSION, P12
   Cussler E. L., 1997, DIFFUSION MASS TRANS
   DAVIDSON GS, 1995, AM J NEURORADIOL, V16, P843
   FISCHER AE, 1995, J PHYS D APPL PHYS, V28, P384, DOI 10.1088/0022-3727/28/2/023
   FISCHER AE, 1995, MAGN RESON IMAGING, V13, P819, DOI 10.1016/0730-725X(95)00040-N
   GEANKOPLIS CJ, 1978, TRANSPORT PROCESSES, P291
   HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580
   HENDERSON E, 1999, IN PRESS MAGN RESON, V17
   HONDA Y, 1986, DOC OPHTHALMOL, V63, P205, DOI 10.1007/BF00157132
   KESSLER L, 1992, BIOMATERIALS, V13, P44, DOI 10.1016/0142-9612(92)90094-5
   Kron T, 1997, MAGN RESON IMAGING, V15, P211, DOI 10.1016/S0730-725X(96)00352-9
   LAURENT TC, 1963, BIOCHIM BIOPHYS ACTA, V78, P351, DOI 10.1016/0006-3002(63)91645-7
   Lozinsky VI, 1989, POLYM SCI USSR, V31A, P1983
   MACFALL JR, 1987, MAGN RESON IMAGING, V5, P209, DOI 10.1016/0730-725X(87)90022-1
   MANO I, 1986, MAGNET RESON MED, V3, P921, DOI 10.1002/mrm.1910030612
   MANSFIELD P, 1977, J PHYS C SOLID STATE, V10, pL55, DOI 10.1088/0022-3719/10/3/004
   MARTEN FL, 1997, KIRKOTHMER ENCY CHEM, P980
   MERCHANT FJA, 1987, BIOTECHNOL BIOENG, V30, P936, DOI 10.1002/bit.260300804
   Mori Y, 1997, J MATER SCI, V32, P491, DOI 10.1023/A:1018586307534
   NAGURA M, 1989, POLYMER, V30, P762, DOI 10.1016/0032-3861(89)90169-9
   NAMBU M, 1990, Patent No. 4958626
   Pedersen TV, 1997, PHYS MED BIOL, V42, P1575, DOI 10.1088/0031-9155/42/8/008
   Peppas NA, 1996, MACROMOLECULES, V29, P8798, DOI 10.1021/ma9613392
   PEPPAS NA, 1991, J CONTROL RELEASE, V16, P302
   Pilkington FH, 1998, CRIT REV BIOTECHNOL, V18, P237
   Potter K, 1996, SOLID STATE NUCL MAG, V6, P323, DOI 10.1016/0926-2040(94)00053-0
   Rae WID, 1996, MED PHYS, V23, P15, DOI 10.1118/1.597787
   RATNER BD, 1989, COMPREHENSIVE POLYM, V7, P201
   STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690
   Su MY, 1998, MAGN RESON MED, V39, P259, DOI 10.1002/mrm.1910390213
   SURRY KJM, 1998, P CAN ORG MED PHYS, V1, P145
   TANABE T, 1998, Patent No. 4734097
   TANFORD C, 1965, PHYSICAL CHEM MACROM
   WATASE M, 1983, POLYM COMMUN, V24, P52
   WATLER PK, 1988, BIOMATERIALS, V9, P150, DOI 10.1016/0142-9612(88)90114-7
   WILLARD HH, 1981, INSTRUMENTAL METHODS, P316
   WOOD LL, 1993, Patent No. 5260066
NR 45
TC 36
Z9 36
U1 1
U2 9
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD NOV 20
PY 1999
VL 65
IS 4
BP 459
EP 467
DI 10.1002/(SICI)1097-0290(19991120)65:4<459::AID-BIT10>3.0.CO;2-O
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 244YN
UT WOS:000083078500010
PM 10506421
DA 2018-10-20
ER

PT J
AU Williams, C
   Ponten, F
   Moberg, C
   Soderkvist, P
   Uhlen, M
   Ponten, J
   Sitbon, G
   Lundeberg, J
AF Williams, C
   Ponten, F
   Moberg, C
   Soderkvist, P
   Uhlen, M
   Ponten, J
   Sitbon, G
   Lundeberg, J
TI A high frequency of sequence alterations is due to formalin fixation of
   archival specimens
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID POLYMERASE CHAIN-REACTION; DNA-POLYMERASE; P53 MUTATIONS; PLASMID DNA;
   AMPLIFICATION; FIDELITY; CANCER; KERATINOCYTES; GENE
AB Genomic analysis of archival tissues fixed in formalin Is of fundamental importance in biomedical research, and numerous studies have used such material. Although the possibility of polymerase chain reaction (PCR)-introduced artifacts is known, the use of direct sequencing has been thought to overcome such problems, Here we report the results from a controlled study, performed in parallel on frozen and formalin-fixed material, where a high frequency of nonreproducible sequence alterations was detected with the use of formalin-fixed tissues, Defined numbers of well-characterized tumor cells were amplified and anal);zed by direct DNA sequencing. No nonreproducible sequence alterations were found in frozen tissues. In formalin-fixed material up to one mutation artifact per 500 bases was recorded. The chance of such artificial mutations in formalin-fixed material was inversely correlated with the number of cells used in the PCR-the fewer cells, the more artifacts, A total of 28 artificial mutations were recorded, of which 27 were C-T or G-A transitions. Through confirmational sequencing of independent amplification products artifacts can be distinguished from true mutations, However, because this problem was not acknowledged earlier, the presence of artifacts may have profoundly influenced previously reported mutations in formalin-fixed material, including those inserted into mutation databases.
C1 KTH Royal Inst Technol, Dept Biotechnol, S-10044 Stockholm, Sweden.
   Univ Hosp, Dept Pathol, Uppsala, Sweden.
   Profess Genet Lab AB, Uppsala, Sweden.
   Linkoping Univ, Fac Hlth Sci, Dept Cell Biol, S-58185 Linkoping, Sweden.
RP Lundeberg, J (reprint author), KTH Royal Inst Technol, Dept Biotechnol, Teknikringen 30, S-10044 Stockholm, Sweden.
RI Williams, Cecilia/A-6677-2009
OI Williams, Cecilia/0000-0002-0602-2062
CR BENEZRA J, 1991, J HISTOCHEM CYTOCHEM, V39, P351, DOI 10.1177/39.3.1704393
   BERG C, 1995, CLIN CHEM, V41, P1461
   CHALKLEY R, 1975, P NATL ACAD SCI USA, V72, P1304, DOI 10.1073/pnas.72.4.1304
   Eckert K A, 1991, PCR Methods Appl, V1, P17
   HULTMAN T, 1991, BIOTECHNIQUES, V10, P84
   HULTMAN T, 1989, NUCLEIC ACIDS RES, V17, P4937, DOI 10.1093/nar/17.13.4937
   LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y
   PAABO S, 1990, J BIOL CHEM, V265, P4718
   Ponten F, 1997, ONCOGENE, V15, P1059, DOI 10.1038/sj.onc.1201435
   Ponten F, 1997, MUTAT RES-GENOMICS, V382, P45, DOI 10.1016/S1383-5726(97)00008-3
   Ren ZP, 1996, ONCOGENE, V12, P765
   Ren ZP, 1997, AM J PATHOL, V150, P1791
   TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027
   Williams C, 1998, CANCER RES, V58, P2449
   Yagi N, 1996, BIOTECH HISTOCHEM, V71, P123, DOI 10.3109/10520299609117148
   Yngveson A, 1999, CANCER EPIDEM BIOMAR, V8, P433
NR 16
TC 331
Z9 335
U1 3
U2 7
PU AMER SOC INVESTIGATIVE PATHOLOGY, INC
PI BALTIMORE
PA 428 EAST PRESTON ST, BALTIMORE, MD 21202-3993 USA
SN 0002-9440
J9 AM J PATHOL
JI Am. J. Pathol.
PD NOV
PY 1999
VL 155
IS 5
BP 1467
EP 1471
DI 10.1016/S0002-9440(10)65461-2
PG 5
WC Pathology
SC Pathology
GA 253ZT
UT WOS:000083587600011
PM 10550302
OA Green Published
DA 2018-10-20
ER

PT J
AU Sobel, ME
AF Sobel, ME
TI Ethical issues in molecular pathology - Paradigms in flux
SO ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
LA English
DT Article; Proceedings Paper
CT XXXIV Conference of the College-of-American-Pathologists on Molecular
   Pathology: Role in Improving Patient Outcome
CY FEB 26-28, 1999
CL BETHESDA, MARYLAND
SP Coll Amer Pathologists
ID INFORMED CONSENT; SAMPLES
AB Recent advances in molecular pathology and molecular genetics have created new concerns about the use of human biologic materials in research. Since researchers now have the ability to extract and amplify DNA from minuscule archived samples, virtually any human tissue sample can potentially become the template for a test that provides information that may relate to the inherited genes of an individual. Researchers using human biologic materials should follow the 3 basic principles that have been defined for all ethical human subjects research: respect for persons, beneficence, and justice. Institutional Review Boards are responsible for providing review of the risks and benefits of research proposals to safeguard the rights and welfare of human subjects. Currently, there is considerable debate concerning the role of informed consent procedures and the Institutional Review Board oversight process in situations when researchers use human biologic materials that have been anonymized or coded. In 1999, the National Bioethics Advisory Commission is expected to make recommendations to President Clinton and the National Science and Technology Council that are expected to clarify the balance between respect for personal autonomy and the societal need to pursue biomedical research to improve the health and welfare of all individuals.
C1 NCI, Mol Pathol Sect, Pathol Lab, Bethesda, MD 20892 USA.
RP Sobel, ME (reprint author), NCI, Mol Pathol Sect, Pathol Lab, 10 Ctr Dr,MSC 1500, Bethesda, MD 20892 USA.
CR CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786
   Grizzle W, 1999, ARCH PATHOL LAB MED, V123, P296
   GRODY WW, 1995, DIAGN MOL PATHOL, V4, P155, DOI 10.1097/00019606-199509000-00001
   HUDSON KL, 1995, SCIENCE, V270, P391, DOI 10.1126/science.270.5235.391
   KANT JA, 1996, MOL DIAGN, V1, P79
   KNOPPERS BM, 1995, JAMA-J AM MED ASSOC, V274, P1806, DOI 10.1001/jama.274.22.1806
   Merz JF, 1999, SCIENCE, V283, P1647, DOI 10.1126/science.283.5408.1647
   *NAT COMM PROT HUM, 1979, FED REG         0418
   Strass E, 1996, AM J HUM GENET, V59, P471
   Taube SE, 1998, BREAST J, V4, P391
NR 10
TC 9
Z9 10
U1 0
U2 2
PU COLLEGE AMER PATHOLOGISTS
PI NORTHFIELD
PA C/O KIMBERLY GACKI, 325 WAUKEGAN RD, NORTHFIELD, IL 60093-2750 USA
SN 0003-9985
J9 ARCH PATHOL LAB MED
JI Arch. Pathol. Lab. Med.
PD NOV
PY 1999
VL 123
IS 11
BP 1076
EP 1078
PG 3
WC Medical Laboratory Technology; Medicine, Research & Experimental;
   Pathology
SC Medical Laboratory Technology; Research & Experimental Medicine;
   Pathology
GA 253YD
UT WOS:000083584000021
PM 10539912
DA 2018-10-20
ER

PT J
AU Vazquez, B
   Ginebra, MP
   Gil, FJ
   Planell, JA
   Bravo, AL
   San Roman, J
AF Vazquez, B
   Ginebra, MP
   Gil, FJ
   Planell, JA
   Bravo, AL
   San Roman, J
TI Radiopaque acrylic cements prepared with a new acrylic derivative of
   iodo-quinoline
SO BIOMATERIALS
LA English
DT Article
DE acrylic bone cement; radiopaque agent; iodine compounds
ID BONE-CEMENT; POLY(METHYL METHACRYLATE); BIOMEDICAL APPLICATIONS;
   POLYMERIC BIOMATERIALS; MONOMERS
AB A novel iodine-containing methacrylate, 2,5-diiodo-8-quinolyl methacrylate, has been synthesized and used in the preparation of acrylic radiopaque cements. The effect of incorporation of this monomer to the self-curing resins, on the curing parameters, swelling behaviour and mechanical properties was studied. The incorporation of the radiopaque compound 2,5-diiodo-8-hydroxyquinoline to the solid phase was also carried out for comparative experiments. A decrease in the peak temperature and an increase in the setting time was observed with the addition of the radiopaque monomer, however, the curing parameters did not appreciably change with the addition of the radiopaque compound to the solid phase. Swelling of the modified cements was in the same range as that of the radiolucent cement; however, the diffusion coefficients calculated according to the Fick's law were higher for the iodine-containing materials. The addition of 5 wt% of the iodine-containing methacrylate provided a significant increase in the tensile properties with respect to either control radiolucent formulations or BaSO4-containing formulations. Biocompatibility of the modified cements was studied by implantation of rods of the cements into rats and histological analysis of the surrounding tissue. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 CSIC, Inst Ciencia & Tecnol Polimeros, Macromol Chem Dept, E-28006 Madrid, Spain.
   UPC, ETSEIB, Dep C Tecnol & Ing Met, Barcelona, Spain.
   Hosp Prov Avila, Avila, Spain.
RP San Roman, J (reprint author), CSIC, Inst Ciencia & Tecnol Polimeros, Macromol Chem Dept, Juan Cierva 3, E-28006 Madrid, Spain.
RI Ginebra, Maria-Pau/J-8149-2017
OI Ginebra, Maria-Pau/0000-0002-4700-5621; Vazquez,
   Blanca/0000-0001-5539-8026
CR BEAUMONT PWR, 1977, J MATER SCI, V12, P1845, DOI 10.1007/BF00566245
   BENZINA A, 1994, BIOMATERIALS, V15, P1122, DOI 10.1016/0142-9612(94)90232-1
   CRANK J, 1978, MATH DIFFUSION, P239
   Davy KWM, 1997, POLYM INT, V43, P143, DOI 10.1002/(SICI)1097-0126(199706)43:2<143::AID-PI717>3.0.CO;2-M
   DAVY KWM, 1982, J DENT, V10, P254, DOI 10.1016/0300-5712(82)90058-6
   Elvira C, 1996, J POLYM SCI POL CHEM, V34, P2783, DOI 10.1002/(SICI)1099-0518(19960930)34:13<2783::AID-POLA24>3.0.CO;2-7
   Horak D, 1997, J BIOMED MATER RES, V34, P183, DOI 10.1002/(SICI)1097-4636(199702)34:2<183::AID-JBM7>3.0.CO;2-M
   JAYAKRISHNAN A, 1990, J BIOMED MATER RES, V24, P993, DOI 10.1002/jbm.820240803
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   Kruft MAB, 1996, BIOMATERIALS, V17, P1803, DOI 10.1016/0142-9612(95)00339-8
   KRUFT MAB, 1994, J BIOMED MATER RES, V28, P1259, DOI 10.1002/jbm.820281103
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   MOSZNER N, 1995, ANGEW MAKROMOL CHEM, V224, P115, DOI 10.1002/apmc.1995.052240112
   OWEN AB, 1980, MECH PROPERTIES BIOM, P277
   SAHA S, 1984, J BIOMED MATER RES, V18, P435, DOI 10.1002/jbm.820180411
   TOPOLESKI LDT, 1990, J BIOMED MATER RES, V24, P135, DOI 10.1002/jbm.820240202
   Vazquez B, 1997, J BIOMED MATER RES, V34, P129
   Vazquez B, 1997, J MATER SCI-MATER M, V8, P455, DOI 10.1023/A:1018565807727
   WIJN JRD, 1975, ACTA ORTHOP SCAND, V46, P38
NR 19
TC 27
Z9 28
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 1999
VL 20
IS 21
BP 2047
EP 2053
DI 10.1016/S0142-9612(99)00108-8
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 245DC
UT WOS:000083090100008
PM 10535816
DA 2018-10-20
ER

PT J
AU Kalltorp, M
   Oblogina, S
   Jacobsson, S
   Karlsson, A
   Tengvall, P
   Thomsen, P
AF Kalltorp, M
   Oblogina, S
   Jacobsson, S
   Karlsson, A
   Tengvall, P
   Thomsen, P
TI In vivo cell recruitment, cytokine release and chemiluminescence
   response at gold, and thiol functionalized surfaces
SO BIOMATERIALS
LA English
DT Article
DE biocompatibility; chemiluminescence; interleukin-1; protein adsorption;
   surface modification; tumour necrosis factor alpha
ID NEUTROPHIL RESPIRATORY BURST; ADHERENT HUMAN-NEUTROPHILS; IMMUNE-COMPLEX
   ALVEOLITIS; SOFT-TISSUE; IN-VITRO; MONOCYTES MACROPHAGES; POLYSTYRENE
   SURFACES; BIOMEDICAL POLYMERS; HYDROGEN-PEROXIDE; ACTIVATION
AB Hydroxylated and methylated surfaces were prepared by the self-assembled monolayer technique (SAM) of alkane thiols on gold. The surfaces were used to evaluate the influence of implant surface chemistry on protein deposition and inflammatory cell response. Implants were inserted subcutaneously in the rat for 3 and 24 h. The surface chemical properties influenced the in vitro rat plasma protein adsorption (ellipsometry/antibody) with few exceptions (albumin not found and fibrinogen always found). The number of recruited cells and their distribution (DNA from implant versus from exudate) was influenced by the different chemistries at 24 h, but not at 3 h. HIS48+, ED1+, ED2+ and small numbers of CD5+ cells were present in the exudate at both time periods (flow cytometry), The cellular oxidative metabolism was low, although cells on -OH surfaces responded with the highest phorbol ester-stimulated chemiluminescence (CL)/DNA. The levels of cytokines IL-1 alpha, IL-1 beta and TNF alpha (ELISA) were not influenced by material surface chemistry. Sham operated sites had a higher cytokine concentration/DNA compared with exudates from an implant milieu. The results of this study show that surface chemical functionalization modifies specific events in the inflammatory response around implants in soft tissues. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Univ Gothenburg, Biomat Res Grp, Inst Anat & Cell Biol, SE-40530 Gothenburg, Sweden.
   Sahlgrens Univ Hosp, Dept Clin Chem, SE-41345 Gothenburg, Sweden.
   Sahlgrens Univ Hosp, Dept Med Microbiol & Immunol, SE-41345 Gothenburg, Sweden.
   Linkoping Univ, Appl Phys Lab, SE-58183 Linkoping, Sweden.
RP Kalltorp, M (reprint author), Univ Gothenburg, Biomat Res Grp, Inst Anat & Cell Biol, Box 420, SE-40530 Gothenburg, Sweden.
RI Karlsson, Anna/A-4130-2012
OI Thomsen, Peter/0000-0003-3910-6665
CR ALLEN RC, 1986, METHOD ENZYMOL, V133, P449
   Altankov G, 1996, J MATER SCI-MATER M, V7, P425, DOI 10.1007/BF00122012
   Anderson James M., 1996, P165
   Bernatchez SF, 1996, BIOMATERIALS, V17, P2077, DOI 10.1016/0142-9612(96)00014-2
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1993, J BIOMED MATER RES, V27, P1195, DOI 10.1002/jbm.820270910
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   BONFIELD TL, 1994, J BIOMED MATER RES, V28, P137, DOI 10.1002/jbm.820280118
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   Dinarello CA, 1997, J BIOL REG HOMEOS AG, V11, P91
   Dinarello Charles A., 1997, Cytokine and Growth Factor Reviews, V8, P253, DOI 10.1016/S1359-6101(97)00023-3
   Eriksson AS, 1996, J CELL PHYSIOL, V166, P138, DOI 10.1002/(SICI)1097-4652(199601)166:1<138::AID-JCP16>3.0.CO;2-B
   ERIKSSON AS, 1994, J MATER SCI-MATER M, V5, P269, DOI 10.1007/BF00122396
   GINIS I, 1990, BLOOD, V76, P1233
   Gretzer C, 1996, BIOMATERIALS, V17, P851, DOI 10.1016/0142-9612(96)83279-0
   HOFFSTEIN ST, 1985, LAB INVEST, V52, P515
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   Hunt JA, 1997, J BIOMED MATER RES, V36, P542
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   JOHANSSON CB, 1992, J MATER SCI-MATER M, V3, P126, DOI 10.1007/BF00705280
   Johnson R. J., 1996, BIOMATERIALS SCI, P173
   Kalltorp M, 1999, J BIOMED MATER RES, V44, P222
   KALLTORP M, 1998, UNPUB MORPHOMETRIC A
   KALLTORP M, 1999, IN PRESS J BIOMED MA
   Kanagaraja S, 1999, J BIOMED MATER RES, V46, P582, DOI 10.1002/(SICI)1097-4636(19990915)46:4<582::AID-JBM17>3.3.CO;2-X
   KAPLAN SS, 1994, J BIOMED MATER RES, V28, P377, DOI 10.1002/jbm.820280313
   KOVACS EJ, 1991, IMMUNOL TODAY, V12, P17, DOI 10.1016/0167-5699(91)90107-5
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   LESTELIU SM, 1994, J BIOMED MATER RES, V28, P871
   Lim F, 1996, J MATER SCI-MATER M, V7, P69, DOI 10.1007/BF00058717
   Lindblad M, 1997, BIOMATERIALS, V18, P1059, DOI 10.1016/S0142-9612(97)00029-X
   Liu L, 1997, CLIN EXP IMMUNOL, V109, P204, DOI 10.1046/j.1365-2249.1997.4311329.x
   LIU L, 1994, J BIOMED MATER RES, V28, P767, DOI 10.1002/jbm.820280703
   Liu L, 1996, J BIOMED MATER RES, V30, P535, DOI 10.1002/(SICI)1097-4636(199604)30:4<535::AID-JBM12>3.0.CO;2-G
   McCrackin F.L, 1969, FORTRAN PROGRAM ANAL
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   Mollnes TE, 1997, EXP CLIN IMMUNOGENET, V14, P24
   NATHAN CF, 1989, BLOOD, V73, P301
   NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241
   Nilsson B, 1998, BLOOD, V92, P1661
   NILSSON UR, 1993, SCAND J IMMUNOL, V37, P349, DOI 10.1111/j.1365-3083.1993.tb02564.x
   NIMERI G, 1994, J BIOMAT SCI-POLYM E, V6, P741
   NIMERI G, 1998, UNPUB INFLUENCE SURF
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   POOT A, 1992, 9 EUR C BIOM, V10, P253
   Rosengren A, 1997, BIOMATERIALS, V18, P979, DOI 10.1016/S0142-9612(97)00012-4
   SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205
   SHANLEY TP, 1995, MOL MED TODAY, V1, P40, DOI 10.1016/1357-4310(95)80019-0
   SISSON SD, 1989, HUMAN MONOCYTES, P183
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   Tengvall P, 1996, J BIOMED MATER RES, V31, P305, DOI 10.1002/(SICI)1097-4636(199607)31:3<305::AID-JBM3>3.0.CO;2-Q
   THORNTON SC, 1990, J LEUKOCYTE BIOL, V47, P312
   USHIDA T, 1992, 9 EUR C BIOM, V10, P99
   WARREN JS, 1989, J CLIN INVEST, V84, P1873, DOI 10.1172/JCI114374
   WARREN JS, 1991, BIOCHEM BIOPH RES CO, V175, P604, DOI 10.1016/0006-291X(91)91608-F
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 58
TC 43
Z9 44
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 1999
VL 20
IS 22
BP 2123
EP 2137
DI 10.1016/S0142-9612(99)00115-5
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 247UH
UT WOS:000083238000005
PM 10555080
DA 2018-10-20
ER

PT J
AU Caorsi, S
   Pastorino, M
   Raffetto, M
AF Caorsi, S
   Pastorino, M
   Raffetto, M
TI EM field prediction inside lossy multilayer elliptic cylinders for
   biological-body modeling and numerical-procedure testing
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Article
DE analytical solution; biological-body modeling; electromagnetic
   scattering; multilayer elliptic model
ID TIME-DOMAIN METHOD; ELECTROMAGNETIC SCATTERING; ILLUMINATION;
   ABSORPTION; BODIES
AB In this paper, a biological model made up of a multilayer elliptic cylinder is considered. This canonical scattering problem is solved by a recursive procedure, which has been generalized to the case of lossy materials by using the analytical properties of Mathieu functions. Although it is a simplified model, this stratified configuration may simulate better than circular cylinders the local behavior of biological subsystems. In addition, it represents an effective tool far producing analytical data far testing direct-scattering numerical codes in biomedical applications and for the evaluation of reconstruction procedures in medical imaging.
C1 Univ Pavia, Dept Elect, I-27100 Pavia, Italy.
   Univ Genoa, Dept Biophys & Elect Engn, I-16145 Genoa, Italy.
RP Caorsi, S (reprint author), Univ Pavia, Dept Elect, Via Ferrata 1, I-27100 Pavia, Italy.
CR BLANCH G, 1965, HDB MATH FUNCTIONS
   BORUP DT, 1984, IEEE T MICROW THEORY, V32, P355, DOI 10.1109/TMTT.1984.1132683
   BUSSEY HE, 1975, IEEE T ANTENN PROPAG, V23, P723, DOI 10.1109/TAP.1975.1141146
   CAORSI M, IN PRESS IEEE T ANTE
   CAORSI S, 1994, IEEE T BIO-MED ENG, V41, P406, DOI 10.1109/10.284973
   Caorsi S, 1997, IEEE T ANTENN PROPAG, V45, P926, DOI 10.1109/8.585739
   CAORSI S, 1996, P 3 INT C EUR BIOEL
   CERRI G, 1994, P COST 244 M REF MOD, P19
   GANDHI OP, 1995, RADIO SCI, V30, P161, DOI 10.1029/94RS01158
   JOFRE L, 1990, IEEE T BIO-MED ENG, V37, P303, DOI 10.1109/10.52331
   JOHNSON CC, 1972, PR INST ELECTR ELECT, V60, P692, DOI 10.1109/PROC.1972.8728
   KUWANO S, 1998, IEICE T COMMUN   JAN, P110
   NISHIZAWA S, 1997, P 27 EUR MICR C JER, V1, P589
   PICHOT C, 1985, IEEE T ANTENN PROPAG, V33, P416, DOI 10.1109/TAP.1985.1143603
   Reuter CE, 1998, IEEE T MICROW THEORY, V46, P313, DOI 10.1109/22.664132
   RICHMOND JH, 1988, RADIO SCI, V23, P1061, DOI 10.1029/RS023i006p01061
   SULLIVAN DM, 1987, IEEE T BIO-MED ENG, V34, P148, DOI 10.1109/TBME.1987.326039
   SULLIVAN DM, 1988, IEEE T BIO-MED ENG, V35, P179, DOI 10.1109/10.1360
   YEH C, 1963, J MATH PHYS, V4, P65, DOI 10.1063/1.1703890
   YUAN XC, 1990, IEEE T ANTENN PROPAG, V38, P386, DOI 10.1109/8.52246
NR 20
TC 7
Z9 7
U1 0
U2 2
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PD NOV
PY 1999
VL 46
IS 11
BP 1304
EP 1309
DI 10.1109/10.797990
PG 6
WC Engineering, Biomedical
SC Engineering
GA 249PK
UT WOS:000083341300005
PM 10582415
DA 2018-10-20
ER

PT J
AU Smit, EE
   Erckens, RJ
   Hendrikse, F
   Motamedi, M
   Wicksted, JP
   March, WF
AF Smit, EE
   Erckens, RJ
   Hendrikse, F
   Motamedi, M
   Wicksted, JP
   March, WF
TI Identification of intraocular lens materials using confocal Raman
   spectroscopy
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article
ID SILICONE OIL ADHESION; FLUID-AIR EXCHANGE; POSTERIOR SURFACE;
   CONDENSATION; SPECTRA
AB Purpose: To develop and test a noninvasive method to identify intraocular lens (IOL) materials in vitro.
   Setting: Center for Biomedical Engineering and the Department of Ophthalmology, University of Texas Medical Branch, Galveston, Texas, USA.
   Methods: A laser confocal Raman spectroscopy system (Conforam) was used for the noninvasive assessment of Raman spectra in the lower and the higher spectral regions (299.1 to 1833.7 cm(-1) and 2633.8 to 3819.6 cm(-1), respectively) of 4 IOL materials. silicone, poly(methyl methacrylate) (PMMA), acrylic, and hydrogel.
   Results: Each lens material showed a distinctive spectrum in both the higher and the lower spectral regions. Most materials had unique peaks and a distinct profile using 1 mW of laser power and a 1 second exposure time. AU materials still had a unique spectrum in both the higher and the lower region that allowed 1 material to be distinguished from the others.
   Conclusions: A Conforam differentiated silicone, PMMA, acrylic, and hydrogel lenses in vitro. Raman spectroscopy using the Conforam may provide a fast, safe, and reliable noninvasive method to gain information about the material of an implanted IOL and the stability of lens materials and their coatings, J Cataract Refract Surg 1999. 25. 1498-1504 (C) 1999 ASCRS and ESCRS.
C1 Univ Texas, Med Branch, Dept Ophthalmol, Galveston, TX 77550 USA.
RP March, WF (reprint author), Univ Texas, Med Branch, Dept Ophthalmol, 700 Univ Blvd, Galveston, TX 77550 USA.
CR Apple DJ, 1996, OPHTHALMOLOGY, V103, P1555, DOI 10.1016/S0161-6420(96)30463-6
   Apple DJ, 1997, J CATARACT REFR SURG, V23, P536, DOI 10.1016/S0886-3350(97)80210-6
   BARRETT GD, 1994, J CATARACT REFR SURG, V20, P18, DOI 10.1016/S0886-3350(13)80038-7
   BARTZSCHMIDT KU, 1995, KLIN MONATSBL AUGENH, V207, P162, DOI 10.1055/s-2008-1035362
   Bauer NJC, 1998, INVEST OPHTH VIS SCI, V39, P831
   Bauer NJC, 1999, J OCUL PHARMACOL TH, V15, P123, DOI 10.1089/jop.1999.15.123
   Dick B, 1997, KLIN MONATSBL AUGENH, V211, P192, DOI 10.1055/s-2008-1035121
   EATON AM, 1995, OPHTHALMOLOGY, V102, P733, DOI 10.1016/S0161-6420(95)30961-X
   GLICKMAN GM, 1987, ARCH OPHTHALMOL-CHIC, V105, P1166
   GOETZ MJ, 1995, IEEE T BIO-MED ENG, V42, P728, DOI 10.1109/10.391172
   Hainsworth DP, 1996, OPHTHALMOLOGY, V103, P1410, DOI 10.1016/S0161-6420(96)30490-9
   Hollick EJ, 1998, J CATARACT REFR SURG, V24, P361, DOI 10.1016/S0886-3350(98)80324-6
   Jongsma FHM, 1997, OPT ENG, V36, P3193, DOI 10.1117/1.601529
   KUTNER BN, 1995, OPHTHALMOLOGY, V102, P1412
   MIZUNO A, 1982, CURR EYE RES, V1, P609, DOI 10.3109/02713688109001862
   RIDLEY H, 1951, T OPHTHAL SOC UK, V71, P617
   Seward HC, 1997, BRIT J OPHTHALMOL, V81, P340, DOI 10.1136/bjo.81.5.340
   Stolba U, 1996, GRAEF ARCH CLIN EXP, V234, P55, DOI 10.1007/BF00186519
   WICKSTED JP, 1995, APPL SPECTROSC, V49, P987, DOI 10.1366/0003702953964912
NR 19
TC 5
Z9 5
U1 1
U2 4
PU AMER SOC CATARACT REFRACTIVE SURGERY
PI FAIRFAX
PA 4000 LEGATO RD, SUITE 850, FAIRFAX, VA 22030 USA
SN 0886-3350
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD NOV
PY 1999
VL 25
IS 11
BP 1498
EP 1504
DI 10.1016/S0886-3350(99)00239-4
PG 7
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 251VR
UT WOS:000083467500017
PM 10569165
DA 2018-10-20
ER

PT J
AU Alikacem, N
   Marois, Y
   Zhang, Z
   Jakubiec, JB
   Roy, R
   King, MW
   Guidoin, R
AF Alikacem, N
   Marois, Y
   Zhang, Z
   Jakubiec, JB
   Roy, R
   King, MW
   Guidoin, R
TI Tissue reactions to polypyrrole-coated polyesters: A magnetic resonance
   relaxometry study
SO ARTIFICIAL ORGANS
LA English
DT Article
DE polypyrrole; woven polyester; magnetic resonance; in vivo; blood
   monocyte activation; histology
ID FIBROBLAST GROWTH-FACTOR; SMOOTH-MUSCLE CELLS; BIOMEDICAL POLYMERS;
   VASCULAR PROSTHESIS; ENDOTHELIAL-CELLS; RELAXATION-TIMES; CHARGED
   SURFACES; SMALL-DIAMETER; IN-VITRO; GRAFTS
AB The electrically conductive properties of polypyrrole (PPy) as a coating on polyester material are very attractive for the manufacture of small diameter blood conduits. However, before these PPy-coated materials can be investigated for their capacity to generate endothelialized luminal surfaces, they must first be studied for their innocuousness in a living environment. The specific goal of the present study was to investigate the in vivo interactions of PPy-coated and noncoated woven polyester materials implanted subcutaneously in rats for prescheduled periods of 2, 5, 10, 20, and 30 days. The in vivo magnetic resonance (MR) relaxation times were computed for a small area of muscle tissue adjacent to the implants. A correlation was concurrently attempted with blood monocyte activation studies as well as histological observations of the tissue-material interface. The progressive pattern of the slower transversal relaxation time (T-2s) values revealed a more persistent tissue reaction for the most conductive PPy-coated materials and a shorter acute tissue response as the surface resistivity increased. Similarly, the blood monocyte activation studies indicated that the thickness of the PPy coating, which correlated with the conductivity, was directly related to tissue response. Furthermore, both the MR and biological studies showed that the PPy-coated material with a high surface resistivity displayed the lowest tissue reaction over the entire period of implantation. The results obtained from the blood monocyte activation studies and histological observations correlate well with the noninvasive MR measurements of the body's healing process. The conductive materials with high surface resistivities must be further investigated. Finally, the noninvasive nature of MR relaxometry reveals its outstanding potential for future in vivo investigations of the body's tissue interactions with polymers and nonferromagnetic biomaterials.
C1 Univ Laval, Expt Surg Lab, Fac Med, Dept Surg, Quebec City, PQ G1K 7P4, Canada.
   Quebec Biomat Inst, Quebec City, PQ, Canada.
   Rheumatol & Immunol Res Ctr, Quebec City, PQ, Canada.
RP Guidoin, R (reprint author), Univ Laval, Expt Surg Lab, Fac Med, Dept Surg, Room 1701,Serv Bldg, Quebec City, PQ G1K 7P4, Canada.
RI Zhang, Ze/A-7902-2008
CR ABRAGAM A, 1961, PRINCIPLES MAGNETIC
   ALIKACEM N, 1995, ASAIO J, V41, pM617, DOI 10.1097/00002480-199507000-00085
   ALIKACEM N, 1997, P INT SOC MAGN RES 5
   ALLCOCK HR, 1990, CONT POLYM CHEM, P570
   BERGSMA JE, 1995, J BIOMED MATER RES, V29, P173, DOI 10.1002/jbm.820290206
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   BOTTOMLEY PA, 1984, MED PHYS, V11, P425, DOI 10.1118/1.595535
   CENNI E, 1994, J APPL BIOMATER, V5, P47, DOI 10.1002/jab.770050107
   DESGRANGES P, 1992, INT J ARTIF ORGANS, V15, P722
   FEIFENG HE, 1995, J APPL POLYM SCI, V55, P283
   FULLERTON G D, 1982, Magnetic Resonance Imaging, V1, P209, DOI 10.1016/0730-725X(82)90172-2
   GELBAND CH, 1992, CIRC RES, V71, P745, DOI 10.1161/01.RES.71.4.745
   GOSSELIN C, 1995, AM J SURG, V170, P126, DOI 10.1016/S0002-9610(99)80270-0
   GRAY JL, 1994, J SURG RES, V57, P596, DOI 10.1006/jsre.1994.1189
   GREISLER HP, 1992, SURGERY, V112, P244
   HALDENBY KA, 1994, J VASC RES, V31, P2, DOI 10.1159/000159025
   HANSEN ME, 1993, CARDIOVASC INTER RAD, V16, P30, DOI 10.1007/BF02603034
   HIRKO MK, 1995, ASAIO J, V41, pM630, DOI 10.1097/00002480-199507000-00087
   Jakubiec B, 1998, J BIOMED MATER RES, V41, P519, DOI 10.1002/(SICI)1097-4636(19980915)41:4<519::AID-JBM2>3.0.CO;2-F
   KANATZIDIS MG, 1990, CHEM ENG NEWS, V68, P36, DOI 10.1021/cen-v068n049.p036
   KAPUR R, 1993, BIOMATERIALS, V14, P854, DOI 10.1016/0142-9612(93)90007-O
   KATAOKA K, 1978, MAKROMOL CHEM, V179, P1121
   KEDDY K, 1981, J BIOMED MATER RES, V15, P335
   KUHN HH, 1991, TECH PAP SOC PLAST E, V37, P760
   LADO MD, 1992, INT J ARTIF ORGANS, V15, P727
   LEE YS, 1993, ASAIO, V39, P740
   LING CR, 1982, PHYS MED BIOL, V27, P853, DOI 10.1088/0031-9155/27/6/006
   Lowkis B, 1993, Polim Med, V23, P15
   MAROUDAS NG, 1975, J THEOR BIOL, V49, P417, DOI 10.1016/0022-5193(75)90182-4
   MIWA H, 1993, ASAIO J, V39, P501
   MO M, 1995, ARTIF ORGANS, V19, P1185, DOI 10.1111/j.1525-1594.1995.tb02281.x
   MURPHY P, 1970, J MACROMOL SCI CHEM, VA  4, P561, DOI 10.1080/00222337008074363
   Niu S, 1993, ASAIO J, V39, pM750
   ROBINSON KA, 1995, ANGIOLOGY, V46, P107, DOI 10.1177/000331979504600203
   Ryu G, 1992, ASAIO J, V38, pM644
   SAWYER PN, 1953, SURGERY, V34, P491
   SAWYER PN, 1964, P NATL ACAD SCI USA, V51, P428, DOI 10.1073/pnas.51.3.428
   SCHAKENRAAD JM, 1990, J BIOMED MATER RES, V24, P529, DOI 10.1002/jbm.820240502
   SCHNEIDER A, 1992, J VASC SURG, V15, P649, DOI 10.1016/0741-5214(92)90010-6
   SHIOYA S, 1990, MAGNET RESON MED, V14, P358, DOI 10.1002/mrm.1910140220
   SIROIS E, 1993, INT J ARTIF ORGANS, V16, P609
   Spartera C, 1990, Eur J Vasc Surg, V4, P69, DOI 10.1016/S0950-821X(05)80041-6
   SRINIVASAN S, 1970, J MACROMOL SCI CHEM, VA  4, P545, DOI 10.1080/00222337008074362
   SUGIMURA K, 1992, BRIT J RADIOL, V65, P502, DOI 10.1259/0007-1285-65-774-502
   SWANSON JA, 1994, AM J PHYSIOL, V266, pH1300
   TAYLOR BC, 1971, T AM SOC ART INT ORG, V17, P22
   UEDA T, 1991, J BIOMAT SCI-POLYM E, V3, P185
   VOGEL MK, 1970, J MACROMOL SCI CHEM, VA  4, P675, DOI 10.1080/00222337008074370
   VOLK KA, 1991, J PHYSIOL-LONDON, V439, P751, DOI 10.1113/jphysiol.1991.sp018691
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   WORLEY JF, 1991, AM J PHYSIOL, V261, pH1951
   YAMAMURA K, 1995, J BIOMED MATER RES, V29, P203, DOI 10.1002/jbm.820290210
NR 52
TC 17
Z9 18
U1 0
U2 4
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD OCT
PY 1999
VL 23
IS 10
BP 910
EP 919
DI 10.1046/j.1525-1594.1999.06231.x
PG 10
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 246ZJ
UT WOS:000083195900004
PM 10564289
DA 2018-10-20
ER

PT J
AU Petrini, P
   Tanzi, MC
   Moran, CR
   Graham, NB
AF Petrini, P
   Tanzi, MC
   Moran, CR
   Graham, NB
TI Linear poly(ethylene oxide)-based polyurethane hydrogels:
   polyurethane-ureas and polyurethane-amides
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB Over the last 30 years, water-swellable and water-insoluble hydrogels have been extensively investigated and developed, leading to a large family of materials which have found uses in a wide range of biomedical applications.
   While hydrogels usually present a crosslinked structure, linear polyurethane-ureas (PUUs) based on poly(ethylene oxide) have been shown to be able to absorb and swell with aqueous media without dissolving. This behavior is due to the phase separated domain morphology, where hydrogen bonded urethane/urea hard segment domains are dispersed in a PEO soft segment domain.
   This work investigates the possibility of obtaining linear poly(ethylene oxide)-based polyurethane-amide (PUA) hydrogels using two amide diols as chain extenders, a mono amide diol (AD) and a diamide diol (DD), and a dicarboxylic acid (maleic acid, MA). Poly(ethylene oxide) based PUAs were obtained using a "one-shot" bulk polymerization technique. The chemicophysical characterization and water-solubility tests showed that these materials, while having molecular weights similar to the PUUs, do not possess sufficient phase separation, hydrogen bonding and hydrophobicity of the hard segment domains to exhibit hydrogel behavior. Crosslinked PUAs using maleic acid as chain extender show interesting hydrogel properties. (C) 1999 Kluwer Academic Publishers.
C1 Politecn Milan, Dept Bioengn, I-20133 Milan, Italy.
   Univ Strathclyde, Dept Pure & Appl Chem, Glasgow G1 1XL, Lanark, Scotland.
RP Petrini, P (reprint author), Politecn Milan, Dept Bioengn, Piazza L Da Vinci 32, I-20133 Milan, Italy.
RI Tanzi, Maria Cristina/I-4620-2013; Petrini, Paola/A-3150-2013
OI Tanzi, Maria Cristina/0000-0002-4913-6633; Petrini,
   Paola/0000-0002-5081-5254
CR COHEN D, 1990, CLIN IMPLANT MAT ADV, V9, P473
   GRAHAM NB, 1987, POLYMERS, V4, P95
   GRAHAM NB, 1993, POLYM MAT
   GRAHAM NB, 1998, MED DEVICE TECHN JAN, P18
   GRAHAM NB, 1998, MED DEVICE TECHN APR, P22
   Peppas N. A., 1987, HYDROGELS MED PHARM
   SILVER JH, 1994, BIOMATERIALS, V15, P695, DOI 10.1016/0142-9612(94)90168-6
   TANZI MC, 1992, BIOMATERIALS, V13, P425, DOI 10.1016/0142-9612(92)90162-H
   TANZI MC, 1997, P 13 EUR C BIOM GOT, P66
NR 9
TC 17
Z9 18
U1 0
U2 18
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT-NOV
PY 1999
VL 10
IS 10-11
BP 635
EP 639
DI 10.1023/A:1008939808819
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 243RX
UT WOS:000083012000009
PM 15347978
DA 2018-10-20
ER

PT J
AU Shelly, DC
   Brown, EM
AF Shelly, DC
   Brown, EM
TI Sampling strategies for infrared spectroscopic studies of raw, pickled,
   and in-process chrome tanned bovine hides
SO JOURNAL OF THE AMERICAN LEATHER CHEMISTS ASSOCIATION
LA English
DT Article
ID COLLAGEN
AB Infrared spectroscopy is a powerful research tool for studying structure and structural changes in complex biomaterials, such as animal hides and leather. Recent advances in optical design and materials have made available accessories that enable the sampling of biomaterials as liquids, gels, pastes, powders and porous solids. For this report, the Gemini, a new sampling device for Horizontal Attenuated Total Reflection (HATR) and Diffuse Reflectance (DR) FTIR spectroscopy was evaluated as an option for the study of bovine hides, in successive stages of chrome tanning. Specifically, raw, pickled and chrome sulfate-treated bovine hides were subjected to HATR FTIR analysis so that changes in collagen structure as a function of chemical treatment could be observed. Also, freeze dried hides were examined by DR FTIR in order to detect the presence and structure of collagen-chromium complexes. Comparisons of HATR and DR FTIR show that the expected chemical changes in the hide can be observed. The quality of the spectra obtained is comparable to that reported by biomedical research groups. The GEMINI shows excellent versatility for in-processing hide sampling, enabling the detailed study of many truly unique chemical and biochemical phenomena of the tanning process.
C1 Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA.
   Texas Tech Univ, Leather Res Inst, Lubbock, TX 79409 USA.
   ARS, USDA, Eastern Reg Res Ctr, Wyndmoor, PA 19038 USA.
RP Shelly, DC (reprint author), Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA.
CR Bajza Z, 1997, J SOC LEATH TECH CH, V81, P219
   BALSER C, 1996, PITTSB C AN CHEM APP
   DAGOSTINO J, 1992, AM LAB, V38, P13
   FORTE JN, 1997, 463 NIC
   Griebenow K, 1996, J AM CHEM SOC, V118, P11695, DOI 10.1021/ja961869d
   HEIDEMANN E, 1991, LEDER, V42, P21
   LEE DC, 1990, BIOCHEMISTRY-US, V29, P9185, DOI 10.1021/bi00491a012
   OZAKI Y, 1992, APPL SPECTROSC, V46, P626, DOI 10.1366/0003702924125104
   OZAKI Y, 1989, APPL SPECTROSC, V43, P138, DOI 10.1366/0003702894201789
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   SILVERSTEIN RM, 1991, SPECTROMETRIC IDENTI
   *SPECTRATECH INC, 1997, GEM US MAN
   TAYLOR MM, JALCA, V93, P83
   YANG WJ, 1985, APPL SPECTROSC, V39, P282, DOI 10.1366/0003702854248917
NR 14
TC 6
Z9 6
U1 0
U2 4
PU AMER LEATHER CHEMISTS ASSN
PI CINCINNATI
PA ROOM 5 CAMPUS STATION-14 TANNER RES LAB, CINCINNATI, OH 45221 USA
SN 0002-9726
J9 J AM LEATHER CHEM AS
JI J. Am. Leather Chem. Assoc.
PD OCT
PY 1999
VL 94
IS 8
BP 315
EP 321
PG 7
WC Chemistry, Applied; Materials Science, Textiles
SC Chemistry; Materials Science
GA 239QW
UT WOS:000082782000003
DA 2018-10-20
ER

PT J
AU Detweiler, J
   Peyton, C
AF Detweiler, J
   Peyton, C
TI Defining occupations - A chronotopic study of narrative genres in a
   health discipline's emergence
SO WRITTEN COMMUNICATION
LA English
DT Review
ID DISCOURSE; THERAPY; PHILOSOPHY; FRAMEWORK; EVOLUTION
AB Extending Bakhtin's chronotopic theory to the interpretation of nonfictional texts, this article examines the role of narrative conventions in the epistemological development of a health care field. The authors argue that changes marking the emergence of occupational therapy as an autonomous profession illustrate how explanatory narrative frames emerge from and embody assumptions about the world. Taking up pivotal lectures by key Figures in this Field as material for analysis, the authors demonstrate how biomedical, psychosocial, and dialogic-intersubjective narrative genres frame the dynamics of the therapeutic situation for clinical practitioners and other members of the field. By using chronotopic analysis to understand the narrative-epistemic transformation of academic and professional Fields, the authors provide new ways to think about the long-term dialogue between explanatory frameworks in knowledge-making communities.
C1 Univ Nevada, Dept English, Reno, NV 89557 USA.
   Creighton Univ, Dept Occupat Therapy, Omaha, NE 68178 USA.
RP Detweiler, J (reprint author), Univ Nevada, Dept English, Reno, NV 89557 USA.
CR *AOTA, 1985, PROF LEG EC SLAGL LE
   *AOTA, 1988, AM J OCCUPATIONAL TH, V42, P795
   ATKINSON P, 1995, HDB QUALITATIVE RES, P248
   AYRES AJ, 1985, PROFESSIONAL LEGACY, P127
   Bakhtin M, 1981, DIALOGIC IMAGINATION
   BAKHTIN M, 1984, PROBLEMS DOSTOYEVSKY
   BAKHTIN M, 1990, ART ANSWERABILITY EA
   Bakhtin Mikhail Mikhailovich, 1986, SPEECH GENRES OTHER
   BATESON MC, 1990, COMPOSING LIFE
   BAUR S, 1994, CONFIDING PSYCHOTHER
   Bazerman C, 1991, TEXTUAL DYNAMICS PRO
   Bazerman C, 1988, SHAPING WRITTEN KNOW
   BEARD GM, 1972, AM NERVOUSNESS ITS C
   Berkenkotter C, 1995, GENRE KNOWLEDGE DISC
   BIALOSTOSKY D, 1994, LEARNING TEACHING GE, P105
   Bialostosky Don, 1991, CONTENDING WORDS COM, P11
   BLAIR CP, 1988, COLL ENGL, V50, P383, DOI 10.2307/377610
   BOOTH W, 1984, PROBLEMS DOSTOYEVSKY
   BORIS E, 1986, ART LABOR RUSKIN MOR
   BRODKEY L, 1987, WRIT COMMUN, V4, P25, DOI 10.1177/0741088387004001002
   BRUNER J, 1991, CRIT INQUIRY, V18, P1, DOI 10.1086/448619
   BRUNER J, 1990, ACTS MEANING
   BRUNER JS, 1986, ACTUAL MINDS POSSIBL
   BURTON S, 1995, COMP LITERATURE, V48, P39
   CAPRA F, 1982, TURNING POINT SCI SO
   Christiansen C., 1991, OCCUPATIONAL THERAPY, P3
   CLARK F, 1993, AM J OCCUP THER, V47, P1067, DOI 10.5014/ajot.47.12.1067
   Clifford James, 1988, PREDICAMENT CULTURE
   Cooper Marilyn M, 1994, J ADV COMPOSITION, V14, P531
   COOPER MM, 1990, COLL ENGL, V52, P847, DOI 10.2307/377388
   CROSS G, 1994, COLLABORATION CONFLI
   CROSS GA, 1990, RES TEACH ENGL, V24, P173
   Daniell B, 1999, COLL COMPOS COMMUN, V50, P393, DOI 10.2307/358858
   DANTO A, 1981, NARRATION KNOWLEDGE
   DAUTERMANN J, 1993, WRITING WORKPLACE NE, P98
   DETWEILER J, 1995, THESIS U LOUISVILLE
   DETWEILER J, 1997, GENRE WRITING ISSUES, P135
   Diasio Serrett K., 1985, OCCUPATIONAL THERAPY, V5, P1
   Doheny-Farina S., 1993, WRITING WORKPLACE NE, P253
   Dunton Jr W.R., 1918, P 1 ANN M NAT SOC PR, P26
   DURANARENAS L, 1991, SOC SCI MED, V32, P643, DOI 10.1016/0277-9536(91)90143-Z
   DWYER E, 1987, HOMES MAD LIFE 2 19
   Elshtain Jean Bethke, 1987, RHETORIC HUMAN SCI L, P319
   ENGLEHARDT HT, 1977, AM J OCCUPATIONAL TH, V31, P666
   EWALD HR, 1993, COLL COMPOS COMMUN, V44, P331, DOI 10.2307/358987
   Fabian J., 1983, TIME OTHER ANTHR MAK
   FARMER F, 1990, FRESHMAN ENGLISH NEW, V19, P16
   FARMER F, 1998, LANDMARK ESSAYS BAKH
   FORSYTH PB, 1985, WORK OCCUPATION, V12, P59, DOI 10.1177/0730888485012001004
   Freedman A., 1994, LEARNING TEACHING GE, P1
   FREEDMAN A, 1997, GENRE WRITING ISSUES, P177
   FRIEDSON E, 1986, PROFESSIONAL POWERS
   GEERTZ C, 1983, LOCAL KNOWLEDGE FURT
   Geertz C., 1988, WORKS LIVES ANTHR AU
   Giltrow J., 1994, LEARNING TEACHING GE, P47
   Goode W. J., 1969, SEMIPROFESSIONS THEI, P266
   Gould S. J., 1989, WONDERFUL LIFE BURGE
   Gritzer Glenn, 1985, MAKING REHABILITATIO
   Grob GN, 1983, MENTAL ILLNESS AM SO
   HALASEK K, 1999, PEDAGOGY POSSIBILITY
   HALASEK K, 1992, RHETOR SOC Q, V22, P63
   HALPERN SA, 1992, AM J SOCIOL, V97, P994, DOI 10.1086/229859
   Haraway Donna J., 1989, PRIMATE VISIONS GEND
   HARDCASTLE J, 1994, LEARNING TEACHING GE, P31
   HENRY J, 1994, COLL ENGL, V56, P810, DOI 10.2307/378487
   HERNDL CG, 1991, COLL ENGL, V53, P320, DOI 10.2307/378107
   HERRNSTEINSMITH B, 1985, NARRATIVE, P209
   Holquist M., 1990, DIALOGISM BAKHTIN HI
   HUNT R, 1994, LEARNING TEACHING GE, P243
   ILLICH I, 1977, MED NEMESIS EXPROPRI
   JOURNET D, 1990, WRIT COMMUN, V7, P171, DOI 10.1177/0741088390007002001
   JOURNET D, 1993, WRIT COMMUN, V10, P510, DOI 10.1177/0741088393010004002
   JOURNET D, 1991, WRIT COMMUN, V8, P446, DOI 10.1177/0741088391008004002
   KAHLER E, 1973, INWARD TURN NARRATIV
   KAPLAN W, 1987, ART THAT IS LIFE ART
   KERMODE F, 1967, STUDIES THEORY FICTI
   KIELHOFNER G, 1980, AM J OCCUP THER, V34, P572, DOI 10.5014/ajot.34.9.572
   KIELHOFNER G, 1977, AM J OCCUP THER, V31, P675
   KING LJ, 1985, PROFESSIONAL LEGACY, P311
   LANDAU M, 1984, AM SCI, V72, P262
   Landau M, 1991, NARRATIVES HUMAN EVO
   LANHAM R, 1991, HANDLIST RHETORICAL
   LEARS TJ, 1981, NO PLACE GRACE
   Levine R., 1991, OCCUPATIONAL THERAPY, P591
   LEVINE R E, 1987, Occupational Therapy in Health Care, V4, P3, DOI 10.1080/J003v04n01_02
   LICHT S, 1948, OCCUPATIONAL THERAPY
   LUMERER K, 1985, LEARNING HEAL DEV AM
   Lyotard J-F., 1985, POSTMODERN CONDITION
   MCCARTHY LP, 1991, RES TEACH ENGL, V25, P419
   McCarthy Lucille P., 1991, TEXTUAL DYNAMICS PRO, P358
   MECHANIC D, 1979, FUTURE ISSUES HLTH C
   Mink, 1978, WRITING HIST LIT FOR, P129
   MISHLER EG, 1990, HARVARD EDUC REV, V60, P415, DOI 10.17763/haer.60.4.n4405243p6635752
   MOORE J, 1985, PROFESSIONAL LEGACY, P277
   MORSON G, 1994, NARRATIVE FREEDOM SH
   Morson Gary Saul, 1990, M BAKHTIN CREATION P
   MOSEY A, 1990, PSYCHOSOCIAL COMPONE
   MOSEY AC, 1981, OCCUPATIONAL THERAPY
   Myers G., 1990, WRITING BIOL TEXTS S
   NELSON D, 1997, AM J OCCUPATIONAL TH, P11
   NEWKIRK T., 1992, METHODS METHODOLOGY, P130
   NORTH S, 1985, MAKING KNOWLEDGE COM
   NYSTRAND M, 1993, WRIT COMMUN, V10, P267, DOI 10.1177/0741088393010003001
   NYSTRAND M, 1997, OPENING DIALOGUE UND
   PADILLA R, 1997, NEUROSCIENCE OCCUPAT, P2
   PADILLA R, IN PRESS NEUROSCIENC
   PHELAN J, 1989, READING PEOPLE READI
   Pierce D, 1999, AM J OCCUP THER, V53, P64, DOI 10.5014/ajot.53.1.64
   Polkinghorne D, 1988, NARRATIVE KNOWING HU
   PRIOR P, 1995, RES TEACH ENGL, V29, P288
   PRIOR P, 1998, WRITING DISCIPLINARI
   QUIROGA VAM, 1995, OCCUPATIONAL THERAPY
   REILLY M, 1985, PROFESSIONAL LEGACY, P87
   Ricoeur P., 1984, TIME NARRATIVE, V1
   ROGERS JC, 1982, AM J OCCUP THER, V36, P709, DOI 10.5014/ajot.36.11.709
   Rosaldo R, 1987, RHETORIC HUMAN SCI L, P87
   Rosenberg Charles E., 1987, CARE STRANGERS RISE
   Schafer R, 1981, NARRATIVE, P25
   Segal J., 1993, WRITING WORKPLACE NE, P84
   SHANNON PD, 1977, AM J OCCUP THER, V31, P229
   SIMONS H, 1990, RHETORICAL TURN INVE
   SLAGLE E, 1944, STATE NEW YORK DEP M
   Starr P, 1982, SOCIAL TRANSFORMATIO
   STATTEL F, 1985, PROFESSIONAL LEGACY, P1
   Taylor C., 1979, INTERPRETIVE SOCIAL, P25
   Van Maanen J., 1988, TALES FIELD WRITING
   Vogel Morris J, 1980, INVENTION MODERN HOS
   WAGNER R, 1975, INVENTION CULTURE
   WEGG L, 1985, PROFESSIONAL LEGACY, P57
   Welch N, 1998, COLL ENGL, V60, P374, DOI 10.2307/378908
   Welch N., 1993, J ADV COMPOSITION, V13, P494
   WHITE H, 1978, TOPICS DISCOURSE
   White H., 1973, METAHISTORY HIST IMA
   White Hayden, 1987, CONTENT FORM NARRATI
   YERXA E, 1985, PROFESSIONAL LEGACY, P155
   YERXA E, 1998, WILLARD SPACKMANS OC, P861
   YOUNG K, 1991, J NARRAT LIFE HIST, V1, P213
   Zimmerman M. E., 1985, PROFESSIONAL LEGACY, P69
NR 138
TC 14
Z9 14
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0741-0883
EI 1552-8472
J9 WRIT COMMUN
JI Writ. Commun.
PD OCT
PY 1999
VL 16
IS 4
BP 412
EP 468
DI 10.1177/0741088399016004002
PG 57
WC Communication
SC Communication
GA 243EX
UT WOS:000082985000002
DA 2018-10-20
ER

PT J
AU Tan, J
   Saltzman, WM
AF Tan, J
   Saltzman, WM
TI Influence of synthetic polymers on neutrophil migration in
   three-dimensional collagen gels
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE neutrophil; migration; collagen; polyethylene glycol; pluronic F68
ID EXTRACELLULAR-MATRIX; POLYETHYLENE-GLYCOL; POLY(ETHYLENE GLYCOL);
   CELL-AGGREGATION; NEURITE GROWTH; ANIMAL-CELLS; ADHESION; CHEMOTAXIS;
   MOTILITY; SURFACES
AB In vitro studies of cell migration within three-dimensional polymeric materials are essential for understanding cell behavior and for developing new biomedical materials. Human neutrophil motility was examined in hydrated collagen gels containing various synthetic polymers. Physical mixtures of collagen and certain water-soluble polymers formed stable gels that were good substrates for cell migration. Addition of either polyethylene glycol (PEG) or the pluronic(TM) copolymer F68 did not change the morphological or mechanical properties of collagen gels, as determined by SEM and oscillatory rheometry; however, addition of either polymer significantly inhibited cell motility in both a modified 96-well chemotaxis chamber assay and a direct visual assay. Although the mechanism for this observed polymer inhibition of neutrophil migration is not yet clear, these results suggest that PEG and F68, two widely used biomedical polymers that are considered to be relatively "inert," may cause significant inhibition of cell motility. (C) 1999 John Wiley & Sons, Inc.
C1 Cornell Univ, Sch Chem Engn, Ithaca, NY 14853 USA.
RP Saltzman, WM (reprint author), Cornell Univ, Sch Chem Engn, 120 Olin Hall, Ithaca, NY 14853 USA.
CR ALLEN TD, 1984, SCAN ELECTRON MICROS, P375
   Baldwin SP, 1996, INT J DEV NEUROSCI, V14, P351, DOI 10.1016/0736-5748(96)00018-4
   BELL E, 1991, J BIOMECH ENG-T ASME, V113, P113, DOI 10.1115/1.2891224
   BONI LT, 1984, BIOCHIM BIOPHYS ACTA, V775, P409, DOI 10.1016/0005-2736(84)90198-6
   BUETTNER HM, 1989, J IMMUNOL METHODS, V123, P25, DOI 10.1016/0022-1759(89)90026-4
   Caldwell KD, 1997, ACS SYM SER, V680, P400
   DEMETRIOU AA, 1986, SCIENCE, V233, P1190, DOI 10.1126/science.2426782
   DICKINSON RB, 1993, AICHE J, V39, P1995, DOI 10.1002/aic.690391210
   DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729
   DOILLON CJ, 1994, J BIOMAT SCI-POLYM E, V6, P715
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   Du H, 1997, BBA-BIOMEMBRANES, V1326, P236, DOI 10.1016/S0005-2736(97)00027-8
   Edwards CM, 1997, ARTIF CELL BLOOD SUB, V25, P493, DOI 10.3109/10731199709118940
   Glauert AM, 1975, FIXATION DEHYDRATION
   Green RJ, 1998, J BIOMED MATER RES, V42, P165, DOI 10.1002/(SICI)1097-4636(199811)42:2<165::AID-JBM1>3.0.CO;2-N
   HAMED G, 1973, THESIS CORNELL U ITH
   HARVATH L, 1980, J IMMUNOL METHODS, V37, P39, DOI 10.1016/0022-1759(80)90179-9
   ISLAM LN, 1985, J IMMUNOL METHODS, V85, P137, DOI 10.1016/0022-1759(85)90282-0
   Knapp DM, 1997, J RHEOL, V41, P971, DOI 10.1122/1.550817
   KRAUSE TL, 1990, P NATL ACAD SCI USA, V87, P1471, DOI 10.1073/pnas.87.4.1471
   KREWSON CE, 1994, BIOTECHNOL BIOENG, V43, P555, DOI 10.1002/bit.260430704
   Kuntz RM, 1997, BIOPHYS J, V72, P1472, DOI 10.1016/S0006-3495(97)78793-9
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   MICHAELS JD, 1991, J BIOTECHNOL, V19, P241, DOI 10.1016/0168-1656(91)90062-Z
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   Orgill DP, 1998, J BIOMED MATER RES, V39, P358, DOI 10.1002/(SICI)1097-4636(19980305)39:3<358::AID-JBM3>3.0.CO;2-I
   PAPOUTSAKIS ET, 1991, TRENDS BIOTECHNOL, V9, P427, DOI 10.1016/0167-7799(91)90145-8
   PARKHURST MR, 1994, CELL IMMUNOL, V156, P77, DOI 10.1006/cimm.1994.1154
   PARKHURST MR, 1992, BIOPHYS J, V61, P306, DOI 10.1016/S0006-3495(92)81838-6
   PUELACHER WC, 1994, BIOMATERIALS, V15, P774, DOI 10.1016/0142-9612(94)90031-0
   REID GG, 1991, CELL BIOL INT REP, V15, P711, DOI 10.1016/0309-1651(91)90071-P
   RHEE W, 1997, CHEM BIOL APPL, P420
   ROSENBLATT J, 1993, J APPL POLYM SCI, V50, P953, DOI 10.1002/app.1993.070500604
   SALTZMAN WM, 1992, ANN NY ACAD SCI, V665, P259, DOI 10.1111/j.1749-6632.1992.tb42590.x
   SALTZMAN WM, IN PRESS J LEUKOCYTE
   SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   VACANTI JP, 1988, J PEDIATR SURG, V23, P3, DOI 10.1016/S0022-3468(88)80529-3
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   YAMAZAKI M, 1990, BIOCHEMISTRY-US, V29, P1309, DOI 10.1021/bi00457a029
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Zalipsky S, 1997, ACS SYM SER, V680, P1
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
   ZHANG Z, 1992, ENZYME MICROB TECH, V14, P980, DOI 10.1016/0141-0229(92)90081-X
NR 44
TC 28
Z9 29
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 15
PY 1999
VL 46
IS 4
BP 465
EP 474
DI 10.1002/(SICI)1097-4636(19990915)46:4<465::AID-JBM4>3.0.CO;2-N
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 213WE
UT WOS:000081295600004
PM 10398007
DA 2018-10-20
ER

PT J
AU Kingshott, P
   St John, HAW
   Griesser, HJ
AF Kingshott, P
   St John, HAW
   Griesser, HJ
TI Direct detection of proteins adsorbed on synthetic materials by
   matrix-assisted laser desorption ionization-mass spectrometry
SO ANALYTICAL BIOCHEMISTRY
LA English
DT Article
DE protein detection; protein adsorption; MALDI mass spectrometry;
   biofouling; surface analysis
ID GEL-ELECTROPHORESIS; ADSORPTION; SURFACES; MEMBRANE; BIOFILMS
AB The irreversible accumulation of biological material on synthetic surfaces ("biofouling") adversely affects for instance contact lenses, implantable biomedical devices, biosensors, water purification, transport and storage systems, and marine structures. It is shown here that proteins adsorbed on contact lenses can be detected directly, rapidly, and conveniently, with high sensitivity, by matrix-assisted laser desorption ionization (MALDI)-mass spectrometry, This new approach allows detection of minor (and major) proteinaceous constituents of biofouled layers on samples retrieved from clinical usage and in vitro protein adsorption studies, at levels substantially below monolayer coverage. Identification of the detected biological molecules can be done by comparison of the detected mass peaks with known protein molecular masses or with spectra recorded of pure compounds or by separate biochemical assays. The MALDI mass spectra re; corded on different contact lenses contain peaks assignable to lysozyme and a number of smaller proteins. Such sensitive characterization of the early stages of biofouling enhances the understanding of protein/materials interactions and assists in designing guided strategies toward control of biological adsorption processes. (C) 1999 Academic Press.
C1 CSIRO Mol Sci, Clayton, Vic 3169, Australia.
RP Griesser, HJ (reprint author), CSIRO Mol Sci, Private Bag 10,Clayton S MDC, Clayton, Vic 3169, Australia.
EM h.griesser@molsci.csiro.au
RI Griesser, Hans/E-5628-2011
OI Griesser, Hans/0000-0003-1072-7863; Kingshott, Peter/0000-0001-5882-5804
CR ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   BLACKLEDGE JA, 1995, ANAL CHEM, V67, P843, DOI 10.1021/ac00101a009
   BRYERS JD, 1994, COLLOID SURFACE B, V2, P9, DOI 10.1016/0927-7765(94)80013-8
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Fenselau C, 1997, ANAL CHEM, V69, pA661, DOI 10.1021/ac971831z
   FRANKLIN VJ, 1993, TRENDS POLYM SCI, V1, P9
   GRIESSER HJ, 1997, POLYM MAT SCI ENG, V76, P79
   HLADY V, 1993, CLIN MATER, V13, P85, DOI 10.1016/0267-6605(93)90094-N
   HOFFMAN AS, 1987, ANN NY ACAD SCI, V516, P96, DOI 10.1111/j.1749-6632.1987.tb33033.x
   HORBETT TA, 1995, ACS S SER, V602
   Huang ZH, 1999, ANAL BIOCHEM, V268, P305, DOI 10.1006/abio.1998.3085
   KARAS M, 1989, BIOMED ENVIRON MASS, V18, P841, DOI 10.1002/bms.1200180931
   KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028
   KINGSHOTT P, 1999, UNPUB
   MCLEAN KM, 1999, IN PRESS COLLOIDS B
   MIREJOVSKY D, 1991, OPTOMETRY VISION SCI, V68, P858, DOI 10.1097/00006324-199111000-00005
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   STJOHN HAW, 1997, POLYM MAT SCI ENG, V76, P83
   STRUPAT K, 1994, ANAL CHEM, V66, P464, DOI 10.1021/ac00076a008
   VESTLING MM, 1994, ANAL CHEM, V66, P471, DOI 10.1021/ac00076a009
   WEDLER FC, 1982, BIOCOMPATIBILITY CLI, V11, P1
   Worrall TA, 1998, ANAL CHEM, V70, P750, DOI 10.1021/ac970969e
   YAN GY, 1993, INVEST OPHTH VIS SCI, V34, P1804
NR 23
TC 35
Z9 36
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0003-2697
EI 1096-0309
J9 ANAL BIOCHEM
JI Anal. Biochem.
PD SEP 10
PY 1999
VL 273
IS 2
BP 156
EP 162
DI 10.1006/abio.1999.4201
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 238MA
UT WOS:000082713000003
PM 10469485
DA 2018-10-20
ER

PT J
AU Santin, M
   Motta, A
   Freddi, G
   Cannas, M
AF Santin, M
   Motta, A
   Freddi, G
   Cannas, M
TI In vitro evaluation of the inflammatory potential of the silk fibroin
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE silk fibroin; inflammation; protein adsorption; macrophage adhesion;
   monocyte activation
ID COMPLEMENT ACTIVATION; FIBROBLAST CELLS; SOLID-SURFACES; HUMAN MONOCYTE;
   IN-VITRO; ADSORPTION; MEMBRANES; POLYMER; ALPHA-1-MICROGLOBULIN;
   BIOMATERIAL
AB Silk fibroin membranes recently have been suggested as matrices for biomedical applications,,such as guided tissue regeneration and burn wound dressings. The aim of this study was to evaluate the inflammatory potential of fibroin films and to compare the fibroin films with two model materials with completely different physico-chemical properties: poly(styrene) and poly(2-hydroxyethyl methacrylate). Fibroin bound lower levels of fibrinogen than did the two synthetic polymers while the same amounts of adsorbed human plasma complement fragment C3 and IgG were detected. Studies of the binding strength of C3 to fibroin, evaluated by a novel experimental procedure, indicated the occurrence of strong hydrophobic interactions at the interface. The activation of the mononuclear cells by fibroin, measured as interleukin 1 beta production,was lower than the reference materials. Adhesion experiments showed the ability of the macrophages to adhere to fibroin by filopodia without a complete spreading of the cells. The results achieved in this study demonstrate that the interactions of fibroin with the humoral components of the inflammatory system were comparable with those of the two model surfaces while the degree of activatiorr and adhesion of the immunocompetent cells appeared more limited. (C) 1999 John Wiley & Sons, Inc. J Biomed Mater Res, 46, 382-389, 1999.
C1 Univ E Peidmont A Avogadro, Dept Med Sci, I-28100 Novara, Italy.
   Univ Brighton, Sch Pharm & Biomol sci, Brighton BN2 4GJ, E Sussex, England.
   Expt Silk Stn, I-20133 Milan, Italy.
RP Cannas, M (reprint author), Univ E Peidmont A Avogadro, Dept Med Sci, Via Solaroli 17, I-28100 Novara, Italy.
OI Motta, Antonella/0000-0003-4893-6863
CR ANDERSON JM, 1988, ASAIO, V11, P101
   Benahmed M, 1997, J BIOMED MATER RES, V34, P115, DOI 10.1002/(SICI)1097-4636(199701)34:1<115::AID-JBM15>3.0.CO;2-J
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   ELWING H, 1988, J COLLOID INTERF SCI, V125, P139, DOI 10.1016/0021-9797(88)90062-8
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P474
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   Jirouskova M, 1997, J MATER SCI-MATER M, V8, P19, DOI 10.1023/A:1018534111419
   LIANG CX, 1992, J APPL POLYM SCI, V45, P1937, DOI 10.1002/app.1992.070451108
   LIU L, 1994, J BIOMED MATER RES, V28, P767, DOI 10.1002/jbm.820280703
   Mahiout A, 1997, J MATER SCI-MATER M, V8, P287, DOI 10.1023/A:1018560211844
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   MONTI P, IN PRESS J RAMAN SPE
   PAYNE MS, 1987, J BIOMED MATER RES, V21, P843, DOI 10.1002/jbm.820210703
   Sakabe H., 1989, SEN-I GAKKAISHI, V45, P487
   Santin M, 1996, BIOMATERIALS, V17, P1459, DOI 10.1016/0142-9612(96)89769-9
   Santin M, 1998, J MATER SCI-MATER M, V9, P135, DOI 10.1023/A:1008863518572
   Santin M, 1997, BIOMATERIALS, V18, P823, DOI 10.1016/S0142-9612(97)00004-5
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
NR 24
TC 319
Z9 332
U1 3
U2 57
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 1999
VL 46
IS 3
BP 382
EP 389
DI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 209QY
UT WOS:000081061000011
PM 10397996
DA 2018-10-20
ER

PT J
AU Ryan, JM
   Humphrey, JD
AF Ryan, JM
   Humphrey, JD
TI Finite element based predictions of preferred material symmetries in
   saccular aneurysms
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE aneurysm mechanics; stress-strain relations; remodeling; collagen
   microstructure
ID CEREBRAL ANEURYSMS; INTRACRANIAL ANEURYSMS; ARTERIES; COLLAGEN; MATRIX;
   STRESSES; GROWTH; MODEL; WALL
AB Over the years, various hypotheses have implicated the role of structural instabilities in the expansion of intracranial saccular aneurysms. Recent nonlinear analyses suggest, however, that particular subclasses of aneurysms are structurally stable (in the mechanics sense) and that we must consider different hypotheses. Indeed, based on an ever-increasing database, it appears that aneurysms may well expand via the remodeling of their constituents. Although more data and a kinetics-based formulation of remodeling are needed to examine this hypothesis, we present results from quasistatic finite element analyses of 12 subclasses of lesions that support the remodeling hypothesis. Briefly, we identify regional variations in material symmetry, for a class of noncomplicated axisymmetric lesions subjected to a uniform distension pressure, that minimize local maxima in multiaxial stress and tend to homogenize the stress field. Such symmetries are termed preferred. It is shown that the numerical predictions are consistent with the teleological concept that some intracranial saccular aneurysms will seek to become spherical, since the sphere is an optimal geometry for resisting a distension pressure. To achieve this, however, different subclasses must develop differently. Lesions having an initially large neck:height ratio must increase in height and therefore may seek to become increasingly stiffer circumferentially from the fundus to the neck. Conversely, lesions having an initially small neck:height ratio must increase in breadth and therefore may seek to become increasingly stiffer meridionally from the fundus to the neck. We submit that these results demonstrate the need for a detailed histological examination of regional variations in collagen organization in human lesions, for it is upon data that an analysis of remodeling must be founded. (C) 1999 Biomedical Engineering Society. [S0090-6964(99)00405-1].
C1 Texas A&M Univ, Zachry Engn Ctr 233, Biomed Engn Program, College Stn, TX 77843 USA.
RP Humphrey, JD (reprint author), Texas A&M Univ, Zachry Engn Ctr 233, Biomed Engn Program, College Stn, TX 77843 USA.
EM jdh@acs.tamu.edu
FU NHLBI NIH HHS [HL-54957]
CR AKKAS N, 1990, NATO ADV SCI I A-LIF, V193, P303
   ASARI S, 1994, ACTA MED OKAYAMA, V48, P257
   AUSTIN GM, 1989, NEUROSURGERY, V24, P722, DOI 10.1227/00006123-198905000-00011
   Bruno G, 1998, J NEUROSURG, V89, P431, DOI 10.3171/jns.1998.89.3.0431
   Canham PB, 1996, J MICROSC-OXFORD, V183, P170, DOI 10.1046/j.1365-2818.1996.840642.x
   CARVER W, 1991, CIRC RES, V69, P116, DOI 10.1161/01.RES.69.1.116
   CHUONG CJ, 1986, J BIOMECH ENG-T ASME, V108, P189, DOI 10.1115/1.3138600
   Connolly ES, 1997, NEUROSURGERY, V40, P903, DOI 10.1097/00006123-199705000-00003
   DZAU VJ, 1993, J CARDIOVASC PHARM, V21, pS1, DOI 10.1097/00005344-199321001-00001
   Gaetani P, 1998, LIFE SCI, V63, P285, DOI 10.1016/S0024-3205(98)00272-0
   Humphrey JD, 1995, CRIT REV BIOMED ENG, V23, P1
   HUNG EJN, 1963, SURGERY ST LOUIS, V54, P347
   Kim SC, 1997, NEUROSURGERY, V41, P642, DOI 10.1097/00006123-199709000-00027
   Kyriacou SK, 1997, J BIOMECH, V30, P761
   Kyriacou SK, 1996, COMPUT MECH, V18, P269
   LANGILLE BL, 1993, J CARDIOVASC PHARM, V21, pS11
   Mimata C, 1997, ACTA NEUROPATHOL, V94, P197, DOI 10.1007/s004010050694
   NIMNI ME, 1992, CARDIOVASCULAR BIOMA
   NISSEN R, 1978, P NATL ACAD SCI USA, V75, P451, DOI 10.1073/pnas.75.1.451
   Rachev A, 1998, J BIOMECH ENG-T ASME, V120, P9, DOI 10.1115/1.2834313
   SCOTT S, 1972, CAN J PHYSIOL PHARM, V50, P328, DOI 10.1139/y72-049
   Shah AD, 1998, COMPUT METHOD BIOMEC, V1, P109, DOI 10.1080/01495739708936698
   Simkins TE, 1973, LETT APPL ENG SCI, V1, P85
   Sumpio BE, 1993, HEMODYNAMIC FORCES V
   Taber LA, 1998, J BIOMECH ENG-T ASME, V120, P348, DOI 10.1115/1.2798001
NR 25
TC 28
Z9 31
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD SEP-OCT
PY 1999
VL 27
IS 5
BP 641
EP 647
DI 10.1114/1.208
PG 7
WC Engineering, Biomedical
SC Engineering
GA 270CN
UT WOS:000084518000006
PM 10548333
DA 2018-10-20
ER

PT J
AU Xu, W
   Frank, TG
   Stockham, G
   Cuschieri, A
AF Xu, W
   Frank, TG
   Stockham, G
   Cuschieri, A
TI Shape memory alloy fixator system for suturing tissue in minimal access
   surgery
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE finite element modelling; suturing; endoscopy
ID NICKEL-TITANIUM ALLOY
AB A new technique for suturing human tissue is described in which tissue closure is achieved by means of small fixators made from shape memory alloy. The aim of the development is to provide an alternative to thread suturing in minimal access surgery, which is quicker and requires less skill to achieve the required suturing quality. The design of the fixators is described in terms of the thermal shape recovery of shape memory alloy and a novel form of finite element analysis, which uses a nonlinear elastic element for the material property. Thermal analysis of the fixators and surrounding tissue is used to predict the temperature distribution during and after the application of electric current heating. This was checked in an in vitro experiment, which confirmed that deployment caused no detectable collateral damage to surrounding tissue. In vivo animal studies on the use of the shape memory alloy fixator for suturing tissue are ongoing to establish safety and healing effects. (C) 1999 Biomedical Engineering Society. [S0090-6964(99)00805-X].
C1 Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg, Dundee DD1 9SY, Scotland.
RP Frank, TG (reprint author), Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg, Dundee DD1 9SY, Scotland.
RI Cuschieri, Alfred/A-7634-2013
FU Wellcome Trust
CR ABSTEN GT, 1988, LASERS MED SURG INTR
   Assad M, 1998, J BIOMED MATER RES, V41, P154, DOI 10.1002/(SICI)1097-4636(199807)41:1<154::AID-JBM18>3.3.CO;2-0
   Cuschieri A., 1995, TISSUE APPROXIMATION
   Duerig TW, 1996, BIO-MED MATER ENG, V6, P255
   Duering TW, 1990, ENG ASPECTS SHAPE ME
   FUNAKUBO H, 1984, SHAPE MEMORY ALLOYS
   LING HC, 1981, MATER SCI ENG, V48, P241, DOI 10.1016/0025-5416(81)90008-2
   *SWANS AN SYST INC, 1996, ANSYS MAN VERS 5 3
   Szabo Z, 1994, Endosc Surg Allied Technol, V2, P55
   TOBUSHI H, 1992, JSME INT J I-SOLID M, V35, P271, DOI 10.1299/jsmea1988.35.3_271
   Trepanier C, 1999, J BIOMED MATER RES, V48, P165, DOI 10.1002/(SICI)1097-4636(1999)48:2<165::AID-JBM11>3.0.CO;2-#
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   XU W, 1998, 6 INT C NEW ACT BREM, P494
NR 13
TC 31
Z9 32
U1 1
U2 3
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
   USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD SEP-OCT
PY 1999
VL 27
IS 5
BP 663
EP 669
DI 10.1114/1.216
PG 7
WC Engineering, Biomedical
SC Engineering
GA 270CN
UT WOS:000084518000009
PM 10548336
DA 2018-10-20
ER

PT J
AU Gott, VL
   Daggett, RL
AF Gott, VL
   Daggett, RL
TI Serendipity and the development of heparin and carbon surfaces
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT Symposium on the Celebration of the 80th Birthday of C Walton Lillehei
CY OCT 23-25, 1998
CL MINNEAPOLIS, MINNESOTA
AB In the early 1960s, bileaflet valves fabricated with polymer housings routinely thrombosed within a few hours after implantation in the canine heart. In a serendipitous series of events, the authors found a way to bond heparin to these bileaflet valves using a coating of graphite-carbon and benzalkonium chloride. Over the ensuing 30 years, improved heparin coatings have been developed by other investigators for bonding to various biomedical devices; currently, about 25% of oxygenators used in this country utilize heparin coatings to minimize surface activation of clotting factors. Also, and somewhat serendipitously, a pyrolytic carbon material developed in the 1960s as a coating for nuclear fuel rods was submitted to the authors' laboratory for possible coating with benzalkonium and heparin. This carbon coating, developed at Gulf General Atomic, Inc, would not bond heparin, but it proved to be the best rigid material available for prosthetic valve construction; more than one million pyrolytic carbon valves have been clinically implanted over the last 29 years. (C) 1999 by The Society of Thoracic Surgeons.
C1 Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA.
RP Gott, VL (reprint author), Johns Hopkins Hosp, Dept Surg, 600 N Wolfe St,Blalock 618, Baltimore, MD 21287 USA.
CR Abramson HA, 1925, J EXP MED, V41, P445, DOI 10.1084/jem.41.4.445
   Aldea GS, 1996, ANN THORAC SURG, V62, P410, DOI 10.1016/0003-4975(96)00249-4
   BOKROS J C, 1970, Journal of Biomedical Materials Research, V4, P145, DOI 10.1002/jbm.820040202
   Gorman RC, 1996, J THORAC CARDIOV SUR, V111, P1, DOI 10.1016/S0022-5223(96)70395-1
   Gott V L, 1972, Ann Thorac Surg, V14, P219
   GOTT VL, 1963, SCIENCE, V142, P1297, DOI 10.1126/science.142.3597.1297
   GOTT VL, 1989, ANN THORAC SURG, V48, P528
   GRODE GA, 1969, T AM SOC ART INT ORG, V15, P1
   HSU L-C, 1991, Perfusion (London), V6, P209, DOI 10.1177/026765919100600310
   KALKE BR, 1969, PROSTHETIC HEART VAL, P285
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   SAWYER PN, 1953, AM J PHYSIOL, V175, P113
   VERDANT A, 1995, ANN THORAC SURG, V60, P1151, DOI 10.1016/0003-4975(95)00172-H
   VONSEGESSER LK, 1994, ANN THORAC SURG, V58, P391
NR 14
TC 16
Z9 16
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD SEP
PY 1999
VL 68
IS 3
SU S
BP S19
EP S22
DI 10.1016/S0003-4975(99)00817-6
PG 4
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 240AW
UT WOS:000082804300005
PM 10505985
DA 2018-10-20
ER

PT J
AU Lowe, KC
AF Lowe, KC
TI Perfluorinated blood substitutes and artificial oxygen carriers
SO BLOOD REVIEWS
LA English
DT Review
ID RESPIRATORY-DISTRESS SYNDROME; PARTIAL LIQUID VENTILATION;
   PERFLUOROCARBON EMULSION MIXTURES; PERFLUOROCHEMICAL EMULSIONS; TISSUE
   OXYGENATION; GAS-EXCHANGE; PERFLUBRON EMULSION; HUMAN HEMOGLOBIN;
   DRUG-DELIVERY; TRANSPORT
AB Blood transfusion is a remarkably safe, routine clinical procedure. However, the need for sophisticated blood processing, storage and cross-matching, coupled with increasing concerns about the safety of blood products, has fuelled the search for safe and efficacious substitutes. Candidate materials based on modified haemoglobin (including recombinant molecules) or highly inert, respiratory gas-dissolving perfluorinated liquids (perfluorochemicals) have been developed. The latter are immiscible in aqueous systems and must, therefore, be injected as emulsions. Second-generation perfluorochemical emulsions are available and in clinical trials as temporary intravascular oxygen carriers during surgery, thereby reducing patient exposure to donor blood. One commercial product is currently under Phase III clinical evaluation, with regulatory approval expected within 1-2 years. Other biomedical applications for perfluorochemicals and their emulsions include their use as pump-priming fluids for cardiopulmonary bypass, lung ventilation fluids, anti-cancer agents, organ perfusates and cell culture media supplements, diagnostic imaging agents and ophthalmologic tools. Novel applications for perfluorochemicals as immunomodulating agents are also being explored. (C) 1999 Harcourt Publishers Ltd.
C1 Univ Nottingham, Sch Biol Sci, Nottingham NG7 2RD, England.
RP Lowe, KC (reprint author), Univ Nottingham, Sch Biol Sci, Univ Pk, Nottingham NG7 2RD, England.
CR AUBUCHON JP, 1994, PRO TRANSFUSION, V34, P79
   Batman C, 1998, OPHTHALMIC SURG LAS, V29, P144
   BATRA S, 1996, ARTIF CELL BLOOD SUB, V24, P307
   BOLLANDS AD, 1989, BLOOD SUBSTITUTES, P451
   BRAUN RD, 1992, J APPL PHYSIOL, V72, P1960
   CHANG S, 1992, INT OPHTHALMOL CLIN, V32, P153, DOI 10.1097/00004397-199203220-00014
   Chang TMS, 1998, VOX SANG, V74, P233, DOI 10.1111/j.1423-0410.1998.tb05425.x
   Chang TMS, 1997, ARTIF CELL BLOOD SUB, V25, P1, DOI 10.3109/10731199709118893
   CHANG TMS, 1998, BLOOD SUBSTITUTES PR, V1
   CHANG TMS, 1998, BLOOD SUBSTITUTES PR, V2
   CHEN HS, 1989, BLOOD SUBSTITUTES, P403
   CLARK LC, 1966, SCIENCE, V152, P1755, DOI 10.1126/science.152.3730.1755
   CLARK LC, 1992, BIOMAT ARTIF CELL IM, V20, P1085, DOI 10.3109/10731199209119767
   CONE A, 1995, BRIT J HOSP MED, V54, P155
   Dieryck W, 1997, NATURE, V386, P29, DOI 10.1038/386029b0
   Dietz NM, 1996, ANESTH ANALG, V82, P390, DOI 10.1097/00000539-199602000-00032
   Eckmann DM, 1998, ARTIF CELL BLOOD SUB, V26, P359, DOI 10.3109/10731199809117677
   Eckmann DM, 1998, ARTIF CELL BLOOD SUB, V26, P259, DOI 10.3109/10731199809117457
   Edwards CM, 1997, ARTIF CELL BLOOD SUB, V25, P255, DOI 10.3109/10731199709118915
   FAITHFULL NS, 1992, BIOMAT ARTIF CELL IM, V20, P797, DOI 10.3109/10731199209119721
   FAITHFULL NS, 1994, ARTIF CELL BLOOD SUB, V22, P181, DOI 10.3109/10731199409117413
   FAITHFULL NS, 1994, OXYGEN TRANSPORT TIS, V16, P41
   Flaim S. F., 1997, ADV BLOOD SUBSTITUTE, P91
   FORMAN MB, 1992, J AM COLL CARDIOL, V19, P205, DOI 10.1016/0735-1097(92)90074-W
   FORMAN MB, 1992, CLIN HEMORHEOL, V12, P121
   FRATANTONI JC, 1998, BLOOD CELL SUBSTITUT, P29
   FUHRMAN BP, 1994, ARTIF CELL BLOOD SUB, V22, P1133, DOI 10.3109/10731199409138808
   Gerstmann DR, 1996, PEDIATRICS, V98, P1044
   GERVITS LL, 1994, FLUORINE MED 21 CENT, P197
   GILLON J, 1994, TRANSFUSION, V34, P269, DOI 10.1046/j.1537-2995.1994.34394196629.x
   Grauer SE, 1996, AM HEART J, V132, P938, DOI 10.1016/S0002-8703(96)90002-2
   Habler OP, 1998, TRANSFUSION, V38, P145, DOI 10.1046/j.1537-2995.1998.38298193096.x
   Hirschl RB, 1996, JAMA-J AM MED ASSOC, V275, P383, DOI 10.1001/jama.275.5.383
   HORSMAN MR, 1995, ACTA ONCOL, V34, P571, DOI 10.3109/02841869509094031
   Ivanitskii G. R., 1996, Biophysics (English Translation of Biofizika), V41, P189
   Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0
   KABALNOV A, 1995, LANGMUIR, V11, P2966, DOI 10.1021/la00008a020
   KAUFMAN RJ, 1995, BLOOD SUBSTITUTES, P53
   KEIPERT PE, 1995, ARTIF CELL BLOOD SUB, V23, P381, DOI 10.3109/10731199509117954
   KEIPERT PE, 1998, BLOOD SUBST PRINC ME, V2, P127
   KEIPERT PE, 1997, P 7 INT S BLOOD SUBS, P38
   KEIPERT PE, 1998, P 6 IBC C BLOOD SUBS
   KERINS DM, 1994, AM J MED SCI, V307, P218, DOI 10.1097/00000441-199403000-00009
   LANZA GM, 1997, CIRCULATION, V95, P3334
   LEACH C, 1996, NEW ENGL J MED, P761
   LEMON DD, 1996, ARTIF CELL BLOOD SUB, V24, P378
   Leonard RC, 1998, ANAESTH INTENS CARE, V26, P11
   LOPEZ R, 1992, AM J OPHTHALMOL, V113, P424, DOI 10.1016/S0002-9394(14)76166-5
   Lowe KC, 1998, TRENDS BIOTECHNOL, V16, P272, DOI 10.1016/S0167-7799(98)01205-0
   LOWE KC, 1994, VASC MED REV, V5, P15
   LOWE KC, 1988, OXYGEN TRANSPORT TIS, V10, P655
   LOWE KC, 1998, PRESENT FUTRE PERSPE, P327
   LOWE KC, 1998, ABC TRANSFUSION, P71
   Lowe Kenneth C., 1997, Science Progress, V80, P169
   MATTREY RF, 1994, ARTIF CELL BLOOD SUB, V22, P295, DOI 10.3109/10731199409117422
   MCGREGOR DP, 1996, BIOTECHNIQUES, V21, P672
   MEINERT H, 1992, BIOMAT ARTIF CELL IM, V20, P95, DOI 10.3109/10731199209117860
   Monk TG, 1995, AM J SURG, V170, pS69, DOI 10.1016/S0002-9610(99)80063-4
   MOORE RE, 1982, OXYGEN CARRYING COLL, P50
   MUKERJI B, 1991, TRANSFUSION, V31, P24
   Ni Y, 1996, ARTIF CELL BLOOD SUB, V24, P81, DOI 10.3109/10731199609118876
   OHYANAGI H, 1995, ARTIFICIAL RED CELLS, P199
   Patel S, 1998, ASAIO J, V44, P157, DOI 10.1097/00002480-199805000-00007
   Patel S, 1998, ASAIO J, V44, P144, DOI 10.1097/00002480-199805000-00006
   Perevedentseva EV, 1998, ARTIF CELL BLOOD SUB, V26, P223, DOI 10.3109/10731199809119780
   PEYMAN GA, 1995, SURV OPHTHALMOL, V39, P375
   QUAY SC, 1994, J ULTRAS MED, V13, P59
   RIESS JG, 1984, ARTIF ORGANS, V8, P44, DOI 10.1111/j.1525-1594.1984.tb04243.x
   Riess JG, 1996, CURR OPIN COLLOID IN, V1, P652, DOI 10.1016/S1359-0294(96)80104-X
   Riess JG, 1997, ARTIF CELL BLOOD SUB, V25, P43, DOI 10.3109/10731199709118896
   Riess JG, 1998, BIOMATERIALS, V19, P1529, DOI 10.1016/S0142-9612(98)00071-4
   RIESS JG, 1998, BLOOD SUBSTITUTES PR, V2, P101
   ROATH S, 1991, BRIT MED J, V303, P659, DOI 10.1136/bmj.303.6804.659
   ROCKWELL S, 1994, ARTIF CELL BLOOD SUB, V22, P1097, DOI 10.3109/10731199409138805
   Roddie PH, 1997, BLOOD REV, V11, P169, DOI 10.1016/S0268-960X(97)90017-5
   Rosoff JD, 1996, ANESTH ANALG, V82, pSC123
   Rossman JE, 1996, J PEDIATR SURG, V31, P1147, DOI 10.1016/S0022-3468(96)90105-0
   RUDOLPH AS, 1998, RED BLOOD CELL SUBST
   Saegusa A, 1998, NATURE, V392, P3, DOI 10.1038/31992
   SHAFFER TH, 1992, PEDIATR PULM, V14, P102, DOI 10.1002/ppul.1950140208
   Shah N, 1996, ASAIO J, V42, P181, DOI 10.1097/00002480-199605000-00011
   SHARMA SK, 1989, BLOOD SUBSTITUTES, P447
   Smith KM, 1997, CRIT CARE MED, V25, P1179, DOI 10.1097/00003246-199707000-00020
   SMITH TM, 1995, CRIT CARE MED, V231, P533
   Soheilian M, 1997, INT OPHTHALMOL, V20, P241
   SPENCE RK, 1996, PRINCIPLES TRANSFUSI, P189
   Spiess BD, 1996, J CARDIOTHOR VASC AN, V10, P83, DOI 10.1016/S1053-0770(96)80182-0
   Stavis RL, 1998, PEDIATR RES, V43, P132, DOI 10.1203/00006450-199801000-00020
   STEHLING L, 1994, PRO TRANSFUSION, V34, P265
   Sukumar M, 1998, J APPL PHYSIOL, V84, P327
   TEICHER BA, 1995, ARTIF CELL BLOOD SUB, V23, P395, DOI 10.3109/10731199509117955
   TEICHER BA, 1994, ARTIF CELL BLOOD SUB, V22, P1109, DOI 10.3109/10731199409138806
   TUTUNCU AS, 1993, CRIT CARE MED, V21, P962
   Vaslef S N, 1994, ASAIO J, V40, pM643, DOI 10.1097/00002480-199407000-00077
   Wahr JA, 1996, ANESTH ANALG, V82, P103, DOI 10.1097/00000539-199601000-00018
   Warden J, 1998, BRIT MED J, V317, P232, DOI 10.1136/bmj.317.7153.232a
   Wilbanks GA, 1996, CORNEA, V15, P329, DOI 10.1097/00003226-199605000-00017
   WINSLOW RM, 1995, NAT MED, V1, P1212, DOI 10.1038/nm1195-1212
   WINSLOW RM, 1996, BLOOD SUBSTITUTES
   WNSLOW RM, 1997, ADV BLOOD SUBSTITUTE
   WOLFSON MR, 1992, J APPL PHYSIOL, V72, P1024
   ZARITSKII AR, 1993, RUSS J PHYS CHEM, V67, P533
   ZUCK TF, 1994, CRIT REV CL LAB SCI, V31, P295, DOI 10.3109/10408369409084678
   Zuckerman SH, 1998, ARTIF CELL BLOOD SUB, V26, P231, DOI 10.3109/10731199809117456
NR 104
TC 72
Z9 73
U1 2
U2 23
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0268-960X
J9 BLOOD REV
JI Blood Rev.
PD SEP
PY 1999
VL 13
IS 3
BP 171
EP 184
DI 10.1054/blre.1999.0113
PG 14
WC Hematology
SC Hematology
GA 243VR
UT WOS:000083018600005
PM 10527269
DA 2018-10-20
ER

PT J
AU Licht, PB
   Christensen, HW
   Svendsen, P
   Hoilund-Carlsen, PF
AF Licht, PB
   Christensen, HW
   Svendsen, P
   Hoilund-Carlsen, PF
TI Vertebral artery flow and cervical manipulation: An experimental study
SO JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS
LA English
DT Article
DE chiropractic manipulation; vertebral artery; volume flow; transit time;
   doppler
ID VERTEBROBASILAR INSUFFICIENCY; BLOOD-FLOW; SPINE
AB Background: Spinal manipulation therapy is used by millions of patients each year to relieve symptoms caused by biomechanical dysfunction of the spine. Cerebrovascular accidents in the posterior cerebral circulation are a feared complication, but little research has been done on vertebral artery hemodynamics during cervical manipulation.
   Objective: The purpose of this study was to develop an experimental model for investigations of volume blood flow changes in the vertebral arteries during premanipulative testing of these vessels and during spinal manipulation therapy of the cervical spine.
   Design and Setting: An experimental study in a university biomedical laboratory.
   Material and Methods: The vertebral arteries were exposed in 8 adult pigs after extensive mediastinal dissection. Volume blood now was measured on both sides simultaneously by advanced transit-time flowmetry.
   Results: After cervical manipulation, the vertebral artery volume blood flow increased significantly for 40 seconds before returning to baseline values in less than 3 minutes. We found no significant changes in volume blood flow during premanipulative testing of the vertebral arteries (DeKleyn's test).
   Conclusion: We present an experimental model for investigations of vertebral artery hemodynamics during biomechanical interventions. We found a modest and transient effect of cervical manipulation on vertebral artery Volume flow. The model may have further applications in future biomechanical research, for example, to determine whether any of several spinal manipulative techniques imposes less strain on the vertebral artery, thereby reducing possible future cerebrovascular accidents after such treatment.
C1 Odense Univ Hosp, Dept Clin Physiol & Nucl Med, DK-5000 Odense, Denmark.
   Nord Inst Chiropract & Clin Biomech, Odense, Denmark.
   Odense Univ, Biomed Lab, Odense, Denmark.
RP Licht, PB (reprint author), Odense Univ Hosp, Dept Clin Physiol & Nucl Med, Sonder Blvd 29, DK-5000 Odense, Denmark.
CR Alback A, 1996, ANN CHIR GYNAECOL FE, V85, P325
   AUSMAN JI, 1985, ARCH NEUROL-CHICAGO, V42, P803, DOI 10.1001/archneur.1985.04210090071021
   *AUSTR PHYS ASS, 1988, AUSTR J PHYSIOTHERAP, V34, P97
   BAUER R, 1961, ARCH NEUROL-CHICAGO, V4, P119, DOI 10.1001/archneur.1961.00450080001001
   BROWN BS, 1963, RADIOLOGY, V81, P80, DOI 10.1148/81.1.80
   CAREY PF, 1995, J CAN CHIROPR ASS, V39, P35
   CIPRIANO JJ, 1997, PHOTOGRAPHIC MANUAL, P31
   Cote P, 1996, J Manipulative Physiol Ther, V19, P159
   CRAWFORD JP, 1984, J MANIP PHYSIOL THER, V7, P149
   DVORAK J, 1991, MANUAL MED, V6, P117
   EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406
   FAST A, 1987, SPINE, V12, P840, DOI 10.1097/00007632-198711000-00003
   GEORGE PE, 1981, J CHIROPR, V15, P26
   Grant R, 1996, MANUAL THER, V1, P149
   HARDESTY WH, 1963, SURG GYNECOL OBSTET, V116, P662
   Haynes M J, 1996, J Manipulative Physiol Ther, V19, P378
   Hurwitz EL, 1996, SPINE, V21, P1746, DOI 10.1097/00007632-199608010-00007
   HUSNI EA, 1966, J AMER MED ASSOC, V196, P475, DOI 10.1001/jama.196.6.475
   Ivancic JJ, 1993, CHIROPR J AUST, V23, P59
   KAWCHUK GN, 1993, J MANIP PHYSIOL THER, V16, P573
   Kuether TA, 1997, NEUROSURGERY, V41, P427, DOI 10.1097/00006123-199708000-00019
   Kunnasmaa KTT, 1994, J ORTHOPAEDIC MED, V16, P17
   Laustsen J, 1996, EUR J VASC ENDOVASC, V12, P91, DOI 10.1016/S1078-5884(96)80282-6
   LEE KP, 1995, NEUROLOGY, V45, P1213, DOI 10.1212/WNL.45.6.1213
   Licht PB, 1998, J MANIP PHYSIOL THER, V21, P141
   LICHT PB, 1998, J MANIP PHYSIOL THER, V21, P29
   REFSHAUGE KM, 1994, J MANIP PHYSIOL THER, V17, P15
   RIVETT DA, 1998, MANUAL THER, V3, P102
   SAKAI F, 1988, STROKE, V19, P1426, DOI 10.1161/01.STR.19.11.1426
   STEVENS A, 1991, MANUAL MED, V6, P102
   THIEL H, 1994, CLIN BIOMECH, V9, P105, DOI 10.1016/0268-0033(94)90032-9
   TOOLE JF, 1960, ARCH NEUROL-CHICAGO, V2, P616, DOI 10.1001/archneur.1960.03840120022003
   Weingart JR, 1992, MANUELLE MED, V30, P62
   1934, JAMA, V103, P1260
NR 34
TC 15
Z9 15
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0161-4754
J9 J MANIP PHYSIOL THER
JI J. Manip. Physiol. Ther.
PD SEP
PY 1999
VL 22
IS 7
BP 431
EP 435
DI 10.1016/S0161-4754(99)70030-8
PG 5
WC Health Care Sciences & Services; Integrative & Complementary Medicine;
   Rehabilitation
SC Health Care Sciences & Services; Integrative & Complementary Medicine;
   Rehabilitation
GA 241XH
UT WOS:000082908800001
PM 10519558
DA 2018-10-20
ER

PT J
AU Korematsu, A
   Li, YJ
   Murakami, T
   Nakaya, T
AF Korematsu, A
   Li, YJ
   Murakami, T
   Nakaya, T
TI Synthesis and blood compatibilities of novel segmented polyurethanes
   containing phosphatidylcholine analogous moieties in the main chains and
   long-chain alkyl groups in the side chains
SO JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
ID PHOSPHOLIPID POLYURETHANES; COMPATIBLE POLYURETHANES; BIOMEDICAL
   APPLICATIONS; POLY(BUTADIENE); POLYMERS; SURFACE
AB New segmented polyurethanes containing phospholipid moieties in the main chains and long-chain alkyl groups in the side chains were synthesized. The soft segments used in this study were poly(butadiene), poly(isoprene), hydrogenated poly(isoprene), and poly( 1,6-hexyl-1,2-ethylcarbonate) diol. The hard segments of these polyurethanes were 4,4'-methylenediphenyl diisocyanate, bis[2-(2-hydroxyethyLdimethylammonio)ethyl]2-cetyl-1,3-propanediphosphate, and 1,4-butanediol. The blood compatibilities of the new polymers were evaluated by platelet-rich plasma contact studies and viewed by scanning electron microscopy using medical grade BioSpan(R) and nonphospholipid polyurethane as references. These new materials have good surfaces in terms of platelet adhesion, and the morphology of adhered platelets undergoes a relatively low degree of variation.
C1 Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, Osaka 5588585, Japan.
RP Nakaya, T (reprint author), Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.
CR BORETOS JW, 1972, J BIOMED MATER RES, V6, P473, DOI 10.1002/jbm.820060513
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   BORETOS JW, 1982, P 8 ANN SOC BIOM, P24
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   COURY AJ, 1987, LIFE SUPPORT SYST, V5, P25
   DURRANI AA, 1986, BIOMATERIALS, V7, P121, DOI 10.1016/0142-9612(86)90068-2
   HARA K, 1993, SEIRIKASSEISHISHITSU, P112
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, HYOMEN, V28, P720
   Korematsu A, 1999, J MATER CHEM, V9, P647, DOI 10.1039/a806279j
   Korematsu A, 1997, POLYM BULL, V38, P133, DOI 10.1007/s002890050029
   Li YJ, 1997, MACROMOL SYMP, V122, P363, DOI 10.1002/masy.19971220156
   Li YJ, 1996, J APPL POLYM SCI, V62, P687
   Li YJ, 1996, CHEM MATER, V8, P1441, DOI 10.1021/cm960014x
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   Li YJ, 1996, BIOMATERIALS, V17, P2179, DOI 10.1016/0142-9612(96)00048-8
   Li YJ, 1998, CHEM MATER, V10, P1596, DOI 10.1021/cm9707869
   Li YJ, 1996, MACROMOL RAPID COMM, V17, P737, DOI 10.1002/marc.1996.030171009
   Li YJ, 1997, CHEM MATER, V9, P1570, DOI 10.1021/cm960615o
   LI YJ, 1995, MACROMOL CHEM PHYSIC, V196, P3143, DOI 10.1002/macp.1995.021961006
   Nakabayashi N, 1996, MACROMOL SYMP, V101, P405, DOI 10.1002/masy.19961010146
   NAKATA M, 1997, KOBUNSHI, V46, P558
   NAKAYA T, 1987, KAGAKU, V42, P725
   NAKAYA T, 1986, Patent No. 207395
   SAKURAI I, 1992, MACROMOLECULES, V25, P7256, DOI 10.1021/ma00052a029
   Saunders J. H., 1962, POLYURETHANE CHEM 1
   SUNG CSP, 1979, J BIOMED MATER RES, V13, P161
   TAKAHARA A, 1991, BIOMATERIALS, V12, P324, DOI 10.1016/0142-9612(91)90042-9
   TAKAHARA A, 1988, ARTIFICIAL HEART, V2, P19
   TSUCHIYA T, 1995, J BIOMED MATER RES, V29, P835, DOI 10.1002/jbm.820290708
   WARD RS, 1994, P TOP S 8 MAT CLIN A
   YAMADA M, 1995, MACROMOL RAPID COMM, V16, P25, DOI 10.1002/marc.1995.030160105
NR 32
TC 6
Z9 7
U1 0
U2 1
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0884-2914
J9 J MATER RES
JI J. Mater. Res.
PD SEP
PY 1999
VL 14
IS 9
BP 3789
EP 3798
DI 10.1557/JMR.1999.0513
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 304RX
UT WOS:000086498900043
DA 2018-10-20
ER

PT J
AU Park, HJ
   Yoo, JJ
   Kershen, RT
   Moreland, R
   Atala, A
AF Park, HJ
   Yoo, JJ
   Kershen, RT
   Moreland, R
   Atala, A
TI Reconstitution of human corporal smooth muscle and endothelial cells in
   vivo
SO JOURNAL OF UROLOGY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the Section on Urology, of the
   American-Academy-of-Pediatrics
CY OCT 17-19, 1998
CL SAN FRANCISCO, CALIFORNIA
SP Amer Acad Pediat, Sect Urol
DE penis; tissue; polymers; mice; nude; biomedical engineering
ID IN-VITRO; SYSTEM
AB Purpose: The availability of autologous erectile tissue composed of corporal smooth muscle and endothelial cells would be beneficial in patients undergoing penile reconstruction. We previously showed that cultured cavernous cells seeded on polymer scaffolds form corporal muscle when implanted in vivo. However, to reconstruct corporal tissue endothelial and corporal muscle cells are necessary. In this study we investigated the possibility of developing tissue composed of corporal cells in vivo by combining smooth muscle and endothelial cells.
   Materials and Methods: Human corporal smooth muscle and endothelial cells were seeded on biodegradable polyglycolic acid polymer scaffolds at concentrations of 20 X 10(6) and 10 x 10(6) cells per cm.(3), respectively. A total of 60 polymer scaffolds seeded with cells and 20 control polymers without cells were implanted in the subcutaneous space of 20 athymic mice. Mice were sacrificed 1, 3, 5, 7, 14, 21, 28 and 42 days, respectively, after implantation. Immunocytochemical and histochemical analyses were performed with antifactor VIII, antipancytokeratins and anti-alpha actin antibodies.
   Results: Histologically the retrieved polymers seeded with corporal smooth muscle and endothelial cells showed the formation of multilayered smooth muscle strips adjacent to endothelial cells 7 days after implantation. Increased organization of the smooth muscle tissue and accumulation of endothelium lining the luminal structures were evident by 14 days. A well organized tissue construct was noted 28 and 42 days after implantation. There was no evidence of tissue formation in controls. Immunocytochemical analysis using antifactor VIII to identify native vasculature only and antipancytokeratins to identify ECV 304 endothelial cells only distinguished the origin of the vascular structures in each construct. Anti-alpha-actin confirmed the smooth muscle phenotype.
   Conclusions: Human corporal smooth muscle and endothelial cells seeded on biodegradable polymer scaffolds formed vascularized corpus cavernosum muscle when implanted in vivo. To our knowledge this is the first demonstration in tissue engineering in which capillary formation was facilitated by the addition of endothelial cells in composite tissue in vivo.
C1 Childrens Hosp, Dept Urol, Lab Tissue Engn & Cellular Therapeut, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA USA.
   Boston Univ, Dept Urol, Boston, MA 02215 USA.
RP Park, HJ (reprint author), Childrens Hosp, Dept Urol, Lab Tissue Engn & Cellular Therapeut, 300 Longwood Ave, Boston, MA 02115 USA.
OI Atala, Anthony/0000-0001-8186-2160
CR ATALA A, 1993, J UROLOGY, V150, P608, DOI 10.1016/S0022-5347(17)35561-1
   Atala Anthony, 1997, P149
   CILENTO BG, 1994, J UROLOGY, V152, P665, DOI 10.1016/S0022-5347(17)32676-9
   GOODWIN WE, 1952, J UROLOGY, V68, P903
   HERRING M, 1978, SURGERY, V84, P498
   HORTON CE, 1990, WORLD J SURG, V14, P757, DOI 10.1007/BF01670522
   Hughes SE, 1996, EXP CELL RES, V225, P171, DOI 10.1006/excr.1996.0168
   KERSHEN RT, 1998, J UROLOGY, V159, P156
   MACHLUF M, 1998, GRAFT, V1, P31
   MORELAND RB, 1995, J UROLOGY, V153, P826, DOI 10.1016/S0022-5347(01)67730-9
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   RIEHMANN M, 1993, J UROLOGY, V149, P1304, DOI 10.1016/S0022-5347(17)36375-9
   TAKAHASHI K, 1990, IN VITRO CELL DEV B, V26, P265
   THOMPSON JA, 1988, SCIENCE, V241, P1349, DOI 10.1126/science.2457952
   WOODHOUSE CRJ, 1994, J UROLOGY, V152, P645, DOI 10.1016/S0022-5347(17)32673-3
   Yoo JJ, 1997, J UROLOGY, V158, P1066, DOI 10.1016/S0022-5347(01)64390-8
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
NR 17
TC 84
Z9 87
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD SEP
PY 1999
VL 162
IS 3
BP 1106
EP 1109
DI 10.1016/S0022-5347(01)68084-4
PN 2
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA 225NF
UT WOS:000081967100046
PM 10458441
DA 2018-10-20
ER

PT J
AU Nagpaul, PS
AF Nagpaul, PS
TI Transnational linkages of Indian science: A structural analysis
SO SCIENTOMETRICS
LA English
DT Article
ID INTERNATIONAL SCIENTIFIC COLLABORATION
AB This study analyzes the pattern of transnational linkages of Indian science in eleven scientific fields (Mathematics, Physics, Chemistry, Biology, Earth & Space Science, Agriculture, Clinical Medicine, Biomedical Research, Engineering & Technology, Computer Science, and Materials Science) during the five-year period: 1990-1994. The following indicators are constructed to examine inter-field and inter-country differences in India's transnational linkages: Internationalization index, Cooperation index, Cooperation extensiveness index and Affinity index. A four-category typology is proposed to classify the fields according to their propensities for attracting bilateral and multilateral cooperation with foreign countries.
   The structure of multidimensional system of relationships between India's thirty-five most significant partner countries and eleven scientific fields is analyzed through correspondence analysis. A series of correspondence analyses are carried out on subsets of the multidimensional data to reveal the fine-grained structure of India's cooperation links in clusters of specific fields and with clusters of specific countries.
C1 Natl Inst Sci Technol & Dev Studies, New Delhi 110012, India.
RP Nagpaul, PS (reprint author), Natl Inst Sci Technol & Dev Studies, Dr KS Krishnan Marg, New Delhi 110012, India.
CR Abd el Kader M, 1998, SCIENTOMETRICS, V42, P405, DOI 10.1007/BF02458379
   ARUNACHALAM S, 1994, SCIENTOMETRICS, V30, P7, DOI 10.1007/BF02017209
   BASU A, 1999, 7 INT INT C SCI INF
   *BIE, 1996, SCI SYST INT BENCHM
   BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806
   Braun T, 1996, SCIENTOMETRICS, V36, P247, DOI 10.1007/BF02017317
   DOBROV GM, 1990, SOCIOLOGY SCI RES
   ENGELSMAN EC, 1994, RES POLICY, V23, P1, DOI 10.1016/0048-7333(94)90024-8
   FEME G, 1989, RECHERCHE, V20, P428
   JAMBU M, 1991, EXPLORATORY MULTIVAR
   LUUKKONEN T, 1993, SCIENTOMETRICS, V28, P15, DOI 10.1007/BF02016282
   LUUKKONEN T, 1992, SCI TECHNOL HUM VAL, V17, P101, DOI 10.1177/016224399201700106
   NAGPAUL PS, 1994, SCIENTOMETRICS, V31, P97, DOI 10.1007/BF02018104
   NAGPAUL PS, 1997, TRANSNATIONAL LINKAG
   NAGPAUL PS, UNPUB EMERGING TREND
   Narin F., 1990, 12900 EUR EN COMM EU
   *OECD, 1992, SCI TECHN POL REV OU, P69
   Salomon Jean-Jacques, 1964, MINERVA, V2, P411
   TIJSSEN RJW, 1991, RES REPORT COMMISSIO
NR 19
TC 8
Z9 8
U1 4
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0138-9130
J9 SCIENTOMETRICS
JI Scientometrics
PD SEP
PY 1999
VL 46
IS 1
BP 109
EP 140
DI 10.1007/BF02766298
PG 32
WC Computer Science, Interdisciplinary Applications; Information Science &
   Library Science
SC Computer Science; Information Science & Library Science
GA 244DX
UT WOS:000083037500008
DA 2018-10-20
ER

PT J
AU Ohl, A
   Schroder, K
AF Ohl, A
   Schroder, K
TI Plasma-induced chemical micropatterning for cell culturing applications:
   a brief review
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 6th International Conference on Plasma Surface Engineering (PSE 98)
CY SEP 14-18, 1998
CL GARMISCH PARTENKI, GERMANY
SP European Joint Comm Plasma & Ion Surface Engn
DE biomaterials; cell culturing; low-temperature plasma; micropatterning;
   polymer scaffold; surface modification
ID COPLANAR MOLECULAR ASSEMBLIES; ETHYLENE-PROPYLENE FILMS; GLOW-DISCHARGE
   TREATMENT; VEIN ENDOTHELIAL-CELLS; BIOMEDICAL APPLICATIONS; SURFACE
   IMMOBILIZATION; RADIOFREQUENCY PLASMAS; BIOMATERIAL SURFACES;
   INTRAOCULAR LENSES; INITIAL ATTACHMENT
AB Plasma-induced chemical micropatterning for cell culturing is a new field of plasma surface modification of biomaterials. It is based on a trend to miniaturization of detailed structures of tissue culture scaffolds. In the present paper plasma methods are discussed with respect to other techniques which also induce micropatterned cell growth. Plasma-based methods might have certain advantages regarding modification of various biocompatible materials. Examples are given to demonstrate this. (C) 1999 Elsevier Science S.A. All rights reserved.
C1 Inst Low Temp Plasma Phys, D-17489 Greifswald, Germany.
RP Ohl, A (reprint author), Inst Low Temp Plasma Phys, FL Jahn Str 19, D-17489 Greifswald, Germany.
EM ohl@inp.greifswald.de
CR Beyer D, 1997, J BIOMED MATER RES, V36, P181, DOI 10.1002/(SICI)1097-4636(199708)36:2<181::AID-JBM6>3.0.CO;2-G
   BHATIA SK, 1992, J AM CHEM SOC, V114, P4432, DOI 10.1021/ja00037a077
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   BREUERS W, 1991, J MATER SCI-MATER M, V2, P106, DOI 10.1007/BF00703468
   BRITLAND S, 1992, EXP CELL RES, V198, P124, DOI 10.1016/0014-4827(92)90157-4
   CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0
   Chau TT, 1996, BIOMATERIALS, V17, P1273, DOI 10.1016/S0142-9612(96)80003-2
   CHESMEL K, 1989, T ANN M SOC BIOMATER, V12, P1
   Chinn J. A., 1994, Journal of Tissue Culture Methods, V16, P155, DOI 10.1007/BF01540643
   CLARK P, 1992, J CELL SCI, V103, P287
   CLARK P, 1993, J CELL SCI, V105, P203
   CLEMENCE JF, 1995, BIOCONJUGATE CHEM, V6, P411, DOI 10.1021/bc00034a011
   CONNOLLY P, 1994, TRENDS BIOTECHNOL, V12, P123, DOI 10.1016/0167-7799(94)90089-2
   CURTIS A, 1994, ENABLING TECHNOLOGIE, P99
   CURTIS ASG, 1992, J CELL SCI, V101, P427
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   DULCEY CS, 1991, SCIENCE, V252, P551, DOI 10.1126/science.2020853
   DUNN GA, 1995, BIOMEDICAL ENG, P1679
   ELOY R, 1993, J CATARACT REFR SURG, V19, P364, DOI 10.1016/S0886-3350(13)80307-0
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   Favia P., 1996, PLASMAS POLYM, V1, P299
   Flounders AW, 1997, BIOSENS BIOELECTRON, V12, P447, DOI 10.1016/S0956-5663(96)00064-4
   FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438
   Fortsch M, 1993, Ophthalmologe, V90, P754
   FROMHERZ P, 1991, NEUROSCI LETT, V129, P77, DOI 10.1016/0304-3940(91)90724-8
   Fuhr G., 1995, Journal of Cellular Engineering Incorporating Molecular Engineering, V1, P47
   HAYAT U, 1992, BIOMATERIALS, V13, P801, DOI 10.1016/0142-9612(92)90022-G
   HEALY KE, 1994, BIOTECHNOL BIOENG, V43, P792, DOI 10.1002/bit.260430814
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HETTLICH HJ, 1991, BIOMATERIALS, V12, P521, DOI 10.1016/0142-9612(91)90153-2
   HICKMAN JJ, 1994, J VAC SCI TECHNOL A, V12, P607, DOI 10.1116/1.578844
   Holland J, 1996, BIOMATERIALS, V17, P2147, DOI 10.1016/0142-9612(96)00028-2
   HOLLER C, 1993, ZBL HYG UMWELTMED, V194, P380
   Ito Y, 1997, FEBS LETT, V403, P159, DOI 10.1016/S0014-5793(97)00045-8
   JANSEN B, 1995, J IND MICROBIOL, V15, P391, DOI 10.1007/BF01569996
   JANSEN J, 1997, VACUUM SOLUTIONS, P25
   KAMEL I, 1994, Patent No. 5326584
   KANG IK, 1993, BIOMATERIALS, V14, P787, DOI 10.1016/0142-9612(93)90045-4
   KESSLER L, 1995, BIOMATERIALS, V16, P185, DOI 10.1016/0142-9612(95)92116-N
   KIAEI D, 1992, J BIOMAT SCI-POLYM E, V4, P35
   Kiss E, 1987, PROG COLLOID POLYM S, V74, P113
   KLEE D, 1995, SPEKT WISS, V9, P90
   KLEIN CPAT, 1994, BIOMATERIALS, V15, P146, DOI 10.1016/0142-9612(94)90264-X
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   KOHNEN W, 1994, BIOTECHNOLOGY AND BIOACTIVE POLYMERS, P317
   LaRocca P, 1996, CELL LINE, V6, P1
   Lhoest JB, 1996, J BIOMAT SCI-POLYM E, V7, P1039, DOI 10.1163/156856296X00534
   LOM B, 1993, J NEUROSCI METH, V50, P385, DOI 10.1016/0165-0270(93)90044-R
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P5877, DOI 10.1021/ja00066a087
   MAN N K, 1990, Artificial Organs, V14, P44
   MAROUDAS NG, 1973, NATURE, V244, P353, DOI 10.1038/244353a0
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   Matsuda T, 1992, ASAIO J, V38, pM243, DOI 10.1097/00002480-199207000-00029
   MOY E, 1994, COLLOID POLYM SCI, V272, P1245, DOI 10.1007/BF00657777
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   OHL A, 1997, P 13 INT S PLASM CHE, V3, P1259
   OKADA T, 1995, J BIOMAT SCI-POLYM E, V7, P171, DOI 10.1163/156856295X00689
   OKADA T, 1992, J BIOMED MATER RES, V26, P1569, DOI 10.1002/jbm.820261204
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   RANIERI JP, 1994, INT J DEV NEUROSCI, V12, P725, DOI 10.1016/0736-5748(94)90052-3
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   ROZSNYAI LF, 1992, ANGEW CHEM INT EDIT, V31, P759, DOI 10.1002/anie.199207591
   Schaffner AE, 1995, J NEUROSCI METH, V62, P111, DOI 10.1016/0165-0270(95)00063-1
   Schnelle T, 1996, LANGMUIR, V12, P801, DOI 10.1021/la950065t
   Seifert B, 1997, BIOMATERIALS, V18, P1495, DOI 10.1016/S0142-9612(97)00079-3
   SHAY JW, 1977, EXP CELL RES, V105, P1, DOI 10.1016/0014-4827(77)90146-X
   SHEU MS, 1993, J ADHES SCI TECHNOL, V7, P1065, DOI 10.1163/156856193X00583
   SHEU MS, 1992, J ADHES SCI TECHNOL, V6, P995, DOI 10.1163/156856192X00890
   SIGRIST H, 1995, OPT ENG, V34, P2339, DOI 10.1117/12.201815
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   SPARGO BJ, 1994, P NATL ACAD SCI USA, V91, P11070, DOI 10.1073/pnas.91.23.11070
   STEELE JG, 1994, J BIOMAT SCI-POLYM E, V6, P511, DOI 10.1163/156856294X00473
   Steele JG, 1995, ACS SYM SER, V602, P436
   STENGER DA, 1992, J AM CHEM SOC, V114, P8435, DOI 10.1021/ja00048a013
   THELEN H, 1995, FRESEN J ANAL CHEM, V353, P290, DOI 10.1007/BF00322054
   TIDWELL CD, 1997, LANGMUIR, V13, P4304
   VARGO TG, 1992, LANGMUIR, V8, P130, DOI 10.1021/la00037a025
   VARGO TG, 1995, J BIOMED MATER RES, V29, P767, DOI 10.1002/jbm.820290613
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   YUAN S, 1993, J BIOMED MATER RES, V27, P811, DOI 10.1002/jbm.820270614
NR 85
TC 84
Z9 85
U1 1
U2 14
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD SEP
PY 1999
VL 116
BP 820
EP 830
DI 10.1016/S0257-8972(99)00150-4
PG 11
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 259VG
UT WOS:000083914200130
DA 2018-10-20
ER

PT J
AU Van Alstine, JM
   Malmsten, M
   Long, MM
   Johnson, VK
   DeLucas, LJ
AF Van Alstine, JM
   Malmsten, M
   Long, MM
   Johnson, VK
   DeLucas, LJ
TI Polymer coatings for improved protein crystal growth
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE adsorption; crystal growth; DLVO; ellipsometry; PEG; polymer; protein
ID AIR-WATER-INTERFACE; POLYETHYLENE OXIDE; POLYSTYRENE SURFACES;
   POLY(ETHYLENE OXIDE); HYDROPHOBIC SURFACES; ADSORPTION BEHAVIOR;
   PLATELET-ADHESION; MOLECULAR-WEIGHT; BLOCK-COPOLYMERS; MICROGRAVITY
AB The ability to grow quality protein crystals is necessary to analyze protein structure by X-ray diffraction and related techniques. As such it plays a key role in enzymology, structure-based drug design, molecular biology, and other biomedical areas. It is also required for macromolecule purification by crystallization. Protein crystal growth (PCG) may be negatively influenced by various factors related to nonspecific adsorption and adherence at growth chamber surfaces. Such factors include nucleation and growth of flawed crystals at chamber walls, or wall growth blockage of optical monitoring paths. Surface localized poly(ethylene glycol) (PEG) and other neutral, hydrophilic polymers are known to significantly reduce nonspecific adsorption of biological macromolecules and particles. Preliminary studies, involving various PCG methods (temperature induction, vapor diffusion), apparatii (test tubes, cuvettes, and specialized PCG hardware), growth chamber materials (glass, polystyrene, polysulfone), chamber volumes (0.1-10 mi) and protein samples (lysozyme, thaumatin, insulin) indicate the potential of PEG coatings to significantly reduce problems related to adsorption in PCG. The results, which match the ability of such coatings to reduce protein adsorption as evaluated by both ellipsometry and enzyme linked immunoassay, are discussed in relation to colloidal stabilization theory and properties of PEG coated surfaces. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Royal Inst Technol, KET TS, Dept Chem Engn & Technol, SE-10044 Stockholm, Sweden.
   Univ Alabama, Dept Chem, Huntsville, AL 35899 USA.
   Inst Surface Chem, SE-11486 Stockholm, Sweden.
   Univ Alabama, Ctr Macromol Crystallog, Birmingham, AL 35294 USA.
CR AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   Azzam R. M. A., 1989, ELLIPSOMETRY POLARIZ
   BALL V, 1998, BIOPOLYMERS INTERFAC, P453
   BAMBERGER S, 1990, PROGR ASTRONAUTICS A, V130, P603
   BERGSTROM K, 1992, COLLOID SURFACE, V63, P273, DOI 10.1016/0166-6622(92)80249-2
   BERGSTROM K, 1992, J BIOMED MATER RES, V26, P779, DOI 10.1002/jbm.820260607
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   BOVIARD JH, 1982, CLIN CHEM, V28, P2423
   BOYCE JF, 1992, J COLLOID INTERF SCI, V149, P153, DOI 10.1016/0021-9797(92)90400-G
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   BURNS NL, 1995, LANGMUIR, V11, P2768, DOI 10.1021/la00007a070
   CARAVAJAL GS, 1988, ANAL CHEM, V60, P1776, DOI 10.1021/ac00168a027
   CHAPMAN D, 1993, LANGMUIR, V9, P39, DOI 10.1021/la00025a012
   COSGROVE T, 1990, COLLOID SURFACE, V51, P255, DOI 10.1016/0166-6622(90)80145-T
   DAY J, 1992, PROTEIN SCI, V1, P1254, DOI 10.1002/pro.5560011004
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   Delgado C, 1997, J CHROMATOGR B, V692, P263, DOI 10.1016/S0378-4347(96)00522-1
   DELUCAS LJ, 1994, J CRYST GROWTH, V135, P183, DOI 10.1016/0022-0248(94)90740-4
   DELUCAS LJ, 1991, J CRYST GROWTH, V109, P12, DOI 10.1016/0022-0248(91)90151-T
   Derjaguin B, 1941, ACTA PHYSICOCHIM URS, V14, P633, DOI DOI 10.1016/0079-6816(93)90013-L
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   Du H, 1997, BBA-BIOMEMBRANES, V1326, P236, DOI 10.1016/S0005-2736(97)00027-8
   EALICK SE, 1991, SCIENCE, V252, P698, DOI 10.1126/science.1902591
   Emoto K, 1996, ANAL CHEM, V68, P3751, DOI 10.1021/ac960114m
   Emoto K, 1998, LANGMUIR, V14, P2722, DOI 10.1021/la971010p
   EMOTO K, 1998, J COLLOID ITNERFACE, V202, P507
   FLEER GJ, 1993, POLYM INTERFACES
   GEORGE JN, 1972, BLOOD-J HEMATOL, V40, P862
   GILGES M, 1994, ANAL CHEM, V66, P2038, DOI 10.1021/ac00085a019
   Golander C, 1992, POLYETHYLENE GLYCOL
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   Harris JM, 1997, ACS S SERIES, V680
   Hayens C. A., 1994, COLLOID SURFACE B, V2, P517
   HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0
   HENDERSON JA, 1993, MACROMOLECULES, V26, P4591, DOI 10.1021/ma00069a027
   *HERRON JN, BIOPOLYMERS INTERFAC, P221
   HIATT CW, 1971, J CHROMATOGR, V56, P362, DOI 10.1016/S0021-9673(00)97825-7
   HOLMBERG K, BIOPOLYMERS INTERFAC, P561
   ISRAELACHVILI JN, 1992, INTERMOLECULAR SURFA
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   JONSSON U, 1982, J COLLOID INTERF SCI, V90, P148, DOI 10.1016/0021-9797(82)90408-8
   KIM S W, 1985, Critical Reviews in Biocompatibility, V1, P229
   KNOX RJ, 1998, ANAL CHEM, V11, P2268
   KOOPAL LK, 1988, J COLLOID INTERF SCI, V121, P49, DOI 10.1016/0021-9797(88)90407-9
   LANDGREN M, 1993, J PHYS CHEM-US, V97, P1656, DOI 10.1021/j100110a030
   LASIC DD, 1995, STEALTH LIPOSOMES
   Lassen B, 1997, J COLLOID INTERF SCI, V186, P9, DOI 10.1006/jcis.1996.4529
   Lassen B, 1996, J COLLOID INTERF SCI, V179, P470, DOI 10.1006/jcis.1996.0239
   Leyden D. E., 1985, SILANES SURFACES INT
   LITTKE W, 1984, SCIENCE, V225, P203, DOI 10.1126/science.225.4658.203
   Long MM, 1996, J CRYST GROWTH, V168, P233, DOI 10.1016/0022-0248(96)00325-9
   LONG MM, 1994, MICROGRAVITY SCI TEC, V7, P196
   MALMSTEN M, 1990, LANGMUIR, V6, P1572, DOI 10.1021/la00100a008
   Malmsten M, 1996, J COLLOID INTERF SCI, V177, P70, DOI 10.1006/jcis.1996.0007
   MALMSTEN M, 1994, J COLLOID INTERF SCI, V166, P333, DOI 10.1006/jcis.1994.1303
   Malmsten M, 1996, J COLLOID INTERF SCI, V178, P123, DOI 10.1006/jcis.1996.0100
   Malmsten M, 1996, J COLLOID INTERF SCI, V177, P502, DOI 10.1006/jcis.1996.0064
   Malmsten M, 1998, BIOPOLYMERS INTERFAC
   MCPHERSON A, 1988, J CRYST GROWTH, V90, P47, DOI 10.1016/0022-0248(88)90297-7
   McPherson A, 1997, TRENDS BIOTECHNOL, V15, P197, DOI 10.1016/S0167-7799(97)01041-X
   McPherson A., 1996, CRYSTALLOGR REV, V6, P157
   MCPHERSON A, 1982, PREPARATION ANAL PRO
   Napper DH, 1983, POLYM STABILIZATION
   NARAYANA SVL, 1994, J MOL BIOL, V235, P695, DOI 10.1006/jmbi.1994.1021
   NAVIA M, 1990, COMMUNICATION
   NORDE W, 1998, BIOPOLYMERS INTERFAC
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   OSTERBERG E, 1993, COLLOID SURFACE A, V77, P159, DOI 10.1016/0927-7757(93)80112-R
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   PUSEY M, 1986, J CRYST GROWTH, V76, P593, DOI 10.1016/0022-0248(86)90176-4
   Rosenberger F, 1979, FUNDAMENTALS CRYSTAL, VI
   ROSENBERGER F, 1996, J CRYSTAL GROWTH
   SCHROEN CGPH, 1995, LANGMUIR, V11, P3068, DOI 10.1021/la00008a036
   SMITH G, 1998, COMMUNICATION
   Smith GD, 1996, PROTEIN SCI, V5, P1502, DOI 10.1002/pro.5560050806
   SMITH GD, 1995, AIP C P, V325, P177
   TIBERG F, 1992, COLLOID POLYM SCI, V270, P1188, DOI 10.1007/BF01095059
   TIBERG F, 1993, LANGMUIR, V9, P927, DOI 10.1021/la00028a009
   VANALSTINE JM, 1993, COLLOID SURFACE A, V77, P149, DOI 10.1016/0927-7757(93)80111-Q
   VANALSTINE JM, 1989, ESA, P399
   VANDENBERG ET, 1991, J COLLOID INTERF SCI, V147, P103, DOI 10.1016/0021-9797(91)90139-Y
   VANOSS CJ, 1993, COLLOID SURFACE A, V78, P1, DOI 10.1016/0927-7757(93)80308-2
   VANOSS CJ, 1990, J MACROMOL SCI CHEM, VA27, P563
   VENDEL M, 1994, AICHEJ
   VENDEL M, 1996, THESIS ROYAL I TECHN
   VERWEY EJW, 1948, THEORY STABILITY LYO
   WOODLE MC, 1994, BIOCONJUGATE CHEM, V5, P493, DOI 10.1021/bc00030a001
   XU B, 1988, J CHROMATOGR, V445, P1, DOI 10.1016/S0021-9673(01)84504-0
NR 89
TC 3
Z9 3
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD AUG 15
PY 1999
VL 14
IS 1-4
BP 197
EP 211
DI 10.1016/S0927-7765(99)00036-3
PG 15
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 230UM
UT WOS:000082268800019
DA 2018-10-20
ER

PT J
AU Tsuda, T
   Nakamura, T
   Yamamoto, Y
   Teramachi, M
   Kiyotani, T
   Lee, YH
   Shimizu, Y
AF Tsuda, T
   Nakamura, T
   Yamamoto, Y
   Teramachi, M
   Kiyotani, T
   Lee, YH
   Shimizu, Y
TI Prevention of postoperative air leakage from lungs using a purified
   human collagen membrane-polyglycolic acid sheet
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
AB Background. Human amnion has useful biomedical applications because it contains a large amount of human collagen fibers. We prepared purified human collagen membrane (HCM) from human amnion and used it to develop a new sheet by combining it with synthetic bioabsorbable polyglycolic acid (PGA) mesh. We evaluated its efficacy in preventing air leakage from the lungs of dogs.
   Methods. In 20 dogs, HCM-PGA sheet (n = 5), sheets using fibrin glue with a separate application method (n = 5), a mixed application method (n = 5), and fibrin glue alone (n = 5), were used as dressing materials after partial lung resection.
   Results. The HCM-PGA sheet using fibrin glue with a separate application method was shown to be significantly more effective by an air leakage pressure test than the other three methods. These results indicate that the HCM-PGA sheet is useful for preventing air leakage from the lung.
   Conclusions. The HCM-PGA sheet is more effective than conventional fibrin glue for controlling postoperative air leakage. (C) 1999 by The Society of Thoracic Surgeons.
C1 Kyoto Univ, Biomed Engn Res Ctr, Dept Artificial Organs, Sakyo Ku, Kyoto 6068507, Japan.
RP Tsuda, T (reprint author), Kyoto Univ, Biomed Engn Res Ctr, Dept Artificial Organs, Sakyo Ku, 3 Kawahara Cho, Kyoto 6068507, Japan.
CR BERAL M, 1992, J PEDIAT SURG, V27, P597
   BURGER K, 1937, ZENTRALB GYNAECOL, V61, P2437
   ERDENER A, 1992, EUR J PEDIATR SURG, V2, P26, DOI 10.1055/s-2008-1063394
   Gharib M, 1975, MMW Munch Med Wochenschr, V117, P1555
   LIU B, 1989, ARCH DERMATOL, V125, P1084, DOI 10.1001/archderm.125.8.1084
   MASSEE JS, 1962, SURG FORUM, V13, P407
   MURALIDHARAN S, 1991, J BIOMED MATER RES, V25, P1201, DOI 10.1002/jbm.820251003
   NAKAMURA T, 1988, P 3 WORLD BIOM C APR, P277
   TRACER ML, 1979, OBSTET GYNECOL, V54, P345
   TRELFORD JD, 1973, J ONCOL, V28, P398
   Tsuda T., 1996, Japanese Journal of Artificial Organs, V25, P417
   WYNN RM, 1968, OBSTET GYNECOL, V31, P759
   YOUNG RL, 1991, FERTIL STERIL, V55, P624
NR 13
TC 22
Z9 22
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD AUG
PY 1999
VL 68
IS 2
BP 339
EP 342
DI 10.1016/S0003-4975(99)00567-6
PG 4
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 230LT
UT WOS:000082253200009
PM 10475392
DA 2018-10-20
ER

PT J
AU Recheis, W
   Weber, GW
   Schafer, K
   Knapp, R
   Seidler, H
   zur Nedden, D
AF Recheis, W
   Weber, GW
   Schafer, K
   Knapp, R
   Seidler, H
   zur Nedden, D
TI Virtual reality and anthropology
SO EUROPEAN JOURNAL OF RADIOLOGY
LA English
DT Article
DE CT; image processing; reconstructions; stereolithographic and fused
   deposition modeling; virtual reality; anthropology
ID CT-GUIDED STEREOLITHOGRAPHY; TOMOGRAPHY; IMAGES; SKULL
AB Since the discovery of the Tyrolean Iceman in 1991 advanced imaging and post processing techniques were successfully applied in anthropology. Specific techniques include spiral computed tomography and 3-dimensional reconstructions including stereolithographic and fused deposition modeling of volume data sets. The Iceman's skull was the first to be reproduced using stereolithography, before this method was successfully applied in preoperative planning. With the advent of high-end graphics workstations and biomedical image processing software packages, 3-dimensional reconstructions were established as a routine tool for analyzing volume data sets. These techniques opened totally new insights in the field of physical anthropology. Computed tomography became the ideal research tool to access the internal structures of various precious fossils without damaging or even touching them, Many of the most precious specimens from the species Autralopithecus (1.8-3.5 Myears). Homo heidelbergensis (200-600 kyears) or Homo neanderthalensis (40-100 kyears) were scanned during the last 5 years. Often the fossils are filled with a stone matrix or other materials. During the postprocessing routines highly advanced algorithms were used to remove virtually these incrustations. Thus it was possible to visualize the morphological structures that lie beneath the matrix. Some specimens were partially destroyed, so the missing parts were reconstructed on computer screen in order to get estimations of the brain volume and endocranial morphology, both major fields of interest in physical anthropology. Moreover the computerized form of the data allows new descriptions of morphologic structures by the means of 'geometric morphometrics'. Some of the results may change aspects and interpretations in human evolution. The introduction of new imaging and post processing techniques created a new field of research: Virtual Anthropology. (C) 1999 Elsevier Science ireland Ltd. All rights reserved.
C1 Univ Innsbruck Hosp Klin, Dept Radiol 2, A-6020 Innsbruck, Austria.
RP Recheis, W (reprint author), Univ Innsbruck Hosp Klin, Dept Radiol 2, Anichstr 35, A-6020 Innsbruck, Austria.
OI Schaefer, Katrin/0000-0002-0173-3092
CR ANDERL H, 1994, BRIT J PLAST SURG, V47, P60, DOI 10.1016/0007-1226(94)90121-X
   Conroy G.C., 1985, P419
   CONROY GC, 1990, SCIENCE, V247, P838, DOI 10.1126/science.2305255
   CONROY GC, 1987, NATURE, V329, P625, DOI 10.1038/329625a0
   Conroy GC, 1998, SCIENCE, V280, P1730, DOI 10.1126/science.280.5370.1730
   Jacobs PF, 1992, RAPID PROTOTYPING MA
   KALENDER WA, 1991, MED PHYS, V18, P910, DOI 10.1118/1.596607
   Kalender WA, 1989, RADIOLOGY, V173, P414
   Marcus L. F., 1996, ADV MORPHOMETRICS
   *MAYO FDN, 1995, BIOM IM RES
   PROSSINGER H, 1998, DUAL C SUN CIT
   PROSSINGER H, 1998, 67 ANN M AM ASS PHYS
   RECHEIS W, 1996, P MAN INT MAN LEIC, P105
   RECHEIS W, 1998, 67 ANN M AM ASS PHYS
   RECHEIS W, 1997, RAD SOC N AM ANN M C
   ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J
   Rubin GD, 1996, RADIOLOGY, V199, P321, DOI 10.1148/radiology.199.2.8668772
   SEIDLER H, 1992, SCIENCE, V258, P455, DOI 10.1126/science.1411539
   Seidler H, 1997, J HUM EVOL, V33, P691, DOI 10.1006/jhev.1997.0163
   UDUPA J, 1993, SPIE P, V1897, P47
   VANNIER MW, 1984, RADIOLOGY, V150, P179, DOI 10.1148/radiology.150.1.6689758
   VINING DJ, 1994, RADIOLOGY, V193, P446
   VINING DJ, 1994, RADIOLOGY, V193, P261
   Weber GW, 1998, COLLEGIUM ANTROPOL, V22, P575
   WILFING H, 1994, COLLEGIUM ANTROPOL, V18, P269
   ZONNEVELD F W, 1989, Medicamundi, V34, P117
   ZURNEDDEN D, 1994, RADIOLOGY, V193, P269, DOI 10.1148/radiology.193.1.8090905
NR 27
TC 16
Z9 17
U1 1
U2 4
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0720-048X
J9 EUR J RADIOL
JI Eur. J. Radiol.
PD AUG
PY 1999
VL 31
IS 2
BP 88
EP 96
DI 10.1016/S0720-048X(99)00089-3
PG 9
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 251RT
UT WOS:000083459200002
PM 10565508
DA 2018-10-20
ER

PT J
AU Chandra, N
   Rama, SC
   Chen, Z
AF Chandra, N
   Rama, SC
   Chen, Z
TI Critical issues in the industrial application of SPF-process modeling
   and design practices
SO MATERIALS TRANSACTIONS JIM
LA English
DT Article
DE superplasticity; process modeling; industrial application of
   superplastic forming; constitutive equation; superplastic forming design
ID SUPERPLASTIC FORMING PROCESSES; FINITE-ELEMENT METHOD; MICROMECHANICAL
   MODEL; SHEET-METAL; PRESSURE
AB With the continued use of superplastic forming (SPF) process in the manufacture of various aerospace and automotive components, there is an imminent need to accurately predict the process parameters for complex 3-D configurations. New SPF products are finding their way into architectural, rail, heavy industry, biomedical, sports and textile sectors apart from the traditional aero- and auto-industries. High fidelity process models in combination with other concurrent design tools (CAD, stress analysis, cost analysis) should be able to provide the platform necessary for the wider use of superplastic (SP) products across a range of industries. The objective of this paper is to first introduce the various industrial applications of SPF products and the design bottlenecks hindering their wider use. Practical considerations in the development of appropriate material constitutive models for superplastic materials and their relevance to numerical simulations are then discussed. Three different models including a micromechanics based model are used to describe the constitutive behavior of a selected SP material (Aluminum 5083). The performance of the models are then compared with respect to experimental results. The effect of the actual material parameters on the simulated results, and hence the design are outlined. Some of the commercial and other finite element codes used in SPF process modeling are enumerated, and the features of each of the codes with respect to the type of elements, contact/friction algorithms, and pressure-prediction schemes are compared. In closing, other practical considerations in the manufacture of SPF products, e.g., die materials, optimal SPF/DB design, alpha-casing, product thickness control are also discussed.
C1 Florida State Univ, Dept Mech Engn, Tallahassee, FL 32310 USA.
   Oakland Univ, Rochester, MI 48309 USA.
RP Chandra, N (reprint author), Florida State Univ, Dept Mech Engn, Tallahassee, FL 32310 USA.
CR ARGYRIS JH, 1984, COMPUT METHOD APPL M, V46, P83, DOI 10.1016/0045-7825(84)90130-0
   ASHBY MF, 1973, ACTA METALL MATER, V21, P149, DOI 10.1016/0001-6160(73)90057-6
   BELLET M, 1989, NUMIFORM 89, P401
   BONET J, 1990, INT J NUMER METH ENG, V30, P1719, DOI 10.1002/nme.1620300823
   BONET J, 1987, P INT C COMP PLAST M, P875
   CHANDRA N, 1992, J ENG IND-T ASME, V114, P452
   Chandra N, 1997, MAT SCI ENG A-STRUCT, V231, P134, DOI 10.1016/S0921-5093(97)00039-7
   CHANDRA N, 1994, MATER SCI FORUM, V170-, P577, DOI 10.4028/www.scientific.net/MSF.170-172.577
   CHANDRA N, 1995, SCRIPTA METALL MATER, V32, P1429, DOI 10.1016/0956-716X(95)00183-V
   CHANDRA N, 1988, INT J NUMER METH ENG, V26, P1925, DOI 10.1002/nme.1620260904
   Chandra N, 1997, SCRIPTA MATER, V36, P1327, DOI 10.1016/S1359-6462(96)00489-7
   CHANDRA N, 1991, SUPERPLASTICITY ADV, P765
   Chandra N, 1991, J MAT SHAPING TECHNO, V9, P27
   CHANDRASEKARAN N, 1987, INT J NUMER METH ENG, V24, P477, DOI 10.1002/nme.1620240302
   CORNFIELD GC, 1970, INT J MECH SCI, V12, P479, DOI 10.1016/0020-7403(70)90075-5
   Dang P, 1998, ACTA MATER, V46, P2851, DOI 10.1016/S1359-6454(97)00450-3
   GHOSH AK, 1982, METALL TRANS A, V13, P733, DOI 10.1007/BF02642386
   GHOSH AK, 1980, P ASM C PROC MOD, P420
   HAMILTON CH, 1982, SUPERPLASTIC FORMING, P173
   Hamilton CH, 1985, SUPERPLASTIC FORMING, P13
   Hamilton CH, 1988, SUPERPLASTICITY AERO, P29
   HOLT DL, 1970, INT J MECH SCI, V12, P491, DOI 10.1016/0020-7403(70)90076-7
   IWASAKI H, 1998, T JAPAN SOC MECH ENG, V64, P1390
   JOVANE F, 1968, INT J MECH SCI, V10, P403, DOI 10.1016/0020-7403(68)90005-2
   *MARC AN RES CORP, 1997, MARC FIN EL COD
   McLean D., 1957, GRAIN BOUNDARIES MET
   MURALI K, 1995, ACTA METALL MATER, V43, P1783, DOI 10.1016/0956-7151(94)00423-F
   NAKAMACHI E, 1988, INT J NUMER METH ENG, V25, P283, DOI 10.1002/nme.1620250121
   ONATE E, 1983, INT J MECH SCI, V25, P305, DOI 10.1016/0020-7403(83)90011-5
   RAMA SC, 1991, INT J NONLINEAR MECH, V26, P711, DOI 10.1016/0020-7462(91)90022-L
   RAMA SC, 1992, THESIS TEXAS A M U C
   SHERBY OD, 1994, MATER SCI FORUM, V170-, P13, DOI 10.4028/www.scientific.net/MSF.170-172.13
   VASTAVA RB, 1979, ACTA METALL MATER, V27, P251, DOI 10.1016/0001-6160(79)90103-2
   WEERTMAN J, 1955, J APPL PHYS, V26, P1213, DOI 10.1063/1.1721875
   WOOD RD, 1992, NUMIFORM 92, P843
   YANG HS, 1992, INT J MECH SCI, V34, P283, DOI 10.1016/0020-7403(92)90036-G
   ZHANG WC, 1986, P AL TECHN 86 LOND
NR 37
TC 12
Z9 13
U1 0
U2 0
PU JAPAN INST METALS
PI SENDAI
PA AOBA ARAMAKI, SENDAI, 980, JAPAN
SN 0916-1821
J9 MATER T JIM
JI Mater. Trans. JIM
PD AUG
PY 1999
VL 40
IS 8
BP 723
EP 736
DI 10.2320/matertrans1989.40.723
PG 14
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 235AK
UT WOS:000082516400004
OA Bronze
DA 2018-10-20
ER

PT J
AU Harding, G
   Schreiber, B
AF Harding, G
   Schreiber, B
TI Coherent X-ray scatter imaging and its applications in biomedical
   science and industry
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article
ID DIFFRACTION COMPUTED-TOMOGRAPHY; PHOTON SCATTERING;
   DIAGNOSTIC-RADIOLOGY; ANGLE; TISSUE; ENERGY; RADIATION; INTERFERENCE;
   OPTIMIZATION; SENSITIVITY
AB Coherent x-ray scatter (CXRS) imaging refers to the spatially-resolved measurement of the coherent scatter cross-section in localised volume elements ("voxels") of an extended object. Following a historical introduction to the subject of CXRS, an account is given of the physical principles on which it is based, Representative coherent scatter plots of materials of interest in medical and industrial applications ape presented. Several alternative measurement configurations based on angular-dispersive and energy-dispersive x-ray diffraction are described and reasons are discussed which have lead to the adoption of the latter in the bulk of published CXRS investigations.
   The coherent scatter signal is subject to various degrading effects, such as self-attenuation of the primary and scatter radiations within the object, multiple scatter and statistical (photon) noise. These effects are described and data processing procedures to account for them in order to derive useful quantitative are illustrated.
   The design of a CXRS device ("RayScan") in use at the Philips Research Labs is discussed in some detail and representative results obtained with it are presented. The utility of coherent scatter imaging is demonstrated with examples drawn from the fields of tissue characterization in the medical environment, explosives detection for airport security screening purposes and the detection of narcotics. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Philips Res Hamburg, Tech Syst Dept, D-22315 Hamburg, Germany.
RP Harding, G (reprint author), Philips Res Hamburg, Tech Syst Dept, Rontgenstr 24-26, D-22315 Hamburg, Germany.
CR ARMSTRONG R, 1993, SPIE, V2092, P411
   Barrett HH, 1981, RADIOLOGICAL IMAGING
   Barroso RC, 1998, NUCL INSTRUM METH A, V418, P458, DOI 10.1016/S0168-9002(98)00759-1
   BIRCH R, 1979, HPA SCI REPORT SERIE, V30
   BORDAS J, 1976, NATURE, V262, P541, DOI 10.1038/262541a0
   BRADLEY DA, 1984, PHYS MED BIOL, V29, P1385, DOI 10.1088/0031-9155/29/11/007
   BRADLEY DA, 1989, MED PHYS, V16, P851, DOI 10.1118/1.596310
   CHAMPENEY DC, 1973, FOURIER TRANSFORMS T
   Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001
   COOPER MJ, 1982, J PHYS E SCI INSTRUM, V15, P568, DOI 10.1088/0022-3735/15/5/022
   CORMACK AM, 1978, PHYS MED BIOL, V23, P1141, DOI 10.1088/0031-9155/23/6/010
   DYSON N. A., 1990, XRAYS ATOMIC NUCL PH
   EVANS SH, 1991, PHYS MED BIOL, V36, P7, DOI 10.1088/0031-9155/36/1/002
   GIGANTE GE, 1985, NUCL INSTRUM METH B, V12, P229, DOI 10.1016/0168-583X(85)90056-4
   GIGANTE GE, 1985, MED PHYS, V12, P321, DOI 10.1118/1.595795
   Gonzalez R. C., 1993, DIGITAL IMAGE PROCES
   GRANT JA, 1993, MEAS SCI TECHNOL, V4, P83, DOI 10.1088/0957-0233/4/1/014
   GUTKNECHT D, 1990, NUCL INSTRUM METH A, V288, P13, DOI 10.1016/0168-9002(90)90456-G
   HARDING G, 1991, PHYS MED BIOL, V36, P1573, DOI 10.1088/0031-9155/36/12/003
   HARDING G, 1990, PHYS MED BIOL, V35, P33, DOI 10.1088/0031-9155/35/1/004
   Harding G, 1997, RADIAT PHYS CHEM, V50, P91, DOI 10.1016/S0969-806X(97)00026-1
   HARDING G, 1989, NUCL INSTRUM METH A, V280, P517, DOI 10.1016/0168-9002(89)90964-9
   HARDING G, 1987, J OPT SOC AM A, V4, P933, DOI 10.1364/JOSAA.4.000933
   HARDING G, 1987, MED PHYS, V14, P515, DOI 10.1118/1.596063
   Harding G, 1995, MED PHYS, V22, P2007, DOI 10.1118/1.597497
   HARDING G, 1987, AGEING SPINE, P157
   HENTSCHEL MP, 1988, BAM MITTEILUNGSBLATT, V18, P374
   HOLT RS, 1983, PHYS MED BIOL, V28, P1435, DOI 10.1088/0031-9155/28/12/009
   Hounsfield G. N., 1973, BRIT J RADIOL, V46, P1023
   Hubbell J. H., 1975, Journal of Physical and Chemical Reference Data, V4, P471
   HUBBELL JH, 1977, J PHYS CHEM REF DATA, V6, P615, DOI 10.1063/1.555554
   HUKINS DL, 1983, XRAY DIFFRACTION DIS
   JOHNS HE, 1980, PHYSICS RADIOLOGY
   JOHNS PC, 1983, MED PHYS, V10, P40, DOI 10.1118/1.595443
   JOHNS PC, 1982, MED PHYS, V9, P231, DOI 10.1118/1.595076
   JOSEPH PM, 1982, MED PHYS, V9, P464, DOI 10.1118/1.595111
   KARELLAS A, 1983, MED PHYS, V10, P605, DOI 10.1118/1.595330
   KERR SA, 1977, T AM NUCL SOC, V33, P253
   Kleuker U, 1998, PHYS MED BIOL, V43, P2911, DOI 10.1088/0031-9155/43/10/017
   Klug H. P., 1988, XRAY DIFFRACTION PRO
   KOSANETZKY J, 1987, MED PHYS, V14, P526, DOI 10.1118/1.596143
   Leliveld CJ, 1996, IEEE T NUCL SCI, V43, P3315, DOI 10.1109/23.552743
   LUGGAR RD, 1995, P SOC PHOTO-OPT INS, V2511, P46, DOI 10.1117/12.219602
   LUGGAR RD, 1995, P SOC PHOTO-OPT INS, V2511, P56, DOI 10.1117/12.219603
   LUGGAR RD, 1993, SPIE SUBSTANCE DETEC, V2092, P378
   MARTENS G, 1993, SPIE, V2092, P387
   MORIN LRM, 1983, PHYS MED BIOL, V28, P789, DOI 10.1088/0031-9155/28/7/002
   MUNTZ EP, 1983, MED PHYS, V10, P819, DOI 10.1118/1.595360
   NDLOVU AM, 1991, MED PHYS, V18, P985, DOI 10.1118/1.596614
   NEITZEL U, 1985, PHYS MED BIOL, V30, P1289, DOI 10.1088/0031-9155/30/12/002
   NEWTON M, 1992, PHYS MED BIOL, V37, P1339, DOI 10.1088/0031-9155/37/6/010
   Peiser H.S., 1960, XRAY DIFFRACTION POL
   Peplow DE, 1998, PHYS MED BIOL, V43, P2431, DOI 10.1088/0031-9155/43/9/001
   PUUMALAINEN P, 1979, NUCL INSTRUM METHODS, V163, P261, DOI 10.1016/0029-554X(79)90058-2
   PUUMALAINEN P, 1976, RADIOLOGY, V120, P723, DOI 10.1148/120.3.723
   PUUMALAINEN P, 1977, INT J APPL RADIAT IS, V28, P785, DOI 10.1016/0020-708X(77)90110-7
   ROYLE GJ, 1991, PHYS MED BIOL, V36, P383, DOI 10.1088/0031-9155/36/3/006
   SPELLER RD, 1989, J PHYS E SCI INSTRUM, V22, P202, DOI 10.1088/0022-3735/22/4/001
   SPELLER RD, 1993, SPIE, V2092, P366
   STRECKER H, 1993, SPIE, V2092, P399
   TARTARI A, 1994, PHYS MED BIOL, V39, P219, DOI 10.1088/0031-9155/39/2/001
   Tartari A, 1996, NUCL INSTRUM METH B, V117, P325, DOI 10.1016/0168-583X(96)00313-8
   Tartari A, 1997, PHYS MED BIOL, V42, P2551, DOI 10.1088/0031-9155/42/12/018
   Westmore MS, 1996, MED PHYS, V23, P723, DOI 10.1118/1.597720
   Westmore MS, 1997, MED PHYS, V24, P3, DOI 10.1118/1.597917
NR 65
TC 74
Z9 76
U1 0
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-806X
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD AUG
PY 1999
VL 56
IS 1-2
BP 229
EP 245
DI 10.1016/S0969-806X(99)00283-2
PG 17
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA 251BZ
UT WOS:000083425900015
DA 2018-10-20
ER

PT J
AU Lahorte, P
   Mondelaers, W
   De Frenne, D
   Callens, F
   Vanhaelewyn, G
   Schacht, E
   Van Calenberg, S
   Van Cleemput, O
   Huyghebaert, A
AF Lahorte, P
   Mondelaers, W
   De Frenne, D
   Callens, F
   Vanhaelewyn, G
   Schacht, E
   Van Calenberg, S
   Van Cleemput, O
   Huyghebaert, A
TI Applied radiation research around a 15 MeV high-average-power linac
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 9th Tihany Symposium on Radiation Chemistry
CY AUG 29-SEP 03, 1998
CL TATABANYA, HUNGARY
ID MONTE-CARLO SIMULATION; EXTRACORPOREAL IRRADIATION; BREMSSTRAHLUNG
   CONVERTER; BONE-TUMORS; ALANINE; BEAMS; GENT; ESR
AB The Department of Subatomic and Radiation Physics of the University Gent is equipped with a 15 MeV 20 kW linear electron accelerator (linac) facility. In its present configuration the accelerator is used as a multipurpose apparatus for research in the fields of polymer chemistry, biomedical materials, medicine, food technology, dosimetry, solid state physics, agriculture and nuclear and radiation physics. We present an overview of both the various research projects around our linac facility involving radiation chemistry and physics and the specialised technologies facilitating this research. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 State Univ Ghent, Dept Subatom & Radiat Phys, B-9000 Ghent, Belgium.
   State Univ Ghent, Lab Crystallog & Study Solid State, B-9000 Ghent, Belgium.
   State Univ Ghent, Polymer Mat Res Grp, Dept Organ Chem, B-9000 Ghent, Belgium.
   State Univ Ghent, Dept Food Technol & Nutr, B-9000 Ghent, Belgium.
RP Mondelaers, W (reprint author), State Univ Ghent, Dept Subatom & Radiat Phys, Proeftuinstr 86, B-9000 Ghent, Belgium.
CR BAUWENS F, 1998, IN PRESS PHYS REV C
   Bertschy M, 1996, NUCL INSTRUM METH B, V113, P146, DOI 10.1016/0168-583X(95)01309-1
   Callens F, 1996, APPL RADIAT ISOTOPES, V47, P1241, DOI 10.1016/S0969-8043(96)00166-2
   GOVAERT K, 1994, NUCL INSTRUM METH A, V337, P265, DOI 10.1016/0168-9002(94)91094-4
   IBRAHIM R, 1998, J PLANT CELL TISSUE, V54, P37
   JOLIE J, 1997, P 9 INT S CAPT GAMM, V2, P873
   Materna T, 1999, NUCL INSTRUM METH B, V149, P141, DOI 10.1016/S0168-583X(98)00620-X
   Mehnert R, 1995, NUCL INSTRUM METH B, V105, P348, DOI 10.1016/0168-583X(95)00634-6
   Moerkerke R, 1998, MACROMOLECULES, V31, P2223, DOI 10.1021/ma971512+
   Mondelaers W, 1996, NUCL INSTRUM METH A, V368, P278, DOI 10.1016/0168-9002(95)00666-4
   MONDELAERS W, 1993, NUCL INSTRUM METH B, V79, P898, DOI 10.1016/0168-583X(93)95494-P
   Mondelaers W, 1998, NUCL INSTRUM METH B, V139, P43, DOI 10.1016/S0168-583X(97)00944-0
   Rakvin B, 1996, APPL RADIAT ISOTOPES, V47, P1251, DOI 10.1016/S0969-8043(96)00165-0
   Ramos MA, 1998, POWDER TECHNOL, V99, P79, DOI 10.1016/S0032-5910(98)00061-8
   Sagstuen E, 1997, J PHYS CHEM A, V101, P9763, DOI 10.1021/jp972158k
   SCHACHT E, 1998, UNPUB POLYMER
   UYTTENDAELE D, 1988, J BONE JOINT SURG BR, V70, P348
   Van Calenberg Sabine, 1998, Lebensmittel-Wissenschaft and Technologie, V31, P252, DOI 10.1006/fstl.1997.0352
   Van Laere K, 1998, J NUCL MED, V39, P1563
   VANHAELEWYN G, 1999, RADIAT RES, P152
   VANHAELEWYN G, 1998, IN PRESS APPL RAD IS
   VanLaere K, 1997, RADIAT PHYS CHEM, V49, P207, DOI 10.1016/S0969-806X(96)00061-8
   VanLaere K, 1997, RADIAT PHYS CHEM, V49, P307, DOI 10.1016/S0969-806X(96)00139-9
NR 23
TC 3
Z9 3
U1 1
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-806X
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD AUG
PY 1999
VL 55
IS 5-6
BP 761
EP 765
DI 10.1016/S0969-806X(99)00226-1
PG 5
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA 221YN
UT WOS:000081755600056
DA 2018-10-20
ER

PT J
AU Erlat, AG
   Spontak, RJ
   Clarke, RP
   Robinson, TC
   Haaland, PD
   Tropsha, Y
   Harvey, NG
   Vogler, EA
AF Erlat, AG
   Spontak, RJ
   Clarke, RP
   Robinson, TC
   Haaland, PD
   Tropsha, Y
   Harvey, NG
   Vogler, EA
TI SiOx gas barrier coatings on polymer substrates: Morphology and gas
   transport considerations
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; FILMS; PERMEATION; ALUMINA; OXYGEN; SCALE
AB Plasma-enhanced chemical vapor deposition (PECVD) of SiOx thin coatings on polymer surfaces yields tough hybrid materials with the gas barrier properties and transparency of glass. Combination of these properties makes these materials ideally suited for food packaging and biomedical device applications. In this study, we employ a Non-Parametric Response Surface Methods optimization to identify the Magnetron-PECVD conditions responsible for superlative SiOx, barrier coatings on poly(ethylene terephthalate) (PET). Oxygen and water vapor permeances of optimized PET/SiOx, composites produced by hexamethyldisiloxane and trimethylsilane have been measured as functions of temperature and are found to exhibit Arrhenius behavior. The thermal activation energy for water val,or permeation, unlike that for oxygen permeation, depends on barrier performance and increases by as much as 20 kJ/mol with an increase in barrier efficacy. Examination of these materials by phase-imaging atomic force microscopy and energy-filtered transmission electron microscopy reveals a correlation between SiOx, morphology (including defects) and barrier performance. Morphological and permeation results are compared to identify some of the physical factors governing water vapor permeation through SiOx-modified polymers.
C1 N Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
   N Carolina State Univ, Dept Chem Engn, Raleigh, NC 27695 USA.
   Becton Dickinson Technol, Polymer Sci & Technol Dept, Res Triangle Pk, NC 27709 USA.
RP Spontak, RJ (reprint author), N Carolina State Univ, Dept Mat Sci & Engn, Box 7907, Raleigh, NC 27695 USA.
CR BARKER CP, 1995, THIN SOLID FILMS, V46, P259
   Benmalek M, 1995, SURF COAT TECH, V76-77, P821, DOI 10.1016/0257-8972(95)02601-0
   BODINO F, 1994, THIN SOLID FILMS, V241, P21, DOI 10.1016/0040-6090(94)90388-3
   CHAHROUDI D, 1991, SVC 34 ANN TECHN C P, P130
   CHAHROUDI D, 1988, SVC 31 ANN TECHN C P, P145
   CHAHROUDI D, 1989, SVC 32 ANN TECHN C P, P29
   Doremus R.H., 1973, GLASS SCI
   EISENBERG D, 1969, STRUCTURE PROPERTIES, P179
   ERLAT AG, UNPUB J MAT RES
   FELTS JR, 1990, SOC VACC COAT 33 ANN, P184
   FELTS JT, 1992, J VAC SCI TECHNOL A, V10, P1675, DOI 10.1116/1.577768
   GarciaAyuso G, 1996, SURF COAT TECH, V80, P203, DOI 10.1016/0257-8972(95)02712-2
   Green P., 1994, NONPARAMETRIC REGRES
   HAALAND PD, 1997, WORKSH TOP MOD FITT
   Henry B. M., 1998, SVC 41 ANN TECHN C P, P434
   JAMIESON EHH, 1983, J MATER SCI, V18, P64, DOI 10.1007/BF00543811
   JANSEN F, 1996, AM43 NAT S AM VAC SO
   KNOLL RW, 1995, SOC VAC COAT 38 ANN, P425
   KRUG T, 1993, SVC 36 ANN TECH C P, P302
   KRUG TG, 1990, SOC VACUUM COATERS, P163
   LANGOWSKI HC, 1996, SVC 39 ANN TECHN C P, P398
   LEE JH, 1996, J ELECTROCHEM SOC, V143, P1442
   Little LH, 1966, INFRARED SPECTRA ABS
   MALLIK RR, 1992, J VAC SCI TECHNOL A, V10, P2412, DOI 10.1116/1.577976
   MARTIN Y, 1987, J APPL PHYS, V61, P4723, DOI 10.1063/1.338807
   MCDONALD RS, 1958, J PHYS CHEM-US, V62, P1168, DOI 10.1021/j150568a004
   MERCEA PV, 1991, J MEMBRANE SCI, V59, P353, DOI 10.1016/S0376-7388(00)80822-4
   MICHALSKE TA, 1987, SCI AM, V257, P122, DOI 10.1038/scientificamerican1287-122
   MISIANO C, 1993, SOC VAC COAT 36 ANN, P307
   MISIANO C, 1992, P 6 INT C VAC WEB CO
   MOULSON AJ, 1961, T FARADAY SOC, V57, P1208, DOI 10.1039/tf9615701208
   NELSON RJ, 1992, SVC 35 ANN TECHN C P, P75
   PERKINS WG, 1971, J CHEM PHYS, V54, P1683, DOI 10.1063/1.1675072
   Philips R. W., 1993, SVC 36 ANN TECHN C P, P293
   REIMER L, 1995, ENERGY FILTERING TRA
   ROBERTS AP, UNPUB
   Robinson G. W. Z., 1996, WATER BIOL CHEM PHYS
   Singh A, 1996, IND ENG CHEM RES, V35, P1231, DOI 10.1021/ie950559l
   Stannett V., 1968, DIFFUSION POLYM, P41
   THEIL JA, 1994, J VAC SCI TECHNOL A, V12, P1365, DOI 10.1116/1.579323
   Thyen R., 1997, SURF COAT TECH, V97, P26
   TROPSHA YG, 1997, J PHYS CHEM B, V101, P2239
   Vossen J. L., 1991, THIN FILM PROCESSES, V2, P443
   Wang BC, 1999, J MATER SCI LETT, V18, P311, DOI 10.1023/A:1006687324051
   WANG BC, 1997, AM CHEM SOC POLYM PR, V38, P1018
   YASUDA H, 1985, PLASMAS POLYM, P277
   1994, Patent No. 5364666
NR 47
TC 177
Z9 178
U1 10
U2 59
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1089-5647
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD JUL 22
PY 1999
VL 103
IS 29
BP 6047
EP 6055
DI 10.1021/jp990737e
PG 9
WC Chemistry, Physical
SC Chemistry
GA 222CM
UT WOS:000081765900020
DA 2018-10-20
ER

PT J
AU Rimmer, S
   Tattersall, P
   Ebdon, JR
   Fullwood, N
AF Rimmer, S
   Tattersall, P
   Ebdon, JR
   Fullwood, N
TI New strategies for the synthesis of amphiphilic networks
SO REACTIVE & FUNCTIONAL POLYMERS
LA English
DT Article; Proceedings Paper
CT 8th International Conference on Polymer-Based Technology (POC 98)
CY JUN 28-JUL 02, 1998
CL MAALE HACHAMISHA, ISRAEL
DE amphiphilic networks
ID RADICAL POLYMERIZATION; METHYL-METHACRYLATE; BIOCOMPATIBILITY; POLYMERS;
   RELEASE
AB Amphiphilic and hydrogel polymers are useful biomedical materials. This paper presents some recent work on new syntheses of such materials. Amphiphilic gels have been prepared by the Diels-Alder reaction of poly(ethylene glycol)s that contain acetylene dicarboxylate groups along the main chain, with furan-ended oligomers. Hexyl methacrylate oligomers with methacrylate end groups have been prepared. These have been copolymerized with hydrophilic monomers to yield segmented amphiphilic gels. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Univ Lancaster, Ctr Polymer, Lancaster LA1 4YA, England.
RP Rimmer, S (reprint author), Univ Lancaster, Ctr Polymer, Lancaster LA1 4YA, England.
OI Ebdon, John/0000-0003-4176-3912; Fullwood, Nigel
   James/0000-0002-9405-8515
CR BLEZER R, 1995, POLYM BULL, V34, P101, DOI 10.1007/BF00294894
   Carrot G, 1998, POLYM BULL, V40, P181, DOI 10.1007/s002890050240
   CHEN D, 1988, J MACROMOL SCI CHEM, VA25, P389, DOI 10.1080/00222338808053376
   CHEN D, 1989, J BIOMED MATER RES, V23, P1327, DOI 10.1002/jbm.820231109
   Dellerba M., 1997, MACROMOL RAPID COMM, V18, P723
   Ebdon JR, 1997, J POLYM SCI POL CHEM, V35, P3255, DOI 10.1002/(SICI)1099-0518(19971115)35:15<3255::AID-POLA19>3.3.CO;2-K
   EBDON JR, 1995, J MACROMOL SCI PURE, VA32, P603, DOI 10.1080/10601329508018949
   EBDON JR, 1991, NEW METHODS POLYM SY
   GADKARI A, 1989, POLYM BULL, V22, P25
   Haddleton DM, 1998, POLYMER, V39, P3119, DOI 10.1016/S0032-3861(97)10116-1
   IVAN B, 1990, ABSTR PAP AM CHEM S, V200, P302
   IVAN B, 1990, ABSTR PAP AM CHEM S, V200, P301
   Ivan B, 1996, MACROMOL SYMP, V102, P81, DOI 10.1002/masy.19961020112
   KENNEDY JP, 1994, J MACROMOL SCI PURE, VA31, P1771, DOI 10.1080/10601329408545881
   KESZLER B, 1992, POLYM BULL, V29, P681, DOI 10.1007/BF01041155
   KESZLER B, 1994, J POLYM SCI POL CHEM, V32, P3153, DOI 10.1002/pola.1994.080321616
   LEE HS, 1991, POLYM BULL, V26, P689, DOI 10.1007/BF00313225
   Listigovers NA, 1997, ABSTR PAP AM CHEM S, V214, P181
   Matyjaszewski K, 1998, J POLYM SCI POL CHEM, V36, P823, DOI 10.1002/(SICI)1099-0518(19980415)36:5<823::AID-POLA15>3.3.CO;2-D
   Park D, 1997, J APPL POLYM SCI, V66, P901, DOI 10.1002/(SICI)1097-4628(19971031)66:5<901::AID-APP10>3.0.CO;2-Q
   PARK D, 1995, MACROMOLECULES, V28, P2595, DOI 10.1021/ma00112a001
   Rimmer S, 1996, J POLYM SCI POL CHEM, V34, P3573, DOI 10.1002/(SICI)1099-0518(199612)34:17<3573::AID-POLA12>3.0.CO;2-B
   Rimmer S, 1996, J POLYM SCI POL CHEM, V34, P3591
   Shamlou S, 1997, J BIOMED MATER RES, V35, P157, DOI 10.1002/(SICI)1097-4636(199705)35:2<157::AID-JBM3>3.0.CO;2-M
   Ueda J, 1998, MACROMOLECULES, V31, P557, DOI 10.1021/ma970476b
   YU H, 1995, J CONTROL RELEASE, V34, P117, DOI 10.1016/0168-3659(94)00127-G
   1987, ICI POLYURETHANES
NR 27
TC 25
Z9 26
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-5148
J9 REACT FUNCT POLYM
JI React. Funct. Polym.
PD JUL 15
PY 1999
VL 41
IS 1-3
BP 177
EP 184
DI 10.1016/S1381-5148(99)00035-8
PG 8
WC Chemistry, Applied; Engineering, Chemical; Polymer Science
SC Chemistry; Engineering; Polymer Science
GA 218RD
UT WOS:000081564700021
DA 2018-10-20
ER

PT J
AU Rachev, A
   Hayashi, K
AF Rachev, A
   Hayashi, K
TI Theoretical study of the effects of vascular smooth muscle contraction
   on strain and stress distributions in arteries
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE vascular mechanics; active stress; residual strain; myogenic response
ID RESIDUAL-STRESSES; RABBIT; CONSTRICTION; MECHANICS; SEGMENTS; TISSUES;
   RAT
AB To study the effects of smooth muscle contraction and relaxation on the strain and stress distribution in the vascular wall, a mathematical model was proposed. The artery was assumed to be a thick-walled orthotropic tube made of nonlinear, incompressible elastic material. Considering that the contraction of smooth muscle generates an active circumferential stress in the wall, a numerical study was performed using data available in the literature. The results obtained showed that smooth muscle contraction affects the residual strains which exist in a ring segment cut out from the artery and exposed to no external load. When the ring specimen is cut radially, it springs open with an opening angle. The predicted monotonic increase of the opening angle with increasing muscular tone was in agreement with recent experimental results reported in the literature. It was shown that basal muscular tone, which exists under physiological conditions, reduces the strain gradient in the arterial wall and yields a near uniform stress distribution. During temporary changes in blood pressure, the increase in muscular tone induced by elevated pressure tends to restore the distribution of circumferential strain in the arterial wall, and to maintain the dow-induced wall shear stress to normal level. (C) 1999 Biomedical Engineering Society. [S0090-6964(99)00404-X].
C1 Bulgarian Acad Sci, Inst Mech, BU-1113 Sofia, Bulgaria.
   Osaka Univ, Div Mech Sci, Dept Syst & Human Sci, Grad Sch Engn Sci, Toyonaka, Osaka 560, Japan.
RP Rachev, A (reprint author), Bulgarian Acad Sci, Inst Mech, Acad G Bonchev Str,Bl 4, BU-1113 Sofia, Bulgaria.
CR Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220
   CHUONG CJ, 1986, J BIOMECH ENG-T ASME, V108, P189, DOI 10.1115/1.3138600
   CHUONG CJ, 1983, J BIOMECH ENG-T ASME, V105, P268, DOI 10.1115/1.3138417
   COX RH, 1978, AM J PHYSIOL, V234, pH280
   COX RH, 1978, AM J PHYSIOL, V234, pH542
   Dobrin P. B., 1973, AM J PHYSIOL, V225, P644
   Dobrin P. B., 1983, HDB PHYSL 2, V3, P65
   FUNG YC, 1989, CIRC RES, V65, P1340, DOI 10.1161/01.RES.65.5.1340
   FUNG YC, 1991, ANN BIOMED ENG, V19, P237, DOI 10.1007/BF02584301
   FUNG YC, 1984, BIODYNAMICS CIRCULAT
   HAYASHI K, 1993, P 3 C BIOM TOK JSME, P61
   Johnson PC., 1980, HDB PHYSL 2, VII, P409
   Matsumoto T, 1996, J BIOMECH ENG-T ASME, V118, P62, DOI 10.1115/1.2795947
   Matsumoto T., 1997, INT J CARDIOVASC MED, V1, P21
   MATSUMOTO T, 1996, AM J PHYSIOL, V271, pJ1711
   Rachev A, 1997, J BIOMECH, V30, P819, DOI 10.1016/S0021-9290(97)00032-8
   RODBARD S, 1970, PERSPECT BIOL MED, V13, P507
   Sipkema P, 1997, ANN BIOMED ENG, V25, P278, DOI 10.1007/BF02648042
   TAKAMIZAWA K, 1987, J BIOMECH, V20, P7, DOI 10.1016/0021-9290(87)90262-4
   TAKAMIZAWA K, 1992, AM J PHYSIOL, V263, pH30
   Vishnav R, 1983, BIOMEDICAL ENG, P330
   VITO RP, 1980, J BIOMECH, V13, P951, DOI 10.1016/0021-9290(80)90166-9
   Zeller PJ, 1998, J VASC RES, V35, P8, DOI 10.1159/000025560
NR 23
TC 154
Z9 157
U1 2
U2 10
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
   USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL-AUG
PY 1999
VL 27
IS 4
BP 459
EP 468
DI 10.1114/1.191
PG 10
WC Engineering, Biomedical
SC Engineering
GA 270CM
UT WOS:000084517900005
PM 10468230
DA 2018-10-20
ER

PT J
AU Yuan, HC
   Westwick, DT
   Ingenito, EP
   Lutchen, KR
   Suki, B
AF Yuan, HC
   Westwick, DT
   Ingenito, EP
   Lutchen, KR
   Suki, B
TI Parametric and nonparametric nonlinear system identification of lung
   tissue strip mechanics
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE stress relaxation; long memory; fractals; Wiener model; collagen fibers;
   elastin fibers; network
ID BIOLOGICAL-SYSTEMS; KERNEL ESTIMATION; FREQUENCY; VISCOELASTICITY;
   PARENCHYMA; VOLUME; MODEL; DOG
AB Lung parenchyma is a soft biological material composed of many interacting elements such as the interstitial cells, extracellular collagen-elastin fiber network, and proteoglycan ground substance. The mechanical behavior of this delicate structure is complex showing several mild but distinct types of nonlinearities and a fractal-like long memory stress relaxation characterized by a power-law function. To characterize tissue nonlinearity in the presence of such long memory, we investigated the robustness and predictive ability of several nonlinear system identification techniques on stress-strain data obtained from lung tissue strips with various input wave forms. We found that in general, for a mildly nonlinear system with long memory, a nonparametric nonlinear system identification in the frequency domain is preferred over time-domain techniques. More importantly, if a suitable parametric nonlinear model is available that captures the long memory of the system with only a few parameters, high predictive ability with substantially increased robustness can be achieved. The results provide evidence that the first-order kernel of the stress-strain relationship is consistent with a fractal-type long memory stress relaxation and the nonlinearity can be described as a Wiener-type nonlinear structure for displacements mimicking tidal breathing. (C) 1999 Biomedical Engineering Society. [S0090-6964(99)00804-8].
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   Brigham & Womens Hosp, Boston, MA 02115 USA.
RP Suki, B (reprint author), Boston Univ, Dept Biomed Engn, 44 Cummington St, Boston, MA 02215 USA.
OI Westwick, David/0000-0002-1470-6800
CR BARNAS GM, 1992, J APPL PHYSIOL, V72, P87
   BATES JHT, 1994, ANN BIOMED ENG, V22, P674, DOI 10.1007/BF02368292
   BATES JHT, 1998, ANN BIOMED ENG, V26, P1
   BAYLISS L. E., 1939, QUART JOUR EXP PHYSIOL, V29, P27
   Csendes T., 1988, Acta Cybernetica, V8, P361
   FREDBERG JJ, 1993, J APPL PHYSIOL, V74, P1387
   FUNG YC, 1972, BIOMECHANICS ITS FDN, P181
   HANTOS Z, 1992, J APPL PHYSIOL, V72, P168
   HILDEBRA.J, 1970, J APPL PHYSIOL, V28, P365
   HILDEBRANDT J, 1969, B MATH BIOPHYS, V31, P651, DOI 10.1007/BF02477779
   HILDEBRANDT J, 1969, J APPL PHYSIOL, V27, P246
   HUNTER IW, 1986, BIOL CYBERN, V55, P135
   Korenberg MJ, 1996, ANN BIOMED ENG, V24, P250, DOI 10.1007/BF02667354
   KORENBERG MJ, 1991, ANN BIOMED ENG, V19, P429, DOI 10.1007/BF02584319
   KORENBERG MJ, 1989, ADV METHODS PHYSL SY, V2, P165
   LJUNG L, 1987, SYSTEM IDENTIFICATIO
   LUTCHEN KR, 1994, J APPL PHYSIOL, V77, P373
   Maksym GN, 1997, ANN BIOMED ENG, V25, P1000
   Maksym GN, 1997, J APPL PHYSIOL, V82, P32
   Maksym GN, 1998, ANN BIOMED ENG, V26, P242, DOI 10.1114/1.119
   MAKSYM GN, 1996, THESIS MCGILL U MONT
   MIJAILOVICH SM, 1994, J APPL PHYSIOL, V76, P773
   SALAZAR E, 1964, J APPL PHYSIOL, V19, P97
   SCHENTZEN M, 1989, VOLTERRA WIENER THEO
   SUKI B, 1995, J APPL PHYSIOL, V79, P660
   SUKI B, 1992, IEEE T BIO-MED ENG, V39, P1142, DOI 10.1109/10.168693
   SUKI B, 1994, J APPL PHYSIOL, V76, P2749
   VICTOR J, 1980, BIOPHYS J, V29, P459, DOI 10.1016/S0006-3495(80)85146-0
   WEST BJ, 1990, ANN BIOMED ENG, V18, P135, DOI 10.1007/BF02368426
   Westwick DT, 1997, ANN BIOMED ENG, V25, P802, DOI 10.1007/BF02684164
   Yuan HC, 1997, J APPL PHYSIOL, V83, P1420
   Zhang Q, 1998, ANN BIOMED ENG, V26, P103, DOI 10.1114/1.82
   Zhang Q, 1999, ANN BIOMED ENG, V27, P1, DOI 10.1114/1.186
NR 33
TC 18
Z9 18
U1 0
U2 3
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
   USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL-AUG
PY 1999
VL 27
IS 4
BP 548
EP 562
DI 10.1114/1.217
PG 15
WC Engineering, Biomedical
SC Engineering
GA 270CM
UT WOS:000084517900014
PM 10468239
DA 2018-10-20
ER

PT J
AU Browne, M
   Langley, RS
   Gregson, PJ
AF Browne, M
   Langley, RS
   Gregson, PJ
TI Reliability theory for load bearing biomedical implants
SO BIOMATERIALS
LA English
DT Article
DE reliability theory; biomedical devices; tibial tray; lifetime prediction
ID 2ND-ORDER RELIABILITY; DESIGN; LEVEL
AB At present, load-bearing implants are designed on a deterministic basis int which the structural strength and applied loading are given fixed values, and global safety factors are applied to (i) cover any uncertainties in these quantities, and (ii) to design against failure of the component. This approach will become increasingly inappropriate as younger and more active patient demands become more exacting and as devices become more complex. The present work describes a preliminary investigation in which a scientific and probabilistic technique is applied to assess the structural integrity of the knee tibial tray. It is envisaged that by applying such a technique to other load bearing biomedical devices, reliability theory may aid in future lifing procedures and materials/design optimisation. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Univ Southampton, Dept Mat Engn, Southampton SO17 1BJ, Hants, England.
   Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.
RP Browne, M (reprint author), Univ Southampton, Dept Mat Engn, Southampton SO17 1BJ, Hants, England.
RI Browne, Martin/M-8229-2013
OI Browne, Martin/0000-0001-5184-050X
CR American Society for Testing and Materials (ASTM), 1997, ANN BOOK ASTM STAND
   [Anonymous], 148791 ISO
   BIRNBAUM ZW, 1969, J APPL PROBAB, V6, P319, DOI 10.2307/3212003
   BOGDANOFF JL, 1985, PROBABILISTIC MODELS
   Boyer C, 1997, RELIAB ENG SYST SAFE, V56, P273, DOI 10.1016/S0951-8320(96)00095-6
   Breitung K, 1996, MATH MODELS STRUCTUR, P227
   Cawlfield JD, 1997, J STAT COMPUT SIM, V57, P353, DOI 10.1080/00949659708811817
   Der Kiureghian A, 1998, STRUCT SAF, V20, P37, DOI 10.1016/S0167-4730(97)00026-X
   *DTI MTS, CAM2 DTIMTS
   Farhangdoost K, 1996, ENG FRACT MECH, V53, P687, DOI 10.1016/0013-7944(95)00131-X
   FREUDENTHAL AM, 1961, STRUCTURAL SAFETY CO, P61
   GALANTE JO, 1975, J BONE JOINT SURG AM, VA 57, P230, DOI 10.2106/00004623-197557020-00017
   KARAMCHANDANI A, 1992, STRUCT SAF, V11, P95, DOI 10.1016/0167-4730(92)90002-5
   Langley RS, 1995, P I MECH ENG G-J AER, V209, P291, DOI 10.1243/PIME_PROC_1995_209_303_02
   Madsen H. O., 1986, METHODS STRUCTURAL S
   PARIS PC, 1963, T ASME D, V85, P528
   PAYNE AO, 1972, ASTM STP, V511, P106
   Pu Y, 1997, J OFFSHORE MECH ARCT, V119, P270, DOI 10.1115/1.2829107
   ROSTOKER W, 1978, J BIOMED MATER RES, V12, P635, DOI 10.1002/jbm.820120506
   SCOTT PM, 1981, FATIGUE ENG MATER, V4, P291, DOI 10.1111/j.1460-2695.1981.tb01127.x
   THROFTCHRISTENS.P, 1982, STRUCTURAL RELIABILI
   Yang J. N., 1987, PROBABILISTIC FRACTU, P171
NR 22
TC 23
Z9 23
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 1999
VL 20
IS 14
BP 1285
EP 1292
DI 10.1016/S0142-9612(99)00027-7
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 207AD
UT WOS:000080912400005
PM 10403046
DA 2018-10-20
ER

PT J
AU Sumiyoshi, T
   Sekita, H
   Arai, T
   Sato, S
   Ishihara, M
   Kikuchi, M
AF Sumiyoshi, T
   Sekita, H
   Arai, T
   Sato, S
   Ishihara, M
   Kikuchi, M
TI High-power continuous-wave 3-and 2-mu m cascade Ho3+: ZBLAN fiber laser
   and its medical applications
SO IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS
LA English
DT Article
DE holmium; infrared lasers; laser biomedical applications; laser
   materials-processing applications; optical fiber lasers; Raman lasers
ID MU-M; ERBIUM; WATER; CW; TRANSITIONS; OPERATION; GLASS
AB A new medical fiber laser oscillating at two useful wavelengths (3 and 2 mu m) is reported. We have demonstrated highly efficient and high-power continuous-wave cascade oscillation at room temperature with a holmium ion-doped fluoride glass fiber laser pumped with a 1.15-mu m fiber Raman laser. The simultaneous oscillation wavelengths were 3 and 2 mu m, and their combined output power was 3.0 W with a slope efficiency of 65%, To our best knowledge, this is the first achievement of watt-level-output power in the mid infrared region with ZrF4-BaF2-LaF3-AlF3-NaF (ZBLAN) glass fiber. In experiments to evaluate potential for medical applications, we tested the two-wavelength beam as a laser surgical knife on soft rabbit tissues and demonstrated that it had strong cutting capability, and that the coagulation layer thickness could be controlled by varying the power ratio of the two-wavelength laser.
C1 NEC Corp Ltd, Optoelect & High Frequency Device Res Labs, Miyamae Ku, Kawasaki, Kanagawa 2168555, Japan.
   Natl Def Med Coll, Dept Med Engn, Tokorozawa, Saitama 3598513, Japan.
   Natl Def Med Coll, Inst Res, Div Biomed Informat Sci, Tokorozawa, Saitama 3598513, Japan.
RP Sumiyoshi, T (reprint author), NEC Corp Ltd, Optoelect & High Frequency Device Res Labs, Miyamae Ku, Kawasaki, Kanagawa 2168555, Japan.
CR BAYLY JG, 1963, INFRARED PHYS, V3, P211, DOI 10.1016/0020-0891(63)90026-5
   BUDNI PA, 1998, OSA TRENDS OPTICS PH, V19, P204
   Chernikov SV, 1998, ELECTRON LETT, V34, P680, DOI 10.1049/el:19980421
   DOWNING HD, 1975, J GEOPHYS RES, V80, P1656, DOI 10.1029/JC080i012p01656
   HAMILTON CE, 1994, OPT LETT, V19, P1627, DOI 10.1364/OL.19.001627
   Jensen T, 1996, OPT LETT, V21, P585, DOI 10.1364/OL.21.000585
   KINTZ GJ, 1987, APPL PHYS LETT, V50, P1553, DOI 10.1063/1.97777
   MUENDEL M, 1997, OSA TECH DIG SER, V10
   PAGE RH, 1997, OSA TRENDS OPTICS PH, V10, P214
   PASK HM, 1995, IEEE J SEL TOP QUANT, V1, P2, DOI 10.1109/2944.468377
   PERCIVAL RM, 1992, ELECTRON LETT, V28, P1866, DOI 10.1049/el:19921194
   Pollnau M, 1997, IEEE J QUANTUM ELECT, V33, P1982, DOI 10.1109/3.641313
   Pollnau M, 1997, OPT LETT, V22, P612, DOI 10.1364/OL.22.000612
   Pratisto H, 1996, APPL OPTICS, V35, P3328, DOI 10.1364/AO.35.003328
   PRATISTO H, 1995, APPL PHYS LETT, V67, P1963, DOI 10.1063/1.114580
   SCHNEIDER J, 1995, ELECTRON LETT, V31, P1250, DOI 10.1049/el:19950858
   SHNERDER J, 1995, IEEE PHOTONIC TECH L, V7, P354
   STONEMAN RC, 1992, OPT LETT, V17, P816, DOI 10.1364/OL.17.000816
   Sumiyoshi T, 1998, OPT LETT, V23, P1837, DOI 10.1364/OL.23.001837
   SUMIYOSHI T, 1997, P IEEE LEOS 1997 ANN
   TANIMURA K, 1984, PHYS REV B, V30, P2429, DOI 10.1103/PhysRevB.30.2429
   WAARTS R, 1994, OPT LETT, V19, P1738, DOI 10.1364/OL.19.001738
   WETENKAMP L, 1990, ELECTRON LETT, V26, P883, DOI 10.1049/el:19900577
   WETENKAMP L, 1992, J NON-CRYST SOLIDS, V140, P35, DOI 10.1016/S0022-3093(05)80737-9
NR 24
TC 71
Z9 75
U1 2
U2 22
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 1077-260X
J9 IEEE J SEL TOP QUANT
JI IEEE J. Sel. Top. Quantum Electron.
PD JUL-AUG
PY 1999
VL 5
IS 4
BP 936
EP 943
DI 10.1109/2944.796314
PG 8
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA 248CM
UT WOS:000083257800010
DA 2018-10-20
ER

PT J
AU Fried, NM
   Hung, VC
   Walsh, JT
AF Fried, NM
   Hung, VC
   Walsh, JT
TI Laser tissue welding: Laser spot size and beam profile studies
SO IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS
LA English
DT Article
DE denaturation; laser biomedical applications; laser materials-processing
   applications; laser welding; Monte Carlo methods; optical propagation
ID OPTICAL PROPERTY CHANGES; CARBON-DIOXIDE LASER; MULTILAYERED TISSUES;
   ND-YAG; MYOCARDIUM; DIAMETER; CLOSURE; IRRADIATION
AB This paper evaluates the effect of laser spot diameter and beam profile on the shape of the thermal denaturation zone produced during laser tissue welding, 2-cm-long full-thickness incisions were made on the epilated backs of guinea pigs in vivo. India ink was used as an absorber and clamps were used to appose the incision edges. Welding was performed using continuous-wave 1.06-mu m, Nd:YAG laser radiation scanned over the incisions to produce similar to 100-ms pulses. Laser spot diameters of 1, 2, 4, and 6 mm were studied, With powers of 1, 4, 16, and 36 W, respectively. The irradiance remained constant at 127 W/cm(2). Monte Carlo simulations were also conducted to examine the effect of laser spot size and beam profile on the distribution of photons absorbed in the tissue, The laser spot diameter was varied from 1 to 6 mm, Gaussian, Bat-top, dual Gaussian, and dual flat-top beam profiles were studied. The experimental results showed that 1-, 2-,4-, and 6-mm-diameter spots produced thermal denaturation to an average depth of 570, 970, 1470, and 1900 mu m, respectively. Monte Carlo simulations demonstrated that the most uniform distribution of photon absorption is achieved using large diameter dual hat-top beams.
C1 Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
RP Fried, NM (reprint author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.
RI Walsh, Joseph/B-7636-2009
CR ABERGEL RP, 1986, J DERMATOL SURG ONC, V12, P1181, DOI 10.1111/j.1524-4725.1986.tb02103.x
   Bass LS, 1995, LASER SURG MED, V17, P315, DOI 10.1002/lsm.1900170402
   Cheong W., 1995, OPTICAL THERMAL RESP
   DERBYSHIRE GJ, 1990, LASER SURG MED, V10, P28, DOI 10.1002/lsm.1900100108
   Fried NM, 1998, J BIOMED OPT, V3, P401, DOI 10.1117/1.429850
   FRIED NM, IN PRESS SUTURELESS
   GARDEN JM, 1986, LASER SURG MED, V6, P67, DOI 10.1002/lsm.1900060114
   Jacques S. L., 1995, OPTICAL THERMAL RESP
   JACQUES SL, 1989, P IEEE EMBS, V11, P1199, DOI 10.1109/IEMBS.1989.96158
   JAYWANT S, 1993, P SOC PHOTO-OPT INS, V1882, P218, DOI 10.1117/12.148080
   KEIJZER M, 1989, LASER SURG MED, V9, P148, DOI 10.1002/lsm.1900090210
   KEIJZER M, 1991, LASER SURG MED, V11, P601, DOI 10.1002/lsm.1900110616
   Kienle A, 1997, LASER SURG MED, V20, P346, DOI 10.1002/(SICI)1096-9101(1997)20:3<346::AID-LSM14>3.0.CO;2-B
   KIM BM, 1995, P SOC PHOTO-OPT INS, V2391, P443, DOI 10.1117/12.209911
   PICKERING JW, 1993, APPL OPTICS, V32, P367, DOI 10.1364/AO.32.000367
   PICKERING JW, 1992, J PHOTOCH PHOTOBIO B, V16, P101, DOI 10.1016/1011-1344(92)80002-D
   PICKERING JW, 1994, LASER SURG MED, V15, P200, DOI 10.1002/lsm.1900150208
   Poppas DP, 1996, LASER SURG MED, V18, P335, DOI 10.1002/(SICI)1096-9101(1996)18:4<335::AID-LSM2>3.0.CO;2-T
   ROBINSON JK, 1987, ANN PLAS SURG, V18, P499, DOI 10.1097/00000637-198706000-00006
   ROGGAN A, 1995, LASER INDUCED INTERS
   SPLINTER R, 1991, LASER SURG MED, V11, P117, DOI 10.1002/lsm.1900110205
   TAN OT, 1988, J INVEST DERMATOL, V90, P877, DOI 10.1111/1523-1747.ep12462144
   THOMSEN S, 1993, P SOC PHOTO-OPT INS, V1882, P230, DOI 10.1117/12.147663
   WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F
   Wang LH, 1997, COMPUT METH PROG BIO, V54, P141, DOI 10.1016/S0169-2607(97)00021-7
   WIDER TM, 1991, PLAST RECONSTR SURG, V88, P1018, DOI 10.1097/00006534-199112000-00011
NR 26
TC 10
Z9 10
U1 0
U2 6
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 1077-260X
J9 IEEE J SEL TOP QUANT
JI IEEE J. Sel. Top. Quantum Electron.
PD JUL-AUG
PY 1999
VL 5
IS 4
BP 1004
EP 1012
DI 10.1109/2944.796323
PG 9
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA 248CM
UT WOS:000083257800019
DA 2018-10-20
ER

PT J
AU Zdrahala, RJ
   Zdrahala, IJ
AF Zdrahala, RJ
   Zdrahala, IJ
TI Biomedical applications of polyurethanes: A review of past promises,
   present realities, and a vibrant future
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
ID PACEMAKER LEADS; HEART-VALVE; CALCIFICATION; ELASTOMERS; CATHETERS
AB Polyurethanes, having extensive structure/property diversity, are one of the most bio- and blood-compatible materials known today. These materials played a major role in the development of many medical devices ranging from catheters to total artificial heart. Properties such as durability, elasticity, elastomer-like character, fatigue resistance, compliance, and acceptance or tolerance in the body during the healing, became often associated with polyurethanes. Furthermore, propensity for bulk and surface modification via hydrophilic/hydrophobic balance or by attachments of biologically active species such as anticoagulants or biorecognizable groups are possible via chemical groups typical for polyurethane structure. These modifications are designed to mediate and enhance the acceptance and healing of the device or implant. Many innovative processing technologies are used to fabricate functional devices, feeling and often behaving like natural tissue.
   The hydrolytically unstable polyester polyurethanes were replaced by more resistant but oxidation-sensitive polyether polyols based polyurethanes and their clones containing silicone and other modifying polymeric intermediates. Chronic in vivo instability, however, observed on prolonged implantation, became a major roadblock for many applications.
   Presently, utilization of more oxidation resistant polycarbonate polyols as soft segments, in combination with antioxidants such as Vitamin E, offer materials which can endure in the body for several years. The applications cover cardiovascular devices, artificial organs, tissue replacement and augmentation, performance enhancing coatings and many others. In situ polymerized, cross-linked systems could extend this biodurability even further.
   The future will expand this field by revisiting chemically-controlled biodegradation, in combination with a mini-version of RIM technology and minimally invasive surgical procedures, to form, in vivo, a scaffold, by delivery of reacting materials to the specific site in the body and polymerizing the mass in situ. This scaffold will provide anchor for tissue regeneration via cell attachment, proliferation, control of inflammation, and healing.
C1 R&I Consulting Int, Eden Prairie, MN 55346 USA.
CR BERNACCA GM, 1995, BIOMATERIALS, V16, P279, DOI 10.1016/0142-9612(95)93255-C
   Boretos J W, 1971, J Biomed Mater Res, V5, P373, DOI 10.1002/jbm.820050408
   BORETOS JW, 1975, J BIOMED MATER RES, V9, P327, DOI 10.1002/jbm.820090308
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   BORETOS JW, 1980, PURE APPL CHEM, V52, P1851, DOI 10.1351/pac198052071851
   BRASH JL, 1973, J BIOMED MATER RES, V7, P313, DOI 10.1002/jbm.820070405
   COLOVOS GC, 1977, SPE TECHN C DENV CO
   COOPER SL, 1966, J APPL POLYM SCI, V10, P1837, DOI 10.1002/app.1966.070101204
   CRITCHFIELD FE, 1971, RUBBER WORLD, V164, P61
   CRITCHFIELD FE, 1972, J ELASTOPLAST, V4, P22
   *ETH INC, 1975, TECHN PROD INF
   FELT JC, 1997, T 13 EUR C BIOM ESB, V13, pP152
   FELT JC, 1996, Patent No. 5556429
   FURMAN S, 1967, J THORAC CARDDIOVASC, V55, P727
   HARTHORNE JW, 1984, INT J CARDIOL, V6, P423, DOI 10.1016/0167-5273(84)90321-8
   IHLENFELD JV, 1979, THROMB RES, V14, P953, DOI 10.1016/0049-3848(79)90013-6
   IVES CL, 1992, J BIOMATER APPL, V6, P340
   JOSHI RR, 1994, J APPL BIOMATER, V5, P65, DOI 10.1002/jab.770050109
   KLEIN A, 1987, ANTEC 87, P1205
   Kolff T, 1973, Biomater Med Devices Artif Organs, V1, P669
   KOLFF WJ, 1959, T AM SOC ART INT ORG, V5, P298
   Lelah M. D., 1986, POLYURETHANES MED
   LYMAN DONALD J., 1967, J BIOMED MAT RES, V1, P17, DOI 10.1002/jbm.820010105
   Mackay TG, 1996, BIOMATERIALS, V17, P1857, DOI 10.1016/0142-9612(95)00242-1
   MARTINEZMARTINEZ L, 1990, J HOSP INFECT, V16, P311, DOI 10.1016/0195-6701(90)90003-7
   MCGEE GM, 1980, T AM SOC ART INT ORG, V26, P299
   MOBITZER J, 1972, J APPL POLYM SCI, V16, P2697
   NG HN, 1973, POLYMER, V14, P255, DOI 10.1016/0032-3861(73)90085-2
   NYILAS E, 1970, 23 C ENG MED BIOL, V12, P147
   PAUL D, 1989, PROG POLYM SCI, V14, P597, DOI 10.1016/0079-6700(89)90011-7
   PECHHOLD E, 1980, RUBBER CHEM TECHNOL, V55, P1032
   PENTZ WJ, 1975, RUBBER AGE, V12
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   PLANCK H, 1987, POLYURETHANES BIOMED, V2
   PLANCK H, 1984, POLYURETHANES BIOMED
   SCHNEIDER NS, 1977, POLYM ENG SCI, V17, P73, DOI 10.1002/pen.760170203
   Schollenberger CS, 1959, US patent, Patent No. 2871218
   SCHOLLENBERGER CS, 1981, RUBBER CHEM TECHNOL, V55, P137
   SCHOLLENBERGER CS, 1975, J ELASTO PLAST, V7, P65
   SEEFRIED CG, 1975, J APPL POLYM SCI, V19, P2503, DOI 10.1002/app.1975.070190913
   SEEFRIED CG, 1975, J APPL POLYM SCI, V19, P3185, DOI 10.1002/app.1975.070191204
   Smith JC, 1996, BIOMATERIALS, V17, P1469, DOI 10.1016/0142-9612(96)89770-5
   SNOW J, 1981, T AM SOC ART INT ORG, V27, P485
   SOLOMON DD, 1986, T SOC BIOMATER, V9, P179
   STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2
   SZYCHER M, 1983, J ELASTOM PLAST, V15, P81, DOI 10.1177/009524438301500205
   SZYCHER M, 1977, 35 ANTEC SPE, V35, P743
   SZYCHER M, 1984, ELASTOMERICS, V7, P20
   Szycher M., 1991, BLOOD COMPATIBLE MAT, P33
   TINGEY KG, 1988, SURFACE CHARACTERIZA, P255
   ZDRAHAL RJ, 1988, IMPLANT MAT BIOFUNCT, P393
   ZDRAHAL RJ, 1987, BIOMATERIALS CLIN AP, P621
   Zdrahala R J, 1988, J Biomater Appl, V2, P544
   Zdrahala RJ, 1996, J BIOMATER APPL, V11, P37, DOI 10.1177/088532829601100102
   ZDRAHALA RJ, 1980, J ELASTOM PLAST, V12, P225, DOI 10.1177/009524438001200404
   ZDRAHALA RJ, 1979, J APPL POLYM SCI, V24, P2041, DOI 10.1002/app.1979.070240912
   ZDRAHALA RJ, 1997, T 13 EUR C BIOM ESB, V13, P109
   ZDRAHALA RJ, 1986, MATER RES SOC S P, V55, P407
   ZDRAHALA RJ, 1981, REACTION INJECTION M, P63
   ZDRAHALA RJ, 1988, T SOC BIOMATER, V11, P425
   ZDRAHALA RJ, 1987, POLYURETHANES BIOMED, V2, P1
   ZDRAHALA RJ, 1998, 60 YEARS POLYURETHAN, P304
   ZHAO QH, 1995, J BIOMED MATER RES, V29, P467, DOI 10.1002/jbm.820290406
   1985, DESERET MED TECHNICA
   1960, Patent No. 2929804
NR 65
TC 308
Z9 314
U1 11
U2 152
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604 USA
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 1999
VL 14
IS 1
BP 67
EP 90
DI 10.1177/088532829901400104
PG 24
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 210AZ
UT WOS:000081084100004
PM 10405885
DA 2018-10-20
ER

PT J
AU Desai, TA
   Hansford, D
   Ferrari, M
AF Desai, TA
   Hansford, D
   Ferrari, M
TI Characterization of micromachined silicon membranes for immunoisolation
   and bioseparation applications
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article
DE bioseparation; biotechnology; inorganic membranes; immunoisolation;
   membrane; micromachining; protein diffusion
ID PORCINE ISLETS; ENCAPSULATION; PANCREAS; BIOCAPSULES; INVITRO; RELEASE
AB The application of microfabrication technology to create precise separation and isolation membranes for biomedical applications is described. By utilizing fabrication techniques commonly employed in the microelectronics industry (MEMS), membranes can be fabricated with well-controlled and uniform pore sizes, allowing the optimization of membrane parameters for biomedical applications in cell immunoisolation and viral filtration. Using bulk and surface micromachining to create diffusion membranes, pore sizes down to 18 nm have been attained through deposition and subsequent etching of sacrificial layers on silicon. Membranes were shown to be sufficiently permeable to small biomolecules such as oxygen, glucose, and insulin, while excluding the passage of larger proteins such as immunoglobulin G (IgG). The semipermeability of microfabricated membranes, their biocompatibility, ease in sterilization, along with their thermal and chemical stability, may provide a significant advantages for biomedical applications. Microfabrication technology may also be applied to other materials of interest for the development of highly controlled membranes. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.
   Univ Calif Berkeley, Biomed Microdevices Ctr, Berkeley, CA 94720 USA.
   Ohio State Univ, Ctr Bioengn, Columbus, OH 43210 USA.
RP Desai, TA (reprint author), Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.
RI Hansford, Derek/B-5306-2012
CR BURCZAK K, 1994, BIOMATERIALS, V15, P231, DOI 10.1016/0142-9612(94)90072-8
   CHICHEPORTICHE D, 1988, DIABETOLOGIA, V31, P54
   Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85
   Chu W., 1995, SPIE P, V2593
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   COLTON CK, 1991, T ASME, V113, P152
   Desai TA, 1997, P SOC PHOTO-OPT INS, V2978, P216, DOI 10.1117/12.269972
   Desai TA, 1998, BIOTECHNOL BIOENG, V57, P118, DOI 10.1002/(SICI)1097-0290(19980105)57:1<118::AID-BIT14>3.0.CO;2-G
   Dionne KE, 1996, BIOMATERIALS, V17, P257, DOI 10.1016/0142-9612(96)85563-3
   Hellerstrom C, 1979, DIABETES, V28, P766
   HUGGETT ASG, 1957, LANCET, V2, P368
   Iwata H, 1995, TRANSPLANT P, V27, P3224
   IWATA H, 1994, J BIOMED MATER RES, V28, P1003, DOI 10.1002/jbm.820280905
   KESSLER L, 1991, HORM METAB RES, V23, P312, DOI 10.1055/s-2007-1003685
   Kuhtreiber W M, 1994, ASAIO J, V40, pM789, DOI 10.1097/00002480-199407000-00106
   Lanza R. P., 1995, SCI AM SCI MED, P16
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Maki T, 1996, TRANSPLANTATION, V62, P136, DOI 10.1097/00007890-199607150-00028
   NAKAMURA H, 1981, SEIKAGAKU DATABOOK, V2, P1107
   Sheppard NF, 1996, J CONTROL RELEASE, V42, P15, DOI 10.1016/0168-3659(96)01337-5
   Shoichet MS, 1996, BIOMATERIALS, V17, P285, DOI 10.1016/0142-9612(96)85566-9
   van Rijn C.J.M., 1995, IEEE P MEMS, P83
   Wang T, 1997, NAT BIOTECHNOL, V15, P358, DOI 10.1038/nbt0497-358
   ZHANG PC, 1997, IEEE ENG MED BIO MAR
NR 24
TC 100
Z9 104
U1 0
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD JUL 1
PY 1999
VL 159
IS 1-2
BP 221
EP 231
DI 10.1016/S0376-7388(99)00062-9
PG 11
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 205GR
UT WOS:000080813400017
DA 2018-10-20
ER

PT J
AU Ishimaru, T
   Lew, D
   Haller, J
   Vannier, MW
AF Ishimaru, T
   Lew, D
   Haller, J
   Vannier, MW
TI Virtual arthroscopy of the visible human female temporomandibular joint
SO JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
ID REALITY; ENDOSCOPY; SURGERY
AB Purpose: This study was designed to obtain views of the temporomandibular joint (TMJ) by means of computed arthroscopic simulation (virtual arthroscopy) using three-dimensional (3D) processing.
   Material and Methods: Volume renderings of the TMJ from very thin cryosection slices of the Visible Human Female were taken off the Internet. Analyze(AVW) software (Biomedical Imaging Resource, Mayo Foundation, Rochester, MN) on a Silicon Graphics O2 workstation (Mountain View, CA) was then used to obtain 3D images and allow the navigation "fly-through" of the simulated joint.
   Results: Good virtual arthroscopic views of the upper and lower joint spaces of both TMJs were obtained by fly-through simulation from the lateral and endaural sides. It was possible to observe the presence of a partial defect in the articular disc and an osteophyte on the condyle. Virtual arthroscopy provided visualization of regions not accessible to real arthroscopy.
   Conclusion: These results indicate that virtual arthroscopy will be a new technique to investigate the TMJ of the patient with TMJ disorders in the near future.
C1 Yamaguchi Univ, Sch Med, Dept Oral & Maxillofacial Surg, Yamaguchi 7558505, Japan.
   Univ Iowa Hosp & Clin, Dept Hosp Dent, Div Oral & Maxillofacial Surg, Iowa City, IA 52242 USA.
   Univ Iowa Hosp & Clin, Dept Radiol, Iowa City, IA 52242 USA.
RP Ishimaru, T (reprint author), Yamaguchi Univ, Sch Med, Dept Oral & Maxillofacial Surg, Yamaguchi 7558505, Japan.
OI Vannier, Michael/0000-0001-9898-384X
CR CHU SA, 1995, ORAL SURG ORAL MED O, V80, P604, DOI 10.1016/S1079-2104(05)80157-X
   COHEN ME, 1996, MACINTOSH BIBLE, P531
   DALGISH GM, 1997, RANDOM HOUSE WEBSTER, P827
   Gilani S, 1997, LARYNGOSCOPE, V107, P25, DOI 10.1097/00005537-199701000-00008
   Hansen D J, 1997, JAMA, V277, P434, DOI 10.1001/jama.277.5.434
   Hara AK, 1996, RADIOLOGY, V200, P49, DOI 10.1148/radiology.200.1.8657944
   MCGOVERN KT, 1994, BRIT MED J, V308, P1054, DOI 10.1136/bmj.308.6936.1054a
   Price C, 1992, Dentomaxillofac Radiol, V21, P148
   Rodenwaldt J, 1997, J COMPUT ASSIST TOMO, V21, P405, DOI 10.1097/00004728-199705000-00013
   SATAVA RM, 1995, CONTEMP SURG, V47, P204
   Vining DJ, 1996, RADIOLOGY, V200, P30, DOI 10.1148/radiology.200.1.8657938
   Volter S, 1995, Z ORTHOP GRENZGEB, V133, P492, DOI 10.1055/s-2008-1039928
   ZIEGLER R, 1995, COMPUT BIOL MED, V25, P193, DOI 10.1016/0010-4825(94)00038-R
NR 13
TC 8
Z9 8
U1 0
U2 58
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0278-2391
J9 J ORAL MAXIL SURG
JI J. Oral Maxillofac. Surg.
PD JUL
PY 1999
VL 57
IS 7
BP 807
EP 811
DI 10.1016/S0278-2391(99)90820-0
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 212QE
UT WOS:000081227100014
PM 10416627
DA 2018-10-20
ER

PT J
AU Miyata, T
   Asami, N
   Uragami, T
AF Miyata, T
   Asami, N
   Uragami, T
TI A reversibly antigen-responsive hydrogel
SO NATURE
LA English
DT Article
ID PHASE-TRANSITIONS; POLYMER GEL; RELEASE; GLUCOSE; COLLAPSE; PH
AB Stimuli-responsive hydrogels that undergo abrupt changes in volume in response to external stimuli such as pH, temperature and solvent composition have potential applications in biomedicine and the creation of 'intelligent' materials systems, for example as media for drug delivery, separation processes and protein immobilization. Hydrogels have been reported that respond to pH(1-3), temperature(4-13), electric fields(14-16) and saccharides(17-22). For some biomedical applications it would be very useful to have a material whose swelling response was dictated by a specific protein. Here we report such a material, which swells reversibly in a buffer solution in response to a specific antigen. The hydrogel was prepared by grafting the antigen and corresponding antibody to the polymer network, so that binding between the two introduces crosslinks in the network. Competitive binding of the free antigen triggers a change in gel volume owing to breaking of these non-covalent crosslinks. In addition, we show that the hydrogel displays shape-memory behaviour, and that stepwise changes in antigen concentration can induce pulsatile permeation of a protein through the network.
C1 Kansai Univ, Fac Engn, Chem Branch, Osaka 5648680, Japan.
   Kansai Univ, High Technol Res Ctr, Osaka 5648680, Japan.
RP Miyata, T (reprint author), Kansai Univ, Fac Engn, Chem Branch, Osaka 5648680, Japan.
CR AOKI T, 1994, MACROMOLECULES, V27, P947, DOI 10.1021/ma00082a010
   Bae Y.H., 1988, MAKROMOL CHEM-RAPID, V9, P185
   BAE YH, 1987, MAKROMOL CHEM-RAPID, V8, P481
   CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0
   FEIL H, 1991, J MEMBRANE SCI, V64, P283, DOI 10.1016/0376-7388(91)80099-R
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   HIROKAWA Y, 1984, J CHEM PHYS, V81, P6379, DOI 10.1063/1.447548
   HOFFMAN A S, 1987, Journal of Controlled Release, V6, P297, DOI 10.1016/0168-3659(87)90083-6
   Kataoka K, 1998, J AM CHEM SOC, V120, P12694, DOI 10.1021/ja982975d
   KOKUFATA E, 1991, NATURE, V351, P302, DOI 10.1038/351302a0
   KWON IC, 1991, NATURE, V354, P291, DOI 10.1038/354291a0
   Lee SJ, 1996, J MOL RECOGNIT, V9, P549, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<549::AID-JMR299>3.0.CO;2-C
   Miyata T, 1996, MACROMOL CHEM PHYSIC, V197, P1135, DOI 10.1002/macp.1996.021970330
   MIYATA T, 1994, MACROMOL CHEM PHYSIC, V195, P1111, DOI 10.1002/macp.1994.021950401
   MURAI N, 1995, J BIOL CHEM, V270, P19957, DOI 10.1074/jbc.270.34.19957
   NATSUME T, 1994, J BIOL CHEM, V269, P31224
   OBIDAT AA, 1996, PHARMACEUT RES, V13, P989
   OBIDAT AA, 1997, BIOMATERIALS, V18, P801
   OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0
   SHOEMAKER SG, 1987, APPL BIOCHEM BIOTECH, V15, P11, DOI 10.1007/BF02798503
   SIEGEL RA, 1988, MACROMOLECULES, V21, P3254, DOI 10.1021/ma00189a021
   STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0
   TANAKA T, 1978, PHYS REV LETT, V40, P820, DOI 10.1103/PhysRevLett.40.820
   TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467
   TANAKA T, 1980, PHYS REV LETT, V45, P1636, DOI 10.1103/PhysRevLett.45.1636
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
NR 26
TC 775
Z9 788
U1 26
U2 501
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD JUN 24
PY 1999
VL 399
IS 6738
BP 766
EP 769
DI 10.1038/21619
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 210JP
UT WOS:000081101600049
PM 10391240
DA 2018-10-20
ER

PT J
AU Skett, P
   Roberts, P
   Khan, S
AF Skett, P
   Roberts, P
   Khan, S
TI Maintenance of steroid metabolism and hormone responsiveness in
   cryopreserved dog, monkey and human hepatocytes
SO CHEMICO-BIOLOGICAL INTERACTIONS
LA English
DT Article
DE liver; cryopreservation; human; monkey; dog; metabolism
ID DRUG-METABOLISM; PRIMARY CULTURE; RAT; PRESERVATION; STORAGE; LIVER
AB The efficient and effective use of hepatocytes from larger species and rare human material requires a reliable storage method for cells not needed on the day of preparation. Cryopreservation would seem to be the only viable alternative. In this study the suitability of a published cryopreservation technique on dog, monkey and human hepatocytes has been examined and the cells were tested for functionality directly after thawing and subsequent to culture using steroid metabolism and hormone responsiveness of glycogen phosphorylase a. Monkey and human hepatocytes appear to survive the freezing and thawing process better than dog cells-the latter losing the ability to respond to adrenergic stimuli and their ability to maintain steroid metabolism in culture. Although monkey and human cells do preserve their steroid metabolising capacity after freeze/thawing, there is not the significant increase in enzyme activity seen during culturing freshly isolated cells. It would appear, therefore, that some damage has occurred to the cells during the freeze/thaw process. As previously noted, Williams' medium E is superior to Ham's F-10 in maintaining enzyme activities in culture. It is suggested that cryopreservation is the way forward for the development of stockpiles of viable hepatocytes for biomedical and toxicological research and development but that further modifications to the process are still necessary to optimise the maintenance of liver-specific functions in the thawed cells. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland.
RP Skett, P (reprint author), Univ Glasgow, Inst Biomed & Life Sci, W Med Bldg, Glasgow G12 8QQ, Lanark, Scotland.
CR BERRY MN, 1991, LAB TECHNIQUES BIOCH, V21, P1
   deSousa G, 1996, CELL BIOL TOXICOL, V12, P351, DOI 10.1007/BF00438170
   DESOUSA G, 1991, TOXICOL IN VITRO, V5, P483, DOI 10.1016/0887-2333(91)90077-Q
   DOU M, 1992, CRYOBIOLOGY, V29, P454, DOI 10.1016/0011-2240(92)90048-7
   EVANS PJ, 1994, CELL BIOL INT, V18, P999, DOI 10.1006/cbir.1994.1023
   FABRE G, 1988, BIOCHEM PHARMACOL, V37, P4389, DOI 10.1016/0006-2952(88)90622-3
   HUSSIN AH, 1990, BIOCHEM PHARMACOL, V40, P2285, DOI 10.1016/0006-2952(90)90724-Y
   KASAI S, 1993, CRYOBIOLOGY, V30, P1, DOI 10.1006/cryo.1993.1001
   Kravchenko L, 1996, CRYO-LETT, V17, P309
   KUNOS G, 1987, BIOCHEM PHARMACOL, V36, P1185, DOI 10.1016/0006-2952(87)90068-2
   LAWRENCE JN, 1991, TOXICOL IN VITRO, V5, P39, DOI 10.1016/0887-2333(91)90046-G
   LORETZ LJ, 1989, XENOBIOTICA, V19, P489, DOI 10.3109/00498258909042288
   POWIS G, 1987, DRUG METAB DISPOS, V15, P826
   RATANASAVANH D, 1991, HEPATOLOGY, V13, P1142, DOI 10.1016/0270-9139(91)92485-Q
   RIJNTJES PJM, 1986, J HEPATOL, V3, P7, DOI 10.1016/S0168-8278(86)80140-4
   ROGIERS V, 1990, BIOCHEM PHARMACOL, V40, P1701, DOI 10.1016/0006-2952(90)90345-L
   SKETT P, 1988, PHARMACOL THERAPEUT, V38, P269, DOI 10.1016/0163-7258(88)90007-1
   SKETT P, 1992, B91B43080015951, P1
   STALMANS W, 1975, EUR J BIOCHEM, V54, P341, DOI 10.1111/j.1432-1033.1975.tb04144.x
   SUN EL, 1990, IN VITRO CELL DEV, V25, P147
   THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9
NR 21
TC 17
Z9 19
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0009-2797
J9 CHEM-BIOL INTERACT
JI Chem.-Biol. Interact.
PD JUN 1
PY 1999
VL 121
IS 1
BP 65
EP 76
DI 10.1016/S0009-2797(99)00091-5
PG 12
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
GA 212JQ
UT WOS:000081213900006
PM 10418971
DA 2018-10-20
ER

PT J
AU Cammas, S
   Bear, MM
   Moine, L
   Escalup, R
   Ponchel, G
   Kataoka, K
   Guerin, P
AF Cammas, S
   Bear, MM
   Moine, L
   Escalup, R
   Ponchel, G
   Kataoka, K
   Guerin, P
TI Polymers of malic acid and 3-alkylmalic acid as synthetic PHAs in the
   design of biocompatible hydrolyzable devices
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article; Proceedings Paper
CT International Symposium on Biological Polyhydroxyalkanoates (ISBP 98)
CY SEP 09-11, 1998
CL RIKEN INST, SAITAMA, JAPAN
HO RIKEN INST
DE biomaterials; poly(beta-3-alkylmalic acid) derivatives; Poly(beta-malic
   acid) derivatives; synthetic PHAs
ID POLY(BETA-MALIC ACID); CYCLODEXTRIN INCLUSION; DRUG-DELIVERY;
   MICELLIZATION; MOLECULES; COMPLEXES; MICELLES; REPAIR
AB Poly(beta-malic acid) and poly(beta-3-alkylmalic acid) derivatives, as synthetic polyhydroxyalkanoates (PHAs), present several advantages as macromolecular materials for temporary biomedical applications. Indeed, such polymers, which can be synthesized through different chemical and biological routes, have cleavable ester beads in their backbone for hydrolytic degradation, stereogenic centres in the monomers units for controlling the macromolecular structure, bioassimilable or non-toxic repeating units and lateral chemical functions which can be adapted to specific requirements. The strategy for building such complex architectures, with one or several specific pendant groups, is based on the anionic ring-opening polymerization or copolymerization of the large family of malolactonic and 3-alkylmalolactonic acid esters. Because we are able to control the monomer synthesis and the polymerization step, we have been able to prepare different degradable materials for the biomedical field; such as: degradable associating networks made up by the association of random copolyesters containing a small percentage of hydrophobic moieties and beta-cyclodextrin copolymers; degradable macromolecular micelles constituted by degradable amphiphilic block copolymers of poly(beta-malic acid) as hydrophilic segments and poly(beta-alkylmalic acid alkyl esters) as hydrophobic blocks; and degradable nanoparticles made up by hydrophobic poly(beta-malic acid alkyl esters) derivatives. We have also prepared a terpolymer which exhibits growth factor-like properties in vivo. Finally, poly-(beta-malic acid) has been used as an additive in the preparation of peritoneal dialysis bags. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Univ Paris 12, Lab Rech Polymeres, CNRS, UMR C7581, F-94320 Thiais, France.
   Univ Paris Sud, Ctr Etud Pharmaceut, CNRS, URA 1218, F-92296 Chatenay Malabry, France.
   Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan.
RP Cammas, S (reprint author), Univ Paris 12, Lab Rech Polymeres, CNRS, UMR C7581, 2-8 Rue Henry Dunant, F-94320 Thiais, France.
EM cammas@glvt-cnrs.fr
RI Kataoka, Kazunori/K-7108-2012
OI Kataoka, Kazunori/0000-0002-8591-413X; Moine,
   Laurence/0000-0003-3306-9795
CR Amiel C, 1996, J INCLUS PHENOM MOL, V25, P61, DOI 10.1007/BF01041537
   ASTAFIEVA I, 1995, MACROMOLECULES, V28, P7127, DOI 10.1021/ma00125a015
   Blanquaert F, 1995, BONE, V17, P499, DOI 10.1016/8756-3282(95)00402-5
   BRANNONPEPPAS L, 1995, INT J PHARM, V116, P1, DOI 10.1016/0378-5173(94)00324-X
   BRAUD C, 1992, POLYM BULL, V29, P177, DOI 10.1007/BF00558054
   Cammas S, 1996, POLYMER, V37, P4215, DOI 10.1016/0032-3861(96)00204-2
   Cammas S, 1996, NATO ADV SCI INST SE, V327, P83
   CAMMAS S, IN PRESS MACROMOL CH
   CAMMAS S, IN PRESS J CONTROL R
   EFTINK MR, 1989, J AM CHEM SOC, V111, P6765, DOI 10.1021/ja00199a041
   FORT RC, 1964, CHEM REV, V64, P277, DOI 10.1021/cr60229a004
   FOURNIE P, 1992, J BIOACT COMPAT POL, V7, P113, DOI 10.1177/088391159200700201
   HARRISON JC, 1982, BIOPOLYMERS, V21, P1153, DOI 10.1002/bip.360210611
   Humberstone AJ, 1996, J PHARM SCI, V85, P525, DOI 10.1021/js950472p
   KATAOKA K, 1994, J MACROMOL SCI PURE, VA31, P1759, DOI 10.1080/10601329408545880
   KIZEROW D, 1992, MACROMOLECULES, V25, P461
   Kreuter J., 1994, COLLOIDAL DRUG DELIV, P219
   LAFONT J, 1994, CELL MATER, V4, P219
   LEBOUCHERDURAND MA, 1996, POLYM B, V35, P36
   MEDDAHI A, 1994, PATHOL RES PRACT, V190, P923
   Moffitt M, 1996, ACCOUNTS CHEM RES, V29, P95, DOI 10.1021/ar940080+
   Moine L, 1997, POLYMER, V38, P3121, DOI 10.1016/S0032-3861(96)01097-X
   Moine L, 1998, MACROMOL SYMP, V130, P45, DOI 10.1002/masy.19981300105
   MOINE L, UNPUB MACROMOLECULES
   PALEPU R, 1990, AUST J CHEM, V43, P2119, DOI 10.1071/CH9902119
   Renard E, 1997, EUR POLYM J, V33, P49, DOI 10.1016/S0014-3057(96)00123-1
   Renard I., 1996, POLYM PREPR, V37, P137
   SCHOLES PD, 1993, J CONTROL RELEASE, V25, P145, DOI 10.1016/0168-3659(93)90103-C
   STOLNIK S, 1994, J CONTROL RELEASE, V30, P57, DOI 10.1016/0168-3659(94)90044-2
   Szejtli J., 1988, CYCLODEXTRIN TECHNOL
   VERT M, 1986, Critical Reviews in Therapeutic Drug Carrier Systems, V2, P291
   ZHANG LF, 1995, MACROMOLECULES, V28, P6055, DOI 10.1021/ma00122a010
NR 32
TC 56
Z9 61
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JUN-JUL
PY 1999
VL 25
IS 1-3
BP 273
EP 282
DI 10.1016/S0141-8130(99)00042-2
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 211HK
UT WOS:000081154700032
PM 10416675
DA 2018-10-20
ER

PT J
AU Teoh, SH
   Tang, ZG
   Ramakrishna, S
AF Teoh, SH
   Tang, ZG
   Ramakrishna, S
TI Development of thin elastomeric composite membranes for biomedical
   applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MOLECULAR-WEIGHT POLYETHYLENE; BLOOD PUMP APPLICATIONS; SOFT SEGMENT
   LENGTH; POLYURETHANE ELASTOMERS; DRIED GELS; MORPHOLOGY; SERIES;
   STABILITY; POLYMERS; TENSILE
AB A breakthrough has been made in blending of two immiscible biocompatible polymers to form thin transparent interpenetrating network composite membranes (CM) with exceptional improvement in properties. Two immiscible polymers, namely the biaxially drawn ultra high molecular weight polyethylene (UHMWPE) film and polyether polyurethane (PU) were used. The fabrication included solution casting and heat compaction. During the fabrication, the CM still preserved the orientation of UHMWPE fibers but introduced the interpenetration of PU in UHMWPE film. The intimate interaction of PU with UHMWPE fibers was viewed through the transparency of CM. Differential scanning calorimetry (DSC) data showed the melting temperature (T-m) of UHMWPE increased by about 10 degrees C in CM and about 5 degrees C in heat-compacted membranes (HCM). Morphological observations indicated that CM presented a layered structure while HCM was a dense material without obvious void inclusions. The ultimate tensile strength and relative Young's modulus of CM are about 62 MPa and 460 MPa, respectively. They are about four times greater in strength and 150 times greater in modulus compared with those of PU. Heat compaction resulted in a membrane with nearly five times the tensile strength and 50 times the Young's modulus of PU. The engineered ultimate strain of CM is about 26%, 8% more than that of the porous UHMWPE film while about 70% of HCM, which is a 50% increase achieved through heat compaction. The tensile fracture toughness is about 93 mJ for CM and 211 mJ for HCM, two and five times that for the porous UHMWPE film, respectively. The significant modification on the properties of the heat-compacted composite may raise broad interest in using the CM to develop membrane-related devices and organ covers in biomedical applications. (C) 1999 Kluwer Academic Publishers.
C1 Natl Univ Singapore, Inst Mat Res & Engn, Ctr Biomed Mat Applicat & Technol, Dept Mech & Prod Engn, Singapore 119260, Singapore.
RP Teoh, SH (reprint author), Natl Univ Singapore, Inst Mat Res & Engn, Ctr Biomed Mat Applicat & Technol, Dept Mech & Prod Engn, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
CR BRANDRUP J, 1975, POLYM HDB
   Brydson J. A., 1982, PLASTICS MAT
   CHENG YY, 1993, J MACROMOL SCI PHYS, VB32, P433, DOI 10.1080/00222349308215527
   CHERRY BW, 1981, POLYMER, V22, P1610, DOI 10.1016/0032-3861(81)90372-4
   COATES PD, 1995, CHEM ENG RES DES, V73, P753
   Fu YG, 1996, J MACROMOL SCI PHYS, VB35, P37, DOI 10.1080/00222349608220375
   GERRITS NSJA, 1991, POLYMER, V32, P1770, DOI 10.1016/0032-3861(91)90361-L
   GERRITS NSJA, 1990, POLYMER, V31, P231, DOI 10.1016/0032-3861(90)90111-B
   GRIESSER HJ, 1991, POLYM DEGRAD STABIL, V33, P329, DOI 10.1016/0141-3910(91)90080-B
   HAYASHI K, 1985, J BIOMED MATER RES, V19, P179, DOI 10.1002/jbm.820190207
   HAYASHI K, 1984, J BIOMED MATER RES, V18, P939, DOI 10.1002/jbm.820180808
   HAYASHI K, 1986, PROGR ARTIFICAL ORGA, P989
   HIN TS, 1984, POLYMER, V25, P727, DOI 10.1016/0032-3861(84)90044-2
   HOU M, 1995, PLAST RUB COMPOS PRO, V23, P279
   Jansen J, 1991, ASAIO Trans, V37, pM451
   Jar PYB, 1996, J POLYM SCI POL PHYS, V34, P707
   JONES AJ, 1988, POLYM BIOMATERIALS B
   Kienzle S. Y., 1988, POLYM BLENDS ALLOYS
   LEEPER HM, 1983, RUBBER CHEM TECHNOL, V56, P523, DOI 10.5254/1.3538140
   LEMM W, 1984, POLYURETHANES BIOMED, P103
   Mackay TG, 1996, ARTIF ORGANS, V20, P1017, DOI 10.1111/j.1525-1594.1996.tb04589.x
   Martin DJ, 1996, J APPL POLYM SCI, V60, P557, DOI 10.1002/(SICI)1097-4628(19960425)60:4<557::AID-APP9>3.0.CO;2-N
   Martin DJ, 1996, J APPL POLYM SCI, V62, P1377
   Martin DJ, 1997, J APPL POLYM SCI, V64, P803, DOI 10.1002/(SICI)1097-4628(19970425)64:4<803::AID-APP20>3.0.CO;2-T
   MCMILLIN CR, 1994, RUBBER CHEM TECHNOL, V67, P417, DOI 10.5254/1.3538684
   Meeten G. H., 1986, OPTICAL PROPERTIES P
   Paris Edouard, 1994, P245
   PIENKOWSKI D, 1995, J BIOMED MATER RES, V29, P1167, DOI 10.1002/jbm.820291002
   PORTER RS, 1994, POLYMER, V35, P4979, DOI 10.1016/0032-3861(94)90652-1
   SAKAI Y, 1993, POLYMER, V34, P318, DOI 10.1016/0032-3861(93)90083-M
   SAKAI Y, 1988, POLYMER, V29, P1608, DOI 10.1016/0032-3861(88)90271-6
   Schubert MA, 1997, J BIOMED MATER RES, V35, P319, DOI 10.1002/(SICI)1097-4636(19970605)35:3<319::AID-JBM6>3.0.CO;2-K
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   STOKES KB, 1984, 42 TECHN C APR 30 MA, P235
   Szycher M, 1991, J Biomater Appl, V6, P110, DOI 10.1177/088532829100600202
   Szycher M., 1991, BLOOD COMPATIBLE MAT, P33
   TANG ZG, 1997, 9 INT C BIOM ENG SIN, P563
   Tanzi MC, 1997, J BIOMED MATER RES, V36, P550, DOI 10.1002/(SICI)1097-4636(19970915)36:4<550::AID-JBM14>3.0.CO;2-E
   Teoh S.H., 1998, HDB BIOMATERIAL PROP, P270
   TEOH SH, 1997, KEYN LECT S EM PLAST
   TEOH SH, 1997, Patent No. 02630
   WEAVER KD, 1993, POLYM COMPOSITE, V14, P515, DOI 10.1002/pc.750140609
NR 43
TC 22
Z9 22
U1 3
U2 16
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 1999
VL 10
IS 6
BP 343
EP 352
DI 10.1023/A:1026421606939
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 204YJ
UT WOS:000080793300004
PM 15348135
DA 2018-10-20
ER

PT J
AU Vail, NK
   Swain, LD
   Fox, WC
   Aufdlemorte, TB
   Lee, G
   Barlow, JW
AF Vail, NK
   Swain, LD
   Fox, WC
   Aufdlemorte, TB
   Lee, G
   Barlow, JW
TI Materials for biomedical applications
SO MATERIALS & DESIGN
LA English
DT Article
DE ceramic matrix; lasers; sintering; rapid prototyping; biomedical
AB This paper discusses the physical and mechanical characterization of a calcium phosphate ceramic material system developed for biomedical applications in the repair of skeletal defects. The rapid prototyping process selective laser sintering (SLS) is the preferred forming process to produce complex porous ceramic matrices suitable for biomedical applications. The effects of SLS processing conditions on the properties of fabricated objects are quantified. The effects of post-processing conditions on the properties of SLS-fabricated objects are also quantified. SLS-fabricated implants are shown to perform well in vivo exhibiting excellent biocompatibility as well as showing considerable osseous integration and remodeling of the ceramic implant material. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Biomed Enterprises Inc, San Antonio, TX 78245 USA.
   Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78284 USA.
   Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
CR BALASUBRAMANIAN B, 1995, THESIS U TEXAS AUSTI
   *DTM CORP, 1998, GUID MAT
   ERICKSON D, 1997, COMMUNICATION
   FAUST GT, 1944, AM J SCI, V242, P447
   FOX WC, 1999, 45 ANN M ORTH RES SO
   Frenkel JJ, 1945, J PHYS USSR, V9, P385
   Holle J, 1996, PLAST RECONSTR SURG, V98, P542, DOI 10.1097/00006534-199609000-00031
   JACOBS PF, 1998, EFFECTS SHRINKAGE VA
   James WJ, 1998, J ORAL MAXIL SURG, V56, P512, DOI 10.1016/S0278-2391(98)90726-1
   LEE G, 1997, THESIS U TEXAS AUSTI
   LEE G, 1996, SOLID FREEFORM FAABR, V7, P15
   NELSON JC, 1995, IND ENG CHEM RES, V34, P1641, DOI 10.1021/ie00044a017
   NELSON JC, 1992, THESIS U TEXAS AUSTI
   NELSON JM, 1998, COMMUNICATION
   SUBRAMANIAN K, 1995, RAPID PROTOTYP J, V1, P13
   Vail NK, 1996, RAPID PROTOTYPING J, V2, P24, DOI 10.1108/13552549610129764
   VAIL NK, 1994, J APPL POLYM SCI, V52, P789, DOI 10.1002/app.1994.070520610
   VAIL NK, 1996, SOLID FREEFORM FABRI, V7, P481
   VAIL NK, 1994, THESIS U TEXAS AUSTI
   1986, ENCY POL SCI ENG
NR 20
TC 64
Z9 70
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0261-3069
J9 MATER DESIGN
JI Mater. Des.
PD JUN
PY 1999
VL 20
IS 2-3
BP 123
EP 132
DI 10.1016/S0261-3069(99)00018-7
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 198RG
UT WOS:000080437300009
DA 2018-10-20
ER

PT J
AU Senuma, Y
   Hilborn, JG
AF Senuma, Y
   Hilborn, JG
TI Key parameters for monodispersed polymer microspheres with spinning disk
   atomization
SO MATERIALS RESEARCH INNOVATIONS
LA English
DT Article
DE monodispersed beads; polymer microspheres; atomization; drop formation;
   powder
ID DROP FORMATION; CONICAL TIPS; COPOLYMERIZATION; METHACRYLATE; PARTICLES
AB Spinning Disk Atomization has been developed to produce high quality powders in the form of narrowly dispersed or monosized spherical beads, in the size range of 50 to 500 mu m, that are hardly accessible by other techniques. This technology, that in principle can be applied to any kind of material, is described in this study for low molecular weight polymers, e.g. poly(ethyleneglycol). A description of the atomization equipment design, ensuring proper liquid distribution, is presented and the influence of key-parameters controlling the droplet formation, such as viscosity and rotation rate used to approach monodispersity, is discussed. Spheres, produced by spinning disk atomization, may find use in various areas from laboratory-scale to large-scale applications such as interlining adhesives, powder coatings, food powders, biomedical products, drug delivery systems, cosmetics, for example. The spinning disk atomization described here is studied and designed for future scale-up aiming at industrial production.
C1 Ecole Polytech Fed Lausanne, LP, DMX, Swiss Fed Inst Technol, CH-1015 Lausanne, Switzerland.
RP Senuma, Y (reprint author), Ecole Polytech Fed Lausanne, LP, DMX, Swiss Fed Inst Technol, CH-1015 Lausanne, Switzerland.
OI Hilborn, Jons/0000-0001-6947-9601
CR AKESSON NB, 1994, J ENVIRON SCI HEAL B, V29, P785, DOI 10.1080/03601239409372904
   ALLEN T, 1990, PARTICLE SIZE MEASUR
   ANDERSSON R, 1989, Patent No. 411478
   ANGERS R, 1992, POWD MET WORLD C SAN
   ARSHADY R, 1993, BIOMATERIALS, V14, P5, DOI 10.1016/0142-9612(93)90015-T
   ARSHADY R, 1989, POLYM ENG SCI, V29, P1746, DOI 10.1002/pen.760292404
   BABU SR, 1986, J PHYS CHEM-US, V90, P4337, DOI 10.1021/j100409a023
   BABU SR, 1987, J COLLOID INTERF SCI, V116, P359
   BABU SR, 1987, J COLLOID INTERF SCI, V116, P350
   BOUSFIELD DW, 1986, J NON-NEWTON FLUID, V21, P79, DOI 10.1016/0377-0257(86)80064-7
   BRENN G, 1995, J ADV SCI, V7, P197
   Denn M. M, 1980, PROCESS FLUID MECH
   DOGAN C, 1994, INT J POWDER METALL, V30, P419
   FRASER RP, 1963, CHEM ENG SCI, V18, P323, DOI 10.1016/0009-2509(63)80026-3
   GOEDDE EF, 1970, J FLUID MECH, V40, P495, DOI 10.1017/S0022112070000289
   HASHIMOTO H, 1987, AIAA J, V25, P727, DOI 10.2514/3.9689
   HILBORN JG, 1994, MRS FALL M BOST
   HORAK D, 1995, J POLYM SCI POL CHEM, V33, P2329, DOI 10.1002/pola.1995.080331405
   Ishizu K, 1997, POLYMER, V38, P5471, DOI 10.1016/S0032-3861(97)00085-2
   LU SM, 1989, AICHE J, V35, P1572, DOI 10.1002/aic.690350922
   NAKA Y, 1995, JAERI C 95
   NORASETTHEKUL S, 1995, J APPL POLYM SCI, V58, P2101, DOI 10.1002/app.1995.070581122
   OSBORNE MG, 1993, 1993 INT C EXH POWD
   PANAGIOTOU T, 1991, J APPL POLYM SCI, V43, P1549, DOI 10.1002/app.1991.070430818
   RUCKENSTEIN E, 1995, POLYMER, V36, P2857, DOI 10.1016/0032-3861(95)93669-D
   Sudol ED, 1997, NATO ADV SCI I E-APP, V335, P141
   Tuncel A, 1996, J POLYM SCI POL CHEM, V34, P45, DOI 10.1002/(SICI)1099-0518(19960115)34:1<45::AID-POLA4>3.0.CO;2-2
   Tuncel A., 1997, HDB ENG POLYM MAT, P189
   UGELSTAD J, 1982, EMULSION POLYM, P384
   YIM P, 1995, INT C EXH POWD MET P
   Yule A.J., 1994, ATOMIZATION MELTS PO
   ZWEIFEL Y, UNPUB POLYM ENG SCI
NR 32
TC 9
Z9 9
U1 2
U2 5
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 1432-8917
J9 MATER RES INNOV
JI Mater. Res. Innov.
PD JUN
PY 1999
VL 3
IS 1
BP 42
EP 49
DI 10.1007/s100190050123
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 210RB
UT WOS:000081117500007
DA 2018-10-20
ER

PT J
AU Ramakrishna, S
   Huang, ZM
   Yew, HM
AF Ramakrishna, S
   Huang, ZM
   Yew, HM
TI Development of a novel flexible composite material
SO JOURNAL OF MATERIALS PROCESSING TECHNOLOGY
LA English
DT Article
DE knitted fabric; flexible composites; composites; textile composites
ID MECHANICAL-PROPERTIES; TENSILE BEHAVIOR
AB The primary objective of this research work is to develop a thin and flexible composite material suitable for biomedical and electronic packing applications. A flexible composite of 0.2 mm thickness was developed using knitted polyester fiber interlock fabric as the reinforcement and polyurethane elastomer as the matrix. Details regarding composite fabrication and mechanical characterization are presented. The failure strain of this new flexible composite material is as high as 85-320%, depending on the fiber architecture. Another objective of this study is to identify the effect of pre-stretching of the knitted fabric on the composite tensile properties. For this purpose different composite specimens were made by reinforcing polyurethane with knitted fabrics that were pre-stretched differently prior to composite fabrication. Both the stiffness and strength of composite improved in the direction of fabric pre-stretch and they deteriorated in the direction normal to pre-stretch. However, the failure strain followed the opposite trend. These trends are attributed to the changes in the failure mechanisms with the pre-stretched condition of the fabric. (C) 1999 Elsevier Science S.A. All rights reserved.
C1 Natl Univ Singapore, Dept Mech & Prod Engn, Polymer & Text Composites Lab, Singapore 119260, Singapore.
RP Ramakrishna, S (reprint author), Natl Univ Singapore, Dept Mech & Prod Engn, Polymer & Text Composites Lab, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
CR deHaan J, 1996, ADV COMPOS LETT, V5, P9
   KargerKocsis J, 1997, APPL COMPOS MATER, V4, P209, DOI 10.1023/A:1008892619464
   LEONG KH, 1997, P ICCM 11 GOLD COAST, P201
   MAYER J, 1995, P EUROMAT 95 VEN PAD, P1
   RAMAKRISHNA S, 1994, COMPOS SCI TECHNOL, V50, P249, DOI 10.1016/0266-3538(94)90146-5
   RAMAKRISHNA S, 1994, COMPOS SCI TECHNOL, V50, P237, DOI 10.1016/0266-3538(94)90145-7
   RAMAKRISHNA S, 1993, COMPOS SCI TECHNOL, V49, P349, DOI 10.1016/0266-3538(93)90066-P
   RAMAKRISHNA S, 1994, COMP SCI TECHNOL, V57, P1
   RAMAKRISHNA S, 1993, P 3 JAP INT SAMPE S, P312
   RAMAKRISHNA S, 1995, P ICCM 10, V4, P245
   Ruan XP, 1996, COMPOS SCI TECHNOL, V56, P1391, DOI 10.1016/S0266-3538(96)00097-8
   RUDD CD, 1990, COMPOS SCI TECHNOL, V39, P261, DOI 10.1016/0266-3538(90)90045-7
   VERPOEST I, 1992, P 37 INT SAMPE S AN, P369
   Verpoest I., 1997, P ICCM 11 AUSTR, P1108
NR 14
TC 5
Z9 5
U1 1
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-0136
J9 J MATER PROCESS TECH
JI J. Mater. Process. Technol.
PD MAY 19
PY 1999
VL 90
SI SI
BP 473
EP 477
DI 10.1016/S0924-0136(99)00056-4
PG 5
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA 204JZ
UT WOS:000080762300080
DA 2018-10-20
ER

PT J
AU Quek, CH
   Khor, KA
   Cheang, P
AF Quek, CH
   Khor, KA
   Cheang, P
TI Influence of processing parameters in the plasma spraying of
   hydroxyapatite/Ti-6Al-4V composite coatings
SO JOURNAL OF MATERIALS PROCESSING TECHNOLOGY
LA English
DT Article
DE hydroxyapatite; plasma spraying parameters; bond strength; plasma spray
   systems
ID HEAT-TREATMENT; IMPLANTS; TITANIUM; APATITE; PHASES
AB Biomedical implants using metals, polymers, ceramics and composites are increasingly being designed to restore body function and to facilitate healing. It is often the material design aspects of such implants that will determine the stability of the device. A hydroxyapatite (HA) coating on Ti-6Al-4V alloy is a common implant used in orthopaedics applications. IIA being a bio-active material combined with non-toxicity and bio-inert Ti-6Al-4V provides an implant that is bio-compatible, light and stable. The plasma spray technique is a popular method of depositing HA onto Ti-6Al-4V. However, there are processing problems associated with this technique and as a result there are inconsistencies in the subsequent in vitro and in vivo investigations. Addressing these inconsistencies from a materials processing standpoint would help to alleviate the problems faced. This paper investigates the influence of plasma spraying parameters on the characteristics of the composite coatings. The plasma spraying parameters under study are the spraying current and the gun transverse speed. Under these spraying parameters, a comparison is made between two different kinds of composite feedstock, namely calcined HA and Ti-6Al-3V in the ratio of 80:20 wt% and 50:50 wt%, respectively. Composite powders in the size range of 75-106 mu m were prepared by the ceramic slurry mixing method. The powder was deposited onto Ti-6Al-4V substrate by means of a robot-controlled 100 kW plasma gun (Praxair Surface Technologies, USA) equipped with an advanced computerized closed-loop powder feed system. The mechanical properties of the individual layers were tested using the tensile adhesion test (ASTM C-633), The surface morphology and microstructure of the composite layers were examined by a back-scattered scanning electron microscope. The phase composition and crystallinity were determined by an X-ray diffractometer. The investigation shows that the as-sprayed coating of the individual layers possesses a higher porosity level in the HA-rich regions. In other words, a porous coating is achieved using composite powders in the ratio of 80:20 wt%. The tensile adhesion test revealed a higher bond strength for the composite coatings compared to that for pure HA coatings. A lower spraying current and a faster gun transverse speed are also considered accountable for the porous microstructure and low bonding strength, (C) 1999 Elsevier Science S.A. All rights reserved.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
   Nanyang Technol Univ, Sch Appl Sci, Singapore 639798, Singapore.
RP Khor, KA (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
OI KHOR, Khiam/0000-0003-1954-8423
CR Aoki H., 1994, MED APPL HYDROXYAPAT
   BOERTZEN D, 1996, J BIOMED MATER RES, V30, P125
   Caulier H, 1997, J BIOMED MATER RES, V34, P121, DOI 10.1002/(SICI)1097-4636(199701)34:1<121::AID-JBM16>3.3.CO;2-2
   Chen JY, 1997, J BIOMED MATER RES, V34, P15, DOI 10.1002/(SICI)1097-4636(199701)34:1<15::AID-JBM3>3.0.CO;2-Q
   CHEN WQ, 1993, BIOMEDICAL MATERIALS, P157
   FILIAGGI MJ, 1993, J BIOMED MATER RES, V27, P191, DOI 10.1002/jbm.820270208
   Gross KA, 1998, J AM CERAM SOC, V81, P106
   JI HX, 1992, J MATER SCI-MATER M, V3, P283, DOI 10.1007/BF00705294
   KOCH B, 1990, J BIOMED MATER RES, V24, P655, DOI 10.1002/jbm.820240603
   Liu DM, 1997, J MATER SCI-MATER M, V8, P227, DOI 10.1023/A:1018591724140
   MALMBERG S, 1993, J THERM SPRAY TECHN, V2, P339
   MCPHERSON R, 1995, J MATER SCI-MATER M, V6, P327, DOI 10.1007/BF00120300
   PARK JB, 1994, BIOMATERIALS SCI ENG
   Vu TA, 1997, J MATER SCI LETT, V16, P1680, DOI 10.1023/A:1018534300072
   WANG BC, 1995, J BIOMED MATER RES, V29, P1483, DOI 10.1002/jbm.820291204
   WANG CY, 1995, J MATER SCI, V6, P249
   Weng J, 1996, J BIOMED MATER RES, V30, P5
   WENG J, 1995, J MATER SCI LETT, V14, P211, DOI 10.1007/BF00318260
   WOJCIECH L, 1998, J AM CERAM SOC, V81, P765
   YANG CY, 1995, J MATER SCI-MATER M, V6, P258, DOI 10.1007/BF00120268
   Yip CS, 1997, J MATER PROCESS TECH, V65, P73, DOI 10.1016/0924-0136(95)02244-9
NR 21
TC 15
Z9 15
U1 0
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-0136
J9 J MATER PROCESS TECH
JI J. Mater. Process. Technol.
PD MAY 19
PY 1999
VL 90
SI SI
BP 550
EP 555
PG 6
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA 204JZ
UT WOS:000080762300094
DA 2018-10-20
ER

PT J
AU Niinomi, M
   Kuroda, D
   Fukunaga, K
   Morinaga, M
   Kato, Y
   Yashiro, T
   Suzuki, A
AF Niinomi, M
   Kuroda, D
   Fukunaga, K
   Morinaga, M
   Kato, Y
   Yashiro, T
   Suzuki, A
TI Corrosion wear fracture of new beta type biomedical titanium alloys
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Proceedings Paper
CT Xian International Titanium Conference_on Metallurgy Technology and
   Applications of Titanim Alloys
CY SEP 15-18, 1998
CL XIAN, PEOPLES R CHINA
DE biomedical titanium alloys; biocompatibility; corrosion friction wear;
   mechanical properties; modulus of elasticity
ID STRENGTH; IMPLANTS
AB Metallic materials such as stainless steel, Co-Cr alloy, pure titanium and titanium alloys have been used for surgical implant materials. The alpha + beta type titanium alloy such as Ti-6Al-4V ELI has been most widely used as an implant material for artificial hip joint and dental implant because of its high strength and excellent corrosion resistance. Toxicity of alloying elements in conventional biomedical titanium alloys like Al and V, and the high modulus of elasticity of these alloy as compared to that of bone have been, however, pointed out [1,2]. New beta type titanium alloys composed of non-toxic elements like Nb, Ta, Zr, Mo and Sn with lower moduli of elasticity, greater strength and greater corrosion resistance were, therefore, designed in this study. The friction wear properties of titanium alloys are, however, low as compared to those of other conventional metallic implant materials such as stainless steels and Co-Cr alloy. Tensile tests and friction wear tests in Ringer's solution were conducted in order to investigate the mechanical properties of designed alloys. The friction wear characteristics of designed alloys and typical conventional biomedical titanium alloys were evaluated using a pin-on-disk type friction wear testing system and measuring the weight loss and width of groove of the specimen. (C) 1999 Elsevier Science S.A, Al rights reserved.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Nagoya Univ, Dept Mat Sci & Engn, Chikusa Ku, Nagoya, Aichi 4640814, Japan.
   Daido Steel Co Ltd, Market Dev Dept, Minato Ku, Nagoya, Aichi 4550022, Japan.
   Daido Steel Co Ltd, R&D Lab, Minami Ku, Nagoya, Aichi 4578545, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, Tempaku Cho,1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.
RI Niinomi, Mitsuo/B-5965-2011
CR Kawahara H., 1992, B JAPAN I METALS, V31, P1033
   MORINAGA M, 1993, P 7 INT C TIT SAN DI, P276
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   Steinemann S. G., 1980, CORROSION SURG IMPLA, P1
   Wang KK, 1996, ASTM STP, V1272, P76
   Zwicker R, 1980, P 4 INT C TIT KYOT J, P505
NR 7
TC 106
Z9 113
U1 5
U2 25
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD MAY 15
PY 1999
VL 263
IS 2
BP 193
EP 199
DI 10.1016/S0921-5093(98)01167-8
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 184NH
UT WOS:000079617900013
DA 2018-10-20
ER

PT J
AU Trevisan, A
   Bicciato, F
   Fanelli, G
   Stocco, E
   Paruzzolo, P
AF Trevisan, A
   Bicciato, F
   Fanelli, G
   Stocco, E
   Paruzzolo, P
TI Risk of hepatitis C virus infection in a population exposed to
   biological materials
SO AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
LA English
DT Article
DE hepatitis C infection; seroprevalence; biological exposure; liver
   involvement
ID HEALTH-CARE WORKERS; NEEDLESTICK INJURY; HOSPITAL EMPLOYEES;
   LIVER-DISEASE; HCV INFECTION; BLOOD-DONORS; ANTIBODIES; PREVALENCE;
   PERSONNEL
AB Background Hepatitis C virus is an important cause of acute and chronic hepatitis and it is an agent parenterally transmitted. Workers handling biological materials may be exposed to high concentration of virus-infected fluids.
   Methods The seroprevalence of hepatitis C virus antibodies was investigated in a population of 809 subjects exposed to varying levels of biological risk owing to the handling of human fluids or tissues and in 408 controls. The exposed group was subdivided in three subgroups according to low and occasional (262), intermediate but continuous (311), and high (236) exposure to biological materials.
   Results The seroprevalence of hepatitis C antibodies was low (1.40%) in all subjects. The risk groups showed no significant differences with respect to the control group; the most exposed group showed a seroprevalence of 1.274%. Age but not sex appeared significantly correlated with seroprevalence of positive antibodies (chi(2) = 5.949, P < 0.025). Aspartate aminotransferase and alanine aminotransferase showed a highly significant increase (P < 0.01 and P < 0.001, respectively) in subjects with posit ive hepatitis C antibodies, other than a high significant prevalence of values above the normal limit (chi(2) = 26.613, P < 0.001 and chi(2) = 39.164, P < 0.001, respectively). Among 17 positive hepatitis C virus subjects, 8 (47.1%) were positive for hepatitis B virus, but not for its antigen.
   Conclusions Hepatitis C virus infection appears to be a low risk for people employed in the biomedical field, yet infection is associated with a significant fiver involvement. Am. J. Ind. Med,35:532-535, 1999. (C) 1999 Wiley-Liss, Inc.
C1 Univ Padua, Inst Occupat Med, I-35128 Padua, Italy.
RP Trevisan, A (reprint author), Univ Padua, Inst Occupat Med, Via Giustiniani 2, I-35128 Padua, Italy.
RI Trevisan, Andrea/E-5325-2013
OI Trevisan, Andrea/0000-0002-0764-1084
CR ALBERTI A, 1991, ANN INTERN MED, V114, P1010, DOI 10.7326/0003-4819-114-12-1010
   ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702
   CAMPELLO C, 1992, INFECTION, V20, P224, DOI 10.1007/BF02033064
   CARIANI E, 1991, LANCET, V337, P850, DOI 10.1016/0140-6736(91)92555-G
   CHIARAMONTE M, 1991, ITAL J GASTROENTEROL, V23, P555
   DELUCA M, 1992, LANCET, V339, P1364
   Djeriri K, 1996, PRESSE MED, V25, P145
   ESTEBAN JI, 1991, ANN INTERN MED, V115, P443, DOI 10.7326/0003-4819-115-6-443
   ESTEBAN JI, 1989, LANCET, V2, P294
   FRANCAVILLA E, 1992, INFECTION, V20, P295, DOI 10.1007/BF01710802
   GERMANAUD J, 1994, AM J PUBLIC HEALTH, V84, P122, DOI 10.2105/AJPH.84.1.122
   HERBERT AM, 1992, LANCET, V339, P305
   HOFMANN H, 1990, INFECTION, V18, P286, DOI 10.1007/BF01647006
   JOCHEN ABB, 1992, LANCET, V339, P304, DOI 10.1016/0140-6736(92)91373-G
   KIYOSAWA K, 1991, ANN INTERN MED, V115, P367, DOI 10.7326/0003-4819-115-5-367
   MARRANCONI F, 1992, INFECTION, V20, P111, DOI 10.1007/BF01711079
   MELE A, 1996, 963 ISTISAN
   MITSUI T, 1992, HEPATOLOGY, V16, P1109, DOI 10.1016/0270-9139(92)90001-P
   PURO V, 1995, AM J PUBLIC HEALTH, V85, P1272, DOI 10.2105/AJPH.85.9.1272
   SCHLIPKOTER U, 1990, SCAND J INFECT DIS, V22, P757, DOI 10.3109/00365549009027136
   SEEFF LB, 1991, ANN INTERN MED, V115, P411, DOI 10.7326/0003-4819-115-5-411_1
   TREMOLADA F, 1991, ANN INTERN MED, V114, P277, DOI 10.7326/0003-4819-114-4-277
   VAGLIA A, 1990, LANCET, V336, P1315, DOI 10.1016/0140-6736(90)92997-V
   ZUCKERMAN J, 1994, LANCET, V343, P1618, DOI 10.1016/S0140-6736(94)93064-3
NR 24
TC 3
Z9 3
U1 0
U2 1
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0271-3586
J9 AM J IND MED
JI Am. J. Ind. Med.
PD MAY
PY 1999
VL 35
IS 5
BP 532
EP 535
DI 10.1002/(SICI)1097-0274(199905)35:5<532::AID-AJIM11>3.0.CO;2-V
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 183LN
UT WOS:000079555200011
PM 10212707
DA 2018-10-20
ER

PT J
AU Ikada, Y
AF Ikada, Y
TI Key factors in tissue engineering
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
DE tissue regeneration; tissue substitution; scaffold; release carrier of
   growth factor; barrier; blast cells
AB Tissue engineering is an emerging biomedical form of engineering aiming at regeneration of natural tissues or creation of biological substitutes for defective or lost tissues and organs using cells of different species. It is essential for time tissue self-regeneration, for instance, to provide a space necessary for regeneration with certain materials and technologies. This article overviews such key factors required for tissue engineering.
C1 Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan.
RP Ikada, Y (reprint author), Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, 53 Kawara Cho, Kyoto 6068507, Japan.
NR 0
TC 2
Z9 2
U1 0
U2 0
PU INDIAN ACADEMY SCIENCES
PI BANGALORE
PA P B 8005 C V RAMAN AVENUE, BANGALORE 560 080, INDIA
SN 0250-4707
J9 B MATER SCI
JI Bull. Mat. Sci.
PD MAY
PY 1999
VL 22
IS 3
BP 627
EP 631
DI 10.1007/BF02749978
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 214EV
UT WOS:000081316400067
DA 2018-10-20
ER

PT J
AU Cerrai, P
   Guerra, GD
   Tricoli, M
   Krajewski, A
   Guicciardi, S
   Ravaglioli, A
   Maltinti, S
   Masetti, G
AF Cerrai, P
   Guerra, GD
   Tricoli, M
   Krajewski, A
   Guicciardi, S
   Ravaglioli, A
   Maltinti, S
   Masetti, G
TI New composites of hydroxyapatite and bioresorbable macromolecular
   material
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID POLY(ESTER-ETHER-ESTER) BLOCK-COPOLYMERS; IN-VITRO; POWDERS
AB Composite materials were prepared by mixing in different proportions of hydroxyapatite (HA) and poly(epsilon-caprolactone-oxyethylene-epsilon-caprolactone) block copolymer (PCL-POE-PCL) to produce a new resorbable material for biomedical applications. This material has proved to be very interesting for production of periodontal membranes. Mechanical properties are linearly proportional to the amount of HA introduced. Fourier transform infrared (FTIR) investigations have pointed out that HA is able to influence some close epsilon-caprolactone molecules to start its homopolymerization giving PCL with an end chain ionic bonding. HA grains are therefore surrounded by a film of PCL which grants close connection of HA grains within copolymeric matrix. This interface bond with PCL is, however, an interesting occurrence for preparations of HA/PCL composites. (C) 1999 Kluwer Academic Publishers.
C1 CNR, CSMM, I-56126 Pisa, Italy.
   CNR, IRTEC, I-48018 Faenza, Italy.
   Dipartimento Ingn Chim, I-56126 Pisa, Italy.
   CNR, IB, I-56127 Pisa, Italy.
   Univ Pisa, Dipartimento Fis, I-56126 Pisa, Italy.
RP Cerrai, P (reprint author), CNR, CSMM, Via Diotisalvi 2, I-56126 Pisa, Italy.
CR CERRAI P, 1994, J MATER SCI-MATER M, V5, P33, DOI 10.1007/BF00121151
   DelGuerra RS, 1995, J MATER SCI-MATER M, V6, P824
   DELGUERRA RS, 1994, J MATER SCI-MATER M, V5, P891, DOI 10.1007/BF01172032
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   HASHIN Z, 1966, P 3 INT S CER MICR T
   Krajewski A, 1996, CRYST RES TECHNOL, V31, P637, DOI 10.1002/crat.2170310519
   KRAJEWSKI A, 1995, CRYST RES TECHNOL, V30, P843, DOI 10.1002/crat.2170300623
   MARTINETTI R, 1995, BIOMATERIALS, V9, P43
   ONDRACEK G, 1986, MATER CHEM PHYS, V15, P281, DOI 10.1016/0254-0584(86)90006-4
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
NR 10
TC 32
Z9 35
U1 0
U2 4
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 1999
VL 10
IS 5
BP 283
EP 289
DI 10.1023/A:1008905529461
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 197VR
UT WOS:000080387000005
PM 15348145
DA 2018-10-20
ER

PT J
AU Rosiak, JM
   Yoshii, F
AF Rosiak, JM
   Yoshii, F
TI Hydrogels and their medical applications
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Ionizing Radiation and Polymers (IRaP 98)
CY SEP 19-24, 1998
CL WEINBOHLA, GERMANY
SP Inst Oberflachen Modifizier, Commissariat Energie Atom, Int Atomic Energy Agency, Gesell Schwerionenforsch, Deutsch Forsch Gemeinschaft, Sachsisches Minist Wissenschaft & Kultur
DE hydrogels; ionizing radiation; biomaterials; polymers
ID CROSS-LINKING COPOLYMERIZATION; PULSE-RADIOLYSIS; AQUEOUS-SOLUTION;
   BIOMEDICAL PURPOSES; POLYMERS; KINETICS; OXYGEN
AB Biomaterials play a key role in most approaches for engineering tissues as substitutes for functional replacement, for components of devices related to therapy and diagnosis, for drug delivery systems and supportive scaffolds for guided tissue growth. Modern biomaterials could be composed of various components, e.g. metals, ceramics, natural tissues, polymers. In this last group, the hydrogels, hydrophilic polymeric gels with requested biocompatibility and designed interaction with living surrounding seem to be one of the most promising group of biomaterials. Especially, if they are formed by means of ionizing radiation. In early 1950s, the pioneers of the radiation chemistry of polymers began some experiments with radiation crosslinking of hydrophilic polymers. However, hydrogels were analyzed mainly from the point of view of the phenomenon associated with radiation synthesis, with topology of network and relation between radiation parameters of the processes. Fundamental monographs on radiation polymer physics and chemistry written by A. Charlesby (Atomic Radition and polymers, Pergamon Press, Oxford, 1960) and A. Chapiro (Radiation Chemistry of Polymeric Systems, Interscience, New York, 1962) proceed from this time. The noticeable interest in the application of radiation techniques to obtain hydrogels for biomedical purposes began in the late sixties as a result of the papers and patents invented by Japanese and American scientists, headed by Kaetsu in Japan and Hoffman in USA. Immobilization of biologically active species in hydrogel matrices, their use as drug delivery systems and enzyme traps as well as the modification of material surfaces to improve biocompatibility and their ability to bond antigens and antibodies had been the main subjects of these investigations. In this article a brief summary of investigations on mechanism and kinetics of radiation formation of hydrogels as well as some examples of commercialized hydrogel biomaterials have been presented. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Lodz Tech Univ, Inst Appl Radiat Chem, PL-93590 Lodz, Poland.
   Japan Atom Energy Res Inst, Takasaki Radiat Chem Res Estab, Takasaki, Gumma 37012, Japan.
RP Rosiak, JM (reprint author), Lodz Tech Univ, Inst Appl Radiat Chem, Wroblewskiego St 15, PL-93590 Lodz, Poland.
CR Charlesby A, 1960, ATOMIC RAD POLYM
   FOX AS, Patent No. 5540033
   ISILDAR M, 1982, INT J RADIAT BIOL, V41, P525, DOI 10.1080/09553008214550601
   Janik I, 1997, J CHIM PHYS PCB, V94, P244, DOI 10.1051/jcp/1997940244
   Janik I, 1999, NUCL INSTRUM METH B, V151, P318, DOI 10.1016/S0168-583X(99)00079-8
   MAKUUCHI K, Patent No. 9262249
   MAKUUCHI K, Patent No. 9263671
   MAKUUCHI K, Patent No. 9262279
   MAKUUCHI K, Patent No. 967453
   MATHESON MS, 1973, J PHYS CHEM-US, V77, P2420, DOI 10.1021/j100639a011
   OLEJNICZAK J, UNPUB
   Peppas N. A., 1986, HYDROGELS MED PHARM, V1
   RATNAR BR, 1996, BIOMATERIALS SCI INT
   ROSIAK J, 1990, RADIAT PHYS CHEM, V36, P747
   ROSIAK J, Patent No. 2200643
   ROSIAK J, Patent No. 3744289
   ROSIAK J, Patent No. 151581
   ROSIAK J, ACS S, V475, P271
   Rosiak J. M., 1989, US patent, Patent No. [US4871490, 4871490]
   ROSIAK JM, 1995, RADIAT PHYS CHEM, V46, P161, DOI 10.1016/0969-806X(95)00007-K
   Rosiak JM, 1995, NUCL INSTRUM METH B, V105, P335, DOI 10.1016/0168-583X(95)00550-1
   ROSIAK JM, Patent No. 204866
   Szycher M., 1991, HIGH PERFORMANCE BIO
   *THET, 1996, 610 THET
   TOBITA H, 1993, MACROMOLECULES, V26, P836, DOI 10.1021/ma00056a039
   TOBITA H, 1993, MACROMOLECULES, V26, P5427, DOI 10.1021/ma00072a021
   Ulanski P, 1996, J CHEM SOC PERK T 2, P23, DOI 10.1039/p29960000023
   ULANSKI P, 1994, MACROMOL CHEM PHYSIC, V195, P1443, DOI 10.1002/macp.1994.021950427
   ULANSKI P, 1995, RADIAT PHYS CHEM, V46, P913, DOI 10.1016/0969-806X(95)00291-5
NR 29
TC 219
Z9 222
U1 4
U2 53
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD MAY
PY 1999
VL 151
IS 1-4
BP 56
EP 64
DI 10.1016/S0168-583X(99)00118-4
PG 9
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 201PN
UT WOS:000080604100007
DA 2018-10-20
ER

PT J
AU McCarthy, DW
   Bass, LA
   Cutler, PD
   Shefer, RE
   Klinkowstein, RE
   Herrero, P
   Lewis, JS
   Cutler, CS
   Anderson, CJ
   Welch, MJ
AF McCarthy, DW
   Bass, LA
   Cutler, PD
   Shefer, RE
   Klinkowstein, RE
   Herrero, P
   Lewis, JS
   Cutler, CS
   Anderson, CJ
   Welch, MJ
TI High purity production and potential applications of copper-60 and
   copper-61
SO NUCLEAR MEDICINE AND BIOLOGY
LA English
DT Article
DE Cu-60; Cu-61; Cu-64; production; PET
ID POSITRON EMISSION TOMOGRAPHY; EXCITATION-FUNCTIONS; SMALL CYCLOTRON;
   NATURAL NICKEL; CU-64
AB Previously we described the high yield production of Cu-64 using a target system designed specifically for low energy, biomedical cyclotrons. In this study, the use of this target system for the production of Cu-60 and Cu-61 is described and the utility of these isotopes in the labeling of biomolecules for tumor and hypoxia imaging is demonstrated. Cu-60 and Cu-61 were produced by the Ni-60(p, n)Cu-60, Ni-61(p,n)Cu-61, and Ni-60(d,n)Cu-61 nuclear reactions. The nickel target (>99% enriched or natural nickel) was plated onto a gold disk as described previously (54-225 mu m thickness) and irradiated (14.7 MeV proton beam and 8.1 MeV deuteron beam). The copper isotopes were separated from the nickel via ion exchange chromatography and the radioisotopic purity was assessed by gamma spectroscopy. Yields of up to 865 mCi of Cu-60 have been achieved using enriched Ni-60. Cu-61 has been produced with a maximum yield of 144 mCi using enriched Ni-61 and 72 mCi using enriched Ni-60. Specific activities (using enriched material) ranged from 80 to 300 mCi/mu g Cu for Cu-60 and from 20 to 81 mCi/mu g Cu for Cu-61. Bombardments of natural Ni targets were performed using both protons and deuterons, Yields and radioisotopic impurities were determined and compared with that for enriched materials. Cu-60 was used to radiolabel diacetyl-bis(N-4-methylthiosemicarbazone), ATSM. Cu-60-ATSM was injected into rats that had an occluded left anterior descending coronary artery. Uptake of Cu-60-ATSM in the hypoxic region of the heart was visualized clearly using autoradiography. In addition, Cu-60-ATSM was injected into dogs and excellent images of the heart and heart walls were obtained using positron emission tomography (PET), Cu-61 was labeled to 1,4,8,11-tetraazacyclotetradecane-N,N',N ",N'''-tetraacetic acid-octreotide (TETA-octreotide) and the PET images of tumor-bearing rats were obtained up to 2 h postinjection. After decay of the Cu-61, the same rat was injected with Cu-64-TETA-octreotide and the images were compared. The tumor images obtained using Cu-61 were found to be superior to those using Cu-64 as predicted based on the larger abundance of positrons emitted by Cu-61 VS. Cu-64, NUCL MED BIOL 26;4:351-358, 1999. (C) 1999 Elsevier Science Inc. All rights reserved.
C1 Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Div Radiol Sci, St Louis, MO 63110 USA.
   Newton Sci Inc, Cambridge, MA USA.
RP Welch, MJ (reprint author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Div Radiol Sci, 510 S Kingshighway Blvd, St Louis, MO 63110 USA.
OI Anderson, Carolyn/0000-0002-5663-282X; Lewis, Jason/0000-0001-7065-4534
FU NCI NIH HHS [CA64475]
CR ANDERS CJ, 1998, IN PRESS J NUCL MED
   ANDERSON CJ, 1995, J NUCL MED, V36, P2315
   DEHDASHTI F, 1997, J NUCL MED, V38, P103
   FUJIBAYASHI Y, 1991, Journal of Nuclear Medicine, V32, P974
   Fujibayashi Y, 1997, J NUCL MED, V38, P1155
   FUJIBAYASHI Y, 1998, IN PRESS NUCL MED BI
   GREEN M A, 1990, Journal of Nuclear Medicine, V31, P815
   GREEN MA, 1987, NUCL MED BIOL, V14, P59
   LACY JL, 1998, J NUCL MED, V39, P142
   LEDERER CM, 1978, TABLE ISOTOPES
   LONGNECKER DS, 1979, CANCER LETT, V7, P197, DOI 10.1016/S0304-3835(79)80080-4
   Martin CC, 1995, IEEE T MED IMAGING, V14, P681, DOI 10.1109/42.476109
   MARTIN CC, 1992, THESIS U WISCONSIN M
   McCarthy DW, 1997, NUCL MED BIOL, V24, P35, DOI 10.1016/S0969-8051(96)00157-6
   PETERING HG, 1964, CANCER RES, V24, P367
   PIEL H, 1992, RADIOCHIM ACTA, V57, P1
   SZELECSENYI F, 1993, APPL RADIAT ISOTOPES, V44, P575, DOI 10.1016/0969-8043(93)90172-7
   Tolmachev V, 1998, APPL RADIAT ISOTOPES, V49, P79, DOI 10.1016/S0969-8043(97)00235-2
   WELCH MJ, 1998, EUR J NUCL MED, V25, P978
   ZWEIT J, 1991, APPL RADIAT ISOTOPES, V42, P193
   ZWEIT J, 1992, EUR J NUCL MED, V19, P418
NR 21
TC 112
Z9 113
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0969-8051
J9 NUCL MED BIOL
JI Nucl. Med. Biol.
PD MAY
PY 1999
VL 26
IS 4
BP 351
EP 358
DI 10.1016/S0969-8051(98)00113-9
PG 8
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 196JE
UT WOS:000080304600002
PM 10382836
DA 2018-10-20
ER

PT J
AU Roussel, P
   Lysenko, V
   Remaki, B
   Delhomme, G
   Dittmar, A
   Barbier, D
AF Roussel, P
   Lysenko, V
   Remaki, B
   Delhomme, G
   Dittmar, A
   Barbier, D
TI Thick oxidised porous silicon layers for the design of a biomedical
   thermal conductivity microsensor
SO SENSORS AND ACTUATORS A-PHYSICAL
LA English
DT Article; Proceedings Paper
CT Symposium H - Materials Aspects in Microsystem Technologies
CY JUN 16-19, 1998
CL STRASBOURG, FRANCE
DE porous silicon; thin film thermopile based microsensor; tissue blood
   micro-flow measurements
AB Porous silicon (PS) offers new possibilities to be applied as thermal insulating material for microsensor design due to its low thermal conductivity (TC) value compared with TC of SiO2. A biomedical TC microsensor based on differential thermoelectric measurements has been designed using a PS substrate. In order to ensure an efficient thermal isolation in the microsensor, main thermal and geometrical characteristics of the PS layers as well as of the whole microsensor have been numerically simulated. PS layers with low TC have to be thick and mechanically stable under further processing. To form thick (50-200 mu m) and stable PS layers, a new approach based on progressive changing of anodisation current density (from 100 to 25 mA/cm(2)) during PS formation has been elaborated. To find a suitable compromise between low TC and mechanical stability of thick PS layers, an adapted thermal oxidation recipe at moderate temperatures (500-600 degrees C) in dry oxygen atmosphere has been applied. It leads to 20-50% oxidation fraction in PS layers (measured by Energy Dispersive Spectroscopy) corresponding to SIO2 TC value. A test device has been realised and characterised. A Seebeck coefficient of 400 mu V/degrees C per junction has been measured for a Poly-Si/Al thermopile deposited on the PS layer. (C) 1999 Elsevier Science S.A. All rights reserved.
C1 Inst Natl Sci Appl, Phys Mat Lab, CNRS, UMR 5511, F-69621 Villeurbanne, France.
RP Roussel, P (reprint author), Inst Natl Sci Appl, Phys Mat Lab, CNRS, UMR 5511, 20 Av Albert Einstein,Bat 502, F-69621 Villeurbanne, France.
RI Delhomme, Georges/G-6094-2016; Lysenko, Vladimir/G-6376-2014
OI Delhomme, Georges/0000-0001-5272-8851; Lysenko,
   Vladimir/0000-0003-1076-7064
CR Benedetto G, 1997, APPL PHYS A-MATER, V64, P155, DOI 10.1007/s003390050457
   DELHOMME G, 1994, IEEE T BIO-MED ENG, V41, P656, DOI 10.1109/10.301732
   DITTMAR A, 1991, INNOV TECH BIOL MED, V12, P121
   Drost A., 1995, Sensors and Materials, V7, P111
   HALIMAOUI A, 1995, POROUS SILICON SCI T, P34
   Lysenko V, 1998, SENSOR ACTUAT A-PHYS, V67, P205, DOI 10.1016/S0924-4247(97)01777-9
   Lysenko V, 1998, APPL SURF SCI, V123, P458, DOI 10.1016/S0169-4332(97)00487-X
   Obraztsov AN, 1997, SEMICONDUCTORS+, V31, P534, DOI 10.1134/1.1187209
NR 8
TC 37
Z9 38
U1 1
U2 13
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-4247
J9 SENSOR ACTUAT A-PHYS
JI Sens. Actuator A-Phys.
PD APR 20
PY 1999
VL 74
IS 1-3
BP 100
EP 103
DI 10.1016/S0924-4247(98)00330-6
PG 4
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA 187ZZ
UT WOS:000079820200022
DA 2018-10-20
ER

PT J
AU Shi, HQ
   Tsai, WB
   Garrison, MD
   Ferrari, S
   Ratner, BD
AF Shi, HQ
   Tsai, WB
   Garrison, MD
   Ferrari, S
   Ratner, BD
TI Template-imprinted nanostructured surfaces for protein recognition
SO NATURE
LA English
DT Article
ID MOLECULAR RECOGNITION; BIOMATERIALS; ENTRAPMENT; ANTIBODIES; ADSORPTION;
   POLYMERS; WATER
AB Synthetic materials capable of selectively recognizing proteins are important in separations(1), biosensors(2) and the development of biomedical materials(3-5). The technique of molecular imprinting creates specific recognition sites in polymers by using template molecules(6-9). Molecular recognition is attributed to binding sites that complement molecules in size, shape and chemical functionality(10). But attempts to imprint proteins have met with only limited success(11-15). Here we report a method for imprinting surfaces with protein-recognition sites. We use radio-frequency glow-discharge plasma deposition to form polymeric thin films(16) around proteins coated with disaccharide molecules. The disaccharides become covalently attached to the polymer film, creating polysaccharide-like cavities that exhibit highly selective recognition for a variety of template proteins, including albumin, immunoglobulin G, lysozyme, ribonuclease and streptavidin, Direct imaging of template recognition is achieved by patterning a surface at the micrometre scale with imprinted regions.
C1 Univ Washington, Ctr Bioengn, Seattle, WA 98195 USA.
   Univ Trento, Trento, Italy.
   Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Ratner, BD (reprint author), Univ Washington, Ctr Bioengn, Box 351720, Seattle, WA 98195 USA.
RI Tsai, Wei-Bor/B-7953-2011
CR Andrade JD, 1985, SURFACE INTERFACIAL, V2, P1
   Ariga K, 1998, ACCOUNTS CHEM RES, V31, P371, DOI 10.1021/ar970014i
   Bernard A, 1998, LANGMUIR, V14, P2225, DOI 10.1021/la980037l
   BRASH JL, 1991, ACS ADV CHEM SERIES, V199, P3
   BYFIELD MP, 1994, BIOSENS BIOELECTRON, V9, P373, DOI 10.1016/0956-5663(94)80038-3
   CRAM DJ, 1988, SCIENCE, V240, P760, DOI 10.1126/science.3283937
   CROWE JH, 1990, CRYOBIOLOGY, V27, P219, DOI 10.1016/0011-2240(90)90023-W
   GLAD M, 1985, J CHROMATOGR, V347, P11, DOI 10.1016/S0021-9673(01)95465-2
   Hjerten S, 1997, CHROMATOGRAPHIA, V44, P227, DOI 10.1007/BF02466386
   HORBATSCH M, 1986, Z PHYS D ATOM MOL CL, V2, P183, DOI 10.1007/BF01429072
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   James CD, 1998, LANGMUIR, V14, P741, DOI 10.1021/la9710482
   KEMPE M, 1995, J MOL RECOGNIT, V8, P35, DOI 10.1002/jmr.300080106
   Lemieux RU, 1996, ACCOUNTS CHEM RES, V29, P373, DOI 10.1021/ar9600087
   MALLICK N, 1994, BIOMETALS, V7, P299
   Mosbach K, 1996, BIO-TECHNOL, V14, P163, DOI 10.1038/nbt0296-163
   Nock S, 1997, FEBS LETT, V414, P233, DOI 10.1016/S0014-5793(97)01040-5
   NORDE W, 1992, COLLOID SURFACE, V66, P73, DOI 10.1016/0166-6622(92)80122-I
   Paleos CM, 1997, ADV MATER, V9, P695, DOI 10.1002/adma.19970090904
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   SHEA KJ, 1994, TRENDS POLYM SCI, V2, P166
   SHI H, UNPUB ADV MAT
   SHI H, IN PRESS J BIOMED MA
   SHIRAHAMA H, 1990, J COLLOID INTERF SCI, V139, P177, DOI 10.1016/0021-9797(90)90455-W
   Steinke J, 1995, ADV POLYM SCI, V123, P80
   VENTON DL, 1995, BBA-PROTEIN STRUCT M, V1250, P117, DOI 10.1016/0167-4838(95)00079-A
   VIJAYALAKSHMI MA, 1989, TRENDS BIOTECHNOL, V7, P71, DOI 10.1016/0167-7799(89)90067-X
   WEAVER DR, 1992, BIOMATERIALS, V13, P577, DOI 10.1016/0142-9612(92)90025-J
   WULFF G, 1995, ANGEW CHEM INT EDIT, V34, P1812, DOI 10.1002/anie.199518121
   Yu C, 1997, J ORG CHEM, V62, P4057, DOI 10.1021/jo961784v
NR 31
TC 514
Z9 555
U1 11
U2 224
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD APR 15
PY 1999
VL 398
IS 6728
BP 593
EP 597
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 186WX
UT WOS:000079754700050
PM 10217142
DA 2018-10-20
ER

PT J
AU Ong, YL
   Razatos, A
   Georgiou, G
   Sharma, MM
AF Ong, YL
   Razatos, A
   Georgiou, G
   Sharma, MM
TI Adhesion forces between E-coli bacteria and biomaterial surfaces
SO LANGMUIR
LA English
DT Article
ID SOLID-SURFACES; HYDROPHOBIC INTERACTIONS; FREE-ENERGY; MICROSCOPY;
   ATTACHMENT; PARTICLES; CELLS; SUBSTRATA; POLYMERS; DLVO
AB Bacterial infection of biomaterial surfaces is an important problem in the biomedical and health industries. The design of materials resistant to infections necessitates an understanding of the forces driving bacterial adhesion. Escherichia coli cells were immobilized onto the tip of a standard atomic force microscope (AFM) cantilever, and force measurements were performed by approaching the modified cantilever onto mica, hydrophilic glass, hydrophobic glass, polystyrene, and Teflon. Consistent with prior qualitative observations, we show that bacterial adhesion is indeed enhanced by the surface hydrophobicity of the substrate. The forces of interaction measured with the AFM are compared to those of model predictions based on an extended-DLVO approach. In this model, short-range acid-base and steric interactions are included with the conventional van der Waals attraction and electrostatic components. The theoretical predictions agree well with experimental data for E. coli D21f2, a strain whose outer surface consists of lipopolysaccharide molecules with severely truncated carbohydrate chains. However, the adhesive behavior off. coli strains with more complex cell surface structures was found to be more difficult to model because of the possible involvement of steric and bridging effects or specific receptor-ligand interactions that remain to be resolved.
C1 Univ Texas, Dept Petr Engn, Austin, TX 78712 USA.
   Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
   Univ Texas, Inst Mol & Cell Biol, Austin, TX 78712 USA.
RP Sharma, MM (reprint author), Univ Texas, Dept Petr Engn, Austin, TX 78712 USA.
CR BOMAN HG, 1975, J BACTERIOL, V121, P455
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   BUTT HJ, 1991, BIOPHYS J, V60, P777, DOI 10.1016/S0006-3495(91)82112-9
   DEGENNES PG, 1987, ADV COLLOID INTERFAC, V27, P189, DOI 10.1016/0001-8686(87)85003-0
   Derjaguin B, 1934, KOLLOID Z, V69, P155, DOI 10.1007/BF01433225
   DUCKER WA, 1994, LANGMUIR, V10, P3279, DOI 10.1021/la00021a061
   DUCKER WA, 1992, LANGMUIR, V8, P1831, DOI 10.1021/la00043a024
   FLETCHER M, 1985, J COLLOID INTERF SCI, V104, P5, DOI 10.1016/0021-9797(85)90004-9
   FLETCHER M, 1979, APPL ENVIRON MICROB, V37, P67
   Freeman A, 1996, BIOTECHNOL BIOENG, V52, P625, DOI 10.1002/(SICI)1097-0290(19961205)52:5<625::AID-BIT10>3.3.CO;2-O
   FRIETAS AM, UNPUB
   Good R.J., 1991, FUNDAMENTALS ADHESIO
   GREGORY J, 1981, J COLLOID INTERF SCI, V83, P138, DOI 10.1016/0021-9797(81)90018-7
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HOH JH, 1994, J CELL SCI, V107, P1105
   Israelachvili J. N., 1991, INTERMOLECULAR SURFA
   ISRAELACHVILI JN, 1974, Q REV BIOPHYS, V6, P341
   KLOTZ SA, 1990, MICROBIAL CELL SURFA
   MCELDOWNEY S, 1986, J GEN MICROBIOL, V132, P513
   MCELDOWNEY S, 1986, APPL ENVIRON MICROB, V52, P460
   MOZES N, 1987, BIOTECHNOL BIOENG, V30, P439, DOI 10.1002/bit.260300315
   NEIDHARDT FC, 1990, ESCHERICHIA COLI SAL
   OFEK I, 1994, BACTERIAL ADHESION C
   PASHLEY RM, 1984, J COLLOID INTERF SCI, V97, P446, DOI 10.1016/0021-9797(84)90316-3
   RAZATOS AP, IN PRESS J BIOMATER
   RAZATOS AP, UNPUB
   RUCKENSTEIN E, 1976, AICHE J, V22, P276, DOI 10.1002/aic.690220209
   SCHOENENBERGER CA, 1994, BIOPHYS J, V67, P929, DOI 10.1016/S0006-3495(94)80556-9
   SEEBERGH JE, 1995, COLLOID SURFACE A, V100, P139, DOI 10.1016/0927-7757(95)03155-7
   STICKLER DJ, 1995, CELL MATER, V5, P167
   UYEN HM, 1988, APPL ENVIRON MICROB, V54, P837
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1898
   VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7
   VANOSS CJ, 1986, J COLLOID INTERF SCI, V111, P378, DOI 10.1016/0021-9797(86)90041-X
   Yoon RH, 1997, J COLLOID INTERF SCI, V185, P363, DOI 10.1006/jcis.1996.4583
   Zita A, 1997, FEMS MICROBIOL LETT, V152, P299, DOI 10.1111/j.1574-6968.1997.tb10443.x
NR 37
TC 324
Z9 327
U1 12
U2 170
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD APR 13
PY 1999
VL 15
IS 8
BP 2719
EP 2725
DI 10.1021/la981104e
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 187FF
UT WOS:000079775700018
DA 2018-10-20
ER

PT J
AU Catanese, J
   Cooke, D
   Maas, C
   Pruitt, L
AF Catanese, J
   Cooke, D
   Maas, C
   Pruitt, L
TI Mechanical properties of medical grade expanded polytetrafluoroethylene:
   The effects of internodal distance, density, and displacement rate
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE expanded polytetrafluoroethylene (e-PTFE); implants; structure;
   mechanical properties
ID SURGERY; GRAFTS
AB Expanded polytetrafluoroethylene (e-PTFE) is used successfully in a multitude of biomedical and clinical applications, The success of this biomaterial is due to its microporous structure that allows biointegration for fixation, as well as overall mechanical integrity. The mechanical properties and degree of tissue ingrowth depend on the microstructure of the expanded polymer foam, yet little is known about the correlation of the internodal distance and other microstructural features with the monotonic tensile properties. Complete structure-property correlation can be used to provide invaluable knowledge for the design of biomedical devices, The purpose of this study was to investigate the monotonic tensile properties of e-PTFE over a range of medically relevant microstructural features and manufacturing parameters. The microstructural and manufacturing parameters considered were internodal distance, linear density, volumetric density, and reduction ratio. Additionally, the effect of displacement rate on mechanical properties was studied. We found that the ultimate stress and strain increased linearly with linear density (R-2 = 0.88 and 0.67, respectively). Surprisingly, elastic modulus did not correlate with any parameter measured and only weak correlations were found between all properties and internodal distance. The yield and ultimate stresses increased with increasing displacement rate (R-2 = 0.88 and 0.57, respectively), The findings from this study indicate that linear density is a better predictor of mechanical properties than internodal distance and may be the preferred parameter to control when specifying a material for implantation in load bearing situations. (C) 1999 John Wiley & Sons, Inc.
C1 Univ Calif Berkeley, Joint Bioengn Grad Grp, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA.
   Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94143 USA.
RP Pruitt, L (reprint author), Univ Calif Berkeley, Joint Bioengn Grad Grp, Berkeley, CA 94720 USA.
EM lpruitt@euler.berkeley.edu
CR AKERS DL, 1993, J VASC SURG, V18, P10, DOI 10.1067/mva.1993.41708
   Bellon J M, 1993, Ann Vasc Surg, V7, P549, DOI 10.1007/BF02000149
   Bolton W, 1983, Aktuelle Probl Chir Orthop, V25, P42
   BOLTON W, 1983, AKTUELLE PROBL CHIR, V26, P40
   BOYCE B, 1983, CONCISE ENCY MED DEN, pCH33
   Brun J. L., 1992, Bio-Medical Materials and Engineering, V2, P203
   CAMPBELL CD, 1975, ANN SURG, V182, P138, DOI 10.1097/00000658-197508000-00010
   COCHRAN RP, 1991, J CARDIAC SURG, V6, P508, DOI 10.1111/j.1540-8191.1991.tb00352.x
   Greene D, 1997, LARYNGOSCOPE, V107, P957, DOI 10.1097/00005537-199707000-00024
   KONIOR RJ, 1992, ARCH OTOLARYNGOL, V118, P1188
   MAAS CS, 1993, ARCH OTOLARYNGOL, V119, P1008
   MOLE B, 1992, PLAST RECONSTR SURG, V90, P200, DOI 10.1097/00006534-199290020-00007
   PAAVOLAINEN P, 1993, ACTA ORTHOP SCAND, V64, P323, DOI 10.3109/17453679308993636
   RITTGERS SE, 1985, J MED ENG TECHNOL, V9, P1, DOI 10.3109/03091908509018197
   SANTIAGO EJ, 1981, ANN ROY COLL SURG, V63, P253
   WATANABE T, 1984, J JPN SURG SOC, V85, P580
NR 16
TC 41
Z9 42
U1 4
U2 16
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 1999
VL 48
IS 2
BP 187
EP 192
DI 10.1002/(SICI)1097-4636(1999)48:2<187::AID-JBM13>3.3.CO;2-D
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 181HW
UT WOS:000079436800013
PM 10331912
DA 2018-10-20
ER

PT J
AU Afanasyeva, NI
   Bruch, RF
AF Afanasyeva, NI
   Bruch, RF
TI Biocompatibility of polymer surfaces interacting with living tissue
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article; Proceedings Paper
CT Surface Analysis 98
CY JUN 16-19, 1998
CL PACIFIC NW NATL LAB, RICHLAND, WA
SP Amer Vacuum Soc, Appl Surface Sci Div, Pacific NW Natl Lab, William R Wiley Environm Molec Sci Lab, Amer Vacuum Soc, Pacific NW Chapter
HO PACIFIC NW NATL LAB
DE FTIR; polymer; implant
AB The method of vibrational spectroscopy has been applied as a new tool for the biodiagnostics of polymer implants and tissue surfaces. In this study the spectral analysis of polymer implants has been accomplished by means of Fourier transform infrared spectroscopy (FTIR) to elucidate the long-term biocompatibility and quality control of biomedical materials. Surface analysis allows the determination of the specific molecular composition and structures most appropriate for long-term compatibility in humans.
   Important information associated with the bioinertness or bioactivity of implants has been obtained from the spectral features of the polymer material used, including the level of polymerization, Passivated surfaces of implants have also been obtained and analyzed by means of FTIR. Copyright (C) 1999 John Wiley & Sons, Ltd.
C1 Univ Nevada, Dept Phys, Reno, NV 89557 USA.
RP Afanasyeva, NI (reprint author), Univ Nevada, Dept Phys, Reno, NV 89557 USA.
CR AFANASIEVA N, 1991, MAKROMOL CHEM-M SYMP, V52, P191, DOI 10.1002/masy.19910520117
   AFANASYEVA NI, 1989, POLYM-PLAST TECHNOL, V28, P635
   AFANASYEVA NI, 1994, 11 EUR S POL SPECTR, P19
   AFANASYEVA NI, 1998, 13 EUR S POL SPEC LA
   AFANASYEVA NI, 1988, P EUR S POL SPECTR B, V8, P20
   AFANASYEVA NI, 1989, P 11 ANN INT C IEEE, V11, P1384
   AFANASYEVA NI, 1993, ESIS 93 LYON FRANC, P62
   AFANASYEVA NI, 1994, SPIE, V2089, P354
   AFANASYEVA NI, 1989, IEEE, V2087, P1684
   AFANASYEVA NI, 1992, EUR S POL SPECTR ESO, pA12
   AFANASYEVA NI, 1991, P 13 ANN INT C IEEE, V13, P1481
   ANDERSON B, 1998, RENO GAZETTE J   JUL
   BRUNETTI WH, 1993, ACHIEVING TOTAL QUAL
   CANNAS M, 1987, Italian Journal of Orthopaedics and Traumatology, V13, P387
   FEDOROV SN, 1985, ANN OPHTHALMOL, V101, P18
   FRAKER AC, 1985, CORROSION DEGRADATIO, P859
   Griffiths P. R, 1986, CHEM ANAL
   HOCKWIN O, 1984, SCI AM, V12, P46
   Kendrick T C, 1991, SILICON HETEROATOM B, P67
   MANDELL RB, 1998, CONTACT LENS PRACTIC
   MANTSCH H, 1998, BIOS 98 TECHNICAL PR, P51
   PATAI S, 1991, SILICON HETEROATOM B
   PAUL JP, 1995, BIOMATERIALS ARTIFIC
   SMITH BC, 1996, FUNDAMENTALS FOURIER, P87
   VORONKOV MG, 1990, SOVIET SCI REV B, V15, P1
   VORONKOV MG, 1978, SILOXANE BOND PHYSIC
   1995, WORLDS BEST ANATOMIC
   1998, VIBRATIONAL SPECTROS
NR 28
TC 8
Z9 8
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
EI 1096-9918
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD APR
PY 1999
VL 27
IS 4
BP 204
EP 212
DI 10.1002/(SICI)1096-9918(199904)27:4<204::AID-SIA545>3.0.CO;2-U
PG 9
WC Chemistry, Physical
SC Chemistry
GA 191GJ
UT WOS:000080014000007
DA 2018-10-20
ER

PT J
AU Mukkamala, R
   Kushner, AM
   Bertozzi, CR
AF Mukkamala, R
   Kushner, AM
   Bertozzi, CR
TI New poly(sulfoxide) hydrogels: High water content-low protein binding
   materials for biomedical applications.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 1
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 21
PY 1999
VL 217
MA 036-BTEC
BP U667
EP U667
PN 2
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 176JP
UT WOS:000079148201999
DA 2018-10-20
ER

PT J
AU Schrooten, J
   Van Oosterwyck, H
   Vander Sloten, J
   Helsen, JA
AF Schrooten, J
   Van Oosterwyck, H
   Vander Sloten, J
   Helsen, JA
TI Adhesion of new bioactive glass coating
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bioactive glass; coating; plasma spraying; adhesion test; finite element
   analysis
ID SPRAYED COATINGS; SUBSTRATE
AB A valuable alternative to the existing biomedical implant coatings is a bioactive glass (BAG) coating that is produced by reactive plasma spraying. A mechanical performance requirement that is of the utmost importance is the adhesion strength of the coating. Considering the application as dental implant, a new adhesion test (shear test), which was close to the service conditions, was designed. A Ti6A14V rod (O3 mm) with a sprayed BAG coating of 50 mu m was glued with an epoxy glue to a hollow cylindrical counterpart and was used as such in the tensile machine. This test was evaluated by finite element analysis (FEA). Preliminary experiments showed that a conversion from shear to tensile adhesion strength is possible by using the Von Mises criterion (sigma = 3(1/2)tau), indicating that thin coatings of brittle materials can behave as a ductile material. The new coating technique was proved to produce a high quality coating with an adhesion strength of 40.1 +/- 4.8 MPa in shear and 69.4 +/- 8.4 MPa in tension. The FEA revealed that no one homogeneously distributed shear stress is present but several nonhomogeneously distributed stress components (shear and tensile) are present in the coating. This analysis indicated that real service conditions are much more complicated than standard adhesion tests. (C) 1999 John Wiley & Sons, Inc.
C1 Katholieke Univ Leuven, Dept Met & Mat Engn, B-3001 Heverlee, Belgium.
   Katholieke Univ Leuven, Dept Mech, Div Biomech & Engn Design, B-3001 Heverlee, Belgium.
RP Schrooten, J (reprint author), Katholieke Univ Leuven, Dept Met & Mat Engn, De Croylaan 2, B-3001 Heverlee, Belgium.
RI Van Oosterwyck, Hans/C-2528-2016
OI Van Oosterwyck, Hans/0000-0002-2142-9717
CR AMBROZ O, 1992, P INT THERM SPRAY C, P921
   [Anonymous], 1990, MET HDB, V1, P871
   *ASM INT, 1990, MET HDB, V1, P621
   *ASTM, 1995, C116194 ASTM
   *ASTM, 1995, C125994 ASTM
   Bansal N. P., 1986, HDB GLASS PROPERTIES
   BARTH E, 1986, BIOMATERIALS, V7, P273, DOI 10.1016/0142-9612(86)90049-9
   BERNDT CC, 1990, J MATER ENG, V12, P151, DOI 10.1007/BF02834068
   BERNDT CC, 1993, J ADHES SCI TECHNOL, V7, P1235, DOI 10.1163/156856193X00088
   BERNDT CC, 1992, P INT THERM SPRAY C, P45
   CHALKER PR, 1991, MAT SCI ENG A-STRUCT, V140, P583, DOI 10.1016/0921-5093(91)90482-3
   FILIAGGI MJ, 1991, J BIOMED MATER RES, V25, P1211, DOI 10.1002/jbm.820251004
   GREVING DJ, 1994, P 7 NAT THERM SPRAY, P639
   GRUTZNER H, 1991, SURF COAT TECH, V45, P317, DOI 10.1016/0257-8972(91)90238-R
   HAN W, 1993, J THERM SPRAY TECHN, V2, P145
   Helsen JA, 1997, J EUR CERAM SOC, V17, P147, DOI 10.1016/S0955-2219(96)00176-8
   KRAJEWSKI A, 1981, SCI CERAM, V11, P85
   LACEFIELD WR, 1986, BIOMATERIALS, V7, P104, DOI 10.1016/0142-9612(86)90064-5
   LEIGH SH, 1994, P 7 NAT THERM SPRAY, P655
   RECK R, 1985, AM J OTOL, V6, P280
   SCHEPERS E, 1996, 5 WORLD BIOM C, V1, P242
   SCHEPERS E, 1996, 5 WORLD BIOM C, V1, P1
   SCHROOTEN J, 1997, REACTIVE PLASMA SPRA
   SHIMIZU Y, 1991, P 4 NAT THERM SPRAY, P257
   WOLKE JGC, 1990, THERMAL SPRAY RES AP, P413
   1993, ACTA ORTHOP SCAND S, V255, P64
NR 26
TC 29
Z9 29
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 1999
VL 44
IS 3
BP 243
EP 252
DI 10.1002/(SICI)1097-4636(19990305)44:3<243::AID-JBM2>3.0.CO;2-O
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 154LK
UT WOS:000077890500002
PM 10397926
DA 2018-10-20
ER

PT J
AU Criscione, JC
   Lorenzen-Schmidt, I
   Humphrey, JD
   Hunter, WC
AF Criscione, JC
   Lorenzen-Schmidt, I
   Humphrey, JD
   Hunter, WC
TI Mechanical contribution of endocardium during finite extension and
   torsion experiments on papillary muscles
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE biomechanics; constitutive behavior; cardiac mechanics; myocardium
AB Finite extension and torsion tests on cardiac papillary muscles are presently the best way to directly measure the response to shear along myocardial fibers. Quantifying this response is necessary for determining the complete three-dimensional constitutive behavior of myocardium as a transversely isotropic material. Analysis of such tests is complicated, however, since papillary muscles are materially inhomogeneous, consisting of a myocardial core surrounded by an endocardial sheath that is rich in collagen. In this article, we show that the papillary muscle response to extension and torsion additively decouples into the response of the bare myocardial core plus the response of an endocardial sheath filled with fluid (assuming the muscle is a radially inhomogeneous and incompressible continuum with cylindrical symmetry). This result allows the endocardial response to be subtracted from the intact papillary muscle response to obtain the response of the bare myocardial core. An initial estimate suggests that the endocardial sheath affects the axial moment significantly (50% of torque for all twists at low stretch) but affects the axial force only slightly (<10% at moderate twists). (C) 1999 Biomedical Engineering Society. [S0090-6964(99)01302-8].
C1 Johns Hopkins Med Inst, Dept Biomed Engn, Baltimore, MD 21205 USA.
   Texas A&M Univ, Biomed Engn Program, College Stn, TX USA.
RP Hunter, WC (reprint author), Johns Hopkins Med Inst, Dept Biomed Engn, 720 Rutland Ave, Baltimore, MD 21205 USA.
FU NHLBI NIH HHS [HL 30552]
CR BRUTSAERT DL, 1989, ANNU REV PHYSIOL, V51, P263, DOI 10.1146/annurev.physiol.51.1.263
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   HUMPHREY JD, 1992, J BIOMECH ENG-T ASME, V114, P461, DOI 10.1115/1.2894095
   HUMPHREY JD, 1987, J BIOMECH ENG-T ASME, V109, P298, DOI 10.1115/1.3138684
   HUMPHREY JD, 1990, J BIOMECH ENG-T ASME, V112, P340, DOI 10.1115/1.2891194
   HUMPHREY JD, 1992, J BIOMECH, V25, P541, DOI 10.1016/0021-9290(92)90094-H
   HUMPHREY JD, IN PRESS COMP METH B
   Kang T, 1996, AM J PHYSIOL-HEART C, V270, pH2169
   LORANG DM, 1995, THESIS
   MACKENNA DA, 1994, AM J PHYSIOL, V266, pH1007
   SPENCER AJM, 1980, CONTINUUM MECH, P160
   Yin FCP, 1996, AM J PHYSIOL-HEART C, V271, pH1864
NR 12
TC 12
Z9 12
U1 0
U2 4
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
   USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR-APR
PY 1999
VL 27
IS 2
BP 123
EP 130
DI 10.1114/1.218
PG 8
WC Engineering, Biomedical
SC Engineering
GA 270CJ
UT WOS:000084517600001
PM 10199688
DA 2018-10-20
ER

PT J
AU Li, YJ
   Hanada, T
   Nakaya, T
AF Li, YJ
   Hanada, T
   Nakaya, T
TI Surface modification of segmented polyurethanes by grafting
   methacrylates and phosphatidylcholine polar headgroups to improve
   hemocompatibility
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID CHAIN ALKYL-GROUPS; BLOOD-COMPATIBLE POLYURETHANES; POLY(ISOPRENE) SOFT
   SEGMENT; PHOSPHOLIPID POLYURETHANES; MAIN CHAINS; SIDE-CHAINS;
   BIOMEDICAL APPLICATIONS; ANALOGOUS MOIETIES; POLY(BUTADIENE);
   CHOLESTEROL
AB A new type of phosphatidylcholine-containing segmented polyurethane (SPU) surface was produced by grafting various methacrylates and phosphatidylcholine polar headgroups to a vinyl-group-containing segmented polyurethane (V-SPU) using alpha,alpha'-azobisisobutyronitrile (AIBN) as a radical initiator. 1,4-Butanediol (BD) as chain extender was used to synthesize the V-SPU, which is based on diphenylmethane diisocyanate (MDI) and vinyl-group-containing poly(butadiene) diol (PBD). Several methacrylates, such as methyl methacrylate (MMA), butyl methacrylate (BMA), stearyl methacrylate (SMA), and a phosphatidylcholine polar-headgroup-containing vinyl monomer, 2-(methacrylorloxy)ethyl-2-(trimethylammonium)ethyl phosphate (MTP), were grafted to the V-SPU. The bulk characteristics of the grafted V-SPUs were investigated by infrared (IR) spectroscopy, viscosity, and gel permeation chromatography (GPC) measurements. Mechanical properties of the typical SPU containing MMA were measured by dynamic viscoelasticity and tensile measurements. The phosphatidylcholine polar headgroups were oriented on the surface of these materials, as revealed by attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR), electron spectroscopy for chemical analysis (ESCA), and contact angle measurements. The phosphatidylcholine polar-headgroup-grafted SPU surfaces showed slightly decreased water contact angles, also indicating that hydrophilic phosphatidylcholine polar headgroups are present at the surface. The hemocompatibility in vitro was evaluated with platelet-rich plasma (PRP) contact tests and viewed by scanning electron microscopy (SEM) using the ingrafted V-SPU as a reference. It was found that fewer platelets adhered to the modified surfaces and showed less shape variation than to the unmodified V-SPU. Platelet adhesion to phosphatidylcholine polar-headgroup-grafted polymers was inhibited 88-95% compared with unmodified V-SPU.
C1 Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, Osaka 5588585, Japan.
RP Nakaya, T (reprint author), Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.
EM nakaya@bioa.eng.osaka-cu.ac.jp
CR CHAPMAN D, 1984, Patent No. 199790
   Chen TM, 1996, MACROMOL CHEM PHYSIC, V197, P1587, DOI 10.1002/macp.1996.021970501
   DURANI AA, 1986, Patent No. 275293
   DURRANI AA, 1986, BIOMATERIALS, V7, P121, DOI 10.1016/0142-9612(86)90068-2
   KOEHLER AS, 1996, J BIOMED MATER RES, P237
   Korematsu A, 1997, POLYM BULL, V38, P133, DOI 10.1007/s002890050029
   LETOURNEUR D, 1991, J POLYM SCI POL CHEM, V29, P1367, DOI 10.1002/pola.1991.080291001
   Li YJ, 1997, MACROMOL SYMP, V122, P363, DOI 10.1002/masy.19971220156
   Li YJ, 1996, J APPL POLYM SCI, V62, P687
   Li YJ, 1996, CHEM MATER, V8, P1441, DOI 10.1021/cm960014x
   Li YJ, 1996, BIOMATERIALS, V17, P2179, DOI 10.1016/0142-9612(96)00048-8
   Li YJ, 1998, CHEM MATER, V10, P1596, DOI 10.1021/cm9707869
   Li YJ, 1996, MACROMOL RAPID COMM, V17, P737, DOI 10.1002/marc.1996.030171009
   Li YJ, 1997, CHEM MATER, V9, P1570, DOI 10.1021/cm960615o
   LI YJ, 1995, MACROMOL CHEM PHYSIC, V196, P3143, DOI 10.1002/macp.1995.021961006
   LI YJ, 1995, MACROMOL RAPID COMM, V16, P253, DOI 10.1002/marc.1995.030160404
   Li YJ, 1996, MACROMOL CHEM PHYSIC, V197, P2827, DOI 10.1002/macp.1996.021970920
   Li YJ, 1996, J BIOMAT SCI-POLYM E, V7, P893, DOI 10.1163/156856296X00066
   Nakaya T, 1997, MET MATER PROCESS, V9, P103
   NAKAYA T, IN PRESS PROG POLYM
   Ramesh S, 1998, J MACROMOL SCI R M C, VC38, P481
   REGEN SL, 1982, J AM CHEM SOC, V104, P791, DOI 10.1021/ja00367a023
   Saunders J. H., 1962, POLYURETHANE CHEM 1
   Sugiyama K, 1997, NIPPON KAGAKU KAISHI, P816, DOI 10.1246/nikkashi.1997.816
   UMEDA T, 1982, MAKROMOL CHEM-RAPID, V3, P457
   van der Heiden AP, 1998, J BIOMED MATER RES, V40, P195, DOI 10.1002/(SICI)1097-4636(199805)40:2<195::AID-JBM4>3.0.CO;2-G
   vanderHeiden AP, 1997, J BIOMED MATER RES, V37, P282, DOI 10.1002/(SICI)1097-4636(199711)37:2<282::AID-JBM19>3.0.CO;2-G
   YAMADA M, 1995, MACROMOL RAPID COMM, V16, P25, DOI 10.1002/marc.1995.030160105
   YAMADA M, 1995, J MACROMOL SCI PURE, VA32, P1235, DOI 10.1080/10601329508009351
   Yung LYL, 1998, BIOMATERIALS, V19, P31, DOI 10.1016/S0142-9612(97)00220-2
NR 30
TC 19
Z9 20
U1 1
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD MAR
PY 1999
VL 11
IS 3
BP 763
EP 770
DI 10.1021/cm9806432
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 178BH
UT WOS:000079245400036
DA 2018-10-20
ER

PT J
AU Mardanov, S
   Seyfried, J
   Fatikow, S
AF Mardanov, S
   Seyfried, J
   Fatikow, S
TI An automated assembly system for a microassembly station
SO COMPUTERS IN INDUSTRY
LA English
DT Article
DE microassembly; microrobots; planning
AB The production of complex microsystems from a number of microcomponents made of different materials requires flexible, precise mechanisms, which can finely manipulate different types of objects. The microassembly has its specifics caused by the tiny dimensions of the robots, high accuracy and complicated vision and control systems required. This paper presents a concept of an intelligent microassembly planning system. This system has been implemented in a micromanipulation station with mobile piezoelectric microrobots, which has been developed at the Institute for Process Control and Robotics (IPR) at the University of Karlsruhe [S. Fatikow, U. Rembold, An automated microrobot-based desktop station for micro assembly and handling of microobjects, ETFA IEEE conference on Emerging Technologies and Factory Automation, Kauai Marriott, Kauai, Hawaii, November 18-21 1996, pp. 586-592; S. Fatikow, R. Munassypov, An intelligent micromanipulation cell for industrial and biomedical applications based on piezoelectric microrobot, Proc. Of the 5th Int. Conference on Micro Electro, Opto, Mechanical Systems and Components (MSTU96), Berlin, September 17-19 1996, pp. 826-828]. This research considers the assembly system as a complex system and represents a microassembly environment for the microassembly station. The information flow, interacting and functioning of separate parts of the micromanipulation station are determined and the integration of the assembly subsystem into the station are presented. The principal approaches for each part of the system are given. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Ufa State Aviat Tech Univ, Dept Tech Cybernet, Ufa 450000, Bashkortostan, Russia.
   Univ Karlsruhe, Inst Proc Control & Robot, D-76128 Karlsruhe, Germany.
RP Mardanov, S (reprint author), Ufa State Aviat Tech Univ, Dept Tech Cybernet, 12 K Marx Str, Ufa 450000, Bashkortostan, Russia.
EM mardanov@kmrb.bashnet.ru; seyfried@ira.uka.de; fatikow@ira.uka.de
CR BOURJAULT A, 1984, THESIS U FRANCE COMT
   DEFAZIO TL, 1987, IEEE T ROBOTIC AUTOM, V3, P640, DOI 10.1109/JRA.1987.1087132
   DEMELLO LH, 1990, IEEE T ROBOTICS  APR, P188
   DEMELLO LSH, 1989, PROCEEDINGS - 1989 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOL 1-3, P56, DOI 10.1109/ROBOT.1989.99967
   FAITKOW S, 1996, P 5 INT C MICR OPT M, P826
   Fatikow S, 1996, ETFA '96 - 1996 IEEE CONFERENCE ON EMERGING TECHNOLOGIES AND FACTORY AUTOMATION, PROCEEDINGS, VOLS 1 AND 2, P586, DOI 10.1109/ETFA.1996.573951
   Fatikow S, 1998, J INTELL MANUF, V9, P73, DOI 10.1023/A:1008851409235
   GU P, 1995, INTELLIGENT MANUFACT, P62
   HATAMURA Y, 1994, CONSTRUCTION NANO MA, P37
   *ISO IS, 1994, 1030311 ISO IS
   KOKKINAKI AI, 1995, J INTELL ROBOT SYST, V13, P201, DOI 10.1007/BF01424008
   LEE S, 1993, J INTELLIGENT MANUFA, P183
   MARDANOV A, 1996, THESIS USATU UFA RUS
   *U KARLSR, 1995, ECCO TOOLK SCHEM MAP
   WOO TC, 1991, T ASME, P207
NR 15
TC 5
Z9 7
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3615
J9 COMPUT IND
JI Comput. Ind.
PD MAR
PY 1999
VL 38
IS 2
BP 93
EP 102
DI 10.1016/S0166-3615(98)00111-0
PG 10
WC Computer Science, Interdisciplinary Applications
SC Computer Science
GA 178BE
UT WOS:000079245000003
DA 2018-10-20
ER

PT J
AU Korematsu, A
   Li, YJ
   Murakami, T
   Sakurai, I
   Kodama, M
   Nakaya, T
AF Korematsu, A
   Li, YJ
   Murakami, T
   Sakurai, I
   Kodama, M
   Nakaya, T
TI Synthesis, characterization and blood compatibilities of novel segmented
   polyurethanes containing poly(butadiene) soft segments and
   phosphatidylcholine analogues in the main chains and long-chain alkyl
   groups in the side chains
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID PHOSPHOLIPID POLYURETHANES; COMPATIBLE POLYURETHANES; BIOMEDICAL
   APPLICATIONS; MOIETIES; SURFACE; CHOLESTEROL; POLYMERS
AB New segmented polyurethanes (SPUs) containing poly(butadiene) (PBD) soft segments and phospholipid moieties in the main chains and long-chain alkyl groups in the side chains were synthesized. The phospholipid moieties include bis[2-(2-hydroxyethyldimethylammonio)ethyl] 2-octylpropane-1,3-diyl bis(phosphate) (OcPDP), bis[2-(2-hydroxyethyldimethylammonio)ethyl] 2-oleylpropane-1,3-diyl bis(phosphate) (OlPDP) and bis[2-(2-hydroxyethyldimethylammonio)ethyl] 2-cetylpropane-1,3-diyl bis(phosphate) (CPDP). The bulk characterization of synthesized SPUs was investigated by infrared (IR) spectroscopy and gel-permeation chromatography (GPC). The mechanical properties were evaluated by dynamic viscoelasticity and tensile measurements. The existence of phospholipid analogous groups on the surface of these SPUs was revealed by attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR), X-ray photoelectron spectroscopy( XPS) and contact angle measurements. The blood compatibilities of the new polymers were evaluated by platelet rich plasma (PRP) contact studies and viewed by scanning electron microscopy (SEM) using medical grade BioSpan(R) and non-phospholipid polyurethane as references. These new materials have good surfaces in terms of platelet adhesion, and the morphology of adhered platelets undergoes a relatively low degree of variation.
C1 Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, Osaka 5588585, Japan.
   RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan.
   Natl Inst Adv Interdisciplinary Res, Bion Design Grp, Tsukuba, Ibaraki 3050046, Japan.
RP Nakaya, T (reprint author), Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.
CR BORETOS JW, 1972, J BIOMED MATER RES, V6, P473, DOI 10.1002/jbm.820060513
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   BORETOS JW, 1982, P 8 ANN SOC BIOM, P24
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   COURY AJ, 1987, LIFE SUPPORT SYST, V5, P25
   DURRANI AA, 1986, BIOMATERIALS, V7, P121, DOI 10.1016/0142-9612(86)90068-2
   EBERHART RC, 1987, ARTIF ORGANS, V11, P375
   EDMUNDSON RS, 1962, CHEM IND-LONDON, P1828
   GRASEL TG, 1987, J BIOMED MATER RES, V21, P815, DOI 10.1002/jbm.820210702
   HARA K, 1993, SEIRIKASSEISHISHITSU, P112
   HSU CS, 1987, MAKROMOL CHEM-RAPID, V8, P331
   Korematsu A, 1997, POLYM BULL, V38, P133, DOI 10.1007/s002890050029
   Li YJ, 1996, J APPL POLYM SCI, V62, P687
   Li YJ, 1996, CHEM MATER, V8, P1441, DOI 10.1021/cm960014x
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   Li YJ, 1996, BIOMATERIALS, V17, P2179, DOI 10.1016/0142-9612(96)00048-8
   Li YJ, 1998, CHEM MATER, V10, P1596, DOI 10.1021/cm9707869
   Li YJ, 1996, MACROMOL RAPID COMM, V17, P737, DOI 10.1002/marc.1996.030171009
   Li YJ, 1997, CHEM MATER, V9, P1570, DOI 10.1021/cm960615o
   LI YJ, 1995, MACROMOL CHEM PHYSIC, V196, P3143, DOI 10.1002/macp.1995.021961006
   LI YJ, 1995, MACROMOL RAPID COMM, V16, P253, DOI 10.1002/marc.1995.030160404
   Li YJ, 1996, MACROMOL CHEM PHYSIC, V197, P2827, DOI 10.1002/macp.1996.021970920
   Li YJ, 1996, J BIOMAT SCI-POLYM E, V7, P893, DOI 10.1163/156856296X00066
   LUCAS HJ, 1950, J AM CHEM SOC, V72, P5491, DOI 10.1021/ja01168a032
   MARCONI W, 1994, MACROMOL CHEM PHYS, V195, P875, DOI 10.1002/macp.1994.021950306
   NAKAYA T, 1989, MACROMOLECULES, V22, P3180, DOI 10.1021/ma00197a048
   NAKAYA T, 1987, KAGAKU, V42, P725
   NAKAYA T, 1986, Patent No. 61207395
   PLANCK H, 1987, POLYURETHANE BIOMEDI, V2
   RAHMAN R, 1989, J POLYM SCI POL CHEM, V27, P2673, DOI 10.1002/pola.1989.080270815
   Saunders J. H., 1962, POLYURETHANE CHEM 1
   STOKES K, 1990, Journal of Biomaterials Science Polymer Edition, V1, P207
   Stokes K, 1987, J Biomater Appl, V1, P411
   STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2
   Stokes K B, 1988, J Biomater Appl, V3, P228, DOI 10.1177/088532828800300205
   STRIZINAR I, 1992, J BIOMED MATER RES, V26, P577
   SUGIYAMA K, 1986, MAKROMOL CHEM-RAPID, V7, P679
   SUNG CSP, 1979, J BIOMED MATER RES, V13, P161
   TAKAHARA A, 1991, BIOMATERIALS, V12, P324, DOI 10.1016/0142-9612(91)90042-9
   TAKAHARA A, 1988, ARTIFICIAL HEART, V2, P19
   THUONG NT, 1974, B SOC CHIM FR II-CH, P667
   UMEDA T, 1985, MAKROMOL CHEM-RAPID, V6, P285
   WARD RS, 1994, P 8 CIMT FOR NEW MAT
   YAMADA M, 1995, MACROMOL RAPID COMM, V16, P25, DOI 10.1002/marc.1995.030160105
   YAMADA M, 1995, J MACROMOL SCI PURE, VA32, P1723, DOI 10.1080/10601329508010017
   YAMADA M, 1995, J MACROMOL SCI PURE, VA32, P1235, DOI 10.1080/10601329508009351
NR 46
TC 21
Z9 22
U1 2
U2 6
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD,, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PD MAR
PY 1999
VL 9
IS 3
BP 647
EP 653
DI 10.1039/a806279j
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 177KZ
UT WOS:000079210300006
DA 2018-10-20
ER

PT J
AU Soten, I
   Ozin, GA
AF Soten, I
   Ozin, GA
TI Porous hydroxyapatite-dodecylphosphate composite film on
   titania-titanium substrate
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID TRANSFORM INFRARED-SPECTROSCOPY; RAY PHOTOELECTRON-SPECTROSCOPY;
   CALCIUM-PHOSPHATE; OCTACALCIUM PHOSPHATE; EARLY DEPOSITS; SOLID-PHASE;
   PO4 DOMAIN; COATINGS; SURFACE; BONE
AB Synthetic analogues of bone are being actively pursued as materials for biomedical applications in the field of bone replacement, augmentation and repair. Numerous stringent criteria have to be met for a biomaterial to be considered as an acceptable bone implant, including the ability to integrate into bone and not cause any deleterious side effects. In this article we describe a materials chemistry approach to synthesizing a new type of bone implant material. The strategy involves the spontaneous growth, under aqueous physiological pH conditions, of an oriented hydroxyapatite film with micron dimension porosity, on the surface of a layer of TiO2, that has been sputter deposited on Ti metal. This procedure creates desirable co-crystallized phases of hydroxyapatite (OHAp) and octacalcium phosphate (OCP) with preferred orientation respectively along the [001] and [101] directions. Subsequently, a calcium dodecylphosphate mesolamellar phase has been grown within these oriented porous films to create a multilayered chemical composite CaDDP-OHAp-TiO2-Ti in which the CaDDP phase is stereochemically and charge matched with the OHAp.
C1 Univ Toronto, Lash Miller Chem Labs, Mat Chem Res Grp, Toronto, ON M5S 3H6, Canada.
RP Ozin, GA (reprint author), Univ Toronto, Lash Miller Chem Labs, Mat Chem Res Grp, 80 St George St, Toronto, ON M5S 3H6, Canada.
EM gozin@alchemy.chem.utoronto.ca
CR Brown PW, 1994, HYDROXYAPATITE RELAT
   Bullock EL, 1996, SURF SCI, V352, P504, DOI 10.1016/0039-6028(95)01188-9
   Campbell AA, 1996, J BIOMED MATER RES, V32, P111, DOI 10.1002/(SICI)1097-4636(199609)32:1<111::AID-JBM13>3.0.CO;2-P
   CRUTCHFIELD MM, 1962, INORG CHEM, V1, P813, DOI 10.1021/ic50004a020
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DUCHEYNE P, 1980, J BIOMED MATER RES, V14, P225, DOI 10.1002/jbm.820140305
   Ducheyne P., 1993, BIOCERAMICS, V6
   Elliot C., 1994, STRUCTURE CHEM APATI
   Elliot J.C., 1994, STRUCTURE CHEM APATI
   FOWLER BO, 1993, CHEM MATER, V5, P1417, DOI 10.1021/cm00034a009
   GORENSTEIN DG, 1975, J AM CHEM SOC, V97, P898, DOI 10.1021/ja00837a039
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   Lacefield W R, 1988, Ann N Y Acad Sci, V523, P72, DOI 10.1111/j.1749-6632.1988.tb38501.x
   LEGEROS RZ, 1989, SCANNING MICROSCOPY, V3, P129
   MISRA DN, 1984, ADSORPTION SURFACE C, P13
   ONG JL, 1994, COLLOID SURFACE A, V87, P151, DOI 10.1016/0927-7757(94)02774-9
   Ozin GA, 1997, J MATER CHEM, V7, P1601, DOI 10.1039/a702416i
   PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0
   RADIN SR, 1993, J BIOMED MATER RES, V27, P35, DOI 10.1002/jbm.820270106
   REY C, 1991, CALCIFIED TISSUE INT, V49, P383, DOI 10.1007/BF02555847
   REY C, 1990, CALCIFIED TISSUE INT, V46, P384, DOI 10.1007/BF02554969
   ROTHWELL WP, 1980, J AM CHEM SOC, V102, P2637, DOI 10.1021/ja00528a020
   SHAM TK, 1979, CHEM PHYS LETT, V68, P426, DOI 10.1016/0009-2614(79)87231-0
   Silver FH., 1994, BIOMATERIALS MED DEV
   Sugiyama S, 1996, J MATER CHEM, V6, P459, DOI 10.1039/jm9960600459
   VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326
   Vincent J. F. V., 1990, STRUCTURAL BIOMATERI
NR 29
TC 26
Z9 27
U1 0
U2 7
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD,, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PD MAR
PY 1999
VL 9
IS 3
BP 703
EP 710
DI 10.1039/a806045b
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 177KZ
UT WOS:000079210300014
DA 2018-10-20
ER

PT J
AU Festing, MFW
AF Festing, MFW
TI Warning: the use of heterogeneous mice may seriously damage your
   research
SO NEUROBIOLOGY OF AGING
LA English
DT Editorial Material
DE inbred strains; aging; genetic variation; outbred stocks; experimental
   design
ID INBRED STRAINS; VARIABILITY
AB Genetically heterogeneous (GH) mice and rats continue to be widely used in research even though the case for using isogenic strains has been argued repeatedly. The paper by Miller et al. in this issue appears to be the only one in the last 22 to attempt a scientific justification for the continued use of (a limited subset of) GH stocks. However, although they are to be commended for bravery, they fail to make their case. GH stocks represent poor material for controlled studies because genetic heterogeneity normally leads to phenotypic variability and a decline in experimental sensitivity. To counter this argument, Miller et al. claim that phenotypic variability may actually be smaller in GH animals than in their isogenic parents. Were this so (e.g., all mice being short lived, small, and aggressive), it, is difficult to see how the use of such a stock could increase the generality of research results based on it, as claimed by Miller et al. Isogenic strains are a vital, proven, and powerful resource for biomedical research, and should be used in preference to GH stocks by all scientists who use laboratory rodents. (C) 1999 Elsevier Science Inc. All rights reserved.
C1 Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England.
RP Festing, MFW (reprint author), Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England.
CR BONHOMME F, 1996, GENETIC VARIANTS STR, V2, P1577
   Crusio Wim E., 1992, V8, P231
   de Haan G, 1998, NAT GENET, V19, P114, DOI 10.1038/465
   Demant P., 1992, V8, P147
   Falconer DS, 1981, INTRO QUANTITATIVE G
   Festing M., 1997, Mouse Genome, V95, P845
   FESTING MFW, 1974, BEHAV GENET, V4, P111, DOI 10.1007/BF01065752
   FESTING MFW, 1976, NATURE, V263, P230, DOI 10.1038/263230a0
   FESTING MFW, 1977, LAB ANIM, V11, P257, DOI 10.1258/002367777780936530
   Festing MFW, 1997, NATURE, V388, P321, DOI 10.1038/40964
   FESTING MFW, 1974, GENET RES, V24, P315, DOI 10.1017/S0016672300015317
   FESTING MFW, 1995, ENVIRON HEALTH PERSP, V103, P44, DOI 10.2307/3432255
   GAITONDE MK, 1976, BRAIN RES, V103, P617, DOI 10.1016/0006-8993(76)90465-0
   GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347
   GRUNEBERG H, 1952, GENETICS MOUSE
   MCCLEARN G. E., 1970, Contributions to behavior-genetic analysis., P3
   Mead R, 1988, DESIGN EXPT, V620
   Miller RA, 1999, NEUROBIOL AGING, V20, P217
   MORIWAKI K, 1994, GENETICS WILD MICE I, P333
   PHELAN JP, 1994, J GERONTOL, V49, pB1, DOI 10.1093/geronj/49.1.B1
   SONTAG JA, 1976, CARCINOGENESIS TECHN, V1
   Takeda T., 1994, SAM MODEL SENESCENCE
   TAYLOR BA, 1972, J HERED, V63, P83, DOI 10.1093/oxfordjournals.jhered.a108235
   Taylor BA, 1996, GENETIC VARIANTS STR, V2, P1597
   TUCKER PK, 1992, MAMM GENOME, V3, P254, DOI 10.1007/BF00292153
   WOLFF GL, 1982, J TOXICOL ENV HEALTH, V10, P131, DOI 10.1080/15287398209530237
NR 26
TC 37
Z9 39
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0197-4580
J9 NEUROBIOL AGING
JI Neurobiol. Aging
PD MAR-APR
PY 1999
VL 20
IS 2
BP 237
EP 244
PG 8
WC Geriatrics & Gerontology; Neurosciences
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA 248JH
UT WOS:000083271000017
PM 10537033
DA 2018-10-20
ER

PT J
AU de Boer, JF
   Milner, TE
   Nelson, JS
AF de Boer, JF
   Milner, TE
   Nelson, JS
TI Determination of the depth-resolved Stokes parameters of light
   backscattered from turbid media by use of polarization-sensitive optical
   coherence tomography
SO OPTICS LETTERS
LA English
DT Article
AB Polarization-sensitive optical coherence tomography (PS-OCT) was used to characterize completely the polarization state of light backscattered from turbid media. Using a low-coherence light source, one can determine the Stokes parameters of backscattered light as a function of optical path in turbid media. To demonstrate the application of this technique we determined the birefringence and the optical axis in fibrous tissue (rodent muscle) and in vivo rodent skin. PS-OCT has potentially useful applications in biomedical optics by imaging simultaneously the structural properties of turbid biological materials and their effects on the polarization state of backscattered light. This method may also find applications in material science for investigation of polarization properties (e.g., birefringence) in opaque media such as ceramics and crystals. (C) 1999 Optical Society of America.
C1 Univ Calif Irvine, Beckman Laser Inst & Med Clin, Irvine, CA 92612 USA.
   Univ Texas, Biomed Engn Program, Austin, TX 78712 USA.
RP de Boer, JF (reprint author), Univ Calif Irvine, Beckman Laser Inst & Med Clin, Irvine, CA 92612 USA.
EM deboer@bli.uci.edu
RI de Boer, Johannes/B-7590-2012
OI de Boer, Johannes/0000-0003-1253-4950
CR de Boer JF, 1998, OPT EXPRESS, V3, P212, DOI 10.1364/OE.3.000212
   deBoer JF, 1997, OPT LETT, V22, P934, DOI 10.1364/OL.22.000934
   Everett MJ, 1998, OPT LETT, V23, P228, DOI 10.1364/OL.23.000228
   HAZEBROEK HF, 1973, J PHYS E SCI INSTRUM, V6, P822, DOI 10.1088/0022-3735/6/9/013
   HEE MR, 1992, J OPT SOC AM B, V9, P903, DOI 10.1364/JOSAB.9.000903
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   MANDEL L, 1995, OPTICAL COHERENCE QU, pCH3
   MISHCHENKO MI, 1995, OPT LETT, V20, P1356, DOI 10.1364/OL.20.001356
   Schmitt JM, 1998, OPT LETT, V23, P1060, DOI 10.1364/OL.23.001060
NR 9
TC 245
Z9 247
U1 1
U2 24
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 0146-9592
J9 OPT LETT
JI Opt. Lett.
PD MAR 1
PY 1999
VL 24
IS 5
BP 300
EP 302
DI 10.1364/OL.24.000300
PG 3
WC Optics
SC Optics
GA 173GW
UT WOS:000078973600010
PM 18071486
DA 2018-10-20
ER

PT J
AU Kaniansky, D
   Masar, M
   Marak, J
   Bodor, R
AF Kaniansky, D
   Masar, M
   Marak, J
   Bodor, R
TI Capillary electrophoresis of inorganic anions
SO JOURNAL OF CHROMATOGRAPHY A
LA English
DT Review
DE reviews; isotachophoresis; water analysis; environmental analysis;
   sample handling; food analysis; vegetables; cosmetics; soil;
   pharmaceutical analysis; inorganic anions
ID INDIRECT UV DETECTION; INDIRECT PHOTOMETRIC DETECTION; MODIFIED
   ELECTROOSMOTIC FLOW; FREE-ZONE ELECTROPHORESIS; CONTACTLESS CONDUCTIVITY
   DETECTION; HIGH-PERFORMANCE ELECTROPHORESIS; INDIRECT ULTRAVIOLET
   DETECTION; ION-SELECTIVE MICROELECTRODE; FUSED-SILICA CAPILLARIES;
   PLASMA-MASS SPECTROMETRY
AB This review deals with the separation mechanisms applied to the separation of inorganic anions by capillary electrophoresis (CE) techniques. It covers various CE techniques that are suitable for the separation and/or determination of inorganic anions in various matrices, including capillary zone electrophoresis, micellar electrokinetic chromatography, electrochromatography and capillary isotachophoresis. Detection and sample preparation techniques used in CE separations are also reviewed. An extensive part of this review deals with applications of CE techniques in various fields (environmental, food and plant materials, biological and biomedical, technical materials and industrial processes). Attention is paid to speciations of anions of arsenic, selenium, chromium, phosphorus, sulfur and halogen elements by CE. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Comenius Univ, Fac Nat Sci, Dept Analyt Chem, SK-84215 Bratislava, Slovakia.
RP Kaniansky, D (reprint author), Comenius Univ, Fac Nat Sci, Dept Analyt Chem, Mlynska Dolina CH-2, SK-84215 Bratislava, Slovakia.
RI Masar, Marian/L-8150-2016; Bodor, Robert/N-1885-2016
OI Masar, Marian/0000-0002-9287-1764; Bodor, Robert/0000-0002-5460-2619
CR Ahumada I, 1997, BOL SOC CHIL QUIM, V42, P527
   ALBERT M, 1992, ANALUSIS, V20, P383
   ALBERT M, 1993, ANALUSIS, V21, P403
   AMRAN MB, 1993, FRESEN J ANAL CHEM, V345, P420, DOI 10.1007/BF00325618
   AMRAN MB, 1995, CHEM ANAL-WARSAW, V40, P309
   Arce L, 1998, FRESEN J ANAL CHEM, V360, P697, DOI 10.1007/s002160050784
   Arce L, 1997, J CHROMATOGR A, V791, P279, DOI 10.1016/S0021-9673(97)00813-3
   Arellano M, 1997, J CHROMATOGR A, V765, P321, DOI 10.1016/S0021-9673(96)00972-7
   ARRELLANO M, 1997, AM J ENOL VITICULT, V48, P408
   AVDALOVIC N, 1993, ANAL CHEM, V65, P1470, DOI 10.1021/ac00058a027
   BACHMANN K, 1992, FRESEN J ANAL CHEM, V343, P901, DOI 10.1007/BF00321963
   BAO LY, 1992, ANAL CHEM, V64, P991, DOI 10.1021/ac00033a006
   Bazzanella A, 1997, CHROMATOGRAPHIA, V45, P59, DOI 10.1007/BF02505538
   BECKERS JL, 1990, J CHROMATOGR, V508, P19, DOI 10.1016/S0021-9673(00)91236-6
   BECKERS JL, 1990, J CHROMATOGR, V508, P3, DOI 10.1016/S0021-9673(00)91235-4
   BECKERS JL, 1991, J CHROMATOGR, V537, P429, DOI 10.1016/S0021-9673(01)88915-9
   Biesaga M, 1997, J CHROMATOGR A, V777, P375, DOI 10.1016/S0021-9673(97)00338-5
   BJERGEGAARD C, 1995, J CHROMATOGR A, V717, P409, DOI 10.1016/0021-9673(95)00554-1
   BLATNY P, 1994, J CHROMATOGR A, V670, P223, DOI 10.1016/0021-9673(94)80298-X
   BOCEK P, 1984, J CHROMATOGR, V313, P189
   BOCEK P, 1978, J CHROMATOGR, V151, P436
   Bocek P., 1988, ANAL ISOTACHOPHORESI
   Boden J, 1997, CHROMATOGRAPHIA, V45, P116, DOI 10.1007/BF02505547
   BODEN J, 1995, J CHROMATOGR A, V716, P311, DOI 10.1016/0021-9673(95)00468-3
   BODEN J, 1995, J CHROMATOGR A, V696, P321, DOI 10.1016/0021-9673(94)01227-6
   BONDOUX G, 1992, J CHROMATOGR, V602, P79, DOI 10.1016/0021-9673(92)80066-4
   BUCHBERGER W, 1992, J CHROMATOGR, V608, P59, DOI 10.1016/0021-9673(92)87105-H
   Burt H, 1996, J CHROMATOGR A, V739, P367, DOI 10.1016/0021-9673(96)00028-3
   CARPIO RA, 1992, ANAL CHEM, V64, P2123, DOI 10.1021/ac00042a017
   Chattopadhyay A, 1997, J CHROMATOGR A, V758, P255, DOI 10.1016/S0021-9673(96)00742-X
   Chien R. L., 1992, ANAL CHEM, V64, P489
   CHOI OK, 1995, ANAL SCI TECHNOL, V8, P835
   Colombara R, 1996, J CAPILLARY ELECTROP, V3, P147
   Corr JJ, 1996, ANAL CHEM, V68, P2155, DOI 10.1021/ac951053f
   COUSINS SM, 1994, J CHROMATOGR A, V671, P397, DOI 10.1016/0021-9673(94)80266-1
   Cowley EA, 1997, AM J PHYSIOL-LUNG C, V273, pL895, DOI 10.1152/ajplung.1997.273.4.L895
   Crompton T.R., 1996, DETERMINATION ANIONS
   Cruz L, 1997, J NEUROCHEM, V69, P110
   Dabek-Zlotorzynska E, 1998, ANAL CHIM ACTA, V359, P1, DOI 10.1016/S0003-2670(97)00635-1
   Dabek-Zlotorzynska E, 1997, ELECTROPHORESIS, V18, P2453, DOI 10.1002/elps.1150181235
   DabekZlotorzynska E, 1997, J CHROMATOGR A, V770, P349, DOI 10.1016/S0021-9673(97)00238-0
   DABEKZLOTORZYNSKA E, 1995, J CHROMATOGR A, V706, P469, DOI 10.1016/0021-9673(94)01108-Q
   DABEKZLOTORZYNSKA E, 1994, J CHROMATOGR A, V671, P389, DOI 10.1016/0021-9673(94)80265-3
   DASGUPTA PK, 1993, ANAL CHEM, V65, P1003, DOI 10.1021/ac00056a010
   DIAMOND RM, 1963, J PHYS CHEM-US, V67, P2513, DOI 10.1021/j100806a002
   Doble P, 1997, ANAL COMMUN, V34, P351, DOI 10.1039/a706001g
   Doble P, 1997, J CHROMATOGR A, V770, P291, DOI 10.1016/S0021-9673(96)01022-9
   DOBOS D, 1980, ELEKTROKHIMICHESKIYE
   DREW NJ, 1997, SPEC PUBL R SOC CHEM, V196, P160
   EHRMANN T, 1997, CHROMATOGRAPHIA, V45, P301
   EVANS KP, 1993, J CHROMATOGR, V636, P153, DOI 10.1016/0021-9673(93)80068-J
   EVERAERTS FM, 1979, J CHROMATOGR, V169, P21, DOI 10.1016/0021-9673(75)85030-8
   EVERAERTS FM, 1976, ISOTACHOPHORESIS
   Fabry L, 1997, ELEC SOC S, V97, P468
   Fernandes I, 1997, J CLIN INVEST, V100, P2196, DOI 10.1172/JCI119756
   Font J, 1996, J CHROMATOGR A, V740, P125, DOI 10.1016/0021-9673(96)00098-2
   FORET F, 1986, ELECTROPHORESIS, V7, P430, DOI 10.1002/elps.1150070909
   Francois C, 1996, HRC-J HIGH RES CHROM, V19, P5
   Friedberg MA, 1997, J CHROMATOGR A, V781, P491, DOI 10.1016/S0021-9673(97)00583-9
   Fukushi K, 1998, J CHROMATOGR A, V802, P211, DOI 10.1016/S0021-9673(97)01218-1
   FUKUSHI K, 1987, BUNSEKI KAGAKU, V36, P712
   FUKUSHI K, 1985, BUNSEKI KAGAKU, V34, P205
   FUKUSHI K, 1985, BUNSEKI KAGAKU, V34, P21
   FUKUSHI K, 1987, FRESEN Z ANAL CHEM, V328, P247, DOI 10.1007/BF00481630
   FUKUSHI K, 1990, J CHROMATOGR, V518, P189, DOI 10.1016/S0021-9673(01)93174-7
   Fukushi K, 1997, J CHROMATOGR A, V760, P253, DOI 10.1016/S0021-9673(96)00629-2
   FUKUSHI K, 1987, J CHROMATOGR, V393, P433, DOI 10.1016/S0021-9673(01)94241-4
   Fung YS, 1998, TALANTA, V45, P641, DOI 10.1016/S0039-9140(97)00284-1
   Galceran MT, 1996, J CHROMATOGR A, V732, P167, DOI 10.1016/0021-9673(95)01248-6
   GALER JM, 1997, SPEC PUBL R SOC CHEM, V196, P187
   GAS B, 1980, J CHROMATOGR, V192, P253, DOI 10.1016/S0021-9673(80)80001-X
   GAS B, 1980, CHEM LISTY, V74, P652
   GAS B, 1989, J CHROMATOGR, V470, P69, DOI 10.1016/S0021-9673(00)94200-6
   GEBAUER P, 1983, J CHROMATOGR, V267, P455, DOI 10.1016/S0021-9673(01)90870-2
   GEBAUER P, 1991, J CHROMATOGR, V545, P299, DOI 10.1016/S0021-9673(01)88720-3
   GEBAUER P, 1992, J CHROMATOGR, V608, P47, DOI 10.1016/0021-9673(92)87104-G
   Gebauer P, 1997, J CHROMATOGR A, V772, P63, DOI 10.1016/S0021-9673(97)00103-9
   GEISE RJ, 1993, J LIQ CHROMATOGR, V16, P3699, DOI 10.1080/10826079308019662
   Gilon N, 1996, J CHROMATOGR A, V732, P369, DOI 10.1016/0021-9673(95)01265-6
   Govindaraju K, 1997, ANAL CHEM, V69, P2793, DOI 10.1021/ac961249v
   GROH T, 1993, J CHROMATOGR, V646, P405, DOI 10.1016/0021-9673(93)83354-U
   GROH T, 1992, ELECTROPHORESIS, V13, P458, DOI 10.1002/elps.1150130196
   Guan FY, 1996, J CHROMATOGR A, V719, P427, DOI 10.1016/0021-9673(95)00735-0
   Guo Q, 1997, CHINESE CHEM LETT, V8, P65
   Haber C, 1998, ANAL CHEM, V70, P2261, DOI 10.1021/ac9712106
   Haber C, 1996, J CAPILLARY ELECTROP, V3, P1
   HADDAD PR, 1995, J CHROMATOGR A, V706, P571, DOI 10.1016/0021-9673(94)01049-K
   Haddad PR, 1997, J CHROMATOGR A, V770, P281, DOI 10.1016/S0021-9673(96)01085-0
   HADDAD PR, 1990, ION CHROMATOGRAPHY P
   Hagege A, 1997, MIKROCHIM ACTA, V127, P113, DOI 10.1007/BF01243174
   Harakuwe AH, 1997, ANAL COMMUN, V34, P67, DOI 10.1039/a607317d
   Harakuwe AH, 1998, J CHROMATOGR A, V793, P187, DOI 10.1016/S0021-9673(97)00878-9
   HARAKUWE AH, 1994, J CHROMATOGR A, V685, P161, DOI 10.1016/0021-9673(94)00671-7
   Harakuwe AH, 1996, ANAL COMMUN, V33, P103, DOI 10.1039/ac9963300103
   HARMS J, 1992, MIKROCHIM ACTA, V108, P251, DOI 10.1007/BF01242434
   HARROLD M, 1995, J CHROMATOGR A, V717, P371, DOI 10.1016/0021-9673(95)00762-X
   HARROLD MP, 1993, J CHROMATOGR, V640, P463, DOI 10.1016/0021-9673(93)80216-U
   Harwood JJ, 1997, J CHROMATOGR A, V788, P105, DOI 10.1016/S0021-9673(97)00706-1
   Hauser PC, 1995, J CAPILLARY ELECTROP, V2, P209
   HAUSER PC, 1994, ANAL CHIM ACTA, V295, P181, DOI 10.1016/0003-2670(94)80349-8
   Himeno S, 1998, ANAL SCI, V14, P369, DOI 10.2116/analsci.14.369
   HINE T, 1984, SHIMADZU REV, V41, P47
   HIROKAWA T, 1982, J CHROMATOGR, V242, P227, DOI 10.1016/S0021-9673(00)81698-2
   HIROKAWA T, 1983, J CHROMATOGR, V271, pD1, DOI 10.1016/S0021-9673(00)80225-3
   HJERTEN S, 1985, J CHROMATOGR, V347, P191, DOI 10.1016/S0021-9673(01)95485-8
   HJERTEN S, 1987, J CHROMATOGR, V403, P47, DOI 10.1016/S0021-9673(00)96340-4
   HONDA S, 1989, ANAL BIOCHEM, V177, P62, DOI 10.1016/0003-2697(89)90014-6
   Hsu JC, 1997, ANALYST, V122, P1393, DOI 10.1039/a700739f
   HUANG X, 1991, ANAL CHEM, V63, P2196
   HUANG XH, 1987, ANAL CHEM, V59, P2747, DOI 10.1021/ac00150a004
   JACKSON PE, 1993, J CHROMATOGR, V640, P481, DOI 10.1016/0021-9673(93)80218-W
   JANDIK P, 1991, J CHROMATOGR, V546, P431, DOI 10.1016/S0021-9673(01)93042-0
   JANDIK P, 1991, LC GC-MAG SEP SCI, V9, P634
   JANDIK P, 1993, CAPILLARY ELECTROPHO
   JANINI GM, 1994, J CHROMATOGR B, V657, P419, DOI 10.1016/0378-4347(94)00141-3
   Jensen BO, 1997, J BIOCHEM BIOPH METH, V35, P185, DOI 10.1016/S0165-022X(97)00046-8
   Jia L, 1996, J LIQ CHROMATOGR R T, V19, P565, DOI 10.1080/10826079608005520
   JIMIDAR M, 1995, J CHROMATOGR A, V706, P479, DOI 10.1016/0021-9673(94)01290-U
   JONES WR, 1992, J CHROMATOGR, V608, P385, DOI 10.1016/0021-9673(92)87146-Y
   JONES WR, 1991, J CHROMATOGR, V546, P445, DOI 10.1016/S0021-9673(01)93043-2
   JONES WR, 1993, J CHROMATOGR, V640, P387, DOI 10.1016/0021-9673(93)80207-O
   JONES WR, 1992, Patent No. 5104506
   JONES WR, 1992, Patent No. 5128005
   JONES WR, 1992, Patent No. 5156724
   JONES WR, 1992, Patent No. 5366601
   JONES WR, 1997, HDB CAPILLARY ELECTR, P155
   JORDAN JM, 1994, J CHROMATOGR A, V671, P445, DOI 10.1016/0021-9673(94)80272-6
   Jung GY, 1997, ANAL SCI, V13, P463, DOI 10.2116/analsci.13.463
   KANETA T, 1993, J CHROMATOGR A, V653, P313, DOI 10.1016/0021-9673(93)83189-Y
   KANETA T, 1992, ANAL CHEM, V64, P798, DOI 10.1021/ac00031a017
   KANIANSKY D, 1990, J CHROMATOGR, V498, P191, DOI 10.1016/S0021-9673(01)84247-3
   Kaniansky D, 1997, J CHROMATOGR A, V792, P483, DOI 10.1016/S0021-9673(97)00743-7
   Kaniansky D, 1996, ELECTROPHORESIS, V17, P1890, DOI 10.1002/elps.1150171214
   KANIANSKY D, 1994, ANAL CHEM, V66, P4258, DOI 10.1021/ac00095a022
   KANIANSKY D, IN PRESS J MICROCOL
   KANIANSKY D, 1981, THESIS COMENIUS U BR
   Kappes T, 1997, ANAL CHIM ACTA, V350, P141, DOI 10.1016/S0003-2670(97)00309-7
   Kar S, 1996, J MICROCOLUMN SEP, V8, P561, DOI 10.1002/(SICI)1520-667X(1996)8:8<561::AID-MCS6>3.0.CO;2-#
   KAR S, 1994, ANAL CHEM, V66, P2537, DOI 10.1021/ac00087a019
   KAROVICOVA J, 1990, NAHRUNG, V34, P765
   Kawamura Y, 1996, PLANT CELL PHYSIOL, V37, P878, DOI 10.1093/oxfordjournals.pcp.a029027
   Kelly RG, 1996, J CHROMATOGR A, V739, P191, DOI 10.1016/0021-9673(96)00223-3
   Kitagawa S, 1997, J MICROCOLUMN SEP, V9, P347, DOI 10.1002/(SICI)1520-667X(1997)9:5<347::AID-MCS2>3.0.CO;2-1
   KODAMA S, 1996, TOYAMA KEN EISEI KEN, V19, P217
   Kotrly S, 1985, HDB CHEM EQUILIBRIA
   Krivacsy Z, 1997, J CHROMATOGR A, V781, P223, DOI 10.1016/S0021-9673(97)00290-2
   Krokhin OV, 1997, J CHROMATOGR A, V776, P329, DOI 10.1016/S0021-9673(97)00420-2
   Krokhin OV, 1996, CHEM LETT, P1095, DOI 10.1246/cl.1996.1095
   Kuban P, 1997, J CHROMATOGR A, V770, P329, DOI 10.1016/S0021-9673(97)00030-7
   Kuban P, 1998, TRAC-TREND ANAL CHEM, V17, P34, DOI 10.1016/S0165-9936(97)00088-5
   Kuban P, 1998, TALANTA, V45, P477, DOI 10.1016/S0039-9140(97)00131-8
   Kuban P, 1997, ANAL CHIM ACTA, V337, P117, DOI 10.1016/S0003-2670(96)00339-X
   Kuban P, 1997, ANAL CHEM, V69, P1169, DOI 10.1021/ac960921l
   Kuban P, 1998, ANAL CHEM, V70, P360, DOI 10.1021/ac9706133
   KUNERT J, 1988, ARCH MICROBIOL, V150, P600, DOI 10.1007/BF00408257
   Lamb JD, 1996, J CHROMATOGR A, V739, P373, DOI 10.1016/0021-9673(96)00055-6
   Lee KW, 1997, ANAL SCI, V13, P247, DOI 10.2116/analsci.13.Supplement_247
   LEONE AM, 1994, BIOCHEM BIOPH RES CO, V200, P951, DOI 10.1006/bbrc.1994.1542
   LEONE AM, 1996, METHODS NITRIC OXIDE, P499
   Li DM, 1997, J CHROMATOGR B, V695, P169, DOI 10.1016/S0378-4347(97)00071-6
   LI J, 1997, CHINESE J ANAL CHEM, V25, P559
   LIN L, 1995, J CHROMATOGR SCI, V33, P177, DOI 10.1093/chromsci/33.4.177
   LIU Y, 1995, ANAL CHEM, V67, P2020, DOI 10.1021/ac00109a019
   Lurie IS, 1996, J CAPILLARY ELECTROP, V3, P237
   LURJE YY, 1979, SPRAVOTSHNIK ANALITI
   MADAJOVA V, 1992, J CHROMATOGR, V589, P329, DOI 10.1016/0021-9673(92)80040-2
   Magnuson ML, 1997, J ANAL ATOM SPECTROM, V12, P689, DOI 10.1039/a607730g
   Magnuson ML, 1997, ANALYST, V122, P1057, DOI 10.1039/a703039h
   Marshall PA, 1996, FOOD CHEM, V57, P339, DOI 10.1016/0308-8146(96)00002-7
   Marti MC, 1997, BIOTECHNOL TECH, V11, P163, DOI 10.1023/A:1018449429551
   MARTI V, 1995, J CHROMATOGR A, V709, P367, DOI 10.1016/0021-9673(95)00446-T
   MARTINEZ M, 1994, J CHROMATOGR A, V676, P443, DOI 10.1016/0021-9673(94)80445-1
   MASAR M, UNPUB J CHROMATOGR A
   MASSELTER SM, 1996, J HIGH RES CHROMATOG, V19, P101
   MATEJOVIC I, 1994, FRESEN J ANAL CHEM, V349, P559, DOI 10.1007/BF00323994
   Meissner T, 1998, FRESEN J ANAL CHEM, V361, P459, DOI 10.1007/s002160050926
   Meissner T, 1998, J CHROMATOGR A, V810, P201, DOI 10.1016/S0021-9673(98)00236-2
   MEISSNER T, 1997, GIT LABORFACHZ, V41, P728
   MEULEMANS A, 1994, J CHROMATOGR B, V660, P401, DOI 10.1016/0378-4347(94)00310-6
   Mihalyi B, 1996, ANN CHIM-ROME, V86, P439
   MIKKERS FEP, 1979, J CHROMATOGR, V169, P1, DOI 10.1016/0021-9673(75)85028-X
   MIKKERS FEP, 1979, J CHROMATOGR, V169, P11, DOI 10.1016/0021-9673(75)85029-1
   MORIN P, 1992, FRESEN J ANAL CHEM, V342, P357, DOI 10.1007/BF00322185
   Motellier S, 1997, J CHROMATOGR A, V770, P311, DOI 10.1016/S0021-9673(96)01021-7
   NAIR JB, 1993, J CHROMATOGR, V640, P445, DOI 10.1016/0021-9673(93)80215-T
   NANN A, 1994, J CHROMATOGR A, V676, P437, DOI 10.1016/0021-9673(94)80444-3
   Oehrle SA, 1996, J CHROMATOGR A, V733, P101, DOI 10.1016/0021-9673(95)00769-5
   OEHRLE SA, 1994, J CHROMATOGR A, V671, P383, DOI 10.1016/0021-9673(94)80264-5
   Oehrle SA, 1996, J CHROMATOGR A, V739, P413, DOI 10.1016/0021-9673(96)00026-X
   OEHRLE SA, 1994, J CHROMATOGR A, V680, P645, DOI 10.1016/0021-9673(94)85164-6
   Oehrle SA, 1996, J CHROMATOGR A, V745, P81, DOI 10.1016/0021-9673(96)00267-1
   OLESIK JW, 1995, ANAL CHEM, V67, P1, DOI 10.1021/ac00097a003
   Pacakova V, 1997, J CHROMATOGR A, V789, P169, DOI 10.1016/S0021-9673(97)00830-3
   Padarauskas A, 1998, J CHROMATOGR A, V800, P369, DOI 10.1016/S0021-9673(97)01108-4
   PANTSARKALLIO M, 1995, CHEMOSPHERE, V31, P3699, DOI 10.1016/0045-6535(95)00219-X
   PantsarKallio M, 1997, CHEMOSPHERE, V35, P1509, DOI 10.1016/S0045-6535(97)00227-0
   Park SW, 1997, ANAL SCI, V13, P243, DOI 10.2116/analsci.13.Supplement_243
   Perrin D., 1974, BUFFERS PH METAL ION
   PRETSWELL EL, 1993, ANALYST, V118, P1265, DOI 10.1039/an9931801265
   REIJENGA JC, 1983, J CHROMATOGR, V260, P241, DOI 10.1016/0021-9673(83)80034-X
   REIJENGA JC, 1994, J CHROMATOGR A, V659, P403, DOI 10.1016/0021-9673(94)85083-6
   REN H, 1996, HUANJING KEXUE, V17, P53
   RHEMREVBOOM MM, 1994, J CHROMATOGR A, V680, P675, DOI 10.1016/0021-9673(94)85168-9
   Robards K, 1994, PRINCIPLES PRACTICE
   ROHLICEK V, 1994, J CHROMATOGR A, V662, P369, DOI 10.1016/0021-9673(94)80523-7
   ROLANDGOSSELIN P, 1997, CAPILLARY ELECTROPHO, P445
   ROMANO J, 1991, J CHROMATOGR, V546, P411, DOI 10.1016/S0021-9673(01)93040-7
   ROMANO JP, 1992, J CHROMATOGR, V602, P205, DOI 10.1016/0021-9673(92)80082-6
   ROMANO JP, 1993, J CHROMATOGR, V640, P403, DOI 10.1016/0021-9673(93)80209-Q
   SAARINORDHAUS R, 1995, J CHROMATOGR A, V706, P563, DOI 10.1016/0021-9673(94)01106-O
   SALIMIMOOSAVI H, 1995, ANAL CHEM, V67, P1067, DOI 10.1021/ac00102a008
   SALOMON DR, 1992, J CHROMATOGR, V602, P219, DOI 10.1016/0021-9673(92)80084-8
   SanzAsensio J, 1997, ANAL CHIM ACTA, V343, P39, DOI 10.1016/S0003-2670(96)00584-3
   Sarmini K, 1997, J CHROMATOGR A, V792, P3, DOI 10.1016/S0021-9673(97)00720-6
   Schlegel D, 1996, FRESEN J ANAL CHEM, V354, P535
   SCHMITT M, 1993, J CHROMATOGR, V640, P419, DOI 10.1016/0021-9673(93)80211-P
   SCHOMBURG G, 1994, J CAPILLARY ELECTROP, V1, P219
   SCHUBERT BA, 1997, GIT FACHZ LAB, V41, P742
   SCHUTZNER W, 1992, ANAL CHEM, V64, P1991, DOI 10.1021/ac00041a039
   Schwedt G, 1996, J CHROMATOGR A, V736, P341, DOI 10.1016/0021-9673(95)01319-9
   Semenova OP, 1996, HRC-J HIGH RES CHROM, V19, P177
   SHAMSI SA, 1995, ANAL CHEM, V67, P1845, DOI 10.1021/ac00107a014
   SHAMSI SA, 1994, ANAL CHEM, V66, P3757, DOI 10.1021/ac00093a035
   Siren H, 1997, J CHROMATOGR A, V767, P293, DOI 10.1016/S0021-9673(96)01036-9
   Soga T, 1997, J AM SOC BREW CHEM, V55, P44
   Soga T, 1995, J CHROMATOGR A, V718, P421, DOI 10.1016/0021-9673(95)00704-0
   Soga T, 1997, J CHROMATOGR A, V767, P223, DOI 10.1016/S0021-9673(96)01055-2
   SONG LG, 1995, J CHROMATOGR A, V715, P376, DOI 10.1016/0021-9673(95)00605-M
   STAHL R, 1994, J CHROMATOGR A, V686, P143, DOI 10.1016/0021-9673(94)00074-3
   STATHAKIS C, 1994, ANAL CHEM, V66, P2110, DOI 10.1021/ac00085a029
   STATHAKIS C, 1995, J CHROMATOGR A, V699, P353, DOI 10.1016/0021-9673(95)00150-L
   STEPHEN SC, 1997, SPEC PUBL R SOC CHEM, V196, P124
   Stover FS, 1997, J CHROMATOGR A, V769, P349, DOI 10.1016/S0021-9673(97)00070-8
   STOVER FS, 1993, J CHROMATOGR A, V657, P450, DOI 10.1016/0021-9673(93)80302-O
   STOVER FS, 1990, ELECTROPHORESIS, V11, P750, DOI 10.1002/elps.1150110912
   STRANSKY Z, 1988, ZIVOCISNA VYROBA, V33, P211
   SWARTZ ME, 1993, J CHROMATOGR, V640, P441, DOI 10.1016/0021-9673(93)80214-S
   TAGA M, 1989, ANAL SCI, V5, P219
   Takayanagi T, 1996, ANAL SCI, V12, P575, DOI 10.2116/analsci.12.575
   Takayanagi T, 1996, BUNSEKI KAGAKU, V45, P697
   TAKAYANAGI T, 1995, KANKYO SEIGYO, V17, P49
   TALASEK T, 1994, MICROCONTAMINATION, V27, P56
   Tavares MFM, 1997, J CHROMATOGR A, V772, P171, DOI 10.1016/S0021-9673(96)00985-5
   TAZAKI M, 1982, CHEM LETT, P639, DOI 10.1246/cl.1982.639
   Tenberken B, 1997, J CHROMATOGR A, V775, P372, DOI 10.1016/S0021-9673(97)00259-8
   Tenberken B, 1996, J CHROMATOGR A, V745, P209, DOI 10.1016/0021-9673(96)00202-6
   THORMANN W, 1990, J CHROMATOGR, V516, P211
   Thornton MJ, 1997, J CHROMATOGR A, V770, P301, DOI 10.1016/S0021-9673(97)00170-2
   Tian XD, 1998, CHEM J CHINESE U, V19, P27
   Timerbaev AR, 1997, J CHROMATOGR A, V792, P495, DOI 10.1016/S0021-9673(97)00618-3
   Timerbaev AR, 1997, ELECTROPHORESIS, V18, P185, DOI 10.1002/elps.1150180203
   TINDALL GW, 1995, J CHROMATOGR A, V696, P349, DOI 10.1016/0021-9673(94)01229-8
   Trenerry VC, 1996, FOOD CHEM, V55, P299, DOI 10.1016/0308-8146(95)00117-4
   Trushina EV, 1997, ELECTROPHORESIS, V18, P1890, DOI 10.1002/elps.1150181027
   TSIKAS D, 1995, J CHROMATOGR A, V699, P363, DOI 10.1016/0021-9673(95)00119-8
   UEDA T, 1995, ELECTROPHORESIS, V16, P1002, DOI 10.1002/elps.11501601167
   UEDA T, 1996, SEIBUTSU BUTSURI KAG, V40, P175
   VACIK J, 1985, J CHROMATOGR, V320, P233, DOI 10.1016/S0021-9673(01)90500-X
   VACIK J, 1979, ELECTROPHORESIS SURV, P1
   Valsecchi S, 1997, J CHROMATOGR A, V760, P326, DOI 10.1016/S0021-9673(96)00798-4
   Van den Broeck K, 1998, MIKROCHIM ACTA, V128, P79, DOI 10.1007/BF01242194
   Van Holderbeke M., 1995, Biomedical Chromatography, V9, P281, DOI 10.1002/bmc.1130090617
   vandenHoop MAGT, 1997, J CHROMATOGR A, V770, P321, DOI 10.1016/S0021-9673(96)01000-X
   vandenHoop MAGT, 1996, J CHROMATOGR A, V739, P241, DOI 10.1016/0021-9673(96)00029-5
   VERHEGGEN TPEM, 1990, J CHROMATOGR, V503, P245, DOI 10.1016/S0021-9673(01)81506-5
   VERHEGGEN TPEM, 1993, J CHROMATOGR, V638, P147, DOI 10.1016/0021-9673(93)83423-P
   Verhelst V, 1997, J CHROMATOGR A, V770, P337, DOI 10.1016/S0021-9673(97)00176-3
   Vogt C, 1996, J CHROMATOGR A, V727, P301, DOI 10.1016/0021-9673(95)01131-5
   VOLGGER D, 1998, J HIGH RES CHROMATOG, V21, P3
   Walker EB, 1996, J CHROMATOGR A, V745, P111, DOI 10.1016/0021-9673(96)00378-0
   WANDERS BJ, 1993, THESIS U TECHNOLOGY
   Wang P, 1998, TALANTA, V45, P657, DOI 10.1016/S0039-9140(97)00296-8
   Wang P, 1997, J CHROMATOGR A, V765, P353, DOI 10.1016/S0021-9673(96)00926-0
   Wang TL, 1996, J CHROMATOGR A, V723, P197, DOI 10.1016/0021-9673(95)00824-1
   Wang TL, 1997, J CHROMATOGR A, V781, P457
   Wang TL, 1998, J CHROMATOGR A, V802, P159, DOI 10.1016/S0021-9673(97)01121-7
   WEAST RC, 1980, HDB CHEM PHYSICS
   Westergaard B, 1998, ANALYST, V123, P721, DOI 10.1039/a707497b
   WILDMAN BJ, 1991, J CHROMATOGR, V546, P411
   Williams R., 1997, J PHARM BIOMED ANAL, V16, P469
   WOJTUSIK MJ, 1994, J CHROMATOGR A, V671, P411, DOI 10.1016/0021-9673(94)80268-8
   Wu MJ, 1996, CHINESE J ANAL CHEM, V24, P1178
   YAMADA A, 1993, BUNSEKI KAGAKU, V42, P867
   YANG Y, 1997, CHINESE J ANAL CHEM, V25, P738
   YEUNG ES, 1989, ACCOUNTS CHEM RES, V22, P125, DOI 10.1021/ar00160a002
   YOSHIDA H, 1986, J CHROMATOGR, V351, P421
   Zaugg SE, 1997, ELECTROPHORESIS, V18, P202, DOI 10.1002/elps.1150180205
   ZELENSKY I, 1987, J CHROMATOGR, V390, P111, DOI 10.1016/S0021-9673(01)94365-1
   Zemann AJ, 1998, ANAL CHEM, V70, P563, DOI 10.1021/ac9707592
   Zemann AJ, 1997, J CHROMATOGR A, V787, P243, DOI 10.1016/S0021-9673(97)00645-6
   1960, LANDOLTBOERNSTEIN 7, V2
NR 291
TC 118
Z9 119
U1 1
U2 51
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0021-9673
J9 J CHROMATOGR A
JI J. Chromatogr. A
PD FEB 26
PY 1999
VL 834
IS 1-2
BP 133
EP 178
DI 10.1016/S0021-9673(98)00789-4
PG 46
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 174VD
UT WOS:000079055900010
PM 10189691
DA 2018-10-20
ER

PT J
AU Suslick, KS
   Didenko, Y
   Fang, MM
   Hyeon, T
   Kolbeck, KJ
   McNamara, WB
   Mdleleni, MM
   Wong, M
AF Suslick, KS
   Didenko, Y
   Fang, MM
   Hyeon, T
   Kolbeck, KJ
   McNamara, WB
   Mdleleni, MM
   Wong, M
TI Acoustic cavitation and its chemical consequences
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL
   AND ENGINEERING SCIENCES
LA English
DT Article
DE sonochemistry; sonoluminescence; materials; nanostructures; microspheres
ID SINGLE-BUBBLE SONOLUMINESCENCE; SONOCHEMICAL SYNTHESIS; AMORPHOUS IRON;
   NONAQUEOUS LIQUIDS; ULTRASOUND; TEMPERATURE; SPECTRA; MICROSPHERES;
   INTENSITY
AB Acoustic cavitation is responsible for both sonochemistry and sonoluminescence. Bubble collapse in liquids results in an enormous concentration of energy from the conversion of the kinetic energy of liquid motion into heating of the contents of the bubble. The high local temperatures and pressures, combined with extraordinarily rapid cooling, provide a unique means for driving chemical reactions under extreme conditions. A diverse set of applications of ultrasound to enhance chemical reactivity has been explored, with important applications in mixed-phase synthesis, materials chemistry, and biomedical uses. For example, the sonochemical decomposition of volatile organometallic precursors in low-volatility solvents produces nanostructured materials in various forms with high catalytic activities. Nanostructured metals, alloys, carbides and sulphides, nanometre colloids, and nanostructured supported catalysts can all be prepared by this general route. Another important application of sonochemistry to materials chemistry has been the preparation of biomaterials, most notably protein microspheres. Such microspheres have a wide range of biomedical applications, including their use as echo contrast agents for sonography, magnetic resonance imaging contrast enhancement, and oxygen or drug delivery.
C1 Univ Illinois, Sch Chem Sci, Urbana, IL 61801 USA.
RP Suslick, KS (reprint author), Univ Illinois, Sch Chem Sci, 600 S Mathews Ave, Urbana, IL 61801 USA.
RI Suslick, Kenneth/C-3281-2011; Hyeon, Taeghwan/J-5315-2012
OI Suslick, Kenneth/0000-0001-5422-0701; Lee, Junyoung/0000-0001-6689-2759
CR BARBER BP, 1992, J ACOUST SOC AM, V91, P3061, DOI 10.1121/1.402942
   Barber BP, 1997, PHYS REP, V281, P65, DOI 10.1016/S0370-1573(96)00050-6
   BARBER BP, 1994, PHYS REV LETT, V72, P1380, DOI 10.1103/PhysRevLett.72.1380
   BARBER BP, 1992, PHYS REV LETT, V69, P3839, DOI 10.1103/PhysRevLett.69.3839
   BELLISSENT R, 1993, PHYS REV B, V48, P15797, DOI 10.1103/PhysRevB.48.15797
   Berkovsky B. M., 1993, MAGNETIC FLUIDS ENG
   Bernstein LS, 1996, J PHYS CHEM-US, V100, P6612, DOI 10.1021/jp953643n
   Cao X, 1997, J MATER RES, V12, P402, DOI 10.1557/JMR.1997.0058
   Cheeke JDN, 1997, CAN J PHYS, V75, P77, DOI 10.1139/cjp-75-2-77
   CRUM LA, 1994, J ACOUST SOC AM, V95, P559, DOI 10.1121/1.408351
   CRUM LA, 1994, PHYS TODAY, V47, P22, DOI 10.1063/1.881402
   DIDENKO YT, 1994, ULTRASONICS, V32, P71, DOI 10.1016/0041-624X(94)90083-3
   DIDENKO YT, 1994, ULTRASON SONOCHEM, V1, pS10
   DOKTYCZ SJ, 1990, SCIENCE, V247, P1067, DOI 10.1126/science.2309118
   Eckburg JJ, 1996, J BIOMECH ENG-T ASME, V118, P193, DOI 10.1115/1.2795959
   FLINT EB, 1991, J PHYS CHEM-US, V95, P1484, DOI 10.1021/j100156a084
   FLINT EB, 1989, J AM CHEM SOC, V111, P6987, DOI 10.1021/ja00200a014
   FLINT EB, 1991, SCIENCE, V253, P1397, DOI 10.1126/science.253.5026.1397
   FLYNN HG, 1964, PHYS ACOUSTICS, V1, P157
   Frenzel H, 1934, Z PHYS CHEM B-CHEM E, V27, P421
   GATES BC, 1992, CATALYTIC CHEM, P387
   Gompf B, 1997, PHYS REV LETT, V79, P1405, DOI 10.1103/PhysRevLett.79.1405
   GRINSTAFF MW, 1993, PHYS REV B, V48, P269, DOI 10.1103/PhysRevB.48.269
   Henglein A., 1993, ADV SONOCHEMISTRY, V3, P17
   Hiller RA, 1998, PHYS REV LETT, V80, P1090, DOI 10.1103/PhysRevLett.80.1090
   HYEON T, 1995, MAT SCI ENG A-STRUCT, V204, P186
   Hyeon TH, 1996, J AM CHEM SOC, V118, P5492, DOI 10.1021/ja9538187
   JEFFRIES JB, 1992, SCIENCE, V256, P248, DOI 10.1126/science.256.5054.248
   KELLER MW, 1988, ECHOCARDIOGRAPHY COR
   Leighton T., 1994, ACOUSTIC BUBBLE, P531
   LIU KJ, 1994, BIOPHYS J, V67, P896, DOI 10.1016/S0006-3495(94)80551-X
   Lohse D, 1997, PHYS REV LETT, V78, P1359, DOI 10.1103/PhysRevLett.78.1359
   Long GJ, 1998, PHYS REV B, V57, P10716, DOI 10.1103/PhysRevB.57.10716
   Mason T. J., 1996, CHEM EXTREME NONCLAS, P317
   Mason T.J., 1988, SONOCHEMISTRY THEORY
   MATULA TJ, 1995, PHYS REV LETT, V75, P2602, DOI 10.1103/PhysRevLett.75.2602
   Mdleleni MM, 1998, J AM CHEM SOC, V120, P6189, DOI 10.1021/ja9800333
   Moser W. R., 1996, ADV CATALYSTS NANOST
   Moss WC, 1997, SCIENCE, V276, P1398, DOI 10.1126/science.276.5317.1398
   NEPPIRAS EA, 1980, PHYS REP, V61, P159, DOI 10.1016/0370-1573(80)90115-5
   PECORARO TA, 1981, J CATAL, V67, P430, DOI 10.1016/0021-9517(81)90303-1
   Preece CM, 1981, ADV MECH PHYS SURF, V1, P199
   PUTTERMAN SJ, 1995, SCI AM, V272, P46, DOI 10.1038/scientificamerican0295-46
   Rayleigh, 1917, PHILOS MAG, V34, P94, DOI 10.1080/14786440808635681
   Richards WT, 1927, J AM CHEM SOC, V49, P3086, DOI 10.1021/ja01411a015
   RIESZ P, 1985, ENVIRON HEALTH PERSP, V64, P233, DOI 10.2307/3430013
   Shafi KVPM, 1997, J APPL PHYS, V81, P6901, DOI 10.1063/1.365250
   Suslick K.S., 1990, ADV SONOCHEMISTRY, V1, P197
   Suslick K. S., 1998, KIRKOTHMER ENCY CHEM, V26, P517
   Suslick K.S, 1997, HDB HETEROGENEOUS CA, V3, P1350
   SUSLICK KS, 1990, J AM CHEM SOC, V112, P7807, DOI 10.1021/ja00177a058
   Suslick KS, 1996, CHEM MATER, V8, P2172, DOI 10.1021/cm960056l
   Suslick KS, 1996, J AM CHEM SOC, V118, P11960, DOI 10.1021/ja961807n
   SUSLICK KS, 1990, SCIENCE, V247, P1439, DOI 10.1126/science.247.4949.1439
   SUSLICK KS, 1986, J AM CHEM SOC, V108, P5641, DOI 10.1021/ja00278a055
   SUSLICK KS, 1991, NATURE, V353, P414, DOI 10.1038/353414a0
   SUSLICK KS, 1995, MRS BULL, V20, P29, DOI 10.1557/S088376940004464X
   SUSLICK KS, 1993, J PHYS CHEM-US, V97, P3098, DOI 10.1021/j100115a007
   Suslick KS, 1997, ENCY ACOUSTICS, V1, P271
   SUSLICK KS, 1988, ULTRASOUND ITS CHEM
   SUSLICK KS, 1994, ENCY INORGANIC CHEM, V7, P3890
   Webb AG, 1996, JMRI-J MAGN RESON IM, V6, P675, DOI 10.1002/jmri.1880060417
   WELLER H, 1993, ADV MATER, V5, P88, DOI 10.1002/adma.19930050204
   WONG M, 1995, MATER RES SOC SYMP P, V372, P89
NR 64
TC 391
Z9 395
U1 3
U2 85
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-503X
J9 PHILOS T R SOC A
JI Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.
PD FEB 15
PY 1999
VL 357
IS 1751
BP 335
EP 353
DI 10.1098/rsta.1999.0330
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 175NN
UT WOS:000079100700008
DA 2018-10-20
ER

PT J
AU Martin, DJ
   Meijs, GF
   Gunatillake, PA
   Yozghatlian, SP
   Renwick, GM
AF Martin, DJ
   Meijs, GF
   Gunatillake, PA
   Yozghatlian, SP
   Renwick, GM
TI The influence of composition ratio on the morphology of biomedical
   polyurethanes
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE Pellethane; degradation; morphology
ID SOFT-SEGMENT LENGTH; MECHANICAL-PROPERTIES; ELASTOMERS; HARD; MDI;
   SERIES; DEGRADATION; SEPARATION; BEHAVIOR; DIOLS
AB Two series of thermoplastic polyurethrtne elastomers were synthesized from 4,4'-methylenediphenyl diisocyanate (MDI), 1,4-butanediol (BDO) chain extender, and each of poly(tetramethylene oxide) (PTMO) and poly(hexamethylene oxide) (PHMO) macrodiols. The PTMO and PHMO molecular weights were kept constant at 993 and 852 g/mol, respectively. In the PTMO-based series, the composition ratio was varied between 48 and 58% (w/w) of macrodiol; 2 commercially available PTMO-based polymers were also included. These were Pellethane 2363 80A(R) and its harder counterpart, Pellethane 2363 55D(R). In the PHMO-based series, the composition ratio was varied between 50 and 60% (w/w) of macrodiol. The materials were characterized by differential scanning calorimetry (DSC), dynamic mechanical thermal analysis (DMTA), wide-angle X-ray diffraction (WAXD), and small-angle X-ray scattering (SAXS). Mechanical performance was also assessed by tensile testing, stress hysteresis, and hardness testing. Altering the composition ratio had a similar effect on morphology and properties for both the PTMO and PHMO-based series. An increase in hard segment content was associated with increased hard microdomain crystallinity, hardness, and stiffness. In both series, he beginning of hard microdomain interconnectivity was observed at a composition ratio of 52% soft segment. That is to say, for the processing and annealing conditions employed, macrodiol contents of 52% and below began to produce continuous, rather than discrete, hard microdomains. Pellethane 80A(R) was shown to have a discrete hard microdomain morphology, while Pellethane 55D(R) was shown to incorporate interconnecting hard microdomains. It is suggested that the superior biostability performance of Pellethane 55D relative to Pellethane 80A may be related to its interconnecting hard microdomain texture. (C) 1999 John Wiley & Sons, Inc.
C1 Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
   CSIRO, Clayton, Vic 3169, Australia.
   Univ Technol Sydney, Dept Mat Sci, Sydney, NSW 2007, Australia.
RP Martin, DJ (reprint author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
RI Gunatillake, Pathiraja/A-1375-2008
OI Gunatillake, Pathiraja/0000-0002-7035-8214; Martin,
   Darren/0000-0002-8537-6765
CR ABOUZAHR S, 1982, POLYMER, V23, P1077, DOI 10.1016/0032-3861(82)90411-6
   Aldissi M., 1988, Materials Science Forum, V27-28, P437
   *ASTM, 1969, D284969 ASTM
   BLACKWELL J, 1984, J POLYM SCI POL PHYS, V22, P759, DOI 10.1002/pol.1984.180220417
   CHRISTENSON CP, 1986, J POLYM SCI POL PHYS, V24, P1401, DOI 10.1002/polb.1986.090240703
   FERGUSON J, 1972, EUR POLYM J, V8, P369, DOI 10.1016/0014-3057(72)90102-4
   GUNATILLAKE PA, 1992, POLYM INT, V27, P275, DOI 10.1002/pi.4990270313
   GUNATILLAKE PA, 1992, J APPL POLYM SCI, V46, P319, DOI 10.1002/app.1992.070460213
   GUNATILLAKE PA, 1993, J APPL POLYM SCI, V47, P199, DOI 10.1002/app.1993.070470202
   HARRIS RF, 1990, J APPL POLYM SCI, V41, P509, DOI 10.1002/app.1990.070410305
   HUH DS, 1971, POLYM ENG SCI, V11, P369, DOI 10.1002/pen.760110504
   HWANG KKS, 1984, J POLYM SCI POL CHEM, V22, P1677, DOI 10.1002/pol.1984.170220714
   KAZMIERCZAK ME, 1998, J POLYM SCI PP, V27, P2188
   KOBAYASHI S, 1968, MAKROMOL CHEM, V112, P225
   KOBERSTEIN JT, 1992, MACROMOLECULES, V25, P5618, DOI 10.1021/ma00047a010
   KOVERSTEIN JT, 1992, MACROMOLECULES, V25, P6195
   LEE HS, 1994, J POLYM SCI POL PHYS, V32, P2085, DOI 10.1002/polb.1994.090321215
   LEUNG LM, 1985, J POLYM SCI POL PHYS, V23, P1883, DOI 10.1002/pol.1985.180230912
   Martin DJ, 1996, J APPL POLYM SCI, V60, P557, DOI 10.1002/(SICI)1097-4628(19960425)60:4<557::AID-APP9>3.0.CO;2-N
   Martin DJ, 1996, J APPL POLYM SCI, V62, P1377
   Martin DJ, 1997, J APPL POLYM SCI, V64, P803, DOI 10.1002/(SICI)1097-4628(19970425)64:4<803::AID-APP20>3.0.CO;2-T
   McCarthy SJ, 1997, BIOMATERIALS, V18, P1387, DOI 10.1016/S0142-9612(97)00083-5
   MEIJS GF, 1993, J BIOMED MATER RES, V27, P345, DOI 10.1002/jbm.820270308
   MEIJS GF, 1992, PROGR PACIFIC POLYM, V2
   PETROVIC ZS, 1989, J POLYM SCI POL PHYS, V27, P545, DOI 10.1002/polb.1989.090270305
   QUAY JR, 1990, POLYMER, V31, P1003, DOI 10.1016/0032-3861(90)90244-S
   Schubert MA, 1997, J BIOMED MATER RES, V34, P519, DOI 10.1002/(SICI)1097-4636(19970315)34:4<519::AID-JBM12>3.0.CO;2-7
   SEEFRIED CG, 1975, J APPL POLYM SCI, V19, P3185, DOI 10.1002/app.1975.070191204
   SEYMOUR RW, 1971, POLYM LETT, V9, P695
   STOKES K, 1987, POLYURETHANES BIOMED, V2, P109
   STOKES KB, 1985, PACEMAKER LEADS, P279
   VANBOGART JWC, 1983, J POLYM SCI POL PHYS, V21, P65, DOI 10.1002/pol.1983.180210106
   WAGENER KB, 1992, MACROMOLECULES, V25, P5591, DOI 10.1021/ma00047a005
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P632
   ZHAO QH, 1995, J BIOMED MATER RES, V29, P467, DOI 10.1002/jbm.820290406
NR 36
TC 66
Z9 69
U1 0
U2 19
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD FEB 7
PY 1999
VL 71
IS 6
BP 937
EP 952
PG 16
WC Polymer Science
SC Polymer Science
GA 151ZL
UT WOS:000077750600009
DA 2018-10-20
ER

PT J
AU Covacci, V
   Bruzzese, N
   Maccauro, G
   Andreassi, C
   Ricci, GA
   Piconi, C
   Marmo, E
   Burger, W
   Cittadini, A
AF Covacci, V
   Bruzzese, N
   Maccauro, G
   Andreassi, C
   Ricci, GA
   Piconi, C
   Marmo, E
   Burger, W
   Cittadini, A
TI In vitro evaluation of the mutagenic and carcinogenic power of high
   purity zirconia ceramic
SO BIOMATERIALS
LA English
DT Article
DE zirconia; ceramic; radiation; mutation; transformation
ID MOUSE EMBRYO CELLS; POSTCONFLUENCE INHIBITION; Y-TZP; TRANSFORMATION;
   FIBROBLASTS; DIVISION
AB Tetragonal zirconia polycrystal (TZP) is a new interesting ceramic for the manufacture of medical devices. Its wide use in orthopedic and odontoiatric implants was limited till now by the high chemical and radiochemical impurities of the raw materials. Purification processes now available allow to obtain high purity ceramic grade powders suitable for TZP ceramics manufacture, even if their possible mutagenic and transforming effects are still unclear. The aim of this work is to study in vitro the mutagenic and oncogenic effects of a new zirconia ceramic stabilized by yttria (Y-TZP). This ceramic was sintered from high purity powders obtained by a process developed under a project carried out within the Brite EuRam programme. For comparison, ceramics made from unpurified zirconia powder were also tested. Fibroblasts irradiated by a linear accelerator were used as positive control. The results obtained show that Y-TZP ceramic does not elicit either mutagenic or transforming effect on C3H/10-T-1/2 (10T(1/2)) cells and demonstrate that ceramic from high purity powders can be considered suitable for biomedical applications from the point of view of the effects of its radioactive impurity content. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Catholic Univ, Sch Med, Inst Gen Pathol, Giovanni Canc Res Ctr 23, I-00168 Rome, Italy.
   ENEA, New Technol Dept, I-00060 Rome, Italy.
   FN Spa, I-15062 Bosco Marengo, AL, Italy.
   CeramTec AG, D-73207 Plochingen, Germany.
RP Covacci, V (reprint author), Catholic Univ, Sch Med, Inst Gen Pathol, Giovanni Canc Res Ctr 23, 1 Lgo F Vito, I-00168 Rome, Italy.
EM ibipg@rm.unicatt.it
OI MACCAURO, Giulio/0000-0002-7359-268X
CR Burger W, 1997, J MATER SCI-MATER M, V8, P113, DOI 10.1023/A:1018562917779
   BURGER W, 1994, T 11 EUR C BIOM PIS, P177
   BURGER W, 1995, EURCERAMICS, V8, P29
   CALES B, 1990, BIOCERAMICS, V2, P152
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   CHRISTEL PS, 1989, B HOSP JOINT DIS ORT, V49, P170
   CLARKE IC, 1992, CLIN ORTHOP RELAT R, P19
   Drouin JM, 1997, J BIOMED MATER RES, V34, P149, DOI 10.1002/(SICI)1097-4636(199702)34:2<149::AID-JBM2>3.0.CO;2-Q
   HAN A, 1979, CANCER RES, V39, P123
   KAKUNAGA T, 1985, TRANSFORMATION ASSAY, P9
   Landolph J R, 1985, Carcinog Compr Surv, V10, P211
   Landolph J. R., 1985, TRANSFORMATION ASSAY, P185
   LANDOLPH JR, 1983, MUTAT RES, V107, P447, DOI 10.1016/0027-5107(83)90183-5
   LANDOLPH JR, 1994, ENVIRON HEALTH PERSP, V102, P119, DOI 10.2307/3431774
   LITTLE JB, 1985, TRANSFORMATION ASSAY, P119
   PATIERNO SR, 1989, CANCER RES, V49, P1038
   Porstendorfer J, 1996, J BIOMED MATER RES, V32, P663, DOI 10.1002/(SICI)1097-4636(199612)32:4<663::AID-JBM20>3.0.CO;2-D
   Reitmair AH, 1997, CANCER RES, V57, P3765
   REZNIKOFF CA, 1973, CANCER RES, V33, P3231
   REZNIKOFF CA, 1973, CANCER RES, V33, P3239
   RICHTER HG, 1995, CERAM T, V48, P73
   VONHOFE E, 1991, RADIAT RES, V127, P220, DOI 10.2307/3577968
   Willmann G, 1996, BIOMATERIALS, V17, P2157, DOI 10.1016/0142-9612(96)00042-7
NR 23
TC 88
Z9 100
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 1999
VL 20
IS 4
BP 371
EP 376
DI 10.1016/S0142-9612(98)00182-3
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 164CW
UT WOS:000078445700010
PM 10048410
DA 2018-10-20
ER

PT J
AU Desai, TA
   Hansford, DJ
   Kulinsky, L
   Nashat, AH
   Rasi, G
   Tu, J
   Wang, Y
   Zhang, M
   Ferrari, M
AF Desai, Tejal A.
   Hansford, Derek J.
   Kulinsky, Lawrence
   Nashat, Amir H.
   Rasi, Guido
   Tu, Jay
   Wang, Yuchun
   Zhang, Miqin
   Ferrari, Mauro
TI Nanopore Technology for Biomedical Applications
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE BioMEMS; nanotechnology; microfabrication; membranes; silicon
AB The ability to create well-defined and controlled interfaces has been an area of great interest over the last few years, particularly in the biomedical arena. This paper will describe the development of technology for the fabrication of nanopore membranes, and their operation in biological environments. With monodisperse pores sizes as small as 10 nanometers, these membranes offer advantages in their reproducibility, and their ability to be integrated with controlled biochemical surface modification protocols. A comprehensive review of results in the areas of nanopore and biocapsule microfabrication technologies, biocompatibility of nanomembrane materials, biologically appropriate post-processing protocols (bonding, sterilization), surface modification protocols, and appropriate mass transport models will be presented. The results point to the potential of using such technologies for therapeutic applications including immunoisolation biocapsules, drug delivery devices, and targeted biorecognition platforms.
C1 Univ Calif Berkeley, Biomed Microdevices Ctr, Dept Civil & Environm Engn, Dept Mat Sci & Mineral Engn,Bioengn Grad Grp, Berkeley, CA 94720 USA.
   [Desai, Tejal A.] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.
   [Hansford, Derek J.] Ohio State Univ, Ctr Biomed Engn, Dept Mat Sci & Engn, Columbus, OH 43210 USA.
   [Kulinsky, Lawrence] Univ Calif Berkeley, Dept Mat Sci & Mineral Engn, Berkeley, CA 94720 USA.
   [Nashat, Amir H.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Rasi, Guido] CNR, Ist Med Sperimentale, I-00137 Rome, Italy.
   [Tu, Jay] Alien Technol, Hayward, CA 94545 USA.
   [Wang, Yuchun] Appl Mat Inc, Chem Mech Polishing Div, Santa Clara, CA 95054 USA.
   [Zhang, Miqin] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA.
   [Ferrari, Mauro] Ohio State Univ, Ctr Biomed Engn, Columbus, OH 43210 USA.
RP Desai, TA (reprint author), Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.
RI Zhang, Miqin/F-5537-2010; Kulinsky, Lawrence/H-1314-2011
OI Zhang, Miqin/0000-0001-8974-1494; Kulinsky, Lawrence/0000-0002-1176-3578
FU MicroFab BioSystems of Vion Pharmaceuticals; National Science Foundation
   through MF's National Young Investigator Award
FX Financial support for the development of nanomembrane and biocapsule
   micromachining, biocompatibility, and characterization protocols (TD,
   MF, DH, LK, JT, YW, MZ) was provided by MicroFab BioSystems, a
   wholly-owned subsidiary of Vion Pharmaceuticals. The study of antibody
   grafting and their quantitative detection by confocal microscopy (MF,
   AN) was supported by the National Science Foundation, through MF's
   National Young Investigator Award. The authors gratefully acknowledge
   the support of others that have participated in the projects of UC
   Berkeley's Biomedical Microdevices Center, and have directly influenced
   the research presented herein: Ruby Chen, Wen-Hua Chu, Tony Huen, Mario
   Moronne, and Robert Szema.
CR Akerman B, 1997, J CHEM PHYS, V106, P6152, DOI 10.1063/1.473237
   AKIN T, 1994, IEEE T BIO-MED ENG, V41, P305, DOI 10.1109/10.284958
   ALDENHOFF YB, 1995, J BIOMED MAT, V29, P17
   ALTMAN JJ, 1991, PANCREATIC ISLET CEL, P216
   Anderson R.C., 1997, IEEE TRANSDUCERS 97, P477
   [Anonymous], 1995, MICR TECHN RES DIAGN
   AranhaCreado H, 1997, PDA J PHARM SCI TECH, V51, P208
   BAXTER GT, 1994, CLIN CHEM, V40, P1800
   Beamson G., 1992, HIGH RESOLUTION XPS
   Beyer D, 1996, LANGMUIR, V12, P2514, DOI 10.1021/la950459k
   BHATIA SK, 1989, ANAL BIOCHEM, V178, P408, DOI 10.1016/0003-2697(89)90662-3
   BHATIA SK, 1993, ANAL BIOCHEM, V208, P197, DOI 10.1006/abio.1993.1027
   BOUSSE L, 1997, IEEE TRANSD, P499
   BRENDEL MD, 1994, CELL TRANSPLANT, V3, P427, DOI 10.1177/096368979400300510
   Brody JP, 1996, BIOPHYS J, V71, P3430, DOI 10.1016/S0006-3495(96)79538-3
   Brundle C. Richard, 1992, ENCY MAT CHARACTERIZ
   BRZOSKA JB, 1994, LANGMUIR, V10, P4367, DOI 10.1021/la00023a072
   BURCZAK K, 1994, BIOMATERIALS, V15, P231, DOI 10.1016/0142-9612(94)90072-8
   BURGREEN D, 1964, J PHYS CHEM-US, V68, P1084, DOI 10.1021/j100787a019
   CALAFIORE R, 1990, HORM METAB RES, V25, P213
   Calhan L.T., 1995, ADV MATER, V7, P1033
   Chan KC, 1997, J CHROMATOGR B, V695, P113, DOI 10.1016/S0378-4347(97)00257-0
   Chu W., 1996, SPIE P MICRO NANOFAB, V2978, P111
   Chu W., 1995, SPIE P, V2593
   CHU WH, 1995, P SOC PHOTO-OPT INS, P9
   Colton, 1991, T ASME, V113, P152
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Craig RG, 1993, RESTORATIVE DENT MAT
   Desai T., 1995, MAT DESIGN TECHNOLOG, P97
   Desai T.A., 1998, BIOMEDICAL IN PRESS
   Desai T.A., 1999, J MEMBRANE SCI
   Desai T.A., MICRO NANOFABRICATED
   Desai TA, 1998, BIOTECHNOL BIOENG, V57, P118, DOI 10.1002/(SICI)1097-0290(19980105)57:1<118::AID-BIT14>3.0.CO;2-G
   Desai TA, 1998, PROG BIOM O, V3258, P40, DOI 10.1117/12.304387
   Dionne KE, 1996, BIOMATERIALS, V17, P257, DOI 10.1016/0142-9612(96)85563-3
   EDELL DJ, 1982, BIOMATER ARTIF CELL, V10, P103, DOI 10.3109/10731198209118775
   EFFENHAUSER CS, 1995, ANAL CHEM, V67, P2284, DOI 10.1021/ac00109a057
   Evans J., 1997, P IEEE MEMS, V97, P96
   Ferrari M, 1996, MATER RES SOC SYMP P, V414, P101
   Ferrari M., 1996, CISM COURSES LECT, V372, P559
   FLOUNDERS AW, 1995, APPL BIOCHEM BIOTECH, V50, P265, DOI 10.1007/BF02788097
   Fodor SPA, 1997, SCIENCE, V277, P393, DOI 10.1126/science.277.5324.393
   Furlong CD, 1997, P IEEE EMBS, V18, P248, DOI 10.1109/IEMBS.1996.656937
   GERASIMIDIVAZEOU A, 1992, TRANSPLANT P, V24, P667
   GOOSEN MFA, 1985, BIOTECHNOL BIOENG, V27, P146, DOI 10.1002/bit.260270207
   Gourley PL, 1996, NAT MED, V2, P942, DOI 10.1038/nm0896-942
   Gravesen P., 1993, Journal of Micromechanics and Microengineering, V3, P168, DOI 10.1088/0960-1317/3/4/002
   Hansford D, 1998, PROG BIOM O, V3258, P164, DOI 10.1117/12.304376
   Hansford D., 1996, THESIS U CALIFORNIA
   HARRISON DJ, 1993, SCIENCE, V261, P895, DOI 10.1126/science.261.5123.895
   HARRISON DJ, 1993, IEEE TRANSD, P403
   Henry S., 1998, P IEEE MEMS, V98, P494
   Ho S.H., 1976, J CHROMATOGRPAHY, V120, P321
   Hsuie G., 1996, J BIOMAT SCI-POLYM E, V7, P839
   HUANG XHC, 1992, ANAL CHEM, V64, P2149, DOI 10.1021/ac00042a021
   JONSSON U, 1985, THIN SOLID FILMS, V124, P117, DOI 10.1016/0040-6090(85)90253-6
   Kamath KR, 1996, J BIOMAT SCI-POLYM E, V7, P977, DOI 10.1163/156856296X00381
   KOVACS GTA, 1994, IEEE T BIO-MED ENG, V41, P567, DOI 10.1109/10.293244
   KULINSKY L, 1998, THESIS U CALIFORNIA
   LACY P, 1992, SCIENCE, V254, P1728
   LAFFERTY KJ, 1989, DIABETES NUTR METAB, V2, P323
   Langer P., 1988, CHEM BIOCHEM ENG Q, V2, P242
   Lanza R. P., 1995, SCI AM SCI MED, P16
   LANZA RP, 1992, DIABETES, V41, P1503, DOI 10.2337/diabetes.41.12.1503
   LASSEN B, 1992, Clinical Materials, V11, P99, DOI 10.1016/0267-6605(92)90034-Q
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   LOM B, 1993, J NEUROSCI METH, V50, P385, DOI 10.1016/0165-0270(93)90044-R
   Maboudian R, 1997, J VAC SCI TECHNOL B, V15, P1, DOI 10.1116/1.589247
   MacNair JE, 1997, RAPID COMMUN MASS SP, V11, P1279, DOI 10.1002/(SICI)1097-0231(199708)11:12<1279::AID-RCM18>3.0.CO;2-S
   Mala GM, 1997, INT J HEAT MASS TRAN, V40, P3079
   Man P.F, 1997, P IEEE MEMS, V97, P311
   MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199
   Morpurgo M, 1996, BIOCONJUGATE CHEM, V7, P363, DOI 10.1021/bc9600224
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Nashat AH, 1998, BIOTECHNOL BIOENG, V60, P137, DOI 10.1002/(SICI)1097-0290(19981020)60:2<137::AID-BIT1>3.0.CO;2-O
   OSHEA GM, 1984, BIOCHIM BIOPHYS ACTA, V804, P133, DOI 10.1016/0167-4889(84)90107-1
   PFAHLER J, 1990, SENSOR ACTUAT A-PHYS, V22, P431, DOI 10.1016/0924-4247(89)80008-1
   Piehler J, 1996, BIOSENS BIOELECTRON, V11, P579, DOI 10.1016/0956-5663(96)83293-3
   Renken J, 1996, ANAL CHEM, V68, P176, DOI 10.1021/ac9504777
   Reynaerts D, 1997, SENSOR ACTUAT A-PHYS, V61, P455, DOI 10.1016/S0924-4247(97)80305-6
   RICE CL, 1965, J PHYS CHEM-US, V69, P4017, DOI 10.1021/j100895a062
   Richter E, 1996, J MATER SCI-MATER M, V7, P85, DOI 10.1007/BF00058719
   ROBESON JL, 1995, BIOPHYS J, V68, P2145, DOI 10.1016/S0006-3495(95)80397-8
   Ross P.E., 1993, SCI AM, P18
   SALTHOUSE TN, 1975, BIOMATER ARTIF CELL, V3, P47, DOI 10.3109/10731197509118613
   Santini JT, 1999, NATURE, V397, P335
   SCHARP DW, 1984, WORLD J SURG, V8, P221, DOI 10.1007/BF01655139
   SCHNABEL R, 1991, J CHROMATOGR, V544, P137, DOI 10.1016/S0021-9673(01)83983-2
   Scott G, 1996, CURR EYE RES, V15, P461, DOI 10.3109/02713689609000757
   SHAH RK, 1975, INT J HEAT MASS TRAN, V18, P849, DOI 10.1016/0017-9310(75)90176-3
   SHOJI S, 1988, SENSOR ACTUATOR, V14, P101, DOI 10.1016/0250-6874(88)80057-X
   STRASSER CM, 1989, J BIOMED MATER RES, V23, P1385
   Sugamori M.E., 1989, ASAIO T, V35, P179
   TANG T, 1997, IEEE TRANSD, P523
   Tesk J.A., 1989, MATER RES SOC S P, V110, P177
   TSENG YC, 1992, J BIOMED MATER RES, V26, P373, DOI 10.1002/jbm.820260308
   Tu JK, 1998, PROG BIOM O, V3258, P148, DOI 10.1117/12.304374
   Turner T.C., 1995, BIOPHYS J, V69, P2782
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   VOLKMUTH WD, 1995, P NATL ACAD SCI USA, V92, P6887, DOI 10.1073/pnas.92.15.6887
   Wang T, 1997, NAT BIOTECHNOL, V15, P358, DOI 10.1038/nbt0497-358
   WANG Y, 1998, THESIS U CALIFORNIA
   Wang YC, 1998, PROG BIOM O, V3258, P20, DOI 10.1117/12.304385
   WASSERMAN SR, 1989, LANGMUIR, V5, P1074, DOI 10.1021/la00088a035
   WEBER CJ, 1991, PANCREATIC ISLET CEL, P177
   WEBSTER JR, 1997, INT C SOL STAT SENS, P503
   WILLIAMS RA, 1994, BIOSENS BIOELECTRON, V9, P159, DOI 10.1016/0956-5663(94)80108-8
   Wise K.D., 1990, ANN C IEEE ENG MED B, V12, P2334
   Woolley AT, 1997, ANAL CHEM, V69, P2181, DOI 10.1021/ac961237+
   WOOLLEY AT, 1994, P NATL ACAD SCI USA, V91, P11348, DOI 10.1073/pnas.91.24.11348
   Zhang MQ, 1998, BIOMED MICRODEVICES, V1, P81, DOI 10.1023/A:1009938507935
   Zhang MQ, 1997, BIOTECHNOL BIOENG, V56, P618, DOI 10.1002/(SICI)1097-0290(19971220)56:6<618::AID-BIT4>3.0.CO;2-Q
   Zhang MQ, 1998, PROG BIOM O, V3258, P15, DOI 10.1117/12.304384
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 114
TC 134
Z9 135
U1 2
U2 29
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
EI 1572-8781
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD FEB
PY 1999
VL 2
IS 1
BP 11
EP 40
DI 10.1023/A:1009903215959
PG 30
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA V33KY
UT WOS:000209018900003
DA 2018-10-20
ER

PT J
AU Grimes, CA
   Kouzoudis, D
   Ong, KG
   Crump, R
AF Grimes, Craig A.
   Kouzoudis, Dimitris
   Ong, Keat G.
   Crump, Rick
TI Thin-Film Magnetoelastic Microsensors for Remote Query Biomedical
   Monitoring
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE magnetoelastic; remote query; microdevice; sensor; glucose
AB Magnetoelastic thin-film sensors can be considered the magnetic analog of an acoustic bell: in response to an externally applied magnetic field impulse the sensors ring like a bell, emitting magnetic flux with a characteristic resonant frequency. The magnetic flux can be detected remotely, external to the test area, using a pick-up coil. By monitoring changes in the characteristic resonant frequency of the sensor multiple environmental parameters can be measured. In this work we report on application of magnetoelastic sensors for remote query measurement of temperature, pressure, viscosity and, in combination with a glucose-responding mass-changing polymer, in situ measurement of biological-level glucose concentrations. The advantage of using magnetoelastic sensors is that they are monitored remotely, without the need for direct physical connections such as wires or cables, nor line-of-sight alignment as needed with optical detection methods. The remote query capability allows the magnetoelastic sensors to be monitored from inside sealed, opaque containers. Depending upon the application magnetoelastic sensors can be sized from micrometer to millimeter dimensional scales, and have a material cost of approximately $0.001 allowing for their use on a disposable basis.
C1 [Grimes, Craig A.; Kouzoudis, Dimitris] Univ Kentucky, Dept Elect Engn, Lexington, KY 40506 USA.
   [Ong, Keat G.; Crump, Rick] SenTech Corp, Adv Sci & Technol Commercializat Ctr 350, Lexington, KY 40506 USA.
RP Grimes, CA (reprint author), Univ Kentucky, Dept Elect Engn, 453 Anderson Hall, Lexington, KY 40506 USA.
EM grimes@engr.uky.edu
FU Life Sciences Division of the National Aeronautics and Space
   Administration of the United States of America [NAG5-4594]; National
   Institutes of Health NIGMS [1-R21-GM057240-01]; National Science
   Foundation [ECS-9701733, ECS-9875104]
FX Support of this work by the Life Sciences Division of the National
   Aeronautics and Space Administration of the United States of America
   under grant NAG5-4594, by the National Institutes of Health NIGMS under
   contract 1-R21-GM057240-01, and by the National Science Foundation under
   contracts ECS-9701733 and ECS-9875104 is gratefully acknowledged.
CR ANDERSON PM, 1982, J APPL PHYS, V53, P8101, DOI 10.1063/1.330271
   [Anonymous], 1974, CRC HDB CHEM PHYS
   BAI MQ, 1994, TALANTA, V41, P993, DOI 10.1016/0039-9140(94)E0049-W
   Barandiaran JM, 1997, SENSOR ACTUAT A-PHYS, V59, P38, DOI 10.1016/S0924-4247(97)80145-8
   Bradbury T.C., 1981, THEORETICAL MECH
   GRATE JW, 1993, ANAL CHEM, V65, pA940, DOI 10.1021/ac00069a002
   GRATE JW, 1993, ANAL CHEM, V65, pA987, DOI 10.1021/ac00070a002
   Grimes CA, 1997, IEEE T MAGN, V33, P3412, DOI 10.1109/20.617961
   Grimes CA, 1999, J PHYS D APPL PHYS, V32, P1329, DOI 10.1088/0022-3727/32/12/308
   HEUSLER KE, 1988, BER BUNSEN PHYS CHEM, V92, P1218, DOI 10.1002/bbpc.198800301
   Jackson L.B., 1991, SIGNALS SYSTEMS TRAN, P171
   KANAZAWA KK, 1985, ANAL CHIM ACTA, V175, P99
   Kikuchi A, 1996, ANAL CHEM, V68, P823, DOI 10.1021/ac950748d
   LANDAU LD, 1986, THEORY ELASTICITY, pCH2
   LIVINGSTON JD, 1982, PHYS STATUS SOLIDI A, V70, P591, DOI 10.1002/pssa.2210700228
   MITCHELL EE, 1986, IEEE T IND ELECTRON, V33, P166, DOI 10.1109/TIE.1986.350212
   OGUEY HJ, 1960, REV SCI INSTRUM, V31, P701, DOI 10.1063/1.1717026
   RYAN J, 1997, SCI AM           MAY, P120
   SCHUMACHER R, 1990, ANGEW CHEM INT EDIT, V29, P329, DOI 10.1002/anie.199003293
   SHANA ZA, 1990, ANAL CHIM ACTA, V231, P317, DOI 10.1016/S0003-2670(00)86434-X
   Shinoda T, 1997, THIN SOLID FILMS, V293, P144, DOI 10.1016/S0040-6090(96)09107-9
   Stoyanov PG, 1998, IEEE T MAGN, V34, P1315, DOI 10.1109/20.706533
   THOMPSON M, 1986, ANAL CHEM, V58, P1206, DOI 10.1021/ac00297a051
   YAO SZ, 1988, ANAL CHIM ACTA, V212, P61, DOI 10.1016/S0003-2670(00)84129-X
NR 24
TC 8
Z9 8
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
EI 1572-8781
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD FEB
PY 1999
VL 2
IS 1
BP 51
EP 60
DI 10.1023/A:1009907316867
PG 10
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA V33KY
UT WOS:000209018900005
DA 2018-10-20
ER

PT J
AU Linton, CJ
   Sherriff, A
   Millar, MR
AF Linton, CJ
   Sherriff, A
   Millar, MR
TI Use of a modified Robbins device to directly compare the adhesion of
   Staphylococcus epidermidis RP62A to surfaces
SO JOURNAL OF APPLIED MICROBIOLOGY
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; POLYSACCHARIDE INTERCELLULAR ADHESIN;
   TRANSPOSON MUTANTS; BIOFILM PRODUCTION; SLIME; HYDROPHOBICITY;
   EXPRESSION; BACTERIA; PROTEINS; CALCIUM
AB Staphylococcus epidermidis is a frequent cause of infection associated with the use of biomedical devices. Flow cell studies of the interaction between bacteria and surfaces do not generally allow direct comparison of different materials using the same bacterial suspension. The use of a modified Robbins Device (MRD) to compare the adhesion to different surfaces of Staph. epidermidis RP62A grown in continuous culture was investigated. Adhesion to glass was compared with siliconized glass, plasma-conditioned glass, titanium, stainless steel and Teflon. Attachment to siliconized glass was also compared with glass under differing ionic strength, and divalent cation concentrations. Both the differences in numbers adhering and changes in adhesion (slope) through the MRD were compared. There was a trend towards higher numbers adhering to the discs at the in-flow end of the MRD than at the outflow end, probably reflecting depletion of adherent bacteria in the interacting stream. Adhesion of Staph. epidermidis RP62A to siliconized glass and Teflon was reduced when compared to glass with increasing flow rates. Adhesion to stainless steel nias not affected by flow rate and titanium gave a different slope of adhesion through the MRD when compared with glass, suggesting an interaction with different sub-populations within the interacting stream. Differences between siliconized glass and glass at flow rates of 300 mi h(-1) were abolished by the addition of calcium or EDTA and reduced by the addition of magnesium. Increasing ionic strength reduced the statistical significance of the differences between glass and siliconized glass, Pre-conditioning of glass with pooled human plasma reduced adhesion compared with untreated glass and again gave a different slope to glass. The MRD linked to a chemostat call be used to compare directly bacterial adhesion to potential biomaterials. Variable depiction of the interacting stream should be taken into account in the interpretation of results. Divalent cation concentration, substrate properties and flow rate were important determinants of the comparative adhesion of Staph. epidermidiss RP62A to surfaces.
C1 Univ Bristol, Dept Pathol & Microbiol, Bristol BS2 8HW, Avon, England.
   Univ Bristol, Dept Paediat Epidemiol, Bristol BS2 8HW, Avon, England.
RP Millar, MR (reprint author), Univ Bristol, Bristol Royal Infirm, Dept Pathol & Microbiol, Level 8,Marlborough St, Bristol BS2 8HW, Avon, England.
CR Baldassarri L, 1996, INFECT IMMUN, V64, P3410
   BUSSCHER HJ, 1995, METHOD ENZYMOL, V253, P445
   CHRISTENSEN GD, 1995, METHOD ENZYMOL, V253, P477
   DUNNE WM, 1992, MICROBIOL IMMUNOL, V36, P1019, DOI 10.1111/j.1348-0421.1992.tb02106.x
   EVANS E, 1994, MICROBIOL-UK, V140, P153, DOI 10.1099/13500872-140-1-153
   FLETCHER M, 1979, APPL ENVIRON MICROB, V37, P67
   GRINSTINA AG, 1987, ZENTRALBLATT BAK S16, V1, P143
   Heilmann C, 1996, INFECT IMMUN, V64, P277
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   HOGT AH, 1983, FEMS MICROBIOL LETT, V18, P211
   Hussain M, 1997, INFECT IMMUN, V65, P519
   JANSEN B, 1995, J IND MICROBIOL, V15, P391, DOI 10.1007/BF01569996
   JASS J, 1995, J IND MICROBIOL, V15, P283, DOI 10.1007/BF01569981
   LJUNGH A, 1995, MICROBIOL IMMUNOL, V39, P753, DOI 10.1111/j.1348-0421.1995.tb03267.x
   Lundberg F, 1997, INFECT IMMUN, V65, P897
   Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881
   MACK D, 1994, INFECT IMMUN, V62, P3244
   Mackinnon LT, 1996, EXERC IMMUNOL REV, V2, P1
   MCDOWELL SG, 1995, LETT APPL MICROBIOL, V21, P1, DOI 10.1111/j.1472-765X.1995.tb00992.x
   MCELDOWNEY S, 1986, APPL ENVIRON MICROB, V52, P460
   Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X
   MULLER E, 1993, INFECT IMMUN, V61, P551
   MULLER E, 1991, INFECT IMMUN, V59, P3323
   PITT WG, 1993, BIOMATERIALS, V14, P605, DOI 10.1016/0142-9612(93)90179-6
   PLOWMAN RM, 1997, HOSP ACQUIRED INFECT, P15
   Rupp ME, 1998, J ANTIMICROB CHEMOTH, V41, P155, DOI 10.1093/jac/41.2.155
   RUPP ME, 1995, J INFECT DIS, V172, P1509, DOI 10.1093/infdis/172.6.1509
   RUTTER P, 1980, J GEN MICROBIOL, V120, P301
   Sambrook J, 1989, MOL CLONING LAB MANU
   THOMAS VL, 1993, J GEN MICROBIOL, V139, P623, DOI 10.1099/00221287-139-3-623
   Veenstra GJC, 1996, J BACTERIOL, V178, P537, DOI 10.1128/jb.178.2.537-541.1996
   WANG I, 1993, J BIOMED MATER RES, V27, P1119, DOI 10.1002/jbm.820270902
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
NR 33
TC 15
Z9 15
U1 0
U2 7
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 1364-5072
J9 J APPL MICROBIOL
JI J. Appl. Microbiol.
PD FEB
PY 1999
VL 86
IS 2
BP 194
EP 202
DI 10.1046/j.1365-2672.1999.00650.x
PG 9
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 170AL
UT WOS:000078782900004
PM 10063617
DA 2018-10-20
ER

PT J
AU O'Neill, PA
   Metcalfe, D
   David, TJ
AF O'Neill, PA
   Metcalfe, D
   David, TJ
TI The core content of the undergraduate curriculum in Manchester
SO MEDICAL EDUCATION
LA English
DT Article
DE competency-based education; curriculum; education, medical,
   undergraduate, methods; England
ID MEDICINE
AB Aim To identify the core content for the new undergraduate medical curriculum in Manchester.
   Method The initial step was to produce a list of 'index clinical situations' (ICSs), for which a newly graduated doctor must have a required level of competence. Using repeated consultation with consultants and general practitioners involved in medical education in the North-West of England, a list of 215 ICSs was agreed. Specialists and generalists were then asked to identify the components of the knowledge base and the performance (skills) base for each ICS. The knowledge base was divided into technical (biomedical facts/concepts) and contextual (effect/management of disease within the individual, family and society) domains. The performance base was divided into intellectual (problem solving and decision making) and interpersonal (history, examination, communication and procedural skills) domains.
   Results Forty specialities were consulted and 11021 items (defined as a piece of knowledge, a concept or a skill) were identified. There was considerable overlap in the items listed, such that when the returns for each ICS were amalgamated, the 215 ICSs contained 6434 items with a mean of 34 +/- 14.2 per situation (range 6-85).
   Utilisation We have used the defined ICSs in the design of the trigger material used in the weekly problem-based learning sessions. Over 4 years almost all (207/215, 96%) of the ICS are covered, with many being revisited at several points in the curriculum.
C1 Univ Manchester, Fac Med, Curriculum Dev Off, Dept Geriatr Med, Manchester M13 9PT, Lancs, England.
   Univ Manchester, Dept Gen Practice, Manchester M13 9PT, Lancs, England.
   Univ Manchester, Dept Paediat & Child Hlth, Manchester M13 9PT, Lancs, England.
RP O'Neill, PA (reprint author), Univ Manchester, Fac Med, Curriculum Dev Off, Dept Geriatr Med, Manchester M13 9PT, Lancs, England.
CR Albano MG, 1996, MED EDUC, V30, P239, DOI 10.1111/j.1365-2923.1996.tb00824.x
   *ASS BRIT NEUR, 1994, TEACH NEUR 21 CENT
   *BRIT GER SOC, 1995, COR CONT UND CURR EL
   *BRIT ORTH ASS, 1992, MUSC ED UND
   *DEP HLTH, 1992, HLTH NAT STRAT HLTH
   *DEP HLTH NUTR TAS, 1994, NUTR COR CURR NUTR E
   *GEN MED COUNC ED, 1993, TOM DOCT REC UND MED
   Glick TH, 1996, MED EDUC, V30, P24, DOI 10.1111/j.1365-2923.1996.tb00713.x
   HARDEN RM, 1986, MED EDUC, V20, P458, DOI 10.1111/j.1365-2923.1986.tb01193.x
   Harden RM, 1997, MED EDUC, V31, P264, DOI 10.1111/j.1365-2923.1997.tb02923.x
   Huppatz C, 1996, MED EDUC, V30, P9, DOI 10.1111/j.1365-2923.1996.tb00710.x
   JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376
   MANDIN H, 1995, ACAD MED, V70, P186, DOI 10.1097/00001888-199503000-00008
   RAYNER HC, 1995, MED TEACH, V17, P409, DOI 10.3109/01421599509036777
   Smith K, 1996, TEACH LEARN MED, V8, P48, DOI 10.1080/10401339609539763
   SWANSON AG, 1993, ACAD MED, V68, pS7
   WALTON LA, 1993, AM J OBSTET GYNECOL, V169, P13, DOI 10.1016/0002-9378(93)90123-Z
   WRIGHT V, 1979, BRIT MED J, V1, P805, DOI 10.1136/bmj.1.6166.805
NR 18
TC 42
Z9 45
U1 0
U2 3
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 0308-0110
J9 MED EDUC
JI Med. Educ.
PD FEB
PY 1999
VL 33
IS 2
BP 121
EP 129
PG 9
WC Education, Scientific Disciplines; Health Care Sciences & Services
SC Education & Educational Research; Health Care Sciences & Services
GA 169UA
UT WOS:000078765900008
PM 10211262
DA 2018-10-20
ER

PT J
AU Li, BY
   Rong, LJ
   Li, YY
AF Li, BY
   Rong, LJ
   Li, YY
TI Microstructure and superelasticity of porous NiTi alloy
SO SCIENCE IN CHINA SERIES E-TECHNOLOGICAL SCIENCES
LA English
DT Article
DE powder sintering; porous alloy; NiTi shape memory alloy; superelasticity
ID SHAPE-MEMORY
AB The microstructure, porosity, phase composition and superelasticity (SE) in porous NiTi alloys produced by elemental powder sintering are examined by SEM, image analysis and XRD. It is found that it is feasible to produce porous NiTi alloy by elemental powder sintering, and the porosity of sintered porous NiTi alloy is in the range of 36.0%-41.5%. The pores are interconnected and the microstructure is sponge-like. Meanwhile, porous NiTi alloy has good SE. XRD patterns show that there is no pure Ni in alloy sintered at 1 223 K-9 h. Compared with the biomedical criteria far choice of implanting materials, porous NiTi alloy is satisfying to a great degree.
C1 Chinese Acad Sci, Inst Met Res, Atom Imaging Solids Lab, Shenyang 110015, Peoples R China.
RP Li, BY (reprint author), Chinese Acad Sci, Inst Met Res, Atom Imaging Solids Lab, Shenyang 110015, Peoples R China.
RI Li, Bingyun/A-9484-2009; Li, Bingyun/P-5320-2018
OI Li, Bingyun/0000-0002-5766-5666
CR GYUNTER VE, 1992, SHAPE MEMORY EFFECTS
   GYUNTER VE, 1995, SUPERELASTIC SHAPE M, P14
   HEY JC, 1994, MAT SCI ENG A-STRUCT, V188, P291, DOI 10.1016/0921-5093(94)90384-0
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   LI BY, IN PRESS J MATER RES
   MARTYNOVA I, 1991, J PHYS IV, V1, P421, DOI 10.1051/jp4:1991463
   YAO DC, 1990, EXPT TECHNIQUE POWDE, P15
   1995, USERS MANUAL DENSITY
NR 8
TC 17
Z9 19
U1 0
U2 1
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1006-9321
J9 SCI CHINA SER E
JI Sci. China Ser. E-Technol. Sci.
PD FEB
PY 1999
VL 42
IS 1
BP 94
EP 99
DI 10.1007/BF02917064
PG 6
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 165LY
UT WOS:000078523700013
DA 2018-10-20
ER

PT J
AU Brown, IG
   Anders, A
   Dickinson, MR
   MacGill, RA
   Monteiro, OR
AF Brown, IG
   Anders, A
   Dickinson, MR
   MacGill, RA
   Monteiro, OR
TI Recent advances in surface processing with metal plasma and ion beams
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 1st Asian-European International Conference on Plasma Surface
   Engineering
CY OCT 05-09, 1997
CL SEOUL, SOUTH KOREA
SP Korea Accelarator & Plasma Res Assoc, Korean Inst Surface Engn, European Joint Comm Plasma & Ion Surface Engn
DE ion implantation; metal plasma; plasma immersion; thin films
ID CATHODIC-ARC DEPOSITION; THIN-FILMS; VACUUM; IMPLANTATION; IMMERSION;
   TRANSPORT; COATINGS; FILTERS; SILICON
AB Surface processing by metal plasma and ion beams can be effected using the dense metal plasma formed in a vacuum are discharge embodied either in a "metal plasma immersion" configuration or as a vacuum are ion source, as well as by many other well-established methods. In the former case the substrate is immersed in the plasma and repetitively pulse-biased to accelerate the ions across the sheath and allow controlled ion energy implantation + deposition, and in the latter case a high energy metal ion beam is formed and ion implantation is done in a more-or-less conventional way. These methods have been used widely; here we limit consideration to work carried out at the Lawrence Berkeley National Laboratory. A number of advances have been made both in the plasma technology and in the surface modification procedures that enhance the effectiveness and versatility of the methods. Recent improvements in plasma technology include dual-source plasma mixing, ion charge state enhancement, and some scale-up of the hardware. We have made and explored some novel kinds of surface films and modified layers, including for example doped diamond-like carbon (DLC), novel multilayers, alumina and more complex ceramic materials such as mullite (3Al(2)O(3). 2SiO(2)), high temperature superconducting films, and others. Recent research has included investigations of these and other surface materials for many different basic and applied applications, such as for high temperature tolerant protective coatings, biomedical compatibility, surface resistivity tailoring of ceramics, novel catalytic surfaces, corrosion resistance of battery electrodes, and more. Here we briefly review the fundamentals of the techniques, and describe some of the applications to which the methods have been put at the Lawrence Berkeley National Laboratory. (C) 1999 Elsevier Science S.A. All rights reserved.
C1 Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.
RP Brown, IG (reprint author), Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.
EM ibrown@lbl.gov
RI Anders, Andre/B-8580-2009
OI Anders, Andre/0000-0002-5313-6505
CR ANDERS A, 1995, PLASMA SOURCES SCI T, V4, P1, DOI 10.1088/0963-0252/4/1/001
   ANDERS A, 1994, J VAC SCI TECHNOL B, V12, P815, DOI 10.1116/1.587351
   ANDERS A, 1994, J APPL PHYS, V75, P4900, DOI 10.1063/1.355777
   ANDERS S, 1994, SURF COAT TECH, V68, P388, DOI 10.1016/0257-8972(94)90191-0
   Boxman R.L., 1995, VACUUM ARC SCI TECHN
   Brown IG, 1996, SURF COAT TECH, V84, P550, DOI 10.1016/S0257-8972(95)02833-1
   BROWN IG, 1993, NUCL INSTRUM METH B, V80-1, P1281, DOI 10.1016/0168-583X(93)90782-2
   BROWN IG, 1994, REV SCI INSTRUM, V65, P3061, DOI 10.1063/1.1144756
   Brown IG, 1995, NUCL INSTRUM METH B, V106, P646, DOI 10.1016/0168-583X(95)00781-4
   BROWN IG, 1993, IEEE T PLASMA SCI, V21, P537, DOI 10.1109/27.249640
   BROWN IG, 1991, APPL PHYS LETT, V58, P1392, DOI 10.1063/1.104318
   Brown IG, 1998, SURF COAT TECH, V104, P293, DOI 10.1016/S0257-8972(98)00426-5
   Chae MS, 1996, PHYSICA C, V270, P173, DOI 10.1016/0921-4534(96)00504-7
   DelplanckeOgletree MP, 1997, MATER RES SOC SYMP P, V438, P639
   Ignatius MJ, 1998, J BIOMED MATER RES, V40, P264, DOI 10.1002/(SICI)1097-4636(199805)40:2<264::AID-JBM11>3.3.CO;2-N
   Liu F, 1998, SURF COAT TECH, V104, P46, DOI 10.1016/S0257-8972(98)00373-9
   MacGill RA, 1996, SURF COAT TECH, V78, P168, DOI 10.1016/0257-8972(95)02422-0
   Markovic NM, 1997, CATAL LETT, V43, P161, DOI 10.1023/A:1018907110025
   Monteiro OR, 1997, J MATER RES, V12, P2401, DOI 10.1557/JMR.1997.0318
   Pharr GM, 1996, APPL PHYS LETT, V68, P779, DOI 10.1063/1.116530
   Walter KC, 1996, SURF COAT TECH, V85, P1, DOI 10.1016/0257-8972(96)02886-1
   YU KM, 1991, NUCL INSTRUM METH B, V58, P27, DOI 10.1016/0168-583X(91)95674-3
   IN PRESS SURF COAT T
NR 23
TC 55
Z9 64
U1 0
U2 15
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD FEB
PY 1999
VL 112
IS 1-3
BP 271
EP 277
DI 10.1016/S0257-8972(98)00769-5
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 186DQ
UT WOS:000079712200054
DA 2018-10-20
ER

PT J
AU Cui, FZ
   Luo, ZS
AF Cui, FZ
   Luo, ZS
TI Biomaterials modification by ion-beam processing
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 1st Asian-European International Conference on Plasma Surface
   Engineering
CY OCT 05-09, 1997
CL SEOUL, SOUTH KOREA
SP Korea Accelarator & Plasma Res Assoc, Korean Inst Surface Engn, European Joint Comm Plasma & Ion Surface Engn
DE biomaterials; ion-beam process; mutation breeding; surface modification
ID DIAMOND-LIKE CARBON; ADHESIVE HYDROXYAPATITE COATINGS; ASSISTED
   DEPOSITION; SURFACE-TREATMENT; IMPLANTATION; BEHAVIOR;
   POLYETHERURETHANE; POLYURETHANE; CULTURE; METALS
AB Biomaterials modification by ion-beam processing is becoming popular for improving medical device function, biocompatibility and as a new mutation breeding method. Ion-beam-based processes, such as ion implantation and ion-beam assisted deposition (IBAD) can provide beneficial surface layers with desirable properties without detrimentally affecting the bulk properties. Ion implantation has been successful in biomaterials modification, such as in improving the wear resistance of artificial joint components, in improving wettability, anticoagulability, anticalcific behavior of biomedical polymers, and in minimizing biofouling of medical devices, etc. IBAD has been used to prepare hydroxyapatite coatings with high adhesive strength on substrates of several implant materials. Biocompatible diamond-like carbon coatings and C-N films, antibacterial coatings and sealant coatings have also been produced by this technique. This paper reviews the present status of applications of the ion-beam process in modifying the surface of biomaterials, as well as the effects induced by ion-beam irradiation to crop seeds, cells and microbes. (C) 1999 Elsevier Science S.A. All rights reserved.
C1 Tsing Hua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
RP Cui, FZ (reprint author), Tsing Hua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
EM cuifz@sun.ihep.ac.cn
CR Allen Matthew, 1994, Clinical Materials, V17, P1, DOI 10.1016/0267-6605(94)90041-8
   BAMBAUER R, 1995, DIALYSIS TRANSPLANT, V24, P228
   CHARNLEY J, 1975, CLIN ORTHOP RELAT R, P170
   CHEN QH, 1997, THESIS TSINGHUA U
   CROWNINSHIELD R, 1990, T 36 ANN M ORTH RES, V15, P470
   CUI FZ, 1983, NUCL INSTRUM METHODS, V209, P881
   Cui FZ, 1997, J MATER SCI-MATER M, V8, P403, DOI 10.1023/A:1018597320022
   DEARNALEY G, 1981, NUCL INSTRUM METHODS, V189, P117, DOI 10.1016/0029-554X(81)90133-6
   Du C, 1998, BIOMATERIALS, V19, P651, DOI 10.1016/S0142-9612(97)00159-2
   GOODMAN SB, 1989, CLIN ORTHOP RELAT R, P182
   HE XM, 1993, NUCL INSTRUM METH B, V82, P528, DOI 10.1016/0168-583X(93)96006-X
   Kim TN, 1998, SURF COAT TECH, V99, P20, DOI 10.1016/S0257-8972(97)00121-7
   KIM TN, 1997, J KOREAN VAC SOC, V6, P27
   LI DJ, 1993, NUCL INSTRUM METH B, V82, P57
   Li DJ, 1997, CHINESE PHYS LETT, V14, P531
   LI DJ, 1994, APPL SURF SCI, V78, P195
   LOMBARDI AV, 1989, J BONE JOINT SURG AM, V71A, P1337, DOI 10.2106/00004623-198971090-00009
   Lu Luo, 1993, Bio-Medical Materials and Engineering, V3, P223
   OKKEMA AZ, 1991, BIOMATERIALS, V12, P668, DOI 10.1016/0142-9612(91)90115-Q
   OLIVER WC, 1984, METALL TRANS A, V15, P2221, DOI 10.1007/BF02647105
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   RODRIGUEZ RJ, 1994, SPRINT DATA BASE ION
   SIOSHANSI P, 1985, J VAC SCI TECHNOL A, V3, P2670, DOI 10.1116/1.572811
   Sioshansi P, 1996, SURF COAT TECH, V83, P175, DOI 10.1016/0257-8972(95)02838-2
   SIOSHANSI P, 1987, NUCL INSTRUM METH B, V2425, P767
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   SUZUKI Y, 1989, MATER RES SOC S P, V110, P669
   TAYULOR SK, 1993, T 39 ANN M ORTH RES, V18, P503
   Wintermantel E, 1996, BIOMATERIALS, V17, P83, DOI 10.1016/0142-9612(96)85753-X
   Yang JB, 1997, SCI CHINA SER C, V40, P107, DOI 10.1007/BF02879113
   YU L, 1993, RES BIOL EFFECTS IND, P1
   ZHANG JQ, 1986, MATER RES SOC S P, V55, P228
NR 32
TC 115
Z9 123
U1 2
U2 16
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD FEB
PY 1999
VL 112
IS 1-3
BP 278
EP 285
DI 10.1016/S0257-8972(98)00763-4
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 186DQ
UT WOS:000079712200055
DA 2018-10-20
ER

PT J
AU Leibfried-Rutledge, ML
AF Leibfried-Rutledge, ML
TI Factors determining competence of in vitro produced cattle embryos
SO THERIOGENOLOGY
LA English
DT Article; Proceedings Paper
CT IETS Post-Conference Satellite Symposium on the Development and
   Application of Embryo Biotechnology in Livestock
CY JAN   13, 1999
CL CHATEAU MONT ST ANNE, CANADA
ID FERTILIZED BOVINE EMBRYOS; OOCYTES MATURED INVITRO; IN-VITRO;
   DEVELOPMENTAL COMPETENCE; MEIOTIC RESUMPTION; PROTEIN-SYNTHESIS; NUCLEAR
   TRANSFER; IMPROVED YIELDS; CULTURE MEDIA; MATURATION
AB Concerns have developed in regard to problems associated with pregnancies and calves produced after use of cattle blastocysts made in the laboratory for embryo transfer. For both empirical studies and commercial purposes, there is a need for assurance that the product of these biotechnolgies results in a normally functioning entity of its kind. Ability to use more genetic material from a donor female and in producing blastocysts needs to be improved to increase the efficiency of utilizing in vitro biotechnologies in animal production agriculture and for biomedical purposes. The role of gametes used as raw materials for laboratory production cattle embryos and adequacy of culture systems in supporting development of embryos are discussed in relation to competency of embryos produced in vitro. (C) 1998 by Elsevier Science Inc.
C1 BOMED Inc, Madison, WI 53705 USA.
RP Leibfried-Rutledge, ML (reprint author), BOMED Inc, Madison, WI 53705 USA.
CR Agca Y, 1998, THERIOGENOLOGY, V50, P147, DOI 10.1016/S0093-691X(98)00121-6
   Agca Y, 1998, THERIOGENOLOGY, V50, P129, DOI 10.1016/S0093-691X(98)00120-4
   Aktas H, 1995, J REPROD FERTIL, V105, P227
   Aktas H, 1995, J REPROD FERTIL, V105, P237
   Arlotto T, 1996, THERIOGENOLOGY, V45, P943, DOI 10.1016/0093-691X(96)00024-6
   ARLOTTO TA, 1994, THESIS ANN ARBOR
   AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581
   BARRET GR, 1948, THESIS U WISCONSIN M
   BAVISTER BD, 1992, THERIOGENOLOGY, V37, P127, DOI 10.1016/0093-691X(92)90251-L
   Biggers J. D., 1987, MAMMALIAN PREIMPLANT, P1
   Blondin P, 1997, THERIOGENOLOGY, V47, P1061, DOI 10.1016/S0093-691X(97)00063-0
   BROWDER LW, 1985, DEV BIOL COMPREHENSI, V1
   CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0
   CHOUDARY JB, 1968, J ANIM SCI, V27, P468
   DELOOS F, 1989, GAMETE RES, V24, P197, DOI 10.1002/mrd.1120240207
   DELOOS FAM, 1994, MOL REPROD DEV, V39, P162
   DOMINKO T, 1992, Theriogenology, V37, P203, DOI 10.1016/0093-691X(92)90272-S
   Duby RT, 1996, THERIOGENOLOGY, V45, P121, DOI 10.1016/0093-691X(95)00361-B
   EDWARDS RG, 1965, NATURE, V208, P349, DOI 10.1038/208349a0
   EID LN, 1994, BIOL REPROD, V51, P1232, DOI 10.1095/biolreprod51.6.1232
   EPPIG JJ, 1990, THERIOGENOLOGY, V33, P89, DOI 10.1016/0093-691X(90)90600-X
   EPPIG JJ, 1993, METHOD ENZYMOL, V225, P77
   ERICKSON BH, 1966, J ANIM SCI, V25, P800
   EYESTONE W H, 1989, Theriogenology, V31, P191, DOI 10.1016/0093-691X(89)90599-2
   FAIR T, 1995, MOL REPROD DEV, V42, P437, DOI 10.1002/mrd.1080420410
   First N L, 1987, J Reprod Fertil Suppl, V34, P151
   FORTUNE JE, 1994, BIOL REPROD, V50, P225, DOI 10.1095/biolreprod50.2.225
   FUHRER F, 1989, J VET MED A, V36, P285
   FUKUI Y, 1980, BIOL REPROD
   FULKA J, 1991, MOL REPROD DEV, V29, P379, DOI 10.1002/mrd.1080290410
   Gandolfi F, 1997, THERIOGENOLOGY, V48, P1153, DOI 10.1016/S0093-691X(97)00348-8
   Gardner DK, 1998, THERIOGENOLOGY, V49, P83, DOI 10.1016/S0093-691X(97)00404-4
   Garry FB, 1996, THERIOGENOLOGY, V45, P141, DOI 10.1016/0093-691X(95)00363-D
   GINTHER OJ, 1989, J REPROD FERTIL, V87, P223
   GORDON I, 1994, LAB PRODUCTION CATTL
   HAFEZ ESE, 1993, REPRODUCTION FARM AN
   HAMANO K, 1993, THERIOGENOLOGY, V3, P1421
   HASLER JF, 1995, THERIOGENOLOGY, V43, P141, DOI 10.1016/0093-691X(94)00020-U
   HASLER JR, 1997, ASAS BIENN S REPR NA
   HAWK HW, 1994, THERIOGENOLOGY, V41, P1571, DOI 10.1016/0093-691X(94)90822-Z
   HAWK HW, 1994, THERIOGENOLOGY, V41, P1585, DOI 10.1016/0093-691X(94)90823-2
   HAZELEGER NL, 1995, THERIOGENOLOGY, V43, P509, DOI 10.1016/0093-691X(94)00043-T
   HILLERYWEINHOLD F, 1991, THESIS U WISCONSIN M
   HUNTER AG, 1987, J DAIRY SCI, V70, P1646, DOI 10.3168/jds.S0022-0302(87)80192-3
   Jones R. E., 1978, VERTEBRATE OVARY
   Khatir H, 1996, MOL REPROD DEV, V45, P231, DOI 10.1002/(SICI)1098-2795(199610)45:2<231::AID-MRD17>3.0.CO;2-3
   Krisher RL, 1998, THERIOGENOLOGY, V49, P103, DOI 10.1016/S0093-691X(97)00405-6
   Kruip TAM, 1997, THERIOGENOLOGY, V47, P43, DOI 10.1016/S0093-691X(96)00338-X
   LEIBFRIED L, 1979, J ANIM SCI, V48, P76
   Leibfried-Rutledge M. L., 1989, The molecular biology of fertilization., P259
   LEIBFRIEDRUTLED.ML, 1995, ASAS BIENN REPR S OR
   LEIBFRIEDRUTLED.ML, 1997, REPROD TISSUE BANKIN, P23
   LEIBFRIEDRUTLEDGE ML, 1989, THERIOGENOLOGY, V31, P61, DOI 10.1016/0093-691X(89)90564-5
   LEIBFRIEDRUTLEDGE ML, 1987, BIOL REPROD, V36, P376, DOI 10.1095/biolreprod36.2.376
   LENZ RW, 1983, BIOL REPROD, V29, P173, DOI 10.1095/biolreprod29.1.173
   Lonergan P, 1997, J REPROD FERTIL, V109, P355
   Lonergan P, 1998, THERIOGENOLOGY, V50, P417, DOI 10.1016/S0093-691X(98)00149-6
   LONERGAN P, 1994, MOL REPROD DEV, V37, P48, DOI 10.1002/mrd.1080370107
   LOONEY CR, 1994, THERIOGENOLOGY, V41, P67, DOI 10.1016/S0093-691X(05)80050-0
   MADISON V, 1992, ANIM REPROD SCI, V27, P1, DOI 10.1016/0378-4320(92)90065-L
   MOTLIK J, 1986, THERIOGENOLOGY, V25, P87, DOI 10.1016/0093-691X(86)90185-8
   NAVARA CS, 1994, DEV BIOL, V162, P29, DOI 10.1006/dbio.1994.1064
   Otoi T, 1997, THERIOGENOLOGY, V48, P769, DOI 10.1016/S0093-691X(97)00300-2
   PARRISH JJ, 1995, THERIOGENOLOGY, V44, P859, DOI 10.1016/0093-691X(95)00271-9
   PAVLOK A, 1992, MOL REPROD DEV, V31, P63, DOI 10.1002/mrd.1080310111
   Pincus G, 1935, J EXP MED, V62, P665, DOI 10.1084/jem.62.5.665
   ROSE TA, 1992, MOL REPROD DEV, V31, P72, DOI 10.1002/mrd.1080310113
   SAACKE RG, 1994, THERIOGENOLOGY, V41, P45, DOI 10.1016/S0093-691X(05)80047-0
   Saeki K, 1997, THERIOGENOLOGY, V48, P1161, DOI 10.1016/S0093-691X(97)00349-X
   SHI D S, 1990, Theriogenology, V33, P324, DOI 10.1016/0093-691X(90)90748-I
   SIMON M, 1989, REPROD NUTR DEV, V29, P533, DOI 10.1051/rnd:19890502
   SIRARD MA, 1989, BIOL REPROD, V40, P1257, DOI 10.1095/biolreprod40.6.1257
   SIRARD MA, 1992, THERIOGENOLOGY, V37, P39, DOI 10.1016/0093-691X(92)90246-N
   Sirard MA, 1998, THERIOGENOLOGY, V49, P483, DOI 10.1016/S0093-691X(97)00420-2
   Sirard Marc-Andre, 1995, Journal of Reproduction and Development, V41, P255, DOI 10.1262/jrd.41.255
   SUSS U, 1988, BIOL REPROD, V38, P871, DOI 10.1095/biolreprod38.4.871
   TAKAGI Y, 1992, J ANIM SCI, V70, P1923
   Telfer EE, 1998, THERIOGENOLOGY, V49, P451, DOI 10.1016/S0093-691X(97)00417-2
   vandenHurk R, 1997, THERIOGENOLOGY, V47, P73, DOI 10.1016/S0093-691X(96)00341-X
   VANDESANDT JJM, 1990, MOL REPROD DEV, V25, P164, DOI 10.1002/mrd.1080250209
   1989, THERIOGENOLOGY, V31, P1
NR 81
TC 18
Z9 21
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0093-691X
J9 THERIOGENOLOGY
JI Theriogenology
PD JAN 15
PY 1999
VL 51
IS 2
BP 473
EP 485
DI 10.1016/S0093-691X(98)00241-6
PG 13
WC Reproductive Biology; Veterinary Sciences
SC Reproductive Biology; Veterinary Sciences
GA 154BQ
UT WOS:000077868500004
PM 10729106
DA 2018-10-20
ER

PT B
AU Walker, FL
   Thoma, GR
AF Walker, FL
   Thoma, GR
BE Nixon, C
   Dengler, H
TI Java-assisted Internet document delivery
SO 14TH ANNUAL COMPUTERS IN LIBRARIES '99 PROCEEDINGS: IN COOPERATION WITH
   THE SPECIAL LIBRARIES ASSOCIATION
LA English
DT Proceedings Paper
CT 14th Annual Conference on Computers in Libraries
CY MAR 08-10, 1999
CL ARLINGTON, VA
SP Informat Today Inc
DE Java; Internet; HotMed; MedJava; document delivery; email; MIME; Ariel;
   DocView; World Wide Web; interlibrary loan
AB An increasing number of libraries are using the Internet for document delivery, not only for interlibrary loan, but for delivering documents directly to the patron's desktop computer. This has been made possible through the widespread adoption of software such as Ariel and DocView. Ariel, a product of the Research Libraries Group, converts paper-based documents to bitmapped images, and delivers them over the Internet. The National Library of Medicine's DocView, released in January 1998 and now used by 2,000 people in over 70 countries, is primarily designed for library patrons to receive, display and manage documents received fr-om Ariel systems. Despite the relative effectiveness of such technologies, Internet document delivery to the patron's desktop remains a challenge to document delivery librarians for several reasons. First, the librarian may need to assist patrons in acquiring document-viewing software, and in helping them install it on a wide variety of computer platforms. The librarian may also need to help patrons upgrade their viewing software as new versions are released. Because a heterogeneous patron population may be expected to have a diverse range of computer skills, the document delivery librarian may indeed face the challenge of training this population in using the document viewing software. As if this were not enough, the potential problem of copyright abuse always exists when copyrighted material is distributed electronically. How does a library cope with the potential problems introduced with Internet document delivery to the patron's desktop? One potential solution to this dilemma is Java-assisted document delivery. The National Library of Medicine's Lister Hill National Center for Biomedical Communications is developing software code-named HotMed and MedJava, which provide a method of delivering library documents through the World Wide Web by using a Java applet. While HotMed is software that delivers multimedia information over the Internet, MedJava is a Java software applet that HotMed delivers with scanned documents. MedJava enables the recipient to view the documents using a Java-enabled web browser. This paper describes the prototype HotMed and MedJava software, and shows how they can significantly reduce or eliminate the problems described here that libraries face in adopting Internet document delivery to the patron's desktop.
C1 Natl Lib Med, Lister Hill Natl Ctr Biomed Commun, Bethesda, MD 20894 USA.
CR *ALD CORP, 1992, TIFF REV 6 0
   Berger M. A., 1996, College & Undergraduate Libraries, V3, P49, DOI 10.1300/J106v03n02_05
   BORENSTEIN N, 1992, MIME MULTIPURPOSE IN
   DELACRUZ I, 1996, INSIDE MAPI
   Postel J, 1985, FILE TRANSFER PROTOC
   Sessions R., 1997, COM DCOM MICROSOFTS
   Walker DW, 1995, CERN REPORT, V95, P165
   WALKER FL, 1996, P IOLS 96, P107
   WALKER FL, 1997, P IOLS 97, P145
NR 9
TC 0
Z9 0
U1 0
U2 0
PU INFORMATION TODAY INC
PI MEDFORD
PA 143 OLD MARLTON PIKE, MEDFORD, NJ 08055 USA
BN 1-57387-077-3
PY 1999
BP 181
EP 190
PG 10
WC Information Science & Library Science
SC Information Science & Library Science
GA BP68L
UT WOS:000085856800041
DA 2018-10-20
ER

PT S
AU Barroso, RC
   Lopes, RT
   de Jesus, EFO
   de Oliveira, LF
AF Barroso, RC
   Lopes, RT
   de Jesus, EFO
   de Oliveira, LF
GP IEEE
   IEEE
   IEEE
TI Synchrotron biomedical applications using X-ray diffraction tomography
SO 1999 IEEE NUCLEAR SCIENCE SYMPOSIUM - CONFERENCE RECORD, VOLS 1-3
SE IEEE NUCLEAR SCIENCE SYMPOSIUM - CONFERENCE RECORD
LA English
DT Proceedings Paper
CT 1999 IEEE Nuclear Science Symposium and Medical Imaging Conference
CY OCT 24-30, 1999
CL SEATTLE, WA
SP IEEE, Nucl & Plasma Sci Soc, Argonne Natl Labs, Bicron Inc, Brookhaven Natl Lab, CTI PET Syst Inc, Ernest Orlando Lawrence Berkeley Natl Lab, Fermi Natl Accelerator Lab, GE Med Syst, INFN Sezione Ferrara Italy, Lawrence Livermore Natl Lab, Los Alamos Natl Lab, NASA, Natl Inst Stand & Technol, Oak Ridge Natl Lab, Picker Int, Sandia Natl Labs, Stanford Linear Accelerator Ctr, Univ Calif Irvine, Univ Washington, Seattle, Univ Ferrara Italy, Univ Utah, US DOE
AB This work reports the feasibility of a non-destructive synchrotron radiation X-ray diffraction imaging technique. This research was performed at the X-ray Diffraction beam line of the National Synchrotron Light Laboratory (LNLS) in Brazil. The coherent scattering properties of different tissue (water, Lucite, nylon and polystyrene) and bone (hydroxyapatite) substitute materials were evaluated. Furthermore, diffraction patterns of some polycrystalline solids (lead, platinum, dysprosium and silicon) were studied due to industrial and environmental human exposure to these metals. The X-ray diffraction measurements were carried out with an 11.101 keV and the diffracted beam was detected by a fast scintillation detector. The obtained diffraction patterns form the basis of a selective tomography technique. Preliminary images are presented. The results encourage us to examine further the application of the two-dimensional selective method to biomedical imaging.
C1 Univ Estado Rio Janeiro, Inst Fis, BR-20550900 Rio De Janeiro, Brazil.
RP Barroso, RC (reprint author), Univ Estado Rio Janeiro, Inst Fis, Rua Sao Francisco Xavier 524 Sala 3001A, BR-20550900 Rio De Janeiro, Brazil.
CR Barroso RC, 1998, NUCL INSTRUM METH A, V418, P458, DOI 10.1016/S0168-9002(98)00759-1
   Barroso RC, 1999, NUCL INSTRUM METH A, V422, P718, DOI 10.1016/S0168-9002(98)01024-9
   Cusatis C, 1998, J SYNCHROTRON RADIAT, V5, P491, DOI 10.1107/S0909049598000685
   EVANS SH, 1991, PHYS MED BIOL, V36, P7, DOI 10.1088/0031-9155/36/1/002
   FOWLER BA, 1993, ENVIRON HEALTH PERSP, V100, P57, DOI 10.2307/3431521
   HARDING G, 1987, J OPT SOC AM A, V4, P933, DOI 10.1364/JOSAA.4.000933
   Shimojo N, 1997, LIFE SCI, V60, P2129, DOI 10.1016/S0024-3205(97)00222-1
   Westmore MS, 1996, MED PHYS, V23, P723, DOI 10.1118/1.597720
NR 8
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1082-3654
BN 0-7803-5697-7
J9 IEEE NUCL SCI CONF R
PY 1999
BP 855
EP 859
PG 3
WC Engineering, Electrical & Electronic; Instruments & Instrumentation;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Engineering; Instruments & Instrumentation; Nuclear Science &
   Technology; Radiology, Nuclear Medicine & Medical Imaging
GA BQ74H
UT WOS:000089372200173
DA 2018-10-20
ER

PT S
AU Augier, A
   Mavilio, A
   Muniz, G
   Garcia, A
   Serra, R
AF Augier, A
   Mavilio, A
   Muniz, G
   Garcia, A
   Serra, R
BE Guzman, AM
TI Researches in optics and laser in the laboratory of coherent optics
SO 3RD IBEROAMERICAN OPTICS MEETING AND 6TH LATIN AMERICAN MEETING ON
   OPTICS, LASERS, AND THEIR APPLICATIONS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 3rd Iberoamerican Optics Meeting / 6th Latin American Meeting on Optics,
   Lasers, and Their Applications
CY SEP 28-OCT 02, 1998
CL CARTAGENA DE INDIAS, COLOMBIA
SP Colombian Network Opt, Univ Nacl Colombia, Univ Valle, Univ Ind Santander, Univ Antioquia, Univ Las Americas, Fundac Multitaller Univ Valle, Colciencias-Inst Colombiano Desarrollo Ciencia & Technol Francisco Jose Caldas, Acad Colombiana Ciencias, Exactas, Fisicas & Naturales, Fundac Promoc Investigac & Technol, Sociedad Colombiana Fisica, Fundac Alejandro Angel Escobar, Centro Latinoamer Fisica, UNESCO, Abdus Salam Int Ctr Tehoret Phys, Int Commiss for Opt, Opt Soc Amer, SPIE, AVIANCA-SAM
DE optics; speckle; velocimetry; particle analysis; laser heat treatment;
   image processing; texture; holography; Photomedicine and Photobiology
ID CW CO2-LASER
AB The Laboratory of Coherent Optics possesses the following lines of investigation: laser material processing, holography, image processing, biomedical applications of laser, speckle techniques and other optical measuring techniques. In the present paper, some of the most important results obtained in the last three years are described.
C1 Higher Polytech Inst Jose A Echeverria, ISPJAE, Fac Elect Engn, Dept Phys,Lab Coherent Opt, Havana 19390, Cuba.
RP Augier, A (reprint author), Higher Polytech Inst Jose A Echeverria, ISPJAE, Fac Elect Engn, Dept Phys,Lab Coherent Opt, Havana 19390, Cuba.
RI Serra Toledo, Rolando/A-7938-2013
OI Serra Toledo, Rolando/0000-0002-4008-1947
CR AUGIER AG, 1995, P 5 LAT AM M OPT LAS, P258
   AUGIER AG, 1997, IN PRESS P TECNOLASE
   AUGIER AG, 1995, P 5 LAT AM M OPT LAS, P254
   CEBALLOS J, 1998, P 1 IB M LAS SYNTH M
   GARCIA A, 1997, IN PRESS P TECNOLASE
   GARCIA A, 1993, REV CUBANA MED DEPOR
   MAVILIO A, 1996, MEMORIAS FORO IBEROA
   Muniz G, 1996, P SOC PHOTO-OPT INS, V2730, P550, DOI 10.1117/12.231042
   Muniz G, 1996, P SOC PHOTO-OPT INS, V2730, P558, DOI 10.1117/12.231016
   NUNEZ A, IN PRESS P TECN 97 2
   NUNEZ A, 1997, IN PRESS P TECHNOLAS
   SERRA R, 1995, MEMORIAS 1 FORO OPTI
   SERRA R, 1997, REV DIALOGO IBEROAME, P43
   TEJERA M, 1995, 5 ENC LAT OPT LAS AP
NR 14
TC 0
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3036-6
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3572
BP 564
EP 567
DI 10.1117/12.358434
PG 4
WC Instruments & Instrumentation; Optics
SC Instruments & Instrumentation; Optics
GA BN39L
UT WOS:000081782700095
DA 2018-10-20
ER

PT S
AU Smith, TI
AF Smith, TI
BE Carr, GL
   Dumas, P
TI Research on picosecond processes in biological, chemical, and materials
   science systems using the infrared beam at the stanford free electron
   laser center
SO ACCELERATOR-BASED SOURCES OF INFRARED AND SPECTROSCOPIC APPLICATIONS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Accelerator-Based Sources of Infrared and Spectroscopic
   Applications
CY JUL 19-20, 1999
CL DENVER, CO
DE free electron laser; infrared; laser; picosecond
ID PHOTON-ECHO EXPERIMENTS; VIBRATIONAL ECHO; MYOGLOBIN-CO; DYNAMICS;
   MICROSCOPY; LIQUIDS; GLASSES
AB The Stanford free electron laser center was established to support a broad range of biomedical and materials science research. This paper will begin with an introduction to the Center's capabilities, and then will present brief descriptions of some of the experiments utilizing the transform and diffraction limited tunable picosecond pulses of infrared light from the free electron lasers at the Center. The experiments share the common characteristic that they exploit unique aspects of the FEL beams and would be much more difficult to perform with any other light source.
C1 Stanford Univ, WW Hansen Expt Phys Labs, Stanford, CA 94305 USA.
RP Smith, TI (reprint author), Stanford Univ, WW Hansen Expt Phys Labs, Stanford, CA 94305 USA.
CR Crosson ER, 1999, REV SCI INSTRUM, V70, P4, DOI 10.1063/1.1149533
   Hill JR, 1996, BIOSPECTROSCOPY, V2, P277, DOI 10.1002/(SICI)1520-6343(1996)2:5<277::AID-BSPY2>3.0.CO;2-2
   KONO J, IN PRESS APPL PHYSIC
   LARECH A, 1996, OPT LETT, V21, P1315
   MITCHELL AP, 1999, SPIE P, V3617, P137
   OKEEFE A, 1988, REV SCI INSTRUM, V59, P2544, DOI 10.1063/1.1139895
   Palanker DV, 1998, OPT COMMUN, V148, P215, DOI 10.1016/S0030-4018(97)00702-5
   PARKER FS, 1971, APPL INFR SPECTR BIO
   Peterson KA, 1999, J PHYS CHEM B, V103, P557, DOI 10.1021/jp982398f
   Rector KD, 1997, J PHYS CHEM B, V101, P1468, DOI 10.1021/jp963226q
   Rella CW, 1996, J PHYS CHEM-US, V100, P15620, DOI 10.1021/jp961129r
   Stuart B., 1997, BIOL APPL INFRARED S
   TOKMAKOFF A, 1995, J PHYS CHEM-US, V99, P13310, DOI 10.1021/j100036a003
   TOKMAKOFF A, 1995, ACCOUNTS CHEM RES, V28, P437, DOI 10.1021/ar00059a001
   TREADO PJ, 1994, APPL SPECTROSC REV, V29, P1, DOI 10.1080/05704929408000896
   ZENHAUSERN F, 1995, SCIENCE, V269, P1083, DOI 10.1126/science.269.5227.1083
NR 16
TC 3
Z9 3
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3261-X
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3775
BP 46
EP 57
DI 10.1117/12.366651
PG 12
WC Instruments & Instrumentation; Microscopy; Optics; Physics,
   Multidisciplinary; Physics, Condensed Matter; Spectroscopy
SC Instruments & Instrumentation; Microscopy; Optics; Physics; Spectroscopy
GA BP12L
UT WOS:000084198100007
DA 2018-10-20
ER

PT J
AU Huang, ZM
   Ramakrishna, S
AF Huang, ZM
   Ramakrishna, S
TI Development of knitted fabric reinforced composite material for
   prosthetic application
SO ADVANCED COMPOSITES LETTERS
LA English
DT Letter
ID FIBER
AB This Letter reports the development of a knitted fabric composite material using Kevlar 49 fibres and ultraviolet (UV) curable resin for a biomedical device, prosthetic socket application. Material fabrication and mechanical characterisation are described. The mechanical properties of this new material are comparable with those of a currently used indirect socket material. Compared with other available direct sockets, this new material is capable of better conforming to patient's stump and has longer gel time for manual operations involved.
C1 Natl Univ Singapore, Dept Mech & Prod Engn, Polymer & Text Composite Lab, Singapore 119260, Singapore.
RP Huang, ZM (reprint author), Natl Univ Singapore, Dept Mech & Prod Engn, Polymer & Text Composite Lab, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
CR CHOU S, 1992, J REINF PLAST COMP, V11, P1239, DOI 10.1177/073168449201101102
   GOMMERS B, 1996, COMP SCI TECH, V56, P1391
   HORSTING K, 1993, SAMPE J, V29, P7
   Huang ZM, 1999, J COMPOS MATER, V33, P1758, DOI 10.1177/002199839903301901
   Karger-Kocsis J, 1996, PLAST RUBB COMPOS PR, V25, P109
   LEONG KH, IN PRESS COMPOSITE A
   MAYER J, 1993, INT TECHT S, V3, P1
   Ramakrishna S, 1997, COMPOS SCI TECHNOL, V57, P1, DOI 10.1016/S0266-3538(96)00098-X
   VARIN RR, 1982, P 27 NAT SAMPE S US, P659
NR 9
TC 11
Z9 11
U1 0
U2 2
PU WOODHEAD PUBL LIMITED
PI LETCHWORTH
PA BLACKHORSE RD, LETCHWORTH SG6 1HN, HERTS, ENGLAND
SN 0963-6935
J9 ADV COMPOS LETT
JI Adv. Compos. Lett.
PY 1999
VL 8
IS 6
BP 289
EP 294
PG 6
WC Materials Science, Composites
SC Materials Science
GA 293CX
UT WOS:000085834900003
DA 2018-10-20
ER

PT J
AU Larson, J
AF Larson, J
TI The animal welfare information center - a brief overview
SO ALTEX-ALTERNATIVEN ZU TIEREXPERIMENTEN
LA English
DT Article
DE 3R; animal welfare information center; national agricultural library;
   information services; publications; electronic resources; user
   statistics
AB The Animal Welfare Information Center (AWIC) of USDA's National Agricultural Library was established by a mandate of the U.S. Congress in the 1985 Amendments of the Animal Welfare Act. The Act regulates how warm-blooded animals are treated as they ave in biomedical research, for toxicity testing, as specimens in higher education, or exhibited in circuses, zoos and aquaria. Large volume dog dealers also come under the Act.
   In the 1985 Amendments, the U.S. Congress instructs the Center fa provide information on topics such as: alternatives to painful procedures, anesthetics, analgesics, tranquilizers, improved methodologies, training materials for those who use animals, environmental enrichment for primates, and exercise for dogs. This overview of the AWIC program discusses the historical aspects of the Center, and will illustrate how the U.S. Congressional mandate is currently carried out via the Center's national and international activities, services, publications, and outreach to U.S. regulated community. Some data regarding the use of the Center's products and services is presented.
C1 USDA, Beltsville, MD 20705 USA.
RP Larson, J (reprint author), USDA, Beltsville, MD 20705 USA.
CR Russell WMS, 1992, PRINCIPLES HUMANE EX
NR 1
TC 0
Z9 0
U1 0
U2 1
PU SPEKTRUM AKADEMISCHER VERLAG
PI HEIDELBERG
PA VANGEROWSTR 20, D-69115 HEIDELBERG, GERMANY
SN 0946-7785
J9 ALTEX-ALTERN TIEREXP
JI Altex Altern. Tierexp.
PY 1999
VL 16
IS 3
BP 192
EP 195
PG 4
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA 251VQ
UT WOS:000083467400032
DA 2018-10-20
ER

PT J
AU Langelier, E
   Rancourt, D
   Bouchard, S
   Lord, C
   Stevens, PP
   Germain, L
   Auger, FA
AF Langelier, E
   Rancourt, D
   Bouchard, S
   Lord, C
   Stevens, PP
   Germain, L
   Auger, FA
TI Cyclic traction machine for long-term culture of fibroblast-populated
   collagen gels
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE tissue engineering; collagen gels; fibroblasts; cyclic traction;
   traction machine; collagen fibers orientation
ID SMOOTH-MUSCLE CELLS; ORIENTATION
AB Our research group has been investigating the effect of cyclic deformations on the evolution of fibroblast populated collagen gels (FPCG). Since existing traction machines are not designed for such an application, we had to design a cyclic traction machine adapted to tissue culture inside an incubator over an extended period of time. Biocompatible materials were used for fabrication to allow for easy sterilization and to prevent any adverse reaction from the tissue. The traction machine is based on a computer-controlled stepping motor system for easy adjustment of the deformation amplitude and frequency. The maximum stretching speed achieved is around 1 mm/s. The traction machine can measure FPCG mechanical properties and perform rupture tests to determine its ultimate strength. Several FPCGs have been successfully cultured with the machine for up to four weeks without any adverse reaction. (C) 1999 Biomedical Engineering Society. [S0090-6964(99)00401-4].
C1 Univ Laval, Dept Chirurg, St Foy, PQ G1K 7P4, Canada.
   Hop St Sacrement, Lab Organogenese Expt, Quebec City, PQ G1S 4L8, Canada.
   Univ Laval, Dept Genie Mecan, St Foy, PQ G1K 7P4, Canada.
RP Rancourt, D (reprint author), Univ Laval, Dept Engn Mech, Room 1504,Pavillon Pouliot, St Foy, PQ G1K 7P4, Canada.
OI Lord, Christopher/0000-0002-3226-0515
CR BUCK RC, 1980, EXP CELL RES, V127, P470, DOI 10.1016/0014-4827(80)90456-5
   DARTSCH PC, 1986, ACTA ANAT, V125, P108
   GOULET F, 1996, TXB TISSUE ENG, P629
   GOULET F, 1996, LIGAMENTS LIGAMENTOP, P367
   HUANG D, 1993, ANN BIOMED ENG, V21, P289, DOI 10.1007/BF02368184
   IVES CL, 1986, IN VITRO CELL DEV B, V22, P500
   Kanda K, 1993, ASAIO J, V39, pM686
   KANDA K, 1994, CELL TRANSPLANT, V3, P537, DOI 10.1177/096368979400300611
   KANDA K, 1994, CELL TRANSPLANT, V3, P481, DOI 10.1177/096368979400300605
   Kanda K, 1992, ASAIO J, V38, pM382, DOI 10.1097/00002480-199207000-00060
   LABELLE S, 1988, THESIS ECOLE POLYTEC
   LEUNG DYM, 1977, EXP CELL RES, V109, P285, DOI 10.1016/0014-4827(77)90008-8
   LIGHT ND, 1982, METHOD ENZYMOL, V82, P360
   SHIRINSKY VP, 1989, J CELL BIOL, V109, P331, DOI 10.1083/jcb.109.1.331
   VALLE CAL, 1992, BRIT J DERMATOL, V127, P365, DOI 10.1111/j.1365-2133.1992.tb00455.x
   Yahia L H, 1991, Biomed Mater Eng, V1, P215
NR 16
TC 27
Z9 30
U1 0
U2 0
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
   USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JAN-FEB
PY 1999
VL 27
IS 1
BP 67
EP 72
DI 10.1114/1.166
PG 6
WC Engineering, Biomedical
SC Engineering
GA 153VJ
UT WOS:000077853400008
PM 9916762
DA 2018-10-20
ER

PT J
AU Suslick, KS
   Price, GJ
AF Suslick, KS
   Price, GJ
TI Applications of ultrasound to materials chemistry
SO ANNUAL REVIEW OF MATERIALS SCIENCE
LA English
DT Review
DE sonochemistry; cavitation; polymer chemistry; nanostructure;
   heterogeneous catalysis; biomaterials
ID HIGH-INTENSITY ULTRASOUND; NANOSTRUCTURED MOLYBDENUM CARBIDE;
   SONOCHEMICAL SYNTHESIS; AMORPHOUS IRON; CATALYTIC PROPERTIES;
   METHYL-METHACRYLATE; HIGH POLYMERS; SURFACE-AREA; POLYMERIZATION;
   NANOPARTICLES
AB The chemical effects of ultrasound derive primarily from acoustic cavitation. Bubble collapse in liquids results in an enormous concentration of energy from the conversion of the kinetic energy of the liquid motion into heating of the contents of the bubble. The high local temperatures and pressures, combined with extraordinarily rapid cooling, provide a unique means for driving chemical reactions under extreme conditions. A diverse set of applications of ultrasound to enhance chemical reactivity has been explored with important uses in synthetic materials chemistry. For example, the sonochemical decomposition of volatile organometallic precursors in low-volatility solvents produces nanostructured materials in various forms with high catalytic activities. Nanostructured metals, alloys, oxides, carbides and sulfides, nanometer colloids, and nanostructured supported catalysts can all be prepared by this general route. Another important application of sonochemistry in materials chemistry has been the preparation of biomaterials, most notably protein microspheres. Such microspheres have a wide range of biomedical applications, including their use in echo contrast agents for sonography, magnetic resonance imaging, contrast enhancement, and oxygen or drug delivery. Other applications include the modification of polymers and polymer surfaces.
C1 Univ Illinois, Dept Chem, Urbana, IL 61801 USA.
   Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England.
RP Suslick, KS (reprint author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.
EM ksuslick@uiuc.edu; chsgjp@bath.ac.uk
RI Suslick, Kenneth/C-3281-2011; Price, Gareth/B-5293-2011
OI Suslick, Kenneth/0000-0001-5422-0701; Price, Gareth/0000-0003-4983-5722
CR BASEDOW AM, 1977, ADV POLYM SCI, V22, P83
   BELLISSENT R, 1993, PHYS REV B, V48, P15797, DOI 10.1103/PhysRevB.48.15797
   BELLISSENT R, 1995, PHYS SCRIPTA, VT57, P79, DOI 10.1088/0031-8949/1995/T57/012
   Bellissent R, 1996, J NON-CRYST SOLIDS, V207, P656
   Berkovsky B. M., 1993, MAGNETIC FLUIDS ENG
   BLANCO E, 1995, MATER LETT, V22, P265, DOI 10.1016/0167-577X(94)00253-3
   BOUDJOUK P, 1981, TETRAHEDRON LETT, V22, P3813, DOI 10.1016/S0040-4039(01)91315-2
   Cao X, 1997, J MATER RES, V12, P402, DOI 10.1557/JMR.1997.0058
   CARLI R, 1993, P EUR SON SOC 3 COIM
   CHATAKONDU K, 1987, J CHEM SOC CHEM COMM, P900, DOI 10.1039/c39870000900
   CHAUMONT D, 1992, J NON-CRYST SOLIDS, V147, P41, DOI 10.1016/S0022-3093(05)80590-3
   COOPER G, 1994, J COLLOID INTERF SCI, V184, P52
   CRUM LA, 1999, P NATO ADV STUDY I C, V524
   DELAROSAFOX N, 1990, J NON-CRYST SOLIDS, V121, P211, DOI 10.1016/0022-3093(90)90134-8
   DESAI NP, 1994, Patent No. 5362478
   DESAI NP, 1995, Patent No. 543686
   DESAI NP, 1996, Patent No. 5560933
   Dhas NA, 1998, CHEM MATER, V10, P1446, DOI 10.1021/cm9708269
   DOKTYCZ SJ, 1990, SCIENCE, V247, P1067, DOI 10.1126/science.2309118
   Eckburg JJ, 1996, J BIOMECH ENG-T ASME, V118, P193, DOI 10.1115/1.2795959
   ELPINER IE, 1964, ULTRASOUND PHYSICAL
   ENCINA MV, 1980, J POLYM SCI POL LETT, V18, P757, DOI 10.1002/pol.1980.130181201
   Esquivias L., 1986, Current Topics on Non-Crystalline Solids. Proceedings of the First Workshop on Non-Crystalline Solids, P409
   ESQUIVIAS L, 1988, ULTRASTRUCTURE PROCE, P255
   EXSTED BJ, 1994, POLYMER, V35, P5560
   FANG Y, 1992, J MATER RES, V7, P2294, DOI 10.1557/JMR.1992.2294
   FLINT EB, 1991, SCIENCE, V253, P1397, DOI 10.1126/science.253.5026.1397
   Flosdorf EW, 1933, J AM CHEM SOC, V55, P3051, DOI 10.1021/ja01334a509
   FREIFELDER D, 1962, BIOPHYS J, V2, P235, DOI 10.1016/S0006-3495(62)86852-0
   GASGNIER M, 1995, J SOLID STATE CHEM, V115, P532, DOI 10.1006/jssc.1995.1170
   GATES BC, 1992, CATALYTIC CHEM, P387
   Grieser F, 1996, ULTRASONICS, V34, P547, DOI 10.1016/0041-624X(96)00036-4
   GRINSTAFF MW, 1992, ULTRASONICS, V30, P168, DOI 10.1016/0041-624X(92)90068-W
   GRINSTAFF MW, 1993, PHYS REV B, V48, P269, DOI 10.1103/PhysRevB.48.269
   GRINSTAFF MW, 1991, P NATL ACAD SCI USA, V88, P7708, DOI 10.1073/pnas.88.17.7708
   GRINSTAFF MW, 1997, Patent No. 5635207
   GRINSTAFF MW, 1996, Patent No. 5512268
   GRINSTAFF MW, 1996, Patent No. 5508021
   GRINSTAFF MW, 1997, Patent No. 5639473
   GRINSTAFF MW, 1996, Patent No. 5505932
   GRINSTAFF MW, 1997, Patent No. 5650156
   Grinstaff MW, 1997, Methods for the preparation of pharmaceutically active agents for in vivo delivery, Patent No. [US5665382, 5665382]
   Grinstaff MW, 1996, Composition useful for in vivo delivery of biologics and methods employing same, Patent No. [5498421, US5498421]
   Grinstaff MW, 1997, US Patent, Patent No. [5,665,383, 5665383]
   Gyorgyi AS, 1933, NATURE, V131, P278, DOI 10.1038/131278a0
   HENGLEIN A, 1954, MAKROMOL CHEM, V14, P15
   Hyeon TH, 1996, J AM CHEM SOC, V118, P5492, DOI 10.1021/ja9538187
   Isayev AI, 1996, J APPL POLYM SCI, V59, P803, DOI 10.1002/(SICI)1097-4628(19960131)59:5<803::AID-APP7>3.0.CO;2-#
   Kataby G, 1997, LANGMUIR, V13, P6151, DOI 10.1021/la960929q
   Kataby G, 1998, LANGMUIR, V14, P1512, DOI 10.1021/la970978i
   KELLER MW, 1988, ECHOCARDIOGRAPHY COR
   KIM HK, 1988, J AM CHEM SOC, V110, P3321, DOI 10.1021/ja00218a064
   KLABUNDE KJ, 1993, ACS SYM SER, V517, P88
   KODA S, 1994, POLYMER, V35, P30, DOI 10.1016/0032-3861(94)90045-0
   Koltypin Y, 1997, J MATER CHEM, V7, P2453, DOI 10.1039/a704008c
   KRUUS P, 1985, J PHYS CHEM-US, V89, P3379, DOI 10.1021/j100261a044
   KRUUS P, 1991, ADV SONOCHEMISTRY, V2, P1
   LEDOUX MJ, 1992, J CATAL, V134, P383, DOI 10.1016/0021-9517(92)90329-G
   LEE JS, 1990, J CATAL, V125, P157, DOI 10.1016/0021-9517(90)90086-Y
   Leighton T., 1994, ACOUSTIC BUBBLE
   Litran R, 1997, J SOL-GEL SCI TECHN, V8, P985, DOI 10.1023/A:1018313819720
   LIU KJ, 1994, BIOPHYS J, V67, P896, DOI 10.1016/S0006-3495(94)80551-X
   LONG GB, 1967, Patent No. 3346472
   Long GJ, 1998, PHYS REV B, V57, P10716, DOI 10.1103/PhysRevB.57.10716
   LORIMER JP, 1991, J CHEM SOC CHEM COMM, P1217, DOI 10.1039/c39910001217
   Luche J.L, 1998, SYNTHETIC ORGANIC SO
   MALTSEV AN, 1976, ZH FIZ KHIM+, V50, P1641
   Mason TJ, 1996, CHEM ENG RES DES, V74, P511
   MASON TJ, 1988, CONOSCHEMISTRY THEOR
   MATYJASZEWSKI K, 1995, MACROMOLECULES, V28, P59, DOI 10.1021/ma00105a007
   McNamara W. B., 1999, P NATO ADV STUDY I C, V524
   Mdleleni MM, 1998, J AM CHEM SOC, V120, P6189, DOI 10.1021/ja9800333
   MILLER RD, 1991, J POLYM SCI POL CHEM, V29, P813, DOI 10.1002/pola.1991.080290604
   MILLER RD, 1989, CHEM REV, V89, P1359, DOI 10.1021/cr00096a006
   MIYATA T, 1975, J CHEM ENG JAPAN, V8, P469
   Moser W. R., 1996, ADV CATALYSTS NANOST
   Nagata Y, 1996, RADIAT RES, V146, P333, DOI 10.2307/3579465
   Nguyen TQ, 1997, POLYMER, V38, P3783, DOI 10.1016/S0032-3861(96)00950-0
   ODELL JA, 1990, MACROMOLECULES, V23, P3092, DOI 10.1021/ma00214a011
   OSHEA JM, 1973, AUST J BIOL SCI, V26, P583, DOI 10.1071/BI9730583
   OSTROSKI AS, 1950, J APPL PHYS, V21, P478, DOI 10.1063/1.1699689
   PECORARO TA, 1981, J CATAL, V67, P430, DOI 10.1016/0021-9517(81)90303-1
   Preece CM, 1981, ADV MECH PHYS SURF, V1, P199
   Price GJ, 1996, MACROMOLECULES, V29, P5664, DOI 10.1021/ma951812w
   PRICE GJ, 1992, MACROMOLECULES, V25, P6447, DOI 10.1021/ma00050a010
   PRICE GJ, 1990, BRIT POLYM J, V23, P63, DOI 10.1002/pi.4980230111
   Price GJ, 1997, EUR POLYM J, V33, P599, DOI 10.1016/S0014-3057(96)00239-X
   PRICE GJ, 1993, EUR POLYM J, V29, P419, DOI 10.1016/0014-3057(93)90114-U
   PRICE GJ, 1992, J CHEM SOC CHEM COMM, P1209, DOI 10.1039/c39920001209
   PRICE GJ, 1995, SILICON CONTAINING P, P147
   PRICE GJ, 1996, CHEM EXTREME NONCLAS
   PRICE GJ, 1990, ADV SONOCHEMISTRY, V1, P231
   RAGAINI V, 1990, Patent No. 20478
   Ramesh S, 1997, CHEM MATER, V9, P2996, DOI 10.1021/cm9703536
   RANHOTRA GS, 1987, J CATAL, V108, P40, DOI 10.1016/0021-9517(87)90153-9
   RIESZ P, 1985, ENVIRON HEALTH PERSP, V64, P233, DOI 10.2307/3430013
   SALENSA TK, 1971, ULTRASONICS, V13, P21
   SATO T, 1977, J COATING TECHNOL, V49, P45
   SCHULTZ DN, 1994, POLYM PREPR, V35, P514
   SENAPATI N, 1985, Patent No. 45489771
   Shafi KVPM, 1998, THIN SOLID FILMS, V318, P38, DOI 10.1016/S0040-6090(97)01135-8
   Shafi KVPM, 1997, J PHYS CHEM B, V101, P6409, DOI 10.1021/jp970893q
   Shafi KVPM, 1998, ADV MATER, V10, P590, DOI 10.1002/(SICI)1521-4095(199805)10:8<590::AID-ADMA590>3.0.CO;2-L
   Shafi KVPM, 1998, J MATER CHEM, V8, P769, DOI 10.1039/a706871i
   Shafi KVPM, 1997, J APPL PHYS, V81, P6901, DOI 10.1063/1.365250
   Sostaric JZ, 1997, J CHEM SOC FARADAY T, V93, P1791, DOI 10.1039/a608567i
   Suslick K.S., 1990, ADV SONOCHEMISTRY, V1, P197
   Suslick K. S., 1998, KIRKOTHMER ENCY CHEM, V26, P517
   Suslick K. S., 1989, CHEM MATER, V1, P6
   Suslick K.S, 1997, HDB HETEROGENEOUS CA, V3, P1350
   SUSLICK KS, 1990, J AM CHEM SOC, V112, P7807, DOI 10.1021/ja00177a058
   Suslick KS, 1996, CHEM MATER, V8, P2172, DOI 10.1021/cm960056l
   Suslick KS, 1996, MATER SCI FORUM, V225, P903, DOI 10.4028/www.scientific.net/MSF.225-227.903
   Suslick KS, 1996, J AM CHEM SOC, V118, P11960, DOI 10.1021/ja961807n
   SUSLICK KS, 1994, MATER RES SOC SYMP P, V351, P443
   SUSLICK KS, 1987, J AM CHEM SOC, V109, P3459, DOI 10.1021/ja00245a047
   SUSLICK KS, 1989, J AM CHEM SOC, V111, P2342, DOI 10.1021/ja00188a081
   SUSLICK KS, 1984, J AM CHEM SOC, V106, P6856, DOI 10.1021/ja00334a073
   SUSLICK KS, 1994, ULTRASON SONOCHEM, V1, pS65, DOI 10.1016/1350-4177(94)90030-2
   SUSLICK KS, 1986, J AM CHEM SOC, V108, P5641, DOI 10.1021/ja00278a055
   SUSLICK KS, 1989, SOLID STATE IONICS, V32-3, P444, DOI 10.1016/0167-2738(89)90254-3
   SUSLICK KS, 1991, NATURE, V353, P414, DOI 10.1038/353414a0
   Suslick KS, 1995, MAT SCI ENG A-STRUCT, V204, P186, DOI 10.1016/0921-5093(95)09958-1
   SUSLICK KS, 1987, ULTRASONICS, V25, P56, DOI 10.1016/0041-624X(87)90013-8
   SUSLICK KS, 1994, MATER RES SOC SYMP P, V351, P201
   SUSLICK KS, 1995, MRS BULL, V20, P29, DOI 10.1557/S088376940004464X
   Suslick KS, 1997, ENCY ACOUSTICS, V1, P271
   SUSLICK KS, 1999, IN PRESS PHILOS T A
   SUSLICK KS, 1993, ENCY MAT SCI ENG, P2093
   SUSLICK KS, 1988, ULTRASOUND ITS CHEM
   SUSLICK KS, 1996, ADV CATALYSTS NANOST, P197
   SUSLICK KS, 1994, ENCY INORGANIC CHEM, V7, P3890
   TABATA M, 1980, CHEM PHYS LETT, V73, P178, DOI 10.1016/0009-2614(80)85230-4
   URBAN MW, 1988, MACROMOLECULES, V21, P372, DOI 10.1021/ma00180a014
   van Eldik R., 1997, CHEM EXTREME NONCLAS
   VANDERHOFF BM, 1974, J MACROMOL SCI CHEM, VA  8, P429, DOI 10.1080/00222337408065839
   VANDERHOFF BME, 1977, J MACROMOL SCI CHEM, VA11, P1739, DOI 10.1080/00222337708063088
   VOLPE L, 1985, J SOLID STATE CHEM, V59, P332, DOI 10.1016/0022-4596(85)90301-9
   WATANABE O, 1985, PROG POLYM PHYS JAPA, V28, P285
   Webb AG, 1996, JMRI-J MAGN RESON IM, V6, P675, DOI 10.1002/jmri.1880060417
   WEIDMAN TW, 1990, ULTRASONICS, V28, P310, DOI 10.1016/0041-624X(90)90037-O
   WELLER H, 1993, ADV MATER, V5, P88, DOI 10.1002/adma.19930050204
   WONG M, 1995, MATER RES SOC SYMP P, V372, P89
NR 143
TC 1085
Z9 1114
U1 30
U2 443
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 0084-6600
J9 ANNU REV MATER SCI
JI Annu. Rev. Mater. Sci.
PY 1999
VL 29
BP 295
EP 326
DI 10.1146/annurev.matsci.29.1.295
PG 32
WC Materials Science, Multidisciplinary
SC Materials Science
GA 235GR
UT WOS:000082534400010
DA 2018-10-20
ER

PT J
AU D'Alessio, L
   Teghil, R
   Zaccagnino, M
   Zaccardo, I
   Ferro, D
   Marotta, V
AF D'Alessio, L
   Teghil, R
   Zaccagnino, M
   Zaccardo, I
   Ferro, D
   Marotta, V
TI Pulsed laser ablation and deposition of bioactive glass as coating
   material for biomedical applications
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT Symposium on Surface Processing - Laser, Lamp, Plasma, at the Annual
   Spring Meeting of the European-Materials-Society (E-MRS 96)
CY JUN 16-19, 1996-1998
CL STRASBOURG, FRANCE
SP European Mat Soc
DE laser ablation; coatings; bioglass; biomaterials
ID HYDROXYAPATITE
AB A study of the laser ablation and deposition, on Ti-Al substrates, of a biologically active glass (Bioglass(R)) suitable for bone implants is reported. The analysis of the gaseous phase by emission spectroscopy and the characterisation of the films from a compositional and morphological point of view have been carried out. The mean chemical composition of the deposits obtained from Bioglass ablation is very close to the target composition and the morphology indicates that different mechanisms of material ejection are present. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Univ Basilicata, Dipartimento Chim, I-85100 Potenza, Italy.
   CNR, Ctr Termodinamica Chim Alte Temp, I-00185 Rome, Italy.
   CNR, Ist Mat Speciali, Tito Scalo, PZ, Italy.
RP Teghil, R (reprint author), Univ Basilicata, Dipartimento Chim, Via N Sauro 85, I-85100 Potenza, Italy.
EM teghil@unibas.it
OI TEGHIL, ROBERTO/0000-0002-8528-8669
CR COOK SD, 1986, J DENT RES, V65, P222
   COTELL CM, 1993, APPL SURF SCI, V69, P140, DOI 10.1016/0169-4332(93)90495-W
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   FOTI G, 1992, LASER DEPOSITION ADV
   Hatton P. V, 1998, EUROP MICR ANAL  JAN, P39
   KOKUBO T, 1993, 3 EUROCERAMICS, V3, P1
   RUCKENSTEIN E, 1983, J COLLOID INTERF SCI, V96, P245, DOI 10.1016/0021-9797(83)90026-7
   Santagata A, 1997, APPL SURF SCI, V109, P376, DOI 10.1016/S0169-4332(96)00753-2
   Santos JD, 1996, J MATER SCI-MATER M, V7, P187, DOI 10.1007/BF00121259
   TEGHIL R, 1995, APPL SURF SCI, V90, P505, DOI 10.1016/0169-4332(95)00179-4
   Teghil R, 1997, APPL SURF SCI, V119, P34, DOI 10.1016/S0169-4332(97)00170-0
   WILSON J, 1992, J APPL BIOMATER, V3, P123, DOI 10.1002/jab.770030208
NR 12
TC 39
Z9 39
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JAN
PY 1999
VL 138
BP 527
EP 532
DI 10.1016/S0169-4332(98)00610-2
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 166KX
UT WOS:000078576400101
DA 2018-10-20
ER

PT J
AU Oktar, FN
   Kesenci, K
   Piskin, E
AF Oktar, FN
   Kesenci, K
   Piskin, E
TI Characterization of processed tooth hydroxyapatite for potential
   biomedical implant applications
SO ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY
LA English
DT Article
DE hydroxyapatite; enamel; dentine
ID CHEMICAL-COMPOSITION; BIOCERAMICS
AB In this study hydroxyapatite (HA) (100-150 mu m) derived from freshly-extracted human teeth in laboratory conditions was investigated. Scanning electron microscope (SEM), energy dispersive x-ray spectroscopy (EDXS), wet chemical, ion chromatographic peak method (ICP), atomic absorption, x-ray diffraction and infra-red (IR) were performed separately for HA obtained from dentine and enamel. This naturally derived HA did not differ from synthetic ones. Its production was simple when compared with other methods. Processed tooth HA could safely be used in animal subjects prior to human studies as a graft material after biocompatibility studies fully conducted.
C1 Bosphorus Univ, Inst Biomed Engn, Istanbul, Turkey.
   Hacettepe Univ, Dept Chem Engn, Bioengn Div, TR-06532 Ankara, Turkey.
RP Oktar, FN (reprint author), Bosphorus Univ, Inst Biomed Engn, Istanbul, Turkey.
CR ABDELFATTAH WI, 1994, BIOMATERIALS, V15, P609, DOI 10.1016/0142-9612(94)90211-9
   Anselme K, 1997, J BIOMED MATER RES, V34, P247, DOI 10.1002/(SICI)1097-4636(199702)34:2<247::AID-JBM14>3.0.CO;2-F
   AOKI H, 1991, SCI MED APPL HYDROXY
   *ASTM COMM, 1988, F118588 ASTM, P514
   AUGAT P, 1995, J APPL BIOMATER, V6, P99, DOI 10.1002/jab.770060203
   BERNT CC, 1992, P INT THERM SPRAYING
   Best S, 1997, J MATER SCI-MATER M, V8, P97, DOI 10.1023/A:1018558816871
   BORETOS JW, 1985, J CERAM B, V64, P1098
   FRAYSSINET P, 1993, BIOMATERIALS, V14, P423, DOI 10.1016/0142-9612(93)90144-Q
   HENCH LL, 1993, AM CERAM SOC BULL, V72, P93
   ISHAWA K, 1993, J MAT SCI MAT MED, V4, P165
   ITOH H, 1990, J DEN MAT, V13, P25
   JARCO M, 1987, INT J ORAL MAXILLOF, V16, P642
   *JOINT COMM POWD D, 1975, 25167 JOINT COMM POW
   JOSHI SV, 1993, J MATER SCI-MATER M, V4, P251, DOI 10.1007/BF00122276
   KELLER L, 1995, J BIOMED MATER RES, V29, P14
   LUGSCHEIDER E, 1992, P INT THER SPRAY CON
   Oonishi H, 1997, J BONE JOINT SURG BR, V79B, P87, DOI 10.1302/0301-620X.79B1.1290
   RECKORT HP, 1988, ZAHN MITT, V78, P843
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   RUNNELLS RR, 1993, J AM DENT ASSOC, V124, P65, DOI 10.14219/jada.archive.1993.0017
   Spitzer W J, 1991, Dtsch Zahnarztl Z, V46, P436
   Tas AC, 1997, J MATER SCI-MATER M, V8, P91
   VANDIJK K, 1995, J BIOMED MATER RES, V29, P369
   WACHTEL HC, 1990, DTSCH ZAHNAERZL Z, V8, P458
   Yubao L, 1993, Biomaterials, V14, P969
   Zhang S, 1997, J MATER SCI-MATER M, V8, P25, DOI 10.1023/A:1018586128257
   1988, ZAHN WOCHE, V26, P11
   1988, ZAHN MITT, V78, P862
   1988, STELLUNGSNAHME DTSCH, V78, P857
   1996, FDI WORLD, V5, P11
NR 31
TC 59
Z9 59
U1 0
U2 5
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 1073-1199
J9 ARTIF CELL BLOOD SUB
JI Artif. Cells Blood Substit. Immobil. Biotechnol.
PY 1999
VL 27
IS 4
BP 367
EP 379
DI 10.3109/10731199909117706
PG 13
WC Biotechnology & Applied Microbiology; Engineering, Biomedical; Materials
   Science, Biomaterials
SC Biotechnology & Applied Microbiology; Engineering; Materials Science
GA 217AT
UT WOS:000081477700004
PM 10427420
DA 2018-10-20
ER

PT J
AU Kokubo, T
AF Kokubo, T
TI Novel biomedical materials based on glasses
SO BIOCERAMICS
SE MATERIALS SCIENCE FORUM
LA English
DT Article
DE bioactive glasses; bioactive glass-ceramics; bone-bonding mechanism;
   bioactive metals; bioactive polymers; bioactive cements; hyperthermia
   treatment; radiotherapy
ID BIOACTIVE BONE-CEMENT; SIMULATED BODY-FLUID; BIOMIMETIC PROCESS; APATITE
   FORMATION; ORGANIC POLYMERS; SILICA-GEL; SUBSTRATE; CERAMICS; LAYER;
   KINDS
AB Some bioactive glasses and glass-ceramics have occupied important positions in bone-repairing materials. Fundamental studies on their bone-bonding mechanism indicate that Si-OH and Ti-OH group on their surfaces induce the nucleation of bonelike apatite which is resposible for bonding to living bone. These findings provide us techniques for forming the biologically active bonelike apatite even on metals and organic polymers. A bioactive composite cement also can be derived from bioactive glass-ceramics. Ferrimagnetic crystals-containing glass-ceramics are useful as thermoseeds for hyperthermia treatment of cancers. Chemically durable glasses containing Y or P at high level can play an important role in radiotherapy of cancers.
C1 Kyoto Univ, Fac Engn, Div Mat Chem, Sakyo Ku, Kyoto 60601, Japan.
RP Kokubo, T (reprint author), Kyoto Univ, Fac Engn, Div Mat Chem, Sakyo Ku, Kyoto 60601, Japan.
CR ANDERSSON OH, 1988, GLASTECH BER-GLASS, V61, P300
   BERGER G, 1989, P 15 INT C GLASS A, V3, P120
   Bromer H., 1973, German patent, Patent No. [2,326,100, 2326100]
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   CHO SB, 1995, BIOCERAMICS, V8, P493
   CHOW LC, 1991, NIPPON SERAM KYO GAK, V99, P954
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Day DE, 1993, INTRO BIOCERAMICS, P305
   EBISAWA Y, 1991, NIPPON SERAM KYO GAK, V99, P7
   HATA K, 1995, J AM CERAM SOC, V78, P1049, DOI 10.1111/j.1151-2916.1995.tb08435.x
   Hench LL., 1993, INTRO BIOCERAMICS, P239
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Holand W., 1983, Wissenschaftliche Zeitschrift der Friedrich-Schiller-Universitaet Jena, Mathematisch-Naturwissenschaftliche Reihe, V32, P571
   IKENAGA M, 1993, J ORTHOP RES, V11, P849, DOI 10.1002/jor.1100110611
   KAWANABE K, 1993, J APPL BIOMATER, V4, P135, DOI 10.1002/jab.770040204
   KAWASHITA M, 1995, BIOCERAMICS, V8, P501
   KIM HJ, UNPUB
   KIM HM, 1995, J AM CERAM SOC, V78, P2405, DOI 10.1111/j.1151-2916.1995.tb08677.x
   KOKUBO T, 1991, J AM CERAM SOC, V74, P1739, DOI 10.1111/j.1151-2916.1991.tb07176.x
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kokubo T., 1993, BONE BONDING BIOMATE, P31
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P1721
   KOKUBO T, 1987, YOGYO-KYOKAI-SHI, V95, P785
   Lacefield WR, 1993, INTRO BIOCERAMICS, P223
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   LUDERER AA, 1983, RADIAT RES, V94, P190, DOI 10.2307/3575874
   Miyaji F, 1994, BIOCERAMICS, V7, P119
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   Ohtsuki C., 1991, J CERAM SOC JPN, V99, P1
   OHURA K, 1991, J BIOMED MATER RES, V25, P357, DOI 10.1002/jbm.820250307
   Otsuki C, 1992, J NONCRYST SOLIDS, V143, P84
   TANAHASHI M, 1994, J AM CERAM SOC, V77, P2805, DOI 10.1111/j.1151-2916.1994.tb04508.x
   TANAHASHI M, 1995, J BIOMED MATER RES, V29, P349, DOI 10.1002/jbm.820290310
   WILSON J, 1993, INTRO BIOCERAMICS, P63
   YAMAMURO T, 1993, INTRO BIOCERAMICS, P89
NR 38
TC 12
Z9 22
U1 0
U2 3
PU TRANSTEC PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 1999
VL 293
BP 65
EP 81
DI 10.4028/www.scientific.net/MSF.293.65
PG 17
WC Materials Science, Multidisciplinary
SC Materials Science
GA BM15E
UT WOS:000077814000005
DA 2018-10-20
ER

PT J
AU Shackelford, JF
AF Shackelford, JF
TI Bioceramics - Current status and future trends
SO BIOCERAMICS
SE MATERIALS SCIENCE FORUM
LA English
DT Article
DE bioceramics; biomaterials; biomimetics; ceramics; glasses;
   hydroxyapatite
ID BONE DEFECTS; REPAIR
AB A wide range of ceramic materials are currently used in biomedical applications, from chemically pure oxides, such as alumina, to the chemically and microstructurally complex ceramic-matrix composites. Among the most significant applications are the hydroxyapatite coatings on hip prostheses and the use of hydroxyapatite and/or related calcium salts for bone defect and fracture repair.;Increasing applications of ceramic and glass materials can be expected in both orthopaedics and dentistry. The use of these materials in cancer treatment also appears promising. The development of biomimetic processing techniques and protein delivery systems represent the cutting edge in bioceramics, involving the merger of materials science with the biological sciences.
C1 Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA.
RP Shackelford, JF (reprint author), Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA.
CR BUNKER BC, 1994, SCIENCE, V264, P48, DOI 10.1126/science.264.5155.48
   Chapman MW, 1993, OPERATIVE ORTHOPAEDI, V1, P355
   CLARK A, 1991, ENG MAT HDB, V4, P1091
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   DAVIDSON J, OR906 SMITH NEPH RIC
   DAY D, 1995, AM CERAM SOC BULL, V74, P64
   DELANGE GL, 1989, BIOMATERIALS, V10, P121, DOI 10.1016/0142-9612(89)90044-6
   FRAKER AC, 1977, JOM-J MIN MET MAT S, V29, P22, DOI 10.1007/BF03354319
   HENCH LL, 1993, AM CERAM SOC BULL, V72, P93
   HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311
   Hulbert S. F., 1982, Ceramics International, V8, P131, DOI 10.1016/0272-8842(82)90003-7
   Hunt M. S., 1987, MATER DESIGN, V8, P113
   Ikenaga M., 1991, BIOCERAMICS, V4, P255
   Johnson KD, 1996, J ORTHOPAED RES, V14, P351, DOI 10.1002/jor.1100140304
   KAWANABE K, 1992, BIOCERAMICS, V5, P233
   KUMAR P, 1991, J BIOMED MATER RES, V25, P813, DOI 10.1002/jbm.820250703
   MCINTYRE JP, 1991, AM CERAM SOC BULL, V70, P1499
   OHGUSHI H, 1997, IN PRESS P 2 INT C B
   Reddi A. Hari, 1997, Cytokine and Growth Factor Reviews, V8, P11, DOI 10.1016/S1359-6101(96)00049-4
   Shackelford J.F., 1996, INTRO MAT SCI ENG
   SHACKELFORD JF, 1998, BIOCERAMICS
   WHITE JE, 1994, KEY ENG MAT, V94
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 23
TC 35
Z9 37
U1 1
U2 12
PU TRANSTEC PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 1999
VL 293
BP 99
EP 106
DI 10.4028/www.scientific.net/MSF.293.99
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA BM15E
UT WOS:000077814000007
DA 2018-10-20
ER

PT S
AU McKelvey, AL
   Ritchie, RO
AF McKelvey, AL
   Ritchie, RO
BE Neenan, T
   Marcolongo, M
   Valentini, RF
TI Fatigue-crack growth in the superelastic endovascular stent material
   nitinol
SO BIOMEDICAL MATERIALS-DRUG DELIVERY, IMPLANTS AND TISSUE ENGINEERING
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Biomedical Materials-Drug Delivery, Implants and Tissue
   Engineering
CY NOV 30-DEC 01, 1998
CL BOSTON, MA
SP Mat Res Soc
ID PARTIALLY-STABILIZED ZIRCONIA; TRANSFORMATION; PROPAGATION; CERAMICS;
   MARTENSITES; MECHANISMS
AB This paper describes a study of fatigue-crack propagation behavior in the superelastic alloy Nitinol. This work is motivated by biomedical applications, and the current interest to improve the design and performance of medical stents for implantation in the human body. Specifically, the objective of this work is to study the effect of environment on cyclic crack-growth resistance in a similar to 50Ni-50Ti (at. %) alloy, and to provide the necessary data for the safe life predication of Nitinol endovascular stents. The material selected for this study has been heat treated such that it is superelastic at human body temperature. Characterization of fatigue-crack growth rates has been performed at 37 degrees C on disc-shaped compact-tension samples, in environments of air, aerated deionized water, and aerated Hank's solution. Results indicate that, in fact, Nitinol has the lowest fatigue-crack growth resistance of metallic alloys currently used for implant-applications.
C1 Univ Calif Berkeley, Dept Mat Sci & Mineral Engn, Berkeley, CA 94720 USA.
RP McKelvey, AL (reprint author), Univ Calif Berkeley, Dept Mat Sci & Mineral Engn, Berkeley, CA 94720 USA.
CR BRAMFITT JE, 1994, SMST 94, P435
   BUDIANSKY B, 1983, INT J SOLIDS STRUCT, V19, P337, DOI 10.1016/0020-7683(83)90031-8
   Buehler W., 1965, US Patent, Patent No. [3,174,851, 3174851]
   CHUTER TAM, 1995, ENDOLUMINAL VASCULAR
   DAUSKARDT RH, 1990, J AM CERAM SOC, V73, P893, DOI 10.1111/j.1151-2916.1990.tb05132.x
   DAUSKARDT RH, 1989, MRS INT M ADV MAT, V9, P243
   Duerig TW, 1996, METALL, V50, P569
   EVANS AG, 1986, ACTA METALL MATER, V34, P761, DOI 10.1016/0001-6160(86)90052-0
   Garvie R. C., 1980, Ceramurgia International, V6, P19, DOI 10.1016/0390-5519(80)90028-9
   HANNINK RHJ, 1978, J MATER SCI, V13, P2487, DOI 10.1007/BF00808066
   HEUER AH, 1982, J AM CERAM SOC, V65, P642, DOI 10.1111/j.1151-2916.1982.tb09946.x
   HORNBOGEN E, 1978, ACTA METALL MATER, V26, P147, DOI 10.1016/0001-6160(78)90211-0
   JACKSON CM, 1972, 5110 NASASP
   LANGE FF, 1982, J MATER SCI, V17, P225, DOI 10.1007/BF00809057
   MCMEEKING RM, 1982, J AM CERAM SOC, V65, P242, DOI 10.1111/j.1151-2916.1982.tb10426.x
   MEI Z, 1990, METALL TRANS A, V21, P3137, DOI 10.1007/BF02647310
   MELTON KN, 1979, ACTA METALL MATER, V27, P137, DOI 10.1016/0001-6160(79)90065-8
   MIYAZAKI S, 1989, MAT RES SOC P, V9, P263
   OLSON GB, 1976, METALL TRANS A, V7, P1897, DOI 10.1007/BF02659822
   PORTER DL, 1977, J AM CERAM SOC, V60, P183, DOI 10.1111/j.1151-2916.1977.tb15509.x
   RITCHIE RO, 1988, MAT SCI ENG A-STRUCT, V103, P15, DOI 10.1016/0025-5416(88)90547-2
   Ritchie RO, 1996, J HEART VALVE DIS, V5, pS9
   SABURI T, 1979, ACTA METALL MATER, V27, P979, DOI 10.1016/0001-6160(79)90186-X
   SURESH S, 1991, FATIGUE MAT, P356
   SWAIN MV, 1983, J AM CERAM SOC, V66, P358, DOI 10.1111/j.1151-2916.1983.tb10049.x
   Wayman CM, 1990, ENG ASPECTS SHAPE ME, P3
NR 26
TC 2
Z9 2
U1 0
U2 1
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-456-4
J9 MATER RES SOC SYMP P
PY 1999
VL 550
BP 281
EP 286
PG 6
WC Biotechnology & Applied Microbiology; Materials Science,
   Multidisciplinary; Materials Science, Biomaterials; Pharmacology &
   Pharmacy
SC Biotechnology & Applied Microbiology; Materials Science; Pharmacology &
   Pharmacy
GA BN11N
UT WOS:000080751700041
DA 2018-10-20
ER

PT S
AU Lezal, D
   Pedlikova, J
   Karel, M
   Horak, L
   Zavadil, J
AF Lezal, D
   Pedlikova, J
   Karel, M
   Horak, L
   Zavadil, J
BE Baldini, F
   Croitoru, NI
   Frenz, M
   Lundstrom, I
   Miyagi, M
   Pratesi, R
   Wolfbeis, OS
TI Special glasses for passive and active IR fibers for medical and
   biomedical applications
SO BIOMEDICAL SENSORS, FIBERS, AND OPTICAL DELIVERY SYSTEMS, PROCEEDINGS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Sensors, Fibers, and Optical Delivery Systems
CY SEP 08-10, 1998
CL STOCKHOLM, SWEDEN
SP EOS-European Opt Soc, SPIE-Int Soc Opt Engn, ELA-European Laser Assoc, SSL-Scandinavian Soc Laser Therapy, IBOS-Int Biomed Opt Soc, SOS-Swedish Opt Soc, Commiss European Communities
DE sulfides; tellurites; glasses; rare earth; active fibers
AB General chemical compositions of prepared glasses with low OH group concentrations are Ge0.25Ga0.10S0.65, Ge0.25Ga0.05As0.05S0.65, (TeO2)(x) - (PbCl2)(1-x) with x = 0.4 to 0.6 and (TeO2)(x) - (ZnO)(1-x) with x = 0.75 to 0.80. Samples doped with 500 to 12000 ppm rare earth in weight were prepared. Rare earth doped glasses are homogeneous when RE concentration is less than 3000 ppm. Heterogeneous inclusions arise beyond 1000 ppm RE when doping is made with chloride or oxide. Electron microscopy, absorption and fluorescence measurements have been made. YAG:Nd, Ar, He-Ne lasers were used for excitation of photoluminiscence.
   The color and the optical quality of the tellurite glasses depend on crucible materials. Rare earth doping results in visible defects or inhomogeneities when concentration is larger than 1000 ppm. The chemical composition and the optical absorption of doped and undoped samples was examined. Fluorescence intensity of Pr and Dy is smaller in these HMO glasses than in the sulfide glasses, this results from higher phonon energy and higher OH concentration. Further development is required for future applications.
C1 IIC AV, Lab Inorgan Mat, Prague 6, Czech Republic.
RP Lezal, D (reprint author), IIC AV, Lab Inorgan Mat, Pelleova 24, Prague 6, Czech Republic.
RI Zavadil, Jiri/G-1930-2014
OI Zavadil, Jiri/0000-0002-1746-4747
CR BERTHEREAU A, 1994, MATER RES BULL, V29, P933, DOI 10.1016/0025-5408(94)90053-1
   BRUCE GB, 1996, 10 INT S NON GLASS C, P302
   HEWAK DW, 1996, P 10 INT S NON GLASS, P157
   LEZAL D, 1996, P SPIE, V2928
   LEZAL D, 1996, CERAMICS SILIKATY, V40
   MacFarlane DR, 1996, CERAM INT, V22, P535, DOI 10.1016/0272-8842(95)00129-8
   McDougall J, 1996, PHYS CHEM GLASSES, V37, P254
   MORGAN SP, 1996, P 10 INT S NON GLASS
NR 8
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3032-3
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3570
BP 53
EP 61
DI 10.1117/12.336915
PG 9
WC Biotechnology & Applied Microbiology; Engineering, Biomedical;
   Microbiology; Optics
SC Biotechnology & Applied Microbiology; Engineering; Microbiology; Optics
GA BM45P
UT WOS:000078785700007
DA 2018-10-20
ER

PT S
AU Ebringerova, A
   Hromadkova, Z
AF Ebringerova, A
   Hromadkova, Z
BE Harding, SE
TI Xylans of industrial and biomedical importance
SO BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, VOL 16
SE Biotechnology & Genetic Engineering Reviews
LA English
DT Review
ID CELL-WALL MATERIAL; SODIUM PENTOSAN POLYSULFATE; MOLECULAR-WEIGHT
   DISTRIBUTION; RYE-BRAN ARABINOXYLAN; CORN COB HETEROXYLANS; LARGE-SCALE
   ISOLATION; PULP OLEA-EUROPAEA; PINE KRAFT PULP; PHASE-I TRIAL;
   WHEAT-FLOUR
C1 Slovak Acad Sci, Inst Chem, Bratislava 84238, Slovakia.
RP Ebringerova, A (reprint author), Slovak Acad Sci, Inst Chem, Dubravska Cesta 9, Bratislava 84238, Slovakia.
CR ADAMCZYK J, 1992, Patent No. 9221769
   Amash A, 1998, POLYM BULL, V40, P251, DOI 10.1007/s002890050249
   Anderson JM, 1997, CURR THER RES CLIN E, V58, P93, DOI 10.1016/S0011-393X(97)80118-X
   Anees M, 1996, J ENZYM INHIB, V10, P203, DOI 10.3109/14756369609030314
   ANNISON G, 1992, CARBOHYD POLYM, V19, P151, DOI 10.1016/0144-8617(92)90155-J
   Antal M, 1997, PAPIER, V51, P223
   ANTAL M, 1991, PAPIER, V45, P232
   AOE S, 1992, Patent No. 4360835
   AOYAMA M, 1994, HOLZ ROH WERKST, V52, P388, DOI 10.1007/BF02615390
   AOYAMA M, 1995, HOLZFORSCHUNG, V49, P193, DOI 10.1515/hfsg.1995.49.3.193
   ASP NG, 1993, CARBOHYD POLYM, V21, P183, DOI 10.1016/0144-8617(93)90016-W
   Aspinall G. O., 1983, POLYSACCHARIDES, P196
   ASPINALL GO, 1991, CARBOHYD RES, V214, P107, DOI 10.1016/S0008-6215(00)90534-2
   ATALLA RH, 1993, INT J BIOL MACROMOL, V15, P109, DOI 10.1016/0141-8130(93)90007-9
   ATKINS EDT, 1992, PROGR BIOTECHNOL, V7, P39
   Baghurst PA, 1996, FOOD AUST, V48, pS3
   Barroso NP, 1997, BOL SOC CHIL QUIM, V42, P301
   Bataillon M, 1998, IND CROP PROD, V8, P37, DOI 10.1016/S0926-6690(97)10002-4
   BAZUS A, 1993, CARBOHYD RES, V243, P323, DOI 10.1016/0008-6215(93)87036-R
   BAZUS A, 1992, BIOSCI BIOTECH BIOCH, V56, P508, DOI 10.1271/bbb.56.508
   BENTOULMOU N, 1997, REPRODUCTION NUTR DE, V37, P356
   BENTOULMOU N, 1997, REPRODUCTION NUTR DE, V37, P361
   BHADURI SK, 1995, IND CROP PROD, V4, P79, DOI 10.1016/0926-6690(95)00018-8
   Billa E, 1997, IND CROP PROD, V6, P297, DOI 10.1016/S0926-6690(97)00031-9
   Buchert J, 1997, TAPPI J, V80, P165
   BUCHERT J, 1995, TAPPI J, V78, P125
   Chan KL, 1997, J PEDIATR SURG, V32, P3, DOI 10.1016/S0022-3468(97)90079-8
   Chanliaud E, 1996, CARBOHYD POLYM, V31, P41, DOI 10.1016/S0144-8617(96)00032-X
   CHANLIAUD E, 1995, J CEREAL SCI, V21, P195, DOI 10.1016/0733-5210(95)90035-7
   CHEN P, 1995, ANAL BIOCHEM, V226, P186, DOI 10.1006/abio.1995.1209
   Chesson Andrew, 1995, V67, P547
   Cleemput G, 1997, J CEREAL SCI, V26, P55, DOI 10.1006/jcrs.1996.0099
   CLEEMPUT G, 1995, J CEREAL SCI, V22, P73, DOI 10.1016/S0733-5210(05)80009-8
   Coimbra MA, 1995, CARBOHYD POLYM, V27, P277, DOI 10.1016/0144-8617(95)00067-4
   COIMBRA MA, 1994, CARBOHYD RES, V252, P245, DOI 10.1016/0008-6215(94)84136-5
   Dace R, 1997, THROMB RES, V87, P113, DOI 10.1016/S0049-3848(97)00110-2
   Dhami R, 1995, CARBOHYD POLYM, V28, P113, DOI 10.1016/0144-8617(95)00099-2
   DIRINGER H, 1991, Patent No. 464759
   DOCTOR VM, 1991, THROMB RES, V64, P413, DOI 10.1016/0049-3848(91)90342-T
   DUDKIN MS, 1991, GEMICELLJULOZY
   EBRINGEROVA A, 1994, CARBOHYD POLYM, V24, P301, DOI 10.1016/0144-8617(94)90075-2
   Ebringerova A, 1996, J APPL POLYM SCI, V62, P1043
   Ebringerova A, 1998, J APPL POLYM SCI, V67, P1523
   Ebringerova A, 1996, ANGEW MAKROMOL CHEM, V242, P97, DOI 10.1002/apmc.1996.052420106
   EBRINGEROVA A, 1992, CARBOHYD POLYM, V19, P99, DOI 10.1016/0144-8617(92)90119-B
   EBRINGEROVA A, 1994, CARBOHYD RES, V264, P97, DOI 10.1016/0008-6215(94)00183-9
   Ebringerova A, 1997, ULTRASON SONOCHEM, V4, P305, DOI 10.1016/S1350-4177(97)00037-0
   EBRINGEROVA A, 1994, CARBOHYD POLYM, V24, P161, DOI 10.1016/0144-8617(94)90126-0
   EBRINGEROVA A, 1992, FOOD HYDROCOLLOID, V6, P437, DOI 10.1016/S0268-005X(09)80029-5
   Ebringerova A, 1995, INT J BIOL MACROMOL, V17, P327, DOI 10.1016/0141-8130(96)81840-X
   EBRINGEROVA A, 1992, PAPIER, V46, P726
   Ebringerova A, 1996, HOLZ ROH WERKST, V54, P127, DOI 10.1007/s001070050151
   EBRINGEROVA A, 1995, J MICROBIOL BIOTECHN, V10, P640
   EBRINGEROVA A, 1993, 7 EUR CARB S AUG 22, pD3
   EBRINGEROVA A, 1998, CARBOHYDRATE ORGANIC, V4, P118
   Elliot SJ, 1997, J AM SOC NEPHROL, V8, pA2388
   Este JA, 1996, ANTIVIR RES, V29, P297, DOI 10.1016/0166-3542(95)00936-1
   FAN YR, 1987, ACTA PHARMACOL SIN, V8, P166
   FAUROT AL, 1995, FOOD SCI TECHNOL-LEB, V28, P436
   Fengel D., 1984, WOOD CHEM ULTRASTRUC, P167
   FERRAO AV, 1993, BIOCHIM BIOPHYS ACTA, V1180, P225, DOI 10.1016/0925-4439(93)90042-Y
   FRANCIS DJ, 1993, RHEUMATOL INT, V13, P61, DOI 10.1007/BF00307735
   Fujisawa M, 1992, Nihon Hinyokika Gakkai Zasshi, V83, P1647
   FUKUSHI Y, 1988, CARBOHYD RES, V182, P313, DOI 10.1016/0008-6215(88)84014-X
   GarciaConesa MT, 1997, REDOX REP, V3, P239, DOI 10.1080/13510002.1997.11747116
   Ghosh P, 1996, OSTEOARTHR CARTILAGE, V4, P43, DOI 10.1016/S1063-4584(96)80006-9
   GILLESPIE L, 1991, Patent No. 466315
   GIRHAMMAR U, 1995, FOOD HYDROCOLLOID, V9, P133, DOI 10.1016/S0268-005X(09)80275-0
   GLASSER WG, 1996, BIOTECHNOL ADV, V14, P605
   GRABBER JH, 1995, PHYTOCHEMISTRY, V40, P1077, DOI 10.1016/0031-9422(95)00413-2
   GREENSHIELDS RN, 1992, Patent No. 2261671
   Gregory ACE, 1998, BIOTECHNOL GENET ENG, V15, P439, DOI 10.1080/02648725.1998.10647965
   GRUPPEN H, 1993, J CEREAL SCI, V18, P111, DOI 10.1006/jcrs.1993.1040
   GRUPPEN H, 1991, J CEREAL SCI, V13, P275, DOI 10.1016/S0733-5210(09)80006-4
   Han JY, 1996, J AM SOC BREW CHEM, V54, P216
   Harkonen H, 1997, J CEREAL SCI, V26, P95, DOI 10.1006/jcrs.1996.0106
   HASHI M, 1979, AGR BIOL CHEM TOKYO, V43, P961, DOI 10.1080/00021369.1979.10863565
   HAWKINS MJ, 1995, EUROPEAN J CANC A, V31, pS14
   HERATH HMTB, 1990, CARBOHYD RES, V198, P343, DOI 10.1016/0008-6215(90)84304-D
   Hoffmann P, 1997, THROMB RES, V86, P325, DOI 10.1016/S0049-3848(97)00075-3
   HOLMES H C, 1991, Antiviral Chemistry and Chemotherapy, V2, P287
   HROMADKOVA Z, 1995, CHEM PAP-CHEM ZVESTI, V49, P97
   Hromadkova Z, 1999, IND CROP PROD, V9, P101, DOI 10.1016/S0926-6690(98)00020-X
   Hromadkova Z, 1996, J WOOD CHEM TECHNOL, V16, P221, DOI 10.1080/02773819608545805
   HROMADKOVA Z, 1991, PAPIER, V45, P157
   HROMADKOVA Z, 1994, CHEM LISTY, V88, P591
   HROMADKOVA Z, 1993, PAPIER, V47, pA587
   HROMADKOVA Z, 1997, P 8 BRAT S SACCH SMO, P95
   Hwang P, 1997, UROLOGY, V50, P39, DOI 10.1016/S0090-4295(97)00110-6
   Imai T, 1997, MOKUZAI GAKKAISHI, V43, P241
   Ishihara M, 1996, MOKUZAI GAKKAISHI, V42, P1211
   Ishii T, 1997, PLANT SCI, V127, P111, DOI 10.1016/S0168-9452(97)00130-1
   Izydorczyk MS, 1995, CARBOHYD POLYM, V28, P33, DOI 10.1016/0144-8617(95)00077-1
   Jerez JR, 1997, CARBOHYD POLYM, V32, P155, DOI 10.1016/S0144-8617(96)00119-1
   KANARI M, 1989, CHEM PHARM BULL, V37, P3191
   Kardosova A, 1998, CARBOHYD RES, V308, P99, DOI 10.1016/S0008-6215(98)00072-X
   KARDOSOVA A, 1990, CHEM PAP-CHEM ZVESTI, V44, P111
   KAVITHA R, 1992, CEREAL CHEM, V69, P440
   KIESEL J, 1991, THROMB RES, V64, P301, DOI 10.1016/0049-3848(91)90001-D
   KINDEL PK, 1989, CARBOHYD RES, V187, P173, DOI 10.1016/0008-6215(89)80001-1
   KLOCKING HP, 1992, THROMB RES, V67, P41, DOI 10.1016/0049-3848(92)90256-A
   Koch P, 1996, CONTACT DERMATITIS, V34, P156, DOI 10.1111/j.1600-0536.1996.tb02162.x
   KOHN R, 1986, COLLECT CZECH CHEM C, V51, P2243, DOI 10.1135/cccc19862243
   KOLLAR L, 1994, PERFUSION, V7, P18
   KOSIKOVA B, 1991, APITTA, V45, P425
   KRONE V, 1991, Patent No. 4540044
   KWAN JS, 1995, CARBOHYD POLYM, V26, P99, DOI 10.1016/0144-8617(94)00098-E
   LAHAYE M, 1993, FOOD CHEM, V47, P29, DOI 10.1016/0308-8146(93)90298-T
   Lawther JM, 1996, J APPL POLYM SCI, V60, P1827, DOI 10.1002/(SICI)1097-4628(19960613)60:11<1827::AID-APP6>3.0.CO;2-N
   Lee ST, 1997, J MICROBIOL METH, V29, P1, DOI 10.1016/S0167-7012(97)00986-X
   Lempereur I, 1997, J CEREAL SCI, V25, P103, DOI 10.1006/jcrs.1996.0090
   LENZ J, 1984, RHEOL ACTA, V23, P570, DOI 10.1007/BF01329291
   Li JB, 1997, CARBOHYD RES, V302, P213, DOI 10.1016/S0008-6215(97)00125-0
   Lush RM, 1996, ANN ONCOL, V7, P939
   Marshall JL, 1997, CLIN CANCER RES, V3, P2347
   MATULEWICZ MC, 1992, INT J BIOL MACROMOL, V14, P29, DOI 10.1016/S0141-8130(05)80016-9
   MATULEWICZ MC, 1987, PHYTOCHEMISTRY, V26, P1033, DOI 10.1016/S0031-9422(00)82344-4
   MELLON JE, 1995, APPL ENVIRON MICROB, V61, P4409
   Methacanon Pawadee, 1997, Carbohydrate Polymers, V34, P435, DOI 10.1016/S0144-8617(97)87391-2
   Mohri T, 1995, J GEN PHYSIOL, V106, P28
   NDiaye S, 1996, BIORESOURCE TECHNOL, V57, P61, DOI 10.1016/0960-8524(96)00041-7
   NETHERY A, 1992, BIOCHEM PHARMACOL, V44, P1549, DOI 10.1016/0006-2952(92)90471-T
   Neto CP, 1997, IND CROP PROD, V6, P51, DOI 10.1016/S0926-6690(96)00205-1
   Neto CP, 1996, IND CROP PROD, V5, P189, DOI 10.1016/0926-6690(96)89448-9
   Ng A, 1997, CARBOHYD RES, V303, P459, DOI 10.1016/S0008-6215(97)00193-6
   NGUYEN NM, 1993, ANTICANCER RES, V13, P2143
   Nilsson M, 1996, CARBOHYD POLYM, V30, P229, DOI 10.1016/S0144-8617(96)00071-9
   Orme CE, 1997, ACTA PHYSIOL SCAND, V159, P179, DOI 10.1046/j.1365-201X.1997.504239000.x
   Papatheofanous MG, 1998, IND CROP PROD, V7, P249, DOI 10.1016/S0926-6690(97)00055-1
   PARISH CR, 1997, BIOTECHNOLOGY ADV, V15, P525
   PARSONS CL, 1992, Patent No. 5180715
   PIENTA KJ, 1992, PROSTATE, V20, P233, DOI 10.1002/pros.2990200308
   PROKSCH A, 1987, PHYTOCHEMISTRY, V26, P1989, DOI 10.1016/S0031-9422(00)81744-6
   PURINA L, 1991, WOOD CHEM KHIMIJA DR, P37
   RAISS R, 1992, Patent No. 9213541
   RALPH J, 1995, CARBOHYD RES, V275, P167, DOI 10.1016/0008-6215(95)00237-N
   Read RA, 1996, J SMALL ANIM PRACT, V37, P108, DOI 10.1111/j.1748-5827.1996.tb02355.x
   Renard CMGC, 1997, INT J BIOL MACROMOL, V21, P155, DOI 10.1016/S0141-8130(97)00055-X
   Rochet V, 1997, REPROD NUTR DEV, V37, P221, DOI 10.1051/rnd:19970210
   ROGACHEFSKY RA, 1994, ANN NY ACAD SCI, V732, P392, DOI 10.1111/j.1749-6632.1994.tb24763.x
   ROSNER H, 1992, CARBOHYD RES, V223, P329, DOI 10.1016/0008-6215(92)80032-V
   SAULNIER L, 1995, CARBOHYD RES, V272, P241, DOI 10.1016/0008-6215(95)00053-V
   SAULNIER L, 1995, CARBOHYD POLYM, V26, P279, DOI 10.1016/0144-8617(95)00020-8
   SAULNIER L, 1998, CARBOHYDRATES ORGANI, V4, P132
   SCHNABELRAUCH M, 1992, Patent No. 299312
   SCHOLS D, 1992, ANTIVIR CHEM CHEMOTH, V3, P23, DOI 10.1177/095632029200300104
   Schwartsmann G, 1996, TUMORI, V82, P360
   SCHWARZ PB, 1995, J AM SOC BREW CHEM, V53, P157
   Senthil D, 1996, MOL CELL BIOCHEM, V156, P31
   SHUBA K, 1992, BIOCH INT, V27, P1011
   SIMKOVIC I, 1992, CARBOHYD POLYM, V17, P285, DOI 10.1016/0144-8617(92)90171-L
   SIMKOVIC I, 1990, HOLZFORSCHUNG, V44, P113, DOI 10.1515/hfsg.1990.44.2.113
   SROKOVA I, 1997, P 8 BRAT S SACCH SEP, P97
   Stephen A.M., 1983, POLYSACCHARIDES, P98
   Stewart D, 1997, IND CROP PROD, V6, P17, DOI 10.1016/S0926-6690(96)00172-0
   STSCHERBINA D, 1991, ACTA POLYM, V42, P345, DOI 10.1002/actp.1991.010420801
   Sun RC, 1998, IND CROP PROD, V7, P121, DOI 10.1016/S0926-6690(97)00040-X
   SWAIN SM, 1995, INVEST NEW DRUG, V13, P55, DOI 10.1007/BF02614221
   SWAMY NR, 1990, CARBOHYD RES, V197, P327
   TAMAGAKI T, 1997, BIOSCIENCE BIOTECHNO, V61, P1077
   Teleman A, 1996, CARBOHYD RES, V293, P1, DOI 10.1016/0008-6215(96)00170-X
   TELEMAN A, 1995, CARBOHYD RES, V272, P55, DOI 10.1016/0008-6215(95)96873-M
   Thiebaud S, 1998, BIORESOURCE TECHNOL, V63, P139, DOI 10.1016/S0960-8524(97)00078-3
   THORMAR H, 1995, ANTIVIR RES, V27, P49, DOI 10.1016/0166-3542(94)00082-J
   vanHazendonk JM, 1996, CARBOHYD RES, V291, P141
   VERBRUGGEN MA, 1993, J CEREAL SCI, V17, P71, DOI 10.1006/jcrs.1993.1008
   VERBRUGGEN MA, 1995, J CEREAL SCI, V21, P271, DOI 10.1006/jcrs.1995.0030
   VIETOR RJ, 1992, J CEREAL SCI, V15, P213, DOI 10.1016/S0733-5210(09)80120-3
   VIETOR RJ, 1994, CARBOHYD POLYM, V24, P113, DOI 10.1016/0144-8617(94)90020-5
   VINCENDON M, 1993, MAKROMOL CHEM, V194, P321
   Vincendon M, 1998, J APPL POLYM SCI, V67, P455
   Vinkx CJA, 1996, J CEREAL SCI, V24, P1, DOI 10.1006/jcrs.1996.0032
   VISSER J, 1992, XYLAN XYLANASES
   VONBRIESEN H, 1990, RES VIROLOGY, V141, P251, DOI 10.1016/0923-2516(90)90029-I
   WAGENKNECHT W, 1992, Patent No. 298643
   WAGNER H, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1069
   WALLACE G, 1995, PHYTOCHEMISTRY, V39, P1293, DOI 10.1016/0031-9422(95)00048-C
   WALLACE G, 1995, CARBOHYD RES, V272, P41, DOI 10.1016/0008-6215(95)00036-S
   Wende G, 1997, PHYTOCHEMISTRY, V44, P1011, DOI 10.1016/S0031-9422(96)00648-6
   Wende G, 1997, PHYTOCHEMISTRY, V44, P1019, DOI 10.1016/S0031-9422(96)00649-8
   Whistler R L, 1976, Adv Carbohydr Chem Biochem, V32, P235
   WHISTLER RL, 1989, FRONTIERS CARBOHYDRA, V1, P289
   WILLIAMS RJ, 1992, THERMOCHIM ACTA, V212, P105, DOI 10.1016/0040-6031(92)80225-L
   WIMALASIRI KMS, 1995, CARBOHYD POLYM, V26, P19, DOI 10.1016/0144-8617(95)98829-6
   Wong KKY, 1995, ACS SYM SER, V618, P352
   WUN TC, 1992, BLOOD, V79, P430
   YAMADA H, 1985, CARBOHYD RES, V144, P101, DOI 10.1016/0008-6215(85)85011-4
   Yamagaki T, 1996, BIOSCI BIOTECH BIOCH, V60, P1222, DOI 10.1271/bbb.60.1222
   Yamagaki T, 1997, BIOSCI BIOTECH BIOCH, V61, P1281, DOI 10.1271/bbb.61.1281
   YOKOTA S, 1995, PULP PAP-CANADA, V96, P39
   YUI T, 1995, BIOSCI BIOTECH BIOCH, V59, P965, DOI 10.1271/bbb.59.965
NR 191
TC 73
Z9 74
U1 2
U2 24
PU INTERCEPT LTD SCIENTIFIC, TECHNICAL & MEDICAL PUBLISHERS
PI ANDOVER
PA PO BOX 716, ANDOVER SP10 1YG, HANTS, ENGLAND
SN 0264-8725
BN 1-898298-58-0
J9 BIOTECHNOL GENET ENG
JI Biotechnol. Genet. Eng. Rev.
PY 1999
VL 16
BP 325
EP 346
DI 10.1080/02648725.1999.10647982
PG 22
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology; Chemistry, Physical; Genetics &
   Heredity; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry; Genetics & Heredity; Pharmacology & Pharmacy
GA BN42Q
UT WOS:000081897100014
PM 10819084
OA Bronze
DA 2018-10-20
ER

PT J
AU Shen, WC
   Wen, SZ
   Cao, NZ
   Zheng, L
   Zhou, W
   Liu, YJ
   Gu, JL
AF Shen, WC
   Wen, SZ
   Cao, NZ
   Zheng, L
   Zhou, W
   Liu, YJ
   Gu, JL
TI Expanded graphite - A new kind of biomedical material
SO CARBON
LA English
DT Letter
DE exfoliated graphite; porosity; adsorption properties
C1 Tsing Hua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
RP Shen, WC (reprint author), Tsing Hua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
RI Zhou, Wei/C-6504-2008
OI Zhou, Wei/0000-0002-5461-3617
CR Cao N, 1996, CHEM B, V4, P37
   Cao N.Z., 1997, CHEM RES APPL, V9, P54
   Cao N.Z., 1997, CHINA ENV SCI, V17, P188
   Cao NZ, 1996, ACTA PHYS-CHIM SIN, V12, P766, DOI 10.3866/PKU.WHXB19960819
   CAO NJ, 1996, CHINESE J BIOMED ENG, V15, P287
   CAO NZ, 1996, P EUR CARB C ROY SOC, P114
   KABOVICH ZK, 1991, Patent No. 1697752
   KABOVICH ZK, 1994, Patent No. 1694124
   SHEN WC, 1996, P EUR CARB C ROY SOC, P348
NR 9
TC 20
Z9 24
U1 0
U2 22
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0008-6223
J9 CARBON
JI Carbon
PY 1999
VL 37
IS 2
BP 356
EP 358
PG 3
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 169EG
UT WOS:000078734100026
DA 2018-10-20
ER

PT J
AU Chen, YL
   Mao, HB
   Zhang, XF
   Gong, YD
   Zhao, NM
AF Chen, YL
   Mao, HB
   Zhang, XF
   Gong, YD
   Zhao, NM
TI Increase in the transition enthalpy of fibrinogen upon adsorption onto
   hydroxyapatite
SO CHINESE PHYSICS LETTERS
LA English
DT Article
ID SOLID-LIQUID INTERFACES; CALCIUM; CALORIMETRY; PROTEINS
AB The increase of the protein transition enthalpy upon adsorption onto biomedical material surfaces was observed by measuring the differential scanning calorimetry (DSC) traces of bovine fibrinogen adsorbed onto a hydroxyapatite surface. The mechanism causing the transition enthalpy increase upon adsorption was clarified by using DSC measurements of bovine fibrinogen for different ionic strength and sodium dodecyl sulfate concentrations. The results suggest that the increased fibrinogen transition enthalpy may be attributed to the electrostatic interactions between the carboxyl of the D domains and the calcium loci of hydroxyapatite, which may result in a more compact protein structure.
C1 Tsing Hua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.
RP Chen, YL (reprint author), Tsing Hua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.
RI Mao, Haibin/B-7609-2011
CR DONOVAN JW, 1985, BIOCHEMISTRY-US, V24, P3434, DOI 10.1021/bi00335a007
   FENG L, 1994, J BIOMED MATER RES, V28, P735, DOI 10.1002/jbm.820280611
   FENG L, 1995, ACS SYM SER, V602, P68
   Giancola C, 1997, INT J BIOL MACROMOL, V20, P193, DOI 10.1016/S0141-8130(97)01159-8
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   MARGUERIE G, 1977, BIOCHIM BIOPHYS ACTA, V490, P94, DOI 10.1016/0005-2795(77)90109-X
   MIHALYI E, 1985, BIOCHEMISTRY-US, V24, P3443, DOI 10.1021/bi00335a008
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   PRIVALOV PL, 1982, J MOL BIOL, V159, P665, DOI 10.1016/0022-2836(82)90107-3
   RIVERO DP, 1988, J BIOMED MATER RES, V22, P191, DOI 10.1002/jbm.820220304
   STEADMAN BL, 1992, BIOTECHNOL BIOENG, V40, P8, DOI 10.1002/bit.260400103
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   Yan GY, 1995, ACS SYM SER, V602, P256
NR 13
TC 1
Z9 1
U1 0
U2 1
PU ALLERTON PRESS INC
PI NEW YORK
PA 150 FIFTH AVE, NEW YORK, NY 10011 USA
SN 0256-307X
J9 CHINESE PHYS LETT
JI Chin. Phys. Lett.
PY 1999
VL 16
IS 6
BP 431
EP 433
DI 10.1088/0256-307X/16/6/016
PG 3
WC Physics, Multidisciplinary
SC Physics
GA 217DK
UT WOS:000081484400016
DA 2018-10-20
ER

PT S
AU Salinas-Rodriguez, A
AF Salinas-Rodriguez, A
BE Disegi, JA
   Kennedy, RL
   Pilliar, R
TI The role of the FCC-HCP phase transformation during the plastic
   deformation of Co-Cr-Mo-C alloys for biomedical applications
SO COBALT-BASE ALLOYS FOR BIOMEDICAL APPLICATIONS
SE AMERICAN SOCIETY FOR TESTING AND MATERIALS SPECIAL TECHNICAL PUBLICATION
LA English
DT Proceedings Paper
CT Symposium on Cobalt-Base Alloys for Biomedical Applications
CY NOV 03-04, 1998
CL NORFOLK, VA
SP ASTM Comm F 4, Med Surg Mat & Dev
DE plastic deformation; strain hardening; microstructure; cobalt-base
   alloys
ID MECHANISMS
AB The plastic deformation behavior of solution treated Co-27Cr-5Mo cast alloys with C contents up to 0.31 wt% were studied at 298 K by means of uniaxial tension and compression tests. In addition, the effect of initial grain size on the plastic flow behavior of annealed Co-27Cr-5Mo-0.05C wrought alloy was investigated. Optical and scanning electron microscopy and X-ray diffraction techniques were used to characterize the microstructures produced by plastic deformation.
   Carbon contents greater than 0.05 wt% and furnace cooling after solution treatments at 1250 degrees C were found to inhibit the occurrence of strain-induced fcc(metastable)double right arrow hcp phase transformation and lead to high strain hardening rate, high strength and low ductility. A similar behavior was found in annealed, 0.05 wt% C alloy for grain sizes smaller than 10 mu m. In contrast, a fast cooling rate after the solution treatment and grain sizes in the range 100-2000 mu m for this later alloy were found to promote phase transformation during deformation which lead to a rapid decrease of the rate of strain hardening. The yield strength and the strain hardening behavior of both cast-solution treated and wrought-annealed materials were found to depend on the type of loading during the tests.
   The results allowed to conclude that the strain-induced fcc(metastable)double right arrow hcp phase transformation plays an important role during large strain plastic deformation of low carbon Co-27Cr-5Mo implant alloys. However, when the carbon C in these alloys is larger than 0.05 wt%, the ductility and the fracture behavior are controlled by the size, morphology and distribution of secondary phase carbide particles in the microstructure.
C1 CINVESTAV, Unidad Saltillo, Coahuila 25000, Mexico.
RP Salinas-Rodriguez, A (reprint author), CINVESTAV, Unidad Saltillo, POB 663, Coahuila 25000, Mexico.
CR GRAHAM AH, 1970, METALL TRANS, V1, P423, DOI 10.1007/BF02811551
   KILNER T, 1986, J MATER SCI, V21, P1349, DOI 10.1007/BF00553274
   KILNER T, 1982, SCRIPTA METALL MATER, V16, P741, DOI 10.1016/0036-9748(82)90333-7
   OLSON GB, 1975, METALL TRANS, VA  6, P791, DOI 10.1007/BF02672301
   RAJAN K, 1982, J MATER SCI, V17, P769, DOI 10.1007/BF00540374
   RAJAN K, 1982, METALL TRANS A, V13, P1161, DOI 10.1007/BF02645497
   Sage M., 1950, REV MET, V47, P139
   SALDIVAR GA, 1998, THESIS CINVESTAV SAL
   SalinasRodriguez A, 1996, J BIOMED MATER RES, V31, P409, DOI 10.1002/(SICI)1097-4636(199607)31:3<409::AID-JBM16>3.0.CO;2-D
   VANDERSANDE JB, 1976, METALL TRANS A, V7, P389
NR 10
TC 4
Z9 4
U1 0
U2 2
PU AMERICAN SOCIETY TESTING AND MATERIALS
PI W CONSHOHOCKEN
PA 100 BARR HARBOR DRIVE, W CONSHOHOCKEN, PA 19428-2959 USA
SN 1040-1695
BN 0-8031-2608-5
J9 AM SOC TEST MATER
PY 1999
VL 1365
BP 108
EP 121
PG 14
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials
SC Engineering; Materials Science
GA BN93M
UT WOS:000083576900010
DA 2018-10-20
ER

PT S
AU Girkin, JM
   Burns, D
   Dawson, MD
AF Girkin, JM
   Burns, D
   Dawson, MD
BE Reed, MK
   Neev, J
TI Macroscopic multiphoton biomedical imaging using semiconductor saturable
   Bragg reflector modelocked Lasers
SO COMMERCIAL AND BIOMEDICAL APPLICATIONS OF ULTRAFAST LASERS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Commercial and Biomedical Applications of Ultrafast Lasers
CY JAN 28-29, 1999
CL SAN JOSE, CA
SP SPIE
DE diode pumped lasers; passive modelocking; semiconductor saturable
   absorber mirror; multiphoton imaging; detection of dental disease
ID FLUORESCENCE
AB We report on the development of practical and user friendly lasers for multiphoton imaging of biological material. The laser developed for the work is a laser diode pumped Cr:LiSAF source modelocked using a saturable Bragg reflector as the passive modelocking element. From this system we routinely obtain 100fs pulses at a repetition rate 200MHz with an average output power of 20mW. The laser has a single operator control and is particularly suitable for use by non-laser specialists.
   We have used the source developed to image a range of biologically significant samples. The initial work has centred on the imaging of intact human dental tissue. The first two-photon images of dental tissue are reported showing the development of early dental disease from depths up to 500 mu m into the tooth. These results demonstrate the detection of carious lesions before the more conventional techniques currently used by dental practitioners.
   Work on other living intact biological tissue is also reported, in particular plants containing a genetically bred fluorescent marker to enable the examination of complete and intact living plant tissue.
C1 Univ Strathclyde, Inst Photon, Glasgow G4 0NW, Lanark, Scotland.
RP Girkin, JM (reprint author), Univ Strathclyde, Inst Photon, Glasgow G4 0NW, Lanark, Scotland.
OI Girkin, John/0000-0003-2568-3576
CR DEJONG EDJ, 1995, CARIES RES, V29, P2, DOI 10.1159/000262032
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Goppert-Mayer M, 1931, ANN PHYS-BERLIN, V9, P273
   Keller U, 1996, IEEE J SEL TOP QUANT, V2, P435, DOI 10.1109/2944.571743
   ORGAARD B, 1994, AM J ORTHOD DENTOFAC, V106, P238
   SUNDSTROM F, 1985, SWED DENT J, V9, P71
NR 6
TC 2
Z9 2
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3086-2
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3616
BP 92
EP 98
DI 10.1117/12.351825
PG 3
WC Engineering, Biomedical; Optics; Radiology, Nuclear Medicine & Medical
   Imaging
SC Engineering; Optics; Radiology, Nuclear Medicine & Medical Imaging
GA BN29H
UT WOS:000081442300011
DA 2018-10-20
ER

PT B
AU Donahue, CA
   Fairchild, RF
AF Donahue, CA
   Fairchild, RF
BE Hylko, JM
   Salyer, RL
TI Radiological considerations in the transport, use, and acceleration of
   isotopes for radioactive ion beams
SO CREATION AND FUTURE LEGACY OF STOCKPILE STEWARDSHIP: ISOTOPE PRODUCTION,
   APPLICATIONS, AND CONSUMPTION
LA English
DT Proceedings Paper
CT 32nd Annual Midyear Topical Meeting of the Health-Physics-Society
CY JAN 24-27, 1999
CL ALBUQUERQUE, NM
SP Hlth Phys Soc Rio Grande Chapter
AB Berkeley Experiments with Accelerated Radioactive Species (BEARS) is an initiative to develop Radioactive Ion Beams (RIBs) capabilities at the 88-Inch Cyclotron at Ernest Orlando Lawrence Berkeley National Laboratory (Berkeley Lab). RIBs offer new opportunities for research into nuclear structure, condensed matter physics, and nuclear astrophysics. The BEARS system in development involves the production of light-mass, proton-rich species using the 10-MeV proton beam of the Biomedical Positron Emission Tomography (PET) Cyclotron at Berkeley Lab. The radioactive material produced includes 20-minute C-11, IO-minute N-13, and 70-second O-14, which will be continually transported to the 88-Inch Cyclotron from the Biomedical Cyclotron via a gas-jet capillary. The transport line will be installed above ground for most of the 300-meter distance between the two facilities. This paper will provide an overview of the BEARS gas-jet transport technique focusing on the health physics concerns associated with this research. Health physics concerns include the shielding of the 0.511-MeV positron annihilation radiation; the containment of gaseous radioactive material produced; the design, shielding, and posting of the transport line; and the monitoring of the effluent.
C1 Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.
RP Donahue, CA (reprint author), Univ Calif Berkeley, Lawrence Berkeley Lab, 1 Cyclotron Rd, Berkeley, CA 94720 USA.
CR CASTEN RF, 1997, P WORKSH SCI ADV RAD
   POWELL J, 1998, P 15 INT C APPL ACC
   POWELL J, 1998, P 2 INT C EX NUCL AT
   XIE ZQ, 1998, P 8 INT C HEAV ION A
NR 4
TC 0
Z9 0
U1 0
U2 1
PU MEDICAL PHYSICS PUBLISHING
PI MADISON
PA 4513 VERNON BLVD, MADISON, WI 53705 USA
BN 0-944838-88-X
PY 1999
BP 59
EP 63
PG 5
WC Nuclear Science & Technology; Physics, Applied; Radiology, Nuclear
   Medicine & Medical Imaging
SC Nuclear Science & Technology; Physics; Radiology, Nuclear Medicine &
   Medical Imaging
GA BM63F
UT WOS:000079308800010
DA 2018-10-20
ER

PT J
AU De Corte, F
AF De Corte, F
TI Thirty years of NAA developments and applications at the THETIS reactor
   of the Institute for Nuclear Sciences, Gent
SO CZECHOSLOVAK JOURNAL OF PHYSICS
LA English
DT Article; Proceedings Paper
CT 13th Radiochemical Conference
CY APR 19-24, 1998
CL JACHYMOV, CZECH REPUBLIC
ID NEUTRON-ACTIVATION ANALYSIS; DATA COMPILATION; KO-MEASUREMENTS;
   TRACE-ELEMENTS; BRAIN
AB A survey is given of the past and present fundamental developments and practical applications of neutron activation analysis performed at the reactor THETIS of the Institute for Nuclear Sciences, Gent, which has already now for more than 30 years played an internationally appreciated pioneering role in this domain. Whereas the applications were mainly dealing with the analysis of semiconductor and high-purity materials, biomedical matrices, geological materials, environmental samples and artefacts, the developments were directed towards the elaboration of irradiation, separation and counting schemes, the determination of nuclear activation and decay constants, and especially towards the introduction of a modern (so-called k(0)-) standardization method which - especially combined with a dedicated software package such as KAYZERO/SOLCOI(C) issued by DSM Research - proved to make NAA to a manageable and competitive analytical tool, nowadays applied in more than 50 NAA-labs worldwide.
C1 State Univ Ghent, Inst Nucl Sci, Analyt Chem Lab, Fund Sci Res Flanders,INW, B-9000 Ghent, Belgium.
RP De Corte, F (reprint author), State Univ Ghent, Inst Nucl Sci, Analyt Chem Lab, Fund Sci Res Flanders,INW, Proeftuinstr 86, B-9000 Ghent, Belgium.
CR De-corte F., 1987, THESIS U GENT
   DECORTE F, 1993, J RADIOAN NUCL CH AR, V169, P125, DOI 10.1007/BF02046790
   DECORTE F, 1989, J RADIOAN NUCL CH AR, V133, P3, DOI 10.1007/BF02039969
   DECORTE F, 1989, J RADIOAN NUCL CH AR, V133, P43, DOI 10.1007/BF02039970
   DECORTE F, 1991, ANAL CHIM ACTA, V254, P127, DOI 10.1016/0003-2670(91)90019-2
   DECORTE F, 1983, J RADIOANAL CHEM, V79, P255
   DECORTE F, 1971, J RADIOANAL CHEM, V8, P287
   DECORTE F, 1971, J RADIOANAL CHEM, V9, P9
   DECORTE F, 1989, J RADIOAN NUCL CH AR, V133, P131, DOI 10.1007/BF02039971
   DECORTE F, 1992, P INT K0 US WORKSH G
   DECORTE F, 1988, NUCL DATA SCI TECHNO, P583
   DECORTE F, 1994, ACTA PHYS HUNGARICA, V75, P189
   DECORTE F, 1996, IN PRESS ADV FISSION
   DECORTE F, 1997, I J STEFAN, P41
   DECORTE F, 1988, NUCL DATA SCI TECHNO, P57
   *DSM RES, 1996, KAYZERO SOLCOI MAN V
   DUFLOU H, 1987, BIOL TRACE ELEM RES, V13, P1, DOI 10.1007/BF02796617
   GIJBELS R, 1983, 8871 EN EUR
   *I J STEF, 1996, P 2 INT K0 US WORKSH
   MAENHAUT W, 1989, ATMOS ENVIRON, V23, P2551, DOI 10.1016/0004-6981(89)90266-7
   SCHUTYSER P, 1978, ANAL CHIM ACTA, V100, P75, DOI 10.1016/S0003-2670(01)93305-7
   SIMONITS A, 1975, J RADIOANAL CHEM, V24, P31, DOI 10.1007/BF02514380
   STRIJCKMANS K, 1991, ANN REPORTS 1987 198
   VANCRAEYNEST L, 1998, THESIS U GENT
   VanLierde S, 1997, NUCL INSTRUM METH B, V130, P444, DOI 10.1016/S0168-583X(97)00237-1
   VANSCHANDEVIJL R, 1971, J RADIOANAL CHEM, V9, P55
NR 26
TC 0
Z9 0
U1 0
U2 0
PU CZECHOSLOVAK JNL OF PHYSICS
PI PRAGUE
PA FYZIKALNI USTAV AV NA SLOVANCE 2, PRAGUE 180 40, CZECH REPUBLIC
SN 0011-4626
J9 CZECH J PHYS
JI Czech. J. Phys.
PY 1999
VL 49
SU 1
BP 247
EP 254
DI 10.1007/s10582-999-0033-4
PN 1
PG 8
WC Physics, Multidisciplinary
SC Physics
GA 205WJ
UT WOS:000080843300033
DA 2018-10-20
ER

PT S
AU Mickan, S
   Abbott, D
   Munch, J
   Zhang, XC
   van Doorn, T
AF Mickan, S
   Abbott, D
   Munch, J
   Zhang, XC
   van Doorn, T
BE Bergmann, NW
   Reinhold, O
   Tien, NC
TI Analysis of system trade-offs for terahertz imaging
SO ELECTRONICS AND STRUCTURES FOR MEMS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT SPIE Conference on Electronics and Structures for MEMS
CY OCT 27-29, 1999
CL QUEENSLAND, AUSTRALIA
SP SPIE, IREE Soc, Queensland Govt State Dev, IEEE, Electron Devices Soc, Electrochem Soc, Griffith Univ Microelectr Engn Soc, Australia
DE terahertz; T-ray imaging; optoelectronics; wavelets
ID TIME-DOMAIN SPECTROSCOPY; QUANTUM-WELLS; OPTICAL RECTIFICATION;
   RADIATION; PULSES; GENERATION; ANTENNAS; EXCITONS; BAND; EXCITATION
AB The rapidly developing field of terahertz (or T-ray) imaging promises to provide a non-invasive method of identifying the composition of various objects. Biomedical diagnostics, semiconductor device diagnostics, trace gas analysis and moisture analysis for agriculture are among the growing number of important T-ray applications. We present results using an electro-optical sampling method and and discuss how this can be simplified by using a micro antenna array realised by MEMs technology. The challenges and advantages of both approaches are compared. In our set-up, sub-picosecond pulses of terahertz radiation are produced via optical rectification, using an LT gallium arsenide wafer. A coherent method is used, whereby both amplitude and phase of the THz beam are detected, providing an exact signature of the material under observation.(1) From the analysis of the amplitude and phase it is possible to tomographically reconstruct a terahertz-domain image of an object.(2) Current terahertz systems, however, remain too slow for many real-time applications and the need for high speed image processing is evident.(3-5) Previous systems have relied on simple signal processing algorithms, based on Fourier transformations, for de-convolving the system response and extracting phase/amplitude information. We discuss enhanced processing based on wavelet transforms. Wavelet techniques for signal analysis provide near optimal thresholding for signal recovery and are computationally inexpensive for pulsed waveforms.(6) The improved signal characterisation and speed of wavelet analysis over Fourier methods is demonstrated on sample T-ray data.
C1 Univ Adelaide, Ctr Biomed Engn, Adelaide, SA 5005, Australia.
RP Mickan, S (reprint author), Univ Adelaide, Ctr Biomed Engn, Adelaide, SA 5005, Australia.
EM spm@ieee.org; dabbott@eleceng.adelaide.edu.au
RI Zhang, Xi-Cheng/G-1306-2016; Abbott, Derek/E-8352-2011
OI Zhang, Xi-Cheng/0000-0003-3721-1357; Abbott, Derek/0000-0002-0945-2674
CR ARNONE D, 1999, C TER SPECTR APPL SP
   AUSTON DH, 1984, APPL PHYS LETT, V45, P284, DOI 10.1063/1.95174
   AUSTON DH, 1984, PHYS REV LETT, V53, P1555, DOI 10.1103/PhysRevLett.53.1555
   AUSTON DH, 1988, TOP APPL PHYS, V60, P183
   BASS M, 1962, PHYS REV LETT, V9, P446, DOI 10.1103/PhysRevLett.9.446
   BONVALET A, 1995, APPL PHYS LETT, V67, P2907, DOI 10.1063/1.114838
   Burrus C.S., 1998, INTRO WAVELETS WAVEL
   Cai Y, 1997, APPL PHYS LETT, V71, P2076, DOI 10.1063/1.119346
   Cai Y, 1998, APPL PHYS LETT, V73, P444, DOI 10.1063/1.121894
   Chansungsan C, 1996, J OPT SOC AM B, V13, P2792, DOI 10.1364/JOSAB.13.002792
   Cheville RA, 1998, OPT LETT, V23, P531, DOI 10.1364/OL.23.000531
   Cheville RA, 1997, IEEE T ANTENN PROPAG, V45, P1518, DOI 10.1109/8.633860
   *CYLC, 1997, IEE P-OPTOELECTRON, V144, P44
   DONOHO DL, 1995, IEEE T INFORM THEORY, V41, P613, DOI 10.1109/18.382009
   Duvillaret L, 1996, IEEE J SEL TOP QUANT, V2, P739, DOI 10.1109/2944.571775
   Flanders BN, 1998, IEEE J SEL TOP QUANT, V4, P353, DOI 10.1109/2944.686742
   FROBERG NM, 1992, IEEE J QUANTUM ELECT, V28, P2291, DOI 10.1109/3.159536
   GALLOT G, 1999, C LAS EL OPT 99, P492
   GRAPS A, 1995, IEEE COMPUT SCI ENG, V2, P50, DOI 10.1109/99.388960
   GRISCHKOWSKY D, 1990, J OPT SOC AM B, V7, P2006, DOI 10.1364/JOSAB.7.002006
   Gu P, 1998, JPN J APPL PHYS 2, V37, pL976, DOI 10.1143/JJAP.37.L976
   HU BB, 1995, OPT LETT, V20, P1716, DOI 10.1364/OL.20.001716
   Hunsche S, 1998, OPT COMMUN, V150, P22, DOI 10.1016/S0030-4018(98)00044-3
   Hunsche S, 1998, IEICE T ELECTRON, VE81C, P269
   IZATT JA, 1999, C LAS EL OPT, P336
   Jacobsen RH, 1996, OPT LETT, V21, P2011, DOI 10.1364/OL.21.002011
   Jepsen PU, 1996, J OPT SOC AM B, V13, P2424, DOI 10.1364/JOSAB.13.002424
   Kindt JT, 1996, J PHYS CHEM-US, V100, P10373, DOI 10.1021/jp960141g
   KLAASSEN T, 1999, C TER SPECTR APPL SP
   Knott M, 1999, NEW SCI, V162, P22
   KOCH M, 1999, C TER SKPECTR APPL
   KOROTKOV AN, 1994, APPL PHYS LETT, V65, P1865, DOI 10.1063/1.112865
   Kovarskii VA, 1997, JETP LETT+, V65, P215, DOI 10.1134/1.567312
   LAX B, 1976, SPRINGER SERIES OPTI, V3, P340
   Li M, 1999, APPL PHYS LETT, V74, P2113, DOI 10.1063/1.123773
   LUO MSC, 1994, IEEE J QUANTUM ELECT, V30, P1478, DOI 10.1109/3.299473
   May M, 1997, NEW SCI, V154, P22
   MEADE ML, 1983, NUMERICAL MEASUREMEN, V1
   Mittleman D. M., 1998, Nonlinear Optics '98. Materials, Fundamentals and Applications Topical Meeting (Cat. No.98CH36244), P294, DOI 10.1109/NLO.1998.710288
   Mittleman DM, 1997, OPT LETT, V22, P904, DOI 10.1364/OL.22.000904
   Mittleman DM, 1997, APPL PHYS LETT, V71, P16, DOI 10.1063/1.119456
   Mittleman DM, 1996, IEEE J SEL TOP QUANT, V2, P679, DOI 10.1109/2944.571768
   Mittleman DM, 1999, APPL PHYS B-LASERS O, V68, P1085, DOI 10.1007/s003400050750
   Nuss MC, 1996, IEEE CIRCUIT DEVIC, V12, P25, DOI 10.1109/101.485909
   PLANKEN PCM, 1992, PHYS REV LETT, V69, P3800, DOI 10.1103/PhysRevLett.69.3800
   RICE A, 1994, APPL PHYS LETT, V64, P1324, DOI 10.1063/1.111922
   Sengers AJ, 1997, J OPT SOC AM B, V14, P1057, DOI 10.1364/JOSAB.14.001057
   SMITH PR, 1988, IEEE J QUANTUM ELECT, V24, P255, DOI 10.1109/3.121
   TEOLIS A, 1998, COMPUTATIONAL SIGNAL
   VALDMANIS JA, 1982, APPL PHYS LETT, V41, P211, DOI 10.1063/1.93485
   VANEXTER M, 1989, OPT LETT, V14, P1128, DOI 10.1364/OL.14.001128
   VANEXTER M, 1990, IEEE T MICROW THEORY, V38, P1684, DOI 10.1109/22.60016
   Verghese S, 1998, APPL PHYS LETT, V73, P3824, DOI 10.1063/1.122906
   WASCHKE C, 1993, PHYS REV LETT, V70, P3319, DOI 10.1103/PhysRevLett.70.3319
   Wu Q, 1996, IEEE J SEL TOP QUANT, V2, P693, DOI 10.1109/2944.571769
   Wu Q, 1996, APPL PHYS LETT, V68, P2924, DOI 10.1063/1.116356
   Wu Q, 1997, APPL PHYS LETT, V71, P1285, DOI 10.1063/1.119873
   Wu Q, 1996, APPL PHYS LETT, V69, P1026, DOI 10.1063/1.116920
   WYNNE K, 1999, C LASERS ELECT OPTIC, P397
   YANG KH, 1971, APPL PHYS LETT, V19, P320, DOI 10.1063/1.1653935
   ZHANG XC, 1997, OSA TOPS ULTRAFAST E, V13
NR 61
TC 3
Z9 3
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 0-8194-3492-2
J9 PROC SPIE
PY 1999
VL 3891
BP 226
EP 237
DI 10.1117/12.364444
PG 12
WC Engineering, Electrical & Electronic; Engineering, Mechanical; Optics
SC Engineering; Optics
GA BP26K
UT WOS:000084509700025
OA Green Published
DA 2018-10-20
ER

PT J
AU Ueng, TH
   Wang, HW
   Chiang, LY
AF Ueng, TH
   Wang, HW
   Chiang, LY
TI Inhibition of drug-metabolizing enzymes in mouse liver by a water
   soluble fullerene C-60
SO FULLERENE SCIENCE AND TECHNOLOGY
LA English
DT Article
ID CYTOCHROME-P450-DEPENDENT MONOOXYGENASES; CHEMISTRY; INDUCTION; TISSUES;
   DNA
AB The microsomal cytochrome P450-dependent monooxygenase system is responsible for the metabolism a variety of xenobiotics including drugs and carcinogens. Fullerenol-1 is a water soluble polyhydroxylated C-60 derivative synthesized by a sequence of reactions involving the electrophilic attack of nitronium tetrafluoroborate on fullerenes in the presence of organocarboxylic acids. The present study has evaluated the acute toxicity of fullerenol-1 and determined the effects of the C-60 compound on the P450-dependent drug-metabolzing activities. Pretreatments with 0.5 and 1.0 g/kg fullerenol-1 decreased P450 and cytochrome b(5) contents, and NADPH-cytochrome P450 reductase, as well as drug metabolizing activities toward test substrates benzo[a]pyrene, 7-ethoxycoumarin, aniline, and erythromycin in liver microsomes. Pretreatments with 0.01 and 0.1 g/kg fullerenol-1 had no effect on these monooxygenases. Immunoblotting anlysis of the microsomal proteins revealed that pretreatments with fullerenol-1 did not alter the protein levels of P450s 1A 2E and 3A. Additions of fullerenol-1 to mouse liver microsomes suppressed monooxygenases activities toward benzo[a]pyrene, 7-ethoxycoumarin, aniline, and erythromycin with IC50 values of 42, 94, 102 and 349 mu M, respectively. These results demonstrate that fullerenol-1 can decrease the activities of microsomal drug-metabolizing enzymes in vivo add in vivo. Proper adjustment of the functionalized fullerene compound may facilitate the biomedical application of the new material.
C1 Natl Taiwan Univ, Inst Toxicol, Coll Med, Taipei 10764, Taiwan.
   Natl Taiwan Univ, Ctr Condensed Matter Sci, Taipei 10764, Taiwan.
RP Ueng, TH (reprint author), Natl Taiwan Univ, Inst Toxicol, Coll Med, Taipei 10764, Taiwan.
CR An YZ, 1996, TETRAHEDRON, V52, P5179, DOI 10.1016/0040-4020(96)00123-8
   BOUTORINE AS, 1994, ANGEW CHEM INT EDIT, V33, P2462
   CHIANG LY, 1995, J CHEM SOC CHEM COMM, P1283, DOI 10.1039/c39950001283
   CHIANG LY, 1992, J AM CHEM SOC, V114, P10154, DOI 10.1021/ja00052a010
   COON MJ, 1992, FASEB J, V6, P669
   Diederich F, 1996, SCIENCE, V271, P317, DOI 10.1126/science.271.5247.317
   Friedman S H, 1993, J AM CHEM SOC, V115, P6505
   GREENLEE WF, 1978, J PHARMACOL EXP THER, V205, P596
   GUENGERICH FP, 1992, PHARMACOL THERAPEUT, V54, P17
   HALPERT JR, 1995, ANNU REV PHARMACOL, V35, P29, DOI 10.1146/annurev.pa.35.040195.000333
   IMAI Y, 1966, J BIOCHEM, V60, P417, DOI 10.1093/oxfordjournals.jbchem.a128453
   Irie K, 1996, BIOSCI BIOTECH BIOCH, V60, P1359, DOI 10.1271/bbb.60.1359
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Nakamura E, 1996, B CHEM SOC JPN, V69, P2143, DOI 10.1246/bcsj.69.2143
   NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416
   NEBERT DW, 1994, BIOCHEM PHARMACOL, V47, P25, DOI 10.1016/0006-2952(94)90434-0
   NEBERT DW, 1968, J BIOL CHEM, V243, P6242
   NELSON MA, 1993, TOXICOL IND HEALTH, V9, P623, DOI 10.1177/074823379300900405
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   PHILLIPS AH, 1962, J BIOL CHEM, V237, P2652
   RYAN DE, 1990, PHARMACOL THERAPEUT, V45, P153, DOI 10.1016/0163-7258(90)90029-2
   Saunders M, 1996, SCIENCE, V271, P1693, DOI 10.1126/science.271.5256.1693
   SCRIVENS WA, 1994, J AM CHEM SOC, V116, P4517, DOI 10.1021/ja00089a067
   TOKUYAMA H, 1993, J AM CHEM SOC, V115, P7918, DOI 10.1021/ja00070a064
   Tsai MC, 1997, J PHARM PHARMACOL, V49, P438, DOI 10.1111/j.2042-7158.1997.tb06821.x
   TSUCHIYA T, 1995, BIOCHEM BIOPH RES CO, V206, P885, DOI 10.1006/bbrc.1995.1126
   Ueng TH, 1998, J TOXICOL ENV HEAL A, V54, P509
   UENG TH, 1993, TOXICOL APPL PHARM, V119, P66, DOI 10.1006/taap.1993.1045
   YAMAGO S, 1995, CHEM BIOL, V2, P385, DOI 10.1016/1074-5521(95)90219-8
NR 29
TC 13
Z9 13
U1 0
U2 7
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 1064-122X
J9 FULLERENE SCI TECHN
JI Fullerene Sci. Technol.
PY 1999
VL 7
IS 4
BP 681
EP 694
DI 10.1080/10641229909351370
PG 14
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Atomic, Molecular & Chemical
SC Chemistry; Materials Science; Physics
GA 213AJ
UT WOS:000081249600015
DA 2018-10-20
ER

PT S
AU Karlsen, W
AF Karlsen, W
BE Hanninen, H
   Hertzman, S
   Romu, J
TI The effect of nitrogen alloying on stellite 21 cobalt chromium
   molybdenum biomedical implant alloy: processing and microstructure
SO HIGH NITROGEN STEELS '98
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 5th International Conference on High Nitrogen Steels
CY MAY 27-28, 1998
CL STOCKHOLM, SWEDEN
SP Helsinki Univ, Swedish Inst Mat Res
DE incipient melting; nitrogen-high pressure melting (N-HPM); Stellite 21;
   biomedical
ID PRESSURE; CR; FE
AB There has been an on-going effort to improve the performance of Co-Cr-Mo biomedical implant alloys. However, efforts have been thwarted by the alloy's dependence upon carbon and carbide structures for strengthening, which are also associated with lower incipient melting temperatures, and lower ductilities. In this study, the effect of nitrogen additions to a Stellite 21 has been explored. Borrowing technology from its cousin, austenitic stainless-steels, additions were made to the alloy through nitrogen-high pressure melting (N-HPM) at pressures ranging from 1.4 to 50 atm. The ingots were then rolled into plates from which bars were extracted, and then heat-treated. This paper describes the microstructural development in terms of the second phase structure and grain size of heat treated plate materials. The total nitrogen achieved increased with pressure, and ranged from 0.19 to 1.34 wt%. The findings indicate not only that additions of nitrogen increase the second phase content, but also that as the nitrogen content is increased, a Cr2N second phase is favored over the traditional Cr23C6 carbide. This phase change apparently leads to the subsequent elevation of the incipient melting temperature to above 1260 degrees C (2300 degrees F).
C1 Helsinki Univ Technol, Lab Engn Mat, FIN-02015 HUT, Finland.
RP Karlsen, W (reprint author), Helsinki Univ Technol, Lab Engn Mat, POB 4100, FIN-02015 HUT, Finland.
RI Hanninen, Hannu/G-2260-2013
CR *ASM INT, 1990, ADV MAT P        AUG, P50
   AZIZ AI, ASM METALS HDB, V13, P658
   BLOSSEY RG, 1966, T METALL SOC AIME, V236, P28
   BONFIELD W, 1987, MET MATER, P712
   CROOK P, 1992, ASM HDB, V18, P766
   DEMPSEY AJ, 1987, J MATER SCI, V22, P575, DOI 10.1007/BF01160771
   DIAS MCM, 1992, J MATER SCI, V27, P5154
   Dobbs H S, 1982, Eng Med, V11, P175
   DOWSON D, 1992, ASM HDB, V18, P656
   FARHANGI H, 1989, THESIS U MARYLAND
   KARLSEN W, 1997, THESIS OREGON GRADUA
   KILNER T, 1987, J MATER SCI, V22, P565, DOI 10.1007/BF01160770
   Kilner T., 1984, THESIS U TORONTO
   RAWERS J, 1992, J MATER RES, V7, P1083, DOI 10.1557/JMR.1992.1083
   RAWERS JC, 1992, METALL TRANS A, V23, P2061, DOI 10.1007/BF02647552
NR 15
TC 2
Z9 2
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-843-5
J9 MATER SCI FORUM
PY 1999
VL 318-3
BP 303
EP 308
DI 10.4028/www.scientific.net/MSF.318-320.303
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BQ55N
UT WOS:000088746300040
DA 2018-10-20
ER

PT J
AU Viik, J
   Malmivuo, J
AF Viik, Jari
   Malmivuo, Jaakko
TI Biomedical Engineering as a Career Resource: Survey from Tampere
   University of Technology
SO INTERNATIONAL JOURNAL OF ENGINEERING EDUCATION
LA English
DT Article
AB This paper presents the results of the survey concerning graduates with a Master of Science in Engineering (hereafter engineers), who have studied Biomedical Engineering (BME) in the Ragnar Granit Institute (RGI) at Tampere University of Technology (TUT), Tampere, Finland. The material of the survey consisted of 267 persons who had included BME as a professional subject in their degree program between 1976 and the spring of 1997. The survey was conducted during the summer of 1997 as a postal questionnaire study (respondence rate was 77%). According to the study, 90% of the respondents had found their first job in less than three months. The type of their first employment for 95% of respondents was full-time. The job description of every second respondent was related to BME. Of those who had submitted their Master's thesis to RGI, first job descriptions were clearly related to BME more often than in the cases of other respondents. The first job corresponded very well with the type of education, and this correspondence has even improved in recent years. When comparing the ability provided by their education with the importance of areas of expertise actually required at work, the respondents said deficiencies lay in the areas of project and teamwork, oral communication skills, and negotiation skills. Education in RGI was perceived as a good, interesting, and respected basis for a career.
C1 [Viik, Jari; Malmivuo, Jaakko] Tampere Univ Technol, Ragnar Granit Inst, FIN-33101 Tampere, Finland.
RP Viik, J (reprint author), Tampere Univ Technol, Ragnar Granit Inst, FIN-33101 Tampere, Finland.
EM viik@ee.tut.fi; malmivuo@cc.tut.fi
RI Viik, Jari/A-6303-2009
OI Viik, Jari/0000-0001-6081-6819
FU Ragnar Granit Foundation
FX The authors would like to express their gratitude to Mr. Raimo Lamminen
   for his assistance in various phases of the study. This part of the work
   was supported by the Ragnar Granit Foundation. The report of this survey
   is available as a printed booklet in English or in Finnish by contacting
   the authors.
NR 0
TC 4
Z9 4
U1 0
U2 1
PU TEMPUS PUBLICATIONS
PI DURRUS, BANTRY
PA IJEE , ROSSMORE,, DURRUS, BANTRY, COUNTY CORK 00000, IRELAND
SN 0949-149X
J9 INT J ENG EDUC
JI Int. J. Eng. Educ
PY 1999
VL 15
IS 4
SI SI
BP 308
EP 320
PG 13
WC Education, Scientific Disciplines; Engineering, Multidisciplinary
SC Education & Educational Research; Engineering
GA V11PK
UT WOS:000207543300013
DA 2018-10-20
ER

PT S
AU Sanchez-Huerta, L
   Hernandez, A
   Ayala, G
   Marroquin, J
   Silva, AB
   Khotiaintsev, KS
   Svirid, VA
   Flores, G
   Khotiaintsev, SN
AF Sanchez-Huerta, L
   Hernandez, A
   Ayala, G
   Marroquin, J
   Silva, AB
   Khotiaintsev, KS
   Svirid, VA
   Flores, G
   Khotiaintsev, SN
BE Melker, AI
TI Laser technique for anatomical-functional study of the medial prefrontal
   cortex of the brain
SO INTERNATIONAL WORKSHOP ON NONDESTRUCTIVE TESTING AND COMPUTER
   SIMULATIONS IN SCIENCE AND ENGINEERING
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT International Workshop on Nondestructive Testing and Computer
   Simulations in Science and Engineering
CY JUN 08-12, 1998
CL ST PETERSBURG, RUSSIA
SP St Petersburg Tech Univ, Russia, St Petersburg Acad Sci Strength Problems, Russia, NPO Special Mat, Russia, SPIE Russia Chapter
DE non-destructive testing; brain; prefrontal cortex; neurology;
   neurodevelopment; physiology; behavior studies; laser biomedical
   applications; laser surgery; laser material processing; infrared
   waveguides
ID IBOTENIC ACID LESIONS; HOLLOW WAVE-GUIDES; INDUCED LOCOMOTION;
   DIODE-LASER; NEUROSURGERY; SCHIZOPHRENIA; STRESS; RAT
AB The brain represents one of the most complex systems that we know yet. Ln its study, non-destructive methods - in particular, behavioral studies play an important role. By alteration of brain functioning (e.g. by pharmacological means) and observation of consequent behavior changes an important information on brain organization and functioning is obtained. For inducing local alterations, permanent brain lesions are employed. However, for correct results this technique has to be quasi-non-destructive, i.e, not to affect the normal brain function. Hence, the lesions should be very small, accurate and applied precisely over the structure (e.g. the brain nucleus) of interest. These specifications are difficult to meet with the existing techniques for brain lesions - specifically, neurotoxical, mechanical and electrical means because they result in too extensive damage.
   In this paper, we present new laser technique for quasi-non-destructive anatomical-functional mapping in vivo of the medial prefrontal cortex (MPFC) of the rat. The technique is based on producing of small-size, well-controlled laser-induced lesions over some areas of the MPFC. The anesthetized animals are subjected to stereotactic surgery and certain points of the MPFC are exposed the confined radiation of the 10 W cw CO2 laser. Subsequent behavioral changes observed in neonatal and adult animals as well as histological data prove effectiveness of this technology for anatomical-functional studies of the brain by areas, and as a treatment method for some pathologies.
C1 Univ Autonoma Puebla, Inst Physiol, Puebla 72570, Mexico.
RP Khotiaintsev, SN (reprint author), Univ Autonoma Puebla, Inst Physiol, AP 406, Puebla 72570, Mexico.
EM lsanches@siu.ccn.buap.mx; svirid@cronos.fi-b.unam.mx;
   gflores@siu.cen.buap.mx; sergeikh@hotmail.com
OI Flores, Gonzalo/0000-0002-4100-2104; Hernandez-Cortes,
   Adan/0000-0002-7098-870X
CR ARRINGTON JA, 1990, MILESTONE SERIES
   DEBRABANDER JM, 1991, BEHAV BRAIN RES, V42, P67, DOI 10.1016/S0166-4328(05)80041-5
   Devaux BC, 1996, ACTA NEUROCHIR, V138, P1135, DOI 10.1007/BF01809742
   Devaux BC, 1998, SURG NEUROL, V50, P33, DOI 10.1016/S0090-3019(98)00042-1
   Doherty MD, 1996, BRAIN RES, V715, P86, DOI 10.1016/0006-8993(95)01557-4
   FASANO V A, 1983, Lasers in Surgery and Medicine, V2, P199
   Flores G, 1996, J NEUROSCI, V16, P2020
   Flores G, 1996, J NEUROSCI, V16, P7366
   FLORES G, 1998, P SPIE, V3565
   GOLDSTEIN M, 1992, FASEB J, V6, P2413
   Inberg A, 1996, P SOC PHOTO-OPT INS, V2928, P28, DOI 10.1117/12.259962
   JASKIW GE, 1992, PHARMACOL BIOCHEM BE, V41, P607, DOI 10.1016/0091-3057(92)90380-X
   JASKIW GE, 1990, BRAIN RES, V534, P263, DOI 10.1016/0006-8993(90)90138-2
   Katzir A., 1993, LASERS OPTICAL FIBER
   KOLB B, 1990, CEREBRAL CORTEX RAT, P437
   LOMBARD CF, 1995, P SOC PHOTO-OPT INS, V2623, P302
   Matsuura Y, 1997, OPT LETT, V22, P1308, DOI 10.1364/OL.22.001308
   MOGENSON GJ, 1984, BEHAV NEURAL BIOL, V42, P38, DOI 10.1016/S0163-1047(84)90412-6
   MORRISON JH, 1979, SCIENCE, V205, P313, DOI 10.1126/science.451605
   Nagatani T, 1997, MINIM INVAS NEUROSUR, V40, P98, DOI 10.1055/s-2008-1053425
   Paxinos G, 1986, RAT BRAIN STEREOTACT
   ROSE JE, 1947, RES PUBL ASSOC RES N, V27, P210
   ROUX FX, 1985, NEUROCHIRURGIE, V31, P412
   ROUX FX, 1992, NEUROCHIRURGIE, V38, P229
   Shalem S., 1995, Proceedings of the SPIE - The International Society for Optical Engineering, V2631, P216, DOI 10.1117/12.229185
   SHALIMOV A, 1986, CLIN SURG, V9, P42
   STEICHEN JD, 1990, J NEUROSURG, V73, P611, DOI 10.3171/jns.1990.73.4.0611
   Watanabe T, 1996, P SOC PHOTO-OPT INS, V2928, P19, DOI 10.1117/12.259961
   WEINBERGER DR, 1995, SCHIZOPHR RES, V16, P87, DOI 10.1016/0920-9964(95)00013-C
NR 29
TC 2
Z9 2
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 0-8194-3161-3
J9 PROC SPIE
PY 1999
VL 3687
BP 34
EP 41
DI 10.1117/12.347469
PG 8
WC Computer Science, Interdisciplinary Applications; Engineering,
   Multidisciplinary; Materials Science, Multidisciplinary; Materials
   Science, Characterization & Testing; Optics; Physics, Applied
SC Computer Science; Engineering; Materials Science; Optics; Physics
GA BN10P
UT WOS:000080723900008
DA 2018-10-20
ER

PT B
AU Muller, RS
AF Muller, RS
BE Wen, T
TI MEMS: the promise for the 3rd millennium
SO ISTM/99: 3RD INTERNATIONAL SYMPOSIUM ON TEST AND MEASUREMENT
LA English
DT Proceedings Paper
CT 3rd International Symposium on Test and Measurement (ISTM 99)
CY JUN 02-04, 1999
CL XIAN, PEOPLES R CHINA
SP Chinese Soc Modern Tech Equipments, Xian Inst Technol, Northwest Inst Mech Elect Engn, North China Inst Technol, Xian Mech Elect Info Res Inst, Chinese Soc Instruments, Chinese Soc Elect Engn
ID POLYCRYSTALLINE SILICON; POLYSILICON; MICROMIRRORS; STRESS
AB "To many of those working in the field of Microeiectromechanical Systems (MEMS), there is a strong sense that a revolution is underway. As MEMS begin to permeate an increasingly wide scope of industrial procedures, not only engineering, but also society as a whole will be strongly affected. MEMS will provide a new design technology having an impact on society that rivals and even surpasses the dizzying effects of integrated circuits." These words, used by the author as a preface to a US National Research Council(*) report, predict a very influential role for MEMS in the 21(st) century. To accept this premise, one has to be convinced that MEMS is more than "miniaturization of engineering systems. " Miniaturization has been an ongoing theme in engineering success over the last century and countless refinements in design and manufacture have contributed to its progress. What is new and revolutionary in MEMS is ifs adaptation to new purpose of the advanced, productive IC technology. Built with countless invested hours and dollars over the past thirty years, silicon IC batch processing today fabricates electrical systems having overwhelming complexity.
   The MEMS revolution arises from harnessing this know-how to the task of building micromechanical and microelectronic elements into engineering microsystems. The scope of MEMS is multidisciplinary, providing challenges and opportunities to electrical mechanical, chemical, and biomedical engineering, and extending beyond engineering to physics, biology, and chemistry.
   Some of the commercial areas in which MEMS has taken root, and in which growth seems clear and healthy are. the automotive industry, where MEMS are in production for sensing applications, particularly for pressure and acceleration, and also for fuel-injection systems printers, where ink-jet technology is revolutionizing a booming field ($3B worldwide market growing at MICROELECTROMECHANICAL SYSTEMS, "Advanced Materials and Fabrication Methods," US National Academy Press, ISBN 0-309-05980-1, December -1997 nearly 20% per year), optical systems where new actuated mirror- and lens- systems are being exploited for display and for fiber-optic communication systems, information storage in which much increased density (expected are 100-fold and greater storage-capacity increases) at increased speed and reduced cost; and bio- and medical applications where MEMS promise truly revolutionary systems.
   The challenges to MEMS progress are many, extending all the way fr om needs for more knowledge of fundamentals to learning a great deal more about materials, processes, and system design as well as about compatibility reliability, and interfacing. To reach a state when MEMS design is as mature as today's IC design, substantial advances in modeling, simulation and computer-aided design must be made. However, with the IC past as prologue, MEMS clearly beckons us towards a fabulous future.
C1 Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA.
RP Muller, RS (reprint author), Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA.
EM r.muller@ieee.org
CR BEHIN B, 1998, 1998 SOL STAT SENS A, P273
   CHOI MS, 1984, J ELECTROCHEM SOC, V131, P2443, DOI 10.1149/1.2115314
   DANEMAN M, 1995, C LASERS ELECTROOPTI, V15
   Daneman MJ, 1996, IEEE PHOTONIC TECH L, V8, P396, DOI 10.1109/68.481129
   DANEMAN MJ, 1995, MEMS 95 1995 INT C M
   DANEMAN MJ, 1996, 1996 TECHNICAL DIGES, V6
   DANEMAN MJ, 1996, 1996 SENS ACT WORKSH, P109
   FRENCH PJ, 1985, SENSORS ACTUATORS, V8
   GOODENOUGH F, 1991, ELECT DESIGN    0808
   GUCKEL H, 1990, SENSOR ACTUAT A-PHYS, V21, P346, DOI 10.1016/0924-4247(90)85069-G
   Guckel H., 1986, International Electron Devices Meeting 1986. Technical Digest (Cat. No.86CH2381-2), P176
   GUCKEL H, 1987, INT C SOL STAT SENS, P277
   HOWE RT, 1986, IEEE T ELECTRON DEV, V33, P499, DOI 10.1109/T-ED.1986.22519
   HOWE RT, 1985, MICROMACHINING MICRO, P169
   HOWE TT, 1982, 1982 SPRING M EL SOC
   JUDY JW, 1996, SOL STAT SENS ACT WO, P187
   Kamins T., 1998, POLYCRYSTALLINE SILI
   Kiang MH, 1996, IEEE PHOTONIC TECH L, V8, P95, DOI 10.1109/68.475790
   Kiang MH, 1996, IEEE PHOTONIC TECH L, V8, P1707, DOI 10.1109/68.544726
   KIANG MH, 1996, 1996 SENS ACT WORKSH
   KIANG MH, 1996, 1996 TECHNICAL DIGES, V6, P545
   KIANG MH, 1998, J MICROELECTROMECH S, V7, P27
   KIANG MH, 1997, IEEE TRANSDUCERS 97, P323
   KIANG MH, 1995, C LASERS ELECTROOPTI, V15, P248
   KIANG MH, 1996, IEEE MEMS 96 WORKSH
   Lebouitz K. S., 1995, 8th International Conference on Solid-State Sensors and Actuators and Eurosensors IX. Digest of Technical Papers (IEEE Cat. No.95TH8173), P224
   Mastrangelo CH, 1997, TRIBOL LETT, V3, P223, DOI 10.1023/A:1019133222401
   MULHERN G. T., 1993, P 7 INT C SOL STAT S, P296
   Muller RS, 1998, P IEEE, V86, P1705, DOI 10.1109/5.704276
   MURARKA SP, 1983, J APPL PHYS, V54, P2069, DOI 10.1063/1.332255
   NATHANSON HC, 1967, IEEE T ELECTRON DEV, VED14, P117, DOI 10.1109/T-ED.1967.15912
   PETERSEN KE, 1982, P IEEE, V70, P420, DOI 10.1109/PROC.1982.12331
   PISANO AP, 1989, 1989 IEEE MICR EL ME, P44
   PISTER KSJ, 1992, SENSOR ACTUAT A-PHYS, V33, P249, DOI 10.1016/0924-4247(92)80172-Y
   SETO JYW, 1976, J APPL PHYS, V47, P4780, DOI 10.1063/1.322515
   SOLGAARD O, 1995, IEEE PHOTONIC TECH L, V7, P41, DOI 10.1109/68.363382
   SOLGAARD O, 1995, 1995 INT S OPT MICR
   SOLGAARD O, 1994 C LAS EL CLEO 9
   TANG WC, 1989, 1989 IEEE MEMS C SAL, P53
   TIEN NC, 1994, 1994 INT EL DEV M SA, P924
   TIEN NC, 1994, 1994 SENS ACT WORKSH
   TIEN NC, 1996, SPIE P, V2687
   TIEN NC, 1995, 1995 IEEE INT C SOL, P352
   TIEN NC, 1995, P 8 INT C SOL STAT S, P352
NR 44
TC 0
Z9 0
U1 0
U2 4
PU WORLD PUBLISHING CORPORATION
PI BEIJING
PA 137 CHAONEI DAJIE, BEIJING 100010, PEOPLES R CHINA
BN 7-80003-441-0
PY 1999
BP 1
EP 8
PG 8
WC Acoustics; Computer Science, Artificial Intelligence; Computer Science,
   Interdisciplinary Applications; Engineering, Electrical & Electronic;
   Engineering, Mechanical; Instruments & Instrumentation; Materials
   Science, Characterization & Testing
SC Acoustics; Computer Science; Engineering; Instruments & Instrumentation;
   Materials Science
GA BN14D
UT WOS:000080858500001
DA 2018-10-20
ER

PT J
AU Ambrosio, L
   Borzacchiello, A
   Netti, PA
   Nicolais, L
AF Ambrosio, L
   Borzacchiello, A
   Netti, PA
   Nicolais, L
TI Rheological study on hyaluronic acid and its derivative solutions
SO JOURNAL OF MACROMOLECULAR SCIENCE-PURE AND APPLIED CHEMISTRY
LA English
DT Article; Proceedings Paper
CT Polymeric Materials - Science and Engineering Symposium at the 216th ACS
   National Meeting on Biomedical Applications of Water-Soluble Polymers
   and Hydrogels
CY AUG 23-27, 1998
CL BOSTON, MASSACHUSETTS
SP Amer Chem Soc, Div Polymer Chem
DE hyaluronic acid; polysaccharides; rheology; viscosity; viscoelasticity;
   molecular weight; concentration
AB Rheological measurements were performed an Hyaluronic acid (HA) and its derivative solutions to evaluate steady flow viscosity and dynamics response with the aim to correlate the materials properties to the concentration, molecular weight and chemical structure. At low molecular weight and concentration, the HA solutions behaved as viscous liquid, whereas a soft-gel response was evident at higher molecular weight and concentration due to chains entanglement. Increasing the molecular weight was more effective than increasing concentration in promoting entanglement of molecular chains of HA. Comparing the behavior of HA solutions with that of Hyaluronic acid derivatives, it is showed that it is possible to modulate the rheological properties of HA based solutions by chemical modification preserving the biocompatibility of the materials. The results of the rheological analysis provide a valuable tool to properly design optimal substitutes for specific biomedical application.
C1 Univ Naples Federico II, Inst Composite Mat Technol, CNR, Interdisciplinary Res Ctr Biomat, Naples, Italy.
RP Ambrosio, L (reprint author), Univ Naples Federico II, Inst Composite Mat Technol, CNR, Interdisciplinary Res Ctr Biomat, Ple Tecchio 80, Naples, Italy.
OI AMBROSIO, LUIGI/0000-0002-8367-2405; NETTI, PAOLO/0000-0002-2435-7181
CR BALAZS EA, 1993, J RHEUMATOL, V20, P3
   BALAZS EA, 1967, ARTHRITIS RHEUM, V10, P357, DOI 10.1002/art.1780100407
   BERRIAUD N, 1994, INT J BIOL MACROMOL, V16, P137, DOI 10.1016/0141-8130(94)90040-X
   CLARK AH, 1987, ADV POLYM SCI, V83, P61
   DE SMEDT SC, 1993, BIORHEOLOGY, V30, P31
   Della V.F., 1987, European Patent, Patent No. 216453
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   KOBAYASHI Y, 1994, BIORHEOLOGY, V31, P235
   LAURENT TC, 1992, FASEB J, V6, P2397
   ROSSMURPHY SB, 1991, POLYMER GELS, P21
   1987, Patent No. 4713488
NR 11
TC 63
Z9 64
U1 1
U2 22
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 1060-1325
J9 J MACROMOL SCI PURE
JI J. Macromol. Sci.-Pure Appl. Chem.
PY 1999
VL A36
IS 7-8
BP 991
EP 1000
DI 10.1080/10601329908951195
PG 10
WC Polymer Science
SC Polymer Science
GA 224VQ
UT WOS:000081921000009
DA 2018-10-20
ER

PT J
AU Czarnowska, E
   Wierzchon, T
   Maranda-Niedbala, A
   Karczmarewicz, E
AF Czarnowska, E
   Wierzchon, T
   Maranda-Niedbala, A
   Karczmarewicz, E
TI Improvement of titanium alloy for biomedical applications by nitriding
   and carbonitriding processes under glow discharge conditions
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID GROOVED SUBSTRATA; FIBROBLASTS; BIOCOMPATIBILITY; ORIENTATION; WEAR
AB Although titanium alloys are used in medicine, they present low wear resistance. In this paper we present the results of studies on surface layers produced by nitriding at three different temperatures, and by carbonitriding under glow discharge conditions in order to improve wear resistance, hardness, and to modulate microstructure and chemical composition of surface layers. A cell culture model using human fibroblasts was chosen to study the effect of such treatments on the cytocompatibility of these materials. The results showed that nitrided and carbonitrided surface layers were cytocompatible. Modulation of surface microstructure by temperature in the nitriding process and chemical composition of surface layers by carbonitriding led to differences in cellular behaviour. Cell proliferation appeared to be slightly reduced from the 6th day of culture on nitrided surfaces produced at 730 degrees C and 1000 degrees C, however after 12 days of culture, the best growth was on surface layers produced at 850 degrees C. The best viability was observed on the carbonitrided layer. The orientation and shape of the cells corresponded to surface topography. Nitriding and carbonitriding under glow discharge conditions may constitute interesting techniques allowing the formation of surface layers on parts with sophisticated shapes. They may also permit modulating surface topography in a way improving the features of titanium alloys for various applications in medicine. (C) 2000 Kluwer Academic Publishers.
C1 Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland.
   Warsaw Univ Technol, Fac Mat Sci & Engn, Warsaw, Poland.
   Childrens Mem Hlth Inst, Dept Expt Med, Warsaw, Poland.
RP Czarnowska, E (reprint author), Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland.
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   AMSTUTZ HC, 1991, CLIN ORTHOP RELAT R, V276, P7
   BEHRNDT H, 1991, MAT SCI ENG A-STRUCT, V139, P58, DOI 10.1016/0921-5093(91)90596-F
   Bianco PD, 1996, BIOMATERIALS, V17, P1937, DOI 10.1016/0142-9612(96)00023-3
   Bordji K, 1996, BIOMATERIALS, V17, P929, DOI 10.1016/0142-9612(96)83289-3
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Eisenbarth E, 1996, BIOMATERIALS, V17, P1399, DOI 10.1016/0142-9612(96)87281-4
   HAYNES DR, 1993, J BONE JOINT SURG AM, V75A, P825, DOI 10.2106/00004623-199306000-00004
   JACOBS JJ, 1991, J BONE JOINT SURG AM, V73A, P1475, DOI 10.2106/00004623-199173100-00005
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   MERRITT K, 1992, J BIOMED MATER RES, V26, P1503, DOI 10.1002/jbm.820261109
   MEYLE J, 1991, J APPL BIOMATER, V2, P273, DOI 10.1002/jab.770020409
   MEYLE J, 1993, J BIOMED MATER RES, V27, P1553, DOI 10.1002/jbm.820271212
   MORTON PH, 1980, MEMOIRES ETUDES SCI, P639
   SCALES JT, 1991, J BONE JOINT SURG BR, V73, P5346
   VANRAAY JJAM, 1995, J MATER SCI-MATER M, V6, P80, DOI 10.1007/BF00120412
   Wierzchon T, 1997, SURF COAT TECH, V96, P205, DOI 10.1016/S0257-8972(97)00113-8
   WIERZCHON T, 1995, P INT C CARB NITR AT, P341
   WOODMAN J L, 1984, Journal of Orthopaedic Research, V1, P421
   1983, PN83H04302
NR 23
TC 4
Z9 4
U1 0
U2 5
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PY 1999
VL 11
IS 2
BP 73
EP 81
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 271ND
UT WOS:000084599600002
DA 2018-10-20
ER

PT J
AU Paquis, P
   Pignol, JP
   Lonjon, M
   Brassart, N
   Courdi, A
   Chauvel, P
   Grellier, P
   Chatel, M
AF Paquis, P
   Pignol, JP
   Lonjon, M
   Brassart, N
   Courdi, A
   Chauvel, P
   Grellier, P
   Chatel, M
TI Boron Neutron Capture Enhancement (BNCE) of fast neutron irradiation for
   glioblastoma: increase of thermal neutron flux with heavy material
   collimation, a theoretical evaluation
SO JOURNAL OF NEURO-ONCOLOGY
LA English
DT Article
DE glioblastoma; BNCT; fast neutron; BPA
ID BRAIN-BARRIER DISRUPTION; CONCOMITANT TUMOR BOOST; HIGH-GRADE
   ASTROCYTOMAS; MALIGNANT GLIOMAS; IN-VITRO; INTRACAROTID INJECTION;
   PHOTON IRRADIATION; IV ASTROCYTOMAS; MIXED NEUTRON; CELL LINES
AB Despite the fact that fast neutron irradiation of glioblastoma has shown on autopsies an ability to sterilize tumors, no therapeutic windows have been found for these particles due to their toxicity toward normal brain. Therefore, the Boron Neutron Capture Enhancement (BNCE) of fast neutron beam has been suggested. This paper addresses the problem of fast neutron beam collimation, which induces a dramatic decrease of the thermal neutron flux in the depth of the tissues when smaller irradiation fields are used. Thermoluminescent dosimeter TLD-600 and TLD-700 were used to determine the thermal neutron flux within a Plexiglas phantom irradiated under the Nice Biomedical Cyclotron p(60)+Be(32) fast neutron beam. A BNCE of 4.6% in physical dose was determined for a 10 x 10 cm(2) field, and of 10.4% for a 20 x 20 cm(2) one. A Dose Modification Factor of 1.19 was calculated for CAL 58 glioblastoma cells irradiated thanks to the larger field. In order to increase the thermal flux in depth while shaping the beam, heavy material collimation was studied with Monte Carlo simulations using coupled FLUKA and MCNP-4A codes. The use of 20 cm width lead blocks allowed a 2 fold thermal neutron flux increase in the depth of the phantom, while shielding the fast neutron beam with a fast neutron dose transmission of 23%. Using the DMF of 1.19, a BNCE of 40% was calculated in the beam axis. This enhancement might be sufficient to open, at least theoretically, a therapeutic window.
C1 Hop Louis Pasteur, Serv Neurochirurg, F-06002 Nice, France.
   Hop Hasenrain, Serv Radiotherapie, Mulhouse, France.
   Ctr Antoine Lacassagne, Cyclotron Biomed, F-06054 Nice, France.
   Hop Louis Pasteur, Serv Neurol, F-06002 Nice, France.
RP Paquis, P (reprint author), Hop Louis Pasteur, Serv Neurochirurg, 30 Ave Voie Romaine, F-06002 Nice, France.
CR Barth RF, 1997, CANCER RES, V57, P1129
   BARTH RF, 1992, CANCER-AM CANCER SOC, V70, P2995
   BRETEAU N, 1989, STRAHLENTHER ONKOL, V165, P320
   Briesmeister J.F., 1986, LA7396M
   Buchholz TA, 1997, J NEURO-ONCOL, V33, P171, DOI 10.1023/A:1005798004420
   BUCHHOLZ TA, 1994, RADIOLOGY, V191, P863, DOI 10.1148/radiology.191.3.8184080
   BUCHHOLZ TA, 1994, ACTA ONCOL, V33, P307, DOI 10.3109/02841869409098422
   Capala J, 1996, RADIAT RES, V146, P554, DOI 10.2307/3579556
   CARLSSON J, 1994, ACTA ONCOL, V33, P315, DOI 10.3109/02841869409098423
   CATERALL M, 1980, INT J RADIAT ONCOL, V6, P261
   CODERRE JA, 1993, INT J RADIAT ONCOL, V27, P1121, DOI 10.1016/0360-3016(93)90533-2
   Courdi A, 1996, ACTA ONCOL, V35, P237, DOI 10.3109/02841869609098507
   COURDI A, 1992, RADIOTHER ONCOL, V24, P102, DOI 10.1016/0167-8140(92)90286-4
   DUNCAN W, 1986, BRIT J RADIOL, V59, P379, DOI 10.1259/0007-1285-59-700-379
   DUNCAN W, 1986, BRIT J RADIOL, V59, P373, DOI 10.1259/0007-1285-59-700-373
   DUNCAN W, 1986, BRIT J RADIOL, V59, P441, DOI 10.1259/0007-1285-59-701-441
   FAIRCHILD RG, 1985, INT J RADIAT ONCOL, V11, P831, DOI 10.1016/0360-3016(85)90318-9
   FASSO A, 1994, P SPEC M SHIELD ASP
   FERTIL B, 1984, RADIAT RES, V99, P73, DOI 10.2307/3576448
   HENDRICKS JS, 1994, LA12891
   HERSKOVIC A, 1982, CANCER, V49, P2463, DOI 10.1002/1097-0142(19820615)49:12<2463::AID-CNCR2820491208>3.0.CO;2-3
   HOCHBERG FH, 1980, NEUROLOGY, V30, P907, DOI 10.1212/WNL.30.9.907
   KOLKER JD, 1990, INT J RADIAT ONCOL, V19, P409, DOI 10.1016/0360-3016(90)90550-4
   LARAMORE GE, 1978, CANCER, V42, P96, DOI 10.1002/1097-0142(197807)42:1<96::AID-CNCR2820420116>3.0.CO;2-W
   LARAMORE GE, 1988, INT J RADIAT ONCOL, V14, P1093, DOI 10.1016/0360-3016(88)90384-7
   LARAMORE GE, 1990, INT J RADIAT ONCOL, V19, P493, DOI 10.1016/0360-3016(90)90564-Z
   LARAMORE GE, 1989, INT J RADIAT ONCOL, V17, P1351, DOI 10.1016/0360-3016(89)90549-X
   LARAMORE GE, 1994, INT J RADIAT ONCOL, V28, P1135, DOI 10.1016/0360-3016(94)90487-1
   LASTER BH, 1991, CANCER RES, V51, P4588
   Mizoe J. E., 1993, Strahlentherapie und Onkologie, V169, P222
   PIGNOL JP, 1996, B CANC RADIOTHER, V83, P201
   POLLER F, 1991, RADIOTHER ONCOL, V21, P179, DOI 10.1016/0167-8140(91)90035-F
   SAROJA KR, 1989, INT J RADIAT ONCOL, V17, P1295, DOI 10.1016/0360-3016(89)90539-7
   SAUERWEIN W, 1990, STRAHLENTHER ONKOL, V166, P26
   SAUERWEIN W, 1989, STRAHLENTHER ONKOL, V165, P208
   STRAGLIOTTO G, 1995, NEUROSURGERY, V36, P285, DOI 10.1227/00006123-199502000-00007
   UTSUMI H, 1991, NUCL SCI APPL, V4, P325
   Yang WL, 1997, J NEURO-ONCOL, V33, P59, DOI 10.1023/A:1005769214899
   YOUNG PG, 1990, LA11753 MS
NR 39
TC 5
Z9 5
U1 0
U2 1
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0167-594X
J9 J NEURO-ONCOL
JI J. Neuro-Oncol.
PD JAN
PY 1999
VL 41
IS 1
BP 21
EP 30
DI 10.1023/A:1006115404262
PG 10
WC Oncology; Clinical Neurology
SC Oncology; Neurosciences & Neurology
GA 186HT
UT WOS:000079723400004
PM 10222419
DA 2018-10-20
ER

PT J
AU Verne, E
   Ferraris, M
   Jana, C
AF Verne, E
   Ferraris, M
   Jana, C
TI Pressureless sintering of Bioverit (R) III/Ti particle biocomposites
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE titanium particles; sintering; composites; glass ceramics; biomedical
   applications
ID MEDICAL APPLICATIONS; MATRIX COMPOSITES; GLASS
AB A new bioactive material, based on Bioverit(R) III glass-ceramic (B3), was synthesised, it is a composite material (named B3T) having a glass-ceramic matrix and titanium particles as toughening phase. The aim was to toughen the Bioverit(R) III glass-ceramic, already successfully tested by in vivo experiments. The B3T biocomposite, reinforced by 15 vol% Ti particles, was prepared by pressureless sintering, starting from Bioverit(R) III base glass powders. The sintering conditions were carefully optimised by using differential scanning calorimetry and hot stage microscopy. On the basis of this study a low temperature viscous flow sintering process was chosen, and high density glass-matrix composites were obtained. A further crystallisation, using the temperature and time conditions for bulk Bioverit(R) III glass ceramic, was performed to obtain a glass-ceramic matrix/Ti particle composite. A qualitative mechanical characterisation revealed toughening benefits in the Ti additions. An in vitro test (fibro-blast growth) was performed on the composites in order to demonstrate their biocompatibility. (C) 1999 Elsevier Science Limited. All rights reserved.
C1 Politecn Torino, Dept Mat Sci & Chem Engn, I-10129 Turin, Italy.
   Univ Jena, Otto Schott Inst, D-07743 Jena, Germany.
RP Verne, E (reprint author), Politecn Torino, Dept Mat Sci & Chem Engn, Cso Duca Abruzzi 24, I-10129 Turin, Italy.
OI Verne, Enrica/0000-0002-8649-4739
CR DONALD IW, 1993, J MATER SCI, V28, P2841, DOI 10.1007/BF00354689
   DUCHEYNE P, 1993, INTRO BIOCERAMICS, P281
   Ferraris M, 1996, J EUR CERAM SOC, V16, P421, DOI 10.1016/0955-2219(95)00114-X
   FERRARIS M, 1994, COMPOSITES, V25, P494, DOI 10.1016/0010-4361(94)90175-9
   Holand W., 1993, INTRO BIOCERAMICS, P125
   Rizkalla AS, 1996, BRIT CERAM T, V95, P151
   SWAIN MV, 1983, AM CERAM SOC COM FEB, pC27
   Verne E, 1998, J EUR CERAM SOC, V18, P363, DOI 10.1016/S0955-2219(97)00134-9
   VERNE E, 1997, 99 ACERS ANN M CINC, P11
   Vogel J, 1997, GLASTECH BER-GLASS, V70, P220
   WANG LH, 1995, PHARMACEUT RES, V12, P275, DOI 10.1023/A:1016243313027
   Wang P., 1990, SILICATES IND, V7-8, P231
NR 12
TC 12
Z9 12
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
EI 1873-619X
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PY 1999
VL 19
IS 12
BP 2039
EP 2047
DI 10.1016/S0955-2219(99)00036-9
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA 227UE
UT WOS:000082097700001
DA 2018-10-20
ER

PT S
AU Herman, PR
   Goodno, G
   Gu, XJ
   Kalbfleisch, JB
   Long, J
   Lukacs, M
   Marjoribanks, RS
   Miller, RJD
   Nantel, M
   Ness, S
   Oettl, A
AF Herman, PR
   Goodno, G
   Gu, XJ
   Kalbfleisch, JB
   Long, J
   Lukacs, M
   Marjoribanks, RS
   Miller, RJD
   Nantel, M
   Ness, S
   Oettl, A
BE Dubowski, JJ
   Helvajian, H
   Kreutz, EW
   Sugioka, K
TI Advanced-laser processing of photonic and microelectronic components at
   Photonics Research Ontario
SO LASER APPLICATIONS IN MICROELECTRONIC AND OPTOELECTRONIC MANUFACTURING
   IV
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Laser Applications in Microelectronic and Optoelectronic
   Manufacturing IV
CY JAN 25-27, 1999
CL SAN JOSE, CA
SP USAF Off Sci Res, SPIE
DE laser micromachining; ablation; laser trimming; photonics; Bragg
   gratings; photosensitivity; ultrafast lasers
ID EXCIMER-LASER; FEMTOSECOND LASER; INDUCED BREAKDOWN; OPTICAL FIBERS;
   FUSED-SILICA; WAVE-GUIDES; PULSES; PHOTOSENSITIVITY
AB Photonics Research Ontario (PRO) is an Ontario Provincial Center of Excellence supporting a broad range of laser-processing activities within its photonics program. These activities are centered at the University of Toronto, and split between an industrial-user facility and the individual research programs of principal investigators. The combined effort furnishes forefront laser systems and advanced optical tools to explore novel processing applications in photonic, biomedical, and microelectronic areas. Facilities include laser micromachining stations, excimer-based mask-projection stations, extremely short wavelength lasers such as the molecular fluorine laser (157 nm), and ultrafast laser systems (100 fs - I ps). The latter two advanced lasers offer interesting advantages and contrasts in processing 'difficult' materials through linear and nonlinear absorption processes, respectively. These laser systems provide fine precision and strong interaction with a wide range of materials, including 'transparent' glasses, and also ceramics and metals. Applications fall broadly into several areas: wafer-level circuit trimming (electronics), high-resolution ultrasonic transducers (biomedical devices), and the shaping of optical waveguides and Bragg-gratings for photonic components (telecommunications). This paper summarizes the laser-processing infrastructure and research activities at PRO.
C1 Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada.
RP Herman, PR (reprint author), Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada.
RI Herman, Peter/A-6464-2008
OI Herman, Peter/0000-0002-9157-8259
CR ALBERT J, 1992, OPT LETT, V17, P1652, DOI 10.1364/OL.17.001652
   ALBERT J, 1995, APPL PHYS LETT, V67, P3529, DOI 10.1063/1.114911
   Allan DC, 1996, OPT LETT, V21, P1960, DOI 10.1364/OL.21.001960
   Ashkenasi D, 1997, APPL SURF SCI, V120, P65, DOI 10.1016/S0169-4332(97)00218-3
   Davis KM, 1996, OPT LETT, V21, P1729, DOI 10.1364/OL.21.001729
   DU D, 1994, APPL PHYS LETT, V64, P3071, DOI 10.1063/1.111350
   FERTEIN E, 1991, ELECTRON LETT, V20, P1838
   Glezer EN, 1996, OPT LETT, V21, P2023, DOI 10.1364/OL.21.002023
   Goodno GD, 1998, J OPT SOC AM B, V15, P1791, DOI 10.1364/JOSAB.15.001791
   Herman PR, 1997, P SOC PHOTO-OPT INS, V2992, P86, DOI 10.1117/12.270086
   Herman PR, 1997, P SOC PHOTO-OPT INS, V2991, P170, DOI 10.1117/12.273724
   HERMAN PR, 1997, OSA TECH DIGEST, P159
   HERMAN PR, 1999, IN PRESS SPIE, V3616
   Jackson BD, 1998, APPL SURF SCI, V127, P595, DOI 10.1016/S0169-4332(97)00712-5
   Kruger J, 1998, APPL SURF SCI, V127, P892, DOI 10.1016/S0169-4332(97)00763-0
   KUPER S, 1987, APPL PHYS B-PHOTO, V44, P199, DOI 10.1007/BF00692122
   Kurosawa K., 1998, Journal of Photopolymer Science and Technology, V11, P367, DOI 10.2494/photopolymer.11.367
   LEMAIRE PJ, 1993, ELECTRON LETT, V29, P1191, DOI 10.1049/el:19930796
   LUKAS M, 1999, THESIS QUEENS U KING
   MORIMOTO Y, 1994, J NON-CRYST SOLIDS, V179, P260, DOI 10.1016/0022-3093(94)90704-8
   PRESS S, 1995, APPL PHYS LETT, V67, P338
   PRONKO PP, 1995, OPT COMMUN, V114, P1036
   Stuart BC, 1996, PHYS REV B, V53, P1749, DOI 10.1103/PhysRevB.53.1749
   Sugioka K, 1996, APPL SURF SCI, V96-8, P347, DOI 10.1016/0169-4332(95)00442-4
   Varel H, 1997, APPL PHYS A-MATER, V65, P367, DOI 10.1007/s003390050593
   Vengsarkar AM, 1996, OPT LETT, V21, P336, DOI 10.1364/OL.21.000336
NR 26
TC 4
Z9 4
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3088-9
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3618
BP 240
EP 250
DI 10.1117/12.352687
PG 11
WC Engineering, Electrical & Electronic; Materials Science, Coatings &
   Films; Optics
SC Engineering; Materials Science; Optics
GA BN65R
UT WOS:000082492400027
DA 2018-10-20
ER

PT S
AU Anikeev, BV
   Khramov, VN
   Podolskii, VL
AF Anikeev, BV
   Khramov, VN
   Podolskii, VL
BE Chikishev, AY
   Zadkov, VN
   Zheltikov, AM
TI Laser-plasma technologies for the biomedical purposes: experiment for
   stomatology
SO LASER SPECTROSCOPY AND OPTICAL DIAGNOSTICS: NOVEL TRENDS AND
   APPLICATIONS IN LASER CHEMISTRY, BIOPHYSICS, AND BIOMEDICINE - ICONO'98
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 16th International Conference on Coherent and Nonlinear Optics (ICONO
   98)
CY JUN 29-JUL 03, 1998
CL MOSCOW, RUSSIA
SP Minist Sci & Technol Russian Federat, Russian Fdn Basic Res, Minist Educ Russian Federat, Basic Opt & Spect Educ & Res Ctr, Opt Soc Amer, SPIE-Int Soc Opt Engn, Int Union Pure & Appl Phys, EPS-European Phys Soc, Lawrence Livermore Natl Lab, European Off Aerosp Res & Dev, SPIE Russia Chapter, US Army European Res Off
DE laser plasma; ultrashort pulses; method of short-term resonance
   modulation of losses; stomatology
AB Results of experiment on dental solid tissues treatment with help the new laser-plasma method used the designed by authors the high energy Nd-glass picosecond laser are informed. Advantages of the method are the dot source of plasma, low transmission of heat deep into treated material etc. According with results proposing arrangement productivity is higher than setup of German company "KAVO" one.
C1 Volgograd State Univ, Volgograd 400062, Russia.
RP Anikeev, BV (reprint author), Volgograd State Univ, 30,2 Ya Prodolnaya St, Volgograd 400062, Russia.
RI Khramov, Vladimir/B-1929-2018
OI Khramov, Vladimir/0000-0002-1876-8216; Khramov,
   Vladimir/0000-0001-8988-0929
CR Anikeev B. V., 1996, Quantum Electronics, V26, P57, DOI 10.1070/QE1996v026n01ABEH000588
   ANIKEEV BV, 1980, Patent No. 716484
   ANIKEEV BV, 1985, KVANTOVAYA ELEKTRON, P3
   PROKHONCHUKOV AA, 1986, LASERS STOMATOLOGY
   YAMAMOTO H, 1980, J DENT RES, V59, P2171
NR 5
TC 0
Z9 0
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3206-7
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3732
BP 367
EP 370
DI 10.1117/12.340037
PG 4
WC Biophysics; Chemistry, Multidisciplinary; Engineering, Biomedical;
   Optics
SC Biophysics; Chemistry; Engineering; Optics
GA BM55P
UT WOS:000079092500049
DA 2018-10-20
ER

PT J
AU Mecerreyes, D
   Jerome, R
   Dubois, P
AF Mecerreyes, D
   Jerome, R
   Dubois, P
TI Novel macromolecular architectures based on aliphatic polyesters:
   Relevance of the "coordination-insertion" ring-opening polymerization
SO MACROMOLECULAR ARCHITECTURES
SE ADVANCES IN POLYMER SCIENCE
LA English
DT Review
DE lactones; lactides; aliphatic polyesters; ring opening polymerization;
   living polymerization; macromolecular engineering
ID EPSILON-CAPROLACTONE POLYMERIZATION; SELECTIVE END-FUNCTIONALIZATION;
   LIVING RADICAL POLYMERIZATION; ALUMINUM ISOPROPOXIDE; BLOCK-COPOLYMERS;
   BULK-POLYMERIZATION; GRAFT-COPOLYMERS; POLYIMIDE NANOFOAMS;
   BIODEGRADABLE HOMOPOLYMERS; METATHESIS POLYMERIZATION
AB Recent developments in the macromolecular engineering of aliphatic polyesters have been overviewed. First, aluminum alkoxides mediated living ring opening polymerization (ROP) of cyclic (di)esters, i.e., lactones, lactides, glycolide, is introduced. An insight into this so-called "coordination-insertion" mechanism and the ability of this living polymerization process to prepare well-defined homopolymers, telechelic polymers, random and block copolymers is then discussed. In the second part, the combination of the living ROP of (di)lactones with other well-controlled polymerization mechanisms such as anionic, cationic, free radical, and metathesis polyadditions of unsaturated comonomers, as well as polycondensations, is reported with special emphasis on the design of new and well-tailored macromolecular architectures. As a result of the above synthetic breakthrough, a variety of novel materials have been developed with versatile applications in very different fields such as biomedical and microelectronics.
C1 Univ Liege, Ctr Educ & Res Macromol, B-4000 Liege, Belgium.
   Univ Mons, Lab Polymer & Composite Mat, B-7000 Mons, Belgium.
RP Mecerreyes, D (reprint author), Univ Liege, Ctr Educ & Res Macromol, B6, B-4000 Liege, Belgium.
RI Mecerreyes, David/K-7541-2014; DUBOIS, Philippe/B-9983-2008
OI Mecerreyes, David/0000-0002-0788-7156; 
CR ANDINI S, 1988, MAKROMOL CHEM-RAPID, V9, P119
   Balsamo V, 1996, MACROMOL CHEM PHYSIC, V197, P1159, DOI 10.1002/macp.1996.021970332
   BARAKAT I, 1994, J POLYM SCI POL CHEM, V32, P2099, DOI 10.1002/pola.1994.080321112
   BARAKAT I, 1994, MACROMOL SYMP, V88, P227, DOI 10.1002/masy.19940880118
   BARAKAT I, 1993, J POLYM SCI POL CHEM, V31, P505, DOI 10.1002/pola.1993.080310222
   BARAKAT I, 1993, THESIS U LIEGE BELGI
   BARAKAT I, 1999, IN PRESS J POLYM PC
   Baran J, 1997, MACROMOL SYMP, V123, P93, DOI 10.1002/masy.19971230110
   BARR SJ, 1993, J ORTHOP RES, V11, P10, DOI 10.1002/jor.1100110103
   Biela T, 1996, J POLYM SCI POL CHEM, V34, P1807, DOI 10.1002/(SICI)1099-0518(19960715)34:9<1807::AID-POLA19>3.0.CO;2-A
   Bisht KS, 1997, MACROMOLECULES, V30, P7735, DOI 10.1021/ma9708858
   CARTER KR, 1996, ACS POLYM PREPR, V37, P607
   CHARLIER Y, 1995, POLYMER, V36, P987, DOI 10.1016/0032-3861(95)93599-H
   CHUJO Y, 1994, J CHEM SOC CHEM COMM, P635, DOI 10.1039/c39940000635
   COX EF, 1972, Patent No. 3021309
   Degee P, 1997, MACROMOL CHEM PHYSIC, V198, P1985, DOI 10.1002/macp.1997.021980624
   Degee P, 1997, MACROMOL CHEM PHYSIC, V198, P1973, DOI 10.1002/macp.1997.021980623
   DEGEE P, 1993, J POLYM SCI POL CHEM, V31, P275, DOI 10.1002/pola.1993.080310132
   Degee P, 1997, MACROMOL SYMP, V123, P67, DOI 10.1002/masy.19971230108
   DEGEE P, 1991, THESIS U LIEGE BELGI
   Demonceau A, 1997, MACROMOLECULES, V30, P3127, DOI 10.1021/ma961040j
   DUBOIS P, 1991, MACROMOLECULES, V24, P2266, DOI 10.1021/ma00009a022
   Dubois P, 1996, MACROMOLECULES, V29, P1965, DOI 10.1021/ma951738h
   DUBOIS P, 1992, MACROMOLECULES, V25, P2614, DOI 10.1021/ma00036a009
   DUBOIS P, 1991, MACROMOLECULES, V24, P977, DOI 10.1021/ma00005a002
   DUBOIS P, 1989, POLYM BULL, V22, P475, DOI 10.1007/BF00718922
   DUBOIS P, 1994, POLYMER, V35, P4998, DOI 10.1016/0032-3861(94)90655-6
   DUBOIS P, 1995, MACROMOLECULES, V28, P1965
   DUBOIS P, 1991, THESIS U LIEGE BELGI
   DUBOIS P, 1997, MACROMOLECULAR DESIG, P247
   DUDA A, 1995, MACROMOL RAPID COMM, V16, P67, DOI 10.1002/marc.1995.030160112
   DUDA A, 1995, MACROMOLECULES, V28, P5981, DOI 10.1021/ma00122a001
   DUDA A, 1991, MAKROMOL CHEM-M SYMP, V47, P127, DOI 10.1002/masy.19910470111
   Duda A, 1996, MACROMOL CHEM PHYSIC, V197, P1273, DOI 10.1002/macp.1996.021970408
   Duda A, 1996, MACROMOLECULES, V29, P1399, DOI 10.1021/ma951442b
   EGIBURU JL, 1996, POLYMER, V37, P3615
   EGIBURU JL, 1996, THESIS U BASQUE COUN
   ENDO M, 1987, MACROMOLECULES, V20, P2982, DOI 10.1021/ma00178a005
   FRECHET JMJ, 1994, SCIENCE, V263, P1710, DOI 10.1126/science.8134834
   FUJINO T, 1985, POLYM PREPR JPN, V25, P2330
   GELVIN ME, 1992, J AM CHEM SOC, V114, P3962
   GITSOV I, 1994, MACROMOL RAPID COMM, V15, P387, DOI 10.1002/marc.1994.030150501
   GITSOV I, 1992, ANGEW CHEM INT EDIT, V31, P1200, DOI 10.1002/anie.199212001
   Grubbs R. H., 1982, COMPREHENSIVE ORGANO, V8, P499
   HAMAIDE T, 1994, MACROMOL SYMP, V88, P191, DOI 10.1002/masy.19940880115
   HAMITOU A, 1977, J POLYM SCI POL CHEM, V32, P285
   HARRIS JF, 1986, MACROMOLECULES, V19, P2903, DOI 10.1021/ma00166a004
   Hawker CJ, 1997, MACROMOL CHEM PHYSIC, V198, P155, DOI 10.1002/macp.1997.021980112
   HAWKER CJ, 1998, MACROMOLECULES, V31, P214
   Hedrick JL, 1998, CHEM MATER, V10, P39, DOI 10.1021/cm960523z
   Hedrick JL, 1996, REACT FUNCT POLYM, V30, P43, DOI 10.1016/1381-5148(96)00020-X
   Hedrick JL, 1996, MACROMOLECULES, V29, P3642, DOI 10.1021/ma950903q
   HEDRICK JL, 1998, UNPUB J POLYM SCI PC
   Heroguez V, 1997, MACROMOLECULES, V30, P4791, DOI 10.1021/ma970098a
   HEUSCHEN J, 1981, MACROMOLECULES, V14, P242, DOI 10.1021/ma50003a003
   HOFMAN A, 1987, MAKROMOL CHEM-RAPID, V8, P387
   Ihre H, 1996, J AM CHEM SOC, V118, P6388, DOI 10.1021/ja954171t
   INOUE S, 1993, MAKROMOL CHEM-M SYMP, V73, P27, DOI 10.1002/masy.19930730105
   JACOBS C, 1991, MACROMOLECULES, V24, P3027, DOI 10.1021/ma00011a001
   JONTE JM, 1986, J MACROMOL SCI CHEM, VA23, P495
   Kessler B, 1998, MACROMOL SYMP, V130, P245, DOI 10.1002/masy.19981300122
   KIMURA Y, 1988, MACROMOLECULES, V21, P3338, DOI 10.1021/ma00189a037
   KOALCZUK M, 1994, MACROMOLECULES, V24, P572
   KOBAYASHI S, 1995, ADV POLYM SCI, V121, P1
   Kricheldorf HR, 1998, MACROMOL SYMP, V128, P121, DOI 10.1002/masy.19981280113
   KRICHELDORF HR, 1989, EUR POLYM J, V25, P585, DOI 10.1016/0014-3057(89)90010-4
   KRICHELDORF HR, 1990, MAKROMOL CHEM-M SYMP, V32, P285, DOI 10.1002/masy.19900320122
   KUHLING S, 1992, MAKROMOL CHEM, V193, P1207
   Kurcok P, 1997, MACROMOLECULES, V30, P5591, DOI 10.1021/ma970212p
   Kurcok P, 1996, POLYM INT, V41, P479, DOI 10.1002/(SICI)1097-0126(199612)41:4<479::AID-PI652>3.0.CO;2-W
   Kylma J, 1997, MACROMOLECULES, V30, P2876, DOI 10.1021/ma961569g
   LEBORGNE A, 1994, MACROMOL RAPID COMM, V15, P955
   Lecomte P, 1998, POLYM BULL, V40, P631, DOI 10.1007/s002890050301
   LOFGREN A, 1994, MACROMOLECULES, V27, P5556
   LOFGREN A, 1995, J MACROMOL SCI R M C, VC35, P379
   LOFGREN A, 1995, J APPL POLYM SCI, V55, P1589
   LUNDBERG RD, 1969, RING OPENING POLYM, V6, P266
   Matsumura S, 1998, MACROMOL SYMP, V130, P285, DOI 10.1002/masy.19981300125
   MCLAIN SJ, 1992, AM CHEM SOC DIV POLY, V33, P463
   Mecerreyes D, 1998, ANGEW CHEM INT EDIT, V37, P1274, DOI 10.1002/(SICI)1521-3773(19980518)37:9<1274::AID-ANIE1274>3.0.CO;2-J
   MECERREYES D, 1998, IN PRESS
   MECERREYES D, 1999, IN PRESS MACROMOL CH
   MECERREYES D, 1997, ACS POLYM MAT SCI EN, V77, P189
   MECERREYES D, 1999, UNPUB
   MECERREYES D, IN PRESS
   MECERREYES D, 1998, IN PRESS MAKROMOL CH
   MIOLA C, 1997, POLYMER, V38, P22
   Moad G, 1995, MACROMOLECULES, V28, P8722, DOI 10.1021/ma00130a003
   MOGSTAD AL, 1994, MACROMOLECULES, V27, P2313, DOI 10.1021/ma00086a050
   NIJENHUIS AJ, 1992, MACROMOLECULES, V25, P6419, DOI 10.1021/ma00050a006
   Nobes GAR, 1996, MACROMOLECULES, V29, P4829, DOI 10.1021/ma951774g
   NYSSEN C, 1996, THESIS U LIEGE LIEGE
   OUHADI T, 1976, MACROMOLECULES, V9, P927, DOI 10.1021/ma60054a009
   OUHADI T, 1975, MAKROMOL CHEM S, V1, P1991
   PALMGREN R, 1997, J POLYM SCI POL CHEM, V35, P9
   PITT CG, 1987, J POLYM SCI POL CHEM, V25, P955, DOI 10.1002/pola.1987.080250402
   RIQUELURBET L, 1994, POLYMER, V35, P4563
   ROPSON N, 1992, MACROMOLECULES, V25, P3820, DOI 10.1021/ma00040a034
   Ropson N, 1997, J POLYM SCI POL CHEM, V35, P183, DOI 10.1002/(SICI)1099-0518(19970115)35:1<183::AID-POLA18>3.0.CO;2-G
   ROPSON N, 1995, MACROMOLECULES, V28, P758
   Shen YQ, 1996, MACROMOLECULES, V29, P8289, DOI 10.1021/ma9518060
   Simic V, 1997, MACROMOLECULES, V30, P7338, DOI 10.1021/ma970615p
   Slomkowski S, 1997, MACROMOL SYMP, V123, P45, DOI 10.1002/masy.19971230106
   SMITH DM, 1995, MATER RES SOC SYMP P, V371, P261
   SMITH DM, 1995, MATER RES SOC S P, V37, P261
   Sobry R, 1996, J MOL STRUCT, V383, P63, DOI 10.1016/S0022-2860(96)09269-1
   Steinbuchel A, 1997, MACROMOL SYMP, V123, P61, DOI 10.1002/masy.19971230107
   Stevels WM, 1996, MACROMOLECULES, V29, P6132, DOI 10.1021/ma9605311
   Stevels WM, 1996, MACROMOLECULES, V29, P8296, DOI 10.1021/ma960701+
   Stevels WM, 1997, TRENDS POLYM SCI, V5, P300
   STOREY RF, 1994, POLYMER, V35, P830, DOI 10.1016/0032-3861(94)90882-6
   THAMM RC, 1977, ANGEW MAKROMOL CHEM, V58, P345, DOI 10.1002/apmc.1977.050580115
   Tian D, 1997, MACROMOLECULES, V30, P1947, DOI 10.1021/ma961614k
   Tian D, 1997, J POLYM SCI POL CHEM, V35, P2295, DOI 10.1002/(SICI)1099-0518(199708)35:11<2295::AID-POLA21>3.0.CO;2-8
   Tian D, 1996, POLYMER, V37, P3983, DOI 10.1016/0032-3861(96)00199-1
   Tian D, 1997, MACROMOLECULES, V30, P406, DOI 10.1021/ma961631+
   Tian D, 1997, MACROMOLECULES, V30, P2575, DOI 10.1021/ma961567w
   Tian D, 1998, MACROMOL SYMP, V130, P217, DOI 10.1002/masy.19981300120
   Tian D, 1997, CHEM MATER, V9, P1704, DOI 10.1021/cm9709030
   TIAN D, 1994, MACROMOLECULES, V27, P4134, DOI 10.1021/ma00093a015
   TIAN D, 1997, THESIS U LIEGE BELGI
   Tortosa K, 1997, J APPL POLYM SCI, V65, P2357, DOI 10.1002/(SICI)1097-4628(19970919)65:12<2357::AID-APP9>3.0.CO;2-8
   Trollsas M, 1998, J POLYM SCI POL CHEM, V36, P3187, DOI 10.1002/(SICI)1099-0518(199812)36:17<3187::AID-POLA21>3.0.CO;2-A
   Trollsas M, 1998, MACROMOLECULES, V31, P2756, DOI 10.1021/ma971645v
   Trollsas M, 1997, MACROMOLECULES, V30, P8508, DOI 10.1021/ma970798f
   TROLLSAS M, 1997, POLYM MAT SCI ENG, V77, P208
   UYAMA H, 1995, MACROMOLECULES, V28, P7046, DOI 10.1021/ma00125a002
   VANHOORNE P, 1992, MACROMOLECULES, V30, P1947
   Vert M., 1979, ACS POLYM PREPT, V20, P608
   Vert M., 1992, BIODEGRADABLE POLYM
   WANG JS, 1995, J AM CHEM SOC, V117, P5614, DOI 10.1021/ja00125a035
   WEBSTER OW, 1991, SCIENCE, V251, P887, DOI 10.1126/science.251.4996.887
   YAMASHITA Y, 1981, ACS SYM SER, V66, P199
   YASUDA H, 1993, PROG POLYM SCI, V18, P1097, DOI 10.1016/0079-6700(93)90011-Z
   YASUDA H, 1995, MACROMOL CHEM PHYSIC, V196, P2417, DOI 10.1002/macp.1995.021960802
NR 135
TC 238
Z9 241
U1 2
U2 65
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
J9 ADV POLYM SCI
PY 1999
VL 147
BP 1
EP 59
PG 59
WC Polymer Science
SC Polymer Science
GA BN41V
UT WOS:000081879100001
DA 2018-10-20
ER

PT S
AU Kline-Schoder, R
   Kynor, D
   Jaeger, M
   Winder, A
   Desilets, C
AF Kline-Schoder, R
   Kynor, D
   Jaeger, M
   Winder, A
   Desilets, C
BE Shung, KK
TI Physical vapor deposition of multi-layered lead-zirconate-titanate films
   for ultrasonic transducer fabrication
SO MEDICAL IMAGING 1999: ULTRASONIC TRANSDUCER ENGINEERING
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Medical Imaging 1999 Conference
CY FEB 21-25, 1999
CL SAN DIEGO, CA
SP SPIE, Amer Assoc Physicists Med, Amer Physiol Soc, FDA Ctr Devices & Radiol Hlth, Soc Imaging Sci & Technol, Natl Elect Mfg Assoc/Diagnost Imaging & Therapy Syst Div, Radiol Soc N Amer, Soc Comp Applicat Radiol
DE sputtering; multi-layer PZT; multi-dimensional array
AB Creare is developing microfabrication techniques to manufacture low-cost, multi-dimensional ultrasonic transducer arrays with single- and multi-layer piezoelectric elements for low impedance and high sensitivity. The manufacturing approach is scaleable for fabrication of transducer arrays in the frequency range of 10-500 MHz in dense or sparse array configurations. Our approach employs the following processes: (1) Physical Vapor Deposition (PVD or sputtering) of high-quality, piezoelectric films using reactive sputtering of metallic targets and (2) Novel use of state-of-the-art photolithography and masking to provide the interlayer electrodes, element interconnections, and array element fabrication. To date, Creare has successfully demonstrated that piezoelectrically active thick films of PZT material can be deposited by using a reactive sputtering approach. In addition, these thick, multi-layer PZT films have been formed into high aspect ratio elements using dicing to fabricate a 12 MHz transducer. Array designs based on these films show that expected performance should meet the requirements for high resolution biomedical imaging.
C1 Creare Res & Dev Inc, Hanover, NH 03755 USA.
RP Kline-Schoder, R (reprint author), Creare Res & Dev Inc, Hanover, NH 03755 USA.
CR FOSTER FS, 1984, ULTRASONIC IMAGING, V6, P234
   GOLDBERG RL, 1994, IEEE T ULTRASON FERR, V41, P761, DOI 10.1109/58.308512
   SHERAR MD, 1987, NATURE, V330, P493, DOI 10.1038/330493a0
NR 3
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3136-2
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3664
BP 221
EP 228
DI 10.1117/12.350679
PG 8
WC Engineering, Biomedical; Optics; Radiology, Nuclear Medicine & Medical
   Imaging
SC Engineering; Optics; Radiology, Nuclear Medicine & Medical Imaging
GA BN29M
UT WOS:000081443300026
DA 2018-10-20
ER

PT S
AU Mariella, R
AF Mariella, R
BE Ferrari, M
TI Instrumentation for biomedical and environmental applications based on
   microtechnology - Lessons learned
SO MICRO- AND NANOFABRICATED STRUCTURES AND DEVICES FOR BIOMEDICAL
   ENVIRONMENTAL APPLICATIONS II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Micro- and Nanofabricated Structures and Devices for
   Biomedical Environmental Applications II
CY JAN 25-26, 1999
CL SAN JOSE, CA
SP SPIE, Int Biomed Opt Soc
DE microtechnology; instrumentation
ID STREAM WAVE-GUIDE; COLLECTION
AB Over the last ten years, LLNL has been developing Microtechnology for instrumentation with applications in the biosciences and environment. In order to build and field high-performance instruments, we have often had to alter our original premises and assumptions, significantly. This meant that we were forced to abandon materials and dimensions that were appealing to us when we began the R&D, Examples include our work on silicon-based electrophoresis systems, etched-fluidics for sample/sheath flow nozzles in flow cytometers, and polymerase-chain-reaction thermal-cycling; chambers based an silicon-nitride. This presentation will discuss these and our work on other devices and instruments.
C1 Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94551 USA.
RP Mariella, R (reprint author), Univ Calif Lawrence Livermore Natl Lab, POB 808,Mail Stop L-222, Livermore, CA 94551 USA.
CR Belgrader P, 1998, J FORENSIC SCI, V43, P315
   BELGRADER P, UNPUB PCR ANAL BACTE
   CIARLO D, UNPUBN
   DAVIDSON JD, COMMUNICATION
   HUANG Z, UNPUB HIGH SIDE SCAT
   LANGLOIS RG, 1998, CYTOMETRY S, V9, P55
   Mariella R, 1996, CYTOMETRY, V24, P27, DOI 10.1002/(SICI)1097-0320(19960501)24:1<27::AID-CYTO3>3.0.CO;2-F
   Mariella R, 1997, P SOC PHOTO-OPT INS, V2982, P367, DOI 10.1117/12.273636
   MARIELLA RP, 1995, Patent No. 5475487
   NORTHRUP MA, 1996, Patent No. 5589136
   YAGER P, 1998, U WASH CTR PROC AN C
NR 11
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3076-5
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3606
BP 74
EP 81
PG 8
WC Chemistry, Analytical; Engineering, Biomedical; Medical Laboratory
   Technology; Optics
SC Chemistry; Engineering; Medical Laboratory Technology; Optics
GA BN19W
UT WOS:000081054000009
DA 2018-10-20
ER

PT S
AU Madou, M
   Zhang, YS
   Xu, T
   Kellogg, GJ
   Duffy, DC
AF Madou, M
   Zhang, YS
   Xu, T
   Kellogg, GJ
   Duffy, DC
BE Ahn, CH
   Frazier, AB
TI From batch to continuous manufacturing of micro-biomedical and
   micro-analytical devices
SO MICROFLUIDIC DEVICES AND SYSTEMS II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT SPIE Conference on Microfluidic Devices and Systems II
CY SEP 20-21, 1999
CL SANTA CLARA, CA
SP SPIE
DE micromachining; modular approach; continuous process; fluidic platform;
   drug delivery; bio-MEMS
ID SYSTEMS; DNA
AB We demonstrate how manufacturing of miniaturized biosensors, fluidic platforms, drug delivery systems and other micro biomedical devices is relying more and more on non-Si micromanufacturing techniques. The new methodologies are hybrid in nature and merge IC fabrication methods (e.g. lithography) with more traditional manufacturing (e.g, lamination, plastic molding and electroplating). These proposed methods may involve large sheets of materials or may even be continuous, i.e., the number of devices that can be produced per single substrate is larger than that of a Si batch. The techniques are also modular rather than integrated and involve methods such as lamination, drop delivery, pick and place, laser drilling and cutting and other methods borrowed from the IC packaging and PC board industries. These new processes will afford for the first time miniaturized sensors, fluidics and other micro-biomedical devices at a cost that will enable them to become pervasive in our daily lives. The greater modularity in combining different components and the wider choice of materials with the required properties ( e.g. biocompatibility, toughness, and optical transparency) will further accelerate the advent of many more innovative micro biomedical devices. In this paper we first discuss four important technology needs crucial to the realization of inexpensive disposable micro biomedical devices and then show early results obtained in our own laboratories towards the manufacture of three micro-biomedical and micro-analytical devices: disposable biosensors, CD based microfluidic platforms and responsive drug delivery pills.
C1 Ohio State Univ, Dept Mat Sci & Engn, Ctr Ind Sensors & Measurements, Columbus, OH 43210 USA.
RP Madou, M (reprint author), Ohio State Univ, Dept Mat Sci & Engn, Ctr Ind Sensors & Measurements, 2041 Coll Rd, Columbus, OH 43210 USA.
RI Madou, Marc/E-5869-2013
OI Madou, Marc/0000-0003-4847-3117
CR Becker H, 1998, P SOC PHOTO-OPT INS, V3515, P177, DOI 10.1117/12.322081
   BECKER H, 1998, SENSORS UPDATE, V3, P208
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Effenhauser CS, 1997, ANAL CHEM, V69, P3451, DOI 10.1021/ac9703919
   EHRFELD W, 1987, P IEEE MICR TEL WORK, P53
   ERHFELD W, 1995, RADIAT PHYS CHEM, V45, P349
   FRAZIER AB, 1994, SOL STAT SENS ACT WO, P90
   Jackman RJ, 1998, ANAL CHEM, V70, P2280, DOI 10.1021/ac971295a
   JUAN WH, 1994, SOL STAT SENS ACT WO, P82
   KOPP MU, 1997, CURRENT OPINION CHEM, P1410
   Lauks IR, 1998, ACCOUNTS CHEM RES, V31, P317, DOI 10.1021/ar9700670
   LOW LCK, IN PRESS
   Madou M., 1994, <IT>US Patent</IT>, Patent No. [5,304,293, 5304293]
   Madou MJ, 1998, P SOC PHOTO-OPT INS, V3259, P80, DOI 10.1117/12.307314
   Madou MJ, 1997, FUNDAMENTALS MICROFA
   Manz A., 1998, TOP CURR CHEM, p[194, 215]
   McCormick RM, 1997, ANAL CHEM, V69, P2626, DOI 10.1021/ac9701997
   Takayama S, 1999, P NATL ACAD SCI USA, V96, P5545, DOI 10.1073/pnas.96.10.5545
NR 18
TC 2
Z9 2
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3474-4
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3877
BP 44
EP 53
DI 10.1117/12.359353
PG 10
WC Engineering, Mechanical; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BP26J
UT WOS:000084509600006
DA 2018-10-20
ER

PT S
AU Bachman, M
   Chiang, YM
   Chu, C
   Li, GP
AF Bachman, M
   Chiang, YM
   Chu, C
   Li, GP
BE Ahn, CH
   Frazier, AB
TI Laminated microfluidic structures using a micromolding technique
SO MICROFLUIDIC DEVICES AND SYSTEMS II
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT SPIE Conference on Microfluidic Devices and Systems II
CY SEP 20-21, 1999
CL SANTA CLARA, CA
SP SPIE
DE microfluidics; micromolding; microfabrication; BioMEMS; plastic chips;
   laminated microdevices
AB Microfluidic networks suitable for biomedical applications have been fabricated in a variety of polymer materials using micromolding and lamination. By molding several layers of 2D microfluidic patterns in a variety of materials, then laminating together, a wide variety of complex 3D systems with micron sized resolution can be constructed. The process of micromolding and lamination, and the integrated fabrication process for biomedical microfluidic devices is presented. Emphasis is on the practical aspects of fabricating fluidic prototypes in the research laboratory.
C1 Univ Calif Irvine, Dept Elect & Comp Engn, Irvine, CA 92697 USA.
RP Bachman, M (reprint author), Univ Calif Irvine, Dept Elect & Comp Engn, Irvine, CA 92697 USA.
RI Li, Guann-Pyng/B-8466-2009
CR AVIRAM A, 1984, Patent No. 4440801
   Brittain S, 1998, PHYS WORLD, V11, P31
   Chan CM, 1996, SURF SCI REP, V24, P3
   Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Folch A, 1999, J MICROELECTROMECH S, V8, P85, DOI 10.1109/84.749407
   Folch A, 1999, J BIOMECH ENG-T ASME, V121, P28, DOI 10.1115/1.2798038
   FOLCH A, 1999, T ASME, V121
   HECKELE M, 1998, MICROSYSTEM TECHNOLO, V4
   LAPCZYNA M, 1998, APPL PHYSICS A
   Larsson O, 1997, TRANSDUCERS 97, V2, P1415
   LINDSAY J, 1982, Patent No. 4395313
   NAKAMOTO T, 1996, J MICROMECHANICS MIC, V6
   PIOTTER V, 1997, MICROSYSTEM TECHNOLO, V3
   Zhao XM, 1997, APPL PHYS LETT, V71, P1017, DOI 10.1063/1.119713
NR 15
TC 3
Z9 3
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3474-4
J9 PROC SPIE
PY 1999
VL 3877
BP 139
EP 146
DI 10.1117/12.359331
PG 8
WC Engineering, Mechanical; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BP26J
UT WOS:000084509600017
DA 2018-10-20
ER

PT S
AU Brazzle, JD
   Mohanty, S
   Frazier, AB
AF Brazzle, JD
   Mohanty, S
   Frazier, AB
BE Ahn, CH
   Frazier, AB
TI Hollow metallic micromachined needles with multiple output ports
SO MICROFLUIDIC DEVICES AND SYSTEMS II
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT SPIE Conference on Microfluidic Devices and Systems II
CY SEP 20-21, 1999
CL SANTA CLARA, CA
SP SPIE
DE microneedles; Navier-Stokes; microchannels; fluid modeling;
   micromachining; drug delivery
AB In this paper, hollow metallic micromachined needles with multiple output ports are designed, fabricated, characterized, and packaged. The hollow metallic needles include design features such as tapered needle tips and multiple output ports on the bottom and top of each needle. The needle tip and shaft are formed by microelectroformed metal. The now characteristics of the needles are currently being experimentally investigated and modeled using a finite element numerical model. The experimental results and theoretical models will be presented as part of this paper. The micromachined needles can be fabricated on a variety of substrates and can use micro-electroformed palladium as the structural material. The use of palladium as a structural material provides high mechanical strength and durability, as well as, biocompatibility for use in biomedical applications. The cross-sectional dimensions of individual needle tips begin at less than 10 mu m in width and 15 mu m in height and then taper to 200 mu m in width and 60 mu m in height. The significance of this work includes the development of hollow metallic micromachined needles for biomedical applications, as well as, a discussion of structural, fluidic, and packaging design considerations.
C1 Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP Brazzle, JD (reprint author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
EM brazzle@eng.utah.edu; kumarlvs@xmission.com; frazier@ee.utah.edu
CR BLACK J, 1992, BIOL PERFORMANCE MAT
   Brazzle J, 1998, P ANN INT IEEE EMBS, V20, P1837, DOI 10.1109/IEMBS.1998.746949
   BRAZZLE JD, 1998, P SPIE MICR FLUID DE, P116
   Constantinescu V, 1995, LAMINAR VISCOUS FLOW
   Dennis J. K., 1993, NICKEL CHROMIUM PLAT
   HENRY S, 1998, IEEE MICR EL MECH SY
   KADIJA I, 1990, P 77 ANN C AM EL SUR
   LIN L, 1999, J MICROELECTROMECH S, V8, P78, DOI DOI 10.1109/84.749406
   LIN L, 1993, P 7 INT C SOL STAT S, P237
   McAllister D. V., 1999, P 10 INT C SOL STAT, P1098
   Papautsky I, 1999, SENSOR ACTUAT A-PHYS, V73, P101, DOI 10.1016/S0924-4247(98)00261-1
   RATNER B, 1996, BIOMATERIALS SCI INT, P346
   Safranek WH, 1974, PROPERTIES ELECTRODE
   TALBOT NH, 1998, IEEE TECH DIG SOLID, P265
NR 14
TC 11
Z9 11
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3474-4
J9 PROC SPIE
PY 1999
VL 3877
BP 257
EP 266
DI 10.1117/12.359344
PG 10
WC Engineering, Mechanical; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BP26J
UT WOS:000084509600030
DA 2018-10-20
ER

PT S
AU Nicolau, DV
   Cross, R
   Carter, N
   Taguchi, T
AF Nicolau, DV
   Cross, R
   Carter, N
   Taguchi, T
BE Conley, W
TI Protein patterning using bilayer lithography and confocal microscopy
SO MICROLITHOGRAPHY 1999: ADVANCES IN RESIST TECHNOLOGY AND PROCESSING XVI,
   PTS 1 AND 2
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Microlithography 1999
CY MAR 15-17, 1999
CL SANTA CLARA, CA
SP SPIE, Semiconductor Equipment & Mat Int
DE protein patterning; bilayer resist; confocal microscopy; biosensors;
   biomicrolithography
AB Protein patterns were printed using conventional microlithographic materials in a bilayer arrangement and unconventional exposure tools. The bilayer resist stack consists of a bottom Poly(tertButylMethAcrylate) layer and a top DNQ/novolak layer. The protein features were printed in both "contact printing", and "step & repeat" mode. The latter printing mode can be managed in a single-cell, "real-time" process, as follows: (i) the exposure step is carried out in a cell by focused beam of a confocal microscope tuned to 488nm exposure; (ii) the development step is performed flowing the photoresist developer through the cell; (iii) the selective deposition of the protein (a green fluorescent protein, FITC avidin) is achieved via the flow of the protein solution through the cell until a desired contrast has been reached; (iv) the control; step consists of an online monitoring of the red fluorescence for the control of the development of the top layer, and of the green fluorescence for the control of the protein patterning, respectively. The techniques have of a seamless portability in a biomedical environment, and for "step & repeat" protein patterning the advantage: of a high and controllable resolution. The process dan be applied in the fabrication of medical microanalysis devices.
C1 Marie Curie Res Inst, Mol Motors Grp, Surrey RH8 0TL, England.
RP Nicolau, DV (reprint author), Marie Curie Res Inst, Mol Motors Grp, Surrey RH8 0TL, England.
CR ALLEN RD, 1994, ACS SYM SER, V537, pCH11
   DAMMEL R, 1993, DIAZONAPHTOQUINOE BA
   FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438
   GALLOP MA, 1994, J MED CHEM, V37, P1233, DOI 10.1021/jm00035a001
   HATZAKIS M, 1969, J ELECTROCHEM SOC, V116, P1033, DOI 10.1149/1.2412145
   McGall G, 1996, P NATL ACAD SCI USA, V93, P13555, DOI 10.1073/pnas.93.24.13555
   Nicolau DV, 1998, LANGMUIR, V14, P1927, DOI 10.1021/la970802g
   NICOLAU DV, IN PRESS COL SURF A
   1986, Patent No. 4007047
NR 9
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3152-4
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3678
BP 602
EP 607
DI 10.1117/12.350244
PG 6
WC Engineering, Electrical & Electronic; Materials Science,
   Characterization & Testing; Optics; Physics, Applied
SC Engineering; Materials Science; Optics; Physics
GA BN32U
UT WOS:000081634600060
DA 2018-10-20
ER

PT S
AU Hafez, M
   Sidler, TC
AF Hafez, M
   Sidler, TC
BE Nelson, BJ
   Breguet, JM
TI Fast steering two-axis tilt mirror for laser pointing and scanning
SO MICROROBOTICS AND MICROASSEMBLY
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Microrobotics and Microassembly
CY SEP 21-22, 1999
CL BOSTON, MA
SP SPIE
DE compact scanner; two-axis tilt mirror; tracking; aim and shoot; beam
   handling
AB Compact fast-steering two axis-tilt mirrors are key components in astronomy, laser communications, material processing applications, imaging systems, biomedical and ophthalmologic applications. The laser scanner presented in this paper can perform a variety of functions such as tracking, beam stabilization and alignment, pointing and scanning. The small overall volume of 30 x 40 x 50 mm(3) can lead to a very stable and compact system design. The fact that the steered mirror has a single point of rotation for the two tilt axes is a clear advantage for systems with scanning lenses designed for this purpose. The scanner is composed of one single mirror driven by two pairs of push-pull linear electromagnetic actuators. The suspension of the mirror is based on a cone-ball bearing with optimized friction and wear behavior. A Position Sensitive Detector (PSD) integrated in the module is used for the closed loop feedback positioning. The mirror can be tilted by more than +/- 52 mrad (+/-3 degrees) with an accuracy better than 50 mu rad. A differential resolution of the order of 5 mu rad and a settling time for maximum deflection of 9 ms is achieved.
   Due to the large active area of the mirror (30 mm x 40 mm), very small spot diameters can be reached (less than 1 mu m) using high quality laser beams. Therefore, the scanner can be used e.g. in high precision micro-material processing of semiconductor and sensor industry.
C1 Swiss Fed Inst Technol, Microengn Dept, Inst Appl Opt, BM, CH-1015 Lausanne, Switzerland.
RP Hafez, M (reprint author), Swiss Fed Inst Technol, Microengn Dept, Inst Appl Opt, BM, CH-1015 Lausanne, Switzerland.
CR BELLOUARD Y, 1998, IN PRESS ICOMAT 98 7
   Hamdi E.S., 1994, DESIGN SMALL ELECT M
   HATTORI S, 1987, Patent No. 4660941
   Hoving W, 1997, P SOC PHOTO-OPT INS, V3097, P284
   Johnson K. L., 1985, CONTACT MECH
   Jufer M., 1995, TRAITE ELECT ELECTRO
   MASOTTI L, 1997, Patent No. 0790512
   SCHWEIZER J, 1997, Patent No. 5668655
   Smith S. T., 1992, FDN ULTRAPRECISION M
   SMITH ST, 1990, P I MECH ENG C-J MEC, V204, P243, DOI 10.1243/PIME_PROC_1990_204_102_02
   WALTI R, 1998, J BIOMEDICAL OPTICS, V3
   ZAGO L, 1997, SPAC MICR ACC CONTR
NR 12
TC 4
Z9 4
U1 0
U2 10
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3427-2
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3834
BP 172
EP 181
DI 10.1117/12.357822
PG 10
WC Automation & Control Systems; Engineering, Manufacturing; Optics
SC Automation & Control Systems; Engineering; Optics
GA BN92L
UT WOS:000083488400019
DA 2018-10-20
ER

PT S
AU Surbled, P
   Le Pioufle, B
   Yang, EH
   Fujita, H
AF Surbled, P
   Le Pioufle, B
   Yang, EH
   Fujita, H
BE Gorecki, C
TI Shape memory alloys for micromembranes actuation
SO MICROSYSTEMS METROLOGY AND INSPECTION
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Microsystems Metrology and Inspection
CY JUN 15-16, 1999
CL MUNICH, GERMANY
SP European Opt Soc, SPIE, Commiss European Communities, Directorate Gen Sci, Res & Dev, Wissenschaftliche Gesell Lasertech eV
DE microsystems; microactuator; micromembrane; shape memory alloy;
   micromachining
ID THIN-FILM; TINI; MICROACTUATORS; DEPOSITION; SILICON
AB More and more technologies and new materials have been combined with silicon process technologies to enhance the performances of microsystems and extend the application fields. Among these technologies, the Shape Memory Alloys (SMA's) as thin films have been developed recently. They have been shown to induce high displacement and large force/mass ratio under low voltage. They can produce work output higher than can be provided with other kinds of actuators. However, such SMA actuators are not easy to make because specific annealing treatments or mechanical bias springs are needed to realize cyclic device operation. Moreover, adhesion problems of SMA thin films may occur during the annealing treatment. We have developed a simple fabrication process allowing a reliable operation principle of a micromembrane. The cyclic actuation is ensured by membrane thickness residual stresses that avoids the assembling steps. These membranes whose surface varies from 200x200 mu m(2) up to 2x2 mm(2) have been successfully tested. As developed, they are very adapted to integration process of microelectronics and can be applied to many applications such as optical, fluidic devices, and especially for biomedical. applications as SMA's are biocompatible.
C1 Univ Tokyo, CNRS, Inst Ind Sci, LIMMS, Tokyo 1068558, Japan.
RP Surbled, P (reprint author), Univ Tokyo, CNRS, Inst Ind Sci, LIMMS, 7-22-1 Roppongi, Tokyo 1068558, Japan.
RI Le Pioufle, Bruno/B-6951-2013; Yang, Eui-Hyeok/B-5339-2012
OI Le Pioufle, Bruno/0000-0002-0010-2475; Yang,
   Eui-Hyeok/0000-0003-4893-1691
CR BARTH PW, 1995, 8 INT C SOL STAT SEN, V2, P276
   BUCHAILLOT L, 1996, MECATRONICS 96, P627
   BUSCH JD, 1990, J APPL PHYS, V68, P6224, DOI 10.1063/1.346914
   Gorecki C, 1997, OPT LETT, V22, P1784, DOI 10.1364/OL.22.001784
   GRUMMON DS, 1992, MATER RES SOC SYMP P, V268, P167, DOI 10.1557/PROC-268-167
   Ikuta K., 1994, IEEE MICRO ELEC MECH, P355
   IKUTA K, 1990, IEEE MICRO ELECTRON, P38
   ISHIDA A, 1993, THIN SOLID FILMS, V228, P210, DOI 10.1016/0040-6090(93)90600-T
   JARDINE AP, 1994, MATER CHARACT, V32, P169
   Krulevitch P, 1996, J MICROELECTROMECH S, V5, P270, DOI 10.1109/84.546407
   MAKINO E, 1999, S DES TEST MICR MEMS, P1030
   MIYAZAKI S, 1994, IEEE INT MICRO ELECT, P176
   NAKAMURA Y, 1997, IEEE MICR EL MECH SY, P262
   NESHEV I, 1993, VACUUM, V44, P209, DOI 10.1016/0042-207X(93)90155-4
   OLANDER A, 1932, J AM CHEM SOC, V56, P3819
   PEIRS J, 1994, P 4 INT C NEW ACT AC, P381
   Ryhanen J, 1998, J BIOMED MATER RES, V41, P481, DOI 10.1002/(SICI)1097-4636(19980905)41:3<481::AID-JBM19>3.0.CO;2-L
   Tsuchiya K, 1998, NANOTECHNOLOGY, V9, P67, DOI 10.1088/0957-4484/9/2/005
   WALKER JA, 1990, SENSOR ACTUAT A-PHYS, V21, P243, DOI 10.1016/0924-4247(90)85047-8
   WAYMAN CM, 1989, JOM-J MIN MET MAT S, V41, P26, DOI 10.1007/BF03220327
   Wolf RH, 1995, J MICROELECTROMECH S, V4, P206, DOI 10.1109/84.475547
NR 21
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3311-X
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3825
BP 63
EP 70
DI 10.1117/12.364304
PG 8
WC Engineering, Electrical & Electronic; Instruments & Instrumentation;
   Optics; Physics, Applied
SC Engineering; Instruments & Instrumentation; Optics; Physics
GA BN80S
UT WOS:000082991800007
DA 2018-10-20
ER

PT J
AU Dresser, R
AF Dresser, R
TI Public advocacy and allocation of federal funds for biomedical research
SO MILBANK QUARTERLY
LA English
DT Article
ID SCIENCE
AB Members of Congress and officials of the National Institutes of Health face heightened pressure from public advocacy groups seeking more funding for research on specific health conditions. In response, Congress and the Institute of Medicine have urged the NIH to create more opportunities for the public to participate in decision making on allocation of biomedical research resources. The ethical and policy implications of including advocates in the deliberations are explored, leading to the conclusion that public participation could contribute to more defensible decisions under three conditions: public participants are fairly selected and meaningful opinions are solicited; public participants look beyond their narrow constituencies to consider the health needs of the broader public; and NIH officials develop materials to assist participants with their deliberations.
C1 Washington Univ, Sch Law, St Louis, MO 63130 USA.
RP Dresser, R (reprint author), Washington Univ, Sch Law, 1 Brookings Dr,Campus Box 1120, St Louis, MO 63130 USA.
CR *AD HOC GROUP MED, 1997, AD HOC GROUP MED RES
   AGNEW B, 1996, J NIH RES, V8, P19
   Anglin MK, 1997, SOC SCI MED, V44, P1403, DOI 10.1016/S0277-9536(96)00321-8
   Callahan D, 1998, FALSE HOPES WHY AM Q
   CALLAHAN D, 1999, HLTH POLICY ANAL
   DICKSON D, 1988, NEW POLITICS SCI
   Dresser R, 1998, HASTINGS CENT REP, V28, P21, DOI 10.2307/3528647
   DRESSER R, 1992, HASTINGS CENT REP, V22, P24, DOI 10.2307/3562720
   Epstein S., 1996, IMPURE SCI AIDS ACTI
   *I MED, 1998, SCI OPP PUBL NEEDS I
   *I MED, 1997, APPR DEATH IMPR CAR
   Johnson J.A., 1998, 97917 C RES SERV
   KAISER J, 1996, SCIENCE, V274, P167
   LAUERMAN JF, 1998, HARVARD MAGAZINE JUL, P26
   Lawler A, 1998, SCIENCE, V281, P635, DOI 10.1126/science.281.5377.635
   Marshall E, 1997, SCIENCE, V276, P344, DOI 10.1126/science.276.5311.344
   MURPHY TF, 1991, HASTINGS CENT REP, V21, P7, DOI 10.2307/3562329
   *NIH, 1998, CALL NOM MEMB NIH DI
   *NIH, 1998, NIH POL INCL CHILDR
   *NIH, 1997, NIH PUB
   Resnik D. B, 1998, ETHICS SCI INTRO
   SAREWITZ D, 1997, ISSUES SCI TECHN SUM, P29
   Sclove Richard, 1995, DEMOCRACY TECHNOLOGY
   STAPLETON S, 1998, AMA NEWS         FEB, P1
   STAPLETON S, 1998, AMA NEWS         FEB, P29
   Stolberg Sheryl Gay, 1997, N Y Times Web, pB10
   Stolberg Sheryl Gay, 1997, N Y Times Web, pA18
   Weijer C, 1996, CAMB Q HEALTHC ETHIC, V5, P334, DOI 10.1017/S0963180100007155
   1998, SCI GOVT REPORT, P2
   1997, J NIH RES, V9, P21
   1998, NY TIMES        0106, pA20
NR 31
TC 21
Z9 21
U1 0
U2 0
PU BLACKWELL PUBLISHERS
PI MALDEN
PA 350 MAIN STREET, STE 6, MALDEN, MA 02148 USA
SN 0887-378X
J9 MILBANK Q
JI Milbank Q.
PY 1999
VL 77
IS 2
BP 257
EP +
DI 10.1111/1468-0009.00133
PG 19
WC Health Care Sciences & Services; Health Policy & Services
SC Health Care Sciences & Services
GA 209NL
UT WOS:000081054600005
PM 10392164
OA Green Published
DA 2018-10-20
ER

PT S
AU Pantelides, ST
   Winkler, R
   Ferconi, M
   Alvarez, JJV
AF Pantelides, ST
   Winkler, R
   Ferconi, M
   Alvarez, JJV
BE Bulatov, VV
   DiazdelaRubia, T
   Phillips, R
   Kaxiras, E
   Ghoniem, N
TI Nonlinear response of solids and molecules in intense infrared radiation
SO MULTISCALE MODELLING OF MATERIALS
SE Materials Research Society Symposium Proceedings
LA English
DT Proceedings Paper
CT Symposium on Multiscale Modelling of Materials, at the 1998 MRS Fall
   Meeting
CY NOV 30-DEC 03, 1998
CL BOSTON, MA
SP Mat Res Soc
ID DENSITY-FUNCTIONAL THEORY; MULTIPHOTON DISSOCIATION; LASER-RADIATION;
   HYDROGEN-ATOMS; DYNAMICS; BOND; CHEMISTRY; MODE; SYSTEMS; PULSES
AB Infrared radiation, which couples with vibrations in molecules and solids, has long been considered as a promising way to selectively control chemical reactions, materials processing, and biomedical applications. The expectation is that particular frequencies couple to specific atomic motions, in contrast to heat which imparts energy indiscriminately. The promise has yet to be fulfilled, but recent successes and the development of new lasers have rekindled interest. We report calculations of the dynamics of solids and molecules under intense infrared radiation. In solids, using a model calculation, we find that narrowly-defined "windows of opportunity" exist for resonant enhancement of impurity diffusion at moderate intensities. In molecules, using a generalization of Car-Parrinello dynamics, we find that, for very intense fields, energy absorption at normal modes is not very efficient and that selective bond-breaking may occur at nonresonant frequencies by "concerted kicks". Finally, time-dependent density functional theory is used to show that the effect of very intense infrared radiation on atoms and molecules is to produce very high harmonics as found experimentally.
C1 Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA.
RP Pantelides, ST (reprint author), Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA.
CR BLOEMBERGEN N, 1984, J PHYS CHEM-US, V88, P5459, DOI 10.1021/j150667a004
   BOTINA J, 1995, J CHEM PHYS, V102, P226, DOI 10.1063/1.469395
   Brewczyk M, 1997, PHYS REV LETT, V78, P191, DOI 10.1103/PhysRevLett.78.191
   BRONIKOWSKI MJ, 1993, J PHYS CHEM-US, V97, P2194, DOI 10.1021/j100112a021
   BRUMER P, 1995, SCI AM, V272, P56, DOI 10.1038/scientificamerican0395-56
   CAR R, 1985, PHYS REV LETT, V55, P2471, DOI 10.1103/PhysRevLett.55.2471
   CHELKOWSKI S, 1990, PHYS REV LETT, V65, P2355, DOI 10.1103/PhysRevLett.65.2355
   CHELKOWSKI S, 1993, J CHEM PHYS, V99, P4279, DOI 10.1063/1.466081
   CHUANG TJ, 1982, PHYS REV LETT, V49, P382, DOI 10.1103/PhysRevLett.49.382
   EDWARDS G, 1994, NATURE, V371, P416, DOI 10.1038/371416a0
   GILLAN MJ, 1986, J PHYS C SOLID STATE, V19, P6169, DOI 10.1088/0022-3719/19/31/012
   GIUSTISUZOR A, 1995, J PHYS B-AT MOL OPT, V28, P309, DOI 10.1088/0953-4075/28/3/006
   HEATHER R, 1988, J CHEM PHYS, V88, P5496, DOI 10.1063/1.454561
   KALUZA M, 1994, J CHEM PHYS, V100, P4211, DOI 10.1063/1.466305
   Kan C, 1997, PHYS REV LETT, V79, P2971, DOI 10.1103/PhysRevLett.79.2971
   KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133
   KULANDER KC, 1991, COMP PHYS COMMUN, V63
   KULANDER KC, 1994, MOL LASER FIELDS
   METZ RB, 1993, J CHEM PHYS, V99, P1744, DOI 10.1063/1.465291
   PAYNE MC, 1992, REV MOD PHYS, V64, P1045, DOI 10.1103/RevModPhys.64.1045
   POTTER ED, 1992, NATURE, V355, P66, DOI 10.1038/355066a0
   RAPPE AK, 1991, J PHYS CHEM-US, V95, P3358, DOI 10.1021/j100161a070
   RICE OK, 1972, UNIMOLECULAR REACTIO
   RUNGE E, 1984, PHYS REV LETT, V52, P997, DOI 10.1103/PhysRevLett.52.997
   SCHATZ GC, 1984, J PHYS CHEM-US, V88, P2971, DOI 10.1021/j150658a011
   SHI S, 1991, COMPUT PHYS COMMUN, V63, P71, DOI 10.1016/0010-4655(91)90239-H
   SINHA A, 1991, J CHEM PHYS, V94, P4928, DOI 10.1063/1.460578
   SINHA A, 1990, J CHEM PHYS, V92, P633
   SINHA A, 1993, J CHEM PHYS, V97, P2204
   TANNOR DJ, 1994, NATURE, V369, P445, DOI 10.1038/369445a0
   TULLY JC, 1987, J ELECTRON SPECTROSC, V45, P381, DOI 10.1016/0368-2048(87)80084-1
   UEDA A, 1994, NUCL INSTRUM METH B, V100, P427
   VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892
   Winkler R, 1997, J CHEM PHYS, V106, P7714, DOI 10.1063/1.473772
   ZARE RN, 1993, NATURE, V365, P105, DOI 10.1038/365105a0
   Zewail A. H., 1994, FEMTOCHEMISTRY ULTRA
   Zhang J, 1996, PHYS REV LETT, V77, P2186, DOI 10.1103/PhysRevLett.77.2186
NR 37
TC 0
Z9 0
U1 0
U2 0
PU MATERIALS RESEARCH SOC
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-444-0
J9 MATER RES SOC SYMP P
PY 1999
VL 538
BP 453
EP 464
PG 12
WC Materials Science, Multidisciplinary; Mechanics
SC Materials Science; Mechanics
GA BN10W
UT WOS:000080728000061
DA 2018-10-20
ER

PT J
AU Bhatt, R
   Scott, B
   Whitney, S
   Bryan, RN
   Cloney, L
   Lebedev, A
AF Bhatt, R
   Scott, B
   Whitney, S
   Bryan, RN
   Cloney, L
   Lebedev, A
TI Detection of nucleic acids by cycling probe technology on magnetic
   particles: High sensitivity and ease of separation
SO NUCLEOSIDES & NUCLEOTIDES
LA English
DT Article; Proceedings Paper
CT XIII International Round Table Conference on Nucleosides, Nucleotides
   and their Biological Applications
CY SEP 06-10, 1998
CL MONTPELLIER, FRANCE
AB Cycling Probe Technology (CPT) is a signal amplification system that allows detection of nucleic acid target sequences without target amplification. CPT employs a sequence specific chimeric probe, typically DNA-RNA-DNA, which hybridizes to a complementary target DNA sequence and becomes a substrate for RNase H. Cleavage occurs at the RNA internucleotide linkages and results in dissociation of the probe from the target, thereby making it available for the next probe molecule. This communication describes the use of oligonucleotides attached to solid supports for target capture and release followed by solution and solid phase cycling. Through the attachment of chimeric probes to Sera-Mag(TM) magnetic particles (SMP) a simple and effective method of separating the cleaved probe from non-cycled probe has been developed. By capturing the target DNA on particles and separating it from the extraneous non-specific DNA we are able to dramatically reduce background and thus discriminate between samples of Methicillin Resistant (MRSA) and Methicillin Sensitive (MSSA) Staphylococcus Aureus. We conjugated oligonucleotide probes to SMPs (similar to 1 um) and Nylon beads (NB) which were coated with ID Biomedical's proprietary coating materials (R, patent pending). The general structure of the constructs is shown below:
   [GRAPHICS]
C1 ID Biomed Inc, San Diego, CA 92121 USA.
   ID Biomed Corp, Burnaby, BC V5J 5J1, Canada.
RP Bhatt, R (reprint author), ID Biomed Inc, 11588 Sorrento Valley Rd 16, San Diego, CA 92121 USA.
NR 0
TC 9
Z9 9
U1 0
U2 4
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 0732-8311
J9 NUCLEOS NUCLEOT
JI Nucleosides Nucleotides
PY 1999
VL 18
IS 6-7
BP 1297
EP 1299
DI 10.1080/07328319908044696
PG 3
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 222VK
UT WOS:000081805900046
PM 10474219
DA 2018-10-20
ER

PT S
AU Ulatowska, A
   Andrzejewski, D
   Maruszewski, K
   Podbielska, H
   Strek, W
AF Ulatowska, A
   Andrzejewski, D
   Maruszewski, K
   Podbielska, H
   Strek, W
BE DalFante, M
   Foth, HJ
   Krasner, N
   Marchesini, R
   Podbielska, H
   Katzir, A
TI Advantages of sol-gel technologies for biomedical applications
SO OPTICAL AND IMAGING TECHNIQUES FOR BIOMONITORING IV, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Optical and Imaging Techniques for Biomonitoring IV
CY SEP 11-12, 1998
CL STOCKHOLM, SWEDEN
SP European Opt Soc, Soc Photo Opt Instrumentat Engineers, European Laser Assoc, Scandinavian Soc Laser Therapy, Int Biomed Opt Soc, Swedish Opt Soc, Commiss European Communities, Directorate Gen Sci Res & Dev
DE sol-gel technology; sol gel matrices; sensors; medical applications
ID ENZYMES; GLASSES
AB Sol-gel techniques have became very popular recently due to their high chemical homogeneity, low processing temperatures, possibility of controlling of the size and morphology of particles. The sol-gel-derived materials provide excellent matrices for a variety of organic and inorganic compounds. One of the most important features of doped sol-gel materials is their ability for preservation of chemical and physical properties of the dopants. This feature marks those materials as almost unique hosts for a number of biologically important molecules what can be exploited in number of biomedical applications. The advantages of sol-gel technology used for construction of biomedical sensors, laser materials or for retarded drug delivery, will be discussed.
C1 Wroclaw Tech Univ, Inst Phys, Bioopt Grp, PL-50370 Wroclaw, Poland.
RP Ulatowska, A (reprint author), Wroclaw Tech Univ, Inst Phys, Bioopt Grp, PL-50370 Wroclaw, Poland.
RI Podbielska, Halina/A-7311-2012
OI Podbielska, Halina/0000-0001-7162-8530
CR ABRAMOFF B, 1990, SPIE, V1328, P241
   Andrzejewski D, 1997, P SOC PHOTO-OPT INS, V2976, P137, DOI 10.1117/12.275549
   ANDRZEJEWSKI D, 1996, THESIS TU WROCLAW
   AVNIR D, 1992, ACS SYM SER, V499, P384
   Boiko AA, 1996, PROC SPIE, V2772, P263, DOI 10.1117/12.238109
   BRAUN S, 1990, MATER LETT, V10, P1, DOI 10.1016/0167-577X(90)90002-4
   BRAUN S, BIOTECHNOLOGY
   BRINKER CJ, 1990, SOL GEL SCI
   EBELMEN M, 1845, CR HEBD ACAD SCI, V21, P502
   Hensh LL, 1990, CHEM REV, V90, P33
   JORGENSEN CK, 1996, STRUCTURE BONDING, V85
   JORGENSEN CK, 1992, STRUCTURE BONDING, V77
   Klein L. C., 1994, SOL GEL OPTICS PROCE
   KURSAWE M, 1997, 6 INT WORKSH GLASS C
   Maruszewski K, 1996, P SOC PHOTO-OPT INS, V2927, P222, DOI 10.1117/12.260647
   POPE EJA, 1997, 9 INT WORKSH GLASS C
   REISFELD R, 1996, STRUCTURE BONDING, V85
   Sermon PA, 1995, P SOC PHOTO-OPT INS, V2633, P464, DOI 10.1117/12.228295
   SHTELZER S, 1992, BIOTECHNOL APPL BIOC, V15, P227
   Sieminska L, 1996, J PHYS CHEM-US, V100, P4591, DOI 10.1021/jp952759g
   WANG R, 1993, ANAL CHEM, V65, P2671, DOI 10.1021/ac00067a020
   WOLFBEIS OS, 1996, SOL GELS CHEM SENSOR, V85
NR 22
TC 4
Z9 4
U1 1
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3029-3
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3567
BP 50
EP 58
DI 10.1117/12.339188
PG 9
WC Engineering, Biomedical; Medical Laboratory Technology; Optics
SC Engineering; Medical Laboratory Technology; Optics
GA BM82D
UT WOS:000079846000007
DA 2018-10-20
ER

PT S
AU Hisaka, M
   Sugiura, T
   Kawata, S
AF Hisaka, M
   Sugiura, T
   Kawata, S
BE Yamaguchi, I
TI Ultrasound-assisted optical measurement for observation inside the
   scattering medium
SO OPTICAL ENGINEERING FOR SENSING AND NANOTECHNOLOGY (ICOSN'99)
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT International Conference on Optical Sensing and Nanotechnology (ICOSN
   99)
CY JUN 16-18, 1999
CL YOKOHAMA, JAPAN
SP Opt Soc Japan, SPIE
DE optical measurement; scattering media; ultrasound; biomedical optics
ID MODULATION; LIGHT
AB We have developed an optical measurement method to investigate the inside of scattering media by using focused ultrasound to specify the measuring point. This method enables us to observe the internal structure of human tissue non-invasively for biomedical applications. This method may give us various kinds of material information such as spectroscopic characteristics. To get the information from only particular region in a tissue sample with light, we use a focused ultrasound. At the focal region of the ultrasound, refractive index of the tissue changes with strong acoustic field. So a part of incident light reflects at the focal region of the ultrasound. The reflected light has information of the sample. According to the scanning of the sample, we can get an image of the sample. In our experiments, we have observed samples that consist of an agarose block which contains a piece of agarose cube stained with dye as absorbing material. The intensity of reflected light from the focal region of the ultrasound decreased when the measuring point was in the stained agarose section, because incident light was absorbed with the dye. Furthermore, we have observed a sample with a weak scattering object made of agarose in strong scattering agarose that contains PMMA particles.
C1 Osaka Univ, Dept Appl Phys, Suita, Osaka 5650871, Japan.
RP Hisaka, M (reprint author), Osaka Univ, Dept Appl Phys, Suita, Osaka 5650871, Japan.
CR HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   LEUTZ W, 1995, PHYSICA B, V204, P14, DOI 10.1016/0921-4526(94)00238-Q
   Leveque S, 1999, OPT LETT, V24, P181, DOI 10.1364/OL.24.000181
   WANG LH, 1995, OPT LETT, V20, P629, DOI 10.1364/OL.20.000629
NR 4
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3214-8
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3740
BP 146
EP 149
DI 10.1117/12.347786
PG 4
WC Instruments & Instrumentation; Optics
SC Instruments & Instrumentation; Optics
GA BN88B
UT WOS:000083313900031
DA 2018-10-20
ER

PT S
AU Griesser, HJ
   McLean, KM
   Beumer, GJ
   Gong, XY
   Kingshott, P
   Johnson, G
   Steele, JG
AF Griesser, HJ
   McLean, KM
   Beumer, GJ
   Gong, XY
   Kingshott, P
   Johnson, G
   Steele, JG
BE Lee, WW
   DAgostino, R
   Wertheimer, MR
TI Surface immobilization of synthetic proteins via plasma polymer
   interlayers
SO PLASMA DEPOSITION AND TREATMENT OF POLYMERS
SE Materials Research Society Symposium Proceedings
LA English
DT Proceedings Paper
CT Symposium on Plasma Deposition and Treatment of Polymers, at the 1998
   MRS Fall Meeting
CY NOV 30-DEC 02, 1998
CL BOSTON, MA
SP Mat Res Soc
ID COLLAGEN-BASED STRUCTURES; N-ISOBUTYLGLYCINE NLEU; CELL ATTACHMENT;
   CIRCULAR-DICHROISM; OPTICAL-ROTATION; PEPTIDES; SEQUENCES; OXIDATION;
   ADHESION
AB Coatings of biologically active molecules on synthetic "bulk'' materials are of much interest for biomedical applications since they can in principle elicit specific, predictable, controlled responses of the host environment to an implanted device. However. issues such as shelf life, storage conditions, biological safety, and enzymatic attack in the biological environment must be considered; synthetic proteins may offer advantages. In this study we investigated the covalent immobilization onto polymeric materials of synthetic proteins which possess some properties that mimic those of the natural protein collagen, particularly the ability to form triple helical structures, and thus may provide similar bio-responses while avoiding enzymatic degradation. In order to perform immobilization of these collagen-like molecules (CLMs) under mild reaction conditions, the bulk materials are first equipped with suitable surface groups using rf plasma methods. Plasma polymer interlayers offer advantages as versatile reactive platforms for the immobilization of proteins and other biologically active molecules. Application of a thin plasma polymer coating from an aldehyde monomer is particularly suitable as it enables direct immobilization of CLMs by reaction with their terminal amine groups, using reductive amination chemistry. An alternative route is via plasma polymer layers that contain carboxylic acid groups and using carbodiimide chemistry. A third route makes use of alkylamine plasma polymer interlayers, which are less process sensitive than aldehyde and acid plasma coatings. A layer of poly-carboxylic acid compounds such as carboxylic acid terminated PAMAM-starburst dendrimers or carboxymethylated dextran is then attached by carbodiimide chemistry onto the amine plasma layer. Amine-terminated CLMs can then be immobilized onto the poly-carboxylic acid layer. Surface analytical methods have been used to characterize the immobilization steps and to assess the surface coverage. Initial cell attachment and growth assays indicate that the biological performance of the CLMs depends on their amino acid sequence.
C1 CSIRO, Clayton Lab, Clayton, Vic 3169, Australia.
RP Griesser, HJ (reprint author), CSIRO, Clayton Lab, Private Bag 10, Clayton, Vic 3169, Australia.
EM h.griesser@molsci.csiro.au
RI McLean, Keith/H-1568-2011; Griesser, Hans/E-5628-2011
OI Griesser, Hans/0000-0003-1072-7863; Kingshott, Peter/0000-0001-5882-5804
CR *BECT DICK LABW, 1986, PRIM UN MOD TISS CUL
   BEUMER GJ, 1996, P 5 WORLD BIOM C MAY, P881
   El-Ghannam A, 1998, J BIOMED MATER RES, V41, P30, DOI 10.1002/(SICI)1097-4636(199807)41:1<30::AID-JBM4>3.0.CO;2-R
   Evans MDM, 1997, EXP CELL RES, V233, P88, DOI 10.1006/excr.1997.3523
   Feng YB, 1997, BIOCHEMISTRY-US, V36, P8716, DOI 10.1021/bi962980z
   Feng YB, 1996, BIOPOLYMERS, V39, P859, DOI 10.1002/(SICI)1097-0282(199612)39:6<859::AID-BIP10>3.3.CO;2-Z
   GENGENBACH TR, 1994, J POLYM SCI POL CHEM, V32, P1399, DOI 10.1002/pola.1994.080320801
   Gengenbach TR, 1996, SURF INTERFACE ANAL, V24, P611, DOI 10.1002/(SICI)1096-9918(19960916)24:9<611::AID-SIA169>3.0.CO;2-7
   Gong X, 1997, PLASMAS POLYM, V2, P261
   Goodman M, 1996, J AM CHEM SOC, V118, P10928, DOI 10.1021/ja961717i
   GRIESSER HJ, 1990, J APPL POLYM SCI APP, V46, P361
   Grzesiak JJ, 1997, BIOMATERIALS, V18, P1625, DOI 10.1016/S0142-9612(97)00103-8
   Huber M, 1998, J BIOMED MATER RES, V41, P278, DOI 10.1002/(SICI)1097-4636(199808)41:2<278::AID-JBM13>3.0.CO;2-H
   KINGSHOTT P, 1998, UNPUB J BIOMED MAT R
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MCLEAN KM, 1998, UNPUB COLL SURF B
   Melacini G, 1996, J AM CHEM SOC, V118, P10725, DOI 10.1021/ja9617193
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   NICOLSON P, 1995, Patent No. 5760100
   Olbrich KC, 1996, BIOMATERIALS, V17, P759, DOI 10.1016/0142-9612(96)81412-8
   SIMON RJ, 1992, P NATL ACAD SCI USA, V89, P9367, DOI 10.1073/pnas.89.20.9367
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
NR 23
TC 4
Z9 4
U1 0
U2 3
PU MATERIALS RESEARCH SOC
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-450-5
J9 MATER RES SOC SYMP P
PY 1999
VL 544
BP 9
EP 20
PG 12
WC Materials Science, Multidisciplinary; Polymer Science
SC Materials Science; Polymer Science
GA BN69B
UT WOS:000082590500002
DA 2018-10-20
ER

PT J
AU Zaikov, GE
   Gumargalieva, KZ
   Polishchuk, AY
   Adamyan, AA
   Vinokurova, TI
AF Zaikov, GE
   Gumargalieva, KZ
   Polishchuk, AY
   Adamyan, AA
   Vinokurova, TI
TI Biodegradation of polyolefins in biomedical applications
SO POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING
LA English
DT Article
AB Although polymer plastics find broad application in different areas of industry, and particularly in the medical industry, the behavior of these materials in biological media still requires better understanding. Biodegradation and biostability of polyolefins are reviewed with reference to the prediction of material durability, which requires permanent study of the stability of material properties.
C1 Russian Acad Sci, Nm Emanuel Inst Biochem Phys, Moscow 117334, Russia.
   Russian Acad Sci, NN Semenov Chem Phys Inst, Moscow 117334, Russia.
   Russian Acad Med Sci, AA Vishnevskii Inst Surg, Moscow 113093, Russia.
RP Zaikov, GE (reprint author), Russian Acad Sci, Nm Emanuel Inst Biochem Phys, 4 Kosygin St, Moscow 117334, Russia.
CR ALBERTSON AC, 1975, P 3 INT S BIOD KINGS, P743
   ALBERTSSON AC, 1987, POLYM DEGRAD STABIL, V18, P73, DOI 10.1016/0141-3910(87)90084-X
   AMRSHALL KC, 1979, MICROBIAL ADHESION A
   BINY J, 1968, ACTA PATHOL MICROB S, V16, P105
   BRUCK, 1977, J BIOMED MAT RES, V11, P1
   CALNAN J, 1963, Br J Plast Surg, V16, P1, DOI 10.1016/S0007-1226(63)80153-8
   DOLEZEL J, 1976, PLASTY KAUT, V13, P257
   FISHER IP, 1980, P 1 BIOM C HUTH VIEN, P20
   GUMARGALIEVA KZ, 1998, BIODEGRADATION POLYM
   Kinley Mc, 1981, VERH INT VER THEOR L, V21, P1348
   LAIFUT E, 1977, TRANSFER PHENOMENA L
   LEBANER D, 1985, MEDIZINTECHNIK, V105, P19
   LEFAUX R, 1964, CHIMIE TOXILOGIE MAT, P57
   LIEBERT TC, 1976, J BIOMED MATER RES, V10, P939, DOI 10.1002/jbm.820100611
   MAZUR FF, 1959, BIOL TESTS WOODPULP
   MEREZHKO TV, 1977, ACTUAL PROBLEMS MODE, P142
   MINAC M, 1978, P 2 INT S DEGR STAB, P8
   MOISEEV YV, 1977, CHEM STABILITY POLYM
   MOISEEV YV, 1984, CHEM RESISTANCE POLY
   Neuman Z., 1957, BRIT J PLAST SURG, V9, P195
   Polishchuk A. Y., 1997, MULTICOMPONENT TRANS
   POSTLETHWAIT RW, 1979, ANN SURG, V190, P10
   SALTHOUSE TN, 1975, J SURG RES, V19, P127, DOI 10.1016/0022-4804(75)90117-1
   SALTHOUSE TN, 1976, J BIOMED MATER RES, V10, P197, DOI 10.1002/jbm.820100204
   VINOKUROVA TI, 1977, P 3 S SYNTH POL MAT, P32
   WYKRISZ NB, 1974, PLAST POLYM, V42, P195
   ZAIKOV GE, 1998, POLYM MED
NR 27
TC 6
Z9 6
U1 0
U2 1
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 0360-2559
J9 POLYM-PLAST TECHNOL
JI Polym.-Plast. Technol. Eng.
PY 1999
VL 38
IS 4
BP 621
EP 646
DI 10.1080/03602559909351604
PG 26
WC Polymer Science
SC Polymer Science
GA 228CZ
UT WOS:000082120500003
DA 2018-10-20
ER

PT J
AU Kelly, PA
   Hills, DA
   O'Connor, JJ
AF Kelly, PA
   Hills, DA
   O'Connor, JJ
TI Elastic contact on a double-layered substrate
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART C-JOURNAL OF
   MECHANICAL ENGINEERING SCIENCE
LA English
DT Article
DE layer; contact; stress
AB Results are given for the contact law and state of stress induced in the contact resulting from application of a pressure distribution on a double-layered half-plane, or its indentation by a body of prescribed shape. The geometry is representative of that found widely in biomedical applications, particularly the knee prosthesis, and also in more general engineering problems. The solution is given in a numerically efficient form, and the stress states at the surface and within the structure that are associated with a number of different combinations of materials are displayed.
C1 Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England.
RP Kelly, PA (reprint author), Univ Auckland, Dept Engn Sci, Private Bag 92019, Auckland, New Zealand.
OI Kelly, Piaras/0000-0002-7120-9421
CR BARTEL DL, 1982, J BONE JOINT SURG AM, V64, P1026, DOI 10.2106/00004623-198264070-00009
   BENTALL RH, 1968, INT J MECH SCI, V10, P637, DOI 10.1016/0020-7403(68)90070-2
   Chen W. T., 1972, International Journal of Solids and Structures, V8, P1257, DOI 10.1016/0020-7683(72)90079-0
   EBERHARDT AW, 1991, J BIOMECH ENG-T ASME, V113, P410, DOI 10.1115/1.2895420
   FELLOWS LJ, 1995, WEAR, V185, P235, DOI 10.1016/0043-1648(95)06613-6
   Johnson K. L., 1985, CONTACT MECH
   Kelly PA, 1997, P I MECH ENG C-J MEC, V211, P301, DOI 10.1243/0954406971522060
   KELLY PA, 1996, 205995 OUEL U OXF IN
   LI H, 1990, INT J NUMER METH ENG, V29, P57, DOI 10.1002/nme.1620290106
   NOWELL D, 1988, INT J SOLIDS STRUCT, V24, P105, DOI 10.1016/0020-7683(88)90102-3
   Sneddon I. N., 1951, FOURIER TRANSFORMS
   URQUHART EE, 1994, INT J SOLIDS STRUCT, V31, P2445, DOI 10.1016/0020-7683(94)90030-2
NR 12
TC 2
Z9 2
U1 0
U2 0
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI BURY ST EDMUNDS
PA NORTHGATE AVENUE,, BURY ST EDMUNDS IP32 6BW, SUFFOLK, ENGLAND
SN 0954-4062
J9 P I MECH ENG C-J MEC
JI Proc. Inst. Mech. Eng. Part C-J. Eng. Mech. Eng. Sci.
PY 1999
VL 213
IS 4
BP 331
EP 342
DI 10.1243/0954406991522293
PG 12
WC Engineering, Mechanical
SC Engineering
GA 221CA
UT WOS:000081705400003
DA 2018-10-20
ER

PT J
AU Guinovart-Diaz, R
   Bravo-Castillero, J
   Rodriguez-Ramos, R
AF Guinovart-Diaz, R
   Bravo-Castillero, J
   Rodriguez-Ramos, R
TI Application of piezoelectric composite materials to sensors design
SO QUIMICA ANALITICA
LA English
DT Article; Proceedings Paper
CT 1st Ibero-American Congress on Sensors and Biosensors (IBERSENSOR 98)
CY NOV 09-13, 1998
CL UNIV HAVANA, HAVANA, CUBA
SP Inst Mat Reactivos, Fac Phys, Ctr Invest Microelectron, Ctr Estudios Aplicados Desarroll Energ Nucl, Inst Cibernet, Ctr Ultrason, Matemat Fis
HO UNIV HAVANA
DE piezocomposite; effective properties; biomedical applications
AB The purpose of this paper is to present analytical expressions of the effective constants of reinforced piezoelectric composite materials with periodical distributed unidirectional cylindrical fibers for transducer applications. Each periodic cell of the medium is a binary piezoelectric composite wherein both constituents are homogeneous piezoelectric materials with hexagonal symmetry. The general formulae obtained allow the prediction of global properties of an important class of piezocomposites. Numerical calculations show an adequate concordance with other theoretical models. Finally, we apply these results to a piezocomposite material and obtain new piezoelectrics with better global properties for biomedical imaging applications.
C1 Univ La Habana, Fac Matemat & Computac, La Habana 10400 4, Cuba.
RP Guinovart-Diaz, R (reprint author), Univ La Habana, Fac Matemat & Computac, La Habana 10400 4, Cuba.
CR BRAVO J, 1998, THESIS U HAVANA HAVA
   BRAVOCASTILLERO J, 1998, INT J SOLIDS STRUCT, V35, P527
   Pastor J, 1997, MECH RES COMMUN, V24, P145, DOI 10.1016/S0093-6413(97)00006-2
   SCHULGASSER K, 1992, J MECH PHYS SOLIDS, V40, P473, DOI 10.1016/S0022-5096(05)80022-5
   SMITH WA, 1991, IEEE T ULTRASON FERR, V38, P40, DOI 10.1109/58.67833
NR 5
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER INFORMACION PROFESSIONAL, S A
PI BARCELONA
PA C/ENTENCA, 28 ENTL, 08015 BARCELONA, SPAIN
SN 0212-0569
J9 QUIM ANAL
JI Quim. Anal.
PY 1999
VL 18
SU 1
BP 46
EP 47
PG 2
WC Chemistry, Analytical
SC Chemistry
GA 328CZ
UT WOS:000087832400012
DA 2018-10-20
ER

PT J
AU Costello, RG
   Emery, R
   Whitehead, L
AF Costello, RG
   Emery, R
   Whitehead, L
TI A field method for validating estimated P-32 activities in solid
   radioactive waste
SO RADIATION PROTECTION DOSIMETRY
LA English
DT Article
ID LARGE UNIVERSITY; COMPLEX
AB Solid radioactive wastes containing P-32 are commonly generated as a byproduct of biomedical research and academic endeavours. The amount of radioactivity contained in these wastes is usually based on generalised mass balance calculations and intimate knowledge of the experiments performed. But since most solid waste is actually incidental to the protocols conducted, activity estimates can be inaccurate. Hence, a rapid field test method to validate activity levels reported by generators would be useful; similar tests are regularly used for the validation of activities of wastes containing photon-emitting radionuclides. Although this methodology is not typically applied to wastes containing beta-emitting radionuclides, due to the significant potential for radiation attenuation by the solid waste material, the beta emission from P-32 is actually energetic enough readily to penetrate most paper, plastic and glass solid waste constituents. In this study, waste packages with variable predetermined amounts of P-32 were monitored at a set of pre-established points using standard portable survey instrumentation. A series of waste activity correction curves were developed and used as a basis for validating actual waste package activity content. The results of the study revealed that over 90% of the waste packages monitored exhibited significant discrepancies between the measured and reported activity content. Although the technique used in this study accurately indicated radioactive content over a wide range, it can be hampered by a significant probability of exhibiting false negative results. Nonetheless, the method can be used as a valuable tool for waste minimisation programmes when applied judiciously.
C1 Univ Texas, Hlth Sci Ctr, Houston, TX 77064 USA.
   Univ Texas, Hlth Sci Ctr, Houston, TX 77030 USA.
RP Costello, RG (reprint author), Univ Texas, Hlth Sci Ctr, 1851 Crosspoint Ave, Houston, TX 77064 USA.
CR *ANSI, 1983, ANSIN15351983
   Beretta A, 1997, RADIAT PROT DOSIM, V71, P223, DOI 10.1093/oxfordjournals.rpd.a032057
   CHASE GD, 1962, PRINCIPLES RADIOISOT
   EMERY R, 1992, HEALTH PHYS, V62, P183, DOI 10.1097/00004032-199202000-00009
   Evans RD, 1955, ATOMIC NUCL
   *INT AT EN AG, 1996, ST1 IAEA
   *INT AT EN AG, 1996, 383 IAEA
   Rees B, 1996, HEALTH PHYS, V70, P639, DOI 10.1097/00004032-199605000-00003
   RING J, 1993, HEALTH PHYS, V65, P193, DOI 10.1097/00004032-199308000-00011
   *TEX DEP HLTH BUR, 1992, TEX REG CONTR RA P21
   *US NUCL REG COMM, 1992, COD FED REG
NR 11
TC 0
Z9 0
U1 0
U2 1
PU NUCLEAR TECHNOLOGY PUBL
PI ASHFORD
PA PO BOX 7, ASHFORD, KENT, ENGLAND TN23 1YW
SN 0144-8420
J9 RADIAT PROT DOSIM
JI Radiat. Prot. Dosim.
PY 1999
VL 81
IS 1
BP 65
EP 70
DI 10.1093/oxfordjournals.rpd.a032572
PG 6
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 156VZ
UT WOS:000078024000008
DA 2018-10-20
ER

PT J
AU Lopez-Cozar, ED
   Ruiz-Perez, R
   Jimenez-Contreras, E
AF Lopez-Cozar, ED
   Ruiz-Perez, R
   Jimenez-Contreras, E
TI Editorial quality, diffusion and bibliometric indicators of the Revista
   Espanola de Enfermedades Digestivas
SO REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
LA English
DT Article
DE Revista Espanola de Enfermedades Digestivas; scientific journal
   evaluation; editorial quality; diffusion; visibility; bibliometric
   analysis; standards
ID INFORMATIVE ABSTRACTS; STRUCTURED ABSTRACTS; SCIENTIFIC JOURNALS;
   MEDICINA-CLINICA; ARTICLES; PUBLICATION; STANDARDS; SCIENCES
AB AIM: to evaluate the editorial quality, diffusion, relevance of the scientific content, and the publication practices of the specialised journal Revista Espanola de Enfermedades Digestivas.
   MATERIALS AND METHODS: We checked 136 parameters based on ISO standards, the recommendations of scientific and editorial organisations, and studies of scientific editing and international publishing practices for biomedical journals. Diffusion was calculated using national and international databases, specialised libraries in Spain, and Internet sources. The analysis of the scientific content and publication practices was based on bibliometric indicators for the journal, authorship, and contributions. The sample for this study comprised six alternate issues of volume number 88 (1996), the last issue of this volume, and the first issue of volume 89 (1997). The samples used for the bibtiometric analysis varied depending on the characteristics of specific indicators and the availability of information.
   RESULTS: the overall mean value for compliance with standards was 46.1%, while the real mean was calculated at 72.21%. The editorial procedures at the journal are similar to those of analogous international journals. The Revista Espanola de Enfermedades Digestivas is included in international databases of biomedical journals, and in the interdisciplinary international database SCI. It was found to be present in 70% of the medical libraries of Spanish universities, and in 73% of the hospital libraries studied. Bibliometric indicators showed co-authorship to be 5.5%; the origin of the authors grouped by province and by type of institutional affiliations showed 27.8% of all authors to be from Madrid, and that more were affiliated with general hospitals than with university hospitals. The mean delay between initial receipt of a manuscript and its publication was 300 days. Cocitation analysis gave the journal a central position amongst the 38 Spanish biomedical journals considered representative of the field. The journal's impact factor for 1996 was 0.260.
   CONCLUSIONS: the Revista Espanola de Enfermedades Digestivas is a high-quality vehicle of research results, and has acceptable internal editorial procedures. The journal is widely distributed, though its visibility on the Internet should be improved. Co-authorship is similar to that seen in other medical journals. Steps should be taken to make this journal better known within Spain, and to reduce the delay between the initial receipt and the final publication of manuscripts. Its impact factor is increasing steadily.
C1 Univ Granada, Dept Biblioteconomia & Documentac, E-18071 Granada, Spain.
RP Ruiz-Perez, R (reprint author), Univ Granada, Dept Biblioteconomia & Documentac, Campus Cartuja, E-18071 Granada, Spain.
RI Delgado Lopez-Cozar, Emilio/I-8406-2012; Ruiz-Perez, Rafael/C-6871-2009
OI Delgado Lopez-Cozar, Emilio/0000-0002-8184-551X; Ruiz-Perez,
   Rafael/0000-0002-2656-1645
CR ABT HA, 1992, SCIENTOMETRICS, V24, P441, DOI 10.1007/BF02051040
   ALAEZ LF, 1986, REV ESP DOC CIENT, V9, P9
   *AM MED ASS, 1989, MAN STYL
   *ANSI, 1996, Z39560 ANSI NISO
   BADIA JG, 1994, ATEN PRIM, V14, P1105
   CAMI J, 1993, MED CLIN-BARCELONA, V101, P721
   Clever L, 1997, NEW ENGL J MED, V336, P309
   *COMP SOFTW INT, 1996, CD 17 96 CAT PUBL PE
   *COUNC BIOL ED, 1987, MAN EST CBE
   DELAVIESCA R, 1979, REV ESP DOC CIENT, V2, P357
   Delgado Lopez-Cozar E., 1997, REV ESP DOC CIENT, V20, P39
   FEDERER A, 1996, CBE VIEWS, V19, P124
   FERNANDEZ CO, 1993, REV ESPANOLA DOCUMEN, V16, P221
   GARFIELD E, 1990, CURR CONTENTS, V22, P5
   GRUNEWALD MD, 1982, PGI79WS8
   GUERRERO R, 1994, MICROBIOLOGIA SEM, V10, P215
   GUIU JM, 1996, REV NEUROL, V24, P5
   GUIU JM, 1996, REV NEUROL BARC, V24, P765
   Hartley J, 1996, J INFORM SCI, V22, P27, DOI 10.1177/016555159602200103
   HAYNES RB, 1990, ANN INTERN MED, V113, P69, DOI 10.7326/0003-4819-113-1-69
   HAYNES RB, 1993, J CLIN EPIDEMIOL, V46, P595, DOI 10.1016/0895-4356(93)90030-5
   HAYNES RB, 1987, ANN INTERN MED, V106, P598
   HILLS J, 1971, 5091 OSTI
   HUTH E, 1987, STYLE FORMAT INT MAN
   KOVENDI D, 1975, B UNESCO BIBL, V29, P220
   Lopez-Cozar ED, 1997, REV NEUROLOGIA, V25, P1942
   LopezCozar ED, 1995, LIBRI, V45, P145, DOI 10.1515/libr.1995.45.3-4.145
   LOPEZCOZAR ED, 1997, PROGR OBSTET GINECOL
   LOPEZCOZAR ED, 1998, NORMALIZACION REV CI
   LOPEZCOZAR ED, 1997, REV ESP SALUD PUBLIC, V71, P511
   MCCAIN KW, 1990, J AM SOC INFORM SCI, V16, P217
   Medicina Clinica, 1993, MAN EST PUBL BIOM
   MULROW CD, 1988, ANN INTERN MED, V108, P613, DOI 10.7326/0003-4819-108-4-613
   PEREZ RR, 1997, ANALES MED INTERNA, V14, P384
   PEREZ RR, 1994, EVALUACION NORMATIVA
   PINERO JML, 1992, MED CLIN-BARCELONA, V98, P101
   PULIDO M, 1994, MED CLIN-BARCELONA, V103, P770
   PULIDO M, 1990, MED CLIN-BARCELONA, V95, P257
   Pulido M, 1991, Aten Primaria, V8, P589
   *REV NEUR, 1996, REV NEUROL, V24, P475
   SILVA A, 1991, MED CLIN-BARCELONA, V97, P744
   SPILKER B, 1992, MED CLIN-BARCELONA, V98, P303
   TADDIO A, 1994, CAN MED ASSOC J, V150, P1611
   TERRADA ML, 1992, INDICE CITAS INDICAD
   VILLA JJ, 1994, ATEN PRIM, V14, P1101
   Yus ES, 1996, MED CLIN-BARCELONA, V107, P319
   1996, REV NEUROL BARC, V24, P1014
NR 47
TC 3
Z9 3
U1 0
U2 5
PU EDITORIAL GARSI
PI MADRID
PA JUAN BRAVO, 46, 28006 MADRID, SPAIN
SN 1130-0108
J9 REV ESP ENFERM DIG
JI Rev. Esp. Enferm. Dig.
PD JAN
PY 1999
VL 91
IS 1
BP 17
EP 32
PG 16
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 172HZ
UT WOS:000078918600001
DA 2018-10-20
ER

PT B
AU Varadan, VK
   Varadan, VV
AF Varadan, VK
   Varadan, VV
BE Tomlinson, GR
   Bullough, WA
TI Microsensors, MEMS and their applications in smart structures and
   devices
SO SMART MATERIALS AND STRUCTURES
LA English
DT Proceedings Paper
CT 4th European Conference on Smart Structures and Materials in conjunction
   with the 2nd International Conference on Micromechanics, Intelligent
   Materials and Robotics
CY JUL 06-08, 1998
CL HARROGATE, ENGLAND
ID SILICON
AB This talk will overview the MEMS and Interdigital Transducer (IDT) sensors, introduce the basis of silicon, polymer and composite material technology and characterize the selected aspects of the signal conditioning for sensors with the applications to aerospace, marine and civil structures. This will be followed by an overview of the currently available MEMS sensors and processing technologies including wafer processing lithography, film growth and deposition, ion implantation, and etching. Finally, the integration of the sensors, MEMS, and smart electronics into structures will be discussed. Wireless communication between sensors and display will be outlined. Topics to be covered include:
   silicon, UV curable conducting polymer, composite material sensor
   health monitoring and condition-based maintenance of structures using MEMS sensors
   transient MEMS design and biomedical devices
   MEMS sensors for automobile, aircraft and underwater vehicles including accelerometers and gyroscope, etc.
   microfabricated 'smart tongue' and 'electronic nose' sensors for food, liquor and beverages.
C1 Penn State Univ, Engn Elect & Acoust Mat Res Ctr, University Pk, PA 16802 USA.
RP Varadan, VK (reprint author), Penn State Univ, Engn Elect & Acoust Mat Res Ctr, University Pk, PA 16802 USA.
CR AEIDEL H, 1987, P INT C SOL STAT SEN, P120
   BRYZEK J, 1994, IEEE SPECTRUM    MAY, P20
   FAN LS, P TRANSDUCERS 87, P849
   IKUTA K, 1993, P IEEE MICR EL MECH, V42
   MARKUS K, 1995, SPIE, V2639
   Middelhoek S., 1989, SILICON SENSORS
   PETERSEN KE, 1982, P IEEE, V70, P420, DOI 10.1109/PROC.1982.12331
   SHAW KA, 1994, SENSOR ACTUAT A-PHYS, V40, P63, DOI 10.1016/0924-4247(94)85031-3
   Varadan VK, 1997, P SOC PHOTO-OPT INS, V3046, P209, DOI 10.1117/12.276610
   VARADAN VK, 1998, SMART ELECT MEMS SPI, V3242
   VARADAN VK, 1997, SPIE PUBLICATION
   VARADAN VK, 1995, INT S MICR INT MAT R
   VARADAN VK, 1996, SPIE P, V2722
   1993, P IEEE MEMS
NR 14
TC 0
Z9 0
U1 0
U2 4
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
BN 0-7503-0547-9
PY 1999
BP 683
EP 691
PG 9
WC Automation & Control Systems; Computer Science, Artificial Intelligence;
   Materials Science, Multidisciplinary; Mechanics
SC Automation & Control Systems; Computer Science; Materials Science;
   Mechanics
GA BQ98C
UT WOS:000165242400087
DA 2018-10-20
ER

PT S
AU Canfield, S
   Edinger, B
   Frecker, M
   Koopmann, G
AF Canfield, S
   Edinger, B
   Frecker, M
   Koopmann, G
BE Wereley, NM
TI Design of piezoelectric inchworm actuator and compliant end-effector for
   Minimally Invasive Surgery
SO SMART STRUCTURES AND MATERIALS 1999: SMART STRUCTURES AND INTEGRATED
   SYSTEMS, PTS 1 AND 2
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 1999 Conference
CY MAR 01-04, 1999
CL NEWPORT BEACH, CA
SP SPIE, Soc Exptl Mech, Amer Soc Mech Engineers, BFGoodrich Aerosp, Def Adv Res Projects Agcy, US Army Res Off, USAF Res Lab, Ceram Soc Japan, Intelligent Mat Forum, Japan
DE Minimally Invasive Surgery (MIS); compliant mechanism; piezoelectric
   actuator; inchworm actuator
ID FORCE-FEEDBACK; MECHANISMS; ROBOTICS
AB Recent advances in robotics, tele-robotics, smart material actuators, and mechatronics raise new possibilities for innovative developments in millimeter-scale robotics capable of manipulating objects only fractions of a millimeter in size. These advances can have a wide range of applications in the biomedical community. A potential application of this technology is in minimally invasive surgery (MIS). The focus of this paper is the development of a single degree of freedom prototype to demonstrate the viability of smart materials, force feedback and compliant mechanisms for minimally invasive surgery. The prototype is a compliant gripper that is 7-mm by 17-mm, made from a single piece of titanium that is designed to function as a needle driver for small scale suturing. A custom designed piezoelectric "inchworm" actuator drives the gripper. The integrated system is computer controlled providing a user interface device capable of force feedback. The design methodology described draws from recent advances in three emerging fields in engineering: design of innovative tools for MIS, design of compliant mechanisms, and design of smart materials and actuators. The focus of this paper is on the design of a millimeter-scale inchworm actuator for use with a compliant end effector in MIS.
C1 Penn State Univ, Dept Mech & Nucl Engn, University Pk, PA 16802 USA.
RP Canfield, S (reprint author), Penn State Univ, Dept Mech & Nucl Engn, University Pk, PA 16802 USA.
CR Ananthasuresh G. K., 1994, Technical Digest. Solid-State Sensor and Actuator Workshop, P189
   ANANTHASURESH GK, 1994, P 1994 ASME WINT DSC, V55
   Arai F, 1998, IEEE-ASME T MECH, V3, P17, DOI 10.1109/3516.662864
   BALAZS M, 1998, IEEE ENG MED BIO MAY, P45
   Beebe DJ, 1995, SENSOR ACTUAT A-PHYS, V50, P55, DOI 10.1016/0924-4247(96)80085-9
   BICCHI A, 1996, IEEE INT C ROB AUT M
   Brett PN, 1997, P I MECH ENG H, V211, P309, DOI 10.1243/0954411971534430
   CAO C, 1996, KINESIOLOGY, P224
   Chen E, 1998, P IEEE, V86, P524, DOI 10.1109/5.662877
   COHN MB, 1995, J ROBOTIC SYST, V12, P401, DOI 10.1002/rob.4620120606
   Dario P, 1998, IEEE-ASME T MECH, V3, P9, DOI 10.1109/3516.662863
   Frecker MI, 1997, J MECH DESIGN, V119, P238, DOI 10.1115/1.2826242
   FRECKER MI, 1997, P ASME DES ENG TECHN
   HOWELL LL, 1994, J MECH DESIGN, V116, P280, DOI 10.1115/1.2919359
   KOOPMANN G, 1998, P SPIE 5 ANN INT S S, P3329
   KU S, 1996, IEEE INT C ROB AUT M
   Larsen UD, 1997, J MICROELECTROMECH S, V6, P99, DOI 10.1109/84.585787
   Lazeroms M, 1996, MECHATRONICS, V6, P437, DOI 10.1016/0957-4158(96)00008-6
   Majeed AW, 1996, LANCET, V347, P989, DOI 10.1016/S0140-6736(96)90143-9
   *NAT INSTR CORP, LABVIEW VER 5 1
   SAGGERE L, 1997, P 1997 ASME DES ENG
   Sastry SS, 1997, ROBOT AUTON SYST, V21, P305, DOI 10.1016/S0921-8890(96)00082-6
   STEINER C, 1994, NEW ENGL J MED, V30, P403
   *STRUCT DYN RES CO, I DEAS MAST SER VER
NR 24
TC 7
Z9 7
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3142-7
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3668
BP 835
EP 843
DI 10.1117/12.350759
PG 9
WC Acoustics; Engineering, Aerospace; Engineering, Mechanical; Optics
SC Acoustics; Engineering; Optics
GA BN32S
UT WOS:000081632900074
DA 2018-10-20
ER

PT S
AU Morgenthaler, GW
   Stodieck, L
AF Morgenthaler, GW
   Stodieck, L
BE ElGenk, MS
TI Potential commercial use of the International Space Station by the
   Biotechnology/Pharmaceutical/Biomedical Sector
SO SPACE TECHNOLOGY AND APPLICATIONS INTERNATIONAL FORUM - 1999, PTS ONE
   AND TWO
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT 1999 Space Technology and Applications International Forum (STAIF-99) -
   Opportunities and Challenges for the New Millennium
CY JAN 31-FEB 04, 1999
CL ALBUQUERQUE, NM
SP Boeing Co, Lockheed Martin Astronaut, NASA, USAF, Air Force Res Lab, US DOE, IAF 99, Amsterdam, Amer Inst Chem Engineers, AIAA, Amer Astronaut Soc, ASME Int, Amer Inst Aeronaut & Astronaut, Amer Inst Chem Engineers, Heat Transfer & Energ Convers Div, Amer Nucl Soc, Trin Sect, Amer Soc Mech Engineers, Nucl Engn Div & Heat Transfer Div, Inst Elect & Electr Engineers Inc, Nucl & Plasma Sci Soc, NASA Natl Space Grant Coll & Fellowship Program, New Mexico Space Grant Consortium, Profess Aerosp Contractors Assoc
ID GRAVITY
AB The International Space Station (ISS) is the linch-pin of NASA's future space plans. It emphasizes scientific research by providing a world-class scientific laboratory in which to perform long-term basic science experiments in the space environment of microgravity, radiation, vacuum, vantage-point, etc. It will serve as a test-bed for determining human system response to long-term space flight and for developing the life support equipment necessary for NASA's Human Exploration and Development of Space (HEDS) enterprise. The ISS will also provide facilities (up to 30% of the U.S. module) for testing material, agricultural, cellular, human, aquatic, and plant/animal systems to reveal phenomena heretofore shrouded by the veil of I-g. These insights will improve life on Earth and will provide a commercial basis for new products and services. In fact, some products, e.g., rare metal-alloys, semiconductor chips, or protein crystals that cannot now be produced on Earth may be found to be sufficiently valuable to be manufactured on-orbit. Biotechnology, pharmaceutical and biomedical experiments have been regularly flown on 10-16 day Space Shuttle flights and on three-month Mir flights for basic science knowledge and for life support system and commercial product development. Since 1985, NASA has created several Commercial Space Centers (CSCs) for the express purpose of bringing university, government and industrial researchers together to utilize space flight and space technology to develop new industrial products and processes. BioServe Space Technologies at the University of Colorado at Boulder and Kansas State University, Manhattan, Kansas, is such a NASA sponsored CSC that has worked with over 65 companies and institutions in the Biotech Sector in the past 11 years and has successfully discovered and transferred new product and process information to its industry partners. While tests in the space environment have been limited to about two weeks on Shuttle or a few months on Mir, tests on ISS can be performed over many months, or even years. More importantly, a test can be regularly scheduled so that the effects of microgravity and other space environment parameters can be thoroughly researched and quantified. This paper attempts to envision the potential benefits of this soon-to-be-available orbital laboratory and the broad commercial utilization of ISS that will likely occur.
C1 Univ Colorado, Dept Aerosp Engn Sci, Boulder, CO 80309 USA.
RP Morgenthaler, GW (reprint author), Univ Colorado, Dept Aerosp Engn Sci, CB 429, Boulder, CO 80309 USA.
CR ARMSTRONG JW, 1994, KANSAS AGR EXPT STAT, P584
   BATEMAN TA, 1998, BONE, V23, P1
   Campbell J, 1996, J PLANT PHYSIOL, V149, P539, DOI 10.1016/S0176-1617(96)80331-2
   HAMACHER H, 1986, MAT SCI SPACE
   HEYENGA AG, 1998, IN PRESS COSPAR
   HOEHN A, 972366 SAE
   IGNATIEV A, 1998, 49 IAF IAA INT SPAC
   KLAUS D, 1998, AIP C P, V420, P633
   Klaus DM, 1998, TRENDS BIOTECHNOL, V16, P369, DOI 10.1016/S0167-7799(98)01197-4
   Lam KS, 1998, APPL MICROBIOL BIOT, V49, P579, DOI 10.1007/s002530051216
   STODIEK LS, 1998, AIP C P, V420, P578
   STODIEK LS, 1998, AIP C P, V420, P627
   Todd P, 1989, ASGSB Bull, V2, P95
   Todd P, 1998, ADV SPACE RES-SERIES, V21, P1263, DOI 10.1016/S0273-1177(97)00397-9
   TODD P, 31 AER SCI M EXH, P1
   ZIMMERMAN RJ, 1994, 12 ANN S SPAC NUCL P, P1
NR 16
TC 0
Z9 0
U1 2
U2 4
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 1-56396-846-0
J9 AIP CONF PROC
PY 1999
VL 458
BP 239
EP 244
PG 6
WC Engineering, Aerospace; Thermodynamics; Engineering, Multidisciplinary;
   Geosciences, Multidisciplinary; Multidisciplinary Sciences; Nuclear
   Science & Technology; Remote Sensing; Physics, Applied; Physics,
   Multidisciplinary
SC Engineering; Thermodynamics; Geology; Science & Technology - Other
   Topics; Nuclear Science & Technology; Remote Sensing; Physics
GA BM78K
UT WOS:000079755200039
DA 2018-10-20
ER

PT S
AU Afanasyeva, N
   Bruch, R
   Katzir, A
AF Afanasyeva, N
   Bruch, R
   Katzir, A
BE Katzir, A
   Harrington, JA
TI Infrared fiberoptic evanescent wave spectroscopy: applications in
   biology and medicine
SO SPECIALTY FIBER OPTICS FOR MEDICAL APPLICATIONS, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Specialty Fiber Optics for Medical Applications
CY JAN 24-25, 1999
CL SAN JOSE, CA
SP SPIE, Int Biomed Opt Soc
ID FEW-FTIR SPECTROSCOPY; CANCER TISSUES; TRANSFORM; DIAGNOSTICS; FIBERS;
   VIVO
AB A new powerful and highly sensitive technique for non-invasive biomedical diagnostics in vivo has been developed using Infrared Fiberoptic Evanescent Wave Fourier Transform Spectroscopy (FEW-FTIR). This compact and portable method allows to detect functional chemical groups and bonds via vibrational spectroscopy directly from surfaces including living tissue. Such differences and similarities in molecular structure of tissue and materials can be evaluated online. Operating in the attenuated total reflection (ATR) regime in the middle-infrared (MIR) range, the FEW-FTIR technique provides direct contact between the fiber probe and tissue for non-destructive, noninvasive, fast and remote (few meters) diagnostics and quality control of materials.
   This method utilizes highly flexible and extremely low loss unclad fibers, for example silver halide fibers. Applications of this method include investigations of normal skin, precancerous and cancerous conditions, monitoring of the process of aging, allergic reactions and radiation damage to the skin. This setup is suitable as well for the detection of the influence of environmental factors (sun, water, pollution, and weather) on skin surfaces. The FEW-FTIR technique is very promising also for fast histological examinations in vitro. In this review, we present recent investigations of skin, breast, lung, stomach, kidney tissues in vivo and ex vivo (during surgery) to define the areas of tumor localization. The main advantages of the FEW-FTIR technique for biomedical, clinical, and environmental applications are discussed.
C1 Univ Nevada, Dept Phys 220, Reno, NV 89557 USA.
RP Afanasyeva, N (reprint author), Univ Nevada, Dept Phys 220, Reno, NV 89557 USA.
CR AFANASYEVA N, 1995, MACROMOL SYMP, V94, P269, DOI 10.1002/masy.19950940124
   AFANASYEVA N, 1998, IN PRESS MACRO MOL S
   AFANASYEVA N, 1995, C OPT BIOPS BIOS EUR, P22
   AFANASYEVA N, 1995, SPECTRAL BIODIAGNOST, V94
   Afanasyeva NI, 1997, P SOC PHOTO-OPT INS, V2979, P478, DOI 10.1117/12.280279
   Afanasyeva NI, 1998, P SOC PHOTO-OPT INS, V3250, P140, DOI 10.1117/12.305383
   Afanasyeva NI, 1998, P SOC PHOTO-OPT INS, V3257, P260, DOI 10.1117/12.306092
   AFANASYEVA NI, 1997, P SOC PHOTO-OPT INS, V3195, P314
   ARTJUSHENKO VG, 1993, P SOC PHOTO-OPT INS, V2085, P142
   BORMASHENKO E, 1999, IN PRESS P SPIE, V3596
   BROOKS A, 1998, IN PRESS JOU SURFACE
   Brooks AL, 1998, P SOC PHOTO-OPT INS, V3195, P323, DOI 10.1117/12.297892
   Bruch R, 1997, P SOC PHOTO-OPT INS, V2970, P408, DOI 10.1117/12.275022
   FRANK CJ, 1995, ANAL CHEM, V67, P777, DOI 10.1021/ac00101a001
   GERMAN A, 1997, BIOS 97, V2977, P106
   GOTSHAL Y, 1998, BIOS 98 C, V3262, P188
   HEISE HM, 1995, J MOL STRUCT, V348, P127, DOI 10.1016/0022-2860(95)08605-U
   HEISE HM, 1989, JOU ANAL CHEM, V61, P2010
   HELM D, 1991, J MICROBIOL METH, V14, P127, DOI 10.1016/0167-7012(91)90042-O
   Hocde S, 1998, P SOC PHOTO-OPT INS, V3262, P144, DOI 10.1117/12.309467
   HUNG J, 1991, LASER SURG MED, V11, P99, DOI 10.1002/lsm.1900110203
   KRIMM S, 1987, VIBRATIONAL SPECTRA
   LAKOWIEZ JR, 1995, P SPIE, V2388
   LeFoulgoc K, 1996, P SOC PHOTO-OPT INS, V2836, P26, DOI 10.1117/12.260610
   Lewis EN, 1996, APPL SPECTROSC, V50, P263, DOI 10.1366/0003702963906618
   Mahadevan-Jansen A, 1996, J Biomed Opt, V1, P31, DOI 10.1117/12.227815
   MANTSCH H, 1996, INFRARED SPECTROSCOP
   MARECHAL Y, 1987, VIBRATIONAL SPECTRA
   Mourant JR, 1995, LASER SURG MED, V17, P350, DOI 10.1002/lsm.1900170403
   MULLER G, 1998, IN PRESS P SPIE
   NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0
   PARKER FS, 1971, INFRARED SPECTROSCOP
   RIGAS B, 1990, P NATL ACAD SCI USA, V87, P8140, DOI 10.1073/pnas.87.20.8140
   SPIELVOGEL J, 1998, BIOS 98 C, V3262, P188
   TSUBOI M, 1969, APPL SPECTROSC REV, V3, P45
   WASCHE W, 1998, IN PRESS P SPIE
   ZHANG XH, 1995, P SOC PHOTO-OPT INS, V2396, P78, DOI 10.1117/12.208388
   1993, NONINVASIVE METHODS
   1998, NANOTECHNOLOGY SCI T, V9
   1989, CUTANEOUS INVESTIGAT
   1998, VIBRATIONAL SPECTROS
   1995, HDB NONINVASIVE METH
NR 42
TC 16
Z9 16
U1 2
U2 7
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3066-8
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3596
BP 152
EP 164
DI 10.1117/12.346712
PG 13
WC Engineering, Biomedical; Optics
SC Engineering; Optics
GA BN04G
UT WOS:000080481400019
DA 2018-10-20
ER

PT S
AU Rahman, SA
AF Rahman, SA
BE Cohn, GE
   Owicki, JC
TI A spectral unmixing algorithm for distributed endmembers with
   applications to biomedical imaging
SO SYSTEMS AND TECHNOLOGIES FOR CLINICAL DIAGNOSTICS AND DRUG DISCOVERY II,
   PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Systems and Technologies for Clinical Diagnostics and Drug
   Discovery II
CY JAN 24-25, 1999
CL SAN JOSE, CA
SP SPIE, Int Biomed Opt Soc
DE multispectral image processing; spectral unmixing; subpixel; anomaly
   detection; edge detection; biomedical imaging
AB Spectral unmixing algorithms tend to make the simplifying assumptions that each type of material (endmember) in a spectral library may be represented by a single reference spectrum and that the mixing process is linear. While these assumptions are convenient in that they allow techniques of linear algebra to be used, they lack realism as each material type in a spectral image will in general emit a distribution of spectra while the mixing itself need not be linear.
   We describe a 'common sense' spectral unmixing algorithm for the general case where endmembers are described by arbitrary D-dimensional probability distributions and the mixing can be non-linear. As an application we outline an unsupervised procedure for deriving the fractional material content of every pixel in an image and identifying anomalies given no a priori knowledge. Accurate endmember distributions are obtained by first masking out impure pixels using locally normalised Sobel and Laplacian filters and then Performing single-link hierarchical clustering on the pure pixels which remain. The most probable endmember decomposition for a given target spectrum is found by selecting an appropriate set of endmembers based on the target's immediate neighbourhood, and performing a constrained maximum likelihood search over the space of fractional abundances. We also explain how the procedure may be applied to subpixel and anomaly detection. To illustrate our ideas the techniques described are applied to biomedical images throughout.
C1 Raytheon Opt Syst Inc, Algorithm Dev & Data Proc, Danbury, CT 06810 USA.
RP Rahman, SA (reprint author), Raytheon Opt Syst Inc, Algorithm Dev & Data Proc, Danbury, CT 06810 USA.
CR BOREL CC, 1994, REMOTE SENS ENVIRON, V47, P403, DOI 10.1016/0034-4257(94)90107-4
   BOSDOGIANNI P, 1995, SIGN IM 5 HELL C INF
   Crist EP, 1998, P SOC PHOTO-OPT INS, V3438, P66, DOI 10.1117/12.328123
   Duda R. O., 1973, PATTERN CLASSIFICATI
   FABER V, 1994, LOS ALAMOS SCI, V22
   Gross HN, 1996, P SOC PHOTO-OPT INS, V2821, P30, DOI 10.1117/12.257182
   Levenson RM, 1998, P SOC PHOTO-OPT INS, V3438, P300, DOI 10.1117/12.328111
   MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020
   Press WH, 1992, NUMERICAL RECIPES C
   Rahman SA, 1998, P SOC PHOTO-OPT INS, V3438, P210, DOI 10.1117/12.328105
   SIBSON R, 1973, COMPUT J, V16, P30, DOI 10.1093/comjnl/16.1.30
NR 11
TC 0
Z9 0
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3073-0
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3603
BP 143
EP 154
DI 10.1117/12.346735
PG 12
WC Chemistry, Medicinal; Engineering, Biomedical; Medical Laboratory
   Technology; Optics
SC Pharmacology & Pharmacy; Engineering; Medical Laboratory Technology;
   Optics
GA BN04J
UT WOS:000080481600015
DA 2018-10-20
ER

PT S
AU Barnett, SM
   Bormett, RW
   Whitley, A
AF Barnett, SM
   Bormett, RW
   Whitley, A
BE Cabib, D
   Cogswell, CJ
   Conchello, JA
   Lerner, JM
   Wilson, T
TI Multi-dimensional Raman spectroscopy: From the UV to the near-IR
SO THREE-DIMENSIONAL AND MULTIDIMENSIONAL MICROSCOPY: IMAGE ACQUISITION AND
   PROCESSING VI, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on 3-Dimensional and Multidimensional Microscopy - Image
   Acquisition and Processing VI
CY JAN 24-25, 1999
CL SAN JOSE, CA
SP SPIE, Int Biomed Opt Soc
AB The structural elucidation of complex systems may be simplified with multi-dimensional spectroscopic techniques with some combination of spatial and spectral resolution. Raman spectroscopy permits the addition of another variable to this scenario -excitation wavelength. Data obtained using excitation wavelengths from the UV (244 nm) to near-IR (785 nm) regions will be presented showing the qualitative and quantitative study of diamond-like carbon (DLC), silicon, and other systems of an industrial or biomedical nature. The choice of appropriate wavelength provides an additional advantage over other spectroscopic techniques for elucidating specific structural information from these systems. The advantages of UV-Raman for materials science and thin film studies will be considered. The design of instruments and probes for the application of Raman spectroscopy to industrial process control and the development of Raman spectroscopic libraries for contaminant analysis will be discussed.
C1 Renishaw Inc, Schaumburg, IL 60173 USA.
RP Barnett, SM (reprint author), Renishaw Inc, 623 Cooper Ct, Schaumburg, IL 60173 USA.
CR BOND JS, 1998, 216 ACS NAT M BOST A
   Freeman TL, 1997, J RAMAN SPECTROSC, V28, P641, DOI 10.1002/(SICI)1097-4555(199708)28:8<641::AID-JRS197>3.0.CO;2-T
   Gilkes KWR, 1997, APPL PHYS LETT, V70, P1980, DOI 10.1063/1.118798
   Magidson V, 1998, APPL PHYS LETT, V73, P1044, DOI 10.1063/1.122079
   Otto C, 1997, J RAMAN SPECTROSC, V28, P143
   Poweleit CD, 1998, APPL PHYS LETT, V73, P2275, DOI 10.1063/1.121700
   Prawer S, 1996, DIAM RELAT MATER, V5, P433, DOI 10.1016/0925-9635(95)00363-0
NR 7
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3075-7
J9 P SOC PHOTO-OPT INS
PY 1999
VL 3605
BP 308
EP 316
DI 10.1117/12.347577
PG 9
WC Microscopy; Optics
SC Microscopy; Optics
GA BN09P
UT WOS:000080657900035
DA 2018-10-20
ER

PT J
AU Sung, HW
   Huang, RN
   Huang, LLH
   Tsai, CC
   Chiu, CT
AF Sung, HW
   Huang, RN
   Huang, LLH
   Tsai, CC
   Chiu, CT
TI Feasibility study of a natural crosslinking reagent for biological
   tissue fixation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biological tissue; crosslinking reagent; genipin; cytotoxicity;
   enzymatic degradation
ID IN-VITRO; COLLAGEN; DEGRADATION; GENIPOSIDE; TEMPERATURE; BIOMATERIAL;
   GENIPIN
AB Bioprostheses derived from biological tissues must be chemically modified and subsequently sterilized before they can be implanted in humans. Various crosslinking reagents, including formaldehyde, glutaraldehyde,dialdehyde starch, and epoxy compound, have been used to chemically modify biological tissues. However, these synthetic crosslinking reagents are all highly (or relatively highly) cytotoxic. It is therefore desirable to provide a crosslinking reagent suitable for use in biomedical applications that is of low cytotoxicity and that forms stable and biocompatible crosslinked products. This study evaluates the feasibility of using a naturally occurring crosslinking reagent-genipin-to chemically modify biological tissues. Genipin and ifs related iridoid compounds, extracted from gardenia fruits, have been used in traditional Chinese medicine for the treatments of jaundice and various inflammatory and hepatic diseases, In this feasibility study, the cytotoxicity of genipin and the crosslinking characteristics of genipin-fixed biological tissues were investigated. Fresh porcine pericardia procured from a slaughterhouse were used as raw materials. Glutaraldehyde and an epoxy compound (ethylene glycol diglycidyl ether), which has been used extensively in developing bioprostheses, were used as controls. It was found that the cytotoxicity of genipin was significantly lower than that of glutaraldehyde and the epoxy compound. The amino acid residues in the porcine pericardium that may react with genipin were lysine, hydroxylysine, and arginine. Additionally, the genipin-fixed tissue had a mechanical strength and resistance against enzymatic degradation comparable to the glutaraldehyde-fixed tissue. This suggests that genipin can form stable crosslinked products. The results of this in vitro study demonstrate that genipin is an effective crosslinking reagent for biological tissue fixation. (C) 1998 John Wiley & Sons, Inc.
C1 Natl Cent Univ, Dept Chem Engn, Chungli 32054, Taiwan.
   Natl Cent Univ, Inst Life Sci, Chungli 32054, Taiwan.
   Natl Taiwan Univ, Coll Med, Ctr Biomed Engn, Taipei, Taiwan.
RP Sung, HW (reprint author), Natl Cent Univ, Dept Chem Engn, Chungli 32054, Taiwan.
RI Huang, Lynn/J-9237-2016
OI Huang, Lynn/0000-0002-6602-7578; Huang, Rong Nan/0000-0002-5117-8672
CR ABURADA M, 1980, PHARMACOMETRICS, V19, P259
   AKAO T, 1994, BIOL PHARM BULL, V17, P1573
   BUCHI G, 1967, J AM CHEM SOC, V89, P2776
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P139, DOI 10.1002/jbm.820290202
   FUJIKAWA S, 1987, TETRAHEDRON LETT, V28, P4699, DOI 10.1016/S0040-4039(00)96601-2
   FUJIKAWA S, 1987, BIOTECHNOL LETT, V9, P697, DOI 10.1007/BF01024600
   HARPER E, 1972, BIOPOLYMERS, V11, P1607, DOI 10.1002/bip.1972.360110807
   LEE JM, 1995, MED ENG PHYS, V17, P115, DOI 10.1016/1350-4533(95)91882-H
   Lohre J M, 1993, ASAIO J, V39, P106, DOI 10.1097/00002480-199304000-00007
   LOHRE JM, 1992, ARTIF ORGANS, V16, P630
   MCCLAIN PE, 1972, J BIOL CHEM, V247, P692
   Nimni ME, 1988, COLLAGEN, VIII, P1
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   NOISHIKI Y, 1993, INT J ARTIF ORGANS, V16, P192
   NOISHIKI Y, 1986, T AM SOC ART INT ORG, V32, P114
   Noishiki Y., 1989, U. S. Patent, Patent No. [4,806,599, 4806599]
   Rosenberg D., 1978, VASCULAR GRAFTS, P261
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Sung H. W., 1993, ASIAN CARDIOVASC THO, V1, P104
   Sung HW, 1996, J BIOMED MATER RES, V31, P511, DOI 10.1002/(SICI)1097-4636(199608)31:4<511::AID-JBM11>3.0.CO;2-J
   Sung HW, 1997, ARTIF ORGANS, V21, P50
   Sung HW, 1997, J BIOMED MATER RES, V35, P147
   TOUYAMA R, 1994, CHEM PHARM BULL, V42, P668
   TSAI TH, 1994, J LIQ CHROMATOGR, V17, P2199
   TU R, 1994, J BIOMED MATER RES, V28, P677, DOI 10.1002/jbm.820280604
   YAMANO T, 1990, FOOD CHEM TOXICOL, V28, P515, DOI 10.1016/0278-6915(90)90122-4
   Yamazaki M, 1996, BIOL PHARM BULL, V19, P791
   YANNAS IV, 1975, J BIOMED MATER RES, V9, P623, DOI 10.1002/jbm.820090608
NR 28
TC 207
Z9 220
U1 4
U2 68
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 1998
VL 42
IS 4
BP 560
EP 567
DI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 135HJ
UT WOS:000076795500012
PM 9827680
DA 2018-10-20
ER

PT J
AU Mastroianni, AC
   Kahn, JP
AF Mastroianni, AC
   Kahn, JP
TI The importance of expanding current training in the responsible conduct
   of research
SO ACADEMIC MEDICINE
LA English
DT Article
ID TEACHING SCIENTIFIC INTEGRITY; SCIENCE
AB Despite the growing need to teach principles of the responsible conduct of research (RCR) to those training to be biomedical researchers, no descriptive, easily compared information about the nation's RCR programs exists. To draw some preliminary conclusions about the state of RCR education and training and to gain insight into what kinds of future initiatives are needed, the authors reviewed materials describing U.S. training programs in RCR that had been collected by the Department of Health and Human Services in June-August 1996.
   In direct response to a 1990 federal policy, formal RCR training programs have been established at many institutions that carry out research. This policy requires that recipients of National Research Service Award Institutional Research Training Grants from the National Institutes of Health provide RCR training to the predoctoral and postdoctoral trainees supported by these grants. The authors found that two thirds of the 45 institutions represented in the materials provided RCR training only to those trainees whom they were required to train, although among the rest of the institutions, a few required that all trainees receive such training. The training programs studied were quite diverse regarding who was responsible for the program (the principal investigator, the ethics faculty, etc.), what kinds of instruction were given (lectures, seminars, small-group discussions, etc.), course content, and how discipline-specific the focus was,
   The authors review the obstacles to effective RCR training (e.g., the needs for culture change and for sizable faculty, financial, course time, and administrative resources; the need for proper evaluation of programs) and discuss ways to foster such programs (e.g., sharing of resources; identifying competencies; tailoring teaching to the individual institution's and department's characteristics; public-private partnerships). They conclude that the institutional efforts needed to establish widespread and effective RCR training are more than justified by the result that such training will help foster: the integrity of the research process and a solid future for the research enterprise.
C1 Univ Minnesota, Ctr Bioeth, Minneapolis, MN 55455 USA.
   Univ Washington, Sch Law, Seattle, WA 98195 USA.
   Univ Washington, Publ Hlth Genet Program, Seattle, WA 98195 USA.
   Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA.
   Univ Minnesota, Sch Publ Hlth, Div Hlth Serv Res & Policy, Minneapolis, MN 55455 USA.
   Univ Minnesota, Dept Philosophy, Minneapolis, MN 55455 USA.
RP Kahn, JP (reprint author), Univ Minnesota, Ctr Bioeth, Suite N504 Boynton,410 Church St SE, Minneapolis, MN 55455 USA.
CR *ADV COMM HUM RAD, 1996, HUM RAD EXP
   *AM ASS ADV SCI, 1996, INT SCI RES 5 VID VI
   BENDITT J, 1995, SCIENCE, V268, P1705, DOI 10.1126/science.11644751
   BULGER RE, 1993, ACAD MED, V68, pS5, DOI 10.1097/00001888-199309000-00026
   BULGER RE, 1995, SOC CHOICES SOCIAL E
   BULGER RE, 1993, ETHICAL DIMENSIONS B
   COHEN J, 1995, SCIENCE, V268, P1715, DOI 10.1126/science.7792594
   COHEN J, 1995, SCIENCE, V268, P1706, DOI 10.1126/science.7540770
   Coughlin SS, 1996, AM J PREV MED, V12, P242
   *DEP HHS, 1995, INT MISC RES
   FRIEDMAN PJ, 1990, ACAD MED, V65, P32, DOI 10.1097/00001888-199001000-00009
   *I MED COMM RESP C, 1989, RESP COND RES HLTH S
   Korenman S. G., 1994, TEACHING RESPONSIBLE
   LENZ ER, 1995, J PROF NURS, V11, P213, DOI 10.1016/S8755-7223(95)80022-0
   MACRINA FL, 1995, J PROF NURS, V11, P40, DOI 10.1016/S8755-7223(95)80071-9
   MACRINA FL, 1995, SCI INTEGRITY INTRO
   MASTROIANNI AC, IN PRESS ACCOUNTABIL
   *NAT AC SCI, 1997, UNPUB PLANN WORKSH G
   *NAT AC SCI, 1995, BEING SCI
   *NAT AC SCI NAT AC, 1992, RESP SCI ENS INT RES
   *NIH, 1998, MENT SCI DEV AW RES
   *NIH, 1998, REM UPD REQ INSTR RE
   *NIH, 1998, SHORT TERM COURS RES
   PRITCHARD IA, 1993, ACAD MED, V68, pS67, DOI 10.1097/00001888-199309000-00037
   Range LM, 1995, ETHICS BEHAV, V5, P49, DOI 10.1207/s15327019eb0501_4
   SACHS GA, 1993, ACAD MED, V68, P871, DOI 10.1097/00001888-199312000-00001
NR 26
TC 26
Z9 26
U1 0
U2 10
PU HANLEY & BELFUS INC
PI PHILADELPHIA
PA 210 S 13TH ST, PHILADELPHIA, PA 19107 USA
SN 1040-2446
J9 ACAD MED
JI Acad. Med.
PD DEC
PY 1998
VL 73
IS 12
BP 1249
EP 1254
DI 10.1097/00001888-199812000-00013
PG 6
WC Education, Scientific Disciplines; Health Care Sciences & Services
SC Education & Educational Research; Health Care Sciences & Services
GA 150ZT
UT WOS:000077697000017
PM 9883199
OA Bronze
DA 2018-10-20
ER

PT J
AU Suarez, N
   Brocchini, S
   Kohn, J
AF Suarez, N
   Brocchini, S
   Kohn, J
TI The study of water uptake in degradable polymers by thermally stimulated
   depolarization currents
SO BIOMATERIALS
LA English
DT Article
DE thermally stimulated depolarization currents (TDSC); degradable
   polymers; tyrosine; degradable biomaterials; mechanisms of hydration;
   secondary relaxations; polyarylate
ID GLASS-TRANSITION; AQUEOUS-MEDIA; RELAXATION; POLYARYLATES; COPOLYMERS;
   MATRICES; NYLON-12; SYSTEMS; DESIGN; ACID)
AB Poly(DTH succinate) is a new, degradable polymer with potential applications as a medical implant material. This polymer can be classified as an alternating copolymer of succinic acid and desaminotyrosyl-tyrosine hexyl ester (DTH), a diphenolic monomer derived from the natural amino acid L-tyrosine. In this study, the effects of water uptake (hydration) on the secondary relaxations of poly(DTH succinate) were investigated using the technique of thermally stimulated depolarization currents (TDSC). Four relaxation peaks were precisely characterized by means of Gaussian activation energy distributions. Drying and rehydration treatments show that only small amounts of water, at most 0.5% (w/w), are necessary to hydrate two of the four polar moieties in poly(DTH succinate): the pendent chain ester carbonyls and the amide carbonyls in the polymer backbone. Water appeared to be more tightly bound to the amide carbonyl group and more loosely bound to the ester carbonyl group in the pendent chain. Even at a high state of hydration (1.2% w/w), TDSC indicated that no water was associated with the phenyl ester bond in the polymer backbone. This finding may explain the unexpectedly high stability of this polymer toward hydrolysis under physiological conditions. Polymer packing was also affected by hydration. In an intermediate hydration state (water content: 0.5% w/w) polymer packing was less dense than in the wet state (water content: 1.2% w/w). This study represents the first application of the TDSC technique to the study of hydration in a degradable biomedical polymer. The results obtained indicate that the TDSC technique may be useful to assist in the understanding of the mechanisms of hydration and subsequent hydrolytic degradation in degradable biomaterials. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 Rutgers State Univ, Dept Chem, New Brunswick, NJ 08903 USA.
   Univ Simon Bolivar, Dept Phys, Caracas, Venezuela.
RP Kohn, J (reprint author), Rutgers State Univ, Dept Chem, 610 Taylor Rd, Piscataway, NJ 08855 USA.
FU NIGMS NIH HHS [GM 49894]
CR ALDANA M, 1994, J POLYM SCI POL PHYS, V32, P2197, DOI 10.1002/polb.1994.090321307
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   CHO CS, 1988, J CONTROL RELEASE, V7, P283
   COLMENERO J, 1988, MAKROMOL CHEM-M SYMP, V20-1, P397, DOI 10.1002/masy.19880200142
   CROMMEN JHL, 1992, BIOMATERIALS, V13, P601, DOI 10.1016/0142-9612(92)90028-M
   DELVAL JJ, 1986, POLYMER, V27, P1771, DOI 10.1016/0032-3861(86)90275-2
   FIORDELISO J, 1994, J BIOMAT SCI-POLYM E, V5, P497
   FIORDELISO J, 1995, POLYM BIOMATERIALS S, P695
   Frank B, 1996, J POLYM SCI POL PHYS, V34, P1853, DOI 10.1002/(SICI)1099-0488(199608)34:11<1853::AID-POLB2>3.0.CO;2-T
   GINDE RM, 1987, J APPL POLYM SCI, V33, P2411, DOI 10.1002/app.1987.070330712
   HOOPER KA, 1998, 24 ANN M SOC BIOM SA, P387
   HOOPER KA, 1998, IN PRESS J BIOMED MA
   KEMNITZER J, 1997, HDB BIODEGRADABLE PO, V7, P251
   LACABANNE C, 1980, J POLYM SCI POL PHYS, V18, P277, DOI 10.1002/pol.1980.180180210
   LEHUY HM, 1994, POLYMER, V35, P136, DOI 10.1016/0032-3861(94)90061-2
   LEONG KW, 1985, J BIOMED MATER RES, V19, P941, DOI 10.1002/jbm.820190806
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   LIN HL, 1993, J BIOMED MATER RES, V27, P153, DOI 10.1002/jbm.820270204
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   PATHMANATHAN K, 1992, J POLYM SCI POL PHYS, V30, P341, DOI 10.1002/polb.1992.090300404
   PATHMANATHAN K, 1995, J CHEM SOC FARADAY T, V91, P337, DOI 10.1039/ft9959100337
   PEPPAS NA, 1980, J MEMBRANE SCI, V7, P241, DOI 10.1016/S0376-7388(00)80471-8
   PERLMAN MM, 1971, J APPL PHYS, V42, P2645, DOI 10.1063/1.1660602
   PISSIS P, 1991, J NON-CRYST SOLIDS, V131, P1174, DOI 10.1016/0022-3093(91)90749-V
   Pissis P, 1996, J POLYM SCI POL PHYS, V34, P1529, DOI 10.1002/(SICI)1099-0488(19960715)34:9<1529::AID-POLB1>3.0.CO;2-G
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   PUFFR R, 1967, J POLYM SCI C, V16, P79
   SCHACHTER DM, 1996, ADV CONTROLLED DELIV, P49
   SCHARTEL B, 1995, POLYMER, V36, P899, DOI 10.1016/0032-3861(95)93586-B
   Shimizu H, 1996, JPN J APPL PHYS 2, V35, pL231, DOI 10.1143/JJAP.35.L231
   SUAREZ N, 1993, FUEL, V72, P13, DOI 10.1016/0016-2361(93)90369-D
   SUAREZ N, 1997, J APPL POLYM SCI, V63, P1157
   Vanderschueren J., 1979, Thermally stimulated relaxation in solids, P135
   VANTURNHOUT J, 1980, TOP APPL PHYS, V33, P2685
   VERT M, 1991, J CONTROL RELEASE, V16, P15, DOI 10.1016/0168-3659(91)90027-B
NR 35
TC 19
Z9 19
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 1998
VL 19
IS 24
BP 2347
EP 2356
DI 10.1016/S0142-9612(98)00151-3
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 150BU
UT WOS:000077643200014
PM 9884049
DA 2018-10-20
ER

PT J
AU Mohanty, M
   Kumary, TV
   Lal, AV
   Sivakumar, R
AF Mohanty, M
   Kumary, TV
   Lal, AV
   Sivakumar, R
TI Short term tissue response to carbon fibre: A preliminary in vitro and
   in vivo study
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
DE carbon fibre; biocompatibility; bone
ID FIBER
AB Carbon in the form of pyrolytic carbon coating is used in a number of implantable medical devices. Carbon-reinforced carbon composite and other forms of diamond-like carbon coatings are being evaluated for their many potential biomedical applications. There is also a possibility of using carbon in fibre form. Though the possibility of using the fibre form of carbon in skeletal and dental implants has been recognized, a detailed study of tissue reaction to carbon fibre has not been reported so far. In this paper, we describe in vitro and irt vivo evaluation of carbon fibre in bone and muscle. Good cell and tissue biocompatibility of the material was observed in bone and muscle. New bone was present in contact with the fibres. Results of this study indicate that carbon fibre has potential in non-load bearing applications, such as skeletal repair and as ligament prosthesis.
C1 Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Pathophysiol, Trivandrum 695012, Kerala, India.
   Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Vivarium & Mat Grp, Trivandrum 695012, Kerala, India.
RP Mohanty, M (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Pathophysiol, Trivandrum 695012, Kerala, India.
CR BENSON J, 1972, BIOCERAMICS ENG ME 1, P41
   BRAND G, 1992, AM BOOK REV, V13, P9
   DIIRSELEN L, 1989, ADV BIOMATER, V9, P439
   Foster I W, 1978, Clin Orthop Relat Res, P299
   JENKINS DHR, 1977, 13 BIENN C CARB U PA, P178
   KEIFER H, 1987, ADV BIOMATER, V7, P253
   LODR GH, 1986, TECHNIQUES BIOCOMPAT, V1, P18
   LYMAN DJ, 1991, ACS SYM SER, V457, P116
   MINNS RJ, 1989, BIOMATERIALS, V10, P273, DOI 10.1016/0142-9612(89)90105-1
   MINNS RJ, 1982, BIOMATERIALS, V3, P81, DOI 10.1016/0142-9612(82)90038-2
   NEUGEBAUER R, 1981, BIOMATERIALS, V2, P182, DOI 10.1016/0142-9612(81)90049-1
   RUSHTON N, 1983, J BONE JOINT SURG BR, V65, P308
   TAYTON K, 1982, J BONE JT SURG B, V64, P112
   TURNER JE, 1973, J BIOMED MATER RES, V7, P39, DOI 10.1002/jbm.820070104
   WOLTER D, 1977, T 3 ANN M SOC BIOM, P126
   YANAGISAWA S, 1986, MAT SCI MONOGRAPHS, V33, P333
NR 16
TC 3
Z9 3
U1 0
U2 3
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0250-4707
J9 B MATER SCI
JI Bull. Mat. Sci.
PD DEC
PY 1998
VL 21
IS 6
BP 439
EP 444
DI 10.1007/BF02790343
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 146HE
UT WOS:000077422600001
DA 2018-10-20
ER

PT J
AU Antonietti, M
   Breulmann, M
   Goltner, CG
   Colfen, H
   Wong, KKW
   Walsh, D
   Mann, S
AF Antonietti, M
   Breulmann, M
   Goltner, CG
   Colfen, H
   Wong, KKW
   Walsh, D
   Mann, S
TI Inorganic/organic mesostructures with complex architectures:
   Precipitation of calcium phosphate in the presence of double-hydrophilic
   block copolymers
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE biomimetic synthesis; biomineralization; calcium; crystal growth;
   colloids
ID PARTICLES; OXIDE
AB Double-hydrophilic block copolymers consisting of a long poly(ethylene oxide) block and a short poly(methacrylic acid) block, modified by partial alkylation with dodecylamine (PEO-b-PMAA-C-12) were employed as dispersed templates for the controlled precipitation of calcium phosphate from aqueous solution at different pH values. Two new and nontrivial superstructures of an organized inorganic/organic hybrid material were characterized by ultracentrifugation, small- and wide-angle X-ray analysis, and electron microscopy. At pH 3.5 and 4.0, and pH 4.5, 5.0, and 6.3, two different types of discrete nested structures are obtained which consist of hybrid nanofilaments arranged to give an unusual neuronlike morphology. The fibers originate from a core of similar size to the primary polymer aggregates, suggesting that cooperative interactions at a local level between dissolving calcium phosphate clusters and disassembling polymer units could be responsible for the highly anisotropic nature of the secondary growth process. Aging of the nanofilaments grown in acidic solution results in a second hybrid morphology, consisting of compact aggregates with a diameter of about 130nm, which show the interlocked layer structure of an ordered inorganic/organic mesophase with a repeat period of about 3 nm. Such calcium phosphate/polymer nanohybrids with complex morphologies are interesting from the viewpoint of prebiotic structure formation, and might also be useful as novel ceramics precursors, reinforcing fillers, or biomedical implants.
C1 Max Planck Inst Kolloid & Grenzflachenforsch, D-14513 Teltow, Germany.
   Univ Bath, Sch Chem, Bath BA2 7AY, Avon, England.
RP Antonietti, M (reprint author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.
RI Mann, Stephen/D-1332-2012
OI Mann, Stephen/0000-0003-3012-8964
CR Antonietti M, 1997, MACROMOL RAPID COMM, V18, P295, DOI 10.1002/marc.1997.030180405
   BRACE R, 1973, J INORG NUCL CHEM, V35, P3691, DOI 10.1016/0022-1902(73)80058-2
   CHITTOFRATI A, 1990, COLLOID SURFACE, V48, P65, DOI 10.1016/0166-6622(90)80219-T
   Colfen H, 1998, LANGMUIR, V14, P582, DOI 10.1021/la970765t
   De Groot K., 1990, HDB BIOACTIVE CERAMI, P3
   Forster S, 1998, ADV MATER, V10, P195, DOI 10.1002/(SICI)1521-4095(199802)10:3<195::AID-ADMA195>3.0.CO;2-V
   Hopwood JD, 1997, CHEM MATER, V9, P1819, DOI 10.1021/cm970113q
   KNEBELKAMP A, 1996, MACROMOL S, V102, P91
   LYSTER RLJ, 1984, BIOCHIM BIOPHYS ACTA, V801, P315, DOI 10.1016/0304-4165(84)90082-5
   Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0
   MANN S, 1995, BIOMINERALIZATION CH
   Mann S, 1995, BIOMIMETIC MAT CHEM
   MANN S, 1989, BIOMINERALIZATION CH
   Nancollas G. H., 1989, BIOMINERALISATION, P157
   SAPIESZKO RS, 1980, J COLLOID INTERF SCI, V74, P405, DOI 10.1016/0021-9797(80)90210-6
   Sedlak M, 1998, MACROMOL CHEM PHYSIC, V199, P247, DOI 10.1002/(SICI)1521-3935(19980201)199:2<247::AID-MACP247>3.0.CO;2-9
   WALSH D, 1993, J CRYST GROWTH, V133, P1, DOI 10.1016/0022-0248(93)90097-G
   WEINER S, 1986, CRC CR REV BIOCH MOL, V20, P365, DOI 10.3109/10409238609081998
NR 18
TC 203
Z9 210
U1 2
U2 46
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 0947-6539
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD DEC
PY 1998
VL 4
IS 12
BP 2493
EP 2500
DI 10.1002/(SICI)1521-3765(19981204)4:12<2493::AID-CHEM2493>3.0.CO;2-V
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 147AN
UT WOS:000077466200013
DA 2018-10-20
ER

PT J
AU Chen, ZH
   Luo, RC
AF Chen, ZH
   Luo, RC
TI Design and implementation of capacitive proximity sensor using
   microelectromechanical systems technology
SO IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS
LA English
DT Article
DE fringe capacitance; microelectromechanical systems; proximity sensor
ID DISPLACEMENT TRANSDUCER
AB This paper presents an innovative proximity sensor using microelectromechanical systems (MEMS) technology. The proximity sensor works on the principle of fringe capacitance. The target object does not need to be part of the measuring system and could be either a conductor or nonconductor. Modeling of the proximity sensor is performed and closed-form analytical solution is obtained for a ring-shaped sensing pattern. The proximity sensors could be batch fabricated using MEMS technology, and the fabrication process is relatively simple. Measurement of the prototype sensors revealed promising results. The size of the proximity sensor could vary from a few hundred micrometers to the size of the substrate. The flexibility on sensor size, sensing patterns, and sensing pattern geometrical parameters makes the sensor very versatile and capable of precision measurement of proximity in the range from micrometers to centimeters. The small size of the sensor makes it possible to surface mount the sensor in many space-constrained places. This advantage is vital in many areas, such as MEMS, microrobotics, precision engineering, machine automation, inspection tools, and many other applications. The ability of the proximity sensor in measuring relative permittivity of materials also finds the sensor useful applications in biomedical and tissue engineering. In addition, this micro proximity sensor is an ideal building block for many other types of sensors, such as force, tactile, and flow sensors.
C1 Rockwell Automat Allen Bradley, Chelmsford, MA 01824 USA.
   Natl Chung Cheng Univ, Dept Elect Engn, Chiayi, Taiwan.
RP Chen, ZH (reprint author), Rockwell Automat Allen Bradley, Chelmsford, MA 01824 USA.
EM luo@cs.ccu.edu.tw
CR BERTONE GA, 1990, IEEE T INSTRUM MEAS, V39, P424, DOI 10.1109/19.52527
   Carslaw H. S., 1959, CONDUCTION HEAT SOLI
   FERTNER A, 1989, IEEE T INSTRUM MEAS, V38, P870, DOI 10.1109/19.31006
   FRANK R, 1991, SENSOR ACTUAT A-PHYS, V28, P93, DOI 10.1016/0924-4247(91)85018-J
   GARRATT JD, 1979, J PHYS E SCI INSTRUM, V12, P563, DOI 10.1088/0022-3735/12/7/002
   HUANG SM, 1992, IEE PROC-G, V139, P83, DOI 10.1049/ip-g-2.1992.0014
   HUISING JH, 1993, SENSOR ACTUAT A-PHYS, V30, P167
   KOBAYASHI T, 1986, SENSOR ACTUATOR, V9, P235, DOI 10.1016/0250-6874(86)80024-5
   Kung J. T., 1992, Journal of Microelectromechanical Systems, V1, P121, DOI 10.1109/84.186391
   LUO RC, 1993, P 1993 IEEE RSJ INT, P1709
   LUO RC, 1993, P 1993 JSME INT C AD, P621
   MICHELSON L, 1979, MACH DES, P117
   Noltingk B.E., 1976, P ACTA IMEKO, P537
   NOLTINGK BE, 1969, J PHYS E SCI INSTRUM, V2, P356, DOI 10.1088/0022-3735/2/4/314
   SYDENHAM PH, 1972, J PHYS E SCI INSTRUM, V5, P721, DOI 10.1088/0022-3735/5/8/001
NR 15
TC 64
Z9 70
U1 1
U2 13
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 0278-0046
J9 IEEE T IND ELECTRON
JI IEEE Trans. Ind. Electron.
PD DEC
PY 1998
VL 45
IS 6
BP 886
EP 894
DI 10.1109/41.735332
PG 9
WC Automation & Control Systems; Engineering, Electrical & Electronic;
   Instruments & Instrumentation
SC Automation & Control Systems; Engineering; Instruments & Instrumentation
GA 144EA
UT WOS:000077299800007
DA 2018-10-20
ER

PT J
AU Rowlands, JA
AF Rowlands, JA
TI Current advances and future trends in X-ray digital detectors for
   medical applications
SO IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT
LA English
DT Article
DE biomedical X-ray imaging; thin-film devices; photoconducting materials
ID AMORPHOUS SELENIUM; RADIOGRAPHY; MAMMOGRAPHY; SYSTEMS; ARRAYS
AB Despite the progress made in imaging modalities based on nonionizing radiation such as ultrasound and magnetic resonance imaging, X-ray is still the primary imaging method in most radiology departments. In recent years, digital electronics and manufacturing methods have led to many approaches for the design and construction of X-ray detectors. The ideal medical X-ray system is a digital, Bat-panel able to perform all current radiological modalities at reduced dose. It would, immediately after the patient's X-ray exposure, provide a high quality radiograph on a video monitor. It would also be usable for real-time imaging (e.g., digital cine loops and fluoroscopy), The physical form would be similar to a film/screen cassette (except for the addition of an umbilical cord) which could easily fit into the Bucky tray of existing X-ray rooms, There are two main approaches both based on active matrix technology developed for lap-top displays. The first, called the direct method employs a photoconductive layer of amorphous selenium (a-Se) to detect X-rays, The charge image formed on the surface of the a-Se is digitally read out in situ using a two-dimensional array of thin-film transistors (TFT's), i.e., an active matrix. The second flat panel method is called the indirect method and uses an active matrix to readout a phosphor layer. Phosphors give off light on interaction with X-rays and this is sensed by photo diodes on the active matrix, The relative practicality of the direct and indirect active matrix readout systems is an area of current investigation.
C1 Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada.
RP Rowlands, JA (reprint author), Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada.
CR ANTONUK LE, 1992, MED PHYS, V19, P1455, DOI 10.1118/1.596802
   BRODIE I, 1982, MED PHYS, V9, P79, DOI 10.1118/1.595054
   CHAN HP, 1987, MED PHYS, V14, P538, DOI 10.1118/1.596065
   FUJIEDA I, 1993, JPN J APPL PHYS 1, V32, P198, DOI 10.1143/JJAP.32.198
   KASAP SO, 1997, FUTURE DIRECTIONS TH
   NUDELMAN S, 1982, P IEEE, V70, P700, DOI 10.1109/PROC.1982.12377
   Powell M.J., 1992, MATER RES SOC S P, V258, P1127
   ROUGEOT H, 1993, AAPM MONOGRAPH, V22, P49
   ROWLANDS JA, 1989, MED PHYS, V16, P553, DOI 10.1118/1.596357
   Rowlands JA, 1996, AM J ROENTGENOL, V167, P409, DOI 10.2214/ajr.167.2.8686617
   SANADA S, 1991, MED PHYS, V18, P414, DOI 10.1118/1.596688
   SCHIEBEL U, 1994, P SOC PHOTO-OPT INS, V2163, P129, DOI 10.1117/12.174248
   SPEKOWIUS G, 1995, P SOC PHOTO-OPT INS, V2432, P12, DOI 10.1117/12.208339
   Yaffe MJ, 1997, PHYS MED BIOL, V42, P1, DOI 10.1088/0031-9155/42/1/001
   ZHAO W, 1995, MED PHYS, V22, P1595, DOI 10.1118/1.597628
NR 15
TC 9
Z9 11
U1 0
U2 4
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 0018-9456
J9 IEEE T INSTRUM MEAS
JI IEEE Trans. Instrum. Meas.
PD DEC
PY 1998
VL 47
IS 6
BP 1415
EP 1418
DI 10.1109/19.746705
PG 4
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA 167NU
UT WOS:000078640800003
DA 2018-10-20
ER

PT J
AU Laidlaw, DH
AF Laidlaw, DH
TI Comments on "Partial-Volume Bayesian classification of material mixtures
   in MR volume data using voxel histograms" - Author's reply
SO IEEE TRANSACTIONS ON MEDICAL IMAGING
LA English
DT Letter
DE Bayesian probability theory; biomedical signal processing; discrete
   signal processing; feature extraction; functional analysis; geometric
   modeling; image processing; partial volume; mixed modeling and
   estimation; multiscale analysis; multidimensional signal processing;
   multispectral classification; multivariate segmentation; tissue
   classification; volume measurement
C1 Henry Ford Hlth Syst, Dept Radiol, Image Anal Lab, Detroit, MI 48202 USA.
   Case Western Reserve Univ, Dept Radiol, Cleveland, OH 44106 USA.
   Univ Tehran, Dept Elect & Comp Engn, Tehran 14399, Iran.
RP Laidlaw, DH (reprint author), Henry Ford Hlth Syst, Dept Radiol, Image Anal Lab, Detroit, MI 48202 USA.
EM dhl@cs.brown.edu
CR ABDALLAH MA, 1993, IEEE T NUCL SCI, V40, P1204
   WINDHAM JP, 1988, J COMPUT ASSIST TOMO, V12, P1, DOI 10.1097/00004728-198801000-00001
NR 2
TC 2
Z9 2
U1 0
U2 0
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0278-0062
J9 IEEE T MED IMAGING
JI IEEE Trans. Med. Imaging
PD DEC
PY 1998
VL 17
IS 6
BP 1094
EP 1096
DI 10.1109/42.746728
PG 3
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Engineering, Electrical & Electronic; Imaging Science &
   Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging
SC Computer Science; Engineering; Imaging Science & Photographic
   Technology; Radiology, Nuclear Medicine & Medical Imaging
GA 166TH
UT WOS:000078592900027
DA 2018-10-20
ER

PT J
AU Spaans, CJ
   De Groot, JH
   Belgraver, VW
   Pennings, AJ
AF Spaans, CJ
   De Groot, JH
   Belgraver, VW
   Pennings, AJ
TI A new biomedical polyurethane with a high modulus based on
   1,4-butanediisocyanate and epsilon-caprolactone
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BIODEGRADABLE POLYMER IMPLANTS; MENISCUS RECONSTRUCTION
AB A new approach to the synthesis of biomedical polyurethanes based on epsilon-caprolactone and 1,4-butanediisocyanate with a high modulus, has been developed. By chain extending an epsilon-caprolactone prepolymer with a long uniform-size diisocyanate block, a segmented polyurethane with uniform-size hard segments was obtained. It shows excellent mechanical properties; an extremely high modulus of 105 MPa and a tensile strength of 35 MPa. The polymer is soluble at high concentrations in various volatile solvents such as chloroform and 1,4-dioxane. By a combination of salt-leaching and freeze-drying, porous materials have been obtained in which macropores ranging in size from 150-300 mu m are highly interconnected by micropores. The material shows a sufficiently high compression modulus of 200 kPa and appears to be suitable for biomedical applications such as meniscal prostheses. (C) 1998 Kluwer Academic Publishers.
C1 Univ Groningen, Dept Polymer Chem, NL-9747 AG Groningen, Netherlands.
RP Pennings, AJ (reprint author), Univ Groningen, Dept Polymer Chem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.
CR ALLEN CFH, 1995, ORGANIC SYNTHESES CO, V3, P846
   COENEN JMF, 1993, EUR BURN ASS 5 C
   COENEN JMF, 1990, 8 INT C BURN INJ NEW
   DEGROOT JH, 1990, COLLOID POLYM SCI, V268, P1073, DOI 10.1007/BF01410672
   deGroot JH, 1996, BIOMATERIALS, V17, P163, DOI 10.1016/0142-9612(96)85761-9
   deGroot JH, 1997, BIOMATERIALS, V18, P613, DOI 10.1016/S0142-9612(96)00169-X
   DEGROOT JH, IN PRESS POLYM B
   ELEMA H, 1990, COLLOID POLYM SCI, V268, P1082, DOI 10.1007/BF01410673
   GOGOLEWSKI S, 1988, P SPE INT C MED PLAS
   HESSELS J, 1991, THESIS U GRONINGEN N
   KLOMPMAKER J, 1992, J ORTHOP RES, V10, P359, DOI 10.1002/jor.1100100308
   Lelah M. D., 1986, POLYURETHANES MED
   PENNINGS AJ, 1990, COLLOID POLYM SCI, V268, P2, DOI 10.1007/BF01410416
   Spaans CJ, 1998, POLYM BULL, V41, P131, DOI 10.1007/s002890050343
   SPAANS CJ, IN PRESS
   Szycher M, 1988, J Biomater Appl, V3, P297, DOI 10.1177/088532828800300207
   WESOLOWSKI SA, 1961, SURGERY, V50, P91
NR 17
TC 35
Z9 36
U1 1
U2 11
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 1998
VL 9
IS 12
BP 675
EP 678
DI 10.1023/A:1008922128455
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 161CK
UT WOS:000078270600002
PM 15348920
DA 2018-10-20
ER

PT J
AU Pereira, CS
   Cunha, AM
   Reis, RL
   Vazquez, B
   San Roman, J
AF Pereira, CS
   Cunha, AM
   Reis, RL
   Vazquez, B
   San Roman, J
TI New starch-based thermoplastic hydrogels for use as bone cements or
   drug-delivery carriers
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID GRAFT-COPOLYMERIZATION; SWELLING BEHAVIOR; ACRYLIC-MONOMERS; AMINE
   ACTIVATORS; RELEASE; POLYMERS; POLYMERIZATION; METHACRYLATE; COMPOSITES;
   MIXTURES
AB The development of new biodegradable hydrogels, based on corn starch/cellulose acetate blends, produced by free-radical polymerization with methyl methacrylate monomer (MMA) and/or an acrylic acid monomer (AA), is reported. The polymerization was initiated by a redox system consisting of a benzoyl peroxide and 4-dimethlyaminobenzyl alcohol at low temperature. These hydrogels may constitute an alternative to the materials currently used as bone cements or drug-delivery carriers. Swelling studies were carried out, as a function of pH and temperature, in buffered solutions. The xerogels were further characterized by Fourier transform-infrared spectroscopy. Tensile and compression tests, and dynamic mechanical thermal analysis were used to assess the mechanical performance of the developed materials. The fracture surfaces were observed by scanning electron microscopy. The developed materials are sensitive to the pH, showing a clear reversible transition in a relatively narrow interval of pH, which is just in the range of physiological conditions. These properties make the materials developed in this study very promising for biomedical applications. Fickian-type diffusion is the mechanism predominant in these systems, except for the composition with a higher concentration of AA, that corresponds to the most desirable kinetical behavior for controlled release (case II-transport mechanism). Furthermore, the results obtained in the mechanical tests are in the range of those reported for typical PMMA bone cements, showing that it is possible to develop partially degradable cements with an adequate mechanical behavior. (C) 1998 Kluwer Academic Publishers.
C1 Univ Minho, Dept Polymer Engn, P-4800 Guimaraes, Portugal.
   INEB Inst Biomed Engn, Biomat Lab, P-4150 Porto, Portugal.
   CSIC, Inst Sci & Technol Polymers, E-28006 Madrid, Spain.
RP Reis, RL (reprint author), Univ Minho, Dept Polymer Engn, Campus Azurem, P-4800 Guimaraes, Portugal.
EM rgreis@fe.up.pt
RI Group, 3Bs/E-4374-2012; Reis, Rui L./A-8938-2008
OI Group, 3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129; Cunha
   M., Antonio/0000-0003-3860-7732; Vazquez, Blanca/0000-0001-5539-8026
CR Abusafieh A, 1997, J BIOMED MATER RES, V38, P314
   ANDREOPOULOS AG, 1994, CLIN MAT, V15, P691
   BASTIOLI C, 1994, RECYCLE 94 DAVOS GLO
   Bastiolli C., 1995, DEGRADABLE POLYM PRI, P112
   Blanco MD, 1996, BIOMATERIALS, V17, P1061, DOI 10.1016/0142-9612(96)85906-0
   CASTELLANO I, 1994, J APPL POLYM SCI, V54, P577, DOI 10.1002/app.1994.070540508
   CLARKE RL, 1989, BIOMATERIALS, V10, P494, DOI 10.1016/0142-9612(89)90092-6
   DISILVIO L, 1994, BIOMATERIALS, V15, P931, DOI 10.1016/0142-9612(94)90120-1
   Domb AJ, 1996, BIOMATERIALS, V17, P411, DOI 10.1016/0142-9612(96)89657-8
   Elvira C, 1996, J POLYM SCI POL CHEM, V34, P2783, DOI 10.1002/(SICI)1099-0518(19960930)34:13<2783::AID-POLA24>3.0.CO;2-7
   HELLER J, 1996, APPL MAT MED DENT 2, P346
   JANE J, 1995, J MACROMOL SCI PURE, VA32, P751, DOI 10.1080/10601329508010286
   Karadag E, 1996, BIOMATERIALS, V17, P67, DOI 10.1016/0142-9612(96)80757-5
   KIM SW, 1992, PHARMACEUT RES, V9, P283, DOI 10.1023/A:1015887213431
   Kost J, 1986, HYDROGELS MED PHARM, V3, P95
   LANGER R, 1995, MRS B            AUG, P18
   LAUTENSCHLAGER EP, 1974, J BIOMED MATER RES 1, P185
   Lewis G, 1997, J BIOMED MATER RES, V38, P221, DOI 10.1002/(SICI)1097-4636(199723)38:3<221::AID-JBM6>3.0.CO;2-R
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Liso PA, 1997, BIOMATERIALS, V18, P15, DOI 10.1016/S0142-9612(96)00082-8
   LOHMANN D, 1995, MACROMOL SYMP, V100, P25, DOI 10.1002/masy.19951000105
   MACK EJ, 1988, HYDROGELS MED PHARM, V2, P65
   MIGIARESI C, 1994, BIOMATERIALS, V15, P875
   NETTI PA, 1993, BIOMATERIALS, V14, P1098, DOI 10.1016/0142-9612(93)90211-J
   NORMAN TL, 1995, J BIOMED MATER RES, V29, P495, DOI 10.1002/jbm.820290409
   Ogawa Y, 1997, J BIOMAT SCI-POLYM E, V8, P391, DOI 10.1163/156856297X00173
   Pascual B, 1996, POLYMER, V37, P1005, DOI 10.1016/0032-3861(96)87284-3
   PEPPAS NA, 1988, HYDROGELS MED PHARM, V1, P1
   PEPPAS NA, 1988, MED PHARM PROPERTIES, V3, P109
   PEPPAS NA, 1996, BIOMATERIALS SCI INT, P60
   PEREIRA CS, 1998, IN PRESS NATO ASI SE
   Reis R. L., 1997, MED PLAST BIOMATER, V4, P46
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reis RL, 1997, ADV POLYM TECH, V16, P263, DOI 10.1002/(SICI)1098-2329(199711)16:4<263::AID-ADV2>3.3.CO;2-9
   Reis RL, 1996, POLYM ADVAN TECHNOL, V7, P784, DOI 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
   Reis RL, 1997, POLYM INT, V43, P347
   REIS RL, 1998, IN PRESS ANTEC 98 PL
   SAHA S, 1984, J BIOMED MATER RES, V18, P435, DOI 10.1002/jbm.820180411
   TOPOLESKI LDT, 1993, BIOMATERIALS, V14, P1165, DOI 10.1016/0142-9612(93)90162-U
   Vazquez B, 1997, J BIOMED MATER RES, V34, P129
   Vazquez B, 1997, POLYMER, V38, P4365, DOI 10.1016/S0032-3861(96)01014-2
   WOERLY S, 1993, BIOMATERIALS, V14, P1056, DOI 10.1016/0142-9612(93)90205-G
   Yang JM, 1997, BIOMATERIALS, V18, P1293, DOI 10.1016/S0142-9612(97)00060-4
NR 43
TC 92
Z9 95
U1 0
U2 29
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 1998
VL 9
IS 12
BP 825
EP 833
DI 10.1023/A:1008944127971
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 161CK
UT WOS:000078270600030
PM 15348948
DA 2018-10-20
ER

PT J
AU Shen, L
   Shah, AM
   Dahlback, B
   Nelsestuen, GL
AF Shen, L
   Shah, AM
   Dahlback, B
   Nelsestuen, GL
TI Enhancement of human protein C function by site-directed mutagenesis of
   the gamma-carboxyglutamic acid domain
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID K-DEPENDENT PROTEINS; CLOTTING FACTOR-X; PHOSPHOLIPID-VESICLES;
   MEMBRANE-BINDING; ANTICOAGULANT ACTIVITY; BLOOD-COAGULATION; FACTOR VA;
   RESIDUES; PHOSPHATIDYLETHANOLAMINE; PROTHROMBIN
AB This study reports properties of site-directed mutants of human protein C that display enhanced calcium and/or membrane binding properties. Mutants containing the S11G modification all showed increased affinity for membranes at saturating calcium concentration. Ser-ll is unique to human protein C, whereas all other vitamin R-dependent proteins contain glycine, This site is located in a compact region of the protein, close to a suggested membrane contact site. Additional changes of H10Q or S12N resulted in proteins with lower calcium requirement for membrane contact but without further increase in membrane affinity at saturating calcium. Mutations Q32E and N33D did not, by themselves, alter membrane affinity to a significant degree. These mutations were included in other mutant proteins and may contribute somewhat to higher function in these mutants. This family of mutants helped discriminate events that are necessary for protein-membrane binding. These include calcium binding to the free protein and subsequent protein-membrane contact. Depending on conditions of the assay used, the mutants displayed increased activity of the corresponding activated protein C (APC) derivatives, The degree of enhanced activity (up to 10-fold) was dependent on the concentration of phospholipid and quality of phospholipid (+/- phosphatidylethanolamine) used in the assay. This was expected, because APC is active in its membrane-associated form, which can be regulated by changes in either the protein or phospholipid. As expected, the largest impact of the mutants occurred at low phospholipid concentration and in the absence of phosphatidylethanolamine. The anticoagulant activity of all proteins was stimulated by protein S, with the greatest impact on the enhanced mutants. Whereas plasma containing Factor V:R506Q was partially resistant to all forms of APC, the enhanced variants were more active than normal APC, Protein C variants with enhanced function present new reagents for study of coagulation and may offer improved materials for biomedical applications.
C1 Univ Minnesota, Dept Biochem, St Paul, MN 55108 USA.
   Malmo Gen Hosp, Dept Clin Chem, S-20502 Malmo, Sweden.
   Univ Lund, S-20502 Malmo, Sweden.
RP Nelsestuen, GL (reprint author), Univ Minnesota, Dept Biochem, 1479 Gortner Ave, St Paul, MN 55108 USA.
FU NHLBI NIH HHS [HL60859]
CR BAZZI MD, 1992, BIOCHEMISTRY-US, V31, P1125, DOI 10.1021/bi00119a022
   CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033
   CHRISTIANSEN WT, 1995, BIOCHEMISTRY-US, V34, P8082, DOI 10.1021/bi00025a014
   CHRISTIANSEN WT, 1994, BIOCHEMISTRY-US, V33, P14993, DOI 10.1021/bi00254a007
   CHRISTIANSEN WT, 1995, BIOCHEMISTRY-US, V34, P10376, DOI 10.1021/bi00033a008
   DAHLBACK B, 1995, THROMB RES, V77, P1, DOI 10.1016/0049-3848(94)00138-4
   ESMON CT, 1989, J BIOL CHEM, V264, P4743
   FUJIKAWA K, 1972, BIOCHEMISTRY-US, V11, P4882, DOI 10.1021/bi00776a002
   Gale AJ, 1997, PROTEIN SCI, V6, P132
   GILBERT GE, 1995, J BIOL CHEM, V270, P18500, DOI 10.1074/jbc.270.31.18500
   HASHIMOTO T, 1988, Patent No. 1085096
   HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8
   HUANG CH, 1969, BIOCHEMISTRY-US, V8, P344, DOI 10.1021/bi00829a048
   Jalbert LR, 1996, BIOCHEMISTRY-US, V35, P7093, DOI 10.1021/bi960290p
   KIM JY, 1994, J BIOL CHEM, V269, P28214
   Larson PJ, 1996, J BIOL CHEM, V271, P3869
   Larson PJ, 1998, BIOCHEMISTRY-US, V37, P5029, DOI 10.1021/bi972428p
   McDonald JF, 1997, BIOCHEMISTRY-US, V36, P5120, DOI 10.1021/bi9626160
   NELSESTUEN GL, 1973, P NATL ACAD SCI USA, V70, P3366, DOI 10.1073/pnas.70.12.3366
   NELSESTUEN GL, 1977, BIOCHEMISTRY-US, V16, P4164, DOI 10.1021/bi00638a005
   NELSESTUEN GL, 1977, BIOCHEMISTRY-US, V16, P4172, DOI 10.1021/bi00638a006
   NELSESTUEN GL, 1978, FED PROC, V37, P2621
   NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P13988, DOI 10.1021/bi00043a004
   PLAGER DA, 1994, BIOCHEMISTRY-US, V33, P13239, DOI 10.1021/bi00249a010
   PLETCHER CH, 1983, J BIOL CHEM, V258, P1086
   RATCLIFFE JV, 1993, J BIOL CHEM, V268, P24339
   Shah AM, 1998, P NATL ACAD SCI USA, V95, P4229, DOI 10.1073/pnas.95.8.4229
   Shen L, 1997, BIOCHEMISTRY-US, V36, P16025, DOI 10.1021/bi971730v
   SMIRNOV MD, 1994, J BIOL CHEM, V269, P816
   Smirnov MD, 1998, J BIOL CHEM, V273, P9031, DOI 10.1074/jbc.273.15.9031
   Smith OP, 1997, LANCET, V350, P1590, DOI 10.1016/S0140-6736(97)06356-3
   SORIANOGARCIA M, 1992, BIOCHEMISTRY-US, V31, P2554, DOI 10.1021/bi00124a016
   Thariath A, 1997, BIOCHEM J, V322, P309, DOI 10.1042/bj3220309
   ZHANG L, 1993, J BIOL CHEM, V268, P12040
   ZHANG L, 1994, J BIOL CHEM, V269, P3590
   ZHANG L, 1992, BLOOD, V80, P942
NR 36
TC 18
Z9 18
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 20
PY 1998
VL 273
IS 47
BP 31086
EP 31091
DI 10.1074/jbc.273.47.31086
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 141HG
UT WOS:000077136900036
PM 9813008
OA Bronze
DA 2018-10-20
ER

PT J
AU Suh, JS
   Jeong, EK
   Shin, KH
   Cho, JH
   Na, JB
   Kim, DH
   Han, CD
AF Suh, JS
   Jeong, EK
   Shin, KH
   Cho, JH
   Na, JB
   Kim, DH
   Han, CD
TI Minimizing artifacts caused by metallic implants at MR imaging:
   Experimental and clinical studies
SO AMERICAN JOURNAL OF ROENTGENOLOGY
LA English
DT Article
ID SPIN-ECHO; SUSCEPTIBILITY ARTIFACTS; MAGNETIC-SUSCEPTIBILITY; BIOMEDICAL
   IMPLANTS; REDUCTION; TITANIUM; IMAGES; 1.5-T; FIELD; 2D
AB OBJECTIVE. The purpose of this study was to investigate the effect of metallic implant positioning on MR imaging artifacts, to determine the optimal imaging conditions for minimizing artifacts, and to show the usefulness of artifact-minimizing methods in imaging of the knee.
   MATERIALS AND METHODS. Using MR images of experimental phantoms (titanium alloy and stainless steel screws), we compared the magnitude of metal-induced artifacts for various pulse sequences, different imaging parameters for the fast spin-echo sequence, and different imaging parameters for several incremental angles between the long axis of the screw and the direction of the main magnetic field. In clinical MR imaging of knees with metallic implants (n = 19), we assessed geometric distortion of anatomic structures to compare the influence of different pulse sequences (n = 19), frequency-encoding directions (n = 7), and knee positions (n = 15).
   RESULTS, Titanium alloy screws consistently produced smaller artifacts than did stainless steel screws. In experimental MR studies, artifacts were reduced with fast spin-echo sequences, with a screw orientation as closely parallel to the main magnetic field as possible, and, particularly, with smaller voxels that correlated positively with artifact size (R-2 = .88, p < .01). In clinical MR studies, fast spin-echo MR imaging obscured articular structures less than did spin-echo imaging (8/19 patients), In particular, the anterior-posterior frequency-encoding direction (3/7 patients) and the flexion position of the knee (5/15 patients) were effective in reducing artifacts.
   CONCLUSION. MR artifacts can be minimized by optimally positioning in the magnet subjects with metallic implants and by choosing fast spin-echo sequences with an anterior-posterior frequency-encoding direction and the smallest voxel size.
C1 Yonsei Univ, Coll Med, Dept Diagnost Radiol, Seoul 120752, South Korea.
   Yonsei Univ, Coll Med, Res Inst Radiol Sci, Seoul, South Korea.
   Yonsei Univ, Coll Med, Dept Orthoped Surg, Seoul, South Korea.
RP Suh, JS (reprint author), Yonsei Univ, Coll Med, Dept Diagnost Radiol, 134 Shinchon Dong Seodaemun Gu, Seoul 120752, South Korea.
OI Na, Jaeboem/0000-0002-6182-2986; Suh, jin-suck/0000-0001-9455-9240
CR AUGUSTINY N, 1987, J COMPUT ASSIST TOMO, V11, P678, DOI 10.1097/00004728-198707000-00024
   BAKKER CJG, 1994, MAGN RESON IMAGING, V12, P767, DOI 10.1016/0730-725X(94)92201-2
   BAKKER CJG, 1993, MAGN RESON IMAGING, V11, P539, DOI 10.1016/0730-725X(93)90473-Q
   BAKKER CJG, 1992, MAGN RESON IMAGING, V10, P597, DOI 10.1016/0730-725X(92)90011-N
   Beuf O, 1996, J MAGN RESON SER B, V112, P111, DOI 10.1006/jmrb.1996.0120
   BHAGWANDIEN R, 1992, MAGN RESON IMAGING, V10, P299, DOI 10.1016/0730-725X(92)90489-M
   CHO ZH, 1992, MAGNET RESON MED, V23, P193, DOI 10.1002/mrm.1910230120
   EBRAHEIM NA, 1992, CLIN ORTHOP RELAT R, P194
   EBRAHEIM NA, 1992, CLIN ORTHOP RELAT R, P133
   KIM JK, 1993, RADIOLOGY, V187, P735, DOI 10.1148/radiology.187.3.8497623
   Ludeke K M, 1985, Magn Reson Imaging, V3, P329, DOI 10.1016/0730-725X(85)90397-2
   LYONS CJ, 1989, SPINE, V14, P670, DOI 10.1097/00007632-198907000-00004
   Petersilge CA, 1996, AM J ROENTGENOL, V166, P1213, DOI 10.2214/ajr.166.5.8615272
   POSSE S, 1990, J MAGN RESON, V88, P473, DOI 10.1016/0022-2364(90)90282-E
   RUPP R, 1993, SPINE, V18, P379
   Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854
   SHELLOCK FG, 1992, JMRI-J MAGN RESON IM, V2, P225, DOI 10.1002/jmri.1880020217
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P811, DOI 10.2214/ajr.151.4.811
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   SHELLOCK FG, 1993, RADIOLOGY, V189, P587, DOI 10.1148/radiology.189.2.8210394
   SIMMONS A, 1994, MAGNET RESON MED, V32, P121, DOI 10.1002/mrm.1910320117
   TARTAGLINO LM, 1994, RADIOLOGY, V190, P565, DOI 10.1148/radiology.190.2.8284417
   VINITSKI S, 1993, JMRI-J MAGN RESON IM, V3, P501, DOI 10.1002/jmri.1880030312
NR 23
TC 120
Z9 121
U1 0
U2 10
PU AMER ROENTGEN RAY SOC
PI RESTON
PA 1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA
SN 0361-803X
J9 AM J ROENTGENOL
JI Am. J. Roentgenol.
PD NOV
PY 1998
VL 171
IS 5
BP 1207
EP 1213
DI 10.2214/ajr.171.5.9798849
PG 7
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 131MT
UT WOS:000076580400007
PM 9798849
OA Bronze
DA 2018-10-20
ER

PT J
AU Dewhurst, DG
   Williams, AD
AF Dewhurst, DG
   Williams, AD
TI An investigation of the potential for a computer-based tutorial program
   covering the cardiovascular system to replace traditional lectures
SO COMPUTERS & EDUCATION
LA English
DT Article
DE cardiovascular physiology; computer-based learning; evaluation;
   undergraduate teaching
ID UNDERGRADUATE STUDENTS; MICROCOMPUTER SIMULATIONS; INSTRUCTION;
   PHYSIOLOGY; EDUCATION; TEACH
AB Although the availability of computer-based learning materials in the biomedical sciences is increasing there are relatively few studies which compare the effectiveness of this mode of teaching with traditional methods. Here we present the results of a comparative study to evaluate the effectiveness of two interactive CBL programs, covering the cardiovascular system (one covering the heart, one the circulatory system), as an alternative to lectures for first year undergraduate students at a UK university. The study demonstrated: (a) that the CBL program was as effective as lectures in disseminating factual information (knowledge gain from pre- and post-tests were equivalent for both topics (P = 0.28; heart topic; P = 0.03; circulation topic); (b) that students generally preferred lectures to using CBL as a mode of study (attitude scales constructed from a pre- and post-test questionnaire demonstrated a slightly more positive attitude on Delivery; Knowledge; and Time and Place for lectures) and (c) that they recognised both the advantages and disadvantages of CBL as a mode of teaching. The results are discussed in relation to the design of evaluative studies and the future use of CBL programs of this type in undergraduate teaching. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 Leeds Metropolitan Univ, Sch Appl Sci, Leeds LS1 3HE, W Yorkshire, England.
RP Dewhurst, DG (reprint author), Leeds Metropolitan Univ, Sch Appl Sci, Caverley St, Leeds LS1 3HE, W Yorkshire, England.
CR ANDERSONHARPER HM, 1988, AM J PHARM EDUC, V52, P259
   CLARK RE, 1985, ECTJ-EDUC COMMUN TEC, V33, P249
   CLARKE KA, 1987, ATLA-ALTERN LAB ANIM, V14, P134
   Coleman I. P., 1994, American Journal of Physiology, V266, pS2
   DEWHURST DG, 1993, BRIT J PHARMACOL, V108, pP238
   DEWHURST DG, 1988, ATLA-ALTERN LAB ANIM, V15, P280
   Dewhurst DG, 1996, BRIT J PHARMACOL, V117, pP345
   DEWHURST DG, 1995, BRIT J PHARMACOL, V115, pP157
   FELDMAN RD, 1989, J CLIN PHARMACOL, V29, P158, DOI 10.1002/j.1552-4604.1989.tb03306.x
   FINCHER RME, 1988, SOUTHERN MED J, V81, P1291, DOI 10.1097/00007611-198810000-00020
   GARRETT TJ, 1987, J MED EDUC, V62, P918
   GARRUD P, 1993, MED EDUC, V27, P474, DOI 10.1111/j.1365-2923.1993.tb00306.x
   HAGLER P, 1987, J COMPUT-BASE INSTR, V14, P84
   HOLLINGSWORTH M, 1991, BRIT J PHARM P S, V102, pP216
   JONES BT, 1992, INT J NURS STUD, V29, P411, DOI 10.1016/0020-7489(92)90018-C
   KULIK JA, 1980, REV EDUC RES, V50, P525, DOI 10.2307/1170294
   Leathard HL, 1995, ASS LEARNING TECHNOL, V3, P118
   LIKERT R, 1932, ARCH PSYCHOL, V140
   MATTHEWS R, 1992, P UYK TOOLB US C 95
   MCCURRIE J, 1992, P CTI CTR MED C, P23
   Modell H. I., 1992, Computers in Life Science Education, V9, P65
   MODELL HI, 1992, AM J PHYSL ADV PHYSL, V261, pS29
   NAPHOLZ L, 1994, COMPUT NURS, V12, P149
NR 23
TC 12
Z9 12
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-1315
J9 COMPUT EDUC
JI Comput. Educ.
PD NOV
PY 1998
VL 31
IS 3
BP 301
EP 317
DI 10.1016/S0360-1315(98)00043-8
PG 17
WC Computer Science, Interdisciplinary Applications; Education &
   Educational Research
SC Computer Science; Education & Educational Research
GA 137XL
UT WOS:000076942300004
DA 2018-10-20
ER

PT J
AU Phillips, TM
   Dickens, BF
AF Phillips, TM
   Dickens, BF
TI Analysis of recombinant cytokines in human body fluids by immunoaffinity
   capillary electrophoresis
SO ELECTROPHORESIS
LA English
DT Article
DE immunoaffinity; capillary electrophoresis; cytokines; body fluids
ID LASER-INDUCED FLUORESCENCE; ALPHA-INTERFERON; INTERLEUKIN-2;
   MICRODIALYSIS; CYCLOSPORINE; IMMUNOASSAY; COMBINATION; PROTEIN; SERUM;
   CELL
AB An immunoaffinity capillary electrophoresis (ICE) system for rapidly quantifying recombinant cytokines in human body fluids has been developed. Cytokines within biological fluids were labeled with a red light emitting fluorochrome and injected into the capillary. Selected cytokines were captured by immobilized antibodies on the internal surface of the capillary, and held while unbound materials were purged. The cytokines were then eluted electrophoretically in acidic buffer. Individual cytokine peaks were detected by on-line laser-induced fluorescence detection coupled to a computerized fiber-optic spectrometer, and analyzed by integration of the eluted peaks. The comparison of the results of ICE to routine assays used for these cytokines demonstrates that ICE provides a fast and accurate procedure for defining these cytokines in complex biological samples. Immunoaffinity separations can be used for any material to which a specific antibody can be raised, making this procedure applicable to a wide range of molecules of biomedical interest.
C1 George Washington Univ, Immunochem Lab, Med Ctr, Washington, DC 20037 USA.
RP Phillips, TM (reprint author), George Washington Univ, Immunochem Lab, Med Ctr, 413 Ross Hall,GWUMC,2300 Eye St NW, Washington, DC 20037 USA.
EM tmphil@erols.com
CR BARBOLLA L, 1993, VOX SANG, V65, P156, DOI 10.1111/j.1423-0410.1993.tb02135.x
   BORDEN EC, 1986, CLIN APPL INTERFERON, P101
   CHEN FTA, 1994, J CHROMATOGR A, V680, P425, DOI 10.1016/0021-9673(94)85139-5
   CHENG YF, 1988, SCIENCE, V242, P562, DOI 10.1126/science.3140381
   DOVICHI NJ, 1993, CAPILLARY ELECTROPHO, P25
   EINHORN S, 1982, INT J CANCER, V30, P167, DOI 10.1002/ijc.2910300207
   Katzmann JA, 1997, ELECTROPHORESIS, V18, P1775, DOI 10.1002/elps.1150181011
   KIRKWOOD JM, 1994, IMMUNOL SER, V61, P239
   Krull IS, 1997, LC GC-MAG SEP SCI, V15, P620
   Legha SS, 1997, SEMIN ONCOL, V24, pS39
   MacTaylor CE, 1997, ELECTROPHORESIS, V18, P2279, DOI 10.1002/elps.1150181218
   MURRAY JL, 1988, J BIOL RESP MODIF, V7, P152
   Oda RP, 1997, ELECTROPHORESIS, V18, P1715, DOI 10.1002/elps.1150181004
   Phillips T M, 1996, Curr Opin Nephrol Hypertens, V5, P380, DOI 10.1097/00041552-199607000-00016
   Phillips TM, 1997, J CHROMATOGR B, V697, P101, DOI 10.1016/S0378-4347(97)00132-1
   PHILLIPS TM, 1994, J CHROMATOGR B, V656, P259, DOI 10.1016/0378-4347(94)00036-0
   PHILLIPS TM, 1994, BIOMED CHROMATOGR, V8, P242, DOI 10.1002/bmc.1130080509
   PINTO DM, 1997, ANAL CHEM, V69, P3016
   Piscitelli SC, 1997, CLIN PHARMACOKINET, V32, P368, DOI 10.2165/00003088-199732050-00003
   QUESADA JR, 1984, NEW ENGL J MED, V310, P15, DOI 10.1056/NEJM198401053100104
   Reali UM, 1998, MELANOMA RES, V8, P77
   SAMUEL CE, 1986, CLIN APPLICATION INT, P1
   SCHULTZ NM, 1993, ANAL CHEM, V65, P3161, DOI 10.1021/ac00069a035
   Staller TD, 1997, ELECTROPHORESIS, V18, P2291, DOI 10.1002/elps.1150181219
   Valaskovic GA, 1996, SCIENCE, V273, P1199, DOI 10.1126/science.273.5279.1199
   WANG TS, 1991, ANAL CHEM, V63, P1372, DOI 10.1021/ac00014a007
   WEIDMANN E, 1991, CANCER IMMUNOL IMMUN, V33, P398, DOI 10.1007/BF01741601
   WHICHER JT, 1990, CLIN CHEM, V36, P1269
   Yang H, 1996, PHARM RES-DORDR, V13, P622, DOI 10.1023/A:1016066609489
NR 29
TC 47
Z9 47
U1 0
U2 5
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0173-0835
J9 ELECTROPHORESIS
JI Electrophoresis
PD NOV
PY 1998
VL 19
IS 16-17
BP 2991
EP 2996
DI 10.1002/elps.1150191632
PG 6
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 147MG
UT WOS:000077570900031
PM 9870401
DA 2018-10-20
ER

PT J
AU Jokinen, M
   Patsi, M
   Rahiala, H
   Peltola, T
   Ritala, M
   Rosenholm, JB
AF Jokinen, M
   Patsi, M
   Rahiala, H
   Peltola, T
   Ritala, M
   Rosenholm, JB
TI Influence of sol and surface properties on in vitro bioactivity of
   sol-gel-derived TiO2 and TiO2-SiO2 films deposited by dip-coating method
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE sol-gel films; titania; silica; dip coating; bioactivity
ID GLASS-CRYSTALLINE MATERIALS; THIN-FILMS; STAINLESS-STEEL; BIOMEDICAL
   APPLICATIONS; OPTICAL-PROPERTIES; ACETIC-ACID; IN-VITRO; TITANIUM;
   HYDROLYSIS; SPECTROSCOPY
AB Different sol-gel-derived titania and titania-silica films were prepared and their properties related to in vitro bioactivity. The films were prepared by depositing the sols on the substrate surface using a dip-coating method. The sols were monitored carefully as a function of time, using theological techniques and dynamic light scattering. The topography of the films was characterized using atomic force microscopy, and thicknesses and refractive indexes of the films were evaluated by fitting: transmittance spectra measured in a wave length region of 370-1100 nm with a spectrophotometer. The in vitro bioactivity tests were performed in simulated body fluid. Surface topography was found to be of great importance with respect to the bioactivity of the studied films. (C) 1998 John Wiley & Sons, Inc.
C1 Abo Akad Univ, Dept Chem Phys, FIN-20500 Turku, Finland.
   Turku Univ, Dept Appl Phys, Mat Sci Lab, FIN-200014 Turku, Finland.
   Univ Turku, Inst Dent, FIN-20520 Turku, Finland.
   Univ Helsinki, Dept Chem, Inorgan Chem Lab, FIN-00014 Helsinki, Finland.
RP Jokinen, M (reprint author), Abo Akad Univ, Dept Chem Phys, Porthaninkatu 3-5, FIN-20500 Turku, Finland.
RI Ritala, Mikko/N-7268-2013
OI Ritala, Mikko/0000-0002-6210-2980
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   Almeida RM, 1997, J SOL-GEL SCI TECHN, V8, P409
   ANAST M, 1994, THIN SOLID FILMS, V253, P303, DOI 10.1016/0040-6090(94)90338-7
   Andersson OH, 1994, BIOCERAMICS, VOL 7, P67
   ARMELAO L, 1992, J NON-CRYST SOLIDS, V139, P198, DOI 10.1016/S0022-3093(05)80826-9
   Arnal P, 1997, CHEM MATER, V9, P694, DOI 10.1021/cm960337t
   ATIK M, 1995, J APPL ELECTROCHEM, V25, P142, DOI 10.1007/BF00248171
   ATIK M, 1994, J MATER SCI LETT, V13, P1301, DOI 10.1007/BF00270967
   BLUM J, 1996, BIOCERAMICS, V9, P89
   BRINKER CJ, 1981, SOL ENERG MATER, V5, P159, DOI 10.1016/0165-1633(81)90027-7
   BRINKER CJ, 1992, CHEMICAL PROCESSING OF ADVANCED MATERIALS, P395
   BRINKER CJ, 1994, J PHYS III, V4, P1231, DOI 10.1051/jp3:1994198
   BRINKER CJ, 1990, SOL GEL SCI PHYSICS
   CHO SB, 1997, THESIS KYOTO U KYOTO
   DOEUFF S, 1987, J NON-CRYST SOLIDS, V89, P206, DOI 10.1016/S0022-3093(87)80333-2
   Du XM, 1997, J SOL-GEL SCI TECHN, V8, P377, DOI 10.1023/A:1026420009842
   DUNUWILA DD, 1994, CHEM MATER, V6, P1556, DOI 10.1021/cm00045a013
   EBISAWA Y, 1990, J MATER SCI-MATER M, V1, P239, DOI 10.1007/BF00701083
   ECKERT KL, 1995, BIOCERAMICS, V8, P447
   FLOOD RU, 1995, J PHYS CHEM-US, V99, P8954, DOI 10.1021/j100022a004
   Greenspan D. C., 1995, BIOCERAMICS, V8, P477
   Greenspan DC, 1994, BIOCERAMICS, VOL 7, P55
   Haddow DB, 1996, J MATER SCI-MATER M, V7, P255, DOI 10.1007/BF00058562
   Haddow DB, 1996, BIOMATERIALS, V17, P501, DOI 10.1016/0142-9612(96)82724-4
   HADDOW DB, 1995, BR CERAM P, V54, P155
   HASHIMOTO T, 1994, B CHEM SOC JPN, V67, P653, DOI 10.1246/bcsj.67.653
   HENCH L, 1993, INTRO BIOCERAMICS
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   HU LL, 1992, THIN SOLID FILMS, V219, P18, DOI 10.1016/0040-6090(92)90718-Q
   Imai H, 1997, J SOL-GEL SCI TECHN, V8, P365, DOI 10.1007/BF02436866
   KALLALA M, 1993, PHYS REV E, V48, P3692, DOI 10.1103/PhysRevE.48.3692
   KARLSSON KH, 1989, J NON-CRYST SOLIDS, V112, P69, DOI 10.1016/0022-3093(89)90495-X
   Kasgoz A, 1994, J SOL-GEL SCI TECHN, V1, P185, DOI 10.1007/BF00490248
   KATO K, 1994, J MATER SCI, V29, P5911, DOI 10.1007/BF00366875
   KEDDIE JL, 1994, J AM CERAM SOC, V77, P1592, DOI 10.1111/j.1151-2916.1994.tb09761.x
   KIM HM, 1996, BIOCERAMICS, V9, P301
   KIM HM, 1997, THESIS KYOTO U KYOTO
   KIM YJ, 1993, J AM CERAM SOC, V76, P737, DOI 10.1111/j.1151-2916.1993.tb03668.x
   Klein L. C., 1991, THIN FILM PROCESSES, VII, P501
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   Kokubo T, 1994, BIOCERAMICS, VOL 7, P49
   Kokubo T, 1991, BIOCERAMICS, V4, P113
   KOTHARI S, 1995, BRIT CERAM P, V54, P173
   KOZHUKHAROV V, 1992, J MATER SCI LETT, V11, P1206, DOI 10.1007/BF00730286
   KUMAR KNP, 1992, J NON-CRYST SOLIDS, V147, P375, DOI 10.1016/S0022-3093(05)80646-5
   LACZKA M, 1995, J MATER SCI LETT, V14, P1417, DOI 10.1007/BF00462202
   LANGLET M, 1992, THIN SOLID FILMS, V221, P44, DOI 10.1016/0040-6090(92)90794-C
   Li P, 1996, J SOL-GEL SCI TECHN, V7, P27, DOI 10.1007/BF00401880
   LI P, 1993, THESIS LEIDEN U NETH
   Lobel KD, 1996, J SOL-GEL SCI TECHN, V7, P69, DOI 10.1007/BF00401885
   MATSUDA A, 1993, J AM CERAM SOC, V76, P2899, DOI 10.1111/j.1151-2916.1993.tb04034.x
   MELPOLDER SM, 1991, J MATER SCI, V26, P3585, DOI 10.1007/BF00557148
   Miyaji F, 1994, BIOCERAMICS, VOL 7, P119
   MUELLERMAI C, 1994, BIOCERAMICS, V7, P159
   NAGPAL VJ, 1995, J MATER RES, V10, P3068, DOI 10.1557/JMR.1995.3068
   NAKAO A, 1996, BIOCERAMICS, V9, P131
   Nishide T, 1997, THIN SOLID FILMS, V298, P89, DOI 10.1016/S0040-6090(96)09140-7
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   OHTSUKI C, 1994, BIOCERAMICS, V7, P73
   Ohya Y, 1996, J AM CERAM SOC, V79, P825, DOI 10.1111/j.1151-2916.1996.tb08512.x
   Orignac X, 1997, J SOL-GEL SCI TECHN, V8, P243, DOI 10.1007/BF02436847
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   PAPOUTSI D, 1995, LANGMUIR, V11, P1, DOI 10.1021/la00001a001
   PAPOUTSI D, 1994, LANGMUIR, V10, P1684, DOI 10.1021/la00018a014
   Pena J, 1997, J BIOMED MATER RES, V35, P129, DOI 10.1002/(SICI)1097-4636(199704)35:1<129::AID-JBM13>3.0.CO;2-E
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   Pereira MM, 1996, J SOL-GEL SCI TECHN, V7, P59, DOI 10.1007/BF00401884
   PEREIRA MM, 1994, J MATER SYNTH PROCES, V2, P189
   PERESDURAND S, 1995, COLLOID SURFACE A, V98, P251, DOI 10.1016/0927-7757(94)03123-H
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   Sakka S, 1994, J SOL-GEL SCI TECHN, V2, P451, DOI 10.1007/BF00486289
   Stathatos E, 1997, J SOL-GEL SCI TECHN, V10, P83, DOI 10.1023/A:1018340423513
   STEPANEK P, 1993, MONOGRAPHS PHYSICS C, V49, P177
   SYMS RRA, 1994, J NON-CRYST SOLIDS, V170, P223, DOI 10.1016/0022-3093(94)90051-5
   TAKAHASHI Y, 1988, J MATER SCI, V23, P2259, DOI 10.1007/BF01115798
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   TORRUELLAS WE, 1991, APPL PHYS LETT, V58, P1128, DOI 10.1063/1.104392
   Turyna B, 1996, BIOMATERIALS, V17, P1379, DOI 10.1016/0142-9612(96)87278-4
   XU QY, 1994, J AM CERAM SOC, V77, P1939, DOI 10.1111/j.1151-2916.1994.tb07074.x
   YAN WQ, 1996, BIOCERAMICS, V9, P305
   YAN YG, 1995, CHEM MATER, V7, P2007, DOI 10.1021/cm00059a006
   Yan YG, 1996, J AM CERAM SOC, V79, P1061, DOI 10.1111/j.1151-2916.1996.tb08548.x
   YLILAMMI M, 1993, THIN SOLID FILMS, V232, P56, DOI 10.1016/0040-6090(93)90762-E
   YOLDAS BE, 1986, J MATER SCI, V21, P1087, DOI 10.1007/BF01117399
   ZAHARESCU M, 1993, J NON-CRYST SOLIDS, V160, P162, DOI 10.1016/0022-3093(93)90296-A
   ZANONI R, 1994, SURF INTERFACE ANAL, V22, P376, DOI 10.1002/sia.740220182
NR 86
TC 118
Z9 124
U1 1
U2 33
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD NOV
PY 1998
VL 42
IS 2
BP 295
EP 302
DI 10.1002/(SICI)1097-4636(199811)42:2<295::AID-JBM15>3.0.CO;2-I
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 122FC
UT WOS:000076060400015
PM 9773826
DA 2018-10-20
ER

PT J
AU Tredget, EE
   Shankowsky, HA
   Groeneveld, A
   Burrell, R
AF Tredget, EE
   Shankowsky, HA
   Groeneveld, A
   Burrell, R
TI A matched-pair, randomized study evaluating the efficacy and safety of
   Acticoat silver-coated dressing for the treatment of burn wounds
SO JOURNAL OF BURN CARE & REHABILITATION
LA English
DT Article
ID PSEUDOMONAS-AERUGINOSA; QUANTITATIVE MICROBIOLOGY; EPIDEMIOLOGY;
   INFECTIONS; OUTBREAK; INJURY; AGENTS
AB A new silver-coating technology was developed to prevent wound adhesion, limit nosocomial infection, control bacterial growth, and facilitate burn wound care through a silver-coated dressing material. For the purposes of this article, Acticoat (Westaim Biomedical Inc, Fort Saskatchawan, Alberta, Canada) silver-coated dressing was used. After in vitro and in vivo studies, a randomized, prospective clinical study was performed to assess the efficacy and ease of use of Acticoat dressing as compared with the efficacy and ease of our institution's standard burn wound care. Thirty burn patients with symmetric wounds were randomized to be treated with either 0.5% silver nitrate solution or Acticoat silver-coated dressing. The dressing was evaluated on the basis of overall patient comfort, ease of use for the wound care provider, and level of antimicrobial effectiveness. Wound pain was rated by the patient using a visual analog scale during dressing removal, application, and 2 hours after application. Ease of use was rated by the nurse providing wound care. Antimicrobial effectiveness was evaluated by quantitative burn wound biopsies performed before and at the end of treatment. Patients found dressing removal less painful with Acticoat than with silver nitrate, but they found the pain to be comparable during application and 2 hours after application. According to the nurses, there was no statistically significant difference in the ease of use. The frequency of burn wound sepsis (> 10(5) organisms per gram of tissue) was less in Acticoat-treated wounds than in those treated with silver nitrate (5 vs 16). Secondary bacteremias arising from infected burn wounds were also less frequent with Acticoat than with silver nitrate-treated wounds (1 vs 5). Acticoat dressing offers a new form of dressing for the burn wound, but it requires further investigation with greater numbers of patients in a larger number of centers and in different phases of burn wound care.
C1 Univ Alberta Hosp, Dept Surg, Edmonton, AB T6G 2B7, Canada.
   Westaim Biomed Inc, Ft Saskatchewan, AB, Canada.
RP Tredget, EE (reprint author), Univ Alberta Hosp, Dept Surg, 2D3-81 WMHSC,8440-112 St, Edmonton, AB T6G 2B7, Canada.
OI Burrell, Robert/0000-0003-0210-8536
CR BALLIN JC, 1984, JAMA-J AM MED ASSOC, V230, P1184
   BOOSALIS MG, 1987, SURGERY, V101, P40
   BRIDGES K, 1979, BRIT MED J, V1, P446, DOI 10.1136/bmj.1.6161.446
   BUCHANAN K, 1986, J CLIN MICROBIOL, V23, P258
   BURRELL RE, 1997, IN VITRO IN VIVO ANT
   DEITCH EA, 1983, ANTIMICROB AGENTS CH, V23, P356, DOI 10.1128/AAC.23.3.356
   DEVIA A, 1996, P AM BURN ASS, V28, pA141
   FARMER JJ, 1982, J CLIN MICROBIOL, V16, P266
   FOX CL, 1968, ARCH SURG-CHICAGO, V96, P184
   GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3
   GREENHALGH D, 1997, P AM BURN ASS, V18, pA67
   Heggers John, 1996, P98
   Iwasaki S, 1997, AM J KIDNEY DIS, V30, P287, DOI 10.1016/S0272-6386(97)90067-6
   KAYE ET, 1995, INFECT DIS CLIN N AM, V9, P547
   Li XZ, 1997, J BACTERIOL, V179, P6127, DOI 10.1128/jb.179.19.6127-6132.1997
   LOEBL EC, 1974, AM J CLIN PATHOL, V61, P20
   Marvin Janet A., 1996, P529
   MAYHALL CG, 1979, J INFECT DIS, V139, P166, DOI 10.1093/infdis/139.2.166
   MCMANUS AT, 1987, ARCH SURG-CHICAGO, V122, P74
   MCMANUS AT, 1985, EUR J CLIN MICROBIOL, V4, P219, DOI 10.1007/BF02013601
   MONAFO WW, 1978, SURG CLIN N AM, V58, P1157
   MOYER CA, 1965, ARCH SURG-CHICAGO, V90, P812
   PRECHT RJ, 1997, J BURN CARE REHABIL, V18, pS178
   PRUITT BA, 1984, AM J MED, V76, P146, DOI 10.1016/0002-9343(84)90334-6
   PRUITT BA, 1992, WORLD J SURG, V16, P57, DOI 10.1007/BF02067116
   RICHARD P, 1994, J INFECT DIS, V170, P377, DOI 10.1093/infdis/170.2.377
   ROSENQUIST MD, 1992, P AM BURN ASS, V24, pA177
   Russell AD, 1994, PROGR MED CHEM, V31, P351, DOI DOI 10.1016/S0079-6468(08)70024-9
   Shankowsky Heather A., 1994, Journal of Burn Care and Rehabilitation, V15, P143, DOI 10.1097/00004630-199403000-00007
   Sheridan R. L., 1997, Journal of Burn Care and Rehabilitation, V18, P139, DOI 10.1097/00004630-199703000-00008
   SLAWSON RM, 1992, PLASMID, V27, P72, DOI 10.1016/0147-619X(92)90008-X
   Steer JA, 1996, BURNS, V22, P173, DOI 10.1016/0305-4179(95)00116-6
   Thomson Philip D., 1990, Journal of Burn Care and Rehabilitation, V11, P151, DOI 10.1097/00004630-199003000-00012
   TREDGET EE, 1992, CLIN INFECT DIS, V15, P941, DOI 10.1093/clind/15.6.941
   TREDGET EE, 1990, ANN SURG, V212, P720, DOI 10.1097/00000658-199012000-00011
   WALKER HL, 1968, J TRAUM, V8, P1049, DOI 10.1097/00005373-196811000-00006
   WAN AT, 1991, CLIN CHEM, V37, P1683
   WARD RS, 1995, PHYS THER, V75, P526, DOI 10.1093/ptj/75.6.526
   WINTER GD, 1963, NATURE, V197, P91, DOI 10.1038/197091b0
NR 39
TC 125
Z9 132
U1 0
U2 11
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0273-8481
J9 J BURN CARE REHABIL
JI J. Burn Care Rehabil.
PD NOV-DEC
PY 1998
VL 19
IS 6
BP 531
EP 537
DI 10.1097/00004630-199811000-00013
PG 7
WC Emergency Medicine; Rehabilitation; Surgery
SC Emergency Medicine; Rehabilitation; Surgery
GA 144HP
UT WOS:000077308700011
PM 9848045
DA 2018-10-20
ER

PT J
AU Kobayashi, E
   Doi, H
   Yoneyama, T
   Hamanaka, H
   Gibson, IR
   Best, SM
   Shelton, JC
   Bonfield, W
AF Kobayashi, E
   Doi, H
   Yoneyama, T
   Hamanaka, H
   Gibson, IR
   Best, SM
   Shelton, JC
   Bonfield, W
TI Influence of aging heat treatment on mechanical properties of biomedical
   Ti-Zr based ternary alloys containing niobium
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB Titanium-zirconium based alloys containing a small amount of niobium were investigated in order to evaluate their possible use as biomedical materials. Zirconium, which belongs to the IVa group, is known to have good corrosion resistance and biocompatibility similar to titanium. As the titanium-zirconium system shows a complete solid solution, a wide variation of alloy design is available and large quantities of solid-solution hardening must be possible. Niobium, having a beta-phase stabilizing effect, was chosen as a ternary element in order to control desirably the microstructure. There have been no reports which suggest its harm to a living body. The alloys containing 2% or 3% niobium showed the highest hardness value after aging heat treatment at 773 K. In contrast to this, no alteration of hardness was seen in specimens aged at 1073 K. Through conventional X-ray diffractometry and in situ X-ray analysis using a hot stage, beta-phase precipitation in the a matrix was identified. From the above results, it is concluded that alloys containing 2%-3% niobium are hopeful candidates for new kinds of biomedical alloys, when they are heat treated under suitable conditions. (C) 1998 Kluwer Academic Publishers.
C1 Tokyo Med & Dent Univ, Inst Med & Dent Engn, Chiyoda Ku, Tokyo 101, Japan.
   Univ London Queen Mary & Westfield Coll, Interdisciplinary Res Ctr Biomed Mat, London E1 4NS, England.
RP Kobayashi, E (reprint author), Tokyo Med & Dent Univ, Inst Med & Dent Engn, Chiyoda Ku, Kanda Surugadai, Tokyo 101, Japan.
RI Gibson, Iain/B-1753-2010
OI Gibson, Iain/0000-0002-3393-1464
CR *ASTM, 1992, 129592 ASTM F
   COLLINGS EW, 1984, PHYSICAL METALLURGY, P69
   DUWEZ P, 1952, J I MET, V80, P525
   ETCHU Y, 1992, J JPN SOC DENT MAT D, V11, P270
   HANSEN M, 1951, T AM I MIN MET ENG, V191, P881
   INGRAM AG, 1962, J LESS-COMMON MET, V4, P217
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   KOBAYASHI E, 1995, J J DENT MAT, V14, P321
   Kobayashi E., 1995, J JPN SOC DENT MAT D, V14, P406
   KOBAYASHI E, 1996, 5 WORLD BIOM C PROGR, V2, P481
   Murray J. L., 1987, PHASE DIAGRAMS BINAR, P340
   OGAWA A, 1994, CURRENT ADV MAT PROC, V7, P654
   OKAZAKI Y, 1993, J JPN SOC BIOMATER, V11, P160
   OKUNO O, 1985, J JPN SOC DENT MAT D, V4, P408
   RUDMAN PS, 1964, ACTA METALL MATER, V12, P1381, DOI 10.1016/0001-6160(64)90126-9
   TSUCHIYA T, 1998, J TISS ENG, V4, P197
   YAMAMOTO A, 1996, J JAPANESE SOC BIOMA, V14, P167
   Yamamoto Y., 1989, Shimadzu Review, V46, P63
   YONEYAMA T, 1994, J JPN DENT MAT DEVIC, V13, P213
NR 19
TC 45
Z9 46
U1 1
U2 8
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 1998
VL 9
IS 11
BP 625
EP 630
DI 10.1023/A:1008927407556
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 170YR
UT WOS:000078835300003
PM 15348680
DA 2018-10-20
ER

PT J
AU Bergveld, P
   Hendrikse, J
   Olthuis, W
AF Bergveld, P
   Hendrikse, J
   Olthuis, W
TI Theory and application of the material work function for chemical
   sensors based on the field effect principle
SO MEASUREMENT SCIENCE AND TECHNOLOGY
LA English
DT Article
DE redox potential; work function; field effect transistor (FET);
   environmental monitoring; process control; biomedical measurements
ID GATE
AB This paper gives first of all the definition of the work function of an electronic as well as an ionic conductor. PET-type gas sensors known from the literature are considered in view of this basic theory and the parameter of the work function which is responsible for the sensing properties is noticed. This appears not always to be possible for the various types of gas sensors, in this case the gas FET, the SGFET and the IGFET. In contrast to this ambiguity, the sensing parameters of the recently developed (MOSFET)-M-E, meant for application in an electrolyte, can clearly be identified. As an example an oxygen sensor based on the developed (MOSFET)-M-E is described.
C1 Univ Twente, MESA Res Inst, NL-7500 AE Enschede, Netherlands.
RP Bergveld, P (reprint author), Univ Twente, MESA Res Inst, Box 217, NL-7500 AE Enschede, Netherlands.
CR BERGVELD P, 1970, IEEE T BIO-MED ENG, VBM17, P70, DOI 10.1109/TBME.1970.4502688
   BLACKBURN GF, 1983, APPL PHYS LETT, V43, P700, DOI 10.1063/1.94536
   Hendrikse J, 1998, SENSOR ACTUAT B-CHEM, V47, P1, DOI 10.1016/S0925-4005(98)00047-1
   HENDRIKSE J, 1998, IN PRESS SENSORS A B
   JANATA J, 1991, ANAL CHEM, V63, P2546, DOI 10.1021/ac00022a003
   JOSOWICZ M, 1986, ANAL CHEM, V58, P514, DOI 10.1021/ac00294a003
   KREY D, 1982, SENSOR ACTUATOR, V3, P169
   Liess M, 1996, THIN SOLID FILMS, V286, P252, DOI 10.1016/S0040-6090(95)08233-6
   LUNDSTROEM I, 1975, APPL PHYS LETT, V26, P55, DOI 10.1063/1.88053
   Papez V, 1997, SENSOR ACTUAT B-CHEM, V40, P143, DOI 10.1016/S0925-4005(97)80253-5
NR 10
TC 38
Z9 38
U1 2
U2 12
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-0233
EI 1361-6501
J9 MEAS SCI TECHNOL
JI Meas. Sci. Technol.
PD NOV
PY 1998
VL 9
IS 11
BP 1801
EP 1808
DI 10.1088/0957-0233/9/11/003
PG 8
WC Engineering, Multidisciplinary; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA 138MH
UT WOS:000076975300003
DA 2018-10-20
ER

PT J
AU Birungi, H
AF Birungi, H
TI Injections and self-help: Risk and trust in Ugandan health care
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE injection practices; health systems; Uganda; domestication;
   personalization; therapeutic relations; risk perceptions and trust
AB The paper draws upon research material collected during a one year long ethnographic study on injection use and a WHO funded Injection Practices Research Project, which were both carried out during 1992/1993. The paper examines the changing trends in injection use and practices in the context of the Ugandan health system and in relation to popular views about risk and trust. Generally, people mistrust injections provided at government health institutions and prefer to gain access to injections as symbolic tokens of healing through personal contacts and private ownership of injecting equipment. It now appears that the use of this Western biomedical technology is widespread at all levels of the health care system; needles, syringes and injectables are readily available in homes for use by Families and untrained providers. In other words, the injection technology has been domesticated and personalized. The Giddens (1990) framework [Giddens, A. (1990) Consequences of Modernity. Stanford University Press, California.] concerning modernity, trust and risk is applied to understand the motivations behind these processes. The basic argument is that the weakening of state institutions of health care has been accompanied by a loss of trust in the treatment offered there. In addition, the massive anti-AIDS education campaigns which have warned people against the dangers of sharing unsterilized needles, have reinforced existing mistrust in public health facilities and induced families to seek care from people they know and using injecting equipment over which they have personal control. The paper concludes that changing the current injection practices in Uganda will necessitate a change in the organization of public health institutions. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 Makerere Univ, Makarere Inst Social Res, Kampala, Uganda.
RP Birungi, H (reprint author), Makerere Univ, Makarere Inst Social Res, POB 16022, Kampala, Uganda.
CR *ACP, 1985, AV AIDS STD AIDS CON
   ADOME OR, 1996, POPULAR PILLS COMMUN
   BANUGIRE FR, 1987, CRISIS DEV ISSUES UG
   BANUGIRE FR, 1989, IMF WORLD BANK AFRIC, V2
   Birungi H, 1994, Essent Drugs Monit, P11
   BIRUNGI H, 1993, IMPACT INJECTIONS DA, P93
   BIRUNGI H, 1994, MED MEANINGS CONTEXT, P125
   BIRUNGI H, 1994, WHODAP9418
   BLUHM LH, 1989, INT J CONT SOCIOLOGY, V26, P133
   Dodge Cole P., 1985, CRISIS UGANDA BREAKD
   Giddens A, 1990, CONSEQUENCES MODERNI
   GLENTHOJ J, 1991, SURVEY PPF PRESCRIPT
   *HLTH POL REV COMM, 1987, REP REC HLTH POL REV
   Kafuko Jessica M., 1996, RATIONAL DRUG USE RU
   KLEINMANN A., 1980, PATIENTS HEALERS CON
   LEWIS JD, 1985, SOC FORCES, V63, P967, DOI 10.2307/2578601
   MBURU FM, 1984, MANAGING ESSENTIAL D
   *MIH HLTH, 1992, HLTH BUDG
   *MIN HLTH MOH, 1991, LIV AIDS COMM
   OBBO C, 1991, CHANGING UGANDA, P98
   *UEDMP, 1990, STAT IMPR PRESCR DRU
   *UEDMP, 1992, PRIM HLTH CAR SUPP U
   *UNICEF, 1989, CHILDR WOM UG SIT AN
   *USAID, 1980, AIDSODPDCC0198
   van der Geest S., 1989, MED ANTHROPOL Q, V3, P345, DOI DOI 10.1525/MAQ.1989.3A.02A00030
   *WHO, 1991, WHODAP918
   *WHO, 1992, WHODAP922
   WHYTE SR, 1992, CULT MED PSYCHIAT, V16, P163, DOI 10.1007/BF00117017
   WHYTE SR, 1994, MED MEANINGS CONTEXT, P137
   Whyte SR, 1991, CHANGING UGANDA DILE, P130
   World Health Organization (WHO), 1989, WHO AIDS SER
   1993, UGANDA GAZETTE  1203, V86
NR 32
TC 60
Z9 61
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD NOV
PY 1998
VL 47
IS 10
BP 1455
EP 1462
DI 10.1016/S0277-9536(98)00194-4
PG 8
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA 130ZA
UT WOS:000076549500006
PM 9823041
DA 2018-10-20
ER

PT J
AU Nenoff, TM
   Thoma, SG
   Provencio, P
   Maxwell, RS
AF Nenoff, TM
   Thoma, SG
   Provencio, P
   Maxwell, RS
TI Novel zinc phosphate phases formed with chiral d-glucosamine molecules
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID ZEOLITE; ZINCOPHOSPHATE; SIEVES; FRAMEWORKS
AB Chiral syntheses and separations of both intermediate and final compounds are currently extremely important areas of research, especially for the chemical, pharmaceutical, agrochemical, and biomedical industries. We are investigating the synthesis of new inorganic porous materials for enantiomeric selectivity. We present a study of inorganic zinc phosphate crystalline phases templated with the chiral molecule d-glucosamine hydrochloride. The crystallization of these phases is highly dependent on reaction time, temperature, and stoichiometry. Resultant new phases include a mesoporous phase and a layered phase. Data indicates that the walls of the new 32 Angstrom sized mesoporous phase are crystalline and ordered. Characterization techniques applied include powder X-ray diffraction, TEM, and P-31 MAS NMR.
C1 Sandia Natl Labs, Albuquerque, NM 87185 USA.
   Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94551 USA.
RP Nenoff, TM (reprint author), Sandia Natl Labs, POB 5800,MS-0710, Albuquerque, NM 87185 USA.
CR Anderson MT, 1998, CHEM MATER, V10, P311, DOI 10.1021/cm9704600
   Bruce DA, 1996, J SOLID STATE CHEM, V125, P228, DOI 10.1006/jssc.1996.0290
   CORMA A, 1991, J CHEM SOC CHEM COMM, P1253, DOI 10.1039/c39910001253
   DAVIS ME, 1992, CHEM MATER, V4, P756, DOI 10.1021/cm00022a005
   DAVIS ME, 1993, ACCOUNTS CHEM RES, V26, P111, DOI 10.1021/ar00027a006
   DAVIS ME, 1995, SYNTHESIS MICROPOROU
   Feng PY, 1997, J AM CHEM SOC, V119, P2497, DOI 10.1021/ja9634841
   FIROUZI A, 1995, SCIENCE, V267, P1138, DOI 10.1126/science.7855591
   GIBSON HW, 1979, LIQ CRYST, P99
   GIER TE, 1992, SYNTHESIS OF MICROPOROUS MATERIALS, VOL 1, P407
   HARRISON WTA, 1991, CHEM MATER, V3, P27, DOI 10.1021/cm00013a012
   Harrison WTA, 1996, CHEM MATER, V8, P145, DOI 10.1021/cm950300t
   HARRISON WTA, 1992, J MATER CHEM, V2, P1127, DOI 10.1039/jm9920201127
   Harrison WTA, 1997, CHEM MATER, V9, P1837, DOI 10.1021/cm9701264
   HARRISON WTA, 1996, J CHEM SOC CHEM COMM, P2771
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Kubota Y, 1996, MICROPOROUS MATER, V6, P213, DOI 10.1016/0927-6513(96)00002-8
   MONNIER A, 1993, SCIENCE, V261, P1299, DOI 10.1126/science.261.5126.1299
   NENOFF TM, 1991, J AM CHEM SOC, V113, P378, DOI 10.1021/ja00001a065
   Nenoff TM, 1996, ENVIRON SCI TECHNOL, V30, P3630, DOI 10.1021/es9605331
   NEWSAM JM, 1988, P ROY SOC LOND A MAT, V420, P375, DOI 10.1098/rspa.1988.0131
   OGUNWUMI SB, 1997, J CHEM SOC CHEM COMM, P901
   Ryoo R, 1996, J PHYS CHEM-US, V100, P17718, DOI 10.1021/jp9620835
   Stucky GD, 1997, STUD SURF SCI CATAL, V105, P3
   TOMBO GMR, 1991, ANGEW CHEM INT EDIT, V30, P1193, DOI 10.1002/anie.199111933
   VARTULI JC, 1994, CHEM MATER, V6, P2070, DOI 10.1021/cm00047a029
   1993, CHEM ENG NEWS, V71, P38
   1994, CHEM ENG NEWS, V72, P38
NR 28
TC 25
Z9 26
U1 0
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD OCT
PY 1998
VL 10
IS 10
BP 3077
EP 3080
DI 10.1021/cm980191t
PG 4
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 132YF
UT WOS:000076658700050
DA 2018-10-20
ER

PT J
AU Bacon, JR
   Crain, JS
   Van Vaeck, L
   Williams, JG
AF Bacon, JR
   Crain, JS
   Van Vaeck, L
   Williams, JG
TI Atomic spectrometry update - Atomic mass spectrometry
SO JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY
LA English
DT Review
ID INDUCTIVELY-COUPLED PLASMA; TRACE-ELEMENT ANALYSIS; PERFORMANCE
   LIQUID-CHROMATOGRAPHY; CURRENT GLOW-DISCHARGE; RARE-EARTH-ELEMENTS;
   NITROGEN ISOTOPE ANALYSIS; 3-DIMENSIONAL DENSITY PROFILES; RAY
   PHOTOELECTRON-SPECTROSCOPY; ION-EXCHANGE CHROMATOGRAPHY; SOLID-PHASE
   MICROEXTRACTION
AB The format of this year's Update follows that used last year(1) with some minor changes in the section headings, Although an attempt is made to consider all relevant refereed papers, conference abstracts, reports, book chapters and patents for inclusion, this review does not attempt to be comprehensive in its coverage, Critical selection is based an criteria which have been applied more strictly this year than in previous years in order to focus more sharply on the mast significant developments reported during the period (approximately corresponding to 1997) covered by this Update, The prime consideration is that the reports should present advances in instrumentation and methodology or improved understanding of the fundamental professes involved in the MS process. As a general rule, conference abstracts are not included because they rarely provide sufficient information to judge whether or not they meet the criteria, We consider it better to wait for full details to appear in a refereed journal. A similar policy applies to those papers in a language other than English and unlikely to reach a wide readership,
   Routine applications of atomic MS are not covered in this Update and readers are referred to the Updates on Industrial Analysis: Metals, Chemicals and Advanced Materials,(2) Environmental Analysis(3) and Clinical and Biological: Materials, Food and Beverages.(4) An additional review that can be recommended is that of Moens(5) on applications of MS in the analysis of biological materials. Comprehensive evaluations of MS techniques for the analysis of solid samples have been reported by Gijbels and Bogaerts(6) and Becker et al.(7)
   Papers included in this Update must be on atomic spectrometry but some areas of study introduce problems in defining atomic and molecular studies, One of the major drives in recent years has been to develop methods for speciation studies, in particular using ESMS, GC-MS or ICP-MS, The study, for example, of organic arsenic species by ICP-MS involves MS of the atomic ions but in ESMS and GC-MS the molecular species are usually detected. In general, studies of 'exotic' nuclei far from stability are excluded but the determination of radioactive elements in 'real' samples can be included. Very few measurements in SIRMS are of atomic species, yet the object of measuring natural isotopic composition is to study or use a fundamental atomic property, Such studies are included but the use of enriched spikes in tracer studies are excluded because the focus of the study is not on the atomic properties of the tracer element.
   The strong progress being made in most areas of atomic MS is evident from the different sections of this Update. The various trends have been identified in each section and range from the continued improvements in sample preparation for TIMS analysis of remarkable sensitivity and precision to the demand for simpler and cheaper AMS instrumentation so that applications to biomedical research can be fully exploited. Much attention continues to be given to sample preparation and introduction for ICP-MS, in particular for speciation analysis, yet relatively little effort is being given to instrumental development. Although SIMS and SNMS are widely used techniques, fundamental problems remain for quantification and work continues on developing methodologies to optimize analyses.
C1 Macaulay Land Use Res Inst, Aberdeen AB15 8QH, Scotland.
   Union Carbide Corp, Ctr Tech, S Charleston, WV 25303 USA.
   Univ Instelling Antwerp, Dept Chem, Micro & Trace Anal Ctr, B-2610 Antwerp, Belgium.
   Univ London Imperial Coll Sci Technol & Med, TH Huxley Sch Environm Earth Sci & Engn, NERC ICP MS Facil, Ascot SL5 7TE, Berks, England.
RP Bacon, JR (reprint author), Macaulay Land Use Res Inst, Aberdeen AB15 8QH, Scotland.
EM j.bacon@mluri.sari.ac.uk
CR Adriaens A, 1997, INT J MASS SPECTROM, V164, P107, DOI 10.1016/S0168-1176(97)00053-0
   Aguilera R, 1996, J CHROMATOGR B, V687, P43, DOI 10.1016/S0378-4347(96)00016-3
   Akatsuka K, 1998, J ANAL ATOM SPECTROM, V13, P271, DOI 10.1039/a708837j
   Allen LA, 1997, ANAL CHEM, V69, P2384, DOI 10.1021/ac9610624
   Alvarez DE, 1997, NUCL INSTRUM METH B, V123, P39, DOI 10.1016/S0168-583X(96)00412-0
   Amakawa H, 1996, CHEM GEOL, V131, P183, DOI 10.1016/0009-2541(96)00066-6
   Anbar AD, 1997, ANAL CHEM, V69, P2444, DOI 10.1021/ac961129n
   Baba T, 1997, NUCL INSTRUM METH B, V123, P183, DOI 10.1016/S0168-583X(96)00784-7
   Bacon JR, 1997, J ANAL ATOM SPECTROM, V12, pR407
   BACON JR, 1996, MASS SPECTROM SOILS, P31
   Barker J, 1997, NUCL INSTRUM METH B, V123, P275, DOI 10.1016/S0168-583X(96)00704-5
   Barnett DA, 1997, J ANAL ATOM SPECTROM, V12, P497, DOI 10.1039/a603643k
   Barnowski C, 1997, J ANAL ATOM SPECTROM, V12, P1155, DOI 10.1039/a702120h
   Barrie A., 1996, MASS SPECTROMETRY SO, P1
   Barth S, 1997, CHEM GEOL, V143, P255, DOI 10.1016/S0009-2541(97)00107-1
   Barth S, 1997, FRESEN J ANAL CHEM, V358, P854, DOI 10.1007/s002160050522
   Bayon MM, 1998, J ANAL ATOM SPECTROM, V13, P277, DOI 10.1039/a707496d
   Beary ES, 1997, ANAL CHEM, V69, P758, DOI 10.1021/ac9606923
   Beauchemin D, 1998, J ANAL ATOM SPECTROM, V13, P1, DOI 10.1039/a703781c
   Beauchemin D, 1997, ANAL CHEM, V69, P3183, DOI 10.1021/ac970273l
   Becker JS, 1997, MIKROCHIM ACTA, V125, P153, DOI 10.1007/BF01246179
   Becker JS, 1997, INT J MASS SPECTROM, V164, P81, DOI 10.1016/S0168-1176(97)00021-9
   Bedard LP, 1997, CHEM GEOL, V138, P1, DOI 10.1016/S0009-2541(96)00169-6
   Begley IS, 1997, J ANAL ATOM SPECTROM, V12, P395, DOI 10.1039/a605078f
   Begley IS, 1997, ANAL CHEM, V69, P1530, DOI 10.1021/ac960935r
   Belkin MA, 1997, J ANAL ATOM SPECTROM, V12, P1255, DOI 10.1039/a700266a
   Belyaev BN, 1997, RADIOCHEMISTRY+, V39, P59
   Bennett J, 1997, SURF INTERFACE ANAL, V25, P454
   BENNINGHOVEN A, 1997, Patent No. 0471958
   BETTINELLI M, 1997, SPEC PUBL R SOC CHEM, V202, P152
   Bhattacharjee S, 1997, NUCL INSTRUM METH B, V129, P123, DOI 10.1016/S0168-583X(97)00145-6
   Birck JL, 1997, GEOSTANDARD NEWSLETT, V21, P19, DOI 10.1111/j.1751-908X.1997.tb00528.x
   BlichertToft J, 1997, CONTRIB MINERAL PETR, V127, P248, DOI 10.1007/s004100050278
   Bock W, 1997, FRESEN J ANAL CHEM, V358, P300, DOI 10.1007/s002160050412
   Bogaerts A, 1997, J ANAL ATOM SPECTROM, V12, P751, DOI 10.1039/a608262i
   Bogaerts A, 1997, J AM SOC MASS SPECTR, V8, P1021, DOI 10.1016/S1044-0305(97)00120-7
   Bogaerts A, 1997, SPECTROCHIM ACTA B, V52, P765, DOI 10.1016/S0584-8547(97)82786-3
   Bogaerts A, 1997, SPECTROCHIM ACTA B, V52, P205, DOI 10.1016/S0584-8547(96)01577-7
   Bogaerts A, 1997, SPECTROCHIM ACTA B, V52, P219, DOI 10.1016/S0584-8547(96)01578-9
   Bogaerts A, 1997, ANAL CHEM, V69, pA719, DOI 10.1021/ac971868j
   Boulyga SF, 1997, RADIAT MEAS, V28, P349, DOI 10.1016/S1350-4487(97)00098-X
   Breuer U, 1997, FRESEN J ANAL CHEM, V358, P47, DOI 10.1007/s002160050342
   Briche CSJ, 1997, ANAL CHEM, V69, P791, DOI 10.1021/ac9607368
   Brown TA, 1997, NUCL INSTRUM METH B, V123, P208, DOI 10.1016/S0168-583X(96)00676-3
   Brunner C, 1997, FRESEN J ANAL CHEM, V358, P233, DOI 10.1007/s002160050392
   Brunner C, 1997, MIKROCHIM ACTA, V125, P69, DOI 10.1007/BF01246164
   Burgoyne TW, 1997, ANAL CHEM, V69, P485, DOI 10.1021/ac960673t
   Burgoyne TW, 1997, J AM SOC MASS SPECTR, V8, P307, DOI 10.1016/S1044-0305(96)00290-5
   Burgoyne TW, 1997, J ANAL ATOM SPECTROM, V12, P1149, DOI 10.1039/a607861c
   Bushaw BA, 1997, SPECTROCHIM ACTA B, V52, P1839, DOI 10.1016/S0584-8547(97)00066-9
   Byrne JP, 1997, SPECTROCHIM ACTA B, V52, P1575, DOI 10.1016/S0584-8547(97)00064-5
   Byrne JP, 1997, CAN J ANAL SCI SPECT, V42, P95
   Caimi RJ, 1997, J CHROMATOGR A, V757, P307, DOI 10.1016/S0021-9673(96)00694-2
   Challa VR, 1998, J NEUROPATH EXP NEUR, V57, P140, DOI 10.1097/00005072-199802000-00005
   Chang CC, 1997, ANAL CHIM ACTA, V353, P173, DOI 10.1016/S0003-2670(97)87775-6
   Chen M, 1997, SPECTROCHIM ACTA B, V52, P1161
   Chen MB, 1997, NUCL INSTRUM METH B, V123, P102, DOI 10.1016/S0168-583X(96)00739-2
   Chen YB, 1997, SPECTROCHIM ACTA B, V52, P231, DOI 10.1016/S0584-8547(96)01576-5
   Chen YW, 1997, CHEM GEOL, V137, P195, DOI 10.1016/S0009-2541(96)00163-5
   Chew A, 1997, J ANAL ATOM SPECTROM, V12, P1101, DOI 10.1039/a700086c
   Chi PH, 1997, J VAC SCI TECHNOL A, V15, P2565, DOI 10.1116/1.580772
   Chisholm W, 1997, ANAL CHIM ACTA, V347, P351, DOI 10.1016/S0003-2670(97)00176-1
   Chu DP, 1997, PHYS REV B, V56, P15167, DOI 10.1103/PhysRevB.56.15167
   Chu PK, 1998, MATER CHEM PHYS, V52, P60, DOI 10.1016/S0254-0584(98)80007-2
   Clemens D, 1997, FRESEN J ANAL CHEM, V358, P122, DOI 10.1007/s002160050361
   Coedo AG, 1997, ISIJ INT, V37, P878, DOI 10.2355/isijinternational.37.878
   Collon P, 1997, NUCL INSTRUM METH B, V123, P122, DOI 10.1016/S0168-583X(96)00674-X
   CORDT HH, 1994, ISOTOPENPRAXIS, V30, P259, DOI 10.1080/00211919408046742
   Cornett RJ, 1997, NUCL INSTRUM METH B, V123, P249, DOI 10.1016/S0168-583X(96)00731-8
   Corso TN, 1997, P NATL ACAD SCI USA, V94, P1049, DOI 10.1073/pnas.94.4.1049
   CREWS HM, 1997, 30 C SPECTR INT CSI
   Crighton JS, 1997, J ANAL ATOM SPECTROM, V12, p509R
   Currie LA, 1997, NUCL INSTRUM METH B, V123, P475, DOI 10.1016/S0168-583X(96)00783-5
   Datar SA, 1997, NUCL INSTRUM METH B, V123, P571, DOI 10.1016/S0168-583X(96)00703-3
   Datta BP, 1997, SPECTROCHIM ACTA B, V52, P471, DOI 10.1016/S0584-8547(96)01603-5
   Dautraix S, 1996, J CHROMATOGR A, V756, P203, DOI 10.1016/S0021-9673(96)00640-1
   Day DA, 1997, MICROCHEM J, V55, P208, DOI 10.1006/mchj.1996.1415
   De Bievre P, 1997, FRESEN J ANAL CHEM, V359, P523, DOI 10.1007/s002160050625
   Dean JR, 1998, J ANAL ATOM SPECTROM, V13, p1R, DOI 10.1039/a704305h
   deBoer JLM, 1997, SPECTROCHIM ACTA B, V52, P389, DOI 10.1016/S0584-8547(96)01604-7
   DelaCalleGuntinas MB, 1997, J ANAL ATOM SPECTROM, V12, P1041
   DeLaeter JR, 1996, MASS SPECTROM REV, V15, P261, DOI 10.1002/(SICI)1098-2787(1996)15:4<261::AID-MAS3>3.0.CO;2-G
   DeNeve K, 1997, J RADIOANAL NUCL CH, V221, P79, DOI 10.1007/BF02035246
   Denniston RF, 1997, GEOCHIM COSMOCHIM AC, V61, P1803, DOI 10.1016/S0016-7037(97)00049-5
   DeNollin S, 1997, PATHOL RES PRACT, V193, P313
   Dias RF, 1997, ANAL CHEM, V69, P944, DOI 10.1021/ac960635+
   Diemer J, 1997, FRESEN J ANAL CHEM, V357, P74, DOI 10.1007/s002160050114
   Ding GJ, 1997, NUCL INSTRUM METH B, V123, P424, DOI 10.1016/S0168-583X(96)00609-X
   Ding GJ, 1997, NUCL INSTRUM METH B, V123, P414, DOI 10.1016/S0168-583X(96)00746-X
   Dixon P, 1997, ANAL CHEM, V69, P1692, DOI 10.1021/ac961159q
   DONAHUE DJ, 1990, RADIOCARBON, V32, P135
   Donahue DJ, 1997, NUCL INSTRUM METH B, V123, P51, DOI 10.1016/S0168-583X(96)00729-X
   Du ZH, 1997, J AM SOC MASS SPECTR, V8, P1230, DOI 10.1016/S1044-0305(97)00220-1
   Duan YX, 1997, INT J MASS SPECTROM, V161, P27, DOI 10.1016/S0168-1176(96)04434-5
   Dummler W, 1997, INT J MASS SPECTROM, V164, P155, DOI 10.1016/S0168-1176(97)00054-2
   Eiden GC, 1997, RAPID COMMUN MASS SP, V11, P37, DOI 10.1002/(SICI)1097-0231(19970115)11:1<37::AID-RCM815>3.0.CO;2-C
   Eiler JM, 1997, CHEM GEOL, V138, P221, DOI 10.1016/S0009-2541(97)00015-6
   Elmore D, 1997, NUCL INSTRUM METH B, V123, P69, DOI 10.1016/S0168-583X(96)00621-0
   Elokhin VA, 1997, J ANAL CHEM+, V52, P1030
   Ender RM, 1997, NUCL INSTRUM METH B, V123, P575, DOI 10.1016/S0168-583X(96)00416-8
   Erdmann N, 1997, FRESEN J ANAL CHEM, V359, P378, DOI 10.1007/s002160050591
   Farquhar GD, 1997, RAPID COMMUN MASS SP, V11, P1554, DOI 10.1002/(SICI)1097-0231(199709)11:14<1554::AID-RCM980>3.0.CO;2-I
   Faude F, 1997, FRESEN J ANAL CHEM, V358, P67, DOI 10.1007/s002160050347
   Faulhaber S, 1997, J AGR FOOD CHEM, V45, P4719, DOI 10.1021/jf970534s
   Faulhaber S, 1997, J AGR FOOD CHEM, V45, P2579, DOI 10.1021/jf9607728
   Feldmann J, 1997, J ANAL ATOM SPECTROM, V12, P1069, DOI 10.1039/a701264k
   Fiala A, 1997, SPECTROCHIM ACTA B, V52, P531, DOI 10.1016/S0584-8547(96)01617-5
   Fifield LK, 1997, NUCL INSTRUM METH B, V123, P400, DOI 10.1016/S0168-583X(96)00428-4
   Fifield LK, 1996, NUCL INSTRUM METH A, V382, P292, DOI 10.1016/S0168-9002(96)00394-4
   Figg D, 1997, APPL SPECTROSC, V51, P1185, DOI 10.1366/0003702971941728
   Fitzgerald N, 1998, J ANAL ATOM SPECTROM, V13, P13, DOI 10.1039/a703491a
   Fletcher IR, 1997, INT J MASS SPECTROM, V163, P1, DOI 10.1016/S0168-1176(96)04540-5
   Fonseca RW, 1997, APPL SPECTROSC, V51, P1800, DOI 10.1366/0003702971939866
   Fourre C, 1997, J ANAL ATOM SPECTROM, V12, P1105, DOI 10.1039/a700777i
   Fragu P, 1997, MICROSC RES TECHNIQ, V36, P296, DOI 10.1002/(SICI)1097-0029(19970215)36:4<296::AID-JEMT7>3.0.CO;2-K
   Frei R, 1997, GEOCHIM COSMOCHIM AC, V61, P393, DOI 10.1016/S0016-7037(96)00343-2
   Friedrich M, 1997, NUCL INSTRUM METH B, V123, P410, DOI 10.1016/S0168-583X(96)00404-1
   Funaya N, 1997, NUCL INSTRUM METH B, V123, P174, DOI 10.1016/S0168-583X(96)00740-9
   Gale NH, 1996, ANAL CHIM ACTA, V332, P15, DOI 10.1016/0003-2670(96)00207-3
   Gard E, 1997, ANAL CHEM, V69, P4083, DOI 10.1021/ac970540n
   Gartenmann P, 1997, NUCL INSTRUM METH B, V123, P132, DOI 10.1016/S0168-583X(96)00403-X
   Gastel M, 1997, FRESEN J ANAL CHEM, V358, P207, DOI 10.1007/s002160050385
   Gautier B, 1996, SURF INTERFACE ANAL, V24, P733, DOI 10.1002/(SICI)1096-9918(199610)24:11<733::AID-SIA173>3.3.CO;2-N
   Gehre M, 1996, ANAL CHEM, V68, P4414, DOI 10.1021/ac9606766
   Gehre M, 1996, ISOT ENVIRON HEALT S, V32, P335, DOI 10.1080/10256019608234026
   Gelbart WZ, 1997, NUCL INSTRUM METH B, V123, P550, DOI 10.1016/S0168-583X(96)00616-7
   Gelinas Y, 1998, ANAL CHEM, V70, P1021, DOI 10.1021/ac970974i
   Gerardi C, 1997, SURF INTERFACE ANAL, V25, P397, DOI 10.1002/(SICI)1096-9918(199706)25:6<397::AID-SIA248>3.3.CO;2-0
   Gerstenberger H, 1997, CHEM GEOL, V136, P309, DOI 10.1016/S0009-2541(96)00033-2
   Gibson JK, 1997, ANAL CHEM, V69, P111, DOI 10.1021/ac960805i
   Gijbels R, 1997, FRESEN J ANAL CHEM, V359, P326, DOI 10.1007/s002160050581
   GIUSSANI A, 1997, ISOT ENVIRON HEALT S, V33, P207
   Gnaser H, 1997, J VAC SCI TECHNOL A, V15, P445, DOI 10.1116/1.580872
   Gnaser H, 1997, FRESEN J ANAL CHEM, V358, P171, DOI 10.1007/s002160050375
   Gnaser H, 1997, APPL SURF SCI, V120, P220, DOI 10.1016/S0169-4332(97)00250-X
   Gnaser H, 1997, SURF INTERFACE ANAL, V25, P737, DOI 10.1002/(SICI)1096-9918(199709)25:10<737::AID-SIA294>3.0.CO;2-M
   Gobel M, 1997, FRESEN J ANAL CHEM, V358, P131, DOI 10.1007/s002160050363
   Goessler W, 1997, J CHROMATOGR A, V789, P233, DOI 10.1016/S0021-9673(97)00874-1
   Golser R, 1997, NUCL INSTRUM METH B, V123, P170, DOI 10.1016/S0168-583X(96)00781-1
   Goltz DM, 1997, J ANAL ATOM SPECTROM, V12, P1175, DOI 10.1039/a703588h
   Gong B, 1997, INT J COAL GEOL, V34, P53, DOI 10.1016/S0166-5162(97)00006-2
   Gong B, 1997, FUEL PROCESS TECHNOL, V50, P69, DOI 10.1016/S0378-3820(96)01057-0
   Gorecki T, 1997, ANAL COMMUN, V34, P275, DOI 10.1039/a704264g
   Goschnick J, 1997, FRESEN J ANAL CHEM, V358, P159, DOI 10.1007/s002160050371
   Gottdang A, 1997, NUCL INSTRUM METH B, V123, P163, DOI 10.1016/S0168-583X(96)00410-7
   Grabowski KS, 1997, NUCL INSTRUM METH B, V123, P566, DOI 10.1016/S0168-583X(96)00627-1
   Graham IJ, 1997, NUCL INSTRUM METH B, V123, P307, DOI 10.1016/S0168-583X(96)00737-9
   Griesser M, 1997, FRESEN J ANAL CHEM, V358, P293, DOI 10.1007/s002160050410
   Grignon N, 1997, J MICROSC-OXFORD, V186, P51, DOI 10.1046/j.1365-2818.1997.1850747.x
   Groenewold GS, 1998, ANAL CHEM, V70, P534, DOI 10.1021/ac9705172
   Grunke K, 1997, SPECTROCHIM ACTA B, V52, P1545, DOI 10.1016/S0584-8547(97)00051-7
   Grunke K, 1997, FRESEN J ANAL CHEM, V359, P465, DOI 10.1007/s002160050613
   GudmandHoyer L, 1996, SURF INTERFACE ANAL, V24, P856, DOI 10.1002/(SICI)1096-9918(199612)24:13<856::AID-SIA194>3.0.CO;2-1
   Gunther D, 1997, FRESEN J ANAL CHEM, V359, P390, DOI 10.1007/s002160050594
   Gunther D, 1997, J ANAL ATOM SPECTROM, V12, P939, DOI 10.1039/a701423f
   Gwizdala AB, 1997, J ANAL ATOM SPECTROM, V12, P503, DOI 10.1039/a606413b
   Hang W, 1997, ANAL CHEM, V69, P4957, DOI 10.1021/ac9710386
   Harris D, 1997, COMMUN SOIL SCI PLAN, V28, P747, DOI 10.1080/00103629709369827
   Harrison WW, 1997, J ANAL ATOM SPECTROM, V12, P891, DOI 10.1039/a701641g
   Heinemeier J, 1997, NUCL INSTRUM METH B, V123, P487, DOI 10.1016/S0168-583X(96)00705-7
   Henry BM, 1997, APPL SURF SCI, V108, P485, DOI 10.1016/S0169-4332(96)00581-8
   Herner SB, 1996, J VAC SCI TECHNOL B, V14, P3593, DOI 10.1116/1.588731
   Hintelmann H, 1997, FRESEN J ANAL CHEM, V358, P378, DOI 10.1007/s002160050433
   Hintelmann H, 1997, FRESEN J ANAL CHEM, V358, P363, DOI 10.1007/s002160050431
   Hirata T, 1997, J ANAL ATOM SPECTROM, V12, P1337, DOI 10.1039/a704169a
   Hobson KA, 1997, CAN J ZOOL, V75, P1720, DOI 10.1139/z97-799
   Holmden C, 1997, GEOCHIM COSMOCHIM AC, V61, P2253, DOI 10.1016/S0016-7037(97)00057-4
   Holt BD, 1997, ANAL CHEM, V69, P2727, DOI 10.1021/ac961096b
   Hoshi T, 1997, APPL SURF SCI, V121, P146, DOI 10.1016/S0169-4332(97)00275-4
   HOTCHKIS MAC, 1995, P AUST C NUCL TECH A, P29
   Houk RS, 1997, J ANAL ATOM SPECTROM, V12, P1139, DOI 10.1039/a607579g
   Huang CC, 1997, ANAL CHEM, V69, P3930, DOI 10.1021/ac970284e
   Huang LJ, 1997, J VAC SCI TECHNOL A, V15, P2196, DOI 10.1116/1.580533
   Hughes DM, 1997, SPECTROCHIM ACTA B, V52, P517, DOI 10.1016/S0584-8547(96)01595-9
   Hughey BJ, 1997, NUCL INSTRUM METH B, V123, P153, DOI 10.1016/S0168-583X(96)00420-X
   Hughey BJ, 1997, NUCL INSTRUM METH B, V123, P186, DOI 10.1016/S0168-583X(96)00408-9
   Hwang TJ, 1997, J ANAL ATOM SPECTROM, V12, P579, DOI 10.1039/a607469c
   Hwang TJ, 1997, ANALYST, V122, P233, DOI 10.1039/a606577e
   Iltgen K, 1997, J VAC SCI TECHNOL A, V15, P460, DOI 10.1116/1.580874
   Im HS, 1997, APPL SURF SCI, V108, P197, DOI 10.1016/S0169-4332(96)00602-2
   Ingelbrecht C, 1997, NUCL INSTRUM METH A, V397, P30, DOI 10.1016/S0168-9002(97)00582-2
   Jager R, 1997, INT J MASS SPECTROM, V171, P183, DOI 10.1016/S0168-1176(97)00119-5
   Jager R, 1997, MIKROCHIM ACTA, V125, P41, DOI 10.1007/BF01246160
   Jager R, 1997, FRESEN J ANAL CHEM, V358, P214, DOI 10.1007/s002160050387
   Jamin E, 1997, PLANT CELL ENVIRON, V20, P589, DOI 10.1111/j.1365-3040.1997.00099.x
   Jiang SS, 1997, NUCL INSTRUM METH B, V123, P405, DOI 10.1016/S0168-583X(96)00747-1
   Jiang ZX, 1997, SURF INTERFACE ANAL, V25, P285, DOI 10.1002/(SICI)1096-9918(199704)25:4<285::AID-SIA235>3.0.CO;2-0
   Jiang ZX, 1997, SURF INTERFACE ANAL, V25, P817, DOI 10.1002/(SICI)1096-9918(199709)25:10<817::AID-SIA305>3.0.CO;2-O
   Joannon S, 1997, SPECTROCHIM ACTA B, V52, P1783, DOI 10.1016/S0584-8547(97)00072-4
   Jochum KP, 1997, FRESEN J ANAL CHEM, V359, P385, DOI 10.1007/s002160050593
   JOCHUM KP, 1997, SPECTROSCOPY EUROPE, V9, P22
   Johnson RR, 1997, NUCL INSTRUM METH B, V123, P283, DOI 10.1016/S0168-583X(96)00617-9
   Jones OR, 1997, RAPID COMMUN MASS SP, V11, P179, DOI 10.1002/(SICI)1097-0231(19970131)11:2<179::AID-RCM757>3.0.CO;2-#
   Karhu JA, 1997, ANAL CHEM, V69, P4728, DOI 10.1021/ac9704467
   Kaviladze MS, 1997, INT J MASS SPECTROM, V161, P87, DOI 10.1016/S0168-1176(96)04432-1
   Kilius LR, 1997, NUCL INSTRUM METH B, V123, P5, DOI 10.1016/S0168-583X(96)00715-X
   Kilius LR, 1997, NUCL INSTRUM METH B, V123, P10, DOI 10.1016/S0168-583X(96)00421-1
   King SJ, 1997, ANALYST, V122, P1049, DOI 10.1039/a702002c
   Kirner DL, 1997, NUCL INSTRUM METH B, V123, P214, DOI 10.1016/S0168-583X(96)00752-5
   Kitagawa H, 1997, NUCL INSTRUM METH B, V123, P218, DOI 10.1016/S0168-583X(96)00622-2
   Klotzli US, 1997, ANALYST, V122, P1239, DOI 10.1039/a704114d
   Knie K, 1997, NUCL INSTRUM METH B, V123, P128, DOI 10.1016/S0168-583X(96)00753-7
   Knies DL, 1997, NUCL INSTRUM METH B, V123, P589, DOI 10.1016/S0168-583X(96)00626-X
   Konarski P., 1996, Electron Technology, V29, P277
   Koslowsky VT, 1997, NUCL INSTRUM METH B, V123, P226, DOI 10.1016/S0168-583X(96)00604-0
   Koslowsky VT, 1997, NUCL INSTRUM METH B, V123, P203, DOI 10.1016/S0168-583X(96)00628-3
   Koslowsky VT, 1997, NUCL INSTRUM METH B, V123, P144, DOI 10.1016/S0168-583X(96)00741-0
   Koziet J, 1997, J MASS SPECTROM, V32, P103, DOI 10.1002/(SICI)1096-9888(199701)32:1<103::AID-JMS463>3.0.CO;2-9
   Kretschmer W, 1997, NUCL INSTRUM METH B, V123, P455, DOI 10.1016/S0168-583X(96)00603-9
   Kretschmer W, 1997, NUCL INSTRUM METH B, V123, P93, DOI 10.1016/S0168-583X(96)00610-6
   Krimke R, 1997, J PHYS D APPL PHYS, V30, P1676, DOI 10.1088/0022-3727/30/11/017
   Kume H, 1997, NUCL INSTRUM METH B, V123, P31, DOI 10.1016/S0168-583X(96)00632-5
   Kutschera W, 1997, NUCL INSTRUM METH B, V123, P47, DOI 10.1016/S0168-583X(96)00782-3
   Kutschera W, 1997, NUCL INSTRUM METH B, V123, P594, DOI 10.1016/S0168-583X(96)00738-0
   LaBelle RD, 1996, PHYS REV A, V54, P4461, DOI 10.1103/PhysRevA.54.4461
   Lancin M, 1997, INT J MASS SPECTROM, V163, P69, DOI 10.1016/S0168-1176(97)00002-5
   LAWSON EM, 1995, P AUST C NUCL TECH A, P130
   Leadley SR, 1997, BIOMATERIALS, V18, P311, DOI 10.1016/S0142-9612(96)00134-2
   LeClercq M, 1997, NUCL INSTRUM METH B, V123, P443, DOI 10.1016/S0168-583X(96)00721-5
   Ledingham KWD, 1997, INT J MASS SPECTROM, V163, P149, DOI 10.1016/S0168-1176(97)00015-3
   Lefevre O, 1996, MIKROCHIM ACTA, P399
   Leloup C, 1997, J ANAL ATOM SPECTROM, V12, P945, DOI 10.1039/a701450c
   Lhuissier F, 1997, BOT ACTA, V110, P378, DOI 10.1111/j.1438-8677.1997.tb00653.x
   LI GQ, 1995, Patent No. 434931
   Litherland AE, 1997, NUCL INSTRUM METH B, V123, P18, DOI 10.1016/S0168-583X(96)00736-7
   Liu BH, 1996, CHINESE SCI BULL, V41, P790
   Liu DY, 1997, ANAL CHEM, V69, P1808, DOI 10.1021/ac9612988
   Liu YZ, 1997, INT J MASS SPECTROM, V171, P73, DOI 10.1016/S0168-1176(97)00114-6
   Liu YZ, 1997, ANAL COMMUN, V34, P171, DOI 10.1039/a701957b
   Lodding AR, 1997, MIKROCHIM ACTA, V125, P317, DOI 10.1007/BF01246205
   Lofthouse SD, 1997, J ANAL ATOM SPECTROM, V12, P1373, DOI 10.1039/a705047j
   Luo XZ, 1997, INT J MASS SPECTROM, V171, P105, DOI 10.1016/S0168-1176(97)00136-5
   Lyon IC, 1998, INT J MASS SPECTROM, V172, P115, DOI 10.1016/S0168-1176(97)00143-2
   Macko SA, 1997, ANAL CHEM, V69, P926, DOI 10.1021/ac960956l
   Mahoney PP, 1997, APPL SPECTROSC, V51, P1464, DOI 10.1366/0003702971939235
   Mahoney PP, 1997, APPL SPECTROSC, V51, pA16, DOI 10.1366/0003702971938759
   MARCHANTEGAYON JM, 1997, SPEC PUBL R SOC CHEM, V202, P85
   Marchetti AA, 1997, NUCL INSTRUM METH B, V123, P230, DOI 10.1016/S0168-583X(96)00611-8
   Marchetti AA, 1997, NUCL INSTRUM METH B, V123, P352, DOI 10.1016/S0168-583X(96)00633-7
   Markey R, 1998, TALANTA, V45, P935, DOI 10.1016/S0039-9140(97)00198-7
   Martin CJ, 1997, ENVIRON GEOL, V32, P107, DOI 10.1007/s002540050199
   Mason RS, 1997, PHYS REV E, V55, P7462, DOI 10.1103/PhysRevE.55.7462
   MASSONET S, 1997, AIP C P 2, V392, P795
   Masters BJ, 1997, ANAL COMMUN, V34, P237, DOI 10.1039/a704726f
   McAninch JE, 1997, NUCL INSTRUM METH B, V123, P137, DOI 10.1016/S0168-583X(96)00411-9
   McIntyre RS, 1997, J ANAL ATOM SPECTROM, V12, P547, DOI 10.1039/a607270d
   McLean JA, 1998, ANAL CHEM, V70, P1012, DOI 10.1021/ac9708553
   MeierAugenstein W, 1997, LC GC-MAG SEP SCI, V15, P244
   Metges CC, 1997, ANAL BIOCHEM, V247, P158, DOI 10.1006/abio.1997.2037
   Milgram KE, 1997, ANAL CHEM, V69, P3714, DOI 10.1021/ac970126n
   MIN H, 1997, ANAL CHEM, V69, P1135
   Minnich MG, 1998, J ANAL ATOM SPECTROM, V13, P167, DOI 10.1039/a704274d
   Moens L, 1997, FRESEN J ANAL CHEM, V359, P309, DOI 10.1007/s002160050579
   Moini M, 1997, J MASS SPECTROM, V32, P420, DOI 10.1002/(SICI)1096-9888(199704)32:4<420::AID-JMS495>3.0.CO;2-N
   Montero P, 1998, ANAL CHIM ACTA, V358, P227, DOI 10.1016/S0003-2670(97)00599-0
   Montgomery NJ, 1997, J ALLOY COMPD, V251, P355, DOI 10.1016/S0925-8388(96)02810-1
   Mootz T, 1997, INT J MASS SPECTROM, V163, P197, DOI 10.1016/S0168-1176(97)00012-8
   Mootz T, 1996, INT J MASS SPECTROM, V156, P1, DOI 10.1016/S0168-1176(96)04410-2
   Mora J, 1998, J ANAL ATOM SPECTROM, V13, P175, DOI 10.1039/a706833f
   Mosandl A, 1997, ANALUSIS, V25, pM31
   Mous DJW, 1997, NUCL INSTRUM METH B, V123, P159, DOI 10.1016/S0168-583X(96)00423-5
   Mulvaney RL, 1997, J AUTOM CHEM, V19, P165, DOI 10.1155/S1463924697000175
   Murphy DM, 1997, J GEOPHYS RES-ATMOS, V102, P6341, DOI 10.1029/96JD00858
   Nadeau MJ, 1997, NUCL INSTRUM METH B, V123, P22, DOI 10.1016/S0168-583X(96)00730-6
   Nagashima Y, 1996, NUCL INSTRUM METH A, V382, P321, DOI 10.1016/S0168-9002(96)00628-6
   Nam SH, 1998, APPL SPECTROSC, V52, P161, DOI 10.1366/0003702981942500
   NAULET N, 1996, HERBA POL, V42, P221
   Nicolussi GK, 1997, ANAL CHEM, V69, P1140, DOI 10.1021/ac960871k
   Nihei Y, 1997, J TRACE MICROPROBE T, V15, P593
   NIHEI Y, 1997, J SURF ANAL, V3, P178
   Nonose N, 1996, SPECTROCHIM ACTA B, V51, P1551, DOI 10.1016/0584-8547(96)01517-0
   Novak SW, 1997, J VAC SCI TECHNOL A, V15, P1724, DOI 10.1116/1.580927
   Nusko R, 1997, FRESEN J ANAL CHEM, V357, P1050, DOI 10.1007/s002160050303
   Ochs M, 1997, NUCL INSTRUM METH B, V123, P235, DOI 10.1016/S0168-583X(96)00680-5
   OConnor G, 1997, J ANAL ATOM SPECTROM, V12, P1263, DOI 10.1039/a703733c
   Ohata M, 1998, J ANAL ATOM SPECTROM, V13, P447, DOI 10.1039/a707117e
   Oi T, 1997, ANAL CHIM ACTA, V340, P221, DOI 10.1016/S0003-2670(96)00519-3
   Okuno M, 1997, NUCL INSTRUM METH B, V123, P470, DOI 10.1016/S0168-583X(96)00614-3
   Olesik JW, 1997, APPL SPECTROSC, V51, pA158, DOI 10.1366/0003702971940792
   Olesik JW, 1997, J ANAL ATOM SPECTROM, V12, P507, DOI 10.1039/a606420e
   OLESIK JW, 1997, SPEC PUBL R SOC CHEM, V202, P1
   Olivas RM, 1998, TALANTA, V45, P1023, DOI 10.1016/S0039-9140(97)00172-0
   Parent M, 1997, TALANTA, V44, P221, DOI 10.1016/S0039-9140(96)02037-1
   Parks CC, 1997, J VAC SCI TECHNOL A, V15, P1328, DOI 10.1116/1.580584
   Passler G, 1997, KERNTECHNIK, V62, P85
   PATTERSON K, 1997, 24 FACSS PROV RI US
   Paul M, 1997, NUCL INSTRUM METH B, V123, P394, DOI 10.1016/S0168-583X(96)00708-2
   Perry M, 1997, NUCL INSTRUM METH B, V123, P178, DOI 10.1016/S0168-583X(96)00719-7
   Persson P, 1998, REV SCI INSTRUM, V69, P1188, DOI 10.1063/1.1148751
   Pin C, 1997, ANAL CHIM ACTA, V339, P79, DOI 10.1016/S0003-2670(96)00499-0
   Potts PJ, 1997, ANALYST, V122, P1179, DOI 10.1039/a704856d
   Pozebon D, 1998, J ANAL ATOM SPECTROM, V13, P363, DOI 10.1039/a707849h
   Pozebon D, 1998, J ANAL ATOM SPECTROM, V13, P7, DOI 10.1039/a706837i
   Pretty JR, 1997, ANAL CHEM, V69, P3544, DOI 10.1021/ac970360d
   Priller A, 1997, NUCL INSTRUM METH B, V123, P193, DOI 10.1016/S0168-583X(96)00780-X
   Prudon G, 1997, THIN SOLID FILMS, V294, P54, DOI 10.1016/S0040-6090(96)09330-3
   Purser KH, 1997, NUCL INSTRUM METH B, V123, P167, DOI 10.1016/S0168-583X(96)00673-8
   Qi HP, 1997, INT J MASS SPECTROM, V171, P263, DOI 10.1016/S0168-1176(97)00125-0
   Quetel CR, 1997, SPECTROCHIM ACTA B, V52, P177, DOI 10.1016/S0584-8547(96)01587-X
   Ramsey CB, 1997, NUCL INSTRUM METH B, V123, P539, DOI 10.1016/S0168-583X(96)00612-X
   Raynor MW, 1997, J ANAL ATOM SPECTROM, V12, P1057
   Rebane JA, 1997, J MATER CHEM, V7, P2085, DOI 10.1039/a702798b
   Rebane JA, 1996, FRESEN J ANAL CHEM, V356, P484
   Rebane JA, 1997, THIN SOLID FILMS, V302, P140, DOI 10.1016/S0040-6090(96)09585-5
   Reger N, 1997, FRESEN J ANAL CHEM, V358, P143, DOI 10.1007/s002160050366
   Riedel M, 1997, RAPID COMMUN MASS SP, V11, P667
   Roberts ML, 1997, NUCL INSTRUM METH B, V123, P57, DOI 10.1016/S0168-583X(96)00426-0
   Roberts ML, 1997, NUCL INSTRUM METH B, V123, P367, DOI 10.1016/S0168-583X(96)00407-7
   Rocholl ABE, 1997, GEOSTANDARD NEWSLETT, V21, P101, DOI 10.1111/j.1751-908X.1997.tb00537.x
   RUSSO R, 1997, 24 FACSS PROV RI US
   Sah RN, 1997, MICROCHEM J, V56, P285, DOI 10.1006/mchj.1997.1428
   Sah RN, 1997, PLANT SOIL, V193, P15, DOI 10.1023/A:1004251606504
   Sahoo SK, 1997, CHEM GEOL, V141, P117, DOI 10.1016/S0009-2541(97)00024-7
   Saito M, 1997, ANAL CHIM ACTA, V355, P129, DOI 10.1016/S0003-2670(97)00506-0
   Saito M, 1997, FRESEN J ANAL CHEM, V357, P18, DOI 10.1007/s002160050103
   Salem AA, 1996, J MATER SCI-MATER EL, V7, P373
   Sands DG, 1997, GEOSTANDARD NEWSLETT, V21, P77, DOI 10.1111/j.1751-908X.1997.tb00533.x
   Sansone FJ, 1997, ANAL CHEM, V69, P40, DOI 10.1021/ac960241i
   Santos GM, 1997, NUCL INSTRUM METH B, V123, P34, DOI 10.1016/S0168-583X(96)00425-9
   Santosa SJ, 1997, ENVIRON MONIT ASSESS, V44, P515, DOI 10.1023/A:1005782500773
   Santosa SJ, 1997, FRESEN J ANAL CHEM, V357, P1122, DOI 10.1007/s002160050317
   Santucci S, 1997, J VAC SCI TECHNOL A, V15, P905, DOI 10.1116/1.580730
   Saprykin AI, 1997, FRESEN J ANAL CHEM, V359, P449, DOI 10.1007/s002160050609
   Saprykin AI, 1997, FRESEN J ANAL CHEM, V358, P145, DOI 10.1007/s002160050367
   Saverwyns S, 1997, J ANAL ATOM SPECTROM, V12, P1047, DOI 10.1039/a701554b
   Scerbo R, 1997, QUIM ANAL, V16, P87
   SCHMIDT G, 1997, ISOT ENVIRON HEALT S, V33, P235
   Schmitz R, 1997, FRESEN J ANAL CHEM, V358, P42, DOI 10.1007/s002160050341
   Schneider RJ, 1997, NUCL INSTRUM METH B, V123, P546, DOI 10.1016/S0168-583X(96)00607-6
   Schoeller DA, 1997, J MASS SPECTROM, V32, P1332, DOI 10.1002/(SICI)1096-9888(199712)32:12<1332::AID-JMS598>3.0.CO;2-E
   Scholz J, 1997, J ALLOY COMPD, V253, P459, DOI 10.1016/S0925-8388(96)03000-9
   Seah MP, 1997, J VAC SCI TECHNOL A, V15, P485, DOI 10.1116/1.580878
   Seki S, 1997, SURF INTERFACE ANAL, V25, P155
   Serrano JJ, 1997, VACUUM, V48, P643, DOI 10.1016/S0042-207X(97)00077-8
   Seufert HM, 1997, FRESEN J ANAL CHEM, V359, P454, DOI 10.1007/s002160050610
   Shackleton CHL, 1997, STEROIDS, V62, P379, DOI 10.1016/S0039-128X(96)00253-X
   Sharma P, 1997, NUCL INSTRUM METH B, V123, P347, DOI 10.1016/S0168-583X(96)00675-1
   Sharp BL, 1997, J ANAL ATOM SPECTROM, V12, P603, DOI 10.1039/a701420a
   Sheng J, 1997, J ELECTRON MATER, V26, P588, DOI 10.1007/s11664-997-0199-0
   Shi BR, 1997, J VAC SCI TECHNOL B, V15, P273, DOI 10.1116/1.589277
   Shibata Y, 1997, NUCL INSTRUM METH B, V123, P554, DOI 10.1016/S0168-583X(96)00424-7
   Shichi H, 1997, RAPID COMMUN MASS SP, V11, P175, DOI 10.1002/(SICI)1097-0231(19970131)11:2<175::AID-RCM725>3.0.CO;2-K
   Sie SH, 1997, MATER SCI FORUM, V248-2, P313, DOI 10.4028/www.scientific.net/MSF.248-249.313
   Sie SH, 1997, NUCL INSTRUM METH B, V123, P558, DOI 10.1016/S0168-583X(96)00422-3
   Sie SH, 1997, NUCL INSTRUM METH B, V123, P112, DOI 10.1016/S0168-583X(96)00417-X
   SIE SH, 1997, AIP C P 2, V392, P799
   Sisterson JM, 1997, NUCL INSTRUM METH B, V123, P324, DOI 10.1016/S0168-583X(96)00409-0
   Sommer D, 1997, FRESEN J ANAL CHEM, V358, P236, DOI 10.1007/s002160050393
   Song KS, 1997, MICROCHEM J, V57, P265, DOI 10.1006/mchj.1996.1472
   Specht AA, 1998, ANAL CHEM, V70, P1036, DOI 10.1021/ac9710691
   Stefanova V, 1997, J ANAL ATOM SPECTROM, V12, P1271, DOI 10.1039/a704472k
   Steiner RE, 1997, ANAL CHEM, V69, P1715, DOI 10.1021/ac961171i
   Stott AW, 1996, ANAL CHEM, V68, P4402, DOI 10.1021/ac960199r
   Sturgeon RE, 1997, ANAL CHEM, V69, P2129, DOI 10.1021/ac9611982
   Sturup S, 1997, J ANAL ATOM SPECTROM, V12, P919, DOI 10.1039/a704079b
   Su YX, 1997, SPECTROCHIM ACTA B, V52, P633, DOI 10.1016/S0584-8547(96)01621-7
   Sun GY, 1997, J NUCL MATER, V246, P9, DOI 10.1016/S0022-3115(97)00080-9
   Suter M, 1997, NUCL INSTRUM METH B, V123, P148, DOI 10.1016/S0168-583X(96)00613-1
   Sylvester PJ, 1997, CHEM GEOL, V141, P49, DOI 10.1016/S0009-2541(97)00057-0
   Synal HA, 1997, NUCL INSTRUM METH B, V123, P62, DOI 10.1016/S0168-583X(96)00608-8
   Takahata N, 1997, APPL GEOCHEM, V12, P377, DOI 10.1016/S0883-2927(97)00007-3
   Takakuwa C, 1996, APPL SURF SCI, V103, P255, DOI 10.1016/0169-4332(96)00529-6
   Takase M, 1997, NUCL INSTRUM METH B, V121, P288, DOI 10.1016/S0168-583X(96)00648-9
   Tangen A, 1997, J ANAL ATOM SPECTROM, V12, P667, DOI 10.1039/a607623h
   Taylor A, 1998, J ANAL ATOM SPECTROM, V13, p57R, DOI 10.1039/a800371h
   Thielecke F, 1997, J MASS SPECTROM, V32, P323, DOI 10.1002/(SICI)1096-9888(199703)32:3<323::AID-JMS491>3.0.CO;2-X
   Thomas P, 1997, ANALUSIS, V25, P19
   Thomas S, 1997, J ANAL ATOM SPECTROM, V12, P553, DOI 10.1039/a606446i
   Tobias HJ, 1997, ANAL CHEM, V69, P3148, DOI 10.1021/ac970332v
   TRAINA AJ, 1995, NUCL MAT MANAGE, V24, P1125
   Trumbore S. E., 1996, Mass spectrometry of soils., P311
   Tucek JC, 1997, SURF SCI, V382, P137, DOI 10.1016/S0039-6028(97)00117-9
   Tuniz C, 1997, NUCL INSTRUM METH B, V123, P73, DOI 10.1016/S0168-583X(96)00732-X
   Uchida H, 1997, ANAL SCI, V13, P391, DOI 10.2116/analsci.13.391
   Uchida H, 1997, J ANAL ATOM SPECTROM, V12, P913, DOI 10.1039/a701269a
   Uggerud HT, 1997, J ANAL ATOM SPECTROM, V12, P1169, DOI 10.1039/a701805c
   vanderBorg K, 1997, NUCL INSTRUM METH B, V123, P97, DOI 10.1016/S0168-583X(96)00713-6
   VANVEEN EH, 1997, SPEC PUBL R SOC CHEM, V202, P77
   Vela NP, 1997, APPL SPECTROSC, V51, P1500, DOI 10.1366/0003702971938993
   Wagter ML, 1997, SURF INTERFACE ANAL, V25, P788, DOI 10.1002/(SICI)1096-9918(199709)25:10<788::AID-SIA300>3.0.CO;2-W
   Walczyk T, 1997, INT J MASS SPECTROM, V161, P217, DOI 10.1016/S0168-1176(96)04532-6
   Wan CC, 1997, J ANAL ATOM SPECTROM, V12, P683, DOI 10.1039/a605765i
   Wayne DM, 1997, J ANAL ATOM SPECTROM, V12, P1195, DOI 10.1039/a701959i
   Wendt K, 1997, RADIOCHIM ACTA, V79, P183
   Wendt K, 1997, KERNTECHNIK, V62, P81
   Wendt K, 1997, FRESEN J ANAL CHEM, V359, P361, DOI 10.1007/s002160050587
   WHITE J, 1994, PHYSICIAN SPORTSMED, V22, P23
   Wijma S, 1997, NUCL INSTRUM METH B, V123, P87, DOI 10.1016/S0168-583X(96)00720-3
   Wilke T, 1997, J ANAL ATOM SPECTROM, V12, P1083, DOI 10.1039/a701654i
   Willie SN, 1997, ANALYST, V122, P751, DOI 10.1039/a701169e
   Wilson GC, 1997, NUCL INSTRUM METH B, V123, P498, DOI 10.1016/S0168-583X(96)00414-4
   Wilson GC, 1997, NUCL INSTRUM METH B, V123, P579, DOI 10.1016/S0168-583X(96)00413-2
   Wilson GC, 1997, NUCL INSTRUM METH B, V123, P583, DOI 10.1016/S0168-583X(96)00415-6
   Wittmaack K, 1997, PHYS REV B, V56, pR5701, DOI 10.1103/PhysRevB.56.R5701
   Wolff JC, 1996, INT J MASS SPECTROM, V156, P67, DOI 10.1016/S0168-1176(96)04419-9
   Wolff JC, 1997, ANAL CHIM ACTA, V346, P3, DOI 10.1016/S0003-2670(96)00544-2
   Wolkenstein M, 1997, ANAL CHEM, V69, P777, DOI 10.1021/ac9605105
   Wolkenstein M, 1997, FRESEN J ANAL CHEM, V358, P165, DOI 10.1007/s002160050373
   Wolkenstein M, 1997, FRESEN J ANAL CHEM, V357, P783, DOI 10.1007/s002160050249
   Woller A, 1998, J ANAL ATOM SPECTROM, V13, P141, DOI 10.1039/a704772j
   Xiao YK, 1997, ANAL CHEM, V69, P5203, DOI 10.1021/ac970621j
   Yamazaki H, 1997, SURF INTERFACE ANAL, V25, P937, DOI 10.1002/(SICI)1096-9918(199711)25:12<937::AID-SIA327>3.0.CO;2-S
   Yamazaki H, 1998, NUCL INSTRUM METH B, V134, P121, DOI 10.1016/S0168-583X(98)80041-4
   Yamazaki H, 1997, NUCL INSTRUM METH B, V124, P91, DOI 10.1016/S0168-583X(97)00075-X
   Yamazaki H, 1997, J VAC SCI TECHNOL A, V15, P2542, DOI 10.1116/1.580767
   Yan XM, 1997, J ANAL ATOM SPECTROM, V12, P697, DOI 10.1039/a606934g
   Yang PY, 1997, ANAL SCI, V13, P3, DOI 10.2116/analsci.13.Supplement_3
   Yoshimura E, 1997, ANAL LETT, V30, P135
   Zhang J, 1997, J VAC SCI TECHNOL A, V15, P243, DOI 10.1116/1.580519
   ZHAO R, 1996, DIZHI KEXUE, V31, P308
   Zhao XL, 1997, NUCL INSTRUM METH B, V126, P297, DOI 10.1016/S0168-583X(96)01034-8
   Zheng R, 1997, SPECTROCHIM ACTA B, V52, P339, DOI 10.1016/S0584-8547(96)01584-4
   Zhu W, 1997, J ANAL ATOM SPECTROM, V12, P661, DOI 10.1039/a607621a
   Zondervan A, 1997, NUCL INSTRUM METH B, V123, P79, DOI 10.1016/S0168-583X(96)00406-5
   Zoorob G, 1997, J ANAL ATOM SPECTROM, V12, P517, DOI 10.1039/a602682f
   Zoppi U, 1997, NUCL INSTRUM METH B, V123, P319, DOI 10.1016/S0168-583X(96)00742-2
NR 416
TC 4
Z9 4
U1 0
U2 10
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0267-9477
EI 1364-5544
J9 J ANAL ATOM SPECTROM
JI J. Anal. At. Spectrom.
PD OCT
PY 1998
VL 13
IS 10
BP 171R
EP 208R
PG 38
WC Chemistry, Analytical; Spectroscopy
SC Chemistry; Spectroscopy
GA 131KT
UT WOS:000076575800025
DA 2018-10-20
ER

PT J
AU Kishida, A
   Murakami, K
   Goto, H
   Akashi, M
   Kubota, H
   Endo, T
AF Kishida, A
   Murakami, K
   Goto, H
   Akashi, M
   Kubota, H
   Endo, T
TI Polymer drugs and polymeric drugs X: Slow release of 5-fluorouracil from
   biodegradable poly(gamma-glutamic acid) and its benzyl ester matrices
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
AB We prepared poly(gamma-glutamic acid)(gamma-PGA) benzyl ester(gamma-PBG) by the esterification of gamma-PGA and benzyl bromide and evaluated the degradation behavior and its usefulness as a drug delivery system (DDS) matrix using B-fluorouracil (5-FU) as a model drug. gamma-PBG degraded in an acidic solution gradually for up to 130 days, and degraded very slowly in a phosphate buffer solution (pH 7.4). After 150 days, the weight loss of the gamma-PBG film was only 10% in a phosphate buffer solution. A slow release of 5-FU from gamma-PBG films was achieved. The release rate was affected by the pH of the outer solution and the loading drug. We observed an initial burst-release on the first day, after that, the release of 5-FU was diffusion-controlled gamma-PBG may be a novel biodegradable material that may be useful in the pharmaceutical, biomedical, and agricultural fields.
C1 Kagoshima Univ, Fac Engn, Dept Chem Engn & Appl Chem, Kagoshima 8900065, Japan.
   Meiji Seika Kaisha Ltd, Pharmaceut Technol Lab, Odawara 2500000, Japan.
   Tokyo Inst Technol, Resources Utilizat Res Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan.
RP Akashi, M (reprint author), Kagoshima Univ, Fac Engn, Dept Chem Engn & Appl Chem, 1-21-40 Korimoto, Kagoshima 8900065, Japan.
CR AKASHI M, 1993, BIOMEDICAL APPL POLY, P371
   BECK LR, 1979, FERTIL STERIL, V31, P545
   Bovarnick M, 1942, J BIOL CHEM, V145, P415
   CHANDY T, 1991, BIOMATERIALS, V12, P667
   DABROWSKA W, 1949, SCIENCE, V110, P95, DOI 10.1126/science.110.2847.95
   HIGUCHI T, 1961, J PHARM SCI, V50, P874, DOI 10.1002/jps.2600501018
   HOLLAND S J, 1986, Journal of Controlled Release, V4, P155, DOI 10.1016/0168-3659(86)90001-5
   Ikada Y, 1989, HIGH TECHNOLOGY FIBE, P253
   Kishida A, 1998, J BIOACT COMPAT POL, V13, P222, DOI 10.1177/088391159801300305
   KUBOTA H, 1993, BIOSCI BIOTECH BIOCH, V57, P1212, DOI 10.1271/bbb.57.1212
   KUBOTA H, 1993, J POLYM SCI POL CHEM, V31, P2877, DOI 10.1002/pola.1993.080311127
   KUBOTA H, 1993, NIPPON KAGAKU KAISHI, V8, P973
   KUROYANAGI Y, 1992, J APPL BIOMATER, V3, P153, DOI 10.1002/jab.770030211
   Li S, 1995, DEGRADABLE POLYM PRI, P43
   THORNE CB, 1954, J BACTERIOL, V68, P307
   VOLCANI BE, 1957, J BACTERIOL, V74, P646
   Wise D L, 1979, DRUG CARRIERS BIOL M, P237
NR 17
TC 38
Z9 39
U1 1
U2 4
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604 USA
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD OCT
PY 1998
VL 13
IS 4
BP 270
EP 278
DI 10.1177/088391159801300403
PG 9
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 121HW
UT WOS:000076008600003
DA 2018-10-20
ER

PT J
AU Chandy, T
   Sharma, CP
AF Chandy, T
   Sharma, CP
TI Activated charcoal microcapsules and their applications
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE activated charcoal; microencapsulation; hemoperfusion; chitosan
   encapsulated charcoal; adsorbent for toxins; blood compatibility
ID IMMOBILIZED CHITOSAN BEADS; PERMEABILITY PROPERTIES; ARTIFICIAL KIDNEY;
   HEMOPERFUSION; ADSORBENTS; PLASMA; ADSORPTION; MOLECULES; REMOVAL;
   INVITRO
AB Activated charcoal, long known to the ancients as a substance of therapeutic value in a variety of maladies, has recently been "rediscovered" to be of great value in medical applications. Activated charcoal hemoperfusion is effective in blood purification for removal of various circulating toxic materials and waste metabolites, directly. However, particulate release and platelet adhesion prevent its continued clinical use. Polymeric coatings or microencapsulation of charcoal within polymers have improved their blood compatibility. Chitosan encapsulated activated charcoal (ACCB) beads have been extensively investigated in our group for the removal of various toxins such as urea, creatinine, uric acid, bilirubin, etc. This article highlights various methods of microencapsulation procedures of activated charcoal and the importance of this novel material for a variety of biomedical applications. Further, this review provides an insight to the future perspectives for using them in clinical practice.
C1 Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Biosurface Technol, Trivandrum 695012, Kerala, India.
RI Sharma, Chandra/A-4140-2009
OI Sharma, Chandra/0000-0002-6982-0926
CR ANDRADE JD, 1972, T AM SOC ART INT ORG, V18, P473
   ASH SR, 1992, INT J ARTIF ORGANS, V15, P151
   Beena M S, 1994, J Biomater Appl, V8, P385, DOI 10.1177/088532829400800405
   BEHM E, 1987, BIOMATER ARTIF CELL, V15, P101, DOI 10.3109/10731198709118511
   BOEHM J J, 1977, Australian Journal of Pharmaceutical Sciences, V6, P107
   Boquet A, 1928, CR HEBD ACAD SCI, V187, P959
   Brockstedt M, 1993, Kinderarztl Prax, V61, P378
   BYSANI GK, 1990, CRIT CARE MED, V18, P67, DOI 10.1097/00003246-199001000-00015
   CHANDY T, 1987, POLYM-PLAST TECHNOL, V26, P143, DOI 10.1080/03602558708071937
   CHANDY T, 1991, BIOMAT ARTIF CELL IM, V19, P745, DOI 10.3109/10731199109117852
   CHANDY T, 1992, ARTIF ORGANS, V16, P568
   CHANDY T, 1989, J COLLOID INTERF SCI, V130, P331, DOI 10.1016/0021-9797(89)90112-4
   CHANDY T, 1993, J MICROENCAPSUL, V10, P475, DOI 10.3109/02652049309015324
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   CHANDY T, 1992, J APPL POLYM SCI, V44, P2145, DOI 10.1002/app.1992.070441210
   CHANDY T, 1987, T SOC BIOMAT, V10, P31
   CHANDY T, 1984, J BIOMED MATER RES, P1115
   CHANDY T, 1993, P 6 NATL C BIOM ART, P54
   CHANG TM, 1978, ARTIFICIAL KIDNEY AR
   CHANG TMS, 1973, T AM SOC ART INT ORG, V19, P87
   CHANG TMS, 1983, LANCET, V2, P1051
   CHANG TMS, 1966, T AM SOC ART INT ORG, V12, P13
   CHANG TMS, 1970, T AM SOC ART INT ORG, V16, P141
   CHANG TMS, 1973, CAN MED ASSOC J, V108, P429
   CHEN GX, 1991, BIOMAT ARTIF CELLS I, V19, P227
   CHEN YM, 1991, J MICROENCAPSUL, V8, P327
   CHIRITO E, 1977, ARTIF ORGANS, V1, P76
   COONEY DO, 1980, ACTIVATED CHARCOAL A, P16
   DALY JS, 1978, J PHARM SCI, V67, P1181, DOI 10.1002/jps.2600670846
   DAVIS TA, 1975, KIDNEY INT, V7, pS406
   DECKER WJ, 1968, TOXICOL APPL PHARM, V13, P454, DOI 10.1016/0041-008X(68)90122-1
   DENT E, 1975, P EUR SOC ARTIF ORGA, V2, P215
   DIRKS E, 1990, Z KARDIOL, V79, P54
   DUNEA G, T AM SOC ARTIF INT O, V11, P179
   EBATA T, 1980, PROGR MED, V113, P173
   ERSTAD BL, 1992, CLIN PHARMACY, V11, P800
   GRIMES DJ, 1990, DRUG SAFETY, V5, P447, DOI 10.2165/00002018-199005060-00005
   HASIRCI N, 1986, J BIOMED MATER RES, V20, P963, DOI 10.1002/jbm.820200711
   HERREN T, 1993, SCHWEIZ MED WOCHENSC, V123, P1175
   ITO M, 1991, BIOMATERIALS, V12, P41, DOI 10.1016/0142-9612(91)90130-3
   KASSNER JT, 1993, ANN EMERG MED, V22, P1392, DOI 10.1016/S0196-0644(05)81984-5
   Kim KY, 1988, T SOC BIOMATER, V11, P558
   KLINKMANN H, 1987, BIOMATER ARTIF CELL, V15, P41, DOI 10.3109/10731198709118507
   Kolff WJ, 1944, ACTA MED SCAND, V117, P121
   LIN JL, 1993, J TOXICOL-CLIN TOXIC, V31, P645, DOI 10.3109/15563659309025768
   LIPSCOMB DJ, 1975, ARCH TOXICOL, V34, P37, DOI 10.1007/BF00353337
   LYMAN DJ, 1971, FED PROC, V30, P1658
   MALCHESKY PS, 1976, P EDTA, P242
   MARANGONI R, 1990, BIOMATER ARTIF CELL, V18, P541, DOI 10.3109/10731199009119631
   MARTINEZCHUECOS J, 1992, CRIT CARE MED, V20, P1538, DOI 10.1097/00003246-199211000-00010
   MORLEY DB, 1991, INT J ARTIF ORGANS, V14, P371
   MURUGAVEL S, 1992, J TOXICOL-CLIN TOXIC, V30, P69, DOI 10.3109/15563659208994447
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   NAGAKI M, 1993, J MED MICROBIOL, V38, P354, DOI 10.1099/00222615-38-5-354
   NOLAN JP, 1981, HEPATOLOGY, V1, P458, DOI 10.1002/hep.1840010516
   PERIAGO JF, 1992, J APPL TOXICOL, V12, P91, DOI 10.1002/jat.2550120205
   Plank G, 1990, Tierarztl Prax, V18, P483
   POND SM, 1991, MED J AUSTRALIA, V154, P617
   SAWAYANAGI Y, 1982, CHEM PHARM BULL, V30, P4213
   SPLENDIANI G, 1987, BIOMATER ARTIF CELL, V15, P175, DOI 10.3109/10731198709118517
   STAFONI S, 1993, B SOC ITAL BIOL SPER, V69, P675
   SULDIN AV, 1976, NAUCH T PERMSK GOS F, V10, P35
   TERMAN DS, 1977, SCAND J IMMUNOL, V6, P195, DOI 10.1111/j.1365-3083.1977.tb00384.x
   TERMAN DS, 1976, J IMMUNOL, V117, P1971
   TIJSSEN J, 1979, ARTIF ORGANS, V3, P11, DOI 10.1111/j.1525-1594.1979.tb03797.x
   TURK J, 1993, VET HUM TOXICOL, V35, P489
   VALE JA, 1975, BRIT MED J, V1, P5, DOI 10.1136/bmj.1.5948.5
   VAUGHAN JH, 1971, IMMUNOLOGICAL DIS, V2, P987
   VROMAN L, 1977, ANN NY ACAD SCI, V283, P65, DOI 10.1111/j.1749-6632.1977.tb41753.x
   WAKABAYASHI Y, 1994, J TOXICOL-CLIN TOXIC, V32, P419, DOI 10.3109/15563659409011043
   WICKS SR, 1980, J BIOMED MATER RES, V14, P743, DOI 10.1002/jbm.820140606
   WILKINSON SP, 1977, SCAND J GASTROENTERO, V12, P385, DOI 10.3109/00365527709181676
   Xiang-Nan D, 1987, BIOMAT ART CELLS ART, V15, P229
   XU CX, 1981, INT J ARTIF ORGANS, V4, P200
   XU CX, 1983, ARTIF ORG ISAO 83, V7, P78
   YATZIDIS H, 1976, KIDNEY INT, V10, P215
   Yatzidis H., 1964, P EUROP DIALYSIS TRA, V1, P83
   YU YT, 1990, BIOMATER ARTIF CELL, V18, P499
   ZHU XX, 1990, BIOMATER ARTIF CELL, V18, P75, DOI 10.3109/10731199009117290
NR 79
TC 19
Z9 21
U1 1
U2 13
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604 USA
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD OCT
PY 1998
VL 13
IS 2
BP 128
EP 157
DI 10.1177/088532829801300204
PG 30
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 122FN
UT WOS:000076061400002
PM 9777464
DA 2018-10-20
ER

PT J
AU Knepper, M
   Milthorpe, BK
   Moricca, S
AF Knepper, M
   Milthorpe, BK
   Moricca, S
TI Interdiffusion in short-fibre reinforced hydroxyapatite ceramics
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID PLASMA-SPRAYED COATINGS
AB Sintering in air and hot isostatic pressing are production methods regarded as being capable of producing fibre-reinforced hydroxyapatite ceramics for biomedical applications. These composites may have the advantage of improved mechanical properties and be suitable for applications in areas where there are significant levels of load on the material. The use of pure hydroxyapatite is restricted to those free of dynamical load. Obtaining improved mechanical strength is a question of the bond between the matrix phase and the fibre-reinforcement phase. However, a chemical bond between both phases, indicated by large diffusion zones, might lead to the dehydration of the hydroxyapatite leading to undesired tricalcium phosphate in the matrix resulting in a weakening of the mechanical and biological stability of the composites. Composites with three fibre types, alumina, 316L-stainless steel and titanium were prepared and sintered in air or hot isostatically pressed. A reaction zone was noted around the titanium and stainless steel fibres, but not around the alumina fibres. The reaction zone was larger for stainless steel than titanium. Hot isostatic pressing also reduced the reaction zone markedly compared to sintering in air.
C1 Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
   Australian Nucl Sci & Technol Org, Adv Mat Div, Menai, NSW 2234, Australia.
RP Knepper, M (reprint author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
RI Milthorpe, Bruce/A-7014-2008
CR BARDOS DI, 1990, CONCISE ENCY MED DEN, P28
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   HEIMKE G, 1990, CONCISE ENCY MED DEN, P360
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   KLEIN CPAT, 1991, J BIOMED MATER RES, V25, P53, DOI 10.1002/jbm.820250105
   Knepper M, 1997, BIOMATERIALS, V18, P1523, DOI 10.1016/S0142-9612(97)00066-5
   KNEPPER M, 1996, ASB S MOL ENG BIOM C, P9
   KNEPPER M, 1996, P PAC RIM 2 C
   Li J, 1990, INTERCERAM, V39, P13
   LUGSCHEIDER E, 1992, ADV BIOMATERIALS, V10
   ONOSHI H, 1991, BIOMATERIALS, V12, P1375
   PFAFF HG, 1993, 10 EUR C BIOM DAV, P78
   RUYS AJ, 1992, CERAMICS ADDING VALU, V1, P591
   SUTOW EJ, 1990, CONCISE ENCY MED DEN, P232
NR 14
TC 19
Z9 20
U1 0
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 1998
VL 9
IS 10
BP 589
EP 596
DI 10.1023/A:1008965626695
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 133JL
UT WOS:000076683400007
PM 15348692
DA 2018-10-20
ER

PT J
AU Amass, W
   Amass, A
   Tighe, B
AF Amass, W
   Amass, A
   Tighe, B
TI A review of biodegradable polymers: Uses, current developments in the
   synthesis and characterization of biodegradable polyesters, blends of
   biodegradable polymers and recent advances in biodegradation studies
SO POLYMER INTERNATIONAL
LA English
DT Review
DE biodegradation; biodegradable polyesters; packaging; synthesis;
   characterization; blends
ID BOVINE SERUM-ALBUMIN; IN-VITRO BIODEGRADATION; LIQUID PHASE-SEPARATION;
   ATOMIC-FORCE MICROSCOPY; LOW-MOLECULAR-WEIGHT; NEWBORN CALF SERUM;
   CELL-CULTURE TEST; DRUG-DELIVERY; BACTERIAL POLY(3-HYDROXYBUTYRATE);
   ENZYMATIC DEGRADABILITY
AB This review considers the uses of biodegradable polymers in terms of their relevance within current plastic waste management of packaging materials, biomedical applications and other uses; research papers and patents are catalogued. The chemical synthesis of polyesters and the microbial production of poly(hydroxyalkanoate)s, including recent publications in these areas, are covered and methods of characterization and structural analysis are outlined. Current research into two- and three-component blends is reviewed as a method of reducing overall costs and modifying both properties and biodegradation rates of materials. Finally, there is a summary of degradation processes. Both abiotic and biotic reactions are discussed, together with the development of biodegradation test methods, particularly with respect to composting. (C) 1998 Society of Chemical Industry.
C1 Aston Univ, CEAC, Specialty Polymer Res Grp, Birmingham B4 7ET, W Midlands, England.
RP Amass, W (reprint author), Aston Univ, CEAC, Specialty Polymer Res Grp, Birmingham B4 7ET, W Midlands, England.
CR Abe H, 1996, MACROMOLECULES, V29, P8683, DOI 10.1021/ma960907a
   ABE H, 1995, MACROMOLECULES, V28, P844, DOI 10.1021/ma00108a007
   ABE H, 1994, MACROMOLECULES, V27, P6012, DOI 10.1021/ma00099a012
   Akamatsu K, 1997, INT J PHARM, V155, P65, DOI 10.1016/S0378-5173(97)00159-2
   ALBERTSSON AC, 1994, J APPL POLYM SCI, V51, P1097, DOI 10.1002/app.1994.070510616
   ALBERTSSON AC, 1987, POLYM DEGRAD STABIL, V18, P73, DOI 10.1016/0141-3910(87)90084-X
   Albertsson AC, 1996, J MACROMOL SCI PURE, VA33, P1565, DOI 10.1080/10601329608014926
   ALBERTSSON AC, 1994, CHEM TECHNOLOGY BIOD, P48
   ALI SAM, 1994, J APPL POLYM SCI, V51, P1389, DOI 10.1002/app.1994.070510805
   ALONSO MJ, 1994, VACCINE, V12, P299, DOI 10.1016/0264-410X(94)90092-2
   *APME, 1997, PLAST REC PERS
   Arvanitoyannis I, 1997, STARCH-STARKE, V49, P306, DOI 10.1002/star.19970490712
   Atkins TW, 1997, J BIOMAT SCI-POLYM E, V8, P833, DOI 10.1163/156856297X00038
   Atkins TW, 1996, J BIOMAT SCI-POLYM E, V7, P1065, DOI 10.1163/156856296X00552
   Atkins TW, 1996, J BIOMAT SCI-POLYM E, V7, P1075, DOI 10.1163/156856296X00561
   Atkins TW, 1997, BIOMATERIALS, V18, P173, DOI 10.1016/S0142-9612(96)00111-1
   Atkins TW, 1997, J MICROENCAPSUL, V14, P35, DOI 10.3109/02652049709056466
   Atkins TW, 1996, J MICROENCAPSUL, V13, P709, DOI 10.3109/02652049609026054
   Avella M, 1996, POLYM INT, V39, P191
   BASA N, 1984, HIGH TECHNOL     FEB, P67
   BASTIOLI C, 1995, J ENVIRON POLYM DEGR, V3, P81, DOI 10.1007/BF02067484
   Beach ED, 1996, APPL MATH MODEL, V20, P388, DOI 10.1016/0307-904X(95)00158-G
   BEAUMER GJ, 1994, J BIOMED MATER RES, V28, P545
   BERO M, 1993, POLYM BULL, V31, P9, DOI 10.1007/BF00298757
   BLOEMBERGEN S, 1989, MACROMOLECULES, V22, P1656, DOI 10.1021/ma00194a027
   BLOEMBERGEN S, 1986, MACROMOLECULES, V19, P2865, DOI 10.1021/ma00165a034
   BLUMM E, 1995, POLYMER, V36, P4077, DOI 10.1016/0032-3861(95)90987-D
   BUCHANAN CM, 1995, J MACROMOL SCI PURE, VA32, P683, DOI 10.1080/10601329508010281
   CABALLERO KP, 1995, INT J BIOL MACROMOL, V17, P86, DOI 10.1016/0141-8130(95)93522-Y
   CAM D, 1995, BIOMATERIALS, V16, P833, DOI 10.1016/0142-9612(95)94144-A
   CECCORULLI G, 1993, MACROMOLECULES, V26, P6722, DOI 10.1021/ma00077a005
   CELLI A, 1992, POLYMER, V33, P2699, DOI 10.1016/0032-3861(92)90440-8
   CHABOT F, 1983, POLYMER, V24, P53, DOI 10.1016/0032-3861(83)90080-0
   CHAPUT C, 1995, BIOMATER LIVING SYST, V3, P19
   CHAPUT C, 1995, BIOMATER LIVING SYST, V3, P29
   CHIELLINI E, 1995, J BIOMAT SCI-POLYM E, V7, P307
   Chiellini E, 1997, MACROMOL SYMP, V123, P25, DOI 10.1002/masy.19971230105
   Chiu LK, 1995, INT J PHARM, V126, P169, DOI 10.1016/0378-5173(95)04119-2
   Choe S, 1995, POLYMER, V36, P4977, DOI 10.1016/0032-3861(96)81624-7
   CHU CC, 1981, J APPL POLYM SCI, V26, P1727, DOI 10.1002/app.1981.070260527
   Chung YJ, 1997, J FERMENT BIOENG, V83, P492, DOI 10.1016/S0922-338X(97)83009-7
   Cleek RL, 1997, J CONTROL RELEASE, V48, P259, DOI 10.1016/S0168-3659(97)00052-7
   Collett J., 1989, POLYM PREPR, V30, P468
   CONTI B, 1997, EUROPEAN J PHARM SCI, V85, P287
   Conway BR, 1997, J CONTROL RELEASE, V49, P1, DOI 10.1016/S0168-3659(97)01641-6
   Coombes AGA, 1997, BIOMATERIALS, V18, P1153, DOI 10.1016/S0142-9612(97)00051-3
   Dang MH, 1997, J ENVIRON POLYM DEGR, V5, P49
   Dang MH, 1996, J ENVIRON POLYM DEGR, V4, P197, DOI 10.1007/BF02067453
   DAVE P, 1990, POLYM MATER SCI ENG, V63, P726
   DAVID C, 1994, ANGEW MAKROMOL CHEM, V216, P21, DOI 10.1002/apmc.1994.052160102
   Dawes E A, 1973, Adv Microb Physiol, V10, P135, DOI 10.1016/S0065-2911(08)60088-0
   Day M, 1997, J ENVIRON POLYM DEGR, V5, P137
   DeGroot JH, 1997, J MATER SCI-MATER M, V8, P707, DOI 10.1023/A:1018544124990
   DEKONING G, 1995, CAN J MICROBIOL, V41, P303, DOI 10.1139/m95-201
   DOHSE DM, 1994, ENVIRON SCI TECHNOL, V28, P541, DOI 10.1021/es00053a003
   DOI Y, 1990, MACROMOLECULES, V23, P26, DOI 10.1021/ma00203a006
   DOI Y, 1987, J APPL MICROBIOL BIO, V28, P330
   Doi Y., 1990, MICROBIAL POLYESTERS
   EGGLESTON D, 1998, EMAP BUSINESS PUBLIC, V1726
   Eldsater C, 1997, ACTA POLYM, V48, P478, DOI 10.1002/actp.1997.010481103
   Engelhardt J, 1996, PAPIER, V50, P701
   Erlandsson B, 1997, POLYM DEGRAD STABIL, V57, P15, DOI 10.1016/S0141-3910(96)00221-2
   Eschenlauer AC, 1996, INT J BIOL MACROMOL, V19, P121, DOI 10.1016/0141-8130(96)01114-2
   Finelli L, 1997, J MACROMOL SCI PURE, VA34, P13, DOI 10.1080/10601329708014931
   FOSTER LJR, 1995, BIOMATERIALS, V16, P341, DOI 10.1016/0142-9612(95)93263-D
   Freeman MB, 1996, ACS SYM SER, V627, P118
   FREEMAN MB, 1994, ABSTR PAP AM CHEM S, V207, P185
   FUKADA E, 1983, Q REV BIOPHYS, V16, P59, DOI 10.1017/S0033583500004923
   GARDNER RM, 1994, J APPL POLYM SCI, V52, P1477, DOI 10.1002/app.1994.070521012
   Gassner F, 1996, POLYM INT, V39, P215, DOI 10.1002/(SICI)1097-0126(199603)39:3<215::AID-PI497>3.0.CO;2-0
   Gazzano M, 1997, MACROMOL CHEM PHYSIC, V198, P71, DOI 10.1002/macp.1997.021980106
   Ghiya VP, 1996, J MACROMOL SCI PURE, VA33, P627, DOI 10.1080/10601329608010883
   Gilmore D. F., 1993, J ENVIRON POLYM DEGR, V1, P269
   GIORDANO GG, 1995, INVEST OPHTH VIS SCI, V36, pS251
   GLASSER WG, 1994, BIOTECHNOL PROGR, V10, P214, DOI 10.1021/bp00026a011
   GOLDBERG D, 1995, J ENVIRON POLYM DEGR, V3, P61, DOI 10.1007/BF02067481
   Grandfils C, 1996, J CONTROL RELEASE, V38, P109, DOI 10.1016/0168-3659(95)00102-6
   GRECO P, 1989, POLYMER, V30, P1475, DOI 10.1016/0032-3861(89)90219-X
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F
   GROSS RA, 1989, MACROMOLECULES, V22, P1106, DOI 10.1021/ma00193a018
   GROSS RA, 1995, J MACROMOL SCI PURE, VA32, P613, DOI 10.1080/10601329508010275
   GURSEL I, 1995, J MICROENCAPSUL, V12, P185, DOI 10.3109/02652049509015289
   HAMILTON JD, 1995, J AIR WASTE MANAGE, V45, P247, DOI 10.1080/10473289.1995.10467364
   Hampl J, 1997, INT J PHARM, V155, P19, DOI 10.1016/S0378-5173(97)00144-0
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   Hashizoe M, 1997, CURR EYE RES, V16, P633, DOI 10.1076/ceyr.16.7.633.5063
   HiljanenVainio M, 1996, J APPL POLYM SCI, V59, P1281, DOI 10.1002/(SICI)1097-4628(19960222)59:8<1281::AID-APP11>3.0.CO;2-9
   Hirt TD, 1996, MACROMOL CHEM PHYSIC, V197, P1609, DOI 10.1002/macp.1996.021970503
   Hirt TD, 1996, MACROMOL CHEM PHYS, V197, P4253, DOI 10.1002/macp.1996.021971221
   Hocking P. J., 1994, CHEM TECHNOLOGY BIOD, P48
   HOCKING PJ, 1995, MACROMOLECULES, V28, P6401, DOI 10.1021/ma00123a003
   Hocking PJ, 1996, MACROMOLECULES, V29, P2472, DOI 10.1021/ma951361f
   HOCKING PJ, 1993, POLYM BULL, V30, P163, DOI 10.1007/BF00296845
   Hocking PJ, 1996, MACROMOLECULES, V29, P2467, DOI 10.1021/ma951360n
   HOFMANN GO, 1995, ARCH ORTHOP TRAUM SU, V114, P123, DOI 10.1007/BF00443385
   HOLLAND SJ, 1986, THESIS ASTON U BIRMI
   HOLLAND SJ, 1992, ADV PHARM SCI, V6, P101
   HOLMES PA, 1985, PHYS TECHNOL, V16, P32, DOI 10.1088/0305-4624/16/1/305
   Hori Y, 1996, MACROMOLECULES, V29, P804, DOI 10.1021/ma951345i
   HORI Y, 1995, CAN J MICROBIOL, V41, P282, DOI 10.1139/m95-198
   HU DSG, 1994, J APPL POLYM SCI, V51, P473, DOI 10.1002/app.1994.070510310
   Huang YY, 1997, INT J PHARM, V156, P9, DOI 10.1016/S0378-5173(97)00154-3
   HUATAN H, 1995, J MICROENCAPSUL, V12, P557, DOI 10.3109/02652049509006786
   IIDA M, 1977, MACROMOLECULES, V10, P275, DOI 10.1021/ma60056a012
   Inoue Y, 1996, POLYM INT, V39, P183
   ITAVAARA M, 1995, CHEMOSPHERE, V31, P4359
   Itavaara M, 1996, J ENVIRON POLYM DEGR, V4, P29, DOI 10.1007/BF02083880
   Itavaara M, 1997, COMPOST SCI UTIL, V5, P84
   IWAMOTO Y, 1994, POLYM PREPR-JAPAN, V43, P4022
   Jacobsen S, 1996, POLYM ENG SCI, V36, P2799, DOI 10.1002/pen.10680
   Jameela SR, 1996, CURR SCI INDIA, V70, P669
   JANE J, 1995, J MACROMOL SCI PURE, VA32, P751, DOI 10.1080/10601329508010286
   JANNACE S, 1995, J MACROMOL SCI CHEM, V32, P881
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   JURGENS C, 1995, UNFALLCHIRURG, V98, P233
   Kamijo A, 1996, J CONTROL RELEASE, V40, P269, DOI 10.1016/0168-3659(95)00194-8
   KARLSSON S, 1995, J MACROMOL SCI PURE, VA32, P599, DOI 10.1080/10601329508010273
   KARLSSON S, 1988, POLYM DEGRAD STABIL, V21, P237, DOI 10.1016/0141-3910(88)90030-4
   Kawai F, 1997, MACROMOL SYMP, V123, P177, DOI 10.1002/masy.19971230118
   KEMNITZER JE, 1995, J ENVIRON POLYM DEGR, V3, P37, DOI 10.1007/BF02067792
   Kim IB, 1995, POLYM-KOREA, V19, P727
   KIM YJ, 1995, POLYM ENG SCI, V35, P1652, DOI 10.1002/pen.760352012
   KIM YJ, 1994, KOREAN J CHEM ENG, V11, P172, DOI 10.1007/BF02697462
   KNOWLES JC, 1991, BIOMATERIALS, V12, P210, DOI 10.1016/0142-9612(91)90202-L
   KOBAYASHI T, 1995, POLYMER, V36, P4707, DOI 10.1016/0032-3861(95)96839-Z
   KOENIG MF, 1994, POLYM DEGRAD STABIL, V45, P139, DOI 10.1016/0141-3910(94)90189-9
   KOENIG MF, 1995, POLYMER, V36, P1877, DOI 10.1016/0032-3861(95)90934-T
   Koyama N, 1996, MACROMOLECULES, V29, P5843, DOI 10.1021/ma960119l
   KOYAMA N, 1995, CAN J MICROBIOL, V41, P316, DOI 10.1139/m95-203
   KRICHELDORF HR, 1993, MAKROMOL CHEM, V194, P1653
   Kricheldorf HR, 1997, MACROMOLECULES, V30, P5693, DOI 10.1021/ma970244c
   KRICHELDORF HR, 1992, POLYMER, V33, P2817, DOI 10.1016/0032-3861(92)90459-A
   KRICHELDORF HR, 1990, MAKROMOL CHEM, V191, P1057
   KUBOTA M, 1988, CHEM PHARM BULL, V36, P333
   KUMAGAI Y, 1992, POLYM DEGRAD STABIL, V35, P87, DOI 10.1016/0141-3910(92)90139-V
   KUMAGAI Y, 1992, POLYM DEGRAD STABIL, V36, P241, DOI 10.1016/0141-3910(92)90062-A
   KWAN L, 1991, Patent No. 406015
   Lacasse FX, 1997, PHARMACEUT RES, V14, P887, DOI 10.1023/A:1012147700014
   LAUZIER C, 1992, POLYMER, V33, P823, DOI 10.1016/0032-3861(92)90343-U
   Leadley SR, 1997, MACROMOLECULES, V30, P6920, DOI 10.1021/ma9702612
   LEFEBVRE F, 1995, J MACROMOL SCI PURE, VA32, P867, DOI 10.1080/10601329508010299
   Li XW, 1997, J APPL POLYM SCI, V66, P583, DOI 10.1002/(SICI)1097-4628(19971017)66:3<583::AID-APP20>3.0.CO;2-V
   LOTTI N, 1993, POLYMER, V34, P4935, DOI 10.1016/0032-3861(93)90022-3
   Mader K, 1997, J PHARM SCI-US, V86, P126, DOI 10.1021/js9505105
   MANESS PC, 1994, APPL BIOCHEM BIOTECH, V45-6, P395, DOI 10.1007/BF02941814
   Marcato B, 1996, J CHROMATOGR B, V682, P147, DOI 10.1016/0378-4347(96)00061-8
   MARGAERT J, 1995, CAN J MICROBIOL, V41, P154
   MARGAERT J, 1993, J APPL ENV MICROBIOL, V50, P3233
   Maruyama A, 1997, BIOCONJUGATE CHEM, V8, P735, DOI 10.1021/bc9701048
   Masson V, 1996, INT J PHARMACEUT, V139, P113, DOI 10.1016/0378-5173(96)04611-X
   Matsumoto A, 1997, J CONTROL RELEASE, V48, P19, DOI 10.1016/S0168-3659(97)00031-X
   MATT T, 1988, Patent No. 293172
   Mayer JM, 1996, ACS SYM SER, V627, P159
   MCCARTHYBATES L, 1993, PLASTICS WORLD   MAR, P22
   Mehta RC, 1996, J CONTROL RELEASE, V41, P249, DOI 10.1016/0168-3659(96)01332-6
   MERLOZ P, 1995, REV CHIR ORTHOP, V81, P433
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   MINO T, 1995, WATER SCI TECHNOL, V31, P95, DOI 10.1016/0273-1223(95)00183-N
   MITOMO H, 1995, RADIAT PHYS CHEM, V46, P233, DOI 10.1016/0969-806X(95)00018-S
   Miyata T, 1997, POLYMER, V38, P4003, DOI 10.1016/S0032-3861(96)00987-1
   Molpeceres J, 1997, J MICROENCAPSUL, V14, P777, DOI 10.3109/02652049709006828
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   MOONEY DJ, 1994, CELL TRANSPLANT, V3, P203, DOI 10.1177/096368979400300209
   Mulhaupt R, 1996, CHIMIA, V50, P191
   Nakashima T, 1996, J MACROMOL SCI PHYS, VB35, P659, DOI 10.1080/00222349608220401
   NAKAYAMA K, 1985, BIOCHIM BIOPHYS ACTA, V827, P63, DOI 10.1016/0167-4838(85)90101-3
   NEDEA ME, 1991, POLYM BULL, V26, P549, DOI 10.1007/BF01032681
   Nishio Y, 1997, CELLULOSE, V4, P131, DOI 10.1023/A:1018475520600
   Nobes GAR, 1996, MACROMOLECULES, V29, P8330, DOI 10.1021/ma961219u
   ODonnell PB, 1996, J MICROENCAPSUL, V13, P667, DOI 10.3109/02652049609026050
   Ogawa Y, 1997, J BIOMAT SCI-POLYM E, V8, P391, DOI 10.1163/156856297X00173
   OHAGAN DT, 1994, INT J PHARM, V103, P37, DOI 10.1016/0378-5173(94)90201-1
   Ohtake Y, 1996, NIPPON KAGAKU KAISHI, P853, DOI 10.1246/nikkashi.1996.853
   OHTAKE Y, 1995, J APPL POLYM SCI, V56, P1789, DOI DOI 10.1002/APP.1995.070561309
   OHURA Y, 1995, SURV OPHTHALMOL, V39, pS17
   OKADA H, 1994, J CONTROL RELEASE, V28, P121
   OKADA H, 1995, CRIT REV THER DRUG, V12, P1
   Orts WJ, 1995, CAN J CHEM, V73, P2094, DOI 10.1139/v95-258
   ORTS WJ, 1991, MACROMOLECULES, V24, P6435, DOI 10.1021/ma00024a010
   Otal E, 1997, J CHEM TECHNOL BIOT, V70, P147
   PAGGA U, 1995, CHEMOSPHERE, V31, P4475, DOI 10.1016/0045-6535(95)00326-4
   Paik YH, 1996, ADV CHEM SER, V248, P79
   Panagiotopoulos E, 1997, ACTA ORTHOP SCAND, V68, P119, DOI 10.1080/17453674.1997.11744763
   Park ES, 1997, J CONTROL RELEASE, V48, P67, DOI 10.1016/S0168-3659(97)00034-5
   PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X
   PEARCE R, 1994, POLYMER, V35, P3990, DOI 10.1016/0032-3861(94)90285-2
   PEARCE R, 1992, POLYMER, V33, P4647, DOI 10.1016/0032-3861(92)90428-Y
   PEARCE R, 1994, POLYMER, V35, P3984, DOI 10.1016/0032-3861(94)90284-4
   PEARCE RP, 1994, MACROMOLECULES, V27, P3869, DOI 10.1021/ma00092a029
   Penco M, 1996, BIOMATERIALS, V17, P1583, DOI 10.1016/0142-9612(95)00323-1
   PERES R, 1994, POLYMER, V35, P1059, DOI 10.1016/0032-3861(94)90952-0
   PETTIGREW CA, 1995, J MACROMOL SCI PURE, VA32, P811, DOI 10.1080/10601329508010291
   Pettit DK, 1997, PHARMACEUT RES, V14, P1422, DOI 10.1023/A:1012176823155
   POIRIER Y, 1995, INT J BIOL MACROMOL, V17, P7, DOI 10.1016/0141-8130(95)93511-U
   POOL R, 1989, SCIENCE, V245, P1187, DOI 10.1126/science.245.4923.1187
   Poulton C.W., 1996, ADV DRUG DELIVERY RE, V18, P133
   Poutanen K, 1996, TRENDS POLYM SCI, V4, P128
   Pranamuda H, 1996, J ENVIRON POLYM DEGR, V4, P1, DOI 10.1007/BF02083877
   PRASAD MP, 1993, J CONTROL RELEASE, V27, P219, DOI 10.1016/0168-3659(93)90153-V
   PUECHNER P, 1995, J ENVIRON POLYM DEGR, V3, P133, DOI 10.1007/BF02068464
   QuintanarGuerrero D, 1997, COLLOID POLYM SCI, V275, P640, DOI 10.1007/s003960050130
   Rafler G, 1997, PHARM IND, V59, P620
   Ramchandani M, 1997, J CONTROL RELEASE, V43, P161, DOI 10.1016/S0168-3659(96)01481-2
   RAMSAY BA, 1993, APPL ENVIRON MICROB, V59, P1242
   RAMSAY JA, 1990, APPL PHYCOL FORUM, V7
   REEVE MS, 1993, MACROMOLECULES, V26, P888, DOI 10.1021/ma00057a002
   REEVE MS, 1994, MACROMOLECULES, V27, P825, DOI 10.1021/ma00081a030
   Rodgers ES, 1997, FOOD AGR IMMUNOL, V9, P159, DOI 10.1080/09540109709354946
   Saad B, 1996, J MATER SCI-MATER M, V7, P56, DOI 10.1007/BF00121191
   Saad B, 1997, J MATER SCI-MATER M, V8, P497, DOI 10.1023/A:1018582311361
   SAH H, 1995, J APPL POLYM SCI, V58, P197, DOI 10.1002/app.1995.070580123
   SAH H, 1995, J CONTROL RELEASE, V35, P137, DOI 10.1016/0168-3659(95)00029-8
   Saito Y, 1996, POLYM INT, V39, P169
   SATOH H, 1994, POLYMER, V35, P286, DOI 10.1016/0032-3861(94)90692-0
   SATOH H, 1992, WATER SCI TECHNOL, V26, P933
   Scandola M, 1997, MACROMOLECULES, V30, P2568, DOI 10.1021/ma961431y
   SCANDOLA M, 1992, MACROMOLECULES, V25, P6441, DOI 10.1021/ma00050a009
   SCANDOLA M, 1995, CAN J MICROBIOL, V41, P310, DOI 10.1139/m95-202
   SCANDOLA M, 1992, MACROMOLECULES, V25, P1405, DOI 10.1021/ma00031a008
   SCANDOLA M, 1998, P 5 INT SCI WORKSH B
   Scherzer T, 1997, NUCL INSTRUM METH B, V131, P382, DOI 10.1016/S0168-583X(97)00195-X
   Schugens C, 1996, J BIOMED MATER RES, V30, P449, DOI 10.1002/(SICI)1097-4636(199604)30:4<449::AID-JBM3>3.0.CO;2-P
   Schugens C, 1996, POLYMER, V37, P1027, DOI 10.1016/0032-3861(96)87287-9
   SCHWACH G, 1994, POLYM BULL, V32, P617, DOI 10.1007/BF00973910
   Seal K. J., 1994, Chemistry and technology of biodegradable polymers., P116
   Semler EJ, 1997, BIOTECHNOL PROGR, V13, P630, DOI 10.1021/bp9700871
   Seneker SD, 1996, ADV CHEM SER, V248, P125
   Shakesheff KM, 1997, J COLLOID INTERF SCI, V185, P538, DOI 10.1006/jcis.1996.4637
   SHAKESHEFF KM, 1995, LANGMUIR, V11, P3921, DOI 10.1021/la00010a049
   Shakesheff KM, 1996, CRIT REV THER DRUG, V13, P225, DOI 10.1615/CritRevTherDrugCarrierSyst.v13.i3-4.20
   SHAKESHEFF KM, 1994, LANGMUIR, V10, P4417, DOI 10.1021/la00024a005
   Shih C, 1996, J CONTROL RELEASE, V38, P69, DOI 10.1016/0168-3659(95)00104-2
   Shih C, 1995, PHARMACEUT RES, V12, P2036, DOI 10.1023/A:1016276830464
   SHIRAKURA Y, 1986, BIOCHIM BIOPHYS ACTA, V880, P46, DOI 10.1016/0304-4165(86)90118-2
   Sobry R, 1996, J MOL STRUCT, V383, P63, DOI 10.1016/S0022-2860(96)09269-1
   *SOLV INT LTD, 1997, PROD INF
   Song CX, 1997, J CONTROL RELEASE, V43, P197, DOI 10.1016/S0168-3659(96)01484-8
   Spitzer B, 1996, J ENVIRON POLYM DEGR, V4, P157, DOI 10.1007/BF02067450
   Spyros A, 1997, MACROMOLECULES, V30, P327, DOI 10.1021/ma9601979
   STAINMESSE S, 1995, COLLOID POLYM SCI, V273, P505, DOI 10.1007/BF00656896
   STEINBUCHEL A, 1993, APPL MICROBIOL BIOT, V39, P443, DOI 10.1007/BF00205030
   STEINBUCHEL A, 1995, J ENVIRON POLYM DEGR, V3, P243, DOI 10.1007/BF02068679
   STOLNIK S, 1995, COLLOID SURFACE A, V97, P235, DOI 10.1016/0927-7757(95)03081-N
   Suominen I, 1997, J IND MICROBIOL BIOT, V19, P104, DOI 10.1038/sj.jim.2900424
   SWIFT G, 1995, J MACROMOL SCI PURE, VA32, P641, DOI 10.1080/10601329508010277
   TAJIMA K, 1995, MOKUZAI GAKKAISHI, V41, P749
   Talaba P, 1997, J CARBOHYD CHEM, V16, P573, DOI 10.1080/07328309708007336
   Thomas PA, 1997, J CONTROL RELEASE, V43, P273, DOI 10.1016/S0168-3659(96)01497-6
   Tighe BJ, 1997, MACROMOL SYMP, V123, P133, DOI 10.1002/masy.19971230114
   Timmins MR, 1996, MACROMOL CHEM PHYSIC, V197, P1193, DOI 10.1002/macp.1996.021970403
   Torres A, 1996, J ENVIRON POLYM DEGR, V4, P213, DOI 10.1007/BF02070690
   TSAI HB, 1991, POLYM BULL, V27, P141, DOI 10.1007/BF00296023
   Tsuji H, 1997, J APPL POLYM SCI, V63, P855
   TUNC DC, 1988, POLYM MAT SCI ENG, V59, P383
   TUNC DC, 1989, Patent No. 321176
   URSTADT S, 1995, J ENVIRON POLYM DEGR, V3, P121, DOI 10.1007/BF02068463
   VACANTI CA, 1994, ACS SYM SER, V540, P16
   VALLINI G, 1994, J GEN APPL MICROBIOL, V40, P445, DOI 10.2323/jgam.40.445
   VANDERHART DL, 1995, MACROMOLECULES, V28, P6394, DOI 10.1021/ma00123a002
   vanGinkel CG, 1996, ENVIRON TOXICOL CHEM, V15, P270, DOI 10.1897/1551-5028(1996)015<0270:TBANOC>2.3.CO;2
   VERHOOGT H, 1995, CAN J MICROBIOL, V41, P323, DOI 10.1139/m95-204
   VERHOOGT H, 1994, POLYMER, V35, P5155, DOI 10.1016/0032-3861(94)90465-0
   VERT M, 1992, BRE2CT920205
   VIKMAN M, 1995, J ENVIRON POLYM DEGR, V3, P23, DOI 10.1007/BF02067790
   VONRECUM HA, 1995, BIOMATERIALS, V16, P441, DOI 10.1016/0142-9612(95)98816-W
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   Wang GB, 1997, J CHROMATOGR B, V698, P69, DOI 10.1016/S0378-4347(97)00282-X
   WASSERBAUER R, 1990, BIOMATERIALS, V11, P36, DOI 10.1016/0142-9612(90)90049-V
   WEILAND M, 1995, POLYM DEGRAD STABIL, V48, P275, DOI 10.1016/0141-3910(95)00040-S
   Westesen K, 1997, J CONTROL RELEASE, V48, P223, DOI 10.1016/S0168-3659(97)00046-1
   Winternitz CI, 1996, PHARMACEUT RES, V13, P368, DOI 10.1023/A:1016032207246
   WOOD LA, 1958, J POLYM SCI, V28, P319, DOI 10.1002/pol.1958.1202811707
   YASIN M, 1989, BIOMATERIALS, V10, P400, DOI 10.1016/0142-9612(89)90132-4
   Yasin M, 1995, POLYMER AND OTHER ADVANCED MATERIALS, P597
   Yoon BS, 1996, J APPL POLYM SCI, V60, P1677, DOI 10.1002/(SICI)1097-4628(19960606)60:10<1677::AID-APP20>3.0.CO;2-0
   Yue CL, 1996, POLYM DEGRAD STABIL, V51, P205, DOI 10.1016/0141-3910(95)00201-4
   Zhang LL, 1997, POLYMER, V38, P5379, DOI 10.1016/S0032-3861(97)84642-3
   Zhang XC, 1996, INT J PHARM, V137, P199, DOI 10.1016/0378-5173(96)04521-8
   1997, SUNDAY TIMES    0323, P5
   1992, GESELLCHAFT VERPACKU
   1997, LEGISLATIVE REQUIREM
NR 283
TC 610
Z9 639
U1 16
U2 258
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD OCT
PY 1998
VL 47
IS 2
BP 89
EP 144
DI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
PG 56
WC Polymer Science
SC Polymer Science
GA 131RL
UT WOS:000076589000001
DA 2018-10-20
ER

PT J
AU Scholz, C
   Iijima, M
   Nagasaki, Y
   Kataoka, K
AF Scholz, C
   Iijima, M
   Nagasaki, Y
   Kataoka, K
TI Polymeric micelles as drug delivery systems: a reactive polymeric
   micelle carrying aldehyde groups
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article
DE polymeric micelle; block copolymer; light scattering; site-specific drug
   delivery
ID HETEROBIFUNCTIONAL POLY(ETHYLENE OXIDE); POLYETHYLENE OXIDE;
   BLOCK-COPOLYMERS; ETHYLENE-OXIDE; HYDROXYL GROUP; ONE END; SURFACES
AB Nanospheric particles as drug delivery systems are gaining increasing interest in the biomedical field. Nanospheres have been proven as efficient drug delivery systems for intravenous administration because of their comparatively long bloodstream circulation. A novel approach in the field of polymeric drug delivery systems was introduced by the formation of polymeric micelles and subsequently by functionalized polymeric micelles. Functionalized polymeric micelles are expected to find a wide application in the fields of drug delivery and diagnosis since the possibility of coupling to bioactive substances is provided. A large number of densely packed functional groups on the outer shell of the micelle allows an immobilization of biologically active substances at a high density. This is a great advantage for utilizing this particular type of nanosphere in the biomedical field. The possibilities synthesizing heterobifunctional block copolymers be demonstrated and the influence of the individual block length on the micelle properties will be discussed. Functionalized polymeric micelles were synthesized from poly(ethylene glycol) (PEG) and poly(lactide) (PLA), and combine the advantages given by the hydrophobic PLA core and the hydrophilic PEG corona. An established quantitative synthetic method for the formation of heterobifunctional PEG was advanced and applied to the block copolymerization. A heterobifunctional block copolymer was synthesized, terminated by an acetal group a the PEG end and a vinyl group was introduced at the PLA end ii a one-pot synthesis. After the micellization the acetal groups on the micelle surface were converted into aldehyde groups by an acidic treatment. Aldehyde groups call react rapidly with primary amines forming Schiff bases, a potential future pathway for the conjugation of functionalized polymeric micelles with proteins. PLA was chosen as core-forming segment since it is a biodegradable, non-toxic polymer that is well established as implant material. Dynamic and static light scattering was applied to determine the micelle size and shape and to study the dependence of the micelle geometry on the block length of the copolymer. (C) 1998 John Wiley & Sons, Ltd.
C1 Univ Massachusetts, Dept Chem, Lowell, MA 01854 USA.
   Sci Univ Tokyo, Int Ctr Biomat Sci, Noda, Chiba 278, Japan.
RP Scholz, C (reprint author), Univ Massachusetts, Dept Chem, 1 Univ Ave, Lowell, MA 01854 USA.
RI Kataoka, Kazunori/K-7108-2012
OI Kataoka, Kazunori/0000-0002-8591-413X
CR Akizawa T., 1989, T AM SOC ART INT ORG, V35, P333
   ANTONIETTI M, 1994, MACROMOLECULES, V27, P3276, DOI 10.1021/ma00090a021
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P122
   BRINKMAN E, 1990, BIOMATERIALS, V11, P200, DOI 10.1016/0142-9612(90)90156-K
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   GRAINGER DW, 1989, J BIOMED MATER RES, V23, P979, DOI 10.1002/jbm.820230903
   HARADA A, 1995, MACROMOLECULES, V28, P5294, DOI 10.1021/ma00119a019
   JEDLINSKI Z, 1991, MAKROMOL CHEM, V192, P2051
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   KATAOKA K, 1994, J MACROMOL SCI PURE, VA31, P1759, DOI 10.1080/10601329408545880
   KATAOKA K, 1996, CONTROLLED DRUG DELI, pCH4
   KIM YJ, 1994, POLYM BULL, V33, P1, DOI 10.1007/BF00313466
   KJELLANDER R, 1981, J CHEM SOC FARAD T 1, V77, P2053, DOI 10.1039/f19817702053
   KOPECEK J, 1991, ANN NY ACAD SCI, V618, P335, DOI 10.1111/j.1749-6632.1991.tb27253.x
   KOPECKOVA P, 1990, NEW POLYM MATER, V1, P289
   KWON GS, 1995, ADV DRUG DELIVER REV, V16, P295, DOI 10.1016/0169-409X(95)00031-2
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LEE JH, 1990, BIOMATERIALS, V11, P455, DOI 10.1016/0142-9612(90)90058-X
   NAGASAKI Y, 1995, BIOCONJUGATE CHEM, V6, P231, DOI 10.1021/bc00032a012
   PERRIN DD, 1980, PURIFICATION LAB CHE
   SCHOLZ C, 1995, MACROMOLECULES, V28, P7295, DOI 10.1021/ma00125a040
   Scott ND, 1936, J AM CHEM SOC, V58, P2442, DOI 10.1021/ja01303a022
   TUZAR Z, 1976, ADV COLLOID INTERFAC, V6, P201, DOI 10.1016/0001-8686(76)80009-7
   VERT M, 1986, Critical Reviews in Therapeutic Drug Carrier Systems, V2, P291
   VILLACAMPA M, 1995, MACROMOLECULES, V28, P1025, DOI 10.1021/ma00108a033
   XU RL, 1991, MACROMOLECULES, V24, P87, DOI 10.1021/ma00001a014
   YOKOYAMA M, 1994, J CONTROL RELEASE, V32, P269, DOI 10.1016/0168-3659(94)90237-2
NR 28
TC 18
Z9 18
U1 4
U2 20
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 1042-7147
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD OCT-NOV
PY 1998
VL 9
IS 10-11
BP 768
EP 776
DI 10.1002/(SICI)1099-1581(1998100)9:10/11<768::AID-PAT828>3.0.CO;2-O
PG 9
WC Polymer Science
SC Polymer Science
GA 134GD
UT WOS:000076733900026
DA 2018-10-20
ER

PT J
AU Sturtevant, B
AF Sturtevant, B
TI Shock wave effects in biomechanics
SO SADHANA-ACADEMY PROCEEDINGS IN ENGINEERING SCIENCES
LA English
DT Article
DE focused shock waves; kidney stone disease; blunt impact trauma;
   extracorporeal shock wave lithotripsy
ID LITHOTRIPSY
AB Focused shock waves convey energy from a source and deposit it in a localized region remote from the source. This mechanism is used to deliver crushing impulses to kidney stones in patients, but it may also be an undesirable source of tissue injury. Tissue injury occurs in extracorporeal shock wave lithotripsy (ESWL), a popular procedure used around the world to treat kidney stone disease. Shock waves can also be responsible for unexpected symptoms appearing remote from the site of blunt impact trauma. This paper describes two examples of the effects of focused shock waves on tissue, A victim of gunshot wound suffered specific neurological symptoms indicating highly localized injury to the spinal cord remote from the impact point and penetration of the missile. We suggest that wave focusing by thoracic vertebrae can concentrate energy into the spinal canal, with consequent injury to the spinal cord. Impulsive stress in repeated shock waves of order 20 MPa strength administered in ESWL is the mechanical stimulus of injury to the kidney. Research to increase the understanding of the causal relationship between the shock-induced mechanical stimulus and the consequent biomedical symptoms in the shock-wave treatment of kidney stone disease is described. The interaction of focusing shock waves with simple, planar polymeric membranes immersed in tissue-mimicking fluids has been studied. We have explored the nature of membrane failure in both cavitating and non-cavitating fluids. In water, thin nitrocellulose membranes are easily damaged during the passage of a lithotriptor shock wave by the collapse of proximal bubbles generated by cavitation. In uniform non-cavitating liquids, focusing shock waves do not by themselves cause damage, but after passing through tissue or simulated tissue, they do. Shocks with large amplitude and short-rise time (for example, in uniform media) cause no damage in non-cavitating fluids, while long-rise time, dispersed shock waves, though only moderately attenuated, do. A simple model of shearing at small scale provides a framework for accounting for the properties of the scattering medium and the membrane material in dynamic fatigue. The fact that the membranes exhibit fatigue-like behaviour suggests that a definition of dose can be formulated based on Miner's Law. This definition gives the dose at failure in terms of the stress applied to the membrane by each shock wave and the failure stress. This analysis suggests that ESWL shock waves induce strain rates in tissue of order 10000 s(-1) and that behind a tissue, phantom membranes fail after a dose of about 1400 effective shock waves, of the same order as the number of shock waves typically used in lithotripsy therapy and research. Above strain rates of about 40000 s(-1), ESWL shocks cause virtually no damage.
C1 CALTECH, Grad Aeronaut Labs, Pasadena, CA 91001 USA.
RP Sturtevant, B (reprint author), CALTECH, Grad Aeronaut Labs, Pasadena, CA 91001 USA.
CR Brown-Sequard C.E., 1860, COURSE LECT PHYSL PA
   Evan A. P., 1996, J ACOUST SOC AM, V99, P2510
   EVAN AP, 1996, NEW DEV MANAGEMENT U, P3
   EVAN AP, 1996, J ACOUST SOC AM, V98, P2943
   GOSS SA, 1978, J ACOUST SOC AM, V64, P423, DOI 10.1121/1.382016
   HOGE KG, 1967, APPL POLYM S, V5, P19
   Howard D, 1997, ULTRASOUND MED BIOL, V23, P1107, DOI 10.1016/S0301-5629(97)00081-1
   JANZON B, 1988, J TRAUMA, V28, P29
   KAUDE JV, 1985, AM J ROENTGENOL, V145, P305, DOI 10.2214/ajr.145.2.305
   MINER MA, 1945, J APPL MECH-T ASME, V12, pA159
   MING L, 1988, J TRAUMA S1, V28, P104
   SAXON M, 1982, J ORAL MAXIL SURG, V40, P299, DOI 10.1016/0278-2391(82)90223-3
   SUNESON A, 1990, J TRAUMA, V30, P281, DOI 10.1097/00005373-199003000-00006
   SUNESON A, 1988, J TRAUMA, V28, P197
   TAYLOR RG, 1957, J BONE JOINT SURG BR, V39, P438
   WILLIAMS PL, 1989, GRAYS ANAT
NR 16
TC 4
Z9 4
U1 1
U2 8
PU INDIAN ACADEMY SCIENCES
PI BANGALORE
PA P B 8005 C V RAMAN AVENUE, BANGALORE 560 080, INDIA
SN 0256-2499
J9 SADHANA-ACAD P ENG S
JI Sadhana-Acad. Proc. Eng. Sci.
PD OCT-DEC
PY 1998
VL 23
BP 579
EP 596
DI 10.1007/BF02744581
PN 5-6
PG 18
WC Engineering, Multidisciplinary
SC Engineering
GA 179WT
UT WOS:000079353500010
DA 2018-10-20
ER

PT J
AU Jakubiec, B
   Marois, Y
   Zhang, Z
   Roy, R
   Sigot-Luizard, MF
   Dugre, FJ
   King, MW
   Dao, L
   Laroche, G
   Guidoin, R
AF Jakubiec, B
   Marois, Y
   Zhang, Z
   Roy, R
   Sigot-Luizard, MF
   Dugre, FJ
   King, MW
   Dao, L
   Laroche, G
   Guidoin, R
TI In vitro cellular response to polypyrrole-coated woven polyester
   fabrics: Potential benefits of electrical conductivity
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE polypyrrole; polyester; conductivity; in vitro; cell culture; cell
   activation; interleukin expression
ID SYNTHETIC VASCULAR PROSTHESES; BIOMEDICAL POLYMERS; MONOCYTES
   MACROPHAGES; CYTOKINE PRODUCTION; IN-VITRO; ELECTRODES;
   POLYDIMETHYLSILOXANE; ADHESION; GLUCOSE; CELLS
AB Electrically conducting polypyrrole-treated films have recently been shown to influence the morphology and function of mammalian cells in vitro. This type of polymer represents a possible alternative biomaterial for use in vascular implantation. The present study compared the in vitro biocompatibility of five different polyester woven fabrics having increasing levels of electrical conductivity ranging from 4.5 x 10(4) to 123 Ohm/square with that of low density polyethylene and polydimethylsiloxane primary reference materials. Biocompatibility was measured in terms of four different types of in vitro cellular response, including (a) an indirect and (b) a direct control organotypic culture assay using endothelial cells, (c) a polymorphonuclear (PMN) cell activation study using flow-cytometric measurements of CD11/CD18 integrin molecule expression and (d) a semiquantification of interleukin (IL)-6 mRNA expression on monotytes/macrophages using reverse-transcriptase polymerase chain reaction. The organotypic culture study revealed that the fabrics with high levels of conductivity exhibited lower cell migration, proliferation, and viability. The PMN activation study of blood from 10 healthy adult donors demonstrated that the two most conductive fabrics were able to identify the more reactive donors. The levels of IL-6 mRNA expression by monocytes/macrophages decreased as the conductivity level of the fabrics increased. The results of the present study therefore indicate that high levels of conductivity (<200 Ohm/square) on polyester fabrics are detrimental to the growth, migration, and viability of endothelial cells; induce elevated PMN activation; and affect the intracellular metabolism of monocytes. They also point to a specific range of conductivity (10(3) < 10(4) Ohm n/square) which is associated with an optimum in vitro cellular response. (C) 1998 John Wiley & Sons, Inc. J Biomed Mater Res, 41, 519-526, 1998.
C1 CHU Quebec, Ctr Rech Rhumatol & Immunol, Quebec City, PQ, Canada.
   CHU Quebec, Inst Biomat Quebec Inc, Quebec City, PQ, Canada.
   Univ Laval, Fac Med, Dept Chirurg, Quebec City, PQ G1K 7P4, Canada.
   Univ Technol Compiegne, Dept Genie Biol, Compiegne, France.
   Univ Manitoba, Dept Clothing & Text, Winnipeg, MB, Canada.
   INRS Energie & Mat, Varennes, PQ, Canada.
RP Guidoin, R (reprint author), Univ Laval, Expt Surg Lab, Room 1701,Serv Bldg, St Foy, PQ G1K 7P4, Canada.
RI Zhang, Ze/A-7902-2008
CR ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   BONFIELD TL, 1991, J BIOMED MATER RES, V25, P165, DOI 10.1002/jbm.820250204
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1993, J BIOMED MATER RES, V27, P1195, DOI 10.1002/jbm.820270910
   BORDENAVE L, 1992, J BIOMAT SCI-POLYM E, V3, P509, DOI 10.1163/156856292X00475
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   DUVAL JL, 1988, BIOMATERIALS, V9, P155, DOI 10.1016/0142-9612(88)90115-9
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P667, DOI 10.1002/jbm.820280603
   FORTIER G, 1990, BIOSENS BIOELECTRON, V5, P473, DOI 10.1016/0956-5663(90)80036-D
   GAO ZQ, 1994, ANALYST, V119, P459, DOI 10.1039/an9941900459
   GREGORY RL, 1991, PERCEPTION, V20, P1
   HORII Y, 1988, J IMMUNOL, V141, P1529
   Jakubiec B, 1994, ASAIO J, V40, pM616, DOI 10.1097/00002480-199407000-00072
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P73, DOI 10.1002/jbm.820280110
   KUHN HH, 1991, TECH PAP SOC PLAST E, V37, P760
   LAGOODEENADAYALAN S, 1993, LYMPHOKINE CYTOK RES, V12, P59
   LIAN A, IN PRESS CONDUCTING
   Marois Y, 1996, BIOMATERIALS, V17, P1835, DOI 10.1016/0142-9612(95)00245-6
   MCFAUL SJ, 1990, J IMMUNOL METHODS, V130, P15, DOI 10.1016/0022-1759(90)90293-5
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   PETILLO O, 1994, J BIOMED MATER RES, V28, P635, DOI 10.1002/jbm.820280514
   ROITT Y, 1991, ESSENTIAL IMMUNOLOGY
   ROTH S, 1993, SYNTHETIC MET, V57, P3623, DOI 10.1016/0379-6779(93)90487-H
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   Selampinar F, 1997, BIOMATERIALS, V18, P1163, DOI 10.1016/S0142-9612(97)00056-2
   SPILIZEWSKI KL, 1987, BIOMATERIALS, V8, P12, DOI 10.1016/0142-9612(87)90021-4
   SUN ZS, 1992, ANAL CHEM, V64, P1112, DOI 10.1021/ac00034a008
   TROJANOWICZ M, 1990, BIOSENS BIOELECTRON, V5, P149, DOI 10.1016/0956-5663(90)80005-X
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   WITKOWSKI A, 1992, ANAL CHEM, V64, P635, DOI 10.1021/ac00030a012
   WITKOWSKI A, 1991, ANAL CHEM, V63, P622, DOI 10.1021/ac00006a013
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   WONG JY, 1993, MATER RES SOC SYMP P, V293, P179
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
   ZHANG WB, 1990, J INORG BIOCHEM, V40, P189, DOI 10.1016/0162-0134(90)80052-Y
NR 35
TC 48
Z9 50
U1 0
U2 12
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 15
PY 1998
VL 41
IS 4
BP 519
EP 526
DI 10.1002/(SICI)1097-4636(19980915)41:4<519::AID-JBM2>3.0.CO;2-F
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 104KM
UT WOS:000075013600002
PM 9697023
DA 2018-10-20
ER

PT J
AU Chen, JH
   Wei, J
   Chang, CY
   Laiw, RF
   Lee, YD
AF Chen, JH
   Wei, J
   Chang, CY
   Laiw, RF
   Lee, YD
TI Studies on segmented polyetherurethane for biomedical application:
   Effects of composition and hard-segment content on biocompatibility
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE segmented polyetherurethane (SPEU); hemolysis; cytotoxicity; cell
   culture; blood compatibility
ID PLATELET-ADHESION; BLOOD COMPATIBILITY; BLOCK COPOLYMER; POLYURETHANE;
   SURFACES; CYTOTOXICITY; BIOMATERIALS; BIOSTABILITY; ELASTOMER; CRACKING
AB Segmented polyetherurethane (SPEU) materials based on polytetramethylene oxide (PTMO, Mw 1000 and 2000) with various hard-segment contents were synthesized and their biocompatibilities studied via different tests. The static contact angle data reveal that the higher hard-segment-content SPEU material possesses a lower contact angle, implying that the surface of the higher hard-segment-content SPEU is more hydrophilic than its low hard-segment-content SPEU counterpart. The catalyst- and additive-free PTMO-based SPEU materials in this study possess neither a hemolytic nor a cytotoxic response that could be considered non toxic for biomedical applications. By using L-929 cell lines, a cell-seeding test indicated that the higher hard-segment-content SPEU material possesses quicker cell attachment and proliferation behaviors. In vitro platelet adhesion tests indicated that the lower hard-segment-content SPEU possesses less platelet adhesion than the high hard-segment-content SPEU material. Both ex vivo canine artery-artery (A-A) and arterio-venous (A-V) shunting tests revealed that the extent of platelet adhesion reaction is less for lower hard-segment-content SPEU. Ln addition, the blood compatibility of SPEU material synthesized from PTMO 1000 excels over PTMO 2000 SPEU material by nearly the same levels as the hard-segment-content SPEU. (C) 1998 John Wiley & Sons, Inc. J Biomed Mater Res, 41, 633-648, 1998.
C1 Ind Technol Res Inst, Union Chem Labs, Hsinchu, Taiwan.
   Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu, Taiwan.
   Cheng Hsin Gen Hosp, Dept Cardiovasc Surg, Taipei, Taiwan.
RP Lee, YD (reprint author), Natl Tsing Hua Univ, Dept Chem Engn, 101 Kuang Fu Rd,Sec 2, Hsinchu, Taiwan.
CR ASHAR B, 1981, T AM SOC ART INT ORG, V27, P372
   BORDENAVE L, 1993, J BIOMED MATER RES, V27, P1367, DOI 10.1002/jbm.820271104
   BOUVIER M, 1991, J BIOMED MATER RES, V25, P773, DOI 10.1002/jbm.820250607
   BUMGARDNER JD, 1989, J BIOMED MATER RES, V23, P1103, DOI 10.1002/jbm.820231002
   CHO CS, 1990, J BIOMED MATER RES, V24, P1369, DOI 10.1002/jbm.820241008
   COOPER SL, 1986, POLYM MED, V2, P199
   DONG A, 1989, J BIOMED MAT RES APP, V23, P211
   FRAYSSINET P, 1994, J MATER SCI-MATER M, V5, P11, DOI 10.1007/BF00121147
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P335, DOI 10.1002/jbm.820270307
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P1559, DOI 10.1002/jbm.820271213
   GREISLER HP, 1993, J BIOMED MATER RES, V27, P955, DOI 10.1002/jbm.820270715
   HASTINGS GW, 1986, POLYM MED, V2, P1
   HAYASHI K, 1990, J BIOMED MATER RES, V24, P1385, DOI 10.1002/jbm.820241010
   HAYCOX CL, 1993, J BIOMED MATER RES, V27, P1181, DOI 10.1002/jbm.820270909
   HELLER J, 1983, POLYM BIOMATERIALS, P167
   ITO Y, 1989, J BIOMED MATER RES, V23, P191, DOI 10.1002/jbm.820230205
   JOHNSON SD, 1992, J BIOMED MATER RES, V26, P915, DOI 10.1002/jbm.820260707
   KIREMITCI M, 1993, J BIOMATER APPL, V7, P251
   KLINKMANN H, 1985, BIOMATERIALS ARTIFIC, P1
   LELAH MD, 1986, POLYURETHANES MED, P1
   LYMAN DJ, 1989, POLYM BIOMATERIALS M, P52
   LYMAN DJ, 1975, POLYM MED SURG, P29
   MARCHANT RE, 1988, SURFACE CHARACTERIZA, P297
   MESTRES CA, 1987, POLYURETHANE BIOMEDI, V2, P4
   MESTRES CA, 1987, POLYURETHANE BIOMEDI, V2, P39
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1151, DOI 10.1002/jbm.820240903
   NYILAS E, 1977, J BIOMED MATER RES, V8, P69
   OLSON, 1986, ARTIF ORG, V11, P63
   PIZZOFERRATO A, 1986, BIOMATERIALS CLIN AP, P1
   RATHBUN MA, 1991, J BIOMED MATER RES, V25, P443
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Reed A M, 1994, J Biomater Appl, V8, P210, DOI 10.1177/088532829400800303
   SCHMALZ G, 1994, J MATER SCI-MATER M, V5, P43, DOI 10.1007/BF00121153
   SILVER JH, 1993, J BIOMED MATER RES, V27, P1443, DOI 10.1002/jbm.820271111
   STOKES K, 1984, POLYURETHANES BIOMED, P243
   STOKES KB, 1986, PACE, V9, P1160, DOI 10.1111/j.1540-8159.1986.tb06687.x
   STOKES KB, 1985, POLYM MATER SCI ENG, V53, P6
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P1095, DOI 10.1002/jbm.820250905
   TSENG YC, 1990, J BIOMED MATER RES, V24, P1335
   TSUCHIYA T, 1993, J BIOMED MATER RES, V27, P885, DOI 10.1002/jbm.820270707
   WU Y, 1991, J BIOMED MATER RES, V25, P725, DOI 10.1002/jbm.820250604
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 43
TC 24
Z9 25
U1 1
U2 9
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 15
PY 1998
VL 41
IS 4
BP 633
EP 648
DI 10.1002/(SICI)1097-4636(19980915)41:4<633::AID-JBM16>3.0.CO;2-F
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 104KM
UT WOS:000075013600016
PM 9697037
DA 2018-10-20
ER

PT J
AU Abraham, GA
   Frontini, PM
   Cuadrado, TR
AF Abraham, GA
   Frontini, PM
   Cuadrado, TR
TI Molding of biomedical segmented polyurethane delamination events and
   stretching behavior
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE segmented polyurethane devices; solution-casting technique;
   delamination; demolding technique; tensile properties
ID DEGRADATION; ELASTOMER
AB Segmented polyurethane devices for medical applications are generally processed by the solution-casting technique. The processing parameters in the molding and demolding stages strongly affect the physicochemical properties of the finished articles. Thus, the solution concentration, immersion cycle and drying temperature, type of mold (material and geometry), additives, and the drying time between the casting of successive layers define the surface and bulk properties of the manufactured articles. In this work, new commercially available medical-grade segmented polyurethanes were processed by two techniques to obtain multilayer films. Processing parameters were chosen to ensure the generation of a coating with the desired structural and surface characteristics. In the solution-casting technique, multiple dipping of the preshaped former into the polymer solution were used to obtain proper film thickness. Thin and uniform plaques were produced by the spin-casting technique. The two materials selected have different chemical compositions: one is an aromatic poly(ether urethane urea) (Biospan(TM)) and the other an aromatic ether-free polyurethane (Chronoflex(TM)). An analysis of the possibility of delamination events, considering the influence of surface-modifying additives and drying times, is presented. The freeze-fracture surface appearance is qualitatively described by SEM. In addition, tensile properties are determined and their influence on demolding and assembling procedures are also discussed. (C) 1998 John Wiley & Sons, Inc.
C1 Univ Mar del Plata, Inst Mat Sci & Technol, INTEMA, Natl Res Council,CONICET, RA-7600 Mar Del Plata, Argentina.
RP Abraham, GA (reprint author), Univ Mar del Plata, Inst Mat Sci & Technol, INTEMA, Natl Res Council,CONICET, JB Justo 4302, RA-7600 Mar Del Plata, Argentina.
RI Abraham, Gustavo/E-2820-2014
OI Abraham, Gustavo/0000-0001-7094-1031
CR Abraham GA, 1997, J APPL POLYM SCI, V65, P1193, DOI 10.1002/(SICI)1097-4628(19970808)65:6<1193::AID-APP15>3.0.CO;2-V
   AHN TO, 1994, J APPL POLYM SCI, V51, P43, DOI 10.1002/app.1994.070510105
   CABLE M, 1996, 5 WORLD BIOM C TOR C
   *CARD TECH INT, PROD INF
   FREIJLARSSON C, 1993, J APPL POLYM SCI, V49, P815, DOI 10.1002/app.1993.070490507
   Galletti PM, 1996, J BIOMED MATER RES, V32, P289
   LELAH MD, 1983, J BIOMED MATER RES, V17, P1, DOI 10.1002/jbm.820170102
   LELAH MD, 1989, POLYURETHANES MED, P73
   LIOTTA D, 1994, ASSISTED CIRCULATION, V4
   MARCHANT RE, 1987, POLYMER, V28, P2032, DOI 10.1016/0032-3861(87)90037-1
   MARCUS GE, 1988, ANTHROPOL QUART, V61, P3, DOI 10.2307/3317867
   MEIJS GF, 1993, J BIOMED MATER RES, V27, P345, DOI 10.1002/jbm.820270308
   Orang F, 1996, BIOMATERIALS, V17, P485, DOI 10.1016/0142-9612(96)82722-0
   PHILLIPS WM, 1985, SYNTHETIC BIOMEDICAL
   PIERCE WS, 1967, T AM SOC ART INT ORG, V13, P299
   *POLYM TECHN GROUP, PROD INF
   Szycher Michael, 1994, P233
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   WANG TLD, 1993, J POLYM SCI POL CHEM, V31, P1983, DOI 10.1002/pola.1993.080310806
   WARD RS, 1995, MED PLASTICS BIOMATE
   WU Y, 1992, J APPL POLYM SCI, V46, P201, DOI 10.1002/app.1992.070460202
   WU Y, 1991, J BIOMED MATER RES, V25, P725, DOI 10.1002/jbm.820250604
NR 22
TC 4
Z9 4
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD SEP 12
PY 1998
VL 69
IS 11
BP 2159
EP 2167
DI 10.1002/(SICI)1097-4628(19980912)69:11<2159::AID-APP7>3.0.CO;2-F
PG 9
WC Polymer Science
SC Polymer Science
GA 106CP
UT WOS:000075112400007
DA 2018-10-20
ER

PT J
AU Hooper, KA
   Macon, ND
   Kohn, J
AF Hooper, KA
   Macon, ND
   Kohn, J
TI Comparative histological evaluation of new tyrosine-derived polymers and
   poly (L-lactic acid) as a function of polymer degradation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE poly(lactic acid); subcutaneous implantation; tyrosine-derived polymers;
   poly(DTE carbonate); poly(DTE adipate); biocompatibility
ID IN-VIVO DEGRADATION; MEDICAL APPLICATIONS; BIOCOMPATIBILITY;
   POLY(L-LACTIDE); POLYCARBONATES; BIOMATERIALS; TISSUE; IMPLANTATION;
   TOXICITY; FIXATION
AB Previous studies demonstrated that poly(DTE carbonate) and poly (DTE adipate), two tyrosine-derived polymers, have suitable properties for use in biomedical applications. This study reports the evaluation of the in vivo tissue response to these polymers in comparison to poly(L-lactic acid) (PLLA). Typically, the biocompatibility of a material is determined through histological evaluations as a function of implantation time in a suitable animal model. However, due to changes that can occur in the tissue response at different stages of the degradation process, a fixed set of time points is not ideal for comparative evaluations of materials having different rates of degradation. Therefore the tissue response elicited by poly(DTE carbonate), poly(DTE adipate), and PLLA was evaluated as a function of molecular weight. This allowed the tissue response to be compared at corresponding stages of degradation. Poly(DTE adipate) consistently elicited the mildest tissue response, as judged by the width and lack of cellularity of the fibrous capsule formed around the implant. The tissue response to poly(DTE carbonate) was mild throughout the 570 day study. However, the response to PLLA fluctuated as a function of the degree of degradation, exhibiting an increase in the intensity of inflammation as the implant began to lose mass. At the completion of the study, tissue ingrowth into the degrading and disintegrating poly(DTE adipate) implant was evident while no comparative ingrowth of tissue was seen far PLLA. The similarity of the in vivo and in vitro degradation rates of each polymer confirmed the absence of enzymatic involvement in the degradation process. A comparison of molecular weight retention, water uptake, and mass loss in vivo with two commonly used in vitro systems [phosphate-buffered saline (PBS) and simulated body fluid (SBF)] demonstrated that for the two tyrosine-derived polymers the in vivo results were equally well simulated in vitro with PBS and SBF;. However, for PLLA the in vivo results were better simulated in vitro using PBS. (C) 1998 John Wiley & Sons, Inc.
C1 Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA.
RP Kohn, J (reprint author), Rutgers State Univ, Dept Chem, 610 Taylor Rd, Piscataway, NJ 08854 USA.
FU NIGMS NIH HHS [GM49894, GM39455]
CR ALTMAN NH, 1979, LAB RAT, V1, P348
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   BERGSMA JE, 1995, J BIOMED MATER RES, V29, P173, DOI 10.1002/jbm.820290206
   BERGSMA JE, 1995, BIOMATERIALS, V16, P267, DOI 10.1016/0142-9612(95)93253-A
   BOS RRM, 1991, BIOMATERIALS, V12, P32, DOI 10.1016/0142-9612(91)90128-W
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   Choueka J, 1996, J BIOMED MATER RES, V31, P35, DOI 10.1002/(SICI)1097-4636(199605)31:1<35::AID-JBM5>3.0.CO;2-R
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   ERTEL SI, 1995, J BIOMED MATER RES, V29, P1337, DOI 10.1002/jbm.820291105
   FIORDELISO J, 1994, J BIOMAT SCI-POLYM E, V5, P497
   FIORDELISO J, 1995, POLYM BIOMATERIALS S, P695
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   GOURLAY SJ, 1978, J BIOMED MATER RES, V12, P219, DOI 10.1002/jbm.820120207
   HOLLANDER CF, 1976, LAB ANIM SCI, V26, P320
   Hooper KA, 1995, J BIOACT COMPAT POL, V10, P327, DOI 10.1177/088391159501000404
   Hooper KA, 1997, J APPL POLYM SCI, V63, P1499, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1499::AID-APP12>3.0.CO;2-Y
   JAMES KS, 1997, 23 ANN M SOC BIOM NE, P120
   Jansen J A, 1994, J Invest Surg, V7, P123, DOI 10.3109/08941939409015356
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   Lewis DH, 1990, BIODEGRADABLE POLYM, V45, P1
   LORD GF, 1986, TECHNIQUES BIOCOMPAT, V1, P5
   PISTNER H, 1993, BIOMATERIALS, V14, P671, DOI 10.1016/0142-9612(93)90066-B
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   Pulapura S, 1992, J Biomater Appl, V6, P216, DOI 10.1177/088532829200600303
   SUGANUMA J, 1993, J APPL BIOMATER, V4, P13, DOI 10.1002/jab.770040103
   TURNER JE, 1973, J BIOMED MATER RES, V7, P39, DOI 10.1002/jbm.820070104
   VANSLIEDREGT A, 1994, BIOMATERIALS, V15, P251, DOI 10.1016/0142-9612(94)90047-7
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P1115, DOI 10.1002/jbm.820270817
   ZHOU J, 1994, 20 ANN M SOC BIOM BO, P371
NR 30
TC 73
Z9 76
U1 0
U2 13
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 1998
VL 41
IS 3
BP 443
EP 454
DI 10.1002/(SICI)1097-4636(19980905)41:3<443::AID-JBM14>3.0.CO;2-J
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ZX504
UT WOS:000074523300014
PM 9659614
DA 2018-10-20
ER

PT J
AU Sosabowski, MH
   Herson, K
   Lloyd, AW
AF Sosabowski, MH
   Herson, K
   Lloyd, AW
TI Implementation and student assessment of Intranet-based learning
   resources
SO AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION
LA English
DT Article
ID PHARMACY STUDENTS; COMPUTER
AB The recent development of Web browsers and tools has enabled the wider use of the Internet for learning and teaching. Such developments have also provided effective methods of information management within institutions through the establishments of Intranets. Within the School of Pharmacy and Biomedical Sciences, University of Brighten, UK, the use of the Intranet has been extended to provide an integrated learning resource to enhance the quality of pharmacy education. The Pharmacy Intranet was developed as a learning support management system for module courses across the Department providing course information, directed access to Internet-based learning support material, academic lecture notes, links to relevant computer aided learning (CAL) packages and worksheets within a structured framework. Electronic monitoring of Intranet usage and subsequent questionnaire-based evaluation demonstrated that the Intranet was deemed to be a useful learning resource, empowering students to take greater responsibility for their own learning.
C1 Brighton Univ, Sch Pharm & Biomed Sci, Brighton BN2 4GJ, E Sussex, England.
RP Sosabowski, MH (reprint author), Brighton Univ, Sch Pharm & Biomed Sci, Cockcroft Bldg, Brighton BN2 4GJ, E Sussex, England.
EM M.H.Sosabowski@Brighton.ac.uk
RI Lloyd, Andrew/D-1369-2011
OI Lloyd, Andrew/0000-0003-2778-8195
CR Blackmore P, 1997, ASLIB PROC, V49, P67, DOI 10.1108/eb051451
   Chandra A, 1996, AM J PHARM EDUC, V60, P297
   DEARING R, 1997, NATL COMMITTEE INQUI, V8, P118
   Kaplan IP, 1996, AM J PHARM EDUC, V60, P422
   MORRELL P, 1997, ASLIB P, V49, P7
   MURALI R, 1997, AM J PHARM EDUC, V61, P141
   Sylvester RK, 1997, AM J PHARM EDUC, V61, P50
   TYSINGER JW, 1995, AM J PHARM EDUC, V59, P43
NR 8
TC 5
Z9 5
U1 0
U2 6
PU AMER ASSOC COLL PHARMACY
PI ALEXANDRIA
PA 1426 PRINCE STREET, ALEXANDRIA, VA 22314-2815 USA
SN 0002-9459
J9 AM J PHARM EDUC
JI Am. J. Pharm. Educ.
PD FAL
PY 1998
VL 62
IS 3
BP 302
EP 306
PG 5
WC Education, Scientific Disciplines; Pharmacology & Pharmacy
SC Education & Educational Research; Pharmacology & Pharmacy
GA 139EM
UT WOS:000077015000011
DA 2018-10-20
ER

PT J
AU Sharp, MK
   Mohammad, SF
AF Sharp, MK
   Mohammad, SF
TI Scaling of hemolysis in needles and catheters
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE blood; blood damage; shear stress; cannula
ID FLOW; CELL
AB Hemolysis in clinical blood samples leads to inaccurate assay results and often to the need for repeated blood draws. In vitro experiments were conducted to determine the influence on hemolysis in phlebotomy needles and catheters of pressure difference, cannula diameter, and cannula material. Fresh blood from five human volunteers was forced from a syringe inside a pressurized chamber through 14, 18, and 27 gauge 304 stainless steel needles and polyurethane and Teflon(R) catheters, all 40 mm long. Hemolysis was measured in the samples by a spectrophotometer. It was found that hemolysis increased with increases in pressure difference and cannula diameter and no consistent trend could be identified with regard to cannula material. The pressure differences required for significant hemolysis were above those typical of clinical venipuncture blood draws. While there was substantial variability among individuals, the hemolysis values scaled with exponent S=(t/t(0))[(tau/tau(0)) - 1](2), where t is the characteristic duration of shear, t(0) is a time constant, tau is the wall shear stress, and tau(0) is the wall shear stress threshold below which no hemolysis occurs. A hemolysis threshold including both time and shear stress was also defined for S= constant. The threshold implies that a threshold shear stress exists below which erythrocytes are not damaged for any length of exposure time, but that red cells may be damaged by an arbitrarily short period of exposure to sufficiently large shear stress. (C) 1998 Biomedical Engineering Society. [S0090-6964(98)02805-7].
C1 Univ Utah, Dept Civil & Environm Engn, Biofluid Mech Lab, Salt Lake City, UT 84112 USA.
   Univ Utah, Artificial Heart Res Lab, Salt Lake City, UT USA.
RP Sharp, MK (reprint author), Univ Utah, Dept Civil & Environm Engn, Biofluid Mech Lab, 160 S Cent Campus Dr,Rm 104, Salt Lake City, UT 84112 USA.
EM m.k.sharp@m.cc.utah.edu
CR BACHER RP, 1970, J LAB CLIN MED, V76, P485
   BEISSINGER RL, 1987, AICHE J, V33, P99, DOI 10.1002/aic.690330112
   BESSIS M, 1975, BLOOD CELLS, V1, P229
   BESSIS M, 1977, BLOOD CELLS, V3, P307
   Blackshear PL, 1987, HDB BIOENGINEERING, P151
   CHANDRAN KB, 1983, J BIOMECH, V16, P865, DOI 10.1016/0021-9290(83)90011-8
   CHANDRAN KB, 1984, J BIOMECH, V17, P9
   COAKLEY WT, 1977, BIORHEOLOGY, V14, P91
   COKELET GR, 1980, ANNU REV PHYSIOL, V42, P311, DOI 10.1146/annurev.ph.42.030180.001523
   FISCHER TM, 1980, BIOPHYS J, V32, P863, DOI 10.1016/S0006-3495(80)85022-3
   Forstrom R. J., 1969, THESIS U MINNESOTA M
   Goldsmith H L, 1972, Prog Hemost Thromb, V1, P97
   GOLDSMITH HL, 1971, FED PROC, V30, P1578
   GOLDSMITH HL, 1974, T AM SOC ART INT ORG, VA 20, P21
   GOLDSMITH HL, 1972, 13 IUTAM C
   Hellums JD, 1977, CARDIOVASCULAR FLOW, P799
   HELLUMS JD, 1981, RHEOLOGY BLOOD BLOOD, P160
   JONES SA, 1995, UNPUB P 1995 BIOENG, P557
   KESHAVIAH PR, 1974, THESIS U MINNESOTA S
   Lee CS, 1996, J BIOMECH ENG-T ASME, V118, P97, DOI 10.1115/1.2795951
   LEUER L, 1986, UNPUB ANN M CAN COUN
   *NIH, 1985, NIH PUBL, P78
   NIIMI H, 1985, J BIOMECH ENG-T ASME, V107, P91, DOI 10.1115/1.3138541
   RAISKY F, 1994, ANN BIOL CLIN-PARIS, V52, P523
   RAND RP, 1964, BIOPHYS J, V4, P303, DOI 10.1016/S0006-3495(64)86784-9
   ROONEY JA, 1970, SCIENCE, V169, P869, DOI 10.1126/science.169.3948.869
   SUTERA SP, 1977, CIRC RES, V41, P2, DOI 10.1161/01.RES.41.1.2
   THURSTON GB, 1989, BIORHEOLOGY, V26, P199
   WILLIAMS A R, 1973, Biorheology, V10, P313
   WILLIAMS AR, 1970, SCIENCE, V169, P871, DOI 10.1126/science.169.3948.871
NR 30
TC 58
Z9 58
U1 0
U2 11
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD SEP-OCT
PY 1998
VL 26
IS 5
BP 788
EP 797
DI 10.1114/1.65
PG 10
WC Engineering, Biomedical
SC Engineering
GA 124ZV
UT WOS:000076213500008
PM 9779951
DA 2018-10-20
ER

PT J
AU Sacks, MS
   Chuong, CJ
AF Sacks, MS
   Chuong, CJ
TI Orthotropic mechanical properties of chemically treated bovine
   pericardium
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE chemical fixation; constitutive modeling; bioprostheses; heart valves;
   small angle light scattering
ID TENSILE VISCOELASTIC PROPERTIES; BIOPROSTHETIC HEART-VALVE; COLLAGEN
   FIBER ARCHITECTURE; CANINE PERICARDIUM; BIAXIAL STRESS; TISSUE;
   QUANTIFICATION; XENOGRAFT; STIFFNESS; FIXATION
AB To facilitate bioprosthetic heart valve design, especially in the use of novel antimineralization chemical technologies, a thorough understanding of the multiaxial mechanical properties of chemically treated bovine pericardium (BP) is needed. In this study. we utilized a small angle light scattering based tissue pre-sorting procedure to select BP specimens with a high degree of structural uniformity. Both conventional glutaraldehyde (GL) and photo-oxidation (PO) chemical treatment groups were studied, with untreated tissue used as the control group. A second set of GL and PO groups was prepared by prestretching them along the preferred fiber direction during the chemical treatment. An extensive biaxial test protocol was used and the resulting stress-strain data fitted to an exponential strain energy Function. The high structural uniformity resulted in both a consistent mechanical response and low variability in the material constants. For free fixed tissues, the strain energy per unit volume for GL treated BP was similar to 2.8 times that of PO treated BP at an equibiaxial Green's strain level of 0.16. Prestretched tissues exhibited a profound increase in both stiffness and the degree of anisotropy, with the GL treatment demonstrating a greater effect. Thus, structural control leads to an improved understanding of chemically treated BP mechanical propel-ties. Judicious use of this knowledge can facilitate the design and enhanced long-term performance of bioprosthetic heart valves. (C) 1998 Biomedical Engineering Society.
C1 Univ Miami, Dept Biomed Engn, Coral Gables, FL USA.
   Univ Texas, Biomed Engn Program, Arlington, TX 76019 USA.
RP Sacks, MS (reprint author), Univ Pittsburgh, Dept Bioengn, 742 Benedum Engn Hall, Pittsburgh, PA 15261 USA.
EM msacks@engrng.pitt.edu
CR Billiar KL, 1997, J BIOMECH, V30, P753, DOI 10.1016/S0021-9290(97)00019-5
   BLACK MM, 1991, J BIOMECH, V24, P793, DOI 10.1016/0021-9290(91)90304-6
   CHEW PH, 1986, J MOL CELL CARDIOL, V18, P567, DOI 10.1016/S0022-2828(86)80965-8
   CHOI HS, 1990, J BIOMECH ENG-T ASME, V112, P153, DOI 10.1115/1.2891166
   CHRISTIE CW, 1982, FINITE ELEMENT BIOME, P153
   DEMIRAY H, 1972, J BIOMECH, V5, P308
   DOWNS J, 1990, IEEE T BIO-MED ENG, V37, P903, DOI 10.1109/10.58600
   FUNG Y, 1965, INT SERIES DYNAMICS, P525
   Fung Y-C, 1993, BIOMECHANICS MECH PR, P129, DOI [DOI 10.1007/978-1-4757-2257-4, 10.1007/978-1-4757-2257-4]
   HAMID MS, 1986, J BIOMECH, V19, P759, DOI 10.1016/0021-9290(86)90199-5
   Haziza F, 1996, J HEART VALVE DIS, V5, P35
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   HUMPHREY JD, 1987, J BIOMECH, V20, P59, DOI 10.1016/0021-9290(87)90267-3
   HWANG NHC, 1982, CRIT REV BIOMED ENG, V9, P99
   KRUCINSKI S, 1993, J BIOMECH, V26, P929, DOI 10.1016/0021-9290(93)90055-J
   LEE JM, 1989, J BIOMED MATER RES, V23, P457, DOI 10.1002/jbm.820230502
   LEE JM, 1984, J BIOMED MATER RES, V18, P61, DOI 10.1002/jbm.820180108
   LEE JM, 1989, J BIOMED MATER RES, V23, P491, DOI 10.1002/jbm.820230504
   MAYNEWMAN K, 1995, AM J PHYSIOL-HEART C, V269, pH1319
   MOORE MA, 1994, J BIOMED MATER RES, V28, P611, DOI 10.1002/jbm.820280511
   MOORE MW, 1996, J BIOMED MATER RES, V32, P20
   Press W. H., 1988, NUMERICAL RECIPES C, P735
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   Sacks MS, 1997, ANN BIOMED ENG, V25, P678, DOI 10.1007/BF02684845
   SACKS MS, 1992, J BIOMECH ENG-T ASME, V114, P183, DOI 10.1115/1.2891370
   SACKS MS, 1993, J BIOMECH ENG-T ASME, V115, P202, DOI 10.1115/1.2894122
   Schoen F J, 1992, Cardiovasc Pathol, V1, P29, DOI 10.1016/1054-8807(92)90006-A
   SIMIONESCU D, 1993, J BIOMED MATER RES, V27, P697, DOI 10.1002/jbm.820270602
   THUBRIKAR MJ, 1986, AM J CARDIOL, V58, P304, DOI 10.1016/0002-9149(86)90067-6
   Vesely I, 1996, ASAIO J, V42, P993, DOI 10.1097/00002480-199642060-00012
   YIN FCP, 1986, J BIOMECH, V19, P27, DOI 10.1016/0021-9290(86)90106-5
   YIN FCP, 1987, J BIOMECH, V20, P577, DOI 10.1016/0021-9290(87)90279-X
   ZIOUPOS P, 1994, BIOMATERIALS, V15, P366, DOI 10.1016/0142-9612(94)90249-6
   ZIOUPOS P, 1994, J BIOMED MATER RES, V28, P49, DOI 10.1002/jbm.820280107
NR 35
TC 108
Z9 108
U1 2
U2 28
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD SEP-OCT
PY 1998
VL 26
IS 5
BP 892
EP 902
DI 10.1114/1.135
PG 11
WC Engineering, Biomedical
SC Engineering
GA 124ZV
UT WOS:000076213500019
PM 9779962
DA 2018-10-20
ER

PT J
AU Long, M
   Rack, HJ
AF Long, M
   Rack, HJ
TI Titanium alloys in total joint replacement - a materials science
   perspective
SO BIOMATERIALS
LA English
DT Review
DE titanium; titanium alloys; total joint replacement; orthopaedics;
   fatigue; wear; biocompatibility
ID ION-IMPLANTED TI-6AL-4V; POLYETHYLENE WEAR; FRETTING-WEAR; SURFACE
   CHARACTERIZATION; MECHANICAL-PROPERTIES; KNEE REPLACEMENT; ACETABULAR
   CUPS; SLIDING WEAR; BEHAVIOR; FRICTION
AB Increased use of titanium alloys as biomaterials is occurring due to their lower modulus, superior biocompatibility and enhanced corrosion resistance when compared to more conventional stainless steels and cobalt-based alloys. These attractive properties were a driving force for the early introduction of alpha (cpTi) and alpha + beta (Ti-6A1-4V) alloys as well as for the more recent development of new Ti-alloy compositions and orthopaedic metastable beta titanium alloys. The later possess enhanced biocompatibility, reduced elastic modulus, and superior strain-controlled and notch fatigue resistance. However, the poor shear strength and wear resistance of titanium alloys have nevertheless limited their biomedical use. Although the wear resistance of beta-Ti alloys has shown some improvement when compared to alpha + beta alloys, the ultimate utility of orthopaedic titanium alloys as wear components will require a more complete fundamental understanding of the wear mechanisms involved. This review examines current information on the physical and mechanical characteristics of titanium alloys used in artifical joint replacement prostheses, with a special focus on those issues associated with the long-term prosthetic requirements, e.g., fatigue and wear. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
C1 Clemson Univ, Sch Chem & Mat Engn, Clemson, SC 29634 USA.
RP Rack, HJ (reprint author), Clemson Univ, Sch Chem & Mat Engn, Clemson, SC 29634 USA.
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   AHMED T, 1995, 8 WORLD TIT C BIRM U
   *AM AC ORTH SURG, 1995, OTH RES SOC ANN M OR
   ARDILL J, 1995, THESIS QUEENS U BELF
   ARGENSON JN, 1992, J BONE JOINT SURG BR, V74, P228
   BANIA PJ, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P3
   BERRY DJ, 1993, CLIN ORTHOP RELAT R, V293, P204
   BERTHIER Y, 1989, TRIBOL INT, V22, P235, DOI 10.1016/0301-679X(89)90081-9
   BERTHIER Y, 1992, EUR C BRAK LILL FRAN, P1
   BILL RC, 1985, WEAR, V106, P283, DOI 10.1016/0043-1648(85)90113-9
   BLACK J, 1990, J BONE JOINT SURG AM, V72A, P126, DOI 10.2106/00004623-199072010-00021
   BLACK J, 1992, BIOL PERFORMANCE MAT
   BLANCHARD P, 1991, METALL TRANS A, V22, P1535, DOI 10.1007/BF02667367
   BOROWY KH, 1995, TITANIUM 84 SCI TECH, V2, P1381
   BOYER RR, 1993, TITANIUM '92: SCIENCE AND TECHNOLOGY, VOLS 1-3, P77
   Boyer RR, 1987, MICROSTRUCTURE FRACT, P149
   BUCHANAN RA, 1987, J BIOMED MATER RES, V21, P367, DOI 10.1002/jbm.820210309
   BUDINSKI KG, 1991, WEAR, V151, P203, DOI 10.1016/0043-1648(91)90249-T
   CATES HE, 1993, J BONE JOINT SURG BR, V75, P249
   CHARNLEY J, 1970, CLIN ORTHOP RELAT R, P7
   CHEAL EJ, 1992, J ORTHOPAED RES, V10, P405, DOI 10.1002/jor.1100100314
   CHENGWEI C, 1995, TRIBOL T, V38, P875
   CHESNUTT JC, 1978, AFMLTR7868 AIR FORC
   CLARKE IC, 1983, ASTM STP, V796, P136
   COLLINGS EW, 1984, CLEVELAND METALS PAR
   COLOMBIE C, 1987, FATIGUE 87 CHARLOTTE, P567
   COOK SD, 1984, J BIOMED MATER RES, V18, P497, DOI 10.1002/jbm.820180504
   CRAPPER DR, 1993, BIOL ASPECTS METALS, P209
   CRONIN J, 1988, TRIBOL INT, V21, P309, DOI 10.1016/0301-679X(88)90107-7
   DEGATICA NLH, 1993, APPL SURF SCI, V68, P107, DOI 10.1016/0169-4332(93)90220-6
   DOBBS HS, 1983, ASTM STP, V796, P173
   DOWSON D, 1985, POLYM WEAR ITS CONTR, P171
   Dowson D., 1992, BIOMECHANICS DIARTHR, V2, P305
   DOWSON D, 1992, ASM HDB, V18, P656
   Dujovne A R, 1993, J Arthroplasty, V8, P7, DOI 10.1016/S0883-5403(06)80102-6
   Dumbleton J H, 1988, J Biomater Appl, V3, P3, DOI 10.1177/088532828800300101
   Dumbleton J.H., 1991, JOINT REPLACEMENT AR, P47
   Dumbleton JH, 1981, TRIBOLOGY SERIES
   EASTER TL, 1994, P 20 ANN M SOC BIOM, P185
   EBERHARDT AW, 1995, J APPL BIOMATER, V6, P171, DOI 10.1002/jab.770060305
   ENGH CA, 1988, CLIN ORTHOP RELAT R, V231, P7
   ENGH GA, 1992, J BONE JOINT SURG BR, V74, P9
   FANNING JC, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P411
   FANNING JC, 1995, TIMET TECHNICAL LAB
   FAYEULLE S, 1993, TRIBOL T, V36, P267, DOI 10.1080/10402009308983158
   Fisher J, 1991, Proc Inst Mech Eng H, V205, P73, DOI 10.1243/PIME_PROC_1991_205_271_02
   FISHER J, 1994, WEAR, V175, P219, DOI 10.1016/0043-1648(94)90185-6
   FLOWER HM, 1985, TITANIUM 84 SCI TECH, V4, P1651
   FREESE H, 1995, COMMUNICATION
   FRICKER DC, 1990, BIOMATERIALS, V11, P495, DOI 10.1016/0142-9612(90)90064-W
   GALANTE JO, 1973, ACTA ORTHOP SCAND, P1
   GIBBESCH B, 1992, BIOMATERIALS, V13, P455, DOI 10.1016/0142-9612(92)90166-L
   GREGORY JK, 1991, 7 INT M TIT 15 NOV 1
   HEILMANN P, 1983, ACTA METALL MATER, V31, P1293, DOI 10.1016/0001-6160(83)90191-8
   HIRTH JP, 1980, STRENGTH METALS ALLO, V3, P1483
   HOEPPNER DW, 1994, WEAR, V173, P189, DOI 10.1016/0043-1648(94)90272-0
   HONG H, 1989, J TRIBOL-T ASME, V111, P504, DOI 10.1115/1.3261958
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Hutchings IM, 1992, TRIBOLOGY FRICTION W
   Jacobs JJ, 1994, J AM ACAD ORTHOP SUR, V2, P212
   JASTY M, 1993, J APPL BIOMATER, V4, P273, DOI 10.1002/jab.770040310
   JONES SMG, 1992, J BONE JOINT SURG BR, V74, P18
   KABO JM, 1993, J BONE JOINT SURG BR, V75, P254
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   KOVACS P, 1993, TITANIUM '92: SCIENCE AND TECHNOLOGY, VOLS 1-3, P2705
   KUHLMAN GW, 1991, MICROSTRUCTURE / PROPERTY RELATIONSHIPS IN TITANIUM ALUMINIDES AND ALLOYS, P465
   KULHMANNWILSDOR.D, 1980, FUNDAMENTALS FRICTIO, P119
   KUO SM, 1992, MAT SCI ENG A-STRUCT, V157, P131, DOI 10.1016/0921-5093(92)90020-2
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   LING FW, 1974, METALL TRANS, V5, P179
   Lorenz M., 1978, Engineering in Medicine, V7, P241
   LOWMAN EW, 1955, JAMA-J AM MED ASSOC, V157, P487, DOI 10.1001/jama.1955.02950230001001
   LUTJERING G, 1985, TITANIUM SCI TECHNOL, V4, P2065
   MAUSLI PA, 1988, 6TH P WORLD C TIT, P1759
   McKee G K, 1966, J Bone Joint Surg Br, V48, P245
   MCKELLOP H, 1981, J BIOMED MATER RES, V15, P619, DOI 10.1002/jbm.820150503
   MCKELLOP HA, 1990, J BIOMED MATER RES, V24, P1413, DOI 10.1002/jbm.820241102
   MEDLEY JB, 1995, T 21 ANN M SOC BIOM, P47
   MERGET M, 1985, TITANIUM 84 SCI TECH, V4, P1393
   Miller P. D., 1958, WEAR, V2, P133, DOI DOI 10.1016/0043-1648(58)90428-9
   MISHRA AK, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P61
   MOORE MA, 1976, METALL TRANS A, V7, P1833, DOI 10.1007/BF02654978
   MORTON PH, 1989, MEM ETUD SCI REV MET, V86, P639
   MOW VC, 1991, FRICTION LUBRICATION, P245
   NOLAN JF, 1992, J BONE JOINT SURG BR, V74, P23
   NUTT SR, 1983, WEAR MAT, P426
   OKAZAKI Y, 1993, J JPN I MET, V57, P332, DOI 10.2320/jinstmet1952.57.3_332
   OONISHI H, 1992, BIOCERAMICS, V3, P147
   OONISHI T, 1992, BIOCERAMICS, V3, P137
   PARK JB, 1992, BIOMATERIALS INTRO
   PERL DP, 1980, SCIENCE, V208, P297, DOI 10.1126/science.7367858
   Peters M, 1981, TITANIUM 80 SCI TECH, P1777
   PETERSON CD, 1988, J BIOMED MATER RES, P22
   POGGIE RA, 1992, AM SOC TEST MATER, V1145, P65, DOI 10.1520/STP15333S
   POLMEAR JJ, 1981, LIGHT ALLOYS, pCH6
   Pourbaix M, 1966, ATLAS ELECTROCHEMICA
   PRENDERGAST PJ, 1990, J BIOMED ENG, V12, P379, DOI 10.1016/0141-5425(90)90020-N
   PROTEK AG, 1994, METASUL METAL ON MET
   RAIKAR GN, 1995, J VAC SCI TECHNOL A, V13, P2633, DOI 10.1116/1.579462
   Rice S., 1989, KEY ENG MATER, P77
   RIES MD, 1995, 62 ANN M AM AC ORTH
   RIEU J, 1991, BIOMATERIALS, V12, P139, DOI 10.1016/0142-9612(91)90192-D
   ROSTOKER W, 1981, BIOMATERIALS, V2, P221, DOI 10.1016/0142-9612(81)90061-2
   Rudinger K., 1985, TITANIUM 84 SCI TECH, V4, P2123
   SAIKKO V, 1994, WEAR, V176, P207, DOI 10.1016/0043-1648(94)90148-1
   SAIKKO V, 1993, WEAR, V166, P169, DOI 10.1016/0043-1648(93)90259-O
   SANDSTROM PW, 1993, WEAR, V166, P163, DOI 10.1016/0043-1648(93)90258-N
   SANNINO AP, 1995, WEAR, V189, P1, DOI 10.1016/0043-1648(95)06657-8
   SANTAVIRTA S, 1993, CLIN ORTHOP RELAT R, P100
   SCHUMACHER HR, 1988, PRIMER RHEUMATIC DIS
   SCHUTZ RW, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P75
   SEMLITSCH MF, 1992, BIOMATERIALS, V13, P781, DOI 10.1016/0142-9612(92)90018-J
   SHANBHAG AS, 1994, J BONE JOINT SURG BR, V76B, P60
   STEIJN RP, 1969, ASLE TRANS, V12, P21
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   STEINEMANN SG, 1993, TITANIUM '92: SCIENCE AND TECHNOLOGY, VOLS 1-3, P2689
   STEINEMANN SG, 1985, TITANIUM SCI TECHNOL, V2, P1373
   STREICHER RM, 1991, BIOMATERIALS, V12, P125, DOI 10.1016/0142-9612(91)90190-L
   STREICHER RM, 1990, BIOMED TECH, V35, P78, DOI 10.1515/bmte.1990.35.4.78
   STREICHER RM, 1994, T 20 ANN M SOC BIOM, P323
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, V274, P202
   SUTULA LC, 1995, 62 ANN M AM AC ORTH
   TATEISHI T, 1992, BIOCERAMICS, V2, P145
   TUMMLER HP, 1985, TITANIUM 84 SCI TECH, V2, P1335
   Unsworth A, 1991, Proc Inst Mech Eng H, V205, P163, DOI 10.1243/PIME_PROC_1991_205_287_02
   *US DEP DEF, 1976, MIL HDB MET MAT EL A, V5
   VASSEL A, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P173
   VINCENT L, 1987, TRAITEMENTS SURFACE
   WAGNER L, 1991, MICROSTRUCTURE / PROPERTY RELATIONSHIPS IN TITANIUM ALUMINIDES AND ALLOYS, P521
   WAGNER L, 1991, FATIGUE 90, P323
   WAGNER L, 1985, TITANIUM 84 SCI TECH, V4, P2147
   WALKER PS, 1971, WEAR, V17, P285, DOI 10.1016/0043-1648(71)90032-9
   WANG K, 1993, TITANIUM '92: SCIENCE AND TECHNOLOGY, VOLS 1-3, P2697
   WANG K, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P49
   WATERHOUSE RB, 1973, WEAR, V25, P171, DOI 10.1016/0043-1648(73)90069-0
   WATERHOUSE RB, 1974, WEAR, V29, P337, DOI 10.1016/0043-1648(74)90019-2
   WATERHOUSE RB, 1980, WEAR, V60, P357, DOI 10.1016/0043-1648(80)90234-3
   WERT JJ, 1989, KEY ENG MATER, V33, P101
   WHITE SE, 1995, 62 ANN M AM AC ORTH
   WILLIAMS DN, 1971, MCIC7101 BATT COL LA
   WINTER M, 1990, BIOCERAMICS, V2, P436
   WOLFARTH D, 1990, J APPL BIOMATER, V1, P3, DOI 10.1002/jab.770010103
   *WRIGHT MED TECHN, 1995, 62 ANN M AM AC ORTH
   ZWICKER J, 1985, TITANIUM 84 SCI TECH, V2, P1343
   ZWICKER R, 1980, TITANIUM 80 SCI TECH, P505
NR 145
TC 1871
Z9 1973
U1 42
U2 721
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 1998
VL 19
IS 18
BP 1621
EP 1639
DI 10.1016/S0142-9612(97)00146-4
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 137VZ
UT WOS:000076938600001
PM 9839998
DA 2018-10-20
ER

PT J
AU Peterson, NC
   Peavey, JE
AF Peterson, NC
   Peavey, JE
TI Comparison of in vitro monoclonal antibody production methods with an in
   vivo ascites production technique
SO CONTEMPORARY TOPICS IN LABORATORY ANIMAL SCIENCE
LA English
DT Article
AB Economic, technical, legislative, and ethical issues influence decisions concerning alternatives to the use of animals in biomedical research. Since the development of cell hybridoma technology, production of ascites in mice has been a popular technique for generating high concentrations of monoclonal antibodies. However, the availability of several in vitro methods that can be performed in most laboratories make these alternative methods of monoclonal antibody production an attractive option. To evaluate the practicality of the use of in vitro techniques, three tissue culture methods and a technique for production of ascites were compared on the basis of yield, material costs, and time requirements. Analysis of results revealed that the time and material costs to produce 100 mg of monoclonal antibody 7.16.4 by inducing ascites in irradiated mice was similar or slightly more than that for tissue culture in standard plastic flasks and hollow fiber cartridge bioreactors; however, tissue culture in gas permeable bags was slightly less expensive than these methods in terms of cost and time. When ascites production in irradiated mice was compared with tissue culture in plastic flasks or gas permeable bags for monoclonal antibody 225, the in vitro methods were approximately five times more expensive than the ascites production technique. Information reported here outlines factors that should be considered and evaluated when choosing a monoclonal antibody production method. Furthermore, these results documented that in vitro technology for the production of monoclonal antibodies can be adapted by most conventional laboratories to provide sufficient resources for the most commonly performed experimental protocols.
C1 Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
RP Peterson, NC (reprint author), Univ Penn, Dept Pathol & Lab Med, 36 & Hamilton Walk, Philadelphia, PA 19104 USA.
CR *AM ANT SOC, 1997, PET REQ NAT I HLTH P
   AMYX HL, 1987, J AM VET MED ASSOC, V191, P1287
   BRODEUR BR, 1984, J IMMUNOL METHODS, V71, P265, DOI 10.1016/0022-1759(84)90073-5
   BRODEUR BR, 1986, J IMMUNOL METHODS, V86, P239, DOI 10.1016/0022-1759(86)90459-X
   DARBY CR, 1993, J IMMUNOL METHODS, V159, P125, DOI 10.1016/0022-1759(93)90149-2
   DREBIN JA, 1984, NATURE, V312, P545, DOI 10.1038/312545a0
   EVANS TL, 1988, BIOTECHNIQUES, V6, P762
   FALKENBERG FW, 1993, J IMMUNOL METHODS, V165, P193, DOI 10.1016/0022-1759(93)90345-8
   FALKENBERG FW, 1995, J IMMUNOL METHODS, V179, P13, DOI 10.1016/0022-1759(94)00266-Y
   FEDERSPIEL G, 1991, J IMMUNOL METHODS, V145, P213, DOI 10.1016/0022-1759(91)90329-E
   GILL GN, 1984, J BIOL CHEM, V259, P7755
   GORTER A, 1993, J IMMUNOL METHODS, V161, P145, DOI 10.1016/0022-1759(93)90289-J
   HOOVER CS, 1990, BIOTECHNIQUES, V8, P76
   Jackson LR, 1996, J IMMUNOL METHODS, V189, P217, DOI 10.1016/0022-1759(95)00251-0
   KNAZEK RA, 1972, SCIENCE, V178, P65, DOI 10.1126/science.178.4056.65
   Marx U, 1997, ATLA-ALTERN LAB ANIM, V25, P121
   MCGILL MW, 1989, ILAR NEWS, V31, P7
   MUELLER UW, 1986, J IMMUNOL METHODS, V87, P193, DOI 10.1016/0022-1759(86)90530-2
   National Research Council, 1996, GUID CAR US LAB AN
   *NIH, 1997, WORKSH J HOPK CTR AL
   NOEMAN SA, 1982, J IMMUNOL METHODS, V55, P319, DOI 10.1016/0022-1759(82)90091-6
   POTTER M, 1972, J NATL CANCER I, V49, P305
   SJOGRENJANSSON E, 1991, HYBRIDOMA, V10, P411, DOI 10.1089/hyb.1991.10.411
   TARLETON RL, 1991, BIOTECHNIQUES, V11, P590
   VELEZ D, 1986, J IMMUNOL METHODS, V86, P45, DOI 10.1016/0022-1759(86)90263-2
NR 25
TC 9
Z9 10
U1 0
U2 2
PU AMER ASSOC LABORATORY ANIMAL SCIENCE
PI MEMPHIS
PA 9190 CRESTWYN HILLS DR, MEMPHIS, TN 38125 USA
SN 1060-0558
J9 CONTEMP TOP LAB ANIM
JI Contemp. Top. Lab. Anim. Sci.
PD SEP
PY 1998
VL 37
IS 5
BP 61
EP 66
PG 6
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA V2596
UT WOS:000165287500003
PM 12456135
DA 2018-10-20
ER

PT J
AU Becker, JS
   Dietze, HJ
AF Becker, JS
   Dietze, HJ
TI Ultratrace and precise isotope analysis by double-focusing sector field
   inductively coupled plasma mass spectrometry
SO JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY
LA English
DT Article; Proceedings Paper
CT Winter Conference on Plasma Spectrochemistry
CY JAN 05-10, 1998
CL SCOTTSDALE, AZ
DE calcium, magnesium and potassium; isotope analysis; double-focusing
   sector field mass spectrometry; high-purity samples; inductively coupled
   plasma; long-lived radionuclides; ultratrace analysis; zirconium oxide
ID LIQUID-LIQUID-EXTRACTION; BIOMEDICAL-RESEARCH; RATIO MEASUREMENT;
   INVITED LECTURE; ICP-MS; TRACE; MULTIELEMENT; ELEMENTS; INTERFERENCES;
   IONIZATION
AB Double-focusing sector field inductively coupled plasma source mass spectrometry with its capability of providing a very sensitive multi-element analysis has been established for the determination of trace and ultratrace elements in high-purity materials, environmental samples and radioactive waste materials. Some applications of double-focusing sector field ICP-MS for the multi-element analysis of trace and ultratrace impurities in high-purity inorganic materials are described. A, matrix separation procedure for ZrO(2) by liquid-liquid extraction after microwave-induced dissolution in an acid mixture is proposed in order to determine ultratrace impurities. The detection limits of ICP-MS reached after matrix separation in solid samples are in the low ng g(-1) concentration range, The detection limits in ICP-MS (determined by the blank values of the chemicals used) are comparable to those of solid-state mass spectrometry, which allows the direct determination of trace impurities in high-purity solids. Isotope ratio measurements of Mg, K and Ca were performed to investigate the transport phenomena of nutrient solutions in plants by tracer experiments using highly enriched (25)Mg, (26)Mg, (41)K, (42)Ca and (44)Ca isotopes. In order to separate the (38)ArH(+) and (40)ArH(+) ions from the (39)K(+) and (41)K(+) analyte ions for potassium isotope ratio measurements, double-focusing sector field ICP-MS with an ultrasonic nebulizer was used at a mass resolution of 9000, The precision of potassium isotope ratio measurements was 0.7% (at a potassium concentration of 100 pg l(-1)). Isotope ratios of Mg and Ca teach at a concentration of 50 mu g l(-1) were determined at a mass resolution of 3000 with a precision of 0.4 and 0.5% on real biological samples. The accuracy of isotope ratio measurements of K and Mg was determined using isotopic standard reference materials with natural isotope composition (NBS SRM 985 and 980), The results of isotope ratio measurements of K, Mg and Ca on real biological samples doped with enriched stable isotopes are discussed.
C1 Forschungszentrum Julich, Zent Abt Chem Anal, D-52425 Julich, Germany.
RP Becker, JS (reprint author), Forschungszentrum Julich, Zent Abt Chem Anal, Postfach 1913, D-52425 Julich, Germany.
CR Alvarado JS, 1996, J ANAL ATOM SPECTROM, V11, P923, DOI 10.1039/ja9961100923
   BARANOV VI, 1998, 1998 WINT C PLASM SP, P301
   Barinaga CJ, 1996, FRESEN J ANAL CHEM, V355, P487
   Barnes RM, 1996, FRESEN J ANAL CHEM, V355, P433
   Becker JS, 1996, J ANAL ATOM SPECTROM, V11, P643, DOI 10.1039/ja9961100643
   Becker JS, 1997, FRESEN J ANAL CHEM, V359, P338, DOI 10.1007/s002160050583
   Becker JS, 1997, J ANAL ATOM SPECTROM, V12, P881, DOI 10.1039/a702178j
   BECKER JS, 1996, BERICHTE FORSCHUNGSZ, V3272, P143
   BECKER JS, 1998, IN PRESS SPECTROCH B, V53
   BECKER JS, 1997, ADV MASS SPECTROM, V14, P681
   BECKER JS, IN PRESS J ANAL AT S
   BECKER JS, 1994, AD MASS SPECTROM, V14
   BECKER JS, 1997, BER FORSCHUNGSZENTRU, V3468, P1
   Bowman J, 1997, J ANAL ATOM SPECTROM, V12, P313, DOI 10.1039/a605704g
   Brenner IB, 1997, J ANAL ATOM SPECTROM, V12, P273, DOI 10.1039/a605533h
   DAHMEN J, 1996, FRESEN J ANAL CHEM, V359, P410
   DELAETER JR, 1991, PURE APPL CHEM, V63, P991
   Doring T, 1997, FRESEN J ANAL CHEM, V359, P382, DOI 10.1007/s002160050592
   Eiden GC, 1997, RAPID COMMUN MASS SP, V11, P37, DOI 10.1002/(SICI)1097-0231(19970115)11:1<37::AID-RCM815>3.0.CO;2-C
   EIDEN GC, 1998, 1998 WINT C PLASM SP, P299
   Feldmann J, 1996, ANAL COMMUN, V33, P11, DOI 10.1039/ac9963300011
   Fletcher IR, 1997, INT J MASS SPECTROM, V163, P1, DOI 10.1016/S0168-1176(96)04540-5
   Gastel M, 1997, SPECTROCHIM ACTA B, V52, P2051, DOI 10.1016/S0584-8547(97)00111-0
   HALLIDAY AN, 1995, INT J MASS SPECTROM, V146, P21, DOI 10.1016/0168-1176(95)04200-5
   HEUMANN KG, 1992, INT J MASS SPECTROM, V118, P575, DOI 10.1016/0168-1176(92)85076-C
   HEUMANN KG, IN PRESS J ANAL AT S
   HEUMANN KG, 1998, 1998 WINT C PLASM SP, P302
   Hieftje GM, 1996, J ANAL ATOM SPECTROM, V11, P613, DOI 10.1039/ja9961100613
   Hoppstock K, 1997, ATOM SPECTROSC, V18, P180
   HOUK RS, 1994, ACCOUNTS CHEM RES, V27, P33
   HOUK RS, 1998, 1998 WINT C PLASM SP, P295
   JIANG SJ, 1988, ANAL CHEM, V60, P1217, DOI 10.1021/ac00162a023
   KERKL W, 1997, AD MASS SPECTROM, V14
   Kerl W, 1996, J ANAL ATOM SPECTROM, V11, P723, DOI 10.1039/ja9961100723
   Kerl W, 1997, FRESEN J ANAL CHEM, V359, P407, DOI 10.1007/s002160050598
   KERL W, IN PRESS FRESENIUS J
   KERL W, 1998, 1998 WINT C PLASM SP, P401
   KIM CK, 1992, J RADIOAN NUCL CH AR, V156, P201, DOI 10.1007/BF02037434
   KIM S, 1998, 1998 WINT C PLASM SP, P368
   KOBOTA M, 1989, ANAL SCI, V5, P701
   KOHL N, 1996, FRESEN J ANAL CHEM, V359, P317
   KOPPENAAL DW, 1998, WINT C PLASM SPECTR, P294
   KUHN AJ, 1997, HOLZFORSCHUNG, V51, P1
   MARRIOTT P, 1998, WINT C PLASM SPECTR, P360
   McLafferty FW, 1995, ADV MASS SPECTROM, V13, P115
   Moens L, 1997, FRESEN J ANAL CHEM, V359, P309, DOI 10.1007/s002160050579
   MONTASER A, 1998, INDUCTIVELY COUPLED
   NONOSE NS, 1994, SPECTROCHIM ACTA B, V49, P955, DOI 10.1016/0584-8547(94)80084-7
   NUI H, 1996, SPECTROCHIM ACTA B, V51, P779
   Panday VK, 1996, ATOM SPECTROSC, V17, P98
   Panday VK, 1996, ANAL CHIM ACTA, V329, P153, DOI 10.1016/0003-2670(96)00138-9
   PAUCOT H, 1998, 1998 WINT C PLASM SP, P350
   REED NM, 1994, J ANAL ATOM SPECTROM, V9, P881, DOI 10.1039/ja9940900881
   Riondato J, 1997, J ANAL ATOM SPECTROM, V12, P933, DOI 10.1039/a701652b
   SCHRODER W, UNPUB
   SPEAKMAN J, 1998, 1998 WINT C PLASM SP, P357
   Sturup S, 1997, J ANAL ATOM SPECTROM, V12, P919, DOI 10.1039/a704079b
   TANNER SD, 1995, ATOM SPECTROSC, V16, P16
   TANNER SD, 1988, 1998 WINT C PLASM SP, P296
   Taylor DB, 1996, J ANAL ATOM SPECTROM, V11, P187, DOI 10.1039/ja9961100187
   Vanhaecke F, 1996, ANAL CHEM, V68, P567, DOI 10.1021/ac9507247
   Vanhaecke F, 1997, ANAL CHEM, V69, P268, DOI 10.1021/ac960740j
   Vanhaecke F, 1996, J ANAL ATOM SPECTROM, V11, P543, DOI 10.1039/ja9961100543
   WALDER AJ, 1993, ANAL SCI, V9, P675, DOI 10.2116/analsci.9.675
   WALDER AJ, 1993, J ANAL ATOM SPECTROM, V8, P19, DOI 10.1039/ja9930800019
   WIEDERIN D, 1998, 1998 WINT C PLASM SP, P349
   Yamasaki SI, 1991, ANAL SCI, V7, P1135, DOI 10.2116/analsci.7.Supple_1135
NR 67
TC 47
Z9 48
U1 0
U2 8
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0267-9477
J9 J ANAL ATOM SPECTROM
JI J. Anal. At. Spectrom.
PD SEP
PY 1998
VL 13
IS 9
BP 1057
EP 1063
DI 10.1039/a801528g
PG 7
WC Chemistry, Analytical; Spectroscopy
SC Chemistry; Spectroscopy
GA 121FP
UT WOS:000076002900035
DA 2018-10-20
ER

PT J
AU Whitson, BA
   Cheng, BC
   Kokini, K
   Badylak, SF
   Patel, U
   Morff, R
   O'Keefe, CR
AF Whitson, BA
   Cheng, BC
   Kokini, K
   Badylak, SF
   Patel, U
   Morff, R
   O'Keefe, CR
TI Multilaminate resorbable biomedical device under biaxial loading
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE multilaminate sheet; biaxial testing; ball burst test; rehydration
   effects; small intestinal submucosa
ID SMALL-INTESTINAL SUBMUCOSA; PRESSURE; GRAFT; DOG
AB The design and test of a multilaminate sheet developed for a hernia repair application is presented. As biomaterial applications become more complex, characterization of uniaxial properties becomes insufficient and biaxial testing becomes necessary. A measure of the in-plane biaxial strength of the device is inferred from a ball burst test. The results of this test for different thicknesses of the device are correlated with the uniaxial strength of the material, A biaxial test such as the ball burst test is more indicative of the properties of a planar material than would be a uniaxial test. The interactions in the biaxial mode of failure are of value and can be related hack to a classical uniaxial tensile test from the ball burst test, The material used in this study to fabricate the device was a resorbable biomaterial called small intestinal submucosa (SIS), The effects of rehydration on the stiffness and associated hall burst properties of the SIS device were also measured, It is shown that at a rehydration time of 5 min from a reference dry state, steady-state mechanical properties are reached. (C) 1998 John Wiley & Sons, Inc.
C1 Purdue Univ, W Lafayette, IN 47907 USA.
   Univ Wisconsin, Madison, WI 53706 USA.
RP Kokini, K (reprint author), Purdue Univ, W Lafayette, IN 47907 USA.
OI Badylak, Stephen/0000-0003-3555-0689
CR ASPDEN RM, 1987, CLIN BIOMECH, V2, P168, DOI 10.1016/0268-0033(87)90010-6
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BADYLAK SF, 1993, IN PRESS J BIOMED MA, P179
   BADYLAK SF, INPRESS J BIOMED MAT
   CLARKE KM, IN PRESS J SURG RES
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   MCGILL SM, 1990, ERGONOMICS, V33, P147, DOI 10.1080/00140139008927106
   PHEASANT S, 1986, ANTHROPOMETRY ERGONO
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   SHIGLEY JE, 1989, MECH ENG DESIGN, P60
NR 13
TC 30
Z9 33
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FAL
PY 1998
VL 43
IS 3
BP 277
EP 281
DI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 112JN
UT WOS:000075490900008
PM 9730065
DA 2018-10-20
ER

PT J
AU Duffee, N
   Fallon, MT
AF Duffee, N
   Fallon, MT
TI Researcher training: A new frontier
SO LAB ANIMAL
LA English
DT Article
AB Few training materials exist to specifically teach biomedical research staff the animal care and use procedures that are relevant to their work. A project is currently in progress to produce computer-based and videotape training materials that address the training needs of this segment of the laboratory animal community. Plans are also underway to construct a self-assessment web server to administer content examinations covering these modules.
C1 Washington Univ, Sch Med, Div Comparat Med, St Louis, MO 63110 USA.
   Dept Vet Affairs, Atlanta VA Med Ctr, Vet Med Unit, Atlanta, GA 30033 USA.
   Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30033 USA.
RP Duffee, N (reprint author), Washington Univ, Sch Med, Div Comparat Med, St Louis, MO 63110 USA.
CR AZARMSA R, 1998, SYLLABUS, V11, P18
   BRENNAN M, 1998, DETROIT FREE PR 0315
   CARMAN J, 1997, CBT SOLUTIONS    NOV
   *CBT, 1997, CBT SOLUTIONS    MAR
   COTTON C, 1997, SYLLABUS, V11, P50
   DANIEL J, 1998, SYLLABUS, V11, P20
   DIAMOND D, 1998, WIRED            MAY
   *I LAB AN RES, 1996, GUID CAR US LAB AN
   JOHNS JF, 1998, P AM SOC TRAIN DEV S, P18
   JULIAN E, 1998, PR NEWSWIRE     0526
   KOPF D, 1998, AM NETWORKS     0701
   LELAND J, 1998, VIDEOGRAPHY      MAY, P126
   LHOTKA PH, 1994, J INTERACTIVE INSTRU, P23
   LIVINGSTON S, 1982, PASSING SCORES
   MCLAREN T, 1997, CBT SOLUTIONS   0707
   *RAYM KARS ASS, 1998, ADV SOLUTIONS TRAINI, V2, P8
   *RAYM KARS ASS, 1998, ADV SOLUTIONS TRAINI, V2, P6
   *RAYM KARS ASS, 1998, ADV SOLUTIONS TRAINI, V2, P1
   Russell WMS, 1992, PRINCIPLES HUMANE EX
   SCHWARZ K, 1996, ENTERPRISE REENG JUL
NR 20
TC 0
Z9 0
U1 0
U2 0
PU NATURE AMERICA INC
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 0093-7355
J9 LAB ANIMAL
JI Lab Anim.
PD SEP
PY 1998
VL 27
IS 8
BP 32
EP 36
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA 116FM
UT WOS:000075713700010
DA 2018-10-20
ER

PT J
AU Maillet, A
   Pavy-Le Traon, A
AF Maillet, A
   Pavy-Le Traon, A
TI MEDES clinical research facility as a tool to prepare ISSA space
   flights.
SO ACTA ASTRONAUTICA
LA English
DT Article
ID BODY NEGATIVE-PRESSURE
AB This new multi-disciplinary medical experimentation center provides the ideal scientific, medical and technical environment required for research programs and to prepare international space station Alpha (ISSA) missions, where space and healthcare industries can share their expertise. Different models are available to simulate space flight effects (bed-rest, confinement,...). This is of particular interest for research in Human psychology, physiology, physiopathology and ergonomics, validation of biomedical materials and procedures, testing of drugs, and other healthcare related products.
   This clinical research facility (CRF) provides valuable services in various fields of Human research requiring healthy volunteers. CRF is widely accessible to national and international, scientific, medical and industrial organisations. Furthermore, users have at their disposal the multi-disciplinary skills of MEDES staff and all MEDES partners on a single site. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 CHU Rangueil, Clin Spatiale Medes, F-31403 Toulouse 4, France.
RP Maillet, A (reprint author), CHU Rangueil, Clin Spatiale Medes, 1 Ave Jean Poulhes, F-31403 Toulouse 4, France.
EM Alain.Maillet@medes.cnes.fr
CR GUELL A, 1992, ACTA ASTRONAUT, V27, P103, DOI 10.1016/0094-5765(92)90185-L
   GUELL A, 1991, AVIAT SPACE ENVIR MD, V62, P331
   MAILLET A, 1995, 951513 SAE, P1
   Pavy-Le Traon A., 1995, Aviation Space and Environmental Medicine, V66, P982
   Pavy-Le Traon A, 1998, EUR J APPL PHYSIOL, V77, P50
   PavyLeTraon A, 1997, AVIAT SPACE ENVIR MD, V68, P829
   PAVYLETRAON A, 1994, ACTA ASTRONAUT, V32, P319
   PavyLeTraon A, 1997, CLIN PHYSIOL, V17, P41, DOI 10.1046/j.1365-2281.1997.01111.x
NR 8
TC 1
Z9 1
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0094-5765
J9 ACTA ASTRONAUT
JI Acta Astronaut.
PD AUG-SEP
PY 1998
VL 43
IS 3-6
BP 321
EP 328
DI 10.1016/S0094-5765(98)00164-7
PG 8
WC Engineering, Aerospace
SC Engineering
GA 121CE
UT WOS:000075993900021
PM 11541934
DA 2018-10-20
ER

PT J
AU Brown, D
   Fleurov, VB
   Carroll, P
   Lawson, CM
AF Brown, D
   Fleurov, VB
   Carroll, P
   Lawson, CM
TI Coherence-based imaging through turbid media by use of degenerate
   four-wave mixing in thin liquid-crystal films and photorefractives
SO APPLIED OPTICS
LA English
DT Article
ID TIME-RESOLVED HOLOGRAPHY; SCATTERING MEDIA; TRANSILLUMINATION;
   AMPLIFICATION
AB We describe a coherence-based imaging technique based on degenerate four-wave mixing in two materials. First, a 45 degrees-cut BaTiO3 crystal was used as a self-pumped phase conjugator to obtain depth-resolved images through a 4 mean-free-path (mfp) scattering media. In addition, an HITC dye-doped K15 liquid-crystal layer was used to provide single-shot image acquisition through a 2 mfp scattering media. This technique can be used to provide instantaneous (single-pulse), depth-resolved, two-dimensional images of the internal structure of scattering materials. Potential applications of this technique include subsurface imaging of biomedical tissue and nondestructive evaluation of composite materials. (C) 1998 Optical Society of America.
C1 Univ Alabama Birmingham, Dept Phys, Birmingham, AL 35294 USA.
RP Brown, D (reprint author), Univ Alabama Birmingham, Dept Phys, 310 Campbell Hall,1300 Univ Blvd, Birmingham, AL 35294 USA.
EM lawson@uab.edu
CR ABRAMSON N, 1996, LIGHT FLIGHT, pCH4
   ANDERSSONENGELS S, 1990, OPT LETT, V15, P1179, DOI 10.1364/OL.15.001179
   BARRY N, 1997, OSA P SERIES, V11, P42
   BOHREN CF, 1983, ABSORPTION SCATTERIN, pCH8
   CRONINGOLOMB M, 1985, APPL PHYS LETT, V47, P1131, DOI 10.1063/1.96352
   DANIELSON BL, 1991, APPL OPTICS, V30, P2975, DOI 10.1364/AO.30.002975
   DEVAUX F, 1995, OPT COMMUN, V118, P25, DOI 10.1016/0030-4018(95)00212-Q
   DUNCAN MD, 1991, OPT LETT, V16, P1868, DOI 10.1364/OL.16.001868
   Fleurov V, 1997, J NONLINEAR OPT PHYS, V6, P95, DOI 10.1142/S0218863597000083
   Fleurov VB, 1996, P SOC PHOTO-OPT INS, V2853, P126, DOI 10.1117/12.253467
   FORD JE, 1989, APPL OPTICS, V28, P4808, DOI 10.1364/AO.28.004808
   FUJIMOTO JG, 1986, OPT LETT, V11, P150, DOI 10.1364/OL.11.000150
   GAYEN SK, 1996, OPT PHOTONICS NEWS, V7, P17
   HEE MR, 1993, OPT LETT, V18, P1107, DOI 10.1364/OL.18.001107
   HYDE SCW, 1995, OPT LETT, V20, P1331, DOI 10.1364/OL.20.001331
   Hyde SCW, 1996, OPT COMMUN, V122, P111, DOI 10.1016/0030-4018(95)00520-X
   Jones R, 1998, OPT LETT, V23, P103, DOI 10.1364/OL.23.000103
   Jones R, 1996, APPL PHYS LETT, V69, P1837, DOI 10.1063/1.117450
   Khoo IC, 1998, OPT LETT, V23, P253, DOI 10.1364/OL.23.000253
   KHOO IC, 1995, OPT LETT, V20, P2137, DOI 10.1364/OL.20.002137
   Khoo IC, 1996, IEEE J QUANTUM ELECT, V32, P525, DOI 10.1109/3.485406
   KHOO IC, 1995, LIQUID CRYSTALS PHYS, pCH10
   LEITH E, 1992, J OPT SOC AM A, V9, P1148, DOI 10.1364/JOSAA.9.001148
   LI L, 1994, LIQ CRYST, V16, P703, DOI 10.1080/02678299408036542
   REBANE A, 1991, NATURE, V351, P378, DOI 10.1038/351378a0
   Simoni F, 1997, OPT LETT, V22, P549, DOI 10.1364/OL.22.000549
   Steele DD, 1998, OPT LETT, V23, P153, DOI 10.1364/OL.23.000153
   WANG L, 1991, SCIENCE, V253, P769, DOI 10.1126/science.253.5021.769
   WECHSLER BA, 1994, OPT LETT, V19, P536, DOI 10.1364/OL.19.000536
   YAN C, 1995, APPL OPTICS, V34, P2993, DOI 10.1364/AO.34.002993
   YARIV A, 1978, IEEE J QUANTUM ELECT, V14, P650, DOI 10.1109/JQE.1978.1069870
   Zhang JW, 1996, OPT COMMUN, V132, P574, DOI 10.1016/0030-4018(96)00087-9
NR 32
TC 2
Z9 2
U1 1
U2 4
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1559-128X
EI 2155-3165
J9 APPL OPTICS
JI Appl. Optics
PD AUG 1
PY 1998
VL 37
IS 22
BP 5306
EP 5312
DI 10.1364/AO.37.005306
PG 7
WC Optics
SC Optics
GA 106AJ
UT WOS:000075107300038
PM 18286011
DA 2018-10-20
ER

PT J
AU Riess, JG
   Krafft, MP
AF Riess, JG
   Krafft, MP
TI Fluorinated materials for in vivo oxygen transport (blood substitutes),
   diagnosis and drug delivery
SO BIOMATERIALS
LA English
DT Article; Proceedings Paper
CT European-Materials-Research-Society 1997 Meeting, Symposium G -
   Biomaterials - Perspectives for Research and Industry at the Century
   Change
CY JUN 16-20, 1997
CL STRASBOURG, FRANCE
SP Council Europe, Commiss European Communities, Banque Populair (France), Elsevier Science (Netherlands), Off Tourisme, Strasbourg
DE fluorocarbons; perfluorochemicals; fluorinated amphiphiles; fluorocarbon
   emulsions; gels; vesicles; liposomes; tubules; bilayers; oxygen
   delivery; drug delivery
ID CHAIN PERFLUOROALKYLATED AMPHIPHILES; PARTIAL LIQUID VENTILATION;
   FLUOROCARBON EMULSIONS; SURFACTANTS; LIPOSOMES; SYSTEMS;
   PERFLUOROCARBON; VESICLES; ASSEMBLIES; PERFLUBRON
AB Fluorocarbons are characterized by exceptional chemical and biological inertness, extreme hydrophobicity, lipophobicity, high gas-dissolving capacities, low surface tensions, high fluidity and spreading coefficients, high density, absence of protons, and magnetic susceptibilities comparable to that of water. These unique properties are the foundation for a range of biomedical applications. An injectable fluorocarbon-in-water emulsion is in advanced clinical trials as a temporary oxygen carrier (blood substitute) to prevent tissue hypoxia or ischemia in the surgical and critical care patient. A liquid fluorocarbon is in Phase II/III clinical trials for treatment of acute respiratory failure through liquid ventilation. Several fluorocarbon-based contrast agents for ultra-sound imaging are in various stages of clinical investigation. Multiple families of well-defined pure fluorinated surfactants have recently been synthesized. These surfactants have a modular structure which allows stepwise adjustment of their physicochemical characteristics. Their polar head group derives from polyols, sugars, aminoacids, amides, amine oxides, phosphocholine, phosphatidylcholine, etc. Fluorinated surfactants are significantly more surface-active than their hydrocarbon analogs and they display a greater tendency to self-assemble, thus forming well-ordered, stable supramolecular assemblies such as vesicles, tubules, fibers, ribbons, etc. Fluorinated amphiphiles also allowed the obtaining of a variety of stable reverse and multiple emulsions and gels. These systems are being investigated as drug delivery devices. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 Inst Charles Sadron, CNRS, F-67083 Strasbourg, France.
   Univ Calif San Diego, Med Ctr, MRI Inst, San Diego, CA 92103 USA.
RP Riess, JG (reprint author), Inst Charles Sadron, CNRS, 6 Rue Boussingault, F-67083 Strasbourg, France.
EM jg.reiss@hol.fr; kraft@europe.4-strasbg.fr
OI KRAFFT, Marie Pierre/0000-0002-3379-2783
CR [Anonymous], 1995, Tobramycin inhalation powder (TIP) administered once daily continuously versus TIP administered BID in 28 day on/28 day off cycles, Patent No. [5,437,272, 5437272]
   BLINDER KJ, 1991, BRIT J OPHTHALMOL, V75, P240, DOI 10.1136/bjo.75.4.240
   BRUNETON JN, 1989, RADIOLOGY, V170, P179, DOI 10.1148/radiology.170.1.2909093
   CARNEY MJ, 1995, Patent No. 5399634
   CEVE G, 1993, PHOSPHOLIPIDS HDB
   CHANG S, 1989, OPHTHALMOLOGY, V96, P785
   CHANG TMS, 1994, ART CELLS BLOOD SUBS, V22
   CHARPIOT B, 1991, Patent No. 4985550
   CHARPIOT B, 1992, Patent No. 0255443
   ELBERT R, 1984, J AM CHEM SOC, V106, P7687, DOI 10.1021/ja00337a005
   FAITHFULL NS, 1994, YB INTENSIVE CARE EM, P237
   FAITHFULL NS, 1992, Patent No. 9219232
   FREZARD F, 1994, BBA-BIOMEMBRANES, V1194, P61, DOI 10.1016/0005-2736(94)90203-8
   FUHRHOP JH, 1993, CHEM REV, V93, P1565, DOI 10.1021/cr00020a008
   GARELLI N, 1993, EUR J MED CHEM, V28, P235, DOI 10.1016/0223-5234(93)90139-6
   GIULIERI F, 1994, ANGEW CHEM INT EDIT, V33, P1514, DOI 10.1002/anie.199415141
   Gregoriadis G, 1993, LIPOSOME TECHNOLOGY
   GREINER J, 1993, ORGANOFLUORINE COMPO, P339
   IMAE T, 1992, J AM CHEM SOC, V114, P3414, DOI 10.1021/ja00035a038
   JAFFE CC, 1988, AM HEART J, V115, P1156, DOI 10.1016/0002-8703(88)90002-6
   Johnson K. A, 1992, Aerosol drug formulations, Patent No. [US Patent 5126123, 5126123, US Patent 5 126, 123]
   JONES MN, 1994, ADV DRUG DELIVER REV, V13, P215, DOI 10.1016/0169-409X(94)90013-2
   KEIPERT PE, 1996, OXYGEN TRANSPORT TIS, V17, P603
   Kissa E., 1993, FLUORINATED SURFACTA
   KRAFFT MP, 1994, ANGEW CHEM INT EDIT, V33, P1100, DOI 10.1002/anie.199411001
   KRAFFT MP, 1993, ANGEW CHEM INT EDIT, V32, P741, DOI 10.1002/anie.199307411
   KRAFFT MP, 1994, COLLOID SURFACE A, V84, P113, DOI 10.1016/0927-7757(93)02681-4
   KRAFFT MP, 1988, NOVEL COSMETIC DELIV
   KRAFFT MP, 1998, SUBMICRON EMULSION D, pR30
   KRAFFT MP, 1997, 15 INTL S FLUOR CHEM
   KRAFFT MP, 1995, Patent No. 2737135
   KRAFT M, 1998, IN PRESS BIOCHIMIE, V80
   KUNITAKE T, 1992, ANGEW CHEM INT EDIT, V31, P709, DOI 10.1002/anie.199207091
   Leach CL, 1996, NEW ENGL J MED, V335, P761, DOI 10.1056/NEJM199609123351101
   LEHN JM, 1993, MAKROMOL CHEM-M SYMP, V69, P1, DOI 10.1002/masy.19930690103
   LONG DC, 1989, BLOOD SUBSTITUTES, P441
   LONG DM, 1991, Patent No. 4987154
   MATHIS G, 1984, J AM CHEM SOC, V106, P6162, DOI 10.1021/ja00333a007
   MATTREY RF, 1994, INVEST RADIOL, V29, pS139, DOI 10.1097/00004424-199406001-00046
   MAURIZIS JC, 1994, XENOBIOTICA, V24, P535, DOI 10.3109/00498259409043256
   NIVET JB, 1992, EUR J MED CHEM, V27, P891, DOI 10.1016/0223-5234(92)90020-2
   Overbeck MC, 1996, CRIT CARE MED, V24, P1208, DOI 10.1097/00003246-199607000-00024
   PAVIA AA, 1996, Patent No. 5527962
   PAVIA AA, 1997, Patent No. 5650393
   PAVIA AA, 1993, Patent No. 2665705
   PAVIA AA, 1997, Patent No. 5637564
   PAVIA AA, 1994, P INT S CONTROL REL, V21, P87
   PAVIA AA, 1994, Patent No. 2694559
   PAVIA AA, 1995, Patent No. 5446023
   POLIDORI A, 1994, NEW J CHEM, V18, P839
   PRICE AK, 1974, Patent No. 3828085
   PRIVITERA N, 1995, BBA-LIPID LIPID MET, V1254, P1, DOI 10.1016/0005-2760(94)00153-P
   QUAY S, Patent No. 9305819
   RAVEY JC, 1990, PROG COLL POL SCI S, V82, P218
   REISS JG, 1994, ART CELLS BLOOD SUBS, V22
   Riess J. G., 1994, U.S. Patent, Patent No. [US5344930A, 5344930]
   RIESS JG, 1995, CHEM PHYS LIPIDS, V75, P1, DOI 10.1016/0009-3084(94)02402-Q
   RIESS JG, 1994, J DRUG TARGET, V2, P455, DOI 10.3109/10611869408996822
   RIESS JG, 1978, ANGEW CHEM INT EDIT, V17, P621, DOI 10.1002/anie.197806213
   RIESS JG, 1991, VOX SANG, V61, P225, DOI 10.1111/j.1423-0410.1991.tb00952.x
   RIESS JG, 1992, BIOMAT ARTIF CELL IM, V20, P839, DOI 10.3109/10731199209119726
   RIESS JG, 1991, ADV MATER, V3, P249, DOI 10.1002/adma.19910030507
   RIESS JG, 1994, ADV EXP MED BIOL, V345, P227
   RIESS JG, 1994, COLLOID SURFACE A, V84, P33, DOI 10.1016/0927-7757(93)02696-C
   Riess JG, 1995, J LIPOS RES, V5, P413, DOI 10.3109/08982109509010232
   Riess JG, 1997, ARTIF CELL BLOOD SUB, V25, P43, DOI 10.3109/10731199709118896
   RIESS JG, 1992, J DISPER SCI TECHNOL, V13, P349, DOI 10.1080/01932699208943319
   RIESS JG, 1995, NEW J CHEM, V19, P891
   RIESS JG, 1989, BLOOD SUBSTITUTES, P421
   RIESS JG, 1995, Patent No. 2677360
   RIESS JG, 1995, Patent No. 2710840
   RIESS JG, 1998, BLOOD SUBSTITUTES ME, P101
   RIESS JG, 1990, Patent No. 2620445
   RIESS JG, 1994, Patent No. 2679150
   RIESS JG, 1994, Patent No. 9407068
   RIESS JG, 1997, Patent No. 5679459
   RIESS JG, 1994, Patent No. 08214411
   RIESS JG, 1996, HDB NONMEDICAL APPL, V3, P98
   RIESS JG, 1992, Patent No. 07916216
   RIESS JG, 1996, P INT S BLOOD SUBST
   RIESS JG, 1993, Patent No. 478686
   RIESS JG, 1993, CARBOHYDRATES ORGANI, V2, P209
   ROSANO HL, 1973, Patent No. 3778381
   Sadtler VM, 1996, ANGEW CHEM INT EDIT, V35, P1976, DOI 10.1002/anie.199619761
   SANTAELLA C, 1993, FEBS LETT, V336, P481, DOI 10.1016/0014-5793(93)80860-W
   SCHNUR JM, 1993, SCIENCE, V262, P1669, DOI 10.1126/science.262.5140.1669
   SCHUBERT KV, 1994, COLLOID SURFACE A, V84, P97, DOI 10.1016/0927-7757(93)02704-I
   SCHUTT EA, 1997, Patent No. 5639443
   SCHUTT EG, 1996, ACAD RADIOL, V35, P188
   TREVINO L, 1994, COLLOID SURFACE A, V88, P223, DOI 10.1016/0927-7757(94)02789-7
   Wahr JA, 1996, ANESTH ANALG, V82, P103, DOI 10.1097/00000539-199601000-00018
   WEERS JG, 1994, ARTIF CELL BLOOD SUB, V22, P1175, DOI 10.3109/10731199409138813
   WEERS JG, 1993, J FLUORINE CHEM, V64, P73, DOI 10.1016/S0022-1139(00)80064-0
   WINSLOW RM, 1994, ART CELLS BLOOD SUBS, V22
   YOKOYAMA K, 1983, LIFE CHEM REPORTS, V2, P35
   ZUCK TF, 1994, CRIT REV CL LAB SCI, V31, P295, DOI 10.3109/10408369409084678
   1993, P 5 INT S BLOOD SUBS
NR 97
TC 140
Z9 140
U1 0
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 1998
VL 19
IS 16
BP 1529
EP 1539
DI 10.1016/S0142-9612(98)00071-4
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 128LU
UT WOS:000076408900021
PM 9794531
DA 2018-10-20
ER

PT J
AU Donachie, M
AF Donachie, M
TI Biomedical alloys
SO ADVANCED MATERIALS & PROCESSES
LA English
DT Article
AB The most widely selected structural materials for implants in the body include stainless steel, cobalt-chromium, and titanium alloys.
C1 Biomed Engn Alliance Connecticut & Rensselaer, Hartford, CT USA.
RP Donachie, M (reprint author), POB 11, Winchester, NH 03470 USA.
NR 0
TC 18
Z9 20
U1 0
U2 3
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA SUBSCRIPTIONS SPECIALIST CUSTOMER SERVICE, MATERIALS PARK, OH 44073-0002
   USA
SN 0026-0665
J9 ADV MATER PROCESS
JI Adv. Mater. Process.
PD JUL
PY 1998
VL 154
IS 1
BP 63
EP 65
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA ZY058
UT WOS:000074582400009
DA 2018-10-20
ER

PT J
AU Grande, KJ
   Cochran, RP
   Reinhall, PG
   Kunzelman, KS
AF Grande, KJ
   Cochran, RP
   Reinhall, PG
   Kunzelman, KS
TI Stress variations in the human aortic root and valve: The role of
   anatomic asymmetry
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE aortic valve; aortic root; anatomy; stress; strain; finite-element
   modeling; asymmetry
ID AGE-RELATED-CHANGES; NORMAL HUMAN HEARTS; MECHANICAL-PROPERTIES;
   LEAFLETS; MICROMECHANICS; CALCIFICATION; STRAIN; CANINE
AB The asymmetry of the aortic valve and aortic root may influence their biomechanics, yet was not considered in previous valve models. This study developed an anatomically representative model to evaluate the regional stresses of the valve within the root environment. A finite-element model was created from magnetic-resonance images of nine human valve-root specimens, carefully preserving their asymmetry. Regional thicknesses and anisotropic material properties were assigned to higher-order elastic shell elements representing the valve and root. After diastolic pressurization, peak principal stresses were evaluated for the right, left, and noncoronary leaflets and root walls. Valve stresses were highest in the noncoronary leaflet (538 kPa vs right 473 kPa vs left 410 kPa); peak stresses were located at the free margin and belly near the coaptation surfaces (averages 537 and 482 kPa for all leaflets, respectively). Right and noncoronary sinus stresses were 21% and 10% greater than the left sinus. In all sinuses, stresses near the annulus were higher than near the sinotubular junction. Stresses vary across the valve and root, likely due to their inherent morphologic asymmetry and stress sharing. These factors may influence bioprosthetic valve durability and the incidence of isolated sinus dilatation. (C) 1998 Biomedical Engineering Society.
C1 Univ Washington, Div Cardiothorac Surg, Seattle, WA 98195 USA.
   Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA.
RP Kunzelman, KS (reprint author), Univ Washington, Div Cardiothorac Surg, Box 356310, Seattle, WA 98195 USA.
RI Grande-Allen, Kathryn/P-4042-2014
OI Grande-Allen, Kathryn/0000-0003-1533-3767
CR HAMID MS, 1987, CIRC RES, V61, P687, DOI 10.1161/01.RES.61.5.687
   HAN HC, 1995, J BIOMECH, V28, P637, DOI 10.1016/0021-9290(94)00091-H
   HANSEN B, 1995, ANN THORAC SURG, V60, pS384, DOI 10.1016/0003-4975(95)00262-J
   KALATH S, 1986, ANN BIOMED ENG, V14, P513, DOI 10.1007/BF02484469
   KITZMAN DW, 1988, MAYO CLIN PROC, V63, P137, DOI 10.1016/S0025-6196(12)64946-5
   Kunzelman K S, 1993, J Heart Valve Dis, V2, P326
   KUNZELMAN KS, 1994, J THORAC CARDIOV SUR, V107, P162
   LO D, 1995, ANN THORAC SURG, V60, pS374, DOI 10.1016/0003-4975(95)00249-K
   Peskin Charles S., 1995, Symposia of the Society for Experimental Biology, V49, P265
   REID K, 1970, THORAX, V25, P79, DOI 10.1136/thx.25.1.79
   SABBAH HN, 1986, ANN THORAC SURG, V42, P93, DOI 10.1016/S0003-4975(10)61845-0
   SAHASAKUL Y, 1988, AM J CARDIOL, V62, P424, DOI 10.1016/0002-9149(88)90971-X
   THUBRIKAR MJ, 1986, ANN THORAC SURG, V42, P434, DOI 10.1016/S0003-4975(10)60554-1
   THUBRIKAR MJ, 1986, J THORAC CARDIOV SUR, V92, P29
   VESELY I, 1992, J CARDIAC SURG, V7, P85, DOI 10.1111/j.1540-8191.1992.tb00779.x
   VESELY I, 1992, J BIOMECH, V25, P101, DOI 10.1016/0021-9290(92)90249-Z
   VESELY I, 1989, J BIOMECH, V22, P655, DOI 10.1016/0021-9290(89)90016-X
NR 17
TC 147
Z9 148
U1 0
U2 11
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL-AUG
PY 1998
VL 26
IS 4
BP 534
EP 545
DI 10.1114/1.122
PG 12
WC Engineering, Biomedical
SC Engineering
GA ZV306
UT WOS:000074291400003
PM 9662146
DA 2018-10-20
ER

PT J
AU Takahashi, K
   Sato, E
   Sagae, M
   Tsukahara, Y
AF Takahashi, K
   Sato, E
   Sagae, M
   Tsukahara, Y
TI Semi-monochromatic plasma flash radiography and its application to
   biomedical imaging simulation
SO JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS SHORT NOTES &
   REVIEW PAPERS
LA English
DT Article
DE plasma flash X-ray generator; biomedical imaging simulation;
   semi-monochromatic radiography; filter of half value layer; Computed
   Radiography; molybdenum target; characteristic X-rays
ID X-RAY GENERATOR; TRIODE
AB A high-intensity plasma flash X-ray generator having a radiation tube with a rod-shaped target and its application to biomedical imaging simulations are described. Plasma flash radiography was performed with charged voltages of 40, 50, and 60 kV, and with filter of the same material as the target. In the present work, molybdenum target was employed. With filter of the half value layer in thickness for each target, nearly monochromatic radiography with only K-characteristic X-ray spectra could be achieved, Next, with real X-ray spectra data acquired from the present generator. we performed a computer aided biomedical imaging simulation using the program SPECTRA. It was developed as an assisting tool for our fundamental research on optimum control of Bash X-ray spectra. Qualitatively, the simulated biomedical phantom images agreed with those from the Computed Radiography.
C1 Iwate Med Univ, Sch Med, Med Comp Res Ctr, Morioka, Iwate 0200015, Japan.
   Iwate Med Univ, Sch Liberal Arts, Dept Phys, Morioka, Iwate 0200015, Japan.
   Tohoku Univ, Grad Sch Informat Sci, Dept Informat Biol, Aoba Ku, Sendai, Miyagi 9800812, Japan.
RP Takahashi, K (reprint author), Iwate Med Univ, Sch Med, Med Comp Res Ctr, 3-16-1 Honcho Dori, Morioka, Iwate 0200015, Japan.
CR DAVANLOO F, 1987, REV SCI INSTRUM, V59, P2103
   GERMER R, 1979, J PHYS E SCI INSTRUM, V12, P336, DOI 10.1088/0022-3735/12/5/001
   GERMER R, 1992, IONIZ RAD, V18, P3
   MATTSSON A, 1972, PHYS SCRIPTA, V5, P99, DOI 10.1088/0031-8949/5/1-2/017
   SATO E, 1991, REV SCI INSTRUM, V62, P2115, DOI 10.1063/1.1142376
   SATO E, 1986, REV SCI INSTRUM, V57, P1399, DOI 10.1063/1.1138609
   SATO E, 1990, REV SCI INSTRUM, V61, P2343, DOI 10.1063/1.1141958
   SATO E, 1992, IONIZ RAD, V18, P17
   SATO E, 1992, P SOC PHOTO-OPT INS, V1801, P628
   SATO E, 1990, P SOC PHOTO-OPT INS, V1358, P193
   TAKAHASHI K, 1994, JPN J APPL PHYS 1, V33, P4146, DOI 10.1143/JJAP.33.4146
   TAKAHASHI K, 1993, P SOC PHOTO-OPT INS, V2002, P141, DOI 10.1117/12.161360
   TAKAHASHI K, 1994, P SOC PHOTO-OPT INS, V2513, P736
   TAKAHASHI K, 1992, P SOC PHOTO-OPT INS, V1801, P658
NR 14
TC 20
Z9 20
U1 0
U2 0
PU JAPAN J APPLIED PHYSICS
PI MINATO-KU TOKYO
PA DAINI TOYOKAIJI BLDG 24-8 SHINBASHI 4-CHOME, MINATO-KU TOKYO, 105, JAPAN
SN 0021-4922
J9 JPN J APPL PHYS 1
JI Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Short Notes Rev. Pap.
PD JUL
PY 1998
VL 37
IS 7
BP 4222
EP 4227
DI 10.1143/JJAP.37.4222
PG 6
WC Physics, Applied
SC Physics
GA 110CV
UT WOS:000075363300070
DA 2018-10-20
ER

PT J
AU Jiang, T
   Ozin, GA
   Verma, A
   Bedard, RL
AF Jiang, T
   Ozin, GA
   Verma, A
   Bedard, RL
TI Adsorption and sensing properties of microporous layered tin sulfide
   materials
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID ARRAY
AB The adsorption and sensing behavior of three structurally well defined microporous layered tin sulfides R2Sn3S7, denoted DABCOH-SnS-1, ATEA-SnS-1 and TEA-SnS-1, have been explored. In the case of small non-polar guests a micropore-filling process is observed, whereas for certain larger guests an integration of micropore-filling and intercalation is found to occur. The former is controlled by the size while the latter depends on the adsorption properties of the guest molecules. It seems that guests with a propensity for hydrogen bonding are favored for intercalation. Electrical and optical responses with respect to adsorption of specific guests, such as NH3, H2S and alcohols, show high sensitivity, reversibility and fast reaction times that are comparable to some commercial semiconductor sensors. This makes microporous layered tin sulfides potentially interesting in environmental, industrial and biomedical monitoring.
C1 Univ Toronto, Dept Chem, Mat Chem Res Grp, Toronto, ON M5S 3H6, Canada.
   Universal Oil Prod, Des Plaines, IL 60017 USA.
RP Ozin, GA (reprint author), Univ Toronto, Dept Chem, Mat Chem Res Grp, Toronto, ON M5S 3H6, Canada.
CR ANDO M, 1994, J MATER CHEM, V4, P631, DOI 10.1039/jm9940400631
   AZAD HM, 1992, J ELECT SOC, P3690
   Balkus KJ, 1997, CHEM MATER, V9, P380, DOI 10.1021/cm960041n
   Bedard R. L., 1989, U.S. Patent, Patent No. 4880761
   BEDARD RL, 1997, Patent No. 5594263
   BEDARD RL, 1990, Patent No. 4933068
   BEIN T, 1989, J AM CHEM SOC, V111, P7640, DOI 10.1021/ja00201a069
   Bein T, 1996, CHEM MATER, V8, P1636, DOI 10.1021/cm960148a
   Bowes CL, 1998, J MATER CHEM, V8, P711, DOI 10.1039/a706278h
   BOWES CL, 1996, THESIS U TORONTO
   BRAKER W, 1980, MATHESON GAS DATA BO, P476
   Breck D. W., 1974, ZEOLITE MOL SIEVES S
   COLES GSV, 1994, CHEM ENG NEWS   1003, P40
   Dickinson TA, 1996, NATURE, V382, P697, DOI 10.1038/382697a0
   Gaskell DR, 1981, INTRO METALLURGICAL
   GREGG SJ, 1982, ADSORPTION SURFACE A
   HAMNETT A, 1987, SOLID STATE CHEM, pCH8
   Jiang T, 1998, ADV MATER, V10, P42, DOI 10.1002/(SICI)1521-4095(199801)10:1<42::AID-ADMA42>3.0.CO;2-W
   Jiang T, 1998, J MATER CHEM, V8, P733, DOI 10.1039/a706042d
   Jiang T, 1998, J MATER CHEM, V8, P721, DOI 10.1039/a706279f
   Jiang T, J MAT CHEM
   LIFSHITZ E, 1993, J PHYS CHEM-US, V97, P238, DOI 10.1021/j100103a041
   Lonergan MC, 1996, CHEM MATER, V8, P2298, DOI 10.1021/cm960036j
   Moy L, 1996, AM LAB, V28, P22
   NEWSAM JM, 1986, SCIENCE, V231, P1093, DOI 10.1126/science.231.4742.1093
   OHARE D, 1992, INORG MATER, pCH4
   OZIN GA, 1992, ADV MATER, V4, P612, DOI 10.1002/adma.19920041003
   PARISE JB, 1994, J CHEM SOC CHEM COMM, P527, DOI 10.1039/c39940000527
   ROBERTSON J, 1979, J PHYS C SOLID STATE, V12, P4735
   Shriver D. F., 1994, INORGANIC CHEM
   THOMAS JM, 1988, ANGEW CHEM INT EDIT, V27, P1673, DOI 10.1002/anie.198816731
   WEST AR, 1989, SOLID STATE CHEM ITS, pCH15
   Whittingham M. S., 1982, INTERCALATION CHEM
   YAN YG, 1992, J PHYS CHEM-US, V96, P9387, DOI 10.1021/j100202a060
   YAN YG, 1992, CHEM MATER, V4, P975, DOI 10.1021/cm00023a007
   YAN YG, 1991, MATER RES SOC SYMP P, V233, P175, DOI 10.1557/PROC-233-175
NR 36
TC 65
Z9 66
U1 0
U2 18
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON ROAD, CAMBRIDGE CB4 4WF,
   CAMBS, ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PD JUL
PY 1998
VL 8
IS 7
BP 1649
EP 1656
DI 10.1039/a801501e
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 100JB
UT WOS:000074812100025
DA 2018-10-20
ER

PT J
AU Chebotareva, G
AF Chebotareva, G
TI Achievement and prospects of pulsed photothermal radiometry techniques
   in diagnostics of laser-tissue interaction
SO LASER PHYSICS
LA English
DT Article
ID HYDRATION MEASUREMENT; ABSORPTION
AB This paper considers the achievements of Pulsed Photothermal Radiometry (PPTR) in the investigation of physical properties of biological materials and the diagnostics of the interaction of laser radiation with biological materials. We separate the main directions of modern studies and present the results of experimental and theoretical investigations. A detailed chronological list of references on the development of biomedical PPTR technologies is presented for the first time.
C1 PN Lebedev Phys Inst, Moscow Phys Soc, Moscow 117924, Russia.
RP Chebotareva, G (reprint author), PN Lebedev Phys Inst, Moscow Phys Soc, Leninsky Prospect 53, Moscow 117924, Russia.
EM chebotar@sci.lpi.ac.ru
CR Bindra R. M. S., 1995, International Journal of Cosmetic Science, V17, P105, DOI 10.1111/j.1467-2494.1995.tb00114.x
   BINDRA RMS, 1994, J PHYS IV, V4, P465, DOI 10.1051/jp4:19947108
   BINDRA RMS, 1995, P SOC PHOTO-OPT INS, V2395, P566, DOI 10.1117/12.209144
   BINDRA RMS, 1994, J PHYS IV, V4, P445, DOI 10.1051/jp4:19947103
   Carslaw H. S., 1959, CONDUCTION HEAT SOLI
   CHEBOTAREVA GP, 1995, P SOC PHOTO-OPT INS, V2394, P243, DOI 10.1117/12.207449
   CHEBOTAREVA GP, 1993, P SOC PHOTO-OPT INS, V2080, P117
   CHEBOTAREVA GP, 1987, 146 GEN PHYS I RUSS
   CHEBOTAREVA GP, 1996, OPT TECHN MED 2 M, P23
   CHEBOTAREVA GP, 1994, P SOC PHOTO-OPT INS, V2327, P188
   CHEBOTAREVA GP, 1994, ADV LASER DENTISTRY
   CHEBOTAREVA GP, 1996, INT C LAS PHYS 96 MO
   CHEBOTAREVA GP, 1996, P 10 NORD BALT C BIO
   CHEBOTAREVA GP, 1996, PW 96 P SPIE, V2681
   GAL D, 1987, IEEE J QUANTUM ELECT, V23, P1827, DOI 10.1109/JQE.1987.1073240
   Imhof R.E, 1994, PROGR PHOTOTHERMAL P, V2, P185
   IMHOF RE, 1984, J PHYS E SCI INSTRUM, V17, P521, DOI 10.1088/0022-3735/17/6/020
   JACQUES SL, 1993, APPL OPTICS, V32, P2439, DOI 10.1364/AO.32.002439
   KANSTAD S, 1979, PHYSICA SCRIPTA, V20, P659
   Kanstad S.O., 1978, POWDER TECHNOL, V22, P133
   LEUNG WP, 1984, OPT LETT, V9, P93, DOI 10.1364/OL.9.000093
   LEUNG WP, 1984, J APPL PHYS, V56, P153, DOI 10.1063/1.333739
   LONG FH, 1987, APPL PHYS LETT, V51, P2076, DOI 10.1063/1.98985
   LONG FH, 1987, IEEE J QUANTUM ELECT, V23, P1821, DOI 10.1109/JQE.1987.1073232
   Milner T E, 1996, J Biomed Opt, V1, P92, DOI 10.1117/12.227537
   MILNER TE, 1993, P SOC PHOTO-OPT INS, V2077, P228
   MILNER TE, 1992, P SOC PHOTO-OPT INS, V1876, P122
   NELSON JS, 1995, P SOC PHOTO-OPT INS, V2623, P20
   NIKITIN AP, 1994, P SOC PHOTO-OPT INS, V2323, P156
   SMITHIES J, 1996, P SPIE, V2975
   TAM AC, 1983, APPL PHYS LETT, V43, P333, DOI 10.1063/1.94346
   XIAO P, 1996, P SPIE, V2681
   ZHAROV VP, 1989, KVANTOVAYA ELEKTRON+, V16, P1941
   ZHAROV VP, 1988, P 13 INT C COH NONL, P412
NR 34
TC 3
Z9 3
U1 0
U2 1
PU INTERPERIODICA
PI BIRMINGHAM
PA PO BOX 1831, BIRMINGHAM, AL 35201-1831 USA
SN 1054-660X
J9 LASER PHYS
JI Laser Phys.
PD JUL-AUG
PY 1998
VL 8
IS 4
BP 941
EP 948
PG 8
WC Optics; Physics, Applied
SC Optics; Physics
GA 120PA
UT WOS:000075963700019
DA 2018-10-20
ER

PT J
AU Magnani, A
   Lamponi, S
   Rappuoli, R
   Barbucci, RB
AF Magnani, A
   Lamponi, S
   Rappuoli, R
   Barbucci, RB
TI Sulphated hyaluronic acids: a chemical and biological characterisation
SO POLYMER INTERNATIONAL
LA English
DT Article
DE hyaluronic acid; sulphated hyaluronic acid; physicochemical
   characterization; enzymatic digestion; anticoagulant activity;
   biocompatibility; platelet aggregation and activation; MW influence;
   copper(II) complexes; endothelial cell migration; angiogenesis; new
   blood-compatible materials
ID HEPARIN-LIKE MOLECULE; VONWILLEBRAND-FACTOR; AQUEOUS-SOLUTION; BEHAVIOR;
   POLYURETHANE; ANGIOGENESIS; CONFORMATION; PERFORMANCE; INHIBITION;
   POLYMERS
AB This review focuses on the possibility of modifying hyaluronic acid by the insertion of sulphate groups in order to obtain heparin-like compounds with controllable properties. In particular, the physicochemical and biological behaviour of sulphated hyaluronic acid (HyalS(x)) with various degrees of sulphation and different molecular weights has been particularly investigated.
   The mobilization of endothelial cells was investigated by the use of copper(II) complexes with HyalS(x) and the results were compared with those from the corresponding complex with heparin.
   New materials containing HyalS(x) are proposed for biomedical applications. (C) 1998 SCI.
C1 Univ Siena, CRISMA, I-53100 Siena, Italy.
   Univ Siena, Dept Chem & Biosyst Sci & Technol, I-53100 Siena, Italy.
RP Barbucci, RB (reprint author), Univ Siena, CRISMA, Via E Bastianini 12, I-53100 Siena, Italy.
RI Magnani, Agnese/E-7999-2017
OI Magnani, Agnese/0000-0002-6960-9418
CR Abatangelo G, 1997, BIOMATERIALS, V18, P1411, DOI 10.1016/S0142-9612(97)00089-6
   ALBANESE A, 1994, BIOMATERIALS, V15, P129, DOI 10.1016/0142-9612(94)90262-3
   ALESSANDRI G, 1983, CANCER RES, V43, P1790
   ANDRESSON LO, 1979, THROMB RES, V15, P531
   ARNOTT S, 1983, J MOL BIOL, V169, P861, DOI 10.1016/S0022-2836(83)80140-5
   ATKINS EDT, 1980, INT J BIOL MACROMOL, V2, P318, DOI 10.1016/0141-8130(80)90053-7
   ATKINS EDT, 1973, SCIENCE, V179, P562, DOI 10.1126/science.179.4073.562
   Balazs E. A., 1970, CHEM MOL BIOL INTERC
   BARBUCCI R, 1983, MACROMOLECULES, V16, P456, DOI 10.1021/ma00237a023
   BARBUCCI R, 1994, J MATER SCI-MATER M, V5, P830, DOI 10.1007/BF00213143
   BARBUCCI R, 1991, POLYMER, V32, P897, DOI 10.1016/0032-3861(91)90517-M
   BARBUCCI R, 1992, COORDIN CHEM REV, V120, P29, DOI 10.1016/0010-8545(92)80046-T
   BARBUCCI R, 1995, GAZZ CHIM ITAL, V125, P169
   Barbucci R, 1996, POLYM ADVAN TECHNOL, V7, P675, DOI 10.1002/(SICI)1099-1581(199608)7:8<675::AID-PAT609>3.3.CO;2-L
   BARBUCCI R, 1994, BIOMATERIALS, V15, P955, DOI 10.1016/0142-9612(94)90075-2
   Barbucci R, 1996, MACROMOL SYMP, V105, P1, DOI 10.1002/masy.19961050103
   BARBUCCI R, IN PRESS BIOMATERIAL
   BARBUCCI R, IN PRESS J THROMB TH
   Bellamy L.J., 1975, INFRARED SPECTRA COM, V1-2
   BOCIEK SM, 1980, EUR J BIOCHEM, V109, P447, DOI 10.1111/j.1432-1033.1980.tb04814.x
   BRAY B, 1989, BIOCHEM J, V262, P225, DOI 10.1042/bj2620225
   CALLEGARIO L, 1998, Patent No. 000037
   CASOLARO M, 1990, P 2 INT S POL EL AMS, P311
   CASU B, 1985, ADV CARBOHYD CHEM BI, V43, P51, DOI 10.1016/S0065-2318(08)60067-0
   Casu B., 1985, NUCL MAGNETIC RESONA, P1
   CATTERAL JB, 1996, CANCER J, V8, P221
   Chen GP, 1997, BIOCONJUGATE CHEM, V8, P730, DOI 10.1021/bc9700493
   CIMMINO S, 1993, J APPL POLYM SCI, V47, P631, DOI 10.1002/app.1993.070470407
   COMPER WD, 1978, PHYSIOL REV, V58, P255
   CUMMING AM, 1986, THROMB RES, V41, P593
   DHAON MK, 1982, J ORG CHEM, V47, P1962, DOI 10.1021/jo00349a028
   FAVIA P, IN PRESS PLASMA POLY
   FERRUTI P, 1984, ADV POLYM SCI, V58, P55
   GANS P, 1977, INORG CHIM ACTA, V25, P41
   GULLINO PM, 1978, JNCI-J NATL CANCER I, V61, P639
   ITO Y, 1986, J BIOMED MATER RES, V20, P1017, DOI 10.1002/jbm.820200715
   KENT KC, 1989, J VASC SURG, V9, P271, DOI 10.1067/mva.1989.vs0090271
   KNUDSON CB, 1993, FASEB J, V7, P1233
   LAURENT TC, 1992, FASEB J, V6, P2397
   Maaroufi RM, 1997, BIOMATERIALS, V18, P203, DOI 10.1016/S0142-9612(96)00125-1
   Magnani A, 1996, THROMB RES, V81, P383, DOI 10.1016/0049-3848(96)00009-6
   MAGNANI A, 1998, FRONTIERS BIOMEDICAL, P171
   MULVIHILL JN, 1993, ROLE OF PLATELETS IN BLOOD-BIOMATERIAL INTERACTIONS, P69
   OBRIEN JR, 1990, LANCET, V335, P711, DOI 10.1016/0140-6736(90)90815-M
   ORDINAS A, 1993, ROLE OF PLATELETS IN BLOOD-BIOMATERIAL INTERACTIONS, P3
   PETITT LD, 1993, STABILITY CONSTANTS
   SHEEHAN JK, 1977, J MOL BIOL, V117, P113, DOI 10.1016/0022-2836(77)90027-4
   SHEEHAN JK, 1975, J MOL BIOL, V91, P153, DOI 10.1016/0022-2836(75)90156-4
   SOBEL M, 1991, J CLIN INVEST, V87, P1787, DOI 10.1172/JCI115198
   SOBEL M, 1992, J BIOL CHEM, V267, P8857
   TUGGERI ZM, 1993, THROMB HEMOSTASIS, V70, P119
   WINTER WT, 1975, J MOL BIOL, V99, P219, DOI 10.1016/S0022-2836(75)80142-2
   WINTER WT, 1977, J MOL BIOL, V117, P761, DOI 10.1016/0022-2836(77)90068-7
NR 53
TC 28
Z9 28
U1 0
U2 6
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD JUL
PY 1998
VL 46
IS 3
BP 225
EP 240
DI 10.1002/(SICI)1097-0126(199807)46:3<225::AID-PI45>3.0.CO;2-I
PG 16
WC Polymer Science
SC Polymer Science
GA ZZ917
UT WOS:000074782400009
DA 2018-10-20
ER

PT J
AU Corneillie, S
   Lan, PN
   Schacht, E
   Davies, M
   Shard, A
   Green, R
   Denyer, S
   Wassall, M
   Whitfield, H
   Choong, S
AF Corneillie, S
   Lan, PN
   Schacht, E
   Davies, M
   Shard, A
   Green, R
   Denyer, S
   Wassall, M
   Whitfield, H
   Choong, S
TI Polyethylene glycol-containing polyurethanes for biomedical applications
SO POLYMER INTERNATIONAL
LA English
DT Article
DE polyurethane; polyethylene oxide; synthesis; characterization;
   biocompatibility
ID PROTEIN ADSORPTION; POLY(ETHER URETHANE); SURFACES; INFECTION; ADHESION
AB The synthesis and characterization of some new polyethylene glycol (PEG)-containing polyurethane elastomers are described. These materials were evaluated with respect to their potential use as biomaterials, more specifically for their use as blood- or urine-contacting materials. The stability of the materials towards heat, hydrolysis and gamma-irradiation was examined. Before biological testing, material purity was investigated using X-ray photoelectron spectroscopy (XPS). Atomic force microscopy (AFM) revealed smooth, continuous films with a stability towards imaging depending on the chain extender used. Surface plasmon resonance (SPR) experiments indicated a strongly reduced adsorption of human serum albumin (HSA) on these PEG-containing polymers. Atomic absorption spectroscopy (AAS) was used to quantify in vitro calcium deposition after incubation in urine. Bacterial adhesion was strongly reduced and cytocompatibility experiments using fibroblast cultures showed the importance of catalyst residues in the materials. (C) 1998 SCI.
C1 Univ Ghent, Inst Biomed Technol, IBITECH, Polymer Mat Res Grp, B-9000 Ghent, Belgium.
   Univ Nottingham, Dept Pharmaceut Sci, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
   Univ Brighton, Dept Pharm, Brighton BN2 4AT, E Sussex, England.
   UCL Hosp, Dept Chem Pathol, London, England.
RP Schacht, E (reprint author), Univ Ghent, Inst Biomed Technol, IBITECH, Polymer Mat Res Grp, Krijgslaan 281,S-4 Bis, B-9000 Ghent, Belgium.
RI Shard, Alexander/B-4530-2010
OI Green, Rebecca/0000-0001-6783-549X; Davies, Martyn/0000-0001-7695-0596;
   Shard, Alexander/0000-0002-8931-5740
CR AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   BAILEY J, 1976, POLYETHYLENEOXIDE
   Brash JL, 1996, CURR OPIN COLLOID IN, V1, P682, DOI 10.1016/S1359-0294(96)80109-9
   DAVIES J, 1994, NANOBIOLOGY, V3, P5
   Dewez JL, 1996, J BIOMED MATER RES, V30, P373
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GREEN RJ, UNPUB
   GRIFFITH DP, 1976, INVEST UROL, V13, P346
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HOFFMAN AS, 1987, ANN NY ACAD SCI, V516, P96, DOI 10.1111/j.1749-6632.1987.tb33033.x
   HOGT AH, 1987, ZENTRALBL BAKTERIO S, V16, P113
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   Joshi RR, 1996, J BIOMED MATER RES, V31, P201
   Lee JH, 1997, J BIOMED MATER RES, V34, P105, DOI 10.1002/(SICI)1097-4636(199701)34:1<105::AID-JBM14>3.0.CO;2-J
   LELAH MD, 1986, POLYURETHANES MED, P1
   LELAH MD, 1986, POLYURETHANES MED, P159
   LELAH MD, 1986, POLYURETHANES MED, P21
   MERRILL EA, 1984, ASAIO J, V6, P60
   PARK K, 1986, J BIOMED MATER RES, V20, P589, DOI 10.1002/jbm.820200506
   PIGLOWSKI J, 1994, BIOMATERIALS, V15, P909, DOI 10.1016/0142-9612(94)90116-3
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   VANWACHEM PB, 1994, J MATER SCI-MATER M, V5, P628, DOI 10.1007/BF00120344
   WESSLEN B, 1994, BIOMATERIALS, V15, P278, DOI 10.1016/0142-9612(94)90052-3
   WILLIAMS D, 1991, MED DEVICE TECHNOL, P44
   ZALIPSKY S, 1995, BIOCONJUGATE CHEM, V6, P150, DOI 10.1021/bc00032a002
NR 27
TC 19
Z9 20
U1 1
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0959-8103
EI 1097-0126
J9 POLYM INT
JI Polym. Int.
PD JUL
PY 1998
VL 46
IS 3
BP 251
EP 259
DI 10.1002/(SICI)1097-0126(199807)46:3<251::AID-PI6>3.0.CO;2-Z
PG 9
WC Polymer Science
SC Polymer Science
GA ZZ917
UT WOS:000074782400011
DA 2018-10-20
ER

PT J
AU Zylinski, J
   Allan, GL
   Jamieson, P
   Maher, KP
   Green, R
   Hislop, J
AF Zylinski, J
   Allan, GL
   Jamieson, P
   Maher, KP
   Green, R
   Hislop, J
TI The implementation of an integrated on-line health education system at
   RMIT
SO INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS
LA English
DT Article; Proceedings Paper
CT 6th International Conference on Health and Medical Informatics Education
CY AUG 14-16, 1997
CL NEWCASTLE, AUSTRALIA
SP Int Med Informat Assoc (IMIA), Asia Pacific Assoc Med Informat (APAMI), Health Informat Soc Australia (HISA)
DE Learning Centre; WWW; collaborative learning; on-line education; systems
   thinking
AB The Faculty of Biomedical and Health Sciences at RMIT has been developing an on-line health education system using a systems thinking approach, to create a learning environment whose basis is supported by Information Technology (IT). The centre-piece of this system is the Faculty Learning Centre, which has been created: both in space and layout, to promote collaborative learning between the students, so that the educator is physically assimilated with the student body. This facility is supplemented by the Faculty WWW server, which has been the main vehicle for course material dissemination to students. To ensure an effective on-line teaching environment, the position of an on-line facilitator has been created, whose responsibilities include both the continual evaluation of the system and the implementation of appropriate system changes. Aspects have included the production of a staff development training program and extensive user documentation. This paper discusses the systems thinking approach used to implement this integrated on-line system, and the establishment of explicit educational rationales in the use of IT to support learning strategies. Some examples of the on-line educational programs are also presented. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
C1 Royal Melbourne Inst Technol, Fac Biomed & Hlth Sci, Melbourne, Vic 3001, Australia.
   Royal Melbourne Inst Technol, Educ Program Improvement Grp, Melbourne, Vic 3001, Australia.
RP Zylinski, J (reprint author), Royal Melbourne Inst Technol, Fac Biomed & Hlth Sci, GPO Box 2476V, Melbourne, Vic 3001, Australia.
CR BERGE ZL, ROLE ONLINE INSTRUCT
   CLARKE RE, REV ED RES, V53, P445
   Harasim LM., 1989, MINDWEAVE COMMUNICAT, P50
   MARJANOVIC O, 1995, ELECT COLLABORATIVE, P306
   REEVES T, EVALUATING WHAT REAL
   SENGE PM, 1997, 5 DISC FIELDB STRAT, P59
   SENGE PM, 1994, 5 DISCIPLINE, P373
NR 7
TC 3
Z9 3
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 1386-5056
J9 INT J MED INFORM
JI Int. J. Med. Inform.
PD JUN
PY 1998
VL 50
IS 1-3
BP 261
EP 265
DI 10.1016/S1386-5056(98)00078-1
PG 5
WC Computer Science, Information Systems; Health Care Sciences & Services;
   Medical Informatics
SC Computer Science; Health Care Sciences & Services; Medical Informatics
GA 104HN
UT WOS:000075008800035
PM 9726521
DA 2018-10-20
ER

PT J
AU Soucek, B
   Abbattista, F
   Bellifemine, F
   Dalbis, D
AF Soucek, B
   Abbattista, F
   Bellifemine, F
   Dalbis, D
TI Quantum mind breeder
SO PERIODICUM BIOLOGORUM
LA English
DT Article
DE mind; quantum mind; brain; mind-brain link; evoked potential;
   neurodiagnoses; quantum mind theory; mind-computer interface; mind
   reading machines; primary oscillator; primary code; primary symbol;
   intelligent agent
AB Background and purpose: The Quantum Mind Breeder QM, is a fine grain computing structure that directly emulates some of the functions of animal and human mind. This work presents the creation of the QM structure that emulates the generation of Evoked Potentials, EP.
   Materials and methods: QM system combines 4 groups of techniques: Analytical. Machine Learning; Personal judgement; Graphic interaction. The response of QM, has been compared with the experimentally observed evoked potential: in human, after short auditory stimulation; in human, after the stimulation with the verbal stimuli; in mice and wistar rats after short electrical pulse stimulation.
   Results: QM structure is based on the Quantum Mind Theory with the focus on the Primary Oscillators PO. Each PO defines the basic timing and behavior of an agent, or oscillator; Flocks of agents operate in parallel and sequentially. The EP record represents the filtered self organized activity of a large set of these individual agents or oscillators.
   Conclusion: Using the Evolution and Association breeder EVA, the highly lit individual QM structure is found. QM responds to the received stimulus in the same way as a natural brain. QM generated Eps are presented, related to healthy and diabetic rodents. normal and sclerotic patients verbal stimulation and perception.
   Applications: Biomedical research; clinical diagnoses; drug testing; QM computing systems; man-machine interfaces; self-organized media; data compression in Internet browsing.
C1 IRIS, I-70125 Bari, Italy.
RP Soucek, B (reprint author), IRIS, Via Michele Troisi 18, I-70125 Bari, Italy.
CR ABBATTISTA F, 1998, PERIOD BIOL, V100, P2
   Bjegovic Milica, 1995, Periodicum Biologorum, V97, P295
   HO R, 1994, FRONTIER DECISION SU
   KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0
   PLANTAMURA VL, 1994, FRONTIER DECISION SU
   Soucek B., 1995, Informatica, V19, P591
   Soucek B., 1994, Informatica, V18, P109
   SOUCEK B, 1998, PERIOD BIOL, V100, P2
   SOUCEK B, 1997, QUANTUM MIND NETWORK
   Soucek Branko, 1996, Periodicum Biologorum, V98, P67
   Soucek Branko, 1997, Periodicum Biologorum, V99, P3
NR 11
TC 0
Z9 0
U1 0
U2 0
PU PERIODICUM BIOLOGORUM
PI ZAGREB
PA HRVATSKO PRIRODOSLOVNO DRUSTVO ILICA 16/111, 41000 ZAGREB, CROATIA
SN 0031-5362
J9 PERIOD BIOL
JI Period. Biol.
PD JUN
PY 1998
VL 100
IS 2
BP 211
EP 215
PG 5
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 159BV
UT WOS:000078152700012
DA 2018-10-20
ER

PT J
AU Martinez-Pardo, E
   Vera-Graziano, R
   Ramos-Duron, LE
AF Martinez-Pardo, E
   Vera-Graziano, R
   Ramos-Duron, LE
TI Biomedical applications of radiation technology in Mexico.
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 10th International Meeting on Radiation Processing (IMRP-10)
CY MAY 11-16, 1997
CL ANAHEIM, CALIFORNIA
DE polydimethylsiloxanes; radiation induced polymerization; amniotic
   membrane; radiosterilization
AB Mexican Health Institutions continuously require suitable medical grade prosthetic materials for reconstructive and plastic surgery. In particular, the requirements of polydimethylsiloxane? PDMS, for soft tissue replacements are rapidly growing. In addition to molecular weight, the properties of PDMS in biomedicine strongly depend on its purity, formulation and processing. High energy radiation has been used for both the synthesis of highly pure PDMS. free of catalyst and chemicals, and for sterilization of biomedical products. Here. are discussed the gamma radiation polymerization of different siloxane precursors to obtain PDMS with specific functionality and molecular structure as well as the radiation sterilization of amniotic membranes used as wound dressing.
C1 Inst Nacl Invest Nucl, Mexico City 11801, DF, Mexico.
   Natl Autonomous Univ Mexico, Inst Invest Mat, Mexico City 04510, DF, Mexico.
   HCSAE, Mexico City 14140, DF, Mexico.
RP Martinez-Pardo, E (reprint author), Inst Nacl Invest Nucl, Apdo Postal 18-1027,Col Escandon, Mexico City 11801, DF, Mexico.
OI Vera-Graziano, Ricardo/0000-0003-2870-9831
CR GARCIA MFD, 1995, THESIS FACULTAD MED
   GUTIERREZ PG, 1995, THESIS U AUTONOMA ED
   Kendrick T. C., 1989, CHEM ORGANIC SILICON, P1289
   LIZARRAGA RRL, 1996, EL USO MEMBRANAS AMN
   PARDO MEM, 1995, FQ9512 ININ
   PHILLIPS GO, 1994, RAD STERILISATION TI
   RIVERA F, 1997, IIM0197 IIMUNAM INF
   SPERLING LH, 1992, INTRO PHYSICAL POLYM
   VERAGRAZIANO R, 1995, J APPL POLYM SCI, V55, P1317, DOI 10.1002/app.1995.070550905
NR 9
TC 0
Z9 0
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD JUN
PY 1998
VL 52
IS 1-6
BP 301
EP 306
PG 6
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA ZX723
UT WOS:000074548000060
DA 2018-10-20
ER

PT J
AU Shellock, FG
   Kanal, E
AF Shellock, FG
   Kanal, E
TI Yasargil aneurysm clips: Evaluation of interactions with a 1.5-T MR
   system
SO RADIOLOGY
LA English
DT Article
DE aneurysm, cerebral; aneurysm, surgery; magnetic resonance (MR), safety;
   radiology and radiologists, iatrogenic injury
ID BIOMEDICAL IMPLANTS; METALLIC IMPLANTS; IMAGE ARTIFACTS; MAGNETIC-FIELD;
   DEVICES; MOTION; FORCES
AB PURPOSE: To evaluate the magnetic field interactions with Yasargil aneurysm clips exposed to a 1.5-T MR system.
   MATERIALS AND METHODS: Sixteen Yasargil aneurysm clips made with Phynox (10 clips returned to the manufacturer due to suspected magnetic field interactions and six clips obtained from the manufacturer in sterile packages) were tested for magnetic field interaction at 1.5 T by using techniques to assess magnetic field-induced translational (deflection angle test) and torque (changes in alignment or rotation) forces.
   RESULTS: None of the aneurysm clips demonstrated magnetic field interactions; that is, deflection angles were zero and there were no changes in alignment or evidence of rotational forces present.
   CONCLUSION: It is safe to perform MR procedures at 1.5 T or less in patients with Yasargil aneurysm clips made with nonferromagnetic material.
C1 Univ So Calif, Sch Med, Dept Radiol, Los Angeles, CA 90033 USA.
   Univ Pittsburgh, Sch Med, Dept Radiol, Pittsburgh, PA USA.
RP Shellock, FG (reprint author), 7511 McConnell Ave, Los Angeles, CA 90045 USA.
CR [Anonymous], 1994, ANN BOOK ASTM STAND
   APPLEBAUM EL, 1990, ANN OTO RHINOL LARYN, V99, P801, DOI 10.1177/000348949009901009
   APPLEBAUM EL, 1985, ARCH OTOLARYNGOL, V111, P820
   BARRAFATO D, 1984, CAN J SURG, V27, P509
   BECKER RL, 1988, AM J NEURORADIOL, V9, P885
   BROWN MA, 1987, MAGN RESON IMAGING, V5, P443, DOI 10.1016/0730-725X(87)90378-X
   Dujovny M, 1997, CRIT REV NEUROSURG, V7, P169, DOI 10.1007/s003290050021
   Dujovny M, 1997, RADIOLOGY, V202, P637, DOI 10.1148/radiology.202.3.9051008
   Dujovny M, 1996, NEUROL RES, V18, P483
   Dujovny M, 1997, SURG NEUROL, V47, P547, DOI 10.1016/S0090-3019(97)00030-X
   DUJOVNY M, 1985, NEUROSURGERY, V17, P543, DOI 10.1227/00006123-198510000-00002
   DUJOVNY M, 1985, CEREBRAL VASCULAR SU, P997
   Fleckenstein JL, 1997, RADIOLOGY, V202, P640, DOI 10.1148/radiology.202.3.9051009
   HOLTAS S, 1988, AM J NEURORADIOL, V9, P891
   JOHNSON GC, 1993, RADIOLOGY, V188, P287, DOI 10.1148/radiology.188.1.8511314
   KAGETSU NJ, 1991, RADIOLOGY, V179, P505, DOI 10.1148/radiology.179.2.2014301
   Kanal E, 1996, RADIOLOGY, V200, P576, DOI 10.1148/radiology.200.2.8685361
   Kanal E, 1997, RADIOLOGY, V202, P641, DOI 10.1148/radiology.202.3.641
   KANAL E, 1994, AM J NEURORADIOL, V15, P1394
   Kanal E, 1997, RADIOLOGY, V202, P638, DOI 10.1148/radiology.202.3.638
   KANAL E, 1993, RADIOLOGY, V187, P612, DOI 10.1148/radiology.187.3.8497603
   Kato Y, 1996, MINIM INVAS NEUROSUR, V39, P82, DOI 10.1055/s-2008-1052223
   KEAN DM, 1985, J NEUROL NEUROSUR PS, V48, P286, DOI 10.1136/jnnp.48.3.286
   KLUCZNIK RP, 1993, RADIOLOGY, V187, P855, DOI 10.1148/radiology.187.3.8497645
   Lawton MT, 1996, NEUROSURGERY, V38, P1170, DOI 10.1097/00006123-199606000-00026
   Lawton MT, 1996, NEUROSURGERY, V38, P1158, DOI 10.1097/00006123-199606000-00022
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   NOGUEIRA M, 1995, AJR, V163, P1472
   Ooka K, 1996, ACTA NEUROCHIR, V138, P1241, DOI 10.1007/BF01809754
   PIEPGRAS A, 1995, RADIOLOGE, V35, P830
   Planert J, 1996, MED PHYS, V23, P851, DOI 10.1118/1.597853
   ROMNER B, 1989, J NEUROSURG, V70, P426, DOI 10.3171/jns.1989.70.3.0426
   Shellock F. G., 1996, MAGNETIC RESONANCE B
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   Shellock FG, 1998, RADIOLOGY, V206, P838, DOI 10.1148/radiology.206.3.9494511
   Shellock FG, 1997, RADIOLOGY, V203, P568, DOI 10.1148/radiology.203.2.9114123
   SHELLOCK FG, 1993, RADIOLOGY, V189, P587, DOI 10.1148/radiology.189.2.8210394
   SHELLOCK FG, 1991, AM J NEURORADIOL, V12, P279
   SHELLOCK FG, 1990, RADIOLOGY P, V177, P271
   Shellock FG, 1997, POCKET GUIDE MR PROC
   *US FOOD DRUG ADM, 1993, MED DEVICES B, V11, P1
   Wichmann W, 1997, AM J NEURORADIOL, V18, P939
NR 42
TC 29
Z9 29
U1 0
U2 1
PU RADIOLOGICAL SOC NORTH AMER
PI EASTON
PA 20TH AND NORTHAMPTON STS, EASTON, PA 18042 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD JUN
PY 1998
VL 207
IS 3
BP 587
EP 591
DI 10.1148/radiology.207.3.9609877
PG 5
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA ZN534
UT WOS:000073655500006
PM 9609877
DA 2018-10-20
ER

PT J
AU Trigwell, S
   Hayden, RD
   Nelson, KF
   Selvaduray, G
AF Trigwell, S
   Hayden, RD
   Nelson, KF
   Selvaduray, G
TI Effects of surface treatment on the surface chemistry of NiTi alloy for
   biomedical applications
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE Ni; Ti; XPS; AES; AFM
AB Alloys of NiTi have gained popularity in biomedical applications; however, Ni is known to cause toxic and allergic reactions in the body, and concerns have been expressed regarding the material's biocompatibility. In this study, coupons of equiatomic NiTi were prepared by four methods, namely, mechanically polishing to a mirror finish, electropolishing, chemical etching and argon plasma etching, to produce various levels of roughness, and then examined by atomic force microscopy (AFM), XPS and AES. The resulting surface chemistry depended upon the method of preparation and was found not to be a function of surface roughness. The mechanically polished samples, although having the smoothest surface, showed the highest level of Ni in the near-surface region. The other preparation methods produced surfaces that were predominantly TiO2, with the electropolished surfaces showing the next smoothest surface and the least Ni in the near-surface region. The correlation between method of preparation, surface roughness and surface chemistry may be important in the preparation of NiTi for biomedical applications. (C) 1998 John Wiley & Sons, Ltd.
C1 VG Sci, Beverly, MA 01915 USA.
   Surface Sci Labs, Mt View, CA 94043 USA.
   San Jose State Univ, Dept Mat Engn, San Jose, CA 95192 USA.
RP Trigwell, S (reprint author), VG Sci, 100 Cummings Ctr,Suite 4075, Beverly, MA 01915 USA.
CR BUEHLER WJ, 1963, J APPL PHYS, V34, P1475, DOI 10.1063/1.1729603
   Castleman L. S., 1981, BIOCOMPATIBILITY CLI, P129
   CHAN CM, 1990, SURF INTERFACE ANAL, V15, P349, DOI 10.1002/sia.740150602
   GYUNTER VE, 1992, SHAPE MEMORY EFFECTS
   KUBASCHEWSKI O, 1958, METALLURGICAL THERMO, P341
   OSHIDA Y, 1991, CORROSION ENG, V40, P1009
   *PERK, 1979, HDB XRAY PHOT SPECTR
   RONDELLI G, 1990, CORROS SCI, V30, P805, DOI 10.1016/0010-938X(90)90004-O
   SHABALOVSKAYA SA, 1995, J VAC SCI TECHNOL A, V13, P2624, DOI 10.1116/1.579461
   SUNDERMANN FW, 1977, ANN CLIN LAB SCI, V7, P337
   WAYMAN CM, 1993, MRS B, V49
   WICKS CE, 1963, B BUR MINES, V605, P120
NR 12
TC 72
Z9 80
U1 1
U2 10
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD JUN
PY 1998
VL 26
IS 7
BP 483
EP 489
DI 10.1002/(SICI)1096-9918(199806)26:7<483::AID-SIA388>3.0.CO;2-5
PG 7
WC Chemistry, Physical
SC Chemistry
GA 100TU
UT WOS:000074832100001
DA 2018-10-20
ER

PT J
AU Dai, LM
   Lu, JP
   Matthews, B
   Mau, AWH
AF Dai, LM
   Lu, JP
   Matthews, B
   Mau, AWH
TI Doping of conducting polymers by sulfonated fullerene derivatives and
   dendrimers
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Letter
ID STARBURST CASCADE DENDRIMERS; NONLINEAR-OPTICAL-RESPONSE;
   CHARGE-TRANSFER; DOPED POLYANILINES; C-60; BUCKMINSTERFULLERENE;
   CHEMISTRY; MOLECULES; STATE; C-70
AB We report here the use of sulfonated fullerene derivatives and dendrimers with multiple -(O)SO3H groups as protonic acid dopants for polyaniline emeraldine base (PANI-EB). While doping of PANI-EB films with the sulfonated dendrimers gives conductivities up to ca. 10 S/cm, the hydrogensulfated fullerenol-doped materials show metallic characteristics with room-temperature conductivities as high as 100 S/cm-about 6 orders of magnitude higher than the typical value for fullerene-doped conducting polymers. This, coupled with the anticipated photoinduced charge-transfer effects characteristic of fullerene C-60 and potential biomedical applications of dendrimers, could make these highly conducting materials useful in many advanced optoelectronic and/or biomedical devices.
C1 CSIRO, S Clayton MDC, Vic 3169, Australia.
RP Dai, LM (reprint author), CSIRO, Private Bag 10, S Clayton MDC, Vic 3169, Australia.
CR Ahlskog M, 1997, SYNTHETIC MET, V84, P619, DOI 10.1016/S0379-6779(96)04077-5
   ANDERSON MR, 1991, SCIENCE, V252, P1412, DOI 10.1126/science.252.5011.1412
   BARTUS J, 1991, J MACROMOL SCI CHEM, VA28, P917, DOI 10.1080/00222339108054069
   BAUM R, 1997, C E NEWS        0106, P29
   BAUM RM, 1994, CHEM ENG NEWS   0613, P7
   BAUM RM, 1993, C E NEWS        1022, P8
   CAO Y, 1992, APPL PHYS LETT, V60, P2711, DOI 10.1063/1.106852
   CAO Y, 1992, SYNTHETIC MET, V48, P91, DOI 10.1016/0379-6779(92)90053-L
   CHEN SA, 1995, MACROMOLECULES, V28, P1239, DOI 10.1021/ma00108a062
   CHIANG LY, 1993, J AM CHEM SOC, V115, P5453, DOI 10.1021/ja00066a014
   CHIANG LY, 1992, J CHEM SOC CHEM COMM, P1791, DOI 10.1039/c39920001791
   CHIANG LY, 1994, J ORG CHEM, V59, P3960, DOI 10.1021/jo00093a030
   Dai LM, 1997, POLYMER, V38, P775, DOI 10.1016/S0032-3861(96)00573-3
   Dai LM, 1997, SYNTHETIC MET, V86, P2277, DOI 10.1016/S0379-6779(97)81124-1
   DAI LM, 1992, J PHYS CHEM-US, V96, P6469, DOI 10.1021/j100194a067
   Dai LM, 1998, J MATER CHEM, V8, P325, DOI 10.1039/a703764c
   DAI LM, 1995, J PHYS CHEM-US, V99, P17302, DOI 10.1021/j100048a002
   DIEDERICH F, 1994, CHEM SOC REV, V23, P243, DOI 10.1039/cs9942300243
   Diederich F, 1996, SCIENCE, V271, P317, DOI 10.1126/science.271.5247.317
   FLOM SR, 1992, PHYS REV B, V46, P15598, DOI 10.1103/PhysRevB.46.15598
   GILMOUR S, 1994, ADV MATER, V6, P494, DOI 10.1002/adma.19940060613
   GONG X, IN PRESS J POLYM S A
   Gong XY, 1998, J POLYM SCI POL CHEM, V36, P633, DOI 10.1002/(SICI)1099-0518(199803)36:4<633::AID-POLA12>3.0.CO;2-N
   GrunnetJepsen A, 1997, SCIENCE, V277, P549, DOI 10.1126/science.277.5325.549
   HADDON RC, 1992, ACCOUNTS CHEM RES, V25, P127, DOI 10.1021/ar00015a005
   Hammond G. S., 1992, ACS S SERIES, V481
   HEBARD AF, 1991, NATURE, V350, P600, DOI 10.1038/350600a0
   HEBARD AF, 1993, ANNU REV MATER SCI, V23, P159, DOI 10.1146/annurev.ms.23.080193.001111
   HENARI FZ, 1993, ADV MATER, V5, P930, DOI 10.1002/adma.19930051212
   Hirsch A, 1994, CHEM FULLERENES
   Holland ER, 1997, SYNTHETIC MET, V84, P777, DOI 10.1016/S0379-6779(96)04141-0
   Hopkins AR, 1996, MACROMOLECULES, V29, P7838, DOI 10.1021/ma9606519
   Imahori H, 1997, ADV MATER, V9, P537, DOI 10.1002/adma.19970090704
   ISSBERNER J, 1994, ANGEW CHEM INT EDIT, V33, P2413
   KAJZAR F, 1994, CHEM PHYS LETT, V217, P418, DOI 10.1016/0009-2614(93)E1396-X
   Kohlman RS, 1997, SYNTHETIC MET, V84, P709, DOI 10.1016/S0379-6779(96)04115-X
   KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0
   KROTO HW, 1991, CHEM REV, V91, P1213, DOI 10.1021/cr00006a005
   KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0
   KROTO HW, 1993, CHEM ENG NEWS   0104, P29
   KROTO HW, 1996, CHEM ENG NEWS   1014, P7
   LEE JY, 1995, SYNTHETIC MET, V74, P103, DOI 10.1016/0379-6779(95)03359-9
   Lee SB, 1996, SYNTHETIC MET, V77, P155, DOI 10.1016/0379-6779(96)80078-6
   LINDLE JR, 1993, PHYS REV B, V48, P9447, DOI 10.1103/PhysRevB.48.9447
   MACDIAMID AG, 1986, CONDUCTING POLYM SPE
   MACDIARMID AG, 1994, SYNTHETIC MET, V65, P103, DOI 10.1016/0379-6779(94)90171-6
   MacDiarmid AG, 1997, SYNTHETIC MET, V84, P27, DOI 10.1016/S0379-6779(97)80658-3
   MATTHEWS BR, 1995, Patent No. 34595
   MEKELBURGER HB, 1992, ANGEW CHEM INT EDIT, V31, P1571, DOI 10.1002/anie.199215711
   MORITA S, 1992, SOLID STATE COMMUN, V82, P249, DOI 10.1016/0038-1098(92)90636-N
   MORITA S, 1993, J PHYS-CONDENS MAT, V5, P2103
   NEWLOME GR, 1992, ALDRICHIM ACTA, V25, P31
   OHNISHI T, 1991, SYNTHETIC MET, V41, P309, DOI 10.1016/0379-6779(91)91069-M
   Prato M, 1997, J MATER CHEM, V7, P1097, DOI 10.1039/a700080d
   SARICIFTCI NS, 1995, PROG QUANT ELECTRON, V19, P131, DOI 10.1016/0079-6727(94)00012-N
   Schlebusch C, 1996, SYNTHETIC MET, V77, P151, DOI 10.1016/0379-6779(96)80077-4
   SERVICE RF, 1995, SCIENCE, V267, P458, DOI 10.1126/science.267.5197.458
   Sixou B, 1996, PHYS REV B, V53, P4509, DOI 10.1103/PhysRevB.53.4509
   SIXOU B, 1995, EUROPHYS LETT, V30, P157, DOI 10.1209/0295-5075/30/3/006
   Taylor R., 1995, CHEM FULLERENES
   TOMALIA DA, 1993, TOP CURR CHEM, V165, P193
   TOMALIA DA, 1994, ADV MATER, V6, P529, DOI 10.1002/adma.19940060703
   TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381
   TUTT LW, 1992, NATURE, V356, P225, DOI 10.1038/356225a0
   vanderSanden MCM, 1997, SYNTHETIC MET, V87, P137, DOI 10.1016/S0379-6779(96)04918-1
   vanderSanden MCM, 1997, SYNTHETIC MET, V87, P141, DOI 10.1016/S0379-6779(96)04919-3
   WANG Y, 1993, J AM CHEM SOC, V115, P3844, DOI 10.1021/ja00062a088
   WANG Y, 1992, NATURE, V356, P585, DOI 10.1038/356585a0
   WEI Y, 1993, J CHEM SOC CHEM COMM, P603, DOI 10.1039/c39930000603
   WUDL F, 1992, ACCOUNTS CHEM RES, V25, P157, DOI 10.1021/ar00015a009
   XIA YN, 1995, CHEM MATER, V7, P443, DOI 10.1021/cm00051a002
   YANG Y, 1994, APPL PHYS LETT, V64, P1245, DOI 10.1063/1.110853
   Yoshino K, 1996, SYNTHETIC MET, V78, P301, DOI 10.1016/0379-6779(96)80154-8
   YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789
   Zakhidov AA, 1996, SYNTHETIC MET, V77, P127, DOI 10.1016/0379-6779(96)80074-9
NR 75
TC 61
Z9 63
U1 0
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1089-5647
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD MAY 21
PY 1998
VL 102
IS 21
BP 4049
EP 4053
DI 10.1021/jp980410y
PG 5
WC Chemistry, Physical
SC Chemistry
GA ZR647
UT WOS:000073999700002
DA 2018-10-20
ER

PT J
AU Hu, ZB
   Chen, YY
   Wang, CJ
   Zheng, YD
   Li, Y
AF Hu, ZB
   Chen, YY
   Wang, CJ
   Zheng, YD
   Li, Y
TI Polymer gels with engineered environmentally responsive surface patterns
SO NATURE
LA English
DT Article
ID SPINODAL DECOMPOSITION; ISOPROPYLACRYLAMIDE
AB The polymer gels called hydrogels may be induced to swell or shrink (taking up or expelling water between the crosslinked polymer chains) in response to a variety of environmental stimuli, such as changes in pH or temperature, or the presence of a specific chemical substrate(1). These gels are being explored for several technological applications, particularly as biomedical materials(2). When hydrogels swell or shrink, complex patterns may be generated on their surfaces(3-7). Here we report the synthesis and controlled modulation of engineered surface patterns on environmentally responsive hydrogels. We modify the character of a gel surface by selectively depositing another material using a mask. For example, we use sputter deposition to imprint the surface of an N-isopropylacrylamide (NIPA) gel with a square array of gold thin films. The periodicity of the array can be continuously varied as a function of temperature or electric field (which alter the gel's volume), and so such an array might serve as an optical grating for sensor applications. We also deposit small areas of an NIPA gel on the surface of an acrylamide gel; the patterned area can be rendered invisible reversibly by switching the temperature above or below the lower critical solution temperature of the NIPA gel. We anticipate that these surface patterning techniques may find applications in display and sensor technology.
C1 Univ N Texas, Dept Phys, Denton, TX 76203 USA.
   Kimberly Clark Corp, Neenal, WI 54956 USA.
RP Hu, ZB (reprint author), Univ N Texas, Dept Phys, Denton, TX 76203 USA.
CR Bansil R, 1996, PHYSICA A, V231, P346, DOI 10.1016/0378-4371(96)00081-7
   GRABAR KC, 1995, ANAL CHEM, V67, P735, DOI 10.1021/ac00100a008
   Hirotsu S., 1985, Japanese Journal of Applied Physics, Supplement, P396
   HU ZB, 1995, SCIENCE, V269, P525, DOI 10.1126/science.269.5223.525
   Imisides MD, 1996, CHEMTECH, V26, P19
   LI CF, 1994, J CHEM PHYS, V100, P4645, DOI 10.1063/1.466247
   LI Y, 1995, MACROMOLECULES, V28, P4194, DOI 10.1021/ma00116a021
   LI Y, 1994, J CHEM PHYS, V100, P4637, DOI 10.1063/1.466296
   MISCH W, 1994, BIOSENS BIOELECTRON, V9, P737
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   SATOMATSUO E, 1992, NATURE, V358, P482
   Suzuki A, 1996, J CHEM PHYS, V104, P1751, DOI 10.1063/1.470760
   TANAKA T, 1987, NATURE, V325, P796, DOI 10.1038/325796a0
   TANAKA T, 1981, SCI AM, V244, P124, DOI 10.1038/scientificamerican0181-124
   WANG J, 1994, ANAL CHEM, V66, P1007, DOI 10.1021/ac00079a013
   Weissman JM, 1996, SCIENCE, V274, P959, DOI 10.1126/science.274.5289.959
NR 16
TC 239
Z9 247
U1 6
U2 95
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW
SN 0028-0836
J9 NATURE
JI Nature
PD MAY 14
PY 1998
VL 393
IS 6681
BP 149
EP 152
DI 10.1038/30205
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ZN200
UT WOS:000073619900042
DA 2018-10-20
ER

PT J
AU Kay, MW
   Roe, SC
   Stikeleather, LF
   Mahmoud, A
   Abrams, CF
AF Kay, MW
   Roe, SC
   Stikeleather, LF
   Mahmoud, A
   Abrams, CF
TI Axial vibration of threaded external fixation pins: Detection of pin
   loosening
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE vibration; external fixation pin; interface; loosening; nondestructive
ID IMPLANTS
AB The hypothesis of this study was that a nondestructive vibrational method could detect bone lysis at the external fixation pin-bone interface prior to current clinical and radiographic methods. In vitro models were used to simulate changes observed during pin loosening in vivo. Fixation pin axial natural frequency decreased with decreasing tensile modulus of the material into which it was implanted. In a live animal study the right tibia of 12 dogs was fractured and stabilized with a four-pin unilateral external fixation frame. The axial natural frequency of each pin was measured and radiographs were taken at 0, 2, 4, 6, 8, and 10 weeks after surgery. The natural frequency did not change when the first radiographic changes around the interface were observed. Pins were palpably stable at this point. As loosening progressed, the natural frequency did decrease. Frequency and quasistatic tests of dissected pin-bone structures revealed a good correlation between natural frequency and pin-bone interface stiffness. In addition, the measurement of natural frequency was more sensitive to bone structure changes at the pin-bone interface than low-load quasi-static stiffness. Therefore, a nondestructive vibration technique could be used instead of low-load quasistatic tests for assessing the pin-bone interface ex vivo. (C) 1998 Biomedical Engineering Society.
C1 N Carolina State Univ, Dept Biol & Agr Engn, Raleigh, NC 27695 USA.
   N Carolina State Univ, Coll Vet Med, Dept Compan Anim & Special Species Med, Raleigh, NC 27695 USA.
RP Kay, MW (reprint author), Washington Univ, Dept Mech Engn, Campus Box 1185,1 Brookings Dr, St Louis, MO 63130 USA.
EM mwkay@spud.me.wustl.edu
CR ANDERSON MA, 1993, VET SURG, V22, P482, DOI 10.1111/j.1532-950X.1993.tb00425.x
   ARO HT, 1993, HAND CLIN, V9, P531
   BEHRENS F, 1989, CLIN ORTHOP RELAT R, P15
   Clary E. M., 1995, Veterinary and Comparative Orthopaedics and Traumatology, V8, P1
   CORNELISSEN M, 1984, ORTHOPEDICS, V7, P623, DOI 10.3928/0147-7447-19840401-12
   DICKENS JR, 1994, ULTRASONICS, V32, P65, DOI 10.1016/0041-624X(94)90082-5
   Fung Y. C., 1993, BIOMECHANICS MECH PR, P251
   GEORGE TF, 1992, J APPL BIOMATER, V3, P29, DOI 10.1002/jab.770030106
   HARDY N, 1984, ORTHOPEDICS, V7, P616, DOI 10.3928/0147-7447-19840401-11
   HORN TS, 1993, BONE, V14, P259, DOI 10.1016/8756-3282(93)90149-5
   KANEKO T, 1987, J MATER SCI, V22, P3495, DOI 10.1007/BF01161448
   LI PLS, 1995, J BONE JOINT SURG BR, V77B, P640
   PETTINE KA, 1993, CLIN ORTHOP RELAT R, P18
   ROEDLICH CB, 1994, THESIS N CAROLINA ST
   RUBIN CT, 1987, J BIOMECH, V20, P723, DOI 10.1016/0021-9290(87)90038-8
   WEINHOLD PS, 1995, ORTHOP T, V20, P534
NR 16
TC 12
Z9 12
U1 0
U2 2
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAY-JUN
PY 1998
VL 26
IS 3
BP 361
EP 368
DI 10.1114/1.92
PG 8
WC Engineering, Biomedical
SC Engineering
GA ZH211
UT WOS:000073084100003
PM 9570219
DA 2018-10-20
ER

PT J
AU Morrison, B
   Meaney, DF
   McIntosh, TK
AF Morrison, B
   Meaney, DF
   McIntosh, TK
TI Mechanical characterization of an in vitro device designed to
   quantitatively injure living brain tissue
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE cell culture; mechanical stimulus; stretch injury; dynamic loading
ID STRETCH-INDUCED INJURY; DIFFUSE AXONAL INJURY; ENDOTHELIAL-CELLS;
   INVITRO; MODEL; TRAUMA; CULTURE; PRIMATE; NEURONS
AB Due to the nonlinear, viscoelastic material properties of brain, its mechanical response is dependent upon its total strain history. Therefore, a low strain rate, large strain will likely produce a tissue injury unique from that due to a high strain rate, moderate strain. Due to a lack of current understanding of specific in vivo physiological injury mechanisms, a priori assumptions cannot be made that a low strain rate injury induced by currently employed in vitro injury devices is representative of clinical, nonimpact, inertial head injuries. in the present study, an in vitro system capable of mechanically injuring cultured tissue at high strain rates was designed and characterized. The design of the device was based upon existing systems in which a clamped membrane, on which cells have been cultured, is deformed. However, the present system incorporates three substantial improvements: (1) noncontact measurement of the membrane deflection during injury; (2) precise and independent control over several characteristics of the deflection; and (3) generation of mechanical insults over a wide range of strains (up to 0.65) and strain rates (up to 15 s(-1)). Such a system will be valuable in the elucidation of the mechanisms of mechanical trauma and determination of injury tolerance criteria on a cellular level utilizing appropriate mechanical injury parameters. (C) 1998 Biomedical Engineering Society.
C1 Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
   Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.
RP McIntosh, TK (reprint author), 3320 Smith Walk,Hayden Hall,Room 120, Philadelphia, PA 19104 USA.
EM mcintosh@eniac.seas.upenn.edu
RI Morrison, Barclay/B-7132-2008
OI Morrison, Barclay/0000-0001-7676-0864
FU NINDS NIH HHS [NINDS-P01-NS08803, NINDS-R01-NS26818]
CR ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610
   ADKINS JE, 1952, PHILOS TR R SOC S-A, V244, P505, DOI 10.1098/rsta.1952.0013
   BALENTINE JD, 1988, LAB INVEST, V58, P93
   BRODLAND GW, 1988, INT J SOLIDS STRUCT, V24, P351
   Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395
   CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173
   ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325
   GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464
   GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357
   GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611
   GORFIEN SF, 1989, J CELL PHYSIOL, V139, P492, DOI 10.1002/jcp.1041390307
   HARTSMIT.LJ, 1967, INT J ENG SCI, V5, P1, DOI 10.1016/0020-7225(67)90051-1
   HARTSMITH LJ, 1966, Z ANGEW MATH PHYS, V17, P608, DOI 10.1007/BF01597242
   KIRKPATRICK JB, 1985, J NEUROPATH EXP NEUR, V44, P268, DOI 10.1097/00005072-198505000-00005
   KLINGBEIL WW, 1964, Z ANGEW MATH PHYS, V15, P608, DOI 10.1007/BF01595147
   KOENEMAN JR, 1966, THESIS CASE I TECHNO
   LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844
   LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355
   LUCAS JH, 1991, BRAIN RES, V543, P181, DOI 10.1016/0006-8993(91)90027-S
   LUCAS JH, 1992, J NEUROTRAUM, V9, P117, DOI 10.1089/neu.1992.9.117
   MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3
   MARGULIES SS, 1990, THESIS U PENNSYLVANI
   McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934
   Meaney D., 1991, THESIS U PENNSYLVANI
   Meaney D.F., 1990, INT C BIOM IMP LYON, P215
   MURPHY EJ, 1993, J NEUROTRAUM, V10, P431, DOI 10.1089/neu.1993.10.431
   OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299
   PAMIDI MR, 1978, J BIOMECH ENG-T ASME, V100, P44, DOI 10.1115/1.3426188
   Press WH, 1992, NUMERICAL RECIPES C, P609
   Rand CW, 1934, ARCH NEURO PSYCHIATR, V31, P527, DOI 10.1001/archneurpsyc.1934.02250030067004
   REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X
   REISSNER E, 1949, P S APPL MATH AM MAT, P213
   SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B
   SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588
   Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767
   THIBAULT LE, 1983, J BIOMECH ENG-T ASME, V105, P31, DOI 10.1115/1.3138381
   WANG HC, 1972, J BIOMECH, V5, P431, DOI 10.1016/0021-9290(72)90002-4
   WILLIAMS JL, 1992, J BIOMECH ENG-T ASME, V114, P377, DOI 10.1115/1.2891398
   WINSTON FK, 1989, J APPL PHYSIOL, V67, P397
NR 39
TC 49
Z9 50
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAY-JUN
PY 1998
VL 26
IS 3
BP 381
EP 390
DI 10.1114/1.61
PG 10
WC Engineering, Biomedical
SC Engineering
GA ZH211
UT WOS:000073084100005
PM 9570221
DA 2018-10-20
ER

PT J
AU Markou, CP
   Lutostansky, EM
   Ku, DN
   Hanson, SR
AF Markou, CP
   Lutostansky, EM
   Ku, DN
   Hanson, SR
TI A novel method for efficient drug delivery
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE local drug delivery; mass transfer; blood-materials interactions
ID INTIMAL HYPERPLASIA; THROMBOSIS; HEPARIN; INFUSION; ANGIOPLASTY;
   CATHETER; GRAFTS
AB Local delivery of anti-thrombotic and anti-restenotic drugs is desired to achieve high concentrations of agents which may be rapidly degraded systemically or which exhibit very short half-lives in vivo. In this article, the operating characteristics of a novel local drug delivery method are described and its effectiveness demonstrated computationally and experimentally. Computational models used a finite volume method to determine the concentration field. Optical dye density measurements of Evans blue in saline were performed in an in vitro steady flow system. Modeling parameters were kept in the physiologic range. Experimental how visualization studies demonstrated high concentrations of infusate near the vessel wall. Computational studies predicted high, clinically significant drug concentrations along the wall downstream of the infusion device. When the radial infusion velocity is large (infusion flow rate, Q(inf)>0.5% of the main flow rate, Q), the wall concentration of the infused drug remains high, e.g., levels are greater than 80% of the infusate concentration 5 cm downstream of the infusion device. At lower infusion rates (Q(inf)<0.001Q), the drug concentration at the wall decreases exponentially with axial distance to less than 25% of the infusate concentration 5 cm downstream of the infusion device, although therapeutic drug levels are still readily maintained. The near wall drug concentration is a function of flow conditions, infusion rate, and the drug diffusivity. Good agreement was obtained between computational and experimental concentration measurements. Flow simulation and experimental results indicate that the technique can effectively sustain high local drug concentrations for inhibition of thrombosis and vascular lesion formation. (C) 1998 Biomedical Engineering Society.
C1 Emory Univ, Sch Med, Dept Med, Div Hematol Oncol, Atlanta, GA 30322 USA.
   Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Hanson, SR (reprint author), Emory Univ, Sch Med, Dept Med, Div Hematol Oncol, 1639 Pierce Dr,Room 1129, Atlanta, GA 30322 USA.
FU NHLBI NIH HHS [HL 48667, HL 31469, HL 39437-07]
CR BIRD RB, 1960, TRANSPORT PHENOMENA, P42
   Chen CY, 1997, J SURG RES, V69, P300, DOI 10.1006/jsre.1997.5052
   Chen CY, 1996, CIRCULATION, V94, P1989, DOI 10.1161/01.CIR.94.8.1989
   CHEN CY, 1995, J VASC SURG, V22, P237, DOI 10.1016/S0741-5214(95)70136-2
   Chen CY, 1996, ANN VASC SURG, V10, P147, DOI 10.1007/BF02000759
   Chen CY, 1997, J SURG RES, V67, P26, DOI 10.1006/jsre.1996.4915
   CUMBERLAND DC, 1994, J AM COLL CARDIOL, V23, pA186
   CUSSLER EL, 1984, DIFFUSION
   Hanson S R, 1995, Adv Pharmacol, V34, P383
   HONG MK, 1993, CORONARY ARTERY DIS, V4, P1023, DOI 10.1097/00019501-199311000-00011
   LAMBERT CR, 1993, CORONARY ARTERY DIS, V4, P469, DOI 10.1097/00019501-199305000-00011
   LINCOFF AM, 1994, CIRCULATION, V90, P2070, DOI 10.1161/01.CIR.90.4.2070
   LOVICH MA, 1995, CIRC RES, V77, P1143, DOI 10.1161/01.RES.77.6.1143
   MA PP, 1994, INT J HEAT MASS TRAN, V37, P2723, DOI 10.1016/0017-9310(94)90389-1
   Markou CP, 1996, CIRCULATION, V94, P1563
   Mattar SG, 1996, J SURG RES, V60, P339, DOI 10.1006/jsre.1996.0054
   MULLER DWM, 1990, CORONARY ARTERY DIS, V1, P438, DOI 10.1097/00019501-199007000-00005
   NATHAN A, 1995, MOL INTERVENTIONS LO, P29
   PINCHAK AC, 1975, J APPL PHYSIOL, V41, P646
   ROGERS C, 1995, MOL INTERVENTIONS LO, P131
   Saavedra JE, 1996, J MED CHEM, V39, P4361, DOI 10.1021/jm960616s
   SCOTT NA, 1994, CIRCULATION, V90, P1951, DOI 10.1161/01.CIR.90.4.1951
   WOLINSKY H, 1990, J AM COLL CARDIOL, V15, P475, DOI 10.1016/S0735-1097(10)80079-8
NR 23
TC 20
Z9 20
U1 0
U2 3
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAY-JUN
PY 1998
VL 26
IS 3
BP 502
EP 511
DI 10.1114/1.97
PG 10
WC Engineering, Biomedical
SC Engineering
GA ZH211
UT WOS:000073084100016
PM 9570232
DA 2018-10-20
ER

PT J
AU Feit, MD
   Rubenchik, AM
   Kim, BM
   da Silva, LB
   Perry, MD
AF Feit, MD
   Rubenchik, AM
   Kim, BM
   da Silva, LB
   Perry, MD
TI Physical characterization of ultrashort laser pulse drilling of
   biological tissue
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Laser Ablation (COLA 97)
CY JUL 21-25, 1997
CL MONTEREY BAY, CA
DE ultrashort laser pulse ablation; biological tissue; physical
   characterization
ID DIELECTRICS; NANOSECOND; ABLATION
AB Ultrashort laser pulse ablation removes material with low-energy fluence required and minimal collateral damage. The ultimate usefulness of this technology for biomedical application depends, in part, on characterization of the physical conditions attained, and determination of the zone of shockwave and heat-affected material in particular tissues. Detailed numerical modeling of the relevant physics (deposition, plasma formation, shockwave generation and propagation, thermal conduction) are providing this information. A wide range of time scales is involved, ranging from picosecond for energy deposition and peak pressure and temperature, to nanosecond for development of shockwave, to microsecond for macroscopic thermophysical response. (C) 1998 Elsevier Science B.V.
C1 Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
RP Feit, MD (reprint author), Univ Calif Lawrence Livermore Natl Lab, POB 808,Mail Stop L-439, Livermore, CA 94550 USA.
EM feit1@llnl.gov; rubenchik1@llnl.gov; kim12@llnl.gov; dasilva1@llnl.gov;
   perry10@llnl.gov
RI Feit, Michael/A-4480-2009
CR Anisimov V. N., 1987, Soviet Journal of Quantum Electronics, V17, P101, DOI 10.1070/QE1987v017n01ABEH006449
   DASILVA LB, 1996, SPIE
   FEIT MD, 1996, SPIE
   Juhasz T, 1996, LASER SURG MED, V19, P23, DOI 10.1002/(SICI)1096-9101(1996)19:1<23::AID-LSM4>3.0.CO;2-S
   Kim BM, 1998, APPL SURF SCI, V127, P857, DOI 10.1016/S0169-4332(97)00756-3
   KRUGER RR, 1995, SPIE, V2393, P94
   London RA, 1996, P SOC PHOTO-OPT INS, V2672, P231, DOI 10.1117/12.238772
   LONDON RA, 1996, SPIE
   Neev J, 1996, IEEE J SEL TOP QUANT, V2, P790, DOI 10.1109/2944.577301
   Oraevsky AA, 1996, IEEE J SEL TOP QUANT, V2, P801, DOI 10.1109/2944.577302
   PERRY MD, 1997, UNPUB PHYS PLASMA
   Rubenchik AM, 1998, APPL SURF SCI, V127, P193, DOI 10.1016/S0169-4332(97)00631-4
   RUBENCHIK AM, 1996, SPIE
   STUART BC, 1995, PHYS REV LETT, V74, P2248, DOI 10.1103/PhysRevLett.74.2248
   Stuart BC, 1996, PHYS REV B, V53, P1749, DOI 10.1103/PhysRevB.53.1749
   Stuart BC, 1996, J OPT SOC AM B, V13, P459, DOI 10.1364/JOSAB.13.000459
NR 16
TC 38
Z9 39
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAY
PY 1998
VL 127
BP 869
EP 874
DI 10.1016/S0169-4332(97)00758-7
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA ZP584
UT WOS:000073768100146
DA 2018-10-20
ER

PT J
AU Krafft, MP
   Riess, JG
AF Krafft, MP
   Riess, JG
TI Highly fluorinated amphiphiles and colloidal systems, and their
   applications in the biomedical field. A contribution
SO BIOCHIMIE
LA English
DT Review
DE fluorocarbons; fluorinated amphiphiles; fluorocarbon emulsions; gels;
   vesicles; liposomes; tubules; bilayers; Langmuir monolayers; oxygen
   delivery; drug delivery; diagnosis
ID SEMIFLUORINATED NORMAL-ALKANES; MOUSE PERITONEAL-MACROPHAGES;
   FLUOROCARBON EMULSIONS; SUPRAMOLECULAR ASSEMBLIES; PERFLUOROCARBON
   EMULSIONS; SYNTHETIC GLYCOLIPIDS; CONTRAST AGENT; PERFLUOROALKYLATED
   AMPHIPHILES; TELOMERIC SURFACTANTS; NONIONIC SURFACTANTS
AB Fluorocarbons and fluorocarbon moieties are uniquely characterized by very strong intramolecular bonds and very weak intermolecular interactions. This results in a combination of exceptional thermal, chemical and biological inertness, low surface tension, high fluidity, excellent spreading characteristics, low solubility in water, and high gas dissolving capacities, which are the basis for innovative applications in the biomedical field. Perfluoroalkyl chains are larger and more rigid than their hydrogenated counterparts. They are considerably more hydrophobic, and are lipophobic as well. A large variety of well-defined, modular fluorinated surfactants whose polar head groups consist of polyols, sugars, sugar phosphates, amino acids, amine oxides, phosphocholine, phosphatidylcholine, etc, has recently been synthesized. Fluorinated surfactants are significantly more surface active than their hydrocarbon counterparts, both in terms of effectiveness and of efficiency. Despite this, they are less hemolytic and less detergent. Fluorosurfactants appear unable to extract membrane proteins. Fluorinated chains confer to surfactants a powerful driving force for collecting and organizing at interfaces. As compared to non-fluorinated analogs, fluorosurfactants have also a much stronger capacity to self-aggregate into discrete molecular assemblies when dispersed in water and other solvents. Even very short, single-chain fluorinated amphiphiles can form highly stable, heat-sterilizable vesicles, without the need for supplementary associative interactions. Sturdy microtubules were obtained from nonchiral, non-hydrogen bonding single-chain fluorosurfactants. Fluorinated amphiphiles can be used to engineer a variety of colloidal systems and manipulate their morphology, structure and properties. Stable fluorinated films, membranes and vesicles can also be prepared from combinations of standard surfactants with fluorocarbon/hydrocarbon diblock molecules. In bilayer membranes made from fluorinated amphiphiles the fluorinated tails segregate to form an internal teflon-like hydrophobic and lipophobic Nm that increases the stability of the membrane and reduces its permeability. This fluorinated film can also influence the behavior of fluorinated vesicles in a biological milieu. For example, it can affect the in vivo recognition and fate of particles, or the enzymatic hydrolysis of phospholipid components. Major applications of fluorocarbons currently in advanced clinical trials include injectable emulsions for delivering oxygen to tissues at risk of hypoxia; a neat fluorocarbon for treatment of acute respiratory failure by liquid ventilation; and gaseous fluorocarbon-stabilized microbubbles for use as contrast agents for ultrasound imaging. Fluorosurfactants also allow the preparation of a range of stable direct and reverse emulsions, microemulsions, multiple emulsions, and gels, some of which may include fluorocarbon and hydrocarbon and aqueous phases simultaneously. Highly fluorinated systems have potential for the delivery of drugs, prodrugs, vaccines, genes, markers, contrast agents and other materials ((C) Societe francaise de biochimie et biologie moleculaire / Elsevier, Paris).
C1 Inst Charles Sadron, UPR, CNRS 22, F-67083 Strasbourg, France.
   Univ Calif San Diego, Ctr Med, MRI Inst, San Diego, CA 92103 USA.
RP Krafft, MP (reprint author), Inst Charles Sadron, UPR, CNRS 22, 6 Rue Boussingault, F-67083 Strasbourg, France.
OI KRAFFT, Marie Pierre/0000-0002-3379-2783
CR Allouch M, 1996, J AM OIL CHEM SOC, V73, P87, DOI 10.1007/BF02523453
   ANTHONY P, 1995, BIOTECHNOL TECH, V9, P777, DOI 10.1007/BF00159400
   BARTON SW, 1992, J CHEM PHYS, V96, P1343, DOI 10.1063/1.462170
   BOULEY L, 1997, 8 INT S BLOOD SUBST
   BRACE NO, 1973, J ORG CHEM, V38, P3167, DOI 10.1021/jo00958a020
   CHANG S, 1994, FLUORINE MED 21 CENT, pCH24
   Chang T.M.S., 1994, ARTIF CELL BLOOD SUB, V22, P123, DOI [10.3109/10731199409117408, DOI 10.3109/10731199409117408]
   CONWAY MD, 1993, INT OPHTHALMOL, V17, P259, DOI 10.1007/BF01007793
   CORNELUS C, 1994, J COLLOID INTERF SCI, V163, P391, DOI 10.1006/jcis.1994.1118
   Der Mardirossian C, 1998, BIOCHIMIE, V80, P531, DOI 10.1016/S0300-9084(00)80018-8
   DERMARDIROSSIAN C, 1995, EUR J CLIN INVEST S2, V25, P141
   DITTRICH HC, 1998, P ULTR CONTR RES S S
   EILENBERG SS, 1994, ARTIF CELL BLOOD SUB, V22, P1477, DOI 10.3109/10731199409138853
   ELBERT R, 1984, J AM CHEM SOC, V106, P7687, DOI 10.1021/ja00337a005
   ELGHOUL M, 1992, J FLUORINE CHEM, V59, P107, DOI 10.1016/S0022-1139(00)80208-0
   ESCOULA B, 1985, SYNTHETIC COMMUN, V15, P35, DOI 10.1080/00397918508063775
   FAITHFULL NS, 1994, YB INTENSIVE CARE EM, P237
   FLAIM SF, 1994, ARTIF CELL BLOOD SUB, V22, P1043, DOI 10.3109/10731199409138801
   FREZARD F, 1994, BBA-BIOMEMBRANES, V1194, P61, DOI 10.1016/0005-2736(94)90203-8
   FREZARD F, 1994, BBA-BIOMEMBRANES, V1192, P61, DOI 10.1016/0005-2736(94)90143-0
   Fritz TA, 1997, INVEST RADIOL, V32, P735, DOI 10.1097/00004424-199712000-00003
   FUHRHOP JH, 1993, CHEM REV, V93, P1565, DOI 10.1021/cr00020a008
   GAINES GL, 1991, LANGMUIR, V7, P3054, DOI 10.1021/la00060a025
   GAO JM, 1995, J MED CHEM, V38, P2292, DOI 10.1021/jm00013a005
   GEYER RP, 1979, P 4 INT S PERFL BLOO, P3
   Giulieri F, 1996, THIN SOLID FILMS, V284, P195, DOI 10.1016/S0040-6090(95)08304-9
   Giulieri F, 1996, CHEM-EUR J, V2, P1335, DOI 10.1002/chem.19960021022
   GIULIERI F, 1996, ANGEW CHEM INT EDIT, V34, P1514
   GOLDMANN M, 1993, PHYSICA A, V200, P688, DOI 10.1016/0378-4371(93)90576-P
   GREC JJ, 1982, C NAT GEN BIOL MED T
   GREINER J, 1993, ORGANOFLUORINE COMPO, P339
   GUEDJ C, 1994, ART CELLS BLOOD SUBS, V22, P1485
   GUILLOD F, 1996, CHEM PHYS LIPIDS, V72, P153
   HAIDT S J, 1982, Investigative Ophthalmology and Visual Science, V22, P233
   Held P, 1997, TETRAHEDRON LETT, V38, P1937, DOI 10.1016/S0040-4039(97)00258-X
   HILDEBRANDT JH, 1970, REGULAR RELATED SOLU
   HIRSCHL RB, 1995, LANCET, V346, P1201, DOI 10.1016/S0140-6736(95)92903-7
   HOEFLING TA, 1991, J PHYS CHEM-US, V95, P7127, DOI 10.1021/j100172a006
   HOLMAN WL, 1995, J THORAC CARDIOV SUR, V110, P774, DOI 10.1016/S0022-5223(95)70111-7
   HOPKEN J, 1988, MAKROMOL CHEM, V189, P911
   Imae T, 1997, PROG COLL POL SCI S, V106, P52, DOI 10.1007/BF01189490
   IMAE T, 1992, J AM CHEM SOC, V114, P3414, DOI 10.1021/ja00035a038
   ISHIKAWA Y, 1994, J AM CHEM SOC, V116, P5579, DOI 10.1021/ja00092a008
   IVANITSKY GR, 1989, PERFTORAN BLOOD SUBS
   JACQUEMAIN D, 1990, J AM CHEM SOC, V112, P7724, DOI 10.1021/ja00177a037
   Johnson K. A, 1992, Aerosol drug formulations, Patent No. [US Patent 5126123, 5126123, US Patent 5 126, 123]
   Johnston KP, 1996, SCIENCE, V271, P624, DOI 10.1126/science.271.5249.624
   KAUFMAN RJ, 1995, BLOOD SUBSTITUTES, P53
   KEIPERT PE, 1996, OXYGEN TRANSPORT TIS, V17, P603
   KHALFOUN S, 1995, TRANSPL P, V27, P2210
   Kissa E., 1994, FLUORINATED SURFACTA
   Krafft M.P., 1996, CELL MOL BIOL LETT, V1, P459
   KRAFFT MP, 1994, ANGEW CHEM INT EDIT, V33, P1100, DOI 10.1002/anie.199411001
   Krafft MP, 1996, PHOSPHORUS SULFUR, V109, P281
   KRAFFT MP, 1993, ANGEW CHEM INT EDIT, V32, P741, DOI 10.1002/anie.199307411
   KRAFFT MP, 1994, COLLOID SURFACE A, V84, P113, DOI 10.1016/0927-7757(93)02681-4
   KRAFFT MP, 1997, 15 INT S FLUOR CHEM
   KRAFFT MP, IN PRESS NOVEL COSME
   KRAFFT MP, 1998, SUBMICRONIC EMULSION, V10, P235
   KRAFFT MP, 1997, Patent No. 9721425
   KRAFFT MP, 1998, AM CHEM SOC S FLUOR
   KRAFFT MP, 1995, Patent No. 2737135
   KRAFFT MP, 1997, INT S FLUOR CHEM VAN
   LASCHEWSKY A, 1985, THIN SOLID FILMS, V134, P153, DOI 10.1016/0040-6090(85)90127-0
   LATGE P, 1991, J DISPER SCI TECHNOL, V12, P227, DOI 10.1080/01932699108913127
   Leach CL, 1996, NEW ENGL J MED, V335, P761, DOI 10.1056/NEJM199609123351101
   LEBLANC M, 1985, PHARMACEUT RES, P245
   LI MY, 1994, NATURE, V367, P151, DOI 10.1038/367151a0
   LI R, S RESP DRUG DEL 5 PH, V5
   Lisby DA, 1997, HUM GENE THER, V8, P919, DOI 10.1089/hum.1997.8.8-919
   MathyHartert M, 1997, ARTIF CELL BLOOD SUB, V25, P563, DOI 10.3109/10731199709117453
   MATHYHARTERT M, 1997, 12 INT S ART CELLS B
   MATTREY RF, 1994, ARTIF CELL BLOOD SUB, V22, P295, DOI 10.3109/10731199409117422
   MATTREY RF, 1994, RADIOLOGY, V191, P841, DOI 10.1148/radiology.191.3.8184076
   MAURIZIS JC, 1994, XENOBIOTICA, V24, P535, DOI 10.3109/00498259409043256
   MAURIZIS JC, 1993, BIOORG MED CHEM LETT, V3, P161, DOI 10.1016/S0960-894X(01)80868-4
   MCCREATH GE, 1994, J CHROMATOGR A, V659, P275, DOI 10.1016/0021-9673(94)85069-0
   MEINERT H, 1993, BIOMAT ARTIF CELL IM, V21, P583, DOI 10.3109/10731199309117383
   Menchen S, 1996, ELECTROPHORESIS, V17, P1451, DOI 10.1002/elps.1150170909
   MUKERJEE P, 1976, J PHYS CHEM-US, V80, P1388, DOI 10.1021/j100553a028
   Mulvagh SL, 1996, J AM COLL CARDIOL, V27, P1519, DOI 10.1016/0735-1097(95)00619-2
   NAITO R, 1981, PERFLUOROCHEMICAL BL
   NAKASHIMA N, 1985, J AM CHEM SOC, V107, P509, DOI 10.1021/ja00288a043
   OLSON CT, 1983, TOXICOL APPL PHARM, V70, P362, DOI 10.1016/0041-008X(83)90154-0
   PAPAHADJOPOULOS D, 1975, BIOCHIM BIOPHYS ACTA, V394, P483, DOI 10.1016/0005-2736(75)90299-0
   PAVIA AA, 1994, P INT S CONTROL REL, V21, P87
   PERMADI H, 1992, BIOCHEM PHARMACOL, V44, P1183, DOI 10.1016/0006-2952(92)90383-T
   PFANNEMULLER B, 1985, CHEM PHYS LIPIDS, V37, P227, DOI 10.1016/0009-3084(85)90011-8
   Polidori A, 1996, MACROMOL RAPID COMM, V17, P229, DOI 10.1002/marc.1996.030170405
   POLIDORI A, 1995, CHEM PHYS LIPIDS, V77, P225, DOI 10.1016/0009-3084(95)02475-X
   PRIVITERA N, 1995, INT J PHARM, V120, P73, DOI 10.1016/0378-5173(94)00411-W
   PRIVITERA N, 1994, INT J PHARM, V104, P41, DOI 10.1016/0378-5173(94)90335-2
   PRIVITERA N, 1994, BIOCHIM BIOPHYS ACTA, V1254, P1
   RABOLT JF, 1984, MACROMOLECULES, V17, P2786, DOI 10.1021/ma00142a060
   RAVEY JC, 1990, PROG COLL POL SCI S, V82, P218
   RAVEY JC, 1994, COLLOID SURFACE A, V91, P237, DOI 10.1016/0927-7757(94)02942-3
   Ravily V, 1997, BBA-BIOMEMBRANES, V1324, P1, DOI 10.1016/S0005-2736(96)00203-9
   Reed T. M., 1964, FLUORINE CHEM, V5, P133
   REMY JS, 1994, BIOCONJUGATE CHEM, V5, P647, DOI 10.1021/bc00030a021
   RicoLattes I, 1997, COLLOID SURFACE A, V123, P37, DOI 10.1016/S0927-7757(96)03778-8
   RICOLATTES I, 1995, SCI CHIM         FEV, P15
   Riess J.G., 1996, HDB NONMEDICAL APPL, P97
   RIESS JG, 1994, J DRUG TARGET, V2, P455, DOI 10.3109/10611869408996822
   RIESS JG, 1991, VOX SANG, V61, P225, DOI 10.1111/j.1423-0410.1991.tb00952.x
   RIESS JG, 1991, ADV MATER, V3, P249, DOI 10.1002/adma.19910030507
   Riess JG, 1996, CURR OPIN COLLOID IN, V1, P652, DOI 10.1016/S1359-0294(96)80104-X
   RIESS JG, 1994, ADV EXP MED BIOL, V345, P227
   RIESS JG, 1994, COLLOID SURFACE A, V84, P33, DOI 10.1016/0927-7757(93)02696-C
   Riess JG, 1995, J LIPOS RES, V5, P413, DOI 10.3109/08982109509010232
   Riess JG, 1997, ARTIF CELL BLOOD SUB, V25, P43, DOI 10.3109/10731199709118896
   RIESS JG, 1992, J DISPER SCI TECHNOL, V13, P349, DOI 10.1080/01932699208943319
   RIESS JG, 1995, NEW J CHEM, V19, P891
   RIESS JG, 1989, BLOOD SUBSTITUTES, P421
   RIESS JG, 1994, ARTIF CELL BLOOD SUB, V22, P945
   RIESS JG, 1998, BLOOD SUBSTITUTES ME, P101
   RIESS JG, 1994, Patent No. 9407068
   RIESS JG, 1998, BLOOD SUBSTITUTES
   RIESS JG, 1998, IN PRESS BIOMATERIAL, V31
   RIESS JG, 1993, CARBOHYDRATES ORGANI, V2, P209
   Ringler P, 1997, CHEM-EUR J, V3, P620, DOI 10.1002/chem.19970030419
   RINGSDORF H, 1988, ANGEW CHEM INT EDIT, V27, P113, DOI 10.1002/anie.198801131
   Ristori S, 1997, J PHYS CHEM B, V101, P4155, DOI 10.1021/jp963745t
   RUSSELL TP, 1986, MACROMOLECULES, V19, P1135, DOI 10.1021/ma00158a035
   Sadtler VM, 1996, ANGEW CHEM INT EDIT, V35, P1976, DOI 10.1002/anie.199619761
   Sadtler VM, 1998, NEW J CHEM, V22, P609, DOI 10.1039/a708757h
   SADTLER VM, 1997, P S CONTR REL SOC ST
   SANCHEZ V, 1994, ARTIF CELL BLOOD SUB, V22, P1421, DOI 10.3109/10731199409138846
   SANTAELLA C, 1991, ANGEW CHEM INT EDIT, V30, P567, DOI 10.1002/anie.199105671
   SANTAELLA C, 1994, BBA-BIOMEMBRANES, V1190, P25, DOI 10.1016/0005-2736(94)90031-0
   SANTAELLA C, 1993, FEBS LETT, V336, P481, DOI 10.1016/0014-5793(93)80860-W
   SCHNUR JM, 1993, SCIENCE, V262, P1669, DOI 10.1126/science.262.5140.1669
   SCHUTT EG, 1996, ACAD RADIOL, V35, P188
   SCIALLI AR, 1990, IN VITRO CELL DEV B, V26, P507, DOI 10.1007/BF02624093
   SELVE C, 1983, TETRAHEDRON, V39, P1313, DOI 10.1016/S0040-4020(01)91897-6
   Smart B. E., 1994, ORGANOFLUORINE CHEM, P57
   Szlavik Z, 1997, TETRAHEDRON LETT, V38, P8757, DOI 10.1016/S0040-4039(97)10344-6
   SZONYI S, 1993, NEW J CHEM, V17, P425
   TANFORD C, 1973, HYDROPHOBIC EFFECT F, P19
   TREMPER KK, 1995, CRITICAL CARE STATE, P143
   TREVINO L, 1994, COLLOID SURFACE A, V88, P223, DOI 10.1016/0927-7757(94)02789-7
   TREVINO L, 1994, P INT S CONTROL REL, V21, P606
   Trevino Leo, 1994, Journal of Liposome Research, V4, P1017, DOI 10.3109/08982109409018619
   TURBERG MP, 1988, J AM CHEM SOC, V110, P7797, DOI 10.1021/ja00231a034
   TWIEG RJ, 1985, MACROMOLECULES, V18, P1361, DOI 10.1021/ma00148a060
   UBEL FA, 1980, AM IND HYG ASSOC J, V41, P584, DOI 10.1080/15298668091425310
   VANDENHEUVEL JP, 1991, J BIOCHEM TOXICOL, V6, P83
   Voiglio EJ, 1996, J SURG RES, V63, P439, DOI 10.1006/jsre.1996.0289
   WEERS JG, 1994, ARTIF CELL BLOOD SUB, V22, P1175, DOI 10.3109/10731199409138813
   Worah Dilip M., 1997, Drugs of the Future, V22, P378
   YAGANAWA H, 1989, J AM CHEM SOC, V111, P4567
   YONETANI M, 1984, FLUORINE COMPOUNDS M, P58
   ZARIF L, 1994, COLLOID SURFACE A, V84, P107, DOI 10.1016/0927-7757(93)02680-D
   ZARIF L, 1994, PHARMACEUT RES, V11, P122, DOI 10.1023/A:1018914215345
   ZUCK TF, 1994, CRIT REV CL LAB SCI, V31, P295, DOI 10.3109/10408369409084678
NR 154
TC 246
Z9 247
U1 4
U2 94
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0300-9084
J9 BIOCHIMIE
JI Biochimie
PD MAY-JUN
PY 1998
VL 80
IS 5-6
BP 489
EP 514
DI 10.1016/S0300-9084(00)80016-4
PG 26
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 120PH
UT WOS:000075964400015
PM 9782389
DA 2018-10-20
ER

PT J
AU Folch, A
   Toner, M
AF Folch, A
   Toner, M
TI Cellular micropatterns on biocompatible materials
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; MATERIALS SCIENCE; ADHESION; SURFACES; CELLS;
   GROWTH; HEPATOCYTES; FIBRONECTIN; CULTURE; CAPILLARIES
AB We present a method to produce micropatterns of cells on tissue culture substrates. A network of deep elastomeric microchannels defining the desired pattern is sealed onto the surface of interest, and a protein template is created by injecting sub-milliliter quantities of protein solution into the microchannels. Protein adsorbs only on the areas that were exposed to the microflow. After the channels are flushed and the elastomer is removed, cells attach only on the protein template. Micropatterns of collagen or fibronectin were used to selectively adhere cells on various biomedical polymers and on heterogeneous or microtextured substrates. Since the bare substrate areas remain apt for seeding other, more adhesive cell types such as fibroblasts, we were able to create micropatterned co-cultures. Our method allows for inexpensive patterning of a rich assortment of biomolecules, cells, and surfaces under physiological conditions.
C1 Harvard Univ, Sch Med, Boston, MA 02114 USA.
   Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02114 USA.
   Massachusetts Gen Hosp, Surg Serv, Boston, MA 02114 USA.
   Shriners Burns Hosp, Boston, MA 02114 USA.
RP Toner, M (reprint author), Shriners Res Ctr Bldg,1400 W,1 Kendall Sq, Cambridge, MA 02139 USA.
CR ALLARA DL, 1995, BIOSENS BIOELECTRON, V10, P771, DOI 10.1016/0956-5663(95)99215-7
   Bhatia SN, 1998, BIOTECHNOL PROGR, V14, P378, DOI 10.1021/bp980036j
   Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M
   CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0
   CARTER SB, 1967, EXP CELL RES, V48, P189, DOI 10.1016/0014-4827(67)90298-4
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CLARK P, 1992, J CELL SCI, V103, P287
   CURTIS ASG, 1986, J CELL SCI, V86, P9
   Delamarche E, 1997, SCIENCE, V276, P779, DOI 10.1126/science.276.5313.779
   DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007
   Garcia AJ, 1997, TISSUE ENG, V3, P197, DOI 10.1089/ten.1997.3.197
   Harrison RG, 1914, J EXP ZOOL, V17, P521, DOI 10.1002/jez.1400170403
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Ito Y, 1997, LANGMUIR, V13, P2756, DOI 10.1021/la961087y
   Kim E, 1996, J AM CHEM SOC, V118, P5722, DOI 10.1021/ja960151v
   KIM E, 1995, NATURE, V376, P581, DOI 10.1038/376581a0
   KLEBE RJ, 1988, EXP CELL RES, V179, P362, DOI 10.1016/0014-4827(88)90275-3
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030
   KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628
   LAIBINIS PE, 1991, J AM CHEM SOC, V113, P7152, DOI 10.1021/ja00019a011
   LEE JS, 1993, BIOMATERIALS, V14, P958, DOI 10.1016/0142-9612(93)90139-S
   LEE JS, 1994, APPL PHYS LETT, V65, P400, DOI 10.1063/1.112314
   LEE SH, 1988, J COLLOID INTERF SCI, V125, P365, DOI 10.1016/0021-9797(88)90001-X
   LETOURNEAU PC, 1975, DEV BIOL, V44, P92, DOI 10.1016/0012-1606(75)90379-6
   MATSUSHIMA N, 1990, MOKUZAI GAKKAISHI, V36, P559
   MOONEY D, 1992, J CELL PHYSIOL, V151, P497, DOI 10.1002/jcp.1041510308
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   ODENTHAL M, 1992, EXP CELL RES, V203, P289, DOI 10.1016/0014-4827(92)90001-O
   Potter M. C., 1982, FLUID MECH
   RATNER BD, 1995, BIOSENS BIOELECTRON, V10, P797, DOI 10.1016/0956-5663(95)99218-A
   RISTIC L, 1994, SENSOR TECHNOLOGY DE
   ROHR S, 1991, CIRC RES, V68, P114, DOI 10.1161/01.RES.68.1.114
   ROVASIO RA, 1983, J CELL BIOL, V96, P462, DOI 10.1083/jcb.96.2.462
   ROVENSKY YA, 1971, EXP CELL RES, V65, P193, DOI 10.1016/S0014-4827(71)80066-6
   Schaffner AE, 1995, J NEUROSCI METH, V62, P111, DOI 10.1016/0165-0270(95)00063-1
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   STENGER DA, 1992, J AM CHEM SOC, V114, P8435, DOI 10.1021/ja00048a013
   TAKEZAWA T, 1990, BIO-TECHNOL, V8, P854, DOI 10.1038/nbt0990-854
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   TRUSKEY GA, 1990, J BIOMED MATER RES, V24, P1333, DOI 10.1002/jbm.820241006
   ULMAN A, 1991, INTRO ULTRATHIN ORGA
   WEISS P, 1959, REV MOD PHYS, V31, P11, DOI 10.1103/RevModPhys.31.11
NR 43
TC 203
Z9 208
U1 2
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 8756-7938
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD MAY-JUN
PY 1998
VL 14
IS 3
BP 388
EP 392
DI 10.1021/bp980037b
PG 5
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA ZT713
UT WOS:000074117200006
PM 9622519
DA 2018-10-20
ER

PT J
AU Weir, L
AF Weir, L
TI Cultural intertexts and scientific rationality: the case of pregnancy
   ultrasound
SO ECONOMY AND SOCIETY
LA English
DT Article
DE Canguilhem; intertextuality; domain; ultrasound; foetus
AB The text begins a line of dialogue between feminist and epistemological work in the life sciences using a case study of the concepts 'foetus' and 'baby' in diagnostic ultrasound and parental discourse. The case material illustrates the multiple, coexisting registers of clinical discourse and the significance of cultural intertexts, the insertion within biomedical discourse of concepts from other cultural domains. It follows that biomedical rationality lacks the autonomy that Canguilhem argued it has; rather than giving itself its own laws, biomedical rationality is heteronomous, receiving and using cultural intertexts from many and varied domains.
C1 Univ York, York, ON, Canada.
RP Weir, L (reprint author), Univ York, York, ON, Canada.
CR BACHELARD G, 1977, MAT RATIONNEL, P207
   BLUME SS, 1992, INSIGHT IND
   Canguilhem G., 1988, IDEOLOGY RATIONALITY
   DUDEN B, 1991, WOMAN BENEATH SKIN
   Duden B., 1993, DISEMBODYING WOMEN P
   DUNSTAN GR, 1990, HUMAN EMBRYO ARISTOT
   FRANKLIN S, 1995, ANNU REV ANTHROPOL, V24, P163, DOI 10.1146/annurev.an.24.100195.001115
   Haraway D, 1989, PRIMATE VISIONS
   Haraway D, 1997, MODEST WITNESS 2 MIL
   JORDANOVA L, 1989, SEXUAL VISIONS IMAGE
   Kristeva Julia, 1986, KRISTEVA READER, P34
   MARTIN E, 1987, WOMAN BODY CULTURAL
   Merchant C., 1980, DEATH NATURE WOMEN E
   Morgan Lynn, 1989, ABORTION RIGHTS FETA, P89
   NEWMAN K, 1996, FOETAL POSITIONS
   Noble David F, 1992, WORLD WOMEN CHRISTIA
   Rabinow Paul, 1994, VITAL RATIONALIST SE, P11
   Ross A, 1996, SCI WARS
   Russett Cynthia Eagle, 1989, SEXUAL SCI
   SCHIEBINGER L., 1989, MIND HAS NO SEX WOME
   STRATHERN M, 1993, TECHNOLOGIES PROCREA, P132
   WEIR L, 1998, IN PRESS VITAL SIGNS
   WEIR L., 1996, ECON SOC, V25, P372
NR 23
TC 6
Z9 6
U1 0
U2 4
PU ROUTLEDGE
PI LONDON
PA 11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND
SN 0308-5147
J9 ECON SOC
JI Econ. Soc.
PD MAY
PY 1998
VL 27
IS 2-3
BP 249
EP 258
DI 10.1080/03085149800000018
PG 10
WC Economics; Sociology
SC Business & Economics; Sociology
GA ZN788
UT WOS:000073682700011
DA 2018-10-20
ER

PT J
AU Prigent-Richard, S
   Cansell, M
   Vassy, J
   Viron, A
   Puvion, E
   Jozefonvicz, J
   Letourneur, D
AF Prigent-Richard, S
   Cansell, M
   Vassy, J
   Viron, A
   Puvion, E
   Jozefonvicz, J
   Letourneur, D
TI Fluorescent and radiolabeling of polysaccharides: Binding and
   internalization experiments on vascular cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE polysaccharides; DTAF labeling; radiolabeling; smooth-muscle cells;
   confocal analysis
ID SMOOTH-MUSCLE CELLS; DEXTRAN DERIVATIVES; ANTICOAGULANT ACTIVITY;
   HEPARIN-BINDING; FUCOIDAN; GLYCOSAMINOGLYCANS; PROLIFERATION;
   INHIBITION; METABOLISM; PROTEINS
AB Glycosaminoglycans (GAGs) such as heparan sulfates are complex carbohydrate polymers. These structural components of the extracellular matrix are essential for the adhesion, migration, and regulation of cellular growth. To understand the physiological role of GAGs and GAG analogues, a practical approach consists of labeling and detecting them in cell extracts, or analyzing binding domains and their distributions into the cells. We propose a convenient and reliable method for preparing and labeling amino-enriched polysaccharides with the fluorescent derivative 5-[(4,6-dichlorotriazine-2-yl)amino]-fluorescein (DTAF). Radioiodination is then performed on the DTAF moiety. This method was applied to polysaccharides known to inhibit vascular smooth-muscle cell (SMC) proliferation such as functionalized dextrans derived from poly(alpha 1-6 glucose) and fucan, poly(l-fucose 4-sulfate) extracted from brown seaweed. Using autoradiography and confocal microscopy, we observed the fixation and internalization of labeled antiproliferative products in SMCs from rat aorta. These probes can be useful for the understanding of polysaccharide-cell interactions. In addition, the method presented here can be applied to various synthetic or natural biomedical materials. (C) 1998 John Wiley & Sons, Inc.
C1 Univ Paris 13, IFREMER URM2, LRM, CNRS,URA 502, F-93430 Villetaneuse, France.
   Univ Paris 07, Hop St Louis, AIPC, F-75475 Paris 10, France.
   IRC, CNRS, UPR 9044, F-94801 Villejuif, France.
RP Letourneur, D (reprint author), Univ Paris 13, IFREMER URM2, LRM, CNRS,URA 502, Av JB Clement, F-93430 Villetaneuse, France.
RI Didier, letourneur/H-5268-2012
OI Didier, letourneur/0000-0003-2197-9468
CR AVRAMOGLOU T, 1991, J BIOMAT SCI-POLYM E, V3, P149, DOI 10.1163/156856291X00241
   Barzu T, 1996, J CELL PHYSIOL, V167, P8, DOI 10.1002/(SICI)1097-4652(199604)167:1<8::AID-JCP2>3.0.CO;2-T
   BIWAS C, 1988, J CELL PHYSL, V136, P147
   BLAKESLEE D, 1976, J IMMUNOL METHODS, V13, P305, DOI 10.1016/0022-1759(76)90078-8
   BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529
   BOURDILLON MC, 1976, BIOMED EXPRESS, V25, P263
   BUSCH SJ, 1992, J CELL BIOL, V116, P31, DOI 10.1083/jcb.116.1.31
   CASTELLOT JJ, 1985, J CELL PHYSIOL, V124, P13, DOI 10.1002/jcp.1041240104
   COLLIEC S, 1991, THROMB RES, V64, P143, DOI 10.1016/0049-3848(91)90114-C
   DAWES J, 1979, THROMB RES, V14, P845, DOI 10.1016/0049-3848(79)90004-5
   FAGER G, 1992, IN VITRO CELL DEV-AN, V28A, P176
   FISCHER AM, 1985, BIOMATERIALS, V6, P198, DOI 10.1016/0142-9612(85)90010-9
   GAUFFEL V, 1989, BIOMATERIALS, V10, P363
   GLABE CG, 1983, ANAL BIOCHEM, V130, P287, DOI 10.1016/0003-2697(83)90590-0
   HATTON MWC, 1980, ANAL BIOCHEM, V106, P417, DOI 10.1016/0003-2697(80)90542-4
   HIGSHIYAMA S, 1993, J CELL BIOL, V122, P933
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   LARSEN AK, 1986, P NATL ACAD SCI USA, V83, P2964, DOI 10.1073/pnas.83.9.2964
   LETOURNEUR D, 1993, J BIOMAT SCI-POLYM E, V4, P431, DOI 10.1163/156856293X00681
   LETOURNEUR D, 1995, J CELL PHYSIOL, V165, P676, DOI 10.1002/jcp.1041650327
   Logeart D, 1996, J BIOMED MATER RES, V30, P501, DOI 10.1002/(SICI)1097-4636(199604)30:4<501::AID-JBM8>3.3.CO;2-F
   Logeart D, 1997, EUR J CELL BIOL, V74, P376
   LOGEART D, 1995, THESIS PARIS N U FRA
   MALSCH R, 1994, ANAL BIOCHEM, V217, P255, DOI 10.1006/abio.1994.1117
   MAUZAC M, 1984, BIOMATERIALS, V5, P301, DOI 10.1016/0142-9612(84)90078-4
   MAUZAC M, 1985, BIOMATERIALS, V6, P61, DOI 10.1016/0142-9612(85)90040-7
   MCCAFFREY TA, 1992, BIOCHEM BIOPH RES CO, V184, P773, DOI 10.1016/0006-291X(92)90657-7
   MEHLMAN T, 1990, ANAL BIOCHEM, V188, P159, DOI 10.1016/0003-2697(90)90545-K
   NEYTS J, 1995, BIOCHEM PHARMACOL, V50, P743, DOI 10.1016/0006-2952(95)00193-4
   ROGERS A, 1979, TECHNIQUES ATORADIOG
   SANANTONIO JD, 1994, ANAL BIOCHEM, V217, P255
   SMITH JW, 1987, ANAL BIOCHEM, V160, P105, DOI 10.1016/0003-2697(87)90619-1
   Stearns NA, 1997, ANAL BIOCHEM, V247, P348, DOI 10.1006/abio.1997.2096
   THOMAS H, 1995, BIOMATERIALS, V16, P1163, DOI 10.1016/0142-9612(95)93581-W
   VANDOORNE F, 1991, MAKROMOL CHEM, V192, P673
   VAUDAUX P, 1992, J BIOMAT SCI-POLYM E, V4, P89
   VISCHER P, 1991, EUR J CELL BIOL, V56, P407
NR 37
TC 25
Z9 25
U1 1
U2 19
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 1998
VL 40
IS 2
BP 275
EP 281
DI 10.1002/(SICI)1097-4636(199805)40:2<275::AID-JBM12>3.0.CO;2-P
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ZD360
UT WOS:000072677400012
PM 9549622
DA 2018-10-20
ER

PT J
AU Culbertson, BM
   Xie, D
   Thakur, A
AF Culbertson, BM
   Xie, D
   Thakur, A
TI Amino acid functionalized ionomeric materials in biomedical applications
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 7th International Symposium on Macromolecule-Metal Complexes
CY OCT 06-10, 1997
CL NOORDWIJKERHOUT, NETHERLANDS
SP Int Union Pure & Appl Chem, Macromolec Div, Royal Netherlands Chem Soc
AB Several N-acryloyl and N-methacryloyl substituted amino acids have been prepared and copolymerized with acrylic acid and itaconic acid to prepare new polyelectrolytes. Due to an acid-base reaction, mixing of the water soluble copolymers with glass powders, having leachable Ca2+, Al3+, etc., type cations, produces inorganic-organic composites hardened by salt -bridge formation. These heretofore unexplored polyelectrolytes are shown to be very useful for preparing improved dental biomaterials.
C1 Ohio State Univ, Columbus, OH 43210 USA.
RP Culbertson, BM (reprint author), Ohio State Univ, 305 W 12th Ave, Columbus, OH 43210 USA.
CR CRISP S, 1980, J DENT RES, V59, P1055, DOI 10.1177/00220345800590060801
   CULBERTSON BM, 1994, Patent No. 5369142
   CULBERTSON BM, 1996, J DENT MAT, V12, P44
   KOVARIK RE, 1993, DENT MATER, V9, P222, DOI 10.1016/0109-5641(93)90065-X
   MITRA SB, 1992, Patent No. 5130347
NR 5
TC 6
Z9 6
U1 0
U2 0
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD MAY
PY 1998
VL 131
BP 11
EP 18
DI 10.1002/masy.19981310104
PG 8
WC Polymer Science
SC Polymer Science
GA ZY874
UT WOS:000074670700003
DA 2018-10-20
ER

PT J
AU Meinert, K
   Uerpmann, C
   Matschullat, J
   Wolf, GK
AF Meinert, K
   Uerpmann, C
   Matschullat, J
   Wolf, GK
TI Corrosion and leaching of silver doped ceramic IBAD coatings on SS 316L
   under simulated physiological conditions
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Surface Modification of Metals by Ion
   Beams (SMMIB 97)
CY SEP 21-26, 1997
CL GATLINBURG, TENNESSEE
SP Oak Ridge Natl Lab, Danfysik, Implant Sci Corp, Spire Corp
DE bactericidal properties; biocompatibility; corrosion protection;
   stainless steel
ID CATHETERS; IMPLANTS
AB In order to improve the biomedical applications of stainless steel AISI 316L, commonly used for medical implants, ceramic coatings in combination with a thin (50 nm) silver layer on the outermost part of the ceramic coating were deposited by IBAD lion beam assisted deposition). The interference of the bactericidal silver layer with the insulating properties of the ceramic coating was of special interest. As corrosion protection coatings for SS 316L, different ceramic materials, Al2O3, TiO2, SiO2 and ZrO2, were deposited by IBAD. They were chosen because of their already known bioinert or bioactive properties. In addition, investigations were performed to determine the most effective minimal thickness of the ceramic coatings. To achieve bactericidal properties, the top layer (50-150 nm) of the ceramic coatings was doped with silver simultaneously with the deposition of the outermost part of the coating. Interesting differences occurred during the corrosion evaluations of the pure ceramic coating in comparison with the silver doped ceramic coatings. The electrochemical corrosion tests were done by potentiodynamic current density and by chronoamperometric measurements under simulated physiological conditions. Leaching tests of the silver doped ceramic coatings were performed in human plasma to determine the amount of dissolved silver. The quantification of the dissolved silver in human plasma was done by using solid sample graphite furnace atomic absorption spectroscopy. The amount of doped silver was determined by Auger depth profiles. During the evaluations, the pure and silver doped ZrO2 coating had the best performance of the investigated coatings, followed by the pure and silver doped TiO2 coatings. (C) 1998 Elsevier Science S.A.
C1 Univ Heidelberg, Phys Chem Inst Radiochem, D-69120 Heidelberg, Germany.
   Univ Heidelberg, Inst Umwelt Geochem, D-69120 Heidelberg, Germany.
RP Meinert, K (reprint author), Univ Heidelberg, Phys Chem Inst Radiochem, Neuenheimer Feld 500, D-69120 Heidelberg, Germany.
CR BAMBAUER R, 1994, ARTIF ORGANS, V18, P272, DOI 10.1111/j.1525-1594.1994.tb02194.x
   GURLAND HJ, 1994, NEPHROLOGY DIALYS S2, V9
   LINDBERG H, 1990, BR J UROL, V65, P379
   MEINERT K, 1998, IN PRESS SURF COAT T
   MUCK D, 1997, THESIS U HEIDELBERG
   ONDRACEK G, 1988, VERBUNDWERKSTOFFE ST, V2, P3
   SELLA C, 1991, SURF COAT TECH, V45, P129, DOI 10.1016/0257-8972(91)90215-I
   SIOSHANSI P, 1994, ARTIF ORGANS, V18, P266, DOI 10.1111/j.1525-1594.1994.tb02193.x
   STREIT B, 1991, LEXIKON OKOTOXIKOLOG, P585
   VIEGAS MF, 1990, J MATER SCI-MATER M, V1, P105, DOI 10.1007/BF00839076
   WILLIAMS M, 1992, INT J NUMER METH FL, V14, P1, DOI 10.1002/fld.1650140102
   WINTERMANTEL E, 1996, BIOKOMPATIBLE WERKST, P139
   Wituschek H, 1995, SURF COAT TECH, V74-75, P729, DOI 10.1016/0257-8972(95)08354-5
   WITUSCHEK H, 1992, REV SCI INSTRUM, V63, P2411, DOI 10.1063/1.1142946
   ZITTER H, 1991, WERKST KORROS, V42, P455
NR 15
TC 31
Z9 36
U1 1
U2 2
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD MAY
PY 1998
VL 104
BP 58
EP 65
DI 10.1016/S0257-8972(98)00375-2
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA ZZ476
UT WOS:000074733200012
DA 2018-10-20
ER

PT J
AU Loinaz, A
   Rinner, M
   Alonso, F
   Onate, JI
   Ensinger, W
AF Loinaz, A
   Rinner, M
   Alonso, F
   Onate, JI
   Ensinger, W
TI Effects of plasma immersion ion implantation of oxygen on mechanical
   properties and microstructure of Ti6Al4V
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Surface Modification of Metals by Ion
   Beams (SMMIB 97)
CY SEP 21-26, 1997
CL GATLINBURG, TENNESSEE
SP Oak Ridge Natl Lab, Danfysik, Implant Sci Corp, Spire Corp
DE plasma immersion ion implantation; Ti6Al4V alloy; oxygen; tribological
   properties
ID TI-6AL-4V ALLOY; NITROGEN; TITANIUM; CARBON
AB Plasma immersion ion implantation (PIII) is a surface treatment with increasing interest, as it offers the possibility of performing three-dimensional ion beam treatments, reducing the need for manipulation under vacuum to obtain a uniform treatment in geometrically complex parts. In this work the PIII process has been used to perform surface treatment on Ti6Al4V alloy. This Ti alloy is commonly used in aerospace and biomedical applications, due to its good combination of mechanical and chemical properties, such as strength to weight ratio, corrosion resistance or bioinertness. However, due to its poor tribological properties, the use of surface treatments to improve wear resistance or decrease friction coefficient is often recommended. PIII has been used to implant the surface of Ti6Al4V alloy with oxygen ions. The oxygen plasma was generated by electron cyclotron resonance microwave excitation, working at two different pressures. At the lower pressure plasma density was increased by means of an external ring magnet. High voltage pulses of -40 kV, at of 400 and 600 Hz pulse repetition rates, were applied. Elastic recoil detection (ERD) analysis showed retained doses in the range of 3 x 10(17) to 1 x 10(18) O atoms cm(-2), with oxygen concentration values ca 65% in the near surface region. Surface mechanical properties such as hardness, wear and friction have been evaluated. Microindentation tests showed an increase of up to 100% in the surface hardness of the ion implanted samples compared to the non implanted material. Dry pin-on-disk tests with spherical ended UHMWPE pins showed a very significant increase in wear resistance in oxygen implanted Ti6Al4V samples. Scanning electron microscopy and optical profilometry showed an important roughening of the Ti alloy surface after PIII treatment under selected conditions. (C) 1998 Elsevier Science S.A.
C1 INASMET, San Sebastian 20009, Spain.
   Univ Augsburg, Inst Phys, D-86159 Augsburg, Germany.
RP Alonso, F (reprint author), INASMET, San Sebastian 20009, Spain.
RI Onate, J. Ignacio/I-1555-2015; Ensinger, Wolfgang/N-7074-2017
OI Ensinger, Wolfgang/0000-0003-3858-6230; Onate de la Presa, Jose
   Ignacio/0000-0002-9078-4480
CR Alonso F, 1995, SURF COAT TECH, V74-75, P986, DOI 10.1016/0257-8972(95)08291-3
   Alonso F, 1997, SURF COAT TECH, V93, P305, DOI 10.1016/S0257-8972(97)00065-0
   Alonso F, 1996, SURF COAT TECH, V83, P301, DOI 10.1016/0257-8972(96)02767-3
   BOLSTER RN, 1987, SURF COAT TECH, V33, P469, DOI 10.1016/0257-8972(87)90211-8
   CHEN A, 1991, WEAR MATERIALS, P667
   Elder J. E., 1989, Surface Engineering, V5, P55
   Ensinger W, 1996, MATER RES SOC SYMP P, V396, P521
   GUNZEL R, 1994, J VAC SCI TECHNOL B, V12, P927, DOI 10.1116/1.587329
   Han SH, 1996, SURF COAT TECH, V82, P270, DOI 10.1016/0257-8972(95)02722-X
   HOHMUTH K, 1985, MATER SCI ENG, V69, P489, DOI 10.1016/0025-5416(85)90351-9
   HUTCHINGS R, 1992, SURF COAT TECH, V51, P489, DOI 10.1016/0257-8972(92)90287-K
   ONATE JI, 1994, SURF COAT TECH, V65, P165, DOI 10.1016/S0257-8972(94)80025-1
   PIVIN JC, 1987, J MATER SCI, V22, P1087, DOI 10.1007/BF01103555
   QIU X, 1990, METALL TRANS A, V21, P1663, DOI 10.1007/BF02672581
   RIEU J, 1992, SURFACE MODIFICATION, V5, P155
   SARITAS S, 1987, MATER SCI ENG, V90, P297, DOI 10.1016/0025-5416(87)90225-4
NR 16
TC 31
Z9 39
U1 0
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD MAY
PY 1998
VL 104
BP 262
EP 267
DI 10.1016/S0257-8972(98)00411-3
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA ZZ476
UT WOS:000074733200050
DA 2018-10-20
ER

PT J
AU Guzman, L
   Celva, R
   Miotello, A
   Voltolini, E
   Ferrari, F
   Adami, M
AF Guzman, L
   Celva, R
   Miotello, A
   Voltolini, E
   Ferrari, F
   Adami, M
TI Polymer surface modification by ion implantation and reactive deposition
   of transparent films
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Surface Modification of Metals by Ion
   Beams (SMMIB 97)
CY SEP 21-26, 1997
CL GATLINBURG, TENNESSEE
SP Oak Ridge Natl Lab, Danfysik, Implant Sci Corp, Spire Corp
DE ion implantation; polycarbonate; cross-linking; hardening
AB The use of polymeric materials is often limited by low hardness, poor wear resistance and wettability considerations. The area of mechanical changes caused by ion beam treatments has been explored only to a limited extent for polymers despite their growing usage in automotive, biomedical and aerospace applications, in which traditionally metals have been used.
   Polycarbonate (PC) specimens were subjected to medium-high energy (160 keV) nitrogen ion implantation at different dosage. Ion irradiation, even at low fluence, can improve surface properties in a well controlled way. A colour change from amber to dark brown with increasing fluence is associated with the ion implantation process. Hardness and elastic modulus, as measured by a nanoindenter, increase dramatically with increasing N dose.
   The surface property improvement can be explained by cross-linking phenomena, responsible for the formation of a three-dimensionally connected rigid network. Such hypothesis is confirmed by TOF-SIMS analyses of untreated and ion bombarded specimens.
   Too high implanted fluence may induce progressive degradation of the PC surface. Should the thickness of the ion-modified layer be too low for a specific application, it is possible to extend the ion irradiation treatment by plasma or ion beam assisted deposition of hard semi-transparent top layers. Using such a method the advantages of both the techniques can be retained to obtain PC surfaces with optimum wear resistance properties. (C) 1998 Elsevier Science S.A.
C1 CMBM, I-38050 Trent, Italy.
   Univ Trent, INFM, I-38050 Trent, Italy.
   Univ Trent, Dept Phys, I-38050 Trent, Italy.
   Univ Trent, Dept Struct Mech, I-38050 Trent, Italy.
RP Guzman, L (reprint author), CMBM, I-38050 Trent, Italy.
CR AWAZU K, 1992, SURF COAT TECH, V51, P509, DOI 10.1016/0257-8972(92)90290-Q
   BRIGGS D, 1986, SURF INTERFACE ANAL, V9, P391
   DICKIE RA, 1988, ACS S SER, V367
   GISSLER W, 1994, SURFACE MODIFICATION, V7, P571
   LEE EH, 1994, J MATER RES, V9, P1043, DOI 10.1557/JMR.1994.1043
   LEE EH, 1993, NUCL INSTRUM METH B, V74, P326, DOI 10.1016/0168-583X(93)95070-L
   ROST A, 1969, METAUX USUELS, P123
   Sioshansi P, 1996, SURF COAT TECH, V83, P175, DOI 10.1016/0257-8972(95)02838-2
NR 8
TC 30
Z9 31
U1 0
U2 1
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD MAY
PY 1998
VL 104
BP 375
EP 379
DI 10.1016/S0257-8972(98)00430-7
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA ZZ476
UT WOS:000074733200070
DA 2018-10-20
ER

PT J
AU Rintoul, L
   Panayiotou, H
   Kokot, S
   George, G
   Cash, G
   Frost, R
   Bui, T
   Fredericks, P
AF Rintoul, L
   Panayiotou, H
   Kokot, S
   George, G
   Cash, G
   Frost, R
   Bui, T
   Fredericks, P
TI Fourier transform infrared spectrometry: a versatile technique for real
   world samples
SO ANALYST
LA English
DT Article; Proceedings Paper
CT XXX Colloquium Spectroscopy International
CY SEP 21-26, 1997
CL MELBOURNE, AUSTRALIA
SP GBC Sci Equipment, Hewlett Packard, Perkin Elmer, Spectro Anal Instruments, Varian
DE Fourier transform infrared spectrometry; infrared microscopy; emission;
   attenuated total reflectance; photoacoustic; chemometrics; hair; skin;
   bauxite; clay; polymer
ID PHOTOACOUSTIC-SPECTROSCOPY; EMISSION SPECTROSCOPY; PHASE-ANALYSIS;
   MINERALS; INSITU
AB The versatility of FTIR spectrometry was explored by considering a variety of samples drawn from industrial applications, materials science and biomedical research. These samples included polymeric insulators, bauxite ore, clay, human hair and human skin. A range of sampling techniques suitable for these samples is discussed, in particular FTIR microscopy, FTIR emission spectroscopy, attenuated total reflectance and photoacoustic FTIR spectrometry, The power of modern data processing techniques, particularly multivariate analysis, to extract useful information from spectral data is also illustrated.
C1 Queensland Univ Technol, Ctr Instrumental & Dev Chem, Brisbane, Qld 4000, Australia.
RP Fredericks, P (reprint author), Queensland Univ Technol, Ctr Instrumental & Dev Chem, 2 George St, Brisbane, Qld 4000, Australia.
CR BAIER RE, 1978, J SOC COSMET CHEM, V29, P283
   BERTRAND L, 1988, APPL SPECTROSC, V42, P134, DOI 10.1366/0003702884428644
   Carter EA, 1996, TEXT RES J, V66, P787, DOI 10.1177/004051759606601207
   COMPTON DAC, 1988, APPL SPECTROSC, V42, P972, DOI 10.1366/0003702884430317
   DITTMAR RM, 1991, APPL SPECTROSC, V45, P1104, DOI 10.1366/0003702914336138
   Farmer V. C., 1974, INFRARED SPECTRA MIN
   Ferraro J. R., 1990, PRACTICAL FOURIER TR
   Frost RL, 1996, CLAY CLAY MINER, V44, P635, DOI 10.1346/CCMN.1996.0440506
   GEORGE GA, 1995, POLYM DEGRAD STABIL, V48, P199, DOI 10.1016/0141-3910(95)00035-K
   Graham J. A., 1985, FOURIER TRANSFORM IN, V4, P345
   GRIFFITHS PR, 1986, FOURIER TRANSFORM IN
   Harrick N. J, 1967, INTERNAL REFLECTION
   JOHNSTON SF, 1991, FOURIER TRANSFORM IN
   JONAS K, 1970, ACTA CHIM HUNG, V66, P1
   Kidder LH, 1997, OPT LETT, V22, P742, DOI 10.1364/OL.22.000742
   KOZLOWSKI TR, 1968, APPL OPTICS, V7, P795, DOI 10.1364/AO.7.000795
   MARCOTT C, 1996, MIKROCHIM ACTA S, V14, P157
   Massart DL, 1988, CHEMOMETRICS TXB
   MEGLEN RR, 1988, CHEMOMETR INTELL LAB, V3, P17, DOI 10.1016/0169-7439(88)80062-5
   Messerschmidt R. G., 1988, INFRARED MICROSPECTR
   Nishikida K., 1996, SELECTED APPL MODERN
   OTTO M, 1988, CHEMOMETR INTELL LAB, V4, P101, DOI 10.1016/0169-7439(88)80083-2
   PUTTNAM NA, 1972, J SOC COSMET CHEM, V23, P209
   RINTOUL L, 1995, APPL SPECTROSC, V49, P1608, DOI 10.1366/0003702953965696
   Smith B.C., 1996, FUNDAMENTALS FOURIER
   SOWA MG, 1994, APPL SPECTROSC, V48, P316, DOI 10.1366/0003702944028182
   VASSALLO AM, 1992, APPL SPECTROSC, V46, P73, DOI 10.1366/0003702924444407
   VIDRINE DW, 1982, FOURIER TRANSFORM IN, V3, P125
   WENTRUPBYRNE E, 1995, APPL SPECTROSC, V49, P1028, DOI 10.1366/0003702953964813
   WILMSHURST JK, 1963, J CHEM PHYS, V39, P2545, DOI 10.1063/1.1734059
   YANG CQ, 1987, APPL SPECTROSC, V41, P889, DOI 10.1366/0003702874448319
NR 31
TC 34
Z9 35
U1 0
U2 11
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON ROAD, CAMBRIDGE CB4 4WF,
   CAMBS, ENGLAND
SN 0003-2654
J9 ANALYST
JI Analyst
PD APR
PY 1998
VL 123
IS 4
BP 571
EP 577
DI 10.1039/a707111f
PG 7
WC Chemistry, Analytical
SC Chemistry
GA ZK143
UT WOS:000073289700008
PM 9684399
DA 2018-10-20
ER

PT J
AU De Aza, PN
   Guitian, F
   De Aza, S
   Valle, FJ
AF De Aza, PN
   Guitian, F
   De Aza, S
   Valle, FJ
TI Analytical control of wollastonite for biomedical applications by use of
   atomic absorption spectrometry and inductively coupled plasma atomic
   emission spectrometry
SO ANALYST
LA English
DT Article
DE wollastonite; pseudowollastonite; biomaterials; impurities analysis;
   cold vapour atomic absorption spectrometry; hydride generation atomic
   absorption spectrometry; inductively coupled plasma atomic emission
   spectrometry
ID SIMULATED BODY-FLUID; GLASSES; BIOACTIVITY; CERAMICS
AB Preliminary in vitro experiments revealed that wollastonite (CaSiO3) is a potentially highly bioactive material that forms a hyroxyapatite (HA) surface layer on exposure to simulated body fluid with an ion concentration, pH and temperature virtually identical with those of human blood plasma. The formation of the HA layer is an essential requirement for an artificial material to be used as bioactive bone substitute, This finding opens up a wide field for biomedical applications of wollastonite, Biomaterials used as implants in the human body require strict control of trace elements and of the toxic species specified in American Society for Testing and Materials F-1185-88 (As, Cd, Hg and Pb) in ceramic hydroxyapatite for surgical implantation. In this work, two types of pseudowollastonite, the high temperature form of wollastonite, mere analysed by using cold vapour atomic absorption spectrometry and hydride generation atomic absorption spectrometry, in order to determine the elements stated in the above-mentioned norm, and inductively coupled plasma atomic emission spectrometry to establish the SiO2/CaO ratio of the two materials and analyse for all other impurities introduced by the raw materials and by the processes of synthesis, sintering and grinding, Barium and Mg were especially prominent in raw materials, and Zr, Y, Mg, W, Co and Ni come mainly from the processing.
C1 CSIC, Inst Ceram & Vidrio, E-28500 Madrid, Spain.
RP De Aza, PN (reprint author), Univ Santiago de Compostela, Inst Ceram, Santiago De Compostela, Spain.
RI De Aza, Piedad/A-7621-2015
OI De Aza, Piedad/0000-0001-9316-4407
CR *ASTM, 1988, 118588 F ASTM
   BOUMANS PWJ, 1987, INDUCTIVELY COUPLED, P102
   DEAZA PN, 1994, SCRIPTA METALL MATER, V31, P1001, DOI 10.1016/0956-716X(94)90517-7
   DeAza PN, 1996, J MICROSC-OXFORD, V182, P24, DOI 10.1111/j.1365-2818.1996.tb04794.x
   DeAza PN, 1996, J MATER SCI-MATER M, V7, P399, DOI 10.1007/BF00122007
   DEAZA PN, 1995, ADV SCI TECHNOLOGY, V12, P9
   DEVESA L, COMMUNICATION
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   GROSS U, 1988, CRC CRITICAL REV BIO, V4, P2
   Hench L. L., 1993, ADV SERIES CERAMICS, V1, P1
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HOROWITZ E, INTRO BIOCERAMICS, V335, P93
   KOBUBO T, 1982, B I CHEM RES KYOTO U, V60, P260
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   KOKUBO T, 1991, CERAMICS 21 CENTURY, P500
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   OHURA K, 1992, J MATER SCI-MATER M, V3, P95, DOI 10.1007/BF00705275
   Potts P., 1987, HDB SILICATE ROCK AN, P47
NR 19
TC 26
Z9 27
U1 1
U2 8
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON ROAD, CAMBRIDGE CB4 4WF,
   CAMBS, ENGLAND
SN 0003-2654
J9 ANALYST
JI Analyst
PD APR
PY 1998
VL 123
IS 4
BP 681
EP 685
DI 10.1039/a708445e
PG 5
WC Chemistry, Analytical
SC Chemistry
GA ZK143
UT WOS:000073289700027
PM 9684401
DA 2018-10-20
ER

PT J
AU Niu, M
   Su, Y
   Yan, JK
   Fu, CP
   Xu, DM
AF Niu, M
   Su, Y
   Yan, JK
   Fu, CP
   Xu, DM
TI An improved open-ended waveguide measurement technique on parameters
   epsilon(r) and mu(r) of high-loss materials
SO IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT
LA English
DT Article
DE electromagnetic parameters; high-loss material; open-ended waveguide;
   simultaneous measurement
AB An improved technique of using rectangular waveguide aperture for simultaneous measurement of the electromagnetic parameters epsilon(r), mu(r) of materials is developed in this paper, Both multilayer and single-layer medium sheet samples can be tested, Samples are sandwiched between a flange of an open-ended waveguide and a shorting plate, The parameters are obtain by using an optimization technique by fitting the theoretical values of the reflection coefficients Gamma(epsilon(r), mu(r)) to the measured values with epsilon(r), mu(r) as the argument. The related details, such as test theories, waveguide design, sample preparation, and error analysis are also discussed in this paper. The experimental results are validated by the measurements performed using the reflection-transmission method using an automatic network analyzer and the published data from manufactures. By virtue of its open-ended waveguide configuration, this technique is well suited for sheet or coating materials, and it might be applied for industrial on-the-worksite testing or biomedical analysis.
C1 Shanghai Univ, Shanghai 201800, Peoples R China.
   Chinese Univ Hong Kong, Hong Kong, Peoples R China.
RP Niu, M (reprint author), Shanghai Univ, Shanghai 201800, Peoples R China.
CR ARJALINGAM, 1990, IEEE T MICROWAVE THE, V38
   BAKHTIARI S, 1994, IEEE T MICROWAVE THE, V24
   CULLEN AL, 1971, PROC R SOC LON SER-A, V325, P493, DOI 10.1098/rspa.1971.0181
   DEMING X, 1987, IEEE T MICROW THEORY, V35, P1424
   GARDIOL FE, 1985, ADV ELECTRON EL PHYS, V63, P139
   Hakki B.W., 1960, Institute of Radio Engineers Transactions on Microwave Theory and Techniques, VMTT-8, P402, DOI 10.1109/TMTT.1960.1124749
   KHAN SA, 1992, P INT C MICR COMM NA, P702
   LI CL, 1995, IEEE T INSTRUM MEAS, V44, P19, DOI 10.1109/19.368108
   MISRA D, 1990, IEEE T MICROWAVE THE, V38
   STUCHLY MA, 1980, IEEE T INSTRUM MEAS, V29, P176, DOI 10.1109/TIM.1980.4314902
   TANABE E, 1976, IEEE T INSTRUM MEAS, V25, P222, DOI 10.1109/TIM.1976.6312350
   WEI YZ, 1991, IEEE T MICROW THEORY, V39, P526, DOI 10.1109/22.75296
   Weir W., 1974, P IEEE, V62
   1975, IEE C PUB
NR 14
TC 3
Z9 3
U1 1
U2 1
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 0018-9456
J9 IEEE T INSTRUM MEAS
JI IEEE Trans. Instrum. Meas.
PD APR
PY 1998
VL 47
IS 2
BP 476
EP 481
DI 10.1109/19.744194
PG 6
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA 166CC
UT WOS:000078557800023
DA 2018-10-20
ER

PT J
AU Tolfree, DWL
AF Tolfree, DWL
TI Microfabrication using synchrotron radiation
SO REPORTS ON PROGRESS IN PHYSICS
LA English
DT Review
ID X-RAY-LITHOGRAPHY; LIGA PROCESS; FABRICATION; GENERATION; PROFILES
AB The realization of precision deep microstructures requires high-energy, intense parallel beams of x-rays from synchrotron radiation sources and novel process technology. Deep x-ray lithography with synchrotron radiation is basically a shadow printing process in which a two-dimensional pattern is accurately transferred from a mask into a resist material by chemical changes induced by the radiation. Subsequent electroforming and moulding processes are used to manufacture microstructures from metals, plastics and ceramics. This process, known as LIGA (Lithographie, Galvanoformung, and Abformung), first developed in Germany, is based on a combination of lithography, electroforming and replication processes. The development of the LIGA process for the fabrication of a wide range of precision microstructures has been stimulated by the increasing use of synchrotron radiation sources for lithography.
   Applications for microstructures exist in many sectors of industry. These include chemical and process engineering, biomedical instrumentation, automotive and aerospace technology, environmental monitoring and information technology. Emphasis is placed on three main areas, micromechanics, micro-optics and microfluidics, which are emerging with the widest range of industrial applications.
   This paper reviews the progress being made in microfabrication technology using x-ray beam lithography and the LIGA process. It includes a description of synchrotron radiation, storage ring sources, the fabrication processes, applications and potential markets. Reference is also made to European networks and R&D activity worldwide.
C1 SERC, Daresbury Lab, CCLRC, Warrington WA4 4AD, Cheshire, England.
RP Tolfree, DWL (reprint author), SERC, Daresbury Lab, CCLRC, Warrington WA4 4AD, Cheshire, England.
CR AIKEN T, 1995, COMMUNICATION
   AITKEN T, 1995, COMMUNICATION
   BACHER W, 1995, IEE T IND ELECT, V42
   BACHER W, 1994, P ACTUATOR 94, P86
   BALLANDRAS S, 1995, J MICROMECH MICROENG, V5, P203, DOI 10.1088/0960-1317/5/3/001
   BARNES P, 1992, NUCL INSTRUM METH A, V314, P345, DOI 10.1016/0168-9002(92)90978-D
   BAUER H, 1994, MST NEWS, V10, P18
   BAUER HD, 1994, ENCY ADV MAT, V3, P1613
   BECKER EW, 1982, NATURWISSENSCHAFTEN, V69, P520
   Becker H, 1993, Endosc Surg Allied Technol, V1, P40
   BECKER H, 1988, P WORKSH MMI TECHN N
   BECKER HM, 1993, INTERDISCIPL SCI REV, V18, P289
   BEERNAERT D, 1995, MST NEWS, V14
   BERG A, 1994, MICRO TOTAL ANAL WOR
   BLEWETT JP, 1946, PHYS REV, V69, P87, DOI 10.1103/PhysRev.69.87
   BLEY P, 1993, INTERDISCIPL SCI REV, V18, P267
   BLEY P, 1991, MICRO SYSTEM TECHNOL, P302
   BLEY P, 1991, MICROELECTRON ENG, V14, P323
   BOURBON C, FABRICATION CAPACITA, P559
   BOURBON C, 1991, SENSOR ACTUAT A-PHYS, V27, P1
   Burbaum C, 1991, SENSOR MATER, V3, P75
   CERRINA F, 1992, MICROELECTRON ENG, V17, P135, DOI 10.1016/0167-9317(92)90027-O
   CERRINA F, 1996, HDB MICROLITHOGRAPHY
   CHAN CT, 1991, EUROPHYS LETT, V16, P563, DOI 10.1209/0295-5075/16/6/009
   CHOWANIETZ E, 1995, P MICROSIM 95
   Cuschieri A, 1992, OPERATIVE MANUAL END
   DARIO P, 1994, IROS '94 - INTELLIGENT ROBOTS AND SYSTEMS: ADVANCED ROBOTIC SYSTEMS AND THE REAL WORLD, VOLS 1-3, P739, DOI 10.1109/IROS.1994.407554
   DEFREEZ RK, 1989, SPIE, V1043, P343
   EHRFELD H, 1992, 3 EUR PART ACC C, P1687
   Ehrfeld W, 1996, DECH MONOG, V132, P1
   Ehrfeld W., 1986, Microelectronic Engineering, V5, P463, DOI 10.1016/0167-9317(86)90078-X
   EHRFELD W, 1995, RADIAT PHYS CHEM, V45, P349, DOI 10.1016/0969-806X(93)E0007-R
   EHRFELD W, 1988, J VAC SCI TECHNOL B, V6, P178, DOI 10.1116/1.584039
   EHRFELD W, 1987, 666 VDI, P85
   EHRFELD W, 1991, NUCL INSTRUM METHODS, V303, P65
   EHRFELD W, 1990, MICROSYST TECHNOL, V2, P521
   EHRFELD W, 1986, MICROELECTRON ENG, V4, P35
   EHRFELD W, 1988, P IEEE
   EHRFELD W, 1988, J VAC SCI B, V6
   EHRFELD W, 1994, J PHYSIQUE, V4, P229
   EHRFELD W, 1987, P IEEE MICR ROB TEL, V87, P1
   ELDER FR, 1947, PHYS REV, V71, P829, DOI 10.1103/PhysRev.71.829.5
   ELKHOLI A, 1993, MICROELECTRON ENG, V21, P271, DOI 10.1016/0167-9317(93)90071-C
   ELKHOLI A, 1993, 5238 KFK, P114
   ELLEAUME P, 1990, PHYS SCRIPTA, VT31, P67, DOI 10.1088/0031-8949/1990/T31/009
   Feiertag G, 1996, NATO ADV SCI INST SE, V315, P63
   FEIERTAG G, 1996, IN PRESS MICROELECTR
   FOULGER M, 1996, XRAY LITHOGRAPHY SEL
   GODWIN RP, 1969, SPRINGER TRACTS MODE, V51
   GOU ZY, 1993, IBM J RES DEV
   GROBMAN W, 1985, SYNCHROTRON RAD RES
   GUCKEL H, 1993, NUCL INSTRUM METH B, V79, P247, DOI 10.1016/0168-583X(93)95336-4
   GUCKEL H, 1995, SPIE M AUST TX
   GUCKEL H, 1994, SPIES S MICR, P2194
   GUCKEL H, 1991, P TRANSDUCERS
   HARMENING M, 1992, 075030497792 IEEE, P202
   *HARMST C, 1997, MICR TECHN, V26
   HECTOR SD, 1993, VAC SCI TECHNOL, V13, P2981
   HEINRICH K, 1981, J VAC SCI TECHNOL, V19, P1254, DOI 10.1116/1.571255
   HESCH K, 1996, MICROFABRICATION SYN
   HEUBERGER A, 1984, MICROENGINEERING 84, V9, P283
   HILL JW, 1994, IEEE INT CONF ROBOT, P2302, DOI 10.1109/ROBOT.1994.350942
   HOH K, 1984, PUBL BUSINESS CTR AC
   HURTEAU R, 1994, IEEE INT CONF ROBOT, P2286, DOI 10.1109/ROBOT.1994.350945
   Ishihara S., 1994, NTT R & D, V43, P585
   ITO H, 1983, POLYM ENG SCI, V23, P1002
   IWANENKO D, 1944, PHYS REV, V65
   KRINSKY S, 1993, HDB SYNCHROTRON RAD, P65
   LAWES RA, 1994, ENG SCI ED J
   LEHMANN O, 1991, APPL PHYS A-MATER, V53, P343, DOI 10.1007/BF00357199
   LINGNAU R, 1989, SOLID STATE TECHNOL, V107
   MAID B, 1989, 4579 KFK
   MANER A, 1989, MAT MANUF PROCESS, V4, P537
   MARKS N, 1995, RADIAT PHYS CHEM, V45, P315, DOI 10.1016/0969-806X(95)92798-4
   MATHIESON D, 1994, MST 94 INT C MICR EL, P889
   McCormick M., 1994, Engineering Science and Education Journal, V3, P255, DOI 10.1049/esej:19940604
   MENCHMEYER D, 1987, SPIE P SERIES, V803, P72
   MENZ W, 1993, INTERDISCIPL SCI REV, V18, P253
   MESINGER H, 1995, MICROMASS ANAL SYSTE, P227
   MOHR J, 1988, J VAC SCI TECHNOL B, V6, P2264, DOI 10.1116/1.584067
   MOHR J, 1993, J MICROMECH MICROENG
   MOREAU WM, 1988, SEMICONDUCTOR LITHOG
   MORISHA H, 1993, RSJ IEEE INT C INT R, P1717
   MULLER RS, 1990, SENSOR ACTUAT A-PHYS, V21, P1, DOI 10.1016/0924-4247(90)85001-K
   MUNRO I, 1991, EUROPEAN SYNCH RAD S
   MURATA K, 1985, J APPL PHYS, V57, P575, DOI 10.1063/1.334740
   PATERSON KE, 1982, P IEEE, V70, P420
   PROSSER S, 1993, IEE C, V183
   RAPP P, 1993, P MEMS 93, P123
   REUBEN R, 1995, IEE C LOND
   RIVKIN, 1996, EPAC
   Rogner A., 1991, Journal of Micromechanics and Microengineering, V1, P167, DOI 10.1088/0960-1317/1/3/007
   ROWE EM, 1979, TOP CURR PHYS, V10, P25
   RUSSEL R, 1993, RSJ IEEE INT C INT R, P471
   SAMOTO N, 1983, J APPL PHYS, V54, P3855, DOI 10.1063/1.332610
   SATEESH S, 1997, IN PRESS HARMST P
   SCHELB W, 1987, 666 VDI, P85
   SCHIFF LI, 1946, REV SCI INSTRUM, V17, P798
   Schmidt A, 1996, MICROELECTRON ENG, V30, P215, DOI 10.1016/0167-9317(95)00230-8
   SCHULZ C, 1994, MEMS COURSE BOOKLET
   SCHULZ C, 1994, UETP MEMS FRSM NEUCH, P119
   SCHWINGER J, 1946, PHYS REV, V70, P798
   SILVERMAN JP, 1994, NUCL INSTRUM METH A, V347, P31, DOI 10.1016/0168-9002(94)91849-X
   Sokolov A. A., 1968, SYNCHROTRON RAD
   SOKOLOV AA, 1957, ZH EKSP TEOR FIZ, V4, P396
   SOUKOULIS CM, 1993, J OPT SOC AM B, V10, P208
   SULLER V, 1992, P 3 EUR PART ACC C E
   TERNOV I.M., 1985, SYNCHROTRON RAD ITS
   TIMOTHY JG, 1983, HDB SYNCHROTRON RA A, V1, P325
   TISCHER P, 1978, P 8 C EL ION BEAM SC, P444
   TOLFREE D, 1994, P TECH T C TCD
   TOLFREE DWL, 1997, MST NEWS, V21
   TOMBOULIAN DH, 1956, PHYS REV, V102, P1423, DOI 10.1103/PhysRev.102.1423
   TURNER S, 1989, 9030 CERN ACC SCH
   WANG T, 1994, IROS '94 - INTELLIGENT ROBOTS AND SYSTEMS: ADVANCED ROBOTIC SYSTEMS AND THE REAL WORLD, VOLS 1-3, P862, DOI 10.1109/IROS.1994.407491
   WEBER, 1997, MICRO MACH DEVICES, V2, P1
   WEBER L, 1994, EUR C EUPAC 94 EUR K
   WECHSUNG R, 1995, MST NEWS, V14, P13
   WILSON MN, 1992, REV SCI INSTRUM, V63, P707, DOI 10.1063/1.1142643
   WILSON MN, 1988, P M EL GROUP IOP, P13
   Winick H., 1980, Synchrotron radiation research, P11
   WOLLERSHEIM O, 1994, J MICROMECH MICROENG, V4, P84, DOI 10.1088/0960-1317/4/2/006
   YAMAMOTO S, 1989, REV SCI INSTRUM, V60, P1834, DOI 10.1063/1.1140916
   ZINNER H, 1994, MST NEWS, P9
   ZURNIQUE H, 1997, SIMULATION STUDIES M
   1992, MICROMECHANICS INT
   1997, SRI CONSULTING REPOR
   1996, MST NEWS, V7
   1996, P C COMM MICR KON HI
   1995, IEE C MICR MIS LOND
   1995, LIGA NEWSLETTER
   1996, MST NEWS, V17
NR 132
TC 50
Z9 51
U1 1
U2 11
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0034-4885
J9 REP PROG PHYS
JI Rep. Prog. Phys.
PD APR
PY 1998
VL 61
IS 4
BP 313
EP 351
DI 10.1088/0034-4885/61/4/001
PG 39
WC Physics, Multidisciplinary
SC Physics
GA ZL100
UT WOS:000073398800001
DA 2018-10-20
ER

PT J
AU Lotters, JC
   Bomer, JG
   Verloop, AJ
   Droog, EA
   Olthuis, W
   Veltink, PH
   Bergveld, P
AF Lotters, JC
   Bomer, JG
   Verloop, AJ
   Droog, EA
   Olthuis, W
   Veltink, PH
   Bergveld, P
TI Design, fabrication and characterization of a highly symmetrical
   capacitive triaxial accelerometer
SO SENSORS AND ACTUATORS A-PHYSICAL
LA English
DT Article; Proceedings Paper
CT 9th International Conference on Solid-State Sensors and Actuators
CY JUN 16-19, 1997
CL CHICAGO, ILLINOIS
SP IEEE Electron Devices Soc
DE triaxial accelerometers; capacitive sensors; three-dimensional
   structures; biomedical applications
ID FILM
AB A highly symmetrical cubic capacitive triaxial accelerometer for biomedical applications has been designed, fabricated and characterized. The outer dimensions of the sensors are 5 mm x 5 mm x 5 mm. The devices are mounted on a standard IC package for easy testing. Features of the triaxial accelerometer are a highly symmetrical cubic structure, capacitive coupling of the high-frequency input voltage to the seismic mass, and the use of the polymer polydimethylsiloxane (PDMS) as spring material between the capacitor plates and the mass and polyimide (PI) as the flexible interconnection layer between the capacitor plates. The sensor structure and its basic operating principle, its mathematical mass-spring-damper model and the cleanroom technology necessary for the fabrication of the devices are described. The measurement results show a sensitivity of similar to 0.2 V (m s(-2))(-1) with a corresponding resolution of 0.01 m s(-2). an off-axis sensitivity of < 5%, a good linearity in the output voltage for accelerations up to at least 50 m s(-2) and a bandwidth of d.c. to similar to 1 kHz. (C) 1998 Elsevier Science S.A. All rights reserved.
C1 Univ Twente, Dept Elect Engn, MESA Res Inst, NL-7500 AE Enschede, Netherlands.
   Bronkhorst High Tech, NL-7261 AK Ruurlo, Netherlands.
   Univ Twente, BMTI, NL-7500 AE Enschede, Netherlands.
RP Olthuis, W (reprint author), Univ Twente, Dept Elect Engn, MESA Res Inst, POB 217, NL-7500 AE Enschede, Netherlands.
RI Veltink, Peter/L-3738-2016
OI Veltink, Peter/0000-0002-1796-9999
CR Andersson G. I., 1995, 8th International Conference on Solid-State Sensors and Actuators and Eurosensors IX. Digest of Technical Papers (IEEE Cat. No.95TH8173), P558
   ANDREWS MK, 1993, SENSOR ACTUAT A-PHYS, V36, P219, DOI 10.1016/0924-4247(93)80196-N
   BATEN CTM, 1996, P 11 ANN INT OCC ERG, V1, P315
   BLOM C, 1985, THESIS U TWENTE, P35
   Bouten CVC, 1997, IEEE T BIO-MED ENG, V44, P136, DOI 10.1109/10.554760
   CHO YH, 1994, SENSOR ACTUAT A-PHYS, V40, P31, DOI 10.1016/0924-4247(94)85027-5
   FRANKEN HM, 1994, IEEE ENG MED BIOL, V13, P564
   JANSEN H, 1995, J MICROMECH MICROENG, V5, P115, DOI 10.1088/0960-1317/5/2/015
   Jono K., 1994, Proceedings IEEE Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robotic Systems (Cat. No.94CH3404-1), P251, DOI 10.1109/MEMSYS.1994.555762
   KWON K, 1997, 9 INT C SOL STAT SEN, P1221
   LEMKIN MA, 1997, 9 INT C SOL STAT SEN, P1185
   LOTTERS JC, UNPUB IEEE T INSTRUM
   LOTTERS JC, 1997, THESIS U TWENTE NETH, P98
   LOTTERS JC, 1997, J MICROSYSTEM TECHNO, V3, P64
   LOTTERS JC, 1997, IN PRESS J MICROMECH, V7
   Mineta T., 1995, 8th International Conference on Solid-State Sensors and Actuators and Eurosensors IX. Digest of Technical Papers (IEEE Cat. No.95TH8173), P554
   Okada K., 1992, 11 SENS S, P245
   SKVOR Z, 1991, STUDIES ELECT ELECT, V40, P176
   SUZUKI K, 1994, J MICROELECTROMECH S, V3, P4, DOI 10.1109/84.285718
   Takao H., 1995, 8th International Conference on Solid-State Sensors and Actuators and Eurosensors IX. Digest of Technical Papers (IEEE Cat. No.95TH8173), P683
   TAKAO H, 1998, IN PRESS SENSORS ACT, V66
   VANHILTEN JJ, 1993, THESIS U LEIDEN NETH
   VANSOMEREN EJW, 1993, J NEUROL SCI, V117, P16, DOI 10.1016/0022-510X(93)90148-R
   WHORLOW RW, 1980, RHEOLOGICAL TECHNIQU, P229
NR 24
TC 18
Z9 20
U1 0
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-4247
J9 SENSOR ACTUAT A-PHYS
JI Sens. Actuator A-Phys.
PD APR 1
PY 1998
VL 66
IS 1-3
BP 205
EP 212
DI 10.1016/S0924-4247(98)00036-3
PG 8
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA ZJ338
UT WOS:000073204000033
DA 2018-10-20
ER

PT J
AU Niinomi, M
AF Niinomi, M
TI Mechanical properties of biomedical titanium alloys
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Proceedings Paper
CT Conference on Thermomechanical Processing and Metallurgy of Titanium
   Alloys
CY JUL 07-11, 1997
CL UNIV WOLLONGONG, WOLLONGONG, AUSTRALIA
SP Asian Off Aerosp Res & Dev, USAF, Off Sci Res
HO UNIV WOLLONGONG
DE biomedical titanium alloys; mechanical properties; fracture
   characteristics; fatigue characteristics
AB Titanium alloys are expected to be much more widely used for implant materials in the medical and dental fields because of their superior biocompatibility, corrosion resistance and specific strength compared with other metallic implant materials. Pure titanium and Ti-6Al-4V, in particular, Ti-6Al-4V ELI have been, however, mainly used for implant materials among various titanium alloys to date. V free alloys like Ti-6Al-7Nb and Ti-5A1-2.5Fe have been recently developed for biomedical use. More recently V and Al free alloys have been developed. Titanium alloys composed of non-toxic elements like Nb, Ta, Zr and so on with lower modulus have been started to be developed mainly in the USA. The beta type alloys are now the main target for medical materials. The mechanical properties of the titanium alloys developed for implant materials to date are described in this paper. (C) 1998 Elsevier Science S.A. All rights reserved.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 441, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 441, Japan.
RI Niinomi, Mitsuo/B-5965-2011
CR Ahmed T., 1996, TITANIUM 95 SCI TECH, P1760
   [Anonymous], 1994, ANN BOOK ASTM STAND
   BOROWY KH, 1985, PROPERTIES NEW TITAN, P1381
   Brown S A, 1996, ASTM STP
   DAVIDSON JA, 1986, P IMPLANT MANUFACTUR, V122, P122
   HIGO Y, 1994, AM SOC TEST MATER, V1173, P148, DOI 10.1520/STP18101S
   *IR STEE I JAP, 1990, DAT BOOK FRACT TOUGH, P37
   KURODA D, 1996, IRON STEEL I JPN, V9, P421
   Niinomi M, 1996, METALL MATER TRANS A, V27, P3925, DOI 10.1007/BF02595641
   OKAZAKI Y, 1995, J JPN I MET, V59, P1078, DOI 10.2320/jinstmet1952.59.10_1078
   OKUNO O, 1996, J JPN SOC BIOMATER, V14, P267
   Semlitsch M., 1986, TITAN, V2, P721
   SEN DYM, 1986, TITAN, V2, P712
   Tokaji K., 1994, Journal of the Society of Materials Science, Japan, V43, P710
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Wang K., 1993, CHARACTERIZATION TI, P49
   ZWICKER U, 1986, Z METALLKD, V77, P714
NR 17
TC 759
Z9 804
U1 14
U2 224
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD MAR 15
PY 1998
VL 243
IS 1-2
BP 231
EP 236
DI 10.1016/S0921-5093(97)00806-X
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA ZH762
UT WOS:000073145100031
DA 2018-10-20
ER

PT J
AU Kuroda, D
   Niinomi, M
   Morinaga, M
   Kato, Y
   Yashiro, T
AF Kuroda, D
   Niinomi, M
   Morinaga, M
   Kato, Y
   Yashiro, T
TI Design and mechanical properties of new beta type titanium alloys for
   implant materials
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Proceedings Paper
CT Conference on Thermomechanical Processing and Metallurgy of Titanium
   Alloys
CY JUL 07-11, 1997
CL UNIV WOLLONGONG, WOLLONGONG, AUSTRALIA
SP Asian Off Aerosp Res & Dev, USAF, Off Sci Res
HO UNIV WOLLONGONG
DE biomedical titanium alloys; d-electron alloy design method; mechanical
   properties; Young's modulus; biocompatibility
ID STRENGTH
AB Pure titanium and Ti-6Al-4V alloy have been mainly used as implant materials. V-free titanium alloys like Ti-6Al-7Nb and Ti-5Al-2.5Fe have been then developed because toxicity of V has been pointed out. Al-and V-free titanium alloys as implant materials have been developed. Most of them are, however, alpha + beta type alloys. beta type titanium alloys with lower moduli of elasticity and greater strength have been developed recently. Design of new beta type titanium alloys composed of non-toxic elements like Nb, Ta, Zr, Mo or Sn with lower moduli of elasticity and greater strength were, therefore, studied based on the d-electron alloy design method, and the basic mechanical properties of designed alloys of button ingots melted by tri-are furnace in the laboratory were investigated in this study. beta type alloys, Ti-Nb-Ta-Zr, Ti-Nb-Ta-Mo and Ti-Nb-Ta-Sn system alloys designed in this study are expected to have greater performance for implant materials. The Young's moduli of these alloys are lower compared with that of Ti-6Al-4V ELI which has been used as an implant material. The alloys on which some heat treatments have been conducted offer suitable tensile properties as implant materials. The tensile strength and elongation of designed alloys in this study are equivalent or greater than required values already reported. (C) 1998 Elsevier Science S.A. All rights reserved.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 441, Japan.
   Nagoya Univ, Dept Mat Sci & Engn, Chikusa Ku, Nagoya, Aichi 46401, Japan.
   Daido Steel, Market Dev Dept, Minato Ku, Nagoya, Aichi, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 441, Japan.
RI Niinomi, Mitsuo/B-5965-2011
CR Morinaga M., 1992, P 7 INT C TIT SAN DI, P276
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   Zwicker R, 1980, P 4 INT C TIT KYOT J, P505
NR 4
TC 674
Z9 709
U1 4
U2 167
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD MAR 15
PY 1998
VL 243
IS 1-2
BP 244
EP 249
DI 10.1016/S0921-5093(97)00808-3
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA ZH762
UT WOS:000073145100033
DA 2018-10-20
ER

PT J
AU De Angelis, AA
   Capitani, D
   Crescenzi, V
AF De Angelis, AA
   Capitani, D
   Crescenzi, V
TI Synthesis and C-13 CP-MAS NMR characterization of a new chitosan-based
   polymeric network
SO MACROMOLECULES
LA English
DT Article
ID SOLID-STATE NMR; CROSS POLARIZATION; CPMAS NMR; RESINS; COATINGS
AB New chemical hydrogels, potentially suitable for biomedical applications, have been synthesized and characterized by C-13 CP-MAS NMR spectroscopy. The polysaccharidic component of these hydrogels is chitosan, while the novel cross-linking agent is diethyl squarate (DES). H-1 and C-13 NMR spectra of chitosan allow a good characterization of the starting materials. In dried chitosan/DES networks, the structure of the chemical bridges (i.e., of the cross-links), has been investigated by C-13 CP-MAS NMR. The spectrum of the cross-linked material appears rather broad and poorly resolved. A large number of weak signals in the 160-190 ppm region is observed, all due to the squarate moiety, but none due to the original diethyl squarate. Squarate may be thought to act both as a bidentate cross-linking agent and as a monodentate substituent. A partial spectral assignment of the CP-MAS spectrum was obtained through a spectral "editing" sequence.
C1 Univ Rome La Sapienza, Dipartimento Chim, I-00185 Rome, Italy.
   CNR, NMR Serv, Area Ric Roma, I-00016 Rome, Italy.
   CNR, Ist Strutturist Chim, Area Ric Roma, I-00016 Rome, Italy.
RP De Angelis, AA (reprint author), Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA.
EM adeangel@ea.oac.uci.edu; nmr@mlib.cnr.it; crescenzi@axrma.uniromal.it
OI Capitani, Donatella/0000-0003-2392-0187
CR AUJLA RS, 1982, POLYM B, V8, P2353
   BAIN AD, 1989, GLINFIT
   BAUER DR, 1984, J POLYM SCI POL PHYS, V22, P2009, DOI 10.1002/pol.1984.180221202
   BAUER DR, 1986, PROG ORG COAT, V14, P45, DOI 10.1016/0033-0655(86)80015-2
   BELFIORE LA, 1984, MACROMOLECULES, V17, P2561, DOI 10.1021/ma00142a017
   BURUM DP, 1991, J MAGN RESON, V95, P184, DOI 10.1016/0022-2364(91)90336-R
   COTTON FA, 1988, ADV INORGANIC CHEM, pCH8
   Crescenzi V, 1997, POLYM GELS NETW, V5, P225, DOI 10.1016/S0966-7822(96)00051-2
   CRESCENZI V, 1995, MACROMOL CHEM PHYSIC, V196, P2873, DOI 10.1002/macp.1995.021960912
   DEANGELIS AA, 1996, THESIS LA SAPIENZA U
   DEMARGERANDRE S, 1994, CARBOHYD POLYM, V23, P211, DOI 10.1016/0144-8617(94)90104-X
   DOMARD A, 1987, INT J BIOL MACROMOL, V9, P98, DOI 10.1016/0141-8130(87)90033-X
   ENGLISH AD, 1983, MACROMOLECULES, V16, P1422, DOI 10.1021/ma00243a004
   GARROWAY AN, 1982, MACROMOLECULES, V15, P1051, DOI 10.1021/ma00232a019
   GORY DG, 1988, CHEM PHYS LETT, V152, P431
   HATFIELD GR, 1987, MACROMOLECULES, V20, P608, DOI 10.1021/ma00169a024
   Hayes E., 1978, P 1 INT C CHIT CHIT, P406
   IJIMA H, BIOCH INT, V19, P353
   Kamath VP, 1996, GLYCOCONJUGATE J, V13, P315, DOI 10.1007/BF00731506
   Law RV, 1996, MACROMOLECULES, V29, P6284, DOI 10.1021/ma951606o
   Law RV, 1997, MACROMOLECULES, V30, P2868, DOI 10.1021/ma9616470
   LINDBERG JJ, 1985, ADV POLYM SCI, V66, P1
   MACIEL GE, 1983, MACROMOLECULES, V16, P598, DOI 10.1021/ma00238a022
   MARK HF, 1990, ENCY POLYM SCI ENG, V13, P441
   MCBRIERTY VJ, 1993, NMR SOLID POLYM
   Muzzarelli R. A. A., 1996, CHITIN ENZYMOLOGY, V2
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   MUZZARELLI RAA, 1993, CHITIN ENZYMOLOGY, V1
   OPELLA SJ, 1979, J AM CHEM SOC, V101, P5854, DOI 10.1021/ja00513a079
   OTTENBRITE RM, 1996, ACS S SERIES, V627
   PEGG DT, 1982, J CHEM PHYS, V77, P2745, DOI 10.1063/1.444188
   RINAUDO M, 1993, INT J BIOL MACROMOL, V15, P281, DOI 10.1016/0141-8130(93)90027-J
   SORENSEN OW, 1982, J MAGN RESON, V46, P180, DOI 10.1016/0022-2364(82)90181-0
   SORENSEN UB, 1985, J MAGN RESON, V65, P222, DOI 10.1016/0022-2364(85)90004-6
   Takai S.M., 1989, NMR XRAY STUDIES CHI
   TIETZE LF, 1991, CHEM BER, V124, P1215, DOI 10.1002/cber.19911240539
   TONELLI AE, 1989, NMR SPECTROSCOPY POL, pCH4
   WANG W, 1994, INT J BIOL MACROMOL, V16, P149, DOI 10.1016/0141-8130(94)90042-6
   WU XL, 1993, J MAGN RESON SER A, V102, P205, DOI 10.1006/jmra.1993.1092
   WU XL, 1993, J MAGN RESON SER A, V104, P119, DOI 10.1006/jmra.1993.1199
   WU XL, 1988, J MAGN RESON, V77, P343
NR 41
TC 40
Z9 40
U1 0
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD MAR 10
PY 1998
VL 31
IS 5
BP 1595
EP 1601
DI 10.1021/ma971619x
PG 7
WC Polymer Science
SC Polymer Science
GA ZB605
UT WOS:000072489300022
DA 2018-10-20
ER

PT J
AU Merritt, K
   Gaind, A
   Anderson, JM
AF Merritt, K
   Gaind, A
   Anderson, JM
TI Detection of bacterial adherence on biomedical polymers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bacterial adherence; Staphylococcus epidermidis; dye elution
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; CAPSULAR POLYSACCHARIDE ADHESIN; SLIME
   PRODUCTION; INTRAVASCULAR CATHETERS; EPIDERMIDIS; IDENTIFICATION;
   INFECTION; DEVICES; INVITRO; MARKER
AB The ability to adhere to materials and promote formation of a biofilm is an important feature of the pathogenicity of some organisms, most notably the coagulase negative staphylococci. Various methods to detect bacterial adherence are available, but detection of adherence to nontransparent materials can be difficult. It was the purpose of this study to establish the suitability of a dye elution technique to detect adherence. The technique involves fixing the bacterial film with formalin, staining with crystal violet, eluting the dye with ethanol, and determining the optical density of the solution using 96-well plates and an enzyme immunosorbent assay reader with a 540-nm filter. This technique distinguished a known adherent from a known nonadherent organism and demonstrated that the presence of protein can inhibit adherence, and that adherence of different organisms to different biomedically important polymers can be measured. The dye elution technique was used to evaluate the adherence of known slime-producing polysaccharide antigen-positive (PSA+) and known nonslime-producing polysaccharide antigen-negative (PSA-) Staphylococcus epidermidis organisms to implant grade materials (polyethylene, expanded polytetrafluoroethylene, Dacron, silicone, and collagen) as well as to polystyrene. (C) 1998 John Wiley & Sons, Inc.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
RP Merritt, K (reprint author), 17704 Stoneridge Dr, Gaithersburg, MD 20878 USA.
FU NHLBI NIH HHS [HL 47300]
CR ARDEHALI R, 1993, J BIOMED MATER RES, V27, P269, DOI 10.1002/jbm.820270217
   BADDOUR LM, 1987, J CLIN MICROBIOL, V25, P207
   BISNO AL, 1989, INFECT ASS INDWELLIN
   Bisno AL, 1994, INFECT ASS INDWELLIN
   CHANG CC, 1994, J ORTHOPAED RES, V12, P526, DOI 10.1002/jor.1100120409
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   CHRISTENSEN GD, 1987, INFECT IMMUN, V55, P2870
   CHRISTENSEN GD, 1990, INFECT IMMUN, V58, P2906
   COLLIGNON PJ, 1989, EUR J CLIN MICROBIOL, V8, P807, DOI 10.1007/BF02185853
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   DEIGHTON MA, 1990, J CLIN MICROBIOL, V28, P2442
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   FRANSON TR, 1986, J CLIN MICROBIOL, V24, P559
   FRANSON TR, 1984, J CLIN MICROBIOL, V20, P500
   GRISTINA AG, 1987, SCIENCE, V237, P1583
   HAAGEN IA, 1990, J INFECT DIS, V161, P266, DOI 10.1093/infdis/161.2.266
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   KOTILAINEN P, 1990, J CLIN MICROBIOL, V28, P2779
   LADD TI, 1985, J CLIN MICROBIOL, V21, P1004
   Merritt K, 1991, J Biomater Appl, V5, P185, DOI 10.1177/088532829100500304
   MULLER E, 1993, INFECT IMMUN, V61, P551
   MULLER E, 1993, J INFECT DIS, V168, P1211, DOI 10.1093/infdis/168.5.1211
   MULLER E, 1991, INFECT IMMUN, V59, P3323
   QUIE PG, 1987, J INFECT DIS, V156, P543, DOI 10.1093/infdis/156.4.543
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   TSAI CL, 1988, J ORTHOPAED RES, V6, P666, DOI 10.1002/jor.1100060507
   VANPETT K, 1990, J ORTHOPAED RES, V8, P321, DOI 10.1002/jor.1100080303
   WANG I, 1993, J BIOMED MATER RES, V27, P1119, DOI 10.1002/jbm.820270902
   YOUNGER JJ, 1987, J INFECT DIS, V156, P548, DOI 10.1093/infdis/156.4.548
NR 30
TC 49
Z9 50
U1 0
U2 10
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 1998
VL 39
IS 3
BP 415
EP 422
DI 10.1002/(SICI)1097-4636(19980305)39:3<415::AID-JBM10>3.0.CO;2-9
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA YR639
UT WOS:000071515400010
PM 9468050
DA 2018-10-20
ER

PT J
AU Engebretson, J
AF Engebretson, J
TI A heterodox model of healing
SO ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE
LA English
DT Article
ID UNITED-STATES
AB A heterodox model of healing incorporating the basic dualism of Western philosophy-the world of concrete material substance versus that of thought, ideals, and spirit-is proposed. Such dualism is reflected in Western constructions of healing. An explanatory paradigm model with a horizontal axis representing paradigms of healing from positivism to metaphysics and a vertical axis representing activities of healing from the material to the spiritual was derive from ethnographic work with healers. A health practice model following the same philosophical patterns illustrates reflected American cultural values in the relative positioning of healing modalities from the orthodox biomedical to the most metaphysical or alternative. Examples of specific modalities of healing, many of which are resurfacing with increasing public interest in alternative therapies, are illustrated. This model places biomedicine in the same context as other philosophical approaches to healing as a standard for comparison. Implications for practice and research are discussed.
C1 InnoVis Commun, Aliso Viejo, CA 92656 USA.
   Univ Texas, Houston Hlth Sci Ctr, Sch Nursing, Houston, TX USA.
RP Engebretson, J (reprint author), InnoVis Commun, 101 Columbia, Aliso Viejo, CA 92656 USA.
CR ANDREWS M, 1995, TRANSCULTURAL CONCEP
   BACH E, 1977, HEAL THYSELF BACH FL
   BROWN PS, 1988, MED HIST, V32, P174, DOI 10.1017/S0025727300047980
   Cassidy C M, 1995, J Altern Complement Med, V1, P19, DOI 10.1089/acm.1995.1.19
   Cox Harvey, 1995, FIRE FROM HEAVEN
   Dossey L, 1995, Altern Ther Health Med, V1, P6
   DOSSEY L, 1995, ALTERN THER HEALTH M, V1, P79
   Dossey L., 1993, HEALING WORDS POWER
   DOUGLAS M, 1989, PURITY DANGER ANAL C
   EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406
   Engebretson J, 1996, QUAL HEALTH RES, V6, P526, DOI 10.1177/104973239600600405
   Engebretson J, 1993, Nurse Pract, V18, P51
   ENGEBRETSON J, 1992, THESIS U TEXAS HOUST
   English-Lueck J. A., 1990, HLTH NEW AGE STUDY C
   EVANS RG, 1994, WHY SOME PEOPLE HLTH
   Foster George, 1978, MED ANTHR
   Freund PES, 1991, HLTH ILLNESS SOCIAL
   Fuller Robert C, 1989, ALTERNATIVE MED AM R
   GOOD BJ, 1994, MED RATIONALITY EXPE
   GROSSINGER R, 1990, PLANET MED
   Guba EB, 1989, 4 GENERATION EVALUAT
   HORGAN J, 1955, END SCI FACING LIMIT
   KALWEIT H, 1987, SHAMANS HEALERS MED
   KAPTCHUK TJ, 1983, WEB THAT HAS NO WEAV
   Kiev Ari, 1964, MAGIC FAITH HEALING
   KONNER M, 1987, BECOMING DOCTOR JOUR
   Lavine T. Z., 1984, SOCRATES SARTRE PHIL
   LEVIN JS, 1986, SOC SCI MED, V23, P889, DOI 10.1016/0277-9536(86)90217-0
   Lloyd J, 1996, J MANAGE ENG, V12, P5, DOI 10.1061/(ASCE)0742-597X(1996)12:6(5.3)
   LOCK M, MED ANTHR CONT THEOR, P90
   Lock M, 1988, BIOMEDICINE EXAMINED
   McGuire M., 1988, RITUAL HEALING SUBUR
   Morris B., 1987, ANTHR STUDIES RELIG
   NEEDLEMAN J, 1982, INDESTRUCTIBLE QUEST
   ORTHGOMER K, 1996, BEHAV MED APPROACHES
   Russell B., 1959, WISDOM W
   SCHNEIDERMAN N, 1992, PERSPECTIVES BEHAV M
   Snow C. P, 1959, 2 CULTURES
   STARR P, 1949, SOCIAL TRANSFORMATIO
   STEIN HF, 1990, AM MED CULTURE
   TARNAS R, 1991, PASSION W WORLD UNDE
   Whorton James C., 1982, CRUSADERS FITNESS HI
NR 42
TC 4
Z9 4
U1 0
U2 0
PU INNOVISION COMMUNICATIONS
PI ALISO VIEJO
PA 101 COLUMBIA, ALISO VIEJO, CA 92656 USA
SN 1078-6791
J9 ALTERN THER HEALTH M
JI Altern. Ther. Health Med.
PD MAR
PY 1998
VL 4
IS 2
BP 37
EP 43
PG 7
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA 141ZL
UT WOS:000077175400014
PM 9682510
DA 2018-10-20
ER

PT J
AU Burns, NL
   Emoto, K
   Holmberg, K
   Van Alstine, JM
   Harris, JM
AF Burns, NL
   Emoto, K
   Holmberg, K
   Van Alstine, JM
   Harris, JM
TI Surface characterization of biomedical materials by measurement of
   electroosmosis
SO BIOMATERIALS
LA English
DT Article
DE biocompatible; coatings; electrophoresis; electroosmosis; polymer;
   poly(ethylene glycol); surface analysis
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; PLASMA POLYMER SURFACES;
   POLY(ETHYLENE GLYCOL); PROTEIN ADSORPTION; POLYSTYRENE SURFACES;
   PELLICLE FORMATION; SILICA; COATINGS; DEXTRAN; QUARTZ
AB This paper reviews recent studies by the authors on the surface characterization of biomedically significant materials through electroosmosis determination. The surfaces studied include transparent and nontransparent materials such as quartz, ceramics, paper, and cast polymer capillaries, slides, and particles, in both native and surface modified form. The method is nondestructive, relatively fast, mechanistically simple, automatable to varying degrees, and can be used to analyze samples under physiologically compatible conditions. New experimental and mathematical modeling approaches allow estimates to be obtained with regard to the surface density and pK of various chemical groups, as well as the thickness of polymer or other surface coatings. Surface modifications which may be characterized include, covalent alteration via radiofrequency plasma discharge or organosilane grafting, noncovalent alteration via polymer adsorption, and covalent grafting of neutral polymers, such as poly(ethylene glycol) or dextran. Results complement those from other surface analysis techniques, and correlate with physiologically significant phenomena such as protein adsorption. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
C1 Univ Alabama, Dept Chem, Huntsville, AL 35899 USA.
   Inst Surface Chem, S-11486 Stockholm, Sweden.
   Univ Alabama, Mat Sci Program, Huntsville, AL 35899 USA.
   Royal Inst Technol, Dept Chem Engn, S-10044 Stockholm, Sweden.
   Royal Inst Technol, Dept Biotechnol, S-10044 Stockholm, Sweden.
RP Van Alstine, JM (reprint author), Univ Alabama, Dept Chem, Huntsville, AL 35899 USA.
CR ANDERSON DJ, 1995, ANAL CHEM, V67, pR475, DOI 10.1021/ac00108a032
   ANDRADE JD, 1988, DYNAMIC ASPECTS POLY
   BALE MD, 1988, J COLLOID INTERF SCI, V125, P516, DOI 10.1016/0021-9797(88)90017-3
   BastosGonzalez D, 1996, J COLLOID INTERF SCI, V177, P372, DOI 10.1006/jcis.1996.0046
   BATTJES KP, SILANES OTHER COUPLI, V199, P92
   BAUER J, 1987, J CHROMATOGR-BIOMED, V418, P359, DOI 10.1016/0378-4347(87)80015-4
   Bergstrom L., 1992, THESIS ROYAL I TECHN
   BOYCE JF, 1992, J COLLOID INTERF SCI, V149, P153, DOI 10.1016/0021-9797(92)90400-G
   BRINK C, 1992, COLLOID SURFACE, V66, P149, DOI 10.1016/0166-6622(92)80131-K
   BROOKS DE, 1973, J COLLOID INTERF SCI, V43, P714, DOI 10.1016/0021-9797(73)90416-5
   Burns NL, 1996, J COLLOID INTERF SCI, V183, P249, DOI 10.1006/jcis.1996.0540
   BURNS NL, 1995, LANGMUIR, V11, P2768, DOI 10.1021/la00007a070
   Burns NL, 1996, J COLLOID INTERF SCI, V178, P116, DOI 10.1006/jcis.1996.0099
   CHURAEV NV, 1995, J COLLOID INTERF SCI, V169, P300, DOI 10.1006/jcis.1995.1037
   CLAESSON PM, 1997, IN PRESS COLLOIDS A
   DEBACHER N, 1992, COLLOID SURFACE, V65, P51, DOI 10.1016/0166-6622(92)80174-Z
   DOREN A, 1989, J COLLOID INTERF SCI, V130, P146, DOI 10.1016/0021-9797(89)90085-4
   DUNSTAN DE, 1994, J CHEM SOC FARADAY T, V90, P1261, DOI 10.1039/ft9949001261
   EKDAHL KN, 1993, J COLLOID INTERF SCI, V158, P121, DOI 10.1006/jcis.1993.1236
   Emoto K, 1996, ANAL CHEM, V68, P3751, DOI 10.1021/ac960114m
   EMOTO K, 1997, IN PRESS LANGMUIR
   EMOTO K, 1996, IN PRESS ANAL CHEM
   EREMENKO BV, 1974, COLLOID J USSR+, V36, P240
   GILGES M, 1994, ANAL CHEM, V66, P2038, DOI 10.1021/ac00085a019
   GROSSMAN PD, 1992, CAPILLARY ELECTROPHO, P3
   HARRIS JM, 1984, J POLYM SCI POL CHEM, V22, P341, DOI 10.1002/pol.1984.170220207
   HARRIS JM, 1987, DYNAMIC ASPECTS POLY, P111
   HARRIS JM, 1992, POLYETHYLENE GYLCOL
   HEALY TW, 1978, ADV COLLOID INTERFAC, V9, P303, DOI 10.1016/0001-8686(78)85002-7
   HERREN BJ, 1987, J COLLOID INTERF SCI, V115, P46, DOI 10.1016/0021-9797(87)90007-5
   HLADY V, 1985, SURFACE INTERFACIAL, V2, P109
   Hommel H, 1996, COLLOID SURFACE A, V111, P67, DOI 10.1016/0927-7757(96)03516-9
   Hunter R. J, 1981, ZETA POTENTIAL COLLO
   James R.O., 1982, SURFACE COLLOID SCI, V12
   KNOX RJ, 1996, IN PRESS ANAL CHEM
   KOHLER J, 1987, J CHROMATOGR, V385, P125, DOI 10.1016/S0021-9673(01)94628-X
   KOOPAL LK, 1988, J COLLOID INTERF SCI, V121, P49, DOI 10.1016/0021-9797(88)90407-9
   LASSEN B, 1994, J MATER SCI-MATER M, V5, P662, DOI 10.1007/BF00120352
   Lin Y S, 1994, Colloids Surf B Biointerfaces, V3, P49, DOI 10.1016/0927-7765(93)01114-7
   LYKLEMA J, 1985, SURFACE INTERFACIAL, V1, P293
   MAKINO K, 1995, J COLLOID INTERF SCI, V174, P400, DOI 10.1006/jcis.1995.1407
   Malmsten M, 1996, COLLOID SURFACE B, V6, P191, DOI 10.1016/0927-7765(95)01255-9
   Malmsten M, 1996, J COLLOID INTERF SCI, V178, P123, DOI 10.1006/jcis.1996.0100
   Malmsten M, 1996, J COLLOID INTERF SCI, V177, P502, DOI 10.1006/jcis.1996.0064
   MATSON RS, 1994, ANAL BIOCHEM, V217, P306, DOI 10.1006/abio.1994.1123
   NORDE W, 1985, SURFACE INTERFACIAL, V2, P293
   NORDT FJ, 1976, ACS SYM SER, V31, P225
   OLSSON J, 1995, COLLOID SURFACE B, V5, P161, DOI 10.1016/0927-7765(95)01212-2
   ONEILL K, 1994, ANAL BIOCHEM, V222, P185, DOI 10.1006/abio.1994.1471
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   OSTERBERG E, 1993, COLLOID SURFACE A, V77, P159, DOI 10.1016/0927-7757(93)80112-R
   PRATTTERPSTRA IH, 1989, J DENT RES, V68, P463, DOI 10.1177/00220345890680030501
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   RUSSEL WB, 1989, COLLOIDAL DISPERSION, P211
   SCALES PJ, 1992, LANGMUIR, V8, P965, DOI 10.1021/la00039a037
   SEAMAN GVF, 1975, RED BLOOD CELL, V1, P1135
   SHARP KA, 1985, BIOPHYS J, V47, P563, DOI 10.1016/S0006-3495(85)83951-5
   THOMAS V, 1993, COLLOID SURFACE A, V77, P125, DOI 10.1016/0927-7757(93)80109-R
   TOWNS JK, 1990, J CHROMATOGR, V516, P69, DOI 10.1016/S0021-9673(01)90205-5
   VANALSTINE JM, 1993, COLLOID SURFACE A, V77, P149, DOI 10.1016/0927-7757(93)80111-Q
   VANALSTINE JM, Patent No. 5108568
   VANALSTINE JM, 1993, ACS SYM SER, P293
   VANALSTINE JM, Patent No. 4690749
   VANDENBERG ET, 1991, J COLLOID INTERF SCI, V147, P103, DOI 10.1016/0021-9797(91)90139-Y
   XU B, 1988, J CHROMATOGR, V445, P1, DOI 10.1016/S0021-9673(01)84504-0
   ZALIPSKY S, 1992, BIOTECHNOL APPL BIOC, V15, P100, DOI 10.1111/j.1470-8744.1992.tb00198.x
NR 66
TC 15
Z9 15
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 1998
VL 19
IS 4-5
BP 423
EP 440
DI 10.1016/S0142-9612(97)00225-1
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ZP913
UT WOS:000073794900010
PM 9677155
DA 2018-10-20
ER

PT J
AU Brook, IM
   Hatton, PV
AF Brook, IM
   Hatton, PV
TI Glass-ionomers: bioactive implant materials
SO BIOMATERIALS
LA English
DT Article; Proceedings Paper
CT 1st European Union Conference on Glass-Ionomers
CY MAY 14-16, 1997
CL UNIV WARWICK, WARWICK, ENGLAND
HO UNIV WARWICK
DE glass-ionomer cement; bone cements; biocompatibility
ID PERIPHERAL-NERVE FUNCTION; ACRYLIC BONE CEMENTS; OTOLOGIC SURGERY;
   DIFFERENTIATION INVIVO; TRICALCIUM PHOSPHATE; FLUORIDE; INVITRO;
   ALUMINUM; PROLIFERATION; INTERFACE
AB Glass-ionomer cements (GICs) originally designed for use as dental materials have a number of advantages over acrylic bone cements. These include lack of exotherm during setting, absence of monomer and improved release of incorporated therapeutic agents; this has resulted in the development of GICs for biomedical applications. Major landmarks in this history are the formulation of defined-composition ionomer glasses and an improved understanding of the biological and material properties of GICs. Following implantation, GICs can form a stable integration with bone, and affect the growth and development of bone, both adjacent to their surface and systemically, through an ion release mechanism. The 'non-inert' nature of this group of materials is also demonstrated by their adverse effects on neural tissue. Successful clinical use of GICs, both as bone cements and as preformed implants for hard tissue replacement, have been reported in the fields of otologic surgery (Cochlear implant fixation, repair of the tympanic chain, eustation tube obliteration and as ear ossicles), and oral and reconstructive surgery. The use of GICs in situations where they will come into contact with nerves or neural tissue is contraindicated. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
C1 Univ Sheffield, Sch Clin Dent, Biomat Res Grp, Sheffield S10 2TA, S Yorkshire, England.
RP Brook, IM (reprint author), Univ Sheffield, Sch Clin Dent, Biomat Res Grp, Claremont Crescent, Sheffield S10 2TA, S Yorkshire, England.
EM i.brook@sheffield.ac.uk
OI Hatton, Paul/0000-0001-5234-1104
CR Babighian G, 1994, Acta Otorhinolaryngol Ital, V14, P107
   BABIGHIAN G, 1992, J LARYNGOL OTOL, V106, P954, DOI 10.1017/S0022215100121450
   BAGAMBISA FB, 1993, J BIOMED MATER RES, V27, P1047, DOI 10.1002/jbm.820270810
   BAGAMBISA FB, 1994, J CRANIO MAXILL SURG, V22, P12, DOI 10.1016/S1010-5182(05)80290-2
   BAKER AS, 1988, J BONE JOINT SURG AM, V70A, P1551, DOI 10.2106/00004623-198870100-00015
   BLUMENTHAL NC, 1984, CALCIFIED TISSUE INT, V36, P438
   BODELL SM, 1993, J DENT RES, V73, P740
   BRADEN M, 1988, Patent No. 47916150
   BROOK I M, 1991, Clinical Materials, V7, P295, DOI 10.1016/0267-6605(91)90073-O
   BROOK IM, 1992, BIOMATERIALS, V13, P721, DOI 10.1016/0142-9612(92)90134-A
   BROOK IM, 1991, BIOMATERIALS, V12, P179, DOI 10.1016/0142-9612(91)90197-I
   BROOK IM, 1994, P 11 EUR C BIOM 13 1, P466
   CARTER DH, 1991, J HISTOCHEM CYTOCHEM, V39, P599, DOI 10.1177/39.5.1707904
   CHARNLEY J, 1970, ACRYLIC CEMENT ORTHO, V33
   CHARNLEY J, 1961, LANCET, V1, P129
   CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075
   DEVLIN AJ, 1994, PUB TIPOGRAFIA VIGO, P459
   DOHERTY P J, 1991, Clinical Materials, V7, P335, DOI 10.1016/0267-6605(91)90078-T
   FARLEY JR, 1983, SCIENCE, V222, P330
   FISCHER AA, 1986, CUTIS, V37, P425
   FORSTEN L, 1991, SCAND J DENT RES, V99, P241
   GEYER G, 1993, EUR ARCH OTO-RHINO-L, V250, P253
   Geyer G, 1992, Eur Arch Otorhinolaryngol Suppl, V1, P185
   GEYER G, 1990, ADV BIOMATER, V10, P529
   GOODMAN WG, 1991, KIDNEY INT, V39, P602, DOI 10.1038/ki.1991.71
   GOODMAN WG, 1985, AM J KIDNEY DIS, V6, P330, DOI 10.1016/S0272-6386(85)80089-5
   Gross U, 1987, BIOMATERIALS CLIN AP, P547
   HATTON PV, 1992, BRIT DENT J, V173, P275, DOI 10.1038/sj.bdj.4808026
   HATTON PV, 1992, MICRON MICROSC ACTA, V23, P363
   HELMS J, 1994, J LARYNGOL OTOL, V108, P202
   HILL RG, 1995, P CERMAICS CELLS TIS
   JARCHO M, 1977, J BIOENG, V1, P79
   JOHAL K, 1995, J MAT SCI MED, V7, P690
   JOHAL K, 1996, J DENT RES, V75, P325
   JONCK L M, 1990, Clinical Materials, V6, P323, DOI 10.1016/0267-6605(90)90052-W
   JONCK LM, 1989, CLIN MAT, V4, P201, DOI DOI 10.1016/0267-6605(89)90030-9
   JONCK LM, 1989, CLIN MATER, V4, P85
   KAVANAGH BF, 1987, J BONE JOINT SURG AM, V69A, P1144, DOI 10.2106/00004623-198769080-00006
   KOTANI S, 1991, J BIOMED MATER RES, V25, P1303, DOI 10.1002/jbm.820251010
   LAU KHW, 1991, MOL CELL BIOCHEM, V105, P93
   LOESCHER AR, 1994, J MATER SCI-MATER M, V5, P551, DOI 10.1007/BF00124888
   LOESCHER AR, 1994, J MATER SCI-MATER M, V5, P108, DOI 10.1007/BF00121699
   LUNDY MW, 1986, BONE, V7, P289, DOI 10.1016/8756-3282(86)90210-3
   MACKIE EJ, 1987, J CELL BIOL, V105, P2569, DOI 10.1083/jcb.105.6.2569
   MALLAKH BF, 1990, DENT MATER, V6, P118
   MCCLEAN JW, 1988, BR DENT J, V164, P293
   MCELVEEN JT, 1994, OTOLARYNG CLIN N AM, V27, P777
   MEHTA S, 1995, BIOMATERIALS, V16, P97, DOI 10.1016/0142-9612(95)98269-K
   MEYER U, 1993, BIOMATERIALS, V14, P917, DOI 10.1016/0142-9612(93)90133-M
   MULLER J, 1993, LARYNGO RHINO OTOL, V72, P36, DOI 10.1055/s-2007-997850
   MULLER J, 1994, LARYNGO RHINO OTOL, V73, P160, DOI 10.1055/s-2007-997102
   NICHOLSON J W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P277, DOI 10.1163/156856291X00179
   NORDENVALL KJ, 1992, SWED DENT J, V6, P87
   PAK CYC, 1989, J CLIN ENDOCR METAB, V68, P150, DOI 10.1210/jcem-68-1-150
   PATEL MP, 1991, BIOMATERIALS, V12, P653, DOI 10.1016/0142-9612(91)90112-N
   QUARLES LD, 1991, MINER ELECTROL METAB, V17, P233
   QUARLES LD, 1990, J BONE MINER RES, V5, P625
   RAMSDEN RT, 1995, ADV OTO-RHINO-LARYNG, V50, P51
   RAMSDEN RT, 1992, J LARYNGOL OTOL, V106, P949, DOI 10.1017/S0022215100121449
   RENARD JL, 1994, LANCET, V344, P63, DOI 10.1016/S0140-6736(94)91089-8
   REUSCHE E, 1994, LANCET, V345, P1633
   SASANALUCKIT P, 1993, BIOMATERIALS, V14, P906, DOI 10.1016/0142-9612(93)90132-L
   SOGAARD CH, 1995, BONE, V16, P163, DOI 10.1016/S8756-3282(94)00025-5
   SZULCZEWSKI DH, 1993, CELL MATER, V3, P83
   TALLROTH K, 1989, J BONE JOINT SURG BR, V71, P571
   TURNER RT, 1989, J BONE MINER RES, V4, P477
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   WEISS RE, 1981, EXP CELL RES, V133, P247, DOI 10.1016/0014-4827(81)90316-5
   WILSON AD, 1973, Patent No. 1316129
   WILSON AD, 1988, GLASS IONOMER CEMENT
   WITTWER C, 1994, J MATER SCI-MATER M, V5, P711, DOI 10.1007/BF00120362
   WOOD D, 1991, Clinical Materials, V7, P301, DOI 10.1016/0267-6605(91)90074-P
NR 72
TC 84
Z9 87
U1 0
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 1998
VL 19
IS 6
BP 565
EP 571
DI 10.1016/S0142-9612(98)00138-0
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ZR149
UT WOS:000073942300013
PM 9645564
DA 2018-10-20
ER

PT J
AU Jones, R
   Barry, NP
   Hyde, SCW
   Tziraki, M
   Dainty, JC
   French, PMW
   Nolte, DD
   Kwolek, KM
   Melloch, MR
AF Jones, R
   Barry, NP
   Hyde, SCW
   Tziraki, M
   Dainty, JC
   French, PMW
   Nolte, DD
   Kwolek, KM
   Melloch, MR
TI Real-time 3-D holographic imaging using photorefractive media including
   multiple-quantum-well devices
SO IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS
LA English
DT Article; Proceedings Paper
CT Meeting on Ultrafast Optics
CY 1997
CL MONTEREY, CALIFORNIA
DE biomedical infrared imaging; holography; photorefractive materials
ID OPTICAL COHERENCE TOMOGRAPHY; HIGHLY SCATTERING MEDIA; DIFFUSING MEDIA;
   THICK TISSUES; AMPLIFICATION
AB We discuss a real-time coherence gated three-dimensional (3-D) imaging system, based on photorefractive holography with ultrashort pulses, which has been applied to imaging through turbid media with a view to developing biomedical instrumentation. Sub-100-mu m depth-resolved images of 3-D objects embedded in a scattering medium have been obtained. Using a long integration time in rhodium-doped barium titanate (Rh:BaTiO3), an image of a test chart has been obtained through 16 mean-free paths of scattering medium. Real-time depth-resolved imaging through 13 mean free paths of scattering medium has been demonstrated using a fast response time (< 0.4 ms) photorefractive multiple quantum well device. This latter system can acquire depth-resolved images direct to video with no requirement for frame grabbing or signal processing. We discuss the tradeoffs and limitations of these photorefractive media for this application.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Phys, Femtosecond Opt Grp, London SW7 2BZ, England.
   Univ Illinois, Fluorescence Dynam Lab, Urbana, IL 61801 USA.
   Purdue Univ, W Lafayette, IN 47907 USA.
RP Jones, R (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Phys, Femtosecond Opt Grp, London SW7 2BZ, England.
CR ABRAMSON N, 1978, OPT LETT, V3, P121, DOI 10.1364/OL.3.000121
   ANDERSON GE, 1994, OPT LETT, V19, P981, DOI 10.1364/OL.19.000981
   CHEN H, 1991, OPT LETT, V16, P487, DOI 10.1364/OL.16.000487
   CHERNIKOV SV, 1997, P CLEO 97, P83
   DAS BB, 1993, OPT LETT, V18, P1092, DOI 10.1364/OL.18.001092
   DILWORTH DS, 1991, APPL OPTICS, V30, P1796, DOI 10.1364/AO.30.001796
   HEE MR, 1993, OPT LETT, V18, P1107, DOI 10.1364/OL.18.001107
   HEE MR, 1993, OPT LETT, V18, P950, DOI 10.1364/OL.18.000950
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   HYDE SCW, 1995, OPT LETT, V20, P2330, DOI 10.1364/OL.20.002330
   Hyde SCW, 1996, IEEE J SEL TOP QUANT, V2, P965, DOI 10.1109/2944.577323
   HYDE SCW, 1995, OPT LETT, V20, P1331, DOI 10.1364/OL.20.001331
   Jones R, 1996, APPL PHYS LETT, V69, P1837, DOI 10.1063/1.117450
   KNUTTEL A, 1994, OPT LETT, V19, P302, DOI 10.1364/OL.19.000302
   LEITH EN, 1991, OPT LETT, V16, P1820, DOI 10.1364/OL.16.001820
   MAMAEV AV, 1993, P C LAS EL, P632
   MELLISH R, 1995, OPT LETT, V20, P2312, DOI 10.1364/OL.20.002312
   MILLER DAB, 1984, PHYS REV LETT, V53, P2173, DOI 10.1103/PhysRevLett.53.2173
   MOON JA, 1994, OPT LETT, V19, P1234, DOI 10.1364/OL.19.001234
   NOLTE DD, 1990, J OPT SOC AM B, V7, P2217, DOI 10.1364/JOSAB.7.002217
   NOLTE DD, 1995, PHOTOREFRACTIVE EFFE, pCH7
   PARTOVI A, 1993, OPT LETT, V18, P906, DOI 10.1364/OL.18.000906
   REBANE A, 1991, NATURE, V351, P378, DOI 10.1038/351378a0
   ROWE MP, 1995, OPT LETT, V20, P608, DOI 10.1364/OL.20.000608
   SPEARS KG, 1989, IEEE T BIO-MED ENG, V36, P1210, DOI 10.1109/10.42116
   WANG Q, 1992, J OPT SOC AM B, V9, P1626, DOI 10.1364/JOSAB.9.001626
   WATSON J, 1995, OPT LETT, V20, P231, DOI 10.1364/OL.20.000231
   YOO KM, 1991, OPT LETT, V16, P1019, DOI 10.1364/OL.16.001019
NR 28
TC 13
Z9 13
U1 0
U2 1
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 1077-260X
J9 IEEE J SEL TOP QUANT
JI IEEE J. Sel. Top. Quantum Electron.
PD MAR-APR
PY 1998
VL 4
IS 2
BP 360
EP 369
DI 10.1109/2944.686743
PG 10
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA ZV019
UT WOS:000074260200026
DA 2018-10-20
ER

PT J
AU Udelson, D
   Nehra, A
   Hatzichristou, DG
   Azadzoi, K
   Moreland, RB
   Krane, J
   de Tejada, IS
   Goldstein, I
AF Udelson, D
   Nehra, A
   Hatzichristou, DG
   Azadzoi, K
   Moreland, RB
   Krane, J
   de Tejada, IS
   Goldstein, I
TI Engineering analysis of penile hemodynamic and structural-dynamic
   relationships: Part I - Clinical implications of penile tissue
   mechanical properties
SO INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH
LA English
DT Article
DE penile rigidity; erectile physiology; impotence; biomedical engineering;
   tissue mechanical properties
ID CLINICOPATHOLOGICAL CORRELATION; IMPOTENCE; ERECTION
AB Purpose: The least investigated physical determinant of penile rigidity has been penile tissue material properties. The goals in this study (Part I) were to define two penile mechanical parameters, cavernosal expandability X and tunical distensibility V-E/V-F, determine their magnitudes in humans and develop an analytical expression for penile volume as a function of these two tissue characteristics and intracavernosal pressure.
   Methods: Dynamic infusion pharmacocavernosometry was performed in 21 impotent patients (age 43+/-19y) to provide human geometric, hemodynamic and structural data. A mathematically derived model of hemodynamic and structural-dynamic characteristics of penile erection was developed (Parts I, II, III) incorporating penile tissue mechanical qualities.
   Results: Cavernosal expandability X provided a measure of the ability to approach maximum volume at relatively low intracavernosal pressures. Tunical distensibility V-E/V-F denoted the maximal erect to flaccid penile volume ratio. The magnitudes of X and V-E/V-F in the study population were 0.04-0.17 mmHg(-1) and 1.7-5.0 respectively.
   Conclusions: Enabling penile volume to be derived as a function of tissue mechanical characteristics and pressure, allows for penile rigidity to be expressed (in Part II) as a function of pressure, geometry and tissue qualities.
C1 Boston Univ, Sch Med, Dept Urol, Boston, MA 02118 USA.
   Boston Univ, Coll Engn, Dept Aerosp & Mech Engn, Boston, MA 02215 USA.
RP Goldstein, I (reprint author), Boston Univ, Sch Med, Dept Urol, 720 Harrison Ave,P606, Boston, MA 02118 USA.
FU NIDDK NIH HHS [DK-39080, DK-40025, DK-40487]
CR BEER FP, 1992, MECH MATER, P77
   Bondil P, 1990, INT J IMPOT RES, V2, P193
   CHAUDHOKE PS, 1989, INT J IMPOT RES, V1, P137
   DETEJADA IS, 1991, AM J PHYSIOL, V260, pH1590
   DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83
   FREIDENBERG DH, 1987, J UROLOGY, V138, P533, DOI 10.1016/S0022-5347(17)43251-4
   FROHRIB DA, 1987, J BIOMECH ENG-T ASME, V109, P110, DOI 10.1115/1.3138651
   HALL SJ, 1995, J UROLOGY, V153, P372, DOI 10.1097/00005392-199502000-00023
   HATZICHRISTOU DG, 1995, J UROLOGY, V153, P1126, DOI 10.1016/S0022-5347(01)67530-X
   KRANE RJ, 1989, NEW ENGL J MED, V321, P1648, DOI 10.1056/NEJM198912143212406
   LUE TF, 1984, UROLOGY, V24, P347, DOI 10.1016/0090-4295(84)90208-5
   NEHRA A, 1995, J UROLOGY, V153, P1140, DOI 10.1016/S0022-5347(01)67533-5
   Nehra A, 1996, J UROLOGY, V156, P1320, DOI 10.1016/S0022-5347(01)65578-2
   NELSON RP, 1989, J UROLOGY, V141, P1123, DOI 10.1016/S0022-5347(17)41188-8
   OLSON, 1990, ESS ENG FLUID MECH, P314
   PUECHLEAO P, 1992, INT J IMPOT RES S2, V4, P43
   Udelson Daniel, 1995, Journal of Urology, V153, p332A
   WESPES E, 1984, BRIT J UROL, V56, P416, DOI 10.1111/j.1464-410X.1984.tb05834.x
   WESPES E, 1990, INT J IMPOT RES, V2, P228
NR 19
TC 50
Z9 52
U1 0
U2 0
PU STOCKTON PRESS
PI BASINGSTOKE
PA HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND
SN 0955-9930
J9 INT J IMPOT RES
JI Int. J. Impot. Res.
PD MAR
PY 1998
VL 10
IS 1
BP 15
EP 24
DI 10.1038/sj.ijir.3900310
PG 10
WC Urology & Nephrology
SC Urology & Nephrology
GA ZB678
UT WOS:000072496600004
PM 9542686
OA Bronze
DA 2018-10-20
ER

PT J
AU Hughes, PSH
   Hughes, AP
AF Hughes, PSH
   Hughes, AP
TI Absence of human papillomavirus DNA in the plume of erbium : YAG
   laser-treated warts
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Article
ID CARBON-DIOXIDE LASER; ABLATION; VAPOR
AB Bnckground: The erbium:YAG laser (Continuum Biomedical, Dublin, Calif.) is a new resurfacing and ablating laser that produces minimal residual thermal damage. Laser safety requires careful attention to the hazards of the laser plume. It is important to know whether viable organisms survive in the vapors. Human papillomavirus (HPV) DNA has been detected in the vapor of carbon dioxide laser-treated and electrodesiccated human warts. The presence or absence of HPV DNA in the laser plume of erbium:YAG laser-treated warts has not been previously studied to out knowledge,
   Objective: Our purpose was to determine the presence or absence of HPV DNA in the laser plume of erbium:YAG laser-treated human warts.
   Methods: One half of clinically typical and histopathologically confirmed verrucae vulgares from five patients were submitted for HPV DNA detection with in situ hybridization. After erbium:YAG laser ablation of the remainder of the warts, the laser plume was deposited on the handpiece as an abundant fluffy material and was submitted for evaluation of HPV DNA by polymerase chain reaction with consensus primers for the HPV type detected in the wart specimens.
   Results: HPV2 DNA was found in all warts. HPV DNA was not detected in the erbium:YAG laser plume after ablation of these same warts.
   Conclusion: The absence of HPV DNA in the plume of erbium:YAG laser-treated warts is a significant safety feature of this laser.
C1 Vanderbilt Univ, Nashville, TN USA.
CR Fitzpatrick RE, 1996, ARCH DERMATOL, V132, P469, DOI 10.1001/archderm.132.4.469
   GAGLIANO FP, 1974, APPL OPTICS, V13, P274, DOI 10.1364/AO.13.000274
   GARDEN JM, 1988, JAMA-J AM MED ASSOC, V259, P1199, DOI 10.1001/jama.259.8.1199
   Hohenleutner U, 1997, LASER SURG MED, V20, P242, DOI 10.1002/(SICI)1096-9101(1997)20:3<242::AID-LSM2>3.0.CO;2-Q
   HRUZA GJ, 1993, ARCH DERMATOL, V129, P1026, DOI 10.1001/archderm.129.8.1026
   KAUFMANN R, 1990, CLIN EXP DERMATOL, V15, P389, DOI 10.1111/j.1365-2230.1990.tb02125.x
   Majewski S, 1997, J AM ACAD DERMATOL, V36, P659, DOI 10.1016/S0190-9622(97)80315-5
   SAWCHUK WS, 1989, J AM ACAD DERMATOL, V21, P41, DOI 10.1016/S0190-9622(89)70146-8
   Teikemeier G, 1997, DERMATOL SURG, V23, P685, DOI 10.1111/j.1524-4725.1997.tb00389.x
   TREVOR M, 1987, HOSP INFECT CONTROL, P166
   WALSH JT, 1989, LASER SURG MED, V9, P314, DOI 10.1002/lsm.1900090403
   WALSH JT, 1988, THESIS MIT ARCH CAMB
   YANG CC, 1995, ANN PLAS SURG, V35, P154, DOI 10.1097/00000637-199508000-00007
NR 13
TC 28
Z9 29
U1 0
U2 3
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PD MAR
PY 1998
VL 38
IS 3
BP 426
EP 428
DI 10.1016/S0190-9622(98)70500-6
PG 3
WC Dermatology
SC Dermatology
GA ZB160
UT WOS:000072442400006
PM 9520024
DA 2018-10-20
ER

PT J
AU Wang, Y
   Khor, KA
   Cheang, P
AF Wang, Y
   Khor, KA
   Cheang, P
TI Thermal spraying of functionally graded calcium phosphate coatings for
   biomedical implants
SO JOURNAL OF THERMAL SPRAY TECHNOLOGY
LA English
DT Article
DE alpha-tricalcium phosphate; calcium phosphates; functionally graded
   materials (FGM); hydroxyapatite; plasma spraying
ID HYDROXYAPATITE COATINGS; COATED IMPLANTS; TITANIUM; FABRICATION; BONE
AB Biomedical requirements in a prosthesis are often complex and diverse in nature. Biomaterials for implants have to display a wide range adaptability to suit the various stages of the bio-integration process of any foreign material into the human body, Often, a combination of materials is needed. The preparation of a functionally graded bioceramic coating composed of essentially calcium phosphate compounds is explored. The coating is graded in accordance to adhesive strength, bioactivity, and bioresorbability. The bond coat on the Ti-6Al-4V stub is deposited with a particle range of the hydroxyapatite (HA) that will provide a high adhesive strength and bioactivity but have poor bioresorption properties. The top coat, however, is composed of predominantly alpha-tricalcium phosphate (alpha-TCP) that is highly bioresorbable. This arrangement has the propensity of allowing accelerated bio-integration of the coating by the body tissues as the top layer is rapidly resorbed, leaving the more bioactive intermediate layer to facilitate the much needed bioactive properties for proper osteoconduction. The processing steps and problems are highlighted, as well as the results of post-spray heat treatment.
C1 Nanyang Technol Univ, Singapore 639798, Singapore.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
OI KHOR, Khiam/0000-0003-1954-8423
CR BERNDT CC, 1992, THERMAL SPRAY : INTERNATIONAL ADVANCES IN COATINGS TECHNOLOGY, P465
   BROWN PW, 1992, J AM CERAM SOC, V75, P17, DOI 10.1111/j.1151-2916.1992.tb05435.x
   Cheang P, 1996, BIOMATERIALS, V17, P537, DOI 10.1016/0142-9612(96)82729-3
   CLAES L, 1990, HDB BIOACTIVE CERAMI, V2, P77
   COOK SD, 1992, J BIOMED MATER RES, V26, P989, DOI 10.1002/jbm.820260803
   De Groot K., 1990, HDB BIOACTIVE CERAMI, P3
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   DUCHEYNE P, 1980, J BIOMED MATER RES, V14, P225, DOI 10.1002/jbm.820140305
   EVANS SL, 1994, J MATER SCI-MATER M, V5, P495, DOI 10.1007/BF00058990
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   GROSS KA, 1995, P 8 INT S CER MED, P361
   HARADA Y, 1989, J TOKYO DENT COLL SO, V89, P263
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HUELSMAN SW, 1994, T MRS JAP, V16, P1259
   JI HX, 1992, J MATER SCI-MATER M, V3, P283, DOI 10.1007/BF00705294
   KAWAMURA M, 1994, T MRS JAP, V16, P1251
   Khor KA, 1997, J MATER PROCESS TECH, V63, P271, DOI 10.1016/S0924-0136(96)02634-9
   KHOR KA, 1997, IN PRESS J THERM SPR
   KHOR KA, 1994, INFLUENCE POWDER CHA, P147
   KIJIMA T, 1979, J AM CERAM SOC, V62, P455, DOI 10.1111/j.1151-2916.1979.tb19104.x
   KLEIN CPAT, 1994, J BIOMED MATER RES, V28, P909, DOI 10.1002/jbm.820280810
   KOIZUMI M, 1995, MRS BULL, V20, P19
   MCPHERSON R, 1995, J MATER SCI-MATER M, V6, P327, DOI 10.1007/BF00120300
   *MILL THERM INC, 1993, OP MAN
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   PARK JB, 1984, BIOMATERIALS SCI ENG, P212
   RAVAGLIOLI A, 1992, BIOCERAMICS, P176
   REY C, 1991, BIOCERAMICS, V4, P57
   TISDEL CL, 1994, J BONE JOINT SURG AM, V76A, P159, DOI 10.2106/00004623-199402000-00001
   WANG BC, 1993, J MATER SCI-MATER M, V4, P394, DOI 10.1007/BF00122198
   YAMASHITA K, 1994, J AM CERAM SOC, V77, P2401, DOI 10.1111/j.1151-2916.1994.tb04611.x
   ZYMAN Z, 1993, BIOMATERIALS, V14, P1140, DOI 10.1016/0142-9612(93)90158-X
NR 33
TC 22
Z9 23
U1 0
U2 4
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA SUBSCRIPTIONS SPECIALIST CUSTOMER SERVICE, MATERIALS PARK, OH 44073-0002
   USA
SN 1059-9630
J9 J THERM SPRAY TECHN
JI J. Therm. Spray Technol.
PD MAR
PY 1998
VL 7
IS 1
BP 50
EP 57
DI 10.1007/s11666-006-5003-9
PG 8
WC Materials Science, Coatings & Films
SC Materials Science
GA ZB684
UT WOS:000072497200033
DA 2018-10-20
ER

PT J
AU Fischer, P
   Hausmann, J
   Overdick, M
   Raith, B
   Wermes, N
   Blanquart, L
   Bonzom, V
   Delpierre, P
AF Fischer, P
   Hausmann, J
   Overdick, M
   Raith, B
   Wermes, N
   Blanquart, L
   Bonzom, V
   Delpierre, P
TI A counting pixel readout chip for imaging applications
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article
DE pixels; imaging; readout chip
AB A pixel readout chip for imaging applications has been designed and tested. It consists of an array of 12 x 63 pixels with an active pixel cell area of 50 mu m x 350 mu m Every pixel contains a low-noise charge sensitive amplifier, a CMOS comparator including individually adjustable thresholds, and a 15 bit counter realized using a linear feedback shift register, During data accumulation, every pixel independently counts the number of signal hits above threshold. After accumulation all counters in a column are sequentially read out, all columns in parallel. Thresholds can be set globally with the possibility of an individual threshold adjust in every cell. The chip can be operated with threshold settings in every cell well below equivalent noise charges (ENC) of 1000 electrons. The dead time of a pixel after being hit is similar to 500 ns. The chip is alive for data accumulation in > 99.9% of the total data acquisition time. For photon counting in biomedical or material science applications, a suitable sensor with high Z material can be bump bonded to the counting chip. (C) 1998 Elsevier Science B.V. All rights reserved.
C1 Univ Bonn, Inst Phys, D-53115 Bonn, Germany.
   CNRS, IN2P3, Ctr Phys Particules, F-13288 Marseille 9, France.
RP Wermes, N (reprint author), Univ Bonn, Inst Phys, Nussallee 12, D-53115 Bonn, Germany.
EM wermes@physik.uni-bonn.de
CR ATLAS Collaboration The ATLAS Collaboration, 1994, CERNLHCC9443 ATLAS C
   *ATLAS INNER DETEC, 1997, CERNLHCC9717 ATLAS I
   Blanquart L, 1997, NUCL INSTRUM METH A, V395, P313, DOI 10.1016/S0168-9002(96)01238-7
   BLANQUART L, UNPUB NUCL INSTR A
   *BLUE BOARD, SIL SOL
   CAMPBELL M, 1994, NUCL INSTRUM METH A, V342, P52, DOI 10.1016/0168-9002(94)91410-9
   Fischer P, 1996, NUCL INSTRUM METH A, V378, P297, DOI 10.1016/0168-9002(96)00200-8
   FISCHER P, 1997, P 7 PIS M ADV DET
   FISCHER P, 1997, BONNHE9703
   Heijne EHM, 1996, NUCL INSTRUM METH A, V383, P55, DOI 10.1016/S0168-9002(96)00658-4
   HEIJNE EHM, 1994, NUCL INSTRUM METH A, V349, P138, DOI 10.1016/0168-9002(94)90617-3
   HEIJNE EHM, 1994, NUCL INSTRUM METH A, V348, P399, DOI 10.1016/0168-9002(94)90769-2
   HORISBERGER R, 1997, P 7 PIS M ADV DET EL
   HOROWITZ P, 1994, IEEE T COMPUT, V43, P560
   Watson J, 1962, MATH COMPUT, V16, P368
   WRIGHT M, 1992, P I8NT C HIGH EN PHY
NR 16
TC 27
Z9 27
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD MAR 1
PY 1998
VL 405
IS 1
BP 53
EP 59
DI 10.1016/S0168-9002(97)01146-7
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA ZD608
UT WOS:000072703600007
DA 2018-10-20
ER

PT J
AU Baglin, JEE
   Davis, JC
   Gabella, P
   Prozesky, VM
   Sie, S
AF Baglin, JEE
   Davis, JC
   Gabella, P
   Prozesky, VM
   Sie, S
TI Future analytical needs for industry and technology
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 13th International Conference on Ion Beam Analysis (IBA-13)
CY JUL 27-AUG 01, 1997
CL LISBON, PORTUGAL
DE future analytical needs; semiconductors; biomedicine; minerals;
   geoscience; PIXE; AMS; ion microbeams
AB This paper summarizes reports and opinions presented during a Roundtable Session of the same title at the 13th International Conference on Ion Beam Analysis, Lisbon, 1997, The evolution of new technologies and new fields of research is creating new demands for advanced materials analysis, often at a level not attainable with current techniques. We therefore explore some opportunities for creative development of new or enhanced ion beam techniques to satisfy major predictable needs of the future. In particular, new analytical applications are discussed for the semiconductor industry. for biomedical research, and for advanced research in minerals and geoscience. (C) 1998 Elsevier Science B.V.
C1 IBM Corp, Almaden Res Ctr, San Jose, CA 95120 USA.
   Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
   SEMATECH, SEMI, Austin, TX 78741 USA.
   Natl Accelerator Ctr, Van de Graaff Grp, ZA-7131 Faure, South Africa.
   CSIRO Explorat & Min, N Ryde, NSW 2113, Australia.
RP Baglin, JEE (reprint author), IBM Corp, Almaden Res Ctr, 650 Harry Rd,K191D1, San Jose, CA 95120 USA.
EM baglin@almaden.ibm.com
NR 0
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD MAR
PY 1998
VL 136
BP 35
EP 41
DI 10.1016/S0168-583X(97)00832-X
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA ZW154
UT WOS:000074380400005
DA 2018-10-20
ER

PT J
AU El Khoby, T
   Galal, N
   Fenwick, A
AF El Khoby, T
   Galal, N
   Fenwick, A
TI The USAID Government of Egypt's Schistosomiasis Research Project (SRP)
SO PARASITOLOGY TODAY
LA English
DT Review
ID NILE DELTA; MANSONI; ANTIGEN
AB Schistosomiasis is the major public health problem in rural Egypt, with almost six million Egyptians infected as at min 1996. lit 1983, the prevalence of schistosomiasis in rural Egypt was greater than 50%(1), but a ten-year campaign of diagnosis and treatment has reduced the prevalence and intensity of infection. Parallel to this campaign, the government of the USA has funded a research project to examine all aspects of schistosomiasis with a view to improving the control strategy. As outlined here by Taha EI Khoby, Nabil Galal and Alan Fenwick, after almost ten years, the project's achievements include: assisting WHO in its attempts to develop a vaccine against schistosomiasis, developing a suspension formulation of praziquantel suitable for young children, and establishing a unit to monitor reports of resistance to praziquantel(2,3). In addition, a large epidemiological study has established the extent of the problem in Egypt(4). Slow-release formulation of niclosamide(5), health education material for use on TV, dipstick diagnostic tests(6), and evaluation of ultrasound as a diagnostic tool have also been achieved(7-9). As the project closes, Egypt is left with an effective strategy for the control of schistosomiasis and several back-tip tools for use in the event of development of resistance to praziquantel. The Ministry of Health and Population has the basis of a Geographical Information System (GIS) unit and the country has a trained and equipped scientific community capable of biomedical research, and almost 100 scientific papers published on their work.
C1 SRP, Cairo, Egypt.
RP Fenwick, A (reprint author), SRP, 51 Wezarat El Zeraa St Agouza, Cairo, Egypt.
EM SRP@FRCU.EUN.EG
CR Al-Sherbiny M., 1996, Journal of the Egyptian German Society of Zoology, V20, P81
   Barakat R, 1995, TROP GEOGR MED, V47, P259
   Bennett JL, 1997, EXP PARASITOL, V87, P260, DOI 10.1006/expr.1997.4229
   CLINE BL, 1989, AM J TROP MED HYG, V41, P56, DOI 10.4269/ajtmh.1989.41.56
   DEJONGE N, 1988, T ROY SOC TROP MED H, V82, P591, DOI 10.1016/0035-9203(88)90523-8
   EMARA LH, 1995, P INT S CONTR REL BI, V22, P220
   Fallon PG, 1996, PARASITOL TODAY, V12, P316, DOI 10.1016/0169-4758(96)10029-6
   HASSAN MM, 1992, AM J TROP MED HYG, V46, P737, DOI 10.4269/ajtmh.1992.46.737
   Ismail M, 1996, AM J TROP MED HYG, V55, P214, DOI 10.4269/ajtmh.1996.55.214
   Katsha S, 1997, TROP MED INT HEALTH, V2, P846
   LEIPER R. T., 1915, Journal of the Royal Army Medical Corps, V25, P1
   Malone JB, 1997, PARASITOL TODAY, V13, P112, DOI 10.1016/S0169-4758(97)01009-0
   Scott JA, 1937, AM J HYG, V25, P566, DOI 10.1093/oxfordjournals.aje.a118323
   STRICKLAND GT, 1993, T ROY SOC TROP MED H, V87, P132, DOI 10.1016/0035-9203(93)90458-3
   WAHAB MFA, 1993, T R SOC TROP MED HYG, V87, P135
   WAHAB MFA, 1993, AM J GASTROENTEROL, V88, P560
   WEBBE G, 1990, T ROY SOC TROP MED H, V84, P394, DOI 10.1016/0035-9203(90)90334-B
   Yousif Fouad, 1995, Journal of Medical and Applied Malacology, V5, P69
   1987, T R SOC TROP MED HYG, V81, P1
NR 19
TC 38
Z9 39
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0169-4758
J9 PARASITOL TODAY
JI Parasitol. Today
PD MAR
PY 1998
VL 14
IS 3
BP 92
EP 96
DI 10.1016/S0169-4758(97)01206-4
PG 5
WC Parasitology
SC Parasitology
GA ZA134
UT WOS:000072332300004
PM 17040713
DA 2018-10-20
ER

PT J
AU Palmaz, JC
AF Palmaz, JC
TI Biopolymers for endovascular use
SO SEMINARS IN INTERVENTIONAL RADIOLOGY
LA English
DT Review
DE vascular polymers, properties; stent grafts; endovascular implants
ID ABDOMINAL AORTIC-ANEURYSMS; BIOMEDICAL POLYMERS; GRAFTS; STENTS;
   POLYTETRAFLUOROETHYLENE; BIOSTABILITY; POLYURETHANE; STIMULATION;
   GENERATION; ARTERIES
AB This article reviews the current status of polymeric graft materials used in stent grafts. The chemical structure, physical properties, and biological properties of polyethylene terephthalate (PET), polytetrafluoroethylene (PET), and polyurethane (PU) are described. Each polymer has specific advantages and disadvantages. Polymer thrombogenicity, porosity, tensile strength, and durability impact on endovascular applications. PTFE appears most suitable to small diameter grafts, while PET materials are used for large (>10 mm diameter) grafts. Endovascular grafts composed of PU are not currently available. The use of currently available polymeric graft materials for endovascular procedures requires careful matching of polymer properties with clinical applications.
C1 Univ Texas, Hlth Sci Ctr, San Antonio, TX 78284 USA.
RP Palmaz, JC (reprint author), Univ Texas, Hlth Sci Ctr, 7703 Floyd Curl Dr, San Antonio, TX 78284 USA.
CR Abbott W M, 1997, Semin Vasc Surg, V10, P3
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   Blum U, 1997, NEW ENGL J MED, V336, P13, DOI 10.1056/NEJM199701023360103
   BURGER K, 1972, ANN SURG, V175, P118
   CLOUSE AW, 1986, AM J PATHOL, V123, P220
   DEREUME JPE, 1997, ENDOVASCULAR SURG AO
   HAMLIN GW, 1978, BRIT J SURG, V65, P272, DOI 10.1002/bjs.1800650416
   HASTINGS GW, 1984, MACROMOLECULAR BIOMA
   *ICI ADV MAT, F1213 ICI
   KALMAN PG, 1993, J VASC SURG, V17, P531, DOI 10.1016/0741-5214(93)90154-E
   KATO N, IN PRESS JVIR
   LEIDNER J, 1983, J BIOMED MATER RES, V17, P229, DOI 10.1002/jbm.820170203
   MARIN ML, 1995, J VASC SURG, V21, P595, DOI 10.1016/S0741-5214(95)70191-5
   Marin ML, 1996, J VASC INTERV RADIOL, V7, P651, DOI 10.1016/S1051-0443(96)70823-0
   MCCLURKEN ME, 1984, J COLLOID INTERF SCI, V101, P436
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   MURPHY JG, 1992, CIRCULATION, V86, P1596, DOI 10.1161/01.CIR.86.5.1596
   Norgren L, 1997, J ENDOVASC SURG, V4, P169, DOI 10.1583/1074-6218(1997)004<0169:BRTETO>2.0.CO;2
   Palmaz F, 1996, J VASC INTERV RADIOL, V7, P657, DOI 10.1016/S1051-0443(96)70824-2
   Palmaz JC, 1995, J VASC INTERV RADIOL, V6, P879, DOI 10.1016/S1051-0443(95)71207-6
   PALMAZ JC, 1993, AM J ROENTGENOL, V160, P613, DOI 10.2214/ajr.160.3.8430566
   PALMAZ JC, 1997, LIF FDN RES IN VASC
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   RUCKENSTEIN E, 1984, J COLLOID INTERF SCI, V101, P436, DOI 10.1016/0021-9797(84)90055-9
   SAPOVAL MR, 1995, AM J ROENTGENOL, V164, P1271, DOI 10.2214/ajr.164.5.7717245
   SNYDER WR, 1983, CLIN APPL TECHNIQUES
   SPEERSCHNEIDER CJ, 1962, J APPL PHYS, V33, P1871, DOI 10.1063/1.1728849
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Szycher M, 1991, J Biomater Appl, V6, P110, DOI 10.1177/088532829100600202
   WHITE RA, 1983, CLIN APPL TECHNIQUES
   Wilson G J, 1993, ASAIO J, V39, pM526
NR 32
TC 0
Z9 0
U1 0
U2 9
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0739-9529
J9 SEMIN INTERVENT RAD
JI Semin. Interv. Radiol.
PD MAR
PY 1998
VL 15
IS 1
BP 13
EP 19
DI 10.1055/s-2008-1057053
PG 7
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 172RT
UT WOS:000078938600004
DA 2018-10-20
ER

PT J
AU Sanz-Medel, A
AF Sanz-Medel, A
TI Trace element analytical speciation in biological systems: importance,
   challenges and trends
SO SPECTROCHIMICA ACTA PART B-ATOMIC SPECTROSCOPY
LA English
DT Article
DE biological materials; speciation; state of the art; trace analysis
ID PLASMA-MASS-SPECTROMETRY; PERFORMANCE LIQUID-CHROMATOGRAPHY; ATOMIC
   EMISSION-SPECTROMETRY; DIRECTLY COUPLED CHROMATOGRAPHY;
   GAS-CHROMATOGRAPHY; ALUMINUM; SPECTROSCOPY; GENERATION; CHEMISTRY;
   MEDICINE
AB Speciation of trace elements is a relatively new field and it was in toxicology that the relationship between the chemical form of a metal and its harmful effects was first recognized. The present need for chemical speciation information in biochemistry bioinorganic and clinical chemistry is documented in an attempt to justify the present demand for innovative chemical speciation strategies and analytical technologies.
   The challenge and complexity of speciation is stressed and three different categories of analytical speciation of increasing analytical difficulty are proposed. Analytical strategies developed so far to try to tackle speciation problems (computational approaches, direct species-specific and hybrid techniques) are reviewed and critically assessed for biological materials. It is indisputable these days that in most cases of real-life analytical speciation we have to resort to the development and use of hybrid techniques combining an adequate separation technique for the species physical separation and an element specific detector such as those based in atomic spectrometry. Examples of such strategies, as developed mainly in the author's laboratory and including chromatographic and non-chromatographic type hybrid strategies coupled to flame, plasma and electrothermal vaporization atomic detectors, are discussed in more detail.
   Finally, in light of the latest trends observed in this new held, the author attempts to cast a forward look into the foreseeable future of analytical speciation research in biological and biomedical sciences. The urgent plea for quality assurance in nonroutine analysis and the concept of using complementary analytical techniques and definitive methods to attack the complexity of chemical speciation in biological systems are particularly highlighted. (C) 1998 Elsevier Science B.V.
C1 Univ Oviedo, Fac Chem, Dept Phys & Analyt Chem, E-33006 Oviedo, Spain.
RP Sanz-Medel, A (reprint author), Univ Oviedo, Fac Chem, Dept Phys & Analyt Chem, C Julian Claveria 8, E-33006 Oviedo, Spain.
OI /0000-0003-2899-1347
CR *ATOM SPECTR UPD, 1996, J ANAL AT SPECTR APR
   BARNES RM, 1993, ANAL CHIM ACTA, V283, P115, DOI 10.1016/0003-2670(93)85214-5
   BEHNE D, 1995, ANALYST, V120, P823, DOI 10.1039/an9952000823
   BERG JM, 1990, J BIOL CHEM, V265, P6513
   CAMARA C, 1995, QUALITY ASSURANCE EN, pCH7
   CARUSO JA, 1996 WINT C PLASM SP, P60
   CORNELIS R, 1994, J ANAL ATOM SPECTROM, V9, P945, DOI 10.1039/ja9940900945
   CORNELIS R, 1993, ANAL CHIM ACTA, V283, P183, DOI 10.1016/0003-2670(93)85221-5
   COSTAFERNANDEZ JM, 1995, J ANAL ATOM SPECTROM, V10, P1019, DOI 10.1039/ja9951001019
   DAWSON JB, 1986, FRESEN Z ANAL CHEM, V324, P463, DOI 10.1007/BF00474118
   DEBIEVRE P, 1993, ANAL PROC, V30, P328
   DEDINA J, 1996, HYDRODE GENERATION A
   DIAZGARCIA ME, 1994, MIKROCHIM ACTA, V113, P211, DOI 10.1007/BF01243612
   DOLPHIN D, 1982, VITAMIN B 12, V1
   DONARD OFX, 1993, ENV ANAL TECHNIQUES, pCH16
   DUNEMANN L, 1993, ANAL CHIM ACTA, V283, P199, DOI 10.1016/0003-2670(93)85223-7
   EBDON L, 1987, ANALYST, V112, P1, DOI 10.1039/an9871200001
   EBDON L, 1986, ANALYST, V111, P1113, DOI 10.1039/an9861101113
   EVANS EH, 1994, ANAL CHEM, V66, P3400, DOI 10.1021/ac00092a017
   FAIRMAN BE, 1995, QUALITY ASSURANCE EN, pCH9
   FANG Z, 1993, FLOW INJECTION SEPAR
   FERNANDEZ MD, 1994, TRACE ELEM MED, V11, P198
   FLORENCE TM, 1983, ANAL CHIM ACTA, V151, P281, DOI 10.1016/S0003-2670(00)80091-4
   GALLORINI M, 1992, J RADIOAN NUCL CH AR, V160, P549, DOI 10.1007/BF02037130
   GARCIAMUNOZ M, 1990, 21ST P INT COSM RAY, V6, P69
   GIDDINGS JC, 1991, UNIFIED SEPARATION S, P189
   Harmer A., 1996, CHEM BIOCH SENSING O
   HARRIS WR, 1992, CLIN CHEM, V38, P1809
   HARRISON RM, 1989, ENV ANAL CHROMATOGRA
   HEUMANN KG, 1996, PLEN LECT 8 JAI EXP
   HILL SJ, 1993, J ANAL ATOM SPECTROM, V8, P499, DOI 10.1039/ja9930800499
   HOLCOMBE D, 1996, QUALITY ASSURANCE BE
   JAKUBOWSKY N, 1996 WINT C PLASM SP, P48
   KARLIN KD, 1993, SCIENCE, V261, P701, DOI 10.1126/science.7688141
   KRULL IS, 1992, TRACE METAL ANAL SPE
   LARSEN EH, 1993, J ANAL ATOM SPECTROM, V8, P557, DOI 10.1039/ja9930800557
   LARSEN EH, 1993, THESIS NATL FOOD AGE
   Lippard S. J., 1994, PRINCIPLES BIOINORGA
   LIU Y, 1995, ANAL CHEM, V67, P2020, DOI 10.1021/ac00109a019
   LIU YM, 1993, J ANAL ATOM SPECTROM, V8, P815, DOI 10.1039/ja9930800815
   LU QH, 1995, ANAL CHEM, V67, P2949, DOI 10.1021/ac00113a033
   MACLEOD CW, 1990, SPECTROSC WORLD, V2, P32
   MARTIN RB, 1986, CLIN CHEM, V32, P1797
   MENENDEZ A, 1990, ANAL CHIM ACTA, V234, P133
   MENENDEZGARCIA A, 1995, FRESEN J ANAL CHEM, V353, P128
   MENENDEZGARCIA A, 1996, MIKROCHIM ACTA, V122, P157
   MERTZ W, 1987, TRACE ELEMENTS HUMAN, V2
   Mertz W., 1987, TRACE ELEMENTS HUMAN, V1
   MOODY JR, 1991, SPECTROCHIM ACTA B, V46, P1571, DOI 10.1016/0584-8547(91)80160-5
   MOTA AM, 1996, ELEMENT SPECIATION B, pCH2
   Okamoto K, 1996, MIKROCHIM ACTA, V123, P15, DOI 10.1007/BF01244373
   OLESIK JW, 1995, ANAL CHEM, V67, P1, DOI 10.1021/ac00097a003
   OSTER O, 1986, FORTSCHR ATOMSPEKTRO, V2, P185
   Quevauviller P, 1996, MIKROCHIM ACTA, V123, P3, DOI 10.1007/BF01244372
   QUEVAUVILLER P, 1994, 1600 EN EUR EUR COMM, P53
   Quijano MA, 1996, J ANAL ATOM SPECTROM, V11, P407, DOI 10.1039/ja9961100407
   RAYMOND KN, 1984, TOP CURR CHEM, V123, P49
   SANZMEDEL A, 1995, ANALYST, V120, P799, DOI 10.1039/an9952000799
   SANZMEDEL A, 1992, MIKROCHIM ACTA, V109, P157, DOI 10.1007/BF01243230
   SANZMEDEL A, 1996, ELEMENT SPECIATION B, pCH7
   SANZMEDEL A, 1996 WINT C PLASM SP, P58
   SEGOVIA E, 1996, 15 REUN NAC ESP OV S
   SHUM SCK, 1992, ANAL CHEM, V64, P2444, DOI 10.1021/ac00044a025
   SPAREN A, 1994, THESIS ROYAL I TECHN
   SULLIVAN JJ, 1991, TRENDS ANAL CHEM, V10, P24
   SULLIVAN JJ, 1992, ACS SERIES, V479, pCH4
   SUZUKI KT, 1995, J CHROMATOGR B, V666, P13, DOI 10.1016/0378-4347(94)00561-I
   TAYLOR HE, 1992, ANAL CHEM, V64, P2036, DOI 10.1021/ac00042a005
   TAYLOR JK, 1987, QUALITY ASSURANCE CH
   TESSIER A, 1979, ANAL CHEM, V51, P884
   Thayer J.S., 1984, ORGANOMETALLIC COMPO
   THOMAS RP, 1994, ANAL CHIM ACTA, V286, P423, DOI 10.1016/0003-2670(94)85088-7
   UDEN PC, 1992, ACS S SERIES, V479
   Valcarcel M., 1991, NONCHROMATOGRAPHIC C
   VANHAECKE F, 1996 WINT C PLASM SP, P310
   VANLANDEGHEM GF, 1994, ANAL CHEM, V66, P216, DOI 10.1021/ac00074a007
   VELA NP, 1993, J ANAL ATOM SPECTROM, V8, P787, DOI 10.1039/ja9930800787
   Wang J., 1988, ELECTROANALYTICAL TE
   WILLIAMS RJP, 1996, CHEM BRIT, P42
   WROBEL K, 1994, J ANAL ATOM SPECTROM, V9, P281, DOI 10.1039/ja9940900281
   YANG MJ, 1996, LC GC, V5, P283
   1996, 1996 WINT C PLASM SP, P319
NR 82
TC 125
Z9 128
U1 0
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0584-8547
J9 SPECTROCHIM ACTA B
JI Spectroc. Acta Pt. B-Atom. Spectr.
PD FEB 27
PY 1998
VL 53
IS 2
BP 197
EP 211
DI 10.1016/S0584-8547(97)00135-3
PG 15
WC Spectroscopy
SC Spectroscopy
GA ZW243
UT WOS:000074389900007
DA 2018-10-20
ER

PT J
AU Lands, WEM
AF Lands, WEM
TI A review of alcohol clearance in humans
SO ALCOHOL
LA English
DT Review
DE acetate; adenosine; alcohol clearance; alcohol dehydrogenase; alcohol
   dependence; binding site; blood alcohol level; catalytic site; enzyme
   kinetics; millimolar alcohol; orphan genes; withdrawal
ID ALDEHYDE DEHYDROGENASE GENOTYPES; CENTRAL-NERVOUS-SYSTEM; FIRST-PASS
   METABOLISM; HUMAN-LIVER; ENZYMATIC-PROPERTIES; ETHANOL ELIMINATION;
   KINETIC CHARACTERIZATION; OXIDOREDUCTION INVIVO; POSTMENOPAUSAL WOMEN;
   HYDROGEN TRANSFER
AB The level of blood or brain alcohol is considered to influence alcohol ingestion by causing subjective perceptions or neural activations that are reinforcing or rewarding. Alcohol-dependent people may try to maintain some desired tissue level, drinking to replace the millimolar levels that were cleared from the blood by metabolism. The biomedical literature describes many approaches to understanding the role of blood alcohol levels in human physiology and behavior, and this review examines some of the published results. They include the general kinetics of intake and removal of beverage alcohol as well as the characteristics of many different catalysts that can interact with alcohol. Because ingested alcohol creates blood levels that are a 1000-fold greater than those normally experienced during abstinence, ethanol may impose itself as an alternate substrate for the many oxidoreductases that act physiologically on other endogenous alcohols. Many enzymes that can act on millimolar ethanol have been isolated, and their structural genes are sequenced. Unfortunately, the genetic sequence does not indicate the physiological material upon which the translated gene product may act. In a sense, the set of enzymes with catalytic sites occupied by millimolar ethanol during alcohol drinking might constructively be regarded as "orphan gene products" whose physiological role remains to be clarified. This review is designed to indicate some of what is known, what is not known, and what needs to be known to improve the interpretations regarding adaptations to beverage alcohol and the ability of millimolar levels of alcohol to diminish dysphoria. The dysphoria may be influenced by ethanol, by ethanol metabolites, or by altered metabolism of currently unspecified endogenous substrates. A major challenge is to evaluate the multiple alternative variables within a context that stimulates curiosity and encourages quantitative tests of the relative contribution of each variable to the overall physiology of an individual. Published by Elsevier Science Inc.
C1 NIAAA, NIH, Bethesda, MD 20892 USA.
RP Lands, WEM (reprint author), NIAAA, NIH, Willco Bldg,Suite 400,6000 Execut Blvd,MSC 7003, Bethesda, MD 20892 USA.
EM wlands@willco.niaaa.nih.gov
CR Ammon E, 1996, CLIN PHARMACOL THER, V59, P503, DOI 10.1016/S0009-9236(96)90178-2
   ANDERSSON S, 1986, ALCOHOL CLIN EXP RES, V10, pS55, DOI 10.1111/j.1530-0277.1986.tb05181.x
   Asai H, 1996, J PHARMACOL EXP THER, V277, P1004
   Atwater WO, 1902, MEM NAT ACAD SCI, VVIII, P231
   BEISSWENGER TB, 1985, P NATL ACAD SCI USA, V82, P8369, DOI 10.1073/pnas.82.24.8369
   BOLEDA MD, 1993, ARCH BIOCHEM BIOPHYS, V307, P85, DOI 10.1006/abbi.1993.1564
   BOSRON WF, 1983, PHARMACOL BIOCHEM BE, V18, P223, DOI 10.1016/0091-3057(83)90175-2
   BOSRON WF, 1983, BIOCHEMISTRY-US, V22, P1852, DOI 10.1021/bi00277a017
   BOSRON WF, 1993, SEMIN LIVER DIS, V13, P126, DOI 10.1055/s-2007-1007344
   BOSRON WF, 1987, ENZYME, V37, P19, DOI 10.1159/000469238
   BURNELL JC, 1987, BIOCHEM BIOPH RES CO, V146, P1227, DOI 10.1016/0006-291X(87)90779-0
   BURNELL JC, 1989, BIOCHEMISTRY-US, V28, P6810, DOI 10.1021/bi00443a005
   CARMICHAEL FJ, 1991, J PHARMACOL EXP THER, V259, P403
   CHAO HM, 1995, ALCOHOL CLIN EXP RES, V19, P104, DOI 10.1111/j.1530-0277.1995.tb01477.x
   CONSALVI V, 1986, BIOCHEM BIOPH RES CO, V139, P1009, DOI 10.1016/S0006-291X(86)80278-9
   CORNELL NW, 1979, ALCOHOL NUTR
   CRABB DW, 1983, ARCH BIOCHEM BIOPHYS, V224, P299, DOI 10.1016/0003-9861(83)90213-8
   CRABB DW, 1993, J LAB CLIN MED, V122, P234
   CRAFT PP, 1994, SOUTHERN MED J, V87, P47, DOI 10.1097/00007611-199401000-00011
   Cronholm T, 1987, Alcohol Alcohol Suppl, V1, P265
   CRONHOLM T, 1985, BIOCHEM J, V229, P315, DOI 10.1042/bj2290315
   CRONHOLM T, 1988, ALCOHOL CLIN EXP RES, V12, P683, DOI 10.1111/j.1530-0277.1988.tb00265.x
   CRONHOLM T, 1985, BIOCHEM J, V229, P323, DOI 10.1042/bj2290323
   Davis GJ, 1996, J BIOL CHEM, V271, P17057, DOI 10.1074/jbc.271.29.17057
   DEETZ JS, 1984, BIOCHEMISTRY-US, V23, P6822, DOI 10.1021/bi00321a084
   DEITRICH RA, 1976, PSYCHONEUROENDOCRINO, V1, P325, DOI 10.1016/0306-4530(76)90002-0
   DERR RF, 1993, J PHARM SCI, V82, P677, DOI 10.1002/jps.2600820702
   DEUSTER G, 1991, DRUGS ALCOHOL ABUSE, V2
   DONG Y, 1988, P NATL ACAD SCI USA, V85, P767, DOI 10.1073/pnas.85.3.767
   EKLUND H, 1990, EUR J BIOCHEM, V193, P303, DOI 10.1111/j.1432-1033.1990.tb19337.x
   EKLUND H, 1987, EUR J BIOCHEM, V167, P185, DOI 10.1111/j.1432-1033.1987.tb13322.x
   EKSTROM G, 1993, BIOCHEM PHARMACOL, V45, P1989, DOI 10.1016/0006-2952(93)90008-K
   Eriksson C J, 1993, Alcohol Alcohol Suppl, V2, P9
   FARRES J, 1995, ADV EXP MED BIOL, V372, P331
   FARRES J, 1994, EUR J BIOCHEM, V193, P303
   FELDER MR, 1988, J BIOL CHEM, V263, P14531
   Ginsburg ES, 1996, JAMA-J AM MED ASSOC, V276, P1747, DOI 10.1001/jama.276.21.1747
   GINSBURG ES, 1995, FERTIL STERIL, V63, P1227, DOI 10.1016/S0015-0282(16)57602-X
   Goldberg L., 1943, ACTA PHYSIOL SCAND, V5, P1
   Haber PS, 1996, GASTROENTEROLOGY, V111, P863, DOI 10.1016/S0016-5085(96)70054-9
   HAHN RG, 1994, ALCOHOL ALCOHOLISM, V29, P673
   HANNAK D, 1985, BIOL CHEM H-S, V366, P749, DOI 10.1515/bchm3.1985.366.2.749
   HENEHAN GTM, 1993, BIOCHEMISTRY-US, V32, P736
   Higuchi S, 1996, ALCOHOL CLIN EXP RES, V20, P493, DOI 10.1111/j.1530-0277.1996.tb01080.x
   Higuchi S, 1996, HUM GENET, V97, P431
   HOOG JO, 1987, BIOCHEMISTRY-US, V26, P1926, DOI 10.1021/bi00381a021
   HOOG JO, 1986, EUR J BIOCHEM, V159, P215, DOI 10.1111/j.1432-1033.1986.tb09855.x
   Hunt WA, 1996, ALCOHOL, V13, P147, DOI 10.1016/0741-8329(95)02026-8
   HURLEY TD, 1991, P NATL ACAD SCI USA, V88, P8149, DOI 10.1073/pnas.88.18.8149
   HURLEY TD, 1994, J MOL BIOL, V239, P415, DOI 10.1006/jmbi.1994.1382
   HURLEY TD, 1990, J BIOL CHEM, V265, P16366
   ISRAEL Y, 1994, ALCOHOL CLIN EXP RES, V18, P144, DOI 10.1111/j.1530-0277.1994.tb00894.x
   JONES AW, 1994, J FORENSIC SCI, V39, P1084
   JONES AW, 1983, PHARMACOL BIOCHEM BE, V18, P267, DOI 10.1016/0091-3057(83)90184-3
   JORNVALL H, 1987, P NATL ACAD SCI USA, V84, P2580, DOI 10.1073/pnas.84.9.2580
   JORNVALL H, 1995, ALCOHOL ALCOHOLISM, V30, P153
   JORNVALL H, 1987, EUR J BIOCHEM, V167, P195, DOI 10.1111/j.1432-1033.1987.tb13323.x
   JORNVALL H, 1987, ENZYME, V37, P5
   Julia P, 1987, Alcohol Alcohol Suppl, V1, P169
   KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502
   KEUNG WM, 1995, BIOCHEM BIOPH RES CO, V215, P1137, DOI 10.1006/bbrc.1995.2581
   Keung WM, 1997, P NATL ACAD SCI USA, V94, P1675, DOI 10.1073/pnas.94.5.1675
   KEUNG WM, 1993, ALCOHOL CLIN EXP RES, V17, P1254, DOI 10.1111/j.1530-0277.1993.tb05238.x
   KREBS HA, 1969, ENERGY LEVEL METABOL
   LANDS WEM, 1991, AM J CLIN NUTR, V54, P47
   LANDS WEM, 1995, AM J CLIN NUTR, V62, P1101
   LARSEN JA, 1959, NATURE, V184, P1236, DOI 10.1038/1841236a0
   Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063
   LEVITT MD, 1994, J PHARMACOL EXP THER, V269, P297
   Levy A, 1996, LANCET, V347, P73, DOI 10.1016/S0140-6736(96)90206-8
   LI TK, 1969, SURG CLIN N AM, V49, P577
   LI TK, 1975, BIOCHEM BIOPH RES CO, V63, P202, DOI 10.1016/S0006-291X(75)80030-1
   LIANG CS, 1978, J CLIN INVEST, V62, P1029, DOI 10.1172/JCI109207
   LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382
   LUNDQUIST F, 1962, J CLIN INVEST, V41, P955, DOI 10.1172/JCI104574
   LUNDQUIST F, 1962, NATURE, V193, P579, DOI 10.1038/193579b0
   LUNDQUIST F, 1970, INT ENCYCLOPAEDIA 20, V1, P95
   MARDH G, 1985, P NATL ACAD SCI USA, V82, P4979, DOI 10.1073/pnas.82.15.4979
   MARDH G, 1986, P NATL ACAD SCI USA, V83, P8908, DOI 10.1073/pnas.83.23.8908
   MARDH G, 1986, P NATL ACAD SCI USA, V83, P2836
   MARDH G, 1986, BIOCHEMISTRY-US, V25, P7279, DOI 10.1021/bi00371a005
   MCEVILY AJ, 1988, BIOCHEMISTRY-US, V27, P4284, DOI 10.1021/bi00412a013
   MCMILLEN BA, 1995, ALCOHOL, V12, P79
   Miyamae M, 1997, P NATL ACAD SCI USA, V94, P3235, DOI 10.1073/pnas.94.7.3235
   MIZOI Y, 1994, ALCOHOL ALCOHOLISM, V29, P707
   MOULIS JM, 1991, BIOCHEMISTRY-US, V30, P5743, DOI 10.1021/bi00237a016
   MUNDT JC, 1995, J STUD ALCOHOL, V56, P491, DOI 10.15288/jsa.1995.56.491
   NOMURA F, 1983, J PHARMACOL EXP THER, V227, P78
   NUUTINEN H, 1985, ALCOHOL, V2, P623, DOI 10.1016/0741-8329(85)90090-4
   OKUDA A, 1983, J BIOL CHEM, V258, P2899
   ORREGO H, 1988, CAN J PHYSIOL PHARM, V66, P1, DOI 10.1139/y88-001
   PAGE RA, 1991, BIOCHEM J, V278, P659, DOI 10.1042/bj2780659
   PARES X, 1993, ADV EXP MED BIOL, V328, P475
   PEOPLES RW, 1995, P NATL ACAD SCI USA, V92, P2825, DOI 10.1073/pnas.92.7.2825
   PIETRUSZKO R, 1972, ARCH BIOCHEM BIOPHYS, V153, P279, DOI 10.1016/0003-9861(72)90446-8
   PIETRUSZKO R, BIOCH PHARM ETHANOL, P87
   POTTER JJ, 1991, ARCH BIOCHEM BIOPHYS, V285, P246, DOI 10.1016/0003-9861(91)90356-N
   REINUS JF, 1989, METABOLISM, V38, P125, DOI 10.1016/0026-0495(89)90251-5
   SATO K, 1995, FASEB J, V9, P651
   SEARLES JS, 1995, J STUD ALCOHOL, V56, P375, DOI 10.15288/jsa.1995.56.375
   SMITH GD, 1993, ALCOHOL ALCOHOLISM, V28, P25
   SMITH M, 1973, ANN HUM GENET, V37, P49, DOI 10.1111/j.1469-1809.1973.tb01814.x
   SMITH M, 1986, ADV HUM GENET, V15, P249
   SMITH M, 1973, ANN HUM GENET, V36, P401, DOI 10.1111/j.1469-1809.1973.tb00604.x
   Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4
   SWIFT RM, 1993, ADDICTION, V88, P1037, DOI 10.1111/j.1360-0443.1993.tb02122.x
   SWIFT RM, 1992, ALCOHOL CLIN EXP RES, V16, P721, DOI 10.1111/j.1530-0277.1992.tb00668.x
   TANK AW, 1986, BIOCHEM PHARMACOL, V35, P4563, DOI 10.1016/0006-2952(86)90779-3
   TEKKANAT KK, 1988, J LAB CLIN MED, V112, P686
   THOMASSON HR, 1993, BEHAV GENET, V23, P131, DOI 10.1007/BF01067417
   Thomasson HR, 1995, ALCOHOL CLIN EXP RES, V19, P1494, DOI 10.1111/j.1530-0277.1995.tb01013.x
   THOMASSON HR, 1991, AM J HUM GENET, V48, P677
   TSUTSUMI M, 1989, HEPATOLOGY, V10, P437, DOI 10.1002/hep.1840100407
   Ueno Y, 1996, ALCOHOL CLIN EXP RES, V20, pA17, DOI 10.1111/j.1530-0277.1996.tb01720.x
   VALLEE BL, 1983, ISOZYMES CURRENT TOP, P219
   VANOOIJ C, 1992, MOL CELL BIOL, V12, P3023, DOI 10.1128/MCB.12.7.3023
   VOLTAIRE A, 1992, ALCOHOL CLIN EXP RES, V16, P281, DOI 10.1111/j.1530-0277.1992.tb01377.x
   VONBAHRLINDSTROM H, 1986, BIOCHEMISTRY-US, V25, P2465
   VONWARTBURG JP, 1964, BIOCHEMISTRY-US, V3, P1775, DOI 10.1021/bi00899a033
   WAGNER FW, 1984, BIOCHEMISTRY-US, V23, P2193, DOI 10.1021/bi00305a014
   WAGNER FW, 1983, BIOCHEMISTRY-US, V22, P1857, DOI 10.1021/bi00277a018
   WALLGREN H, 1970, ACTIONS ALCOHOL, V1, P95
   WALLGREN H, 1970, ACTIONS ALCOHOL, V1, P47
   WALLGREN H, 1970, ACTIONS ALCOHOL, V1, P89
   WANG YL, 1989, MOL MECH ALCOHOL, P97
   WATSON PE, 1981, J STUD ALCOHOL, V42, P547, DOI 10.15288/jsa.1981.42.547
   Widmark EMP, 1932, THEORETISCHEN GRUNDL
   WILKINSON PK, 1977, J PHARMACOKINET BIOP, V5, P207, DOI 10.1007/BF01065396
   WINTER LA, 1990, GENE, V91, P233, DOI 10.1016/0378-1119(90)90093-7
   WRATTEN CC, 1963, BIOCHEMISTRY-US, V2, P935, DOI 10.1021/bi00905a007
   Yamamoto Kenji, 1993, Japanese Journal of Alcohol Studies and Drug Dependence, V28, P13
   YANG ZN, 1994, ALCOHOL CLIN EXP RES, V17, P496
   YIN SJ, 1989, MOL MECHANISMS ALCOH, P227
   ZIMATKIN SM, 1992, ALCOHOL CLIN EXP RES, V16, P1162, DOI 10.1111/j.1530-0277.1992.tb00713.x
NR 134
TC 58
Z9 60
U1 1
U2 24
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0741-8329
EI 1873-6823
J9 ALCOHOL
JI Alcohol
PD FEB
PY 1998
VL 15
IS 2
BP 147
EP 160
DI 10.1016/S0741-8329(97)00110-9
PG 14
WC Substance Abuse; Pharmacology & Pharmacy; Toxicology
SC Substance Abuse; Pharmacology & Pharmacy; Toxicology
GA YT983
UT WOS:000071667700007
PM 9476961
DA 2018-10-20
ER

PT J
AU Del Bigio, MR
AF Del Bigio, MR
TI Biological reactions to cerebrospinal fluid shunt devices: A review of
   the cellular pathology
SO NEUROSURGERY
LA English
DT Review
DE cerebrospinal fluid; foreign body; hydrocephalus; inflammation; silicone
ID LATERAL PERIVENTRICULAR TISSUE; SILICONE BREAST IMPLANTS; CENTRAL
   NERVOUS-SYSTEM; VENTRICULOPERITONEAL SHUNTS; LONG-TERM; BIOMEDICAL
   POLYMERS; TUBING IMPLANTS; NEURAL TISSUE; BRAIN-TISSUE; INTRAVENTRICULAR
   HEMORRHAGE
AB OBJECTIVE: To understand the interaction between cerebrospinal fluid shunt components and the brain and other tissues.
   METHODS: A systematic review of the medical literature directly pertaining to shunt complications, and that dealing with tissues' reactions to implants in general, was conducted.
   RESULTS: Vascularized pedicles of glial tissue or choroid plexus grow into ventricular catheters, primarily as a mechanical phenomenon. Cellular debris or blood can cause dysfunction of valve components. Chronic inflammation, which is nonspecific, might contribute to degradation of the components.
   CONCLUSION: Care must be taken to prevent early entry of debris or blood into the shunt system. Ventricular collapse onto the shunt must be avoided. Refinement of manufacturing methods or modification of shunt materials could reduce the susceptibility of shunts to infection and improve longevity of the apparatus.
C1 Hlth Sci Ctr, Dept Pathol, Winnipeg, MB R3E 0W3, Canada.
   Univ Manitoba, Winnipeg, MB R3E 0W3, Canada.
RP Del Bigio, MR (reprint author), Hlth Sci Ctr, Dept Pathol, D212-770 Bannatyne Ave, Winnipeg, MB R3E 0W3, Canada.
OI Del Bigio, Marc/0000-0001-8366-0394
CR ABBAS AK, 1994, CELLULAR MOL IMMUNOL, P286
   AGNEW WILLIAM F., 1962, JOUR SURG RES, V2, P357, DOI 10.1016/S0022-4804(62)80047-X
   ALLEYNE CH, 1994, J NEUROSURG, V81, P610, DOI 10.3171/jns.1994.81.4.0610
   ALTKANOV G, 1996, J BIOMED MATER RES, V30, P385
   AMMAR A, 1990, NEUROSURG REV, V13, P299, DOI 10.1007/BF00346368
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   ANDERSSON H, 1966, NEUROCHIRURGIA, V9, P61
   AOKI N, 1990, SURG NEUROL, V33, P256, DOI 10.1016/0090-3019(90)90045-Q
   BABB TL, 1984, EXP NEUROL, V86, P171, DOI 10.1016/0014-4886(84)90179-1
   BARRETT SP, 1985, J MED MICROBIOL, V20, P249, DOI 10.1099/00222615-20-2-249
   BAYSTON R, 1981, J CLIN PATHOL, V34, P1057, DOI 10.1136/jcp.34.9.1057
   BECKER DP, 1968, J NEUROSURG, V28, P215, DOI 10.3171/jns.1968.28.3.0215
   BEHLING CA, 1986, J BIOMED MATER RES, V20, P653, DOI 10.1002/jbm.820200509
   Bhatnagar V, 1983, Indian J Pediatr, V50, P133, DOI 10.1007/BF02821431
   BIGNER SH, 1985, ACTA CYTOL, V29, P391
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P457, DOI 10.1002/jbm.820260404
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   BORGES LF, 1982, NEUROSURGERY, V10, P55, DOI 10.1227/00006123-198201000-00010
   BREM H, 1989, SELECT CANCER THER, V5, P55, DOI 10.1089/sct.1989.5.55
   BREM H, 1990, BIOMATERIALS, V11, P699, DOI 10.1016/0142-9612(90)90030-T
   BREM H, 1994, J NEUROSURG, V80, P283, DOI 10.3171/jns.1994.80.2.0283
   BROSNAN CF, 1982, J NEUROPATH EXP NEUR, V41, P221, DOI 10.1097/00005072-198203000-00009
   BROWNLEE RD, 1995, PEDIATR NEUROSURG, V22, P315, DOI 10.1159/000120922
   BRUNI JE, 1986, NEUROSURGERY, V19, P337, DOI 10.1227/00006123-198609000-00001
   Brydon HL, 1996, BRIT J NEUROSURG, V10, P267, DOI 10.1080/02688699650040124
   Brydon HL, 1996, BRIT J NEUROSURG, V10, P245, DOI 10.1080/02688699650040098
   Brydon HL, 1996, NEUROSURGERY, V38, P498, DOI 10.1097/00006123-199603000-00016
   Brydon HL, 1996, J NEUROL NEUROSUR PS, V60, P671, DOI 10.1136/jnnp.60.6.671
   COLLIAS JC, 1957, J NEUROSURG, V14, P302, DOI 10.3171/jns.1957.14.3.0302
   COLLINS P, 1978, J NEUROSURG, V48, P609, DOI 10.3171/jns.1978.48.4.0609
   Craver RD, 1996, PEDIATR PATHOL LAB M, V16, P713, DOI 10.1080/107710496175336
   DABERNAT H, 1985, NOUV REV MED TOULOUS, V3, P15
   DASILVA MC, 1992, PEDIATR NEUROSURG, V17, P304
   DELBIGIO MR, 1995, GLIA, V14, P1, DOI 10.1002/glia.440140102
   DELBIGIO MR, 1986, J NEUROSURG, V64, P932, DOI 10.3171/jns.1986.64.6.0932
   DELBIGIO MR, 1992, J BIOMED MATER RES, V26, P979, DOI 10.1002/jbm.820260802
   DEWAN PA, 1995, BRIT J UROL, V75, P666, DOI 10.1111/j.1464-410X.1995.tb07429.x
   ECHIZENYA K, 1987, J NEUROSURG, V67, P584, DOI 10.3171/jns.1987.67.4.0584
   EDVINSSON L, 1971, ACTA PHYSIOL SCAND, V82, P527, DOI 10.1111/j.1748-1716.1971.tb04998.x
   ELISEVICH K, 1994, PEDIATR NEUROSURG, V21, P71, DOI 10.1159/000120818
   Ferguson JH, 1997, NEUROLOGY, V48, P1504, DOI 10.1212/WNL.48.6.1504
   FERRARO FT, 1989, NEUROSURGERY, V25, P209, DOI 10.1227/00006123-198908000-00009
   GEDIKOGLU Y, 1993, ACTA NEUROCHIR, V122, P266, DOI 10.1007/BF01405540
   GERMANO IM, 1992, J NEUROSURG, V76, P607, DOI 10.3171/jns.1992.76.4.0607
   GIUFFRE R, 1976, J NEUROSURG SCI, V20, P123
   GO KG, 1981, CLIN NEUROL NEUROSUR, V83, P47, DOI 10.1016/0303-8467(81)90001-9
   GOLDBLUM RM, 1992, LANCET, V340, P510, DOI 10.1016/0140-6736(92)91710-P
   GOWER DJ, 1986, PEDIATR NEUROSCI, V12, P127
   GOWER DJ, 1984, J NEUROSURG, V61, P1079, DOI 10.3171/jns.1984.61.6.1079
   GOWER DJ, 1992, NEUROSURGERY, V31, P1132, DOI 10.1227/00006123-199212000-00024
   GRABB PA, 1992, NEUROSURGERY, V30, P630
   GRIEBEL RW, 1987, CHILD NERV SYST, V3, P180, DOI 10.1007/BF00717898
   GUEVARA JA, 1987, J NEUROSURG, V67, P438, DOI 10.3171/jns.1987.67.3.0438
   GUEVARA JA, 1981, CHILD BRAIN, V8, P284
   HAASE J, 1976, ACTA NEUROCHIR, V33, P213, DOI 10.1007/BF01886670
   HABAL MB, 1984, ARCH SURG-CHICAGO, V119, P843
   HAKIM S, 1969, DEV MED CHILD NEUROL, VS, P42
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   IMBER G, 1974, PLAST RECONSTR SURG, V54, P183, DOI 10.1097/00006534-197408000-00010
   IRVING IM, 1971, J PEDIATR SURG, V6, P724, DOI 10.1016/0022-3468(71)90852-9
   JAEGER CB, 1991, BRAIN RES, V551, P163, DOI 10.1016/0006-8993(91)90929-P
   JIMENEZ DF, 1994, CHILD NERV SYST, V10, P59, DOI 10.1007/BF00313586
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KENNEDY CR, 1988, DEV MED CHILD NEUROL, V30, P386
   KOLMEL HW, 1990, FORTSCHR NEUROL PSYC, V58, P191, DOI 10.1055/s-2007-1001183
   KOSSOVSKY N, 1983, SURG FORUM, V34, P527
   KOSSOVSKY N, 1989, J BIOMED MATER RES-A, V23, P73, DOI 10.1002/jbm.820231308
   Leininger R I, 1972, CRC Crit Rev Bioeng, V1, P333
   LILLA JA, 1976, PLAST RECONSTR SURG, V57, P637, DOI 10.1097/00006534-197605000-00012
   LLOYD DA, 1993, J PEDIATR SURG, V28, P345, DOI 10.1016/0022-3468(93)90229-E
   MENEI P, 1993, BIOMATERIALS, V14, P470, DOI 10.1016/0142-9612(93)90151-Q
   MENEI P, 1994, J BIOMED MATER RES, V28, P1079, DOI 10.1002/jbm.820280913
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   Nakamura S, 1982, MONOGR NEURAL SCI, V8, P191
   NAKAOKA T, 1983, Neurologia Medico-Chirurgica, V23, P818, DOI 10.2176/nmc.23.818
   Nicolai U, 1992, Ger J Ophthalmol, V1, P180
   PAGE LK, 1985, CONCEPTS PAEDIATRIC, V5, P75
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   PHELPS CP, 1995, J SUBMICR CYTOL PATH, V27, P83
   PIATT JH, 1995, PEDIATR NEUROSURG, V23, P133, DOI 10.1159/000120950
   PITTMAN T, 1994, BRIT J NEUROSURG, V8, P41, DOI 10.3109/02688699409002391
   PUDENZ RH, 1981, SURG NEUROL, V15, P15, DOI 10.1016/S0090-3019(81)80084-5
   RAFTOPOULOS C, 1994, ACTA NEUROCHIR, V129, P177, DOI 10.1007/BF01406499
   RATNER BD, 1993, CARDIOVASC PATHOL, V2, pS87, DOI 10.1016/1054-8807(93)90049-8
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   RAUCH HC, 1986, J BIOMED MATER RES, V20, P1277, DOI 10.1002/jbm.820200905
   REINBERG Y, 1993, J UROLOGY, V150, P594
   REINHARDT V, 1980, ADV NEUROSURG, V8, P267
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   ROSSITCH E, 1985, NEUROSURGERY, V17, P838, DOI 10.1227/00006123-198511000-00021
   SAINTEROSE C, 1993, PEDIATR NEUROSURG, V19, P156, DOI 10.1159/000120722
   SANCHEZGUERRERO J, 1995, NEW ENGL J MED, V332, P1666, DOI 10.1056/NEJM199506223322502
   SANGER JR, 1992, PLAST RECONSTR SURG, V89, P931, DOI 10.1097/00006534-199205000-00025
   SCARFF TB, 1983, CONCEPTS PEDIAT NEUR, V4, P81
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P1059, DOI 10.1016/0142-9612(92)90138-E
   SCHMIDT S, 1993, J BIOMED MATER RES, V27, P1393, DOI 10.1002/jbm.820271106
   Schoener W, 1991, HYDROCEPHALUS PATHOG, P452
   SEIFERT LM, 1985, J BIOMED MATER RES, V19, P1043, DOI 10.1002/jbm.820190916
   SEKHAR LN, 1982, J NEUROSURG, V56, P411, DOI 10.3171/jns.1982.56.3.0411
   SERGOTT TJ, 1986, PLAST RECONSTR SURG, V78, P104, DOI 10.1097/00006534-198607000-00018
   SEVASTIANOV VI, 1984, J BIOMED MATER RES, V18, P969, DOI 10.1002/jbm.820180902
   SHERERTZ RJ, 1995, J BIOMED MATER RES, V29, P635, DOI 10.1002/jbm.820290511
   SHIMOTAKE K, 1988, SURG NEUROL, V30, P156, DOI 10.1016/0090-3019(88)90104-8
   SMETANA K, 1990, J BIOMED MATER RES, V24, P463, DOI 10.1002/jbm.820240405
   STEINBERG J, 1989, J BIOMED MATER RES, V23, P591, DOI 10.1002/jbm.820230605
   STENSAAS SS, 1976, ACTA NEUROPATHOL, V35, P187
   SUGAR O, 1974, J NEUROSURG, V41, P367, DOI 10.3171/jns.1974.41.3.0367
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   TAYLOR DE, 1986, BIOMATERIALS, V7, P277, DOI 10.1016/0142-9612(86)90050-5
   TRAVIS WD, 1985, HUM PATHOL, V16, P19, DOI 10.1016/S0046-8177(85)80209-4
   TRAYNELIS VC, 1988, NEUROSURGERY, V23, P645, DOI 10.1227/00006123-198811000-00019
   TUCKER OP, 1983, Z KINDERCHIR, V38, P71
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   TURNER MS, 1995, SURG NEUROL, V43, P314, DOI 10.1016/0090-3019(95)80056-M
   TZVETANOVA EM, 1986, ACTA CYTOL, V30, P277
   VALE BH, 1982, J BIOMED MATER RES, V16, P471, DOI 10.1002/jbm.820160414
   VARIEND S, 1982, LANCET, V2, P1162
   VONDRACEK P, 1984, BIOMATERIALS, V5, P209, DOI 10.1016/0142-9612(84)90017-6
   VONHOLST H, 1981, ACTA NEUROCHIR, V56, P239, DOI 10.1007/BF01407234
   WINN SR, 1989, J BIOMED MATER RES, V23, P31, DOI 10.1002/jbm.820230104
   WOERLY S, 1993, BIOMATERIALS, V14, P1056, DOI 10.1016/0142-9612(93)90205-G
   WOERLY S, 1991, BIOMATERIALS, V12, P197, DOI 10.1016/0142-9612(91)90200-T
   WOERLY S, 1990, BIOMATERIALS, V11, P97, DOI 10.1016/0142-9612(90)90123-8
   Wong TT, 1991, HYDROCEPHALUS PATHOG, P438
   WOODRUFF WW, 1986, RADIOLOGY, V158, P171, DOI 10.1148/radiology.158.1.3940376
   WU MP, 1994, J BIOMED MATER RES, V28, P387, DOI 10.1002/jbm.820280314
   YUEN TGH, 1990, NEURAL PROSTHESES FU, P197
   ZUMSTEIN B, 1974, ACTA NEUROCHIR, V30, P287, DOI 10.1007/BF01405585
NR 128
TC 64
Z9 65
U1 1
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0148-396X
EI 1524-4040
J9 NEUROSURGERY
JI Neurosurgery
PD FEB
PY 1998
VL 42
IS 2
BP 319
EP 325
DI 10.1097/00006123-199802000-00064
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA YV348
UT WOS:000071814200023
PM 9482182
DA 2018-10-20
ER

PT J
AU Yamamoto, S
   Miyamoto, T
   Kokubo, T
   Nakamura, T
AF Yamamoto, S
   Miyamoto, T
   Kokubo, T
   Nakamura, T
TI Preparation of polymer-silicate hybrid materials bearing silanol groups
   and the apatite formation on/in the hybrid materials
SO POLYMER BULLETIN
LA English
DT Article
ID GLASS; WOLLASTONITE; GEL
AB The aim of this work is to develop a basic approach to the preparation of biologically active polymer-apatite composites with various mechanical properties. To this end, a type of hybrid materials bearing silanol groups were prepared from triethoxysilyl-terminated poly(oxyethylene) (PEG) and tetraethoxysilane (TEOS) by using the in-situ sol-gel process. The hybrid materials having different PEG contents were subjected to the biomimetic process for forming the bone-like apatite layer on/in the hybrid materials. It was found that a dense bone-like apatite layer can be prepared in an arbitrary thickness on/in the hybrid materials, indicating that the silanol groups introduced provide the effective sites for the apatite nucleation and formation. The polymer-apatite composites thus obtained are expected to have a great potential in the biomedical applications.
C1 Kyoto Univ, Inst Chem Res, Kyoto 611, Japan.
   Kyoto Univ, Grad Sch Engn, Div Mat Chem, Sakyo Ku, Kyoto 60601, Japan.
   Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 606, Japan.
RP Miyamoto, T (reprint author), Kyoto Univ, Inst Chem Res, Kyoto 611, Japan.
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
CR HUANG ZH, 1995, POLYM BULL, V35, P607, DOI 10.1007/BF00324115
   KOHJIYA S, 1991, POLYMER GELS, P77
   KOHJIYA S, 1991, POLYM-PLAST TECHNOL, V30, P351, DOI 10.1080/03602559108021001
   KOKUBO T, 1991, NIPPON SERAM KYO GAK, V99, P965
   KOKUBO T, 1985, J MATER SCI, V20, P2001, DOI 10.1007/BF01112282
   KOKUBO T, 1987, J MATER SCI, V22, P4067, DOI 10.1007/BF01133359
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   ONO K, 1990, BIOMATERIALS, V11, P265
   SUZUKI K, 1993, BIOCERAMICS, V6, P245
   TANAHASHI M, 1994, J AM CERAM SOC, V77, P2805, DOI 10.1111/j.1151-2916.1994.tb04508.x
   YAMAMOTO S, IN PRESS
   YAMAMURO T, 1990, J BONE JOINT SURG BR, V72, P889
NR 12
TC 17
Z9 19
U1 0
U2 2
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0170-0839
J9 POLYM BULL
JI Polym. Bull.
PD FEB-MAR
PY 1998
VL 40
IS 2-3
BP 243
EP 250
DI 10.1007/s002890050248
PG 8
WC Polymer Science
SC Polymer Science
GA ZA846
UT WOS:000072407900017
DA 2018-10-20
ER

PT J
AU Min, S
   Nakamura, T
   Teramoto, A
   Abe, K
AF Min, S
   Nakamura, T
   Teramoto, A
   Abe, K
TI Preparation and characterization of crosslinked porous silk fibroin gel
SO SEN-I GAKKAISHI
LA English
DT Article
ID MEMBRANE
AB In order to develop new biomedical materials, the preparation and characterization of crosslinked porous silk fibroin gel (CPFG) were investigated by using ethylene glycol diglycidyl ether (EGDE) as a crosslinking agent. The CPFG was prepared by freezing (-50 degrees C similar to -5 degrees C) and thawing a homogeneous fibroin solution containing EGDE. The average pore size of CPFG was varied from 100 similar to 300 mu m by adjusting the concentrations of silk fibroin, EGDE and the freezing temperature. The tenacity and elongation ratio of CPFG were improved by increasing the concentration of silk fibroin and EGDE within a certain range. From these results, it was found that CPFG with excellent properties can be prepared at low temperatures by using EGDE as a crosslinking agent.
C1 Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 386, Japan.
OI Nakamura, Toshinobu/0000-0003-3881-3368
CR Asakura T, 1987, BIOINDUSTRY, V4, P878
   CHEN K, 1992, J SERICUET SCI JPN, V62, P56
   DEMURA M, 1991, J MEMBRANE SCI, V59, P39, DOI 10.1016/S0376-7388(00)81220-X
   HANAWA T, 1995, CHEM PHARM BULL, V43, P284
   KAMIISHI Y, 1995, J SERICUET SCI JPN, V64, P323
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   SHIOZAKI H, 1980, STRUCTURES SILK, P625
   TSUKADA M, 1994, J APPL POLYM SCI, V54, P507, DOI 10.1002/app.1994.070540411
NR 8
TC 6
Z9 7
U1 0
U2 3
PU SOC FIBER SCIENCE TECHNOLOGY
PI TOKYO
PA KAMIOSAKI 3-3-9-208, SHINAGAWA-KU, TOKYO, 141-0025, JAPAN
SN 0037-9875
J9 SEN-I GAKKAISHI
JI Sen-I Gakkaishi
PD FEB
PY 1998
VL 54
IS 2
BP 85
EP 92
DI 10.2115/fiber.54.2_85
PG 8
WC Materials Science, Textiles; Polymer Science
SC Materials Science; Polymer Science
GA ZF709
UT WOS:000072924200010
OA Bronze
DA 2018-10-20
ER

PT B
AU Richardson, MC
   Rajyaguru, JM
   Kado, M
   Yamamoto, Y
   Friedman, H
   Muszynski, MJ
AF Richardson, MC
   Rajyaguru, JM
   Kado, M
   Yamamoto, Y
   Friedman, H
   Muszynski, MJ
BE Talwar, GP
   Nath, I
   Ganguly, NK
   Rao, KVS
TI High resolution (nanometer scale) X-ray imaging of live macrophage
   surface and pseudopodia
SO 10TH INTERNATIONAL CONGRESS ON IMMUNOLOGY, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT 10th International Congress of Immunology
CY NOV 01-06, 1998
CL NEW DELHI, INDIA
AB Macrophage motility and migration are critical in phagocytosis but the mechanisms are not well defined, High resolution X-ray microscopy of live cells is relatively new in biomedical application, We used laser plasma to X-ray images of live hydrated macrophages. A sealed 5 mu l cell suspension was placed on photoresist, and exposed to X-rays tuned for carbon-rich material. Atomic force microscope scans for differential absorption showed the first X-ray images of live thioglycollate-elicited murine peritoneal macrophages, No fixatives or stains were used, Macrophages expressing circular and oval globuiar pseudopodia were seen, Higher resolution scans of cell surface showed fine long hair-like extensions protruding out and extending away from the cell, These latter processes may be involved in determination of chemotaxis which is very important in phagocytosis.
C1 Univ Cent Florida, Orlando, FL 32816 USA.
RP Richardson, MC (reprint author), Univ Cent Florida, Orlando, FL 32816 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MEDIMOND S R L
PI 40128 BOLOGNA
PA VIA MASERATI 5, 40128 BOLOGNA, 00000, ITALY
BN 88-323-1101-1
PY 1998
BP 595
EP 598
PG 4
WC Immunology
SC Immunology
GA BM18S
UT WOS:000077938500099
DA 2018-10-20
ER

PT S
AU Powell, DJ
   Mould, J
   Wojcik, GL
AF Powell, DJ
   Mould, J
   Wojcik, GL
BE Schneider, SC
   Levy, M
   McAvoy, BR
TI Dielectric and mechanical absorption mechanisms for time and frequency
   domain transducer modeling
SO 1998 IEEE ULTRASONICS SYMPOSIUM - PROCEEDINGS, VOLS 1 AND 2
SE ULTRASONICS SYMPOSIUM
LA English
DT Proceedings Paper
CT 1998 IEEE Ultrasonics Symposium
CY OCT 05-08, 1998
CL SENDAI, JAPAN
SP IEEE, Ultrason Ferroelect & Frequency Control Soc
AB In all practical transduction systems-such as biomedical imaging arrays, underwater sonar systems or piezoelectric actuators and transformers, electromechanical losses impact overall system performance. Adverse effects of these losses include heat generation, sub-optimal electrical matching, and reduced operational efficiency. Consequently, it is imperative to fully understand the implications of loss mechanisms and incorporate them properly in numerical and analytical models. In this paper, time-domain electromechanical absorption mechanisms are studied in terms of their physical mechanisms and frequency-domain counterparts. We examine the mechanical and dielectric losses of some common piezoelectric materials and discuss some of the issues that arise in attempting to measure and model them.
C1 Weidlinger Assoc Inc, Los Altos, CA 94022 USA.
RP Powell, DJ (reprint author), Weidlinger Assoc Inc, Los Altos, CA 94022 USA.
CR GERHARDT R, 1998, ADV DIELECTRIC CERAM, V88, P41
   HAYWARD G, 1984, ULTRASONICS      JUL, P153
   IEEE An American National Standard, 1988, IEEE STAND PIEZ
   Kino G. S., 1987, ACOUSTIC WAVES DEVIC
   *PENNW CORP, 1987, KYN PIEZ FILM TECHN
   *TASI, TASI TECHN SOFTW
   WOJCIK G, P 1995 IEEE ULTR S, P1617
NR 7
TC 3
Z9 3
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1051-0117
BN 0-7803-4096-5
J9 ULTRASON
PY 1998
BP 1019
EP 1024
PG 6
WC Acoustics; Engineering, Electrical & Electronic
SC Acoustics; Engineering
GA BM87A
UT WOS:000079968900223
DA 2018-10-20
ER

PT S
AU LeClair, T
   Harper, A
   Graham, S
   Ackley, D
AF LeClair, T
   Harper, A
   Graham, S
   Ackley, D
GP SOC PHOTO OPT INSTRUMENTAT ENGINEERS
   SOC PHOTO OPT INSTRUMENTAT ENGINEERS
TI Flip chin interconnection of DNA chip devices
SO 1998 INTERNATIONAL SYMPOSIUM ON MICROELECTRONICS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 1998 International Symposium on Microelectronics
CY NOV 01-04, 1998
CL SAN DIEGO, CA
SP Int Microelectron & Pkg Soc
DE gene chips; flip chip interconnects; Ag adhesive bumps; Sn/Pb solder
   bumps; fine line polyimide flex circuits; fluidic interfaces to Si chips
AB Nanogen has developed a novel instrument system that utilizes silicon microelectronic technologies to execute rapid DNA hybridization analyses optimized for diagnostic and research applications. This system incorporates an active DNA away-formatted Si microchip, that is flip-chip mounted to a polyimide flex circuit microfluidic cartridge assembly. This disposable cartridge assembly is inserted for analysis into Nanogen's desktop instrument much like a music CD enters the CD player drawer. Multiplex DNA hybridization, electronic control of hybridization stringency, sample detection, and computer analysis functions can be automatically performed within a 10 to 15 minute timeframe. Present applications are directed at infectious disease detection, genetic testing, drug discovery, and biomedical research. The microelectronic materials and processes selected for the DNA chip, the interconnection circuits, the cartridge fluidics, and the optical detection system will be presented.
C1 Nanogen Inc, San Diego, CA 92121 USA.
RP LeClair, T (reprint author), Nanogen Inc, 10398 Pacific Ctr Court, San Diego, CA 92121 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-930815-52-1
J9 P SOC PHOTO-OPT INS
PY 1998
VL 3582
BP 732
EP 736
PG 3
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BM46L
UT WOS:000078815800124
DA 2018-10-20
ER

PT J
AU Callesen, H
   Greve, T
   Avery, B
AF Callesen, H
   Greve, T
   Avery, B
TI Embryo technology in cattle: Brief review
SO ACTA AGRICULTURAE SCANDINAVICA SECTION A-ANIMAL SCIENCE
LA English
DT Article; Proceedings Paper
CT Bertebos Prize Symposium on Impact of Reproductive Technology on Animal
   Breeding and Genetic Conservation
CY SEP 18-19, 1997
CL FALKENBERG, SWEDEN
DE embryo cloning; embryo technology; in vitro embryo production; in vivo
   embryo production; sexing of semen; vitrification of embryos
ID PREIMPLANTATION MOUSE EMBRYOS; LOW-TEMPERATURE PRESERVATION;
   INVITRO-FERTILIZED EMBRYOS; CHROMOSOME-BEARING SPERM; VITRIFIED BOVINE
   EMBRYOS; VITRO PRODUCED EMBRYOS; DEVELOPMENT PED GENE; IN-VITRO; NUCLEAR
   TRANSFER; SEX DETERMINATION
AB Aspects of embryo technology are discussed with the main emphasis on cattle. In vivo embryo production with recovery of embryos from superovulated animals followed by freezing and transfer of embryos is performed routinely. The average yield of transferable embryos obtained in the Danish MOET project is six originating from approximately 80% of the superovulated donors. The pregnancy rate following non-surgical transfer of fresh or frozen embryos is around 50% and the fetal loss 5%. In vitro production of embryos based on oocytes recovered from slaughterhouse material or from live animals following ultrasound guided transvaginal oocyte recovery (OPU or TVOR) is used in many laboratories for experimentation and also in practice as an alternative or supplement to in vivo embryo production. The expected rate of blastocyst formation on day 8 after insemination reaches 40-50% in several laboratories. The main problem encountered with in vitro production is the reduced viability of embryos compared with their in vivo counterparts. This is particularly apparent following freezing and thawing. Vitrification of embryos seems to be a valuable alternative to conventional freezing of embryos which have a more fragile constitution, e.g. early in vitro produced or cloned embryos. Sexing of embryos through PCR analysis of embryo biopsies is used in embryo transfer practice in several countries. Sexing of semen is still at the experimental level and is used in conjunction with in vitro production of calves. Cloning of embryos is in progress in many laboratories, but with limited success. Current blastocyst and pregnancy rates are 30% and 20%, respectively, but the rate of fetal loss is high. Factors such as cell cycle synchrony, remodelling and reprogramming of the introduced nucleus still need further elucidation before a more widespread practical use of this technology. Genetically modified animals are used for production of certain valuable pharmaceuticals in their milk and to improve certain growth charateristics. The actual success is still limited, but transgenic pigs will be used in biomedical research in the future. Production of embryonic stem cell-like cell lines has been successful in certain laboratories.
C1 Danish Inst Agr, Embryo Technol Ctr, DK-8830 Tjele, Denmark.
   Royal Vet & Agr Univ, Dept Clin Studies, DK-1870 Frederiksberg C, Denmark.
RP Callesen, H (reprint author), Danish Inst Agr, Embryo Technol Ctr, DK-8830 Tjele, Denmark.
OI Callesen, Henrik/0000-0002-0185-7300
CR ARMSTRONG DT, 1993, THERIOGENOLOGY, V39, P7, DOI 10.1016/0093-691X(93)90021-V
   Avery B., 1993, Ars Veterinaria, V9, P35
   AVERY B, 1992, MOL REPROD DEV, V32, P265, DOI 10.1002/mrd.1080320312
   AVERY B, 1991, THERIOGENOLOGY, V35, P953, DOI 10.1016/0093-691X(91)90306-X
   AVERY B, 1989, J REPROD FERTIL, V87, P627
   AVERY B, 1989, ACTA VET SCAND, V30, P147
   AVERY B, 1995, P 30 INT S SIPZ, P171
   BAK A, 1989, Theriogenology, V31, P170, DOI 10.1016/0093-691X(89)90578-5
   BAK A, 1989, Theriogenology, V31, P169, DOI 10.1016/0093-691X(89)90577-3
   BARNES F, 1993, J REPROD FERTIL, V97, P317
   BARNES FL, 1993, MOL REPROD DEV, V36, P33, DOI 10.1002/mrd.1080360106
   BOLAND MP, 1993, MOL REPROD DEV, V36, P266, DOI 10.1002/mrd.1080360227
   BOLAND MP, 1978, THERIOGENOLOGY, V10, P175, DOI 10.1016/0093-691X(78)90018-3
   BOLAND MP, 1994, P 1 EUR C PROGR EMBR, P103
   BONDIOLI KR, 1990, THERIOGENOLOGY, V33, P165, DOI 10.1016/0093-691X(90)90607-U
   BRAND A, 1978, ANIM PROD, V26, P55, DOI 10.1017/S0003356100012009
   BRAND A, 1977, EMBRYO TRANSFER FARM, V16, P31
   BRANDENHOFF HR, 1994, P 10 SCI M AETE LYON, P156
   BREDBACKA P, 1994, THERIOGENOLOGY, V41, P1023, DOI 10.1016/S0093-691X(05)80025-1
   BREM G, 1992, PORTL PR P, P147
   BUEHR M, 1994, GENETICALLY MODIFIED
   CALLESEN H, 1992, PORTL PR P, P207
   CALLESEN H, 1995, J ANIM SCI, V73, P1539
   CALLESEN H, 1986, THERIOGENOLOGY, V25, P71, DOI 10.1016/0093-691X(86)90184-6
   Callesen H, 1996, ANIM REPROD SCI, V42, P215, DOI 10.1016/0378-4320(96)01513-8
   CALLESEN H, 1997, EMBRYO TRANSFER PHYS, P23
   Callesen H, 1994, P 10 SCI M AETE LYON, P125
   Callesen H, 1994, P 1 INT EUR C PROGR, P97
   Campbell K. H. S., 1993, Theriogenology, V39, P199, DOI 10.1016/0093-691X(93)90054-9
   CAMPBELL KHS, 1994, BIOL REPROD, V50, P1385, DOI 10.1095/biolreprod50.6.1385
   CAMPBELL KHS, 1993, BIOL REPROD, V49, P933, DOI 10.1095/biolreprod49.5.933
   CASSAR G, 1994, J REPROD FERTIL, V101, P317
   CHESNE P, 1992, P 8 SCI M AETE LYON, P138
   CHRISTENSEN LG, 1991, THERIOGENOLOGY, V35, P141, DOI 10.1016/0093-691X(91)90153-5
   CHUPIN D, 1979, ANN BIOL ANIM BIOCH, V19, P1489, DOI 10.1051/rnd:19790911
   CLARK AJ, 1989, BIO-TECHNOL, V7, P487, DOI 10.1038/nbt0589-487
   CLEMENTSENGEWALD A, 1993, REPROD DOMEST ANIM, V28, P399, DOI 10.1111/j.1439-0531.1993.tb01015.x
   CRAN DG, 1993, VET REC, V132, P40, DOI 10.1136/vr.132.2.40
   CRAN DG, 1992, PORTL PR P, P125
   CRITSER JK, 1980, THERIOGENOLOGY, V13, P397, DOI 10.1016/0093-691X(80)90066-7
   DENDAAS N, 1994, P 10 REUN AETE LY SE, P117
   DIELEMAN SJ, 1993, MOL REPROD DEV, V36, P271, DOI 10.1002/mrd.1080360228
   Ding Jianchi, 1995, Theriogenology, V43, P196, DOI 10.1016/0093-691X(95)92350-I
   DUFOUR E, 1994, P 10 SCI M AETE LYON, P166
   Fair T., 1995, Theriogenology, V43, P209, DOI 10.1016/0093-691X(95)92363-E
   FAIR T, 1994, P 10 SCI M AETE LYON, P168
   FIGUEIREDO JR, 1994, THERIOGENOLOGY, V42, P1303, DOI 10.1016/0093-691X(94)90250-M
   Gall L., 1995, Theriogenology, V43, P215, DOI 10.1016/0093-691X(95)92369-K
   GALLI C, 1994, P 1 EUR C PROGR EMBR, P111
   GOLDBARD SB, 1985, BIOL REPROD, V33, P30, DOI 10.1095/biolreprod33.1.30
   GORDON I, 1994, LAB PRODUCTION CATTL
   GREVE T, 1991, REPROD NUTR DEV, V31, P147, DOI 10.1051/rnd:19910205
   GREVE T, 1992, REPROD DOMEST ANIM, V27, P22, DOI 10.1111/j.1439-0531.1992.tb00372.x
   GREVE T, 1993, REPROD DOMEST ANIM, V28, P164, DOI 10.1111/j.1439-0531.1993.tb00113.x
   GREVE T, 1977, THERIOGENOLOGY, V7, P239, DOI 10.1016/0093-691X(77)90220-5
   GREVE T, 1979, ACTA VET SCAND, V20, P135
   GREVE T, 1981, THESIS COPENHAGEN
   HAHN J, 1978, DEUT TIERARZTL WOCH, V85, P140
   HAHN J, 1992, THERIOGENOLOGY, V38, P269, DOI 10.1016/0093-691X(92)90235-J
   HASLER JF, 1995, THERIOGENOLOGY, V43, P141, DOI 10.1016/0093-691X(94)00020-U
   HASLER JF, 1987, THERIOGENOLOGY, V27, P139, DOI 10.1016/0093-691X(87)90075-6
   HEYMAN Y, 1994, THERIOGENOLOGY, V42, P695, DOI 10.1016/0093-691X(94)90386-W
   Heyman Y., 1995, Theriogenology, V43, P234, DOI 10.1016/0093-691X(95)92388-P
   HEYMAN Y, 1993, P 9 SCI M AETE LYON, P210
   HYTTEL P, 1988, J REPROD FERTIL, V82, P1
   JENSEN AM, 1982, THERIOGENOLOGY, V18, P33, DOI 10.1016/0093-691X(82)90046-2
   Johnson LA, 1995, REPROD FERT DEVELOP, V7, P893, DOI 10.1071/RD9950893
   KRIMPENFORT P, 1991, BIO-TECHNOL, V9, P844, DOI 10.1038/nbt0991-844
   KRUIP TAM, 1994, P 1 EUR C PROGR EMBR, P117
   LAVITRANO M, 1992, PORTL PR P, P165
   LEHNJENSEN H, 1978, THERIOGENOLOGY, V9, P313, DOI 10.1016/0093-691X(78)90124-3
   LEHNJENSEN H, 1986, THESIS COPENHAGEN
   LOHUIS MM, 1993, ANIM PROD, V57, P369, DOI 10.1017/S1357729800042697
   Loskutoff N. M., 1993, Theriogenology, V39, P263, DOI 10.1016/0093-691X(93)90118-O
   LU KH, 1987, VET REC, V121, P259, DOI 10.1136/vr.121.11.259
   MAHMOUDZADEH AR, 1994, THERIOGENOLOGY, V42, P1389, DOI 10.1016/0093-691X(94)90259-L
   MAHMOUDZADEH AR, 1993, THERIOGENOLOGY, V39, P1291, DOI 10.1016/0093-691X(93)90231-S
   Marquant-Le-Guienne B, 1992, THERIOGENOLOGY, V37, P253, DOI DOI 10.1016/0093-691X(92)90322-I
   MARQUANTLEGUIENNE B, 1990, REPROD NUTR DEV, V30, P259, DOI 10.1051/rnd:19900212
   MASSIP A, 1993, J REPROD FERTIL, V97, P65
   MASSIP A, 1979, THERIOGENOLOGY, V12, P79, DOI 10.1016/0093-691X(79)90012-8
   MASSIP A, 1993, P 9 SCI M AETE LYON, P240
   MERMILLOD P, 1992, P 8 SCI M AETE LYON, P194
   MILLER JR, 1991, REPROD DOMEST ANIM, V26, P58, DOI 10.1111/j.1439-0531.1991.tb01515.x
   MOOR R, 1992, ANIM REPROD SCI, V28, P423, DOI 10.1016/0378-4320(92)90129-2
   MULLER M, 1992, J INTERFERON RES, V12, P119, DOI 10.1089/jir.1992.12.119
   NEWCOMB R, 1980, VET REC, V106, P48, DOI 10.1136/vr.106.3.48
   Newcomb R., 1976, Egg transfer in cattle. Seminar on egg transfer in cattle in the EEC programme of co-ordination of research on beef production, Cambridge, 1975., P1
   Newcomb R., 1978, CURRENT TOPICS VET M, VI, P292
   NIBART M, 1992, PORTL PR P, P215
   Nicholas FW, 1996, ANIM REPROD SCI, V42, P205, DOI 10.1016/0378-4320(96)01511-4
   NIEMANN H, 1993, LIVEST PROD SCI, V36, P17, DOI 10.1016/0301-6226(93)90132-2
   NIEMANN H, 1982, THERIOGENOLOGY, V18, P445, DOI 10.1016/0093-691X(82)90166-2
   NIEMANN H, 1991, THERIOGENOLOGY, V35, P109, DOI 10.1016/0093-691X(91)90151-3
   NIEMANN H, 1992, Theriogenology, V37, P265, DOI 10.1016/0093-691X(92)90334-N
   NIEMANN H, 1994, P 1 EUR C PROGR EMBR, P157
   NOTARIANNI E, 1992, PORTL PR P, P175
   OTTESEN J, 1997, THESIS ROYAL VET AGR
   PAVLOK A, 1992, MOL REPROD DEV, V31, P63, DOI 10.1002/mrd.1080310111
   PEURA T, 1991, THERIOGENOLOGY, V35, P547, DOI 10.1016/0093-691X(91)90451-I
   PIETERSE MC, 1991, THERIOGENOLOGY, V35, P857, DOI 10.1016/0093-691X(91)90426-E
   PIETERSE MC, 1988, THERIOGENOLOGY, V30, P751, DOI 10.1016/0093-691X(88)90310-X
   POLGE C, 1991, P 7 SCI M AETE CAMBR, P103
   PROCHAZKA R, 1990, Theriogenology, V33, P301, DOI 10.1016/0093-691X(90)90725-9
   PURSEL VG, 1993, J ANIM SCI, V71, P10, DOI 10.2527/1993.71suppl_310x
   Rao V. H., 1993, Theriogenology, V39, P292, DOI 10.1016/0093-691X(93)90147-W
   RATH D, 1996, P 12 SCI M AETE LYON, P103
   REICHENBACH HD, 1992, J REPROD FERTIL, V95, P363
   Reinders J. M. C., 1995, Theriogenology, V43, P306, DOI 10.1016/0093-691X(95)92460-Q
   RENARD JP, 1981, THERIOGENOLOGY, V15, P311, DOI 10.1016/0093-691X(81)90052-2
   Roschlau K, 1989, J Reprod Fertil Suppl, V38, P153
   ROWSON LEA, 1972, J REPROD FERTIL, V28, P427
   ROWSON LEA, 1971, NATURE, V233, P379, DOI 10.1038/233379a0
   SAUMANDE J, 1978, CURRENT TOPICS VET M, V1, P195
   SAUMANDE J, 1978, CURRENT TOPICS VET M, V1, P169
   SCHAMS D, 1979, ZUCHTHYGIENE, V14, P11
   SCHIEWE MC, 1983, THERIOGENOLOGY, V19, P147, DOI 10.1016/0093-691X(83)90165-6
   Schmidt M, 1996, THERIOGENOLOGY, V46, P527, DOI 10.1016/0093-691X(96)00174-4
   SCHROEDER A, 1990, Animal Biotechnology, V1, P121
   SCHWERIN M, 1994, THERIOGENOLOGY, V41, P553, DOI 10.1016/0093-691X(94)90090-6
   SHAMSUDDIN M, 1993, THERIOGENOLOGY, V39, P1067, DOI 10.1016/0093-691X(93)90007-R
   Sims M. M., 1993, Theriogenology, V39, P313, DOI 10.1016/0093-691X(93)90168-5
   Smith S, 1994, P 10 SCI M AETE LYON, P248
   Techakumphu M., 1993, Theriogenology, V39, P328, DOI 10.1016/0093-691X(93)90183-6
   TECHAKUMPHU M, 1992, P 8 SCI M AETE LYON, P218
   THIBIER M, 1995, THERIOGENOLOGY, V43, P71, DOI 10.1016/0093-691X(94)00008-I
   THIBIER M, 1996, EMBRYO TRANSFER NEWS, V14, P27
   THOMSEN PD, 1991, REPROD DOMEST ANIM, V26, P66, DOI 10.1111/j.1439-0531.1991.tb01516.x
   TROUNSON AO, 1978, THERIOGENOLOGY, V10, P111, DOI 10.1016/0093-691X(78)90085-7
   Vajta G, 1997, J REPROD FERTIL, V111, P65
   Vajta G, 1997, THERIOGENOLOGY, V47, P501, DOI 10.1016/S0093-691X(97)00008-3
   Vajta G, 1996, THERIOGENOLOGY, V45, P683, DOI 10.1016/0093-691X(95)00414-4
   Vajta G, 1997, CRYO-LETT, V18, P191
   Vajta G, 1996, ANIM REPROD SCI, V45, P191, DOI 10.1016/S0378-4320(96)01583-7
   VALDIVIA RPA, 1993, MOL REPROD DEV, V35, P121, DOI 10.1002/mrd.1080350204
   Van Wagtendonk-De Leeuw A. M., 1994, Theriogenology, V41, P326, DOI 10.1016/S0093-691X(05)80236-5
   VANDERSCHANS A, 1992, 12TH P INT C AN REPR, V3, P1366
   VANSOOM A, 1994, THERIOGENOLOGY, V41, P855, DOI 10.1016/0093-691X(94)90501-9
   Wall RJ, 1996, THERIOGENOLOGY, V45, P57, DOI 10.1016/0093-691X(95)00355-C
   WARNER CM, 1987, BIOL REPROD, V36, P611, DOI 10.1095/biolreprod36.3.611
   WARNER CM, 1987, BIOL REPROD, V36, P606, DOI 10.1095/biolreprod36.3.606
   WESTHUSIN ME, 1992, J REPROD FERTIL, V95, P475
   WILLADSEN S, 1978, J REPROD FERTIL, V52, P391
   WILLADSEN SM, 1986, NATURE, V320, P63, DOI 10.1038/320063a0
   WILLADSEN SM, 1991, THERIOGENOLOGY, V35, P161, DOI 10.1016/0093-691X(91)90155-7
   WILLADSEN SM, 1979, NATURE, V277, P298, DOI 10.1038/277298a0
   WILLADSEN SM, 1981, VET REC, V108, P211, DOI 10.1136/vr.108.10.211
   WILMUT, 1992, EMBRYONIC DEV MANIPU, P135
   WILMUT I, 1973, VET REC, V92, P686, DOI 10.1136/vr.92.26.686
   Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0
   WILMUT I, 1992, ANIM REPROD SCI, V28, P149, DOI 10.1016/0378-4320(92)90101-I
   WILMUT I, 1972, J REPROD FERTIL, V31, P513
   WURTH YA, 1994, THERIOGENOLOGY, V42, P1275, DOI 10.1016/0093-691X(94)90247-G
   XU KP, 1992, MOL REPROD DEV, V31, P249, DOI 10.1002/mrd.1080310404
   XU KP, 1987, J REPROD FERTIL, V81, P501
   YADAV BR, 1993, MOL REPROD DEV, V36, P434, DOI 10.1002/mrd.1080360405
NR 156
TC 0
Z9 0
U1 1
U2 7
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 0906-4702
J9 ACTA AGR SCAND A-AN
JI Acta Agric. Scand. Sect. A-Anim. Sci.
PY 1998
SU 29
BP 19
EP 29
PG 11
WC Agriculture, Dairy & Animal Science
SC Agriculture
GA 146WU
UT WOS:000077456200004
DA 2018-10-20
ER

PT J
AU Burtscher, IM
   Owman, T
   Romner, B
   Stahlberg, F
   Holtas, S
AF Burtscher, IM
   Owman, T
   Romner, B
   Stahlberg, F
   Holtas, S
TI Aneurysm clip MR artifacts - Titanium versus stainless steel and
   influence of imaging parameters
SO ACTA RADIOLOGICA
LA English
DT Article
DE brain, aneurysm clip; implants; MR imaging, artifacts
ID FAST SPIN-ECHO; METALLIC IMPLANTS; BIOMEDICAL IMPLANTS; POTENTIAL
   HAZARDS; MAGNETIC-FIELDS; DEVICES; FERROMAGNETISM; STRENGTH; IMAGES;
   SAFETY
AB Purpose. The aim of this study was to evaluate the extent to which titanium aneurysm clips could improve the quality of MR imaging compared with stainless steel clips, and to determine whether the clip artifacts could be reduced by controlling certain MR imaging parameters in frequently used pulse sequences.
   Material and Methods. The metal artifacts induced by 3 aneurysm clips were compared in 3 pulse sequences. The clips were: a Yasargil titanium aneurysm clip FT 752 T; a Yasargil standard aneurysm clip FE 752 K; and, for comparison. a ferromagnetic Scoville aneurysm clip En-58J. The pulse sequences were: spin echo (SE); gradient echo (GE); and fast SE. An evaluation was made of 3 imaging parameters with regard to their influence on the size of the metal artifacts. The parameters were: bandwidth; echo time (TE); and echo-train length.
   Results: The titanium clip showed artifacts that were about 60% smaller than those from the stainless steel clip. The only parameter that influenced artifact size to any major degree was bandwidth in the SE sequences but not in the GE sequences. GE sequences induced larger artifacts than SE sequences and showed larger artifacts with longer TE.
   Conclusion: Titanium aneurysm clips reduced MR artifacts by approximately 60% compared to stainless steel clips. Artifacts were further reduced by using SE-based sequences with a high bandwidth or, if necessary, GE sequences with a low TE.
C1 Univ Lund Hosp, Dept Diagnost Radiol, S-22185 Lund, Sweden.
   Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden.
   Univ Lund Hosp, Dept Radiat Phys, S-22185 Lund, Sweden.
RP Burtscher, IM (reprint author), Univ Lund Hosp, Dept Diagnost Radiol, S-22185 Lund, Sweden.
CR BECKER RL, 1988, AM J NEURORADIOL, V9, P885
   BELLON EM, 1986, AM J ROENTGENOL, V147, P1271, DOI 10.2214/ajr.147.6.1271
   DAVIS PL, 1981, AM J ROENTGENOL, V137, P857, DOI 10.2214/ajr.137.4.857
   DISEGI JA, 1992, INJURY, V23, P1
   GOMORI JM, 1987, J COMPUT ASSIST TOMO, V11, P684, DOI 10.1097/00004728-198707000-00025
   HOLTAS S, 1988, AM J NEURORADIOL, V9, P891
   JOHNSON GC, 1993, RADIOLOGY, V188, P287, DOI 10.1148/radiology.188.1.8511314
   JONES KM, 1992, AM J ROENTGENOL, V158, P1313, DOI 10.2214/ajr.158.6.1590133
   JONES KM, 1992, RADIOLOGY, V182, P53, DOI 10.1148/radiology.182.1.1727309
   KAGETSU NJ, 1991, RADIOLOGY, V179, P505, DOI 10.1148/radiology.179.2.2014301
   KANAL E, 1990, RADIOLOGY, V176, P593, DOI 10.1148/radiology.176.3.2202008
   KANAL E, 1994, AM J NEURORADIOL, V15, P1394
   KANAL E, 1993, RADIOLOGY, V187, P612, DOI 10.1148/radiology.187.3.8497603
   KANAL E, 1993, RADIOLOGY, V186, P914
   KANAL E, 1992, TODAY VIDEO, P6
   KLUCZNIK RP, 1993, RADIOLOGY, V187, P855, DOI 10.1148/radiology.187.3.8497645
   LAAKMAN RW, 1985, RADIOLOGY, V157, P711, DOI 10.1148/radiology.157.3.4059558
   Ludeke K M, 1985, Magn Reson Imaging, V3, P329, DOI 10.1016/0730-725X(85)90397-2
   MESGARZADEH M, 1985, SKELETAL RADIOL, V14, P205, DOI 10.1007/BF00355565
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   OEHLER MC, 1995, AM J NEURORADIOL, V16, P1135
   PHILLIPS DS, 1978, BASIC STAT HLTH SCI
   PIEPGRAS A, 1995, RADIOLOGE, V35, P1
   ROMNER B, 1989, J NEUROSURG, V70, P426, DOI 10.3171/jns.1989.70.3.0426
   RUPP R, 1993, SPINE, V18, P379
   SHELLOCK FG, 1991, RADIOLOGY, V180, P541, DOI 10.1148/radiology.180.2.2068325
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   SHELLOCK FG, 1994, J MAGN RESON IMAGING, V4, P756, DOI 10.1002/jmri.1880040521
   SHELLOCK FG, 1993, RADIOLOGY, V189, P587, DOI 10.1148/radiology.189.2.8210394
   SHELLOCK FG, 1994, RADIOLOGY P, V193, P266
   SZE G, 1993, AM J NEURORADIOL, V14, P1203
   TARTAGLINO LM, 1994, RADIOLOGY, V190, P565, DOI 10.1148/radiology.190.2.8284417
   TEITELBAUM GP, 1988, RADIOLOGY, V166, P657, DOI 10.1148/radiology.166.3.3340759
   VACCARO AR, 1994, SPINE, V19, P1237, DOI 10.1097/00007632-199405310-00008
   VINITSKI S, 1993, JMRI-J MAGN RESON IM, V3, P501, DOI 10.1002/jmri.1880030312
NR 35
TC 22
Z9 28
U1 0
U2 1
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0284-1851
J9 ACTA RADIOL
JI Acta Radiol.
PD JAN
PY 1998
VL 39
IS 1
BP 70
EP 76
PG 7
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA YU555
UT WOS:000071729600013
PM 9498874
DA 2018-10-20
ER

PT S
AU Narayan, RJ
   Wei, Q
   Sharma, AK
   Cuomo, JJ
   Narayan, J
AF Narayan, RJ
   Wei, Q
   Sharma, AK
   Cuomo, JJ
   Narayan, J
BE Singh, RK
   Lowndes, DH
   Chrisey, DB
   Fogarassy, E
   Narayan, J
TI Diamondlike carbon, carbon nitride, and titanium nitride coatings on
   metal and polymer substrates
SO ADVANCES IN LASER ABLATION OF MATERIALS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Advances in Laser Ablation of Materials at the 1998 MRS
   Spring Meeting
CY APR 13-16, 1998
CL SAN FRANCISCO, CA
SP Mat Res Soc (MRS)
AB We have deposited diamondlike carbon, carbon nitride, and titanium nitride biocompatible coatings using pulsed laser deposition and magnetron sputtering on metallic (cobalt-chromium and titanium- 6% aluminum- 4% vanadium) and polymeric (high-density polyethylene) substrates commonly used in human prosthetic devices. A major advantage of the magnetron sputtering deposition technique is that it provides conformal coverage of large-area films. The coatings were characterized by electron diffraction and imaging, Raman spectroscopy, X- ray photoelectron spectroscopy, and electron- energy loss spectroscopy, and nanoindenter hardness measurements. The physical properties (especially hardness) of the diamondlike carbon films were controlled using carbide and noncarbide forming elements. By varying the doping concentration as a function of thickness, functionally gradient materials with superior tribological and mechanical properties can be created. The implications of these results are discussed in the context of biomedical applications.
C1 N Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
RP Narayan, RJ (reprint author), N Carolina State Univ, Dept Mat Sci & Engn, Box 7907, Raleigh, NC 27695 USA.
RI Narayan, Roger/J-2789-2013; Wei, Qiuming/B-7579-2008; Narayan,
   Jagdish/D-1874-2009
OI Narayan, Roger/0000-0002-4876-9869; 
NR 0
TC 2
Z9 2
U1 0
U2 6
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-432-7
J9 MATER RES SOC SYMP P
PY 1998
VL 526
BP 355
EP 360
DI 10.1557/PROC-526-355
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Optics
SC Materials Science; Optics
GA BM12Q
UT WOS:000077696000054
DA 2018-10-20
ER

PT S
AU Cales, B
   Chevalier, J
AF Cales, B
   Chevalier, J
BE Jacobs, JJ
   Craig, TL
TI Wear behavior of ceramic pairs compared on different testing
   configurations
SO ALTERNATIVE BEARING SURFACES IN TOTAL JOINT REPLACEMENT
SE American Society for Testing and Materials Selected Technical Papers
LA English
DT Proceedings Paper
CT Symposium on Alternative Bearing Surfaces in Total Joint Replacement
CY NOV 11-12, 1997
CL SAN DIEGO, CA
SP ASTM Comm F04
DE zirconia ceramic; ceramic-on-ceramic; wear test; hip joint simulator;
   finite element analysis; total hip prosthesis
ID ZIRCONIA
AB The wear properties of ceramic pairs including a biomedical grade zirconia ceramic (PROZYR(R)) were studied. In a simple disk-on-disk wear test in synthetic serum, the best wear behavior was observed with alumina-zirconia pairing. These tests also showed that the zirconia-zirconia combination can be considered for hip joint applications because it demonstrates wear behavior close to the classic alumina-alumina pairing. Hip simulator tests up to 10 million cycles for zirconia-alumina combinations confirm the previous experiments. It is clearly shown, if zirconia ceramic material and convenient wear test procedures are used, that the wear behavior of zirconia ceramic in ceramic-ceramic pairing is outstanding. The wear performance of zirconia was similar to, if not better than, that of alumina. Furthermore, tensile stresses in heads and cups, determined using finite element analysis, were found to be significantly higher in ceramic-on-ceramic bearings than in conventional ceramic-on-polyethylene couplings. This may influence the incidence of ceramic component fractures in ceramic-on ceramic bearings and may have implications concerning ceramic material selection for this application.
C1 Norton Desmarquest, Biomed Act, F-27025 Evreux, France.
RP Cales, B (reprint author), Norton Desmarquest, Biomed Act, ZI N1,Rue de Ind, F-27025 Evreux, France.
CR Birkby I., 1989, Journal of the European Ceramic Society, V5, P37, DOI 10.1016/0955-2219(89)90007-1
   Black J, 1996, CLIN ORTHOP RELAT R, pS244
   BOUTIN P, 1988, J BIOMED MATER RES, V22, P1203, DOI 10.1002/jbm.820221210
   CALES B, 1995, 4 EUROCERAMICS, V8, P45
   Chan FW, 1996, CLIN ORTHOP RELAT R, P96
   CHEVALIER J, 1997, BIOCERAMICS, V8, P271
   CHRISTEL PS, 1989, B HOSP JOINT DIS ORT, V49, P170
   Fritsch EW, 1996, CLIN ORTHOP RELAT R, P129
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Jacobs JJ, 1996, CLIN ORTHOP RELAT R, pS256
   KABO JM, 1993, J BONE JOINT SURG BR, V75, P254
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   LEE SW, 1993, J AM CERAM SOC, V76, P1937, DOI 10.1111/j.1151-2916.1993.tb08315.x
   MANLEY MT, 1994, CLIN ORTHOP RELAT R, V298, P37
   McKee G K, 1966, J Bone Joint Surg Br, V48, P245
   MCKELLOP H, 1996, 5 WORLD BIOM C TOR M
   MCKELLOP H, 1992, P ORTH RES SOC M WAS
   Michaud RJ, 1995, J ARTHROPLASTY, V10, P863, DOI 10.1016/S0883-5403(05)80089-0
   MULLER ME, 1970, CLIN ORTHOP RELAT R, P46
   Paul J. P, 1967, P I MECH ENG, V181, P8
   POLINELI VK, 1992, 23 ANN M SOC BIOM NE
   Ring P A, 1968, J Bone Joint Surg Br, V50, P720
   RISKA EB, 1993, CLIN ORTHOP RELAT R, V297, P87
   Schmalzried TP, 1996, J ARTHROPLASTY, V11, P322, DOI 10.1016/S0883-5403(96)80085-4
   SCHMALZRIED TP, 1992, CLIN ORTHOP RELAT R, P60
   SCHMALZRIED TP, 1994, J BONE JOINT SURG AM, V76A, P677, DOI 10.2106/00004623-199405000-00008
   SEDEL L, 1994, CLIN ORTHOP RELAT R, V298, P175
   SYCHTERZ CJ, 1995, J BONE JOINT SURG AM, V78, P1311
   Willmann G, 1996, BIOMATERIALS, V17, P2157, DOI 10.1016/0142-9612(96)00042-7
   WRIGHT TM, 1996, IMPLANT WEAR FUTURE
NR 30
TC 3
Z9 3
U1 0
U2 0
PU AMER SOCIETY TESTING AND MATERIALS
PI W CONSHOHOCKEN
PA 100 BARR HARBOR DRIVE, W CONSHOHOCKEN, PA 19428-2959 USA
SN 0066-0558
BN 0-8031-2490-2
J9 AM SOC TEST MATER
PY 1998
VL 1346
BP 186
EP 196
DI 10.1520/STP12839S
PG 11
WC Engineering, Biomedical; Orthopedics
SC Engineering; Orthopedics
GA BM49Q
UT WOS:000078897100013
DA 2018-10-20
ER

PT J
AU Chang, CY
   Glassman, AB
   Bueso-Ramos, CE
AF Chang, CY
   Glassman, AB
   Bueso-Ramos, CE
TI Applicability of direct in situ reverse transcription-polymerase chain
   reaction on bone marrow smears
SO ANNALS OF CLINICAL AND LABORATORY SCIENCE
LA English
DT Article
ID LEUKEMIA PATIENTS; REACTION PCR; EXPRESSION; ABL; BCR; AMPLIFICATION;
   LOCALIZATION; CELLS
AB In situ reverse transcription (RT)-polymerase chain reaction (PCR) is a promising laboratory tool for biomedical investigation at the molecular level in tissues. Direct in-cell amplification of the breakpoint cluster region (BCR)-Abelson (ABL) fusion transcript of chronic myeloid leukemia (CML) has recently been accomplished in Italy using bone marrow mononuclear cell suspensions. The goals of this study are to determine if in situ RT-PCR amplification is possible on bone marrow spirate smears and to demonstrate any unique factors in this procedure. A commercially available method was used because of the existence of published protocols for adaptation. Bone marrow (BM) aspirate smears (n = 17) from patients with CML in blast crisis (positive case material) or other hematological malignancies (negative case material) were evaluated. Satisfactory amplification of the BCR-ABL fusion transcript occurred, and distinct blue cytoplasmic granules that varied in intensity were found in most CML blasts. The negative case materials lacked the specifically amplified granular signals. Overall signal strength and backgrounds were readily affected by the quality of the specimen as well as by changes in assay parameters. In conclusion, the direct in situ RT-PCR technique is applicable for bone marrow aspirate smear evaluation. However, it remains an investigative tool until optimization for sensitivity, specificity, and accuracy can be achieved.
C1 Univ Texas, Md Anderson Canc Ctr, Div Lab Med, Hematopathol Sect, Houston, TX 77030 USA.
RP Bueso-Ramos, CE (reprint author), Univ Texas, Md Anderson Canc Ctr, Div Lab Med, Hematopathol Sect, Box 72,1515 Holcombe Blvd, Houston, TX 77030 USA.
CR BIERNAUX C, 1995, BLOOD, V86, P3118
   CROSS NCP, 1994, LEUKEMIA, V8, P186
   Henegariu O, 1997, BIOTECHNIQUES, V23, P504, DOI 10.2144/97233rr01
   HENIFORD BW, 1993, NUCLEIC ACIDS RES, V21, P3159, DOI 10.1093/nar/21.14.3159
   KOMMINOTH P, 1993, VIRCHOWS ARCH B, V64, P67, DOI 10.1007/BF02915097
   KONOPKA JB, 1986, P NATL ACAD SCI USA, V83, P4049, DOI 10.1073/pnas.83.11.4049
   MAKOWSKI GS, 1995, CLIN CHEM, V41, P477
   MARTINEZ A, 1995, J HISTOCHEM CYTOCHEM, V43, P739, DOI 10.1177/43.8.7542678
   Nuovo GJ, 1995, J HISTOTECHNOL, V18, P295
   NUOVO GJ, 1997, IN SITU HYBRIDIZATIO, P74
   OLeary JJ, 1996, J PATHOL, V178, P11
   PESTANER JP, 1994, ACTA CYTOL, V38, P676
   Roberts WM, 1997, NEW ENGL J MED, V336, P317, DOI 10.1056/NEJM199701303360501
   SALLSTROM JF, 1993, ANTICANCER RES, V13, P1153
   TAOKA T, 1993, LEUKEMIA RES, V17, P695, DOI 10.1016/0145-2126(93)90076-W
   Testoni N, 1996, BLOOD, V87, P3822
   TSONGALIS GJ, 1994, ANN CLIN LAB SCI, V24, P436
   WETZLER M, 1993, J CLIN INVEST, V92, P1925, DOI 10.1172/JCI116786
NR 18
TC 4
Z9 5
U1 0
U2 2
PU INST CLINICAL SCIENCE INC
PI PHILADELPHIA
PA 1833 DELANCEY PLACE, PHILADELPHIA, PA 19103 USA
SN 0091-7370
J9 ANN CLIN LAB SCI
JI Ann. Clin. Lab. Sci.
PD JAN-FEB
PY 1998
VL 28
IS 1
BP 34
EP 42
PG 9
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA YY337
UT WOS:000072137000006
PM 9512783
DA 2018-10-20
ER

PT J
AU Weiss, KM
AF Weiss, KM
TI Coming to terms with human variation
SO ANNUAL REVIEW OF ANTHROPOLOGY
LA English
DT Article
DE human genetics
ID HUMAN GENOME PROJECT; POPULATION-GENETICS; NATIVE-AMERICANS;
   HUMAN-EVOLUTION; HUMAN-DISEASES; HUMAN ORIGINS; DIVERSITY; DNA;
   MICROSATELLITES; MITOCHONDRIAL
AB Genetics has become the major tool of the life sciences. This is driven partly by technology, and partly by the belief that genes are the ultimate units of biomedical or evolutionary information. The search for variation associated with disease has motivated the Human Genome Project to construct a detailed road map of the entire set of human genetic material, and some additional form of globally representative human genome diversity resource has been proposed for the anthropological purposes of reconstructing human population history. Any such resource raises complex societal and ethical issues as well as scientific ones. However, the amount and complexity of genetic variation has frustrated hopes for simple genetic answers to important biomedical or anthropological questions, and a consequent converging of these differing interests suggests that developing a genetic variation resource will be important in many disciplines.
C1 Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA.
RP Weiss, KM (reprint author), Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA.
EM kmw4@psu.edu
CR Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516
   BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0
   Boyd W. C., 1950, GENETICS RACES MAN
   CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0
   Cavalli-Sforza L. L., 1971, GENETICS HUMAN POPUL
   Cavalli-Sforza LL, 1994, HSIT GEOGRAPHY HUMAN
   CAVALLISFORZA LL, 1990, AM J HUM GENET, V46, P649
   CAVALLISFORZA LL, 1991, GENOMICS, V11, P490, DOI 10.1016/0888-7543(91)90169-F
   CHADWICK D, 1996, CIBA FDN S, V197
   COLLINS F, 1993, SCIENCE, V262, P43, DOI 10.1126/science.8211127
   COLLINS FS, 1991, FASEB J, V5, P77
   Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580
   Cook-Deegan R., 1994, GENE WARS SCI POLITI
   DEKA R, 1995, AM J HUM GENET, V56, P461
   Deka R, 1996, GENOME RES, V6, P1177, DOI 10.1101/gr.6.12.1177
   Durham W. H., 1991, COEVOLUTION GENES CU
   EVANS E, 1995, GENOME DIG, V2, P12
   Friedlaender J. S., 1996, CULTURAL SURVIVAL Q, V20, P22
   Friedlaender J. S., 1975, PATTERNS HUMAN VARIA
   GREELY HT, 1996, CULTURAL SURVIVAL Q, V20, P54
   HAMMER M, 1997, EVOL ANTHROPOL, P116
   Harding RM, 1998, NAT GENET, V18, P307
   Harding RM, 1997, AM J HUM GENET, V60, P772
   HARPENDING H, 1974, ANNU REV ANTHROPOL, V3, P229, DOI 10.1146/annurev.an.03.100174.001305
   HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195
   Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961
   Hartl D. L., 1997, PRINCIPLES POPULATIO
   Hey J, 1997, MOL BIOL EVOL, V14, P166, DOI 10.1093/oxfordjournals.molbev.a025749
   *HGDP COMM, 1994, HUM GEN DIV HGD PROJ
   Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100
   KIDD JR, 1993, HUM BIOL, V65, P1
   Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4
   Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21
   LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226
   Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536
   LIVINGSTONE FB, 1958, AM ANTHROPOL, V60, P533, DOI 10.1525/aa.1958.60.3.02a00110
   Merriwether DA, 1996, MOL PHYLOGENET EVOL, V5, P241, DOI 10.1006/mpev.1996.0017
   Moore J. H., 1996, RACE OTHER MISADVENT, P217
   MOORE JH, 1994, AM ANTHROPOL, V96, P925, DOI 10.1525/aa.1994.96.4.02a00110
   MOORE JH, 1994, RES EXPLOR, V10, P10
   MOORE JH, 1996, CULT SURVIVAL, V20, P60
   MOURANT A, 1978, DISTRIBUTION HUMAN B
   Mourant A, 1978, BLOOD GROUPS DIS
   National Research Council, 1997, EV HUM GEN DIV
   NEEL JV, 1978, ANNU REV GENET, V12, P365, DOI 10.1146/annurev.ge.12.120178.002053
   Nei M., 1987, MOL EVOLUTIONARY GEN
   OLSON MV, 1993, P NATL ACAD SCI USA, V90, P4338, DOI 10.1073/pnas.90.10.4338
   OROURKE DH, 1985, AM J PHYS ANTHROPOL, V67, P241, DOI 10.1002/ajpa.1330670309
   OROURKE DH, 1986, ANN HUM BIOL, V13, P13, DOI 10.1080/03014468600008171
   OTT J, 1991, ANAL HUMAN GENETIC L
   Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516
   Roychoudhury A. K., 1988, HUMAN POLYMORPHIC GE
   SARICH VM, 1967, SCIENCE, V158, P1200, DOI 10.1126/science.158.3805.1200
   Sherry ST, 1997, GENOME RES, V7, P947, DOI 10.1101/gr.7.10.947
   Stone AC, 1998, AM J HUM GENET, V62, P1153, DOI 10.1086/301838
   STONEKING M, 1996, HUMAN GENOME EVOLUTI
   SUAREZ B, 1985, AM J PHYS ANTHROPOL, V67, P271
   Templeton AR, 1997, CURR OPIN GENET DEV, V7, P841, DOI 10.1016/S0959-437X(97)80049-4
   TERWILLIGER J, 1998, IN PRESS HUM HERED
   Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380
   TORRONI A, 1995, AM J HUM GENET, V56, P1234
   TORRONI A, 1993, AM J HUM GENET, V53, P591
   Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996
   Vogel F, 1997, HUMAN GENETICS PROBL
   vonHaeseler A, 1996, NAT GENET, V14, P135, DOI 10.1038/ng1096-135
   WATSON JD, 1990, SCIENCE, V248, P44, DOI 10.1126/science.2181665
   WEISS K, 1995, BIOTECHNOLOGY GENOME
   WEISS K, 1982, PHYSICAL ANTHR 50 YE, P371
   WEISS K, 1998, IN PRESS GENOME RES
   Weiss K. M., 1992, EVOLUTIONARY ANTHR, V1, P80
   Weiss KM, 1996, MOL PHYLOGENET EVOL, V5, P259, DOI 10.1006/mpev.1996.0019
   WEISS KM, 1976, AM J PHYS ANTHROPOL, V44, P31, DOI 10.1002/ajpa.1330440106
   WEISS KM, 1995, GENETIC VARIATION HU
   WEISS KM, 1996, CULT SURVIVAL Q, V20, P26
   WEISS KM, 1989, J QUANT ANTHR, V1, P79
NR 75
TC 15
Z9 15
U1 0
U2 1
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 0084-6570
EI 1545-4290
J9 ANNU REV ANTHROPOL
JI Annu. Rev. Anthropol.
PY 1998
VL 27
BP 273
EP 300
DI 10.1146/annurev.anthro.27.1.273
PG 28
WC Anthropology
SC Anthropology
GA 134RZ
UT WOS:000076758100014
DA 2018-10-20
ER

PT S
AU Datskos, PG
   Demos, SG
   Rajic, S
AF Datskos, PG
   Demos, SG
   Rajic, S
BE Lieberman, RA
   VoDinh, T
   Katzir, A
TI Miniature uncooled infrared sensitive detectors for in vivo biomedical
   applications
SO BIOMEDICAL SENSING AND IMAGING TECHNOLOGIES, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Sensing and Imaging Technologies
CY JAN 26-27, 1998
CL SAN JOSE, CA
SP Soc Photo Opt Instrumentat Engineers, Int Biomed Opt Soc
DE infrared detection; photon detector; thermal detector; in vivo;
   temperature mapping
AB Broadband infrared (IR) radiation detectors have been developed using miniature, inexpensive, mass produced microcantilevers capable of detecting temperature differences as small as 10(-6) K. Microcantilevers made out of semiconductor materials with dimensions of 50 to 200 mu m long, 10 to 30 mu m wide and 0.4 to 4 mu m thick, undergo bending when exposed to IR radiation and can be used either as uncooled photon or thermal detectors. Mounted on a probe 1 mm in diameter a number of microcantilevers can be accommodated in the working channel of existing endoscopes for in vivo proximity focus measurements inside the human body.
C1 Univ Tennessee, Knoxville, TN 37996 USA.
RP Datskos, PG (reprint author), Univ Tennessee, 401 Nielsen Phys Bldg, Knoxville, TN 37996 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-2692-X
J9 P SOC PHOTO-OPT INS
PY 1998
VL 3253
BP 94
EP 100
DI 10.1117/12.308020
PG 7
WC Engineering, Biomedical; Medical Laboratory Technology; Optics
SC Engineering; Medical Laboratory Technology; Optics
GA BL08J
UT WOS:000074223000013
DA 2018-10-20
ER

PT S
AU Golub, M
   Grossinger, I
AF Golub, M
   Grossinger, I
BE Baldini, F
   Croitoru, NI
   Dickinson, MR
   Frenz, M
   Miyagi, M
   Pratesi, R
   Seeger, S
   Katzir, A
TI Diffractive optical elements for biomedical applications
SO BIOMEDICAL SYSTEMS AND TECHNOLOGIES II, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Systems and Technologies II
CY SEP 04-06, 1997
CL SAN REMO, ITALY
SP Soc Italiana Laser Chirurg & Med, European Laser Assoc, Int Biomed Opt Soc, European Opt Soc, Soc Photo Opt Instrumentat Engineers, Commiss European Communities, Directorate Gen Sci Res & Dev
DE diffractive optics; DOE; laser focusing; multifocal lens; contact lens;
   beam shaping; computer modeling
AB The set of diffractive optical elements for CO2 and Nd-Yag lasers was theoretically calculated, fabricated by microlithographic technology and experimentally tested. It is shown that the laser systems for therapy, surgery and welding gain from advanced capabilities of the DOEs: uniform focal-spot intensity, simultaneous formation of focal line contours, sharp and multiple-spot focusing, dual-wavelength achromatization, miniaturization. Novel multifocal diffractive contact lenses are elaborated based on diffractive microrelief considerations, nonparaxial variant of diffraction integral on curved surface and computer simulations of intensity distribution on eye retina. Tri-focal diffractive contact lenses that were diamond-turned on rigid and soft materials successfully passed tests.
C1 Holo Or Ltd, IL-76114 Rehovot, Israel.
RP Golub, M (reprint author), Holo Or Ltd, Kiryat Weizmann,POB 1051, IL-76114 Rehovot, Israel.
NR 0
TC 4
Z9 4
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-2631-8
J9 P SOC PHOTO-OPT INS
PY 1998
VL 3199
BP 220
EP 231
DI 10.1117/12.301110
PG 12
WC Engineering, Biomedical; Optics
SC Engineering; Optics
GA BK45Y
UT WOS:000072273800028
DA 2018-10-20
ER

PT J
AU Tsafrir, J
   Grinberg, M
AF Tsafrir, J
   Grinberg, M
TI Who needs evidence-based health care?
SO BULLETIN OF THE MEDICAL LIBRARY ASSOCIATION
LA English
DT Article; Proceedings Paper
CT 5th Conference of the
   European-Association-of-Health-Information-and-Libraries
CY SEP 18-21, 1996
CL COIMBRA, PORTUGAL
SP European Assoc Hlth Info & Lib
ID EVIDENCE-BASED MEDICINE; SYSTEMATIC REVIEWS; CLINICAL-PRACTICE;
   METAANALYSIS; BIAS
AB The vast amount of published material in clinical and biomedical sciences, and conflicting results on diagnostic and therapeutic procedures may introduce doubts in decision-making for patient care. Information retrieving skills and the critical appraisal of published literature, together with elaboration of practice guidelines based on epidemiological methodology, form the basis of the trend towards evidence-based health care, which aims to overcome these problems. A survey conducted by questionnaire at the Chaim Sheba Medical Center analyzed which types of information sources are considered most relevant and useful for patient care by a cross-section of physicians with varying degrees of experience. They considered review articles and meta-analyses extremely reliable for information purposes, while for practical patient-care purposes they tended to rely more on the opinions of peers and experts. As the requirements of evidence-based health care may influence the attitudes of clinicians to the published literature and its evaluation, they have implications for medical libraries and information centers. Specifically information specialists will be called upon more and more to impart information-retrieval and critical appraisal skills to clinicians. The involvement of information specialists in information gathering and selection will provide added value to the expertise and knowledge of in-house experts for decision-making.
C1 Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Miriam Gutwirth Med Lib,Reference Serv, IL-52621 Tel Hashomer, Israel.
   Tel Aviv Univ, Gitter Smolarz Lib Life Sci & Med, Reference Serv, IL-69978 Tel Aviv, Israel.
RP Tsafrir, J (reprint author), Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Miriam Gutwirth Med Lib,Reference Serv, IL-52621 Tel Hashomer, Israel.
EM jtsafrir@post.tau.ac.il; miriamg@taulib.tau.ac.il
RI Grinberg, Miriam/D-2259-2009
CR Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637
   Buckley NA, 1996, LANCET, V347, P1167, DOI 10.1016/S0140-6736(96)90615-7
   CARRHILL R, 1995, SOC SCI MED, V41, P1467, DOI 10.1016/0277-9536(95)00351-7
   DAVIDOFF F, 1995, ANN INTERN MED, V122, P727, DOI 10.7326/0003-4819-122-9-199505010-00012
   Dep. Clin. Epidemiol. Biostat. McMaster Univ., 1981, CAN MED ASSOC J, V124, P985
   DICKERSIN K, 1993, ANN NY ACAD SCI, V703, P135, DOI 10.1111/j.1749-6632.1993.tb26343.x
   DICKERSIN K, 1994, BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286
   Dickersin K, 1993, ANN NY ACAD SCI, V703, P146
   EYSENCK HJ, 1994, BRIT MED J, V309, P789, DOI 10.1136/bmj.309.6957.789
   FOWLER PBS, 1995, LANCET, V346, P838
   Freemantle N, 1997, ANN INTERN MED, V126, P81, DOI 10.7326/0003-4819-126-1-199701010-00011
   FULLERTONSMITH I, 1995, EVIDENCE BASED MED, V1, P7
   GREGOIRE G, 1995, J CLIN EPIDEMIOL, V48, P159, DOI 10.1016/0895-4356(94)00098-B
   GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032
   HAYNES RB, 1981, CAN MED ASSOC J, V124, P703
   IVES DG, 1994, EPIDEMIOLOGY, V5, P456
   *JOINT COMM ACCR H, 1994, MED REF SERV Q, V13, P85
   LEWIS S, 1995, CAN MED ASSOC J, V153, P1073
   McCarthy Laine H., 1996, Medical Reference Services Quarterly, V15, P63
   MEAD TL, 1995, B MED LIBR ASSOC, V83, P461
   NAYLOR CD, 1995, LANCET, V345, P840, DOI 10.1016/S0140-6736(95)92969-X
   RAFUSE J, 1994, CAN MED ASSOC J, V150, P1479
   REES J, 1995, BRIT MED J, V310, P850, DOI 10.1136/bmj.310.6983.850
   ROSENBERG W, 1995, BRIT MED J, V310, P1122, DOI 10.1136/bmj.310.6987.1122
   Sackett D. L., 1995, EVIDENCE BASED MED, V1, P5
   SACKETT DL, 1981, CAN MED ASSOC J, V124, P555
   Sackett DL, 1996, BRIT MED J, V312, P71
   SACKETT DL, 1981, CAN MED ASSOC J, V124, P1156
   Smith Jack T. Jr., 1994, Medical Reference Services Quarterly, V13, P57
   Sorensen TIA, 1996, LANCET, V348, P351, DOI 10.1016/S0140-6736(05)64988-4
   TANENBAUM SJ, 1993, NEW ENGL J MED, V329, P1268, DOI 10.1056/NEJM199310213291713
   TUGWELL PX, 1981, CAN MED ASSOC J, V124, P869
   Urquhart CJ, 1996, B MED LIBR ASSOC, V84, P482
NR 33
TC 7
Z9 8
U1 0
U2 0
PU MEDICAL LIBRARY ASSOC
PI CHICAGO
PA 65 EAST WACKER PLACE, STE 1900, CHICAGO, IL 60601-7298 USA
SN 0025-7338
J9 B MED LIBR ASSOC
JI Bull. Med. Libr. Assoc.
PD JAN
PY 1998
VL 86
IS 1
BP 40
EP 45
PG 6
WC Information Science & Library Science
SC Information Science & Library Science
GA ZC511
UT WOS:000072587500006
PM 9549011
DA 2018-10-20
ER

PT J
AU Dilworth, JR
   Parrott, SJ
AF Dilworth, JR
   Parrott, SJ
TI The biomedical chemistry of technetium and rhenium
SO CHEMICAL SOCIETY REVIEWS
LA English
DT Review
ID MYOCARDIAL IMAGING AGENT; TC-99M; COMPLEXES; RADIOPHARMACEUTICALS; SPECT
AB This review describes recent developments in the chemistry of both first and second generation 99m-technetium-based imaging agents. The material is presented according to the biological target for the agent, and where possible actual images are presented to indicate the type of information available to the clinician, Beta emitting isotopes of rhenium offer a possible method for the in situ treatment of cancerous tissue using analogous targeting strategies to those for technetium. Recent developments in the relevant coordination chemistry of rhenium and their extension to in vitro and in vivo studies are presented.
C1 Univ Oxford, Inorgan Chem Lab, Oxford OX1 3QR, England.
   Univ Essex, Dept Chem & Biol Sci, Colchester CO4 3SQ, Essex, England.
RP Dilworth, JR (reprint author), Univ Oxford, Inorgan Chem Lab, S Parks Rd, Oxford OX1 3QR, England.
CR ARCHER CM, 1996, CURRENT DIRECTIONS R, P81
   BLOWER P J, 1990, Journal of Nuclear Medicine, V31, P768
   CHEESEMAN EH, 1986, J NUCL MED, V29, P288
   CHI DY, 1994, J MED CHEM, V37, P928, DOI 10.1021/jm00033a010
   CLARKE MJ, 1987, COORDIN CHEM REV, V78, P253, DOI 10.1016/0010-8545(87)85029-4
   COSTELLO CE, 1983, J NUCL MED, V24, P353
   DEROSCH MA, 1992, J NUCL MED, V33, P850
   DEUTSCH E, 1983, PROG INORG CHEM, V30, P75, DOI 10.1002/9780470166314.ch2
   DEVOUS MD, 1988, BRAIN IMAGING APPLIC, P147
   DILWORTH JR, 1996, DIRECTIONS RADIOPHAR
   FRITZBERG AR, 1986, J NUCL MED, V27, P111
   FRITZBERG AR, 1994, CHEM STRUCTURAL APPR, P125
   FRITZBERG AR, 1995, HANDB PHARM TOX, P83
   GEORGE AJT, 1995, P NATL ACAD SCI USA, V92, P8538
   GERSON MC, 1983, EUR J NUCL MED, V8, P371
   HNATOWICH DJ, 1993, J NUCL MED CHEM, V34, P172
   HOLMAN BL, 1992, J NUCL MED, V33, P1888
   HOLMAN BL, 1984, J NUCL MED, V25, P1350
   KELLY JD, 1992, J NUCL MED, V24, P353
   KRAMER EL, 1995, CLIN SPECT IMAGING
   Kung HF, 1996, EUR J NUCL MED, V23, P1527, DOI 10.1007/BF01254479
   LEONARD JP, 1986, J NUCL MED, V27, P1819
   LIBSON K, 1980, J AM CHEM SOC, V102, P2476, DOI 10.1021/ja00527a066
   LINDER KE, 1990, INORG CHEM, V29, P2428, DOI 10.1021/ic00338a009
   LISTERJAMES J, 1994, TECHNETIUM RHENIUM C, V3, P269
   LIU S, 1996, BIOCONJ CHEM, V7, P203
   LIU S, 1996, BIOCONJ CHEM, V7, P83
   Nicolini M., 1995, TECHNETIUM RHENIUM N, V4
   PASQUALINI R, 1992, J CHEM SOC CHEM COMM, P1354, DOI 10.1039/c39920001354
   PONTO JA, 1990, PHARM MED IMAGING, P501
   SINGH J, 1991, J CHEM SOC CHEM COMM, P15
   Spies H., 1995, TECHNETIUM RHENIUM C, V4, P243
   TISATO F, 1994, COORDIN CHEM REV, V135, P235
   TOP S, 1995, J AM CHEM SOC, V117, P8372, DOI 10.1021/ja00137a010
   VOLKERT WA, 1993, ADV METALS MED, V1, P115
   Welch M. J., 1996, CURRENT DIRECTIONS R, P137
   Yoshihava K., 1996, TOP CURR CHEM, V176, P2
NR 37
TC 485
Z9 489
U1 3
U2 56
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON ROAD, CAMBRIDGE CB4 4WF,
   CAMBS, ENGLAND
SN 0306-0012
J9 CHEM SOC REV
JI Chem. Soc. Rev.
PD JAN
PY 1998
VL 27
IS 1
BP 43
EP 55
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA YV681
UT WOS:000071852100005
DA 2018-10-20
ER

PT B
AU Simon, BR
   Kaufmann, MV
   Liu, J
   Baldwin, AL
AF Simon, BR
   Kaufmann, MV
   Liu, J
   Baldwin, AL
BE Middleton, J
   Jones, ML
   Pande, GN
TI Porohyperelastic-transport-swelling finite element models: Applications
   and material properties for large arteries
SO COMPUTER METHODS IN BIOMECHANICS & BIOMEDICAL ENGINEERING - 2
LA English
DT Proceedings Paper
CT 3rd International Symposium on Computer Methods in Biomechanics and
   Biomedical Engineering
CY MAY, 1997
CL BARCELONA, SPAIN
SP 3M Unitek (Div 3M Hlth Care Ltd), Gordon & Breach Publishers, Welsh Dev Agcy, Wilde & Partners (FE Div)
DE finite element models; porohyperelastic; transport; arteries
AB This communication summarizes a presentation at the Third International Symposium on Computer Methods in Biomechanics and Biomedical Engineering,(1) and describes the development and applications of porohyperelastic-transport-swelling (PHETS) formulations and finite element models (FEMs) for the analysis of soft, hydrated rabbit aortic tissues. These PHETS models include both material and geometric nonlinearity and coupled transport of mobile tissue fluid and species dissolved in the fluid. Corresponding Eulerian and Lagrangian field theories allow identification of material property functions and form the basis for the FEMs. Data-reduction procedures provided intimal and medial elasticity, permeability, and diffusion-convection transport properties. PHETS FEM results compare well with data from our laboratory and data presented in the literature for pressure-radius response, free tissue fluid flux, and diffusive-convective flux of labeled mobile albumin in the walls of rabbit aortas.
C1 Univ Arizona, Tucson, AZ 85721 USA.
RP Simon, BR (reprint author), Univ Arizona, Tucson, AZ 85721 USA.
CR Kaufmann M. V., 1996, THESIS U ARIZONA TUC
   SIMON BR, 1997, 3 INT S COMP METH BI
   SIMON BR, 1997, IN PRESS J BIOMECH E
   TEDGUI A, 1985, CIRC RES, V57, P856, DOI 10.1161/01.RES.57.6.856
NR 4
TC 0
Z9 0
U1 0
U2 1
PU GORDON AND BREACH SCIENCE PUBL
PI 1062 EV AMSTERDAM
PA RIJSWIJKSTRAAT 175, 1062 EV AMSTERDAM, NETHERLANDS
BN 90-5699-206-6
PY 1998
BP 505
EP 510
PG 6
WC Computer Science, Interdisciplinary Applications; Dentistry, Oral
   Surgery & Medicine; Engineering, Biomedical; Orthopedics; Surgery
SC Computer Science; Dentistry, Oral Surgery & Medicine; Engineering;
   Orthopedics; Surgery
GA BM39Z
UT WOS:000078630800062
DA 2018-10-20
ER

PT S
AU Roberts, RS
   Aimonetti, WD
   Bixler, JV
AF Roberts, RS
   Aimonetti, WD
   Bixler, JV
BE Matthews, MB
TI Material characterization using a hyperspectral infrared imaging
   spectrometer
SO CONFERENCE RECORD OF THE THIRTY-SECOND ASILOMAR CONFERENCE ON SIGNALS,
   SYSTEMS & COMPUTERS, VOLS 1 AND 2
SE CONFERENCE RECORD OF THE ASILOMAR CONFERENCE ON SIGNALS, SYSTEMS AND
   COMPUTERS
LA English
DT Proceedings Paper
CT 32nd Asilomar Conference on Signals, Systems and Computers
CY NOV 01-04, 1998
CL PACIFIC GROVE, CA
SP Naval Postgrad Sch, Monterey, San Jose State Univ, San Jose, Monterey Bay Aquarium Res Inst, IEEE Signal Proc Soc
AB Fourier transform spectroscopy has found application ill many areas including chemometrics, biomedical and biochemical studies, and atmospheric chemistry. This paper describes an investigation into the application of the LLNL Hyperspectral Infrared Imaging Spectrometer (HIRIS) to the non-destructive evaluation of man-made and natural materials. We begin by describing the HIRIS system and the objects studied In the investigation. Next, we describe the technique used to collect the hyperspectral imagery, and discuss the processing required to transform the data into usable form. We then describe a technique to analyze the data, and provide some preliminary results.
C1 Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
RP Roberts, RS (reprint author), Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
CR *ASTM, ASTM MET REF BOOK
   Beer R., 1992, REMOTE SENSING FOURI
   BENNETT CL, 1998, FOUR TRANSF SPECTR 1
   BYLER D, 1998, FOUR TRANSF SPECTR 1
   DING Q, 1998, FOUR TRANSF SPECTR 1
   FUKUNAGA K, 1990, INTRO STAT PATTERN R
   Jain A. K, 1989, FUNDAMENTALS DIGITAL
   MALINOWSKI ER, 1991, FACTOR ANAL CHEM
   TAUB W, 1998, FOUR TRANSF SPECTR 1
   TILLEY CE, 1959, ENCY BRITANNICA
NR 10
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1058-6393
BN 0-7803-5149-5
J9 CONF REC ASILOMAR C
PY 1998
BP 1273
EP 1277
PG 5
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Computer Science, Theory & Methods;
   Engineering, Electrical & Electronic; Telecommunications
SC Computer Science; Engineering; Telecommunications
GA BM43X
UT WOS:000078743600240
DA 2018-10-20
ER

PT B
AU Gaiseanu, F
   Postolache, C
   Dascalu, D
   Esteve, J
   Tsoukalas, D
   Badoiu, A
   Vasile, E
AF Gaiseanu, F
   Postolache, C
   Dascalu, D
   Esteve, J
   Tsoukalas, D
   Badoiu, A
   Vasile, E
BE White, NM
TI Material characterization of the capacitive pressure sensors for
   biomedical applications fabricated by surface micromachining technology
SO EUROSENSORS XII, VOLS 1 AND 2
SE SENSORS SERIES
LA English
DT Proceedings Paper
CT 12th European Conference on Solid-State Transducers - 9th UK Conference
   on Sensors and Their Applications
CY SEP 13-16, 1998
CL SOUTHAMPTON, ENGLAND
AB An integrated structure of capacitive pressure sensor for biomedical applications achieved by surface micromachining technology, consisting in the pressure sensor and a testing component is presented.. The test structure permitted to apply the pull-in voltage method for the evaluation of the residual stress in the polysilicon layer on the basis of a new form of the set of two equations describing the beam pull-in voltage effect. The integrated structure allowed the optimization of the phosphorus diffusion process to obtain low stress polysilicon membranes of the capacitive pressure sensors for biomedical applications.
C1 Natl Inst Res Dev Microtechnol, IMT, R-72996 Bucharest, Romania.
RP Gaiseanu, F (reprint author), Natl Inst Res Dev Microtechnol, IMT, Erou Lancu Nicolae 32B,POB 38-160, R-72996 Bucharest, Romania.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
BN 0-7503-0536-3
J9 SENSORS SER
PY 1998
BP 43
EP 46
PG 4
WC Engineering, Multidisciplinary; Instruments & Instrumentation; Materials
   Science, Multidisciplinary
SC Engineering; Instruments & Instrumentation; Materials Science
GA BL96Z
UT WOS:000077311200011
DA 2018-10-20
ER

PT B
AU Williams, WS
   Kaloyeros, AE
AF Williams, WS
   Kaloyeros, AE
BE Kumar, A
   Chung, YW
   Chia, RWJ
TI Synthesis, characterization and potential applications of amorphous
   coatings of titanium carbide and titanium diboride
SO HARD COATINGS: BASED ON BORIDES, CARBIDES & NITRIDES: SYNTHESIS,
   CHARACTERIZATION & APPLICATIONS
LA English
DT Proceedings Paper
CT International Symposium on Hard Coatings Based on Borides, Carbides and
   Nitrides - Synthesis, Characterization and Applications at the 1998 TMS
   Annual Meeting
CY FEB 16-19, 1998
CL SAN ANTONIO, TX
SP Minerals Met & Mat Soc, Mat Design & Mfg Div, Surface Modificat & Coatings Technol Comm
AB Amorphous materials have an advantage over crystalline versions: the absence of grain boundaries reduces the probability of fracture and corrosion. However, many amorphous metal alloys crystallize at moderate temperatures, thus limiting their applications. One amorphous titanium carbide (TiC) film to be described did not crystallize until 1000 degrees C. The TiC film was synthesized by metal-organic chemical vapor deposition (MOCVD). The organometallic precursor molecule dissociated and left hydrogen and organic fragments which help stabilize the carbide with respect to crystallization and corrosion. The reason for its amorphous state-determined by X-ray diffraction (XRD) and transmission electron microscopy selected area diffraction (TEM/SAD)-was the low substrate temperature required, between 150 degrees C and 300 degrees C. Pure amorphous TiC and titanium diboride (TiB2) films were prepared by electron-beam vaporization (EBV) of single crystal chips onto liquuid-nitrogen cooled substrates; they crystallized at lower temperatures. All the films analyzed by extended X-ray absorption fine structure (EXAFS) and extended electron energy loss fine structure (EXELFS) exhibited short-range order but no long-range order, so they could still be described as "amorphous." Potential applications of these high hardness, high melting-point, corrosion-resistant, low-friction and diffusion-resistant coatings could include bearings, cylinder linings, microcircuits and biomedical implants.
C1 Univ Illinois, Dept Phys, Urbana, IL 61801 USA.
RP Williams, WS (reprint author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.
NR 0
TC 1
Z9 1
U1 1
U2 2
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-389-9
PY 1998
BP 269
EP 280
PG 12
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Coatings & Films
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BK53L
UT WOS:000072465900024
DA 2018-10-20
ER

PT B
AU Drukier, AK
   Volkovitsky, P
   Coursey, BM
   Karam, LR
   Stodolsky, L
AF Drukier, AK
   Volkovitsky, P
   Coursey, BM
   Karam, LR
   Stodolsky, L
BE Kumar, A
   Chung, YW
   Chia, RWJ
TI MPD technology for tribology applications
SO HARD COATINGS: BASED ON BORIDES, CARBIDES & NITRIDES: SYNTHESIS,
   CHARACTERIZATION & APPLICATIONS
LA English
DT Proceedings Paper
CT International Symposium on Hard Coatings Based on Borides, Carbides and
   Nitrides - Synthesis, Characterization and Applications at the 1998 TMS
   Annual Meeting
CY FEB 16-19, 1998
CL SAN ANTONIO, TX
SP Minerals Met & Mat Soc, Mat Design & Mfg Div, Surface Modificat & Coatings Technol Comm
AB The new ultra-sensitive MPD technology, already employed successfully in biomedical applications, has such a high sensitivity that it is possible to use extremely low level radioactive materials, below licensing requirements and presenting no health hazard. It can now be employed in tribology, both as a research tool and in industrial and consumer applications. We discuss a few straightforward tribological applications of the MPD technique.
C1 Biotraces Inc, Fairfax, VA 22030 USA.
RP Drukier, AK (reprint author), Biotraces Inc, 10517-A W Dr, Fairfax, VA 22030 USA.
OI stodolsky, leo/0000-0002-4842-1889
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-389-9
PY 1998
BP 321
EP 327
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Coatings & Films
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BK53L
UT WOS:000072465900028
DA 2018-10-20
ER

PT B
AU Mitra, K
   Kumar, S
AF Mitra, K
   Kumar, S
BE Lee, JS
TI Interaction of short pulse radiation with scattering media: Issues and
   transient radiative transfer formulation
SO HEAT TRANSFER 1998, VOL 7: GENERAL PAPERS
LA English
DT Proceedings Paper
CT 11th International Heat Transfer Conference
CY AUG 23-28, 1998
CL KYONGJU, SOUTH KOREA
SP Korean Soc Mech Engineers
ID OPTICAL-PROPERTIES; TISSUE; LIGHT; DIFFUSION; ABLATION; LASERS
AB This paper discusses the various applications of short pulse radiation and the research issues related to the understanding of the fundamentals of the physics of interaction of such radiation with material and the associated modeling. The focus is on the interaction of pulsed radiation with absorbing and scattering media, with an emphasis on biomedical applications.
C1 Florida Inst Technol, Mech Engn Program, Melbourne, FL 32901 USA.
RP Mitra, K (reprint author), Florida Inst Technol, Mech Engn Program, 150 W Univ Blvd, Melbourne, FL 32901 USA.
CR AKHMANOV SA, 1992, OPTICS FEMTOSECONDS
   BIRNGRUBER R, 1987, IEEE J QUANTUM ELECT, V23, P1836, DOI 10.1109/JQE.1987.1073235
   BREWSTER MQ, 1995, INT J HEAT MASS TRAN, V38, P2569, DOI 10.1016/0017-9310(95)00013-Y
   CAIN SR, 1992, J APPL PHYS, V72, P5172, DOI 10.1063/1.351997
   Churnside JH, 1997, APPL OPTICS, V36, P6011, DOI 10.1364/AO.36.006011
   FORK RL, 1987, OPT LETT, V12, P483, DOI 10.1364/OL.12.000483
   GANDJBAKHCHE AH, 1993, APPL OPTICS, V32, P504, DOI 10.1364/AO.32.000504
   GEMERT MJC, 1989, IEEE ENG MED BIOL, P10
   GORDON CL, 1995, OPT LETT, V20, P1056, DOI 10.1364/OL.20.001056
   GRANT KJ, 1991, APPL OPTICS, V31, P4515
   HALLER JD, 1992, P IEEE, V80, P861, DOI 10.1109/5.149449
   HONG JS, 1994, ASME HTD, V288, P17
   ISHIMARU A, 1989, APPL OPTICS, V28, P2210, DOI 10.1364/AO.28.002210
   ISHIMARU A, 1978, WAVE PROPAGATION SCA, V1, P175
   KOSHAK WJ, 1994, J GEOPHYS RES-ATMOS, V99, P14361, DOI 10.1029/94JD00022
   Kumar S, 1996, APPL OPTICS, V35, P3372, DOI 10.1364/AO.35.003372
   KUMAR S, 1995, P 1 INT S RAD HEAT T, P488
   KUMAR S, 1995, INT MECH ENG C EXP, V322, P43
   PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331
   RACKMIL CI, 1983, NUMERICAL HEAT TRANS, V6, P135
   Siegel R., 1981, THERMAL RAD HEAT TRA
   SKOCYPEC RD, 1982, J QUANT SPECTROSC RA, V28, P425, DOI 10.1016/0022-4073(82)90008-5
   SRINIVASAN R, 1986, SCIENCE, V234, P559, DOI 10.1126/science.3764428
   THOMPSON KP, 1992, P IEEE, V80, P838, DOI 10.1109/5.149448
   Tien C.L., 1994, THERMAL SCI ENG, V2, P1
   VISKANTA R, 1987, PROG ENERG COMBUST, V13, P97, DOI 10.1016/0360-1285(87)90008-6
   WEINMAN JA, 1972, J GEOPHYS RES, V77, P7123, DOI 10.1029/JC077i036p07123
   White SM, 1990, J THERMOPHYS HEAT TR, V4, P305, DOI 10.2514/3.181
   Yamada Y, 1995, ANN REV FLUID MECH H, V6, P1
   YODH A, 1995, PHYS TODAY, V48, P34, DOI 10.1063/1.881445
   YOO KM, 1990, PHYS REV LETT, V64, P2647, DOI 10.1103/PhysRevLett.64.2647
NR 31
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI LONDON
PA 11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND
PY 1998
BP 313
EP 318
PG 6
WC Thermodynamics; Engineering, Mechanical; Mechanics
SC Thermodynamics; Engineering; Mechanics
GA BQ70Y
UT WOS:000089221200051
DA 2018-10-20
ER

PT S
AU Saidane, A
   Amri, A
AF Saidane, A
   Amri, A
GP INST ELECT ENGINEERS, LONDON
   INST ELECT ENGINEERS, LONDON
   INST ELECT ENGINEERS, LONDON
TI A Transmission-Line-Matrix model for microwave heating problems
SO INTERNATIONAL CONFERENCE ON SIMULATION '98
SE IEE CONFERENCE PUBLICATIONS
LA English
DT Proceedings Paper
CT International Conference on Simulation
CY SEP 30-OCT 02, 1998
CL UNIV YORK, YORK, ENGLAND
SP Inst Elect Engineers, Control Div, AES, CEA, IFAC, BCS, EPSRC, EUREL, IEEE, UKRI Sect, InstMC, ISCS, UKSS
HO UNIV YORK
AB The use of microwaves to melt, dry, sinter or join materials is gaining acceptance in many industrial applications extending to the field of biomedical engineering. Such technology, however, is characterized by thermal runaway and the formation of localized areas of high temperature or hot-spots that develop as the material is being irradiated Hot-spots can be utilized in smelting or joining since they enhance the process but avoided in sintering or drying since they can lead to damage. In any case, it is important to predict the conditions of their occurrence and how to control them.
   Microwave heating is a highly coupled nonlinear problem and the purpose of this paper is to show how the Transmission-Line-Matrix (TLM) technique can be used to model this complex physical process. The numericals solutions are compared with some analytical and other numerical results. Our preliminary results show that the TLM method is well suited to wicrowave heat modelling and that the conditions under which hot spots develop can be predicted.
C1 ORAN, ENSET, Oran, Algeria.
RP Saidane, A (reprint author), ORAN, ENSET, Oran, Algeria.
NR 0
TC 1
Z9 1
U1 0
U2 1
PU INST ELECTRICAL ENGINEERS INSPEC INC
PI EDISON
PA 379 THORNALL ST, EDISON, NJ 08837 USA
SN 0537-9989
BN 0-85296-709-8
J9 IEE CONF PUBL
PY 1998
IS 457
BP 317
EP 324
PG 8
WC Engineering, Aerospace; Engineering, Biomedical; Engineering,
   Industrial; Engineering, Electrical & Electronic; Transportation
SC Engineering; Transportation
GA BM06G
UT WOS:000077496200050
DA 2018-10-20
ER

PT J
AU Simmons-Potter, K
   Potter, B
   Sinclair, M
AF Simmons-Potter, K
   Potter, B
   Sinclair, M
TI Photosensitive thin films: Manipulation of defects through synthesis
   control
SO JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS BRIEF
   COMMUNICATIONS & REVIEW PAPERS
LA English
DT Article; Proceedings Paper
CT International Workshop on Structure and Functional Optical Properties of
   Silica and Silica-Related Glasses
CY JUL 10-11, 1997
CL TOYOTA MOTOR CORP, MIKKABI CREAT CTR, SHIZUOKA, JAPAN
SP US Govt
HO TOYOTA MOTOR CORP, MIKKABI CREAT CTR
DE photosensitivity; defects; germanosilicate; rf-sputtering; thin film
ID GLASS-FILMS; SIO2-GEO2 GLASSES; WAVE-GUIDES; FIBERS; BAND; CENTERS
AB Multi-functional, integrated optical devices are the foundation for technologies commanding a significant high-tech market share. Areas such as telecommunications, remote sensing, biomedical applications, information processing and data storage benefit from devices based on the patterning of refractive index modulations. Current synthesis techniques used to achieve the desired device structures typically involve multi-step processing, relying on complex chemical and/or mechanical procedures. We have demonstrated the ability to produce highly photosensitive germanosilicate thin films using a novel sputtering approach which enables us to obtain the largest reported Delta n in as-synthesized materials. In addition, control of processing environment has allowed us to engineer not only the magnitude of the optical response of the films but also the sign of the induced index change. We have developed a defect model to describe the effects observed and have demonstrated proof-of-principle devices in our waveguides.
C1 Sandia Natl Labs, Albuquerque, NM 87185 USA.
RP Simmons-Potter, K (reprint author), Sandia Natl Labs, POB 5800,MS 1423, Albuquerque, NM 87185 USA.
CR AWAZU K, 1990, J APPL PHYS, V68, P2713, DOI 10.1063/1.346445
   FRIEBELE EJ, 1986, MATER RES SOC S P, V61, P319
   HAND DP, 1990, OPT LETT, V15, P102, DOI 10.1364/OL.15.000102
   HOSONO H, 1992, PHYS REV B, V46, P11445, DOI 10.1103/PhysRevB.46.11445
   LEMAIRE PJ, 1993, ELECTRON LETT, V29, P1191, DOI 10.1049/el:19930796
   MIZRAHI V, 1993, APPL PHYS LETT, V63, P1727, DOI 10.1063/1.110696
   NAKAHARA M, 1986, J LIGHTWAVE TECHNOL, V4, P127, DOI 10.1109/JLT.1986.1074693
   NEUSTRUEV VB, 1989, FIBER INTEGRATED OPT, V8, P143, DOI 10.1080/01468038908202872
   Nishii J, 1995, RADIAT EFF DEFECT S, V136, P133, DOI 10.1080/10420159508218808
   NISHII J, 1994, APPL PHYS LETT, V64, P282, DOI 10.1063/1.111181
   POTTER BG, 1997, SPIE P, V2998, P146
   SIMMONS KD, 1991, OPT LETT, V16, P141, DOI 10.1364/OL.16.000141
   SIMMONS KD, 1993, OPT LETT, V18, P25, DOI 10.1364/OL.18.000025
   SimmonsPotter K, 1996, APPL PHYS LETT, V68, P2011, DOI 10.1063/1.115621
   SIMMONSPOTTER K, 1995, APPL PHYS LETT, V66, P2104, DOI 10.1063/1.113917
   Warren WL, 1996, APPL PHYS LETT, V69, P1453, DOI 10.1063/1.117612
NR 16
TC 8
Z9 8
U1 1
U2 1
PU JAPAN SOC APPLIED PHYSICS
PI TOKYO
PA KUDAN-KITA BUILDING 5TH FLOOR, 1-12-3 KUDAN-KITA, CHIYODA-KU, TOKYO,
   102-0073, JAPAN
SN 0021-4922
J9 JPN J APPL PHYS 1
JI Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Brief Commun. Rev. Pap.
PY 1998
VL 37
SU 1
BP 8
EP 11
DI 10.7567/JJAPS.37S1.8
PG 4
WC Physics, Applied
SC Physics
GA ZP235
UT WOS:000073731500004
OA Bronze
DA 2018-10-20
ER

PT J
AU Lemmouchi, Y
   Schacht, E
   Dejardin, S
AF Lemmouchi, Y
   Schacht, E
   Dejardin, S
TI Biodegradable poly[(amino acid ester)phosphazenes] for biomedical
   applications
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
ID DEGRADABLE POLYPHOSPHAZENES; POLY(ORGANOPHOSPHAZENES)
AB Polyphosphazene derivatives with amino acid ester side groups were prepared by reacting poly(dichlorophosphazene) with ethyl esters of amino acids and were characterizedby H-1, P-31-NMR and DSC analyses. The in vitro rate of degradation of these polymers depended on the nature of the amino acids while introducing small amounts of depsipeptide ester co-substituents increased degradation rates. The rate of hydrolytic degradation of the poly[(organo)phosphazene] materials could be controlled by the amino acid ester by the depsipeptide ester side group content and by blending poly[(amino acid ester)phosphazenes] with poly[(amino acid ester)-co-(depsipeptide ester)phosphazenes]. Poly[(glycine ethyl ester)phosphazenes] prepared from poly[(dichloro)phosphazenes] degradation rates were independent of molecular weight. Degradations of polymer blends indicate that an intramolecular catalysis of the polymer by the pendent carboxylic acid.
C1 State Univ Ghent, IBITECH, Inst Biomed Technol, Polymer Mat Res Grp, B-9000 Ghent, Belgium.
RP Schacht, E (reprint author), State Univ Ghent, IBITECH, Inst Biomed Technol, Polymer Mat Res Grp, Krijgslaan 281, B-9000 Ghent, Belgium.
CR Allcock H.R., 1979, CONT TOPICS POLYM SC, V3, P55
   ALLCOCK HR, 1986, MAKROMOL CHEM-M SYMP, V6, P101, DOI 10.1002/masy.19860060112
   ALLCOCK HR, 1972, CHEM REV, V72, P315, DOI 10.1021/cr60278a002
   ALLCOCK HR, 1983, MACROMOLECULES, V16, P715, DOI 10.1021/ma00239a001
   ALLCOCK HR, 1994, BIOMATERIALS, V15, P563, DOI 10.1016/0142-9612(94)90205-4
   ALLCOCK HR, 1982, INORG CHEM, V21, P515, DOI 10.1021/ic00132a009
   ALLCOCK HR, 1983, MACROMOLECULES, V16, P1401, DOI 10.1021/ma00243a001
   ALLCOCK HR, 1990, BIODEGRADABLE POLYM, P163
   ALLCOCK HR, 1977, MACROMOLECULES, V10, P24
   BOISSONNAS RA, 1953, HELV CHIM ACTA, V36, P875, DOI 10.1002/hlca.19530360418
   BOS RRM, 1991, BIOMATERIALS, V12, P32, DOI 10.1016/0142-9612(91)90128-W
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   CROMMEN J, 1993, J CONTROL RELEASE, V24, P167, DOI 10.1016/0168-3659(93)90176-6
   CROMMEN JHL, 1992, BIOMATERIALS, V13, P511, DOI 10.1016/0142-9612(92)90102-T
   CROMMEN JHL, 1992, BIOMATERIALS, V13, P601, DOI 10.1016/0142-9612(92)90028-M
   CROMMEN JHL, 1991, B SOC CHIM BELG, V10, P747
   DHALLUIN G, 1992, MACROMOLECULES, V25, P1254, DOI 10.1021/ma00030a008
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   GOEDEMOED JH, 1991, J CONTROL RELEASE, V170, P245
   GOEDEMOED JH, 1990, POLYPHOSPHAZENE DRUG, pCH7
   GROLLEMAN C W J, 1986, Journal of Controlled Release, V4, P119, DOI 10.1016/0168-3659(86)90047-7
   HELLER J, 1984, MED APPL CONTROLLED, V2, P70
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, P290
   Lewis DH, 1990, BIODEGRADABLE POLYM, V45, P1
   Schacht E, 1996, BIOTECHNOL BIOENG, V52, P102, DOI 10.1002/(SICI)1097-0290(19961005)52:1<102::AID-BIT10>3.3.CO;2-B
   SCHLINDLER A, 1977, POLYM SCI, V2, P251
NR 26
TC 19
Z9 19
U1 0
U2 3
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604 USA
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JAN
PY 1998
VL 13
IS 1
BP 4
EP 18
DI 10.1177/088391159801300102
PG 15
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA ZA151
UT WOS:000072334000002
DA 2018-10-20
ER

PT J
AU Andreopoulos, AG
   Plytaria, M
AF Andreopoulos, AG
   Plytaria, M
TI Biomedical silicone elastomers as carriers for controlled release
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE biomedical elastomers; silicones; controlled release of drugs;
   propranolol; membranes
ID BIODEGRADABLE SYSTEMS; QUINOLONES; NETWORKS
AB Biomedical silicone elastomers have been studied for their potential application as carriers for controlled release of drugs, since these materials display a unique combination of properties, which might be favorable to the above use. A two component silicone gel system was used and various cross-linker ratio was applied, in order to produce networks with varying crosslink density. Swelling experiments in toluene were run in order to evaluate the network characteristics. The silicone elastomer was loaded with salicylic acid and propranolol hydrochloride and their delivery in distilled water was followed. The results showed that release is almost of zero order for high loading of salicylic acid, while delivery seems to be diffusion controlled up to a certain limit. The administered drug concentrations are relatively low if silicone discs are used, due to the hydrophobic nature of this material. On the other hand, when membranes are used with a thickness of 0.1-0.2 mm, then the delivery rate is much higher depending of course on the hydrophilic character of the drug.
C1 Natl Tech Univ Athens, Dept Chem Engn, Athens 15780, Greece.
CR Andreopoulos A G, 1994, J Biomater Appl, V8, P344, DOI 10.1177/088532829400800403
   Andreopoulos A. G., 1994, Clinical Materials, V15, P89, DOI 10.1016/0267-6605(94)90074-4
   ANDREOPOULOS AG, 1989, J APPL POLYM SCI, V37, P2121, DOI 10.1002/app.1989.070370804
   ANDREOPOULOS AG, 1989, BIOMATERIALS, V10, P101, DOI 10.1016/0142-9612(89)90040-9
   Andreopoulos AG, 1995, J BIOMATER APPL, V10, P163, DOI 10.1177/088532829501000206
   Andreopoulos AG, 1996, J BIOMATER APPL, V10, P338, DOI 10.1177/088532829601000404
   ANDREOPOULOS AG, 1993, J APPL POLYM SCI, V50, P729, DOI 10.1002/app.1993.070500419
   ANDREOPOULOS AG, 1992, J APPL POLYM SCI, V45, P1005, DOI 10.1002/app.1992.070450609
   ANDREOPOULOS AG, 1988, J MATER SCI LETT, V7, P235, DOI 10.1007/BF01730181
   BRAND C, 1983, POLYM PREPRINTS, V24, P71
   DEMETRIOU PP, 1988, J MATER SCI LETT, V7, P233, DOI 10.1007/BF01730180
   LEE P I, 1985, Journal of Controlled Release, V2, P277, DOI 10.1016/0168-3659(85)90051-3
   LEE PI, 1987, ACS SYM SER, V348, P1
   LINHARDT RJ, 1983, POLYM PREPR-ACS, V24, P47
   LONTZ JF, 1976, 1 INT S FACIAL PROTH
   MIGLIARESI C, 1984, POLYMER, V25, P686, DOI 10.1016/0032-3861(84)90037-5
   PINCHUK L, 1984, J APPL POLYM SCI, V29, P1749, DOI 10.1002/app.1984.070290528
   Vlachou M, 1996, J BIOMATER APPL, V10, P217, DOI 10.1177/088532829601000303
NR 18
TC 21
Z9 22
U1 0
U2 4
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604 USA
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 1998
VL 12
IS 3
BP 258
EP 271
DI 10.1177/088532829801200306
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA YW018
UT WOS:000071887400005
PM 9493072
DA 2018-10-20
ER

PT J
AU Han, DK
   Park, KD
   Kim, YH
AF Han, DK
   Park, KD
   Kim, YH
TI Sulfonated poly(ethylene oxide)-grafted polyurethane copolymer for
   biomedical applications
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE biomaterial; polyurethane; sulfonated PEO; copolymer; bulk modification;
   biocompatibility
ID BLOOD COMPATIBILITY; ANTICOAGULANT ACTIVITY; SURFACE; PEO; ADHESION;
   ADSORPTION; POLYMERS
AB Sulfonated poly(ethylene oxide) (PEO-SO3)-grafted polyurethane (PU) copolymer (PU-PEO-SO3) was developed for utilization as a material for biomedical applications. Its bulk properties and biocompatibility were investigated and the results were compared to those of PU and PU-PEO (not sulfonated). PU-PEO-SO3 copolymer showed higher water uptake than PU and PU-PEO, indicative of increased hydrophilicity due to the grafting of PEO-SO3. Compared with PU, PU-PEO-SO3 displayed lower glass transition temperature (T-g) and melting endotherm from DSC analysis, suggesting the increase of microphase separation and the suppression of hard-segment packing. PU-PEO-SO3 had practically similar mechanical properties to PU, indicating that the chemical modification of PU was accomplished without reducing its bulk properties. From the results of biocompatibility tests, PU-PEO-SO3 copolymer showed significantly lower adhesion of platelets and S. epidermidis than PU control and PU-PEO. In addition, the platelet factor 4 (PF4) released from platelets was the lowest in PU-PEO-SO3 among the test materials. PU-PEO-SO3 copolymer, which has excellent mechanical properties and biocompatibility, is expected to be useful as coating, molding, and blending materials for artificial organs and medical devices.
C1 Korea Inst Sci & Technol, Biomat Res Ctr, Seoul 130650, South Korea.
RP Kim, YH (reprint author), Korea Inst Sci & Technol, Biomat Res Ctr, POB 131, Seoul 130650, South Korea.
EM yhakim@kistmail.kist.re.kr
OI Han, Dong Keun/0000-0003-4641-7883
CR Andrade J. D., 1987, ASAIO J, V33, P75
   BRUNSTEDT MR, 1995, J BIOMED MATER RES, V29, P455, DOI 10.1002/jbm.820290405
   CHEN WY, 1982, J POLYM SCI POL CHEM, V20, P547, DOI 10.1002/pol.1982.170200228
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   HAN DK, 1995, BIOMATERIALS, V16, P467, DOI 10.1016/0142-9612(95)98819-Z
   HAN DK, 1993, J BIOMED MATER RES, V27, P1063, DOI 10.1002/jbm.820270812
   HAN DK, 1991, J BIOMED MATER RES, V25, P561, DOI 10.1002/jbm.820250502
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P211
   Han DK, 1996, J BIOMED MATER RES, V30, P23, DOI 10.1002/(SICI)1097-4636(199601)30:1<23::AID-JBM4>3.0.CO;2-T
   HAN DK, 1993, J BIOMAT SCI-POLYM E, V4, P579
   HAN DK, 1993, ASAIO J, V39, P537
   HAN DK, 1993, THESIS SEOUL NATL U
   IKADA Y, 1984, ADV POLYM SCI, V57, P103
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ITO Y, 1989, CRIT REV BIOCOMPAT, V5, P45
   ITO Y, 1988, ARTIFICIAL HEART, V2, P35
   JOZEFONVICZ J, 1990, Journal of Biomaterials Science Polymer Edition, V1, P147
   KIM S W, 1985, Critical Reviews in Biocompatibility, V1, P229
   KIM YH, 1995, ENCY HDB BIOMATERI B, V2, P1071
   KIM YH, 1996, POLYM MAT ENCY, V1, P825
   Lelah M. D., 1986, POLYURETHANES MED
   LELAH MD, 1986, J BIOMED MATER RES, V20, P433, DOI 10.1002/jbm.820200403
   MILLER GW, 1970, J POLYM SCI A, V18, P1923
   Nagel JA, 1996, J BIOMAT SCI-POLYM E, V7, P769, DOI 10.1163/156856296X00110
   *NIH, 1985, NIH PUBL
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   PARK KD, 1992, J BIOMED MATER RES, V26, P739, DOI 10.1002/jbm.820260605
   Ratner B. D., 1976, ACS SYM SER, V31, P1, DOI [DOI 10.1021/SYMPOSIUM, 10.1021/bk-1976-0031.ch001]
   SALZMAN EW, 1977, ANN NY ACAD SCI, V283, P114, DOI 10.1111/j.1749-6632.1977.tb41760.x
   SEMOUR RW, 1973, MACROMOLECULES, V6, P48
   Szycher M., 1991, HIGH PERFORMANCE BIO
   Tsuruta T, 1996, ADV POLYM SCI, V126, P1
   YU J, 1994, BIOMATERIALS, V15, P805, DOI 10.1016/0142-9612(94)90035-3
NR 33
TC 43
Z9 46
U1 1
U2 16
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1998
VL 9
IS 2
BP 163
EP 174
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA YX386
UT WOS:000072034800005
PM 9493843
DA 2018-10-20
ER

PT J
AU Bhaduri, A
   Das, KP
AF Bhaduri, A
   Das, KP
TI Covalent grafting of tryptophan to solid surfaces inhibit protein
   adsorption
SO JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY
LA English
DT Article
ID BETA-LACTOGLOBULIN; ALBUMIN; BIOCOMPATIBILITY
AB In recent years, increasing attention has been paid to improve biocompatibility of polymer surfaces because of their potential application hs drug release(1), drug carrier systems(2) and most important of all as high tensile material for artificial organs(3). Development of suitable synthetic materials for artificial organs has long been a major objective of biomedical research. When a foreign synthetic material is implanted as a replacement of damaged or deseased organ the human body, it elicits hundreds of immune responses(4) and interactions that mainly involve several phenomena like platelet adhesion(5), intrinsic coagulation(6), activation of erythrocyte(7) and morphological changes inmonocyte/macrophage(8) and most importantly activation of the complement cascade of immune system(9). So any implant must be biocompatible which is able to generate nonthrombotic foreign-body response and call evade undesired immune responses.
C1 Bose Inst, Dept Chem, Prot Chem Lab, Calcutta 700009, W Bengal, India.
RP Das, KP (reprint author), Bose Inst, Dept Chem, Prot Chem Lab, 93-1 APC Rd, Calcutta 700009, W Bengal, India.
CR ALMAKHLAFI H, 1995, APPL ENVIRON MICROB, V61, P2013
   ANDERHEIDEN D, 1992, J MATER SCI-MATER M, V3, P1, DOI 10.1007/BF00702936
   ARMSTRONG JM, 1967, BIOCHIM BIOPHYS ACTA, V147, P60, DOI 10.1016/0005-2795(67)90090-6
   Beena M S, 1994, J Biomater Appl, V8, P385, DOI 10.1177/088532829400800405
   BHADURI A, 1994, J DISPER SCI TECHNOL, V15, P165, DOI 10.1080/01932699408943551
   BHADURI A, 1997, THESIS JADAVPUR U
   BIRDI KS, 1977, P MEMBRANE TRANSPORT
   BIZZI B, 1993, INT J ARTIF ORGANS, V16, P209
   BODMEIER R, 1993, J PHARM SCI, V82, P191, DOI 10.1002/jps.2600820215
   Cazenave J.-P., 1986, BLOOD SURFACE INTERA
   CHATTORAJ DK, 1984, ADSORPTION GIBBS SUR, P612
   CHATTORAJ DK, 1984, ADSORPTION GIBBS SUR, P204
   Dawson R. M. C., 1986, DATA BIOCH RES
   Di Massimo C, 1993, Riv Eur Sci Med Farmacol, V15, P199
   FAVEL A, 1989, INT J PEPT PROT RES, V33, P202
   GIUDELLI R, 1992, NATO ASI SER, V335, P337
   HORBETT TA, 1982, ADV CHEM SER, V199, P233
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   KOHLCHUTTER HW, 1969, THIN LAYER CHROMATOG
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   MUNRO MS, 1981, T AM SOC ART INT ORG, V27, P499
   NAGAOKA S, 1983, POLYM PREPR-ACS, V24, P67
   NOZAKI Y, 1971, J BIOL CHEM, V246, P2211
   PERI JB, 1965, J PHYS CHEM-US, V69, P211, DOI 10.1021/j100885a032
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   SADHUKHAN BK, 1984, SURFACTANTS SOLUTION
   SHEPPARD JI, 1994, J BIOMED MATER RES, V28, P1175, DOI 10.1002/jbm.820281008
   WIRZING G, 1963, NATURWISSENSCHAFTEN, V50, P466, DOI 10.1007/BF00632911
NR 28
TC 1
Z9 1
U1 0
U2 1
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 0193-2691
J9 J DISPER SCI TECHNOL
JI J. Dispersion Sci. Technol.
PY 1998
VL 19
IS 4
BP 451
EP 464
DI 10.1080/01932699808913188
PG 14
WC Chemistry, Physical
SC Chemistry
GA ZT885
UT WOS:000074127800003
DA 2018-10-20
ER

PT S
AU Chapyak, EJ
   Godwin, RP
AF Chapyak, EJ
   Godwin, RP
BE Anderson, RR
   Bartels, KE
   Bass, LS
   Garrett, CG
   Gregory, KW
   Lui, H
   Malek, RS
   Perlmutter, AP
   Reinisch, L
   Smalley, PJ
   Tate, LP
   Thomsen, SL
   Watson, GM
   Katzir, A
TI Physical mechanisms of importance to Laser Thrombolysis
SO LASERS IN SURGERY: ADVANCED CHARACTERIZATION, THERAPEUTICS, AND SYSTEMS
   VIII, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Lasers in Surgery - Advanced Characterization,
   Therapeutics, and Systems VIII
CY JAN 24-25, 1998
CL SAN JOSE, CA
SP Int Biomed Opt Soc, Soc Photo Opt Instrumentat Engineers
DE Laser Thrombolysis; bubble dynamics; numerical methods; hydrodynamics;
   material properties; tissue properties
AB Bubble dynamics plays a key role in many medical procedures including Laser Thrombolysis (L-T), acoustic and laser lithotripsy, interocular laser surgery, photoacoustic drug delivery, and perhaps ultrasonic imaging. We are investigating the effect that interfaces of different materials, especially biological and biomedical materials, have on the dynamics of nearby bubbles. Collapsing bubbles often become nonspherical, resulting in spectacular directed motion with potentially both beneficial and undesirable consequences. This directed motion may explain L-T mass removal and some types of laser-induced tissue damage.
C1 Univ Calif Los Alamos Natl Lab, Appl Theoret & Computat Phys Div, Los Alamos, NM 87545 USA.
RP Chapyak, EJ (reprint author), Univ Calif Los Alamos Natl Lab, Appl Theoret & Computat Phys Div, POB 1663, Los Alamos, NM 87545 USA.
NR 0
TC 11
Z9 11
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-2684-9
J9 P SOC PHOTO-OPT INS
PY 1998
VL 3245
BP 12
EP 18
DI 10.1117/12.312270
PG 7
WC Dermatology; Optics; Otorhinolaryngology; Surgery; Veterinary Sciences
SC Dermatology; Optics; Otorhinolaryngology; Surgery; Veterinary Sciences
GA BL37M
UT WOS:000075318900002
DA 2018-10-20
ER

PT J
AU Goldman, L
AF Goldman, L
TI Future of laser dermatology
SO LASERS IN SURGERY AND MEDICINE
LA English
DT Article
DE laser diagnostics; microscopies; multiwavelength lasers; melanocyte
   cells; langerhans cells
AB Background and Objective: Laser dermatology, a long-time model for laser tissue interactions, will play an important part in the future of research, diagnostics, and therapeutics. Study
   Design/Materials and Methods: Laser research continues in photobiology, especially in molecular reactions, and it continues at the cellular level in melanocyte and Langerhans cells.
   Results: Laser diagnostics in the development of opto-electronics concern new developments in imagery. Some studies include new types of microscopes for living skin and vary from the portable illuminated skin microscopes, the current dermatoscopes, to the coaxial polarizing microscope and the new scanning confocal microscope of Gmitro for living tissues. The regular confocal microscope for fixed tissue slides will revolutionize dermatopathology. The other research microscopes include the ultrasonic biomedical microscope and the IR microscope and the holographic microscope of optical phase conjugation used for living tissues.
   Conclusion: New lasers for therapy include micromedical lasers, economical junction diode lasers alone and for pumping solid-state lasers, FEL of the future, and multiwavelength laser units. These later units include seven-wavelength units of barium, copper vapor and ruby, and are available for other heavy metal laser heads, ds gold-628 nm and lead-722 nm. Copper vapor can pump also Ti sapphire. The MOPO series (200 nm in the UV to >4,500 in the IR) is the most extensive modern multiwavelength laser box type. (C) 1998 Wiley-Liss, Inc.(dagger)
C1 USN, Med Ctr, Dept Clin Invest, San Diego, CA 92134 USA.
   USN, Med Ctr, Dept Dermatol, San Diego, CA 92134 USA.
RP Goldman, L (reprint author), USN, Med Ctr, Dept Clin Invest, San Diego, CA 92134 USA.
CR BERGFELT L, 1993, ACTA DERM-VENER    S, P180
   DECKELBAUM LI, 1990, LASERS CARDIOVASCULA
   GOLDMAN L, 1985, LASER SURG MED, V5, P453, DOI 10.1002/lsm.1900050503
   GOLDMAN L, 1958, ARCH DERMATOL, V78, P246, DOI 10.1001/archderm.1958.01560080106017
   GOLDMAN L, 1951, J INVEST DERMATOL, V16, P407, DOI 10.1038/jid.1951.48
   GOLDMAN L, 1967, BIOMEDICAL ASPECTS L
   GOLDMAN L, 1973, APPL LASER
   GOLDMAN L, 1993, SPIE, P17
   GOLDMAN L, 1980, J DERMATOL SURG ONC, V6, P9
   Goldman L., 1971, LASERS MED
   GOLDMAN L, 1981, BIOMEDICAL LASER TEC
   GOLDMAN L, 1990, LASERS CARDIOVASCULA
   GOLDMAN L, 1991, LASER NONSURGICAL ME
   GOLDMAN L, 1966, LASER CANC RES
   GOLDMAN L, 1990, LASERS SYSTEMS PHOTO
   GOLDMAN L, 1947, J INVEST DERMATOL, V9, P1116
   GOLDMAN L, 1975, ARCH DERMAOL, V75, P345
   KENET RO, 1993, ARCH DERMATOL, V129, P157, DOI 10.1001/archderm.129.2.157
   STEFANATO CM, 1993, J AM ACAD DERMATOL, V29, P486, DOI 10.1016/S0190-9622(08)82002-6
NR 19
TC 5
Z9 5
U1 0
U2 1
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0196-8092
J9 LASER SURG MED
JI Lasers Surg. Med.
PY 1998
VL 22
IS 1
BP 3
EP 8
DI 10.1002/(SICI)1096-9101(1998)22:1<3::AID-LSM3>3.0.CO;2-T
PG 6
WC Dermatology; Surgery
SC Dermatology; Surgery
GA YP485
UT WOS:000071281500003
PM 9443142
DA 2018-10-20
ER

PT S
AU Centeno, JA
   Ramos, MS
   Mullick, FG
   Offiah, OO
   Rastogi, T
   Panos, RG
AF Centeno, JA
   Ramos, MS
   Mullick, FG
   Offiah, OO
   Rastogi, T
   Panos, RG
BE Collery, P
   Bratter, P
   deBratter, VN
   Khassanova, L
   Etienne, JC
TI Biophysical findings associated with silicone-gel breast implants:
   determination of silicon, calcium, and magnesium levels in capsular
   tissues
SO METAL IONS IN BIOLOGY AND MEDICINE, VOL 5
SE METAL IONS IN BIOLOGY AND MEDICINE
LA English
DT Proceedings Paper
CT 5th International Symposium on Metal Ions in Biology and Medicine
CY MAY 08-10, 1998
CL NEUHERBERG, GERMANY
SP Hahn Meitner Inst Berlin, Dept Trace Elements Hlth & Nutr, GSF Forschungszent Umwelt & Gesundheit, Inst Int Rech Ions Metall, G N PHARM Umwelt & Med, Hewlett Packard GmbH, F Kolher Chem, Ursapharm Arzneimittel GmbH, PROTINA GmbH
ID ASSAYS
AB Background: Recent concerns about medical problems associated with the use of silicone-gel breast implants (SBI) including immune problems sand local tissue reactions have continue to appear in the clinical and medical literature. In order to study the possible role of trace elements as markers of exposure and patient morbidity, reproducible basic scientific data on the analysis of biological materials is needed. The present study was designed to measure silicon (originating from silicone), calcium and magnesium levels in capsular implant tissues of patients with SBI and saline breast implants.
   Design: Breast implant capsular tissues (BICT) were studied by histological, biophysical, and chemical methods. Fifty-three capsules from patients with silicone-gel breast implants (N=32), patients with saline implants (N=5), cases with observable "bleed" materials (N=5), and normal non-silicone exposed controls (N=10) were investigated. Breast capsules were obtained from patients with well established clinical records and with local problems such as capsular contractures whom requested to have their implants removed. Normal tissues were obtained from patients without any history of exposure to biomedical implants, and from patients undergoing reduction mammoplasty. Prior to the chemical analyses, all tissues were prepared by employing acid-induced microwave digestion, and analysed by inductively coupled plasma optical emission spectrometry (ICP-OES).
   Results: High levels of calcium and magnesium in BICT were strongly associated with the use of implant fixation patches and double-lumen textured surfaces. Similarly, elevated levels of silicon in breast capsular tissues were associated with the use of gel-filled implants and the "bleed" effect of the gel material migrating to the adjacent connective fibrous tissues.
   Conclusions Breast implant capsular tissues demonstrated significantly higher levels of silicon (similar to 1000 - 4000x) than the control group (p<0.05). Capsular silicon levels from saline breast implants approached those of the control non-exposed patients. High levels of calcium and magnesium correlated with the use of fixation materials and with the formation of foreign body response reactions. The significance of these results in determining the role of silicone on the development of immune problems remains to be established.
C1 Armed Forces Inst Pathol, Dept Environm & Toxicol Pathol, Washington, DC 20306 USA.
RP Centeno, JA (reprint author), Armed Forces Inst Pathol, Dept Environm & Toxicol Pathol, Washington, DC 20306 USA.
CR BARKER DE, 1978, PLAST RECONSTR SURG, V61, P836, DOI 10.1097/00006534-197861060-00002
   BRAUTBAR N, 1992, TOXICOL IND HEALTH, V8, P231
   CENTENO JA, UNPUB AM J CLIN PATH
   EVANS GRD, 1994, PLAST RECONSTR SURG, V93, P1117, DOI 10.1097/00006534-199405000-00001
   Evans GRD, 1996, PLAST RECONSTR SURG, V97, P1207, DOI 10.1097/00006534-199605000-00016
   Luke JL, 1997, PLAST RECONSTR SURG, V100, P1558, DOI 10.1097/00006534-199711000-00029
   McConnell JP, 1997, AM J CLIN PATHOL, V107, P236, DOI 10.1093/ajcp/107.2.236
   PETERS W, 1995, ANN PLAS SURG, V34, P578, DOI 10.1097/00000637-199506000-00003
   TEUBER SS, 1995, BIOL TRACE ELEM RES, V48, P121, DOI 10.1007/BF02789186
NR 9
TC 1
Z9 1
U1 0
U2 1
PU JOHN LIBBEY EUROTEXT
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
SN 1257-2535
BN 2-7420-0214-6
J9 METAL IONS BIOL MED
PY 1998
VL 5
BP 362
EP 366
PG 5
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism; Nutrition
   & Dietetics; Physiology; Toxicology
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism; Nutrition
   & Dietetics; Physiology; Toxicology
GA BM31W
UT WOS:000078374100067
DA 2018-10-20
ER

PT S
AU Hansford, D
   Desai, T
   Tu, J
   Ferrari, M
AF Hansford, D
   Desai, T
   Tu, J
   Ferrari, M
BE Gourley, PL
   Katzir, A
TI Biocompatible silicon wafer bonding for biomedical microdevices
SO MICRO- AND NANOFABRICATED STRUCTURES AND DEVICES FOR BIOMEDICAL
   ENVIRONMENTAL APPLICATIONS
SE PROGRESS IN BIOMEDICAL OPTICS
LA English
DT Proceedings Paper
CT Conference on Microfabricated and Nanofabricated Structures and Devices
   for Biomedical Environmental Applications
CY JAN 26-27, 1998
CL SAN JOSE, CA
SP SPIE, Int Soc Opt Engn, Int Biomed Opt Soc
DE biocompatible; wafer bonding; adhesive; methacrylates
AB In this paper, several candidate bonding materials are reviewed for use in biomedical microdevices. These include poly propylmethacrylate (PPMA), poly methylmethacrylate (PMMA), a copolymer of poly (ethyl, butyl) methacrylate (PBEMA) and two types of silicone gels. They were evaluated based on their cytotoxicity and bond strength, as well as several other qualitative assessments. The cytotoxicity was determined through a cell growth assay protocol in which cells were grown on the various substrata and their growth was compared to cells sown on control substrata. The adhesive strength was assessed by using a pressurized plate test in which the adhesive interface was pressurized to failure, Ab of the substrata were found (once cured) to be non-cytotoxic in an inert manner except for the industrial silicone adhesive gel (Dow Coming 736). The adhesive strengths of the various materials are compared to each other and to previously published adhesive strengths. All of the materials were found to have a sufficient bonding strength for biomedical applications, but several other factors were determined that limit the use of each material (including defect density, patternability, and ease of application).
C1 Univ Calif Berkeley, Biomed Microdevices Ctr, Berkeley, CA 94720 USA.
RP Hansford, D (reprint author), Univ Calif Berkeley, Biomed Microdevices Ctr, 721 Davis Hall, Berkeley, CA 94720 USA.
NR 0
TC 6
Z9 6
U1 2
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 1017-2661
BN 0-8194-2697-0
J9 PROG BIOM O
PY 1998
VL 3258
BP 164
EP 168
DI 10.1117/12.304376
PG 5
WC Engineering, Multidisciplinary; Engineering, Biomedical; Optics
SC Engineering; Optics
GA BK80K
UT WOS:000073452100020
DA 2018-10-20
ER

PT S
AU Ingal, VN
   Beliaevskaya, EA
AF Ingal, VN
   Beliaevskaya, EA
BE Melker, AI
TI Phase image testing of an internal structure of x-ray transparent
   materials.
SO NEW APPROACHES TO HIGH-TECH MATERIALS: NONDESTRUCTIVE TESTING AND
   COMPUTER SIMULATIONS IN MATERIALS SCIENCE AND ENGINEERING
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT International Workshop on New Approaches to High-Tech Materials -
   Nondestructive Testing and Computer Simulations in Materials Science and
   Engineering
CY JUN 09-13, 1997
CL ST PETERSBURG, RUSSIA
SP St Petersburg State Tech Univ, Russia, St Petersburg Acad Sci Strength Problems, Russia, NPO Special Mat, Russia, Soc Photo Opt Instrumentat Engineers, Russia Chapter, Polytest Co Ltd, Russia
DE phase imaging; Bragg diffraction; plane wave; internal structure; x-ray
   transparent materials; biological objects; soft tissues; treated
   diamonds
AB A new technique for imaging an inner structure of x-ray transparent materials and biomedical objects characterized by small density changes of their structure components is presented. The phase imaging is based on two principal phenomena; radiation refraction in a tested object and diffraction in highly perfect crystals used both for creation of an incident beam and for imaging. It is shown that a phase, radiography providing possibilities of an opacification free investigation of biomedical objects soft tissues can be developed upon the technique reported here.
C1 Xray Lab, St Petersburg 195252, Russia.
RP Ingal, VN (reprint author), Xray Lab, 68 Maloochtinskiy Pr, St Petersburg 195252, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-2792-6
J9 P SOC PHOTO-OPT INS
PY 1998
VL 3345
BP 61
EP 75
DI 10.1117/12.299573
PG 15
WC Computer Science, Interdisciplinary Applications; Engineering,
   Multidisciplinary; Materials Science, Multidisciplinary; Materials
   Science, Characterization & Testing; Optics
SC Computer Science; Engineering; Materials Science; Optics
GA BK57X
UT WOS:000072612100014
DA 2018-10-20
ER

PT S
AU Kunz, R
   Anders, C
   Gersonde, K
AF Kunz, R
   Anders, C
   Gersonde, K
BE Haris, PI
   Chapman, D
TI Principles for the reduction of bacterial adhesion to surface-modified
   polymers
SO NEW BIOMEDICAL MATERIALS: BASIC AND APPLIED STUDIES
SE BIOMEDICAL AND HEALTH RESEARCH
LA English
DT Proceedings Paper
CT 1st International Conference on Biomedical Materials
CY MAY, 1997
CL ANCONA, ITALY
SP Biocompatibles Int, Dideco SPA, Johnson & Johnson Corp Biomat Ctr, Smith & Nephew Res Ltd, Univ London, Interdisciplinary Res Ctr Biomed Appl Sci
AB Bacterial infection is a frequent complication associated with the use of biomedical materials. Our strategy is to reduce bacterial adhesion by surface modification of biomaterials to such an extent that biofilm formation and thus infections are inhibited.
C1 Huls AG, DNE Med Technol, D-45764 Marl, Germany.
RP Kunz, R (reprint author), Huls AG, DNE Med Technol, Paul Baumann Str 1, D-45764 Marl, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU I O S PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0929-6743
BN 90-5199-365-X
J9 BIOM HLTH R
PY 1998
VL 16
BP 115
EP 121
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BL79T
UT WOS:000076774700015
DA 2018-10-20
ER

PT B
AU Okabe, T
   Watanabe, I
   Okuno, O
   Takada, Y
AF Okabe, T
   Watanabe, I
   Okuno, O
   Takada, Y
BE Froes, FHS
   Allen, PG
   Niinomi, M
TI Dental casting of titanium and titanium alloys
SO NON-AEROSPACE APPLICATIONS OF TITANIUM
LA English
DT Proceedings Paper
CT 1998 TMS Annual Meeting on Non-Aerospace Applications of Titanium
CY FEB 16-19, 1998
CL SAN ANTONIO, TX
SP Minerals Met & Mat Soc, Div Struct Mat
AB The dental profession has become increasingly concerned with problems related to biocompatibility and the corrosion behavior of intraoral materials. Because of the well-documented safety of titanium for biomedical uses, interest in applying titanium and its alloys to dental applications has recently grown. A tremendous amount of international effort has been directed toward the development of a titanium casting system that would successfully produce dental prostheses using the lost-wax technique (used for many years in dentistry). By adapting applicable technologies from the titanium casting industry, the evolution of casting machines and investment materials specifically made for dental casting has greatly advanced during the last 20 years. It appears that dental titanium casting has now almost reached the stage where its practical applications should seriously be assessed, although some problems have not been completely solved. In this article, a brief review is given of the present status of dental titanium casting, including some recently acquired experimental results obtained in the authors' laboratories.
C1 Texas A&M Univ, Baylor Coll Dent, Dept Biomat Sci, Dallas, TX USA.
RP Okabe, T (reprint author), Texas A&M Univ, Baylor Coll Dent, Dept Biomat Sci, Dallas, TX USA.
NR 0
TC 6
Z9 6
U1 0
U2 2
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-394-5
PY 1998
BP 207
EP 215
PG 3
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BL56E
UT WOS:000075891500021
DA 2018-10-20
ER

PT B
AU Niinomi, M
   Daisuke, K
   Morinaga, M
   Kato, Y
   Yashiro, T
AF Niinomi, M
   Daisuke, K
   Morinaga, M
   Kato, Y
   Yashiro, T
BE Froes, FHS
   Allen, PG
   Niinomi, M
TI New beta-type titanium alloys with high biocompatibility
SO NON-AEROSPACE APPLICATIONS OF TITANIUM
LA English
DT Proceedings Paper
CT 1998 TMS Annual Meeting on Non-Aerospace Applications of Titanium
CY FEB 16-19, 1998
CL SAN ANTONIO, TX
SP Minerals Met & Mat Soc, Div Struct Mat
AB Pure titanium and Ti - 6Al - 4V alloy have been mainly used as implant materials. V free titanium alloys like Ti - 6Al - 7Nb and Ti - 5Al - 2.5Fe have been then del eloped because toxicity of V has een pointed out. Al and V free titanium alloys as implant materials have been then developed. Most of them are, however, alpha + beta type alloys. beta type titanium alloys with lower moduli of elasticity and greater strength have been started to be developed recently. Design of new beta type titanium alloys composed of non - toxic elements like Nb, Ta, Zr, Mo or Sn with lower moduli of elasticity and eater strength were, therefore,done based on the d - electron alloy design method, and the basic mechanical properties of designed alloys of button ingots melted by tri - are furnace in the laboratory ere investigated in this study. beta type alloys, Ti - Nb - Ta - Zr, Ti - Nb - Ta - Mo and Ti - Nb - Ta - system alloys designed in this study are expected to have greater performance for implant materials. The Young's moduli of these alloys are lower comparing with that of Ti - 6Al - 4V ELI which has been used as an implant material. The alloys conducted with some heat treatments offer suitable tensile properties as implant materials. The tensile strength, elongation and wear resistance of designed alloys in this study are equivalent or greater comparing with those of conventional biomedical titanium alloys for implant materials.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 441, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 441, Japan.
NR 0
TC 13
Z9 13
U1 0
U2 1
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-394-5
PY 1998
BP 217
EP 223
PG 3
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BL56E
UT WOS:000075891500022
DA 2018-10-20
ER

PT S
AU Ramakrishna, S
   Tang, ZG
   Teoh, SH
   Tsai, KT
AF Ramakrishna, S
   Tang, ZG
   Teoh, SH
   Tsai, KT
BE Ye, L
   Mai, YW
TI Knitted fabric reinforced flexible composite material
SO POLYMER BLENDS AND POLYMER COMPOSITES
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT International Workshop on Polymer Blends and Polymer Composites
CY JUL 08-11, 1997
CL UNIV SYDNEY, CTR ADV MAT TECHNOL, SYDNEY, AUSTRALIA
HO UNIV SYDNEY, CTR ADV MAT TECHNOL
DE biomaterials; textile composites; knitted fabrics; polyurethane;
   biomedical applications
AB Primary objective of this research work is to develop a flexible and biocompatible composite material by reinforcing polyurethane elastomer with knitted fabric of polyester fibers. A new composite fabrication method has been developed, as the conventional thermoplastic composite fabrication methods are not suitable for reinforcing a polymer of high melting temperature with fibers of low melting temperature, The flexible composite material displayed an elastic modulus of 22.3 MPa, tensile strength of 19.5 MPa and a failure strain of 141%.
C1 Natl Univ Singapore, Ctr Biomed Mat Applicat & Technol, Singapore 119260, SINGAPORE.
   Natl Univ Singapore, Dept Mech & Prod Engn, Singapore 119260, SINGAPORE.
   Natl Univ Singapore, Inst Mat Res & Engn, Singapore 119260, SINGAPORE.
   INSTRON Singapore Pte Ltd, Singapore 0511, SINGAPORE.
RP Ramakrishna, S (reprint author), Natl Univ Singapore, Ctr Biomed Mat Applicat & Technol, 10 Kent Ridge Crescent, Singapore 119260, SINGAPORE.
CR BJORCK CG, 1994, EUR J SURG, V160, P9
   JONES AJ, 1988, POLYM BIOMATERIALS B
   Marois Y, 1996, BIOMATERIALS, V17, P1289, DOI 10.1016/0142-9612(96)88674-1
   ROMAN JS, 1996, J BIOMED MATER RES, V32, P19
   Sharma C. P., 1991, BLOOD COMPATIBLE MAT
   Zhang Z, 1997, BIOMATERIALS, V18, P113, DOI 10.1016/S0142-9612(96)00054-3
NR 6
TC 1
Z9 1
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-766-8
J9 KEY ENG MATER
PY 1998
VL 137
BP 16
EP 23
DI 10.4028/www.scientific.net/KEM.137.16
PG 8
WC Materials Science, Multidisciplinary; Materials Science, Composites;
   Polymer Science
SC Materials Science; Polymer Science
GA BJ19C
UT WOS:A1998BJ19C00003
DA 2018-10-20
ER

PT J
AU Schmitt-Thomas, KG
   Yang, ZG
   Hiermer, T
AF Schmitt-Thomas, KG
   Yang, ZG
   Hiermer, T
TI Development of torsion loading facility used for evaluating shear
   performance of polymeric composite implant rods
SO POLYMER TESTING
LA English
DT Article
ID BONE
AB A torsion loading facility, which integrates a specially-devised torsion tester with an Instron universal testing machine, was developed to evaluate shear performance and failure behavior of implant rods comprised of a variety of materials. The experimental technique and some key instruments employed during the torsion test are described in detail. With this newly-developed facility, torsion fracture test for seven kinds of implant rods made up of polymeric composites and metallic materials were conducted to assess their comprehensive shear properties and characterize their failure behavior. it was concluded that the novel testing facility was able to provide satisfactory measurement for shear performance of the rods consisting of various materials, and polymeric composite rod with braiden-fabrics is an ideal replacement metal material for biomedical implant. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 Tech Univ Munich, Inst Appl Mat Engn, D-80333 Munich, Germany.
RP Hiermer, T (reprint author), Tech Univ Munich, Inst Appl Mat Engn, Arcisstr 21, D-80333 Munich, Germany.
CR Akay M, 1996, J BIOMED MATER RES, V31, P167
   [Anonymous], 1991, 5835 ISO
   *ASTM, 1979, ASTM DES F117 STAND
   Dupraz A, 1996, J MATER SCI-MATER M, V7, P52, DOI 10.1007/BF00121190
   HASTINGS GW, 1976, BIOCOMPATIBILITY IMP, P128
   *INA, 1992, TECHN POCK, P148
   *ISO, 1987, 5382 ISO
   *ISO, 1989, 6475 ISO
   LIAO K, 1993, AM SOC TEST MATER, V1178, P72, DOI 10.1520/STP15544S
   MARTENS M, 1985, THESIS U LEIDEN NETH
   MATTHEW RM, 1994, J BIOMED MATER RES, V28, P1221
   REILLY DT, 1974, J BIOMECH, V7, P271, DOI 10.1016/0021-9290(74)90018-9
NR 12
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9418
J9 POLYM TEST
JI Polym. Test
PY 1998
VL 17
IS 2
BP 117
EP 130
DI 10.1016/S0142-9418(97)00037-8
PG 14
WC Materials Science, Characterization & Testing; Polymer Science
SC Materials Science; Polymer Science
GA 100AX
UT WOS:000074792700005
DA 2018-10-20
ER

PT B
AU Nelson, RC
   Goldman, M
   Anspaugh, LR
   Hoover, MD
   James, AC
   McCraw, TF
   Napier, B
   Templeton, WL
AF Nelson, RC
   Goldman, M
   Anspaugh, LR
   Hoover, MD
   James, AC
   McCraw, TF
   Napier, B
   Templeton, WL
BE Mosleh, A
   Bari, RA
TI Assessing consequences of plutonium releases from potential spacecraft
   accidents
SO PROBABILISTIC SAFETY ASSESSMENT AND MANAGEMENT (PSAM 4), VOLS 1-4
LA English
DT Proceedings Paper
CT 4th International Conference on Probabilistic Safety Assessment and
   Management
CY SEP 13-18, 1998
CL NEW YORK, NY
SP Int Assoc Probabilist Safety Assessment & Management, Amer Inst Chem Engineers, Amer Nucl Soc, Amer Soc Civil Engineers, Amer Soc Mech Engineers, Atom Energy Soc Japan, European Nucl Soc, European Safety & Reliabil Assoc, Fed Aviat Adm, Human Factors Soc, Inst Elect & Electr Engineers, Int Atom Energy Agcy, European Union, Joint Res Ctr, NASA, Org Econ Cooperat & Dev, Soc Risk Analy, Syst Safety Soc, UK Safety & Reliabil Soc, US Coast Guard, US DOE, US Nucl Regulatory Commiss, Associated Univ Inc, Beta Corp Int, BOOZ ALLEN & HAMILTON Inc, Brookhaven Sci Associates, ERIN Engn & Res Inc, PLG Inc, Sci Applicat Int Corp, SCIENTECH INC, Univ Maryland, Ctr Technol Risk Stud
AB All United States space missions involving launch vehicles carrying significant amounts of nuclear material are required by U.S. law to obtain approval from the Office of the President. Pursuant to that approval, the mission and all its systems must undergo evaluations of the associated nuclear environmental, health and safety risks. These evaluations are documented in a Safety Analysis Report prepared by the organization proposing the mission, and by an overall Safety Evaluation Report prepared for the President by an independent Nuclear Safety Review Panel (INSRP).
   Recent deep space missions have had their onboard electrical power derived from Radioisotopic Thermoelectric Generators (RTGs) whose thermal energy is provided by using the decay heat from encapsulated plutonium-238 General Purpose Heat Sources (GPHS). Smaller Light Weight Radioisotope Heater Units (LWRHU) are also used to maintain the temperatures of critical components. This paper will summarize the central part of the overall evaluation with a risk assessment of potential "source terms" of plutonium which might be released following postulated accidents. The amount of plutonium released, the fraction in particle sizes which could be inhaled, the subsequent dispersion, deposition, resuspension and absorption all must be evaluated for each accident scenario. In addition the population densities, integrated air concentrations and physiological and sociological aspects mustbe included Special consideration is given to the chemical form of particles and to their size distributions and inhalability.
   The assessment integrates the newest information on local and global environmental and biomedical factors, and provides new means to derive radiation doses and consequences as well as approaches to understanding associated uncertainties. Finally, individual and collective population radiation doses are estimated and are coupled with appropriate risk coefficients to yield estimates for potential early and late lifetime radiation effects.
C1 ATL Int Inc, Richland, WA USA.
RP Nelson, RC (reprint author), ATL Int Inc, Richland, WA USA.
RI Hoover, Mark/I-4201-2012
OI Hoover, Mark/0000-0002-8726-8127
CR *INSRP, 1990, 9006 INSRP
   *INSRP, 1997, BIOM ENV EFF SUBP BE
   International Commission on Radiological Protection, 1994, ICRP PUBL, V66
   MAXWELL R, IN PRESS RAD RES
   WHICKER FW, 1982, RADIOECOLOGY NUCL EN, V1, P161
   *WHO, 1983, 25 WHO
NR 6
TC 0
Z9 0
U1 0
U2 5
PU SPRINGER-VERLAG LONDON LTD
PI GODALMING
PA SWEETAPPLE HOUSE CATTESHALL RD FARNCOMBE, GODALMING GU7 1NH, SURREY,
   ENGLAND
BN 3-540-76262-0
PY 1998
BP 939
EP 944
PG 6
WC Engineering, Multidisciplinary; Multidisciplinary Sciences
SC Engineering; Science & Technology - Other Topics
GA BP34L
UT WOS:000084758100142
DA 2018-10-20
ER

PT B
AU Sendemir, A
   Altintas, S
AF Sendemir, A
   Altintas, S
GP IEEE
TI Production of hydroxylapatite reinforced polymer composites for
   biomedical applications
SO PROCEEDINGS OF THE 1998 2ND INTERNATIONAL CONFERENCE BIOMEDICAL
   ENGINEERING DAYS
LA English
DT Proceedings Paper
CT 2nd International Biomedical Engineering Days Conference
CY MAY 20-22, 1998
CL ISTANBUL, TURKEY
SP Bogazici Univ, Inst Biomed Engn, IEEE, Engn Med & Biol Soc
AB In this study, hydroxylapatite (HAp) reinforced polymer composites were produced and evaluated to be used in bone implants. The aim was to produce a material that has similar modulus of elasticity (E) and other mechanical properties to those of bone in order to achieve mechanical compatibility in the body. Hydroxylapatite was mixed with high density polyethylene (HDPE) and polypropylene (PP) in different amounts. The resulting composite materials were injection molded into standard tensile and impact test specimens and their mechanical properties were examined, Stiffness and hardness of the composites were increased toughness, percent elongation and impact energy were decreased with increasing HAp content. No significant change was observed in ultimate tensile strength while an increase was significant in the yield strength related to HAp content. PP composites were found to have better impact properties in spite of more ductile behavior of HDPE composites under tension. Although the problem of mechanical compatibility in bone implants has not totally been solved, hydroxylapatite reinforced polymer composites are suggested as promising alternatives to traditional implant materials.
C1 Bogazici Univ, Dept Engn Mech, Istanbul, Turkey.
RP Sendemir, A (reprint author), Bogazici Univ, Dept Engn Mech, PK 2, Istanbul, Turkey.
RI Sendemir Urkmez, Aylin/A-6347-2014
OI Sendemir Urkmez, Aylin/0000-0003-1818-6651
NR 0
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-4242-9
PY 1998
BP 114
EP 117
DI 10.1109/IBED.1998.710601
PG 4
WC Engineering, Biomedical
SC Engineering
GA BL61J
UT WOS:000076010900033
DA 2018-10-20
ER

PT S
AU Lal, A
AF Lal, A
BE Chang, HK
   Zhang, YT
TI Silicon-based ultrasonic surgical actuators
SO PROCEEDINGS OF THE 20TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 20, PTS 1-6: BIOMEDICAL
   ENGINEERING TOWARDS THE YEAR 2000 AND BEYOND
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 10th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY OCT 29-NOV 01, 1998
CL HONG KONG, PEOPLES R CHINA
SP IEEE Engn Med & Biol Soc
AB A novel ultrasonic biomedical actuator technology fabricated using micromachining and piezoelectric ceramics is presented. Advantages and limitations of micromachining technology in the context of biomedical actuators are outlined. Micromachining allows the fabrication of extremely small devices with integrated electronics. Silicon's material properties make it ideal for high-intensity ultrasonic applications. Cutting tip velocity and sharpness were shown to be superior to that of conventional ultrasonic surgical tool technology.
C1 Univ Wisconsin, Dept Elect & Comp Engn, Madison, WI 53706 USA.
RP Lal, A (reprint author), Univ Wisconsin, Dept Elect & Comp Engn, 1415 Johnson Dr, Madison, WI 53706 USA.
CR Ashby M. F., 1992, MAT SELECTION MECH D
   CHARLES S, 1981, VITREOUS MICROSURGER
   Lal A, 1996, SENSOR ACTUAT A-PHYS, V54, P542, DOI 10.1016/S0924-4247(97)80011-8
   LAL A, 1997, ASME WORLD C DALL
   LAL A, 1994, IEEE ULTR S CANN FRA
   Madou MJ, 1997, FUNDAMENTALS MICROFA
   NEZHAT CR, 1998, FUNDAMENTALS SURG
   Rosen A., 1995, WILEY SERIES MICROWA
   SUSLICK KS, 1988, ULTRASOUND ITS CHEM
NR 9
TC 9
Z9 9
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-5164-9
J9 P ANN INT IEEE EMBS
PY 1998
VL 20
BP 2785
EP 2790
PN 1-6
PG 6
WC Cardiac & Cardiovascular Systems; Engineering, Biomedical; Medical
   Informatics; Medical Laboratory Technology; Clinical Neurology;
   Radiology, Nuclear Medicine & Medical Imaging
SC Cardiovascular System & Cardiology; Engineering; Medical Informatics;
   Medical Laboratory Technology; Neurosciences & Neurology; Radiology,
   Nuclear Medicine & Medical Imaging
GA BM59Y
UT WOS:000079210400762
DA 2018-10-20
ER

PT S
AU Wang, CX
   Chen, ZQ
   Zhang, HL
AF Wang, CX
   Chen, ZQ
   Zhang, HL
BE Chang, HK
   Zhang, YT
TI Design of Ti/HA biomedical implants using ion-beam-assisted deposition
SO PROCEEDINGS OF THE 20TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 20, PTS 1-6: BIOMEDICAL
   ENGINEERING TOWARDS THE YEAR 2000 AND BEYOND
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 10th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY OCT 29-NOV 01, 1998
CL HONG KONG, PEOPLES R CHINA
SP IEEE Engn Med & Biol Soc
ID CALCIUM-PHOSPHATE COATINGS; SURFACE MODIFICATION; THIN-FILMS
AB Hydroxy-apatite (Ca(10)(PO(4))(6)(OH)(2), HA), owing to its bioaffinity and osteo-integration to body, is potential materials for coating on metal implants. At present, in addition to bulk HA directly used in restoration and reconstruction surgery, hydroxy-apatite is also coated on metal implants by plasma-spraying method, adhesion and sintering. However, these kinds of biomaterials are restricted in application due to their insufficient strength and weak bonding between substrate and coating. It is of great advantage to modify the surface of titanium and its alloy by ion-beam-assisted deposition (IBAD) combining ion implantation with physical vapor deposition (PVD). This paper is focused on the design of Ti/HA implants by ion-beam-assisted deposition technique and the computation of fabricating parameter using Trim 96 program The present investigation lays a foundation of the further research and application.
C1 W China Univ Med Sci, Coll Stomatol, Chengdu 610041, Peoples R China.
RP Wang, CX (reprint author), W China Univ Med Sci, Coll Stomatol, Chengdu 610041, Peoples R China.
EM wcumsdds@public.sc.cninfo.net
CR CHEN A, 1991, SURF COAT TECH, V50, P1, DOI 10.1016/0257-8972(91)90184-X
   Ektessabi AM, 1995, THIN SOLID FILMS, V270, P335, DOI 10.1016/0040-6090(95)06714-0
   EKTESSABI AM, 1995, NUCL INSTRUM METH B, V99, P610, DOI 10.1016/0168-583X(94)00568-0
   HOWLETT CR, 1994, J MATER SCI-MATER M, V5, P715, DOI 10.1007/BF00120363
   KORBER FJ, 1993, SURF COAT TECH, V59, P226, DOI 10.1016/0257-8972(93)90088-6
   Leitao E, 1997, J MATER SCI-MATER M, V8, P365, DOI 10.1023/A:1018532900458
   MATTOX DM, 1989, J VAC SCI TECHNOL A, V7, P1105, DOI 10.1116/1.576238
   Murayama Y, 1997, NUCL INSTRUM METH B, V127, P1015, DOI 10.1016/S0168-583X(97)00080-3
   ONG JL, 1992, BIOMATERIALS, V13, P249, DOI 10.1016/0142-9612(92)90192-Q
   ONG JL, 1994, BIOMATERIALS, V15, P337, DOI 10.1016/0142-9612(94)90245-3
   SINGH RK, 1994, BIOMATERIALS, V15, P522, DOI 10.1016/0142-9612(94)90018-3
   Sioshansi P, 1996, SURF COAT TECH, V83, P175, DOI 10.1016/0257-8972(95)02838-2
   SUZUKI, 1994, NUCL INSTRUMENTS MET, V91, P580
   YOSHINARI M, 1994, BIOMATERIALS, V15, P529, DOI 10.1016/0142-9612(94)90019-1
NR 14
TC 3
Z9 4
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-5164-9
J9 P ANN INT IEEE EMBS
PY 1998
VL 20
BP 2890
EP 2892
PN 1-6
PG 3
WC Cardiac & Cardiovascular Systems; Engineering, Biomedical; Medical
   Informatics; Medical Laboratory Technology; Clinical Neurology;
   Radiology, Nuclear Medicine & Medical Imaging
SC Cardiovascular System & Cardiology; Engineering; Medical Informatics;
   Medical Laboratory Technology; Neurosciences & Neurology; Radiology,
   Nuclear Medicine & Medical Imaging
GA BM59Y
UT WOS:000079210400790
DA 2018-10-20
ER

PT B
AU Stockton, E
   Fisher, RJ
AF Stockton, E
   Fisher, RJ
BE Wolpert, S
   Weiss, WJ
   Gaumond, RP
TI Designing biomimetic membranes for ion transport
SO PROCEEDINGS OF THE IEEE 24TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
LA English
DT Proceedings Paper
CT IEEE 24th Annual Northeast Bioengineering Conference
CY APR 09-10, 1998
CL HERSHEY, PA
SP IEEE
AB Supported Liquid Membrane Systems (SLMS) have previously been shown to be effective mimics of active transport of ions. This can be controlled through use of thin film, fixed site carrier membranes on the external surfaces of an SLMS, to encapsulate it. This film must exhibit selective facilitated transport characteristics. We demonstrate this entrapping concept here by incorporating our previously successful SLMS with a thin film coating of a cation exchange membrane, Nafion (R) 124. Successful experiments for nickel transport were conducted in a recirculating dialysis unit. We also attempted to use fixed site carrier membranes; an ethylene-acrylic acid ionomer. Preliminary data indicates the approach is be sound for some cations, however the data for nickel was not conclusive. The most probable design for biomedical applications appears to be combination (laminate) system that incorporates supported liquid membranes and highly selective molecularly engineered thin film entrapping membranes utilizing advanced materials technologies.
C1 Univ Connecticut, SABRE Lab Engn Biosci, Dept Chem Engn, Storrs, CT 06269 USA.
RP Stockton, E (reprint author), Univ Connecticut, SABRE Lab Engn Biosci, Dept Chem Engn, Storrs, CT 06269 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-4544-4
PY 1998
BP 49
EP 51
DI 10.1109/NEBC.1998.664873
PG 3
WC Engineering, Biomedical
SC Engineering
GA BK95J
UT WOS:000073938800018
DA 2018-10-20
ER

PT J
AU Gil, FJ
   Planell, JA
AF Gil, FJ
   Planell, JA
TI Shape memory alloys for medical applications
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE shape memory; pseudoelasticity; NiTi alloys
ID ZN-AL ALLOYS; MARTENSITIC TRANSFORMATIONS; WIRE; PSEUDOELASTICITY;
   BEHAVIOR; DSC
AB The shape memory alloys exhibit a number of remarkable properties, which open new possibilities in engineering and more specifically in biomedical engineering. The most important alloy used in biomedical applications is NiTi. This alloy combines the characeristics of the shape memory effect and superelasticity with excellent corrosion resistance, wear characteristics, mechanical properties and a good biocompatibility. These properties make it an ideal biological engineering material, especially in orthopaedic surgery and orthodontics. In this work the basis of the memory effect lies in the fact that the materials exhibiting such a property undergo a thermoelastic martensitic transformation. In order to understand even the most elementary engineering aspects of the shape memory effect it is necessary to review some basic principles of the formation and the characteristics of the martensitic phase. The different properties of shape memory, superelasticity, two-way shape memory, rubber-like behaviour and a high damping capacity are reviewed. Some applications proposed in recent years are described and classified according to different medical fields.
C1 Univ Politecn Cataluna, Escola Tecn Super Engn Barcelona, Dept Ciencia Mat & Engn Met, Barcelona, Spain.
RP Gil, FJ (reprint author), Univ Politecn Cataluna, Escola Tecn Super Engn Barcelona, Dept Ciencia Mat & Engn Met, Barcelona, Spain.
CR AHLERS M, 1978, SCRIPTA METALL MATER, V12, P1075, DOI 10.1016/0036-9748(78)90077-7
   AMENGUAL A, 1989, THERMOCHIM ACTA, V145, P101, DOI 10.1016/0040-6031(89)85130-5
   AMENGUAL A, 1991, THERMOCHIM ACTA, V188, P63, DOI 10.1016/0040-6031(91)80205-W
   ANDREASEN G, 1980, AM J ORTHOD DENTOFAC, V78, P528, DOI 10.1016/0002-9416(80)90303-6
   ANDREASEN GF, 1978, AM J ORTHOD DENTOFAC, V73, P141
   BARCELO G, 1978, SCRIPTA METALL MATER, V12, P1069, DOI 10.1016/0036-9748(78)90076-5
   BAUMGART F, 1977, TECH MITT KRUPP FORS, V35, P157
   BUEHLER WJ, 1963, J APPL PHYS, V34, P1475, DOI 10.1063/1.1729603
   BURSTONE CJ, 1985, AM J ORTHOD DENTOFAC, V87, P445, DOI 10.1016/0002-9416(85)90083-1
   BUSH RE, 1966, 65021 AMRA CR
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   CASTLEMAN LS, 1981, BIOCOMPATIBILITY CLI, P567
   CUTRIGHT DE, 1973, ORAL SURG ORAL MED O, V35, P578, DOI 10.1016/0030-4220(73)90017-0
   DEHAVEN K, 1993, 3 C INT SOC KNEE GLE, P256
   DELAEY L, 1974, J MATER SCI, V9, P1521, DOI 10.1007/BF00552939
   DELAEY L, 1987, MAT SCI TECHNOLOGY, V5, P339
   DELAEY L, 1975, SHAPE MEMORY EFFECTS, P124
   DELAEY L, 1978, 78R1 KATH U LEUV DEP, P24
   FUKUYO S, 1990, SHAPE MEMORY ENG ASP, P470
   GIL FJ, 1993, J MATER SCI-MATER M, V4, P281, DOI 10.1007/BF00122281
   GIL FJ, 1991, THERMOCHIM ACTA, V191, P179, DOI 10.1016/0040-6031(91)87248-U
   GIL FJ, 1989, THESIS U BARCELONA, P250
   GIL FJ, 1996, BIOMED MAT ENG, V6, P153
   Gil FX, 1996, J MATER SCI-MATER M, V7, P403, DOI 10.1007/BF00122008
   GOLESTANEH AA, 1980, ACTA METALL MATER, V28, P1427, DOI 10.1016/0001-6160(80)90011-5
   Greninger AB, 1938, T AM I MIN MET ENG, V128, P337
   GUILEMANY JM, 1990, MATER RES BULL, V25, P1325, DOI 10.1016/0025-5408(90)90092-G
   GYUNTER VE, 1992, SHAPE MEMORY EFFECTS, P600
   GYUNTER VE, 1993, SUPERELASTIC IMPLANT, P213
   HAARSTERS J, 1990, SHAPE MEMORY ENG ASP, P426
   HAASTERS J, 1980, CURRENT CONCEPTS INT, P128
   HAMADA H, P 4 C JAP SOC BIOM, P191
   HAMANAKA H, 1982, P 8 ANN M SOC BIOM, P91
   HORNBOGEN E, 1990, SHAPE MEMORY ENG ASP, P267
   HUGHES JL, 1977, 1774C4041 DAMD US AR, P72
   JAMES DW, 1969, MATER SCI ENG, V4, P322
   JARDINE AP, 1989, J MATER SCI, V24, P2587, DOI 10.1007/BF01174530
   KAUFMAN L, 1958, PROG MET PHYS, V7, P165, DOI 10.1016/0502-8205(58)90005-4
   KROUSBROCK R, 1984, SHAPE MEMORY ALLOYS, V2, P82
   KROUSBROECK R, 1982, ADV BIOMATER, V3, P767
   KURDYUMOV GV, 1949, DOKL AKAD NAUK SSSR+, V66, P211
   LI L, 1988, SCRIPTA METALL, V22, P1435
   LIBENSON C, 1996, ORTHOD KIEFERORTHOP, V28, P135
   LIBENSON C, 1996, REV ORTHOP DENTO FAC, V30, P129
   LIN HC, 1993, METALL TRANS A, V24, P2189, DOI 10.1007/BF02648593
   LU S, 1990, SHAPE MEMORY ENG ASP, P445
   MELLOR BG, 1980, SCI TECHNOLOGY SHAPE, P125
   MELTON KN, 1990, SHAPE MEMORY ENG ASP, P21
   MIURA F, 1988, AM J ORTHOD DENTOFAC, V94, P89, DOI 10.1016/0889-5406(88)90356-3
   MonteroOcampo C, 1996, J BIOMED MATER RES, V32, P583, DOI 10.1002/(SICI)1097-4636(199612)32:4<583::AID-JBM11>3.0.CO;2-F
   NETSU N, 1978, B RES I MINERAL DRES, V34, P67
   Olander A, 1932, J AM CHEM SOC, V54, P3819, DOI 10.1021/ja01349a004
   OLEARY J, 1990, SHAPE MEMORY ENG ASP, P477
   ORTIN J, 1988, ACTA METALL MATER, V36, P1873, DOI 10.1016/0001-6160(88)90291-X
   Otsuka K., 1981, P INT C SOLID SOLID, P1267
   OTSUKA K, 1976, INT METALS REV, V31, P93
   OTSUKA K, 1977, INT Q SCI REV J REV, V2
   PERKINS J, 1990, SHAPE MEMORY ENG ASP, P195
   PICORNELL C, 1989, SCRIPTA METALL MATER, V23, P371, DOI 10.1016/0036-9748(89)90385-2
   PONS J, 1993, MATER T JIM, V34, P888, DOI 10.2320/matertrans1989.34.888
   SABRIA J, 1995, BIOMED MAT ENG, V5, P161
   SADE M, 1988, Z METALLKD, V79, P487
   SADE M, 1988, Z METALLKD, V79, P678
   SAWYER PN, 1971, T AM SOC ART INT ORG, V17, P470
   SCHMERLING MA, 1976, J BIOMED MATER RES, V10, P879, DOI 10.1002/jbm.820100607
   SCHROEDER TA, 1976, METALL TRANS A, V7, P535, DOI 10.1007/BF02643969
   SEKIGUCI Y, 1984, MED APPL SHAPE MEMOR, P10
   Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267
   SHIMIZU K, 1984, SHAPE MEMORY EFFECT, P10
   SIMON M, 1977, RADIOLOGY, V125, P89, DOI 10.1148/125.1.89
   STALMANS R, 1992, ACTA METALL MATER, V40, P501, DOI 10.1016/0956-7151(92)90399-Y
   STICE J, 1990, SHAPE MEMORY ENG ASP, P483
   SUZUKI Y, 1990, SHAPE MEMORY ENG ASP, P256
   WARLIMONT H, 1974, PROG MATER SCI, V18, P93
   WASILEWSKI RJ, 1975, METALL TRANS A, V6, P1405, DOI 10.1007/BF02641933
   WAYMAN CM, 1990, INTRO MARTENSITE SHA, P5
   ZHANG XF, 1986, SHAPE MEMORY ALLOY 8, P24
   ZHONGGUO W, 1988, SCRIPTA METALL, V22, P1245
NR 78
TC 49
Z9 49
U1 0
U2 19
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0954-4119
EI 2041-3033
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PY 1998
VL 212
IS H6
BP 473
EP 488
DI 10.1243/0954411981534231
PG 16
WC Engineering, Biomedical
SC Engineering
GA 140LJ
UT WOS:000077088500008
PM 9852742
DA 2018-10-20
ER

PT B
AU German, RM
AF German, RM
BE Khor, KA
   Srivatsan, TS
   Moore, JJ
TI Powder injection molding applications to new materials
SO PROCESSING AND FABRICATION OF ADVANCED MATERIALS VI, VOLS 1 & 2
LA English
DT Proceedings Paper
CT International Symposium on Processing and Fabrication of Advanced
   Materials
CY NOV 24-26, 1997
CL SINGAPORE, SINGAPORE
SP Nanyang Technol Univ, Sch Mech & Prod Engn, Inst Mat, Minerals Met & Mat Soc, Adv Mat Res Ctr
DE powder injection molding; applications; new materials
ID COMPONENTS
AB A new technology known as powder injection molding (PIM) has grown from a curiosity to a viable production process over the past 15 years. It is now the manufacturing route of choice for many biomedical, computer, automotive, firearm, and turbine components. The process uses the shaping advantage of plastic injection molding, while delivering competitive mechanical, physical, and thermal properties. Original materials were alumina, steel, and stainless steel, but most all ceramics and metals can now be formed by the technique. Some exciting developments are occurring in the forming of complex components with high production volumes. A few of the challenges are associated with the production of titanium golf clubs, superelastic eyewear, zirconia toughened spraying nozzles, gold and silver jewelry, tool steel drilling components, cobalt-chromium biomedical implants, and novel cemented carbide tools. These developments continue to expand the applications and materials as more difficult systems are mastered.
C1 Penn State Univ, PM Lab, University Pk, PA 16802 USA.
RP German, RM (reprint author), Penn State Univ, PM Lab, 118 Res W, University Pk, PA 16802 USA.
CR BOSE A, 1992, POWDER INJECTION MOLDING SYMPOSIUM - 1992, P261
   BOSE A, 1990, ADV POWDER METALLURG, V3, P401
   EBENHOCH J, 1994, ADV PARTICULATE MAT, V4, P261
   German R.M., 1997, INJECTION MOLDING ME
   German R. M., 1989, ADV POWDER METALLURG, V3, P51
   GERMAN RM, 1993, REV PARTICUL MATER, V1, P109
   GERMAN RM, 1993, ADV POWDER MET PART, V6, P180
   HECKER R, 1990, HIGH TEMP HIGH PRESS, V22, P79
   Hens K F, 1994, ADV POWDER METALLURG, V4, P217
   HENS KF, 1994, ADV POWDER MET PART, V4, P249
   Kaneko Y., 1990, Journal of the Japan Society of Powder and Powder Metallurgy, V37, P191
   KANEKO Y, 1990, J JAPAN SOC POWDER P, V37, P13
   Kusaka K., 1996, ADV POWDER MET PART, V19, P127
   Kusaka K., 1995, J JPN SOC POWDER POW, V42, P383
   Kyogoku H., 1995, J JPN SOC POWDER POW, V42, P1052
   LIN ST, 1989, POWDER METALL INT, V21, P19
   MARTYN MT, 1994, INT J REFRACT MET H, V12, P61
   MOON IH, 1996, ADV POWDER MET PART
   MOON IH, 1989, INT J REFRACT MET H, V8, P244
   WEI TS, 1988, INT J POWDER METALL, V24, P327
   WIECH RE, 1980, MODERN DEV POWDER ME, V12, P317
   YANG B, 1995, TUNGSTEN REFRACTORY, P237
   YANG B, 1993, ADV POWDER METALLURG, V5, P105
   YANG MJ, 1995, ADV POWDER MET PART
   Zu YS, 1996, J MATER ENG PERFORM, V5, P609, DOI 10.1007/BF02646090
NR 25
TC 0
Z9 0
U1 0
U2 6
PU IOM COMMUNICATIONS LTD
PI LONDON
PA 1 CARLTON HOUSE TERRACE, LONDON SW1Y 5DB, ENGLAND
BN 1-86125-039-8
PY 1998
BP 1363
EP 1375
PG 13
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering; Materials Science, Composites
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BP03C
UT WOS:000083931500125
DA 2018-10-20
ER

PT B
AU Racz, LM
   Abedian, B
AF Racz, LM
   Abedian, B
BE Li, BQ
TI Dynamic interfacial phenomena in polymer-matrix composites
SO PROCESSING OF METALS AND ADVANCED MATERIALS: MODELING, DESIGN AND
   PROPERTIES
LA English
DT Proceedings Paper
CT International Symposium on Processing of Metals and Advanced Materials -
   Modeling, Design and Properties at the 1998 TMS Annual Meeting
CY FEB 16-19, 1998
CL SAN ANTONIO, TX
SP Minerals Met & Mat Soc, Mat Design & Mfg Div, Synthesis Control & Anal Mat Proc Comm, Minerals Met & Mat Soc, Extract & Proc Div, Synthesis Control & Analy Mat Proc Comm
AB We address dynamic interactions between high-energy, reactive surfaces of polymer-matrix composites and solid surfaces. A common characteristic of these interfaces is that bonding occurs readily upon contact. In many industrial and biomedical applications, it is desirable to suppress this bonding phenomenon. This interfacial effect is discussed in light of the development of our new method of handling polymer-matrix composites in dental applications. This method involves vibration of the solid-polymer interface at different frequencies. For each material, there is a critical frequency at which the sum of the viscoelastic and inertial energies of the fluid at the surface exceeds the energy available for bonding. When the polymer is vibrated at or beyond this frequency, it does not adhere to solid surfaces. An important aspect of the developed process is that it can be used to characterize surface and interfacial properties of polymers under dynamic conditions, whereas existing techniques are restricted to the study of bulk dynamic properties.
C1 Tufts Univ, Dept Mech Engn, Medford, MA 02155 USA.
RP Racz, LM (reprint author), Tufts Univ, Dept Mech Engn, Medford, MA 02155 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-395-3
PY 1998
BP 41
EP 51
PG 11
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BK53P
UT WOS:000072467400004
DA 2018-10-20
ER

PT B
AU Armstrong, BL
   Song, L
   Smith, PA
   Coffey, GW
AF Armstrong, BL
   Song, L
   Smith, PA
   Coffey, GW
BE Alman, DE
   Hawk, JA
   Simmons, JW
TI Processing and characterization of biomaterials
SO ROLL OF CHARACTERIZATION IN UNDERSTANDING ENVIRONMENTAL DEGRADATION OF
   MATERIALS
SE MICROSTRUCTURAL SCIENCE
LA English
DT Proceedings Paper
CT 30th Annual Technical Meeting of the
   International-Metallographic-Society
CY JUL 20-23, 1997
CL SEATTLE, WA
SP Int Met Soc
AB A variety of materials are currently being used in biomedical applications. With these materials, there are also a variety of processing methods which have characteristic advantages and disadvantages. An overview of these traditional materials and processes will be presented. Promising advances in processes and materials will also be discussed.
C1 Pacific NW Natl Lab, Richland, WA 99352 USA.
RP Armstrong, BL (reprint author), Pacific NW Natl Lab, Richland, WA 99352 USA.
RI Armstrong, Beth/E-6752-2017
OI Armstrong, Beth/0000-0001-7149-3576
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 0-87170-658-X
J9 MICROSTR SC
PY 1998
VL 25
BP 217
EP 220
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BL08V
UT WOS:000074227900026
DA 2018-10-20
ER

PT B
AU Karlsen, W
   Atteridge, D
AF Karlsen, W
   Atteridge, D
BE Alman, DE
   Hawk, JA
   Simmons, JW
TI Microstructure and mechanical properties of high-nitrogen Stellite 21
   Co-Cr-Mo biomedical implant alloy
SO ROLL OF CHARACTERIZATION IN UNDERSTANDING ENVIRONMENTAL DEGRADATION OF
   MATERIALS
SE MICROSTRUCTURAL SCIENCE
LA English
DT Proceedings Paper
CT 30th Annual Technical Meeting of the
   International-Metallographic-Society
CY JUL 20-23, 1997
CL SEATTLE, WA
SP Int Met Soc
AB Stellite 21 Co-Cr-Mo alloy was melted under a nitrogen atmosphere at pressures ranging from 1.4 to 50 atm. The total nitrogen achieved increased with pressure, and ranged from 0.19 to 1.34 wt%. Nitrogen was present interstitially, and as chrome nitride precipitates, Cr2N and CrN, A finer grain size achieved by hot-rolling, and the presence of second phase material were observed to increase the yield strength. Increased interstitial nitrogen was observed to increase the ductility, but with increasing nitride formation, the ductility decreased. With increasing nitrogen contents, there was a shift from the traditional Cr23C6 to a Cr2N, with an apparent elevation in the incipient melting temperature to above 1260 degrees C (2300 degrees F).
C1 Oregon Grad Inst, Portland, OR 97208 USA.
RP Karlsen, W (reprint author), Oregon Grad Inst, Portland, OR 97208 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 0-87170-658-X
J9 MICROSTR SC
PY 1998
VL 25
BP 221
EP 230
PG 10
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BL08V
UT WOS:000074227900027
DA 2018-10-20
ER

PT S
AU Beutel, H
   Stieglitz, T
   Meyer, JU
AF Beutel, H
   Stieglitz, T
   Meyer, JU
BE Varadan, VK
   McWhorter, PJ
   Singer, RA
   Vellekoop, MJ
TI Versatile 'microflex'-based interconnection technique
SO SMART STRUCTURES AND MATERIALS 1998: SMART ELECTRONICS AND MEMS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT SPIE Conference on Smart Electronics and MEMS
CY MAR 02-04, 1998
CL SAN DIEGO, CA
SP SPIE, Soc Exptl Mech Inc, Amer Soc Mech Engineers, BFGoodrich Aerosp
DE interconnects; flexible microcable; biocompatibility; micromachining;
   small pitch; flip chip; stud bonding
AB A new interconnection technique has been developed that allows versatile multiple strand connections between microsensors, sensor arrays, and chips designed for wire bonding. The new technique has been termed 'microflex interconnects' (MFI).
   Conventional wire bonding technique is commonly restricted to planar interconnects with a limited degree of freedom for placing microsystem components. The MFI technique has overcome this limitation by interconnecting microsystem components through custom designed flexible foils with embedded metallized conductors. The MFI foils may also serve as circuit substrates. This basic foil material is polyimide (Du Pont PI 2611)(1) or BCB2 which are patterned photolithographically. Platinum, gold or either conductive metals are sputtered or evaporated on the foil and patterned using lift-off technique. Several metallization layers can be embedded in the material. Pitch and shape of the MFI contact pads correspond to the one of the chips to be interconnected. A via hole is placed in the center of the MFI contact pads. MFI pads and chip pads are adjusted. Metal balls or wedges generate the electrical and mechanical contact through the vias between the chips and the MFI substrate. An commercial wire bonder is the only equipment needed to perform, the MFI method.
   The MFI technique was applied to bond standard CMOS integrated circuit (IC) bond pads with a width of 30 mu m and a pitch of 70 mu m to a 10 mu m thick MFI foil. The integration density of the MFI technique correspond to one of the flip-chip technology(3). Special advantages of the MFI technique are three-dimensional interconnects, the flexibility in design and shape, and easy visual inspection of alignment qualities. The MFI method is also suited for biomedical applications because all materials used are biocompatible.
C1 Fraunhofer Inst Biomed Engn, Dept Sensor Syst Microsyst, D-66386 Sankt Ingbert, Germany.
RP Beutel, H (reprint author), Fraunhofer Inst Biomed Engn, Dept Sensor Syst Microsyst, Ensheimer Str 48, D-66386 Sankt Ingbert, Germany.
RI Stieglitz, Thomas/C-7916-2013
OI Stieglitz, Thomas/0000-0002-7349-4254
NR 0
TC 4
Z9 4
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-2772-1
J9 P SOC PHOTO-OPT INS
PY 1998
VL 3328
BP 174
EP 182
DI 10.1117/12.320167
PG 9
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BL49P
UT WOS:000075701400019
DA 2018-10-20
ER

PT S
AU Giurgiutiu, V
   Rogers, CA
AF Giurgiutiu, V
   Rogers, CA
BE Regelbrugge, ME
TI Recent advancements in the electro-mechanical (E/M) impedance method for
   structural health monitoring and NDE
SO SMART STRUCTURES AND MATERIALS 1998: SMART STRUCTURES AND INTEGRATED
   SYSTEMS, PTS 1 AND 2
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT SPIE Conference on Smart Structures and Integrated Systems
CY MAR 02-05, 1998
CL SAN DIEGO, CA
SP SPIE, Soc Exptl Mech, Amer Soc Mech Engineers, BFGoodrich Aerosp
DE damage detection; health monitoring; failure prevention;
   electro-mechanical impedance; NDE; non-destructive evaluation; incipient
   damage; piezo-electric transducer; crack propagation; crack detection
AB The emerging electro-mechanical impedance technology has high potential for in-situ health monitoring and NDE of structural systems and complex machinery. At first, the fundamental principles of the electro-mechanical impedance method are briefly reviewed and ways for practical implementation are highlighted. The equations of piezo-electric material response are given, and the coupled electro-mechanical impedance of a piezo-electric wafer transducer as affixed to the monitored structure is discussed. Due to the high frequency operation of this NDE method, wave propagation phenomena are identified as the primary coupling method between the structural substrate and the piezo-electric wafer transducer. Attention is then focused on several recent advancements that have extended the electro-mechanical impedance method into new areas of applications and/or have developed its underlying principles. US Army Construction Engineering Research Laboratory used the electro-mechanical impedance method to monitor damage development in composite overlaid civil infrastructure specimens under full-scale static testing. A simplified E/M impedance measuring technique was employed at the Polytechnic University of Madrid, Spain, to detect damage in GFRP composite specimens. The development of miniaturized "barebones" impedance analyzer equipment that could be easily packaged into transponder-size dimensions is being studied at the University of South Carolina. US Army Research Laboratory developed novel piezo-composite film transducers for embedment into composite structures. Disbond gauges for monitoring the structural joints of adhesively bonded rotor blades have been studies in the Mechanical Engineering Department at the University of South Carolina.
   These recent developments accentuate the importance and benefits of using the electro-mechanical impedance method for online health monitoring and damage detection in a variety of applications. Further investigation of the electro-mechanical impedance method is warranted. A further examination of the complex interaction between wave propagation, drive-point impedance, structural damage and electro-mechanical impedance of the piezo-electric wafer transducer is needed. Once these aspects are better understood, the E/M impedance method has the potential to become a widely used NDE technique with large applicability in diverse engineering fields (aerospace, automotive, infrastructure and biomedical implants).
C1 Univ S Carolina, Dept Mech Engn, Columbia, SC 29212 USA.
RP Giurgiutiu, V (reprint author), Univ S Carolina, Dept Mech Engn, Columbia, SC 29212 USA.
RI GIURGIUTIU, VICTOR/B-3137-2012; Giurgiutiu, Victor/F-1394-2011
OI GIURGIUTIU, VICTOR/0000-0001-8948-677X; 
NR 0
TC 79
Z9 85
U1 1
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-2773-X
J9 P SOC PHOTO-OPT INS
PY 1998
VL 3329
BP 536
EP 547
DI 10.1117/12.316923
PN 1-2
PG 12
WC Acoustics; Engineering, Aerospace; Engineering, Mechanical; Optics
SC Acoustics; Engineering; Optics
GA BL52W
UT WOS:000075786600046
DA 2018-10-20
ER

PT B
AU Hahn, KL
AF Hahn, KL
BE Nielsen, CS
   Herkert, JR
TI Developing a picture of electronic publishing: A qualitative study of
   the ecology community
SO SOCIOECONOMIC DIMENSIONS OF ELECTRONIC PUBLISHING WORKSHOP -
   PROCEEDINGS: MEETING THE NEEDS OF THE ENGINEERING AND SCIENTIFIC
   COMMUNITIES
LA English
DT Proceedings Paper
CT Socioeconomic Dimensions of Electronic Publishing Workshop - Meeting the
   Needs of the Engineering and Scientific Communities
CY APR 23-25, 1998
CL SANTA BARBARA, CA
SP Natl Sci Fdn, IEEE Fdn
AB There is widespread recognition that scientists acting as the producers of the raw material of electronic publications will, to a large extent, drive the ultimate adoption process of electronic publishing. However, there has been little research focusing on the interests and perceptions of scientists acting as authors and editors. At the same time, it should be recognized that various scientific communities are pursuing different paths in the development and adoption of electronic publication and dissemination of research results. This variation in developmental approaches may well reflect different needs and interests of the communities involved. To date the physics community and some biomedical communities have received greatest attention for their early work in developing new modes of publishing. However, these communities may well have unique practices and history that are shaping developments in ways that may not be indicative of subsequent electronic publishing in other disciplines. This work reports preliminary results of a qualitative study of authors and editors of two new journals serving the environmental science community, a community that is relatively new to the arena of scientific publishing. One journal is entirely electronic, while the other provides both paper and electronic formats. Some of the questions investigated include how the participants in these ventures perceive electronic publishing and its impact and how their individual encounters with electronic publishing shape those perceptions.
C1 Univ Maryland Lib, College Pk, MD 20742 USA.
RI Strieb, Karla/B-1835-2008
OI Strieb, Karla/0000-0002-9160-1834
NR 0
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-5101-0
PY 1998
BP 23
EP 29
DI 10.1109/SEDEP.1998.730704
PG 7
WC Communication; Information Science & Library Science
SC Communication; Information Science & Library Science
GA BM14T
UT WOS:000077803600004
DA 2018-10-20
ER

PT S
AU Vail, NK
   Swain, LD
   Fox, WC
   Aufdemorte, TB
   Lee, G
   Barlow, JW
AF Vail, NK
   Swain, LD
   Fox, WC
   Aufdemorte, TB
   Lee, G
   Barlow, JW
BE Marcus, HL
   Beaman, JJ
   Bourell, DL
   Barlow, JW
   Crawford, RH
TI Materials for biomedical applications
SO SOLID FREEFORM FABRICATION PROCEEDINGS, AUGUST, 1998
SE SOLID FREEFORM FABRICATION PROCEEDINGS (SERIES)
LA English
DT Proceedings Paper
CT 9th Solid Freeform Fabrication (SFF) Symposium
CY AUG 10-12, 1998
CL UNIV TEXAS, AUSTIN, TX
SP DARPA, Rapid Prototyping Assoc, Soc Mfg Engineers, Minerals Met & Mat Soc, Univ Connecticut Storrs, Univ Texas Austin, Mech Engn Dept, Lab Freeform Fabricat, Univ Texas Austin, Texas Mat Inst
HO UNIV TEXAS
DE selective laser sintering; porous; ceramic implant; biocompatible
ID CONTOUR AUGMENTATION; GRAFT
AB This paper discusses two ceramic material systems for selective laser sintering (SLS) that are being developed for biomedical applications for use in repair of bone defects. SLS is the preferred method of fabricating ceramic implants that exhibit well defined porous microstructures. Implants fabricated in this manner have proven effective in-vivo showing excellent biocompatibility as well as considerable osseous integration and remodeling of the implant material.
C1 BioMed Enterprises Inc, San Antonio, TX 78245 USA.
RP Vail, NK (reprint author), BioMed Enterprises Inc, Texas Res Pk,14785 Omicron Dr,Suite 205, San Antonio, TX 78245 USA.
CR BALASUBRAMANIAN.B, 1995, THESIS U TEXAS AUSTI
   ERICKSON D, 1997, COMMUNICATION
   FAUST GT, 1944, AM J SCI, V242, P447
   Holle J, 1996, PLAST RECONSTR SURG, V98, P542, DOI 10.1097/00006534-199609000-00031
   HOLMES RE, 1987, J ORAL MAXIL SURG, V45, P421, DOI 10.1016/0278-2391(87)90010-3
   James WJ, 1998, J ORAL MAXIL SURG, V56, P512, DOI 10.1016/S0278-2391(98)90726-1
   LEE G, 1996, SOLID FREEFORM FAABR, V7, P15
   NELSON JC, 1992, THESIS U TEXAS AUSTI
   PAPACHARALAMBOUS SK, 1993, INT J ORAL MAX SURG, V22, P260, DOI 10.1016/S0901-5027(05)80511-9
   VAIL NK, 1994, J APPL POLYM SCI, V52, P789, DOI 10.1002/app.1994.070520610
   VAIL NK, 1996, SOLID FREEFORM FABRI, V7, P481
   VAIL NK, 1994, THESIS U TAXAS AUSTI
   WHITE E, 1986, DENT CLIN N AM, V30, P49
NR 13
TC 3
Z9 3
U1 0
U2 1
PU UNIV TEXAS AUSTIN
PI AUSTIN
PA MECHANICAL ENGINEERING DEPT, AUSTIN, TX 00000 USA
SN 1053-2153
J9 SOL FREEFORM FABRIC
PY 1998
BP 621
EP 628
PG 8
WC Engineering, Manufacturing; Engineering, Mechanical; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BN63N
UT WOS:000082420400071
DA 2018-10-20
ER

PT B
AU Khor, KA
   Wang, Y
   Cheang, P
AF Khor, KA
   Wang, Y
   Cheang, P
BE Sudarshan, TS
   Jeandin, M
   Khor, KA
TI Thermal spraying of functionally graded coatings for biomedical
   applications
SO SURFACE MODIFICATION TECHNOLOGIES XI
LA English
DT Proceedings Paper
CT 11th International Conference on Surface Modification Technologies
CY SEP 08-10, 1997
CL PARIS, FRANCE
SP Soc Francaise Met & Materiaux, Federat European Mat Soc, Inst Mat, London, Minerals, Met & Mat Soc, ASM Int
ID HYDROXYAPATITE COATINGS; COATED IMPLANTS; PLASMA; FABRICATION; TITANIUM;
   BONE
AB Biomedical requirements in a prosthesis are often complex and diverse in nature. These multifaceted requirements can be met by functionally graded materials (FGM). Biomaterials for implants have to display a wide range of adaptability to suit the various stages of the biointegration of a foreign material into the human body. This paper reports the preparation of functionally graded bioceramic coatings that are composed of essentially calcium phosphate compounds. Two FGM systems were investigated. System 1 utilised the thermal response of different size ranges of hydroxyapatite (HA) powders in the plasma name to form the gradient in biological/physical properties while System 2 synergized two types of calcium phosphates, namely, cr-tricalcium phosphate and HA, to form the FGM. The coating is graded in accordance to adhesive strength and bioresorbability. The bond coat on the metal stub is deposited with a particle range of HA that will provide high adhesive strength but have poor biocompatibility. The top coat of System 1 is composed of a particle size range of HA that elicit a layer that is highly biocompatible while in System 2, the top coat is mainly a-tricalcium phosphate that is highly bioresorbable. This arrangement has the propensity of allowing accelerated biointegration of the coating by the body tissues. The processing steps and problems will be highlighted in this paper as well as the results of post-spray treatment by conventional heat treatment and hot isostatic pressing (HIP).
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RP Khor, KA (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, Nanyang Ave, Singapore 639798, Singapore.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
CR BROWN SR, 1994, J MATER SCI-MATER M, V5, P756, DOI 10.1007/BF00120371
   Cheang P, 1996, BIOMATERIALS, V17, P537, DOI 10.1016/0142-9612(96)82729-3
   CHEANG P, 1995, J MATER PROCESS TECH, V48, P429, DOI 10.1016/0924-0136(94)01679-U
   Cheang P, 1996, J THERM SPRAY TECHN, V5, P310, DOI 10.1007/BF02645883
   CLAES L, 1990, HDB BIOACTIVE CERAMI, V2, P77
   COOK SD, 1992, J BIOMED MATER RES, V26, P989, DOI 10.1002/jbm.820260803
   DANTONIO JA, 1992, J BONE JOINT SURG AM, V74A, P995, DOI 10.2106/00004623-199274070-00006
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DOUGLAS HH, 1990, P 3 NTSC LONG BEACH, P419
   DUCHEYNE P, 1988, J BIOMED MATER RES, V22, P1137, DOI 10.1002/jbm.820221207
   DUCHEYNE P, 1980, J BIOMED MATER RES, V14, P225, DOI 10.1002/jbm.820140305
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   HARADA Y, 1989, J TOKYO DENT COLL SO, V89, P263
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HUELSMAN SW, 1994, T MRS JAP, V16, P1259
   KAWAMURA M, 1994, T MRS JAP, V16, P1251
   KAY J F, 1992, Dental Clinics of North America, V36, P1
   Khor KA, 1997, J MATER PROCESS TECH, V63, P271, DOI 10.1016/S0924-0136(96)02634-9
   KOCH B, 1990, J BIOMED MATER RES, V24, P655, DOI 10.1002/jbm.820240603
   KOIZUMI M, 1995, MRS BULL, V20, P19
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   WANG BC, 1993, J MATER SCI-MATER M, V4, P394, DOI 10.1007/BF00122198
   WANG PE, 1993, J MATER SCI-MATER M, V4, P150, DOI 10.1007/BF00120384
   WEINLAENDER M, 1992, J MATER SCI-MATER M, V3, P397, DOI 10.1007/BF00701234
   WENG J, 1995, BIOMATERIALS, V16, P39, DOI 10.1016/0142-9612(95)91094-F
NR 25
TC 0
Z9 0
U1 0
U2 2
PU INST MATERIALS
PI LONDON
PA 1 CARLTON HOUSE TERRACE, LONDON SW1Y 5DB, ENGLAND
BN 1-86125-055-X
PY 1998
BP 1038
EP 1050
PG 13
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BN40T
UT WOS:000081833400113
DA 2018-10-20
ER

PT J
AU Burg, KJL
   Shalaby, SW
AF Burg, KJL
   Shalaby, SW
TI Water fugacity in absorbing polymers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE water fugacity; absorbing polymers; differential scanning calorimetry
ID HYDROLYTIC DEGRADATION; ACID)
AB Absorbable biomaterials, as dynamic systems, require special handling, processing, and characterization techniques beyond those of the traditional nonabsorbable materials. As the material degrades or absorbs, in vitro or in vivo, it undergoes structural, physical, and chemical changes. These changes in the base material may significantly impact the performance of a particular biomedical device; hence, it is important that the investigator consider the full range of properties that constitute the lifetime of a given absorbable material. The long term degradation study presented here sought to identify. one such property, the change in water retention of a degrading oriented polylactide film. The investigation found through differential scanning calorimetry that later stages of degradation are often characterized by a stronger retention of water, potentially due to a higher number of polar carboxyl groups within the relatively hydrophobic polymer matrix. (C) 1997 John Wiley & Sons, Inc.
C1 CLEMSON UNIV,DEPT BIOENGN,RHODES ENGN RES CTR,CLEMSON,SC.
   POLY MED INC,CTR APPL TECHNOL,PENDLETON,SC.
CR BURG KJL, IN PRESS J BIOMATER
   CAM D, 1995, BIOMATERIALS, V16, P833, DOI 10.1016/0142-9612(95)94144-A
   GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F
   HAUSBERGER AG, 1995, J PHARMACEUT BIOMED, V13, P747, DOI 10.1016/0731-7085(95)01276-Q
   LIN HL, 1993, J BIOMED MATER RES, V27, P153, DOI 10.1002/jbm.820270204
   Perrin D., 1974, BUFFERS PH METAL ION
   SHALABY SW, 1996, Patent No. 5529736
   VONRECUM HA, 1995, BIOMATERIALS, V16, P441, DOI 10.1016/0142-9612(95)98816-W
NR 8
TC 5
Z9 6
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD WIN
PY 1997
VL 38
IS 4
BP 337
EP 341
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA YJ612
UT WOS:A1997YJ61200006
PM 9421754
DA 2018-10-20
ER

PT J
AU Filmon, R
   Chappard, D
   Basle, MF
AF Filmon, R
   Chappard, D
   Basle, MF
TI Scanning and transmission electron microscopy of poly 2-hydroxyethyl
   methacrylate-based biomaterials
SO JOURNAL OF HISTOTECHNOLOGY
LA English
DT Article
DE biomaterial; bone mineralization; HEMA; pHEMA; poly 2-hydroxyethyl
   methacrylate; scanning electron microscopy; transmission electron
   microscopy; 2-hydroxyethyl methacrylate
ID BONE; SPECIMENS
AB Hydrogels, especially poly 2-hydroxyethyl methacrylate, or pHEMA, have received increased attention for numerous biomedical applications. We have prepared several pHEMA-based biomaterials suitable as bone substitutes; alkaline phosphatase, for example, when immobilized in pHEMA in a copolymerization technique at 4 degrees C retains its biological activity. When pellets of the biomaterial were placed in synthetic body fluids or tissue culture medium containing organic phosphates, numerous calcified nodules formed spontaneously. Osteoblast-like cells harvested on pHEMA or pHEMA/alkaline phosphatase materials can spread and establish direct contacts. However, the hydrophilicity of pHEMA is a real handicap for preparing scanning and transmission electron microscopic analyses. We have found that 2-propanol was an excellent dehydrating preparing for scanning electron microscopy before critical point drying. HEMA itself was found to dehydrate the transmission electron microscopy blocks because it can copolymerize with the methacrylate-based embedding resin Lowicryl K4M. These 2 preparation techniques have allowed us to study calcium-phosphate crystal growth and cellular responses in vitro on these hydrogel biomaterials.
C1 FAC MED,LHEA,F-49045 ANGERS,FRANCE.
   SERV COMMUN MICROSCOPIE ELECTON,ANGERS,FRANCE.
   CGU,LAB HISTOL EMBRYOL,ANGERS,FRANCE.
CR ACETARIN JD, 1986, J MICROSC-OXFORD, V143, P81, DOI 10.1111/j.1365-2818.1986.tb02766.x
   ARMBRUSTER BL, 1982, J MICROSC-OXFORD, V126, P77, DOI 10.1111/j.1365-2818.1982.tb00358.x
   BECKSTEAD JH, 1981, BLOOD, V57, P1088
   BENNETT HS, 1976, STAIN TECHNOL, V51, P71, DOI 10.3109/10520297609116677
   BRADBEER JN, 1992, J BONE MINER RES, V7, P905
   CASWELL AM, 1991, CRIT REV CL LAB SCI, V28, P175, DOI 10.3109/10408369109106862
   CHAPPARD D, 1983, STAIN TECHNOL, V58, P299, DOI 10.3109/10520298309066802
   FILMON R, IN PRESS CELLS MAT
   GLAUERT AM, 1965, TECHNICS ELECT MICRO
   MONTHEARD JP, 1992, J MACROMOL SCI R M C, VC32, P1, DOI 10.1080/15321799208018377
   MONTHEARD JP, 1997, DESK REFERENCE FUNCT, P669
   PINCHUK L, 1984, J BIOMED MATER RES, V18, P671, DOI 10.1002/jbm.820180608
   SMETANA K, 1992, BIOMATERIALS, V13, P639, DOI 10.1016/0142-9612(92)90033-K
   WUTHIER RE, 1982, CLIN ORTHOP RELAT R, V169, P219
   YAMADA S, 1994, J BIOMED MATER RES, V28, P1357, DOI 10.1002/jbm.820281114
NR 15
TC 6
Z9 6
U1 0
U2 3
PU NATL SOC HISTOTECHNOLOGY
PI BOWIE
PA 4201 NORTHVIEW DR, STE 502, BOWIE, MD 20716-1073
SN 0147-8885
J9 J HISTOTECHNOL
JI J. Histotechnol.
PD DEC
PY 1997
VL 20
IS 4
BP 343
EP 346
PG 4
WC Cell Biology
SC Cell Biology
GA YJ241
UT WOS:A1997YJ24100008
DA 2018-10-20
ER

PT J
AU Schober, A
   Schlingloff, G
   Thamm, A
   Kiel, HJ
   Tomandl, D
   Gebinoga, M
   Doring, M
   Kohler, JM
   Mayer, G
AF Schober, A
   Schlingloff, G
   Thamm, A
   Kiel, HJ
   Tomandl, D
   Gebinoga, M
   Doring, M
   Kohler, JM
   Mayer, G
TI System integration of microsystems chip elements in miniaturized
   automata for high-throughput synthesis and screening in biology,
   biochemistry and chemistry
SO MICROSYSTEM TECHNOLOGIES
LA English
DT Article
AB Microsystems recently have been introduced as tools for screening in modern chemistry, biochemistry and biology. It has been shown that new microsystems can be implemented in the biomedical laboratory by using the microsystemic approach for the sample carrier-the miniaturized microtiter plate ("the nanotiter plate")-or the production of nanodroplets with ink jetters and to integrate those systems in macrodevices like xyz tables and detection devices like CCD-cameras. We show in this paper that decisive problems of the approach-the evaporation problem and the problem of chemical/biochemical/biological compatibility of the assays and the used materials can be solved successfully. It is possible to realize chemical synthesis in miniaturized flow systems and to perform isothermal amplification of RNA in silicon wafers. Furthermore real high throughput screening with in vivo systems can be performed and all relevant parameters as evaporation, pipetting and detection can be controlled on reasonable time scales.
C1 Inst Mol Biotechnol eV, D-07745 Jena, Germany.
   EVOTEC Biosyst GmbH, D-22529 Hamburg, Germany.
   Fa Microdrop, D-22844 Norderstedt, Germany.
   Inst Phys High Technol eV, D-07745 Jena, Germany.
RP Schober, A (reprint author), Inst Mol Biotechnol eV, Beutenbergstr 11, D-07745 Jena, Germany.
CR BOREGO B, 1995, NUCL ACIDS RES, V23
   EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740
   Gebinoga M, 1996, EUR J BIOCHEM, V235, P256, DOI 10.1111/j.1432-1033.1996.00256.x
   GEBINOGA M, 1995, UNPUB ENDOCYTOBI SEP
   KOHLER JM, 1996, MICROSYSTEMS TECHNOL
   KOHLER JM, 1995, MICROSYST TECHNOL, V1, P202
   KOPPEL DE, 1994, BIOPHYS J, V66, P502
   Schena M., 1995, SCIENCE, V270
   SCHOBER A, 1993, BIOL CYBERN, V69, P493, DOI 10.1007/BF01185421
   SCHOBER A, 1995, MICROSYST TECHNOL, V1, P168
   SCHOBER A, 1993, Patent No. 02173
   Tomandl D, 1997, J COMPUT AID MOL DES, V11, P29, DOI 10.1023/A:1008071310472
NR 12
TC 48
Z9 48
U1 1
U2 3
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0946-7076
J9 MICROSYST TECHNOL
JI Microsyst. Technol.
PD DEC
PY 1997
VL 4
IS 1
BP 35
EP 39
DI 10.1007/s005420050089
PG 5
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Materials Science;
   Physics
GA YN076
UT WOS:000071130700010
DA 2018-10-20
ER

PT J
AU McMillen, BA
AF McMillen, BA
TI Going forward or in reverse with GABA neurotransmission: Reviews and
   comments on alcohol research
SO ALCOHOL
LA English
DT Article
ID ETHANOL; INTOXICATION; DEPENDENCE; RO15-4513
AB This section of the journal is designed to provide readers with reviews of recent literature, and to stimulate research on ques tions that are important in the treatment and prevention of alcohol addiction. Research can provide insight into the causes of alcohol abuse and addiction, as well as answers to questions concerning the biomedical and psychological consequences of alcohol consumption. The ideas and critique expressed ir. this department are those of the author and do not necessarily represent the views of the editor, editorial board, or publisher of Alcohol. Reference to the original articles is recommended before quoting any of this material in scientific publications.
C1 E CAROLINA UNIV,DEPT PHARMACOL,SCH MED,GREENVILLE,NC 27858.
RP McMillen, BA (reprint author), E CAROLINA UNIV,CTR ALCOHOL & DRUG ABUSE STUDIES,SCH MED,GREENVILLE,NC 27858, USA.
CR DURCAN MJ, 1989, PHARMACOL BIOCHEM BE, V32, P667, DOI 10.1016/0091-3057(89)90015-4
   GALLIMBERTI L, 1992, ALCOHOL CLIN EXP RES, V16, P673, DOI 10.1111/j.1530-0277.1992.tb00658.x
   JUNE HL, 1991, ALCOHOL CLIN EXP RES, V15, P406, DOI 10.1111/j.1530-0277.1991.tb00538.x
   LISTER RG, 1989, LIFE SCI, V44, P111, DOI 10.1016/0024-3205(89)90528-6
   LISTER RG, 1989, BRAIN RES, V482, P141, DOI 10.1016/0006-8993(89)90551-9
   MICZEK KA, 1987, SCIENCE, V235, P1127
   SUZDAK PD, 1988, J PHARMACOL EXP THER, V245, P880
   Whitworth AB, 1996, LANCET, V347, P1438, DOI 10.1016/S0140-6736(96)91682-7
NR 8
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0741-8329
J9 ALCOHOL
JI Alcohol
PD NOV-DEC
PY 1997
VL 14
IS 6
BP 623
EP 625
DI 10.1016/S0741-8329(97)00081-5
PG 3
WC Substance Abuse; Pharmacology & Pharmacy; Toxicology
SC Substance Abuse; Pharmacology & Pharmacy; Toxicology
GA YG467
UT WOS:A1997YG46700016
DA 2018-10-20
ER

PT J
AU Pollnau, M
AF Pollnau, M
TI The route toward a diode-pumped 1-W erbium 3-mu m fiber laser
SO IEEE JOURNAL OF QUANTUM ELECTRONICS
LA English
DT Article
DE diode-pumped lasers; infrared lasers; laser biomedical applications;
   optical fiber lasers; rare earth lasers
ID EXCITED-STATE ABSORPTION; 3 MU-M; CASCADE LASER; UP-CONVERSION; OUTPUT
   POWER; OPERATION; ER-LIYF4; CRYSTAL
AB A rate-equation analysis of the erbium 3-mu m ZBLAN fiber laser is performed, The computer calculation includes the longitudinal spatial resolution of the host material, It considers ground-state bleaching, excited-state absorption (ESA), interionic processes, lifetime quenching by co-doping, and stimulated emission at 2.7 mu m and 850 nm, State-of-the-art technology including double-clad diode pumping is assumed in the calculation, Pump ESA is identified as the major problem of this laser, With high Er3+ concentration, suitable Pr3+ co-doping, and low pump density, ESA is avoided and a diode-pumped erbium 3-mu m ZBLAN laser is predicted which is capable of emitting a transversely single-mode output power of 1.0 W when pumped with 7-W incident power at 800 nm, The corresponding output intensity which is relevant for surgical applications will be in the range of 1.8 MW/cm(2), Compared to Ti:sapphire-pumped cascade-lasing regimes, the proposed approach represents a strong decrease of the requirements on mirror coatings, cavity alignment, and especially pump intensity, Of the possible drawbacks investigated in the simulation, only insufficient lifetime quenching is found to have a significant influence on laser performance.
C1 UNIV BERN,INST APPL PHYS,CH-3012 BERN,SWITZERLAND.
CR BEDO S, 1995, ELECTRON LETT, V31, P199, DOI 10.1049/el:19950151
   BEDO S, 1995, OPT COMMUN, V116, P81, DOI 10.1016/0030-4018(95)00040-F
   CHOU H, 1989, OSA P SERIES, V5, P167
   Clarkson WA, 1996, OPT LETT, V21, P375, DOI 10.1364/OL.21.000375
   ESTEROWITZ L, 1991 TECH DIG SER, P160
   ESTEROWITZ L, 1989, SPIE INFRARED FIBER, V1048, P129
   FRIEL GJ, 1996 OSA TECH DIG SE, V9, P144
   GHISLER C, 1995, ELECTRON LETT, V31, P373, DOI 10.1049/el:19950276
   ITH M, 1994, APPL PHYS B-LASERS O, V59, P621, DOI 10.1007/BF01081183
   JACQUES SL, 1991, SPIE LASER TISSUE IN, V1427, P63
   Jensen T, 1996, OPT LETT, V21, P585, DOI 10.1364/OL.21.000585
   JENSEN T, 1996, ADV SOLID STATE LASE, P265
   KNOWLES DS, 1992, IEEE J QUANTUM ELECT, V28, P1197, DOI 10.1109/3.135247
   MUENDEL MH, 1996 OSA TECH DIG SE, V9, P209
   POLLNAU M, 1994, PHYS REV A, V49, P3990, DOI 10.1103/PhysRevA.49.3990
   Pollnau M, 1996, APPL PHYS B-LASERS O, V62, P339, DOI 10.1007/BF01081195
   POLLNAU M, 1992, APPL PHYS A-MATER, V54, P404, DOI 10.1007/BF00324164
   POLLNAU M, 1995, APPL PHYS LETT, V66, P3564, DOI 10.1063/1.113788
   Pollnau M, 1997, J OPT SOC AM B, V14, P974, DOI 10.1364/JOSAB.14.000974
   Pollnau M, 1997, OPT LETT, V22, P612, DOI 10.1364/OL.22.000612
   Pollnau M, 1996, IEEE J QUANTUM ELECT, V32, P657, DOI 10.1109/3.488840
   POLLNAU M, C LAS EL OPT EUR 199, P132
   Prokhorov AM, 1993, LASER PHYS, V3, P79
   QUIMBY RS, 1989, APPL OPTICS, V28, P14, DOI 10.1364/AO.28.000014
   QUIMBY RS, 1991, SPIE FIBER LASER SOU, V1581, P72
   SCHNEIDER J, 1994, INT J INFRARED MILLI, V15, P1907, DOI 10.1007/BF02096058
   WETENKAMP L, 1992, J NON-CRYST SOLIDS, V140, P25, DOI 10.1016/S0022-3093(05)80735-5
   WETENKAMP L, 1991, THESIS TU BRAUNSCHWE
   Wyss C, 1997, OPT COMMUN, V139, P215, DOI 10.1016/S0030-4018(97)00130-2
   ZELLMER H, 1995, OPT LETT, V20, P578, DOI 10.1364/OL.20.000578
   ZEMON S, 1990, SPIE P, V1373, P21
NR 31
TC 41
Z9 43
U1 1
U2 9
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394
SN 0018-9197
J9 IEEE J QUANTUM ELECT
JI IEEE J. Quantum Electron.
PD NOV
PY 1997
VL 33
IS 11
BP 1982
EP 1990
DI 10.1109/3.641313
PG 9
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA YC838
UT WOS:A1997YC83800010
DA 2018-10-20
ER

PT J
AU Bendel, LP
   Shellock, FG
   Steckel, M
AF Bendel, LP
   Shellock, FG
   Steckel, M
TI The effect of mechanical deformation on magnetic properties and MRI
   artifacts of type 304 and type 316L stainless steel
SO JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING
LA English
DT Article
DE stainless steel; MRI; deformation
ID EX-VIVO EVALUATION; METALLIC IMPLANTS; FERROMAGNETISM; SYSTEM; DEVICES;
   STENTS
AB The purpose of this study was to evaluate the influence of composition and deformation of biomedical stainless steels on mechanical properties, magnetic properties, and MRI artifacts. Type 304 and Type 316L samples were prepared using standard wire-drawing techniques. Mechanical properties were determined using standard test methods. The amount of ferromagnetic phase present was estimated using a Severn Gage and x-ray diffraction. Magnetic field attraction and artifacts were determined using previously described techniques. The strength of both steels increased significantly with increasing deformation. None of the type 316L wires transformed to the magnetic phase. The amount of magnetic phase in the type 304 wires increased with increasing deformation. There was no magnetic field attraction, and artifacts were minimal for all of type 316L wires and the undeformed type 304 wire. Deflection and artifacts were significant for the deformed type 304 stainless steel. These results provide guidance regarding the use of type 304 and type 316L stainless steels for bioimplants. In this regard, type 316L stainless steel seems to be a more acceptable material with respect to MR compatibility.
C1 Mat Technol Associates, Lebanon, NJ 08833 USA.
RP Bendel, LP (reprint author), Mat Technol Associates, 2 Country Hill Rd, Lebanon, NJ 08833 USA.
CR [Anonymous], 1995, ANN BOOK ASTM STAND
   BARDOS DI, 1977, HDB STAINLESS STEEL
   BELLON EM, 1986, AM J ROENTGENOL, V147, P1271, DOI 10.2214/ajr.147.6.1271
   DAVIS JR, 1994, ASM SPECIALTY HDB ST, P498
   DUJOVNY M, 1985, NEUROSURGERY, V17, P543, DOI 10.1227/00006123-198510000-00002
   FAGAN LL, 1995, JMRI-J MAGN RESON IM, V5, P614
   HOKE JH, 1977, HDB STAINLESS STEEL
   LAAKMAN RW, 1985, RADIOLOGY, V157, P711, DOI 10.1148/radiology.157.3.4059558
   MATSUMOTO AH, 1989, RADIOLOGY, V170, P753, DOI 10.1148/radiology.170.3.2916029
   MECHLIN M, 1984, AM J ROENTGENOL, V143, P1281, DOI 10.2214/ajr.143.6.1281
   MOSCATEL MA, 1995, JMRI-J MAGN RESON IM, V5, P369, DOI 10.1002/jmri.1880050324
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   SHELLOCK FG, 1994, J MAGN RESON IMAGING, V4, P756, DOI 10.1002/jmri.1880040521
   SHELLOCK FG, 1994, MAGNETIC RESONANCE B
   SHELLOCK FG, 1996, POCKET GUIDE MR PROC
   TEITELBAUM GP, 1988, RADIOLOGY, V166, P657, DOI 10.1148/radiology.166.3.3340759
   TEITELBAUM GP, 1990, AM J NEURORADIOL, V11, P267
NR 18
TC 13
Z9 13
U1 0
U2 2
PU SOC MAGNETIC RESONANCE IMAGING
PI EASTON
PA 1991 NORTHAMPTON ST, EASTON, PA 18042-3189 USA
SN 1053-1807
J9 JMRI-J MAGN RESON IM
JI JMRI-J. Magn. Reson. Imaging
PD NOV-DEC
PY 1997
VL 7
IS 6
BP 1170
EP 1173
DI 10.1002/jmri.1880070635
PG 4
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 102UU
UT WOS:000074944300032
PM 9400866
DA 2018-10-20
ER

PT J
AU Doillon, CJ
   Drouin, R
   Cote, MF
   Dallaire, N
   Pageau, JF
   Laroche, G
AF Doillon, CJ
   Drouin, R
   Cote, MF
   Dallaire, N
   Pageau, JF
   Laroche, G
TI Chemical inactivators as sterilization agents for bovine collagen
   materials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE collagen materials; chemical inactivators; sterilization; prion; nucleic
   acids
ID SCRAPIE; SKIN; CONTRACTION; INFECTIVITY; INVITRO; PROTEIN; TISSUE
AB The use of collagen as a biomedical implant raises safety issues with regard to viruses and prions. Specific chemical agents that inactivate prion infectivity could be applied to collagen implants. The physicochemical changes and the in vitro and in vivo biocompatibility of collagen treated by formic acid (FA), trifluoroacetic acid (TFA), tetrafluoroethanol (TFE), and hexafluoroisopropanol (HFIP) were investigated. In addition, the effects of these treatments on nucleic acids incorporated in collagen were analyzed. The molecules of FA and, more important, of TFA remained within collagen. FA, TFA and HFIP treatments modify the secondary structure of collagen, as shown by Fourier transform infrared spectroscopy, while TFE does not. Differential scanning calorimetry measurements showed a decrease in the denaturation temperature compared to untreated collagen. However, resistance to collagenase was modified only after HFIP treatment. In vitro, cell growth was not impaired; in vivo, implants induced a temporary inflammatory reaction that was prolonged with TFA and HFIP treatments. TFE and FA-treated collagen were thoroughly infiltrated by fibroblasts. On the other hand, FA and TFA resulted in extensive depurination of nucleic acids while HFIP and TFE did so to a lesser degree. Among the investigated chemical scrapie inactivators, FA treatment could offer a safe and biocompatible collagen-derived material for biomedical use. (C) 1997 John Wiley & Sons, Inc.
C1 UNIV LAVAL,DEPT SURG,LAVAL,PQ,CANADA.
   HOSP ST FRANCOIS ASSISE,RES UNIT HUMAN GENET,QUEBEC CITY,PQ G1L 3L5,CANADA.
   UNIV LAVAL,DEPT PATHOL,LAVAL,PQ,CANADA.
RP Doillon, CJ (reprint author), HOSP ST FRANCOIS ASSISE,INST BIOMAT E0 178,10 ESPINAY,QUEBEC CITY,PQ G1L 3L5,CANADA.
CR BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   BERG RA, 1982, METHOD ENZYMOL, V82, P372
   BROWN DM, 1974, BASIC PRINCIPLES NUC, V2, P1
   BROWN P, 1990, J INFECT DIS, V161, P467, DOI 10.1093/infdis/161.3.467
   COTE MF, 1992, J BIOMAT SCI-POLYM E, V3, P301, DOI 10.1163/156856292X00394
   DEBLOIS C, 1994, BIOMATERIALS, V15, P665, DOI 10.1016/0142-9612(94)90164-3
   DOILLON CJ, 1985, SCANNING ELECT MICRO, V2, P897
   Drouin Regen, 1996, P37
   ELLENDER G, 1994, CLIN MAT, V9, P201
   ELLWART JW, 1990, CYTOMETRY, V11, P239, DOI 10.1002/cyto.990110204
   GRIFFITHS PR, 1986, TRAC-TREND ANAL CHEM, V5, P209, DOI 10.1016/0165-9936(86)80015-2
   KAJAVA AV, 1991, J MOL BIOL, V218, P815, DOI 10.1016/0022-2836(91)90269-C
   KEEFE J, 1994, CLIN MAT, V9, P155
   KLUNK WE, 1994, J NEUROCHEM, V62, P349
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   LAZAREV YA, 1985, BIOPOLYMERS, V24, P1449, DOI 10.1002/bip.360240804
   LEE JM, 1995, MED ENG PHYS, V17, P115, DOI 10.1016/1350-4533(95)91882-H
   LILLIE JH, 1977, J ULTRA MOL STRUCT R, V58, P134, DOI 10.1016/S0022-5320(77)90025-9
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P33
   MIYATAT, 1994, CLIN MAT, V9, P139
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   PRUSINER SB, 1994, P NATL ACAD SCI USA, V91, P4611, DOI 10.1073/pnas.91.11.4611
   PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762
   Ramachandran G.N., 1967, TREATISE COLLAGEN, P103
   ROSENBERG RN, 1986, ANN NEUROL, V19, P75, DOI 10.1002/ana.410190113
   SAFAR J, 1993, PROTEIN SCI, V2, P2206, DOI 10.1002/pro.5560021220
   Sambrook J, 1989, MOL CLONING LAB MANU
   TATEISHI J, 1988, ANN NEUROL, V24, P466, DOI 10.1002/ana.410240325
   VEIS A, 1964, MACROMOLECULAR CHEM, V5
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
   YOSHIZATO K, 1994, MAT SCI ENG C-BIOMIM, V1, P95, DOI 10.1016/0928-4931(94)90061-2
NR 31
TC 22
Z9 22
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD NOV
PY 1997
VL 37
IS 2
BP 212
EP 221
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA YD952
UT WOS:A1997YD95200010
PM 9358314
DA 2018-10-20
ER

PT J
AU Meurman, JH
   Pyrhonen, S
   Teerenhovi, L
   Lindqvist, C
AF Meurman, JH
   Pyrhonen, S
   Teerenhovi, L
   Lindqvist, C
TI Oral sources of septicaemia in patients with malignancies
SO ORAL ONCOLOGY
LA English
DT Article
DE bacterial infections; septicaemia; mouth diseases; immunosuppression;
   antineoplastic agents; cancer; xerostomia; oral health care
ID ACUTE MYELOID-LEUKEMIA; REMISSION-INDUCTION THERAPY; BONE-MARROW
   TRANSPLANTATION; RECEIVING CYTOSTATIC DRUGS; IMMUNOCOMPROMISED PATIENTS;
   HEMATOLOGIC MALIGNANCIES; PATHOGENIC MICROORGANISMS; MICROBIOLOGICAL
   FINDINGS; PERIODONTAL INFECTION; FEBRILE EPISODES
AB This article reviews papers dealing with oral infections of adult septicaemia patients, searched from MEDLINE, Current Contents and Core Biomedical Collection databases from January 1966 to November 1996. Case reports were excluded. The systematic review of literature revealed that our knowledge of the topic is mostly based on very small patient material. There are no multicentre studies on the effects of various oral health treatment modes on the prevention of septicaemia of oral origin. The number of controlled and comparative studies on the efficacy of the different treatment protocols of oral infections is also small. Current recommendations in this respect are mainly empirical and not evidence based. Clinical practice guidelines are therefore urgently needed. Nevertheless, close co-operation between oncological and oral health units is emphasised because many studies have shown that the oral cavity is indeed an important source of bacteraemia. Life-threatening infections may follow if maintenance of oral health is neglected during anticancer therapy and if potential oral infection foci are left untreated before immunosuppressive therapy. (C) 1997 Elsevier Science Ltd. All rights reserved.
C1 Univ Helsinki, Inst Dent, Helsinki, Finland.
   Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland.
   Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Surg, Helsinki, Finland.
RP Meurman, JH (reprint author), Univ Helsinki, Inst Dent, Helsinki, Finland.
OI Meurman, Jukka/0000-0001-6702-6836
CR BARRETT AP, 1987, ORAL SURG ORAL MED O, V63, P424, DOI 10.1016/0030-4220(87)90253-2
   BERGMANN OJ, 1988, J CLIN MICROBIOL, V26, P2105
   BERGMANN OJ, 1990, SCAND J INFECT DIS, V22, P353, DOI 10.3109/00365549009027059
   BERGMANN OJ, 1991, SCAND J INFECT DIS, V23, P355, DOI 10.3109/00365549109024323
   BERGMANN OJ, 1989, SCAND J INFECT DIS, V21, P43, DOI 10.3109/00365548909035679
   BERGMANN OJ, 1992, DAN MED BULL, V39, P15
   BERGMANN OJ, 1990, EUR J HAEMATOL, V44, P296
   BERGMANN OJ, 1989, EUR J CLIN MICROBIOL, V8, P207, DOI 10.1007/BF01965262
   BERGMANN OJ, 1992, J CLIN PERIODONTOL, V19, P169, DOI 10.1111/j.1600-051X.1992.tb00634.x
   BROWN LR, 1978, J DENT RES, V57, P882, DOI 10.1177/00220345780570090901
   CARL W, 1986, Seminars in Surgical Oncology, V2, P187, DOI 10.1002/ssu.2980020402
   Dawes C., 1996, SALIVA ORAL HLTH, V2, P27
   DEPAOLA L G, 1986, Journal of the American Dental Association, V112, P198
   Dreizen S, 1990, NCI Monogr, P11
   DREIZEN S, 1992, POSTGRAD MED, V91, P349
   DREIZEN S, 1986, ORAL SURG ORAL MED O, V62, P650, DOI 10.1016/0030-4220(86)90258-6
   DREIZEN S, 1983, ORAL SURG ORAL MED O, V55, P1113
   DREIZEN S, 1992, POSTGRAD MED, V91, P353
   DREIZEN S, 1992, POSTGRAD MED, V91, P357
   DUGGAN JM, 1985, J HOSP INFECT, V6, P406, DOI 10.1016/0195-6701(85)90057-X
   Edgar WM, 1990, SALIVA DENT HLTH
   ELLEGAARD B, 1989, J ORAL PATHOL MED, V18, P54, DOI 10.1111/j.1600-0714.1989.tb00734.x
   EPSTEIN JB, 1992, ORAL SURG ORAL MED O, V73, P682, DOI 10.1016/0030-4220(92)90009-F
   Fine DH, 1996, J AM DENT ASSOC, V127, P641, DOI 10.14219/jada.archive.1996.0276
   HEIMDAHL A, 1985, J CLIN MICROBIOL, V22, P299
   HEIMDAHL A, 1990, ACTA ODONTOL SCAND, V48, P77, DOI 10.3109/00016359009012737
   HEIMDAHL A, 1985, CHEMIOTERAPIA, V4, P186
   HEIMDAHL A, 1990, J CLIN PERIODONTOL, V17, P501
   HEIMDAHL A, 1990, J CLIN MICROBIOL, V28, P12
   KEENE HJ, 1987, ORAL SURG ORAL MED O, V64, P421, DOI 10.1016/0030-4220(87)90146-0
   KOSTIALA I, 1982, CURR THER RES CLIN E, V31, P752
   LAINE P, 1993, J CLIN PERIODONTOL, V20, P628, DOI 10.1111/j.1600-051X.1993.tb00707.x
   LAINE P, 1992, ORAL ONCOL, V28B, P125
   LAINE P, 1993, ORAL FINDINGS LYMPHO
   LAINE PO, 1992, ORAL ONCOL, V28B, P103
   LAWSON RD, 1980, CURR THER RES CLIN E, V27, P774
   MAKKONEN TA, 1986, ORAL SURG ORAL MED O, V62, P270, DOI 10.1016/0030-4220(86)90007-1
   MAKKONEN TA, 1989, BRIT J ORAL MAX SURG, V27, P334, DOI 10.1016/0266-4356(89)90048-X
   MANDEL ID, 1980, CRC CR REV CL LAB SC, V12, P321, DOI 10.3109/10408368009108733
   Maxymiw W G, 1989, J Can Dent Assoc, V55, P193
   MCELROY TH, 1984, J AM DENT ASSOC, V109, P454, DOI 10.14219/jada.archive.1984.0406
   MEURMAN JH, 1991, ORAL MICROBIOL IMMUN, V6, P177, DOI 10.1111/j.1399-302X.1991.tb00473.x
   MEURMAN JH, 1991, J CLIN PERIODONTOL, V18, P587, DOI 10.1111/j.1600-051X.1991.tb00094.x
   MEURMAN JH, 1994, ORAL ONCOL, V30B, P204
   MEURMAN JH, 1995, EUR J ORAL SCI, V103, P253, DOI 10.1111/j.1600-0722.1995.tb00169.x
   NAUM BJ, 1985, J SPECIAL CARE DENT, V5, P274
   NEWMAN HN, 1992, J DENT RES, V71, P1854, DOI 10.1177/00220345920710111801
   NIKOSKELAINEN J, 1990, J CLIN PERIODONTOL, V17, P504
   OLMOS RAV, 1994, CANCER, V73, P2886
   OTIS LL, 1985, ORAL SURG ORAL MED O, V60, P125, DOI 10.1016/0030-4220(85)90228-2
   OVERHOLSER CD, 1982, ARCH INTERN MED, V142, P551, DOI 10.1001/archinte.142.3.551
   PETERSON DE, 1987, J CLIN ONCOL, V5, P1461, DOI 10.1200/JCO.1987.5.9.1461
   PETERSON DE, 1990, ORAL SURG ORAL MED O, V70, P720, DOI 10.1016/0030-4220(90)90007-F
   RONALD D, 1980, CURRENT THERAPEUTIC, V27, P774
   Sackett DL, 1996, EVIDENCE BASED MED, V1, P37
   Scully C, 1996, ORAL ONCOL, V32B, P281
   Semba SE, 1994, COMPEND, V15, P1380
   Semba SE, 1994, COMPEND, V15, P1388
   SEMBS SE, 1994, COMPENDIUM, V14, P1378
   SPIJKERVET FKL, 1991, IRRADIATION MUCOSITI
   Sweeney MP, 1996, NT RES, V1, P389
   TOTH B B, 1983, Current Problems in Cancer, V7, P7, DOI 10.1016/S0147-0272(83)80011-7
   TOTH BB, 1990, J CLIN PERIODONTOL, V17, P508
   Uhari M, 1996, BRIT MED J, V313, P1180, DOI 10.1136/bmj.313.7066.1180
   VALDEZ IH, 1993, INT J RADIAT ONCOL, V25, P41, DOI 10.1016/0360-3016(93)90143-J
   WADE JC, 1982, ANN INTERN MED, V97, P503, DOI 10.7326/0003-4819-97-4-503
   WAHLIN YB, 1988, ORAL SURG ORAL MED O, V65, P411, DOI 10.1016/0030-4220(88)90354-4
   WEISDORF DJ, 1989, BONE MARROW TRANSPL, V4, P89
   WRIGHT WE, 1985, J AM DENT ASSOC, V110, P43, DOI 10.14219/jada.archive.1985.0292
   YEO E, 1985, J CLIN ONCOL, V3, P1668, DOI 10.1200/JCO.1985.3.12.1668
NR 70
TC 33
Z9 33
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0964-1955
J9 ORAL ONCOL
JI Oral Oncol.
PD NOV
PY 1997
VL 33
IS 6
BP 389
EP 397
DI 10.1016/S0964-1955(97)00032-8
PG 9
WC Oncology; Dentistry, Oral Surgery & Medicine
SC Oncology; Dentistry, Oral Surgery & Medicine
GA YR472
UT WOS:000071498700002
PM 9509121
DA 2018-10-20
ER

PT J
AU Schmitt, JM
   Lee, SL
   Yung, KM
AF Schmitt, JM
   Lee, SL
   Yung, KM
TI An optical coherence microscope with enhanced resolving power in thick
   tissue
SO OPTICS COMMUNICATIONS
LA English
DT Article
DE microscopy; tomography; interferometry; biomedical optics
ID TOMOGRAPHY; LIGHT
AB A new configuration of an optical coherence microscope for high-resolution imaging of biological tissues and other scattering materials is described. The microscope employs multiple sources and detectors combined with high-numerical-aperture optics to suppress speckle fluctuations and enhance resolution. Results of experiments on living tissue and tissue phantoms are presented to demonstrate the design principles of the microscope and to compare its performance to that of a conventional optical coherence microscope. (C) 1997 Elsevier Science B.V.
RP Schmitt, JM (reprint author), HONG KONG UNIV SCI & TECHNOL,DEPT ELECT & ELECT ENGN,CLEAR WATER BAY,KOWLOON,HONG KONG.
CR BOUMA B, 1995, OPT LETT, V20, P1486, DOI 10.1364/OL.20.001486
   BURCKHARDT CB, 1978, IEEE T SON ULTRASON, V25, P1
   CHAN KP, 1992, APPL OPTICS, V31, P1505, DOI 10.1364/AO.31.001505
   CLIVAZ X, 1995, P SOC PHOTO-OPT INS, V2083, P338
   FERCHER AF, 1988, OPT LETT, V13, P186, DOI 10.1364/OL.13.000186
   FUJIMOTO JG, 1995, NAT MED, V1, P970, DOI 10.1038/nm0995-970
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   PULIAFITO CA, 1995, OPHTHALMOLOGY, V102, P217
   RAO YJ, 1993, OPT LETT, V18, P462, DOI 10.1364/OL.18.000462
   SCHMITT JM, 1994, PHYS MED BIOL, V39, P1705, DOI 10.1088/0031-9155/39/10/013
   SCHMITT JM, 1995, DERMATOLOGY, V191, P93, DOI 10.1159/000246523
   SCHMITT JM, IN PRESS J OPT SOC A
   SWANSON EA, 1992, OPT LETT, V17, P151, DOI 10.1364/OL.17.000151
   Tearney GJ, 1996, OPT LETT, V21, P543, DOI 10.1364/OL.21.000543
NR 14
TC 127
Z9 128
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0030-4018
J9 OPT COMMUN
JI Opt. Commun.
PD OCT 15
PY 1997
VL 142
IS 4-6
BP 203
EP 207
DI 10.1016/S0030-4018(97)00280-0
PG 5
WC Optics
SC Optics
GA YB814
UT WOS:A1997YB81400009
DA 2018-10-20
ER

PT J
AU Grady, RE
   Wass, CT
   Maus, TP
   Felmlee, JP
AF Grady, RE
   Wass, CT
   Maus, TP
   Felmlee, JP
TI Fiberoptic intracranial pressure monitoring during magnetic resonance
   imaging
SO ANESTHESIOLOGY
LA English
DT Article
DE biocompatible material, chemistry, metals; magnetic resonance imaging,
   adverse effects, contraindications; material testing; radiofrequency
ID BIOMEDICAL IMPLANTS; DEVICES
C1 MAYO CLIN & MAYO GRAD SCH MED,DEPT ANESTHESIOL,ROCHESTER,MN 55905.
   MAYO CLIN & MAYO GRAD SCH MED,DEPT RADIOL,ROCHESTER,MN 55905.
CR BARNETT GH, 1988, J NEUROSURG, V68, P246, DOI 10.3171/jns.1988.68.2.0246
   ELSTER AD, 1994, AM J ROENTGENOL, V162, P195, DOI 10.2214/ajr.162.1.8273665
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   SHELLOCK FG, 1991, RADIOLOGY, V180, P541, DOI 10.1148/radiology.180.2.2068325
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   SHELLOCK FG, 1993, RADIOLOGY, V189, P587, DOI 10.1148/radiology.189.2.8210394
   TOBIAS M, 1994, ANESTHESIA NEUROSURG, P435
NR 7
TC 2
Z9 2
U1 0
U2 0
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0003-3022
J9 ANESTHESIOLOGY
JI Anesthesiology
PD OCT
PY 1997
VL 87
IS 4
BP 1001
EP 1003
DI 10.1097/00000542-199710000-00042
PG 3
WC Anesthesiology
SC Anesthesiology
GA YD117
UT WOS:A1997YD11700042
PM 9357910
DA 2018-10-20
ER

PT J
AU Bernatchez, SF
   Atkinson, MR
   Parks, PJ
AF Bernatchez, SF
   Atkinson, MR
   Parks, PJ
TI Expression of intercellular adhesion molecule-1 on macrophages in vitro
   as a marker of activation
SO BIOMATERIALS
LA English
DT Article
DE macrophages; cytokines; cell surface markers; activation; polylactic
   acid
ID TUMOR-NECROSIS-FACTOR; BIOMEDICAL POLYMERS; HUMAN-MONOCYTES; IN-VITRO;
   IMMUNOMODULATORS IMIQUIMOD; INTERLEUKIN-1 GENERATION; CYTOKINE
   PRODUCTION; TISSUE DISTRIBUTION; INTERFERON-GAMMA; FACTOR-ALPHA
AB Macrophage activation is a major component of wound healing. It also determines the extent of inflammatory reactions and the response of the body to implanted materials. We have previously shown, using an in vitro model, that the extent of spreading of macrophages on different materials is a marker of activation, and that a soluble inducer has a dose-response effect on the secretion of cytokines in the culture medium. This work investigates the expression of three different cell surface markers [macrophages MAC-1, MAC-3 and intercellular adhesion molecule-1 (ICAM-1)] on macrophages in vitro using confocal microscopy and shows that ICAM-1 is also a marker of macrophage activation in this model. We observed increased amounts of ICAM-1 on activated macrophages compared to unactivated macrophages, whereas MAC-1 and MAC-3 were either expressed constitutively or demonstrated no quantitative change in expression after activation under the same experimental conditions. We also tested the expression of ICAM-1 with various concentrations of soluble inducers (lipopolysaccharide, 0.001, 0.01, 0.1, 1 and 10 mu g ml(-1); S-27609, 0.1, 0.25, 0.5, 1, 2 and 3 mu g ml(-1)) and on a sheet of polylactic acid alone or in combination with soluble inducers. All doses of soluble inducers induced the expression of ICAM-1 on cells grown in glass chamber slides. The induction was not dose related but seemed to work rather in an on-off manner. There was no effect of material on ICAM-1 expression on the cell surface when no soluble inducer was added. This was similar to cytokine secretion, which was not induced by our material alone. When either lipopolysaccharide or S-27609 was used in combination with the material, there was an increase in the average measured intensity of ICAM-1. In this in vitro model, ICAM-1 staining as measured by confocal microscopy is a marker for macrophage activation. Our results suggest that the extent of macrophage activation as measured by ICAM-1 and by cytokine secretion is more sensitive to soluble inducers than to the action of the flat sheet of polylactic acid. (C) 1997 Elsevier Science Limited. All rights reserved.
C1 LIFE SCI SECTOR LAB, ST PAUL, MN 55144 USA.
   ANALYT & PROPERTIES RES LABS, ST PAUL, MN 55144 USA.
RP Bernatchez, SF (reprint author), UNIV MINNESOTA, CTR INTERFACIAL ENGN, SHEPHERD LABS 187, 100 UNION ST SE, MINNEAPOLIS, MN 55455 USA.
CR ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   BEHLING CA, 1986, J BIOMED MATER RES, V20, P653, DOI 10.1002/jbm.820200509
   Bernatchez SF, 1996, BIOMATERIALS, V17, P2077, DOI 10.1016/0142-9612(96)00014-2
   BOCK E, 1991, BIOCHEM SOC T, V19, P1076, DOI 10.1042/bst0191076
   BONFIELD TL, 1991, J BIOMED MATER RES, V25, P165, DOI 10.1002/jbm.820250204
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P457, DOI 10.1002/jbm.820260404
   BRANDWOOD A, 1992, BIOMATERIALS, V13, P646, DOI 10.1016/0142-9612(92)90035-M
   BROWDER W, 1988, SURGERY, V104, P224
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   Chapekar MS, 1996, J BIOMED MATER RES, V31, P251, DOI 10.1002/(SICI)1097-4636(199606)31:2<251::AID-JBM12>3.0.CO;2-O
   DARVILLE T, 1992, IMMUNOL INVEST, V21, P539, DOI 10.3109/08820139209069389
   DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D
   DUBOIS CM, 1989, AM REV RESPIR DIS, V139, P1257, DOI 10.1164/ajrccm/139.5.1257
   DUSTIN ML, 1986, J IMMUNOL, V137, P245
   FRASER I, 1994, J IMMUNOL METHODS, V174, P95, DOI 10.1016/0022-1759(94)90013-2
   FRASER I, 1993, BLOOD CELL BIOCH, V5, P1
   GASPAR R, 1992, PHARM RES-DORDR, V9, P782, DOI 10.1023/A:1015807706530
   GIBSON SJ, 1995, J INTERF CYTOK RES, V15, P537, DOI 10.1089/jir.1995.15.537
   GORDON S, 1992, CURR OPIN IMMUNOL, V4, P25, DOI 10.1016/0952-7915(92)90119-Y
   HO MK, 1983, J BIOL CHEM, V258, P636
   HUNT TK, 1984, SURGERY, V96, P48
   JOHANSSON A, 1995, CELL IMMUNOL, V161, P61, DOI 10.1006/cimm.1995.1009
   JOHNSTON RB, 1988, NEW ENGL J MED, V318, P747, DOI 10.1056/NEJM198803243181205
   Kapur R, 1996, J BIOMED MATER RES, V32, P133
   KRIEGSMANN J, 1993, CELL MOL BIOL, V39, P791
   LAMBERT LE, 1989, CELL IMMUNOL, V120, P401, DOI 10.1016/0008-8749(89)90208-6
   LEAKE ES, 1975, J RETICULOENDOTH SOC, V17, P370
   LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1
   LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71
   LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0
   LEIBOVICH SJ, 1988, GROWTH FACTORS OTHER, P131
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MCANALLEY BH, 1994, Patent No. 5308838
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MILLER KM, 1989, BIOMATERIALS, V10, P187, DOI 10.1016/0142-9612(89)90023-9
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815
   POLVERINI PJ, 1977, NATURE, V269, P804, DOI 10.1038/269804a0
   PRIETO J, 1989, EUR J IMMUNOL, V19, P1551, DOI 10.1002/eji.1830190906
   PUEYO ME, 1993, J BIOMAT SCI-POLYM E, V5, P197
   REITER MJ, 1994, J LEUKOCYTE BIOL, V55, P234
   RICH A, 1981, J CELL SCI, V50, P1
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   SCHMIDT JA, 1991, BIOMATERIALS, V12, P385, DOI 10.1016/0142-9612(91)90006-V
   SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0
   SUZUKI Y, 1993, AGENTS ACTIONS, V38, P32, DOI 10.1007/BF02027210
   TABATA Y, 1988, J BIOMED MATER RES, V22, P837, DOI 10.1002/jbm.820221002
   TESTERMAN TL, 1995, J LEUKOCYTE BIOL, V58, P365
   THORENS B, 1987, CELL, V48, P671, DOI 10.1016/0092-8674(87)90245-5
   TIZARD I R, 1989, Molecular Biotherapy, V1, P290
   TREZZINI C, 1988, BIOCHEM BIOPH RES CO, V156, P477, DOI 10.1016/S0006-291X(88)80866-0
   UFF CR, 1995, BIOMATERIALS, V16, P355, DOI 10.1016/0142-9612(95)93852-5
   WYNN TA, 1992, CELL IMMUNOL, V140, P184, DOI 10.1016/0008-8749(92)90186-S
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
   Zenni G C, 1994, J Invest Surg, V7, P135, DOI 10.3109/08941939409015357
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 59
TC 17
Z9 17
U1 2
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 1997
VL 18
IS 20
BP 1371
EP 1378
DI 10.1016/S0142-9612(97)00072-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA YB250
UT WOS:A1997YB25000007
PM 9363337
DA 2018-10-20
ER

PT J
AU Moens, L
AF Moens, L
TI Applications of mass spectrometry in the trace element analysis of
   biological materials
SO FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 3rd Symposium on Mass Spectrometric Method of Elemental Trace Analysis
   and 12th ICP-MS Users Meeting
CY SEP 23-26, 1996
CL RES CTR, JULICH, GERMANY
HO RES CTR
ID INDUCTIVELY-COUPLED PLASMA; PERFORMANCE LIQUID-CHROMATOGRAPHY; CAPILLARY
   ELECTROPHORESIS; SPECTRAL INTERFERENCES; THERMAL IONIZATION; ISOTOPE
   RATIOS; HUMAN-SERUM; ION-SOURCE; ICP-MS; URINE
AB The importance of mass spectrometry for the analysis of biological material is illustrated by reviewing the different mass spectrometric methods applied and describing some typical applications published recently. Though atomic absorption spectrometry is used in the majority of analyses of biological material, most mass spectrometric methods have been used to some extent for trace element determination in biomedical research. The relative importance of the different methods is estimated by reviewing recent research papers. It is striking that especially inductively coupled plasma mass spectrometry is increasingly being applied, partly because the method can be used on-line after chromatographic separation, in speciation studies. Mass spectrometric methods prove to offer unique possibilities in stable isotope tracer studies and for this purpose also experimentally demanding methods such as thermal ionization mass spectrometry and accelerator mass spectrometry are frequently used.
RP Moens, L (reprint author), STATE UNIV GHENT,ANALYT CHEM LAB,PROEFTUINSTR 86,B-9000 GHENT,BELGIUM.
CR AGGARWAL SK, 1994, CRIT REV CL LAB SCI, V31, P35, DOI 10.3109/10408369409084673
   AGGARWAL SK, 1994, ANAL CHEM, V66, P1316, DOI 10.1021/ac00080a017
   AGGARWAL SK, 1992, ANAL BIOCHEM, V202, P367, DOI 10.1016/0003-2697(92)90120-V
   Begerow J, 1996, J ANAL ATOM SPECTROM, V11, P303, DOI 10.1039/ja9961100303
   BRADSHAW N, 1989, J ANAL ATOM SPECTROM, V4, P801, DOI 10.1039/ja9890400801
   CAREY JM, 1992, J ANAL ATOM SPECTROM, V7, P1173, DOI 10.1039/ja9920701173
   CREWS HM, 1994, ANALYST, V119, P2491, DOI 10.1039/an9941902491
   DeSmaele T, 1996, FRESEN J ANAL CHEM, V355, P778, DOI 10.1007/s0021663550778
   GIESSMANN U, 1994, FRESEN J ANAL CHEM, V350, P186, DOI 10.1007/BF00322469
   HEITKEMPER D, 1989, J ANAL ATOM SPECTROM, V4, P279, DOI 10.1039/ja9890400279
   HEUMANN KG, 1985, FRESEN Z ANAL CHEM, V320, P457, DOI 10.1007/BF00479812
   HOHL C, 1994, NUCL INSTRUM METH B, V92, P478, DOI 10.1016/0168-583X(94)96058-5
   JOHNSON RR, 1994, NUCL INSTRUM METH B, V92, P483, DOI 10.1016/0168-583X(94)96059-3
   Kinzer JA, 1996, ANAL CHEM, V68, P3250, DOI 10.1021/ac951143k
   LARSEN EH, 1993, J ANAL ATOM SPECTROM, V8, P557, DOI 10.1039/ja9930800557
   Lu QH, 1996, MICROCHEM J, V54, P129, DOI 10.1006/mchj.1996.0086
   MOENS L, 1995, J ANAL ATOM SPECTROM, V10, P569, DOI 10.1039/ja9951000569
   TAYLOR A, 1994, J ANAL ATOM SPECTROM, V9, pR87, DOI 10.1039/ja994090087r
   Taylor A, 1996, J ANAL ATOM SPECTROM, V11, pR103, DOI 10.1039/ja996110103r
   TAYLOR A, 1995, J ANAL ATOM SPECTROM, V10, pR61
   TURNLUND JR, 1993, ANAL CHEM, V65, P1717, DOI 10.1021/ac00061a014
   Vanhaecke F, 1996, ANAL CHEM, V68, P567, DOI 10.1021/ac9507247
   Vanhaecke F, 1997, ANAL CHEM, V69, P268, DOI 10.1021/ac960740j
   VANHOE H, 1994, J ANAL ATOM SPECTROM, V9, P177, DOI 10.1039/ja9940900177
   VANHOE H, 1995, TRACE ELEM ELECTROLY, V12, P81
   VANLOON JC, 1986, SPECTROSC LETT, V19, P1125, DOI 10.1080/00387018608069314
   VELA NP, 1993, ANAL CHEM, V65, pA585, DOI 10.1021/ac00061a002
   VERSIECK J, 1988, ANAL CHIM ACTA, V204, P63, DOI 10.1016/S0003-2670(00)86346-1
   VOGEL JS, 1994, NUCL INSTRUM METH B, V92, P445, DOI 10.1016/0168-583X(94)96052-6
   VOLLKOPF U, 1995, ATOM SPECTROSC, V16, P19
   WAIDMANN E, 1994, FRESEN J ANAL CHEM, V350, P293, DOI 10.1007/BF00322485
   WALDER AJ, 1992, J ANAL ATOM SPECTROM, V7, P571, DOI 10.1039/ja9920700571
NR 32
TC 26
Z9 27
U1 0
U2 6
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0937-0633
J9 FRESEN J ANAL CHEM
JI Fresenius J. Anal. Chem.
PD OCT-NOV
PY 1997
VL 359
IS 4-5
BP 309
EP 316
DI 10.1007/s002160050579
PG 8
WC Chemistry, Analytical
SC Chemistry
GA YC028
UT WOS:A1997YC02800002
DA 2018-10-20
ER

PT J
AU Schmit, BD
   Mortimer, JT
AF Schmit, BD
   Mortimer, JT
TI The tissue response to epimysial electrodes for diaphragm pacing in dogs
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Article
DE biological tissues; biomedical materials; implantable electrodes;
   nervous system; neuromuscular stimulation; prostheses/orthoses;
   respiratory system
ID INTRAMUSCULAR ELECTRICAL ACTIVATION; PHRENIC-NERVE; VENTILATORY SUPPORT;
   RIB CAGE; STIMULATION; QUADRIPLEGIA; SILICONE; IMPLANTS
AB Epimysial electrodes stapled to the abdominal surface of the diaphragm produced a chronic inflammatory response that appeared to be mediated by mechanical stresses placed on the encapsulation tissue by periodic diaphragm contraction, The tissue response surrounding 34 epimysial electrodes implanted in 11 dogs was studied three months post implant, The tissue response was characterized by a capsule having a mean thickness of 1.24 mm between the electrode and the muscle, while having only a very thin capsule on the back, or abdominal side of the electrode, The tissue response between the electrode and the muscle was comprised of two tissue layers: a layer of granulation tissue and a layer of collagen, The granulation tissue layer contained evidence of acute inflammatory processes including the presence of polymorphonuclear leukocytes in 68% of the samples, Granulation layer thickness was inversely correlated with back encapsulation indicating a reduction in granulation tissue for mechanically stabilized electrodes, In addition, encapsulation tissue surrounding the granulation layer was comprised of collagen fibers with an oblique orientation and an extraperitoneal locale suggesting mechanical load transfers between the electrode and the surrounding tissue, As a result, the histological response to epimysial electrodes implanted on the diaphragm suggests that mechanical loading, induced by movement associated with the contraction of adjacent muscle, must be a consideration for devices that employ epimysial electrodes.
C1 CASE WESTERN RESERVE UNIV,DEPT BIOMED ENGN,APPL NEURAL CONTROL LAB,CLEVELAND,OH 44106.
   VET ADM MED CTR,CLEVELAND,OH 44106.
CR AKERS JM, 1994, THESIS CASE W RESERV
   CIESIELSKI TE, 1983, J NEUROSURG, V58, P92, DOI 10.3171/jns.1983.58.1.0092
   COREY JM, 1990, THESIS CASE W RESERV
   DANIELSEN CC, 1981, EUR SURG RES, V13, P194, DOI 10.1159/000128185
   DETROYER A, 1982, J APPL PHYSIOL, V53, P30
   ESKELAND G, 1977, J BONE JOINT SURG BR, V59, P206
   FRISCH EE, 1983, BIOMATERIALS RECONST, P73
   Fung Y-C, 1993, BIOMECHANICS
   GALLIN JI, 1984, CLIN RES, V67, P329
   GLENN WWL, 1984, NEW ENGL J MED, V310, P1150, DOI 10.1056/NEJM198405033101804
   GLENN WWL, 1988, PACE, V11, P2121, DOI 10.1111/j.1540-8159.1988.tb06360.x
   GLENN WWL, 1976, ANN SURG, V183, P566, DOI 10.1097/00000658-197605000-00014
   GOLDMAN MD, 1973, J APPL PHYSIOL, V35, P197
   GRANDJEAN PA, 1986, ANN BIOMED ENG, V14, P53, DOI 10.1007/BF02364648
   HABAL MB, 1984, ARCH SURG-CHICAGO, V119, P843
   KEITH MW, 1989, J HAND SURG-AM, V14A, P524, DOI 10.1016/S0363-5023(89)80017-6
   KEITH MW, 1988, CLIN ORTHOPAEDICS, V233, P25
   KIM JH, 1976, J THORAC CARDIOV SUR, V72, P602
   KULONEN E, 1980, EXP PATHOL-JENA, V18, P456, DOI 10.1016/S0014-4908(80)80047-0
   LASSER A, 1983, HUM PATHOL, V14, P108, DOI 10.1016/S0046-8177(83)80239-1
   MATLAGA BF, 1976, J BIOMED MATER RES, V10, P391, DOI 10.1002/jbm.820100308
   MORTIMER JT, 1994, UNPUB
   NOCHOMOVITZ ML, 1983, AM REV RESPIR DIS, V127, P325
   PETERSON DK, 1994, IEEE T BIO-MED ENG, V41, P1115, DOI 10.1109/10.335860
   PETERSON DK, 1989, PACE, V12, P854, DOI 10.1111/j.1540-8159.1989.tb01910.x
   PETERSON DK, 1986, IEEE T BIO-MED ENG, V33, P342, DOI 10.1109/TBME.1986.325720
   PETERSON DK, 1994, IEEE T BIO-MED ENG, V41, P1127, DOI 10.1109/10.335861
   PILLIAR RM, 1981, CLIN ORTHOP RELAT R, V156, P249
   SCHMIT BD, 1995, THESIS CASE W RESERV
   STELLATO TA, 1985, SURG FORUM, V36, P297
   TAYLOR DE, 1986, BIOMATERIALS, V7, P277, DOI 10.1016/0142-9612(86)90050-5
   WALTERS RL, 1988, CLIN ORTHOPED RELATE, V233, P44
   WHALEN RL, 1988, T SOC ARTIFICIAL INT, V24, P887
NR 33
TC 8
Z9 8
U1 0
U2 2
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PD OCT
PY 1997
VL 44
IS 10
BP 921
EP 930
DI 10.1109/10.634644
PG 10
WC Engineering, Biomedical
SC Engineering
GA XW750
UT WOS:A1997XW75000002
PM 9311161
DA 2018-10-20
ER

PT J
AU Dmitriev, SN
   Zaitseva, NG
   Starodub, GY
   Maslov, OD
   Shishkin, SV
   Shishkina, TV
   Buklanov, GV
   Sabelnikov, AV
AF Dmitriev, SN
   Zaitseva, NG
   Starodub, GY
   Maslov, OD
   Shishkin, SV
   Shishkina, TV
   Buklanov, GV
   Sabelnikov, AV
TI High-purity radionuclide production: material, construction, target
   chemistry for Al-26, Ru-97, W-178, Np-235, Pu-235,Pu-237
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article; Proceedings Paper
CT 18th World Conference of the
   International-Nuclear-Target-Development-Society
CY OCT 07-11, 1996
CL STRASBOURG, FRANCE
SP Int Nucl Target Dev Soc
ID PROTON ENERGY-RANGE; EXCITATION-FUNCTION; METABOLISM; PU-237
AB The work on isotopically pure Al-26, Ru-97, W-178/Ta-178, Np-235, Pu-236 and Pu-237 production was initiated because of intensive research on their applications in the biomedical held and environmental chemistry. The conditions for isotopically pure production have been investigated. This paper describes the data for the nuclear reactions of the radionuclide production, the different target designs and target chemistry procedures.
C1 JOINT INST NUCL RES,FLEROV LAB NUCL REACT,DUBNA 141980,MOSCOW REGION,RUSSIA.
CR DMITRIEV SN, 1995, APPL RADIAT ISOTOPES, V46, P307, DOI 10.1016/0969-8043(94)00134-L
   DMITRIEV SN, 1993, APPL RADIAT ISOTOPES, V44, P1097, DOI 10.1016/0969-8043(93)90112-N
   DMITRIEV SN, 1995, INT C IS BEIJ CHIN, P71
   LACY JL, 1984, J NUCL MED, V25, P1003
   MEIRAV O, 1990, NUCL INSTRUM METH B, V52, P536, DOI 10.1016/0168-583X(90)90472-7
   NEIRINCKX RD, 1981, INT J APPL RADIAT IS, V32, P85, DOI 10.1016/0020-708X(81)90138-1
   PERELYGIN VP, 1993, HEAVY ION PHYSICS, P375
   TALBOT RJ, 1993, HEALTH PHYS, V65, P41, DOI 10.1097/00004032-199307000-00006
   TANAKA S, 1975, J INORG NUCL CHEM, V37, P2002, DOI 10.1016/0022-1902(75)80937-7
   Zaitseva NG, 1996, APPL RADIAT ISOTOPES, V47, P145, DOI 10.1016/0969-8043(95)00272-3
   ZAITSEVA NG, 1992, RADIOCHIM ACTA, V56, P59, DOI 10.1524/ract.1992.56.2.59
   ZAITSEVA NG, 1994, RADIOCHIM ACTA, V64, P1
NR 12
TC 7
Z9 7
U1 2
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD SEP 21
PY 1997
VL 397
IS 1
BP 125
EP 130
DI 10.1016/S0168-9002(97)00735-3
PG 6
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA XZ065
UT WOS:A1997XZ06500027
DA 2018-10-20
ER

PT J
AU LaIuppa, JA
   McAdams, TA
   Papoutsakis, ET
   Miller, WM
AF LaIuppa, JA
   McAdams, TA
   Papoutsakis, ET
   Miller, WM
TI Culture materials affect ex vivo expansion of hematopoietic progenitor
   cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hematopoietic cultures; biocompatibility; culture materials; serum-free
   medium; CD34(+) cells
ID HUMAN-BONE-MARROW; EXVIVO EXPANSION; RECOMBINANT CYTOKINES;
   MONONUCLEAR-CELLS; CD34(+) CELLS; PERFUSION; STEM; BIOCOMPATIBILITY;
   TRANSPLANTATION; BIOREACTORS
AB Ex vivo expansion of hematopoietic cells is important for applications such as cancer treatment, gene therapy, and transfusion medicine. While cell culture systems are widely used to evaluate the biocompatibility of materials for implantation, the ability of materials to support proliferation of primary human cells in cultures for reinfusion into patients has not been addressed. We screened a variety of commercially available polymer (15 types), metal (four types), and glass substrates for their ability to support expansion of hematopoietic cells when cultured under conditions that would be encountered in a clinical setting. Cultures of peripheral blood (PB) CD34(+) cells and mononuclear cells (MNC) were evaluated for expansion of total cells and colony-forming unit-granulocyte monocyte (CFU-GM; progenitors committed to the granulocyte and/or monocyte lineage). Human hematopoietic cultures in serum-free medium were found to be extremely sensitive to the substrate material. The only materials tested that supported expansion at or near the levels of polystyrene were tissue culture polystyrene, Teflon perfluoroalkoxy, Tenon fluorinated ethylene propylene, cellulose acetate, titanium, new polycarbonate, and new polymethylpentene. MNC were less sensitive to the substrate materials than the primitive CD34(+) progenitors, although similar trends were seen for expansion of the two cell populations on the substrates tested. CFU-GM expansion was more sensitive to substrate materials than was total cell expansion. The detrimental effects of a number of the materials on hematopoietic cultures appear to be caused by protein adsorption and/or leaching of toxins. Factors such as cleaning, sterilization, and reuse significantly affected the performance of some materials as culture substrates. We also used PB CD34(+) cell cultures to examine the biocompatibility of gas-permeable cell culture and blood storage bags and several types of tubing commonly used with biomedical equipment. While many of the culture bag materials gave satisfactory results, all of the tubing materials severely inhibited total cell and CFU-GM expansion. Taken together, our results show that many materials approved for blood contact or considered biocompatible are not suitable for use with hematopoietic cells cultured in serum-free medium. As hematopoietic cultures are scaled up for a variety of clinical applications, it will be essential to carefully examine the biocompatibility of all materials involved. (C) 1997 John Wiley & Sons, Inc.
C1 NORTHWESTERN UNIV,DEPT CHEM ENGN,EVANSTON,IL 60208.
RI Papoutsakis, Eleftherios/A-5254-2010; Papoutsakis,
   Eleftherios/B-7612-2009; Miller, William/B-7650-2009
OI Miller, William/0000-0003-0750-6314
FU NIGMS NIH HHS [GM08449]
CR ANDREESEN R, 1983, J IMMUNOL METHODS, V56, P295, DOI 10.1016/S0022-1759(83)80019-2
   BARNES D, 1980, ANAL BIOCHEM, V102, P255, DOI 10.1016/0003-2697(80)90151-7
   Bender J G, 1992, J Hematother, V1, P329, DOI 10.1089/scd.1.1992.1.329
   BENTLEY KL, 1985, J BIOMED MATER RES, V19, P757, DOI 10.1002/jbm.820190704
   BRUGGER W, 1993, BLOOD, V81, P2579
   CHANDY T, 1991, BLOOD COMPATIBILITY, P131
   COHEN PA, 1994, CIBA F SYMP, V187, P179
   COURTNEY JM, 1993, INT J ARTIF ORGANS, V16, P164
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P667, DOI 10.1002/jbm.820280603
   HAAS R, 1995, BLOOD, V85, P3754
   HAYLOCK DN, 1992, BLOOD, V80, P1405
   HENSCHLER R, 1994, BLOOD, V84, P2898
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P403, DOI 10.1002/jbm.820150311
   JOHNSON HJ, 1983, J BIOMED MATER RES, V17, P571, DOI 10.1002/jbm.820170403
   KOLLER M, 1995, AM I CHEM ENG ANN M
   KOLLER MR, 1993, BIO-TECHNOL, V11, P358, DOI 10.1038/nbt0393-358
   KOLLER MR, 1993, BLOOD, V82, P378
   LEMOLI RM, 1992, EXP HEMATOL, V20, P569
   MARTINSON J, 1993, BLOOD, V82, pA393
   MCALISTER IB, 1992, EXP HEMATOL, V20, P626
   MELBERG SG, 1988, DIABETIC MED, V5, P243, DOI 10.1111/j.1464-5491.1988.tb00977.x
   Northup S. J, 1986, HDB BIOMATERIALS EVA, P209
   PALSSON BO, 1993, BIO-TECHNOL, V11, P368, DOI 10.1038/nbt0393-368
   SANDSTROM CE, 1994, BIOTECHNOL BIOENG, V43, P706, DOI 10.1002/bit.260430806
   SANDSTROM CE, 1995, BLOOD, V86, P958
   SARDONINI CA, 1993, BIOTECHNOL PROGR, V9, P131, DOI 10.1021/bp00020a600
   SHAPIRO F, 1994, BLOOD, V84, P3567
   SMITH SL, 1993, EXP HEMATOL, V21, P870
   TAKAUE Y, 1992, ANN HEMATOL, V64, P217, DOI 10.1007/BF01738299
   Tzannis ST, 1996, P NATL ACAD SCI USA, V93, P5460, DOI 10.1073/pnas.93.11.5460
   *US FDA, 1996, DRAFT DOC REG PER BL
   *US FDA, 1991, 91N0428 FDA
   VANDERMEER JWM, 1982, J RETICULOENDOTH SOC, V32, P355
   VANDERMEER JWM, 1978, J EXP MED, V147, P271, DOI 10.1084/jem.147.1.271
   VISOR GC, 1990, J PARENT SCI TECHN, V44, P130
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   WENZ LM, 1990, J BIOMED MATER RES, V24, P207, DOI 10.1002/jbm.820240207
   WIESLANDER A, 1990, BIOMATER ARTIF CELL, V18, P367, DOI 10.3109/10731199009117314
   Williams SF, 1996, BLOOD, V87, P1687
   YANG MB, 1994, CELL TRANSPLANT, V3, P373, DOI 10.1177/096368979400300504
   ZANDSTRA PW, 1994, BIO-TECHNOL, V12, P909, DOI 10.1038/nbt0994-909
NR 41
TC 40
Z9 40
U1 2
U2 13
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 1997
VL 36
IS 3
BP 347
EP 359
DI 10.1002/(SICI)1097-4636(19970905)36:3<347::AID-JBM10>3.0.CO;2-B
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA XP501
UT WOS:A1997XP50100010
PM 9260106
DA 2018-10-20
ER

PT J
AU SanchezGuerrero, J
AF SanchezGuerrero, J
TI Autoantibody testing in patients with silicone implants
SO CLINICS IN LABORATORY MEDICINE
LA English
DT Article
ID GEL BREAST IMPLANTS; CONNECTIVE-TISSUE DISEASES; SJOGRENS-LIKE SYNDROME;
   AUGMENTATION MAMMAPLASTY; RHEUMATIC DISEASE; SYMPTOMATIC WOMEN;
   ANTIBODIES; RISK; MANIFESTATIONS; SCLERODERMA
AB Since 1938, when silicone was first synthesized, it has been in widespread use, including as a base material for many biomedical implants and devices. Silicone breast implants (SBI), the most popular silicone implants, have been in use for more than 30 years(35); however, during this decade a controversy over the safety of SBI has developed, a controversy that is still not resolved and has extended to other medical implants.
   At first, the controversy was about the potential association of SBI and connective tissue diseases (CTD); later, other rheumatic diseases such as fibromyalgia (FM), myofascial syndromes, and chronic fatigue syndrome (CFS) were involved. Lately, an increasing number of diseases, including neurologic diseases, nonspecific symptoms, and even the possibility of a novel disease caused by silicone have been mentioned.
   It will take many years before firm conclusions can be drawn; meanwhile, between 1 and 2 million women with SBI ask whether they are at an increased risk of developing any of the many diseases in question, and what can be done to identify and prevent such risk.
   In this review, the published evidence about the utility of autoantibody testing in women with SBI and other silicone devices will be discussed. Because it is impossible to generalize published results to all women with SBI, discussion will be separated into symptomatic and asymptomatic women. Also, many immunologic abnormalities, clinical and investigational, have been reported in these women. This review will focus on clinical immunologic tests, mostly antinuclear antibodies (ANA), rheumatoid factor (RF), and ANA profile, according to the following classification of symptoms: (1) local reactions; (2) nonimmunologic rheumatic diseases;and (3) definite/possible connective tissue diseases. Autoantibody screening in women with SBI, antisilicone antibodies, and other silicone devices also will be reviewed.
   This article presents the information available about autoantibody testing in women with silicone breast implants. Definite connective tissue diseases, non-autoimmune rheumatic diseases and a possible novel disease are covered. Autoantibody testing in asymptomatic women with breast implants, anti-silicone antibodies and other silicone implants are also discussed.
C1 UNIV NACL AUTONOMA MEXICO,MEXICO CITY 04510,DF,MEXICO.
CR BARMEIR E, 1995, J AUTOIMMUN, V8, P267, DOI 10.1006/jaut.1995.0020
   Basbug Eray, 1995, Arthritis and Rheumatism, V38, pS265
   BATES DW, 1995, ARCH INTERN MED, V155, P97, DOI 10.1001/archinte.155.1.97
   BLACKBURN WD, 1992, ARTHRITIS RHEUM, V35, pS212
   BOENSTEIN D, 1993, ARTHRITIS RHEUM, V36, pS117
   BRIDGES AJ, 1993, ARTHRITIS RHEUM, V36, pS70
   BRIDGES AJ, 1993, ANN INTERN MED, V118, P929, DOI 10.7326/0003-4819-118-12-199306150-00003
   BULPITT KJ, 1992, ARTHRITIS RHEUM, V35, pS161
   Burns CJ, 1996, J RHEUMATOL, V23, P1904
   Chow Henry Y., 1995, Arthritis and Rheumatism, V38, pS264
   Cuellar M. L., 1994, Arthritis and Rheumatism, V37, pS270
   CUELLAR ML, 1995, J RHEUMATOL, V22, P236
   DECAMARA DL, 1993, PLAST RECONSTR SURG, V91, P828, DOI 10.1097/00006534-199304001-00012
   DUGOWSON CE, 1992, ARTHRITIS RHEUM, V35, pS66
   Edworthy S. M., 1995, Arthritis and Rheumatism, V38, pS325
   FREUNDLICH B, 1994, SEMIN ARTHRITIS RHEU, V24, P44, DOI 10.1016/0049-0172(94)90109-0
   FREUNDLICH B, 1992, ARTHRITIS RHEUM, V35, pS67
   FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009
   GABRIEL SE, 1994, NEW ENGL J MED, V330, P1697, DOI 10.1056/NEJM199406163302401
   GOIN JM, 1981, CHANGING BODY PSYCHO, P191
   GOLDBLUM RM, 1995, FASEB J, V9, pA1029
   GOLDBLUM RM, 1992, LANCET, V340, P510, DOI 10.1016/0140-6736(92)91710-P
   HENNEKENS CH, 1987, EPIDEMIOLOGY MED, P327
   Hochberg MC, 1996, ARTHRITIS RHEUM, V39, P1125, DOI 10.1002/art.1780390708
   KEYSTONE E, 1993, ARTHRITIS RHEUM, V36, pS71
   Marcus DM, 1996, ARTHRITIS RHEUM, V39, P1619, DOI 10.1002/art.1780391003
   Martin L., 1995, Arthritis and Rheumatism, V38, pS264
   MARTIN L, 1993, ARTHRITIS RHEUM, V36, pS117
   Mease Philip J., 1995, Arthritis and Rheumatism, V38, pS324
   Nardella Francis A., 1995, Arthritis and Rheumatism, V38, pS264
   OSBORN TG, 1993, ARTHRITIS RHEUM, V36, pS118
   PRESS RI, 1992, LANCET, V340, P1304, DOI 10.1016/0140-6736(92)92491-W
   RANDALL T, 1992, JAMA-J AM MED ASSOC, V268, P1821
   Rosenau B, 1996, CURR TOP MICROBIOL, V210, P69
   SANCHEZGUERRERO J, 1994, ARTHRITIS RHEUM-US, V37, P158
   SANCHEZGUERRERO J, 1995, NEW ENGL J MED, V332, P1666, DOI 10.1056/NEJM199506223322502
   Silverman BG, 1996, ANN INTERN MED, V124, P744, DOI 10.7326/0003-4819-124-8-199604150-00008
   SOLOMON G, 1994, SEMIN ARTHRITIS RHEU, V24, P29, DOI 10.1016/0049-0172(94)90107-4
   STROM BL, 1994, J CLIN EPIDEMIOL, V47, P1211, DOI 10.1016/0895-4356(94)90109-0
   TEUBER SS, 1993, J AUTOIMMUN, V6, P367, DOI 10.1006/jaut.1993.1031
   VASEY FB, 1994, SEMIN ARTHRITIS RHEU, V24, P22, DOI 10.1016/0049-0172(94)90106-6
   VASEY FB, 1992, ARTHRITIS RHEUM, V35, pS212
   WEINER SR, 1992, ARTHRITIS RHEUM, V35, pS212
   WOLF LE, 1993, FASEB J, V7, P1265
   WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203
   Wolfe F., 1995, Arthritis and Rheumatism, V38, pS265
   WRONA N, 1993, ARTHRITIS RHEUM, V36, pS144
   ZANDMANGODDAR G, IN PRESS J RHEUMATOL
NR 48
TC 5
Z9 5
U1 0
U2 3
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0272-2712
J9 CLIN LAB MED
JI Clin. Lab. Med.
PD SEP
PY 1997
VL 17
IS 3
BP 341
EP &
PG 14
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA XX955
UT WOS:A1997XX95500003
PM 9316762
DA 2018-10-20
ER

PT J
AU Sievert, MC
   Johnson, DT
   Hartman, T
   Patrick, TB
AF Sievert, MC
   Johnson, DT
   Hartman, T
   Patrick, TB
TI New educational strategies for training information professionals:
   Building awareness, concepts, and skills through learning technologies
SO JOURNAL OF EDUCATION FOR LIBRARY AND INFORMATION SCIENCE
LA English
DT Article
AB Libraries, Medical Informatics, and Health Care was an experimental distance-education course aimed at both health sciences and other librarians and graduate students. The course included three modalities for delivering instruction: a satellite broadcast, materials on the Internet, and an intensive seminar. The teleconference focused, on two topics, consumer health care information and telemedicine and the relation of each to librarianship. The Internet-based materials covered the U.S. health care delivery system, the language of medicine, MeSH (Medical Subject Headings), and MEDLINE. The intensive seminar covered other health sciences resources, the biomedical community, trends in health sciences librarianship, and medical informatics. Each modality presented opportunities and challenges to the instructional team and the students. Evaluations revealed that participants were generally favorable about the experience but that there were more problems with the Internet section of the course than with the other sections.
C1 Univ Missouri, Coll Educ, Sch Informat Sci & Learning Technol, Columbia, MO 65211 USA.
   Univ Missouri, Sch Med, Integrated Technol Serv, Columbia, MO 65211 USA.
RP Sievert, MC (reprint author), Univ Missouri, Coll Educ, Sch Informat Sci & Learning Technol, Columbia, MO 65211 USA.
OI Hartman, Teresa/0000-0003-1621-6167
CR BARRON D, 1991, WILSON LIBR BULL, V66, P41
   DELAPENAMCCOOK K, 1993, PROJECT CENTURY 21 R, P1
   JOHNSON DT, 1997, IN PRESS 3 INT C CON
   *MED LIB ASS, 1991, PLATF CHANG ED POL S
   *NIH, 1996, REP PLANN PAN ED TRA
   SMITH B, 1992, BYTE, V17, P37
   TODD RD, 1990, TECHNOLOGY TEACH DEC, P3
NR 7
TC 1
Z9 1
U1 0
U2 4
PU ASSOC LIBRARY INFORMATION SCIENCE EDUCATION
PI ARLINGTON
PA PO BOX 7640, ARLINGTON, VA 22207 USA
SN 0748-5786
J9 J EDUC LIBR INF SCI
JI J. Educ. Libr. Inf. Sci.
PD FAL
PY 1997
VL 38
IS 4
BP 303
EP 313
DI 10.2307/40324191
PG 11
WC Education & Educational Research; Information Science & Library Science
SC Education & Educational Research; Information Science & Library Science
GA 192JJ
UT WOS:000080075000005
DA 2018-10-20
ER

PT J
AU Sim, CP
   Cheang, P
   Liang, MH
   Khor, KA
AF Sim, CP
   Cheang, P
   Liang, MH
   Khor, KA
TI Injection moulding of hydroxyapatite composites
SO JOURNAL OF MATERIALS PROCESSING TECHNOLOGY
LA English
DT Article
DE injection moulding; rheology; hydroxyapatite; composites; microwave;
   mechanical properties
ID IMPLANTS; HYDROXYLAPATITE; COATINGS
AB Hydroxyapatite (HA) is an important bioceramic with tremendous potential for biomedical applications. Its unique bioactivity promotes rapid bone growth and strong interfacial fixation that has particular benefit to orthopaedic and dental applications. Although it possesses good biocompatibility, its mechanical properties in terms of toughness and modulus values are still not comparable to those of cortical bone, which has severely limited its usage to mainly low-stress applications. Composite blending with a low modulus polymeric material introduces new improvement possibilities, but often requires high HA loading to attain useful properties. This high loading creates poor flow characteristics which hinders processing. In this study the critical powder loading and the rheological behaviour of hydroxyapatite-high density polyethylene (HA-HDPE) composites are studied using a capillary rheometer to ascertain the injection mouldability of the composite system. The mechanical properties of the injection moulded composites are evaluated by tensile testing. The effects of coupling agents and lubricant on the flow and mechanical property of HA-HDPE composite are examined in addition to the post heat-treatment of the composites. (C) 1997 Elsevier Science S.A.
C1 NANYANG TECHNOL UNIV,SCH MECH & PROD ENGN,SINGAPORE 639798,SINGAPORE.
   NANYANG TECHNOL UNIV,SCH APPL SCI,SINGAPORE 639798,SINGAPORE.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
OI KHOR, Khiam/0000-0003-1954-8423
CR CHEANG P, 1995, J MATER PROCESS TECH, V48, P429, DOI 10.1016/0924-0136(94)01679-U
   DELANGE GL, 1989, J DENT RES, V68, P509, DOI 10.1177/00220345890680031601
   Frame, 1989, INT J ORAL MAXILLOF, V16, P142
   GEESINK RGT, 1995, J BONE JOINT SURG BR, V77B, P534
   Hirota Kazushi, 1993, Bio-Medical Materials and Engineering, V3, P147
   KHOR KA, 1994, J THERM SPRAY TECHN, V3, P45, DOI 10.1007/BF02648998
   KOCH B, 1990, J BIOMED MATER RES, V24, P655, DOI 10.1002/jbm.820240603
   LIANG MH, 1993, J I MAT, V2, P53
   PILLIAR RM, 1991, MRS BULL, V16, P55
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   SOBELLE ES, 1990, ACTA ORTHOP SCAND, V61, P299
   TANNER KE, 1991, 7 INT C BIOM ENG SIN, P400
   VERHEYEN CCPM, 1992, J BIOMED MATER RES, V26, P1277, DOI 10.1002/jbm.820261003
   VOLFON SA, 1985, NEGNATOR PRINCIPLES
NR 15
TC 13
Z9 13
U1 0
U2 4
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-0136
J9 J MATER PROCESS TECH
JI J. Mater. Process. Technol.
PD SEP
PY 1997
VL 69
IS 1-3
BP 75
EP 78
DI 10.1016/S0924-0136(96)00044-1
PG 4
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA XW219
UT WOS:A1997XW21900010
DA 2018-10-20
ER

PT J
AU Lee, YM
   Kim, SS
   Kim, SH
AF Lee, YM
   Kim, SS
   Kim, SH
TI Synthesis and properties of poly(ethylene glycol) macromer/beta-chitosan
   hydrogels
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID INTERPENETRATING POLYMER NETWORKS; BETA-CHITIN; SQUID CHITIN;
   MORPHOLOGY; OXIDE); WATER; EPOXY
AB Semi-interpenetrating polymer network (semi-IPN) hydrogels composed of beta-chitosan a nd poly(ethylene glycol) diacrylate macromer (PEGM) were synthesized and characterized for the application as potential biomedical materials. The mixture of PEGM and beta-chitosan, dissolved in water including a small amount of acetic acid, was cast to prepare hydrogel films, followed by a subsequent crosslinking with 2,2-dimethoxy-2-phenylacetophenone as a non-toxic photoinitiator by ultraviolet irradiation. Photocrosslinked hydrogels exhibited relatively high equilibrium water content in the range 77-83% which is mainly attributed to the free water content rather than to the bound water, hydrogen bonded with components in semi-IPN hydrogels. The crystallinity, thermal properties and mechanical properties of semi-IPN hydrogels were studied. All the photocrosslinked hydrogels revealed a remarkable decrease in crystallinity. The glass transition temperatures, T-g, of crosslinked PEGM segment in semi-IPNs increased compared with poly(ethylene glycol) itself. However, with increasing beta-chitosan content their T-g decreased owing to the higher degree of crosslinking. The tensile strengths of semi-IPNs in dry state were rather high, but those of hydrogels in wet state decreased drastically.
RP Lee, YM (reprint author), HANYANG UNIV,COLL ENGN,DEPT IND CHEM,SEOUL 133791,SOUTH KOREA.
RI Lee, Young Moo/G-5920-2015
OI Lee, Young Moo/0000-0002-5047-3143
CR DAS B, 1994, J APPL POLYM SCI, V53, P1491, DOI 10.1002/app.1994.070531111
   DAVIS TP, 1990, POLYMER, V31, P513, DOI 10.1016/0032-3861(90)90395-F
   DESAI NP, 1992, MACROMOLECULES, V25, P226, DOI 10.1021/ma00027a038
   DOMSZY JG, 1985, MAKROMOL CHEM, V186, P1671
   GRAHAM NB, 1990, POLYMER, V31, P909, DOI 10.1016/0032-3861(90)90055-4
   GUPTA N, 1994, POLYMER, V35, P3769, DOI 10.1016/0032-3861(94)90560-6
   HACKMAN RH, 1954, AUST J BIOL SCI, V7, P168, DOI 10.1071/BI9540168
   KHARE AR, 1993, POLYMER, V34, P4736, DOI 10.1016/0032-3861(93)90710-R
   KIM SS, 1995, POLYMER, V36, P4497, DOI 10.1016/0032-3861(95)96859-7
   KIM SS, 1995, J POLYM SCI POL CHEM, V33, P2285, DOI 10.1002/pola.1995.080331324
   Kim SS, 1996, J POLYM SCI POL PHYS, V34, P2367
   KURITA K, 1993, J POLYM SCI POL CHEM, V31, P485, DOI 10.1002/pola.1993.080310220
   KURITA K, 1994, J POLYM SCI POL CHEM, V32, P1027, DOI 10.1002/pola.1994.080320603
   LEE YM, 1997, IN PRESS POLYMER
   LIN MS, 1993, J POLYM SCI POL CHEM, V31, P3317, DOI 10.1002/pola.1993.080311320
   MAGHAMI GG, 1988, MAKROMOL CHEM, V189, P195
   MIMA S, 1983, J APPL POLYM SCI, V28, P1909, DOI 10.1002/app.1983.070280607
   PENG T, 1994, J POLYM SCI POL CHEM, V32, P591, DOI 10.1002/pola.1994.080320322
   PRIOLA A, 1993, POLYMER, V34, P3653, DOI 10.1016/0032-3861(93)90050-K
   RAMARAJ B, 1994, J APPL POLYM SCI, V52, P837, DOI 10.1002/app.1994.070520701
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Yao KD, 1994, J POLYM SCI A, V32, P1213
NR 22
TC 42
Z9 44
U1 1
U2 22
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 1997
VL 8
IS 9
BP 537
EP 541
DI 10.1023/A:1018594614087
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA XV771
UT WOS:A1997XV77100003
PM 15348705
DA 2018-10-20
ER

PT J
AU Bistue, G
   Elizalde, JG
   GarciaAlonso, I
   Olaizola, S
   Castano, E
   Gracia, FJ
   GarciaAlonso, A
AF Bistue, G
   Elizalde, JG
   GarciaAlonso, I
   Olaizola, S
   Castano, E
   Gracia, FJ
   GarciaAlonso, A
TI A micromachined pressure sensor for biomedical applications
SO JOURNAL OF MICROMECHANICS AND MICROENGINEERING
LA English
DT Article; Proceedings Paper
CT 7th Workshop on Micromachining, Micromechanics and Microsystems in
   Europe (MME 96)
CY OCT 21-22, 1996
CL BARCELONA, SPAIN
ID SILICON
AB A silicon pressure microsensor fabrication process is reported. The microsensor has been designed as a low-cost disposable device for invasive blood pressure measurements. Results obtained from static, dynamic and leakage pressure tests are presented. A sensitivity of 20 (mu V/V)/mmHg has been measured. The combined linearity and hysteresis is less than 1.5% FSO. The dynamic response is fast enough to reproduce the blood pressure waveform of the human heart, Results based on a material biocompatibility study are also included.
C1 UNIV BASQUE COUNTRY, LAB CIRUGIA EXPT, E-48940 LEJONA, SPAIN.
RP Bistue, G (reprint author), CTR ESTUDIOS & INVEST TECN GUIPUZCOA, POB 1555, E-20009 SAN SEBASTIAN, SPAIN.
RI Elizalde, Jorge/A-5508-2013
OI Elizalde, Jorge/0000-0002-5785-0618; Garcia-Alonso,
   Ignacio/0000-0002-3701-1761
CR Berne RM, 1993, PHYSL MOSBY YB
   BRYSEK J, 1991, SILICON SENSORS MICR
   DZIUBAN J, 1994, SENSOR ACTUAT A-PHYS, V41, P368
   GHANDHI SK, 1994, VLSI FABRICATION PRI
   GOTZ A, 1993, SENSOR ACTUAT A-PHYS, V37-8, P744, DOI 10.1016/0924-4247(93)80126-2
   KLOECK B, 1989, IEEE T ELECTRON DEV, V36, P663, DOI 10.1109/16.22472
   KO WH, 1979, IEEE T ELECTRON DEV, V26, P1896
   Ning XJ, 1996, J ELECTROCHEM SOC, V143, P3389, DOI 10.1149/1.1837217
   Samaun K. D. Wise, 1973, IEEE T BIOMED ENG, V20, P101
   Terry S., 1990, SENSOR ACTUAT A-PHYS, VA21-A23, P1070
NR 10
TC 13
Z9 13
U1 1
U2 2
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0960-1317
J9 J MICROMECH MICROENG
JI J. Micromech. Microeng.
PD SEP
PY 1997
VL 7
IS 3
BP 244
EP 246
DI 10.1088/0960-1317/7/3/044
PG 3
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Instruments & Instrumentation; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Instruments &
   Instrumentation; Physics
GA YA662
UT WOS:A1997YA66200044
DA 2018-10-20
ER

PT J
AU Ciardelli, G
   Kojima, K
   Lendlein, A
   Neuenschwander, P
   Suter, UW
AF Ciardelli, G
   Kojima, K
   Lendlein, A
   Neuenschwander, P
   Suter, UW
TI Synthesis of biomedical, fluorescence-labelled polyesterurethanes for
   the investigation of their degradation
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
ID POLY<(R)-3-HYDROXYBUTYRIC ACID>; PHOTORESPONSIVE POLYMERS; PEPTIDE;
   POLY(EPSILON-CAPROLACTONE); DICYCLOHEXYLCARBODIIMIDE; DIISOCYANATE;
   ACTIVATION
AB The synthesis and characterization of fluorescence-labelled, phase segregating block polyesterurethanes based on the known biocompatible and degradable materials poly[(R)-3-hydroxybutyric acid] (PHB), poly(epsilon-caprolactone) (PCL), and poly[(epsilon-caprolactone)-co-glycolide] (PCL/PGA) is described. To introduce fluorescence labels in the amorphous domains of the polymers, phenacyl 10,11-dihydroxyundecanoate (PDUA) was synthesized and copolymerized with a PHB diol, a PCL diol, and aliphatic diisocyanates. After cleavage of the protecting group (without degradation of the polymer backbone), the carboxyl group was reacted with a fluorescent amine (dansylcadaverine) in the presence of 4,6-diphenylthieno[3,4-d]-1,3-dioxol-2-one 5,5-dioxide (Steglich reagent). Also a polymer containing C-13-labelled carboxy groups was synthesized and the labelling reaction monitored by C-13 NMR spectroscopy. To introduce fluorescence labels in the hard segment of the polymers, a new low-molecular-weight diol based on poly[(R)-hydroxybutyric acid] and containing protected carboxy groups was synthesized. After the deprotection, the carboxy groups were reacted with a fluorescent amine (dansylcadaverine) in the presence of an activating system based on dicyclohexylcarbodiimide. The labelled PHB diol was then copolymerized with a poly[(epsilon-caprolactone)-co-glycolide] diol and an aliphatic diisocyanate. The so obtained fluorescence-labelled block polyesterurethanes are promising materials for the investigation of the biocompatibility and degradation of the corresponding, non-labelled materials (DegraPol(R)) by means of fluorescence-aided microscopic and spectroscopic techniques.
C1 ETH ZURICH,INST POLYMERS,DEPT MAT,CH-8092 ZURICH,SWITZERLAND.
RI Lendlein, Andreas/K-9553-2013; Suter, Ulrich/H-8900-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Suter,
   Ulrich/0000-0001-7467-7346; Ciardelli, Gianluca/0000-0003-0199-1427
CR ALDINGER W, 1908, THESIS U STUTTGART
   BAKER JW, 1947, J CHEM SOC, P713, DOI 10.1039/jr9470000713
   BAKER JW, 1949, J CHEM SOC, P19, DOI 10.1039/jr9490000019
   BERGBREITER DE, 1975, J ORG CHEM, V40, P779, DOI 10.1021/jo00894a605
   BOCHNITSCHEK SF, 1989, J ORG CHEM, V54, P751
   BRUIN P, 1990, BIOMATERIALS, V11, P291, DOI 10.1016/0142-9612(90)90013-G
   CHEN RF, 1967, ARCH BIOCHEM BIOPHYS, V120, P609, DOI 10.1016/0003-9861(67)90526-7
   Ciardelli G, 1997, MACROMOL CHEM PHYSIC, V198, P1481, DOI 10.1002/macp.1997.021980514
   CLARK JH, 1977, TETRAHEDRON LETT, V7, P599
   COGNETGEORJON E, 1995, MACROMOL CHEM PHYSIC, V196, P3733, DOI 10.1002/macp.1995.021961125
   FISSI A, 1987, BIOPOLYMERS, V26, P1993, DOI 10.1002/bip.360261203
   FISSI A, 1989, MACROMOLECULES, V22, P1115, DOI 10.1021/ma00193a019
   GEFFKEN D, 1987, CHEM ZTG, V111, P245
   Hassner A., 1978, TETRAHEDRON LETT, V19, P4475
   HAUGLAND RP, 1992, HDB FLUORESCENT PROB
   HENDRICKSON JB, 1970, TETRAHEDRON LETT, V5, P343
   Hirt TD, 1996, MACROMOL CHEM PHYSIC, V197, P1609, DOI 10.1002/macp.1996.021970503
   Hirt TD, 1996, MACROMOL CHEM PHYS, V197, P4253, DOI 10.1002/macp.1996.021971221
   HOLLITZER O, 1976, ANGEW CHEM INT EDIT, V15, P444, DOI 10.1002/anie.197604441
   HOLLITZER O, 1976, ANGEW CHEM, V88, P480
   HUYNHBA G, 1981, ACS SYM SER, V172, P205
   ITO Y, 1991, J BIOMED MATER RES, V25, P1325, DOI 10.1002/jbm.820251102
   KABALKA GW, 1980, J ORG CHEM, V45, P3578, DOI 10.1021/jo01306a007
   KIRSTGEN R, 1987, J CHEM SOC CHEM COMM, P1870, DOI 10.1039/c39870001870
   KLAUSNER YS, 1972, SYNTH-INT J METHODS, P453
   KONIG W, 1970, CHEM BER-RECL, V103, P2034, DOI 10.1002/cber.19701030705
   KONIG W, 1970, CHEM BER-RECL, V103, P788, DOI 10.1002/cber.19701030319
   KOVACS J, 1967, J AM CHEM SOC, V89, P183, DOI 10.1021/ja00977a059
   KOVACS L, 1969, TETRAHEDRON, V25, P2555
   KURTH MJ, 1988, INT J PEPT PROT RES, V31, P388
   Larock R. C., 1989, COMPREHENSIVE ORGANI
   LEE KN, 1985, J BIOL CHEM, V260, P4689
   LENDLEIN A, UNPUB
   MIRVISS SB, 1989, J ORG CHEM, V54, P1948, DOI 10.1021/jo00269a038
   NEISES B, 1978, ANGEW CHEM INT EDIT, V17, P522, DOI 10.1002/anie.197805221
   Neises B., 1978, ANGEW CHEM, V90, P556, DOI DOI 10.1002/ANGE.19780900718
   PIERONI O, COMMUNICATION
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   ROBINS MJ, 1974, BIOCHEMISTRY-US, V13, P553, DOI 10.1021/bi00700a023
   Saad B, 1996, J BIOMED MATER RES, V30, P429, DOI 10.1002/(SICI)1097-4636(199604)30:4<429::AID-JBM1>3.3.CO;2-D
   SAAD B, IN PRESS J MAT SCI M
   SAAD B, IN PRESS J BIOMED MA
   SHEEHAN JC, 1955, J AM CHEM SOC, V77, P1067, DOI 10.1021/ja01609a099
   STOLL R, COMMUNICATION
   STRYER L, 1988, BIOCHEMISTRY
   VINCZER P, 1988, ACTA CHIM HUNG, V125, P797
   WEYGAND F, 1966, Z NATURFORSCH PT B, VB 21, P426
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
   WUNSCH E, 1966, CHEM BER-RECL, V99, P110, DOI 10.1002/cber.19660990119
NR 49
TC 5
Z9 6
U1 1
U2 13
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4, CH-4052 BASEL, SWITZERLAND
SN 1022-1352
J9 MACROMOL CHEM PHYSIC
JI Macromol. Chem. Phys.
PD SEP
PY 1997
VL 198
IS 9
BP 2667
EP 2688
DI 10.1002/macp.1997.021980903
PG 22
WC Polymer Science
SC Polymer Science
GA XW915
UT WOS:A1997XW91500003
DA 2018-10-20
ER

PT J
AU Alonso, F
   Rinner, M
   Loinaz, A
   Onate, JI
   Ensinger, W
   Rauschenbach, B
AF Alonso, F
   Rinner, M
   Loinaz, A
   Onate, JI
   Ensinger, W
   Rauschenbach, B
TI Characterization of Ti-6Al-4V modified by nitrogen plasma immersion ion
   implantation
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 3rd International Workshop on Plasma-Based Ion Implantation
CY SEP 15-18, 1996
CL DRESDEN, GERMANY
SP Res Ctr Rossendorf, Dresden, State Saxony, Saxonian Minist Sci & Arts, Dresden, AP & T Adv Prod & Technol GmbH, Nurtingen, Germany, DANFYSIK, Jyllinge, Denmark, Hiden Anal, Ried, Germany, Leybold Serv GmbH, Dresden, N Star Res Corp, Albuquerque, NM, Roth & Rau Oberfiachentech GmbH, Wustenbrand, Germany, SASKIA Hochvakuum GmbH, Ilmenau, Germany, SENTECH, Berlin
DE friction; load bearing capacity; plasma immersion ion implantation;
   Ti-6Al-4V; wear
ID SURFACE MODIFICATION; PROFILES; OXYGEN; CARBON; ALLOY
AB Ti-6Al-4V alloy is commonly used in biomedical or aerospace applications, due to its excellent combination of chemical and mechanical properties, such as bioinertness, corrosion resistance or high strength to weight ratio. The use of surface treatments or coatings has widened the application possibilities of this alloy. The often observed poor tribological performance can be overcome by the correct choice of surface: engineering methods. Ion implantation is a candidate among the different available processes and excellent results have been obtained in biomedical applications. However, when complex geometries are involved, it can be a difficult and less economically effective treatment. Plasma immersion ion implantation (PIII) offers the possibility of performing three-dimensional ion beam treatments, reducing the need for manipulation under vacuum to obtain a uniform treatment of geometrically complex parts.
   In this work, PIII was used to implant nitrogen in the Ti-6Al-4V alloy. The nitrogen plasma was generated with a 2.45 GHz microwave excitation, and a pulsed bias voltage of 45 kV with pulse repetition rates of 50 and 400 Hz were applied. Nitrogen retained doses were evaluated by means crf Rutherford backscattering spectroscopy (RES). Pin-on-disc wear and friction tests were performed on the implanted samples. An ultra high molecular weight polyethylene pin was used as the counterface material to partially simulate the conditions encountered in biomedical applications. A reasonable improvement in load bearing capacity with respect to the unimplanted alloy was observed after these tribological tests. However, no hardening could be measured after ion implantation. The worn surfaces were observed by scanning electron microscopy and optical profilometry after the tests and the type of wear mechanism was studied. The effect of the implantation was to increase the load at which breakthrough occurred on the protective surface layer. (C) 1997 Elsevier Science S.A.
C1 UNIV AUGSBURG,INST PHYS,D-86135 AUGSBURG,GERMANY.
RP Alonso, F (reprint author), INASMET,CAMINO PORTUETXE 12,SAN SEBASTIAN 20009,SPAIN.
RI Ensinger, Wolfgang/N-7074-2017; Onate, J. Ignacio/I-1555-2015
OI Ensinger, Wolfgang/0000-0003-3858-6230; Onate de la Presa, Jose
   Ignacio/0000-0002-9078-4480
CR Alonso F, 1995, SURF COAT TECH, V74-75, P986, DOI 10.1016/0257-8972(95)08291-3
   Alonso F, 1996, SURF COAT TECH, V83, P301, DOI 10.1016/0257-8972(96)02767-3
   CHEN A, 1991, SURF COAT TECH, V50, P1, DOI 10.1016/0257-8972(91)90184-X
   CHEN A, 1991, WEAR MATERIALS, P667
   Collins GA, 1996, SURF COAT TECH, V84, P537, DOI 10.1016/S0257-8972(95)02792-0
   CONRAD JR, 1990, J VAC SCI TECHNOL A, V8, P3146, DOI 10.1116/1.576598
   CONRAD JR, 1989, J APPL PHYS, V65, P1707, DOI 10.1063/1.342942
   CONRAD JR, 1987, J APPL PHYS, V62, P777, DOI 10.1063/1.339858
   DOOLITTLE LR, 1985, NUCL INSTRUM METH B, V9, P344, DOI 10.1016/0168-583X(85)90762-1
   Ensinger W, 1996, MATER RES SOC SYMP P, V396, P521
   GUNZEL R, 1994, J VAC SCI TECHNOL B, V12, P927, DOI 10.1116/1.587329
   Han SH, 1996, SURF COAT TECH, V82, P270, DOI 10.1016/0257-8972(95)02722-X
   Hartmann J, 1996, J VAC SCI TECHNOL A, V14, P3144, DOI 10.1116/1.580183
   Hartmann J, 1996, NUCL INSTRUM METH B, V112, P255, DOI 10.1016/0168-583X(95)01248-6
   HUTCHINGS R, 1994, MAT SCI ENG A-STRUCT, V184, P87, DOI 10.1016/0921-5093(94)91023-5
   Munson CP, 1996, SURF COAT TECH, V84, P528, DOI 10.1016/S0257-8972(95)02836-6
   ONATE JI, 1994, SURF COAT TECH, V65, P165, DOI 10.1016/S0257-8972(94)80025-1
   QIU X, 1990, METALL TRANS A, V21, P1663, DOI 10.1007/BF02672581
   TENDYS J, 1988, APPL PHYS LETT, V53, P2143, DOI 10.1063/1.100299
   VAJO JJ, 1994, J APPL PHYS, V76, P5666, DOI 10.1063/1.357072
   XIE L, 1991, MAT SCI ENG A-STRUCT, V139, P179, DOI 10.1016/0921-5093(91)90614-S
NR 21
TC 24
Z9 26
U1 1
U2 4
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD SEP
PY 1997
VL 93
IS 2-3
BP 305
EP 308
DI 10.1016/S0257-8972(97)00065-0
PG 4
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA YH798
UT WOS:A1997YH79800029
DA 2018-10-20
ER

PT J
AU Kobayashi, K
   Tawada, E
   Akaike, T
   Usui, T
AF Kobayashi, K
   Tawada, E
   Akaike, T
   Usui, T
TI Artificial glycopolypeptide conjugates: Simple synthesis of lactose- and
   N,N'-diacetylchitobiose-substituted poly(L-glutamic acid)s through
   N-beta-glycoside linkages and their interaction with lectins
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE glycopolypeptide; lectin; biomedical material; glycotechnology
ID DERIVATIVES
AB Poly(glutamic acid)s carrying lactose-and N,N'-diacetylchitobiose residues were synthesized via a simple two-step procedure. The oligosaccharides were treated with ammonium hydrogen carbonate and the resulting N-beta-glycosylamine was coupled with pendant carboxyl groups of poly(L-glutamic acid) in the presence of a mixture of benzotriazol-1-yl-oxy-tris(dimethylamino)phosphonium hexafluorophosphate (BOP) and 1-hydroxybenzotriazole (HOBt) in dimethyl sulfoxide. The oligosaccharide incorporated as pendant N-glycosides was estimated by H-1-NMR spectroscopy to be 30 mol% (or 45 wt%) for lactose and 27 mol% (46 wt%) for chitobiose. The glycopolypeptide carrying N,N'-diacetyl-chitobiose inhibited hemagglutination activity of wheat germ agglutinin (WGA) much more strongly (about 10(6) times) than N,N'-diacetylchitobiose itself, The high activity is due to the cluster or high density effect of the glycopolypeptides.
C1 NAGOYA UNIV, SCH AGR SCI, CHIKUSA KU, NAGOYA, AICHI 46401, JAPAN.
   TOKYO INST TECHNOL, FAC BIOSCI & TECHNOL, YOKOHAMA, KANAGAWA 226, JAPAN.
   SHIZUOKA UNIV, FAC AGR, OYA, SHIZUOKA 422, JAPAN.
RP Kobayashi, K (reprint author), NAGOYA UNIV, GRAD SCH ENGN, CHIKUSA KU, NAGOYA, AICHI 46401, JAPAN.
CR ANISFELD ST, 1990, J ORG CHEM, V55, P5566
   BODANSZKY M, 1975, J ORG CHEM, V40, P2495, DOI 10.1021/jo00905a016
   COHENANISFELD ST, 1993, J AM CHEM SOC, V115, P10531, DOI 10.1021/ja00076a010
   KAWAGISHI H, 1994, J BIOL CHEM, V269, P1375
   Kiessling LL, 1996, CHEM BIOL, V3, P71, DOI 10.1016/S1074-5521(96)90280-X
   KOBAYASHI K, IN PRESS MACROMOLECU
   LEE YC, 1994, NEOGLYCOCONJUGATES P
   LEE YC, 1994, METHODS ENZYMOLOGY, V247
   LEE YC, 1994, METHODS ENZYMOLOGY, V242
   LIKHOSHERSTOV LM, 1986, CARBOHYD RES, V146, pC1, DOI 10.1016/0008-6215(86)85037-6
   Montreuil J, 1995, GLYCOPROTEINS A, V29a
   NISHIMURA SI, 1994, MACROMOLECULES, V27, P4876, DOI 10.1021/ma00096a004
   UEDA M, 1992, B CHEM SOC JPN, V65, P1636, DOI 10.1246/bcsj.65.1636
NR 13
TC 28
Z9 28
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD AUG 29
PY 1997
VL 1336
IS 2
BP 117
EP 122
DI 10.1016/S0304-4165(97)00018-4
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA XU954
UT WOS:A1997XU95400001
PM 9305781
DA 2018-10-20
ER

PT J
AU Abraham, GA
   Frontini, PM
   Cuadrado, TR
AF Abraham, GA
   Frontini, PM
   Cuadrado, TR
TI Physical and mechanical behavior of sterilized biomedical segmented
   polyurethanes
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE mechanical properties; segmented polyurethanes; biomedical
   polyurethanes; sterilization; irradiation-
ID POLY(ETHER URETHANE UREAS); PROTEIN ADSORPTION; DEGRADATION; ELASTOMERS;
   ADDITIVES; POLYMER; FTIR
AB Changes in the physical and mechanical behavior induced by two sterilization methods, gamma irradiation and ethylene oxide, were determined on two commercial medical-grade segmented polyurethanes. The two materials have different chemical composition: one is an aromatic poly(ether urethane urea), Biospan(TM), and the other an aliphatic ether-free polyurethane, Chronoflex(TM). Properties before and after sterilization procedures were compared resulting in specific structural changes for each formulation. The thermal and mechanical properties were examined using differential scanning calorimetry (DSC), dynamic mechanical analysis (DMA), stress-strain measurements, and its hysteresis cycle. Molecular weight measurements were performed by gel permeation chromatography (GPC). Sterilized Biospan samples showed a decrease in the soft-segment glass transition temperature (T-g,T-s) and an increase in the soft. segment crystallization heat along the quenching process. Sterilized Chronoflex materials showed the opposite behavior. The hysteresis percent and residual strain percent increased after sterilization. The same effect was observed when irradiation dose and strain level increased. Surface analysis performed by scanning electron microscopy showed magnification of original surface defects after sterilization. (C) 1997 John Wiley & Sons, Inc.
RP Abraham, GA (reprint author), UNIV MAR DEL PLATA,INST MAT SCI & TECHNOL,CONICET,JB JUSTO 4302,RA-7600 MAR DEL PLATA,ARGENTINA.
RI Abraham, Gustavo/E-2820-2014
OI Abraham, Gustavo/0000-0001-7094-1031
CR ABOUZAHR S, 1982, POLYMER, V23, P1077, DOI 10.1016/0032-3861(82)90411-6
   AHN TO, 1994, J APPL POLYM SCI, V51, P43, DOI 10.1002/app.1994.070510105
   BIAGINI E, 1983, MAKROMOL CHEM, V184, P1213
   BORETOS JW, 1975, J BIOMED MATER RES, V9, P327, DOI 10.1002/jbm.820090308
   BORETOS JW, 1980, PURE APPL CHEM, V52, P1851, DOI 10.1351/pac198052071851
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P255, DOI 10.1002/jbm.820270216
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P367, DOI 10.1002/jbm.820270310
   COLEMAN MM, 1988, MACROMOLECULES, V21, P59, DOI 10.1021/ma00179a014
   DENG M, 1995, J APPL POLYM SCI, V58, P2111, DOI 10.1002/app.1995.070581123
   DUMITRIU S, 1994, POLYM BIOMATERIALS, pCH1
   FREIJLARSSON C, 1993, J APPL POLYM SCI, V49, P815, DOI 10.1002/app.1993.070490507
   Kolff T, 1973, Biomater Med Devices Artif Organs, V1, P669
   LELAH MD, 1983, J BIOMED MATER RES, V17, P1, DOI 10.1002/jbm.820170102
   LELAH MD, 1989, POLYURETHANES MED, pCH7
   MARCHANT RE, 1987, POLYMER, V28, P2032, DOI 10.1016/0032-3861(87)90037-1
   MARCHANT RE, 1988, SURFACE CHARACTERIZA
   MARTAKIS N, 1994, J APPL POLYM SCI, V51, P313, DOI 10.1002/app.1994.070510214
   MEIJS GF, 1993, J BIOMED MATER RES, V27, P345, DOI 10.1002/jbm.820270308
   MERRILL EW, 1985, POLYM COMMUN, V26, P105
   MORBITZER L, 1972, J APPL POLYM SCI, V16, P2697, DOI 10.1002/app.1972.070161022
   PIERCE WS, 1967, T AM SOC ART INT ORG, V13, P299
   *POL IND INC, PROD INF
   *POL TECHN GROUP I, PROD INF
   SEYMOUR RW, 1970, MACROMOLECULES, V3, P579, DOI 10.1021/ma60017a021
   SEYMOUR RW, 1973, MACROMOLECULES, V6, P896, DOI 10.1021/ma60036a021
   Sung C.S., 1980, MACROMOLECULES, V13, P117
   Szycher M., 1991, BLOOD COMPATIBLE MAT
   SZYCHER M, 1994, POLYM BIOMATERIALS, pCH6
   Takigawa T, 1996, J APPL POLYM SCI, V59, P1563, DOI 10.1002/(SICI)1097-4628(19960307)59:10<1563::AID-APP9>3.0.CO;2-K
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   WU Y, 1992, J APPL POLYM SCI, V46, P201, DOI 10.1002/app.1992.070460202
   WU Y, 1991, J BIOMED MATER RES, V25, P725, DOI 10.1002/jbm.820250604
NR 32
TC 40
Z9 40
U1 0
U2 14
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 8
PY 1997
VL 65
IS 6
BP 1193
EP 1203
DI 10.1002/(SICI)1097-4628(19970808)65:6<1193::AID-APP15>3.0.CO;2-V
PG 11
WC Polymer Science
SC Polymer Science
GA XH702
UT WOS:A1997XH70200015
DA 2018-10-20
ER

PT J
AU DiMartino, E
   Pietrabissa, R
   Mantero, S
AF DiMartino, E
   Pietrabissa, R
   Mantero, S
TI The computational approach applied to the design and structural
   verification of a trileaflet polymeric heart valve
SO ADVANCES IN ENGINEERING SOFTWARE
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Computer Simulations in Biomedicine
   (BIOMED 97)
CY JUN 09-11, 1997
CL ACQUASPARTA, ITALY
SP Wessex Inst Technol, Southampton, UK, Univ Perugia, Mat Engn Ctr, Italy, Ctr Ric WIT Ingegneria Computaz, Terni, Italy
DE computational methods; structural FEM analysis; polymeric trileaflet
   heart valves
AB This study represents an application of the computational methods to the design and structural verification of a cardiac trileaflet polymeric valve. Numerical methods are commonly used for mechanic, fluid dynamic and thermal preliminary testing of engineering devices. In this paper commercial codes have been used to design and analyse a device which operates in contact with a biologic environment. Several simplifications are necessary to fulfill this aim due to the actual characteristics of the material, loads and boundary conditions. Six 3-D valve models have been developed and their mechanic behavior compared. The results allow an evaluation of the method that has been adopted and of the simplifications imposed. The method can be used to solve biomedical engineering problems though it requires an accurate description of the geometric and operating characteristics of both the device and its environment together with a critical evaluation of the results. (C) 1997 Elsevier Science Ltd.
RP DiMartino, E (reprint author), POLITECN MILAN,DIPARTIMENTO BIOINGN,I-20133 MILAN,ITALY.
RI Mantero, Sara/F-6587-2013
OI MANTERO, SARA/0000-0002-1264-0465
CR BERNACCA GM, 1995, BIOMATERIALS, V16, P279, DOI 10.1016/0142-9612(95)93255-C
   GHISTA DN, 1977, J BIOMECH, V10, P313, DOI 10.1016/0021-9290(77)90004-5
   KNIERBEIN B, 1990, INT J ARTIF ORGANS, V13, P307
   KNIERBEIN B, 1992, J BIOMED ENG, V14, P275, DOI 10.1016/0141-5425(92)90001-2
   KRUCINSKY S, 1992, J BIOMECH, V26, P929
   LOCKIE KJ, 1993, ANN THORAC SURG, V56, P125, DOI 10.1016/0003-4975(93)90415-E
   Pinchuk L., 1992, US Patent, Patent No. [5,133,742, 5133742]
   POWELL G, 1981, INT J NUMER METH ENG, V17, P1455, DOI 10.1002/nme.1620171003
   Ramm E., 1981, NONLINEAR FINITE ELE
   SWANSON WM, 1974, CIRC RES, V35, P871, DOI 10.1161/01.RES.35.6.871
   TANZI MC, 1994, J MATER SCI-MATER M, V5, P705, DOI 10.1007/BF00120361
   Thubrikar MJ, 1990, AORTIC VALVE
NR 12
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0965-9978
J9 ADV ENG SOFTW
JI Adv. Eng. Softw.
PD AUG
PY 1997
VL 28
IS 6
BP 341
EP 346
DI 10.1016/S0965-9978(97)00026-4
PG 6
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering; Engineering, Multidisciplinary
SC Computer Science; Engineering
GA XT703
UT WOS:A1997XT70300002
DA 2018-10-20
ER

PT J
AU Streicher, J
   Weninger, TJ
   Muller, GB
AF Streicher, J
   Weninger, TJ
   Muller, GB
TI External marker-based automatic congruencing: A new method of 3D
   reconstruction from serial sections
SO ANATOMICAL RECORD
LA English
DT Article
DE histology; serial sections; 3D reconstruction; section alignment;
   molecular morphology
ID AIDED 3-DIMENSIONAL RECONSTRUCTION; DISSIMILAR IMAGES; FIDUCIAL MARKERS;
   ALIGNMENT; SYSTEM; HEART; SEGMENTATION; RESOLUTION; MICROSCOPY
AB Background: Computer-based three-dimensional (3D) visualizations reconstructed from sectional images represent a valuable tool in biomedical research and medical diagnosis. Particularly with those imaging techniques that provide virtual sections, such as CT, MRI, and CLSM, 3D reconstructions have become routine. Reconstructions from physical sections, such as those used in histological preparations, have not experienced an equivalent breakthrough, due to inherent shortcomings in sectional preparation that impede automated image-processing and reconstruction. The increased use of molecular techniques in morphological research, however, generates an overwhelming amount of 3D molecular information, stored within series of physical sections. This valuable information can be fully appreciated and interpreted only through an adequate method of 3D visualization.
   Methods and results: In this paper we present a new method for a reliable and largely automated 3D reconstruction from physically sectioned material. The 'EMAC' concept (External Marker-based Automatic Congruencing) successfully approaches the three major obstacles Lo automated 3D reconstruction from serial physical sections: misalignment, distortion, and staining variation. It utilizes the objectivity of external markers for realignment of the sectional images and or geometric correction of distortion. A self-adapting dynamic thresholding technique compensates for artifactual staining variation and automatically selects the desired object contours.
   Conclusions: Implemented on a low-cost hardware platform, EMAC provides a fast and efficient tool that largely facilitates the use of computer-based 3D visualization for the analysis of complex structural, molecular, and genetic information in morphological research. Due to its conceptual versatility, EMAC can be easily adapted for a broad range of tasks, including all modern molecular-staining techniques, such as immunohistochemistry and in situ hybridization. (C) 1997 Wiley-Liss, Inc.
RP Streicher, J (reprint author), UNIV VIENNA,DEPT ANAT,WAHRINGERSTR 13,A-1090 VIENNA,AUSTRIA.
CR ANDREASEN A, 1991, J NEUROSCI METH, V37, P151, DOI 10.1016/0165-0270(91)90125-J
   ARNOLDS WJA, 1978, STAIN TECHNOL, V53, P287
   Born G, 1883, ARCH MIKROSK ANAT, V22, P584
   BRANDLE K, 1989, COMPUT BIOMED RES, V22, P52, DOI 10.1016/0010-4809(89)90015-3
   BRAVERMAN MS, 1986, J INVEST DERMATOL, V86, P290, DOI 10.1111/1523-1747.ep12285445
   BRON C, 1992, VISUALIZATION BIOMED, P75
   BURSTON WR, 1957, J ANAT, V91, P409
   CHATEL D, 1993, SURG RADIOL ANAT, V15, P341, DOI 10.1007/BF01627890
   CHAWLA SD, 1981, CANCER BIOCHEM BIOPH, V5, P153
   DAVIS RE, 1991, LARYNGOSCOPE, V101, P573
   DORUP J, 1983, J ULTRA MOL STRUCT R, V85, P82, DOI 10.1016/S0022-5320(83)90118-1
   DRUSHEL RF, 1993, SURVEY METHODS 3 DIM
   GEIGER B, 1993, 2105 N NATL RECH INF
   HARALICK RM, 1991, PATTERN RECOGN, V24, P69, DOI 10.1016/0031-3203(91)90117-N
   HERBIN M, 1989, COMPUT VISION GRAPH, V47, P77, DOI 10.1016/0734-189X(89)90055-8
   HIBBARD LS, 1988, J NEUROSCI METH, V26, P55, DOI 10.1016/0165-0270(88)90129-X
   HIBBARD LS, 1992, J NEUROSCI METH, V41, P133, DOI 10.1016/0165-0270(92)90056-J
   HIBBARD LS, 1987, SCIENCE, V236, P1641, DOI 10.1126/science.3603004
   HIS W, 1885, UEBER METHODEN PLAST, V3
   His W, 1887, ANAT ANZEIGER, VII, P382
   HUIJSMANS DP, 1986, ANAT RECORD, V216, P449, DOI 10.1002/ar.1092160402
   JAEGERS SMHJ, 1992, SURG RADIOL ANAT, V14, P241, DOI 10.1007/BF01794948
   JOHNSON CL, 1989, ANAT REC, V223, P104, DOI 10.1002/ar.1092230115
   KANG YK, 1993, J BIOMED ENG, V15, P497, DOI 10.1016/0141-5425(93)90065-7
   KNOX CK, 1990, P E MULT SOC COMP SI, P12
   LAAN AC, 1989, ANAT REC, V224, P443, DOI 10.1002/ar.1092240313
   LIU HC, 1990, IEEE T PATTERN ANAL, V12, P1072, DOI 10.1109/34.61706
   MCLEAN MR, 1987, ANAT REC, V219, P434, DOI 10.1002/ar.1092190415
   MITCHIE A, 1983, COMPUTER GRAPHICS IM, V22, P296
   MOSS VA, 1990, J MICROSC-OXFORD, V158, P187, DOI 10.1111/j.1365-2818.1990.tb02992.x
   ONGARO I, 1991, ANAT REC, V229, P285, DOI 10.1002/ar.1092290217
   POELMANN RE, 1987, ACTA ANAT, V130, P132
   PROTHERO JS, 1986, COMPUT BIOMED RES, V19, P361, DOI 10.1016/0010-4809(86)90048-0
   RINGWALD M, 1994, SCIENCE, V265, P2033, DOI 10.1126/science.8091224
   Rittenhouse DR, 1996, ACTA ANAT, V155, P282
   RYDMARK M, 1992, J MICROSC-OXFORD, V165, P29, DOI 10.1111/j.1365-2818.1992.tb04303.x
   SCHOOK P, 1978, ACTA MORPHOL NEER SC, V16, P157
   SJOSTRAND FS, 1958, J ULTRA MOL STRUCT R, V2, P122, DOI 10.1016/S0022-5320(58)90050-9
   Stevens J. K., 1994, 3 DIMENSIONAL CONFOC
   STOCKLEY EW, 1993, J NEUROSCI METH, V47, P39, DOI 10.1016/0165-0270(93)90020-R
   SUNDSTEN JW, 1983, ANAT RECORD, V207, P665, DOI 10.1002/ar.1092070415
   TAKAGI A, 1989, ANN OTO RHINOL LARYN, V98, P515, DOI 10.1177/000348948909800705
   THEILER K, 1972, HOUSE MOUSE
   VERBEEK F, 1995, THESIS TU DELFT
   VERWEY A, 1992, THESIS TU DELFT
   VUILLEMIN M, 1992, EUR J MORPHOL, V30, P181
   WONG V, 1983, AM J ANAT, V167, P143, DOI 10.1002/aja.1001670202
   WRIGHT SJ, 1991, J ELECTRON MICR TECH, V18, P2, DOI 10.1002/jemt.1060180103
   YASUMURA S, 1993, LARYNGOSCOPE, V103, P1043
   ZHANG YJ, 1991, CYTOMETRY, V12, P308, DOI 10.1002/cyto.990120404
   ZINREICH SJ, 1992, AM J NEURORADIOL, V13, P893
NR 51
TC 72
Z9 77
U1 0
U2 3
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0003-276X
J9 ANAT REC
JI Anat. Rec.
PD AUG
PY 1997
VL 248
IS 4
BP 583
EP 602
PG 20
WC Anatomy & Morphology
SC Anatomy & Morphology
GA XP478
UT WOS:A1997XP47800010
PM 9268147
DA 2018-10-20
ER

PT J
AU Lindblad, M
   Lestelius, M
   Johansson, A
   Tengvall, P
   Thomsen, P
AF Lindblad, M
   Lestelius, M
   Johansson, A
   Tengvall, P
   Thomsen, P
TI Cell and soft tissue interactions with methyl- and hydroxyl-terminated
   alkane thiols on gold surfaces
SO BIOMATERIALS
LA English
DT Article
DE cell-material interactions; methyl; hydroxyl; protein adsorption
ID HUMAN-ENDOTHELIAL-CELLS; PROTEIN ADSORPTION; POLYMER SURFACES;
   PLASMA-PROTEIN; STRUCTURAL CHARACTERIZATION; BIOMEDICAL POLYMERS;
   HUMAN-MONOCYTES; ABDOMINAL-WALL; METAL-SURFACES; L-CYSTEINE
AB In order to evaluate the biological response induced by true methyl and hydroxyl surfaces, alkane thiols were immobilized onto gold. Initial protein adsorption from human plasma was measured in vitro by ellipsometry-antibody techniques and in vivo surface-cell interactions were evaluated in rat subcutaneous tissues for time periods ranging between 1 and 28 days. Rat mononuclear cells were studied after culturing (24 h) on the surfaces. Plasma protein experiments revealed deposition of fibrinogen onto the pure gold and the methylated surface. The hydroxylated surface tended to release the surface-associated proteins tested for by antibodies. None of the in vivolin vitro models used showed differences between the hydroxyl and methyl surfaces for spontaneous or augmented cell hydrogen peroxide and interleukin-1 alpha secretions. However, the different surface chemistries markedly affected the distribution of the cells that were recruited to the interfaces (cells in the fluid space and surface-associated DNA content on the retrieved implants) at late and early time periods. The results indicate that different implant surface properties, such as chemical functionality and hydrophobicity, influence specific events in the inflammatory cell response, and ultimately the wound healing around implantable materials. (C) 1997 published by Elsevier Science Limited. All rights reserved.
C1 LINKOPING UNIV,DEPT PHYS & MEASUREMENT TECHNOL,S-58183 LINKOPING,SWEDEN.
RP Lindblad, M (reprint author), GOTHENBURG UNIV,INST ANAT & CELL BIOL,MED AREGATAN 3,S-41390 GOTHENBURG,SWEDEN.
OI Thomsen, Peter/0000-0003-3910-6665
CR ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   ANDERSON JM, 1981, FUNDAMENTAL ASPECTS, V11, P205
   ANKER M, 1995, UNPUB CELL INTERACTI
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   BERTILSSON L, 1993, LANGMUIR, V9, P141, DOI 10.1021/la00025a032
   BJURSTEN LM, 1990, BIOMATERIALS, V11, P596, DOI 10.1016/0142-9612(90)90085-5
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   BRADLEY JV, 1968, DISTRIBUTION FREE ST, P68
   BRAIDE M, 1986, J IMMUNOL METHODS, V93, P183, DOI 10.1016/0022-1759(86)90187-0
   CAMARERO VCPC, 1990, J CELL PHYSIOL, V145, P481, DOI 10.1002/jcp.1041450313
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   DEKKER A, 1991, J MATER SCI-MATER M, V2, P227, DOI 10.1007/BF00703376
   DION I, 1993, BIOMATERIALS, V14, P712, DOI 10.1016/0142-9612(93)90070-I
   ENGQUIST I, 1995, J PHYS CHEM-US, V99, P12257, DOI 10.1021/j100032a031
   ERIKSSON AS, 1994, J MATER SCI-MATER M, V5, P269, DOI 10.1007/BF00122396
   Gretzer C, 1996, BIOMATERIALS, V17, P851, DOI 10.1016/0142-9612(96)83279-0
   GUILBAULT GG, 1968, ANAL CHEM, V40, P190, DOI 10.1021/ac60257a002
   JANSEN JA, 1992, BIOMATERIALS, V13, P959, DOI 10.1016/0142-9612(92)90121-4
   JOHANSSON CB, 1992, J MATER SCI-MATER M, V3, P126, DOI 10.1007/BF00705280
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P467
   LEE JH, 1991, BIOMATERIALS, V12, P443
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   LESTELIUS M, 1994, J BIOMED MATER RES, V28, P871, DOI 10.1002/jbm.820280806
   MARTENSSON J, 1995, LANGMUIR, V11, P963
   McCrackin F. L., 1969, 479 NBS
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MIRZADEH H, 1995, BIOMATERIALS, V16, P641, DOI 10.1016/0142-9612(95)93862-8
   NAKAGAWARA A, 1981, J CLIN INVEST, V68, P1243, DOI 10.1172/JCI110370
   NUZZO RG, 1990, J AM CHEM SOC, V112, P558, DOI 10.1021/ja00158a012
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011
   ROSENGREN A, 1994, BIOMATERIALS, V15, P17, DOI 10.1016/0142-9612(94)90190-2
   ROSTLUND T, 1990, J BIOMED MATER RES, V24, P847, DOI 10.1002/jbm.820240705
   SHERMAN LA, 1977, J EXP MED, V145, P76, DOI 10.1084/jem.145.1.76
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   TENGVALL P, 1992, LANGMUIR, V8, P1236, DOI 10.1021/la00041a001
   THOMSEN P, 1996, UNPUB H2O2 PRODUCTIO
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   VANWACHEM PB, 1987, J BIOMED MATER RES, V21, P701, DOI 10.1002/jbm.820210603
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   WILLIAMS DF, 1985, J BIOMED MATER RES, V19, P313, DOI 10.1002/jbm.820190312
   WILLIAMS RL, 1988, BIOMATERIALS, V9, P206, DOI 10.1016/0142-9612(88)90085-3
NR 47
TC 65
Z9 67
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 1997
VL 18
IS 15
BP 1059
EP 1068
DI 10.1016/S0142-9612(97)00029-X
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA XJ968
UT WOS:A1997XJ96800006
PM 9239468
DA 2018-10-20
ER

PT J
AU Wever, DJ
   Veldhuizen, AG
   Sanders, MM
   Schakenraad, JM
   vanHorn, JR
AF Wever, DJ
   Veldhuizen, AG
   Sanders, MM
   Schakenraad, JM
   vanHorn, JR
TI Cytotoxic, allergic and genotoxic activity of a nickel-titanium alloy
SO BIOMATERIALS
LA English
DT Article
DE NiTi; memory metal; biocompatibility; biological safety
ID NITINOL
AB The nearly equiatomic nickel-titanium (NiTi) alloy is known for its shape memory properties. These properties can be put to excellent use in various biomedical applications, such as wires for orthodontic tooth alignment and osteosynthesis staples. The aim of this study was to evaluate the short-term biological safety of the NiTi alloy. We carried out an end-point dilution minimal essential medium (MEM) extract cytotoxicity test, a guinea-pig sensitization test and two genotoxicity tests: the Salmonella reverse mutation test and the chromosomal aberration test. The NiTi alloy showed no cytotoxic, allergic or genotoxic activity, similar to the clinical reference control material AISI 316 LVM stainless steel. This promising biological behaviour was most likely due to a minimal release of ions and in that way a reflection of the good corrosion resistance of the NiTi alloy. Given these very good results, together with the good tissue compatibility as shown in several implantation studies in the literature, the NiTi alloy can be regarded as a biologically safe implant material with many promising clinical applications. (C) 1997 Elsevier Science Limited. All rights reserved.
C1 BIOSCAN,LAB MED DEVICE EVALUAT,BILTHOVEN,NETHERLANDS.
   ACROMED BV,ROTTERDAM,NETHERLANDS.
RP Wever, DJ (reprint author), UNIV GRONINGEN HOSP,DEPT ORTHOPAED,POB 30001,NL-9700 RB GRONINGEN,NETHERLANDS.
CR ANDREASEN G, 1980, AM J ORTHOD DENTOFAC, V78, P528, DOI 10.1016/0002-9416(80)90303-6
   ASSAD M, 1994, P 40 ANN M ORTH RES, P591
   BENSMANN G, 1982, TECH MITT KRUPP FORS, V40, P123
   Buehler WJ, 1968, OCEAN ENGNG, V1, P105
   Castleman L. S., 1981, BIOCOMPATIBILITY CLI, V1, P129
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   CRAGG AH, 1993, RADIOLOGY, V189, P775, DOI 10.1148/radiology.189.3.8234703
   CUTWRIGHT DE, 1973, ORAL SURG, V35, P578
   EVANS EJ, 1994, BIOMATERIALS, V15, P713, DOI 10.1016/0142-9612(94)90170-8
   GALANTE JO, 1991, J ORTHOPAED RES, V9, P760, DOI 10.1002/jor.1100090516
   GORBET M, 1996, P 5 WORLD BIOM C TOR, P599
   *ISO, 1992, 10993EN30993 ISO 3
   KAMBIC H, 1988, INT J ARTIF ORGANS, V11, P487
   LATAL D, 1994, UROL RES, V22, P295, DOI 10.1007/BF00297198
   McKay GC, 1996, BIOMATERIALS, V17, P1339, DOI 10.1016/0142-9612(96)88681-9
   OSHIDA Y, 1991, CORROSION ENG, V40, P1009
   PRINCE MR, 1988, INVEST RADIOL, V23, P249
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   SANDERS JO, 1993, SPINE, V18, P1640, DOI 10.1097/00007632-199309000-00012
   SANDERS MM, 1992, P INT S 3D SCOL DEF, P343
   SIMON M, 1989, RADIOLOGY, V172, P99, DOI 10.1148/radiology.172.1.2662259
   VICENTINI B, 1986, P INT S SHAP MEM ALL, P447
   WILLIAMS DF, 1982, BIOCOMPATIBILITY ORT, P197
   1993, ANN BOOK ASTM STANDA, P22
NR 24
TC 217
Z9 226
U1 1
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 1997
VL 18
IS 16
BP 1115
EP 1120
DI 10.1016/S0142-9612(97)00041-0
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA XK250
UT WOS:A1997XK25000006
PM 9247349
DA 2018-10-20
ER

PT J
AU Draget, KI
   SkjakBraek, G
   Smidsrod, O
AF Draget, KI
   SkjakBraek, G
   Smidsrod, O
TI Alginate based new materials
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article; Proceedings Paper
CT Plant Polysaccharide Symposium
CY JUL 17-19, 1996
CL NANTES, FRANCE
DE alginates; gels; polysaccharides
ID AZOTOBACTER-VINELANDII; CHEMICAL-COMPOSITION; URONATE RESIDUES; GELS;
   ACID; SEQUENCE; ISLETS
AB Present and future applications of alginates are mainly linked to the most striking feature of the alginate molecule; i.e. a sol/gel transition in the presence of multivalent cations, e.g. Ca2+, almost independent on temperature. These very mild conditions, combined with the fact that alginates are highly characterised and understood both in the liquid and in the gel phase, makes this biopolymer unique compared to other gelling polysaccharides. Only pectins resemble alginate in the sol/gel transition behaviour, but this system can hardly be said to be as well characterised and understood as the alginates. The properties of alginate solutions and gels suggest biomedical and pharmaceutical uses. In this paper, the question of the specifications required by a polymer for applications in some biomedical areas will be discussed. (C) 1997 Elsevier Science B.V.
RP Draget, KI (reprint author), NORWEGIAN UNIV SCI & TECHNOL, DEPT BIOTECHNOL, NORWEGIAN BIOPOLYMER LAB, NBOIPOL, N-7034 TRONDHEIM, NORWAY.
CR DELLAVALLE F, Patent No. 874014640
   Draget KI, 1996, CARBOHYD POLYM, V29, P209, DOI 10.1016/0144-8617(96)00029-X
   DRAGET KI, 1994, CARBOHYD POLYM, V25, P31, DOI 10.1016/0144-8617(94)90159-7
   DRAGET KI, 1989, APPL MICROBIOL BIOT, V31, P79
   DRAGET KI, 1988, J PLANT PHYSIOL, V132, P552, DOI 10.1016/S0176-1617(88)80252-9
   ERTESVAG H, 1995, MOL MICROBIOL, V16, P719, DOI 10.1111/j.1365-2958.1995.tb02433.x
   ERTESVAG H, 1994, J BACTERIOL, V176, P2846
   Espevik T., 1996, CARBOHYDR EUR, V14, P19
   GRASDALEN H, 1979, CARBOHYD RES, V68, P23, DOI 10.1016/S0008-6215(00)84051-3
   GRASDALEN H, 1983, CARBOHYD RES, V118, P255, DOI 10.1016/0008-6215(83)88053-7
   GRASDALEN H, 1977, CARBOHYD RES, V56, pC11, DOI 10.1016/S0008-6215(00)83369-8
   HAUG A, 1967, ACTA CHEM SCAND, V21, P2859, DOI 10.3891/acta.chem.scand.21-2859
   HAUG A, 1963, ACTA CHEM SCAND, V17, P1466, DOI 10.3891/acta.chem.scand.17-1466
   HAUG A, 1963, ACTA CHEM SCAND, V17, P1653, DOI 10.3891/acta.chem.scand.17-1653
   KOHN R, 1972, ACTA CHEM SCAND, V26, P2455, DOI 10.3891/acta.chem.scand.26-2455
   LARSEN B, 1970, ACTA CHEM SCAND, V24, P726, DOI 10.3891/acta.chem.scand.24-0726
   LEO WJ, 1990, BIOTECHNOL PROGR, V6, P51, DOI 10.1021/bp00001a008
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   MARTINSEN A, 1992, BIOTECHNOL BIOENG, V39, P186, DOI 10.1002/bit.260390210
   MIKKELSEN A, 1995, BIOPOLYMERS, V36, P1741
   Moe S., 1992, US Patent, Patent No. [5,144,016, 5144016]
   MOE ST, 1993, MACROMOLECULES, V26, P3589, DOI 10.1021/ma00066a017
   PENMAN A, 1972, CARBOHYD RES, V25, P273, DOI 10.1016/S0008-6215(00)81637-7
   SIME WJ, 1990, FOOD GELS, P53
   SKJAKBRAEK G, 1986, INT J BIOL MACROMOL, V8, P330, DOI 10.1016/0141-8130(86)90051-6
   SKJAKBRAEK G, 1989, CARBOHYD POLYM, V10, P31, DOI 10.1016/0144-8617(89)90030-1
   SMIDSROD O, 1972, ACTA CHEM SCAND, V26, P79, DOI 10.3891/acta.chem.scand.26-0079
   SMIDSROD O, 1963, ACTA CHEM SCAND, V17, P1473, DOI 10.3891/acta.chem.scand.17-1473
   SMIDSROD O, 1963, ACTA CHEM SCAND, V17, P2628, DOI 10.3891/acta.chem.scand.17-2628
   SMIDSROD O, 1969, MACROMOLECULES, V2, P42, DOI 10.1021/ma60007a008
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   SMIDSROD O, 1974, FARADAY DISCUSS, V57, P263
   SMIDSROD O, FOOD COLLOIDS PROTEI, P279
   SMIDSROD O, 1967, CARBOHYD RES, V5, P482
   SOONSHIONG P, 1993, P NATL ACAD SCI USA, V90, P5843, DOI 10.1073/pnas.90.12.5843
   SOONSHIONG P, 1991, TRANSPLANT P, V23, P758
   SOONSHIONG P, 1994, LANCET, V343, P950, DOI 10.1016/S0140-6736(94)90067-1
   SOONSHOING P, Patent No. 92709364
   STOKKE BT, 1993, CARBOHYD POLYM, V21, P39, DOI 10.1016/0144-8617(93)90115-K
   Thu B, 1996, BIOMATERIALS, V17, P1031, DOI 10.1016/0142-9612(96)84680-1
   Thu B, 1996, BIOMATERIALS, V17, P1069, DOI 10.1016/0142-9612(96)85907-2
   Thu B, 1996, PROGR BIOTECHNOL, V11, P19
NR 42
TC 297
Z9 305
U1 1
U2 89
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD AUG
PY 1997
VL 21
IS 1-2
BP 47
EP 55
DI 10.1016/S0141-8130(97)00040-8
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA XQ942
UT WOS:A1997XQ94200008
PM 9283015
DA 2018-10-20
ER

PT J
AU Ozin, GA
   Varaksa, N
   Coombs, N
   Davies, JE
   Perovic, DD
   Ziliox, M
AF Ozin, GA
   Varaksa, N
   Coombs, N
   Davies, JE
   Perovic, DD
   Ziliox, M
TI Bone mimetics: A composite of hydroxyapatite and calcium
   dodecylphosphate lamellar phase
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID TRANSFORM INFRARED-SPECTROSCOPY; PHOSPHATE ESTER; EARLY DEPOSITS;
   SOLID-PHASE; PO4 DOMAIN; ENVIRONMENT; EVOLUTION; ENAMEL; AGE; NMR
AB The synthesis of composites based upon mineral and organic constituents is of importance for the development of materials for biomedical applications, such as bone replacement, augmentation and repair. Herein we describe a biologically inspired inorganic materials chemistry approach to bone mimetics. The synthetic strategy is based upon the surfactant-templated cooperative assembly of a composite that is composed of a calcium dodecylphosphate lamellar phase (CaDDP) and a calcium hydroxyphosphate (CaP) mineral phase. The measured properties of the chemically formed composite suggest that it is distinct from simple physical mixtures of the CaDDP and CaP components. A key difference is the generation of biologically important hydrogenphosphate located at the interface between the CaDDP and CaP phases only in the chemically formed composite. The synthesis of the composite is considered to involve the synergistic interaction of CaDDP and CaP, possibly aided by interfacial complementarity of charge and geometry. CaDDP is chemically stable and non-toxic, rendering the composite potentially useful for biomedical applications.
C1 IMAGETEK ANALYT IMAGING,TORONTO,ON M6J 2K4,CANADA.
   UNIV TORONTO,CTR BIOMAT,TORONTO,ON M5S 1A1,CANADA.
   UNIV TORONTO,DEPT MET & MAT SCI,TORONTO,ON M5S 3E4,CANADA.
   BRUKER INSTRUMENTS INC,BILLERICA,MA 01821.
RP Ozin, GA (reprint author), UNIV TORONTO,LASH MILLER CHEM LABS,MAT CHEM RES GRP,80 ST GEORGE ST,TORONTO,ON M5S 3H6,CANADA.
CR AUE WP, 1984, BIOCHEMISTRY-US, V23, P6110, DOI 10.1021/bi00320a032
   BUNTON CA, 1958, J CHEM SOC, V3, P3574
   BUTCHER WW, 1955, J AM CHEM SOC, V77, P2420, DOI 10.1021/ja01614a018
   DALLEMAGNE MJ, 1973, BIOL MINERALIZATION
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Emsley J., 1976, CHEM PHOSPHORUS
   FOWLER BO, 1993, CHEM MATER, V5, P1417, DOI 10.1021/cm00034a009
   GORENSTEIN DG, 1975, J AM CHEM SOC, V97, P898, DOI 10.1021/ja00837a039
   HULL D, 1981, INTRO COMPOSITE MATE
   MIQUEL J L, 1990, Clinical Materials, V5, P115, DOI 10.1016/0267-6605(90)90011-J
   *MRS, 1996, MRS BULL, V21, P18
   *NAT MAT ADV BOARD, 1994, HIER STRUCT BIOL AS
   OKAZAKI M, 1989, BIOMATERIALS, V10, P126, DOI 10.1016/0142-9612(89)90045-8
   OKAZAKI M, 1991, BIOMATERIALS, V12, P46, DOI 10.1016/0142-9612(91)90131-S
   REY C, 1991, CALCIFIED TISSUE INT, V49, P383, DOI 10.1007/BF02555847
   REY C, 1990, CALCIFIED TISSUE INT, V46, P384, DOI 10.1007/BF02554969
   ROTHWELL WP, 1980, J AM CHEM SOC, V102, P2637, DOI 10.1021/ja00528a020
   SUBIRADE M, 1961, ANN CHIM FR, V16, P41
   Vincent J. F. V., 1990, STRUCTURAL BIOMATERI
   YESINOWSKI JP, 1987, J AM CHEM SOC, V109, P6274, DOI 10.1021/ja00255a009
NR 20
TC 50
Z9 52
U1 0
U2 7
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON ROAD, CAMBRIDGE, CAMBS,
   ENGLAND CB4 4WF
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PD AUG
PY 1997
VL 7
IS 8
BP 1601
EP 1607
DI 10.1039/a702416i
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA XQ209
UT WOS:A1997XQ20900050
DA 2018-10-20
ER

PT J
AU HernandezBorges, AA
   Pareras, LG
   Jimenez, A
AF HernandezBorges, AA
   Pareras, LG
   Jimenez, A
TI Comparative analysis of pediatric mailing lists on the Internet
SO PEDIATRICS
LA English
DT Article
DE Internet; mailing lists; pediatric information sources
AB Objective. To analyze quantitative aspects and the relative quality of various pediatric discussion groups on the Internet and to contrast them with qualitative aspects of a selected number of pediatric journals.
   Material and Methods. An extensive number of mailing lists an the Internet of interest to pediatricians was compiled. Twelve of them concerned with pediatric specialties were selected. Six representative journals of pediatric specialties were also analyzed and compared with the corresponding mailing lists. From the list of subscribers we studied the potential quality of each mailing list. The postings sent by each member to the on-line discussions were also analyzed. As an estimate of the standing as author of each list member as well as of each first author of the selected journals, we calculated several indexes of quality using the 1995 Medline database and the impact factors of the biomedical journals reported by the 1994 Science Citation Index. Results. The most popular lists were NICU-NET and PICU, both having more than 1100 subscribers. PEDPATH and PEDIHEART had the highest percentage of subscribers who were published authors, and their papers also yielded the highest impact factors. The most active lists were NICU-NET and PICU. The most participative ones were CHILD-NEURO and FED-LUNG. CHILD-NEURO had the highest percentage of authors among the participants. PEDPATH and CHILD-NEURO had the authors with the highest impact factors among the people who participated in the discussions. These latter two lists also showed the highest impact factor per posting. Those which had the highest yield (highest activity with highest quality per posting) were CHILD-NEURO and PEDIHEART. The average impact factor per first author of the analyzed journals was always higher than the average impact factor per participant of the lists.
   Conclusions. The electronic-mad discussion groups on the Internet are new nonacademic forums in which knowledge and experience in pediatrics can be shared. They cannot replace but they complement other more academic sources such as medical journals.
C1 UNIV HOSP CANARY ISL, DEPT PEDIAT, TENERIFE, CANARY ISLANDS, SPAIN.
   UNIV HOSP CANARY ISL, DEPT NEUROSURG, TENERIFE, CANARY ISLANDS, SPAIN.
   UNIV HOSP CANARY ISL, RES UNIT, TENERIFE, CANARY ISLANDS, SPAIN.
CR Baldwin F D, 1995, Pa Med, V98, P22
   Cochran W.G., 1977, SAMPLING TECHNIQUES
   Elliott SJ, 1996, PEDIATRICS, V97, P399
   Gilas T, 1995, J Am Coll Surg, V181, P277
   GILAS T, 1995, DIS COLON RECTUM, V38, P780, DOI 10.1007/BF02048043
   LAPORTE RE, 1995, BRIT MED J, V310, P1387, DOI 10.1136/bmj.310.6991.1387
   MONTGOMERY CH, 1995, B MED LIBR ASSOC, V83, P234
   Pallen M, 1995, BRIT MED J, V311, P1626, DOI 10.1136/bmj.311.7020.1626
   PALLEN M, 1995, BRIT MED J, V311, P1487, DOI 10.1136/bmj.311.7018.1487
   PARERAS LG, 1996, INTERNET MED, P1
   PARKIN D, 1993, PUBLIC HLTH PHYSICIA, V4, P10
   TarczyHornoch P, 1996, PEDIATRICS, V97, P398
NR 12
TC 11
Z9 11
U1 0
U2 0
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD, ELK GROVE VILLAGE, IL 60007-1098
SN 0031-4005
J9 PEDIATRICS
JI Pediatrics
PD AUG
PY 1997
VL 100
IS 2
BP art. no.
EP e8
DI 10.1542/peds.100.2.e8
PG 7
WC Pediatrics
SC Pediatrics
GA XP050
UT WOS:A1997XP05000023
PM 9233979
OA Bronze
DA 2018-10-20
ER

PT J
AU Chen, XH
   McCarthy, SP
   Gross, RA
AF Chen, XH
   McCarthy, SP
   Gross, RA
TI Synthesis and characterization of [L]-lactide - Ethylene oxide
   multiblock copolymers
SO MACROMOLECULES
LA English
DT Article
ID RING-OPENING POLYMERIZATION; CONTROLLED MOLECULAR-WEIGHT; ALUMINUM
   PORPHYRIN; BLOCK-COPOLYMERS; POLY(ETHYLENE GLYCOL); LIVING
   POLYMERIZATION; EPSILON-CAPROLACTONE; PROPYLENE-OXIDE; L-LACTIDE;
   DEGRADATION
AB [L]-Lactide ([L]-LA)/ethylene oxide (EO) ring-opening copolymerizations were successfully carried out by using various catalysts including isobutylaluminoxane (IBAO), in situ AlR3 . 0.5H(2)O systems (R = ethyl, isobutyl) and Sn-Al bimetallic catalysts. Analysis of products by H-1 NMR showed that methanol insoluble copolymer fractions had multiblock structures. The multiblock segment length and molecular weight of the copolymers were regulated by a variation in the reaction temperature, reaction time, reaction medium, and the catalyst structure. An increase in the reaction temperature was used to obtain shorter segment block lengths. Bulk reactions at elevated temperatures gave shorter block lengths than those of corresponding polymerizations conducted in solution (xylene). Differential scanning calorimetry (DSC) results showed two melting transitions corresponding to poly(ethylene oxide) (PEG) and [L]-polylactide ([L]-PLA) crystalline phases. The melting temperature and enthalpy of fusion for the phase-separated [L]-PLA crystalline phase was ''tailored'' by modulating the copolymer composition and the [L]-PLA block length. Blends with PW were prepared by substituting poly(ethylene glycol) (PEG) with a high EO content [L]-PLA/EO multiblock copolymer. The idea explored was that the multiblock copolymers would be expected to leach into aqueous environments at a slower rate than PEGs. Substitution of the [L]-PLA/EO copolymer in place of PEG resulted in important increases in the film modulus and yield strength without loss in elongation at yield, break stress, and elongation at break. Thus, we demonstrated a versatile route to important new multiblock [L]-PLA/EO copolymers which have excellent potential to be useful for a wide range of biomedical applications including bioresorbable implant materials and tissue engineering. Furthermore, the synthetic methods developed herein provide routes which will be useful in ''fine-tuning'' product physicomechanical properties and degradation rates.
C1 UNIV MASSACHUSETTS,NSF,BIODEGRADABLE POLYMER RES CTR,LOWELL,MA 01854.
CR AIDA T, 1980, MAKROMOL CHEM-RAPID, V1, P677
   AIDA T, 1981, MACROMOLECULES, V14, P1162, DOI 10.1021/ma50006a004
   Alexander H, 1981, ORTHOP REV, V10, P41
   ANDREOPOULOS AG, 1994, J ELASTOM PLAST, V26, P308, DOI 10.1177/009524439402600401
   BERGSMA JE, 1995, BIOMATERIALS, V16, P267, DOI 10.1016/0142-9612(95)93253-A
   BRANDRUP J, 1975, POLYM HDB, P250
   CAKMAK I, 1995, MACROMOL REP A, V32, P1113
   CERRAI P, 1994, J MATER SCI-MATER M, V5, P308, DOI 10.1007/BF00058953
   Chen X., UNPUB
   COHN D, 1988, J BIOMED MATER RES, V22, P993, DOI 10.1002/jbm.820221104
   DENG XM, 1995, J APPL POLYM SCI, V55, P1193, DOI 10.1002/app.1995.070550806
   ECHEVERR.E, 1970, SURG GYNECOL OBSTETR, V131, P1
   ELING B, 1982, POLYMER, V23, P1587, DOI 10.1016/0032-3861(82)90176-8
   ENDO M, 1987, MACROMOLECULES, V20, P2982, DOI 10.1021/ma00178a005
   FREDERICKS RJ, 1984, J POLYM SCI POL PHYS, V22, P57, DOI 10.1002/pol.1984.180220106
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   GRIJPMA DW, 1994, MACROMOL CHEM PHYSIC, V195, P1633, DOI 10.1002/macp.1994.021950515
   GROSS RA, 1988, MACROMOLECULES, V21, P2657, DOI 10.1021/ma00187a002
   Inoue S, 1992, NEW METHOD POLYM SYN, P33
   KIM SH, 1992, MAKROMOL CHEM, V193, P1623
   KIMURA Y, 1989, POLYMER, V30, P1342, DOI 10.1016/0032-3861(89)90058-X
   Li S., UNPUB
   ODIAN G, 1991, PRINCIPLES POLYM, P554
   OKTEM Z, 1993, EUR POLYM J, V29, P637, DOI 10.1016/0014-3057(93)90121-U
   OUCHI T, 1987, J MACROMOL SCI CHEM, VA24, P1011, DOI 10.1080/00222338708078140
   SHEN ZQ, 1994, J POLYM SCI POL CHEM, V32, P597, DOI 10.1002/pola.1994.080320401
   SHETH M, IN PRESS J APPL POLY
   SHIMASAKI K, 1987, MACROMOLECULES, V20, P3076, DOI 10.1021/ma00178a023
   STEVELS WM, 1995, MACROMOL CHEM PHYSIC, V196, P3687, DOI 10.1002/macp.1995.021961121
   TIJSMA EJ, 1994, J MACROMOL SCI R M C, VC34, P515, DOI 10.1080/15321799408014166
   TROFIMOFF L, 1987, CHEM LETT, P991, DOI 10.1246/cl.1987.991
   WANG Y, 1995, J FUNCT MAT, V26, P567
   YASHUDA T, 1983, MACROMOLECULES, V16, P1792
   ZHANG Y, 1990, MACROMOLECULES, V23, P3206, DOI 10.1021/ma00215a002
   ZHANG YF, 1989, INORG CHIM ACTA, V155, P263
NR 35
TC 90
Z9 94
U1 2
U2 38
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JUL 28
PY 1997
VL 30
IS 15
BP 4295
EP 4301
DI 10.1021/ma970385e
PG 7
WC Polymer Science
SC Polymer Science
GA XP202
UT WOS:A1997XP20200008
DA 2018-10-20
ER

PT J
AU Thompson, JY
   Bayne, SC
   Swift, EJ
   Stamatiades, F
AF Thompson, JY
   Bayne, SC
   Swift, EJ
   Stamatiades, F
TI Dental materials citations: Part A, January to June 1997
SO DENTAL MATERIALS
LA English
DT Bibliography
AB Objective. A search was conducted in biomedical journals published from January 1997 to June 1997 to identify all dental materials publications and sort them into major categories.
   Methods. Tables of contents for 79 journals for the period of January to June, 1997 were inspected and divided into 17 categories. Citations were analyzed by both frequency in journals and in categories, as well as compared to frequencies for previous years.
   Results. A total of 445 citations were detected in 79 journals for the period January 1997 to June 1997. Certain journals (n = 19) demonstrated a higher citation frequency (greater than or equal to 10 citations for 6 months) and represented 77.8% of all citations. The greatest number of citations continued to involve bonding (n = 97), resin-based restorative materials (composites; glass ionomers) (n = 95), prosthodontic materials (n = 51), and pulp protection I luting materials (n = 48). Frequencies by category were very similar to those for the last four years.
   Significance. The compiled literature citations provide a supplement for researchers and academicians seeking information in existing electronic databases.
C1 Univ N Carolina, Sch Dent, Dept Operat Dent, Chapel Hill, NC 27599 USA.
RP Thompson, JY (reprint author), Univ N Carolina, Sch Dent, Dept Operat Dent, Chapel Hill, NC 27599 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD JUL
PY 1997
VL 13
IS 4
BP 270
EP 285
DI 10.1016/S0109-5641(97)80039-5
PG 16
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 110DJ
UT WOS:000075364600008
PM 11696907
DA 2018-10-20
ER

PT J
AU Arazi, ZS
   Harel, H
   Marom, G
   Yavin, B
AF Arazi, ZS
   Harel, H
   Marom, G
   Yavin, B
TI Polyethylene/polyethylene composite materials for ballistic protection
SO SAMPE JOURNAL
LA English
DT Article
ID POLYETHYLENE
AB The ability to manufacture polyethylene fiber reinforced polyethylene (PE/PE) composites (classified as ''single polymer composites'') without causing fiber relaxation and loss of mechanical properties is currently utilized in a number of engineering and biomedical applications. This paper describes the manufacture and characterization of PE/LDPE and PE/HDPE composites for ballistic protection. Preliminary ballistic impact testing and fracture analysis show that both, and in particular the PE/HDPE, system exhibit impressive ballistic resistance.
C1 ISRAEL MIL IND,ROCKET SYST DIV,RAMAT HASHARON,ISRAEL.
RP Arazi, ZS (reprint author), HEBREW UNIV JERUSALEM,GRAD SCH APPL SCI,CASALI INST APPL CHEM,IL-91905 JERUSALEM,ISRAEL.
CR ARAZI ZS, 1996, THESIS HEBREW U JERU
   CHARNIS CC, 1972, ASTM STP, V497
   FRISSEN R, 1995, P ICCM 10, V5, P759
   JANG BZ, 1990, POLYM COMPOSITE, V11, P144, DOI 10.1002/pc.750110303
   LEE BL, 1994, J COMPOS MATER, V28, P1202, DOI 10.1177/002199839402801302
   PENNINGS AJ, 1979, J POLYM SCI POL PHYS, V17, P1011, DOI 10.1002/pol.1979.180170610
   STERN T, UNPUB
   STERN T, 1995, ADV COMPOS LETT, V5, P103
   STERN T, 1997, IN PRESS COMPOSITE A, V6
   TEISHEV A, 1993, J APPL POLYM SCI, V50, P503, DOI 10.1002/app.1993.070500314
   TEISHEV A, 1995, J APPL POLYM SCI, V56, P503
   VANMELE B, 1995, COMPOS INTERFACE, V3, P83
   YOUNG RJ, 1992, INTRO POLYM, P341
NR 13
TC 9
Z9 10
U1 0
U2 9
PU SAMPE PUBLISHERS
PI COVINA
PA 1161 PARKVIEW DRIVE, COVINA, CA 91722
SN 0091-1062
J9 SAMPE J
JI Sampe J.
PD JUL-AUG
PY 1997
VL 33
IS 4
BP 72
EP 75
PG 4
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA XK810
UT WOS:A1997XK81000012
DA 2018-10-20
ER

PT J
AU Bistue, G
   Elizalde, JG
   GarciaAlonso, S
   Castano, E
   Gracia, FJ
   GarciaAlonso, A
AF Bistue, G
   Elizalde, JG
   GarciaAlonso, S
   Castano, E
   Gracia, FJ
   GarciaAlonso, A
TI A design tool for pressure microsensors based on FEM simulations
SO SENSORS AND ACTUATORS A-PHYSICAL
LA English
DT Article; Proceedings Paper
CT EUROSENSORS X Meeting
CY SEP 08-11, 1996
CL LOUVAIN, BELGIUM
DE silicon; microsensors; pressure; simulation
ID SENSOR
AB The main features involved in the design of a pressure sensor are :he maximum non-destructive pressure and the sensitivity. In this work, these two characteristics are related to the following design variables: dimensions of the membrane and mechanical properties of the selected material. Von Misses stress and strain distributions have been calculated by the finite-element method (FEM). The knowledge of these distributions is a good design guideline for an accurate location of the piezoresistors. The results obtained have been applied to the design of silicon microsensors for biomedical and domestic applications. (C) 1997 Elsevier Science S.A.
C1 UNIV NAVARRA,ESCUELA SUPER INGN IND,E-20009 SAN SEBASTIAN,SPAIN.
RP Bistue, G (reprint author), CEIT,CTR ESTUD & INVEST TECN GUIPUZCOA,POB 1555,E-20009 SAN SEBASTIAN,SPAIN.
RI Elizalde, Jorge/A-5508-2013
OI Elizalde, Jorge/0000-0002-5785-0618
CR FOLKMER B, 1992, SENSOR ACTUAT A-PHYS, V32, P521, DOI 10.1016/0924-4247(92)80037-4
   Hoffmann K., 1989, INTRO MEASUREMENTS U, P145
   KOVACS A, 1994, SENSOR ACTUAT A-PHYS, V42, P672, DOI 10.1016/0924-4247(94)80073-1
   MARCO S, 1991, REAL SOC ESPANOLA P, V19, P912
   SEIDE P, 1992, THEORETICAL MANUAL C, P141
   SUZUKI K, 1987, IEEE T ELECTRON DEV, V34, P1360, DOI 10.1109/T-ED.1987.23092
   TANIGAWA H, 1985, IEEE T ELECTRON DEV, V32, P1191, DOI 10.1109/T-ED.1985.22099
   TIMOSHENKO S, 1959, THEORY PLATES SHELLS, P5
   ZIENKIEWICZ OC, 1982, METODO ELEMENTOS FIN, P6
NR 9
TC 20
Z9 20
U1 1
U2 3
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-4247
J9 SENSOR ACTUAT A-PHYS
JI Sens. Actuator A-Phys.
PD JUL
PY 1997
VL 62
IS 1-3
BP 591
EP 594
DI 10.1016/S0924-4247(97)01598-7
PG 4
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA YD906
UT WOS:A1997YD90600023
DA 2018-10-20
ER

PT J
AU DeWitte, JI
   Welie, JVM
AF DeWitte, JI
   Welie, JVM
TI The status of genetic material and genetic information in the
   Netherlands
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE ownership; body material; genetic material; genetic information
AB The moral status of genetic material and information and the ethics of controlling and manipulating them, is a topic of hot debate in many European countries, including The Netherlands. That heat is due partly to the complexity of the topic, and partly to researchers' fear that their investigations will be hampered by restrictions on the use of personal data or body material. But there is little doubt that manifold diverging interpretations about the status of the human body, body materials, and personal information in Dutch law, written and unwritten, contribute to the intensity of the debates. This article intends to structure the debate by creating more clarity at the conceptual level. By carefully examining relevant articles of the Constitution and Civil Codes, as well as policy documents and authoritative publications, notably in reference to prominent legal concepts such as property, ownership and privacy, an answer should be provided to the following crucial question: is the status of genetic material and information in any sense special in comparison with other body parts and other kinds of information about a person? This paper first discusses the status of human body materials and personal information in general, and then continues with a more specific discussion about the status of genetic material and information. It concludes that the Dutch legislature had carefully avoided (or not felt the need to employ) the concept of ownership in regulating biomedical research; rather, privacy is found to be the prime regulatory concept. (C) 1997 Elsevier Science Ltd.
C1 UNIV NIJMEGEN,DEPT ETH PHILOSOPHY & HIST MED,NL-6500 HB NIJMEGEN,NETHERLANDS.
RP DeWitte, JI (reprint author), UNIV NIJMEGEN,CTR ETH,POB 9103,NL-6500 HD NIJMEGEN,NETHERLANDS.
CR ABBING HDC, 1989, TIJDSCHRIFT GEZONDHE, V13, P362
   De Wert G, 1990, MAG IK UW GENENPASPO
   DOPPEGIETER RMS, 1991, MEDISCH CONTACT, V46, P1081
   *ERF GENTH, 1990, BRIEF STAATSS WELZ V
   FRANKENA HC, 1990, TIJDSCHRIFT GEZONDHE, V14, P185
   Gevers J K, 1989, Ned Tijdschr Geneeskd, V133, P173
   GEVERS JKM, 1988, METAMEDICA, V67, P56
   GEVERS JKM, 1987, JURIDISCHE ASPECTEN
   GEVERS JKM, 1990, BESCHIKKEN OVER CELL
   *GEZ, 1989, ERF MAATSCH WET
   KUITERT HM, 1989, MAG ALLES WAT KAN, P177
   LEENEN HJJ, 1978, TIJDSCHRIFT GEZONDHE, V2, P1
   LEENEN HJJ, 1988, HDB GEZONDHEIDSRECHT
   *NAT RAAD VOLKSG, 1991, ADV NORM OND LICH
   *RICHTL VER GEZ, 1991, MEDISCH CONTACT, V46, P1086
   TENKATE LP, 1976, METAMEDICA, V55, P49
   VANGALENHERMAN RE, 1992, NEDERLANDS JURISTENB, V67, P1263
   *VERW IMM DEF, 1989, BRIEF MIN JUST AANH
NR 18
TC 1
Z9 1
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD JUL
PY 1997
VL 45
IS 1
BP 45
EP 49
DI 10.1016/S0277-9536(96)00308-5
PG 5
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA XE824
UT WOS:A1997XE82400007
PM 9203270
OA Green Published
DA 2018-10-20
ER

PT J
AU McVea, KLSP
AF McVea, KLSP
TI Lay injection practices among migrant farmworkers in the age of AIDS:
   Evolution of a biomedical folk practice
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE injections; HIV-infection; migrant farmworkers; self medication
ID POLIOMYELITIS; KINSHASA; WORKERS; ZAIRE
AB The practice of injecting vitamins and antibiotics by lay people is common among Hispanic migrant farmworkers in the U.S.A. This practice has recent roots in the Latin American cultures from which these farmworkers originate, but it presents a public health concern in its new context because of the high prevalence of HIV infection among this disenfranchised population. Reasons for use of lay injections include cultural beliefs about the superiority of injections over oral forms of medications, perceived irrelevance of a professional diagnostician in prescribing empirical treatment, and a multitude of barriers to access to Western medicine. Although HIV educational materials directed at migrant farmworkers do not address the issue of sharing needles for these types of injections, some farmworkers indicated they had already modified their injection techniques in response to simple directives from physicians in their home country. In contrast to other folk treatment practices that have been resistant to change mediated solely through the provision of information, lay injection is such a new development that considerable experimentation and incorporation of new knowledge are still actively shaping its use. In this process; physicians are seen as legitimate sources of information about the use of Western pharmaceuticals; they should use this role to discourage unsafe injection practices. Efforts to extinguish the practice of lay injection entirely are less likely to meet with success so long as other means of accessing Western medicine are limited. (C) 1997 Elsevier Science Ltd.
RP McVea, KLSP (reprint author), UNIV NEBRASKA,MED CTR,DEPT FAMILY PRACTICE,600 S 42ND ST,OMAHA,NE 68198, USA.
CR Angeles-Chimal P, 1992, Salud Publica Mex, V34, P554
   BLOEM M, 1993, IMPACT INJECTIONS DA
   *CDC, 1988, MMWR-MORBID MORTAL W, V37, P517
   COSMINSKY S, 1980, SOC SCI MED-MED ANTH, V14, P267, DOI 10.1016/0160-7987(80)90052-6
   CUNNINGH.CE, 1970, SOC SCI MED, V4, P1, DOI 10.1016/0037-7856(70)90056-9
   Ferguson Anne, 1988, CONTEXT MED DEV COUN, P19
   Finkler K., 1985, SPIRITUALIST HEALERS
   FITZSIMMONS CI, 1974, THESIS U TEXAS AUSTI
   JONES JL, 1991, SOUTHERN MED J, V84, P1088, DOI 10.1097/00007611-199109000-00007
   LAFFERTY J, 1991, AM J PUBLIC HEALTH, V81, P221, DOI 10.2105/AJPH.81.2.221
   Lewis Oscar, 1961, CHILDREN SANCHEZ
   Lewis Oscar, 1959, 5 FAMILIES MEXICAN C
   LILLESAND D, 1977, ESTIMATE NUMBER MIGR
   LOGAN K, 1988, CONTEXT MED DEV COUN, P107
   LOUE S, 1994, AIDS EDUC PREV, V6, P74
   MANN JM, 1986, LANCET, V2, P654
   MANN JM, 1986, JAMA-J AM MED ASSOC, V256, P3099, DOI 10.1001/jama.256.22.3099
   MARIN G, 1989, PUBLIC HEALTH REP, V104, P411
   MESSER E, 1975, THESIS U MICHIGAN AN
   MURDOCK GP, 1985, OUTLINE WORLD CULTUR
   NASH J, 1967, AM ANTHROPOL, V69, P455, DOI 10.1525/aa.1967.69.5.02a00020
   QUINN TC, 1986, SCIENCE, V234, P955, DOI 10.1126/science.3022379
   REELER AV, 1990, SOC SCI MED, V31, P1119, DOI 10.1016/0277-9536(90)90233-I
   RODRIGUEZ BU, 1994, ATENCION PRIMARIA, V13, P57
   RUBEL AJ, 1966, TRACKS MEXICAN AM TE
   SAUNDERS L, 1954, CULTURAL DIFFERENCE
   TAYLOR RB, 1960, THESIS U OREGON EUGE
   VAN DER GEEST S., 1988, CONTEXT MED DEV COUN
   VANDERGEEST S, 1982, MED ANTHR        FAL, P197
   WOLFF MJ, 1993, CLIN INFECT DIS, V17, pS346, DOI 10.1093/clinids/17.Supplement_2.S346
   WOODS CM, 1977, MED ANTHROPOL, V1, P25
   WYATT HV, 1992, SOC SCI MED, V35, P795, DOI 10.1016/0277-9536(92)90079-6
   WYATT HV, 1984, SOC SCI MED, V19, P911, DOI 10.1016/0277-9536(84)90320-4
NR 33
TC 26
Z9 27
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD JUL
PY 1997
VL 45
IS 1
BP 91
EP 98
DI 10.1016/S0277-9536(96)00318-8
PG 8
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA XE824
UT WOS:A1997XE82400011
PM 9203274
DA 2018-10-20
ER

PT J
AU Chate, DM
   Kamra, AK
AF Chate, DM
   Kamra, AK
TI Collection efficiencies of large water drops collecting aerosol
   particles of various densities
SO ATMOSPHERIC ENVIRONMENT
LA English
DT Article
DE scavenging; washout; aerosol removal; deposition
ID CLOUD DROPS; RAINDROPS; COLLIDE
AB A laboratory experiment to study the effect of the density of aerosol material on collection efficiency of water drops, is conducted with MgSO4 and MnCl2 particles. When compared with the earlier results for NaCl and other particles, our observations show that the collection efficiency of water drops increases with increase in impaction parameter, irrespective of whether the change in impaction parameter is caused by the change in the density of particles or the size of particles/water drop. Our results are correlated through the aerodynamical diameter parameter and with earlier experimental results of other investigators for particles of different densities. The agreement between our experimental results and the theory of Slinn (1983, Precipitation Scavenging in Atmospheric Sciences and Power Production, Chap. 11. Division of Biomedical Environmental Research, U.S. Department of Energy) increases with the increase in the density or size of the particles. Moreover, our experimental results confirm the prediction of Slinn's theory that inertial impaction mechanism is dominant for smaller particles if their density is higher. (C) 1997 Elsevier Science Ltd.
RP Chate, DM (reprint author), INDIAN INST TROP METEOROL,PUNE 411008,MAHARASHTRA,INDIA.
CR ADAM JR, 1970, PRECIPITATION SCAVEN
   BEARD KV, 1976, J ATMOS SCI, V33, P851, DOI 10.1175/1520-0469(1976)033<0851:TVASOC>2.0.CO;2
   BERGLUND RN, 1973, ENVIRON SCI TECHNOL, V7, P147, DOI 10.1021/es60074a001
   GROVER SN, 1975, J ATMOS SCI, V32, P2156, DOI 10.1175/1520-0469(1975)032<2156:ANDOTE>2.0.CO;2
   HORN HG, 1988, J AEROSOL SCI, V19, P855, DOI 10.1016/0021-8502(88)90051-1
   KERKER M, 1974, J ATMOS SCI, V31, P1368, DOI 10.1175/1520-0469(1974)031<1368:SOAPBA>2.0.CO;2
   LAI KY, 1978, J ATMOS SCI, V35, P674, DOI 10.1175/1520-0469(1978)035<0674:SOAPBA>2.0.CO;2
   LEONG KH, 1982, J ATMOS SCI, V39, P1130
   MCGANN BT, 1991, ATMOS ENVIRON A-GEN, V25, P791, DOI 10.1016/0960-1686(91)90077-K
   NETO PJG, 1994, ATMOS ENVIRON, V28, P2335
   Pranesha TS, 1996, J GEOPHYS RES-ATMOS, V101, P23373, DOI 10.1029/96JD01311
   SEINFELD JH, 1986, ATMOSPHERIC CHEM PHY, P620
   Slinn W., 1983, PRECIPITATION SCAVEN
   SOOD SK, 1969, IIRT1C61059 IL RES I
   STARR JR, 1966, Q J ROY METEOR SOC, V92, P490, DOI 10.1002/qj.49709239405
   Walton W. H., 1960, AERODYNAMIC CAPTURE, P129
   WHITBY KT, 1968, ATMOS ENVIRON, V2, P103, DOI 10.1016/0004-6981(68)90026-7
NR 17
TC 20
Z9 20
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 1352-2310
J9 ATMOS ENVIRON
JI Atmos. Environ.
PD JUN
PY 1997
VL 31
IS 11
BP 1631
EP 1635
DI 10.1016/S1352-2310(96)00338-X
PG 5
WC Environmental Sciences; Meteorology & Atmospheric Sciences
SC Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences
GA WR161
UT WOS:A1997WR16100004
DA 2018-10-20
ER

PT J
AU Nicolas, FL
   Gagnieu, CH
AF Nicolas, FL
   Gagnieu, CH
TI Denatured thiolated collagen .2. Cross-linking by oxidation
SO BIOMATERIALS
LA English
DT Article
DE collagen; gelatin; thiol; cross-linking; disulphide bridge
ID GLUTARALDEHYDE; SUSCEPTIBILITY; IRRADIATION; PROTEOLYSIS
AB We have recently described a new method for the thiolation of denatured collagen, which allows precise amounts of SH groups to be attached onto the protein backbone. The oxidation of denatured thiolated collagen produces disulphide cross-linking. The cross-linking of these products has been studied, optimized and compared to the cross-linking of native and denatured collagen with 0.5% aqueous glutaraldehyde. Films have been prepared and their tensile mechanical properties and biodegradation rates with trypsin and collagenase have been evaluated. Our results indicate that the cross-linking in oxidized thiolated collagen depends on the number of the disulphide bridges formed and on their intermolecular versus intramolecular repartition. Since the number of disulphide bridges can be controlled by the level of thiol in the denatured collagen and by the oxidation procedure, it is possible to control the mechanical properties and the biodegradation rates of these new materials. Under optimized conditions, oxidized denatured thiolated collagen films are more resistant and rigid than glutaraldehyde-cross-linked collagen films. Cross-linked thiolated collagen materials are also more resistant to collagenase degradation. However, because of the loss of the triple-helical structure, they are more susceptible to trypsin degradation relative to glutaraldehyde-cross-linked triple-helical collagen. Denatured collagen cross-linked by physiological bridges such as disulphide bridges, with controllable mechanical properties and biodegradation rates, is of considerable interesting biomedical applications. (C) 1997 Elsevier Science Limited.
C1 INST NATL SCI APPL,EQUIPE BIOMAT,CHIM BIOL LAB,F-69621 VILLEURBANNE,FRANCE.
CR ACHET D, 1995, POLYMER, V36, P787, DOI 10.1016/0032-3861(95)93109-Y
   BOEDTKER H, 1954, J PHYS CHEM-US, V58, P968, DOI 10.1021/j150521a010
   CAPOZZI G, 1974, CHEM THIOL GROUP 2, P785
   CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P201, DOI 10.3109/03008208209034419
   DELUSTRO F, 1986, J BIOMED MATER RES, V20, P109, DOI 10.1002/jbm.820200110
   DIAMOND AM, 1991, MATRIX, V11, P321, DOI 10.1016/S0934-8832(11)80203-9
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   GORHAM SD, 1992, INT J BIOL MACROMOL, V14, P129, DOI 10.1016/S0141-8130(05)80002-9
   HUC A, 1985, J AM LEATHER CHEM AS, V80, P195
   JOCELYN PC, 1987, METHOD ENZYMOL, V143, P44
   KATO YP, 1990, BIOMATERIALS, V11, P169, DOI 10.1016/0142-9612(90)90150-O
   KAWAMOTO Y, 1990, BIOCHIM BIOPHYS ACTA, V1035, P361, DOI 10.1016/0304-4165(90)90101-2
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   LIU BC, 1989, J BIOMED MATER RES, V23, P833, DOI 10.1002/jbm.820230803
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   MIYATA T, 1971, BIOCHIM BIOPHYS ACTA, V229, P672, DOI 10.1016/0005-2795(71)90283-2
   Nicolas FL, 1997, BIOMATERIALS, V18, P807, DOI 10.1016/S0142-9612(97)00002-1
   PETERKOFSKY B, 1982, METHOD ENZYMOL, V82, P453
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   PIEZ KA, 1989, ENCY POLYM SCI ENG, V3, P699
   ROE SC, 1990, ARTIF ORGANS, V14, P443, DOI 10.1111/j.1525-1594.1990.tb03001.x
   Rose PJ, 1989, ENCY POLYM SCI ENG, V7, P488
   SIEGEL RC, 1985, Patent No. 4544638
   STEGEMANN H, 1958, H-S Z PHYSIOL CHEM, V311, P41, DOI 10.1515/bchm2.1958.311.1.41
   TARDY M, 1990, Patent No. 4931546
   WALLACE TJ, 1963, J ORG CHEM, V28, P1311, DOI 10.1021/jo01040a038
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
NR 28
TC 33
Z9 33
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 1997
VL 18
IS 11
BP 815
EP 821
DI 10.1016/S0142-9612(97)00003-3
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA XA275
UT WOS:A1997XA27500008
PM 9177861
DA 2018-10-20
ER

PT J
AU Baumgartner, JN
   Yang, CZ
   Cooper, SL
AF Baumgartner, JN
   Yang, CZ
   Cooper, SL
TI Physical property analysis and bacterial adhesion on a series of
   phosphonated polyurethanes
SO BIOMATERIALS
LA English
DT Article
DE glycerophosphorylcholine; polyurethane; physical properties; bacterial
   adhesion
ID SURFACES; CHAIN; FLOW
AB Grycerophosphorylcholine (GPC) was incorporated as the chain extender in a series of poly(tetramethylene oxide)-based polyurethane block copolymers. in order to determine the feasibility of use of these polyurethanes in biomedical devices, the effects of GPC incorporation on physical properties were studied. The effect of soft-segment molecular weight was also investigated. Biocompatibility of these materials was studied with regard to bacterial adhesion and protein deposition. Tensile testing showed that as GPC content increased, elongation at break decreased, while Young's modulus increased. Differential scanning calorimetry (DSC) results showed slightly decreased glass transition temperatures (T(g)s) with increasing GPC content, indicating increased phase separation. Dynamic mechanical analysis (DMA) confirmed the decrease in T-g and the increase in rubbery plateau modulus with increasing GPC content. Water absorption was also increased with GPC content. Decreased bacterial adhesion was found on the GPC-containing materials compared to other functionalized polyurethanes. These experiments were carried out in a radial flow chamber utilizing automated video microscopy. Bacterial attachment was found to be lower on the GPC-containing polyurethanes both in the absence of and after pre-adsorption with plasma proteins. (C) 1997 Elsevier Science Limited.
C1 UNIV DELAWARE,DEPT CHEM ENGN,NEWARK,DE 19716.
   NANJING UNIV,DEPT CHEM,NANJING 210093,JIANGSU,PEOPLES R CHINA.
CR ANDERSON JM, 1993, CARDIOVASCULAR PATHO, V2
   ARICOLA CR, 1993, BIOMATERIALS, V14, P1161
   CHAPMAN D, 1993, BIOCHEM SOC T, V21, P258, DOI 10.1042/bst0210258
   CHAPMAN D, 1995, CHEM BRIT, V28, P253
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P107, DOI 10.1016/S0006-3495(90)82357-2
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   DICKINSON RB, 1995, INFECT IMMUN, V63, P3143
   DICKINSON RB, 1995, AICHE J, V41, P2160, DOI 10.1002/aic.690410915
   GODDARD RJ, 1994, J POLYM SCI POL PHYS, V32, P1557, DOI 10.1002/polb.1994.090320827
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   HERGENROTHER RW, 1992, J MATER SCI-MATER M, V3, P313, DOI 10.1007/BF00705361
   ISHIHARA K, 1995, J BIOMED MATER RES, V29, P181, DOI 10.1002/jbm.820290207
   ISHIHARA K, 1994, J BIOMED MATER RES, V28, P225, DOI 10.1002/jbm.820280213
   MAKI DG, 1992, INF CONT S INFL MED, P27
   MOLLER PS, 1963, AERONAUT QUART, V14, P163, DOI 10.1017/S0001925900002742
   Nagel JA, 1996, J BIOMAT SCI-POLYM E, V7, P769, DOI 10.1163/156856296X00110
   OKKEMA AZ, 1991, J BIOMED MATER RES, V25, P1371, DOI 10.1002/jbm.820251106
   RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803
   SILVER JH, 1993, J BIOMED MATER RES, V27, P1443, DOI 10.1002/jbm.820271111
NR 19
TC 52
Z9 54
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 1997
VL 18
IS 12
BP 831
EP 837
DI 10.1016/S0142-9612(96)00197-4
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA XB095
UT WOS:A1997XB09500001
PM 9184746
DA 2018-10-20
ER

PT J
AU Schierholz, JM
   Steinhauser, H
   Rump, AFE
   Berkels, R
   Pulverer, G
AF Schierholz, JM
   Steinhauser, H
   Rump, AFE
   Berkels, R
   Pulverer, G
TI Controlled release of antibiotics from biomedical polyurethanes:
   Morphological and structural features
SO BIOMATERIALS
LA English
DT Article
DE controlled release; antibiotics; polyurethanes; drug-polymer
   compatibility
ID CONTROLLED DRUG RELEASE; IN-VITRO; PREVENTION; COLONIZATION;
   IMPREGNATION; CATHETERS; INFECTION; DEVICES; GRAFT
AB Polymer-associated infections are of increasing importance. Antistaphylococcal antimicrobial substances (ciprofloxacin, gentamycin, fosfomycin, flucloxacillin) were incorporated into polyurethanes by the solvent casting technique. Drug release rates, bacterial colonization and morphological features were evaluated to predict and understand the antimicrobial activity of these delivery systems. Drug release characteristics were investigated by standard bioassay and high-performance liquid chromatography (HPLC), and the physico-chemical mechanisms of the delivery were discussed. Ciprofloxacin hydrochloride showed a fast initial release rate, whereas gentamicin-base was characterized by a more continuous release type of behaviour. Bacterial colonization to the antibiotic-loaded polyurethanes was inhibited effectively by preparations showing a slower but more sustained antimicrobial delivery. Polyurethane-antibiotic combinations were most homogeneous for gentamicin-base and flucloxacillin as shown by scanning electron microscopy (SEM). In polymers loaded with fosfomycin and ciprofloxacin a granular structure of the crystallized drug embedded in the polyurethane matrix could be demonstrated. Physico-chemical similarity of the polymeric material and the antibiotics is important for the homogeneity of polymer-antibiotic combinations. High homogeneity is required for a sustained and prolonged release over time and effective inhibition of bacterial colonization. (C) 1997 Elsevier Science Limited.
C1 UNIV COLOGNE,INST MED MICROBIOL & HYG,COLOGNE,GERMANY.
   UNIV COLOGNE,INST CHEM PHYS,COLOGNE,GERMANY.
   UNIV COLOGNE,INST PHARMACOL,COLOGNE,GERMANY.
CR BACH A, 1994, J ANTIMICROB CHEMOTH, V33, P969
   BAYSTON R, 1989, J NEUROL NEUROSUR PS, V52, P605, DOI 10.1136/jnnp.52.5.605
   BENVENISTY AI, 1988, J SURG RES, V44, P1, DOI 10.1016/0022-4804(88)90116-3
   BROWN MRW, 1985, J ANTIMICROB CHEMOTH, V15, P7, DOI 10.1093/jac/15.suppl_A.7
   CHIEN YW, 1974, J PHARM SCI, V63, P365, DOI 10.1002/jps.2600630311
   CHIEN YW, 1974, J PHARM SCI, V63, P515, DOI 10.1002/jps.2600630405
   CHIEN YW, 1985, J PHARM SCI, V68, P689
   CHIEN YW, 1976, J PHARM SCI, V65, P481
   DESAI J, 1965, J PHARM SCI, V54, P1469
   DESAI SJ, 1966, J PHARM SCI-US, V55, P1224, DOI 10.1002/jps.2600551112
   HAMPL J, 1995, ACTA NEUROCHIR, V133, P147, DOI 10.1007/BF01420065
   Maki DG, 1989, INFECT ASS INDWELLIN, P161
   MAKI DG, 1992, HOSP INFECT, P849
   McDougal E G, 1986, J Vasc Surg, V4, P5
   PEPPAS NA, 1984, ANN NY ACAD SCI, V5, P26
   Raad I, 1996, J INFECT DIS, V173, P418, DOI 10.1093/infdis/173.2.418
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   SAMPATH LA, 1995, J HOSP INFECT, V30, P201, DOI 10.1016/S0195-6701(95)90315-1
   SCHIERHOLZ J, 1994, BIOMATERIALS, V15, P996, DOI 10.1016/0142-9612(94)90080-9
   SCHIERHOLZ J, 1991, NEW POLYM MAT, V3, P61
   SCHIERHOLZ J, 1996, HYG MED S1, V21
   SCHIERHOLZ J, 1995, HOSPITALIS, V65, P1
   Schierholz JM, 1996, ZBL BAKT-INT J MED M, V284, P390
   SOLOMON DD, 1987, CONTR REL, P343
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
NR 25
TC 95
Z9 100
U1 4
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 1997
VL 18
IS 12
BP 839
EP 844
DI 10.1016/S0142-9612(96)00199-8
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA XB095
UT WOS:A1997XB09500002
PM 9184747
DA 2018-10-20
ER

PT J
AU Zasadzinski, JA
AF Zasadzinski, JA
TI Novel approaches to lipid based drug delivery
SO CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE
LA English
DT Review
ID LIPOSOMES; VESICLES; EQUILIBRIUM; PHASE
AB Lipid based drug delivery is hardly new; however, it is experiencing a renaissance due to new applications, such as gene therapy, new methods of enhancing vesicle circulation in the bloodstream by steric stabilization, and novel self-assembly approaches to more complex structures. Interfacing electronic materials with lipids and proteins is also showing promise with possible applications toward combinatorial chemistry, biosensors, and protein separations. What appears necessary in all of these endeavors is a better appreciation of lipid phase behavior and its modifications due to the proteins, polymers and ions, and how these interactions can be best controlled to provide an optimal microstructure, combined with a careful understanding of the biomedical application to determine just what that optimal microstructure might be.
C1 UNIV CALIF SANTA BARBARA,DEPT MAT,SANTA BARBARA,CA 93106.
RP Zasadzinski, JA (reprint author), UNIV CALIF SANTA BARBARA,DEPT CHEM ENGN,SANTA BARBARA,CA 93106, USA.
CR ALLEN TM, 1995, ADV DRUG DELIVER REV, V16, P267, DOI 10.1016/0169-409X(95)00029-7
   ALLEN TM, 1993, BIOCHIM BIOPHYS ACTA, V1150, P9, DOI 10.1016/0005-2736(93)90115-G
   BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6
   BAYER EA, 1979, BIOCHIM BIOPHYS ACTA, V550, P464, DOI 10.1016/0005-2736(79)90149-4
   Boman NL, 1996, CANCER CHEMOTH PHARM, V37, P351, DOI 10.1007/s002800050396
   CANTU L, 1994, J PHYS II, V4, P1585, DOI 10.1051/jp2:1994219
   Chen HM, 1996, PHARMACEUT RES, V13, P1378, DOI 10.1023/A:1016030202104
   CHIRUVOLU S, 1994, SCIENCE, V264, P1753, DOI 10.1126/science.8209255
   CHIRUVOLU S, 1994, SCIENCE, V266, P1222, DOI 10.1126/science.7973704
   CHONN A, 1995, J BIOL CHEM, V270, P25845, DOI 10.1074/jbc.270.43.25845
   Corti M, 1996, TENSIDE SURFACT DET, V33, P214
   Gelbart WM, 1996, J PHYS CHEM-US, V100, P13169, DOI 10.1021/jp9606570
   GRAYSON LS, 1995, CRIT CARE MED, V23, P84, DOI 10.1097/00003246-199501000-00016
   Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651
   GulikKrzywicki T, 1996, LANGMUIR, V12, P4668, DOI 10.1021/la960069d
   HERVE P, 1993, J PHYS II, V3, P1255, DOI 10.1051/jp2:1993196
   Holland JW, 1996, BIOCHEMISTRY-US, V35, P2610, DOI 10.1021/bi951999j
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   ISRAELACHVILI JN, 1992, INTERMOLECULAR SURFA
   KALER EW, 1989, SCIENCE, V245, P1371, DOI 10.1126/science.2781283
   KELLER SL, 1997, IN PRESS PHYS REV LE
   Kim T, 1996, ANESTHESIOLOGY, V85, P331, DOI 10.1097/00000542-199608000-00015
   Kirpotin D, 1996, FEBS LETT, V388, P115, DOI 10.1016/0014-5793(96)00521-2
   Lasic DD, 1996, CURR OPIN SOLID ST M, V1, P392, DOI 10.1016/S1359-0286(96)80031-3
   LASIC DD, 1996, LIPOSOMES GENE DELIV
   LASIC DD, 1993, LIPOSOMES PHYSICS AP
   Longman SA, 1995, CANCER CHEMOTH PHARM, V36, P91
   PAPAHADJOPOULOS D, 1977, BIOCHIM BIOPHYS ACTA, V465, P579, DOI 10.1016/0005-2736(77)90275-9
   Radler JO, 1997, SCIENCE, V275, P810, DOI 10.1126/science.275.5301.810
   Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43
   Service RF, 1997, SCIENCE, V275, P31, DOI 10.1126/science.275.5296.31
   Spector MS, 1996, LANGMUIR, V12, P4704, DOI 10.1021/la960218s
   STOLOWITZ M, 1997, Patent No. 5594151
   Stolowitz M.L., 1997, US Patent, Patent No. [5594111 A, 5594111, 5, 594, 111]
   SZOKA F, 1980, ANNU REV BIOPHYS BIO, V9, P467, DOI 10.1146/annurev.bb.09.060180.002343
   Uster PS, 1996, FEBS LETT, V386, P243, DOI 10.1016/0014-5793(96)00452-8
   Walker SA, 1997, NATURE, V387, P61, DOI 10.1038/387061a0
   WALKER SA, 1996, THESIS U CALIFORNIA
   Warriner HE, 1996, SCIENCE, V271, P969, DOI 10.1126/science.271.5251.969
   Wong JY, 1997, SCIENCE, V275, P820, DOI 10.1126/science.275.5301.820
   Zalipsky S, 1996, J CONTROL RELEASE, V39, P153, DOI 10.1016/0168-3659(95)00149-2
   ZALIPSKY S, 1994, FEBS LETT, V353, P71, DOI 10.1016/0014-5793(94)01013-7
NR 42
TC 18
Z9 18
U1 0
U2 6
PU CURRENT SCIENCE LTD
PI LONDON
PA 34-42 CLEVELAND STREET, LONDON, ENGLAND W1P 6LB
SN 1359-0286
J9 CURR OPIN SOLID ST M
JI Curr. Opin. Solid State Mat. Sci.
PD JUN
PY 1997
VL 2
IS 3
BP 345
EP 349
DI 10.1016/S1359-0286(97)80126-X
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA XL161
UT WOS:A1997XL16100013
DA 2018-10-20
ER

PT J
AU Solaro, R
   Chiellini, EE
   Giannasi, D
   Morganti, F
   Chiellini, E
AF Solaro, R
   Chiellini, EE
   Giannasi, D
   Morganti, F
   Chiellini, E
TI Multifunctional polymeric materials for biomedical applications
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 36th International Symposium on Macromolecules (IUPAC MACRO SEOUL 96)
CY AUG 04-09, 1996
CL SEOUL, SOUTH KOREA
SP Int Union Pure & Appl Chem, Polym Soc Korea, Minist Sci & Technol Republic Korea, Korea Petrochem Ind Assoc, Korea Sci & Engn Fdn, Korea Res Fdn
ID BETA-CYCLODEXTRIN; INCLUSION-COMPOUNDS; PHARMACEUTICAL INTERACTIONS;
   AQUEOUS-SOLUTION; DOSAGE FORMS; WATER; COMPLEXATION; STATES; ETHERS;
   DRUGS
AB The work performed by our research group during the last few years in the area of bioerodible-biodegradable polymers as designed to the formulation of systems for the controlled delivery of drugs and as specific sorbents of uraemic toxins is broadly reviewed. In particular, attention has been focused on the strategies adopted in the preparation of functional polymers containing hydroxyl or carboxyl groups, suitable to establish specific bonding and non-bonding interactions with conventional and proteic drugs.
RP Solaro, R (reprint author), UNIV PISA,DIPARTIMENTO CHIM & CHIM IND,VIA RISORGIMENTO 35,I-56126 PISA,ITALY.
CR AHMAD MB, 1994, POLYM INT, V33, P273, DOI 10.1002/pi.1994.210330306
   BALESTRI LP, 1972, CLIN SCI, V42, P395
   BARSOTTI G, 1989, NUTR TREATMENT CHRON, P33
   CHIELLINI A, 1989, POLYM MED SURG
   CHIELLINI E, 1995, MACROMOL SYMP, V98, P803, DOI 10.1002/masy.19950980168
   CHIELLINI E, 1992, MAKROMOL CHEM-M SYMP, V54-5, P483, DOI 10.1002/masy.19920540136
   CHIELLINI E, 1992, J CONTROL RELEASE, V22, P273, DOI 10.1016/0168-3659(92)90102-W
   Chiellini E, 1996, ADV MATER, V8, P305, DOI 10.1002/adma.19960080406
   CHIELLINI E, 1992, J BIOACT COMPAT POL, V7, P161, DOI 10.1177/088391159200700204
   CHIELLINI E, 1994, J BIOACT COMPAT POL, V9, P152, DOI 10.1177/088391159400900203
   CHIELLINI E, 1993, CHEMTECH, P29
   CHIELLINI E, 1994, P 1994 WORKSH PROD S, P235
   CHIELLINI E, 1994, DEV SCI IMPROVEMENT, P133
   CHIELLINI E, 1995, ADV BIOMATERIALS BIO, P28
   CHIELLINI E, 1978, INF CHEM, V176, P221
   GARDNER DL, 1971, T AM SOC ART INT ORG, V17, P239
   GIORDANO C, 1975, KIDNEY INT, V7, pS380
   Giordano C, 1973, Proc Eur Dial Transplant Assoc, V10, P136
   GIORDANO C, 1979, CLIN NEPHROL, V11, P142
   HIGUCHI A, 1984, POLYM BULL, V11, P203
   HOFFMAN AS, 1995, ARTIF ORGANS, V19, P458, DOI 10.1111/j.1525-1594.1995.tb02359.x
   IKEDA K, 1974, J PHARM SCI, V63, P1186
   JOHN MS, 1973, J BIOMED MATER RES, V7, P509
   KIZUMI K, 1974, YAKUGAKU ZASSHI, V94, P1515
   KNOCHEL JP, 1976, KIDNEY, P1448
   KUROZUMI M, 1975, CHEM PHARM BULL, V23, P3062
   LACH JL, 1963, J PHARM SCI-US, V52, P137, DOI 10.1002/jps.2600520207
   LEE CJ, 1990, J BIOMED MATER RES, V24, P243, DOI 10.1002/jbm.820240210
   MIYAJI T, 1976, CHEM PHARM BULL, V24, P1155
   NAKAMURA K, 1983, POLYMER, V24, P871, DOI 10.1016/0032-3861(83)90206-9
   NAMBU N, 1978, CHEM PHARM BULL, V26, P2952
   OTAGIRI M, 1978, PHARM ACTA HELV, V53, P241
   Peppas N. A., 1987, HYDROGELS MED PHARM, V1-3
   PITHA J, 1981, LIFE SCI, V29, P30
   SAENGER W, 1980, ANGEW CHEM INT EDIT, V19, P344, DOI 10.1002/anie.198003441
   SOLARO R, 1994, ACS SYM SER, V575, P112
   SPARKS RE, 1969, T AM SOC ART INT ORG, V15, P353
   SPARKS RE, 1972, T AM SOC ART INT ORG, V18, P458
   SZEJTLI J, 1981, PHARMAZIE, V36, P283
   Szejtli J., 1988, CYCLODEXTRIN TECHNOL
   UEKAMA K, 1978, CHEM PHARM BULL, V26, P1162
   WOJCIK JF, 1975, J PHYS CHEM-US, V79, P225
   YOSHIDA A, 1988, INT J PHARM, V46, P217, DOI 10.1016/0378-5173(88)90081-6
NR 43
TC 1
Z9 1
U1 0
U2 1
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4, CH-4052 BASEL, SWITZERLAND
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JUN
PY 1997
VL 118
BP 603
EP 617
DI 10.1002/masy.19971180179
PG 15
WC Polymer Science
SC Polymer Science
GA XP301
UT WOS:A1997XP30100078
DA 2018-10-20
ER

PT J
AU Vecchiato, NL
AF Vecchiato, NL
TI Sociocultural aspects of tuberculosis control in Ethiopia
SO MEDICAL ANTHROPOLOGY QUARTERLY
LA English
DT Article
DE tuberculosis; ethnomedical knowledge; primary health care; Ethiopia
ID PULMONARY TUBERCULOSIS; DEVELOPING-COUNTRIES; KNOWLEDGE; ILLNESS;
   CHILDREN; DISEASE; HEALTH; SURVEILLANCE; PERCEPTIONS; EXPERIENCE
AB This article examines ethnomedical knowledge and practices related to tuberculosis conceptualization and management in a rural southern Ethiopian community. An adult health-status survey, administered to 217 adults selected through quota sampling procedures, investigated prevailing nosological structures. Additionally, disease-enhancing behaviors were identified through qualitative-research methods. The findings show that while symptomatological concepts coincide with biomedicine, the local etiological model postulates empirically based causational factors unrelated to tubercle bacilli. Therapeutic preference hinges on the utilization of ethnobotanical remedies and their expected emetic effects. The relevance of tuberculosis-related ethnomedical knowledge and management practices is discussed in relation to primary health care and disease-control programs in Ethiopia. It is recommended that health-education interventions, illustrating the nature and transmission avenues of tuberculosis and the effects of biomedical therapies, precede and/or accompany vaccination campaigns or chemotherapy. Teaching materials should valorize existing ethnomedical notions that emphasize contagion as an avenue of disease transmission, and the importance of nutritional adequacy in fighting the disease.
C1 UNIV WASHINGTON,DEPT ANTHROPOL,SEATTLE,WA 98195.
CR ARATA K, 1991, TUBERCLE, V72, P1
   AZBITE M, 1992, ETHIOPIAN MED J, V30, P215
   BARNESDEAN VL, 1986, AFRICA, V56, P334, DOI 10.2307/1160688
   BARNHOORN F, 1992, SOC SCI MED, V34, P291, DOI 10.1016/0277-9536(92)90271-Q
   BISHAW M, 1991, SOC SCI MED, V33, P193, DOI 10.1016/0277-9536(91)90180-K
   BONNLANDER H, 1993, AM J PUBLIC HEALTH, V83, P583, DOI 10.2105/AJPH.83.4.583
   BRIEGER WR, 1992, HEALTH EDUC RES, V7, P471, DOI 10.1093/her/7.4.471
   Brieger WR, 1996, SOC SCI MED, V42, P233, DOI 10.1016/0277-9536(95)00098-4
   BROEKMANS JF, 1991, TROP GEOGR MED, V43, pS13
   BROWN PJ, 1990, MED ANTHR CONT THEOR, P187
   COLLINGS DA, 1990, TROP DOCT, V20, P151, DOI 10.1177/004947559002000403
   DEMISSIE M, 1994, ETHIOPIAN MED J, V32, P97
   Dunn Frederick L., 1986, ANTHR EPIDEMIOLOGY, P3
   ETKIN NL, 1986, PLANTS INDIGENOUS ME
   FINERMAN R, 1989, Medical Anthropology Quarterly, V3, P162, DOI 10.1525/maq.1989.3.2.02a00040
   Finkler K, 1984, Med Anthropol, V8, P195
   GARRO LC, 1988, AM ETHNOL, V15, P98, DOI 10.1525/ae.1988.15.1.02a00070
   GARRO LC, 1986, AM ANTHROPOL, V88, P351, DOI 10.1525/aa.1986.88.2.02a00040
   GEBRE N, 1995, T ROY SOC TROP MED H, V89, P191, DOI 10.1016/0035-9203(95)90491-3
   GHIDEY Y, 1983, ETHIOPIAN MED J, V21, P161
   Good C., 1987, ETHNOMEDICAL SYSTEMS
   *GOV ETH, 1986, ETH STAT ABSTR, P23
   GRANGE JM, 1993, TUBERCLE LUNG DIS, V74, P219, DOI 10.1016/0962-8479(93)90046-Z
   Hamer J. H., 1987, HUMANE DEV PARTICIPA
   HODES RM, 1988, NEW ENGL J MED, V31, P918
   HODES RM, 1993, ECOLOGY HLTH DIS ETH, P265
   Iyun BF, 1996, SOC SCI MED, V42, P437, DOI 10.1016/0277-9536(95)00103-4
   JONES K, 1987, HLTH DIS SOC INTRO M
   Kokwaro JO, 1976, MED PLANTS E AFRICA
   KOPANOFF DE, 1988, AM J PUBLIC HEALTH, V78, P30, DOI 10.2105/AJPH.78.1.30
   LEMMA E, 1989, ETHIOPIAN MED J, V27, P147
   Liefooghe R, 1995, SOC SCI MED, V41, P1685, DOI 10.1016/0277-9536(95)00129-U
   MAMMO A, 1992, ETHIOPIAN REV, V3, P38
   MENZIES R, 1993, TUBERCLE LUNG DIS, V74, P32, DOI 10.1016/0962-8479(93)90066-7
   MESSING SD, 1972, TARGET HLTH ETHIOPIA
   *MOH, 1991, COMPR HLTH SERV DIR
   Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6
   NGOKWEY N, 1988, SOC SCI MED, V26, P793, DOI 10.1016/0277-9536(88)90173-6
   NICHTER M, 1994, SOC SCI MED, V38, P649, DOI 10.1016/0277-9536(94)90456-1
   NKHOMA WA, 1987, E AFR MED J, V64, P643
   Pankhurst R., 1990, MED HIST ETHIOPIA
   Pankhurst R, 1965, ETHIOPIA OBSERVER, V9, P114
   REYNARD JM, 1989, TROPICAL MED PARASIT, P133
   RIEDER HL, 1992, TUBERCLE LUNG DIS, V73, P181, DOI 10.1016/0962-8479(92)90082-U
   RUBEL AJ, 1992, PUBLIC HEALTH REP, V107, P626
   RUBEL AJ, 1990, MED ANTHR CONT THEOR, P115
   SAUNDERSON P, 1994, ETHIOPIAN MED J, V32, P269
   SAUNDERSON PR, 1995, SOC SCI MED, V40, P1203, DOI 10.1016/0277-9536(94)00240-T
   Schaller K.F., 1972, ETHIOPIA GEOMEDICAL
   Sofowora Abayomi, 1982, MED PLANTS TRADITION
   STONE L, 1992, SOC SCI MED, V35, P409, DOI 10.1016/0277-9536(92)90333-L
   STYBLO K, 1991, HEALTH POLICY PLANN, V6, P391, DOI 10.1093/heapol/6.4.391
   TEKLU B, 1984, TUBERCLE, V65, P17, DOI 10.1016/0041-3879(84)90026-6
   TRUE WR, 1990, MED ANTHR CONT THEOR, P115
   VANDERWERF TS, 1990, TUBERCLE, V71, P247, DOI 10.1016/0041-3879(90)90036-8
   Vecchiato N, 1993, ECOLOGY HLTH DIS ETH, P157
   Vecchiato N. L., 1993, AFRICA, V63, P176
   VECCHIATO NL, IN PRESS ANTHR INFEC
   VECCHIATO NL, 1985, THESIS U CALIFORNIA
   VECCHIATO NL, 1994, NEW TRENDS ETHIOPIAN, P1033
   VECCHIATO NL, 1991, INT Q COMMUNITY HLTH, V11, P285
   WESTAWAY MS, 1994, TUBERCLE LUNG DIS, V75, P70, DOI 10.1016/0962-8479(94)90107-4
   WESTAWAY MS, 1990, TUBERCLE, V71, P55, DOI 10.1016/0041-3879(90)90062-D
   Yoder Stanley P., 1981, SOCIAL SCI MED B, V15B, P237
   ZERIHUN G, 1984, ETHIOPIAN MED J, V22, P49
NR 65
TC 25
Z9 26
U1 0
U2 5
PU AMER ANTHROPOLOGICAL ASSOC
PI ARLINGTON
PA 4350 NORTH FAIRFAX DRIVE SUITE 640, ARLINGTON, VA 22203
SN 0745-5194
J9 MED ANTHROPOL Q
JI Med. Anthropol. Q.
PD JUN
PY 1997
VL 11
IS 2
BP 183
EP 201
DI 10.1525/maq.1997.11.2.183
PG 19
WC Anthropology; Public, Environmental & Occupational Health; Social
   Sciences, Biomedical
SC Anthropology; Public, Environmental & Occupational Health; Biomedical
   Social Sciences
GA XR865
UT WOS:A1997XR86500004
PM 9186960
DA 2018-10-20
ER

PT J
AU Davy, KWM
   Anseau, MR
   Odlyha, M
   Foster, GM
AF Davy, KWM
   Anseau, MR
   Odlyha, M
   Foster, GM
TI X-ray opaque methacrylate polymers for biomedical applications
SO POLYMER INTERNATIONAL
LA English
DT Article; Proceedings Paper
CT Cambridge Polymer Conference: Partnership in Polymers
CY SEP 30-OCT 02, 1996
CL CAMBRIDGE, ENGLAND
DE iodinated methacrylate monomers; methacrylates; polymers; X-ray opaque
   polymers
ID RADIOPAQUE
AB The synthesis of a number of halogenated aromatic methacrylate monomers was achieved by (1) the esterification of hydroxyl-containing methacrylate esters with 2,3,5-tri-iodobenzoic acid and (2) by the nucleophilic addition of 2,3,5-tri-iodobenzoic acid, or polyhalogenated phenols, to 2,3-epoxypropyl methacrylate, yielding white crystalline products which were fully characterized. These monomers could be homopolymerized in the melt to produce clear, intensely X-ray opaque glasses possessing high refractive indices. The monomers themselves were soluble in a variety of methacrylate monomers with which they could be copolymerized to produce clear radiopaque materials. The stability of the homopolymers in an aqueous environment was excellent as was thermal stability, exhibiting little decomposition below 300 degrees C.
C1 UNIV LONDON BIRKBECK COLL,DEPT CHEM,ULIRS,THERMAL METHODS LAB,LONDON WC1H 0AJ,ENGLAND.
RP Davy, KWM (reprint author), UNIV LONDON,ST BARTHOLOMEWS & ROYAL LONDON HOSP,SCH MED & DENT,IRC BIOMED MAT,LONDON E1 2AD,ENGLAND.
CR CHANDLER H H, 1971, Journal of Biomedical Materials Research, V5, P253, DOI 10.1002/jbm.820050312
   COOMBE E, 1971, DENTAL PRACTIT, V22, P51
   DAVY KWM, 1995, Patent No. 953035086
   DAVY KWM, IN PRESS J DENT
   DAVY KWM, 1995, Patent No. 953075058
   HOLDEN G, 1968, DENTAL PRACTIT, V18, P209
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   Kruft MAB, 1996, BIOMATERIALS, V17, P1803, DOI 10.1016/0142-9612(95)00339-8
   LEADER SA, 1948, Patent No. 2439374
   PARKER RE, 1959, CHEM REV, V59, P737, DOI 10.1021/cr50028a006
   RAWLS HR, 1990, DENT MATER, V6, P250, DOI 10.1016/S0109-5641(05)80006-5
   RAWLS HR, 1992, DENT MATER, V8, P54, DOI 10.1016/0109-5641(92)90054-G
   SAUNSBURY P, 1964, DENT PRACT, V14, P243
   SIMMONS GC, 1975, THESIS U ASTON BIRMI
   SODERHOLM KJM, 1990, SCAND J DENT RES, V98, P82
   WILLEMS G, 1991, J DENT, V19, P362, DOI 10.1016/0300-5712(91)90056-5
NR 16
TC 62
Z9 63
U1 0
U2 4
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD JUN
PY 1997
VL 43
IS 2
BP 143
EP 154
DI 10.1002/(SICI)1097-0126(199706)43:2<143::AID-PI717>3.0.CO;2-M
PG 12
WC Polymer Science
SC Polymer Science
GA XF717
UT WOS:A1997XF71700008
DA 2018-10-20
ER

PT J
AU Evans, C
   Lambert, H
AF Evans, C
   Lambert, H
TI Health-seeking strategies and sexual health among female sex workers in
   urban India: Implications for research and service provision
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE health-seeking behaviour; India; HIV; sex work; sexual health; sexually
   transmitted diseases; compliance
ID BEHAVIOR; THERAPY; ANTHROPOLOGY; DISTANCE; CARE
AB This paper presents and discusses selected findings from a study of health-seeking strategies in relation to sexual health among a group of female sex workers in Calcutta, India. Background information on sex work and sexually transmitted disease in Calcutta is followed by the presentation of findings pertaining to women's understandings of(sexual) health, treatment-seeking and service utilisation. In the urban context where health services are readily available, patterns of initial treatment-seeking are shown to be generally (biomedically) appropriate, but subsequent ''non-compliant'' therapeutic practices give cause for concern. Conventional approaches to the study of ''health-seeking behaviour'' are reviewed in the light of these findings and questions raised about the appropriateness of approaches that focus on initial choice of treatment type and/or assume processes of health-seeking to be determined primarily by cultural ''beliefs'' about illness. Inherent biomedical and culturalist biases in the orientation of such research are shown to produce an analytic neglect of the dual influences of material life conditions and people's perceptions of health, rather than illness, upon health-related strategies. Recommendations are made for operational research and policy formulation on the provision of effective sexual health services, and implications are drawn for the scope of interventions and applied research directed at improving sexual health. (C) 1997 Elsevier Science Ltd.
C1 UNIV LONDON LONDON SCH HYG & TROP MED, DEPT PUBL HLTH & POLICY, LONDON WC1E 7HT, ENGLAND.
OI Evans, Catrin/0000-0002-5338-2191
CR *ABVA, 1990, WOM AIDS DEN BLAM CI
   *AIIHPH, 1992, REP COMM BAS SURV SE
   *ALLHPH, 1994, EV STD HIV INT SEX W
   *ALLHPH, 1993, ASS SEX TRAD CALC HO
   *ALLHPH, 1994, SEX WORK NEED CAR CH
   *BCC, 1991, REP IND INT COND 30
   BECKER MH, 1974, HEALTH EDUC QUART, V2, P409, DOI 10.1177/109019817400200407
   BENTLEY M, 1990, P INT C RAP ASS METH
   BOTTERO A, 1991, CULT MED PSYCHIAT, V15, P303, DOI 10.1007/BF00046541
   BRUNHAM RC, 1991, RES ISSUES HUMAN BEH, P61
   CALNAN M, 1987, HLTH ILLNESS LAY PER
   CARSTAIRS M, 1957, TWICE BORN STUDY COM
   CATANIA JA, 1990, HEALTH EDUC QUART, V17, P53, DOI 10.1177/109019819001700107
   *CENTR SOC WELF BO, 1992, REP SOC EC STUD FEM
   Chand A D, 1994, Med Anthropol, V15, P395
   Chaudhuri S., 1990, CALCUTTA LIVING CITY, Vii
   *CINI, 1994, GYN MORB WOM W BENG
   CORNWELL J, 1984, HARD EARNED LIVES AC
   DASGUPTA A, 1990, W BENGAL J SOCIAL WE, P9
   DCUNHA J, 1990, LEGALISATION PROSTIT
   DUA V, 1994, SOC SCI MED, V38, P717, DOI 10.1016/0277-9536(94)90462-6
   EARLY EA, 1982, SOC SCI MED, V16, P1491, DOI 10.1016/0277-9536(82)90064-8
   ELIAS CJ, 1991, 5 POP COUNC PROGR DI
   EVANS C, 1993, THESIS SCH ORIENT AF
   EVANS C, 1994, PILOT STUDY EXPLORE
   GOOD BJ, 1994, MED RATIONALITY EXPE
   *GOV W BENG, 1994, FACTS AIDS W BENG FA
   GRAHAM H, 1984, WOMEN HLTH FAMILY
   GREENHALGH T, 1987, SOC SCI MED, V25, P307, DOI 10.1016/0277-9536(87)90233-4
   GROSSKURTH H, 1995, LANCET, V346, P519
   HO S, 1984, SOC SCI MED, V25, P745
   JOARDAR B, 1984, PROSTITUTION HIST MO
   KAMAT VR, 1995, SOC SCI MED, V41, P87, DOI 10.1016/0277-9536(94)00309-H
   KANANI S, 1991, C WOM HLTH ACT AG 90
   KENDALL C, 1984, SOC SCI MED, V19, P253, DOI 10.1016/0277-9536(84)90216-8
   KLOOS H, 1987, SOC SCI MED, V25, P1003, DOI 10.1016/0277-9536(87)90005-0
   LAGA M, 1995, LANCET, V346, P518, DOI 10.1016/S0140-6736(95)91374-2
   LAGA M, 1992, REPROD BIOL, P131
   LUTHRA UK, 1992, REPROD BIOL, P317
   MAHILA S, BARBONITA BOLCHI PRO
   MANDERSON L, 1992, SOC SCI MED, V35, P839, DOI 10.1016/0277-9536(92)90098-B
   McGilvray D., 1982, ETHNOGRAPHY FERTILIT, P25
   Mull D S, 1994, Med Anthropol, V15, P335
   *NACO, 1994, NAT AIDS CONTR PROGR
   NATARAJ S, 1994, PRIVATE DECISIONS PU, P7
   NICHTER M, 1994, SOC SCI MED, V39, P1509, DOI 10.1016/0277-9536(94)90003-5
   NICHTER M, 1980, SOC SCI MED-MED ANTH, V14, P225, DOI 10.1016/0160-7987(80)90048-4
   Nichter M, 1994, Med Anthropol, V15, P353
   NICHTER M, 1994, MED ANTHROPOL, V14, P319
   NICHTER M, 1978, MED ANTHROPOL, V2, P29
   NICHTER M, 1988, CULT MED PSYCHIAT, V13, P367
   Nichter Mark, 1989, ANTHR INT HLTH S ASI
   PARKER RL, 1986, SOC SCI MED, V22, P23, DOI 10.1016/0277-9536(86)90304-7
   PELTO PJ, 1990, ANTHR PRIMARY HLTH C, P253
   RAHAMAN MM, 1982, AM J PUBLIC HEALTH, V72, P1124, DOI 10.2105/AJPH.72.10.1124
   SACHS L, 1989, CULT MED PSYCHIAT, V13, P335, DOI 10.1007/BF00054342
   *SANL, 1994, SOC EC SURV COMM SEX
   Scrimshaw S.C.M, 1987, RAPID ASSESSMENT PRO
   SHEPPERDSON M, 1988, IND NAT C POL EC IND
   SINGER M, 1990, SOC SCI MED, V30, P179, DOI 10.1016/0277-9536(90)90078-7
   SINGER M, 1988, Medical Anthropology Quarterly, V2, P370, DOI 10.1525/maq.1988.2.4.02a00060
   STANDING H, 1990, DEPENDENCE AUTONOMY
   Stewart KM, 1994, MED ANTHROPOL, V15, P377
   STOCK R, 1983, SOC SCI MED, V17, P563, DOI 10.1016/0277-9536(83)90298-8
   VAN DER GEEST S., 1988, CONTEXT MED DEV COUN
   WASSERHEIT JN, 1992, REPROD BIOL, P7
   *WHO, 1995, MAN SEX TRANS DIS
   YESUDIAN C, 1989, HLTH SERVICES UTILIS
   YESUDIAN C, 1988, UTILISATION HLTH SER
   YESUDIAN CAK, 1994, HEALTH POLICY PLANN, V9, P72, DOI 10.1093/heapol/9.1.72
   Young JC, 1981, MED CHOICE MEXICAN V
   Zimmerman Francis, 1987, JUNGLE AROMA MEATS E
NR 72
TC 41
Z9 41
U1 1
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD JUN
PY 1997
VL 44
IS 12
BP 1791
EP 1803
DI 10.1016/S0277-9536(96)00288-2
PG 13
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA XD563
UT WOS:A1997XD56300003
PM 9194241
DA 2018-10-20
ER

PT J
AU Miyata, T
   Nakamae, K
AF Miyata, T
   Nakamae, K
TI Polymers with pendent saccharides - 'Glycopolymers'
SO TRENDS IN POLYMER SCIENCE
LA English
DT Article
ID SURFACE FREE-ENERGY; CHEMOENZYMATIC SYNTHESIS; PENDANT MONOSACCHARIDES;
   GLYCOPROTEIN MODELS; COPOLYMER FILMS; DRUG-DELIVERY; GLYCOSIDES; SUGAR;
   HYDROGELS; BEARING
AB Synthetic polysaccharides have been found to be useful for basic biomedical research and practice medical applications. Those polysaccharides having a backbone consisting of a synthetic polymer are called 'glycopolymers'. Most glycopolymers are linear synthetic polymers with pendent mono-, oligo- and polysaccharides. Saccharide units in glycopolymers are recognized by a variety of carbohydrate receptors in a similar manner to natural polysaccharides. Investigation of glycopolymers has significantly contributed to our understanding of biochemical phenomena in relation to cell-cell interactions through molecular recognition. Furthermore, the properties of glycopolymers suggest that they have much potential as suitable materials for biochemical and biomedical applications, such as protein separation, cell culture and drug-delivery systems. This article provides a short overview of current research in the synthesis of glycopolymers and their applications to be biochemical and biomedical fields.
C1 KANSAI UNIV,FAC ENGN,SUITA,OSAKA 564,JAPAN.
CR BLINKOVSKY AM, 1993, TETRAHEDRON-ASYMMETR, V4, P1221, DOI 10.1016/S0957-4166(00)80231-1
   CHEN XM, 1994, MACROMOL CHEM PHYSIC, V195, P3567, DOI 10.1002/macp.1994.021951105
   CHEN XM, 1995, MACROMOLECULES, V28, P6014, DOI 10.1021/ma00122a005
   DORDICK JS, 1994, CHEMTECH, V24, P33
   DUSEK K, 1993, ADV POLYM SCI, V109
   DUSEK K, 1993, ADV POLYM SCI, V110
   FUKUDOME N, 1994, J APPL POLYM SCI, V52, P1759, DOI 10.1002/app.1994.070521210
   FURUIKE T, 1995, CHEM LETT, P823, DOI 10.1246/cl.1995.823
   GOTO M, 1994, J CONTROL RELEASE, V28, P223
   HOREJSI V, 1978, BIOCHIM BIOPHYS ACTA, V538, P293, DOI 10.1016/0304-4165(78)90357-4
   KIM S W, 1990, Journal of Controlled Release, V11, P193
   KITAZAWA S, 1990, CHEM LETT, P1733, DOI 10.1246/cl.1990.1733
   KOBAYASHI K, 1994, J CARBOHYD CHEM, V13, P753, DOI 10.1080/07328309408011678
   KOBAYASHI K, 1993, MAKROMOL CHEM-RAPID, V14, P293
   KOBAYASHI K, 1994, NEOGLYCOCONJUGATES P, P262
   KOBAYASHI K, 1994, METHOD ENZYMOL, V247, P47
   KOPECEK J, 1992, J CONTROL RELEASE, V19, P121, DOI 10.1016/0168-3659(92)90070-8
   KOPECKOVA P, 1994, J CONTROL RELEASE, V28, P211, DOI 10.1016/0168-3659(94)90168-6
   Lee Y. C., 1994, P3
   LEE YC, 1978, CARBOHYD RES, V67, P509
   LEE YC, 1994, NEOGLYCOCONJUGATES
   MAKINO K, 1990, J CONTROL RELEASE, V12, P235, DOI 10.1016/0168-3659(90)90104-2
   MARTIN BD, 1992, MACROMOLECULES, V25, P7081, DOI 10.1021/ma00052a001
   MATSUOKA K, 1995, MACROMOLECULES, V28, P2961, DOI 10.1021/ma00112a049
   MIYATA T, 1994, MACROMOL CHEM PHYSIC, V195, P3597, DOI 10.1002/macp.1994.021951107
   MIYATA T, 1995, J APPL POLYM SCI, V56, P1615, DOI 10.1002/app.1995.070561212
   Miyata T, 1996, MACROMOL CHEM PHYSIC, V197, P1135, DOI 10.1002/macp.1996.021970330
   NAKAMAE K, 1994, MACROMOL CHEM PHYSIC, V195, P2663, DOI 10.1002/macp.1994.021950733
   NAKAMAE K, 1993, MAKROMOL CHEM-RAPID, V14, P413
   NAKAMAE K, 1994, J BIOMAT SCI-POLYM E, V6, P79, DOI 10.1163/156856295X00779
   NAKAMAE K, 1994, MACROMOL CHEM PHYSIC, V195, P1953, DOI 10.1002/macp.1994.021950606
   NISHIMURA SI, 1994, MACROMOLECULES, V27, P157, DOI 10.1021/ma00079a023
   NISHIMURA SI, 1994, MACROMOLECULES, V27, P4876, DOI 10.1021/ma00096a004
   NISHIMURA SI, 1990, MACROMOLECULES, V23, P4182, DOI 10.1021/ma00220a024
   NISHIMURA SI, 1991, MACROMOLECULES, V24, P4236, DOI 10.1021/ma00015a002
   Ouchi Tatsuro, 1994, P465
   PATIL DR, 1991, MACROMOLECULES, V24, P3462, DOI 10.1021/ma00011a068
   SPALTENSTEIN A, 1991, J AM CHEM SOC, V113, P686, DOI 10.1021/ja00002a053
   USUI T, 1993, CARBOHYD RES, V244, P315, DOI 10.1016/0008-6215(83)85010-1
   WULFF G, 1994, MACROMOL CHEM PHYSIC, V195, P2603, DOI 10.1002/macp.1994.021950728
NR 40
TC 69
Z9 70
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0966-4793
J9 TRENDS POLYM SCI
JI Trends Polym. Sci.
PD JUN
PY 1997
VL 5
IS 6
BP 198
EP 206
PG 9
WC Polymer Science
SC Polymer Science
GA XG735
UT WOS:A1997XG73500006
DA 2018-10-20
ER

PT J
AU Bradbury, SR
   Lewis, DB
   Archer, PM
   Ahmed, W
AF Bradbury, SR
   Lewis, DB
   Archer, PM
   Ahmed, W
TI Impact of surface engineering technologies on the performance and life
   of multi-point cutting tools
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE surface engineering technologies; multi-point cutting tools
ID NITROGEN; STEEL
AB Advanced surface engineering technologies such as chemical vapour deposition, sputtering and ion-implantation have shown considerable potential for use in a variety of industrial applications, These include a wide range of decorative, optical, electronic, biomedical and engineering products. Much of the success of surface engineering treatments have been in the laboratories and in products that use flat substrates such as nar panel displays and microelectronic devices. However, for applications requiring samples that have complex geometrical features such as cutting tools and biomedical prosthesis the results of surface engineering treatments have been rather variable and less spectacular,
   In this paper pre focus on the application of surface engineering on multi-point cutting tools, in particular band saws and circular saws. The effects of substrate surface preparation, coating materials and-processes, and surface modifications through ion implantation are considered on the performance and life of multi-point cutting tools. The results presented utilise a key performance parameter that has been applied to all the types of tools considered to compare the effects of each surface engineering treatment. For the product under consideration we show that careful substrate preparation, ion-implantation of Ar+ and N+ ions, coatings of TiN, TiAlN, WC, TiAlVN and the coating process have led to significant improvements in performance and life compared to untreated cutting edges, The trends observed may also be applied to other multi-point and single point cutting tools. (C) 1997 Elsevier Science S.A.
C1 MANCHESTER POLYTECH,DEPT CHEM,MANCHESTER M1 5GD,LANCS,ENGLAND.
   UNIV SHEFFIELD,DEPT MECH ENGN,SHEFFIELD S1 3JD,S YORKSHIRE,ENGLAND.
   SHEFFIELD HALLAM UNIV,INST MAT RES,SHEFFIELD S1 1WB,S YORKSHIRE,ENGLAND.
OI Ahmed, Waqar/0000-0003-4152-5172
CR AHMED NAG, 1987, ION PLATING TECHNOLO
   AHMED W, 1992, FLAGSHIP, P55
   AHMED W, 1989, J CRYST GROWTH, V79, P394
   ALONSO F, 1994, SURF COAT TECH, V66, P291, DOI 10.1016/0257-8972(94)90015-9
   ARCHER PM, 1991, THESIS SHEFFIELD HAL, P26
   BIERSACK JP, 1980, NUCL INSTRUM METHODS, V174, P257, DOI 10.1016/0029-554X(80)90440-1
   BOOTHROYD G, 1965, FUNDAMENTALS METAL M, P18
   BUNSHAH RF, 1982, DEPOSITION TECHNOLOG, P83
   FAYEULLE S, 1985, NUCL INSTRUM METH B, V7-8, P171, DOI 10.1016/0168-583X(85)90550-6
   KELLY PJ, 1993, MAT WORLD, V3, P161
   Lewis DB, 1996, WEAR, V197, P82, DOI 10.1016/0043-1648(95)06835-X
   LEWIS DB, 1995, INT C ADV MATS P TEC, P310
   MCNALLY JI, 1989, HDB PLASMA PROCESSES, P466
   MESSIER R, 1987, THIN SOLID FILMS, V153, P1, DOI 10.1016/0040-6090(87)90164-7
   MONAGHAN D, 1992, FINISHING        OCT, P37
   PETHICA JB, 1983, NUCL INSTRUM METHODS, V209, P995, DOI 10.1016/0167-5087(83)90911-0
   SARWAR M, 1984, P 1 IR MAN COMM DUBL, P84
   SARWAR M, 1993, P 3 INT S ADV MATS, P499
   SARWAR M, 1993, P INT C ADV MAT PROC, P1939
   SARWAR M, 1995, P 4 INT S ADV MATS, P197
   SARWAR M, 1995, P 1 INT C QUAL REL, V2, P23
   SARWAR M, 1988, P 4 NATL C PROD RES, P494
   SINGER IL, 1980, J VAC SCI TECHNOL, V17, P327, DOI 10.1116/1.570379
   TRENT EM, 1977, METAL CUTTING, P93
NR 24
TC 9
Z9 9
U1 0
U2 3
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD MAY 20
PY 1997
VL 91
IS 3
BP 192
EP 199
DI 10.1016/S0257-8972(96)03183-0
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA XF657
UT WOS:A1997XF65700006
DA 2018-10-20
ER

PT J
AU Geckeler, KE
   Rupp, F
   GeisGerstorfer, J
AF Geckeler, KE
   Rupp, F
   GeisGerstorfer, J
TI Interfaces and interphases of (Bio)materials: Definitions, structures,
   and dynamics
SO ADVANCED MATERIALS
LA English
DT Article
ID COMMERCIALLY PURE TITANIUM; PROTEIN ADSORPTION; IN-VITRO; ADHESION;
   SURFACES; IMPLANTS; HYDROXYAPATITE; DEPOSITION; POLYMERS; SUPPORTS
AB What exactly is an interface, and when is an interphase the more correct concept? The nature of interfaces and the phenomena occurring there are described before the role of interphases is illustrated with a series of examples taken from purely artificial systems (e.g., polymer and polymer-metal ''interfaces'') and natural and mixed artificial-natural systems (e.g., the multilayer interphase of a biomedical system such as a dental implant). The approach presented demonstrates that ''interphase'' or ''interface'' depends to some extent on the point of view.
C1 UNIV TUBINGEN, DEPT PROSTHODONT, D-72076 TUBINGEN, GERMANY.
RP Geckeler, KE (reprint author), UNIV TUBINGEN, FAC CHEM & PHARM, DEPT ORGAN CHEM, MORGENSTELLE 18, D-72076 TUBINGEN, GERMANY.
RI Rupp, Frank/G-4725-2012
CR ADAM G, 1995, PHYSIKALISCHE CHEM B, P293
   BALL P, 1991, NATURE, V349, P101, DOI 10.1038/349101a0
   BERGETHON PR, 1990, BIOPHYSICAL CHEM MOL, P217
   BHUSHAN B, 1995, NATURE, V374, P607, DOI 10.1038/374607a0
   BREME J, 1995, BIOMATERIALS, V16, P239, DOI 10.1016/0142-9612(95)92123-N
   BRUCE A, 1995, MOLEKULARBIOLOGIE ZE, P563
   CAHN JW, 1958, J CHEM PHYS, V28, P258, DOI 10.1063/1.1744102
   CAIAZZA S, 1991, BIOMATERIALS, V12, P474, DOI 10.1016/0142-9612(91)90145-Z
   CHAKRABORTY AK, 1990, J POLYM SCI POL CHEM, V28, P3185, DOI 10.1002/pola.1990.080281201
   CLAROTTI G, 1992, BIOMATERIALS, V13, P832, DOI 10.1016/0142-9612(92)90176-O
   CLAROTTI G, 1991, MAKROMOL CHEM, V192, P2581
   COLLIS JJ, 1992, BIOMATERIALS, V13, P548, DOI 10.1016/0142-9612(92)90107-Y
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   DELANGE GL, 1989, BIOMATERIALS, V10, P121, DOI 10.1016/0142-9612(89)90044-6
   DORFLER HD, 1994, GRENZFLACHEN KOLLOID, P88
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   ELIAS HG, 1993, INTRO PLASTICS, P220
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   FEAST WJ, 1985, POLYM SURFACES INTER, V1
   GECKELER K, 1981, ADV POLYM SCI, V39, P65
   GECKELER KE, 1992, NATURWISSENSCHAFTEN, V79, P325, DOI 10.1007/BF01138713
   GECKELER KE, 1995, ADV POLYM SCI, V121, P31
   GECKELER KE, 1993, NATURWISSENSCHAFTEN, V80, P487, DOI 10.1007/BF01140804
   GECKELER KE, 1989, TELECHELIC POLYM SYN, P229
   HOFFMAN AS, 1982, BIOMATERIALS INTERFA
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   JOHANSSON CB, 1990, BIOMATERIALS, V11, P277, DOI 10.1016/0142-9612(90)90010-N
   Junqueira L.C., 1996, HISTOLOGIE
   KAPS C, 1993, KERAM Z, V45, P147
   KASEMO B, 1994, ENVIRON HEALTH PERSP, V102, P41, DOI 10.2307/3432057
   KRAMER A, 1989, Z ZAHNARZTLICHE IMPL, V5, P283
   Krekeler G, 1984, Schweiz Monatsschr Zahnmed (1984), V94, P647
   LASSEN B, 1994, COLLOID POLYM SCI, V272, P1143, DOI 10.1007/BF00652384
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   LECKBAND D, 1995, NATURE, V376, P617, DOI 10.1038/376617a0
   LEE LH, 1994, J ADHESION, V46, P15, DOI 10.1080/00218469408026646
   Lelah M. D., 1986, POLYURETHANES MED
   McAlarney M E, 1993, N Y State Dent J, V59, P45
   MILLER JD, 1991, FUNDAMENTALS ADHESIO, pCH10
   MIYAZAKI T, 1994, B KANAGAWA DENT COL, V22, P113
   MYERS D, 1991, SURFACES INTERFACES, P7
   NYVAD B, 1989, CARIES RES, V23, P151, DOI 10.1159/000261169
   PETTY MC, 1985, POLYM SURFACES INTER, V1, P163
   Ponec V, 1995, CATALYSIS METALS ALL
   RATNER BD, 1985, POLYM SURFACES INTER, V1, P231
   Richards R. W., 1993, POLYM SURFACES INTER
   ROALD HE, 1994, BLOOD COAGUL FIBRIN, V5, P355
   Rupp F, 1996, ADV MATER, V8, P254, DOI 10.1002/adma.19960080316
   SCHAMBERGER PC, 1994, COLLOID SURFACE B, V2, P209, DOI 10.1016/0927-7765(94)80036-7
   SCHROEDER HE, 1970, DENTAL PLAQUE, P49
   SHI GQ, 1995, SCIENCE, V267, P994, DOI 10.1126/science.267.5200.994
   SONJU T, 1973, CARIES RES, V7, P30
   SUTHERLAND DS, 1993, BIOMATERIALS, V14, P893, DOI 10.1016/0142-9612(93)90130-T
   THULL R, 1994, NATURWISSENSCHAFTEN, V81, P481, DOI 10.1007/s001140050113
   VANOSS CJ, 1993, POLYM SURFACES INTER, V2, P267
   VANSANTEN RA, 1991, THEORETICAL HETEROGE
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   WANG J, 1991, NATURE, V354, P377, DOI 10.1038/354377a0
   WILLIAMS DF, 1992, MAT SCI TECHNOLOGY, V14
   Wool R. P., 1991, FUNDAMENTALS ADHESIO, P207
NR 60
TC 21
Z9 21
U1 0
U2 5
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD MAY
PY 1997
VL 9
IS 6
BP 513
EP +
DI 10.1002/adma.19970090614
PG 1
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA WZ682
UT WOS:A1997WZ68200013
DA 2018-10-20
ER

PT J
AU Litvin, AL
   Kaplan, DL
   Sung, CM
AF Litvin, AL
   Kaplan, DL
   Sung, CM
TI Microstructure of aragonite grown at an air-liquid interface
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID TEMPERATURE
AB Aragonite particles dispersed in a bioresorbable polymer matrix a re considered to be a good candidate for bone prosthesis materials. It is important to characterize the microstructure of synthetic aragonite used for biomedical applications, since the microstructure may influence its integration, resorption and replacement by bone. We studied late stages of aragonite growth, at an air-liquid interface, from a solution not doped with additives. Comparison was made between the types of synthetic aragonite microstructure and that of aragonite which is found in nature (mollusc shells, gallstones, Earth's crust). The microstructure of natural aragonite is unique to certain classes of living organisms and the understanding of its structure/function relationships may help to select the types of synthetic aragonite for specific biomedical applications. Three types of synthetic aragonite were observed based on grain size and grain morphology.
C1 GEOCENTERS INC,NATICK,MA 01760.
   TUFTS UNIV,CTR BIOTECHNOL,MEDFORD,MA 02155.
   UNIV LOWELL,CTR ADV MAT,LOWELL,MA 01854.
RP Litvin, AL (reprint author), USA,NATICK RES DEV & ENGN CTR,DIV BIOTECHNOL,NATICK,MA 01760, USA.
CR ADAMS AE, 1983, J SEDIMENT PETROL, V2, P417
   BASSI N, 1994, CURR THER RES CLIN E, V55, P1169, DOI 10.1016/S0011-393X(05)80257-7
   Bathurst R. C. G., 1975, CARBONATE SEDIMENTS
   BUEHRER TF, 1940, J PHYS CHEM-US, V44, P551
   CHIROFF RT, 1977, J BIOMED MATER RES, V11, P165, DOI 10.1002/jbm.820110203
   CHRISTEL P, 1995, Patent No. 5433751
   FRANKE WA, 1992, CRYST RES TECHNOL, V27, P295, DOI 10.1002/crat.2170270302
   GIRAUDGUILLE MM, 1994, MICROSC RES TECHNIQ, V5, P420
   GUO L, 1992, SEDIMENTOLOGY, V39, P1067, DOI 10.1111/j.1365-3091.1992.tb01997.x
   HENCH L, 1993, INTRO BIOCERAMICS
   HONDA E, 1994, B I OCEANOGR MONACO, V14, P115
   LITVIN AL, 1995, J PHYS CHEM-US, V99, P492, DOI 10.1021/j100002a006
   LITVIN AL, 1995, J PHYS CHEM-US, V99, P12065, DOI 10.1021/j100032a001
   LITVIN AL, 1995, P SMART STRUCT MAT S, P54
   LITVIN AL, 1997, UNPUB ADV MAT
   LITVIN JL, 1996, BIOCERAMICS, V9, P363
   Lowenstam HA, 1989, BIOMINERALIZATION
   MANN H, 1987, J PHYCOL, V23, P506, DOI 10.1111/j.1529-8817.1987.tb02539.x
   Mann S., 1996, BIOMIMETIC MAT CHEM
   OKUMURA M, 1986, GEOCHIM COSMOCHIM AC, V50, P49, DOI 10.1016/0016-7037(86)90047-5
   PUTNIS A, 1993, INTRO MINERAL SCI
   Reeder R. J., 1990, CARBONATES MINERALOG
   SARIKAYA M, 1994, MICROS RES TECH, V5, P360
   Zum Gahr K.-H., 1987, TRIBOLOGY SERIES, V10
NR 24
TC 5
Z9 5
U1 0
U2 2
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD MAY 1
PY 1997
VL 32
IS 9
BP 2233
EP 2236
DI 10.1023/A:1018511930559
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA WY350
UT WOS:A1997WY35000001
DA 2018-10-20
ER

PT J
AU Dahmen, KG
   Maurin, N
   Richter, HA
   Mittermayer, CH
AF Dahmen, KG
   Maurin, N
   Richter, HA
   Mittermayer, CH
TI Screening of biomedical polymer biocompatibility in NMRI-mice peritoneal
   cavity - A comparison between ultra-high-molecular-weight polyethylene
   (UHMW-PE) and polyethyleneterephthalate (PET)
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID INVITRO; CELLS
AB The peritoneal resident cell population is influenced by various inflammatory and immunogenic stimuli. The influence of intraperitoneal application of polyethyleneterephthalate (PET) (group A) and ultra-high-molecular-weight polyethylene (UHMW-PE) (group B) powders on peritoneal cell count and macrophage activity was investigated. Powders were tested to mimic wear particles from solid implant devices as these particles often cause chronic granulomatous inflammation. The results were compared with the inflammatory response following an abdominal midline incision (group C) and untreated animals (group D). On days 1,7,14 and 30 peritoneal cells were quantified and the number of active macrophages was assessed. Groups A and C mice showed a significant loss of macrophages in the peritoneal ravage at day 1 but this returned to normal values (group D) on day 7. In contrast, group B animals remained at low peritoneal cell counts but showed the highest number of active macrophages. Only in this latter group was adhesion formation and granulomatous clustering of polymer powder observed. Applying the parameters macrophage count and the number of active macrophages it can be concluded that PET elicits a weaker inflammatory reaction than UHMW-PE in mice peritoneal cavity. Thus this animal model may be used as a screening test for biomedical materials, especially their wear products.
C1 UNIV PARIS,FAC MED ST ANTOINE,HISTOL LAB,F-75571 PARIS 12,FRANCE.
   RHEIN WESTFAL TH AACHEN,INST PATHOL,D-52074 AACHEN,GERMANY.
RP Dahmen, KG (reprint author), TECH UNIV DRESDEN,INST ANESTHESIOL & INTENS CARE,INST BIOL,FETSCHERSTASSE 74,D-01307 DRESDEN,GERMANY.
CR BACHELET CM, 1987, EXP LUNG RES, V13, P241, DOI 10.3109/01902148709069592
   CANNISTRA SA, 1994, EXP HEMATOL, V22, P996
   CHARNLEY J, 1970, CLIN ORTHOPAEDICS, V72, P7
   COHEN J, 1959, J BONE JOINT SURG AM, V41, P152, DOI 10.2106/00004623-195941010-00018
   COLEMAN DL, 1974, J BIOMED MATER RES, V8, P199, DOI 10.1002/jbm.820080503
   JONJIC N, 1992, J EXP MED, V176, P1165, DOI 10.1084/jem.176.4.1165
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   Matturri L, 1990, Minerva Cardioangiol, V38, P279
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   NELSON DS, 1963, IMMUNOLOGY, V6, P264
   NELSON DS, 1965, LAB INVEST, V14, P89
   RENDELLBAKER L, 1970, ANESTH ANAL CURR RES, V49, P919
   SANTAVIRTA S, 1990, J BONE JOINT SURG AM, V72A, P252, DOI 10.2106/00004623-199072020-00014
   SMITH R, 1987, J BIOMED MATER RES, V21, P991, DOI 10.1002/jbm.820210805
   SULTAN AM, 1978, J PATHOL, V126, P221, DOI 10.1002/path.1711260406
   Tardito E, 1993, Minerva Cardioangiol, V41, P59
   TETIK RD, 1974, J BIOMED MATER RES, V8, P231, DOI 10.1002/jbm.820080506
   VANSLIEDREGT A, 1992, BIOMATERIALS, V13, P819, DOI 10.1016/0142-9612(92)90174-M
   Willert HG, 1990, CLIN ORTHOPAEDICS, V258, P95
   Woodward SC, 1986, HDB BIOMATERIALS EVA, P364
   WORTMAN RS, 1983, BIOMATER ARTIF CELL, V11, P103, DOI 10.3109/10731198309118799
NR 21
TC 5
Z9 5
U1 0
U2 1
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 1997
VL 8
IS 5
BP 239
EP 245
DI 10.1023/A:1018595825048
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA WX994
UT WOS:A1997WX99400001
PM 15348744
DA 2018-10-20
ER

PT J
AU Zhang, QQ
   Ren, L
   Liu, LR
   Wang, C
AF Zhang, QQ
   Ren, L
   Liu, LR
   Wang, C
TI Structure investigation of poly(vinyl alcohol)-collagen composite
SO JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY
LA English
DT Article
ID COLLAGEN; HYDROGELS
AB Naturally derived collagen protein was mixed thoroughly with medical grade poly (vinyl alcohol) (PVA) at the ratio of 90:10 (w/w) and was crosslinked by formaldehyde to form a homogeneous composite membrane. The bulk structure of the membrane was characterized by means of X-ray diffraction (XRD) and transmission electron microscopy (TEM). The membrane surface structure was investigated using Fourier transform-infrared spectroscopy (attenuated total refraction) (FTIR-ATR), electron spectroscopy for chemical analysis (ESCA) and contact angle measurement. It was found that collagen and PVA can remain stable. This was supported by the fact that no sign of phase separation had been observed. The use of crosslinking agent can substantially influence the structure of the composite. It is suggested that this new composite deserves further investigation and is potentially usable as a biomedical material.
C1 UNIV UTAH,CCCD,SALT LAKE CITY,UT 84112.
RP Zhang, QQ (reprint author), CHINESE ACAD MED SCI,INST BIOMED ENGN,TIANJIN 300192,PEOPLES R CHINA.
RI ren, lei/G-3459-2010; Zhang, QQ/G-3361-2010
OI ren, lei/0000-0003-2131-1601; 
CR CHIELLINI E, 1983, POLYM MED BIOMEDICAL, P23
   CIFKOVA I, 1987, BIOMATERIALS, V8, P30, DOI 10.1016/0142-9612(87)90024-X
   EVANGELISTA RA, 1986, BIOMATERIALS, V7, P206, DOI 10.1016/0142-9612(86)90104-3
   GIUSTI P, 1994, BIOMATERIALS, V15, P1229, DOI 10.1016/0142-9612(94)90274-7
   RAO JK, 1994, BIOMATERIALS, V15, P383, DOI 10.1016/0142-9612(94)90251-8
   SAWHNEY AS, 1993, BIOMATERIALS, V14, P1008, DOI 10.1016/0142-9612(93)90194-7
   WATLER PK, 1988, BIOMATERIALS, V9, P150, DOI 10.1016/0142-9612(88)90114-7
   ZHANG QQ, 1991, POLYM BIOMATERIALS, V3, P289
   ZHANG QQ, 1990, P FAR E C MED BIOL E, P264
NR 9
TC 13
Z9 16
U1 0
U2 1
PU JOURNAL MATER SCI TECHNOL
PI SHENYANG
PA 72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA
SN 1005-0302
J9 J MATER SCI TECHNOL
JI J. Mater. Sci. Technol.
PD MAY
PY 1997
VL 13
IS 3
BP 179
EP 183
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA WX547
UT WOS:A1997WX54700003
DA 2018-10-20
ER

PT J
AU Ektessabi, AM
AF Ektessabi, AM
TI Surface modification of biomedical implants using ion-beam-assisted
   sputter deposition
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Ion Beam Modification of Materials
   (IBMM-96)
CY SEP 01-06, 1996
CL ALBUQUERQUE, NM
ID CALCIUM-PHOSPHATE; TRICALCIUM PHOSPHATE; CERAMIC COATINGS; THIN-FILMS;
   IN-VIVO; HYDROXYAPATITE; TITANIUM; ALLOYS
AB Hydroxy-apatite (Ca-10(PO4)(6)(OH)(2)), owing to its good bioaffinity and enhancement of osseo-integration, is a potential material for costing on dental and orthopedic implants. At present, hydroxy-apatite is coated on metal implants by a plasma spraying method or is used in its bulk form in reconstruction surgery. In this paper, experimental results are given for preparation of hydroxy-apatite thin films on various biomedical implant materials using ion-beam sputter deposition and ion-beam-assisted sputter deposition methods. By using the ion-beam-assisted sputter deposition method, the adhesion of hydroxy-apatite thin films to substrate has improved significantly and increased to a level comparable to Ti and Al oxide thin films. Relative atomic densities of Ca, P, O and H in hydroxy-apatite thin films were obtained using ion-beam analysis methods such as RES, RE-RES, ERDA, and PIXE. The relative concentrations of Ca, and P were affected by assisting-beam density, and stoichiometric films were obtained for certain assisting-beam current densities.
RP Ektessabi, AM (reprint author), KYOTO UNIV,GRAD SCH ENGN,SAKYO KU,KYOTO 60601,JAPAN.
CR BABA S, 1986, J VAC SCI TECHNOL A, V4, P3015, DOI 10.1116/1.573617
   BARHELL BL, 1988, MATER RES SOC S P, P709
   BENGHUZZI HA, 1995, IEEE P 14 S BIOM ENG, P289
   BENJAMIN P, 1960, PROC R SOC LON SER-A, V254, P163, DOI 10.1098/rspa.1960.0012
   BUMA P, 1995, J ARTHROPLASTY, V10, P389, DOI 10.1016/S0883-5403(05)80190-1
   DALTON JE, 1995, J BIOMED MATER RES, V29, P239, DOI 10.1002/jbm.820290215
   DEAZA PN, 1995, J AM CERAM SOC, V78, P1653
   DING XF, 1995, J CERAM SOC JPN, V103, P867, DOI 10.2109/jcersj.103.867
   DUCHEYNE P, 1988, J BIOMED MATER RES, V22, P1137, DOI 10.1002/jbm.820221207
   EKTESSABI AM, 1994, SURF COAT TECH, V68, P208, DOI 10.1016/0257-8972(94)90162-7
   Ektessabi AM, 1995, THIN SOLID FILMS, V270, P335, DOI 10.1016/0040-6090(95)06714-0
   EKTESSABI AM, 1995, NUCL INSTRUM METH B, V99, P610, DOI 10.1016/0168-583X(94)00568-0
   EKTESSABI AM, 1995, 3 INT S SPUTT PLASM, P341
   Feldman LE, 1986, FUNDAMENTALS SURFACE
   Geesink R G, 1993, Acta Orthop Belg, V59 Suppl 1, P160
   GOTTLANDER M, 1991, International Journal of Oral and Maxillofacial Implants, V6, P399
   Jansen J A, 1993, Clin Oral Implants Res, V4, P28, DOI 10.1034/j.1600-0501.1993.040104.x
   JANSEN JA, 1993, J BIOMED MATER RES, V27, P603, DOI 10.1002/jbm.820270507
   KAY JF, 1993, COMPENDIUM S, V15, pS520
   KLEIN CPAT, 1994, BIOMATERIALS, V15, P146, DOI 10.1016/0142-9612(94)90264-X
   Kramer EJ, 1996, MRS BULL, V21, P37
   Lacefield W R, 1988, Ann N Y Acad Sci, V523, P72, DOI 10.1111/j.1749-6632.1988.tb38501.x
   MUDRA DR, 1995, IEEE P 14 S BIOM ENG, P111
   Nimb L, 1993, Acta Orthop Belg, V59, P333
   ONG JL, 1992, BIOMATERIALS, V13, P249, DOI 10.1016/0142-9612(92)90192-Q
   PAN J, 1995, UNPUB
   PAN J, IN PRESS BIOMATERIAL
   SINGH RK, 1994, BIOMATERIALS, V15, P522, DOI 10.1016/0142-9612(94)90018-3
   STEVENSON JR, 1988, MATER RES SOC S P, P715
   THOMAS KA, 1994, ORTHOPEDICS, V17, P267
   Umegaki T., 1988, Memoirs of Faculty of Technology, Tokyo Metropolitan University, V38, P133
   VANDIJK K, 1995, SURFACE COATINGS TEC
   VANDIJK K, 1995, BIOMATERIALS
   VAUGHN B K, 1992, Dental Clinics of North America, V36, P263
   YAMASHITA K, 1994, J AM CERAM SOC, V77, P2401, DOI 10.1111/j.1151-2916.1994.tb04611.x
   YOSHINARI M, 1994, BIOMATERIALS, V15, P529, DOI 10.1016/0142-9612(94)90019-1
NR 36
TC 23
Z9 24
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD MAY
PY 1997
VL 127
BP 1008
EP 1014
DI 10.1016/S0168-583X(97)00049-9
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA XG605
UT WOS:A1997XG60500222
DA 2018-10-20
ER

PT J
AU Anglin, MK
AF Anglin, MK
TI Working from the inside out: Implications of breast cancer activism for
   biomedical policies and practices
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Review
DE breast cancer; activism; treatment; policy; research
ID AFRICAN-AMERICAN WOMEN; LATE-STAGE DIAGNOSIS; SOCIAL-CLASS;
   RISK-FACTORS; MEDICAL PROGRESS; CERVICAL-CANCER; FAMILIAL BREAST;
   OVARIAN-CANCER; AIDS TRIALS; AGE
AB Much has been written about women with breast cancer: about women's lifestyles and reproductive strategies as possible risk Factors for the disease, factors which impede or Facilitate women's participation in mammography screening, ways to involve women in treatment decision-making, and women's ability to cope with breast cancer diagnoses. Seldom do these accounts examine breast cancer from the perspective of women with the disease. This essay presents material from an ethnographic study in the United Stales to explore the ways that women have come forward as informed consumers and activists working to make biomedical practices more responsive to the needs of women with breast cancer. Insofar as breast cancer activists reflect the concerns of a predominantly white, middle class constituency, however, additional questions are raised concerning their constructions of breast cancer and the problematics of treatment. (C) 1997 Elsevier Science Ltd.
RP Anglin, MK (reprint author), UNIV KENTUCKY, DEPT ANTHROPOL, 211 LAFFERTY HALL, LEXINGTON, KY 40506 USA.
FU NIA NIH HHS [T32 AG00045]
CR *AM CANC SOC, 1996, CANC FACTS FIG 1996
   ANGELL M, 1994, NEW ENGL J MED, V330, P1448, DOI 10.1056/NEJM199405193302010
   ANGLIN MK, 1992, UNPUB
   ANGLIN MK, 1994, SOWING SEEDS MOUNTAI, P179
   [Anonymous], 1992, NY TIMES        1029
   ASTROW AB, 1994, LANCET, V343, P494, DOI 10.1016/S0140-6736(94)91454-0
   BAIR B, 1993, WINGS GAUZE WOMEN CO
   Baker R, 1995, BETA, P6
   BALSHEM M, 1991, AM ETHNOL, V18, P152, DOI 10.1525/ae.1991.18.1.02a00070
   BASSETT MT, 1986, AM J PUBLIC HEALTH, V76, P1400, DOI 10.2105/AJPH.76.12.1400
   BATT S, 1994, PATIENT NO MORE POLI
   BIESELE M, 1996, PERFORMANCE HEALING
   BLACK WC, 1995, J NATL CANCER I, V87, P720, DOI 10.1093/jnci/87.10.720
   BLOOM JR, 1994, CANCER, V74, P1464, DOI 10.1002/1097-0142(19940815)74:4+<1464::AID-CNCR2820741611>3.0.CO;2-K
   BRADY J, 1991, ONE 3 WOMEN CANC CON
   BURTNESS BA, 1995, JAMA-J AM MED ASSOC, V273, P1702, DOI 10.1001/jama.273.21.1702
   Butler Sandra, 1991, CANC 2 VOICES
   BYAR DP, 1990, NEW ENGL J MED, V323, P1343, DOI 10.1056/NEJM199011083231912
   CHAVEZ LR, 1995, MED ANTHROPOL Q, V9, P40, DOI 10.1525/maq.1995.9.1.02a00030
   COLDITZ GA, 1993, JAMA-J AM MED ASSOC, V270, P338, DOI 10.1001/jama.270.3.338
   COOPER CL, 1992, PSYCHOL MED, V22, P447, DOI 10.1017/S0033291700030397
   COPE O, 1965, AM J SURG, V110, P119, DOI 10.1016/0002-9610(65)90165-0
   COPE O, 1977, BREAST ITS TROUBLES
   COTTON P, 1990, JAMA-J AM MED ASSOC, V264, P666
   CRILE G, 1961, ANN SURG, V153, P745
   CRILE G, 1973, WHAT WOMEN SHOULD KN
   DAYAL HH, 1970, J CHRON DIS, V23, P105
   EASTON DF, 1993, AM J HUM GENET, V52, P678
   ELEY JW, 1994, JAMA-J AM MED ASSOC, V272, P947, DOI 10.1001/jama.272.12.947
   ERIKSON J, 1995, SCIENCE, V269, P1508, DOI 10.1126/science.7667631
   FARLEY TA, 1989, AM J PUBLIC HEALTH, V79, P1508, DOI 10.2105/AJPH.79.11.1508
   FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302
   FRIEDMAN LS, 1994, CANCER RES, V54, P6374
   FUGHBERMAN A, 1992, LANCET, V340, P1143, DOI 10.1016/0140-6736(92)93161-F
   FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630
   GANZ PA, 1995, CA-CANCER J CLIN, V45, P114, DOI 10.3322/canjclin.45.2.114
   GANZ PA, 1992, J CLIN EPIDEMIOL, V45, P473, DOI 10.1016/0895-4356(92)90096-6
   GANZ PA, 1992, NEW ENGL J MED, V326, P1147, DOI 10.1056/NEJM199204233261708
   Gifford S., 1986, ANTHR EPIDEMIOLOGY, P213
   GLANZ K, 1992, Annals of Behavioral Medicine, V14, P204
   GOOD MJD, 1995, AM MED QUEST COMPETE
   GREGG J, 1994, SOC SCI MED, V39, P519, DOI 10.1016/0277-9536(94)90094-9
   HACK TF, 1994, SOC SCI MED, V39, P279, DOI 10.1016/0277-9536(94)90336-0
   HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482
   HARRIS JR, 1992, NEW ENGL J MED, V327, P473, DOI 10.1056/NEJM199208133270706
   HARRIS JR, 1992, NEW ENGL J MED, V327, P390, DOI 10.1056/NEJM199208063270606
   HARRIS JR, 1992, NEW ENGL J MED, V327, P319, DOI 10.1056/NEJM199207303270505
   HELLMAN S, 1993, CANCER-AM CANCER SOC, V71, P2430, DOI 10.1002/1097-0142(19930401)71:7<2430::AID-CNCR2820710743>3.0.CO;2-Z
   HENDERSON BE, 1991, BREAST CANCER RES TR, V18, pS11, DOI 10.1007/BF02633520
   HENDERSON IC, 1990, CURR PROB CANCER, V14, P163
   HENDERSON IC, 1993, CANCER-AM CANCER SOC, V71, P2127, DOI 10.1002/1097-0142(19930315)71:6+<2127::AID-CNCR2820711602>3.0.CO;2-2
   HENDERSON IC, 1992, NEW ENGL J MED, V326, P1774, DOI 10.1056/NEJM199206253262611
   HENDERSON IC, 1991, BREAST DISEASES, P547
   HENDERSON IC, 1991, BREAST DIS, P427
   HILTS PJ, 1996, NY TIMES        0330, P1
   HILTS PJ, 1996, NY TIMES        0330, P8
   HOLMES FF, 1981, J AM GERIATR SOC, V29, P55, DOI 10.1111/j.1532-5415.1981.tb01227.x
   *I MED, 1993, STRAT MAN BREAST CAN
   JENG MH, 1992, CANCER RES, V52, P6539
   JONES JH, 1981, BAD BLOOD TUSKEGEE S
   KANG SH, 1993, J NATL CANCER I, V85, P737, DOI 10.1093/jnci/85.9.737
   KELSEY JL, 1991, CA-CANCER J CLIN, V41, P146, DOI 10.3322/canjclin.41.3.146
   KELSEY JL, 1993, EPIDEMIOL REV, V15, P7, DOI 10.1093/oxfordjournals.epirev.a036118
   KLIJN JGM, 1994, HUM REPROD, V9, P181, DOI 10.1093/humrep/9.suppl_1.181
   KOHLMEIER L, 1990, ANN NY ACAD SCI, V609, P259, DOI 10.1111/j.1749-6632.1990.tb32073.x
   KRIEGER N, 1990, AM J EPIDEMIOL, V131, P804, DOI 10.1093/oxfordjournals.aje.a115571
   Kushner R., 1975, BREAST CANC PERSONAL
   KUSHNER R, 1984, ALTERNATIVES
   KUSKA B, 1995, J NATL CANCER I, V87, P1578, DOI 10.1093/jnci/87.21.1578
   KUSKA B, 1995, J NATL CANCER I, V87, P1505, DOI 10.1093/jnci/87.20.1505
   Langston AA, 1996, NEW ENGL J MED, V334, P137, DOI 10.1056/NEJM199601183340301
   LAUVER D, 1994, RES NURS HEALTH, V17, P421, DOI 10.1002/nur.4770170605
   LORDE A, 1988, BURST LIGHT
   Lorde Audre, 1980, CANC J
   LOVE SM, 1993, JAMA-J AM MED ASSOC, V269, P2417, DOI 10.1001/jama.269.18.2417
   Mahon S M, 1990, Oncol Nurs Forum, V17, P47
   MANDELBLATT J, 1991, AM J PUBLIC HEALTH, V81, P646, DOI 10.2105/AJPH.81.5.646
   MARSHALL E, 1992, SCIENCE, V258, P732, DOI 10.1126/science.1439774
   MATHEWS HF, 1994, SOC SCI MED, V38, P789, DOI 10.1016/0277-9536(94)90151-1
   MATHEWS J, 1992, WASHINGTON POST 1102
   McCoy H V, 1992, J Community Health, V17, P27
   MCPHERSON K, 1994, BRIT MED J, V309, P1003, DOI 10.1136/bmj.309.6960.1003
   MERIGAN TC, 1990, NEW ENGL J MED, V323, P1341, DOI 10.1056/NEJM199011083231911
   Metzger D., 1981, WOMAN WHO SLEPT MEN
   MILLER AB, 1992, CAN MED ASSOC J, V147, P1459
   MILLONUNDERWOOD S, 1993, CANCER NURS, V16, P25
   MONTINI T, 1989, RES SOCIOLOGY HLTH C, V8, P3
   MONTINI TM, 1991, THESIS
   *NAT CTR HLTH STAT, 1990, DHHS PUBL
   NAYFIELD SG, 1994, J NATL CANCER I, V86, P1202, DOI 10.1093/jnci/86.16.1202
   *NIH, 1994, NIH GUID, V2310
   *NIH, 1993, P SECR C EST NAT ACT
   *NO CA CTR, 1994, 5 NO CAL CTR GREAT B
   *NORCAL, UNPUB BRIEF HIST
   *NORCAL CBCC, UNPUB CANC IN RESP
   *PRES CANC PAN, 1992, M SUMM PAT ADV VOL O
   QUINN SC, 1993, HEALTH EDUC QUART, V20, P305, DOI 10.1177/109019819302000303
   Raloff Janet, 1992, Sci News, V142, P378, DOI 10.2307/4017895
   RAPP R, 1993, KNOWLEDGE POWER PRAC, P55
   RIES LAG, 1994, NIH PUB
   RIMER BK, 1995, J NATL CANCER I, V87, P703, DOI 10.1093/jnci/87.10.703
   Rollin Betty, 1976, 1 YOU CRY
   ROWELL S, 1994, AM J HUM GENET, V55, P861
   ROWLAND JH, 1991, BREAST DISEASES, P849
   ROY B, 1995, J NATL MED ASSOC, V87, P56
   Ruzek S, 1978, WOMENS HLTH MOVEMENT
   SALISBURY DA, 1990, CAN MED ASSOC J, V142, P1057
   SCHAG CAC, 1993, J CLIN ONCOL, V11, P783, DOI 10.1200/JCO.1993.11.4.783
   SEACHRIST L, 1994, SCIENCE, V264, P499, DOI 10.1126/science.8160006
   SOLOMON A, 1992, CAMERA OBSCURA, P157
   SPIEGEL D, 1990, PSYCHOSOMATICS, V31, P361, DOI 10.1016/S0033-3182(90)72130-5
   SPIEGEL D, 1989, LANCET, V2, P888
   STOCKER M, 1991, CANC WOMENS ISSUE SC
   Stocker Midge, 1993, CONFRONTING CANC CON
   THOMAS SB, 1991, AM J PUBLIC HEALTH, V81, P1498, DOI 10.2105/AJPH.81.11.1498
   THOMPSON D, 1992, TIME            1012, P66
   THOMPSON WD, 1994, CANCER, V74, P279
   VITETTA ES, 1994, CANCER RES, V54, P5301
   WACHTER RM, 1992, NEW ENGL J MED, V326, P128, DOI 10.1056/NEJM199201093260209
   WADLER J, 1992, MY BREAST ONE WOMANS
   WEBER BL, 1994, NEW ENGL J MED, V331, P1523, DOI 10.1056/NEJM199412013312214
   WEBER BL, 1996, JNCI-J NATL CANCER I, V88, P70
   WHITE EC, 1990, BLACK WOMENS HLTH BO
   Williams T.T., 1991, REFUGE UNNATURAL HIS
   ZUCKER A, 1994, DEATH STUD, V18, P555, DOI 10.1080/07481189408252699
   1992, NY TIMES        1019
   1996, LANCET, V347, P133
NR 127
TC 37
Z9 37
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD MAY
PY 1997
VL 44
IS 9
BP 1403
EP 1415
DI 10.1016/S0277-9536(96)00321-8
PG 13
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA WV612
UT WOS:A1997WV61200014
PM 9141172
DA 2018-10-20
ER

PT J
AU Kobayashi, K
   Tsuchida, A
   Usui, T
   Akaike, T
AF Kobayashi, K
   Tsuchida, A
   Usui, T
   Akaike, T
TI A new type of artificial glycoconjugate polymer: A convenient synthesis
   and its interaction with lectins
SO MACROMOLECULES
LA English
DT Article
ID WHEAT-GERM-AGGLUTININ; SPECIFICITY; BINDING; OLIGOSACCHARIDES;
   GLYCOSYLAMINES; PURIFICATION
AB A convenient synthetic route to a new type of artificial glycoconjugate polymer has been designed to develop biomedical materials using oligosaccharide moieties as recognition signals. An amino function was introduced to the reducing end of lactose and N,N'-diacetylchitobiose with ammonium hydrogen carbonate and then was allowed to react with p-vinylbenzoyl chloride. The N-glycosidation proceeded stereospecifically in one flask to give only the beta-glycoside without any protection and deprotection steps; The resulting p-vinylbenzamide glycoside derivatives were homo- and copolymerized with acrylamide using 2,2'-azobisisobutyronitrile as initiator in dimethyl sulfoxide at 60 degrees C. The interaction of the glycopolymers with lectins was investigated by means of a two-dimensional immunodiffusion test in agar and inhibition of the hemagglutinating activity. The specificity of lectins with these glycopolymers was similar to that reported for naturally-occurring glycoconjugates. Binding between wheat germ agglutinin lectin (WGA) and poly((p-vinylbenzamido)-beta-diacetylchitobiose) was increased by 10(3) times compared with that of the oligosaccharide itself. The enhancement was attributed to the presence of the hydrophobic phenyl aglycon as well as the high density, multiantennary disaccharide ligands along the polymer chain. The present synthetic method is useful to introduce biologically important, complex oligosaccharides into glycopolymers.
C1 NAGOYA UNIV, GRAD SCH ENGN, DEPT BIOTECHNOL, NAGOYA, AICHI 46401, JAPAN.
   SHIZUOKA UNIV, FAC AGR, SHIZUOKA 422, JAPAN.
   TOKYO INST TECHNOL, FAC BIOSCI & TECHNOL, YOKOHAMA, KANAGAWA 226, JAPAN.
RP Kobayashi, K (reprint author), NAGOYA UNIV, GRAD SCH ENGN, DEPT MOL DESIGN, NAGOYA, AICHI 46401, JAPAN.
CR Bock K., 1974, J CHEM SOC        P2, V2, P293
   BYSTROV VF, 1973, TETRAHEDRON, V29, P873, DOI 10.1016/0040-4020(73)80031-6
   COHENANISFELD ST, 1993, J AM CHEM SOC, V115, P10531, DOI 10.1021/ja00076a010
   CROWLEY JF, 1984, ARCH BIOCHEM BIOPHYS, V231, P524, DOI 10.1016/0003-9861(84)90417-X
   GOLDSTEIN IJ, 1972, METHODS CARBOHYD CHE, V6, P106
   IGLESIAS JL, 1982, EUR J BIOCHEM, V123, P247, DOI 10.1111/j.1432-1033.1982.tb19760.x
   KALLIN E, 1989, J CARBOHYD CHEM, V8, P597, DOI 10.1080/07328308908048020
   KAWAGISHI H, 1994, J BIOL CHEM, V269, P1375
   KOBAYASHI A, 1994, J BIOMAT SCI-POLYM E, V6, P325, DOI 10.1163/156856295X00030
   KOBAYASHI K, 1988, J MACROMOL SCI CHEM, VA25, P655, DOI 10.1080/00222338808053391
   KOBAYASHI K, 1985, POLYM J, V17, P567, DOI 10.1295/polymj.17.567
   KOBAYASHI K, 1994, J CARBOHYD CHEM, V13, P753, DOI 10.1080/07328309408011678
   KOBAYASHI K, 1994, NEOGLYCOCONJUGATES B, P409
   KOBAYASHI K, 1990, TRENDS GLYCOSCI GLYC, V2, P26
   Kobayashi Kazukiyo, 1994, P261
   LANDSCHOOT AV, 1977, EUR J BIOCHEM, V79, P275
   LEE YC, 1995, ACCOUNTS CHEM RES, V28, P321, DOI 10.1021/ar00056a001
   LEE YC, 1994, NEOGLYCOCONJUGATES P
   LEE YC, 1994, METHODS ENZYMOLOGY, V247
   LEE YC, 1994, METHODS ENZYMOLOGY, V242
   LIKHOSHERSTOV LM, 1986, CARBOHYD RES, V146, pC1, DOI 10.1016/0008-6215(86)85037-6
   LOTAN R, 1975, J BIOL CHEM, V250, P8518
   MATSUOKA K, 1995, MACROMOLECULES, V28, P2961, DOI 10.1021/ma00112a049
   NAGATA Y, 1974, J BIOL CHEM, V249, P3116
   NICOLSON GL, 1972, BIOCHIM BIOPHYS ACTA, V266, P543, DOI 10.1016/0005-2736(72)90109-5
   NISHIMURA SI, 1994, MACROMOLECULES, V27, P4876, DOI 10.1021/ma00096a004
   WRIGHT CS, 1990, J MOL BIOL, V215, P635, DOI 10.1016/S0022-2836(05)80174-3
NR 27
TC 129
Z9 130
U1 1
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
EI 1520-5835
J9 MACROMOLECULES
JI Macromolecules
PD APR 7
PY 1997
VL 30
IS 7
BP 2016
EP 2020
DI 10.1021/ma961681e
PG 5
WC Polymer Science
SC Polymer Science
GA WT213
UT WOS:A1997WT21300021
DA 2018-10-20
ER

PT J
AU Yang, ZH
   Yu, H
AF Yang, ZH
   Yu, H
TI Preserving a globular protein shape on glass slides: A self-assembled
   monolayer approach
SO ADVANCED MATERIALS
LA English
DT Article
ID LATERAL DIFFUSION; SURFACE INTERACTIONS; POLYETHYLENE OXIDE; ADSORPTION;
   MEMBRANE
AB The manufacture of low-cost, protein-friendly, biocompatible materials is important for biomedical applications. A method is presented for making glass surfaces-on which the globular protein shape is often lost-benign to proteins by covalently grafting relatively short poly(ethylene glycol) chains (functionalized with trimethylsilane, see Figure), which form a brush-like self-assembled monolayer.
C1 UNIV WISCONSIN,DEPT CHEM,MADISON,WI 53706.
CR ALLARA DL, 1992, POLYM SURFACES INTER, V2
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   ANDRADE JD, 1996, HYDROPHILIC POLYM
   DETTRE RH, 1965, J PHYS CHEM-US, V69, P1507, DOI 10.1021/j100889a012
   Fadley C. S., 1976, Progress in Solid State Chemistry, P265, DOI 10.1016/0079-6786(76)90013-3
   FRITZ M, 1995, LANGMUIR, V11, P3529, DOI 10.1021/la00009a040
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   HENIS YI, 1988, BIOPOLYMERS, V27, P123, DOI 10.1002/bip.360270110
   Hoffman AS, 1996, MACROMOL SYMP, V101, P443, DOI 10.1002/masy.19961010150
   JENNISSEN HP, 1989, BER BUNSEN PHYS CHEM, V93, P948, DOI 10.1002/bbpc.19890930905
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   KIM S, 1992, PROG COLL POL SCI S, V89, P202
   KIM SH, 1992, J PHYS CHEM-US, V96, P4034, DOI 10.1021/j100189a023
   PALEGROSDEMANGE C, 1991, J AM CHEM SOC, V113, P12, DOI 10.1021/ja00001a002
   PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0
   POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   SMITH BA, 1978, P NATL ACAD SCI USA, V75, P2759, DOI 10.1073/pnas.75.6.2759
   TAKEZOE H, 1981, BIOCHEMISTRY-US, V20, P5275, DOI 10.1021/bi00521a028
   VROMAN L, 1966, BLOOD
   ZHDANOV SP, 1987, LANGMUIR, V3, P960, DOI 10.1021/la00078a014
NR 24
TC 11
Z9 11
U1 0
U2 4
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD APR
PY 1997
VL 9
IS 5
BP 426
EP &
DI 10.1002/adma.19970090515
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA WT969
UT WOS:A1997WT96900014
DA 2018-10-20
ER

PT J
AU Wink, T
   vanZuilen, SJ
   Bult, A
   vanBennekom, WP
AF Wink, T
   vanZuilen, SJ
   Bult, A
   vanBennekom, WP
TI Self-assembled monolayers for biosensors
SO ANALYST
LA English
DT Review
DE self-assembled monolayer; immunoassay; electrochemistry; surface plasmon
   resonance; (electrochemical) quartz crystal microbalance; biosensor
ID SURFACE-PLASMON RESONANCE; ORGANIZED MOLECULAR ASSEMBLIES;
   SCANNING-TUNNELING-MICROSCOPY; QUARTZ-CRYSTAL MICROBALANCE; GOLD
   SURFACES; ENZYME ELECTRODES; METAL-SURFACES; STRUCTURAL
   CHARACTERIZATION; COVALENT IMMOBILIZATION; ALKANETHIOL MONOLAYERS
AB The use of self-assembled monolayers (SAMs) in various fields of research is rapidly growing, In particular, many biomedical fields apply SAMs as an interface-layer between a metal surface and a solution or vapour, This review summarises methods for the formation of SAMs upon the most commonly used materials and techniques used for monolayer characterisation, Emphasis will lie on uniform, mixed and functionalised monolayers applied for immobilisation of biological components including (oligo-)nucleotides, proteins, antibodies and receptors as well as polymers, The application of SAMs in today's research, together with some applications will be discussed.
RP Wink, T (reprint author), UNIV UTRECHT, FAC PHARM, DEPT PHARMACEUT ANAL, POB 80082, NL-3508 TB UTRECHT, NETHERLANDS.
CR ACHTNICH UR, 1992, BIOSENS BIOELECTRON, V7, P279, DOI 10.1016/0956-5663(92)87006-B
   ALLARA DL, 1995, BIOSENS BIOELECTRON, V10, P771, DOI 10.1016/0956-5663(95)99215-7
   BAIN CD, 1989, J AM CHEM SOC, V111, P7155, DOI 10.1021/ja00200a039
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   BAIN CD, 1989, J AM CHEM SOC, V111, P7164, DOI 10.1021/ja00200a040
   BERTILSSON L, 1993, LANGMUIR, V9, P141, DOI 10.1021/la00025a032
   BHARATHI S, 1993, LANGMUIR, V9, P1614, DOI 10.1021/la00031a002
   BYFIELD MP, 1994, BIOSENS BIOELECTRON, V9, P373, DOI 10.1016/0956-5663(94)80038-3
   Carraway K L, 1972, Methods Enzymol, V25, P616, DOI 10.1016/S0076-6879(72)25060-1
   CHENG CA, 1995, ANAL CHEM, V67, P2767
   CHENG Q, 1992, ANAL CHEM, V64, P1998, DOI 10.1021/ac00041a041
   CHIDSEY CED, 1990, LANGMUIR, V6, P682, DOI 10.1021/la00093a026
   COLLINSON M, 1992, LANGMUIR, V8, P1247, DOI 10.1021/la00041a004
   CREAGER SE, 1995, ANAL CHIM ACTA, V307, P277, DOI 10.1016/0003-2670(94)00506-H
   DELAMARCHE E, 1994, LANGMUIR, V10, P4103, DOI 10.1021/la00023a033
   DEWELDIGE K, 1995, FRESEN J ANAL CHEM, V353, P329, DOI 10.1007/BF00322062
   DOWNS MEA, 1987, ANAL LETT, V20, P1897
   DUAN CM, 1994, ANAL CHEM, V66, P1369, DOI 10.1021/ac00081a003
   DUBOIS LH, 1992, ANNU REV PHYS CHEM, V43, P437, DOI 10.1146/annurev.pc.43.100192.002253
   Duschl C, 1996, BIOPHYS J, V70, P1985, DOI 10.1016/S0006-3495(96)79763-1
   EBERSOLE RC, 1990, J AM CHEM SOC, V112, P3239, DOI 10.1021/ja00164a070
   EDINGER K, 1993, LANGMUIR, V9, P4, DOI 10.1021/la00025a002
   FAGERSTAM LG, 1992, J CHROMATOGR, V597, P397, DOI 10.1016/0021-9673(92)80137-J
   Finklea H. O., 1996, ELECTROANALYTICAL CH, V19, P110
   FINKLEA HO, 1987, LANGMUIR, V3, P409, DOI 10.1021/la00075a024
   Ford JF, 1996, LANGMUIR, V12, P1944, DOI 10.1021/la950913k
   GODDARD NJ, 1994, ANALYST, V119, P583, DOI 10.1039/an9941900583
   GOPEL W, 1995, BIOSENS BIOELECTRON, V10, P853, DOI 10.1016/0956-5663(95)99225-A
   Grate JW, 1996, ANAL CHEM, V68, P913, DOI 10.1021/ac950518z
   GRUNZE M, 1993, PHYS SCRIPTA, VT49B, P711, DOI 10.1088/0031-8949/1993/T49B/056
   Harsanyi G, 1996, MATER CHEM PHYS, V43, P199, DOI 10.1016/0254-0584(95)01629-9
   HAUSSLING L, 1991, LANGMUIR, V7, P1837
   HEINEMAN WR, 1985, ANAL CHEM, V57, P1321, DOI 10.1021/ac00289a804
   HOSHI T, 1994, ANAL CHIM ACTA, V289, P321, DOI 10.1016/0003-2670(94)90008-X
   IVARSSON B A, 1985, Colloids and Surfaces, V13, P169, DOI 10.1016/0166-6622(85)80015-9
   JIANG L, 1995, J CHEM SOC CHEM COMM, P1293, DOI 10.1039/c39950001293
   JONSSON U, 1988, METHOD ENZYMOL, V137, P381
   KARPOVICH DS, 1994, LANGMUIR, V10, P3315, DOI 10.1021/la00021a066
   KELLER H, 1992, THIN SOLID FILMS, V210, P799, DOI 10.1016/0040-6090(92)90408-4
   KEPLEY LJ, 1992, ANAL CHEM, V64, P3191, DOI 10.1021/ac00048a018
   KIM YT, 1993, LANGMUIR, V9, P1941, DOI 10.1021/la00032a001
   KOOYMAN RPH, 1994, THIN SOLID FILMS, V244, P913, DOI 10.1016/0040-6090(94)90599-1
   KRETSCHM.E, 1968, Z NATURFORSCH PT A, VA 23, P2135
   LIEDBERG B, 1985, PROG COLL POL SCI S, V70, P67
   LOFAS S, 1990, J CHEM SOC CHEM COMM, P1526, DOI 10.1039/c39900001526
   LOFAS S, 1995, BIOSENS BIOELECTRON, V10, P813
   Lu B, 1996, ANALYST, V121, pR29, DOI 10.1039/an996210029r
   LUNDSTROM I, 1985, PROG COLL POL SCI S, V70, P76
   LUNDSTROM I, 1985, J COLLOID INTERF SCI, V108, P288, DOI 10.1016/0021-9797(85)90264-4
   MALEM F, 1993, ANAL CHEM, V65, P37, DOI 10.1021/ac00049a009
   Mandler D, 1996, ELECTROANAL, V8, P207, DOI 10.1002/elan.1140080302
   MATSUDA T, 1995, LANGMUIR, V11, P2267
   MILLAN KM, 1993, ANAL CHEM, V65, P2317, DOI 10.1021/ac00065a025
   MINUNNI M, 1995, ANAL LETT, V28, P749, DOI 10.1080/00032719508001422
   MITTLERNEHER S, 1995, BIOSENS BIOELECTRON, V10, P903, DOI 10.1016/0956-5663(95)99228-D
   MORGAN H, 1992, THIN SOLID FILMS, V210, P773, DOI 10.1016/0040-6090(92)90400-6
   MORGEN H, 1995, BIOSENS BIOELECTRON, V10, P841, DOI 10.1016/0956-5663(95)99223-8
   MRKSICH M, 1995, LANGMUIR, V11, P4383, DOI 10.1021/la00011a034
   NUZZO RG, 1990, J AM CHEM SOC, V112, P558, DOI 10.1021/ja00158a012
   NUZZO RG, 1987, J AM CHEM SOC, V109, P2358, DOI 10.1021/ja00242a020
   NUZZO RG, 1987, J AM CHEM SOC, V109, P733, DOI 10.1021/ja00237a017
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   PAN J, 1993, LANGMUIR, V9, P1556, DOI 10.1021/la00030a022
   Pang DW, 1996, J ELECTROANAL CHEM, V403, P183, DOI 10.1016/0022-0728(95)04383-7
   PISCEVIC D, 1995, APPL SURF SCI, V90, P425, DOI 10.1016/0169-4332(95)00171-9
   PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011
   POSTLETHWAITE TA, 1995, LANGMUIR, V11, P4109, DOI 10.1021/la00010a076
   Rickert J, 1996, BIOSENS BIOELECTRON, V11, P591, DOI 10.1016/0956-5663(96)83294-5
   RIKLIN A, 1995, ANAL CHEM, V67, P4118, DOI 10.1021/ac00118a014
   ROBERTS GG, 1983, LANGMUIR BLODGETT FI
   Rubin S, 1996, LANGMUIR, V12, P363, DOI 10.1021/la950071p
   SADIK OA, 1993, ANAL CHIM ACTA, V279, P209, DOI 10.1016/0003-2670(93)80319-G
   SAGIV J, 1980, J AM CHEM SOC, V102, P2
   SAYRE CN, 1995, LANGMUIR, V11, P302, DOI 10.1021/la00001a051
   SCHIERBAUM KD, 1994, SCIENCE, V265, P1413, DOI 10.1126/science.265.5177.1413
   Schmidt A., 1992, Biophysical Journal, V63, P1185
   SCHMITT FJ, 1992, THIN SOLID FILMS, V210, P815, DOI 10.1016/0040-6090(92)90412-5
   SCHNEIDER TW, 1993, J AM CHEM SOC, V115, P12391, DOI 10.1021/ja00079a021
   SCHRAMM W, 1993, IMMUNOMETHODS, V3, P93
   SCOUTEN WH, 1987, METHOD ENZYMOL, V135, P30
   Sellergren B, 1996, ANAL CHEM, V68, P402, DOI 10.1021/ac9508356
   Sigal GB, 1996, ANAL CHEM, V68, P490, DOI 10.1021/ac9504023
   SPINKE J, 1993, J CHEM PHYS, V99, P7012, DOI 10.1063/1.465447
   STRONG L, 1988, LANGMUIR, V4, P546, DOI 10.1021/la00081a009
   SUN L, 1993, LANGMUIR, V9, P1951, DOI 10.1021/la00032a004
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V113, P530, DOI 10.1016/S0021-9797(86)90446-7
   TERRETTAZ S, 1993, LANGMUIR, V9, P1361, DOI 10.1021/la00029a033
   TROUGHTON EB, 1988, LANGMUIR, V4, P365, DOI 10.1021/la00080a021
   Truong KD, 1995, PROG SURF SCI, V50, P207, DOI 10.1016/0079-6816(95)00055-0
   Turner A., 1987, BIOSENSORS FUNDAMENT
   ULMAN A, 1995, CHARACTERIZATION ORG
   VANDENHEUVEL DJ, 1993, ANAL BIOCHEM, V215, P223, DOI 10.1006/abio.1993.1579
   VANOS PJHJ, 1995, ANAL CHIM ACTA, V305, P18, DOI 10.1016/0003-2670(94)00374-U
   Wagner P, 1996, BIOPHYS J, V70, P2052, DOI 10.1016/S0006-3495(96)79810-7
   WALCZAK MM, 1991, LANGMUIR, V7, P2687, DOI 10.1021/la00059a048
   WEISSHAAR DE, 1992, J AM CHEM SOC, V114, P5860, DOI 10.1021/ja00040a058
   WIDRIG CA, 1991, J ELECTROANAL CHEM, V310, P335, DOI 10.1016/0022-0728(91)85271-P
   WILLICUT RJ, 1995, ADV MATER, V7, P759, DOI 10.1002/adma.19950070819
   WILLNER I, 1994, ANAL CHEM, V66, P1535, DOI 10.1021/ac00081a028
   WOLFE CAC, 1995, ANAL BIOCHEM, V231, P123, DOI 10.1006/abio.1995.1511
   XU J, 1995, J COLLOID INTERF SCI, V176, P138, DOI 10.1006/jcis.1995.0017
   ZHAO S, 1992, LANGMUIR, V8, P2785, DOI 10.1021/la00047a034
NR 102
TC 320
Z9 330
U1 6
U2 109
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0003-2654
EI 1364-5528
J9 ANALYST
JI Analyst
PD APR
PY 1997
VL 122
IS 4
BP R43
EP R50
DI 10.1039/a606964i
PG 8
WC Chemistry, Analytical
SC Chemistry
GA WU814
UT WOS:A1997WU81400001
PM 9177074
DA 2018-10-20
ER

PT J
AU Jha, LJ
   Best, SM
   Knowles, JC
   Rehman, I
   Santos, JD
   Bonfield, W
AF Jha, LJ
   Best, SM
   Knowles, JC
   Rehman, I
   Santos, JD
   Bonfield, W
TI Preparation and characterization of fluoride-substituted apatites
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CRYSTAL-GROWTH; HYDROXYAPATITE; TEMPERATURE
AB Apatites were prepared with three different fluoride concentrations: 0.0 mM (pure hydroxyapatite) 2.5 mM and 5 mM. Reactions were performed in aqueous medium using a reaction between diammonium orthophosphate and calcium nitrate 4-hydrate and ammonium fluoride at temperatures of 3 degrees, 25 degrees, 60 degrees and 90 degrees C. The effects of reaction temperature and fluoride concentration on the crystal morphology, phase purity and crystallinity of the precipitates were observed, using transmission electron microscopy (TEM), X-ray diffraction (XRD), Fourier transform infrared (FTIR) spectroscopy and ion chromatography. Transmission electron micrographs revealed that the crystallites precipitated at 3 degrees C were spheroidal, but became increasingly acicular with increasing precipitation temperature. X-ray diffraction results indicated that all the materials produced were phase pure and that the crystallinity of apatites prepared at higher precipitation temperatures was higher than those prepared at lower precipitation temperatures. A significant difference in the a-axis dimension of fluoride-substituted apatites was observed, as compared to hydroxyapatite. FTIR spectroscopy revealed a hydroxyl band at 3568 cm(-1), along with a broad peak of adsorbed water in the region of 3568 cm(-1) to 2670 cm(-1) in the hydroxyapatite and fluoride-substituted apatite powders. Hence by careful selection of the precipitation conditions and fluoride contents, the composition and morphology of fluoride-substituted apatite may be controlled and this has interesting implications for the development of these materials for biomedical implantation.
C1 UNIV PORTO, FAC ENGN, DEPT MET, P-4099 OPORTO, PORTUGAL.
   UNIV LONDON QUEEN MARY & WESTFIELD COLL, INTERDISCIPLINARY RES CTR BIOMED MAT, LONDON E1 4NS, ENGLAND.
RP Jha, LJ (reprint author), UNIV PORTO, FAC ENGN, NATL INST BIOMED ENGN, RUA BRAGAS, P-4099 OPORTO, PORTUGAL.
RI Knowles, Jonathan Campbell/B-9019-2008
OI Knowles, Jonathan Campbell/0000-0003-3917-3446; Santos, Jose
   Domingos/0000-0002-6871-9850
CR ABRAHAMS I, 1994, J MATER CHEM, V4, P185, DOI 10.1039/jm9940400185
   ARENDS J, 1981, J CRYST GROWTH, V53, P135, DOI 10.1016/0022-0248(81)90060-9
   BARONE JP, 1978, J DENT RES, V57, P735, DOI 10.1177/00220345780570051601
   BETTS F, 1981, J CRYST GROWTH, V53, P63, DOI 10.1016/0022-0248(81)90056-7
   BOIVIN G, 1990, METABOLLIC MOL BASIS
   CHRISTOFFERSEN J, 1980, J CRYST GROWTH, V49, P29, DOI 10.1016/0022-0248(80)90057-3
   CHRISTOFFERSEN J, 1995, 12 EUR C BIOM PORT P
   CHRISTOFFERSEN MR, 1990, J CRYST GROWTH, V106, P349, DOI 10.1016/0022-0248(90)90079-Z
   Dorozhkin S. V., 1994, Russian Journal of Inorganic Chemistry, V39, P217
   DRIESSENS FCM, 1988, BIOCERAMICS CALCIUM, P1
   DUFF EJ, 1971, J CHEM SOC A, P33, DOI 10.1039/j19710000033
   ISHIKAWA K, 1994, J DENT RES, V73, P1462, DOI 10.1177/00220345940730081101
   KANDORI K, 1995, CHEM MATER, V7, P26, DOI 10.1021/cm00049a007
   LARSON AC, 1990, GSAS GEN CRYSTAL STR
   LEGEROS RZ, 1988, J FLUORINE CHEM, V41, P53, DOI 10.1016/S0022-1139(00)83016-X
   MEYER JL, 1972, J DENT RES, V51, P1443, DOI 10.1177/00220345720510053201
   MORENO EC, 1981, J CRYST GROWTH, V53, P20, DOI 10.1016/0022-0248(81)90052-X
   MORENO EC, 1974, NATURE, V247, P64, DOI 10.1038/247064a0
   NANCOLLAS GH, 1979, ACS SYM SER, V93, P475
   PANTUMVANIT P, 1977, CARIES RES, V11, P52
   TENHUISEN KS, 1994, J DENT RES, V73, P598, DOI 10.1177/00220345940730030501
   VANDENHOEK WGM, 1980, J PHYS CHEM-US, V84, P3312, DOI 10.1021/j100461a035
NR 22
TC 103
Z9 110
U1 1
U2 22
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 1997
VL 8
IS 4
BP 185
EP 191
DI 10.1023/A:1018531505484
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA WU945
UT WOS:A1997WU94500002
PM 15348758
DA 2018-10-20
ER

PT J
AU Baselt, DR
   Lee, GU
   Hansen, KM
   Chrisey, LA
   Colton, RJ
AF Baselt, DR
   Lee, GU
   Hansen, KM
   Chrisey, LA
   Colton, RJ
TI A high-sensitivity micromachined biosensor
SO PROCEEDINGS OF THE IEEE
LA English
DT Article
DE biomedical transducers; magnetic forces; magnetic materials, devices;
   magnetic transducers; microelectromechanical devices; piezoresistive
   materials, devices
ID ATOMIC-FORCE MICROSCOPE; DNA
AB The Force Amplified Biological Sensor (FABS) is a desktop or portable instrument currently under development at the Naval Research Laboratory. FABS will use a rapid automated immunoassay to detect analytes such as proteins, viruses, and bacteria. The assay uses forces produced by micron-sized magnetic particles to pull on antibody-antigen bonds. Microfabricated piezoresistive cantilevers measure the resulting piconewton-level forces with sufficient sensitivity to detect single antibody-antigen bonds. These forces also serve to characterize the bonds, allowing FABs to distinguish specific antibody-antigen bonds from nonspecific interactions.
C1 GEOCENTERS INC, FT WASHINGTON, MD 20375 USA.
RP Baselt, DR (reprint author), USN, RES LAB, WASHINGTON, DC 20375 USA.
RI Lee, Gil/P-8696-2016
OI Lee, Gil/0000-0002-7949-5848
CR ALBRECHT TR, 1990, J VAC SCI TECHNOL A, V8, P3386, DOI 10.1116/1.576520
   Baselt DR, 1996, J VAC SCI TECHNOL B, V14, P789, DOI 10.1116/1.588714
   BHATIA SK, 1989, ANAL BIOCHEM, V178, P408, DOI 10.1016/0003-2697(89)90662-3
   BHATIA SK, 1992, J AM CHEM SOC, V114, P4432, DOI 10.1021/ja00037a077
   BHATIA SK, 1993, ANAL BIOCHEM, V208, P197, DOI 10.1006/abio.1993.1027
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BOLAND T, 1995, P NATL ACAD SCI USA, V92, P5297, DOI 10.1073/pnas.92.12.5297
   CALVERT JM, 1995, THIN FILMS ORGANIC T, V20, P109
   Chilkoti A, 1995, BIOPHYS J, V69, P2125, DOI 10.1016/S0006-3495(95)80083-4
   CHRISEY LA, IN PRESS NUCL ACIDS
   CHRISEY LA, 1994, MATER RES SOC S P, V300, P179
   Chui BW, 1996, APPL PHYS LETT, V69, P2767, DOI 10.1063/1.117669
   CUSSLER EL, 1994, MASS TRANSFER FLUID, P230
   DAMMER U, 1995, SCIENCE, V267, P1173, DOI 10.1126/science.7855599
   Dammer U, 1995, NATO ADV SCI INST SE, V286, P625
   Dammer U, 1996, BIOPHYS J, V70, P2437, DOI 10.1016/S0006-3495(96)79814-4
   DULCEY CS, 1991, SCIENCE, V252, P551, DOI 10.1126/science.2020853
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C
   GIMZEWSKI JK, 1994, CHEM PHYS LETT, V217, P589, DOI 10.1016/0009-2614(93)E1419-H
   Harley John, COMMUNICATION
   Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477
   HOH JH, 1992, J AM CHEM SOC, V114, P4917, DOI 10.1021/ja00038a075
   KRICKA LJ, 1994, CLIN CHEM, V40, P347
   LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003
   LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628
   LEE GU, IN PRESS ISRAELI J C
   MANNING B, 1996, BIOSENS BIOELECTRON, V7, P391
   MEYER G, 1988, APPL PHYS LETT, V53, P1045, DOI 10.1063/1.100061
   Morgan CL, 1996, CLIN CHEM, V42, P193
   MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660
   NATISHAN PM, 1992, SURF COAT TECH, V51, P30, DOI 10.1016/0257-8972(92)90210-2
   OShea SJ, 1996, J VAC SCI TECHNOL B, V14, P1383, DOI 10.1116/1.589103
   RICHTER HJ, 1988, REV SCI INSTRUM, V59, P1388, DOI 10.1063/1.1139674
   SAKAGUCHI Y, 1994, MAT SCI ENG A-STRUCT, V181, P1232, DOI 10.1016/0921-5093(94)90837-0
   STENBERG M, 1988, J IMMUNOL METHODS, V113, P5
   STUART JK, 1995, LANGMUIR, V11, P1368, DOI 10.1021/la00004a051
   Sugawara Y, 1996, J VAC SCI TECHNOL B, V14, P953, DOI 10.1116/1.589182
   THUNDAT T, 1995, ANAL CHEM, V67, P519, DOI 10.1021/ac00099a006
   TORTONESE M, 1993, APPL PHYS LETT, V62, P834, DOI 10.1063/1.108593
NR 40
TC 102
Z9 102
U1 0
U2 17
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0018-9219
J9 P IEEE
JI Proc. IEEE
PD APR
PY 1997
VL 85
IS 4
BP 672
EP 680
DI 10.1109/5.573755
PG 9
WC Engineering, Electrical & Electronic
SC Engineering
GA WX055
UT WOS:A1997WX05500014
DA 2018-10-20
ER

PT J
AU Meydan, T
   Oduncu, H
AF Meydan, T
   Oduncu, H
TI Enhancement of magnetostrictive properties of amorphous ribbons for a
   biomedical application
SO SENSORS AND ACTUATORS A-PHYSICAL
LA English
DT Article; Proceedings Paper
CT 1st European Magnetic Sensors and Actuators Conference
CY JUL 22-24, 1996
CL AL I CUZA UNIV, IASI, ROMANIA
SP Inst Tech Phys
HO AL I CUZA UNIV
DE inverse magnetostriction; amorphous ribbon; bone fracture healing;
   biomedical sensor; prestressing
ID FRACTURE
AB A novel method of monitoring bone fracture healing has been developed. The sensor is based on the stress dependence of permeability of the highly magnetostrictive amorphous ribbons. The magnetoelastic sensor is bonded to a stainless steel plate. The detection is provided by an outside coil surrounding the limb. Stresses introduced by the adhesives degrade the sensor's performance. These are overcome by prestressing and annealing the material bonded with ii high temperature adhesive. Using these techniques, it is possible to design a tensile stress or compressive stress sensor to be used in strain measurement of the plates. Such a sensor has considerably higher sensitivity, lower power consumption and is less invasive than a traditional strain gauge, The characteristics of these enhanced sensors are studied and optimum conditions on sensors' performance are reported. (C) 1997 Elsevier Science S.A.
RP Meydan, T (reprint author), UNIV WALES COLL CARDIFF,CARDIFF SCH ENGN,WOLFSON CTR MAGNET TECHNOL,POB 917,CARDIFF CF2 1XH,S GLAM,WALES.
OI Meydan, Turgut/0000-0002-4608-0507
CR BOURGOIS R, 1972, J BIOMECH, V5, P85, DOI 10.1016/0021-9290(72)90021-8
   BURNY F, 1984, ORTHOPEDICS, V7, P1823, DOI 10.3928/0147-7447-19841201-08
   HINZ G, 1989, MAGNETIC SENSORS, V5, P98
   MEYDAN T, 1994, J MAGN MAGN MATER, V133, P525, DOI 10.1016/0304-8853(94)90613-0
   Oduncu H, 1996, J MAGN MAGN MATER, V160, P233, DOI 10.1016/0304-8853(96)00214-4
   SAVAGE HT, 1982, J APPL PHYS, V53, P8092, DOI 10.1063/1.330269
   VANSCHUYLENBERG.K, 1992, P 14 ANN INT C IEEE, P2672
   WUNFOGLE M, 1989, J MAT ENG, V11, P1023
NR 8
TC 8
Z9 8
U1 0
U2 2
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-4247
J9 SENSOR ACTUAT A-PHYS
JI Sens. Actuator A-Phys.
PD APR
PY 1997
VL 59
IS 1-3
BP 192
EP 196
DI 10.1016/S0924-4247(97)80172-0
PG 5
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA XN008
UT WOS:A1997XN00800036
DA 2018-10-20
ER

PT J
AU Lebrun, JP
   Corre, Y
   Douet, M
AF Lebrun, JP
   Corre, Y
   Douet, M
TI Cold plasma for surface treatment of titanium alloys
SO VIDE-SCIENCE TECHNIQUE ET APPLICATIONS
LA English
DT Article
ID WEAR
AB Because of their poor tribological properties, titanium alloys have a restricted field of applications.
   Modifying their surface properties is thus a real concern. The introduction of nitrogen on the surface improves significantly the tribological behaviour of these materials.
   Nitrogen ion implantation is a technique largely used in titanium alloy surface treatment. Industrial applications of this process are numerous (biomedical, aeronautics,...) but the limitations of this technique (essentially treatment depth) prevent its use in certain cases. The increase in treatment temperature can overcome these limitations. Thus, the analysis of the properties obtained after treatment at various temperatures (20 degrees C to 1000 degrees C) enables us to find the best compromise between metallurgic, geometrical properties (surface condition, deformation) and friction properties. This compromise enables us to solve a majority of tribological problems of titanium alloys.
   TITANIUM AND ITS ALLOYS are materials which are more and more frequently used in mechanical applications. Their low density combined with their very advantageous mechanical characteristics (such as resistance to fatigue), make them the first choice of material in many areas (aeronautics, automobile precision mechanics, biomedical applications, for example), especially in chlorinated environments. However, their mediocre tribological properties often lead to their rejection as friction surfaces.
   Treating the surface of these materials with nitrogen can give them excellent tribological properties.
   It is necessary, though, to choose the most suitable surface treatment in accordance with the stresses and frictional pairs encountered, in order to avoid deterioration of the mass properties of the pieces.
   We present here an industrial technique for adding nitrogen to the surface of titanium alloys, ion implantation together with a development of this process towards a surface heat treatment effect.
C1 NITRUVID, F-42490 FRAISSE, FRANCE.
   ECOLE MINES, F-42100 ST ETIENNE, FRANCE.
RP Lebrun, JP (reprint author), NITRUVID, F-95100 ARGENTEUIL, FRANCE.
CR AURELLE JL, 1992, AMELIORATION MATRIAU
   FLECHE D, 1985, EUROTRIB 85
   HUTCHINGS R, 1983, WEAR, V92, P143, DOI 10.1016/0043-1648(83)90014-5
   MARTINELLA R, 1984, MATER RES SOC S P, V27, P711
   PICHAT A, 1990, 44TD EC MIN SAINT ET
   RABBE LM, 1993, 99TD EC MIN SAINT ET
   SIOSHANSI P, 1985, J VAC SCI TECHNOL A, V3, P2670, DOI 10.1116/1.572811
NR 7
TC 0
Z9 0
U1 0
U2 1
PU SOC FRANCAISE DU VID
PI PARIS
PA 19 RUE DU RENARD, 75004 PARIS, FRANCE
SN 1266-0167
J9 VIDE
JI Vide-Sci. Techn. Appl.
PD APR-JUN
PY 1997
VL 53
IS 284
BP 219
EP +
PG 1
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA XB068
UT WOS:A1997XB06800003
DA 2018-10-20
ER

PT J
AU Tangpasuthadol, V
   Shefer, A
   Yu, C
   Zhou, J
   Kohn, J
AF Tangpasuthadol, V
   Shefer, A
   Yu, C
   Zhou, J
   Kohn, J
TI Thermal properties and enthalpy relaxation of tyrosine-derived
   polyarylates
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE physical aging; enthalpy relaxation; glass transition temperature;
   differential scanning calorimetry; tyrosine; biomaterial; biopolymer;
   structure-property correlation
ID GLASS-TRANSITION TEMPERATURE; POLYVINYL METHYL-ETHER); AGING
   TEMPERATURE; DESIGN
AB Sixteen degradable, tyrosine-derived polyarylates with well-defined chemical structures were used to study the effect of polymer structure on the glass transition temperature and enthalpy relaxation kinetics (physical aging). These polyarylates compose a model system where the number of methylene groups present in either the pendent chain or the polymer backbone can be altered independently and in a systematic fashion. Quantitative differential scanning calorimetry was employed to measure the glass transition temperature and the enthalpy relaxation kinetics. Correlations between these material properties and the polymer structure were established. The glass transition temperature of this family of polymers ranged from 13 to 78 degrees C. The addition of methylene groups to either the pendent chain or the polymer backbone made a fairly constant contribution to lowering the glass transition temperature. The rate of enthalpy relaxation increased with an increasing number of methylene groups in the polymer backbone, but was independent of the number of methylene groups in the pendent chain. This observation indicated that the rate of enthalpy relaxation in these polymers was limited by the mobility of the polymer backbone. The enthalpy relaxation data was fitted to the Cowie-Ferguson model and the relaxation times obtained ranged from 44 min to about 100 min. Although these structure-property correlations facilitate the design of new materials with predictable thermal properties, they are rarely investigated for biomedical polymers. (C) 1997 John Wiley & Sons, Inc.
C1 RUTGERS STATE UNIV,DEPT CHEM,NEW BRUNSWICK,NJ 08903.
RI Tangpasuthadol, Varawut/F-9260-2010
CR BAUWENSCROWET C, 1986, POLYMER, V27, P709, DOI 10.1016/0032-3861(86)90128-X
   BROCCHINI S, 1996, POLYM MAT ENCY
   BRON S, 1993, POLYM MAT SCI ENG, V69, P37
   CAI H, 1995, POLYM PREPR, V36, P422
   CELLI A, 1992, POLYMER, V33, P2699, DOI 10.1016/0032-3861(92)90440-8
   CHENG SZD, 1991, POLYMER, V32, P2053, DOI 10.1016/0032-3861(91)90172-F
   CLARSON SJ, 1985, POLYMER, V26, P930, DOI 10.1016/0032-3861(85)90140-5
   COWIE JMG, 1986, POLYM COMMUN, V27, P258
   COWIE JMG, 1989, MACROMOLECULES, V22, P2312, DOI 10.1021/ma00195a054
   COWIE JMG, 1989, MACROMOLECULES, V22, P2307, DOI 10.1021/ma00195a053
   DIX LR, 1993, TRENDS POLYM SCI, V1, P25
   FIORDELISO J, 1994, J BIOMAT SCI-POLYM E, V5, P497
   FIORDELISO J, 1993, THESIS RUTGERS U
   JAMES K, 1996, CONTROLLED DRUG DELI
   KOHN J, 1994, 20 ANN M SOC BIOM BO, P67
   KOHN J, 1993, TRENDS POLYM SCI, V1, P206
   KOHN JB, 1993, Patent No. 5216115
   MONTSERRAT S, 1994, J POLYM SCI POL PHYS, V32, P509, DOI 10.1002/polb.1994.090320312
   PETHRICK RA, 1993, TRENDS POLYM SCI, V1, P226
   SCHERER GW, 1986, RELAXATION GLASS COM, P51
   SHEFER A, 1992, MACROMOLECULES, V25, P4036, DOI 10.1021/ma00041a028
   STRUIK LCE, 1978, PHYSICAL AGING AMORP
   TANGPASUTHADOL V, 1996, BIOMATERIALS, V17, P465
   YOSHIDA H, 1982, J MACROMOL SCI PHYS, VB21, P565, DOI 10.1080/00222348208215191
   ZHOU J, 1994, 20 ANN M SOC BIOM BO, P371
NR 25
TC 11
Z9 11
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAR 14
PY 1997
VL 63
IS 11
BP 1441
EP 1448
PG 8
WC Polymer Science
SC Polymer Science
GA WH586
UT WOS:A1997WH58600007
DA 2018-10-20
ER

PT J
AU Peluso, G
   Petillo, O
   Anderson, JM
   Ambrosio, L
   Nicolais, L
   Melone, MAB
   Eschbach, FO
   Huang, SJ
AF Peluso, G
   Petillo, O
   Anderson, JM
   Ambrosio, L
   Nicolais, L
   Melone, MAB
   Eschbach, FO
   Huang, SJ
TI The differential effects of poly(2-hydroxyethyl methacrylate) and
   poly(2-hydroxyethyl methacrylate)/poly(caprolactone) polymers on cell
   proliferation and collagen synthesis by human lung fibroblasts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID ANCHORAGE-DEPENDENT FIBROBLASTS; EXTRACELLULAR-MATRIX; MESSENGER-RNA;
   GROWTH; SHAPE; SURFACE; ANGIOGENESIS; INITIATION; INVITRO; BETA
AB Because of its chemical versatility and demonstrated biocompatibility, poly(2-hydroxyethyl methacrylate) (pHEMA) has been widely used as a polymer for biomedical applications. Since this hydrophilic material shows a poor interface with cells, blendings with other polymers were done to improve cytocompatibility. In our polymer, the presence of hydrophobic dominions on the material surface, due to the interpenetrating polymerization of pHEMA with poly(caprolactone) (PCL), seems to ameliorate the cytocompatibility in terms of cell adhesion and metabolism. For our experiments, we used IMR-90 human fibroblasts, as these cells strongly regulate DNA, RNA, and protein synthesis as anchorage-dependent variables. Cell attachment on a pHEMA/PCL interpenetrating polymer network was optimal, suggesting a strong adhesion between the cells and the polymer surface. Cell adhesion was weaker on pHEMA, as a significant fraction of the fibroblasts revealed a lack of spreading, with most cells remaining spherical. Moreover, only fibroblasts seeded on pHEMA significantly decreased mRNA synthesis; collagen production and cell shapes ranged from fully flat and proliferating, to minimally spread and nonproliferating. Finally, DNA synthesis, as a measure of cell proliferation, was markedly inhibited in cells cultured on pHEMA but not on pHEMA/PCL. Ln conclusion, our results suggest that control of cell growth and metabolism by biomedical polymers is based on physicochemical mechanism(s) in which the hydrophilicity/hydrophobicity ratio of the material surfaces may play an important role. (C) 1997 John Wiley & Sons, Inc.
C1 CASE WESTERN RESERVE UNIV, INST PATHOL, CLEVELAND, OH 44106 USA.
   UNIV NAPLES 2, DIV NEUROL 2, NAPLES, ITALY.
   UNIV NAPLES, DEPT MAT & PROD ENGN, I-80125 NAPLES, ITALY.
   CNR, INST COMPOSITE MAT TECHNOL, I-80125 NAPLES, ITALY.
   UNIV CONNECTICUT, INST MAT SCI, STORRS, CT 06269 USA.
RP Peluso, G (reprint author), INST PROT BIOCHEM & ENZYMOL, VIA TOIANO 6, I-80072 ARCO, NAPLES, ITALY.
RI TERRACCIANO, CHIARA/C-2955-2018; Melone, Mariarosa/N-6788-2015
OI TERRACCIANO, CHIARA/0000-0002-1853-5578; Melone,
   Mariarosa/0000-0002-7213-9277; AMBROSIO, LUIGI/0000-0002-8367-2405
CR BENECKE BJ, 1978, CELL, V14, P931, DOI 10.1016/0092-8674(78)90347-1
   BENECKE BJ, 1980, J CELL PHYSIOL, V103, P247, DOI 10.1002/jcp.1041030209
   BENZEEV A, 1980, CELL, V21, P365, DOI 10.1016/0092-8674(80)90473-0
   BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CHU ML, 1985, J BIOL CHEM, V260, P2315
   DEPHILIP RM, 1980, BIOCHEMISTRY-US, V19, P1662, DOI 10.1021/bi00549a022
   ESCHBACH FO, 1994, ADV CHEM SER, V239, P205
   FARMER SR, 1978, CELL, V15, P627, DOI 10.1016/0092-8674(78)90031-4
   FARRELL RE, 1992, J CELL PHYSIOL, V153, P429, DOI 10.1002/jcp.1041530223
   FINE A, 1987, J BIOL CHEM, V262, P3897
   FOLKMAN J, 1982, ANN NY ACAD SCI, V401, P212, DOI 10.1111/j.1749-6632.1982.tb25720.x
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   GALL WE, 1981, SCIENCE, V213, P903, DOI 10.1126/science.7196087
   GOSPODAROWICZ D, 1978, CANCER RES, V38, P4155
   HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0
   INGBER DE, 1987, IN VITRO CELL DEV B, V23, P387
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   LASMAN JB, 1987, NATURE, V325, P811
   MANIATIS T, 1982, MOL CLONING LABORATO, P196
   NICOLINI C, 1986, CELL BIOPHYS, V8, P103, DOI 10.1007/BF02788475
   SACHS F, 1989, CELL SHAPE DETERMINA
   SALTZMAN WM, 1991, J BIOMED MATER RES, V25, P741, DOI 10.1002/jbm.820250605
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   TOKUNAGA K, 1986, NUCLEIC ACIDS RES, V14, P2829
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 26
TC 35
Z9 36
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 1997
VL 34
IS 3
BP 327
EP 336
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA WL071
UT WOS:A1997WL07100007
PM 9086402
DA 2018-10-20
ER

PT J
AU Li, SH
   Liu, Q
   deWijn, JR
   Zhou, BL
   deGroot, K
AF Li, SH
   Liu, Q
   deWijn, JR
   Zhou, BL
   deGroot, K
TI In vitro calcium phosphate formation on a natural composite material,
   bamboo
SO BIOMATERIALS
LA English
DT Article
DE bamboo; grafts; calcium phosphate
ID CORROSION FILMS
AB A natural self-reinforced composite material, bamboo, is studied for the first time as a biomedical material. Its anatomical structure was investigated and its mechanical properties were measured and compared with those of some common bone-bonding or bone-repairing biomaterials. It is found that, among all kinds of biomaterials, bamboo has the closest modulus of elasticity to human long bone. The cytotoxicity of bamboo was tested using the agar overlay method before and after heat or chemical treatments. The results reveal that ethanol, methanol and toluene can remove toxic leachable components from bamboo to some extent through extraction. After grafting a polymer whose molecule includes poly(ethylene glycol), alpha,omega-di(aminopropyl)poly(ethylene glycol) 800 on bamboo, bamboo has the ability to form a calcium phosphate coating after being immersed in calcification solution (simulated body fluid and accelerated calcification solution). The characteristics and the morphology of the mineral formed on bamboo were studied by infrared spectroscopy and scanning electron microscopy. (C) 1997 Elsevier Science Limited. All rights reserved.
C1 ACAD SINICA,INST MET RES,SHENYANG 110015,PEOPLES R CHINA.
RP Li, SH (reprint author), LEIDEN UNIV,BIOMAT RES GRP,PROF BRONKHORSTLAAN 10,NL-3723 MB BILTHOVEN,NETHERLANDS.
CR AOKI H, 1991, SCI MED APPL HYDROXY, P104
   BEDNAR H, 1982, BIOMATERIALS 1980, P97
   CHARNOT Y, 1978, P269
   CLARK AE, 1976, J AM CERAM SOC, V59, P37, DOI 10.1111/j.1151-2916.1976.tb09382.x
   FENGEL D, 1984, WOOD SCI TECHNOL, V18, P103
   FRENSDORFF HK, 1971, J AM CHEM SOC, V93, P4684, DOI 10.1021/ja00748a006
   GRENOBLE DE, 1972, J BIOMED MATER RES, V6, P221, DOI 10.1002/jbm.820060311
   HAMON RF, 1982, TALANTA, V29, P313, DOI 10.1016/0039-9140(82)80118-5
   Hench L., 1992, BONE GRAFTS BONE SUB, P263
   HENCH LL, 1991, BONE-BIOMATERIAL INTERFACE, P33
   HOSSAINY SFA, 1994, BIOMATERIALS, V15, P921, DOI 10.1016/0142-9612(94)90118-X
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   KOKUBO T, 1992, BONE BONDING BIOMATE, P31
   LEGEROS RZ, 1991, BONE-BIOMATERIAL INTERFACE, P76
   Li SH, 1995, MAT SCI ENG C-BIOMIM, V3, P125, DOI 10.1016/0928-4931(95)00115-8
   Li Shihong, 1994, Biomimetics, V2, P15
   LIU Q, 1996, 5 WORLD BIOM C TOR C
   PANTANO CG, 1974, J AM CERAM SOC, V57, P412, DOI 10.1111/j.1151-2916.1974.tb11429.x
   PARK JB, 1992, BIOMATERIALS INTRO, P197
   RADDER AM, 1995, CELL MATER, V5, P55
   TORRISI L, 1993, THIN SOLID FILMS, V227, P32, DOI 10.1016/0040-6090(93)90183-P
   VANBLITTERSWIJK CA, 1992, BONE BONDING BIOMATE, P31
   VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326
NR 23
TC 33
Z9 34
U1 2
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 1997
VL 18
IS 5
BP 389
EP 395
DI 10.1016/S0142-9612(96)00122-6
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA WK062
UT WOS:A1997WK06200003
PM 9061179
DA 2018-10-20
ER

PT J
AU Green, RJ
   Davies, J
   Davies, MC
   Roberts, CJ
   Tendler, SJB
AF Green, RJ
   Davies, J
   Davies, MC
   Roberts, CJ
   Tendler, SJB
TI Surface plasmon resonance for real time in situ analysis of protein
   adsorption to polymer surfaces
SO BIOMATERIALS
LA English
DT Article
DE surface plasmon resonance; AFM; protein adsorption; polystyrene
ID SCANNING-TUNNELING-MICROSCOPY; ATOMIC-FORCE MICROSCOPY; HUMAN
   SERUM-ALBUMIN; MICROTITER WELLS; KINETIC-ANALYSIS; FIBRINOGEN;
   MICROSPHERES; MORPHOLOGY; BIOSENSOR; BLOOD
AB The adsorption of a range of plasma proteins to metal and polymer surfaces has been examined using surface plasmon resonance (SPR). The adsorption of proteins was initially studied on the SPR silver sensor surface, and then on a model polystyrene film spun coated directly onto this substrate. In both cases, reproducible adsorption profiles for albumin were attained which compared well with corresponding atomic force microscopy (AFM) and ellipsometry data on protein monolayer packing and thickness respectively. The SPR data revealed the influence of concentration on both protein adsorption kinetics and the time for formation of a monolayer coating. SPR data also highlighted different adsorption kinetics and final monolayer SPR angle shift values for three plasma proteins which have been interpreted in terms of their molecular dimensions and orientation at the polymer interface. AFM data confirmed the presence of a closely packed protein layer for all three protein systems. These studies are discussed in terms of employing SPR in the study of protein interactions at surfaces which are important in the design and evaluation of novel biomedical polymeric materials. (C) 1997 Elsevier Science Limited. All rights reserved.
C1 UNIV NOTTINGHAM,DEPT PHARMACEUT SCI,LAB BIOPHYS & SURFACE ANAL,NOTTINGHAM NG7 2RD,ENGLAND.
   JOHNSON & JOHNSON CLIN DIAG LTD,POLLARDS WOOD LABS,CHALFONT ST GILES HP8 4SP,BUCKS,ENGLAND.
RI Roberts, Clive/C-6970-2009
OI Roberts, Clive/0000-0001-9443-3445; Green, Rebecca/0000-0001-6783-549X;
   Davies, Martyn/0000-0001-7695-0596
CR ANDRADE JD, 1985, PRINCIPLES PROTEIN A, V2, pCH1
   BONDESON K, 1993, ANAL BIOCHEM, V214, P245, DOI 10.1006/abio.1993.1484
   BRASH JL, 1977, ANN NY ACAD SCI, V283, P356, DOI 10.1111/j.1749-6632.1977.tb41781.x
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P367, DOI 10.1002/jbm.820270310
   Chen XY, 1996, ANAL CHEM, V68, P1451, DOI 10.1021/ac950844e
   CHENG YL, 1987, J COLLOID INTERF SCI, V118, P212, DOI 10.1016/0021-9797(87)90450-4
   DAVIES J, 1994, LANGMUIR, V10, P2654, DOI 10.1021/la00020a026
   DAVIES J, 1994, J IMMUNOL METHODS, V167, P263, DOI 10.1016/0022-1759(94)90095-7
   DAVIES J, 1994, NANOBIOLOGY, V3, P5
   DAVIES J, 1994, P INT C SURF PROP BI, P117
   DAVIS SS, 1995, DRUGS EXPT CLIN RES, V11, P633
   DEBRUIJN HE, 1992, APPL OPTICS, V31, P440
   DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211
   GREEN NM, 1969, ADV IMMUNOL, P1
   GREEN RJ, 1995, 42 NAT S AM VAC SOC, P278
   HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0
   IKADA Y, 1994, ACS SYM SER, V540, P35
   KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9
   KOOYMAN RPH, 1990, J MOL STRUCT, V218, P345, DOI 10.1016/0022-2860(90)80291-Q
   LAWRENCE CR, 1992, THIN SOLID FILMS, V208, P269, DOI 10.1016/0040-6090(92)90655-U
   LEATHERBARROW RJ, 1991, J MOL BIOL, V221, P361, DOI 10.1016/0022-2836(91)80056-Z
   LIEDBERG B, 1993, SENSOR ACTUAT B-CHEM, V11, P63, DOI 10.1016/0925-4005(93)85239-7
   LIEDBERG B, 1983, SENSOR ACTUATOR, V4, P299, DOI 10.1016/0250-6874(83)85036-7
   LOK BK, 1983, J COLLOID INTERF SCI, V91, P104, DOI 10.1016/0021-9797(83)90317-X
   LYMAN DJ, 1975, T AM SOC ART INT ORG, V21, P49
   MARQUART M, 1980, J MOL BIOL, V141, P369, DOI 10.1016/0022-2836(80)90252-1
   NORMAN ME, 1992, BIOMATERIALS, V13, P841, DOI 10.1016/0142-9612(92)90177-P
   NORMAN ME, 1993, BIOMATERIALS, V14, P193, DOI 10.1016/0142-9612(93)90023-U
   OSTERBERG E, 1993, COLLOID SURFACE A, V77, P159, DOI 10.1016/0927-7757(93)80112-R
   POOT AA, 1991, MODERN ASPECTS OF PROTEIN ADSORPTION ON BIOMATERIALS, P29
   ROBERTS CJ, 1995, LANGMUIR, V11, P1822, DOI 10.1021/la00005a063
   ROBERTS CJ, 1996, IN PRESS ULTRAMICROS
   SHAKESHEFF KM, 1995, LANGMUIR, V11, P3921, DOI 10.1021/la00010a049
   SHAKESHEFF KM, 1995, MACROMOLECULES, V28, P1108, DOI 10.1021/ma00108a044
   SILIN VI, 1993, OPT COMMUN, V97, P19, DOI 10.1016/0030-4018(93)90610-H
   VROMAN L, 1980, BLOOD, V55, P156
   WIGREN R, 1991, FEBS LETT, V280, P225, DOI 10.1016/0014-5793(91)80298-H
   WILLIAMS M, 1992, INT J NUMER METH FL, V14, P1, DOI 10.1002/fld.1650140102
   Williams PM, 1996, J VAC SCI TECHNOL B, V14, P1557, DOI 10.1116/1.589138
NR 39
TC 178
Z9 182
U1 2
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 1997
VL 18
IS 5
BP 405
EP 413
DI 10.1016/S0142-9612(96)00141-X
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA WK062
UT WOS:A1997WK06200005
PM 9061181
DA 2018-10-20
ER

PT J
AU Bayne, SC
   Swift, EJ
   Thompson, JY
AF Bayne, SC
   Swift, EJ
   Thompson, JY
TI Dental materials citations .B. July to December 1996
SO DENTAL MATERIALS
LA English
DT Article
ID RESTORATIVE-DENTISTRY; AMERICAN-ACADEMY; COMMITTEE
AB Objective. A search was conducted in biomedical journals from July 1996 to December 1996 to identify dental materials publications and sort them into major categories. They were compared by frequency in different journals and in different categories during recent years.
   Methods. Tables of contents for 16 primary and 51 secondary journals were inspected from July to December of 1996 and were divided into 17 categories. The frequencies of citations for primary journals and for different citation categories were examined over a four-year period from 1993 to 1996.
   Results. There were 334 total citations from July to December 1996. The greatest number of citations continued to involve bonding (n = 159) and resin-based (composites; glass ionomers) restorative materials (n = 158). The numbers of articles by journal and by category were very similar over the last four years. The average number of articles per year was 531 +/- 15.
   Significance. The literature citations compiled in this list provide a supplement for researchers and academicians to the current electronic databases.
RP Bayne, SC (reprint author), UNIV N CAROLINA,SCH DENT,DEPT OPERAT DENT,CHAPEL HILL,NC 27599, USA.
CR Allen EP, 1996, J PROSTHET DENT, V76, P56, DOI 10.1016/S0022-3913(96)90347-9
   BAYNE SC, 1995, DENT MATER, V11, P281, DOI 10.1016/0109-5641(95)80064-6
   BAYNE SC, 1994, DENT MATER, V10, P59, DOI 10.1016/0109-5641(94)90023-X
   JENDRESEN MD, 1993, J PROSTHET DENT, V70, P44, DOI 10.1016/0022-3913(93)90036-N
   JENDRESEN MD, 1995, J PROSTHET DENT, V74, P60, DOI 10.1016/S0022-3913(05)80231-8
   JENDRESEN MD, 1994, J PROSTHET DENT, V72, P39, DOI 10.1016/0022-3913(94)90214-3
   LLOYD CH, 1995, J DENT, V23, P67, DOI 10.1016/0300-5712(95)98973-7
   Swift EJ, 1996, DENT MATER, V12, P127
   SWIFT EJ, 1995, DENT MATER, V11, P52, DOI 10.1016/0109-5641(95)80009-3
   Thompson JY, 1996, DENT MATER, V12, P272, DOI 10.1016/S0109-5641(96)80034-0
   VANNOORT R, 1993, J DENT, V21, P5, DOI 10.1016/0300-5712(93)90046-S
   VANNOORT R, 1994, J DENT, V22, P5, DOI 10.1016/0300-5712(94)90139-2
NR 12
TC 2
Z9 2
U1 0
U2 1
PU ACAD DENTAL MATERIALS
PI DALLAS
PA BAYLOR COLLEGE DENTISTRY, 3302 GASTON AVE, DALLAS, TX 75266-0677
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD MAR
PY 1997
VL 13
IS 2
BP 128
EP 142
DI 10.1016/S0109-5641(97)80022-X
PG 15
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA XM605
UT WOS:A1997XM60500008
PM 9467315
DA 2018-10-20
ER

PT J
AU Rutherford, KL
   Hutchings, IM
AF Rutherford, KL
   Hutchings, IM
TI Theory and application of a micro-scale abrasive wear test
SO JOURNAL OF TESTING AND EVALUATION
LA English
DT Article; Proceedings Paper
CT Symposium on Needs and Applications in Precision Measurement and
   Monitoring of Wear
CY MAY   22, 1996
CL ORLANDO, FL
SP ASTM, Comm G2
DE abrasion; wear test; coatings; surface engineering
ID METALLIC GLASSES; RESISTANCE; COATINGS; WIRES
AB A micro-scale abrasion test has recently been developed that allows measurement of the wear resistance of the surface regions of a material. The typical penetration depth is less than 30 mu m The test uses a simple mechanical and optical system and involves rotating a hard steel sphere against a specimen in the presence of small abrasive particles. The method has been used to investigate the wear resistance of thin PVD coatings (1 to 5 mu m), metallic glass ribbons, and paint films in addition to bulk samples of metals, ceramics, and glasses. The associated theory has been extended so that results may be obtained from any curved surface. This furthers its applicability to practical surface-engineered components such as twist drills, bearings, turbine blades, and biomedical prostheses. A detailed characterization of the experimental procedure has been undertaken to provide an understanding of the repeatability and sensitivity of the test. In a study of cutting-tool coatings, the wear resistance measured by this method has been shown to correlate with scratch test response and with the performance of coated end-mills in cutting tests.
RP Rutherford, KL (reprint author), UNIV CAMBRIDGE,DEPT MAT SCI & MET,PEMBROKE ST,CAMBRIDGE CB2 3QZ,ENGLAND.
CR BRINELL JA, 1921, JERNKONTORETS ANN, V76, P347
   DONOVAN PE, 1983, PHILOS MAG A, V47, P537, DOI 10.1080/13642818308246456
   GAHLIN R, 1996, UNPUB SURFACE COATIN
   GREER AL, 1995, SCIENCE, V267, P1947, DOI 10.1126/science.267.5206.1947
   GRODZINSKI P, 1949, NATURE, V164, P193, DOI 10.1038/164193a0
   HAPP W, 1956, B AM PHYS SOC, V1, P382
   HAWORTH RD, 1949, T AM SOC METAL, V41, P819
   HEDENQVIST P, 1994, SURF COAT TECH, V63, P115, DOI 10.1016/S0257-8972(05)80015-5
   HUTCHINGS IM, 1995, ADV CERAMICS STRUCTU, P127
   KASSMAN A, 1991, SURF COAT TECH, V50, P75, DOI 10.1016/0257-8972(91)90196-4
   KIM YH, 1994, MATER T JIM, V35, P293, DOI 10.2320/matertrans1989.35.293
   LANCASTE.JK, 1969, WEAR, V14, P223, DOI 10.1016/0043-1648(69)90047-7
   MCDONALD B, 1962, J ELECTROCHEM SOC, V109, P141, DOI 10.1149/1.2425346
   MCNSHUTKIN BN, 1952, RUSSIAS LOMONOSOV
   Mott B. W, 1956, MICRO INDENTATION HA
   NOTHNAGEL G, 1993, SURF COAT TECH, V57, P151, DOI 10.1016/0257-8972(93)90032-J
   PENSAERT S, 1994, WEAR, V171, P99, DOI 10.1016/0043-1648(94)90352-2
   PENSAERT S, 1994, WEAR, V171, P109, DOI 10.1016/0043-1648(94)90353-0
   Rutherford KL, 1996, TRIBOL LETT, V2, P1
   Rutherford KL, 1996, SURF COAT TECH, V79, P231, DOI 10.1016/0257-8972(95)02461-1
   Rutherford KL, 1996, SURF COAT TECH, V86-7, P472, DOI 10.1016/S0257-8972(96)02956-8
   Rutherford KL, 1996, SURF COAT TECH, V80, P176, DOI 10.1016/0257-8972(95)02706-8
   SANTNER E, 1995, WEAR, V181, P350
   SCHOFF CK, 1995, STANDARDIZATION NEWS, P24
   SILVA SRP, 1995, SURF COAT TECH, V73, P132, DOI 10.1016/0257-8972(94)02377-8
   THOMPSON V, 1979, SURF TECHNOL, V8, P421, DOI 10.1016/0376-4583(79)90005-0
   TOLANSKY S, 1949, NATURE, V164, P194, DOI 10.1038/164194a0
   VALLI J, 1985, 435 TECHN RES CTR FI
   WILKS EM, 1952, PHILOS MAG, V43, P1140
   ZHONG ZC, IN PRESS PHILOS MA B
NR 30
TC 151
Z9 154
U1 3
U2 31
PU AMER SOC TESTING MATERIALS
PI W CONSHOHOCKEN
PA 100 BARR HARBOR DR, W CONSHOHOCKEN, PA 19428-2959
SN 0090-3973
J9 J TEST EVAL
JI J. Test. Eval.
PD MAR
PY 1997
VL 25
IS 2
BP 250
EP 260
PG 11
WC Materials Science, Characterization & Testing
SC Materials Science
GA WU021
UT WOS:A1997WU02100016
DA 2018-10-20
ER

EF